Name	Gene(s)	Condition(s)	Frequency	Clinical significance (Last reviewed)	Review status	Chromosome	Location	Assembly	VariationID	AlleleID(s)	
46;XY;t(18;20)(q21.1;p11;23)dn		Motor delay|Visual impairment|Long palpebral fissure|Secundum atrial septal defect|Mandibular prognathia|Broad forehead|Cyanosis|Defect in the atrial septum|Premature birth|Shawl scrotum|Short neck|Short nose|Epicanthus|Square face|Long philtrum|Sclerocornea|Pulmonary artery stenosis|Respiratory failure requiring assisted ventilation|Corneal opacity|Ectopia pupillae|Ebstein's anomaly of the tricuspid valve|Prominent forehead|Mild global developmental delay|Generalized opacification of the cornea|Chin with horizontal crease|Wide nasal base|Anterior synechiae of the anterior chamber		Uncertain significance(Last reviewed: Aug 20, 2016)	criteria provided, single submitter			GRCh38	268042	263418
46;XY;t(2;14)(p22;q24.3)dn		Hypertonia|Hemiparesis|Defect in the atrial septum|Patent ductus arteriosus|Transposition of the great arteries|Coarctation of aorta|Cerebral ischemia|Lower limb muscle weakness|Double inlet left ventricle|Hypoplastic aortic arch|Muscular hypotonia|Abnormality of cardiovascular system morphology		Likely pathogenic(Last reviewed: Aug 20, 2016)	criteria provided, single submitter			GRCh38	268037	263413
46;XY;inv(6)(p22q13)dn		Inguinal hernia|Hydronephrosis|Hirsutism|Large earlobe|Abnormal facial shape|Defect in the atrial septum|Short nose|Single transverse palmar crease|Synophrys|Thin vermilion border|Micropenis|Horseshoe kidney|Epicanthus|Entropion|Reduced tendon reflexes|Umbilical hernia|Abnormality of the nail|Patent ductus arteriosus|Mitral regurgitation|Aortic regurgitation|Capillary hemangiomas|2-3 toe cutaneous syndactyly|Muscular hypotonia		Pathogenic(Last reviewed: Aug 20, 2016)	criteria provided, single submitter			GRCh38	267941	263317
46;XX;inv(14)(q24.1q32.1)dn		Tricuspid regurgitation|Abnormal facial shape|Defect in the atrial septum|Arrhythmia|Strabismus|Mitral regurgitation|Dysautonomia|Abnormality of the periventricular white matter|Ectopic pancreatic tissue|Abnormality of skin physiology|Abnormal renal morphology|Vasovagal syncope|Type I diabetes mellitus		Uncertain significance(Last reviewed: Aug 20, 2016)	criteria provided, single submitter			GRCh38	267889	263265
46;XX;ins(5;6)(p13;p24p25)dn		Tapered finger|Tricuspid regurgitation|Abnormal facial shape|Overlapping toe|Ovarian cyst|Cleft palate|Pierre-Robin sequence|Pulmonic stenosis|Patent ductus arteriosus|Calcaneovalgus deformity|Abnormal muscle tone|Short metatarsal|Left-to-right shunt|Short palpebral fissure|Blue nevus		Pathogenic(Last reviewed: Aug 20, 2016)	criteria provided, single submitter			GRCh38	267851	263227
46;XY;t(1;5)(p35.3;q31.3)dn		Inguinal hernia|Bilateral cryptorchidism|Bicuspid aortic valve|Downslanted palpebral fissures|Short neck|Thin vermilion border|Wide intermamillary distance|Wide nose|Hypospadias|Epicanthus|Hypertelorism|Smooth philtrum|Low-set, posteriorly rotated ears|Thickened helices|Strabismus|Global developmental delay|Coarctation of aorta|Abnormal number of hair whorls		Pathogenic(Last reviewed: Aug 20, 2016)	criteria provided, single submitter			GRCh38	267817	263193
NM_003239.2:c.698A>T	TGFB3	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 15, 2015)	criteria provided, single submitter			GRCh38	263997	259215
NM_000090.3:c.4059T>G	COL3A1	Thoracic aortic aneurysm and aortic dissection		Benign(Last reviewed: Nov 19, 2014)	criteria provided, single submitter			GRCh38	263846	259214
NM_000138.4:c.1415G>A	FBN1	Thoracic aortic aneurysm and aortic dissection		Benign(Last reviewed: Aug 7, 2015)	criteria provided, single submitter			GRCh38	263845	259213
NM_004006.2:c.7096A>C	DMD	Cardiovascular phenotype		Benign(Last reviewed: Mar 27, 2015)	criteria provided, single submitter			GRCh38	263800	259212
NM_004612.2:c.76_78delCGC	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Benign(Last reviewed: Jun 4, 2013)	criteria provided, single submitter			GRCh38	263659	259211
NM_004612.2:c.76_78dupCG	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Benign(Last reviewed: Mar 25, 2013)	criteria provided, single submitter			GRCh38	263574	259210
NM_002474.2:c.5919+5C>G	MYH11	Thoracic aortic aneurysm and aortic dissection		Benign(Last reviewed: Dec 27, 2012)	criteria provided, single submitter			GRCh38	263467	259209
NM_004006.2:c.8810G>A	DMD	Cardiovascular phenotype		Benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter			GRCh38	263461	259208
NM_133378.4:c.86951_86953delGGA	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 26, 2012)	criteria provided, single submitter			GRCh38	263439	259207
NM_004006.2:c.2645A>G	DMD	Cardiovascular phenotype		Benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter			GRCh38	263429	259206
NM_032578.2:c.2886T>C	MYPN	Cardiovascular phenotype		Benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter			GRCh38	263374	259205
NM_004415.2:c.2091A>G	DSP	Cardiovascular phenotype		Benign(Last reviewed: Mar 9, 2015)	criteria provided, single submitter			GRCh38	263372	259204
NM_004415.2:c.741T>G	DSP	Cardiovascular phenotype		Benign(Last reviewed: Mar 9, 2015)	criteria provided, single submitter			GRCh38	263371	259203
NM_001103.2:c.378C>T	ACTN2	Cardiovascular phenotype		Benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter			GRCh38	263360	259202
NM_001103.2:c.351T>C	ACTN2	Cardiovascular phenotype		Benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter			GRCh38	263359	259201
FLNC, ALA1539THR	FLNC	Cardiomyopathy, familial hypertrophic, 26		Pathogenic(Last reviewed: Jul 21, 2016)	no assertion criteria provided			GRCh38	253123	247535
NM_004387.3(NKX2-5):c.-229-?_*465+?del	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter			GRCh38	239928	239513
NM_000256.3(MYBPC3):c.1091-?_2308+?del	MYBPC3	Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, single submitter			GRCh38	219725	222010
NM_000256.3:c.3315delG	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter			GRCh38	181099	179922
NM_000256.3:c.929insG	MYBPC3	Cardiomyopathy		Benign(Last reviewed: Jul 11, 2011)	criteria provided, single submitter			GRCh38	180924	179921
NM_005159.4:c.129+19insT	ACTC1	Cardiomyopathy		Benign(Last reviewed: Jul 24, 2013)	criteria provided, single submitter			GRCh38	180751	179914
NM_005159.4:c.129+17insC	ACTC1	Cardiomyopathy		Benign(Last reviewed: Feb 24, 2014)	criteria provided, single submitter			GRCh38	180750	179913
COA6, TRP59CYS	COA6	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4		Pathogenic(Last reviewed: Jul 9, 2015)	no assertion criteria provided			GRCh38	144036	153775
PRNP, TYR163TER	PRNP	CEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED		Pathogenic(Last reviewed: Nov 14, 2013)	no assertion criteria provided			GRCh38	88928	94485
SMAD2, TRP244CYS	SMAD2	Variant of unknown significance		Uncertain significance(Last reviewed: Jun 13, 2013)	no assertion criteria provided			GRCh38	56825	71448
LTBP4, ARG1337TER	LTBP4	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities		Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided			GRCh38	40004	48517
STK4, TRP250TER	STK4	T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations		Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided			GRCh38	37325	45900
STK4, 1-BP DEL, 1103T	STK4	T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations		Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided			GRCh38	37324	45899
ALMS1, 333-BP ALU INS, EX16	ALMS1	Alstrom syndrome		Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided			GRCh38	37246	45839
CCDC11, IVS6DS, G-A, +1	CFAP53	Heterotaxy, visceral, 6, autosomal		Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided			GRCh38	37014	45680
TTC37, TRP936TER	TTC37	Trichohepatoenteric syndrome 1		Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided			GRCh38	31230	40187
DOLK, MET1ILE	DOLK	Congenital disorder of glycosylation type 1M		Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided			GRCh38	30852	39809
AGK, IVS3DS, T-C, +2	AGK	Cataract and cardiomyopathy		Pathogenic(Last reviewed: Jan 25, 2012)	no assertion criteria provided			GRCh38	30823	39780
IGFBP7, IVS4, G-A, -1	IGFBP7	Retinal arterial macroaneurysm with supravascular pulmonic stenosis		Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided			GRCh38	30280	39236
GATA6, 2-BP DEL, 1456GA	GATA6	Persistent truncus arteriosus		Pathogenic(Last reviewed: Aug 18, 2009)	no assertion criteria provided			GRCh38	30206	39162
NKX2-5, 3-BP DEL, 871AAC	NKX2-5	Double outlet right ventricle		Pathogenic(Last reviewed: Nov 5, 2003)	no assertion criteria provided			GRCh38	30114	39069
FLNC, 12-BP DEL, NT2997	FLNC	Myofibrillar myopathy, filamin C-related		Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided			GRCh38	18467	33506
TFAP2A, PHE319SER	TFAP2A	Branchiooculofacial syndrome		Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided			GRCh38	17940	32979
COL1A2, IVS24DS, G-C, +1	COL1A2	Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form		Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided			GRCh38	17274	32313
COL1A2, IVS11DS, G-A, +5	COL1A2	Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form		Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided			GRCh38	17273	32312
COL1A2, IVS9DS, G-A, +5	COL1A2	Osteogenesis imperfecta/Ehlers-Danlos crossover syndrome		Pathogenic(Last reviewed: Jun 23, 2011)	no assertion criteria provided			GRCh38	17269	32308
DES, 3-BP DEL, 720GAA	DES	Myofibrillar myopathy 1		Pathogenic(Last reviewed: Mar 15, 2003)	no assertion criteria provided			GRCh38	16833	31872
DES, GLU359-ALA360-SER361 DEL	DES	Myofibrillar myopathy 1		Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided			GRCh38	16831	31870
DES, IVS2, G-A, -1	DES	Myofibrillar myopathy 1		Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided			GRCh38	16828	31867
DES, IVS3, A-G, +3	DES	Myofibrillar myopathy 1		Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided			GRCh38	16827	31866
ELN, 1-BP DEL, 1040C	ELN	Supravalvar aortic stenosis		Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided			GRCh38	16730	31769
FBN1, EX13-49DEL	FBN1	Marfan syndrome		Pathogenic(Last reviewed: May 15, 2008)	no assertion criteria provided			GRCh38	16468	31507
FBN1, 1-BP DEL, 3192A	FBN1	Marfan syndrome		Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided			GRCh38	16448	31487
FBN1, 4-BP INS, NT5138	FBN1	MASS syndrome		Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided			GRCh38	16434	31473
FBN1, 366-BP DEL	FBN1	Marfan syndrome		Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided			GRCh38	16423	31462
MYH6, MYH6/MYH7 HYBRID	MYH6	Myosin, cardiac, heavy chain variant		Pathogenic(Last reviewed: Sep 7, 1990)	no assertion criteria provided			GRCh38	14146	29185
MYH7, GLU743ASP	MYH7	Cardiomyopathy, hypertrophic, midventricular, digenic		Pathogenic(Last reviewed: Nov 30, 2001)	no assertion criteria provided			GRCh38	14110	29149
nsv513807	MYH7	Familial hypertrophic cardiomyopathy 1		Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided			GRCh38	14096	29135
TTN, 2-BP INS, 43628AT	TTN	Dilated cardiomyopathy 1G		Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided			GRCh38	12650	27689
TNNI3, 3-BP DEL, LYS183	TNNI3	Familial hypertrophic cardiomyopathy 7		Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided			GRCh38	12433	27472
TNNI3, A2V	TNNI3	Dilated cardiomyopathy 2A		Pathogenic(Last reviewed: Aug 14, 2009)	no assertion criteria provided			GRCh38	12427	27466
TNNT2, 3-BP DEL, 285GGA	TNNT2	Familial restrictive cardiomyopathy 3		Pathogenic(Last reviewed: Jan 25, 2008)	no assertion criteria provided			GRCh38	12418	27457
TNNT2, IVS15, G-A, +1	TNNT2	Familial hypertrophic cardiomyopathy 2		Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided			GRCh38	12410	27449
ETFDH, 1-BP DEL, 36A	ETFDH	Glutaric acidemia IIC		Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided			GRCh38	12027	27066
FLNA, 1-BP DEL, 2762G	FLNA	X-linked periventricular heterotopia		Pathogenic(Last reviewed: Jan 25, 2005)	no assertion criteria provided			GRCh38	11763	26802
FHL1, 1-BP INS, NT817	FHL1	Emery-Dreifuss muscular dystrophy 6		Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided			GRCh38	11558	26597
IKBKG, 1-BP DUP, 1167C	IKBKG	Hypohidrotic ectodermal dysplasia with immune deficiency|Incontinentia pigmenti, atypical		Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided			GRCh38	11455	26494
DMD, IVS1, G-T, +1	DMD	Dilated cardiomyopathy 3B		Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided			GRCh38	11235	26274
DMD, EX1DEL	DMD	Dilated cardiomyopathy 3B		Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided			GRCh38	11231	26270
TAZ, IVS1DS, G-C, +5	TAZ	3-Methylglutaconic aciduria type 2		Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided			GRCh38	11106	26145
GLA, 4-BP DEL, 1284ACTT	GLA	Fabry disease		Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided			GRCh38	10773	25812
F9, ALA-10THR	F9	Warfarin response		Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided			GRCh38	10659	25698
LAMP2, 1-BP DEL, 1219A	LAMP2	Danon disease		Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided			GRCh38	9984	25023
LAMP2, 7-BP DEL	LAMP2	Danon disease		Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided			GRCh38	9980	25019
NKX2-5, IVS1DS, G-T, +1	NKX2-5	Atrioventricular block, idiopathic second-degree		Uncertain significance(Last reviewed: Dec 1, 1999)	no assertion criteria provided			GRCh38	9007	24046
NODAL, IVS2DS, G-A, +1	NODAL	Visceral heterotaxy 5, autosomal		Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided			GRCh38	8271	23310
NODAL, 9-BP INS/24-BP DEL, NT700	NODAL	Visceral heterotaxy 5, autosomal		Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided			GRCh38	8270	23309
CITED2, 6-BP DEL, NT592	CITED2	Atrial septal defect 8		Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided			GRCh38	6723	21762
PTRF, 1-BP DUP, 362T	PTRF	Lipodystrophy, congenital generalized, type 4		Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided			GRCh38	6604	21643
SLC22A5, 1394-BP DEL	SLC22A5	Renal carnitine transport defect		Pathogenic(Last reviewed: Nov 18, 1998)	no assertion criteria provided			GRCh38	6413	21452
RPL5, 2-BP DEL, 173GA	RPL5	Aase syndrome		Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided			GRCh38	6181	21220
GYG1, 1-BP DEL, 487G	GYG1	Glycogen storage disease XV		Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided			GRCh38	5953	20992
COG7, IVS1DS, A-C, +4	COG7	Congenital disorder of glycosylation type 2E		Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided			GRCh38	3650	18689
EVC2, 1-BP DEL, 3660C	EVC2	Chondroectodermal dysplasia		Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided			GRCh38	3380	18419
ALG8, IVS6DS, A-G, +4	ALG8	Congenital disorder of glycosylation type 1H		Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided			GRCh38	2562	17601
CHD7, 1-BP INS, 8682T	CHD7	CHARGE association		Pathogenic(Last reviewed: Nov 15, 2007)	no assertion criteria provided			GRCh38	2037	17076
LMBRD1, 2-BP DEL, 515AC	LMBRD1	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE		Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided			GRCh38	517	15556
NEXN, 3-BP DEL, 1948GGA	NEXN	Dilated cardiomyopathy 1CC		Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided			GRCh38	325	15364
NM_003036.3(SKI):c.94C>G (p.Leu32Val)	SKI	Shprintzen-Goldberg syndrome		Pathogenic(Last reviewed: Feb 1, 2015)	criteria provided, single submitter	1	2228860	GRCh38	37259	45849
NM_003036.3(SKI):c.100G>A (p.Gly34Ser)	SKI	Shprintzen-Goldberg syndrome|not provided		Pathogenic(Last reviewed: Feb 1, 2015)	criteria provided, multiple submitters, no conflicts	1	2228866	GRCh38	37261	45851
NM_003036.3(SKI):c.103C>T (p.Pro35Ser)	SKI	Shprintzen-Goldberg syndrome		Pathogenic(Last reviewed: Feb 1, 2015)	criteria provided, single submitter	1	2228869	GRCh38	39786	48385
NM_003036.3(SKI):c.104C>A (p.Pro35Gln)	SKI	Shprintzen-Goldberg syndrome		Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	1	2228870	GRCh38	39785	48384
NM_003036.3(SKI):c.216C>T (p.Pro72=)	SKI	Shprintzen-Goldberg syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00102(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2016)	criteria provided, conflicting interpretations	1	2228982	GRCh38	193249	190413
NM_003036.3(SKI):c.249_251dupGCC (p.Pro84_Val85insPro)	SKI	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	1	2229015 - 2229017	GRCh38	264471	257939
NM_003036.3(SKI):c.294C>T (p.Thr98=)	SKI	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.01320(T), GO-ESP:0.00393(T)	Benign(Last reviewed: Aug 11, 2015)	criteria provided, multiple submitters, no conflicts	1	2229060	GRCh38	213681	209446
NM_003036.3(SKI):c.311T>C (p.Val104Ala)	SKI	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	1	2229077	GRCh38	264417	257941
NM_003036.3(SKI):c.393G>A (p.Leu131=)	SKI	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Oct 4, 2015)	criteria provided, single submitter	1	2229159	GRCh38	264423	257943
NM_003036.3(SKI):c.456C>T (p.Arg152=)	SKI	Shprintzen-Goldberg syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00500(T), GO-ESP:0.01070(T)	Benign(Last reviewed: Feb 29, 2016)	criteria provided, multiple submitters, no conflicts	1	2229222	GRCh38	139111	142814
NM_003036.3(SKI):c.625C>A (p.Leu209Met)	SKI	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Jul 24, 2015)	criteria provided, single submitter	1	2229391	GRCh38	264172	257942
NM_003036.3(SKI):c.798C>T (p.Ala266=)	SKI	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(T), GO-ESP:0.00079(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2015)	criteria provided, conflicting interpretations	1	2229564	GRCh38	193248	190412
NM_003036.3(SKI):c.844C>A (p.Arg282=)	SKI	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	1	2229610	GRCh38	264492	257944
NM_003036.3(SKI):c.964C>T (p.Pro322Ser)	SKI	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	1	2229730	GRCh38	264199	257945
NM_003036.3(SKI):c.1070G>A (p.Arg357Gln)	SKI	not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jun 18, 2014)	criteria provided, single submitter	1	2303078	GRCh38	213689	209459
NM_003036.3(SKI):c.1139G>A (p.Arg380Gln)	SKI	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	1	2303328	GRCh38	213690	209461
NM_003036.3(SKI):c.1263C>T (p.Leu421=)	SKI	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00013(T)	Likely benign(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	1	2303891	GRCh38	263904	257947
NM_003036.3(SKI):c.1264G>A (p.Ala422Thr)	SKI	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Oct 20, 2014)	criteria provided, single submitter	1	2303892	GRCh38	213707	209470
NM_003036.3(SKI):c.1309G>A (p.Ala437Thr)	SKI	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00022(A)	Uncertain significance(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	1	2303937	GRCh38	263895	257946
NM_003036.3(SKI):c.1311C>T (p.Ala437=)	SKI	Shprintzen-Goldberg syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00520(T), GO-ESP:0.00723(T)	Benign(Last reviewed: Feb 29, 2016)	criteria provided, multiple submitters, no conflicts	1	2303939	GRCh38	139114	142817
NM_003036.3(SKI):c.1446G>A (p.Ala482=)	SKI	Shprintzen-Goldberg syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00260(A), GO-ESP:0.00609(A)	Benign/Likely benign(Last reviewed: Mar 7, 2016)	criteria provided, multiple submitters, no conflicts	1	2304074	GRCh38	139115	142818
NM_003036.3(SKI):c.1527C>T (p.Ser509=)	SKI	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00160(T), GO-ESP:0.00096(T)	Benign/Likely benign(Last reviewed: Feb 24, 2015)	criteria provided, multiple submitters, no conflicts	1	2304345	GRCh38	213674	209474
NM_003036.3(SKI):c.1834C>T (p.Leu612=)	SKI	Shprintzen-Goldberg syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00200(T), GO-ESP:0.00636(T)	Benign/Likely benign(Last reviewed: Nov 30, 2015)	criteria provided, multiple submitters, no conflicts	1	2306086	GRCh38	139116	142819
NM_003036.3(SKI):c.2007C>G (p.Asp669Glu)	SKI	Shprintzen-Goldberg syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00367(G)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2015)	criteria provided, conflicting interpretations	1	2306585	GRCh38	213699	209486
NM_003036.3(SKI):c.2056G>A (p.Ala686Thr)	SKI	not specified	GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	1	2306634	GRCh38	213709	209487
NM_022114.3(PRDM16):c.2104A>T (p.Lys702Ter)	PRDM16	Left ventricular noncompaction 8		Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	1	3412301	GRCh38	60724	75284
NM_022114.3(PRDM16):c.2447A>G (p.Asn816Ser)	PRDM16	Left ventricular noncompaction 8	GO-ESP:0.00058(G)	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	1	3412644	GRCh38	60726	75286
NM_022114.3(PRDM16):c.2809_2810dupCC (p.Thr938Glnfs)	PRDM16	not specified		Uncertain significance(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	1	3417945 - 3417946	GRCh38	229166	228456
NM_007375.3(TARDBP):c.787A>G (p.Lys263Glu)	TARDBP	FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED		Pathogenic(Last reviewed: Sep 15, 2009)	no assertion criteria provided	1	11022196	GRCh38	5238	20277
NM_006172.3(NPPA):c.123+16C>T	NPPA|NPPA-AS1	Cardiac arrhythmia|not specified	GO-ESP:0.15524(A), GMAF:0.12960(A), GO-ESP:0.08941(A)	Benign(Last reviewed: Aug 18, 2011)	criteria provided, multiple submitters, no conflicts	1	11847546	GRCh38	36663	45324
NM_000302.3(PLOD1):c.30G>C (p.Leu10=)	PLOD1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	1	11934809	GRCh38	264292	257908
NM_000302.3(PLOD1):c.95C>T (p.Thr32Met)	PLOD1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	1	11947994	GRCh38	264381	257909
NM_000302.3(PLOD1):c.177C>T (p.Gly59=)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient|Thoracic aortic aneurysm and aortic dissection	GMAF:0.02680(T), GO-ESP:0.00787(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	11949781	GRCh38	263887	257910
NM_000302.3(PLOD1):c.250G>A (p.Ala84Thr)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient|Thoracic aortic aneurysm and aortic dissection	GMAF:0.02740(A), GO-ESP:0.01487(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	11949854	GRCh38	263938	257912
NM_000302.3(PLOD1):c.265G>T (p.Ala89Ser)	PLOD1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	1	11949869	GRCh38	264618	257914
NM_000302.3(PLOD1):c.404_423del20 (p.Asp135Valfs)	PLOD1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jun 24, 2015)	criteria provided, single submitter	1	11950458 - 11950477	GRCh38	264119	257918
NM_000302.3(PLOD1):c.555G>T (p.Lys185Asn)	PLOD1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00100(T), GO-ESP:0.00284(T)	Benign(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	1	11952711	GRCh38	263963	257913
NM_000302.3(PLOD1):c.804C>T (p.Thr268=)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00060(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	11957904	GRCh38	264284	257919
NM_000302.3(PLOD1):c.936C>T (p.His312=)	PLOD1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00100(T), GO-ESP:0.00063(T)	Likely benign(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	1	11958608	GRCh38	263947	257915
NM_000302.3(PLOD1):c.1140C>T (p.Ser380=)	PLOD1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00033(T)	Likely benign(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	1	11963574	GRCh38	264103	257920
NM_000302.3(PLOD1):c.1141G>A (p.Val381Met)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00940(A), GO-ESP:0.00358(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	11963575	GRCh38	263885	257916
NM_000302.3(PLOD1):c.1299C>T (p.Asp433=)	PLOD1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Sep 6, 2015)	criteria provided, single submitter	1	11964271	GRCh38	264283	257925
NM_000302.3(PLOD1):c.1534C>T (p.Arg512Cys)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00180(T), GO-ESP:0.00345(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	11965543	GRCh38	255801	249375
NM_000302.3(PLOD1):c.1685C>T (p.Thr562Met)	PLOD1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Jul 13, 2015)	criteria provided, single submitter	1	11967021	GRCh38	264138	257917
NM_000302.3(PLOD1):c.1788G>T (p.Val596=)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient|Thoracic aortic aneurysm and aortic dissection	GMAF:0.02620(T), GO-ESP:0.01054(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	11970702	GRCh38	263892	257924
NM_000302.3(PLOD1):c.1927G>A (p.Val643Ile)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00063(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	11972896	GRCh38	263957	257921
NM_000302.3(PLOD1):c.2075C>T (p.Pro692Leu)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00100(T), GO-ESP:0.00053(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	11974699	GRCh38	242449	215017
NM_000302.3(PLOD1):c.2124T>C (p.His708=)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient|Thoracic aortic aneurysm and aortic dissection	GMAF:0.06130(C), GO-ESP:0.02244(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	11974748	GRCh38	263886	257927
NM_000302.3(PLOD1):c.2133C>G (p.Leu711=)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient|Thoracic aortic aneurysm and aortic dissection	GMAF:0.02600(G), GO-ESP:0.01038(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	11974757	GRCh38	263889	257923
NM_000302.3(PLOD1):c.2181C>T (p.Pro727=)	PLOD1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00005(T)	Likely benign(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	1	11974805	GRCh38	264177	257935
NM_015164.2(PLEKHM2):c.1929_1930delAG (p.Lys645Alafs)	PLEKHM2	not provided		Uncertain significance(Last reviewed: Jul 22, 2016)	no assertion criteria provided	1	15728676 - 15728677	GRCh38	253148	247560
NM_003000.2(SDHB):c.79C>T (p.Arg27Ter)	SDHB	Paragangliomas 4|Pheochromocytoma|Hereditary cancer-predisposing syndrome		Pathogenic(Last reviewed: Feb 10, 2014)	criteria provided, single submitter	1	17044882	GRCh38	12783	27822
NM_001113348.1(ECE1):c.2212C>T (p.Arg738Cys)	ECE1	Hirschsprung disease, cardiac defects, and autonomic dysfunction	GO-ESP:0.00015(A), GO-ESP:0.00021(A)	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	1	21220008	GRCh38	9133	24172
NM_003665.3(FCN3):c.349delC (p.Leu117Serfs)	FCN3	Immunodeficiency due to ficolin 3 deficiency	GMAF:0.01880(-), GO-ESP:0.01661(-)	Pathogenic(Last reviewed: Jun 18, 2009)	no assertion criteria provided	1	27373180	GRCh38	5285	20324
NM_152268.3(PARS2):c.1130dupC (p.Lys378Terfs)	PARS2	not provided		Uncertain significance(Last reviewed: Jan 1, 2015)	no assertion criteria provided	1	54758032	GRCh38	183148	181284
NM_015978.2(TNNI3K):c.1577G>A (p.Gly526Asp)	TNNI3K|FPGT-TNNI3K	Cardiac conduction disease with or without dilated cardiomyopathy		Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	1	74369495	GRCh38	161447	171283
NM_144573.3(NEXN):c.237T>C (p.Ala79=)	NEXN	Dilated cardiomyopathy 1CC|Familial hypertrophic cardiomyopathy 20|not specified|Cardiovascular phenotype	GO-ESP:0.00003(C)	Likely benign(Last reviewed: Sep 8, 2015)	criteria provided, multiple submitters, no conflicts	1	77917977	GRCh38	178935	172457
NM_144573.3(NEXN):c.363G>A (p.Thr121=)	NEXN	Dilated cardiomyopathy 1CC|Familial hypertrophic cardiomyopathy 20|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01339(A), GMAF:0.01280(A), GO-ESP:0.00373(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	77918189	GRCh38	47906	57070
NM_144573.3(NEXN):c.392A>C (p.Gln131Pro)	NEXN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 4, 2015)	criteria provided, single submitter	1	77918218	GRCh38	264597	257981
NM_144573.3(NEXN):c.634T>A (p.Tyr212Asn)	NEXN	Cardiovascular phenotype	GO-ESP:0.00007(A)	Uncertain significance(Last reviewed: May 28, 2013)	criteria provided, single submitter	1	77926558	GRCh38	263611	257983
NM_144573.3(NEXN):c.733G>A (p.Gly245Arg)	NEXN	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.15781(A), GMAF:0.15080(A), GO-ESP:0.18459(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	77926761	GRCh38	47911	57075
NM_144573.3(NEXN):c.817C>T (p.Arg273Cys)	NEXN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	1	77926845	GRCh38	263645	257982
NM_144573.3(NEXN):c.856C>T (p.Arg286Trp)	NEXN	not specified|Cardiovascular phenotype	GO-ESP:0.00010(T)	Uncertain significance(Last reviewed: May 11, 2016)	criteria provided, multiple submitters, no conflicts	1	77926884	GRCh38	201919	198082
NM_144573.3(NEXN):c.893C>G (p.Thr298Arg)	NEXN	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00034(G), GO-ESP:0.00010(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	77929344	GRCh38	47914	57078
NM_144573.3(NEXN):c.995A>C (p.Glu332Ala)	NEXN	Dilated cardiomyopathy 1CC|Familial hypertrophic cardiomyopathy 20|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00202(C), GMAF:0.00320(C), GO-ESP:0.00400(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	77929446	GRCh38	47915	57079
NM_144573.3(NEXN):c.1400T>C (p.Ile467Thr)	NEXN	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 9, 2015)	criteria provided, multiple submitters, no conflicts	1	77935971	GRCh38	222753	224216
NM_144573.3(NEXN):c.1408G>C (p.Glu470Gln)	NEXN	Dilated cardiomyopathy 1CC|Familial hypertrophic cardiomyopathy 20|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00240(C), GO-ESP:0.00083(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	77935979	GRCh38	138511	142214
NM_144573.3(NEXN):c.1419_1421delAAG (p.Arg475del)	NEXN	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: May 14, 2014)	criteria provided, multiple submitters, no conflicts	1	77935990 - 77935992	GRCh38	201940	198090
NM_144573.3(NEXN):c.1785C>T (p.Asp595=)	NEXN	Cardiovascular phenotype	GMAF:0.00100(T), GO-ESP:0.00014(T)	Likely benign(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	1	77942586	GRCh38	264504	257984
NM_144573.3(NEXN):c.1831C>A (p.Pro611Thr)	NEXN	Dilated cardiomyopathy 1CC		Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	1	77942632	GRCh38	327	15366
NM_144573.3(NEXN):c.1935C>G (p.Phe645Leu)	NEXN	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: May 7, 2015)	criteria provided, conflicting interpretations	1	77942736	GRCh38	201935	198105
NM_144573.3(NEXN):c.1949_1951delGAG (p.Gly650del)	NEXN	Cardiomyopathy|not specified|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2015)	criteria provided, conflicting interpretations	1	77942750 - 77942752	GRCh38	47899	57063
NM_144573.3(NEXN):c.1955A>G (p.Tyr652Cys)	NEXN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1CC|Familial hypertrophic cardiomyopathy 20|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(G), GO-ESP:0.00010(G)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2015)	criteria provided, conflicting interpretations	1	77942756	GRCh38	326	15365
NM_004980.4(KCND3):c.1646G>A (p.Arg549His)	KCND3	Cardiovascular phenotype	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	1	111777146	GRCh38	264530	257907
NM_004980.4(KCND3):c.1174G>A (p.Val392Ile)	KCND3	Brugada syndrome 9		Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	1	111787039	GRCh38	192255	190052
NM_004980.4(KCND3):c.855C>G (p.Ala285=)	KCND3	Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00001(C)	Likely benign(Last reviewed: May 26, 2015)	criteria provided, single submitter	1	111981872	GRCh38	264072	257906
NM_004980.4(KCND3):c.641A>G (p.Lys214Arg)	KCND3	not specified|Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00024(C)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 12, 2015)	criteria provided, conflicting interpretations	1	111982086	GRCh38	222665	224176
NM_004980.4(KCND3):c.627G>C (p.Thr209=)	KCND3	Cardiovascular phenotype	GMAF:0.00140(G), GO-ESP:0.00050(G)	Benign(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	1	111982100	GRCh38	264148	257911
NM_003051.3(SLC16A1):c.41dupC (p.Asp15Argfs)	SLC16A1	Monocarboxylate transporter 1 deficiency, autosomal recessive		Pathogenic(Last reviewed: Nov 13, 2014)	no assertion criteria provided	1	112929268	GRCh38	160369	170213
NM_002524.4(NRAS):c.38G>A (p.Gly13Asp)	NRAS	Juvenile myelomonocytic leukemia|Noonan syndrome 6|RAS-associated autoimmune leukoproliferative disorder|not provided	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	1	114716123	GRCh38	13901	28940
NM_001232.3(CASQ2):c.1194_1196delTGA (p.Asp398del)	CASQ2	not specified|not provided		Uncertain significance(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	1	115701245 - 115701247	GRCh38	190752	188301
NM_001232.3(CASQ2):c.1194T>C (p.Asp398=)	CASQ2|VANGL1	Neural tube defect|Caudal dysgenesis syndrome|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.04406(G), GMAF:0.03100(G), GO-ESP:0.05421(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	115701247	GRCh38	44159	53327
NM_001232.3(CASQ2):c.1185_1187delCGA (p.Asp398del)	CASQ2	not specified|not provided|Cardiovascular phenotype	GMAF:0.00140(-), GO-ESP:0.00549(-)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 28, 2014)	criteria provided, conflicting interpretations	1	115701254 - 115701256	GRCh38	44158	53326
NM_001232.3(CASQ2):c.1185C>T (p.Asp395=)	CASQ2|VANGL1	Neural tube defect|Caudal dysgenesis syndrome|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.38797(A), GMAF:0.42570(A), GO-ESP:0.38379(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	115701256	GRCh38	44157	53325
NM_001232.3(CASQ2):c.1127A>G (p.Asp376Gly)	CASQ2	not specified		Uncertain significance(Last reviewed: Nov 18, 2014)	criteria provided, single submitter	1	115701314	GRCh38	190756	188303
NM_001232.3(CASQ2):c.1082G>C (p.Trp361Ser)	CASQ2	not provided		Likely pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	1	115701359	GRCh38	190748	188304
NM_001232.3(CASQ2):c.985C>T (p.Pro329Ser)	CASQ2	not specified|not provided	GMAF:0.00020(A), GO-ESP:0.00035(A)	Uncertain significance(Last reviewed: Sep 28, 2016)	criteria provided, multiple submitters, no conflicts	1	115702950	GRCh38	190747	188306
NM_001232.3(CASQ2):c.[730C>T;731A>G]	CASQ2	not specified	GO-ESP:0.02660(C), GMAF:0.02840(C), GO-ESP:0.00829(C), GMAF:0.00140(A), GO-ESP:0.00023(A)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	1|1	115726998	GRCh38	228471	44436|228262
NM_001232.3(CASQ2):c.731A>G (p.His244Arg)	CASQ2	Cardiac arrhythmia|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.02660(C), GMAF:0.02840(C), GO-ESP:0.00829(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	115726998	GRCh38	35772	44436
NM_001232.3(CASQ2):c.730C>T (p.His244Tyr)	CASQ2	not specified|Cardiovascular phenotype	GMAF:0.00140(A), GO-ESP:0.00023(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2015)	criteria provided, conflicting interpretations	1	115726999	GRCh38	227210	228262
NM_001232.3(CASQ2):c.633G>T (p.Met211Ile)	CASQ2	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jun 23, 2014)	criteria provided, single submitter	1	115727096	GRCh38	190744	188310
NM_001232.3(CASQ2):c.503T>C (p.Ile168Thr)	CASQ2	not provided	GO-ESP:0.00002(G)	Likely pathogenic(Last reviewed: Aug 20, 2014)	criteria provided, single submitter	1	115738253	GRCh38	190741	188313
NM_001232.3(CASQ2):c.481A>G (p.Ile161Val)	CASQ2	not specified|Cardiovascular phenotype	GO-ESP:0.00031(C), GMAF:0.00020(G), GO-ESP:0.00059(C)	Uncertain significance(Last reviewed: Sep 25, 2013)	criteria provided, multiple submitters, no conflicts	1	115738275	GRCh38	44167	53335
NM_001232.3(CASQ2):c.376G>C (p.Asp126His)	CASQ2	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Feb 11, 2016)	criteria provided, multiple submitters, no conflicts	1	115740772	GRCh38	162818	172477
NM_001232.3(CASQ2):c.339_354del16 (p.Ser113Argfs)	CASQ2	Ventricular tachycardia, catecholaminergic polymorphic, 2|not provided		Pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	1	115740794 - 115740809	GRCh38	17611	32650
NM_001232.3(CASQ2):c.338G>A (p.Ser113Asn)	CASQ2	not specified|not provided	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	1	115740810	GRCh38	162820	172338
NM_001232.3(CASQ2):c.226G>A (p.Val76Met)	CASQ2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.00146(T), GMAF:0.03040(T), GO-ESP:0.02506(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	115768316	GRCh38	44162	53330
NM_001232.3(CASQ2):c.213delA (p.Gln71Hisfs)	CASQ2	not provided		Pathogenic(Last reviewed: Apr 12, 2012)	criteria provided, single submitter	1	115768329	GRCh38	190759	188315
NM_001232.3(CASQ2):c.196A>G (p.Thr66Ala)	CASQ2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.33938(C), GMAF:0.40120(C), GO-ESP:0.32650(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	115768346	GRCh38	44160	53328
NM_001232.3(CASQ2):c.118A>G (p.Lys40Glu)	CASQ2	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	1	115768424	GRCh38	190757	188317
NM_001232.3(CASQ2):c.97C>T (p.Arg33Ter)	CASQ2	Ventricular tachycardia, catecholaminergic polymorphic, 2|not provided		Pathogenic(Last reviewed: Mar 25, 2014)	criteria provided, single submitter	1	115768445	GRCh38	41043	49465
NM_001232.3(CASQ2):c.94G>A (p.Asp32Asn)	CASQ2	not provided		Likely pathogenic(Last reviewed: Aug 20, 2014)	criteria provided, single submitter	1	115768448	GRCh38	68878	79769
NM_001232.3(CASQ2):c.34T>A (p.Tyr12Asn)	CASQ2	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: May 15, 2014)	criteria provided, single submitter	1	115768508	GRCh38	190750	188319
NM_024408.3(NOTCH2):c.5930-1G>A	NOTCH2	Alagille syndrome 2		Pathogenic(Last reviewed: Feb 28, 2013)	no assertion criteria provided	1	119917763	GRCh38	9229	24268
NM_213653.3(HFE2):c.959G>T (p.Gly320Val)	HFE2	Hemochromatosis type 2A|Hemochromatosis type 1	GO-ESP:0.00031(T), GO-ESP:0.00017(T)	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	1	146018399	GRCh38	2365	17404
NM_000157.3(GBA):c.[1448T>C];[167T>G]	GBA	Gaucher's disease, type 1	GO-ESP:0.00031(G), GMAF:0.00340(G), GO-ESP:0.00310(G)	Likely pathogenic(Last reviewed: Sep 25, 2015)	no assertion criteria provided	1|1	155235252	GRCh38	236403	19327|237962
NM_000157.3(GBA):c.1342G>C (p.Asp448His)	GBA	Gaucher's disease, type 1|Acute neuronopathic Gaucher's disease|Subacute neuronopathic Gaucher's disease|Gaucher disease, perinatal lethal|Gaucher disease type 3C|Gaucher disease|not provided	GO-ESP:0.00015(G), GO-ESP:0.00011(G)	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, multiple submitters, no conflicts	1	155235727	GRCh38	4293	19332
NM_170707.3(LMNA):c.3G>C (p.Met1Ile)	LMNA	not provided		Pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	1	156114921	GRCh38	245838	244206
NM_170707.3(LMNA):c.3G>T (p.Met1Ile)	LMNA	not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, multiple submitters, no conflicts	1	156114921	GRCh38	200949	196446
NM_170707.3(LMNA):c.29C>T (p.Thr10Ile)	LMNA	Dilated cardiomyopathy 1A|not provided		Pathogenic/Likely pathogenic, not provided(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	1	156114947	GRCh38	66888	77785
NM_005572.3(LMNA):c.51C>T (p.Ser17=)	LMNA	Primary dilated cardiomyopathy|Hutchinson-Gilford syndrome|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy|Mandibuloacral dysplasia|not specified|not provided|Familial partial lipodystrophy|Cardiovascular phenotype|Charcot-Marie-Tooth, Type 2|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00945(T), GMAF:0.00680(T), GO-ESP:0.02399(T)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	156114969	GRCh38	36479	45141
NM_005572.3(LMNA):c.111G>A (p.Glu37=)	LMNA	not specified|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Aug 23, 2016)	criteria provided, conflicting interpretations	1	156115029	GRCh38	263718	257922
NM_170707.3(LMNA):c.176T>G (p.Leu59Arg)	LMNA	Malouf syndrome|not provided		Pathogenic(Last reviewed: Feb 15, 2009)	no assertion criteria provided	1	156115094	GRCh38	18457	33496
NM_170707.3(LMNA):c.178C>G (p.Arg60Gly)	LMNA	Dilated cardiomyopathy 1A|Familial partial lipodystrophy 2|not provided		Pathogenic(Last reviewed: Aug 27, 2002)	no assertion criteria provided	1	156115096	GRCh38	14479	29518
NM_005572.3(LMNA):c.207G>C (p.Val69=)	LMNA	Cardiovascular phenotype		Likely benign(Last reviewed: Oct 3, 2012)	criteria provided, single submitter	1	156115125	GRCh38	263426	257929
NM_170707.3(LMNA):c.354_355delGCinsAG (p.Arg119Gly)	LMNA	Cardiac conduction defect, nonspecific		Likely pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	1	156115272 - 156115273	GRCh38	222695	224179
NM_170707.3(LMNA):c.357C>T (p.Arg119=)	LMNA	Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy|not specified|not provided|Dilated cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00269(T), GMAF:0.00200(T), GO-ESP:0.00319(T)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	156130617	GRCh38	48062	57226
NM_170707.3(LMNA):c.367_369delAAG (p.Lys123del)	LMNA	Primary dilated cardiomyopathy|not provided		Likely pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, multiple submitters, no conflicts	1	156130627 - 156130629	GRCh38	200947	196459
NM_170707.3(LMNA):c.398G>A (p.Arg133Gln)	LMNA	Charcot-Marie-Tooth disease, type 2|not provided		Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	1	156130658	GRCh38	200934	196461
NM_170707.3(LMNA):c.427T>C (p.Ser143Pro)	LMNA	not provided		Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	1	156130687	GRCh38	66899	77796
NM_170707.3(LMNA):c.481G>A (p.Glu161Lys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|not provided		Pathogenic(Last reviewed: May 27, 2015)	criteria provided, single submitter	1	156130741	GRCh38	14504	29543
NM_170707.3(LMNA):c.497G>C (p.Arg166Pro)	LMNA	not provided	GMAF:0.00080(A)	Pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	1	156130757	GRCh38	66901	77798
NM_170707.3(LMNA):c.513+1G>A	LMNA	not provided		Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	1	156130774	GRCh38	245721	244219
NM_005572.3(LMNA):c.513+1G>C	LMNA	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	1	156130774	GRCh38	48069	57233
NM_170707.3(LMNA):c.513+45T>G	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy		Pathogenic(Last reviewed: Apr 26, 2016)	no assertion criteria provided	1	156130818	GRCh38	236201	237758
NM_170707.3(LMNA):c.568C>T (p.Arg190Trp)	LMNA	Dilated cardiomyopathy 1A|not provided		Pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, multiple submitters, no conflicts	1	156134457	GRCh38	66908	77805
NM_170707.3(LMNA):c.585C>G (p.Asn195Lys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|not provided		Pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, multiple submitters, no conflicts	1	156134474	GRCh38	14483	29522
NM_170707.3(LMNA):c.612G>A (p.Leu204=)	LMNA	Hutchinson-Gilford syndrome|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy|Mandibuloacral dysplasia|not specified|not provided|Familial partial lipodystrophy|Cardiovascular phenotype|Charcot-Marie-Tooth, Type 2|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00569(A), GMAF:0.00800(A), GO-ESP:0.00972(A)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	156134501	GRCh38	48071	57235
NM_170707.3(LMNA):c.618C>G (p.Phe206Leu)	LMNA	not provided		Likely pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	1	156134507	GRCh38	66916	77813
NM_170707.3(LMNA):c.646C>T (p.Arg216Cys)	LMNA	Primary dilated cardiomyopathy|not specified|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2016)	criteria provided, conflicting interpretations	1	156134811	GRCh38	200938	196467
NM_170707.3(LMNA):c.658C>T (p.Arg220Cys)	LMNA	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Dec 31, 2015)	criteria provided, single submitter	1	156134823	GRCh38	264626	257926
NM_005572.3(LMNA):c.673C>T (p.Arg225Ter)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Limb-girdle muscular dystrophy, type 1B|not provided		Pathogenic(Last reviewed: Sep 2, 2016)	criteria provided, multiple submitters, no conflicts	1	156134838	GRCh38	48074	57238
NM_170707.3(LMNA):c.736C>T (p.Gln246Ter)	LMNA	not provided		Pathogenic/Likely pathogenic, not provided(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	1	156134901	GRCh38	66927	77824
NM_170707.3(LMNA):c.777T>A (p.Tyr259Ter)	LMNA	Limb-girdle muscular dystrophy, type 1B|not provided		Pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	1	156134942	GRCh38	14511	29550
NM_170707.3(LMNA):c.799T>C (p.Tyr267His)	LMNA	Primary dilated cardiomyopathy|not provided		Pathogenic(Last reviewed: Aug 19, 2015)	criteria provided, multiple submitters, no conflicts	1	156134964	GRCh38	48084	57248
NM_005572.3(LMNA):c.861T>C (p.Ala287=)	LMNA	Hutchinson-Gilford syndrome|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Emery-Dreifuss muscular dystrophy|Mandibuloacral dysplasia|not specified|not provided|Familial partial lipodystrophy|Cardiovascular phenotype|Charcot-Marie-Tooth, Type 2|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.19783(C), GMAF:0.19310(C), GO-ESP:0.10943(C)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	156135237	GRCh38	48088	57252
NM_170707.3(LMNA):c.871G>A (p.Glu291Lys)	LMNA	not provided		Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	1	156135247	GRCh38	200942	196473
NM_005572.3(LMNA):c.895A>G (p.Ile299Val)	LMNA	Charcot-Marie-Tooth disease, type 2|not specified|not provided|Partial lipodystrophy, Dunnigan	GO-ESP:0.00038(G), GMAF:0.00020(G), GO-ESP:0.00040(G)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 13, 2016)	criteria provided, conflicting interpretations	1	156135271	GRCh38	48092	57256
NM_005572.3(LMNA):c.899A>G (p.Asp300Gly)	LMNA	Hutchinson-Gilford progeria syndrome, atypical		Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	1	156135275	GRCh38	217451	214091
NM_170707.3(LMNA):c.908_909delCT (p.Ser303Cysfs)	LMNA	not provided		Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	1	156135284 - 156135285	GRCh38	66955	77852
NM_005572.3(LMNA):c.927C>A (p.Leu309=)	LMNA	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Jul 12, 2013)	criteria provided, single submitter	1	156135303	GRCh38	263661	257936
NM_170707.3(LMNA):c.949G>T (p.Glu317Ter)	LMNA	not provided		Pathogenic(Last reviewed: Jun 14, 2013)	no assertion criteria provided	1	156135913	GRCh38	235004	236736
NM_170707.3(LMNA):c.949G>A (p.Glu317Lys)	LMNA	Primary dilated cardiomyopathy|not provided		Likely pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	1	156135913	GRCh38	48093	57257
NM_170707.3(LMNA):c.958delC (p.Leu320Phefs)	LMNA	Primary dilated cardiomyopathy|not provided		Pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, multiple submitters, no conflicts	1	156135922	GRCh38	48095	57259
NM_170707.3(LMNA):c.961C>T (p.Arg321Ter)	LMNA	Primary dilated cardiomyopathy|not provided		Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, multiple submitters, no conflicts	1	156135925	GRCh38	48096	57260
NM_005572.3(LMNA):c.1017G>A (p.Ala339=)	LMNA	not specified|not provided|Cardiovascular phenotype	GMAF:0.00100(A), GO-ESP:0.00063(A)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 15, 2016)	criteria provided, conflicting interpretations	1	156135981	GRCh38	191702	189383
NM_170707.3(LMNA):c.1039G>A (p.Glu347Lys)	LMNA	not provided		Likely pathogenic(Last reviewed: Mar 24, 2016)	criteria provided, single submitter	1	156136003	GRCh38	66760	77657
NM_170707.3(LMNA):c.1045C>T (p.Arg349Trp)	LMNA	not provided		Pathogenic(Last reviewed: Apr 11, 2013)	criteria provided, single submitter	1	156136009	GRCh38	66762	77659
NM_170707.3(LMNA):c.1057C>T (p.Gln353Ter)	LMNA	Charcot-Marie-Tooth disease, type 2|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: May 5, 2016)	criteria provided, multiple submitters, no conflicts	1	156136021	GRCh38	200939	196476
NM_170707.3(LMNA):c.1072G>A (p.Glu358Lys)	LMNA	Dilated cardiomyopathy 1A|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Familial partial lipodystrophy 2|Mandibuloacral dysostosis|Limb-girdle muscular dystrophy, type 1B|Congenital muscular dystrophy, LMNA-related|not provided		Pathogenic(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	1	156136036	GRCh38	14525	29564
NM_170707.3(LMNA):c.1081G>C (p.Glu361Gln)	LMNA	not specified		Uncertain significance(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	1	156136045	GRCh38	245948	244225
NM_170707.3(LMNA):c.1122C>T (p.His374=)	LMNA	not specified|Cardiovascular phenotype	GO-ESP:0.00013(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2015)	criteria provided, conflicting interpretations	1	156136086	GRCh38	163870	172346
NM_170707.3(LMNA):c.1129C>T (p.Arg377Cys)	LMNA	Primary dilated cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, multiple submitters, no conflicts	1	156136093	GRCh38	48031	57195
NM_170707.3(LMNA):c.1130G>A (p.Arg377His)	LMNA	Dilated cardiomyopathy 1A|Limb-girdle muscular dystrophy, type 1B|not provided		Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	1	156136094	GRCh38	14495	29534
NM_170707.3(LMNA):c.1146C>T (p.Gly382=)	LMNA	Limb-girdle muscular dystrophy|not provided		Pathogenic/Likely pathogenic, not provided(Last reviewed: Apr 11, 2016)	criteria provided, multiple submitters, no conflicts	1	156136110	GRCh38	48032	57196
NM_170707.3(LMNA):c.1157G>C (p.Arg386Thr)	LMNA	Cardiovascular phenotype		Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	1	156136121	GRCh38	264271	257932
NM_170707.3(LMNA):c.1157+1G>T	LMNA	not provided		Pathogenic(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	1	156136122	GRCh38	246075	244228
NM_170707.3(LMNA):c.1157+1G>A	LMNA	not provided		Pathogenic(Last reviewed: Aug 30, 2011)	criteria provided, single submitter	1	156136122	GRCh38	66781	77678
NM_170707.3(LMNA):c.1184C>T (p.Ser395Leu)	LMNA	not provided|Collapse (finding)|History of Sudden Cardiac Death	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Feb 12, 2014)	no assertion criteria provided	1	156136240	GRCh38	66792	77689
NM_005572.3(LMNA):c.1338T>C (p.Asp446=)	LMNA	Hutchinson-Gilford syndrome|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Emery-Dreifuss muscular dystrophy|Mandibuloacral dysplasia|not specified|not provided|Familial partial lipodystrophy|Cardiovascular phenotype|Charcot-Marie-Tooth, Type 2|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.25412(C), GMAF:0.24920(C), GO-ESP:0.16114(C)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	156136394	GRCh38	48037	57201
NM_170707.3(LMNA):c.1376A>G (p.Asn459Ser)	LMNA	not specified	GO-ESP:0.00005(G)	Conflicting interpretations of pathogenicity(Last reviewed: May 13, 2016)	criteria provided, conflicting interpretations	1	156136432	GRCh38	178062	172348
NM_170707.3(LMNA):c.1411C>T (p.Arg471Cys)	LMNA	Mandibuloacral dysplasia with type A lipodystrophy, atypical|Charcot-Marie-Tooth disease|not provided	GO-ESP:0.00003(T)	Pathogenic(Last reviewed: Apr 30, 2015)	no assertion criteria provided	1	156136951	GRCh38	14503	29542
NM_170707.3(LMNA):c.1426G>T (p.Asp476Tyr)	LMNA	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 26, 2015)	criteria provided, single submitter	1	156136966	GRCh38	264073	257930
NM_170707.3(LMNA):c.1477C>T (p.Gln493Ter)	LMNA	Limb-girdle muscular dystrophy, type 1B|not provided		Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	1	156137017	GRCh38	14514	29553
NM_170707.3(LMNA):c.1489-2A>G	LMNA	not provided		Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	1	156137111	GRCh38	246076	244233
NM_170707.3(LMNA):c.1560G>A (p.Trp520Ter)	LMNA	not provided		Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	1	156137184	GRCh38	200944	196481
NM_005572.3(LMNA):c.1566C>A (p.Cys522Ter)	LMNA	Cardiovascular phenotype	GMAF:0.00240(T)	Likely pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	1	156137190	GRCh38	263601	257928
NM_170707.3(LMNA):c.1566C>T (p.Cys522=)	LMNA	Hutchinson-Gilford syndrome|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy|Mandibuloacral dysplasia|not specified|Familial partial lipodystrophy|Cardiovascular phenotype|Charcot-Marie-Tooth, Type 2|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00131(T), GMAF:0.00240(T), GO-ESP:0.00069(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	156137190	GRCh38	48043	57207
NM_170707.3(LMNA):c.1567G>A (p.Gly523Arg)	LMNA	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00011(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Nov 12, 2015)	criteria provided, conflicting interpretations	1	156137191	GRCh38	48045	57209
NM_170707.3(LMNA):c.1580G>A (p.Arg527His)	LMNA	Mandibuloacral dysostosis|Mandibuloacral dysplasia with type A lipodystrophy, atypical|Mandibuloacral dysplasia|not provided	GO-ESP:0.00008(A), GO-ESP:0.00007(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 23, 2015)	criteria provided, conflicting interpretations	1	156137204	GRCh38	14499	29538
NM_170707.3(LMNA):c.1580G>C (p.Arg527Pro)	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Familial partial lipodystrophy 2|not provided		Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	1	156137204	GRCh38	14481	29520
NM_170707.3(LMNA):c.1609-3C>G	LMNA	Limb-girdle muscular dystrophy|not provided		Likely pathogenic(Last reviewed: Mar 8, 2013)	criteria provided, single submitter	1	156137651	GRCh38	66856	77753
NM_170707.3(LMNA):c.1609-1G>A	LMNA	Primary dilated cardiomyopathy|Limb-girdle muscular dystrophy, type 1B|not provided		Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, multiple submitters, no conflicts	1	156137653	GRCh38	179809	172349
NM_170707.3(LMNA):c.1621C>T (p.Arg541Cys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, multiple submitters, no conflicts	1	156137666	GRCh38	48046	57210
NM_170707.3(LMNA):c.1621C>G (p.Arg541Gly)	LMNA	Dilated cardiomyopathy 1A|not provided		Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	1	156137666	GRCh38	29775	38730
NM_170707.3(LMNA):c.1622G>A (p.Arg541His)	LMNA	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00009(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 6, 2016)	criteria provided, conflicting interpretations	1	156137667	GRCh38	66860	77757
NM_170707.3(LMNA):c.1637C>T (p.Ser546Leu)	LMNA	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 6, 2015)	criteria provided, single submitter	1	156137682	GRCh38	263973	257937
NM_005572.3(LMNA):c.1698C>T (p.His566=)	LMNA	Hutchinson-Gilford syndrome|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Emery-Dreifuss muscular dystrophy|Mandibuloacral dysplasia|not specified|not provided|Familial partial lipodystrophy|Cardiovascular phenotype|Mandibuloacral dysplasia with type A lipodystrophy|Charcot-Marie-Tooth, Type 2|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.19701(T), GMAF:0.22030(T), GO-ESP:0.26551(T)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	156137743	GRCh38	48048	57212
NM_005572.3(LMNA):c.1711_1712delCGinsTC (p.Arg571Ser)	LMNA	not specified|not provided|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2016)	criteria provided, conflicting interpretations	1	156137756 - 156137757	GRCh38	200963	196485
NM_005572.3(LMNA):c.1711C>A (p.Arg571Ser)	LMNA	Dilated cardiomyopathy 1A|not provided	GO-ESP:0.00006(A)	Pathogenic(Last reviewed: Apr 5, 2011)	no assertion criteria provided	1	156137756	GRCh38	14485	29524
NM_170707.3(LMNA):c.1718C>T (p.Ser573Leu)	LMNA	Dilated cardiomyopathy 1A|Familial partial lipodystrophy 2|Mandibuloacral dysplasia with type A lipodystrophy, atypical|not specified|not provided	GO-ESP:0.00011(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jul 9, 2015)	criteria provided, conflicting interpretations	1	156138507	GRCh38	14517	29556
NM_170707.3(LMNA):c.1761G>A (p.Leu587=)	LMNA	Charcot-Marie-Tooth disease, type 2|Cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00154(A), GMAF:0.00060(A), GO-ESP:0.00208(A)	Benign/Likely benign(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	1	156138550	GRCh38	36477	45139
NM_170707.3(LMNA):c.1890G>C (p.Gly630=)	LMNA	Cardiovascular phenotype		Likely benign(Last reviewed: Nov 14, 2012)	criteria provided, single submitter	1	156138679	GRCh38	263454	257934
NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	LMNA	Primary dilated cardiomyopathy|Variant of unknown significance|Charcot-Marie-Tooth disease|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00108(T), GMAF:0.00040(T), GO-ESP:0.00124(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 27, 2016)	criteria provided, conflicting interpretations	1	156138719	GRCh38	14527	29566
NM_170707.3(LMNA):c.1931G>A (p.Arg644His)	LMNA	Congenital muscular dystrophy|Charcot-Marie-Tooth disease, type 2|not specified|Cardiovascular phenotype	GO-ESP:0.00012(A)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 16, 2016)	criteria provided, conflicting interpretations	1	156138720	GRCh38	161291	171050
NM_170707.3(LMNA):c.1968+5G>A	LMNA	Hutchinson-Gilford syndrome|Hutchinson-Gilford progeria syndrome, atypical		Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	1	156138762	GRCh38	162417	172117
NM_014697.2(NOS1AP):c.864C>T (p.Ser288=)	NOS1AP	Cardiac arrhythmia	GO-ESP:0.00538(T), GMAF:0.00160(T), GO-ESP:0.00568(T)	Likely benign(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	1	162357061	GRCh38	36662	45323
NM_014697.2(NOS1AP):c.1217C>T (p.Ala406Val)	NOS1AP	Cardiac arrhythmia	GO-ESP:0.00438(T), GMAF:0.00500(T), GO-ESP:0.00134(T)	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	1	162367163	GRCh38	36661	45322
NM_001677.3(ATP1B1):c.571C>T (p.Pro191Ser)	ATP1B1|NME7	Cardiac arrhythmia		Uncertain significance(Last reviewed: Aug 18, 2011)	no assertion criteria provided	1	169130013	GRCh38	35698	44362
NM_002065.6(GLUL):c.970C>T (p.Arg324Cys)	GLUL	Glutamine deficiency, congenital	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Nov 3, 2005)	no assertion criteria provided	1	182384557	GRCh38	16083	31122
NM_000069.2(CACNA1S):c.3257G>A (p.Arg1086His)	CACNA1S	Malignant hyperthermia susceptibility type 5		risk factor(Last reviewed: Mar 1, 2001)	no assertion criteria provided	1	201060815	GRCh38	17626	32665
NM_001001430.2(TNNT2):c.*66G>A	TNNT2	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00740(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	201359144	GRCh38	294893	278453
NM_001001430.2(TNNT2):c.861G>A (p.Trp287Ter)	TNNT2	not provided		Pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	1	201359216	GRCh38	181636	178913
NM_001001430.2(TNNT2):c.860G>A (p.Trp287Ter)	TNNT2	Familial hypertrophic cardiomyopathy 2|Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00001(T)	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2015)	criteria provided, multiple submitters, no conflicts	1	201359217	GRCh38	177636	172354
NM_000364.3(TNNT2):c.878G>A (p.Arg293His)	TNNT2	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(T), GMAF:0.00020(A), GO-ESP:0.00008(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2016)	criteria provided, conflicting interpretations	1	201359220	GRCh38	43677	52846
NM_000364.3(TNNT2):c.877C>T (p.Arg293Cys)	TNNT2	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2014)	criteria provided, conflicting interpretations	1	201359221	GRCh38	43676	52845
NM_001001430.2(TNNT2):c.853G>A (p.Gly285Arg)	TNNT2	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Oct 7, 2014)	no assertion criteria provided	1	201359224	GRCh38	180555	178434
NM_000364.3(TNNT2):c.869T>A (p.Val290Asp)	TNNT2	Primary familial hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Oct 8, 2014)	no assertion criteria provided	1	201359229	GRCh38	180556	178435
NM_001001430.2(TNNT2):c.836G>A (p.Gly279Glu)	TNNT2	not specified		Uncertain significance(Last reviewed: Mar 5, 2015)	criteria provided, single submitter	1	201359241	GRCh38	179939	172494
NM_001001430.2(TNNT2):c.833G>C (p.Arg278Pro)	TNNT2	not specified|not provided	GMAF:0.00020(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2016)	criteria provided, conflicting interpretations	1	201359244	GRCh38	177635	172355
NM_001001430.2(TNNT2):c.833G>A (p.Arg278His)	TNNT2	Familial hypertrophic cardiomyopathy 1|not specified	GMAF:0.00020(T), GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Feb 11, 2015)	criteria provided, single submitter	1	201359244	GRCh38	43674	52843
NM_000364.3(TNNT2):c.853C>T (p.Arg285Cys)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial hypertrophic cardiomyopathy 1|Costello syndrome|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00046(A), GO-ESP:0.00043(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2016)	criteria provided, conflicting interpretations	1	201359245	GRCh38	12411	27450
NM_000364.3(TNNT2):c.849G>A (p.Lys283=)	TNNT2	Dilated cardiomyopathy 1DD		Uncertain significance	no assertion criteria provided	1	201359249	GRCh38	132939	136688
NM_000364.3(TNNT2):c.845C>A (p.Ser282Tyr)	TNNT2	not specified		Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	1	201359253	GRCh38	229339	228283
NM_001001430.2(TNNT2):c.822-1G>T	TNNT2	not provided		Pathogenic(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	1	201359256	GRCh38	181634	178914
NM_001001430.2(TNNT2):c.821+22C>T	TNNT2	not specified	GMAF:0.01460(A), GO-ESP:0.00538(A)	Benign/Likely benign(Last reviewed: Sep 24, 2013)	criteria provided, multiple submitters, no conflicts	1	201359601	GRCh38	188691	186296
NM_001001432.2(TNNT2):c.803+5G>A	TNNT2	Cardiomyopathy|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Aug 12, 2016)	criteria provided, conflicting interpretations	1	201359618	GRCh38	36886	45547
NM_001001430.2(TNNT2):c.821+1G>C	TNNT2	Cardiomyopathy		Pathogenic(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	1	201359622	GRCh38	181649	178915
NM_000364.3(TNNT2):c.842+1G>T	TNNT2	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Dec 4, 2015)	criteria provided, single submitter	1	201359622	GRCh38	165533	172495
NM_000364.3(TNNT2):c.842+1G>A	TNNT2	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Dec 22, 2014)	criteria provided, single submitter	1	201359622	GRCh38	43673	52842
NM_001001430.2(TNNT2):c.814dupC (p.Gln272Profs)	TNNT2	Cardiomyopathy		Pathogenic(Last reviewed: Sep 11, 2013)	criteria provided, single submitter	1	201359630	GRCh38	181639	178916
NM_000364.3(TNNT2):c.833A>T (p.Asn278Ile)	TNNT2	Familial hypertrophic cardiomyopathy 2		Likely pathogenic	criteria provided, single submitter	1	201359632	GRCh38	217495	214101
NM_000364.3(TNNT2):c.829G>A (p.Asp277Asn)	TNNT2	Left ventricular noncompaction 6		Pathogenic(Last reviewed: Nov 16, 2004)	no assertion criteria provided	1	201359636	GRCh38	12417	27456
NM_000364.3(TNNT2):c.828C>A (p.Asn276Lys)	TNNT2	Primary familial hypertrophic cardiomyopathy	GMAF:0.00020(A)	Likely pathogenic(Last reviewed: Feb 13, 2013)	no assertion criteria provided	1	201359637	GRCh38	177855	172356
NM_000364.3(TNNT2):c.828C>T (p.Asn276=)	TNNT2	not specified	GO-ESP:0.00008(A), GMAF:0.00020(A), GO-ESP:0.00016(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2015)	criteria provided, conflicting interpretations	1	201359637	GRCh38	43672	52841
NM_001001430.2(TNNT2):c.805A>T (p.Asn269Tyr)	TNNT2	not specified		Uncertain significance(Last reviewed: Sep 21, 2011)	criteria provided, single submitter	1	201359639	GRCh38	181648	178917
NM_001001430.2(TNNT2):c.795A>C (p.Arg265=)	TNNT2	not specified		Uncertain significance(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	1	201359649	GRCh38	188690	186297
NM_001001430.2(TNNT2):c.794G>A (p.Arg265Gln)	TNNT2	not provided	GO-ESP:0.00002(T)	Likely pathogenic(Last reviewed: Oct 4, 2011)	criteria provided, single submitter	1	201359650	GRCh38	181646	178919
NM_000364.3(TNNT2):c.806A>G (p.Asn269Ser)	TNNT2	not specified		Uncertain significance(Last reviewed: Sep 26, 2014)	criteria provided, multiple submitters, no conflicts	1	201359659	GRCh38	43671	52840
NM_001001430.2(TNNT2):c.781-33C>T	TNNT2	not specified	GMAF:0.27720(A), GO-ESP:0.20840(A)	Benign	criteria provided, single submitter	1	201359696	GRCh38	256846	249664
NM_001001430.2(TNNT2):c.780+41C>G	TNNT2	not specified	GMAF:0.05790(C), GO-ESP:0.02234(C)	Likely benign(Last reviewed: Mar 15, 2012)	criteria provided, single submitter	1	201361238	GRCh38	188689	186298
NM_000364.3(TNNT2):c.801+6C>T	TNNT2	not specified	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	1	201361273	GRCh38	177655	172496
NM_001001430.2(TNNT2):c.780+5G>A	TNNT2	not provided		Likely pathogenic(Last reviewed: Jul 31, 2012)	criteria provided, single submitter	1	201361274	GRCh38	181633	178920
NM_001001430.2(TNNT2):c.775T>C (p.Tyr259His)	TNNT2	not provided		Likely pathogenic(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	1	201361284	GRCh38	181632	178921
NM_001001430.2(TNNT2):c.773A>T (p.Lys258Ile)	TNNT2	not specified		Uncertain significance(Last reviewed: Jun 6, 2016)	criteria provided, multiple submitters, no conflicts	1	201361286	GRCh38	43670	52839
NM_001001430.2(TNNT2):c.758A>G (p.Lys253Arg)	TNNT2	Primary familial hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.06020(C), GMAF:0.09740(C), GO-ESP:0.05073(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	201361301	GRCh38	43669	52838
NM_000364.3(TNNT2):c.775G>A (p.Glu259Lys)	TNNT2	not specified		Uncertain significance(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	1	201361305	GRCh38	178850	172357
NM_001001430.2(TNNT2):c.751C>A (p.Gln251Lys)	TNNT2	not specified		Uncertain significance(Last reviewed: Jun 26, 2014)	criteria provided, single submitter	1	201361308	GRCh38	181631	178922
NM_001001430.2(TNNT2):c.745G>A (p.Asp249Asn)	TNNT2	not provided	GMAF:0.00020(T), GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2013)	criteria provided, conflicting interpretations	1	201361314	GRCh38	181630	178923
NM_000364.3(TNNT2):c.765C>T (p.Phe255=)	TNNT2	not specified	GO-ESP:0.00007(A)	Likely benign(Last reviewed: Mar 1, 2008)	criteria provided, single submitter	1	201361315	GRCh38	43668	52837
NM_001001430.2(TNNT2):c.742T>G (p.Phe248Val)	TNNT2	not specified		Uncertain significance(Last reviewed: Oct 14, 2014)	criteria provided, single submitter	1	201361317	GRCh38	181645	178924
NM_001001430.2(TNNT2):c.742T>C (p.Phe248Leu)	TNNT2	not specified		Uncertain significance(Last reviewed: Mar 26, 2014)	criteria provided, single submitter	1	201361317	GRCh38	181629	178925
NM_001001430.2(TNNT2):c.737A>G (p.Glu246Gly)	TNNT2	not provided		Likely pathogenic(Last reviewed: Mar 8, 2012)	criteria provided, single submitter	1	201361322	GRCh38	181628	178926
NM_000364.3(TNNT2):c.755C>T (p.Ala252Val)	TNNT2	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jan 23, 2013)	no assertion criteria provided	1	201361325	GRCh38	177873	172497
NM_000364.3(TNNT2):c.753G>T (p.Glu251Asp)	TNNT2	Primary familial hypertrophic cardiomyopathy|not specified|not provided	GO-ESP:0.00008(A), GO-ESP:0.00033(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2015)	criteria provided, conflicting interpretations	1	201361327	GRCh38	43667	52836
NM_001001430.2(TNNT2):c.722A>G (p.Tyr241Cys)	TNNT2	not provided		Uncertain significance(Last reviewed: Jun 24, 2013)	criteria provided, single submitter	1	201361337	GRCh38	191800	189384
NM_001001430.2(TNNT2):c.706C>T (p.Leu236=)	TNNT2	not specified		Uncertain significance(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	1	201361353	GRCh38	188688	186299
NM_001001430.2(TNNT2):c.690-4G>T	TNNT2	Sudden cardiac death|not specified	GO-ESP:0.00015(A), GO-ESP:0.00016(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 22, 2015)	criteria provided, conflicting interpretations	1	201361373	GRCh38	43664	52833
NM_001001430.2(TNNT2):c.690-5T>G	TNNT2	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00002(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	201361374	GRCh38	181605	178927
NM_000364.3(TNNT2):c.711-6G>A	TNNT2	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	1	201361375	GRCh38	43665	52834
NM_000364.3(TNNT2):c.711-7C>T	TNNT2	not specified	GO-ESP:0.00008(A), GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	1	201361376	GRCh38	43666	52835
NM_001001430.2(TNNT2):c.690-9C>A	TNNT2	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	201361378	GRCh38	294894	279740
NM_000364.3(TNNT2):c.711-13_711-11delCTT	TNNT2	not specified	GMAF:0.00060(-), GO-ESP:0.00009(-)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	1	201361380 - 201361382	GRCh38	43663	52832
NM_000364.3(TNNT2):c.710+13A>C	TNNT2	not specified	GMAF:0.00020(G), GO-ESP:0.00002(G)	Likely benign(Last reviewed: Apr 17, 2014)	criteria provided, single submitter	1	201361900	GRCh38	165538	172358
NM_001001430.2(TNNT2):c.682C>G (p.Gln228Glu)	TNNT2	not specified		Uncertain significance(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	1	201361920	GRCh38	181627	178928
NM_001001430.2(TNNT2):c.676G>A (p.Glu226Lys)	TNNT2	not specified		Uncertain significance(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	1	201361926	GRCh38	181626	178929
NM_001001430.2(TNNT2):c.662T>C (p.Ile221Thr)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00020(G), GO-ESP:0.00012(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	201361940	GRCh38	181604	178930
NM_001001430.2(TNNT2):c.661A>G (p.Ile221Val)	TNNT2	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	201361941	GRCh38	294895	278568
NM_000364.3(TNNT2):c.673G>T (p.Val225Leu)	TNNT2	Familial hypertrophic cardiomyopathy 1|not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jun 4, 2015)	criteria provided, multiple submitters, no conflicts	1	201361950	GRCh38	43662	52831
NM_000364.3(TNNT2):c.670A>G (p.Lys224Glu)	TNNT2	not specified		Uncertain significance(Last reviewed: Dec 7, 2009)	no assertion criteria provided	1	201361953	GRCh38	43661	52830
NM_001276347.1(TNNT2):c.635T>A (p.Leu212Gln)	TNNT2	Left ventricular noncompaction cardiomyopathy		Uncertain significance(Last reviewed: Jul 3, 2015)	criteria provided, single submitter	1	201361967	GRCh38	222842	224185
NM_000364.3(TNNT2):c.653T>C (p.Ile218Thr)	TNNT2	Familial hypertrophic cardiomyopathy 2		Likely pathogenic	criteria provided, single submitter	1	201361970	GRCh38	217496	214102
NM_001001430.2(TNNT2):c.629_631delAGA (p.Lys210del)	TNNT2	Primary dilated cardiomyopathy|Left ventricular noncompaction 6|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, multiple submitters, no conflicts	1	201361971 - 201361973	GRCh38	43659	52828
NM_000364.3(TNNT2):c.635G>C (p.Arg212Pro)	TNNT2	not specified		Uncertain significance(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	1	201361988	GRCh38	229338	228281
NM_000364.3(TNNT2):c.635G>A (p.Arg212Gln)	TNNT2	not specified		Uncertain significance(Last reviewed: Jun 13, 2013)	criteria provided, single submitter	1	201361988	GRCh38	165539	172498
NM_000364.3(TNNT2):c.635G>T (p.Arg212Leu)	TNNT2	Left ventricular noncompaction 6		Pathogenic(Last reviewed: Nov 16, 2004)	no assertion criteria provided	1	201361988	GRCh38	12416	27455
NM_001001430.2(TNNT2):c.613C>T (p.Arg205Trp)	TNNT2	Primary dilated cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	1	201361989	GRCh38	180554	178436
NM_000364.3(TNNT2):c.629C>T (p.Thr210Ile)	TNNT2	not specified		Uncertain significance(Last reviewed: Nov 28, 2012)	criteria provided, single submitter	1	201361994	GRCh38	43658	52827
NM_000364.3(TNNT2):c.619A>G (p.Lys207Glu)	TNNT2	not specified		Uncertain significance(Last reviewed: Mar 21, 2014)	criteria provided, single submitter	1	201362004	GRCh38	165540	172359
NM_001001430.2(TNNT2):c.580A>G (p.Thr194Ala)	TNNT2	Primary familial hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Oct 11, 2013)	no assertion criteria provided	1	201362022	GRCh38	155842	165594
NM_001001430.2(TNNT2):c.580-45_580-20delins275	TNNT2	not specified		Uncertain significance	no assertion criteria provided	1	201362042 - 201362067	GRCh38	188687	186300
NM_001001430.2(TNNT2):c.571-1G>A	TNNT2	Dilated cardiomyopathy 1DD|not specified|not provided	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2015)	criteria provided, conflicting interpretations	1	201362395	GRCh38	132940	136689
NM_000364.3(TNNT2):c.601-379G>A	TNNT2	not specified	GO-ESP:0.00008(T), GO-ESP:0.00009(T)	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	1	201362401	GRCh38	43656	52825
NM_001001430.2(TNNT2):c.571-8C>T	TNNT2	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00009(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	201362402	GRCh38	43657	52826
NM_001001430.2(TNNT2):c.571-29G>A	TNNT2	not specified	GMAF:0.00060(T), GO-ESP:0.00096(T)	Uncertain significance(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	1	201362423	GRCh38	188686	186301
NM_001001430.2(TNNT2):c.571-32A>C	TNNT2	not specified	GMAF:0.25780(T)	Benign	criteria provided, single submitter	1	201362426	GRCh38	256845	249665
NM_001001430.2(TNNT2):c.569A>C (p.Lys190Thr)	TNNT2	not specified		Uncertain significance(Last reviewed: Nov 25, 2013)	criteria provided, single submitter	1	201363297	GRCh38	181623	178933
NM_001001430.2(TNNT2):c.563T>C (p.Ile188Thr)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6		Uncertain significance(Last reviewed: Feb 17, 2016)	criteria provided, single submitter	1	201363303	GRCh38	238203	238208
NM_001001430.2(TNNT2):c.562A>G (p.Ile188Val)	TNNT2	not specified		Likely benign(Last reviewed: Aug 11, 2011)	criteria provided, single submitter	1	201363304	GRCh38	181644	178934
NM_000364.3(TNNT2):c.573G>T (p.Met191Ile)	TNNT2	not specified		Uncertain significance(Last reviewed: Feb 16, 2015)	criteria provided, single submitter	1	201363323	GRCh38	229337	228284
NM_000364.3(TNNT2):c.572T>G (p.Met191Arg)	TNNT2	Primary dilated cardiomyopathy		Uncertain significance(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	1	201363324	GRCh38	222841	224186
NM_000364.3(TNNT2):c.567C>T (p.Ser189=)	TNNT2	not specified	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	1	201363329	GRCh38	43655	52824
NM_001001430.2(TNNT2):c.536C>T (p.Ser179Phe)	TNNT2	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Aug 13, 2014)	criteria provided, single submitter	1	201363330	GRCh38	177634	172499
NM_001001430.2(TNNT2):c.534G>C (p.Leu178Phe)	TNNT2	not specified|not provided		Uncertain significance(Last reviewed: Jun 24, 2013)	criteria provided, multiple submitters, no conflicts	1	201363332	GRCh38	43654	52823
NM_000364.3(TNNT2):c.560C>A (p.Ala187Asp)	TNNT2	not specified		Uncertain significance(Last reviewed: Jun 1, 2012)	criteria provided, single submitter	1	201363336	GRCh38	43653	52822
NM_001001430.2(TNNT2):c.518G>A (p.Arg173Gln)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|not provided		Likely pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, multiple submitters, no conflicts	1	201363348	GRCh38	43649	52818
NM_001001430.2(TNNT2):c.517C>T (p.Arg173Trp)	TNNT2	Primary dilated cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	1	201363349	GRCh38	228409	228285
NM_000364.3(TNNT2):c.547C>G (p.Arg183Gly)	TNNT2	not specified		Uncertain significance(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	1	201363349	GRCh38	165542	172360
NM_001001430.2(TNNT2):c.496A>G (p.Arg166Gly)	TNNT2	not provided		Likely pathogenic(Last reviewed: Feb 28, 2014)	criteria provided, single submitter	1	201363370	GRCh38	181622	178936
NM_001001430.2(TNNT2):c.492C>A (p.Asn164Lys)	TNNT2	not specified	GMAF:0.00120(A)	Uncertain significance(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	1	201363374	GRCh38	181621	178937
NM_000364.3(TNNT2):c.522C>T (p.Asn174=)	TNNT2	Dilated cardiomyopathy 1DD|not specified	GMAF:0.00120(A), GO-ESP:0.00046(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 11, 2015)	criteria provided, conflicting interpretations	1	201363374	GRCh38	132941	136690
NM_001001430.2(TNNT2):c.487_489delGAG (p.Glu163del)	TNNT2	Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: May 1, 2015)	criteria provided, multiple submitters, no conflicts	1	201363377 - 201363379	GRCh38	43648	52817
NM_001001430.2(TNNT2):c.486_487delGGinsTT (p.Glu162_Glu163delinsAspTer)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|not specified		Uncertain significance(Last reviewed: Jan 9, 2016)	criteria provided, single submitter	1	201363379 - 201363380	GRCh38	181638	178938
NM_001001430.2(TNNT2):c.476G>A (p.Arg159Gln)	TNNT2	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Mar 11, 2015)	criteria provided, conflicting interpretations	1	201363390	GRCh38	43647	52816
NM_000364.3(TNNT2):c.505C>T (p.Arg169Ter)	TNNT2	Primary dilated cardiomyopathy	GO-ESP:0.00002(A)	Likely pathogenic(Last reviewed: May 23, 2008)	no assertion criteria provided	1	201363391	GRCh38	43646	52815
NM_000364.3(TNNT2):c.503G>A (p.Arg168Gln)	TNNT2	not specified		Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	1	201363393	GRCh38	43645	52814
NM_001001430.2(TNNT2):c.472C>G (p.Arg158Gly)	TNNT2	not specified		Uncertain significance(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	1	201363394	GRCh38	181620	178939
NM_001001430.2(TNNT2):c.460-1G>C	TNNT2	not specified		Uncertain significance(Last reviewed: May 25, 2014)	criteria provided, single submitter	1	201363407	GRCh38	181619	178940
NM_000364.3(TNNT2):c.490-69C>T	TNNT2	Dilated cardiomyopathy 1DD		Uncertain significance	no assertion criteria provided	1	201363475	GRCh38	132942	136691
NM_000364.3(TNNT2):c.489+7dupG	TNNT2	not specified		Likely benign(Last reviewed: Jun 10, 2011)	criteria provided, single submitter	1	201364291	GRCh38	43644	52813
NM_000364.3(TNNT2):c.487G>A (p.Ala163Thr)	TNNT2	not specified		Uncertain significance(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	1	201364300	GRCh38	179660	172500
NM_001001430.2(TNNT2):c.450C>A (p.Asn150Lys)	TNNT2	Familial hypertrophic cardiomyopathy 1		Uncertain significance(Last reviewed: Dec 17, 2014)	criteria provided, single submitter	1	201364307	GRCh38	192311	190101
NM_001001430.2(TNNT2):c.444G>C (p.Arg148=)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00830(G), GMAF:0.00620(G), GO-ESP:0.00243(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	201364313	GRCh38	43641	52810
NM_001001430.2(TNNT2):c.443G>A (p.Arg148Gln)	TNNT2	not provided		Likely pathogenic(Last reviewed: Mar 19, 2015)	criteria provided, single submitter	1	201364314	GRCh38	181618	178941
NM_001001430.2(TNNT2):c.442C>T (p.Arg148Trp)	TNNT2	not specified		Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	1	201364315	GRCh38	181643	178942
NM_001001430.2(TNNT2):c.430C>T (p.Arg144Trp)	TNNT2	Dilated cardiomyopathy 1DD|Cardiomyopathy	GMAF:0.00020(A), GO-ESP:0.00004(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 2, 2011)	criteria provided, conflicting interpretations	1	201364327	GRCh38	132943	136692
NM_001001430.2(TNNT2):c.423G>C (p.Arg141=)	TNNT2	not specified		Uncertain significance(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	1	201364334	GRCh38	188685	186302
NM_001001430.2(TNNT2):c.422G>A (p.Arg141Gln)	TNNT2	not provided		Pathogenic(Last reviewed: Sep 16, 2013)	criteria provided, single submitter	1	201364335	GRCh38	181617	178943
NM_001001430.2(TNNT2):c.421delC (p.Arg141Glyfs)	TNNT2	Left ventricular noncompaction 6|not specified	GO-ESP:0.00004(-)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 9, 2016)	criteria provided, conflicting interpretations	1	201364336	GRCh38	181635	178944
NM_000364.3(TNNT2):c.451C>A (p.Arg151=)	TNNT2	not specified	GMAF:0.00060(T), GO-ESP:0.00017(T)	Likely benign(Last reviewed: Jan 6, 2012)	criteria provided, single submitter	1	201364336	GRCh38	43643	52812
NM_001001430.2(TNNT2):c.421C>T (p.Arg141Trp)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not provided	GMAF:0.00060(T)	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, multiple submitters, no conflicts	1	201364336	GRCh38	12414	27453
NM_001001430.2(TNNT2):c.416G>A (p.Arg139His)	TNNT2	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2016)	criteria provided, conflicting interpretations	1	201364341	GRCh38	43642	52811
NM_001001430.2(TNNT2):c.415C>T (p.Arg139Cys)	TNNT2	not specified		Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	1	201364342	GRCh38	43640	52809
NM_001276345.1(TNNT2):c.443A>G (p.Gln148Arg)	TNNT2	Cardiomyopathy|not specified		Uncertain significance(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	1	201364344	GRCh38	180553	178437
NM_001001430.2(TNNT2):c.406G>A (p.Glu136Lys)	TNNT2	Primary dilated cardiomyopathy	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Sep 29, 2014)	no assertion criteria provided	1	201364351	GRCh38	180552	178438
NM_001001430.2(TNNT2):c.400C>T (p.Arg134Trp)	TNNT2	Primary dilated cardiomyopathy|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2015)	criteria provided, conflicting interpretations	1	201364357	GRCh38	127070	132581
NM_000364.3(TNNT2):c.430C>G (p.Arg144Gly)	TNNT2	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: Feb 21, 2014)	criteria provided, single submitter	1	201364357	GRCh38	43639	52808
NM_000364.3(TNNT2):c.422G>C (p.Arg141Pro)	TNNT2	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: Dec 11, 2012)	criteria provided, single submitter	1	201364365	GRCh38	43638	52807
NM_000364.3(TNNT2):c.422G>A (p.Arg141Gln)	TNNT2	Primary dilated cardiomyopathy		Pathogenic(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	1	201364365	GRCh38	43637	52806
NM_001001430.2(TNNT2):c.391C>T (p.Arg131Trp)	TNNT2	Primary dilated cardiomyopathy|Left ventricular noncompaction 6|not provided	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 13, 2016)	criteria provided, conflicting interpretations	1	201364366	GRCh38	12415	27454
NM_001001430.2(TNNT2):c.388C>T (p.Arg130Cys)	TNNT2	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, multiple submitters, no conflicts	1	201364369	GRCh38	43636	52805
NM_001001430.2(TNNT2):c.382G>A (p.Glu128Lys)	TNNT2	not provided		Likely pathogenic(Last reviewed: Apr 23, 2012)	criteria provided, single submitter	1	201364375	GRCh38	181616	178945
NM_000364.3(TNNT2):c.412-6_412-4delCCT	TNNT2	not specified	GO-ESP:0.00011(-)	Likely benign(Last reviewed: Nov 9, 2010)	criteria provided, single submitter	1	201364379 - 201364381	GRCh38	43635	52804
NM_000364.3(TNNT2):c.411C>T (p.Ile137=)	TNNT2	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	1	201365191	GRCh38	177785	172361
NM_001001430.2(TNNT2):c.376A>T (p.Arg126Trp)	TNNT2	not specified		Uncertain significance(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	1	201365196	GRCh38	188684	186303
NM_000364.3(TNNT2):c.382G>A (p.Glu128Lys)	TNNT2	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	1	201365220	GRCh38	43634	52803
NM_001001430.2(TNNT2):c.330T>G (p.Phe110Leu)	TNNT2	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2015)	criteria provided, multiple submitters, no conflicts	1	201365242	GRCh38	177807	172501
NM_001001430.2(TNNT2):c.328T>G (p.Phe110Val)	TNNT2	not specified		Uncertain significance(Last reviewed: Apr 8, 2015)	no assertion criteria provided	1	201365244	GRCh38	235065	236738
NM_001001430.2(TNNT2):c.328T>C (p.Phe110Leu)	TNNT2	not provided		Likely pathogenic(Last reviewed: Feb 21, 2014)	no assertion criteria provided	1	201365244	GRCh38	235064	236739
NM_001001430.2(TNNT2):c.328T>A (p.Phe110Ile)	TNNT2	Familial hypertrophic cardiomyopathy 2|not provided		Pathogenic(Last reviewed: Jan 30, 2013)	no assertion criteria provided	1	201365244	GRCh38	12412	27451
NM_000364.3(TNNT2):c.354_355delTCinsGT (p.His119Tyr)	TNNT2	not specified		Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	1	201365247 - 201365248	GRCh38	229336	228287
NM_000364.3(TNNT2):c.355C>T (p.His119Tyr)	TNNT2	not specified		Uncertain significance(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	1	201365247	GRCh38	43633	52802
NM_001001430.2(TNNT2):c.319G>T (p.Glu107Ter)	TNNT2	not provided		Pathogenic(Last reviewed: Mar 8, 2012)	criteria provided, single submitter	1	201365253	GRCh38	181615	178946
NM_001001430.2(TNNT2):c.319G>A (p.Glu107Lys)	TNNT2	not provided		Likely pathogenic(Last reviewed: Apr 30, 2013)	criteria provided, single submitter	1	201365253	GRCh38	181614	178947
NM_001001430.2(TNNT2):c.318C>G (p.Ile106Met)	TNNT2	not specified	GMAF:0.30490(G)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	1	201365254	GRCh38	188683	186304
NM_001001430.2(TNNT2):c.318C>T (p.Ile106=)	TNNT2	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.68276(A), GMAF:0.30490(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	201365254	GRCh38	43632	52801
NM_001001430.2(TNNT2):c.311C>T (p.Ala104Val)	TNNT2	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 12, 2015)	criteria provided, conflicting interpretations	1	201365261	GRCh38	177633	172362
NM_000364.3(TNNT2):c.329A>G (p.Asn110Ser)	TNNT2	not specified		Uncertain significance(Last reviewed: May 1, 2014)	criteria provided, single submitter	1	201365273	GRCh38	179657	172502
NM_001001430.2(TNNT2):c.291G>T (p.Lys97Asn)	TNNT2	Primary familial hypertrophic cardiomyopathy|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Mar 11, 2015)	criteria provided, conflicting interpretations	1	201365281	GRCh38	43631	52800
NM_000364.3(TNNT2):c.315_317delGGA (p.Glu106del)	TNNT2	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	1	201365285 - 201365287	GRCh38	177683	172363
NM_000364.3(TNNT2):c.316G>A (p.Glu106Lys)	TNNT2	Left ventricular noncompaction 6		Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	1	201365286	GRCh38	224775	226594
NM_000364.3(TNNT2):c.313A>G (p.Met105Val)	TNNT2	not specified	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Mar 3, 2009)	no assertion criteria provided	1	201365289	GRCh38	43630	52799
NM_001001430.2(TNNT2):c.281G>T (p.Arg94Leu)	TNNT2	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2016)	criteria provided, conflicting interpretations	1	201365291	GRCh38	43629	52798
NM_001001430.2(TNNT2):c.281G>A (p.Arg94His)	TNNT2	Familial hypertrophic cardiomyopathy 2|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, multiple submitters, no conflicts	1	201365291	GRCh38	43628	52797
NM_001001430.2(TNNT2):c.280C>T (p.Arg94Cys)	TNNT2	Familial restrictive cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, multiple submitters, no conflicts	1	201365292	GRCh38	165549	172503
NM_001001430.2(TNNT2):c.279G>T (p.Lys93Asn)	TNNT2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	1	201365293	GRCh38	264318	257933
NM_001001430.2(TNNT2):c.275G>T (p.Arg92Leu)	TNNT2	not provided		Pathogenic(Last reviewed: Jan 18, 2012)	no assertion criteria provided	1	201365297	GRCh38	235063	236740
NM_001001430.2(TNNT2):c.274_275insTTC (p.His91_Arg92insLeu)	TNNT2	Cardiomyopathy		Uncertain significance(Last reviewed: Apr 30, 2012)	criteria provided, single submitter	1	201365297 - 201365298	GRCh38	181637	178949
NM_001001430.2(TNNT2):c.275G>A (p.Arg92Gln)	TNNT2	Familial hypertrophic cardiomyopathy 2|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: May 6, 2016)	criteria provided, multiple submitters, no conflicts	1	201365297	GRCh38	12409	27448
NM_000364.3(TNNT2):c.304C>T (p.Arg102Trp)	TNNT2	Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00001(A)	Pathogenic/Likely pathogenic(Last reviewed: Jul 28, 2016)	criteria provided, multiple submitters, no conflicts	1	201365298	GRCh38	43627	52796
NM_000364.3(TNNT2):c.295-14C>T	TNNT2	not specified	GO-ESP:0.00012(A)	Likely benign(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	1	201365321	GRCh38	228021	228286
NM_001001430.2(TNNT2):c.265-19C>T	TNNT2	not specified	GO-ESP:0.00008(A)	Benign(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	1	201365326	GRCh38	137689	141392
NM_000364.3(TNNT2):c.294+7G>A	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Primary familial hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01076(T), GMAF:0.01000(T), GO-ESP:0.00317(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	201365603	GRCh38	36884	45545
NM_000364.3(TNNT2):c.294T>G (p.Asp98Glu)	TNNT2	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	1	201365610	GRCh38	43625	52794
NM_001001430.2(TNNT2):c.261T>G (p.Phe87Leu)	TNNT2	Cardiomyopathy		Pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	1	201365613	GRCh38	181613	178950
NM_001001430.2(TNNT2):c.257A>C (p.Asp86Ala)	TNNT2	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00001(G)	Likely pathogenic(Last reviewed: Nov 14, 2014)	criteria provided, single submitter	1	201365617	GRCh38	43626	52795
NM_000364.3(TNNT2):c.282A>T (p.Arg94Ser)	TNNT2	not specified		Uncertain significance(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	1	201365622	GRCh38	43624	52793
NM_001001430.2(TNNT2):c.251G>C (p.Arg84Thr)	TNNT2	not specified|not provided|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2015)	criteria provided, conflicting interpretations	1	201365623	GRCh38	43623	52792
NM_000364.3(TNNT2):c.279G>C (p.Glu93Asp)	TNNT2	not specified		Uncertain significance(Last reviewed: Jan 7, 2013)	no assertion criteria provided	1	201365625	GRCh38	165551	172364
NM_001001430.2(TNNT2):c.247G>A (p.Glu83Lys)	TNNT2	Primary familial hypertrophic cardiomyopathy|not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2015)	criteria provided, conflicting interpretations	1	201365627	GRCh38	177632	172504
NM_001001430.2(TNNT2):c.244G>A (p.Gly82Arg)	TNNT2	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, multiple submitters, no conflicts	1	201365630	GRCh38	177644	172365
NM_000364.3(TNNT2):c.270C>T (p.Pro90=)	TNNT2	not specified	GMAF:0.00020(C)	Likely benign(Last reviewed: Oct 3, 2012)	criteria provided, single submitter	1	201365634	GRCh38	43622	52791
NM_001001430.2(TNNT2):c.240C>G (p.Pro80=)	TNNT2	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00015(C), GMAF:0.00020(C), GO-ESP:0.00008(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	201365634	GRCh38	43621	52790
NM_001001430.2(TNNT2):c.239C>T (p.Pro80Leu)	TNNT2	not provided		Pathogenic(Last reviewed: Oct 14, 2014)	criteria provided, single submitter	1	201365635	GRCh38	181641	178951
NM_001001430.2(TNNT2):c.238C>A (p.Pro80Thr)	TNNT2	not provided		Pathogenic(Last reviewed: Jun 24, 2013)	criteria provided, single submitter	1	201365636	GRCh38	181611	178952
NM_001001430.2(TNNT2):c.238C>T (p.Pro80Ser)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|not specified		Uncertain significance(Last reviewed: Sep 26, 2015)	criteria provided, multiple submitters, no conflicts	1	201365636	GRCh38	43620	52789
NM_001001430.2(TNNT2):c.236T>A (p.Ile79Asn)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2016)	criteria provided, multiple submitters, no conflicts	1	201365638	GRCh38	12408	27447
NM_000364.3(TNNT2):c.260C>T (p.Pro87Leu)	TNNT2	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00008(A), GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	1	201365644	GRCh38	43619	52788
NM_001001430.2(TNNT2):c.229C>A (p.Pro77Thr)	TNNT2	not provided		Likely pathogenic(Last reviewed: Sep 2, 2014)	criteria provided, single submitter	1	201365645	GRCh38	181610	178953
NM_001001430.2(TNNT2):c.224T>G (p.Val75Gly)	TNNT2	not specified	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Jul 17, 2014)	criteria provided, single submitter	1	201365650	GRCh38	181609	178954
NM_000364.3(TNNT2):c.248A>G (p.Asn83Ser)	TNNT2	Primary dilated cardiomyopathy	GO-ESP:0.00002(C)	Likely pathogenic(Last reviewed: Mar 9, 2009)	no assertion criteria provided	1	201365656	GRCh38	43618	52787
NM_000364.3(TNNT2):c.245C>A (p.Pro82His)	TNNT2	not provided		Uncertain significance	no assertion criteria provided	1	201365659	GRCh38	91910	97388
NM_001001430.2(TNNT2):c.208T>C (p.Phe70Leu)	TNNT2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	1	201365666	GRCh38	264128	257931
NM_001001430.2(TNNT2):c.207G>A (p.Ser69=)	TNNT2	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.09196(T), GMAF:0.08250(T), GO-ESP:0.06442(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	201365667	GRCh38	43617	52786
NM_001001430.2(TNNT2):c.203+6T>C	TNNT2	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	201366832	GRCh38	43616	52785
NM_000364.3(TNNT2):c.228G>C (p.Lys76Asn)	TNNT2	not specified		Uncertain significance(Last reviewed: Nov 21, 2013)	criteria provided, single submitter	1	201366843	GRCh38	179442	172505
NM_000364.3(TNNT2):c.208A>C (p.Met70Leu)	TNNT2	not specified	GMAF:0.00040(C)	Uncertain significance(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	1	201366863	GRCh38	165554	172366
NM_000364.3(TNNT2):c.208A>G (p.Met70Val)	TNNT2	not specified	GO-ESP:0.00008(C), GMAF:0.00040(C), GO-ESP:0.00005(C)	Likely benign(Last reviewed: Nov 13, 2014)	criteria provided, single submitter	1	201366863	GRCh38	43615	52784
NM_001001430.2(TNNT2):c.170-4C>G	TNNT2	not specified	GO-ESP:0.00001(C)	Benign/Likely benign(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	1	201366875	GRCh38	43614	52783
NM_001001430.2(TNNT2):c.170-11A>G	TNNT2	not specified	GMAF:0.00120(C), GO-ESP:0.00064(C)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	1	201366882	GRCh38	188682	186305
NM_001001430.2(TNNT2):c.170-29C>G	TNNT2	not specified	GMAF:0.02880(C), GO-ESP:0.00891(C)	Benign/Likely benign(Last reviewed: Sep 24, 2013)	criteria provided, multiple submitters, no conflicts	1	201366900	GRCh38	188681	186306
NM_000364.3(TNNT2):c.199+14G>A	TNNT2	not specified		Likely benign(Last reviewed: Mar 21, 2015)	criteria provided, single submitter	1	201367757	GRCh38	228020	228289
NM_001001430.2(TNNT2):c.134-29C>G	TNNT2	not specified		Likely benign(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	1	201367835	GRCh38	188680	186307
NM_001001430.2(TNNT2):c.134-50G>A	TNNT2	not specified	GMAF:0.28550(T), GO-ESP:0.41283(T)	Benign	criteria provided, single submitter	1	201367856	GRCh38	256843	249666
NM_001001430.2(TNNT2):c.133+12G>A	TNNT2	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01722(T), GMAF:0.01640(T), GO-ESP:0.00494(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	201368150	GRCh38	43613	52782
NM_000364.3(TNNT2):c.163+5G>A	TNNT2	not specified		Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	1	201368157	GRCh38	177643	172506
NM_001001430.2(TNNT2):c.133G>A (p.Glu45Lys)	TNNT2	Cardiomyopathy		Uncertain significance(Last reviewed: Aug 30, 2011)	criteria provided, single submitter	1	201368162	GRCh38	181640	178955
NM_000364.3(TNNT2):c.144C>T (p.Thr48=)	TNNT2	not specified	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	1	201368181	GRCh38	228019	228288
NM_000364.3(TNNT2):c.136G>C (p.Ala46Pro)	TNNT2	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00005(G)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2014)	criteria provided, conflicting interpretations	1	201368189	GRCh38	43612	52781
NM_000364.3(TNNT2):c.113C>T (p.Ala38Val)	TNNT2	Primary familial hypertrophic cardiomyopathy|not specified|Increased left ventricular wall thickness	GO-ESP:0.00031(A), GMAF:0.00020(T), GO-ESP:0.00049(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 13, 2015)	criteria provided, conflicting interpretations	1	201368212	GRCh38	43675	52844
NM_001001430.2(TNNT2):c.68-81G>A	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6	GMAF:0.00260(T)	Likely benign(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	1	201368308	GRCh38	238204	238209
NM_000364.3(TNNT2):c.97G>A (p.Glu33Lys)	TNNT2	not specified	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Jan 10, 2012)	criteria provided, single submitter	1	201369816	GRCh38	43402	52572
NM_000364.3(TNNT2):c.90C>T (p.Asp30=)	TNNT2	not specified	GO-ESP:0.00017(A)	Likely benign(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	1	201369823	GRCh38	165556	172367
NM_001001430.2(TNNT2):c.68-1621C>T	TNNT2	not specified		Benign(Last reviewed: May 24, 2014)	criteria provided, single submitter	1	201369848	GRCh38	137690	141393
NM_000364.3(TNNT2):c.68-5_68-3delinsTT	TNNT2	not specified|Cardiomyopathy	GMAF:0.00800(-)	Benign/Likely benign(Last reviewed: Aug 27, 2015)	criteria provided, multiple submitters, no conflicts	1	201369848 - 201369850	GRCh38	43400	52570
NM_000364.3(TNNT2):c.68-8A>G	TNNT2	not specified	GO-ESP:0.00969(C), GMAF:0.00560(C), GO-ESP:0.00233(C)	Benign(Last reviewed: Dec 23, 2011)	criteria provided, single submitter	1	201369853	GRCh38	43401	52571
NM_000364.3(TNNT2):c.63T>G (p.Val21=)	TNNT2	not specified	GO-ESP:0.00009(C)	Likely benign(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	1	201372031	GRCh38	43660	52829
NM_001001430.1(TNNT2):c.53-11_53-7delCTTCT	TNNT2	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.47960(AGAAG)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	201372048 - 201372052	GRCh38	43652	52821
NM_001001430.2(TNNT2):c.53-12delT	TNNT2	Cardiomyopathy		Benign(Last reviewed: Apr 11, 2012)	criteria provided, single submitter	1	201372053	GRCh38	181608	178957
NM_001001430.2(TNNT2):c.53-22C>A	TNNT2	not specified	GMAF:0.00060(T), GO-ESP:0.00040(T)	Uncertain significance(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	1	201372063	GRCh38	188679	186308
NM_001001430.2(TNNT2):c.52+7G>A	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00018(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	201372138	GRCh38	43651	52820
NM_000364.3(TNNT2):c.52+6C>T	TNNT2	not specified		Uncertain significance(Last reviewed: Jan 14, 2009)	no assertion criteria provided	1	201372139	GRCh38	43650	52819
NM_001001430.2(TNNT2):c.42-20G>A	TNNT2	not specified	GMAF:0.01160(T), GO-ESP:0.00325(T)	Likely benign(Last reviewed: Jan 3, 2013)	criteria provided, multiple submitters, no conflicts	1	201372175	GRCh38	188678	186309
NM_001001430.2(TNNT2):c.42-29C>T	TNNT2	not specified		Likely benign	criteria provided, single submitter	1	201372184	GRCh38	256844	249667
NM_000364.3(TNNT2):c.41+16A>G	TNNT2	not specified	GO-ESP:0.00046(C), GMAF:0.00020(C), GO-ESP:0.00008(C)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	1	201373198	GRCh38	93442	99349
NM_000364.3(TNNT2):c.39G>A (p.Glu13=)	TNNT2	not specified		Uncertain significance(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	1	201373216	GRCh38	165557	172507
NM_001001430.2(TNNT2):c.-1C>A	TNNT2	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	201373255	GRCh38	294896	279841
NM_001001430.2(TNNT2):c.-5A>G	TNNT2	not specified	GO-ESP:0.00001(C)	Likely benign(Last reviewed: Nov 7, 2012)	criteria provided, single submitter	1	201373259	GRCh38	181606	178958
NM_001001430.2(TNNT2):c.-22G>C	TNNT2	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	201377630	GRCh38	294898	279751
NM_001001430.2(TNNT2):c.-22G>T	TNNT2	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	201377630	GRCh38	294897	278454
NM_003238.3(TGFB2):c.114G>A (p.Glu38=)	TGFB2	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00340(A), GO-ESP:0.00334(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	218346815	GRCh38	213834	209426
NM_003238.3(TGFB2):c.199G>A (p.Val67Met)	TGFB2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Dec 16, 2015)	criteria provided, multiple submitters, no conflicts	1	218346900	GRCh38	213839	209429
NM_003238.3(TGFB2):c.357G>A (p.Pro119=)	TGFB2	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00089(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	218405179	GRCh38	213836	209434
NM_003238.3(TGFB2):c.583G>T (p.Glu195Ter)	TGFB2	not provided		Pathogenic(Last reviewed: Sep 3, 2014)	criteria provided, single submitter	1	218434154	GRCh38	213841	209436
NM_003238.3(TGFB2):c.588C>T (p.Gly196=)	TGFB2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(T), GO-ESP:0.00020(T)	Uncertain significance(Last reviewed: Oct 4, 2015)	criteria provided, single submitter	1	218434159	GRCh38	264449	257940
NM_001135599.2(TGFB2):c.703G>C (p.Val235Leu)	TGFB2	Holt-Oram syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(C), GO-ESP:0.00334(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	218434190	GRCh38	155837	165589
NM_003238.3(TGFB2):c.644_645insT (p.Arg216Glnfs)	TGFB2	not provided		Pathogenic(Last reviewed: Feb 25, 2015)	criteria provided, single submitter	1	218434338 - 218434339	GRCh38	213848	209437
NM_001135599.2(TGFB2):c.877A>G (p.Lys293Glu)	TGFB2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	1	218436008	GRCh38	263896	257938
NM_003238.3(TGFB2):c.823A>G (p.Ser275Gly)	TGFB2	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(G), GO-ESP:0.00017(G)	Uncertain significance(Last reviewed: Oct 4, 2015)	criteria provided, multiple submitters, no conflicts	1	218436038	GRCh38	213843	209440
NM_003238.3(TGFB2):c.1239C>T (p.Cys413=)	TGFB2	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00280(T), GO-ESP:0.00085(T)	Benign/Likely benign(Last reviewed: Apr 2, 2015)	criteria provided, multiple submitters, no conflicts	1	218441356	GRCh38	213838	209444
NM_003240.4(LEFTY2):c.940C>T (p.Arg314Ter)	LEFTY2	Left-right axis malformations		Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	1	225937602	GRCh38	7639	22678
NM_001100.3(ACTA1):c.1074G>T (p.Trp358Cys)	ACTA1	Nemaline myopathy 3		Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	1	229431559	GRCh38	127188	132672
NM_001103.3(ACTN2):c.26A>G (p.Gln9Arg)	ACTN2	Dilated cardiomyopathy 1AA|not specified|Dilated cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00054(G), GMAF:0.00060(G), GO-ESP:0.00070(G)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 15, 2016)	criteria provided, conflicting interpretations	1	236686699	GRCh38	18313	33352
NM_001103.3(ACTN2):c.278G>A (p.Arg93Gln)	ACTN2	Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jan 11, 2016)	criteria provided, multiple submitters, no conflicts	1	236718930	GRCh38	201627	198042
NM_001103.3(ACTN2):c.332G>T (p.Gly111Val)	ACTN2	Familial hypertrophic cardiomyopathy 23		Pathogenic(Last reviewed: Dec 29, 2006)	no assertion criteria provided	1	236718984	GRCh38	189514	187391
NM_001103.3(ACTN2):c.355G>A (p.Ala119Thr)	ACTN2	Dilated cardiomyopathy 1AA|Cardiomyopathy|Familial hypertrophic cardiomyopathy 23		Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	1	236719007	GRCh38	162727	172928
NM_001103.3(ACTN2):c.439T>C (p.Ser147Pro)	ACTN2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 12, 2013)	criteria provided, single submitter	1	236720182	GRCh38	263761	257948
NM_001103.3(ACTN2):c.441G>A (p.Ser147=)	ACTN2	not specified|Cardiovascular phenotype	GMAF:0.00140(A), GO-ESP:0.00036(A)	Benign/Likely benign(Last reviewed: Mar 26, 2014)	criteria provided, multiple submitters, no conflicts	1	236720184	GRCh38	136284	139987
NM_001103.3(ACTN2):c.667C>T (p.Leu223=)	ACTN2	Cardiovascular phenotype	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Sep 18, 2013)	criteria provided, single submitter	1	236731284	GRCh38	263792	257949
NM_001103.3(ACTN2):c.705G>C (p.Val235=)	ACTN2	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00054(C), GMAF:0.03360(C), GO-ESP:0.01353(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	236735642	GRCh38	43943	53112
NM_001103.3(ACTN2):c.745G>A (p.Val249Ile)	ACTN2	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	1	236735682	GRCh38	264452	257951
NM_001103.3(ACTN2):c.870G>A (p.Ala290=)	ACTN2	Dilated cardiomyopathy 1AA|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00507(A), GMAF:0.00600(A), GO-ESP:0.00163(A)	Benign(Last reviewed: Jan 12, 2016)	criteria provided, multiple submitters, no conflicts	1	236737208	GRCh38	43948	53117
NM_001103.3(ACTN2):c.979C>T (p.Arg327Cys)	ACTN2	Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	236739404	GRCh38	263547	257950
NM_001103.3(ACTN2):c.1235C>T (p.Thr412Met)	ACTN2	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00015(T), GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Aug 5, 2016)	criteria provided, multiple submitters, no conflicts	1	236743023	GRCh38	43897	53066
NM_001103.3(ACTN2):c.1236G>A (p.Thr412=)	ACTN2	Cardiovascular phenotype		Likely benign(Last reviewed: Dec 11, 2012)	criteria provided, single submitter	1	236743024	GRCh38	263457	257952
NM_001103.3(ACTN2):c.1296G>A (p.Ala432=)	ACTN2	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.04967(A), GMAF:0.03470(A), GO-ESP:0.01825(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	236744666	GRCh38	43899	53068
NM_001103.3(ACTN2):c.1298C>T (p.Ser433Leu)	ACTN2	Dilated cardiomyopathy 1AA|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00160(T), GO-ESP:0.00080(T)	Benign/Likely benign(Last reviewed: Mar 21, 2016)	criteria provided, multiple submitters, no conflicts	1	236744668	GRCh38	177977	172392
NM_001103.3(ACTN2):c.1311G>A (p.Val437=)	ACTN2	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	1	236744681	GRCh38	263707	257953
NM_001103.3(ACTN2):c.1323G>A (p.Leu441=)	ACTN2	Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant		Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	236744693	GRCh38	264330	257954
NM_001103.3(ACTN2):c.1333G>A (p.Glu445Lys)	ACTN2	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	1	236744703	GRCh38	264337	257955
NM_001103.3(ACTN2):c.1341C>T (p.Phe447=)	ACTN2	not specified|Cardiovascular phenotype	GO-ESP:0.00315(T), GMAF:0.00040(T), GO-ESP:0.00234(T)	Benign/Likely benign(Last reviewed: May 7, 2015)	criteria provided, multiple submitters, no conflicts	1	236744711	GRCh38	43902	53071
NM_001103.3(ACTN2):c.1423G>A (p.Asp475Asn)	ACTN2	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00023(A), GMAF:0.02580(A), GO-ESP:0.00723(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	236747683	GRCh38	43908	53077
NM_001103.3(ACTN2):c.1484C>T (p.Thr495Met)	ACTN2	Primary familial hypertrophic cardiomyopathy|not specified|Familial hypertrophic cardiomyopathy 23	GO-ESP:0.00008(T), GO-ESP:0.00022(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 20, 2015)	criteria provided, conflicting interpretations	1	236747744	GRCh38	43911	53080
NM_001103.3(ACTN2):c.1691C>T (p.Thr564Met)	ACTN2	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	1	236751504	GRCh38	234977	236741
NM_001103.3(ACTN2):c.1704G>A (p.Ala568=)	ACTN2	not specified|Cardiovascular phenotype	GO-ESP:0.00014(A)	Benign/Likely benign(Last reviewed: Jun 18, 2015)	criteria provided, multiple submitters, no conflicts	1	236751517	GRCh38	136286	139989
NM_001103.3(ACTN2):c.1748A>G (p.Glu583Gly)	ACTN2	Dilated cardiomyopathy 1AA|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00088(G)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 3, 2016)	criteria provided, conflicting interpretations	1	236751561	GRCh38	201642	198058
NM_001103.3(ACTN2):c.1810A>G (p.Met604Val)	ACTN2	not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02114(G), GMAF:0.01960(G), GO-ESP:0.00585(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	236751623	GRCh38	43915	53084
NM_001103.3(ACTN2):c.1864G>A (p.Asp622Asn)	ACTN2	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00085(A), GMAF:0.00060(A), GO-ESP:0.00030(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	236753971	GRCh38	43917	53086
NM_001103.3(ACTN2):c.1972G>C (p.Glu658Gln)	ACTN2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 9, 2013)	criteria provided, single submitter	1	236754079	GRCh38	263482	257956
NM_001103.3(ACTN2):c.2076C>T (p.Ile692=)	ACTN2	Dilated cardiomyopathy 1AA|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00123(T), GMAF:0.00120(T), GO-ESP:0.00034(T)	Benign/Likely benign(Last reviewed: Jan 2, 2016)	criteria provided, multiple submitters, no conflicts	1	236755120	GRCh38	43924	53093
NM_001103.3(ACTN2):c.2139G>A (p.Thr713Thr=)	ACTN2	Cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.03268(A), GMAF:0.03650(A), GO-ESP:0.01001(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	236755183	GRCh38	35649	44314
NM_001103.3(ACTN2):c.2147C>T (p.Thr716Met)	ACTN2	Familial hypertrophic cardiomyopathy 1|Dilated cardiomyopathy 1AA|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00033(T)	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	1	236755191	GRCh38	35650	44315
NM_001103.3(ACTN2):c.2161C>A (p.Arg721Ser)	ACTN2	Dilated cardiomyopathy 1AA|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00038(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 4, 2016)	criteria provided, conflicting interpretations	1	236757492	GRCh38	177937	172397
NM_001103.3(ACTN2):c.2194G>A (p.Ala732Thr)	ACTN2	not specified|Cardiovascular phenotype	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Dec 3, 2015)	criteria provided, multiple submitters, no conflicts	1	236757525	GRCh38	201647	198063
NM_001103.3(ACTN2):c.2276G>C (p.Arg759Thr)	ACTN2	Familial hypertrophic cardiomyopathy 23		Pathogenic(Last reviewed: Dec 29, 2006)	no assertion criteria provided	1	236757607	GRCh38	189516	187393
NM_001103.3(ACTN2):c.2568G>A (p.Pro856=)	ACTN2	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00015(A), GO-ESP:0.00013(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	236762502	GRCh38	43931	53100
NM_001103.3(ACTN2):c.2610G>A (p.Ser870=)	ACTN2	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.15570(A), GMAF:0.19610(A), GO-ESP:0.16881(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	236762544	GRCh38	43933	53102
NM_001103.3(ACTN2):c.2658C>T (p.Ser886=)	ACTN2	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00005(T)	Likely benign(Last reviewed: Apr 15, 2013)	criteria provided, single submitter	1	236762592	GRCh38	263591	257957
NM_001035.2(RYR2):c.19G>A (p.Gly7Ser)	RYR2	not specified	GO-ESP:0.00014(A)	Uncertain significance(Last reviewed: Mar 25, 2014)	criteria provided, single submitter	1	237042540	GRCh38	201287	196502
NM_001035.2(RYR2):c.37T>C (p.Phe13Leu)	RYR2	not provided|Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 8, 2014)	criteria provided, multiple submitters, no conflicts	1	237042558	GRCh38	201289	196504
NM_001035.2(RYR2):c.169-199_273+819del	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1		Pathogenic(Last reviewed: Nov 24, 2009)	no assertion criteria provided	1	237330679 - 237331801	GRCh38	29879	38834
NM_001035.2(RYR2):c.184C>T (p.Leu62Phe)	RYR2	not provided		Pathogenic(Last reviewed: Aug 15, 2011)	criteria provided, single submitter	1	237330893	GRCh38	201368	196505
NM_001035.2(RYR2):c.218T>G (p.Leu73Arg)	RYR2	not provided		Likely pathogenic(Last reviewed: Aug 6, 2013)	criteria provided, single submitter	1	237330927	GRCh38	201189	196506
NM_001035.2(RYR2):c.364C>T (p.Arg122Cys)	RYR2	not specified		Uncertain significance(Last reviewed: Aug 20, 2014)	criteria provided, multiple submitters, no conflicts	1	237369588	GRCh38	43774	52943
NM_001035.2(RYR2):c.378T>A (p.Ser126Arg)	RYR2	Cardiac arrest		Uncertain significance(Last reviewed: Aug 31, 2015)	criteria provided, single submitter	1	237369602	GRCh38	222783	224197
NM_001035.2(RYR2):c.383T>C (p.Met128Thr)	RYR2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 2, 2013)	criteria provided, single submitter	1	237369607	GRCh38	263677	257959
NM_001035.2(RYR2):c.499A>G (p.Lys167Glu)	RYR2	not provided		Likely pathogenic(Last reviewed: Nov 20, 2013)	criteria provided, single submitter	1	237377358	GRCh38	201193	196511
NM_001035.2(RYR2):c.527G>T (p.Arg176Leu)	RYR2	not provided		Likely pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	1	237377386	GRCh38	201195	196514
NM_001035.2(RYR2):c.527G>A (p.Arg176Gln)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1|not provided		Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, multiple submitters, no conflicts	1	237377386	GRCh38	201194	196513
NM_001035.2(RYR2):c.535G>A (p.Asp179Asn)	RYR2	not provided		Likely pathogenic(Last reviewed: Mar 28, 2012)	criteria provided, single submitter	1	237377394	GRCh38	201196	196515
NM_001035.2(RYR2):c.719A>C (p.His240Pro)	RYR2	not provided		Likely pathogenic(Last reviewed: Jun 17, 2013)	criteria provided, single submitter	1	237388129	GRCh38	201199	196520
NM_001035.2(RYR2):c.719A>G (p.His240Arg)	RYR2	not specified	GO-ESP:0.00008(G), GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	1	237388129	GRCh38	43823	52992
NM_001035.2(RYR2):c.727G>A (p.Glu243Lys)	RYR2	not specified		Uncertain significance(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	1	237388137	GRCh38	201200	196521
NM_001035.2(RYR2):c.796G>A (p.Ala266Thr)	RYR2	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	1	237417071	GRCh38	201370	196523
NM_001035.2(RYR2):c.818C>T (p.Ser273Phe)	RYR2	not provided		Likely pathogenic(Last reviewed: Aug 2, 2012)	criteria provided, single submitter	1	237417093	GRCh38	201203	196525
NM_001035.2(RYR2):c.839T>C (p.Leu280Pro)	RYR2	not specified		Uncertain significance(Last reviewed: Dec 13, 2013)	criteria provided, single submitter	1	237417114	GRCh38	201204	196526
NM_001035.2(RYR2):c.848+2dupT	RYR2	not provided		Uncertain significance(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	1	237417125	GRCh38	201406	196528
NM_001035.2(RYR2):c.893G>A (p.Arg298His)	RYR2	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	1	237423136	GRCh38	201205	196529
NM_001035.2(RYR2):c.1066T>G (p.Tyr356Asp)	RYR2	not provided		Likely pathogenic(Last reviewed: Aug 20, 2014)	criteria provided, single submitter	1	237441379	GRCh38	201207	196531
NM_001035.2(RYR2):c.1134C>T (p.Asp378=)	RYR2	Cardiac arrhythmia|not specified	GMAF:0.00060(T), GO-ESP:0.00064(T)	Likely benign(Last reviewed: Aug 6, 2015)	criteria provided, multiple submitters, no conflicts	1	237441447	GRCh38	36730	45391
NM_001035.2(RYR2):c.1135G>A (p.Val379Met)	RYR2	not specified|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00026(A)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 23, 2015)	criteria provided, conflicting interpretations	1	237441448	GRCh38	43708	52877
NM_001035.2(RYR2):c.1143C>T (p.Ser381=)	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00067(T), GMAF:0.00060(T), GO-ESP:0.00027(T)	Benign/Likely benign(Last reviewed: Dec 23, 2015)	criteria provided, multiple submitters, no conflicts	1	237441456	GRCh38	43710	52879
NM_001035.2(RYR2):c.1178T>G (p.Met393Arg)	RYR2	not specified		Uncertain significance(Last reviewed: Sep 3, 2014)	criteria provided, single submitter	1	237445408	GRCh38	201372	196535
NM_001035.2(RYR2):c.1240C>T (p.Arg414Cys)	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Dec 31, 2015)	criteria provided, multiple submitters, no conflicts	1	237445470	GRCh38	201212	196538
NM_001035.2(RYR2):c.1258C>T (p.Arg420Trp)	RYR2	not provided|Ventricular fibrillation|Catecholaminergic polymorphic ventricular tachycardia	GMAF:0.00020(T), GO-ESP:0.00002(T)	Pathogenic(Last reviewed: Sep 2, 2016)	criteria provided, multiple submitters, no conflicts	1	237445488	GRCh38	201214	196540
NM_001035.2(RYR2):c.1259G>A (p.Arg420Gln)	RYR2	Long QT syndrome|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Oct 10, 2016)	criteria provided, conflicting interpretations	1	237445489	GRCh38	201215	196541
NM_001035.2(RYR2):c.1298T>C (p.Leu433Pro)	RYR2	Arrhythmogenic right ventricular dysplasia, familial, 2|Long QT syndrome|Catecholaminergic polymorphic ventricular tachycardia		Conflicting interpretations of pathogenicity(Last reviewed: Feb 4, 2015)	criteria provided, conflicting interpretations	1	237454396	GRCh38	12959	27998
NM_001035.2(RYR2):c.1319C>T (p.Ala440Val)	RYR2	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	1	237454417	GRCh38	201160	196542
NM_001035.2(RYR2):c.1359C>T (p.Ser453=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.51193(T), GMAF:0.46430(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237454457	GRCh38	43728	52897
NM_001035.2(RYR2):c.1476+4C>T	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00008(T), GMAF:0.00020(T), GO-ESP:0.00017(T)	Uncertain significance(Last reviewed: Dec 12, 2015)	criteria provided, multiple submitters, no conflicts	1	237454578	GRCh38	43747	52916
NM_001035.2(RYR2):c.1519G>A (p.Val507Ile)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.01160(A), GMAF:0.01780(A), GO-ESP:0.00420(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237456642	GRCh38	43750	52919
NM_001035.2(RYR2):c.1611G>A (p.Leu537=)	RYR2	Cardiomyopathy|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.05747(A), GMAF:0.05990(A), GO-ESP:0.01702(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237456734	GRCh38	36736	45397
NM_001035.2(RYR2):c.1614G>A (p.Ala538=)	RYR2	not provided	GMAF:0.00020(A), GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	1	237469093	GRCh38	201218	196546
NM_001035.2(RYR2):c.1776A>T (p.Gly592=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.02415(T), GMAF:0.02160(T), GO-ESP:0.02875(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237491873	GRCh38	43753	52922
NM_001035.2(RYR2):c.1791T>G (p.Ile597Met)	RYR2	not specified		Uncertain significance(Last reviewed: Dec 17, 2012)	criteria provided, single submitter	1	237491888	GRCh38	201223	196553
NM_001035.2(RYR2):c.1822C>T (p.His608Tyr)	RYR2	not specified	GO-ESP:0.00017(T)	Uncertain significance(Last reviewed: Mar 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237491919	GRCh38	179220	172545
NM_001035.2(RYR2):c.1863C>T (p.His621=)	RYR2	Cardiomyopathy|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00615(T), GMAF:0.00220(T), GO-ESP:0.00756(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237492989	GRCh38	36737	45398
NM_001035.2(RYR2):c.2038G>A (p.Asp680Asn)	RYR2	not specified		Uncertain significance(Last reviewed: Aug 26, 2013)	criteria provided, single submitter	1	237496587	GRCh38	201226	196556
NM_001035.2(RYR2):c.2046A>G (p.Thr682=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00653(G), GMAF:0.00720(G), GO-ESP:0.00200(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237496595	GRCh38	43755	52924
NM_001035.2(RYR2):c.2050C>A (p.Pro684Thr)	RYR2	not provided		Uncertain significance(Last reviewed: Nov 7, 2011)	criteria provided, single submitter	1	237496599	GRCh38	201377	196557
NM_001035.2(RYR2):c.2267G>A (p.Ser756Asn)	RYR2	Cardiac arrhythmia|Paroxysmal familial ventricular fibrillation 1|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00020(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2016)	criteria provided, conflicting interpretations	1	237500774	GRCh38	36739	45400
NM_001035.2(RYR2):c.2399T>C (p.Val800Ala)	RYR2	not specified		Uncertain significance(Last reviewed: May 8, 2014)	criteria provided, single submitter	1	237503291	GRCh38	201229	196563
NM_001035.2(RYR2):c.2402G>T (p.Arg801Leu)	RYR2	not specified	GO-ESP:0.00025(T), GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Apr 9, 2015)	criteria provided, multiple submitters, no conflicts	1	237503294	GRCh38	43759	52928
NM_001035.2(RYR2):c.2711A>G (p.Tyr904Cys)	RYR2	not specified|not provided	GO-ESP:0.00012(G)	Uncertain significance(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	1	237506807	GRCh38	179436	172547
NM_001035.2(RYR2):c.2935G>T (p.Ala979Ser)	RYR2	not specified|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00016(T)	Uncertain significance(Last reviewed: Oct 21, 2015)	criteria provided, multiple submitters, no conflicts	1	237548459	GRCh38	178118	172410
NM_001035.2(RYR2):c.2973A>G (p.Ser991=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.85111(G), GMAF:0.16970(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237548497	GRCh38	43763	52932
NM_001035.2(RYR2):c.3037C>T (p.Arg1013Trp)	RYR2	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Aug 29, 2014)	criteria provided, single submitter	1	237548561	GRCh38	201379	196572
NM_001035.2(RYR2):c.3054T>C (p.Tyr1018=)	RYR2	not specified|Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00017(C)	Likely benign(Last reviewed: Jul 28, 2015)	criteria provided, multiple submitters, no conflicts	1	237548578	GRCh38	178116	172549
NM_001035.2(RYR2):c.3151C>T (p.Arg1051Cys)	RYR2	not provided	GO-ESP:0.00017(T)	Likely pathogenic(Last reviewed: Oct 28, 2013)	criteria provided, single submitter	1	237550628	GRCh38	201235	196573
NM_001035.2(RYR2):c.3153C>T (p.Arg1051=)	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00011(T)	Likely benign(Last reviewed: May 22, 2015)	criteria provided, multiple submitters, no conflicts	1	237550630	GRCh38	43766	52935
NM_001035.2(RYR2):c.3164G>A (p.Arg1055His)	RYR2	not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	1	237550641	GRCh38	201236	196574
NM_001035.2(RYR2):c.3251G>A (p.Arg1084Lys)	RYR2	Primary dilated cardiomyopathy|Cardiac arrhythmia|not specified|not provided	GO-ESP:0.00015(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2015)	criteria provided, conflicting interpretations	1	237566603	GRCh38	36740	45401
NM_001035.2(RYR2):c.3320C>T (p.Thr1107Met)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1|not specified|Death in infancy|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.00040(T), GO-ESP:0.00032(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2016)	criteria provided, conflicting interpretations	1	237566672	GRCh38	43768	52937
NM_001035.2(RYR2):c.3356G>A (p.Arg1119His)	RYR2	not specified	GO-ESP:0.00017(A)	Uncertain significance(Last reviewed: Apr 26, 2016)	criteria provided, multiple submitters, no conflicts	1	237566708	GRCh38	196110	193271
NM_001035.2(RYR2):c.3372G>A (p.Pro1124=)	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00008(A)	Benign/Likely benign(Last reviewed: Mar 11, 2014)	criteria provided, multiple submitters, no conflicts	1	237566724	GRCh38	138942	142645
NM_001035.2(RYR2):c.3380A>G (p.Glu1127Gly)	RYR2	Sudden cardiac death|not specified|not provided	GO-ESP:0.00056(G), GMAF:0.00060(G), GO-ESP:0.00113(G)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2015)	criteria provided, conflicting interpretations	1	237566732	GRCh38	43769	52938
NM_001035.2(RYR2):c.3407C>T (p.Ala1136Val)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1|not specified|Cardiovascular phenotype	GO-ESP:0.00951(T), GMAF:0.00240(T), GO-ESP:0.00706(T)	Benign(Last reviewed: Nov 2, 2015)	criteria provided, multiple submitters, no conflicts	1	237566759	GRCh38	43770	52939
NM_001035.2(RYR2):c.3425C>T (p.Ala1142Val)	RYR2	not specified		Uncertain significance(Last reviewed: Feb 13, 2013)	criteria provided, single submitter	1	237569146	GRCh38	201238	196576
NM_001035.2(RYR2):c.3565G>A (p.Glu1189Lys)	RYR2	not specified		Uncertain significance(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	1	237569286	GRCh38	201239	196578
NM_001035.2(RYR2):c.3720C>T (p.Ala1240=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.00016(T)	Benign/Likely benign(Last reviewed: Mar 8, 2016)	criteria provided, multiple submitters, no conflicts	1	237589914	GRCh38	201167	196580
NM_001035.2(RYR2):c.3849A>G (p.Leu1283=)	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00229(G), GMAF:0.00180(G), GO-ESP:0.00081(G)	Benign(Last reviewed: Nov 26, 2013)	criteria provided, multiple submitters, no conflicts	1	237590681	GRCh38	43777	52946
NM_001035.2(RYR2):c.3950C>T (p.Thr1317Met)	RYR2	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: May 1, 2014)	criteria provided, single submitter	1	237590782	GRCh38	201242	196584
NM_001035.2(RYR2):c.4010A>G (p.Tyr1337Cys)	RYR2	not specified	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Feb 28, 2014)	criteria provided, single submitter	1	237590842	GRCh38	201243	196586
NM_001035.2(RYR2):c.4040T>G (p.Met1347Arg)	RYR2	Cardiac arrhythmia|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2015)	criteria provided, conflicting interpretations	1	237590872	GRCh38	36742	45403
NM_001035.2(RYR2):c.4198A>G (p.Ser1400Gly)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.01610(G), GMAF:0.00720(G), GO-ESP:0.01825(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237591776	GRCh38	43782	52951
NM_001035.2(RYR2):c.4361A>G (p.Asp1454Gly)	RYR2	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	1	237593561	GRCh38	201245	196590
NM_001035.2(RYR2):c.4445G>A (p.Arg1482His)	RYR2	not specified|not provided	GMAF:0.00020(A), GO-ESP:0.00020(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 7, 2016)	criteria provided, conflicting interpretations	1	237595506	GRCh38	191544	189190
NM_001035.2(RYR2):c.4489G>A (p.Gly1497Arg)	RYR2	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	1	237595550	GRCh38	263552	257958
NM_001035.2(RYR2):c.4605G>A (p.Pro1535=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00111(A), GMAF:0.00120(A), GO-ESP:0.00349(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237602033	GRCh38	43787	52956
NM_001035.2(RYR2):c.4684-5G>C	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.01169(C), GMAF:0.01720(C), GO-ESP:0.00944(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237610757	GRCh38	43792	52961
NM_001035.2(RYR2):c.4692G>A (p.Met1564Ile)	RYR2	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00009(A)	Uncertain significance(Last reviewed: Apr 2, 2015)	criteria provided, multiple submitters, no conflicts	1	237610770	GRCh38	155831	165583
NM_001035.2(RYR2):c.4740G>A (p.Pro1580=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00017(A), GMAF:0.00880(A), GO-ESP:0.00466(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237610818	GRCh38	43795	52964
NM_001035.2(RYR2):c.4902G>A (p.Glu1634=)	RYR2	Cardiovascular phenotype	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	1	237610980	GRCh38	264621	257960
NM_001035.2(RYR2):c.5096G>A (p.Arg1699His)	RYR2	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	1	237614224	GRCh38	201383	196602
NM_001035.2(RYR2):c.5136C>T (p.Ser1712=)	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00013(T)	Likely benign(Last reviewed: Oct 2, 2015)	criteria provided, multiple submitters, no conflicts	1	237614264	GRCh38	43802	52971
NM_001035.2(RYR2):c.5400A>G (p.Lys1800=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.03264(G), GMAF:0.06230(G), GO-ESP:0.02103(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237614528	GRCh38	43805	52974
NM_001035.2(RYR2):c.5586C>T (p.Asp1862=)	RYR2	Cardiac arrhythmia|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00097(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	237614714	GRCh38	36745	45406
NM_001035.2(RYR2):c.5588C>T (p.Thr1863Met)	RYR2	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 29, 2015)	criteria provided, multiple submitters, no conflicts	1	237614716	GRCh38	201255	196605
NM_001035.2(RYR2):c.5619A>G (p.Ala1873=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00016(G), GO-ESP:0.00034(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	237614747	GRCh38	43807	52976
NM_001035.2(RYR2):c.5654G>A (p.Gly1885Glu)	RYR2	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.01753(A), GMAF:0.00980(A), GO-ESP:0.01540(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237614782	GRCh38	36746	45407
NM_001035.2(RYR2):c.5656G>A (p.Gly1886Ser)	RYR2	Cardiomyopathy|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.06285(A), GMAF:0.07630(A), GO-ESP:0.04385(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237614784	GRCh38	36747	45408
NM_001035.2(RYR2):c.5717T>C (p.Met1906Thr)	RYR2	not specified	GO-ESP:0.00004(C)	Uncertain significance(Last reviewed: Jul 10, 2012)	criteria provided, single submitter	1	237617287	GRCh38	201257	196607
NM_001035.2(RYR2):c.5821C>A (p.Arg1941Ser)	RYR2	not specified		Uncertain significance(Last reviewed: Jun 30, 2014)	criteria provided, single submitter	1	237617391	GRCh38	201260	196610
NM_001035.2(RYR2):c.5878A>G (p.Arg1960Gly)	RYR2	not specified		Uncertain significance(Last reviewed: Apr 28, 2014)	criteria provided, single submitter	1	237617448	GRCh38	201261	196611
NM_001035.2(RYR2):c.5923A>G (p.Met1975Val)	RYR2	not specified|not provided	GO-ESP:0.00008(G)	Uncertain significance(Last reviewed: Feb 10, 2016)	criteria provided, multiple submitters, no conflicts	1	237623771	GRCh38	191483	189195
NM_001035.2(RYR2):c.6280G>A (p.Gly2094Ser)	RYR2	Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237627920	GRCh38	263982	257961
NM_001035.2(RYR2):c.6337G>A (p.Val2113Met)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1|not specified	GMAF:0.00020(A), GO-ESP:0.00043(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 7, 2016)	criteria provided, conflicting interpretations	1	237627977	GRCh38	43813	52982
NM_001035.2(RYR2):c.6445A>G (p.Ile2149Val)	RYR2	not specified	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Mar 15, 2014)	criteria provided, single submitter	1	237631431	GRCh38	201262	196612
NM_001035.2(RYR2):c.6455A>G (p.Asn2152Ser)	RYR2	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	1	237631441	GRCh38	201263	196613
NM_001035.2(RYR2):c.6515T>A (p.Met2172Lys)	RYR2	not specified		Uncertain significance(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	1	237631501	GRCh38	201264	196614
NM_001035.2(RYR2):c.6737C>T (p.Ser2246Leu)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1|not provided		Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	1	237634937	GRCh38	12954	27993
NM_001035.2(RYR2):c.6906T>C (p.Leu2302=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.95921(C), GMAF:0.04510(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237638470	GRCh38	43819	52988
NM_001035.2(RYR2):c.6916G>A (p.Val2306Ile)	RYR2	not provided|Catecholaminergic polymorphic ventricular tachycardia		Pathogenic(Last reviewed: Mar 13, 2016)	criteria provided, multiple submitters, no conflicts	1	237638480	GRCh38	201387	196622
NM_001035.2(RYR2):c.6916G>C (p.Val2306Leu)	RYR2	not provided		Pathogenic(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	1	237638480	GRCh38	201268	196623
NM_001035.2(RYR2):c.6928+4G>A	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.01286(A), GMAF:0.01460(A), GO-ESP:0.00436(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237638496	GRCh38	43820	52989
NM_001035.2(RYR2):c.6949G>A (p.Ala2317Thr)	RYR2	not provided		Pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	1	237639035	GRCh38	201271	196626
NM_001035.2(RYR2):c.6982C>T (p.Pro2328Ser)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1		Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	1	237639068	GRCh38	12960	27999
NM_001035.2(RYR2):c.7025G>A (p.Gly2342Glu)	RYR2	not provided		Likely pathogenic(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	1	237639111	GRCh38	201273	196629
NM_001035.2(RYR2):c.7155G>T (p.Gly2385=)	RYR2	not specified		Uncertain significance(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	1	237640936	GRCh38	201275	196631
NM_001035.2(RYR2):c.7159G>A (p.Ala2387Thr)	RYR2	not provided|Catecholaminergic polymorphic ventricular tachycardia		Likely pathogenic(Last reviewed: May 27, 2016)	criteria provided, multiple submitters, no conflicts	1	237640940	GRCh38	201276	196632
NM_001035.2(RYR2):c.7160C>T (p.Ala2387Val)	RYR2	not provided		Likely pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	1	237640941	GRCh38	201277	196633
NM_001035.2(RYR2):c.7161G>A (p.Ala2387=)	RYR2	not specified|Cardiovascular phenotype	GMAF:0.00120(A), GO-ESP:0.00042(A)	Benign/Likely benign(Last reviewed: Oct 27, 2015)	criteria provided, multiple submitters, no conflicts	1	237640942	GRCh38	138949	142652
NM_001035.2(RYR2):c.7202G>A (p.Arg2401His)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, multiple submitters, no conflicts	1	237640983	GRCh38	201279	196635
NM_001035.2(RYR2):c.7233C>T (p.Ala2411=)	RYR2	Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00016(T)	Likely benign(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	1	237643338	GRCh38	264184	257962
NM_001035.2(RYR2):c.7314C>T (p.Ile2438=)	RYR2	Cardiovascular phenotype	GO-ESP:0.00010(T)	Likely benign(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	1	237643419	GRCh38	263678	257963
NM_001035.2(RYR2):c.7365C>T (p.Asp2455=)	RYR2	Cardiomyopathy|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00523(T), GMAF:0.00160(T), GO-ESP:0.00509(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237648466	GRCh38	36748	45409
NM_001035.2(RYR2):c.7422G>C (p.Arg2474Ser)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1		Pathogenic(Last reviewed: Jan 16, 2001)	no assertion criteria provided	1	237648523	GRCh38	12955	27994
NM_001035.2(RYR2):c.7443A>G (p.Gln2481=)	RYR2	Cardiovascular phenotype	GO-ESP:0.00004(G)	Likely benign(Last reviewed: Nov 20, 2013)	criteria provided, single submitter	1	237648544	GRCh38	263777	257964
NM_001035.2(RYR2):c.7488C>T (p.Leu2496=)	RYR2	Cardiac arrhythmia|not specified|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00399(T), GMAF:0.00140(T), GO-ESP:0.00492(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237648589	GRCh38	36749	45410
NM_001035.2(RYR2):c.7542G>A (p.Leu2514=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00022(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	237649906	GRCh38	201176	196638
NM_001035.2(RYR2):c.7619A>G (p.His2540Arg)	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00014(G)	Uncertain significance(Last reviewed: Apr 30, 2015)	criteria provided, multiple submitters, no conflicts	1	237649983	GRCh38	43826	52995
NM_001035.2(RYR2):c.7806C>T (p.His2602=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.45073(T), GMAF:0.44510(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237651483	GRCh38	43827	52996
NM_001035.2(RYR2):c.7855A>G (p.Lys2619Glu)	RYR2	not provided		Likely pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	1	237654304	GRCh38	201282	196639
NM_001035.2(RYR2):c.8028G>A (p.Leu2676=)	RYR2	Cardiovascular phenotype	GO-ESP:0.00010(A)	Likely benign(Last reviewed: Sep 16, 2013)	criteria provided, single submitter	1	237655883	GRCh38	263737	257965
NM_001035.2(RYR2):c.8041A>T (p.Met2681Leu)	RYR2	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	1	237655896	GRCh38	201284	196642
NM_001035.2(RYR2):c.8162T>C (p.Ile2721Thr)	RYR2	not specified|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.00057(C)	Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, multiple submitters, no conflicts	1	237657976	GRCh38	43828	52997
NM_001035.2(RYR2):c.8209-4T>C	RYR2	Primary dilated cardiomyopathy|Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 29, 2014)	criteria provided, single submitter	1	237659981	GRCh38	180498	178457
NM_001035.2(RYR2):c.8262G>C (p.Gln2754His)	RYR2	not specified	GO-ESP:0.00004(C)	Uncertain significance(Last reviewed: Oct 2, 2014)	criteria provided, single submitter	1	237660038	GRCh38	201390	196645
NM_001035.2(RYR2):c.8367T>C (p.Ile2789=)	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00005(C)	Benign/Likely benign(Last reviewed: Dec 31, 2015)	criteria provided, multiple submitters, no conflicts	1	237660878	GRCh38	201178	196646
NM_001035.2(RYR2):c.8378G>A (p.Arg2793Gln)	RYR2	not specified	GMAF:0.00020(A), GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	1	237660889	GRCh38	201391	196647
NM_001035.2(RYR2):c.8448C>T (p.Asp2816=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00579(T), GMAF:0.00700(T), GO-ESP:0.01134(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237666523	GRCh38	43833	53002
NM_001035.2(RYR2):c.8453C>T (p.Ala2818Val)	RYR2	not specified		Uncertain significance(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	1	237666528	GRCh38	201286	196649
NM_001035.2(RYR2):c.8596_8598delGGA (p.Gly2866del)	RYR2	not provided		Uncertain significance(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	1	237674101 - 237674103	GRCh38	201409	196651
NM_001035.2(RYR2):c.8873A>G (p.Gln2958Arg)	RYR2	Cardiomyopathy|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.22487(G), GMAF:0.09920(G), GO-ESP:0.25333(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237678090	GRCh38	36750	45411
NM_001035.2(RYR2):c.9125C>A (p.Ala3042Glu)	RYR2	not specified		Uncertain significance(Last reviewed: May 14, 2015)	criteria provided, single submitter	1	237699022	GRCh38	201291	196653
NM_001035.2(RYR2):c.9318T>G (p.Ser3106=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.97182(G), GMAF:0.03080(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237700418	GRCh38	43836	53005
NM_001035.2(RYR2):c.9358G>C (p.Asp3120His)	RYR2	not specified		Uncertain significance(Last reviewed: Jul 2, 2014)	criteria provided, single submitter	1	237700458	GRCh38	201293	196656
NM_001035.2(RYR2):c.9412T>C (p.Tyr3138His)	RYR2	not specified		Uncertain significance(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	1	237702022	GRCh38	201294	196657
NM_001035.2(RYR2):c.9519T>C (p.Thr3173=)	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00083(C), GO-ESP:0.00102(C)	Likely benign(Last reviewed: Oct 27, 2015)	criteria provided, multiple submitters, no conflicts	1	237705282	GRCh38	43839	53008
NM_001035.2(RYR2):c.9560A>G (p.Lys3187Arg)	RYR2	not specified|not provided|Catecholaminergic polymorphic ventricular tachycardia	GMAF:0.00080(G), GO-ESP:0.00055(G)	Likely benign(Last reviewed: Nov 30, 2015)	criteria provided, multiple submitters, no conflicts	1	237705323	GRCh38	43840	53009
NM_001035.2(RYR2):c.9655G>A (p.Val3219Met)	RYR2	not specified|Inborn genetic diseases	GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Dec 3, 2015)	criteria provided, multiple submitters, no conflicts	1	237707023	GRCh38	201179	196661
NM_001035.2(RYR2):c.9750G>T (p.Trp3250Cys)	RYR2	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: May 29, 2013)	criteria provided, single submitter	1	237707118	GRCh38	263612	257967
NM_001035.2(RYR2):c.9887T>C (p.Met3296Thr)	RYR2	not specified		Uncertain significance(Last reviewed: Nov 10, 2014)	no assertion criteria provided	1	237707255	GRCh38	235056	236745
NM_001035.2(RYR2):c.9911A>G (p.Gln3304Arg)	RYR2	not specified		Uncertain significance(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	1	237708867	GRCh38	201298	196663
NM_001035.2(RYR2):c.9923A>G (p.Asn3308Ser)	RYR2	Primary familial hypertrophic cardiomyopathy|not provided|Catecholaminergic polymorphic ventricular tachycardia	GMAF:0.00020(G), GO-ESP:0.00036(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 14, 2016)	criteria provided, conflicting interpretations	1	237708879	GRCh38	180500	178459
NM_001035.2(RYR2):c.9942C>G (p.Leu3314=)	RYR2	Cardiovascular phenotype	GO-ESP:0.00002(G)	Likely benign(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	1	237708898	GRCh38	264296	257966
NM_001035.2(RYR2):c.10035G>A (p.Arg3345=)	RYR2	Cardiovascular phenotype	GO-ESP:0.00009(A)	Likely benign(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	1	237708991	GRCh38	264295	257968
NM_001035.2(RYR2):c.10043T>G (p.Met3348Arg)	RYR2	not specified		Uncertain significance(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	1	237708999	GRCh38	201299	196665
NM_001035.2(RYR2):c.10125A>G (p.Arg3375=)	RYR2	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Jan 21, 2014)	no assertion criteria provided	1	237709081	GRCh38	235051	236746
NM_001035.2(RYR2):c.10230+20T>C	RYR2	Cardiac arrhythmia|not specified	GO-ESP:0.01277(C), GMAF:0.00940(C), GO-ESP:0.01449(C)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2011)	criteria provided, conflicting interpretations	1	237709587	GRCh38	36728	45389
NM_001035.2(RYR2):c.10231-4T>C	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GMAF:0.00240(C), GO-ESP:0.00115(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	237711741	GRCh38	167631	172565
NM_001035.2(RYR2):c.10254C>T (p.Asn3418=)	RYR2	Cardiomyopathy|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.00238(T), GMAF:0.00340(T), GO-ESP:0.00468(T)	Benign/Likely benign(Last reviewed: Jan 31, 2016)	criteria provided, multiple submitters, no conflicts	1	237711768	GRCh38	36729	45390
NM_001035.2(RYR2):c.10258G>A (p.Val3420Ile)	RYR2	not specified	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Aug 19, 2014)	criteria provided, multiple submitters, no conflicts	1	237711772	GRCh38	43697	52866
NM_001035.2(RYR2):c.10324-4A>G	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1|not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.00241(G), GMAF:0.00060(G), GO-ESP:0.00183(G)	Benign/Likely benign(Last reviewed: Jan 29, 2016)	criteria provided, multiple submitters, no conflicts	1	237717194	GRCh38	43698	52867
NM_001035.2(RYR2):c.10503C>T (p.Thr3501=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.96162(T), GMAF:0.03950(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237718470	GRCh38	43699	52868
NM_001035.2(RYR2):c.10700G>A (p.Arg3567His)	RYR2	Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00015(A)	Uncertain significance(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	1	237726283	GRCh38	264154	257969
NM_001035.2(RYR2):c.10776C>T (p.Ser3592=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.96078(T), GMAF:0.03970(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237727137	GRCh38	43702	52871
NM_001035.2(RYR2):c.10897G>A (p.Glu3633Lys)	RYR2	not specified|Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Oct 30, 2013)	criteria provided, multiple submitters, no conflicts	1	237730318	GRCh38	201348	196673
NM_001035.2(RYR2):c.10970G>A (p.Gly3657Asp)	RYR2	not specified		Uncertain significance(Last reviewed: Jan 5, 2016)	criteria provided, single submitter	1	237732080	GRCh38	234433	231467
NM_001035.2(RYR2):c.11152G>A (p.Glu3718Lys)	RYR2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	1	237756294	GRCh38	264589	257971
NM_001035.2(RYR2):c.11318T>C (p.Val3773Ala)	RYR2	not specified		Uncertain significance(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	1	237757769	GRCh38	201311	196679
NM_001035.2(RYR2):c.11557+19C>T	RYR2	Cardiac arrhythmia|not specified	GO-ESP:0.01714(T), GMAF:0.00620(T), GO-ESP:0.01344(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2014)	criteria provided, conflicting interpretations	1	237770906	GRCh38	36731	45392
NM_001035.2(RYR2):c.11587G>A (p.Gly3863Ser)	RYR2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	1	237772041	GRCh38	264573	257970
NM_001035.2(RYR2):c.11591A>G (p.Asn3864Ser)	RYR2	not specified		Uncertain significance(Last reviewed: Aug 25, 2011)	no assertion criteria provided	1	237772045	GRCh38	201314	196684
NM_001035.2(RYR2):c.11605A>G (p.Asn3869Asp)	RYR2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	1	237772059	GRCh38	264185	257972
NM_001035.2(RYR2):c.11835C>T (p.Val3945=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00901(T), GMAF:0.01140(T), GO-ESP:0.00265(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237778725	GRCh38	43715	52884
NM_001035.2(RYR2):c.11880+13_11880+16delACTG	RYR2	not specified|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GMAF:0.00980(-), GO-ESP:0.01113(-)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237778783 - 237778786	GRCh38	177974	172571
NM_001035.2(RYR2):c.11934G>A (p.Met3978Ile)	RYR2	not provided		Pathogenic(Last reviewed: Nov 28, 2011)	criteria provided, single submitter	1	237781618	GRCh38	201398	196690
NM_001035.2(RYR2):c.11959G>A (p.Glu3987Lys)	RYR2	not provided		Likely pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	1	237781643	GRCh38	201317	196692
NM_001035.2(RYR2):c.11965A>C (p.Asn3989His)	RYR2	not provided		Pathogenic(Last reviewed: Dec 9, 2014)	criteria provided, single submitter	1	237783677	GRCh38	201318	196693
NM_001035.2(RYR2):c.11988C>T (p.Gly3996=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.01489(T), GMAF:0.01240(T), GO-ESP:0.01393(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237783700	GRCh38	43717	52886
NM_001035.2(RYR2):c.11995A>T (p.Met3999Leu)	RYR2	not provided		Pathogenic(Last reviewed: Nov 8, 2011)	criteria provided, single submitter	1	237783707	GRCh38	201400	196696
NM_001035.2(RYR2):c.12056T>C (p.Met4019Thr)	RYR2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	1	237783768	GRCh38	264421	257973
NM_001035.2(RYR2):c.12159G>A (p.Glu4053=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00131(A), GMAF:0.00020(A), GO-ESP:0.00086(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	237783871	GRCh38	43719	52888
NM_001035.2(RYR2):c.12268C>T (p.Pro4090Ser)	RYR2	not provided		Likely pathogenic(Last reviewed: Jun 26, 2014)	criteria provided, single submitter	1	237783980	GRCh38	201324	196700
NM_001035.2(RYR2):c.12272C>T (p.Ala4091Val)	RYR2	Long QT syndrome|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2013)	criteria provided, conflicting interpretations	1	237783984	GRCh38	201325	196702
NM_001035.2(RYR2):c.12298G>A (p.Val4100Ile)	RYR2	not provided	GO-ESP:0.00001(A)	Likely pathogenic(Last reviewed: Nov 22, 2013)	criteria provided, single submitter	1	237784010	GRCh38	201328	196705
NM_001035.2(RYR2):c.12312C>G (p.Asn4104Lys)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1		Pathogenic(Last reviewed: Jan 16, 2001)	no assertion criteria provided	1	237784024	GRCh38	12956	27995
NM_001035.2(RYR2):c.12325A>G (p.Met4109Val)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Jul 21, 2014)	criteria provided, single submitter	1	237784037	GRCh38	180502	178461
NM_001035.2(RYR2):c.12545A>C (p.Glu4182Ala)	RYR2	not provided		Likely pathogenic(Last reviewed: Jun 26, 2014)	criteria provided, single submitter	1	237784257	GRCh38	201335	196714
NM_001035.2(RYR2):c.12583G>A (p.Asp4195Asn)	RYR2	not provided		Likely pathogenic(Last reviewed: Aug 14, 2013)	criteria provided, single submitter	1	237784295	GRCh38	201338	196717
NM_001035.2(RYR2):c.12611C>T (p.Ala4204Val)	RYR2	not specified		Uncertain significance(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	1	237784323	GRCh38	201340	196719
NM_001035.2(RYR2):c.12627G>A (p.Ser4209=)	RYR2	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00006(A)	Likely benign(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	1	237784339	GRCh38	263346	257976
NM_001035.2(RYR2):c.12919C>T (p.Arg4307Cys)	RYR2	not specified|not provided	GO-ESP:0.00022(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 30, 2015)	criteria provided, conflicting interpretations	1	237784631	GRCh38	191546	189203
NM_001035.2(RYR2):c.13081G>A (p.Glu4361Lys)	RYR2	not specified		Uncertain significance(Last reviewed: Oct 2, 2013)	criteria provided, single submitter	1	237784793	GRCh38	201343	196726
NM_001035.2(RYR2):c.13270G>C (p.Ala4424Pro)	RYR2	not provided		Uncertain significance(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	1	237785978	GRCh38	201344	196727
NM_001035.2(RYR2):c.13291G>A (p.Glu4431Lys)	RYR2	not specified	GMAF:0.00040(A), GO-ESP:0.00041(A)	Uncertain significance(Last reviewed: Jun 20, 2016)	criteria provided, multiple submitters, no conflicts	1	237785999	GRCh38	165128	172435
NM_001035.2(RYR2):c.13489C>T (p.Arg4497Cys)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1		Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	1	237791441	GRCh38	12957	27996
NM_001035.2(RYR2):c.13528G>T (p.Ala4510Ser)	RYR2	not provided		Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	1	237791480	GRCh38	201350	196733
NM_001035.2(RYR2):c.13528G>A (p.Ala4510Thr)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1|not specified|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.00006(A)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2015)	criteria provided, conflicting interpretations	1	237791480	GRCh38	43725	52894
NM_001035.2(RYR2):c.13566C>T (p.Val4522=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.00330(T), GMAF:0.00460(T), GO-ESP:0.00223(T)	Benign(Last reviewed: Feb 15, 2016)	criteria provided, multiple submitters, no conflicts	1	237792107	GRCh38	43727	52896
NM_001035.2(RYR2):c.13600C>T (p.Pro4534Ser)	RYR2	not specified|not provided	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Oct 30, 2015)	criteria provided, multiple submitters, no conflicts	1	237792141	GRCh38	191491	189205
NM_001035.2(RYR2):c.13656T>C (p.His4552=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GMAF:0.00040(C), GO-ESP:0.00048(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	237792197	GRCh38	43729	52898
NM_001035.2(RYR2):c.13689G>A (p.Glu4563=)	RYR2	Cardiovascular phenotype		Likely benign(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	1	237792230	GRCh38	264437	257974
NM_001035.2(RYR2):c.13740G>A (p.Thr4580=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00264(A), GMAF:0.00460(A), GO-ESP:0.00117(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237792281	GRCh38	43730	52899
NM_001035.2(RYR2):c.13759A>C (p.Ile4587Leu)	RYR2	Cardiac arrest		Uncertain significance(Last reviewed: Sep 4, 2014)	no assertion criteria provided	1	237792300	GRCh38	180504	178463
NM_001035.2(RYR2):c.13763T>C (p.Ile4588Thr)	RYR2	not specified		Uncertain significance(Last reviewed: Jul 24, 2015)	no assertion criteria provided	1	237792304	GRCh38	235052	236747
NM_001035.2(RYR2):c.13822C>T (p.Arg4608Trp)	RYR2	not provided		Likely pathogenic(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	1	237793906	GRCh38	201352	196736
NM_001035.2(RYR2):c.13957G>T (p.Val4653Phe)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1		Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2014)	no assertion criteria provided	1	237798037	GRCh38	12961	28000
NM_001035.2(RYR2):c.13977G>A (p.Glu4659=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.00994(A), GMAF:0.01340(A), GO-ESP:0.00372(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237798057	GRCh38	43733	52902
NM_001035.2(RYR2):c.13984G>A (p.Gly4662Ser)	RYR2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 26, 2015)	criteria provided, single submitter	1	237798064	GRCh38	264631	257978
NM_001035.2(RYR2):c.14220C>T (p.Ala4740=)	RYR2	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00009(T)	Likely benign(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	1	237806205	GRCh38	264585	257975
NM_001035.2(RYR2):c.14251A>C (p.Lys4751Gln)	RYR2	not provided		Pathogenic(Last reviewed: May 5, 2014)	criteria provided, single submitter	1	237806236	GRCh38	201355	196740
NM_001035.2(RYR2):c.14311G>A (p.Val4771Ile)	RYR2	not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, multiple submitters, no conflicts	1	237808913	GRCh38	201357	196743
NM_001035.2(RYR2):c.14314G>A (p.Gly4772Ser)	RYR2	Cardiac arrhythmia|not provided		Likely pathogenic(Last reviewed: Dec 11, 2013)	criteria provided, multiple submitters, no conflicts	1	237808916	GRCh38	36734	45395
NM_001035.2(RYR2):c.14421C>T (p.Asp4807=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.01751(T), GMAF:0.02120(T), GO-ESP:0.00526(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237809023	GRCh38	43742	52911
NM_001035.2(RYR2):c.14481C>T (p.Ile4827=)	RYR2	not specified|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy, ARVC	GO-ESP:0.01038(T), GMAF:0.00980(T), GO-ESP:0.00278(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237819083	GRCh38	43746	52915
NM_001035.2(RYR2):c.14493C>T (p.Ile4831=)	RYR2	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: May 27, 2013)	criteria provided, single submitter	1	237819095	GRCh38	263627	257977
NM_001035.2(RYR2):c.14579C>G (p.Ala4860Gly)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 1		Pathogenic(Last reviewed: Nov 13, 2007)	no assertion criteria provided	1	237819181	GRCh38	12963	28002
NM_001035.2(RYR2):c.14623G>C (p.Asp4875His)	RYR2	not provided		Likely pathogenic(Last reviewed: Jan 16, 2014)	criteria provided, single submitter	1	237828413	GRCh38	201359	196745
NM_001035.2(RYR2):c.14695G>A (p.Asp4899Asn)	RYR2	not provided		Likely pathogenic(Last reviewed: Jan 16, 2014)	criteria provided, single submitter	1	237830569	GRCh38	201360	196746
NM_001035.2(RYR2):c.14711G>A (p.Gly4904Asp)	RYR2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 15, 2013)	criteria provided, single submitter	1	237830585	GRCh38	263679	257979
NM_001035.2(RYR2):c.14848G>C (p.Glu4950Gln)	RYR2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 14, 2015)	criteria provided, single submitter	1	237832591	GRCh38	264483	257980
NM_001035.2(RYR2):c.14876G>A (p.Arg4959Gln)	RYR2	not provided		Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	1	237832619	GRCh38	201365	196751
NC_000001.10:g.(?_197811907)_(228997888_?)dup	ADORA1|PARP1|ARF1|ATF3|ATP2B4|AVPR1B|C4BPA|C4BPB|CACNA1S|CAPN2|CD34|CENPF|CHI3L1|CHIT1|CR1|CR1L|CR2|CSRP1|CTSE|CD55|EIF2D|ELF3|ELK4|EPHX1|EPRS|ESRRG|FMOD|NR5A2|GPR25|GUK1|H3F3A|HLX|HSD11B1|IL10|IRF6|ITPKB|KCNH1|KCNK2|KISS1|LAD1|LAMB3|LBR|MARK1|CD46|MDM4|MYBPH|MYOG|PPP1R12B|NEK2|NVL|CDK18|PFKFB2|PIGR|PIK3C2B|PKP1|PLXNA2|PPP2R5A|PRELP|PROX1|PSEN2|PTPN7|PTPN14|PTPRC|RABIF|RBBP5|REN|RNPEP|SNRPE|SRP9|CNTN2|TGFB2|LEFTY2|TLR5|TNNI1|TNNT2|TP53BP2|TRAF5|USH2A|WNT9A|SLC30A1|BTG2|HIST3H3|DYRK3|CDC42BPA|PPFIA4|DEGS1|RAB29|TAF1A|FCMR|MAPKAPK2|GPR37L1|SOX13|IKBKE|TMEM63A|ZC3H11A|TMCC2|LPGAT1|KIF14|BPNT1|TIMM17A|LRRN2|LEFTY1|KDM5B|IL24|DUSP10|PLEKHA6|KIF21B|NFASC|FBXO28|CAMSAP2|SRGAP2|ZNF281|PHLDA3|DSTYK|RAB3GAP2|LMOD1|INTS7|NSL1|OPTC|RPS6KC1|DIEXF|FLVCR1|UBE2T|CNIH4|PYCR2|NENF|IL19|G0S2|IL20|RRP15|ADIPOR1|TRIM17|KCTD3|DTL|CYB5R1|LAX1|MARC2|SUSD4|GPATCH2|KLHDC8A|ETNK2|TMEM206|YOD1|BATF3|SLC30A10|IARS2|IPO9|HHAT|ENAH|RCOR3|C1orf106|SERTAD4|SMYD2|LHX9|COQ8A|GJC2|CAMK1G|RHOU|KLHL12|LGR6|NUCKS1|ACBD3|MARC1|AIDA|JMJD4|C1orf116|C1orf35|C1orf115|HHIPL2|VASH2|WDR26|TRAF3IP3|TRIM11|NUAK2|DDX59|RASSF5|MIXL1|FCAMR|OBSCN|PPP1R15B|DISP1|SLC45A3|WNT3A|NAV1|ANGEL2|IGFN1|TMEM183A|HIST3H2A|LEMD1|SLC26A9|SNAP47|LYPLAL1|ATP6V1G3|DNAH14|ARL8A|SYT2|GOLT1A|SPATA17|MRPL55|HIST3H2BB|TATDN3|NEK7|C1orf74|BROX|MFSD4A|PM20D1|CNIH3|SHISA4|RNF187|SPATA45|FAM71A|SDE2|CCDC185|IBA57|TMEM9|SLC41A1|SYT14|LIN9|ZNF678|PRSS38|RD3|MIA3|STUM|C1orf53|TMEM81|CAPN8|FAM177B|MIR181B1|MIR194-1|MIR205|MIR181A1|MIR215|MIR29C|C1orf186|C1orf147|MIR205HG|FLVCR1-AS1|ASCL5|FAM72A|C1orf132|BTNL10|ZBED6|PCAT6|LINC00538	See cases		Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter			GRCh38	253654	248102
NM_170707.3(LMNA):c.(?_1)_(356_?)del (p.(?))	LMNA	Laminopathy		Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	1	156114919 - 156115274	GRCh38	180106	172880
GRCh38/hg38 1q21.1(chr1:145635445-146009630)x1	PDZK1|ITGA10|PEX11B|RBM8A|PIAS3|POLR3C|TXNIP|CD160|RNF115|POLR3GL|GNRHR2|LIX1L|ANKRD35|NUDT17|ANKRD34A|GPR89A|MIR6736	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, multiple submitters, no conflicts	1	145635445 - 146009630	GRCh38	160833	170677
GRCh38/hg38 1q21.1-21.2(chr1:146987841-148436984)x1	BCL9|FMO5|GJA5|GJA8|PRKAB2|CHD1L|RNU1-13P|RNVU1-7|ACP6|GPR89B|NBPF12|NBPF11|LINC01138|TRQ-CTG7-1|TRQ-CTG4-1|TRQ-CTG3-2|TRH-GTG1-4|TRN-GTT9-2|TRH-GTG1-3|TRH-GTG1-2|LINC00624|LOC100505824|MIR5087|RNVU1-8|LOC101927468|RNVU1-3|RNVU1-1|MIR6077	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, multiple submitters, no conflicts	1	146987841 - 148436984	GRCh38	160792	170636
GRCh38/hg38 1q21.1(chr1:145601946-145809957)x1	PDZK1|CD160|RNF115|GPR89A	See cases		Uncertain significance(Last reviewed: May 14, 2013)	no assertion criteria provided	1	145601946 - 145809957	GRCh38	155369	165123
GRCh38/hg38 1p31.3(chr1:61234063-61660298)x3	NFIA|NFIA-AS1	See cases		Uncertain significance(Last reviewed: Mar 24, 2014)	no assertion criteria provided	1	61234063 - 61660298	GRCh38	155330	165084
GRCh38/hg38 1p36.31-36.13(chr1:5363826-18360302)x1	RERE|CA6|CASP9|TNFRSF8|CLCN6|CLCNKA|CLCNKB|CORT|DFFA|EPHA2|ENO1|MTOR|ZBTB48|TNFRSF9|MFAP2|MTHFR|NPPA|NPPB|PEX14|PGD|PIK3CD|PLOD1|EXOSC10|RNU1-4|RPL22|RSC1A1|SDHB|SLC2A5|SRM|TNFRSF1B|TRE-TTC3-1|TRNAG1|ZBTB17|PRDM2|KCNAB2|TNFRSF25|PER3|DHRS3|VAMP3|H6PD|CROCC|KLHL21|MFN2|ANGPTL7|UBE4B|MAD2L2|PDPN|MASP2|UTS2|MST1L|PADI2|PARK7|CTRC|ACOT7|CLSTN1|SPEN|KIF1B|PLEKHM2|KAZN|CAMTA1|DNAJC16|ATP13A2|TARDBP|ICMT|PADI4|CHD5|SZRD1|FBXO2|FBXO6|RNU5E-1|RNU1-3|RNU1-2|RNU1-1|HSPB7|UBIAD1|PADI1|SLC45A1|CELA2B|PADI3|ERRFI1|FBXO42|HES2|FBLIM1|CASZ1|TMEM51|ARHGEF10L|VPS13D|NBPF1|NECAP2|DNAJC11|RCC2|CTNNBIP1|AGTRAP|PLEKHG5|DISP3|MIIP|CELA2A|NMNAT1|PRAMEF1|PRAMEF2|EFHD2|RSG1|NOL9|AGMAT|GPR157|SPSB1|TAS1R1|ACTL8|ESPN|SLC25A33|DDI2|LZIC|IGSF21|KIAA2013|THAP3|C1orf158|FBXO44|FHAD1|RBP7|LRRC38|AADACL3|ARHGEF19|C1orf127|PHF13|LINC00337|C1orf64|SLC2A7|TMEM201|TMEM51-AS1|NPHP4|C1orf167|SLC25A34|AADACL4|PRAMEF5|HNRNPCL1|PRAMEF9|PRAMEF10|FAM131C|PADI6|DRAXIN|SPATA21|CENPS|GPR153|RNF207|TMEM82|HES3|PRAMEF12|PRAMEF8|PRAMEF18|PRAMEF17|PRAMEF4|PRAMEF13|MIR34A|PRAMEF11|PRAMEF6|HNRNPCL2|UQCRHL|PRAMEF7|PRAMEF25|PIK3CD-AS1|PRAMEF26|PRAMEF33P|PRAMEF19|PRAMEF20|HNRNPCL3|PRAMEF15|PRAMEF16|SNORA59A|C1orf195|PRAMEF14|FAM231A|FLJ37453|TRN-GTT4-1|LOC100132147|FAM231B|TRG-CCC5-1|TRN-GTT13-1|TRG-CCC1-2|TRQ-CTG14-1|NPPA-AS1|MIR1273D|MIR4252|MIR3675|LOC100505887|ENO1-AS1|LOC100506022|APITD1-CORT|MIR3972|MIR4689|MIR4632|MIR4417|MIR5697|MTOR-AS1|CAMTA1-IT1|HNRNPCL4|ANO7P1|LOC101927876|PIK3CD-AS2|LOC101929181|PRAMEF27|MIR6728|MIR7846|MIR6730|MIR6729|LOC102724450|LOC102724539|LOC102724552|LOC102724571|LOC102724659|LOC105376736|LOC105376805|MIR34AHG|SNORD128	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	1	5363826 - 18360302	GRCh38	154704	164458
GRCh38/hg38 1q25.2(chr1:180062193-180248477)x3	QSOX1|CEP350|LHX4|FLJ23867	See cases		Uncertain significance(Last reviewed: Dec 22, 2010)	no assertion criteria provided	1	180062193 - 180248477	GRCh38	154520	164274
GRCh38/hg38 1q44(chr1:245979870-246615151)x3	TFB2M|SMYD3|CNST|LOC255654	See cases		Likely benign(Last reviewed: Aug 30, 2010)	no assertion criteria provided	1	245979870 - 246615151	GRCh38	154428	164182
GRCh38/hg38 1q44(chr1:248804574-248895548)x3	ZNF692|ZNF672|SH3BP5L|PGBD2|TRL-CAA4-1|TRE-CTC2-1|MIR3124	See cases		Benign(Last reviewed: Jun 30, 2010)	no assertion criteria provided	1	248804574 - 248895548	GRCh38	154353	164107
GRCh37/hg19 1q21.2(chr1:149041013-149768855)x1	FCGR1A|HIST2H2BF|FAM72C|PPIAL4C|FCGR1CP|TRH-GTG2-1	See cases		Benign(Last reviewed: Jan 30, 2010)	no assertion criteria provided			GRCh38	144372	154123
GRCh38/hg38 1p13.3(chr1:107456821-108010045)x3	VAV3|NTNG1|VAV3-AS1|MIR7852	See cases		Uncertain significance(Last reviewed: Dec 30, 2009)	no assertion criteria provided	1	107456821 - 108010045	GRCh38	144346	154097
GRCh38/hg38 1q44(chr1:247613108-248093562)x3	TRIM58|OR1C1|OR2L2|OR2L5|OR2L13|OR14A16|OR6F1|OR2W3|OR2T8|OR11L1|OR2L8|OR2AK2|OR2L3|OR13G1	See cases		Benign(Last reviewed: Feb 28, 2010)	no assertion criteria provided	1	247613108 - 248093562	GRCh38	144301	154052
GRCh38/hg38 1q32.1(chr1:200144603-203112078)x1	CACNA1S|CSRP1|ELF3|NR5A2|GPR25|LAD1|MYOG|PPP1R12B|PKP1|PTPN7|RABIF|RNPEP|TNNI1|TNNT2|PPFIA4|GPR37L1|KIF14|TIMM17A|KDM5B|KIF21B|CAMSAP2|ZNF281|PHLDA3|LMOD1|UBE2T|ADIPOR1|CYB5R1|IPO9|C1orf106|KLHL12|LGR6|DDX59|NAV1|IGFN1|TMEM183A|ARL8A|SYT2|SHISA4|TMEM9|LINC00862|MROH3P|ASCL5|MIR1231|PCAT6|MIR5191|IPO9-AS1|LOC101929224|MIR6740|MIR6739|LOC107985246	See cases		Pathogenic(Last reviewed: Aug 2, 2013)	no assertion criteria provided	1	200144603 - 203112078	GRCh38	144143	153894
GRCh38/hg38 1q23.3-25.1(chr1:161740907-173965154)x1	ALDH9A1|FASLG|SERPINC1|ATP1B1|CD247|DPT|F5|FMO1|FMO2|FMO3|FMO4|LMX1A|MGST3|MYOC|DDR2|PBX1|PIGC|PRRX1|POU2F1|RGS4|RXRG|XCL1|SELE|SELL|SELP|UAP1|XCL2|TNFSF4|UCK2|RGS5|BLZF1|VAMP4|CREG1|TNFSF18|MPZL1|TBX19|PRDX6|NOS1AP|GPA33|SLC19A2|DUSP12|KIFAP3|ATF6|PRRC2C|GPR161|MPC2|OLFML2B|DNM3|SNORD81|SNORD79|SNORD80|SNORD47|SNORD44|KLHL20|NME7|SUCO|HSD17B7|METTL13|TMCO1|DARS2|C1orf112|ADCY10|DCAF6|SCYL3|POGK|CCDC181|GAS5|LINC00626|MROH9|NUF2|ZBTB37|MAEL|CENPL|DUSP27|RCSD1|METTL18|GORAB|C1orf105|TADA1|SH2D1B|UHMK1|RC3H1|METTL11B|FAM78B|TIPRL|SLC9C2|C1orf111|LINC01142|ANKRD45|CCDC190|SFT2D2|ILDR2|C1orf226|LOC400794|MIR199A2|MIR214|LRRC52|SNORD74|SNORD75|SNORD76|SNORD77|SNORD78|MIR556|MIR557|LOC730159|MIR921|LOC100147773|TRP-AGG2-1|TRP-CGG1-1|MIR1295A|MIR1255B2|MIR3119-1|MIR3120|MIR3119-2|MIR3658|LOC100505795|LOC100505918|LOC100506023|GAS5-AS1|MIR4654|DNM3OS|MIR1295B|DNM3-IT1|LOC101928404|LINC01363|LOC101928565|LOC101928596|LOC101928650|LOC101928673|LINC00970|SNORA103	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	161740907 - 173965154	GRCh38	60042	74637
GRCh38/hg38 1q21.1-21.2(chr1:147029419-148342687)x1	BCL9|FMO5|GJA5|GJA8|PRKAB2|CHD1L|RNVU1-7|ACP6|GPR89B|NBPF11|TRQ-CTG7-1|TRQ-CTG4-1|TRQ-CTG3-2|TRH-GTG1-4|TRN-GTT9-2|TRH-GTG1-3|TRH-GTG1-2|LINC00624|LOC100505824|MIR5087|RNVU1-8|LOC101927468	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	147029419 - 148342687	GRCh38	58534	73129
GRCh38/hg38 1p36.33-36.32(chr1:844147-5020772)x1	CDK11B|DFFB|DVL1|MEGF6|GABRD|GNB1|PEX10|PRKCZ|SCNN1D|SKI|TP73|TNFRSF4|MMP23B|MMP23A|TNFRSF14|TNFRSF18|ISG15|PLCH2|CEP104|SLC35E2|RER1|NOC2L|ARHGEF16|SSU72|WRAP73|SDF4|MXRA8|CPSF3L|C1orf159|AURKAIP1|MRPL20|ATAD3A|PANK4|AJAP1|TP73-AS1|LRRC47|HES4|PRDM16|VWA1|NADK|MMEL1|MORN1|CPTP|CCNL2|TAS1R3|ATAD3B|PLEKHN1|PERM1|CFAP74|LOC115110|ACAP3|UBE2J2|PUSL1|B3GALT6|TPRG1L|FAM213B|ACTRT2|MIB2|SAMD11|LOC148413|CCDC27|CALML6|FAAP20|ATAD3C|LINC01342|TTLL10|FAM41C|LOC284661|C1orf174|KLHL17|TMEM240|TMEM52|AGRN|FAM132A|HES5|SMIM1|RNF223|MIR200A|MIR200B|LINC00982|ANKRD65|MIR429|LINC01128|TMEM88B|FNDC10|MIR551A|CDK11A|SLC35E2B|LINC01346|LOC100130417|LINC01134|TTC34|MIR4251|TTLL10-AS1|LOC100996583|MIR6726|MIR6727|MIR6808|LOC102724312|LOC105378591|LOC105378949	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	844147 - 5020772	GRCh38	58267	72862
GRCh38/hg38 1p36.33-36.32(chr1:821713-4155674)x1	CDK11B|DFFB|DVL1|MEGF6|GABRD|GNB1|PEX10|PRKCZ|SCNN1D|SKI|TP73|TNFRSF4|MMP23B|MMP23A|TNFRSF14|TNFRSF18|ISG15|PLCH2|CEP104|SLC35E2|RER1|NOC2L|ARHGEF16|SSU72|WRAP73|SDF4|MXRA8|CPSF3L|C1orf159|AURKAIP1|MRPL20|ATAD3A|PANK4|TP73-AS1|LRRC47|HES4|PRDM16|VWA1|NADK|MMEL1|LINC00115|MORN1|CPTP|CCNL2|TAS1R3|ATAD3B|PLEKHN1|PERM1|CFAP74|LOC115110|ACAP3|UBE2J2|PUSL1|B3GALT6|TPRG1L|FAM213B|ACTRT2|MIB2|SAMD11|LOC148413|CCDC27|CALML6|FAAP20|ATAD3C|LINC01342|TTLL10|FAM41C|C1orf174|KLHL17|TMEM240|TMEM52|AGRN|FAM132A|HES5|SMIM1|RNF223|MIR200A|MIR200B|LINC00982|ANKRD65|MIR429|LINC01128|TMEM88B|FNDC10|MIR551A|CDK11A|SLC35E2B|LINC01346|LOC100130417|LINC01134|TTC34|MIR4251|TTLL10-AS1|LOC100996583|MIR6726|MIR6727|MIR6808|LOC102724312|LOC105378591|LOC105378949	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	821713 - 4155674	GRCh38	58245	72840
GRCh38/hg38 1p36.33-36.31(chr1:629044-7008678)x1	CDK11B|DFFB|DVL1|MEGF6|GABRD|GNB1|ZBTB48|PEX10|PRKCZ|RPL22|SCNN1D|SKI|TP73|TNFRSF4|MMP23B|MMP23A|KCNAB2|TNFRSF25|TNFRSF14|TNFRSF18|ISG15|PLCH2|CEP104|KLHL21|SLC35E2|RER1|ACOT7|CAMTA1|ICMT|CHD5|NOC2L|ARHGEF16|SSU72|WRAP73|SDF4|MXRA8|HES2|CPSF3L|C1orf159|AURKAIP1|MRPL20|ATAD3A|PANK4|DNAJC11|AJAP1|TP73-AS1|PLEKHG5|LRRC47|HES4|PRDM16|VWA1|NADK|MMEL1|NOL9|LINC00115|MORN1|CPTP|TAS1R1|OR4F16|CCNL2|ESPN|TAS1R3|ATAD3B|PLEKHN1|PERM1|CFAP74|THAP3|LOC115110|ACAP3|UBE2J2|PUSL1|B3GALT6|TPRG1L|FAM213B|ACTRT2|MIB2|SAMD11|LOC148413|PHF13|LINC00337|CCDC27|CALML6|FAAP20|ATAD3C|LINC01342|TTLL10|NPHP4|FAM41C|LINC01777|C1orf174|KLHL17|TMEM240|TMEM52|AGRN|GPR153|FAM132A|HES5|SMIM1|RNF207|HES3|FAM87B|RNF223|MIR200A|MIR200B|LINC00982|ANKRD65|MIR429|LINC01128|TMEM88B|FNDC10|MIR551A|CDK11A|SLC35E2B|LINC01346|LOC100130417|LOC100133331|LINC01134|TTC34|LOC100288069|MIR4251|MIR4252|LINC01672|TTLL10-AS1|MIR4689|MIR4417|LOC100996583|MIR6723|MIR6726|MIR6727|MIR6808|LINC01770|LOC102724450|LOC105378591|LOC105378949	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	629044 - 7008678	GRCh38	58244	72839
GRCh38/hg38 1p36.33-36.32(chr1:629044-3346226)x1	CDK11B|DVL1|GABRD|GNB1|PEX10|PRKCZ|SCNN1D|SKI|TNFRSF4|MMP23B|MMP23A|TNFRSF14|TNFRSF18|ISG15|PLCH2|SLC35E2|RER1|NOC2L|SSU72|SDF4|MXRA8|CPSF3L|C1orf159|AURKAIP1|MRPL20|ATAD3A|PANK4|HES4|PRDM16|VWA1|NADK|MMEL1|LINC00115|MORN1|CPTP|OR4F16|CCNL2|TAS1R3|ATAD3B|PLEKHN1|PERM1|CFAP74|LOC115110|ACAP3|UBE2J2|PUSL1|B3GALT6|FAM213B|ACTRT2|MIB2|SAMD11|LOC148413|CALML6|FAAP20|ATAD3C|LINC01342|TTLL10|FAM41C|KLHL17|TMEM240|TMEM52|AGRN|FAM132A|HES5|FAM87B|RNF223|MIR200A|MIR200B|LINC00982|ANKRD65|MIR429|LINC01128|TMEM88B|FNDC10|CDK11A|SLC35E2B|LOC100130417|LOC100133331|TTC34|LOC100288069|MIR4251|TTLL10-AS1|LOC100996583|MIR6723|MIR6726|MIR6727|MIR6808|LOC102724312|LOC105378591|LOC105378949	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	629044 - 3346226	GRCh38	58243	72838
GRCh38/hg38 1q31.1-42.11(chr1:187143981-224299417)x3	ADORA1|ATF3|ATP2B4|AVPR1B|C4BPA|C4BPB|CACNA1S|CAPN2|CD34|CENPF|CHI3L1|CHIT1|CR1|CR1L|CR2|CSRP1|CTSE|CD55|EIF2D|ELF3|ELK4|EPRS|ESRRG|F13B|FMOD|NR5A2|GPR25|CFH|CFHR1|CFHR2|HLX|HSD11B1|IL10|IRF6|KCNH1|KCNK2|KISS1|LAD1|LAMB3|MARK1|CD46|MDM4|MYBPH|MYOG|PPP1R12B|NEK2|NVL|CDK18|PFKFB2|PIGR|PIK3C2B|PKP1|PLXNA2|PPP2R5A|PRELP|PROX1|PTPN7|PTPN14|PTPRC|RABIF|RBBP5|REN|RGS1|RGS2|RGS13|RNPEP|SNRPE|TROVE2|CNTN2|TGFB2|TLR5|TNNI1|TNNT2|TP53BP2|TRAF5|USH2A|SLC30A1|BTG2|DYRK3|PPFIA4|DEGS1|B3GALT2|RAB29|TAF1A|FCMR|MAPKAPK2|GPR37L1|SOX13|IKBKE|ZC3H11A|TMCC2|LPGAT1|KIF14|BPNT1|TIMM17A|LRRN2|KDM5B|CFHR4|CFHR3|IL24|DUSP10|PLEKHA6|KIF21B|NFASC|FBXO28|CAMSAP2|SRGAP2|CRB1|ZNF281|PHLDA3|DSTYK|RAB3GAP2|LMOD1|INTS7|NSL1|OPTC|RPS6KC1|DIEXF|FLVCR1|UBE2T|NENF|IL19|G0S2|IL20|RRP15|GLRX2|ADIPOR1|KCTD3|UCHL5|DTL|CYB5R1|LAX1|MARC2|SUSD4|GPATCH2|KLHDC8A|ETNK2|TMEM206|YOD1|BATF3|SLC30A10|IARS2|IPO9|HHAT|RCOR3|C1orf106|SERTAD4|SMYD2|LHX9|CAMK1G|KLHL12|LGR6|RGS18|NUCKS1|MARC1|AIDA|C1orf116|CDC73|C1orf115|HHIPL2|VASH2|TRAF3IP3|CFHR5|NUAK2|DDX59|RASSF5|FCAMR|LINC00260|LINC00467|PPP1R15B|DISP1|SLC45A3|NAV1|ANGEL2|IGFN1|TMEM183A|LEMD1|SLC26A9|LYPLAL1|ATP6V1G3|ARL8A|SYT2|LINC00628|GOLT1A|SPATA17|TATDN3|NEK7|C1orf74|BROX|LOC148696|MFSD4A|PM20D1|SHISA4|SPATA45|FAM71A|DENND1B|CCDC185|TMEM9|SLC41A1|SYT14|ASPM|LINC00303|LEMD1-AS1|LOC284578|LOC284581|RAB7B|BRINP3|RD3|KCNT2|ZBTB41|MIA3|C1orf53|TMEM81|CAPN8|C1orf140|FAM177B|MIR181B1|MIR194-1|MIR205|MIR181A1|MIR215|MIR29B2|MIR29C|RGS21|LOC440704|C1orf186|MIR135B|LINC00862|SERTAD4-AS1|C1orf147|MIR205HG|FLVCR1-AS1|LYPLAL1-AS1|MROH3P|ASCL5|SNORA36B|SNORA77|SNORA16B|TGFB2-AS1|FAM72A|LINC01136|C1orf132|MIR181A1HG|TRK-TTT8-1|TRK-TTT3-1|TRT-TGT2-1|TRK-TTT3-2|MIR1231|MIR1278|MIR664A|MIR320B2|ZBED6|MIR4260|MIR3122|PROX1-AS1|TAF1A-AS1|PCAT6|LINC01353|MIR4426|MIR4735|MIR5191|LINC00538|HLX-AS1|IPO9-AS1|KCNH1-IT1|LINC00210|BLACAT1|LOC101927143|LOC101927164|LINC01351|LINC01031|LOC101929224|LOC101929441|LOC101929541|LOC101929565|LOC101929631|LINC01352|LOC101929771|LOC101930114|MIR6740|MIR6769B|MIR6739|LOC102723727|LOC102723833|LOC102723886|LINC01032|LINC01222|LOC103021295|LOC103021296|TGFB2-OT1|SPATA17-AS1|LINC01036|LINC01221|LOC105372897|LOC105748977|LINC01037|SCARNA18B|LOC107985246	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	187143981 - 224299417	GRCh38	58112	72707
GRCh38/hg38 1p36.21-36.13(chr1:13619979-18466172)x3	CASP9|CLCNKA|CLCNKB|EPHA2|MFAP2|RNU1-4|RSC1A1|SDHB|TRE-TTC3-1|TRNAG1|ZBTB17|PRDM2|CROCC|MST1L|PADI2|CTRC|SPEN|PLEKHM2|KAZN|DNAJC16|ATP13A2|PADI4|SZRD1|RNU1-3|RNU1-2|RNU1-1|HSPB7|PADI1|CELA2B|PADI3|FBXO42|FBLIM1|TMEM51|ARHGEF10L|NBPF1|NECAP2|RCC2|CELA2A|EFHD2|RSG1|AGMAT|ACTL8|DDI2|IGSF21|FHAD1|ARHGEF19|C1orf64|TMEM51-AS1|SLC25A34|FAM131C|PADI6|SPATA21|TMEM82|UQCRHL|C1orf195|FAM231A|FLJ37453|TRN-GTT4-1|LINC01783|FAM231B|TRG-CCC5-1|TRN-GTT13-1|TRG-CCC1-2|TRQ-CTG14-1|MIR3675|MIR3972|ANO7P1|LINC01654|LOC105376805	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	13619979 - 18466172	GRCh38	58056	72651
GRCh38/hg38 1p36.31-36.21(chr1:6652339-12724844)x3	RERE|CA6|TNFRSF8|CLCN6|CORT|DFFA|ENO1|MTOR|TNFRSF9|MTHFR|NPPA|NPPB|PEX14|PGD|PIK3CD|PLOD1|EXOSC10|SLC2A5|SRM|TNFRSF1B|PER3|DHRS3|VAMP3|H6PD|MFN2|ANGPTL7|UBE4B|MAD2L2|MASP2|UTS2|PARK7|CLSTN1|KIF1B|CAMTA1|TARDBP|FBXO2|FBXO6|RNU5E-1|UBIAD1|SLC45A1|ERRFI1|CASZ1|VPS13D|DNAJC11|CTNNBIP1|AGTRAP|DISP3|MIIP|NMNAT1|GPR157|SPSB1|SLC25A33|LZIC|KIAA2013|FBXO44|RBP7|AADACL3|C1orf127|SLC2A7|TMEM201|C1orf167|AADACL4|DRAXIN|CENPS|MIR34A|PIK3CD-AS1|SNORA59A|NPPA-AS1|MIR1273D|LOC100505887|ENO1-AS1|LOC100506022|APITD1-CORT|MIR4632|MIR5697|MTOR-AS1|CAMTA1-IT1|PIK3CD-AS2|LOC101929181|MIR6728|MIR7846|MIR6730|MIR6729|LOC102724539|LOC102724552|LOC102724571|LOC102724659|LOC105376736|MIR34AHG|SNORD128	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	6652339 - 12724844	GRCh38	58051	72646
GRCh38/hg38 1p36.33-36.32(chr1:792758-5006311)x3	CDK11B|DFFB|DVL1|MEGF6|GABRD|GNB1|PEX10|PRKCZ|SCNN1D|SKI|TP73|TNFRSF4|MMP23B|MMP23A|TNFRSF14|TNFRSF18|ISG15|PLCH2|CEP104|SLC35E2|RER1|NOC2L|ARHGEF16|SSU72|WRAP73|SDF4|MXRA8|CPSF3L|C1orf159|AURKAIP1|MRPL20|ATAD3A|PANK4|AJAP1|TP73-AS1|LRRC47|HES4|PRDM16|VWA1|NADK|MMEL1|LINC00115|MORN1|CPTP|CCNL2|TAS1R3|ATAD3B|PLEKHN1|PERM1|CFAP74|LOC115110|ACAP3|UBE2J2|PUSL1|B3GALT6|TPRG1L|FAM213B|ACTRT2|MIB2|SAMD11|LOC148413|CCDC27|CALML6|FAAP20|ATAD3C|LINC01342|TTLL10|FAM41C|LINC01777|C1orf174|KLHL17|TMEM240|TMEM52|AGRN|FAM132A|HES5|SMIM1|FAM87B|RNF223|MIR200A|MIR200B|LINC00982|ANKRD65|MIR429|LINC01128|TMEM88B|FNDC10|MIR551A|CDK11A|SLC35E2B|LINC01346|LOC100130417|LINC01134|TTC34|MIR4251|TTLL10-AS1|LOC100996583|MIR6726|MIR6727|MIR6808|LINC01770|LOC105378591|LOC105378949	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	792758 - 5006311	GRCh38	58036	72631
GRCh38/hg38 1q32.1(chr1:201226425-202014204)x3	CSRP1|ELF3|LAD1|PKP1|RNPEP|TNNI1|TNNT2|TIMM17A|PHLDA3|LMOD1|IPO9|NAV1|IGFN1|SHISA4|MIR1231|MIR5191|IPO9-AS1|MIR6740|MIR6739|LOC107985246	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	201226425 - 202014204	GRCh38	57818	72413
GRCh38/hg38 1q21.1(chr1:145601946-145804778)x1	PDZK1|CD160|RNF115|GPR89A	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	1	145601946 - 145804778	GRCh38	57518	72113
GRCh38/hg38 1q21.1(chr1:145635445-146009630)x1	PDZK1|ITGA10|PEX11B|RBM8A|PIAS3|POLR3C|TXNIP|CD160|RNF115|POLR3GL|GNRHR2|LIX1L|ANKRD35|NUDT17|ANKRD34A|GPR89A|MIR6736	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	1	145635445 - 146009630	GRCh38	32650	41315
NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not provided	GO-ESP:0.00069(T), GO-ESP:0.00023(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2016)	criteria provided, conflicting interpretations	2	21006288	GRCh38	17890	32929
NM_000183.2(HADHB):c.1331G>A (p.Arg444Lys)	HADHB	Mitochondrial trifunctional protein deficiency		Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	2	26285513	GRCh38	14847	29886
NM_000183.2(HADHB):c.1364T>G (p.Val455Gly)	HADHB	Mitochondrial trifunctional protein deficiency	GMAF:0.00020(A)	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	2	26285546	GRCh38	14849	29888
NM_005633.3(SOS1):c.1297G>A (p.Glu433Lys)	SOS1	Noonan syndrome|not provided		Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, multiple submitters, no conflicts	2	39023131	GRCh38	40669	49139
NM_022437.2(ABCG8):c.1720G>A (p.Gly574Arg)	ABCG8	Sitosterolemia	GO-ESP:0.00015(A), GO-ESP:0.00006(A)	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	43875377	GRCh38	4968	20007
NM_001743.5(CALM2):c.293A>T (p.Asn98Ile)	CALM2	Long QT syndrome 1|Long QT syndrome 15		Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	2	47161851	GRCh38	96721	102608
NM_003494.3(DYSF):c.5429G>A (p.Arg1810Lys)	DYSF	Miyoshi muscular dystrophy 1|Limb-girdle muscular dystrophy, type 2B		Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, multiple submitters, no conflicts	2	71668842	GRCh38	18443	33482
NM_005911.5(MAT2A):c.1031A>C (p.Glu344Ala)	MAT2A	not provided		Uncertain significance(Last reviewed: Oct 12, 2016)	no assertion criteria provided	2	85542980	GRCh38	265866	260582
NM_032545.3(CFC1):c.522delC (p.Ala175Argfs)	CFC1|POTEI	Heterotaxy, visceral, 2, autosomal		Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	2	130593027	GRCh38	5188	20227
NM_032545.3(CFC1):c.334C>T (p.Arg112Cys)	CFC1|POTEI	Heterotaxy, visceral, 2, autosomal		Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	2	130597896	GRCh38	5187	20226
NM_014795.3(ZEB2):c.3211T>C (p.Ser1071Pro)	ZEB2	Mowat-Wilson syndrome		Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	2	144389885	GRCh38	56826	71449
NM_014795.3(ZEB2):c.3134A>G (p.His1045Arg)	ZEB2	Mowat-Wilson syndrome		Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	2	144389962	GRCh38	56827	71450
NM_022168.3(IFIH1):c.2465G>A (p.Arg822Gln)	IFIH1	Singleton-Merten syndrome 1	GO-ESP:0.00003(T)	Pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	2	162272377	GRCh38	189338	187227
NM_001267550.2(TTN):c.107961T>C (p.His35987=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00040(G), GO-ESP:0.00063(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178527027	GRCh38	178150	172800
NM_133378.4(TTN):c.100062T>C (p.Gly33354=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00067(G), GMAF:0.00020(G), GO-ESP:0.00024(G)	Benign/Likely benign(Last reviewed: Jun 10, 2015)	criteria provided, multiple submitters, no conflicts	2	178527222	GRCh38	46574	55739
NM_133378.4(TTN):c.99872T>C (p.Met33291Thr)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00107(G), GMAF:0.00220(G), GO-ESP:0.00225(G)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2016)	criteria provided, conflicting interpretations	2	178527550	GRCh38	47720	56884
NM_133378.4(TTN):c.99563T>C (p.Val33188Ala)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.05134(G), GMAF:0.09210(G), GO-ESP:0.04466(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178528384	GRCh38	47718	56882
NM_133378.4(TTN):c.99083C>T (p.Thr33028Ile)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00492(A), GMAF:0.00380(A), GO-ESP:0.00979(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178528964	GRCh38	47712	56876
NM_133378.4(TTN):c.98971G>C (p.Glu32991Gln)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00040(G), GO-ESP:0.00042(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178529076	GRCh38	192135	189409
NM_133378.4(TTN):c.98915T>C (p.Ile32972Thr)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01361(G), GMAF:0.00460(G), GO-ESP:0.01423(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178529132	GRCh38	47710	56874
NM_001267550.2(TTN):c.106476T>C (p.Cys35492=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01565(G), GMAF:0.01240(G), GO-ESP:0.00435(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178530015	GRCh38	47706	56870
NM_003319.4(TTN):c.79266T>A (p.Ser26422Arg)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	2	178530030	GRCh38	264042	257985
NM_133378.4(TTN):c.98571G>C (p.Gly32857=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.08400(G), GMAF:0.05090(G), GO-ESP:0.06654(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178530340	GRCh38	47704	56868
NM_133378.4(TTN):c.98511C>T (p.Thr32837=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Nov 16, 2012)	criteria provided, single submitter	2	178530400	GRCh38	263407	257986
NM_001267550.2(TTN):c.105787_105788delGCinsTT (p.Ala35263Phe)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype		Benign/Likely benign(Last reviewed: Feb 23, 2016)	criteria provided, multiple submitters, no conflicts	2	178530827 - 178530828	GRCh38	202340	198701
NM_133378.4(TTN):c.98084C>T (p.Ala32695Val)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.01046(A), GMAF:0.00520(A), GO-ESP:0.01138(A)	Benign/Likely benign(Last reviewed: Jun 24, 2013)	criteria provided, multiple submitters, no conflicts	2	178530827	GRCh38	47702	56866
NM_133378.4(TTN):c.98083G>T (p.Ala32695Ser)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.01046(A), GMAF:0.00520(A), GO-ESP:0.01134(A)	Benign/Likely benign(Last reviewed: Jun 24, 2013)	criteria provided, multiple submitters, no conflicts	2	178530828	GRCh38	47701	56865
NM_133378.4(TTN):c.98078C>T (p.Pro32693Leu)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03584(A), GMAF:0.07930(A), GO-ESP:0.04013(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178530833	GRCh38	47700	56864
NM_133378.4(TTN):c.98065G>A (p.Glu32689Lys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.01275(T), GMAF:0.00660(T), GO-ESP:0.01394(T)	Benign/Likely benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	2	178530846	GRCh38	47699	56863
NM_133378.4(TTN):c.97878C>T (p.Ser32626=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.05019(A), GMAF:0.09130(A), GO-ESP:0.04429(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178531033	GRCh38	47694	56858
NM_133378.4(TTN):c.97825G>A (p.Val32609Met)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01058(T), GMAF:0.01060(T), GO-ESP:0.00308(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178531086	GRCh38	47693	56857
NM_001267550.2(TTN):c.105468G>A (p.Pro35156=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00869(T), GMAF:0.00320(T), GO-ESP:0.00888(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178531147	GRCh38	47691	56855
NM_133378.4(TTN):c.97680A>G (p.Ala32560=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.31944(C), GMAF:0.49180(T), GO-ESP:0.35180(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178531231	GRCh38	47689	56853
TTN:c.105180G>C (p.Glu35060Asp)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03334(G), GMAF:0.02300(G), GO-ESP:0.03781(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178531435	GRCh38	47684	56848
NM_003319.4(TTN):c.77954G>C (p.Arg25985Thr)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00008(G), GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Sep 28, 2015)	criteria provided, multiple submitters, no conflicts	2	178531466	GRCh38	96329	102223
NM_133378.4(TTN):c.97284C>T (p.Val32428=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.14197(A), GMAF:0.23180(A), GO-ESP:0.18245(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178531627	GRCh38	47681	56845
NM_001267550.2(TTN):c.104936G>C (p.Gly34979Ala)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00006(G)	Uncertain significance(Last reviewed: Oct 20, 2015)	criteria provided, multiple submitters, no conflicts	2	178531679	GRCh38	220679	221120
NM_133378.4(TTN):c.97070A>C (p.Glu32357Ala)	TTN|TTN-AS1	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00234(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jul 8, 2015)	criteria provided, conflicting interpretations	2	178531841	GRCh38	178153	172609
NM_001256850.1(TTN):c.99846A>C (p.Thr33282=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00478(G), GMAF:0.00380(G), GO-ESP:0.01002(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178531846	GRCh38	47677	56841
NM_133378.4(TTN):c.96872G>A (p.Arg32291Gln)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01061(T), GMAF:0.00360(T), GO-ESP:0.01295(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178532039	GRCh38	47675	56839
NM_133378.4(TTN):c.96856G>C (p.Val32286Leu)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00623(G), GMAF:0.00240(G), GO-ESP:0.00497(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 9, 2016)	criteria provided, conflicting interpretations	2	178532055	GRCh38	47674	56838
NM_133378.4(TTN):c.96673A>C (p.Met32225Leu)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00872(G), GMAF:0.00760(G), GO-ESP:0.00241(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178532238	GRCh38	47670	56834
NM_003319.4(TTN):c.77087G>A (p.Arg25696Gln)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	2	178532333	GRCh38	264486	257987
NM_133378.4(TTN):c.96547G>C (p.Ala32183Pro)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00122(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 23, 2016)	criteria provided, conflicting interpretations	2	178532364	GRCh38	47667	56831
NM_133379.4(TTN):c.*265+212679C>T	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00149(A), GMAF:0.00040(A), GO-ESP:0.00121(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 19, 2016)	criteria provided, conflicting interpretations	2	178532641	GRCh38	47665	56829
NM_133378.4(TTN):c.96077G>A (p.Arg32026His)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.12144(T), GMAF:0.20870(T), GO-ESP:0.17535(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178532834	GRCh38	47663	56827
NM_001256850.1(TTN):c.98765T>C (p.Val32922Ala)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00056(G), GO-ESP:0.00056(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178532927	GRCh38	47662	56826
NM_133378.4(TTN):c.95906G>A (p.Arg31969Gln)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Nov 28, 2012)	criteria provided, single submitter	2	178533005	GRCh38	263435	257988
NM_133378.4(TTN):c.95876T>C (p.Ile31959Thr)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00003(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2015)	criteria provided, conflicting interpretations	2	178533035	GRCh38	228179	228558
NM_003319.4(TTN):c.76245C>T (p.Thr25415=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	2	178533175	GRCh38	264531	257989
NM_133378.4(TTN):c.95259C>T (p.Asn31753=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2016)	criteria provided, conflicting interpretations	2	178533652	GRCh38	130689	136135
NM_003319.4(TTN):c.75690T>C (p.Gly25230=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2016)	criteria provided, conflicting interpretations	2	178533730	GRCh38	264498	257991
NM_133378.4(TTN):c.95129G>T (p.Gly31710Val)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03392(A), GMAF:0.07810(A), GO-ESP:0.03919(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178533782	GRCh38	47655	56819
NM_001256850.1(TTN):c.97773C>T (p.Val32591=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00025(A)	Benign/Likely benign(Last reviewed: Aug 29, 2014)	criteria provided, multiple submitters, no conflicts	2	178533919	GRCh38	202284	198737
NM_133378.4(TTN):c.94815C>T (p.Gly31605=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.14487(A), GMAF:0.23200(A), GO-ESP:0.18234(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178534096	GRCh38	47650	56814
NM_133378.4(TTN):c.94486G>A (p.Ala31496Thr)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00021(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178534425	GRCh38	47647	56811
NM_003319.4(TTN):c.74978G>A (p.Arg24993Lys)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 21, 2015)	criteria provided, single submitter	2	178534442	GRCh38	264010	257990
NM_001256850.1(TTN):c.97227delT (p.Asp32410Thrfs)	TTN|TTN-AS1	not provided		Uncertain significance(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	2	178534465	GRCh38	202499	198741
NM_003319.4(TTN):c.74730A>G (p.Leu24910=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00022(C)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 24, 2016)	criteria provided, conflicting interpretations	2	178534690	GRCh38	178158	173035
NM_133378.4(TTN):c.94099A>G (p.Ile31367Val)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01539(C), GMAF:0.01240(C), GO-ESP:0.00433(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178534812	GRCh38	47642	56806
TTN:c.101766G>C (p.Gln33922His)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00780(G), GMAF:0.00460(G), GO-ESP:0.00682(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178534849	GRCh38	47641	56805
NM_133378.4(TTN):c.93961G>A (p.Val31321Ile)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00497(T), GMAF:0.00120(T), GO-ESP:0.00331(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2016)	criteria provided, conflicting interpretations	2	178534950	GRCh38	47639	56803
NM_133378.4(TTN):c.93508C>T (p.Arg31170Cys)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00737(A), GMAF:0.00280(A), GO-ESP:0.00564(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178535403	GRCh38	47633	56797
NM_133378.4(TTN):c.93278G>A (p.Arg31093Lys)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00041(T)	Uncertain significance(Last reviewed: Jun 24, 2013)	criteria provided, multiple submitters, no conflicts	2	178535633	GRCh38	191827	189435
NM_133378.4(TTN):c.92875G>A (p.Val30959Ile)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03243(T), GMAF:0.06550(T), GO-ESP:0.03121(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178536168	GRCh38	47629	56793
NM_133378.4(TTN):c.92755C>T (p.Pro30919Ser)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01077(A), GMAF:0.01380(A), GO-ESP:0.00357(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178536288	GRCh38	47628	56792
NM_133378.4(TTN):c.92541A>C (p.Pro30847=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00259(G)	Likely benign(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	2	178536502	GRCh38	263362	257993
NM_133378.4(TTN):c.92392G>A (p.Val30798Ile)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01580(T), GMAF:0.02320(T), GO-ESP:0.02882(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178537013	GRCh38	47625	56789
TTN:c.100094G>A (p.Arg33365Gln)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01597(T), GMAF:0.00480(T), GO-ESP:0.01277(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178537015	GRCh38	47624	56788
NM_003319.4(TTN):c.72855C>A (p.Thr24285=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	2	178537059	GRCh38	264023	257994
NM_001256850.1(TTN):c.95068T>C (p.Cys31690Arg)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(G), GMAF:0.00140(G), GO-ESP:0.00027(G)	Benign/Likely benign, not provided(Last reviewed: Mar 17, 2016)	criteria provided, multiple submitters, no conflicts	2	178537118	GRCh38	47622	56786
NM_001256850.1(TTN):c.94978G>A (p.Glu31660Lys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00042(T), GO-ESP:0.00032(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178537208	GRCh38	47621	56785
NM_133378.4(TTN):c.91971A>C (p.Val30657=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00315(G)	Likely benign(Last reviewed: Aug 9, 2012)	criteria provided, single submitter	2	178537532	GRCh38	263363	257992
NM_133378.4(TTN):c.91863C>G (p.Leu30621=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(C)	Likely benign(Last reviewed: Sep 13, 2013)	criteria provided, single submitter	2	178537640	GRCh38	263714	257995
NM_003319.4(TTN):c.72326T>C (p.Ile24109Thr)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	2	178537686	GRCh38	264274	257996
NM_133378.4(TTN):c.91792G>T (p.Glu30598Ter)	TTN|TTN-AS1	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	2	178537711	GRCh38	263491	257997
NM_003319.4(TTN):c.72226C>T (p.Leu24076Phe)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	2	178537786	GRCh38	264362	258000
NM_003319.4(TTN):c.71967G>A (p.Lys23989=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00023(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178538667	GRCh38	178162	173044
NM_001267550.2(TTN):c.99111T>C (p.Tyr33037=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00893(G), GMAF:0.00700(G), GO-ESP:0.00206(G)	Benign(Last reviewed: Nov 11, 2015)	criteria provided, multiple submitters, no conflicts	2	178538718	GRCh38	47613	56777
NM_001256850.1(TTN):c.94108T>A (p.Ser31370Thr)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GMAF:0.00240(T), GO-ESP:0.00082(T)	Benign/Likely benign(Last reviewed: Mar 21, 2016)	criteria provided, multiple submitters, no conflicts	2	178538798	GRCh38	47611	56775
NM_133378.4(TTN):c.91208G>A (p.Arg30403His)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02442(T), GMAF:0.07690(T), GO-ESP:0.06803(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178539023	GRCh38	47610	56774
NM_133379.4(TTN):c.*265+206277C>T	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00055(A)	Benign/Likely benign(Last reviewed: Apr 14, 2015)	criteria provided, multiple submitters, no conflicts	2	178539043	GRCh38	137817	141520
NM_133379.4(TTN):c.*265+206106C>A	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00116(T), GMAF:0.00100(T), GO-ESP:0.00028(T)	Benign/Likely benign(Last reviewed: Jun 11, 2015)	criteria provided, multiple submitters, no conflicts	2	178539214	GRCh38	47607	56771
NM_133378.4(TTN):c.90891A>G (p.Glu30297=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01271(C), GMAF:0.00400(C), GO-ESP:0.01165(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178539470	GRCh38	47604	56768
NM_003319.4(TTN):c.71349C>G (p.Ser23783=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(C)	Likely benign(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	2	178539521	GRCh38	264135	257998
NM_003319.4(TTN):c.71311C>T (p.Arg23771Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, multiple submitters, no conflicts	2	178539559	GRCh38	223329	225060
NM_001267550.2(TTN):c.98299_98300delAG (p.Arg32767Glyfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00001(-)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 16, 2016)	criteria provided, conflicting interpretations	2	178539765 - 178539766	GRCh38	47599	56763
NM_133378.4(TTN):c.90592G>T (p.Asp30198Tyr)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Feb 7, 2013)	criteria provided, multiple submitters, no conflicts	2	178539769	GRCh38	178661	172631
NM_133378.4(TTN):c.90590C>G (p.Ala30197Gly)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00285(C), GMAF:0.00100(C), GO-ESP:0.00283(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178539771	GRCh38	47598	56762
NM_133378.4(TTN):c.90563C>T (p.Thr30188Ile)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00100(A), GO-ESP:0.00042(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178539798	GRCh38	178164	173049
NM_133378.4(TTN):c.90534T>C (p.Ser30178=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	2	178539827	GRCh38	263531	258002
NM_003319.4(TTN):c.71010A>C (p.Ile23670=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00007(G)	Likely benign(Last reviewed: Dec 31, 2015)	criteria provided, single submitter	2	178539860	GRCh38	264588	257999
NM_133378.4(TTN):c.90460A>T (p.Ile30154Phe)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01276(A), GMAF:0.04250(A), GO-ESP:0.02511(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178539901	GRCh38	47595	56759
NM_133378.4(TTN):c.90056G>C (p.Arg30019Pro)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00160(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178541317	GRCh38	47589	56753
NM_133378.4(TTN):c.90056G>A (p.Arg30019His)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00371(T), GMAF:0.00160(T), GO-ESP:0.00374(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178541317	GRCh38	47588	56752
NM_133378.4(TTN):c.89909G>A (p.Arg29970His)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.12206(T), GMAF:0.20930(T), GO-ESP:0.17782(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178541464	GRCh38	47586	56750
NM_133378.4(TTN):c.89875G>A (p.Gly29959Ser)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: May 20, 2013)	criteria provided, single submitter	2	178541498	GRCh38	263602	258001
NM_133378.4(TTN):c.89874C>G (p.Asp29958Glu)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00080(A)	Uncertain significance(Last reviewed: Feb 4, 2013)	criteria provided, single submitter	2	178541499	GRCh38	263486	258003
NM_133378.4(TTN):c.89834G>A (p.Arg29945His)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00046(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Aug 21, 2015)	criteria provided, conflicting interpretations	2	178541539	GRCh38	192140	189451
NM_133378.4(TTN):c.89776C>T (p.Arg29926Cys)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jul 25, 2014)	criteria provided, multiple submitters, no conflicts	2	178542276	GRCh38	165690	173054
NM_133378.4(TTN):c.89732G>A (p.Arg29911His)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	2	178542320	GRCh38	202337	198789
NM_001267550.2(TTN):c.97386C>T (p.Thr32462=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00040(A), GO-ESP:0.00046(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178542370	GRCh38	96320	102214
NM_133378.4(TTN):c.89669C>T (p.Thr29890Met)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	2	178542383	GRCh38	263592	258004
NM_001256850.1(TTN):c.92176C>T (p.Arg30726Cys)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00017(A), GO-ESP:0.00041(A)	Uncertain significance(Last reviewed: Jan 29, 2015)	criteria provided, multiple submitters, no conflicts	2	178542755	GRCh38	47579	56743
NM_001256850.1(TTN):c.92075G>A (p.Arg30692His)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00154(T), GMAF:0.00120(T), GO-ESP:0.00042(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 11, 2015)	criteria provided, conflicting interpretations	2	178542856	GRCh38	47577	56741
NM_133378.4(TTN):c.89240C>T (p.Thr29747Ile)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02095(A), GMAF:0.01640(A), GO-ESP:0.00551(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178542910	GRCh38	47574	56738
NM_001256850.1(TTN):c.91681G>T (p.Val30561Leu)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	2	178543369	GRCh38	203023	198797
NM_133378.4(TTN):c.88454T>C (p.Ile29485Thr)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.07138(G), GMAF:0.11580(G), GO-ESP:0.08082(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178543986	GRCh38	47566	56730
NM_001256850.1(TTN):c.91175G>A (p.Arg30392His)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00139(T), GMAF:0.00100(T), GO-ESP:0.00035(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 11, 2015)	criteria provided, conflicting interpretations	2	178544046	GRCh38	47562	56726
NM_003319.4(TTN):c.68820C>T (p.Pro22940=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00017(A), GMAF:0.00040(A), GO-ESP:0.00018(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 2, 2015)	criteria provided, conflicting interpretations	2	178544214	GRCh38	96317	102211
NM_133378.4(TTN):c.88263C>T (p.Asn29421=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Oct 25, 2013)	criteria provided, single submitter	2	178544262	GRCh38	263723	258005
NM_001267550.2(TTN):c.95851_95853delAAG (p.Lys31951del)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(-)	Uncertain significance(Last reviewed: May 27, 2013)	criteria provided, single submitter	2	178544376 - 178544378	GRCh38	263626	258014
NM_001256850.1(TTN):c.90643C>T (p.Arg30215Cys)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Nov 25, 2013)	criteria provided, single submitter	2	178545544	GRCh38	203015	198809
NM_133378.4(TTN):c.87851T>C (p.Leu29284Pro)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01179(G), GMAF:0.00560(G), GO-ESP:0.01026(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178545555	GRCh38	47559	56723
NM_133378.4(TTN):c.87849C>T (p.Ser29283=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02148(A), GMAF:0.01640(A), GO-ESP:0.00548(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178545557	GRCh38	47558	56722
NM_133378.4(TTN):c.87846G>A (p.Lys29282=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Sep 12, 2013)	criteria provided, single submitter	2	178545560	GRCh38	263715	258006
NM_003319.4(TTN):c.68238C>T (p.Pro22746=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	2	178545677	GRCh38	264171	258010
NM_003319.4(TTN):c.68169T>C (p.Tyr22723=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(G)	Likely benign(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	2	178545872	GRCh38	264220	258007
NM_003319.4(TTN):c.68140A>C (p.Ile22714Leu)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	2	178545901	GRCh38	264170	258015
NM_133378.4(TTN):c.87601G>A (p.Val29201Ile)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	2	178545931	GRCh38	263493	258008
NM_133378.4(TTN):c.87555C>T (p.Leu29185=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00791(A), GMAF:0.00220(A), GO-ESP:0.00731(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178545977	GRCh38	47554	56718
NM_133378.4(TTN):c.87541G>A (p.Glu29181Lys)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00012(T)	Uncertain significance(Last reviewed: Dec 16, 2014)	criteria provided, multiple submitters, no conflicts	2	178545991	GRCh38	196195	193356
NM_133379.4(TTN):c.*265+199328C>T	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00113(A), GMAF:0.00100(A), GO-ESP:0.00033(A)	Benign/Likely benign(Last reviewed: Jun 11, 2015)	criteria provided, multiple submitters, no conflicts	2	178545992	GRCh38	47553	56717
NM_133378.4(TTN):c.87343A>G (p.Ser29115Gly)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01558(C), GMAF:0.02240(C), GO-ESP:0.02619(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178546284	GRCh38	47547	56711
NM_133379.4(TTN):c.*265+198852C>T	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00057(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178546468	GRCh38	165715	172647
NM_133378.4(TTN):c.87147T>A (p.Asp29049Glu)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00263(T), GMAF:0.00180(T), GO-ESP:0.00291(T)	Benign/Likely benign, not provided(Last reviewed: Mar 19, 2016)	criteria provided, multiple submitters, no conflicts	2	178546480	GRCh38	47545	56709
NM_001267550.2(TTN):c.94655_94657delGAG (p.Gly31552del)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 26, 2012)	criteria provided, single submitter	2	178546771 - 178546773	GRCh38	263445	258012
NM_133378.4(TTN):c.86925A>G (p.Ile28975Met)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00007(C)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178546799	GRCh38	47542	56706
NM_003319.4(TTN):c.66777A>G (p.Glu22259=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00001(C)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 17, 2016)	criteria provided, conflicting interpretations	2	178547654	GRCh38	178905	173069
NM_133378.4(TTN):c.86197G>A (p.Val28733Ile)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03294(T), GMAF:0.03590(T), GO-ESP:0.01059(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178547725	GRCh38	47537	56701
NM_001256850.1(TTN):c.88974delT (p.Phe29658Leufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, multiple submitters, no conflicts	2	178547729	GRCh38	47535	56699
NM_133378.4(TTN):c.85683C>T (p.Ser28561=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02038(A), GMAF:0.00900(A), GO-ESP:0.02132(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178548239	GRCh38	47532	56696
NM_133378.4(TTN):c.85539C>T (p.Ala28513=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.14365(A), GMAF:0.23420(A), GO-ESP:0.18404(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178548383	GRCh38	47530	56694
NM_133378.4(TTN):c.85301G>T (p.Ser28434Ile)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00090(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 14, 2016)	criteria provided, conflicting interpretations	2	178548621	GRCh38	192143	189467
NM_133378.4(TTN):c.85197C>T (p.Ser28399=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02327(A), GMAF:0.01220(A), GO-ESP:0.01949(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178548725	GRCh38	47529	56693
NM_001256850.1(TTN):c.87776A>G (p.Asn29259Ser)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00080(C), GO-ESP:0.00028(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178548927	GRCh38	202990	198838
NM_003319.4(TTN):c.65436dupG (p.Lys21813Glufs)	TTN|TTN-AS1	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	2	178548995	GRCh38	264404	258009
NM_133378.4(TTN):c.84487A>G (p.Ile28163Val)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00198(C), GMAF:0.03470(C), GO-ESP:0.03134(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178549435	GRCh38	47521	56685
NM_133378.4(TTN):c.84472C>T (p.Pro28158Ser)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00174(A), GMAF:0.00200(A), GO-ESP:0.00248(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178549450	GRCh38	47520	56684
NM_133378.4(TTN):c.84427G>A (p.Val28143Met)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.10265(T), GMAF:0.15020(T), GO-ESP:0.09056(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178549591	GRCh38	47519	56683
NM_001256850.1(TTN):c.87014A>G (p.Asn29005Ser)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00209(C), GMAF:0.00120(C), GO-ESP:0.00066(C)	Benign/Likely benign, not provided(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	2	178549785	GRCh38	47517	56681
NM_003319.4(TTN):c.64739T>A (p.Leu21580His)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	2	178549788	GRCh38	263942	258017
NM_001256850.1(TTN):c.86720C>T (p.Ala28907Val)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GMAF:0.00180(A), GO-ESP:0.00095(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Sep 16, 2015)	criteria provided, conflicting interpretations	2	178550195	GRCh38	179010	173081
NM_001256850.1(TTN):c.86666C>T (p.Pro28889Leu)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GMAF:0.00200(A), GO-ESP:0.00034(A)	Likely benign(Last reviewed: Nov 27, 2015)	criteria provided, multiple submitters, no conflicts	2	178550249	GRCh38	196156	193317
NM_133378.4(TTN):c.83869A>G (p.Ile27957Val)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00756(C), GMAF:0.00160(C), GO-ESP:0.00690(C)	Benign(Last reviewed: Jun 10, 2015)	criteria provided, multiple submitters, no conflicts	2	178550265	GRCh38	47511	56675
NM_133378.4(TTN):c.83680C>T (p.Arg27894Trp)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: May 31, 2013)	criteria provided, single submitter	2	178551147	GRCh38	263633	258011
NM_001256850.1(TTN):c.86384G>A (p.Arg28795Gln)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	2	178551224	GRCh38	202977	198853
NM_133378.4(TTN):c.83469A>C (p.Glu27823Asp)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00036(G)	Uncertain significance(Last reviewed: Mar 5, 2015)	criteria provided, multiple submitters, no conflicts	2	178551727	GRCh38	165751	172665
NM_133378.4(TTN):c.83367T>G (p.Thr27789=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.10396(C), GMAF:0.15240(C), GO-ESP:0.09154(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178551829	GRCh38	47504	56668
NM_133378.4(TTN):c.83264G>A (p.Arg27755Lys)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03353(T), GMAF:0.03590(T), GO-ESP:0.01060(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178551932	GRCh38	47503	56667
NM_133378.4(TTN):c.83141C>T (p.Thr27714Met)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jun 10, 2013)	criteria provided, single submitter	2	178552055	GRCh38	263651	258016
NM_133378.4(TTN):c.82934T>C (p.Ile27645Thr)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00622(G), GMAF:0.00660(G), GO-ESP:0.00194(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2016)	criteria provided, conflicting interpretations	2	178552262	GRCh38	130683	136129
NM_001267550.2(TTN):c.90624T>C (p.Asn30208=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00033(G), GO-ESP:0.00014(G)	Likely benign(Last reviewed: Jan 23, 2016)	criteria provided, multiple submitters, no conflicts	2	178552276	GRCh38	47499	56663
NM_133378.4(TTN):c.82542A>G (p.Ile27514Met)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Dec 17, 2012)	criteria provided, single submitter	2	178552654	GRCh38	263456	258013
NM_003319.4(TTN):c.62964A>C (p.Lys20988Asn)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 23, 2015)	criteria provided, single submitter	2	178552741	GRCh38	264301	258018
NM_133378.4(TTN):c.82280T>C (p.Ile27427Thr)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Jun 3, 2015)	criteria provided, multiple submitters, no conflicts	2	178552916	GRCh38	196154	193315
NM_133378.4(TTN):c.81682G>A (p.Val27228Met)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00025(T), GMAF:0.00100(T), GO-ESP:0.00132(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178553619	GRCh38	96314	102208
NM_133378.4(TTN):c.81610G>A (p.Glu27204Lys)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00027(T)	Uncertain significance(Last reviewed: May 20, 2015)	criteria provided, multiple submitters, no conflicts	2	178553691	GRCh38	191860	189478
NM_003319.4(TTN):c.61903_61905delGAA (p.Glu20635del)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00010(-)	Uncertain significance(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	2	178554011 - 178554013	GRCh38	264141	258020
NM_133378.4(TTN):c.81313C>T (p.Arg27105Ter)	TTN|TTN-AS1	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	2	178554094	GRCh38	263764	258019
NM_133378.4(TTN):c.81154C>T (p.Leu27052=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00606(A), GMAF:0.00660(A), GO-ESP:0.00203(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178554489	GRCh38	47484	56648
NM_133378.4(TTN):c.80868C>A (p.Ala26956=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 19, 2012)	criteria provided, single submitter	2	178554887	GRCh38	263408	258022
NM_133378.4(TTN):c.80868C>T (p.Ala26956=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 19, 2012)	criteria provided, single submitter	2	178554887	GRCh38	263406	258021
NM_133378.4(TTN):c.80690C>T (p.Ser26897Phe)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00342(A), GMAF:0.00180(A), GO-ESP:0.00273(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178555065	GRCh38	47477	56641
NM_133378.4(TTN):c.80568G>A (p.Glu26856=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03145(T), GMAF:0.08430(T), GO-ESP:0.07006(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178556882	GRCh38	47476	56640
NM_133378.4(TTN):c.80483T>C (p.Ile26828Thr)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.31828(G), GMAF:0.49280(A), GO-ESP:0.35060(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178556967	GRCh38	47475	56639
NM_133378.4(TTN):c.80479T>C (p.Phe26827Leu)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GMAF:0.00040(G), GO-ESP:0.00013(G)	Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, multiple submitters, no conflicts	2	178556971	GRCh38	47474	56638
NM_133378.4(TTN):c.80173C>T (p.Arg26725Cys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00320(A), GO-ESP:0.00184(A)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178557385	GRCh38	47470	56634
NM_003319.4(TTN):c.60620A>G (p.Tyr20207Cys)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	2	178557447	GRCh38	264210	258023
NM_133379.4(TTN):c.*265+187761G>T	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00181(A), GMAF:0.00080(A), GO-ESP:0.00166(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178557559	GRCh38	96312	102206
NM_133378.4(TTN):c.79967T>C (p.Ile26656Thr)	TTN|TTN-AS1	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 16, 2016)	criteria provided, multiple submitters, no conflicts	2	178557683	GRCh38	263791	258024
TTN:c.87669T>C (p.His29223=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02119(G), GMAF:0.01660(G), GO-ESP:0.00552(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178557685	GRCh38	47467	56631
NM_001256850.1(TTN):c.82700A>T (p.Tyr27567Phe)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00041(A), GO-ESP:0.00018(A)	Uncertain significance(Last reviewed: Mar 6, 2016)	criteria provided, multiple submitters, no conflicts	2	178557731	GRCh38	47465	56629
NM_001256850.1(TTN):c.82688C>G (p.Thr27563Arg)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GMAF:0.00140(C), GO-ESP:0.00022(C)	Uncertain significance(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	2	178557743	GRCh38	202942	198895
NM_133378.4(TTN):c.79383T>C (p.Leu26461=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01593(G), GMAF:0.02240(G), GO-ESP:0.02669(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178558372	GRCh38	47460	56624
NM_003319.4(TTN):c.59846G>A (p.Arg19949Gln)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	2	178558418	GRCh38	264476	258025
NM_003319.4(TTN):c.59779T>C (p.Cys19927Arg)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	2	178558485	GRCh38	264316	258027
NM_003319.4(TTN):c.59678G>A (p.Ser19893Asn)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	2	178558586	GRCh38	264600	258026
NM_133378.4(TTN):c.79107A>G (p.Val26369=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02387(C), GMAF:0.01620(C), GO-ESP:0.02430(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178559321	GRCh38	47457	56621
NM_001256850.1(TTN):c.81378G>A (p.Lys27126=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00861(T), GMAF:0.00280(T), GO-ESP:0.00892(T)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	2	178559831	GRCh38	47452	56616
NM_133378.4(TTN):c.78299T>A (p.Ile26100Lys)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	2	178560129	GRCh38	263479	258028
NM_133378.4(TTN):c.77876G>A (p.Gly25959Asp)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	2	178560552	GRCh38	263671	258029
NM_133378.4(TTN):c.77688T>C (p.Thr25896=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: May 2, 2013)	criteria provided, single submitter	2	178560740	GRCh38	263608	258031
NM_133378.4(TTN):c.77564G>A (p.Arg25855Gln)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	2	178560864	GRCh38	263596	258030
NM_003319.4(TTN):c.57895C>T (p.Arg19299Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Sep 10, 2015)	criteria provided, multiple submitters, no conflicts	2	178561042	GRCh38	223295	225027
NM_133378.4(TTN):c.77273G>A (p.Arg25758Gln)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00017(T), GMAF:0.00020(T), GO-ESP:0.00029(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178561155	GRCh38	47442	56606
NM_003319.4(TTN):c.57781C>T (p.Arg19261Trp)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	2	178561156	GRCh38	264324	258032
NM_003319.4(TTN):c.57398G>C (p.Ser19133Thr)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	2	178561539	GRCh38	264136	258033
NM_133378.4(TTN):c.76749A>G (p.Pro25583=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00882(C), GMAF:0.01180(C), GO-ESP:0.00337(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178561679	GRCh38	47436	56600
NM_133378.4(TTN):c.76702G>A (p.Gly25568Arg)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Mar 1, 2013)	criteria provided, single submitter	2	178561726	GRCh38	263551	258035
NM_003319.4(TTN):c.57167C>A (p.Thr19056Lys)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	2	178561770	GRCh38	47434	56598
TTN:c.84352C>T (p.Arg28118Cys)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02067(A), GMAF:0.01620(A), GO-ESP:0.00553(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178561780	GRCh38	47433	56597
NM_133378.4(TTN):c.76559G>C (p.Ser25520Thr)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00060(T)	Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	2	178561869	GRCh38	263759	258034
NM_133378.4(TTN):c.75969T>C (p.Gly25323=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.31803(G), GMAF:0.49120(A), GO-ESP:0.35130(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178562459	GRCh38	47429	56593
NM_003319.4(TTN):c.56376C>T (p.Pro18792=)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00003(A)	Likely benign(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	2	178562561	GRCh38	264347	258036
NM_001256850.1(TTN):c.78593G>A (p.Arg26198Gln)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00040(T), GO-ESP:0.00041(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178562616	GRCh38	196060	193221
NM_133378.4(TTN):c.75619A>G (p.Ile25207Val)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.31999(C), GMAF:0.49160(T), GO-ESP:0.35359(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178562809	GRCh38	47425	56589
NM_003319.4(TTN):c.55996T>C (p.Leu18666=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	2	178562941	GRCh38	264249	258037
NM_133378.4(TTN):c.75467T>G (p.Val25156Gly)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00041(C), GO-ESP:0.00042(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jul 16, 2014)	criteria provided, conflicting interpretations	2	178562961	GRCh38	47421	56586
NM_003319.4(TTN):c.55878T>C (p.Ala18626=)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00040(G), GO-ESP:0.00002(G)	Likely benign(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	2	178563059	GRCh38	264558	258039
TTN:c.83056G>A (p.Val27686Ile)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02083(T), GMAF:0.01620(T), GO-ESP:0.00549(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178563076	GRCh38	47419	56584
NM_133378.4(TTN):c.75100G>A (p.Val25034Ile)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	2	178563328	GRCh38	263483	258038
NM_133378.4(TTN):c.75094G>A (p.Ala25032Thr)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03250(T), GMAF:0.03550(T), GO-ESP:0.01056(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178563334	GRCh38	47418	56583
NM_003319.4(TTN):c.55602C>T (p.Gly18534=)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00140(A), GO-ESP:0.00023(A)	Likely benign(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	2	178563335	GRCh38	264455	258040
NM_133378.4(TTN):c.75036G>A (p.Thr25012=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00548(T), GMAF:0.00780(T), GO-ESP:0.00877(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178563392	GRCh38	47417	56582
NM_003319.4(TTN):c.55532A>G (p.Asn18511Ser)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	2	178563405	GRCh38	264244	258041
NM_001267550.2(TTN):c.82575G>A (p.Thr27525=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00876(T), GMAF:0.00840(T), GO-ESP:0.00280(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178563557	GRCh38	47415	56580
NM_001256850.1(TTN):c.77462C>T (p.Thr25821Met)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GMAF:0.01560(T)	Uncertain significance(Last reviewed: Sep 15, 2015)	criteria provided, multiple submitters, no conflicts	2	178563747	GRCh38	202911	198943
TTN:c.82385C>A (p.Thr27462Lys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01553(T), GMAF:0.01560(T), GO-ESP:0.00514(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178563747	GRCh38	47410	56575
NM_003319.4(TTN):c.54889A>G (p.Ile18297Val)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	2	178564048	GRCh38	264516	258042
NM_133378.4(TTN):c.74377C>G (p.Pro24793Ala)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00500(C), GO-ESP:0.00286(C)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178564051	GRCh38	47407	56572
TTN:c.81958G>A (p.Ala27320Thr)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02088(T), GMAF:0.01620(T), GO-ESP:0.00548(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178564174	GRCh38	47405	56570
NM_003319.4(TTN):c.54753T>C (p.Leu18251=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: May 18, 2015)	criteria provided, single submitter	2	178564184	GRCh38	264059	258043
NM_133378.4(TTN):c.74151C>T (p.Ile24717=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01570(A), GMAF:0.02220(A), GO-ESP:0.02591(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178564277	GRCh38	47402	56567
NM_001256850.1(TTN):c.76635T>C (p.Asn25545=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00479(G), GMAF:0.00300(G), GO-ESP:0.00542(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178564574	GRCh38	47399	56564
NM_133378.4(TTN):c.73636_73640delAAGAA (p.Lys24546Glnfs)	TTN|TTN-AS1	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Nov 13, 2013)	criteria provided, single submitter	2	178564788 - 178564792	GRCh38	263802	258044
NM_001256850.1(TTN):c.76324T>C (p.Ser25442Pro)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00050(G), GMAF:0.00060(G), GO-ESP:0.00025(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 9, 2016)	criteria provided, conflicting interpretations	2	178564885	GRCh38	96307	102201
NM_001267550.2(TTN):c.81057T>C (p.Thr27019=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00824(G), GMAF:0.00680(G), GO-ESP:0.00199(G)	Benign(Last reviewed: Nov 11, 2015)	criteria provided, multiple submitters, no conflicts	2	178565075	GRCh38	47394	56559
NM_001256850.1(TTN):c.76114C>T (p.Arg25372Ter)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|Familial hypertrophic cardiomyopathy 9|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2016)	criteria provided, multiple submitters, no conflicts	2	178565095	GRCh38	265437	259712
NM_133378.4(TTN):c.73154C>T (p.Thr24385Met)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00160(A), GO-ESP:0.00098(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178565274	GRCh38	179002	172697
NM_133378.4(TTN):c.73095C>A (p.Thr24365=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01593(T), GMAF:0.02220(T), GO-ESP:0.02602(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178565333	GRCh38	47392	56557
NM_133378.4(TTN):c.72721G>A (p.Gly24241Ser)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(T), GO-ESP:0.00022(T)	Uncertain significance(Last reviewed: Dec 20, 2015)	criteria provided, multiple submitters, no conflicts	2	178565707	GRCh38	47386	56551
NM_133378.4(TTN):c.72567C>T (p.Val24189=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00041(A), GMAF:0.00200(A), GO-ESP:0.00164(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178565861	GRCh38	47384	56549
NM_133378.4(TTN):c.72158C>T (p.Thr24053Met)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.21763(A), GMAF:0.34230(A), GO-ESP:0.23431(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178566270	GRCh38	47382	56547
NM_003319.4(TTN):c.52666A>G (p.Thr17556Ala)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	2	178566271	GRCh38	264466	258045
NM_133378.4(TTN):c.72079G>C (p.Asp24027His)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.01504(G), GMAF:0.00740(G), GO-ESP:0.01478(G)	Benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	2	178566349	GRCh38	47380	56545
NM_001256850.1(TTN):c.74777A>G (p.Asn24926Ser)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GMAF:0.00300(C), GO-ESP:0.00128(C)	Benign/Likely benign, not provided(Last reviewed: Mar 11, 2015)	criteria provided, multiple submitters, no conflicts	2	178566432	GRCh38	202893	198969
NM_001267550.2(TTN):c.79689C>A (p.Val26563=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00966(T), GMAF:0.00900(T), GO-ESP:0.00234(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178566443	GRCh38	47379	56544
NM_133378.4(TTN):c.71887G>A (p.Glu23963Lys)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Dec 12, 2012)	criteria provided, single submitter	2	178566541	GRCh38	263459	258047
NM_003319.4(TTN):c.52252dupG (p.Asp17418Glyfs)	TTN|TTN-AS1	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	2	178566685	GRCh38	264625	258046
NM_133378.4(TTN):c.71615G>A (p.Arg23872His)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00561(T), GMAF:0.00460(T), GO-ESP:0.00156(T)	Benign/Likely benign(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	2	178566813	GRCh38	47375	56540
NM_001267550.2(TTN):c.79318C>T (p.Arg26440Cys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00837(A), GMAF:0.00660(A), GO-ESP:0.00230(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178566814	GRCh38	47374	56539
NM_133378.4(TTN):c.71561T>C (p.Ile23854Thr)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01596(G), GMAF:0.02240(G), GO-ESP:0.02626(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178566867	GRCh38	47373	56538
NM_003319.4(TTN):c.51908G>T (p.Gly17303Val)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 20, 2015)	criteria provided, single submitter	2	178567029	GRCh38	264020	258049
NM_133378.4(TTN):c.71358T>A (p.Gly23786=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.05047(T), GMAF:0.09270(T), GO-ESP:0.04598(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178567070	GRCh38	47370	56535
NM_003319.4(TTN):c.51749G>C (p.Gly17250Ala)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	2	178567188	GRCh38	264586	258050
NM_001256850.1(TTN):c.73969G>A (p.Gly24657Arg)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00050(T), GO-ESP:0.00027(T)	Uncertain significance(Last reviewed: Nov 13, 2015)	criteria provided, multiple submitters, no conflicts	2	178567240	GRCh38	47368	56533
NM_133378.4(TTN):c.70970T>C (p.Ile23657Thr)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.22586(G), GMAF:0.13000(G), GO-ESP:0.23681(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178567458	GRCh38	47367	56532
NM_003319.4(TTN):c.51298G>A (p.Ala17100Thr)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	2	178567639	GRCh38	264202	258048
NM_133378.4(TTN):c.69934A>G (p.Thr23312Ala)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01604(C), GMAF:0.02240(C), GO-ESP:0.02618(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178568494	GRCh38	47359	56524
NM_133378.4(TTN):c.69929A>G (p.Gln23310Arg)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	2	178568499	GRCh38	263658	258053
NM_133378.4(TTN):c.69575A>G (p.Asn23192Ser)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01583(C), GMAF:0.02240(C), GO-ESP:0.02616(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178568853	GRCh38	47356	56521
NM_133378.4(TTN):c.69283G>A (p.Asp23095Asn)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00012(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 11, 2015)	criteria provided, conflicting interpretations	2	178569145	GRCh38	192154	189523
NM_133378.4(TTN):c.69035C>T (p.Thr23012Met)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GMAF:0.00460(A), GO-ESP:0.00166(A)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 25, 2015)	criteria provided, conflicting interpretations	2	178569393	GRCh38	47351	56516
NM_001267550.2(TTN):c.76722T>C (p.Tyr25574=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00258(G), GMAF:0.00040(G), GO-ESP:0.00230(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178569410	GRCh38	47350	56515
NM_133378.4(TTN):c.69016T>C (p.Tyr23006His)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01578(G), GMAF:0.02240(G), GO-ESP:0.02621(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178569412	GRCh38	47349	56514
NM_003319.4(TTN):c.49292C>G (p.Pro16431Arg)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	2	178569645	GRCh38	264259	258051
NM_133378.4(TTN):c.68639G>A (p.Ser22880Asn)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03392(T), GMAF:0.07930(T), GO-ESP:0.04127(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178569789	GRCh38	47347	56512
NM_003319.4(TTN):c.48501T>C (p.Asp16167=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	2	178570436	GRCh38	264576	258057
NM_133378.4(TTN):c.67818A>C (p.Ala22606=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.09038(G), GMAF:0.14320(G), GO-ESP:0.08837(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178570610	GRCh38	47339	56504
NM_001267550.2(TTN):c.75451_75453delGAG (p.Glu25151del)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	2	178570679 - 178570681	GRCh38	263675	258058
NM_001256850.1(TTN):c.70518A>G (p.Lys23506=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00439(C), GMAF:0.00600(C), GO-ESP:0.00639(C)	Benign/Likely benign(Last reviewed: Mar 5, 2016)	criteria provided, multiple submitters, no conflicts	2	178570691	GRCh38	47338	56503
NM_133378.4(TTN):c.67488T>C (p.Thr22496=)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00060(G), GO-ESP:0.00022(G)	Likely benign(Last reviewed: Feb 26, 2013)	criteria provided, single submitter	2	178570940	GRCh38	263537	258054
NM_001256850.1(TTN):c.69972A>C (p.Gln23324His)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00141(G), GMAF:0.00040(G), GO-ESP:0.00099(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 24, 2015)	criteria provided, conflicting interpretations	2	178571237	GRCh38	47332	56497
NM_133378.4(TTN):c.67135C>T (p.Arg22379Cys)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.12208(A), GMAF:0.20810(A), GO-ESP:0.17456(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178571293	GRCh38	47329	56494
NM_001267550.2(TTN):c.74763C>T (p.Ser24921=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Cardiovascular phenotype	GO-ESP:0.00005(A)	Likely benign(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	2	178571369	GRCh38	238841	238430
NM_133378.4(TTN):c.66486T>G (p.Gly22162=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.20495(C)	Likely benign(Last reviewed: Oct 16, 2012)	criteria provided, single submitter	2	178571942	GRCh38	263410	258052
NM_133378.4(TTN):c.66338A>G (p.Gln22113Arg)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00100(C), GO-ESP:0.00039(C)	Uncertain significance(Last reviewed: Jan 30, 2013)	criteria provided, single submitter	2	178572090	GRCh38	263494	258060
NM_001256850.1(TTN):c.68902G>C (p.Glu22968Gln)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00173(G), GMAF:0.00160(G), GO-ESP:0.00318(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178572307	GRCh38	47322	56487
NM_133378.4(TTN):c.65933A>T (p.Asp21978Val)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: May 22, 2013)	criteria provided, single submitter	2	178572495	GRCh38	263616	258059
NM_001267550.2(TTN):c.73508delA (p.Asn24503Ilefs)	TTN|TTN-AS1	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Mar 14, 2013)	criteria provided, single submitter	2	178572624	GRCh38	263529	258055
NM_003319.4(TTN):c.46173T>C (p.Pro15391=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(G)	Likely benign(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	2	178572764	GRCh38	264617	258056
NM_133378.4(TTN):c.65520G>A (p.Gly21840=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2015)	criteria provided, conflicting interpretations	2	178572908	GRCh38	263624	258063
NM_133378.4(TTN):c.65464A>G (p.Thr21822Ala)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00120(C), GO-ESP:0.00064(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178572964	GRCh38	47320	56485
NM_133378.4(TTN):c.65227A>G (p.Thr21743Ala)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00372(C), GMAF:0.00080(C), GO-ESP:0.00479(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 10, 2015)	criteria provided, conflicting interpretations	2	178573201	GRCh38	47318	56483
NM_001256850.1(TTN):c.67663C>T (p.Arg22555Cys)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00009(A)	Uncertain significance(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	2	178573546	GRCh38	202842	199043
NM_133378.4(TTN):c.64442T>C (p.Leu21481Pro)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00020(G), GO-ESP:0.00059(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178573986	GRCh38	191903	189539
NM_001267550.2(TTN):c.72132T>C (p.Gly24044=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00458(G), GMAF:0.00040(G), GO-ESP:0.00382(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178574000	GRCh38	47308	56473
NM_003319.4(TTN):c.44879A>C (p.Glu14960Ala)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	2	178574058	GRCh38	264228	258066
NM_001267550.2(TTN):c.72033A>G (p.Pro24011=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00829(C), GMAF:0.00640(C), GO-ESP:0.00228(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178574099	GRCh38	47306	56471
NM_133378.4(TTN):c.64289G>A (p.Arg21430His)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.04784(T), GMAF:0.09780(T), GO-ESP:0.07444(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178574139	GRCh38	47305	56470
NM_133378.4(TTN):c.64240A>G (p.Asn21414Asp)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00005(C)	Uncertain significance(Last reviewed: Sep 22, 2016)	criteria provided, multiple submitters, no conflicts	2	178574188	GRCh38	191904	189540
NM_001267550.2(TTN):c.71940G>A (p.Leu23980=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00833(T), GMAF:0.00640(T), GO-ESP:0.00227(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178574192	GRCh38	47304	56469
NM_133378.4(TTN):c.64001T>C (p.Ile21334Thr)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00272(G), GMAF:0.00060(G), GO-ESP:0.00216(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178574427	GRCh38	47302	56467
NM_003319.4(TTN):c.44306A>C (p.Gln14769Pro)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	2	178574631	GRCh38	264122	258062
NM_133378.4(TTN):c.63665G>A (p.Arg21222His)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00580(T), GO-ESP:0.00141(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178574763	GRCh38	47298	56463
NM_003319.4(TTN):c.44173C>T (p.Arg14725Cys)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Jul 22, 2015)	criteria provided, single submitter	2	178574764	GRCh38	264186	258061
NM_133378.4(TTN):c.63400G>T (p.Gly21134Trp)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Sep 10, 2015)	criteria provided, multiple submitters, no conflicts	2	178575028	GRCh38	263588	258073
NM_133378.4(TTN):c.63332G>A (p.Arg21111Lys)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00041(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Aug 21, 2015)	criteria provided, conflicting interpretations	2	178575096	GRCh38	192159	189541
NM_133378.4(TTN):c.63294A>G (p.Thr21098=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00018(C)	Likely benign(Last reviewed: Sep 17, 2016)	criteria provided, multiple submitters, no conflicts	2	178575134	GRCh38	263724	258068
NM_133378.4(TTN):c.63203G>A (p.Arg21068His)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00008(T), GMAF:0.00280(T), GO-ESP:0.00145(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178575225	GRCh38	96301	102195
NM_133378.4(TTN):c.63128C>T (p.Ala21043Val)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00289(A), GMAF:0.00420(A), GO-ESP:0.00091(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178575300	GRCh38	47294	56459
NM_133378.4(TTN):c.63126C>T (p.Ser21042=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.23862(A), GMAF:0.14660(A), GO-ESP:0.23999(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178575302	GRCh38	47293	56458
NM_001267550.2(TTN):c.70815G>A (p.Val23605=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00209(T), GMAF:0.00100(T), GO-ESP:0.00236(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178575317	GRCh38	47292	56457
NM_133378.4(TTN):c.62992G>C (p.Gly20998Arg)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01135(G), GMAF:0.00440(G), GO-ESP:0.01065(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178575436	GRCh38	47290	56455
NM_001267550.2(TTN):c.70677T>C (p.Asp23559=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00375(G), GMAF:0.00060(G), GO-ESP:0.00278(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178575455	GRCh38	47289	56454
NM_133378.4(TTN):c.62556G>A (p.Pro20852=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Nov 18, 2013)	criteria provided, single submitter	2	178575872	GRCh38	263730	258064
NM_133378.4(TTN):c.62200G>A (p.Val20734Ile)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00018(T)	Uncertain significance(Last reviewed: Jul 19, 2013)	criteria provided, multiple submitters, no conflicts	2	178576228	GRCh38	47279	56444
NM_001256850.1(TTN):c.64898G>A (p.Gly21633Asp)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00157(T), GMAF:0.00020(T), GO-ESP:0.00104(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Aug 23, 2016)	criteria provided, conflicting interpretations	2	178576311	GRCh38	47277	56442
NM_001267550.2(TTN):c.69740C>T (p.Pro23247Leu)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00992(A), GMAF:0.00780(A), GO-ESP:0.00252(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178576392	GRCh38	47276	56441
NM_001267550.2(TTN):c.69716-5C>G	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GMAF:0.00180(C), GO-ESP:0.00267(C)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	2	178576421	GRCh38	137806	141509
NM_133378.4(TTN):c.61972A>G (p.Ser20658Gly)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00659(C), GMAF:0.00300(C), GO-ESP:0.00752(C)	Benign(Last reviewed: Jan 27, 2016)	criteria provided, multiple submitters, no conflicts	2	178576568	GRCh38	47275	56440
NM_133378.4(TTN):c.61881C>T (p.Ser20627=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00956(A), GMAF:0.00300(A), GO-ESP:0.01208(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178576659	GRCh38	47274	56439
NM_133378.4(TTN):c.61634G>A (p.Arg20545Gln)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Jun 30, 2015)	criteria provided, multiple submitters, no conflicts	2	178576997	GRCh38	191909	189548
NM_133378.4(TTN):c.61441A>G (p.Ile20481Val)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03368(C), GMAF:0.03630(C), GO-ESP:0.01078(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178577190	GRCh38	47271	56436
NM_001256850.1(TTN):c.64207C>T (p.Pro21403Ser)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00410(A), GMAF:0.00100(A), GO-ESP:0.00340(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178577205	GRCh38	47265	56430
NM_133378.4(TTN):c.61120G>A (p.Glu20374Lys)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00034(T), GMAF:0.00060(T), GO-ESP:0.00030(T)	Uncertain significance(Last reviewed: Sep 16, 2016)	criteria provided, multiple submitters, no conflicts	2	178577602	GRCh38	96298	102192
NM_133378.4(TTN):c.61058C>T (p.Thr20353Ile)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00026(A)	Uncertain significance(Last reviewed: Nov 20, 2013)	criteria provided, multiple submitters, no conflicts	2	178577664	GRCh38	178998	172967
NM_133378.4(TTN):c.60777C>A (p.Gly20259=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 15, 2012)	criteria provided, single submitter	2	178578034	GRCh38	263375	258065
NM_133378.4(TTN):c.60733G>A (p.Glu20245Lys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00027(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178578078	GRCh38	178196	172829
NM_003319.4(TTN):c.41023C>T (p.Pro13675Ser)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	2	178578812	GRCh38	264208	258075
NM_133378.4(TTN):c.60513T>C (p.His20171=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.08376(G), GMAF:0.13600(G), GO-ESP:0.08677(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178578813	GRCh38	47263	56428
NM_133378.4(TTN):c.60457G>A (p.Glu20153Lys)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Jun 24, 2013)	criteria provided, multiple submitters, no conflicts	2	178578869	GRCh38	191911	189553
NM_003319.4(TTN):c.40888G>A (p.Ala13630Thr)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	2	178578947	GRCh38	264080	258071
NM_001267550.2(TTN):c.68079G>A (p.Thr22693=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00505(T), GMAF:0.00380(T), GO-ESP:0.00166(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178578951	GRCh38	47260	56425
NM_001267550.2(TTN):c.67809G>A (p.Ala22603=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Cardiovascular phenotype	GMAF:0.00160(T), GO-ESP:0.00062(T)	Benign/Likely benign(Last reviewed: Jan 7, 2016)	criteria provided, multiple submitters, no conflicts	2	178579221	GRCh38	238829	238441
NM_001256850.1(TTN):c.62737G>C (p.Gly20913Arg)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Jan 31, 2013)	criteria provided, single submitter	2	178579370	GRCh38	202812	199087
NM_133378.4(TTN):c.59933-1G>C	TTN|TTN-AS1	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Feb 7, 2013)	criteria provided, single submitter	2	178579394	GRCh38	263509	258069
NM_133378.4(TTN):c.59931T>C (p.Val19977=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01728(G), GMAF:0.02840(G), GO-ESP:0.03055(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178579562	GRCh38	47255	56420
NM_001267550.2(TTN):c.67604G>A (p.Ser22535Asn)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Oct 20, 2015)	criteria provided, multiple submitters, no conflicts	2	178579593	GRCh38	220680	221124
NM_001267550.2(TTN):c.67542T>G (p.Thr22514=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00033(C), GMAF:0.00380(C), GO-ESP:0.00092(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178579655	GRCh38	47253	56418
NM_133378.4(TTN):c.59542G>C (p.Ala19848Pro)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.99562(G), GMAF:0.00540(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178580041	GRCh38	47250	56415
NM_133378.4(TTN):c.59371G>A (p.Val19791Ile)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.22395(T), GMAF:0.35120(T), GO-ESP:0.24199(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178580212	GRCh38	47247	56412
NM_001256850.1(TTN):c.62135-1G>C	TTN|TTN-AS1	not provided		Pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	2	178580230	GRCh38	202519	199099
NM_133378.4(TTN):c.59310C>A (p.Asn19770Lys)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Apr 1, 2013)	criteria provided, single submitter	2	178580365	GRCh38	263570	258067
NM_003319.4(TTN):c.39707A>G (p.Asn13236Ser)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	2	178580477	GRCh38	264523	258081
NM_133378.4(TTN):c.58910G>A (p.Arg19637Lys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01621(T), GMAF:0.00580(T), GO-ESP:0.01495(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178581654	GRCh38	47236	56401
NM_001256850.1(TTN):c.61667G>A (p.Arg20556Gln)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	2	178581678	GRCh38	165886	172977
NM_133378.4(TTN):c.58823C>T (p.Ser19608Phe)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Nov 20, 2013)	criteria provided, single submitter	2	178581741	GRCh38	263782	258072
NM_133378.4(TTN):c.58777G>A (p.Ala19593Thr)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	2	178581787	GRCh38	263672	258074
NM_133378.4(TTN):c.58377G>T (p.Gln19459His)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 5, 2012)	criteria provided, single submitter	2	178582375	GRCh38	263357	258070
NM_003319.4(TTN):c.38720G>A (p.Arg12907His)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00009(T)	Uncertain significance(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	2	178582541	GRCh38	264599	258083
NM_001256850.1(TTN):c.60824G>A (p.Arg20275Gln)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00114(T), GMAF:0.00080(T), GO-ESP:0.00040(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178583056	GRCh38	47229	56394
NM_001256850.1(TTN):c.60806T>C (p.Ile20269Thr)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00040(G), GO-ESP:0.00022(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178583074	GRCh38	179042	172981
NM_133378.4(TTN):c.57978A>G (p.Thr19326=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.32176(C), GMAF:0.48620(T), GO-ESP:0.35880(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178583121	GRCh38	47227	56392
NM_003319.4(TTN):c.38477C>T (p.Pro12826Leu)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	2	178583131	GRCh38	47226	56391
NM_001256850.1(TTN):c.60681T>C (p.Ala20227=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00075(G), GO-ESP:0.00064(G)	Benign/Likely benign(Last reviewed: Jun 9, 2015)	criteria provided, multiple submitters, no conflicts	2	178583199	GRCh38	47225	56390
NM_133378.4(TTN):c.57812C>T (p.Ala19271Val)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01367(A), GMAF:0.01420(A), GO-ESP:0.00432(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178583666	GRCh38	47223	56388
NM_133378.4(TTN):c.57782A>G (p.Gln19261Arg)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 4, 2013)	criteria provided, single submitter	2	178583696	GRCh38	263775	258076
NM_133378.4(TTN):c.57554C>T (p.Thr19185Ile)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jan 30, 2013)	criteria provided, single submitter	2	178584293	GRCh38	263495	258077
NM_133378.4(TTN):c.57490T>C (p.Phe19164Leu)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00029(G)	Uncertain significance(Last reviewed: Mar 11, 2013)	criteria provided, multiple submitters, no conflicts	2	178584357	GRCh38	47220	56385
NM_133378.4(TTN):c.57443C>T (p.Ser19148Leu)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03170(A), GMAF:0.01080(A), GO-ESP:0.02564(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178584404	GRCh38	47218	56383
NM_133378.4(TTN):c.57388C>T (p.Arg19130Cys)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00191(A), GMAF:0.01300(A), GO-ESP:0.00883(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178584459	GRCh38	47216	56381
NM_133378.4(TTN):c.56984delC (p.Pro18995Leufs)	TTN|TTN-AS1	not specified|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2013)	criteria provided, conflicting interpretations	2	178584953	GRCh38	235071	236752
NM_001256850.1(TTN):c.59758G>A (p.Gly19920Ser)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Aug 2, 2013)	criteria provided, single submitter	2	178584960	GRCh38	202788	199118
NM_133378.4(TTN):c.56504C>T (p.Thr18835Ile)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.31228(A), GMAF:0.49240(G), GO-ESP:0.35089(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178586693	GRCh38	47209	56374
NM_133378.4(TTN):c.56470C>T (p.Arg18824Cys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00082(A), GO-ESP:0.00066(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 17, 2016)	criteria provided, conflicting interpretations	2	178586727	GRCh38	47208	56373
NM_133378.4(TTN):c.56328C>T (p.Asn18776=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00386(A), GMAF:0.01320(A), GO-ESP:0.01017(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178587179	GRCh38	47205	56370
NM_133378.4(TTN):c.56238G>A (p.Ser18746=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00066(T), GO-ESP:0.00059(T)	Likely benign(Last reviewed: Oct 14, 2015)	criteria provided, multiple submitters, no conflicts	2	178587269	GRCh38	47202	56367
NM_003319.4(TTN):c.36684C>T (p.Asp12228=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00091(A), GO-ESP:0.00032(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178587332	GRCh38	47200	56365
NM_133378.4(TTN):c.55922G>A (p.Arg18641Gln)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	2	178587683	GRCh38	202318	199130
NM_001256850.1(TTN):c.58516G>A (p.Ala19506Thr)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00076(T)	Uncertain significance(Last reviewed: Sep 2, 2016)	criteria provided, multiple submitters, no conflicts	2	178587968	GRCh38	178202	172850
NM_133378.4(TTN):c.55648C>T (p.Arg18550Trp)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00028(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178588055	GRCh38	47194	56359
NM_001256850.1(TTN):c.58280delC (p.Pro19427Glnfs)	TTN|TTN-AS1	not provided		Pathogenic(Last reviewed: Apr 28, 2014)	criteria provided, single submitter	2	178588204	GRCh38	202455	199136
NM_133378.4(TTN):c.55412A>C (p.Lys18471Thr)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 12, 2013)	criteria provided, single submitter	2	178588609	GRCh38	263662	258078
NM_133378.4(TTN):c.55322G>A (p.Arg18441Gln)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00713(T), GMAF:0.00480(T), GO-ESP:0.00195(T)	Benign/Likely benign(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	2	178588699	GRCh38	47189	56354
NM_001256850.1(TTN):c.58102C>T (p.Arg19368Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, multiple submitters, no conflicts	2	178588700	GRCh38	202518	199141
NM_133378.4(TTN):c.55319C>T (p.Thr18440Ile)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01211(A), GMAF:0.00580(A), GO-ESP:0.00940(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178588702	GRCh38	47188	56353
NM_133378.4(TTN):c.55239T>C (p.Thr18413=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00018(G)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 11, 2015)	criteria provided, conflicting interpretations	2	178588782	GRCh38	165912	172852
NM_133378.4(TTN):c.54868A>G (p.Thr18290Ala)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00100(C), GMAF:0.00020(C), GO-ESP:0.00042(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178589153	GRCh38	47185	56350
NM_133378.4(TTN):c.54843G>A (p.Thr18281=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00005(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 3, 2016)	criteria provided, conflicting interpretations	2	178589178	GRCh38	263442	258084
NM_001256850.1(TTN):c.57509A>G (p.Asp19170Gly)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GMAF:0.00140(C), GO-ESP:0.00022(C)	Uncertain significance(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	2	178589293	GRCh38	202762	199148
NM_133378.4(TTN):c.54720C>T (p.Asp18240=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00011(A)	Likely benign(Last reviewed: Apr 29, 2013)	criteria provided, single submitter	2	178589301	GRCh38	263610	258082
NM_133379.4(TTN):c.*265+155980C>A	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00066(T), GO-ESP:0.00046(T)	Benign/Likely benign(Last reviewed: Aug 22, 2016)	criteria provided, multiple submitters, no conflicts	2	178589340	GRCh38	47182	56347
NM_133378.4(TTN):c.54576T>C (p.Val18192=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00018(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178589445	GRCh38	195921	193082
NM_001256850.1(TTN):c.57255T>C (p.Thr19085=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.01505(G), GMAF:0.01160(G), GO-ESP:0.00415(G)	Benign(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	2	178589547	GRCh38	47180	56345
NM_133378.4(TTN):c.54354T>C (p.Tyr18118=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.32070(G), GMAF:0.48760(A), GO-ESP:0.35396(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178589667	GRCh38	47179	56344
NM_003319.4(TTN):c.34442dupA (p.Tyr11482Valfs)	TTN|TTN-AS1	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	2	178590088	GRCh38	264218	258079
NM_003319.4(TTN):c.34397G>A (p.Arg11466His)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Dec 20, 2015)	criteria provided, single submitter	2	178590133	GRCh38	264601	258080
NM_133378.4(TTN):c.53541A>G (p.Thr17847=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.31943(C), GMAF:0.48760(T), GO-ESP:0.35438(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178590480	GRCh38	47170	56335
NM_003319.4(TTN):c.33947A>G (p.Lys11316Arg)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	2	178590583	GRCh38	264246	258086
NM_133378.4(TTN):c.53396G>A (p.Arg17799Gln)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00333(T), GMAF:0.00120(T), GO-ESP:0.00383(T)	Benign/Likely benign, not provided(Last reviewed: Jan 17, 2016)	criteria provided, multiple submitters, no conflicts	2	178590625	GRCh38	47168	56333
NM_001267550.2(TTN):c.61029T>C (p.Phe20343=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00100(G), GO-ESP:0.00040(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178590696	GRCh38	165925	172999
NM_133378.4(TTN):c.53240G>A (p.Gly17747Asp)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Mar 6, 2013)	criteria provided, single submitter	2	178590781	GRCh38	263530	258085
NM_001256850.1(TTN):c.55898C>T (p.Pro18633Leu)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00083(A), GMAF:0.00300(A), GO-ESP:0.00377(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178590904	GRCh38	47165	56330
NM_133378.4(TTN):c.53083A>G (p.Thr17695Ala)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Apr 4, 2013)	criteria provided, single submitter	2	178590938	GRCh38	263575	258087
NM_133378.4(TTN):c.52786G>C (p.Val17596Leu)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00447(G), GMAF:0.00480(G), GO-ESP:0.00130(G)	Benign(Last reviewed: Mar 6, 2016)	criteria provided, multiple submitters, no conflicts	2	178591235	GRCh38	47162	56327
NM_003319.4(TTN):c.33071T>C (p.Val11024Ala)	TTN|TTN-AS1	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 27, 2015)	criteria provided, multiple submitters, no conflicts	2	178591459	GRCh38	264221	258088
NM_133378.4(TTN):c.52528G>A (p.Val17510Met)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00713(T), GMAF:0.00480(T), GO-ESP:0.00217(T)	Benign/Likely benign(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	2	178591493	GRCh38	47160	56325
NM_133378.4(TTN):c.52304G>A (p.Arg17435His)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Nov 13, 2013)	criteria provided, single submitter	2	178591811	GRCh38	263757	258089
NM_133378.4(TTN):c.[52301A>G];[38532C>A]	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Familial hypertrophic cardiomyopathy 9	GO-ESP:0.00076(C), GO-ESP:0.00053(C)	Likely pathogenic(Last reviewed: Apr 24, 2012)	criteria provided, single submitter	2|2	178591814	GRCh38	217021	56322|213530
NM_001267550.2(TTN):c.59943C>A (p.Pro19981=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00051(T), GMAF:0.00220(T), GO-ESP:0.00256(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178591876	GRCh38	47156	56321
NM_133378.4(TTN):c.52145G>A (p.Arg17382Gln)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Oct 15, 2013)	criteria provided, single submitter	2	178592055	GRCh38	263721	258090
NM_133378.4(TTN):c.51881C>T (p.Pro17294Leu)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.12529(A), GMAF:0.21310(A), GO-ESP:0.17678(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178592420	GRCh38	47152	56317
NM_003319.4(TTN):c.32156_32157delCT (p.Pro10719Argfs)	TTN|TTN-AS1	Cardiovascular phenotype		Likely pathogenic(Last reviewed: May 20, 2015)	criteria provided, single submitter	2	178592653 - 178592654	GRCh38	264060	258091
NM_001267550.2(TTN):c.59344+3G>A	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00100(T), GO-ESP:0.00018(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178592772	GRCh38	137799	141502
NM_133378.4(TTN):c.51615G>A (p.Glu17205=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00083(T), GMAF:0.00020(T), GO-ESP:0.00032(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178592800	GRCh38	47150	56315
NM_001256850.1(TTN):c.54392C>T (p.Pro18131Leu)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00282(A), GMAF:0.00240(A), GO-ESP:0.00096(A)	Benign(Last reviewed: May 6, 2015)	criteria provided, multiple submitters, no conflicts	2	178592804	GRCh38	47148	56313
NM_001256850.1(TTN):c.54190C>T (p.Arg18064Cys)	TTN|TTN-AS1	not specified|not provided	GO-ESP:0.00017(A), GO-ESP:0.00021(A)	Uncertain significance(Last reviewed: Sep 18, 2016)	criteria provided, multiple submitters, no conflicts	2	178593006	GRCh38	47146	56311
NM_133378.4(TTN):c.51243G>A (p.Gln17081=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Oct 4, 2013)	criteria provided, single submitter	2	178593261	GRCh38	263776	258092
NM_133378.4(TTN):c.51229C>T (p.Leu17077=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00203(A), GMAF:0.03440(A), GO-ESP:0.03070(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178593275	GRCh38	47142	56307
NM_133378.4(TTN):c.50732G>A (p.Arg16911His)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.12523(T), GMAF:0.21250(T), GO-ESP:0.17611(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178593864	GRCh38	47136	56301
NM_133378.4(TTN):c.50715A>G (p.Gln16905=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00040(C), GO-ESP:0.00091(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178593974	GRCh38	179046	173008
NM_001256850.1(TTN):c.53440G>A (p.Gly17814Ser)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00012(T)	Uncertain significance(Last reviewed: Jul 17, 2015)	criteria provided, multiple submitters, no conflicts	2	178594030	GRCh38	195843	193004
NM_133378.4(TTN):c.50315T>A (p.Leu16772His)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: May 15, 2013)	criteria provided, single submitter	2	178594475	GRCh38	263609	258093
NM_003319.4(TTN):c.30665G>A (p.Arg10222His)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	2	178594634	GRCh38	264456	258095
NM_133379.4(TTN):c.*265+149735C>T	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Sep 22, 2015)	criteria provided, conflicting interpretations	2	178595585	GRCh38	202392	199189
NM_133378.4(TTN):c.49882C>G (p.Leu16628Val)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00027(C)	Uncertain significance(Last reviewed: Jun 21, 2016)	criteria provided, multiple submitters, no conflicts	2	178595768	GRCh38	47126	56291
NM_001267550.2(TTN):c.57462_57464delGAGinsAAA (p.Arg19155Lys)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Dec 7, 2012)	criteria provided, single submitter	2	178597618 - 178597620	GRCh38	263477	258094
TTN:c.57464G>A (p.Arg19155Lys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00679(T), GMAF:0.00540(T), GO-ESP:0.00184(T)	Benign/Likely benign(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	2	178597618	GRCh38	47124	56289
NM_001256850.1(TTN):c.52539G>A (p.Gln17513=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00679(T), GMAF:0.00540(T), GO-ESP:0.00184(T)	Benign/Likely benign(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	2	178597620	GRCh38	47123	56288
NM_133378.4(TTN):c.49611T>C (p.His16537=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.22001(G), GMAF:0.12700(G), GO-ESP:0.23487(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178597767	GRCh38	47120	56285
NM_003319.4(TTN):c.29655G>A (p.Val9885=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00006(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2015)	criteria provided, conflicting interpretations	2	178598860	GRCh38	195840	193001
NM_133378.4(TTN):c.48982G>A (p.Val16328Met)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided|Cardiovascular phenotype	GO-ESP:0.00013(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	2	178599024	GRCh38	191938	189585
NM_133378.4(TTN):c.48825G>A (p.Thr16275=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00846(T), GMAF:0.00360(T), GO-ESP:0.00892(T)	Benign/Likely benign(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	2	178599264	GRCh38	47111	56276
NM_133378.4(TTN):c.48551C>T (p.Pro16184Leu)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GO-ESP:0.00018(A)	Uncertain significance(Last reviewed: May 20, 2015)	criteria provided, multiple submitters, no conflicts	2	178599646	GRCh38	191939	189586
NM_133378.4(TTN):c.48397A>G (p.Asn16133Asp)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.32205(C), GMAF:0.48720(T), GO-ESP:0.35535(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178599800	GRCh38	47110	56275
NM_133378.4(TTN):c.48221T>A (p.Leu16074Gln)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00020(T), GO-ESP:0.00044(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178600979	GRCh38	177978	172879
NM_133378.4(TTN):c.47955G>A (p.Val15985=)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00024(T)	Likely benign(Last reviewed: Jun 11, 2013)	criteria provided, single submitter	2	178601338	GRCh38	263665	258096
NM_133378.4(TTN):c.47849A>G (p.Lys15950Arg)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00206(C), GMAF:0.00260(C), GO-ESP:0.00137(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178601444	GRCh38	47106	56271
NM_133378.4(TTN):c.47325G>A (p.Arg15775=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01050(T), GMAF:0.00180(T), GO-ESP:0.00704(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178602373	GRCh38	47099	56264
NM_001267550.2(TTN):c.54903C>G (p.Gly18301=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GMAF:0.00160(C), GO-ESP:0.00096(C)	Benign/Likely benign(Last reviewed: Jan 25, 2016)	criteria provided, multiple submitters, no conflicts	2	178602499	GRCh38	165971	173864
NM_133378.4(TTN):c.47151G>A (p.Thr15717=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00021(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178602547	GRCh38	263758	258101
NM_133378.4(TTN):c.47006T>C (p.Leu15669Pro)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00080(G), GO-ESP:0.00052(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178603977	GRCh38	191944	189591
NM_133378.4(TTN):c.46970G>T (p.Gly15657Val)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 27, 2013)	criteria provided, single submitter	2	178604013	GRCh38	263635	258098
NM_133378.4(TTN):c.46656T>C (p.Thr15552=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(G)	Likely benign(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	2	178604729	GRCh38	263622	258099
NM_001256850.1(TTN):c.49225C>T (p.Arg16409Cys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GMAF:0.00140(A), GO-ESP:0.00068(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	2	178605029	GRCh38	47083	56248
NM_133378.4(TTN):c.46411G>A (p.Asp15471Asn)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Jul 26, 2013)	criteria provided, single submitter	2	178605062	GRCh38	263669	258097
NM_133378.4(TTN):c.46211G>A (p.Arg15404Gln)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00008(T), GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: May 29, 2013)	criteria provided, multiple submitters, no conflicts	2	178605262	GRCh38	47077	56242
NM_003319.4(TTN):c.26095G>A (p.Val8699Ile)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 23, 2015)	criteria provided, single submitter	2	178607312	GRCh38	264297	258103
NM_133378.4(TTN):c.45488T>C (p.Ile15163Thr)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01053(G), GMAF:0.00460(G), GO-ESP:0.01369(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178607496	GRCh38	47074	56239
NM_133378.4(TTN):c.45419A>T (p.Lys15140Ile)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01566(A), GMAF:0.02960(A), GO-ESP:0.02916(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178607565	GRCh38	47072	56237
NM_133378.4(TTN):c.45308C>T (p.Ala15103Val)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Sep 15, 2014)	criteria provided, multiple submitters, no conflicts	2	178607676	GRCh38	165992	172710
NM_133378.4(TTN):c.45246A>G (p.Ala15082=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(C)	Likely benign(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	2	178607837	GRCh38	263751	258109
NM_133378.4(TTN):c.45213T>C (p.Asp15071=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02145(G), GMAF:0.02300(G), GO-ESP:0.00721(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178607870	GRCh38	47068	56233
NM_001256850.1(TTN):c.47968G>A (p.Val15990Ile)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Oct 18, 2013)	criteria provided, single submitter	2	178607896	GRCh38	202705	199234
NM_133378.4(TTN):c.45117T>C (p.Asp15039=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01560(G), GMAF:0.03060(G), GO-ESP:0.02958(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178607966	GRCh38	47065	56230
NM_133378.4(TTN):c.44801T>C (p.Leu14934Ser)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Feb 27, 2013)	criteria provided, single submitter	2	178608378	GRCh38	263538	258100
NM_133378.4(TTN):c.44613A>G (p.Lys14871=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00010(C)	Likely benign(Last reviewed: Nov 15, 2013)	criteria provided, single submitter	2	178608694	GRCh38	263752	258106
NM_133378.4(TTN):c.44435A>T (p.Asp14812Val)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Aug 20, 2013)	criteria provided, multiple submitters, no conflicts	2	178608872	GRCh38	130670	136116
NM_003319.4(TTN):c.24857T>C (p.Val8286Ala)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00010(G)	Uncertain significance(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	2	178609258	GRCh38	264232	258105
NM_001256850.1(TTN):c.46886G>T (p.Ser15629Ile)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00075(A), GO-ESP:0.00048(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178609501	GRCh38	47057	56222
NM_001256850.1(TTN):c.46859G>A (p.Arg15620Gln)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00013(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178609528	GRCh38	202697	199249
NM_133378.4(TTN):c.43980G>A (p.Ala14660=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01585(T), GMAF:0.03000(T), GO-ESP:0.02903(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178609739	GRCh38	47056	56221
NM_133378.4(TTN):c.43778C>T (p.Ala14593Val)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03021(A), GMAF:0.07270(A), GO-ESP:0.03465(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178609941	GRCh38	47053	56218
NM_003319.4(TTN):c.23927A>G (p.Asn7976Ser)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 22, 2015)	criteria provided, single submitter	2	178611007	GRCh38	264187	258113
NM_003319.4(TTN):c.23563C>G (p.Pro7855Ala)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GMAF:0.00060(C), GO-ESP:0.00025(C)	Uncertain significance(Last reviewed: Nov 5, 2015)	criteria provided, multiple submitters, no conflicts	2	178611471	GRCh38	229449	228739
NM_133378.4(TTN):c.42938G>C (p.Gly14313Ala)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00017(G)	Uncertain significance(Last reviewed: Mar 18, 2015)	criteria provided, multiple submitters, no conflicts	2	178611587	GRCh38	229448	228740
NM_001267550.2(TTN):c.50385T>C (p.Gly16795=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00017(G), GO-ESP:0.00004(G)	Likely benign(Last reviewed: Mar 6, 2016)	criteria provided, multiple submitters, no conflicts	2	178611924	GRCh38	47043	56208
NM_003319.4(TTN):c.22956G>C (p.Glu7652Asp)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	2	178612374	GRCh38	264123	258102
NM_003319.4(TTN):c.22888C>A (p.Arg7630=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	2	178612442	GRCh38	264137	258108
NM_133378.4(TTN):c.42335G>T (p.Gly14112Val)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 12, 2013)	criteria provided, single submitter	2	178612486	GRCh38	263745	258107
NM_133378.4(TTN):c.42281A>C (p.Asn14094Thr)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01460(G), GMAF:0.00640(G), GO-ESP:0.01604(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178612540	GRCh38	47037	56202
NM_133378.4(TTN):c.42027T>C (p.His14009=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03062(G), GMAF:0.07370(G), GO-ESP:0.03476(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178612990	GRCh38	47035	56200
NM_133378.4(TTN):c.41945-4G>T	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00146(A)	Likely benign(Last reviewed: Jan 16, 2013)	criteria provided, single submitter	2	178613076	GRCh38	263364	258116
NM_133378.4(TTN):c.41871G>A (p.Val13957=)	TTN|TTN-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Jan 23, 2013)	criteria provided, single submitter	2	178613234	GRCh38	263496	258104
NM_001267550.2(TTN):c.49443A>C (p.Pro16481=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00930(G), GMAF:0.00960(G), GO-ESP:0.00240(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178613840	GRCh38	47031	56196
NM_001256850.1(TTN):c.44490G>T (p.Trp14830Cys)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00057(A), GO-ESP:0.00039(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178613870	GRCh38	47030	56195
NM_133378.4(TTN):c.41691C>T (p.Asp13897=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00004(A)	Likely benign(Last reviewed: Oct 18, 2013)	criteria provided, single submitter	2	178613888	GRCh38	263747	258111
NM_001256850.1(TTN):c.44440A>G (p.Thr14814Ala)	TTN|TTN-AS1	not provided|Cardiovascular phenotype	GO-ESP:0.00004(C)	Uncertain significance(Last reviewed: Nov 18, 2013)	criteria provided, single submitter	2	178613920	GRCh38	202676	199285
NM_133378.4(TTN):c.41292G>A (p.Glu13764=)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02911(T), GMAF:0.07250(T), GO-ESP:0.03416(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178614518	GRCh38	47026	56191
NM_003319.4(TTN):c.21796_21798delATT (p.Ile7266del)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	2	178614521 - 178614523	GRCh38	264124	258110
NM_133378.4(TTN):c.41249T>C (p.Ile13750Thr)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00124(G), GMAF:0.00040(G), GO-ESP:0.00124(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Sep 12, 2016)	criteria provided, conflicting interpretations	2	178614561	GRCh38	47025	56190
NM_133378.4(TTN):c.41199G>C (p.Gln13733His)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 22, 2013)	criteria provided, single submitter	2	178614611	GRCh38	263512	258117
NM_133378.4(TTN):c.41123T>C (p.Ile13708Thr)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Jan 28, 2013)	criteria provided, single submitter	2	178614687	GRCh38	263497	258112
NM_133378.4(TTN):c.41023C>T (p.Pro13675Ser)	TTN|TTN-AS1	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00230(A), GMAF:0.00160(A), GO-ESP:0.00524(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178614880	GRCh38	47024	56189
NM_003319.4(TTN):c.21256A>G (p.Thr7086Ala)	TTN|TTN-AS1	Cardiovascular phenotype	GMAF:0.00120(C), GO-ESP:0.00028(C)	Likely benign(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	2	178615650	GRCh38	264279	258114
NM_133378.4(TTN):c.40649A>G (p.Asp13550Gly)	TTN|TTN-AS1	not specified|not provided|Cardiovascular phenotype	GMAF:0.00040(C), GO-ESP:0.00020(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 25, 2015)	criteria provided, conflicting interpretations	2	178615748	GRCh38	179187	173144
NM_001256850.1(TTN):c.43241G>A (p.Arg14414His)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided|Cardiovascular phenotype	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	2	178616627	GRCh38	202663	199306
NM_133378.4(TTN):c.40019G>A (p.Arg13340His)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00656(T), GMAF:0.00300(T), GO-ESP:0.01130(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178617362	GRCh38	47015	56180
NM_003319.4(TTN):c.20299C>T (p.Arg6767Ter)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	2	178617857	GRCh38	264517	258115
NM_133378.4(TTN):c.39696G>A (p.Lys13232=)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01100(T), GMAF:0.01080(T), GO-ESP:0.00320(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178617951	GRCh38	47011	56176
NM_133378.4(TTN):c.39611G>A (p.Arg13204Gln)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00344(T), GMAF:0.00140(T), GO-ESP:0.00305(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178618036	GRCh38	47010	56175
NM_003319.4(TTN):c.20083G>A (p.Gly6695Ser)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Nov 18, 2015)	criteria provided, multiple submitters, no conflicts	2	178618073	GRCh38	264445	258121
NM_133378.4(TTN):c.39544G>A (p.Val13182Ile)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00183(T), GMAF:0.00060(T), GO-ESP:0.00157(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178618210	GRCh38	47008	56173
NM_003319.4(TTN):c.20022C>T (p.Gly6674=)	TTN|TTN-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00002(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 16, 2015)	criteria provided, conflicting interpretations	2	178618241	GRCh38	264057	258119
NM_133378.4(TTN):c.39487C>T (p.Arg13163Cys)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00214(A), GMAF:0.00140(A), GO-ESP:0.00225(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178618267	GRCh38	47007	56172
NM_003319.4(TTN):c.19942_19943delAG (p.Ser6648Leufs)	TTN|TTN-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	2	178618320 - 178618321	GRCh38	264325	258124
NM_133378.4(TTN):c.39042C>A (p.Gly13014=)	TTN|TTN-AS1	Cardiovascular phenotype	GO-ESP:0.00006(T)	Likely benign(Last reviewed: Aug 15, 2012)	criteria provided, single submitter	2	178618804	GRCh38	263376	258118
NM_133378.4(TTN):c.38989G>T (p.Ala12997Ser)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00177(A), GMAF:0.00120(A), GO-ESP:0.00051(A)	Benign/Likely benign, not provided(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	2	178619624	GRCh38	47002	56167
NM_133378.4(TTN):c.38357A>G (p.Tyr12786Cys)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	2	178620460	GRCh38	263615	258123
NM_003319.4(TTN):c.18785G>A (p.Arg6262His)	TTN	Cardiovascular phenotype	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	2	178620541	GRCh38	264134	258120
NM_133378.4(TTN):c.38044A>T (p.Ser12682Cys)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Sep 22, 2015)	criteria provided, multiple submitters, no conflicts	2	178620862	GRCh38	263564	258129
NM_133378.4(TTN):c.38034T>C (p.Ala12678=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01729(G), GMAF:0.03630(G), GO-ESP:0.03334(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178620872	GRCh38	46993	56158
NM_133378.4(TTN):c.37895C>G (p.Ala12632Gly)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00066(C), GO-ESP:0.00043(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2016)	criteria provided, conflicting interpretations	2	178621119	GRCh38	46991	56156
NM_133378.4(TTN):c.37822C>T (p.Leu12608=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02296(A), GMAF:0.02200(A), GO-ESP:0.00700(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178621192	GRCh38	46990	56155
NM_133378.4(TTN):c.37704G>T (p.Lys12568Asn)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00610(A), GMAF:0.00220(A), GO-ESP:0.00465(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 26, 2016)	criteria provided, conflicting interpretations	2	178621310	GRCh38	46988	56153
NM_133378.4(TTN):c.37624G>A (p.Asp12542Asn)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00667(T), GMAF:0.00300(T), GO-ESP:0.00758(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178621496	GRCh38	46987	56152
NM_133378.4(TTN):c.37502A>T (p.Glu12501Val)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01741(A), GMAF:0.01700(A), GO-ESP:0.00580(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178621618	GRCh38	46983	56148
NM_001256850.1(TTN):c.39893-1G>A	TTN	not specified|not provided	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2016)	criteria provided, conflicting interpretations	2	178622768	GRCh38	202368	199342
NM_133378.4(TTN):c.36826G>A (p.Ala12276Thr)	TTN	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jul 25, 2013)	criteria provided, single submitter	2	178625291	GRCh38	263648	258125
NM_133379.4(TTN):c.*265+120028C>T	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00880(A), GO-ESP:0.00240(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178625292	GRCh38	178215	173158
NM_133378.4(TTN):c.36671T>A (p.Ile12224Asn)	TTN	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Feb 27, 2013)	criteria provided, single submitter	2	178629350	GRCh38	263536	258131
NM_133378.4(TTN):c.36506G>T (p.Arg12169Leu)	TTN	Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00018(A)	Uncertain significance(Last reviewed: Sep 10, 2013)	criteria provided, single submitter	2	178630312	GRCh38	263732	258122
NM_133378.4(TTN):c.36282T>G (p.Asp12094Glu)	TTN	Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00005(C)	Uncertain significance(Last reviewed: Jan 8, 2013)	criteria provided, single submitter	2	178631062	GRCh38	263480	258132
NM_003319.4(TTN):c.16641A>G (p.Ala5547=)	TTN	Cardiovascular phenotype	GO-ESP:0.00002(C)	Likely benign(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	2	178631212	GRCh38	263941	258128
NM_133378.4(TTN):c.35899C>T (p.Arg11967Cys)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00115(A), GMAF:0.01620(A), GO-ESP:0.02098(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178632291	GRCh38	46971	56136
NM_133378.4(TTN):c.35892T>C (p.Asn11964=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00279(G), GMAF:0.03950(G), GO-ESP:0.02206(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178632298	GRCh38	46970	56135
NM_001267550.2(TTN):c.43565A>G (p.His14522Arg)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Cardiovascular phenotype	GO-ESP:0.00009(C)	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	2	178632329	GRCh38	238778	238489
NM_133378.4(TTN):c.35784G>A (p.Arg11928=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02149(T), GMAF:0.00700(T), GO-ESP:0.02243(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178632406	GRCh38	46968	56133
NM_003319.4(TTN):c.16086T>C (p.Phe5362=)	TTN	Cardiovascular phenotype	GO-ESP:0.00002(G)	Likely benign(Last reviewed: Nov 3, 2015)	criteria provided, single submitter	2	178632725	GRCh38	264389	258134
NM_001267550.2(TTN):c.42978C>T (p.Tyr14326=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GMAF:0.00120(A), GO-ESP:0.00103(A)	Benign/Likely benign(Last reviewed: Jun 7, 2016)	criteria provided, multiple submitters, no conflicts	2	178633295	GRCh38	178218	173166
NM_133378.4(TTN):c.35254A>G (p.Lys11752Glu)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.08132(C), GMAF:0.05090(C), GO-ESP:0.08303(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178633315	GRCh38	46963	56128
NM_133378.4(TTN):c.35079A>G (p.Lys11693=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.05901(C), GMAF:0.10940(C), GO-ESP:0.07193(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178633576	GRCh38	46959	56124
NM_133378.4(TTN):c.35021C>T (p.Ala11674Val)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 16, 2013)	criteria provided, single submitter	2	178633634	GRCh38	263727	258126
NM_003319.4(TTN):c.15314T>C (p.Met5105Thr)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00008(G), GO-ESP:0.00017(G)	Uncertain significance(Last reviewed: Nov 4, 2015)	criteria provided, multiple submitters, no conflicts	2	178633990	GRCh38	46956	56121
NM_001267550.2(TTN):c.42219C>T (p.Phe14073=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00920(A), GMAF:0.00900(A), GO-ESP:0.00237(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178634562	GRCh38	46954	56119
NM_133379.4(TTN):c.*265+110695C>T	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00665(A), GMAF:0.00660(A), GO-ESP:0.00192(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178634625	GRCh38	46953	56118
NM_133378.4(TTN):c.34367A>G (p.His11456Arg)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01587(C), GMAF:0.03060(C), GO-ESP:0.02912(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178634803	GRCh38	46952	56117
NM_133379.4(TTN):c.*265+110089A>G	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00160(C), GO-ESP:0.00063(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178635231	GRCh38	178219	173169
NM_001256850.1(TTN):c.36870C>A (p.Tyr12290Ter)	TTN	not specified		Uncertain significance(Last reviewed: Oct 24, 2014)	criteria provided, single submitter	2	178635531	GRCh38	202517	199371
NM_003319.4(TTN):c.14508T>C (p.Thr4836=)	TTN	Cardiovascular phenotype	GO-ESP:0.00003(G)	Likely benign(Last reviewed: Dec 20, 2015)	criteria provided, single submitter	2	178635621	GRCh38	264603	258137
NM_133378.4(TTN):c.33804T>C (p.Ala11268=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01682(G), GMAF:0.03650(G), GO-ESP:0.03343(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178636063	GRCh38	46946	56111
NM_001256850.1(TTN):c.36565G>A (p.Val12189Ile)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00014(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	2	178636083	GRCh38	202620	199373
NM_133379.4(TTN):c.*265+108696C>T	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00304(A), GMAF:0.00120(A), GO-ESP:0.00351(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178636624	GRCh38	46943	56108
NM_133378.4(TTN):c.33269A>G (p.Lys11090Arg)	TTN	not specified|Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00015(C)	Uncertain significance(Last reviewed: Jul 17, 2013)	criteria provided, multiple submitters, no conflicts	2	178636754	GRCh38	178220	173311
NM_003319.4(TTN):c.13386A>G (p.Glu4462=)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00018(C)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2016)	criteria provided, conflicting interpretations	2	178641293	GRCh38	264051	258130
NM_133378.4(TTN):c.32853C>T (p.Ser10951=)	TTN	Cardiovascular phenotype	GO-ESP:0.00006(A)	Likely benign(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	2	178642238	GRCh38	263597	258140
NM_001267550.2(TTN):c.39895+1G>T	TTN	Primary dilated cardiomyopathy		Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178649816	GRCh38	223350	225079
NM_133378.4(TTN):c.32447_32464del18 (p.Ile10816_Glu10821del)	TTN	not specified|Cardiovascular phenotype	GMAF:0.03320(-)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178650215 - 178650232	GRCh38	46932	56097
NM_133378.4(TTN):c.32402C>G (p.Pro10801Arg)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00267(C), GMAF:0.03930(C), GO-ESP:0.03058(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178650756	GRCh38	46929	56094
NM_133378.4(TTN):c.32164C>A (p.Pro10722Thr)	TTN	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00071(T)	Uncertain significance(Last reviewed: Feb 9, 2015)	criteria provided, multiple submitters, no conflicts	2	178651534	GRCh38	178221	173316
NM_133378.4(TTN):c.31742-9T>A	TTN	Primary dilated cardiomyopathy|not specified	GMAF:0.00060(T), GO-ESP:0.00033(T)	Uncertain significance(Last reviewed: Oct 22, 2015)	criteria provided, multiple submitters, no conflicts	2	178652550	GRCh38	166093	173321
NM_133378.4(TTN):c.31361A>C (p.Lys10454Thr)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00162(G), GMAF:0.00120(G), GO-ESP:0.00063(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178671134	GRCh38	46914	56079
NM_133378.4(TTN):c.31067G>A (p.Arg10356His)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00720(T), GMAF:0.00900(T), GO-ESP:0.00306(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178672228	GRCh38	46911	56076
NM_133378.4(TTN):c.30961G>A (p.Val10321Ile)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00288(T), GMAF:0.00100(T), GO-ESP:0.00368(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 17, 2016)	criteria provided, conflicting interpretations	2	178672473	GRCh38	46909	56074
NM_133378.4(TTN):c.30484C>A (p.Pro10162Thr)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00060(T), GO-ESP:0.00047(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178677696	GRCh38	191992	189655
NM_133378.4(TTN):c.30102G>A (p.Glu10034=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.15270(T), GMAF:0.23840(T), GO-ESP:0.25990(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178678490	GRCh38	46894	56059
NM_133379.4(TTN):c.*265+65971G>A	TTN	not specified|Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00026(T)	Benign/Likely benign(Last reviewed: Aug 13, 2014)	criteria provided, multiple submitters, no conflicts	2	178679349	GRCh38	46890	56055
NM_001267550.2(TTN):c.33513_33515dupAGA (p.Glu11172_Tyr11173insGlu)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Paroxysmal familial ventricular fibrillation 1|not specified|Cardiovascular phenotype	GMAF:0.00460(TCT)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 10, 2016)	criteria provided, conflicting interpretations	2	178679959 - 178679961	GRCh38	46889	56054
NM_133378.4(TTN):c.29766T>C (p.Leu9922=)	TTN	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 22, 2013)	criteria provided, single submitter	2	178679976	GRCh38	263673	258127
NM_001267550.2(TTN):c.33418+1G>A	TTN	Primary dilated cardiomyopathy	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178680253	GRCh38	223272	225003
NM_133378.4(TTN):c.29555G>A (p.Arg9852His)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.22636(T), GMAF:0.12600(T), GO-ESP:0.23473(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178681132	GRCh38	46886	56051
NM_133378.4(TTN):c.29331A>G (p.Glu9777=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00657(C), GMAF:0.00460(C), GO-ESP:0.00560(C)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	2	178682728	GRCh38	46884	56049
NM_001256850.1(TTN):c.32108A>G (p.Tyr10703Cys)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(C), GO-ESP:0.00016(C)	Uncertain significance(Last reviewed: Dec 24, 2012)	criteria provided, multiple submitters, no conflicts	2	178682732	GRCh38	46883	56048
NM_133378.4(TTN):c.29321G>A (p.Arg9774Gln)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00100(T), GMAF:0.00140(T), GO-ESP:0.00084(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Dec 25, 2015)	criteria provided, conflicting interpretations	2	178682738	GRCh38	46882	56047
NM_001267550.2(TTN):c.32888-1delG	TTN	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178682904	GRCh38	223271	225002
NM_001256850.1(TTN):c.31799C>T (p.Pro10600Leu)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00289(A), GMAF:0.00200(A), GO-ESP:0.00079(A)	Benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	2	178684055	GRCh38	46878	56043
NM_001256850.1(TTN):c.31792G>C (p.Ala10598Pro)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00264(G), GMAF:0.00220(G), GO-ESP:0.00091(G)	Benign(Last reviewed: May 6, 2015)	criteria provided, multiple submitters, no conflicts	2	178684062	GRCh38	46877	56042
NM_133378.4(TTN):c.28916G>A (p.Arg9639Lys)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01330(T), GMAF:0.00540(T), GO-ESP:0.01241(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178684404	GRCh38	46874	56039
NM_133378.4(TTN):c.28892C>T (p.Pro9631Leu)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00431(A), GMAF:0.00180(A), GO-ESP:0.00506(A)	Benign/Likely benign, not provided(Last reviewed: Dec 14, 2015)	criteria provided, multiple submitters, no conflicts	2	178684680	GRCh38	46873	56038
NM_001256850.1(TTN):c.31642G>C (p.Val10548Leu)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GMAF:0.00100(G), GO-ESP:0.00039(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Dec 17, 2015)	criteria provided, conflicting interpretations	2	178684711	GRCh38	178227	173193
NM_001267550.2(TTN):c.32557C>T (p.Pro10853Ser)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00039(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 17, 2016)	criteria provided, conflicting interpretations	2	178684747	GRCh38	46871	56036
NM_001267550.2(TTN):c.32554+1G>C	TTN	Primary dilated cardiomyopathy		Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178684905	GRCh38	223336	225067
NM_133378.4(TTN):c.28618C>G (p.Leu9540Val)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00399(C), GMAF:0.00360(C), GO-ESP:0.00200(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178685560	GRCh38	46864	56029
TTN:c.32254G>A (p.Val10752Ile)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01071(T), GMAF:0.01320(T), GO-ESP:0.00349(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178688168	GRCh38	46863	56028
NM_001256850.1(TTN):c.31235C>T (p.Thr10412Met)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00125(A), GMAF:0.00080(A), GO-ESP:0.00033(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jul 29, 2015)	criteria provided, conflicting interpretations	2	178688688	GRCh38	46860	56025
NM_001267550.2(TTN):c.32095+5G>A	TTN	Primary dilated cardiomyopathy		Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178689048	GRCh38	223335	225066
NM_133378.4(TTN):c.28132G>A (p.Gly9378Arg)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.43349(T), GMAF:0.41330(T), GO-ESP:0.39948(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178689578	GRCh38	46859	56024
NM_001256850.1(TTN):c.30812-1G>A	TTN	Primary dilated cardiomyopathy|not specified	GO-ESP:0.00042(T), GO-ESP:0.00027(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2015)	criteria provided, conflicting interpretations	2	178689897	GRCh38	46855	56020
NM_001267550.2(TTN):c.31762G>A (p.Val10588Ile)	TTN	Primary dilated cardiomyopathy	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178692016	GRCh38	223361	225090
NM_001267550.2(TTN):c.31594G>T (p.Val10532Phe)	TTN	Primary dilated cardiomyopathy		Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178693609	GRCh38	223349	225078
NM_133378.4(TTN):c.27832A>G (p.Ile9278Val)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.32966(C), GMAF:0.47780(C), GO-ESP:0.35364(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178693639	GRCh38	46852	56017
NM_133378.4(TTN):c.27694+1G>C	TTN	Primary dilated cardiomyopathy|not specified		Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, multiple submitters, no conflicts	2	178694598	GRCh38	46849	56014
NM_133378.4(TTN):c.27220G>A (p.Glu9074Lys)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03105(T), GMAF:0.03870(T), GO-ESP:0.01456(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178696120	GRCh38	46844	56009
NM_001267550.2(TTN):c.30803-2A>G	TTN	Primary dilated cardiomyopathy		Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178696271	GRCh38	223334	225065
NM_133378.4(TTN):c.26981A>G (p.Lys8994Arg)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00018(C)	Uncertain significance(Last reviewed: Sep 22, 2015)	criteria provided, multiple submitters, no conflicts	2	178698884	GRCh38	263565	258138
NM_001256850.1(TTN):c.29560+5G>A	TTN	not specified		Uncertain significance(Last reviewed: May 5, 2015)	criteria provided, single submitter	2	178702163	GRCh38	202357	199446
NM_001256850.1(TTN):c.29534C>T (p.Thr9845Met)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00106(A), GMAF:0.00020(A), GO-ESP:0.00045(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178702194	GRCh38	46837	56002
NM_133378.4(TTN):c.26228T>A (p.Ile8743Asn)	TTN	Cardiovascular phenotype	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	2	178704512	GRCh38	263674	258133
NM_133378.4(TTN):c.26080A>T (p.Thr8694Ser)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02046(A), GMAF:0.01060(A), GO-ESP:0.01988(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178704660	GRCh38	46826	55991
NM_133378.4(TTN):c.26067G>A (p.Ser8689=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.04199(T), GMAF:0.08430(T), GO-ESP:0.05201(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178704673	GRCh38	46825	55990
NM_133378.4(TTN):c.26031T>C (p.Ile8677=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.05835(G), GMAF:0.09690(G), GO-ESP:0.05739(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178704709	GRCh38	46823	55988
NM_133378.4(TTN):c.25446C>A (p.Ile8482=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00185(T), GMAF:0.01020(T), GO-ESP:0.00591(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178706696	GRCh38	46819	55984
NM_133378.4(TTN):c.25421T>C (p.Ile8474Thr)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.07832(G), GMAF:0.12740(G), GO-ESP:0.07970(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178706721	GRCh38	46818	55983
NM_133378.4(TTN):c.25396G>A (p.Val8466Ile)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00025(T), GMAF:0.00460(T), GO-ESP:0.00171(T)	Benign/Likely benign(Last reviewed: Dec 25, 2015)	criteria provided, multiple submitters, no conflicts	2	178706868	GRCh38	46817	55982
NM_001267550.2(TTN):c.29062delG (p.Ala9688Glnfs)	TTN	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178706934	GRCh38	223270	225001
NM_001256850.1(TTN):c.28091-2A>C	TTN	Primary dilated cardiomyopathy|not specified	GMAF:0.00020(G), GO-ESP:0.00016(G)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 7, 2016)	criteria provided, conflicting interpretations	2	178706956	GRCh38	202355	199459
NM_133378.4(TTN):c.24930G>A (p.Arg8310=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03484(T), GMAF:0.07530(T), GO-ESP:0.04876(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178709657	GRCh38	46812	55977
NM_001256850.1(TTN):c.27596G>A (p.Arg9199His)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GMAF:0.00120(T), GO-ESP:0.00044(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 23, 2016)	criteria provided, conflicting interpretations	2	178709772	GRCh38	199241	196400
NM_133378.4(TTN):c.24775G>A (p.Val8259Ile)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00037(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178709812	GRCh38	166133	173344
TTN:c.28313G>A (p.Arg9438Gln)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.04320(T), GMAF:0.02740(T), GO-ESP:0.04512(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178710784	GRCh38	46808	55973
NM_133378.4(TTN):c.24388A>G (p.Thr8130Ala)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 8, 2013)	criteria provided, single submitter	2	178711116	GRCh38	263625	258144
NM_133378.4(TTN):c.24323T>C (p.Leu8108Ser)	TTN	Cardiovascular phenotype	GO-ESP:0.00012(G)	Uncertain significance(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	2	178711181	GRCh38	263795	258135
NM_133378.4(TTN):c.24282C>A (p.Gly8094=)	TTN	Cardiovascular phenotype	GMAF:0.07410(T), GO-ESP:0.00042(T)	Likely benign(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	2	178711222	GRCh38	263365	258139
NM_133378.4(TTN):c.24011C>A (p.Thr8004Asn)	TTN	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 13, 2013)	criteria provided, multiple submitters, no conflicts	2	178712087	GRCh38	46798	55963
NM_133379.4(TTN):c.*265+33192T>C	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00067(G), GMAF:0.00100(G), GO-ESP:0.00061(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 19, 2016)	criteria provided, conflicting interpretations	2	178712128	GRCh38	96275	102169
NM_001267550.2(TTN):c.27607G>A (p.Glu9203Lys)	TTN	Primary dilated cardiomyopathy	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178712315	GRCh38	223269	225000
NM_133378.4(TTN):c.23634C>T (p.Ser7878=)	TTN	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Jan 23, 2013)	criteria provided, single submitter	2	178712556	GRCh38	263498	258136
NM_133378.4(TTN):c.23596+5G>A	TTN	Primary dilated cardiomyopathy|not specified	GMAF:0.00080(T), GO-ESP:0.00046(T)	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, multiple submitters, no conflicts	2	178712692	GRCh38	46793	55958
NM_133378.4(TTN):c.23259A>G (p.Thr7753=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02259(C), GMAF:0.02440(C), GO-ESP:0.00742(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178713143	GRCh38	46792	55957
NM_133378.4(TTN):c.23140T>C (p.Ser7714Pro)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 18, 2013)	criteria provided, single submitter	2	178713262	GRCh38	263748	258147
NM_133378.4(TTN):c.23129C>A (p.Pro7710Gln)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 27, 2013)	criteria provided, single submitter	2	178713273	GRCh38	263539	258142
NM_133378.4(TTN):c.22949C>T (p.Pro7650Leu)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.06153(A), GMAF:0.11140(A), GO-ESP:0.07511(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178713977	GRCh38	46786	55951
NM_133378.4(TTN):c.22923C>T (p.Ser7641=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.26415(A), GMAF:0.44470(A), GO-ESP:0.30605(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178714003	GRCh38	46784	55949
NM_133378.4(TTN):c.22736C>T (p.Thr7579Met)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00008(A), GMAF:0.00020(A), GO-ESP:0.00003(A)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 3, 2015)	criteria provided, conflicting interpretations	2	178714306	GRCh38	46781	55946
NM_133378.4(TTN):c.22676A>G (p.Asn7559Ser)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.15287(C), GMAF:0.24700(C), GO-ESP:0.17930(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178714366	GRCh38	46777	55942
NM_133378.4(TTN):c.22645A>G (p.Thr7549Ala)	TTN	Cardiovascular phenotype	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Oct 4, 2013)	criteria provided, single submitter	2	178714397	GRCh38	263703	258141
NM_133378.4(TTN):c.22557A>G (p.Glu7519=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.30562(C), GMAF:0.48340(C), GO-ESP:0.31966(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178714485	GRCh38	46776	55941
NM_133378.4(TTN):c.22513G>A (p.Val7505Ile)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01174(T), GMAF:0.01620(T), GO-ESP:0.00481(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178714529	GRCh38	46775	55940
NM_133378.4(TTN):c.22384G>A (p.Asp7462Asn)	TTN	Cardiovascular phenotype	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Apr 4, 2013)	criteria provided, single submitter	2	178715070	GRCh38	263344	258145
NM_133378.4(TTN):c.22359A>T (p.Leu7453=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.26432(A), GMAF:0.44450(A), GO-ESP:0.30620(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178715095	GRCh38	46773	55938
NM_133379.4(TTN):c.*265+30153C>T	TTN	not specified|Cardiovascular phenotype	GMAF:0.00080(A), GO-ESP:0.00008(A)	Benign/Likely benign(Last reviewed: Dec 16, 2013)	criteria provided, multiple submitters, no conflicts	2	178715167	GRCh38	137846	141549
NM_133378.4(TTN):c.22246G>A (p.Val7416Ile)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00343(T), GMAF:0.00380(T), GO-ESP:0.00139(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178715208	GRCh38	46771	55936
NM_133378.4(TTN):c.22205G>A (p.Arg7402His)	TTN	Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00008(T)	Likely benign(Last reviewed: Jan 8, 2013)	criteria provided, single submitter	2	178715249	GRCh38	263481	258150
NM_133378.4(TTN):c.22204C>T (p.Arg7402Cys)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01734(A), GMAF:0.00940(A), GO-ESP:0.01673(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178715250	GRCh38	46770	55935
NM_133378.4(TTN):c.21975T>C (p.Tyr7325=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01639(G), GMAF:0.05070(G), GO-ESP:0.05432(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178715707	GRCh38	46766	55931
NM_133378.4(TTN):c.21894G>T (p.Gln7298His)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01623(A), GMAF:0.05130(A), GO-ESP:0.03971(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178717108	GRCh38	46763	55928
TTN:c.25398T>A (p.Asp8466Glu)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02358(T), GMAF:0.02880(T), GO-ESP:0.01122(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178717336	GRCh38	46758	55923
TTN:c.25274G>A (p.Ser8425Asn)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.15458(T), GMAF:0.24380(T), GO-ESP:0.17836(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178717600	GRCh38	46756	55921
NM_133379.4(TTN):c.*265+27655T>C	TTN	not specified|Cardiovascular phenotype	GMAF:0.00120(G), GO-ESP:0.00047(G)	Benign/Likely benign(Last reviewed: May 9, 2014)	criteria provided, multiple submitters, no conflicts	2	178717665	GRCh38	137842	141545
NM_133378.4(TTN):c.21415A>G (p.Ile7139Val)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 4, 2013)	criteria provided, single submitter	2	178717727	GRCh38	263504	258151
TTN:c.25064C>A (p.Ala8355Glu)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.26581(T), GMAF:0.44490(T), GO-ESP:0.30877(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178717810	GRCh38	46750	55915
NM_133378.4(TTN):c.21241A>G (p.Lys7081Glu)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00571(C), GMAF:0.00160(C), GO-ESP:0.00614(C)	Benign(Last reviewed: Feb 24, 2016)	criteria provided, multiple submitters, no conflicts	2	178718033	GRCh38	46745	55910
NM_133378.4(TTN):c.21232G>T (p.Val7078Leu)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00075(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 16, 2014)	criteria provided, conflicting interpretations	2	178718042	GRCh38	166151	173218
NM_133378.4(TTN):c.21177G>A (p.Lys7059=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01616(T), GMAF:0.02360(T), GO-ESP:0.01366(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178718097	GRCh38	46743	55908
NM_133378.4(TTN):c.21148A>G (p.Arg7050Gly)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02299(C), GMAF:0.01220(C), GO-ESP:0.02105(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178718126	GRCh38	46742	55907
NM_133378.4(TTN):c.20920A>G (p.Ser6974Gly)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00224(C), GMAF:0.00160(C), GO-ESP:0.00072(C)	Benign/Likely benign(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	2	178718454	GRCh38	46739	55904
NM_133378.4(TTN):c.20858C>T (p.Thr6953Ile)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 11, 2013)	criteria provided, single submitter	2	178718516	GRCh38	263716	258143
NM_133378.4(TTN):c.20784C>T (p.Thr6928=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.09811(A), GMAF:0.07350(A), GO-ESP:0.08972(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178718590	GRCh38	46734	55899
NM_133379.4(TTN):c.*265+26591C>T	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00555(A), GMAF:0.00500(A), GO-ESP:0.00141(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178718729	GRCh38	46733	55898
NM_001256850.1(TTN):c.23503G>A (p.Val7835Ile)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Feb 3, 2015)	criteria provided, multiple submitters, no conflicts	2	178718746	GRCh38	46732	55897
TTN:c.24431A>C (p.Glu8144Ala)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.15065(G), GMAF:0.23880(G), GO-ESP:0.17663(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178718769	GRCh38	46731	55896
NM_133378.4(TTN):c.20207-4A>G	TTN	Cardiovascular phenotype		Likely benign(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	2	178719455	GRCh38	263492	258146
NM_133378.4(TTN):c.20169T>G (p.Val6723=)	TTN	Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00002(C)	Likely benign(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	2	178719591	GRCh38	263799	258156
NM_001267550.2(TTN):c.23853C>A (p.Ala7951=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00259(T), GMAF:0.00280(T), GO-ESP:0.00338(T)	Benign/Likely benign(Last reviewed: Mar 11, 2016)	criteria provided, multiple submitters, no conflicts	2	178719639	GRCh38	46722	55887
NM_133378.4(TTN):c.19943T>C (p.Ile6648Thr)	TTN	Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00005(G)	Uncertain significance(Last reviewed: Sep 17, 2013)	criteria provided, single submitter	2	178719817	GRCh38	263720	258158
NM_001267550.2(TTN):c.23386C>T (p.Arg7796Ter)	TTN	Primary dilated cardiomyopathy	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178720256	GRCh38	223348	225077
NM_001267550.2(TTN):c.23378-10C>A	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified	GO-ESP:0.00042(T), GO-ESP:0.00047(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2016)	criteria provided, conflicting interpretations	2	178720274	GRCh38	46718	55883
NM_133378.4(TTN):c.19570G>A (p.Asp6524Asn)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00118(T), GO-ESP:0.00075(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178720460	GRCh38	46717	55882
NM_133379.4(TTN):c.*265+24859C>T	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00193(A), GMAF:0.00360(A), GO-ESP:0.00073(A)	Benign/Likely benign(Last reviewed: Jul 28, 2016)	criteria provided, multiple submitters, no conflicts	2	178720461	GRCh38	46716	55881
NM_133378.4(TTN):c.19500C>G (p.Asn6500Lys)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00153(C), GMAF:0.00500(C), GO-ESP:0.00436(C)	Benign/Likely benign, not provided(Last reviewed: Feb 10, 2016)	criteria provided, multiple submitters, no conflicts	2	178720530	GRCh38	46715	55880
NM_133378.4(TTN):c.19491G>A (p.Gln6497=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.98141(T), GMAF:0.01800(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178720539	GRCh38	46714	55879
NM_133378.4(TTN):c.19445C>T (p.Ser6482Leu)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00655(A), GMAF:0.00200(A), GO-ESP:0.00668(A)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178720585	GRCh38	46713	55878
NM_133378.4(TTN):c.19367-3T>C	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.28165(G), GMAF:0.46010(G), GO-ESP:0.32316(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178720666	GRCh38	46710	55875
NM_133378.4(TTN):c.19297G>A (p.Gly6433Arg)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00040(T), GO-ESP:0.00023(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178720990	GRCh38	166164	173225
NM_001256850.1(TTN):c.22072G>T (p.Asp7358Tyr)	TTN	not specified|not provided|Cardiovascular phenotype	GMAF:0.00220(A), GO-ESP:0.00136(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Sep 3, 2015)	criteria provided, conflicting interpretations	2	178720996	GRCh38	179419	173364
NM_133378.4(TTN):c.19269G>A (p.Thr6423=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.01100(T), GMAF:0.01640(T), GO-ESP:0.00360(T)	Benign/Likely benign(Last reviewed: Feb 15, 2016)	criteria provided, multiple submitters, no conflicts	2	178721018	GRCh38	46708	55873
NM_133378.4(TTN):c.19054G>C (p.Asp6352His)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02795(G), GMAF:0.02020(G), GO-ESP:0.02979(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178721877	GRCh38	46705	55870
NM_133378.4(TTN):c.18879T>C (p.His6293=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01649(G), GMAF:0.02020(G), GO-ESP:0.00525(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178722052	GRCh38	46702	55867
TTN:c.22384G>C (p.Asp7462His)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.15719(G), GMAF:0.24700(G), GO-ESP:0.17861(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178722403	GRCh38	46698	55863
NM_133378.4(TTN):c.18348T>C (p.Asp6116=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.04337(G), GMAF:0.09410(G), GO-ESP:0.07060(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178722819	GRCh38	46695	55860
NM_133378.4(TTN):c.18342A>G (p.Lys6114=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00896(C), GMAF:0.00280(C), GO-ESP:0.00707(C)	Benign/Likely benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	2	178722825	GRCh38	46693	55858
NM_001256850.1(TTN):c.20705C>T (p.Ser6902Phe)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00040(A), GO-ESP:0.00024(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178723444	GRCh38	203300	199526
NM_133378.4(TTN):c.17559T>A (p.Asn5853Lys)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jul 21, 2015)	criteria provided, multiple submitters, no conflicts	2	178723968	GRCh38	263713	258148
NM_133378.4(TTN):c.17441G>A (p.Gly5814Asp)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00274(T), GMAF:0.00380(T), GO-ESP:0.00171(T)	Benign/Likely benign(Last reviewed: Feb 24, 2016)	criteria provided, multiple submitters, no conflicts	2	178724086	GRCh38	46682	55847
NM_001267550.2(TTN):c.21142C>T (p.Arg7048Ter)	TTN	Primary dilated cardiomyopathy|not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	2	178724117	GRCh38	223333	225064
NM_133378.4(TTN):c.17374G>A (p.Asp5792Asn)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01498(T), GMAF:0.01560(T), GO-ESP:0.00518(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178724269	GRCh38	46681	55846
NM_133378.4(TTN):c.17312C>T (p.Ala5771Val)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00265(A), GMAF:0.03570(A), GO-ESP:0.01645(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178724331	GRCh38	46680	55845
NM_133378.4(TTN):c.17160G>A (p.Thr5720=)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00006(T)	Likely benign(Last reviewed: Sep 19, 2013)	criteria provided, multiple submitters, no conflicts	2	178724483	GRCh38	179098	173235
NM_133378.4(TTN):c.17129C>T (p.Ala5710Val)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01518(A), GMAF:0.05150(A), GO-ESP:0.05105(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178724514	GRCh38	46677	55842
NM_133378.4(TTN):c.16873G>C (p.Glu5625Gln)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	2	178725599	GRCh38	263653	258152
NM_133378.4(TTN):c.16870G>A (p.Gly5624Arg)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.01300(T), GMAF:0.00660(T), GO-ESP:0.01160(T)	Benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	2	178725602	GRCh38	46672	55837
NM_133378.4(TTN):c.16665G>A (p.Arg5555=)	TTN	Cardiovascular phenotype	GO-ESP:0.00002(T)	Likely benign(Last reviewed: May 27, 2013)	criteria provided, single submitter	2	178725925	GRCh38	263621	258157
NM_133379.4(TTN):c.*265+18102T>A	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00644(T), GMAF:0.00440(T), GO-ESP:0.00161(T)	Benign(Last reviewed: Jun 23, 2014)	criteria provided, multiple submitters, no conflicts	2	178727218	GRCh38	46666	55831
NM_133378.4(TTN):c.16244C>T (p.Thr5415Met)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.01170(A), GMAF:0.01660(A), GO-ESP:0.00395(A)	Benign/Likely benign(Last reviewed: Feb 15, 2016)	criteria provided, multiple submitters, no conflicts	2	178727602	GRCh38	46664	55829
NM_133378.4(TTN):c.15651T>C (p.Asn5217=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00778(G), GMAF:0.00220(G), GO-ESP:0.00717(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178728543	GRCh38	46658	55823
NM_133378.4(TTN):c.15569G>A (p.Ser5190Asn)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.04282(T), GMAF:0.09330(T), GO-ESP:0.06986(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178728625	GRCh38	46656	55821
TTN:c.19204A>G (p.Met6402Val)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01412(C), GMAF:0.01500(C), GO-ESP:0.00488(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178728722	GRCh38	46655	55820
NM_001267550.2(TTN):c.19191G>A (p.Thr6397=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00008(T), GMAF:0.00400(T), GO-ESP:0.00107(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178728735	GRCh38	46654	55819
TTN:c.18903C>T (p.Thr6301=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00592(A), GMAF:0.02420(A), GO-ESP:0.02584(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178729135	GRCh38	46649	55814
NM_133378.4(TTN):c.15084T>C (p.Ile5028=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00140(G), GO-ESP:0.00073(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178729340	GRCh38	46645	55810
NM_133378.4(TTN):c.15044C>G (p.Thr5015Ser)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00338(C), GMAF:0.00060(C), GO-ESP:0.00298(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178729380	GRCh38	46644	55809
NM_133378.4(TTN):c.14988A>G (p.Arg4996=)	TTN	Cardiovascular phenotype	GO-ESP:0.00003(C)	Likely benign(Last reviewed: Jul 12, 2013)	criteria provided, single submitter	2	178729436	GRCh38	263663	258161
NM_001256850.1(TTN):c.17599G>A (p.Ala5867Thr)	TTN	not provided|Cardiovascular phenotype	GO-ESP:0.00046(T)	Uncertain significance(Last reviewed: Oct 18, 2013)	criteria provided, single submitter	2	178729703	GRCh38	203272	199555
NM_001256850.1(TTN):c.17428T>G (p.Cys5810Gly)	TTN	not specified|not provided|Cardiovascular phenotype	GMAF:0.00040(C), GO-ESP:0.00049(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 21, 2015)	criteria provided, conflicting interpretations	2	178729874	GRCh38	203270	199557
NM_133378.4(TTN):c.14563C>T (p.Leu4855Phe)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Feb 4, 2016)	criteria provided, multiple submitters, no conflicts	2	178730105	GRCh38	263438	258149
NM_001256850.1(TTN):c.17038G>A (p.Ala5680Thr)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00634(T), GMAF:0.00380(T), GO-ESP:0.00154(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178730544	GRCh38	46635	55800
NM_133378.4(TTN):c.14156A>G (p.Glu4719Gly)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00792(C), GMAF:0.00220(C), GO-ESP:0.00698(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178730645	GRCh38	46633	55798
NM_001267550.2(TTN):c.17818T>C (p.Cys5940Arg)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00018(G)	Uncertain significance(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	2	178730715	GRCh38	178252	173383
NM_133378.4(TTN):c.13452A>G (p.Glu4484=)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00005(C)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 21, 2016)	criteria provided, conflicting interpretations	2	178731582	GRCh38	263546	258153
NM_133378.4(TTN):c.13316A>G (p.Tyr4439Cys)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00559(C), GMAF:0.00200(C), GO-ESP:0.00585(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178731827	GRCh38	46621	55786
NM_133378.4(TTN):c.12814G>T (p.Asp4272Tyr)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00092(A), GMAF:0.00040(A), GO-ESP:0.00053(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Dec 22, 2015)	criteria provided, conflicting interpretations	2	178732515	GRCh38	46618	55783
NM_133378.4(TTN):c.12797A>G (p.Tyr4266Cys)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00025(C), GMAF:0.00680(C), GO-ESP:0.00224(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178732532	GRCh38	46617	55782
NM_133378.4(TTN):c.12571G>A (p.Val4191Met)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00820(T), GMAF:0.00360(T), GO-ESP:0.00564(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178732873	GRCh38	46614	55779
NM_133378.4(TTN):c.12381T>C (p.Asn4127=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00008(G), GMAF:0.00100(G), GO-ESP:0.00030(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178733063	GRCh38	46613	55778
NM_133378.4(TTN):c.12363C>T (p.Asn4121=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01125(A), GMAF:0.00860(A), GO-ESP:0.00408(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178733081	GRCh38	46612	55777
NM_133378.4(TTN):c.12325C>A (p.Arg4109=)	TTN	Cardiovascular phenotype	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	2	178733119	GRCh38	263593	258159
NM_133378.4(TTN):c.12129G>A (p.Thr4043=)	TTN	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Jun 10, 2013)	criteria provided, single submitter	2	178733432	GRCh38	263652	258162
TTN:c.15792T>C (p.Ile5264=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.05894(G), GMAF:0.02960(G), GO-ESP:0.05368(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178733501	GRCh38	46607	55772
NM_001267550.2(TTN):c.15776-1G>T	TTN	Primary dilated cardiomyopathy		Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178733518	GRCh38	223255	224986
NM_003319.4(TTN):c.13282+4410G>A	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01930(T), GMAF:0.02400(T), GO-ESP:0.00633(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178733672	GRCh38	46606	55771
NM_133378.4(TTN):c.11830C>A (p.Gln3944Lys)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 16, 2013)	criteria provided, single submitter	2	178733827	GRCh38	263728	258154
NM_133378.4(TTN):c.11820C>T (p.Thr3940=)	TTN	not specified|Cardiovascular phenotype	GMAF:0.00160(A), GO-ESP:0.00074(A)	Benign/Likely benign(Last reviewed: Dec 5, 2013)	criteria provided, multiple submitters, no conflicts	2	178733837	GRCh38	166218	173252
NM_001256850.1(TTN):c.14544A>C (p.Lys4848Asn)	TTN	not provided|Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 12, 2013)	criteria provided, single submitter	2	178734329	GRCh38	203245	199582
NM_133378.4(TTN):c.11446G>C (p.Val3816Leu)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00275(G), GMAF:0.00440(T), GO-ESP:0.00351(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178734746	GRCh38	46599	55764
NM_133378.4(TTN):c.11354G>A (p.Arg3785Gln)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00019(T)	Uncertain significance(Last reviewed: Sep 22, 2015)	criteria provided, multiple submitters, no conflicts	2	178734838	GRCh38	192032	189698
NM_133378.4(TTN):c.11252C>G (p.Pro3751Arg)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00671(C), GMAF:0.00440(C), GO-ESP:0.01062(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178734940	GRCh38	46595	55760
NM_133378.4(TTN):c.11166T>C (p.Ala3722=)	TTN	not specified|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00012(G)	Benign/Likely benign(Last reviewed: Mar 2, 2016)	criteria provided, multiple submitters, no conflicts	2	178735548	GRCh38	263490	258155
NM_133378.4(TTN):c.11138C>G (p.Thr3713Ser)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00260(C), GMAF:0.00180(C), GO-ESP:0.00315(C)	Benign/Likely benign, not provided(Last reviewed: Mar 19, 2016)	criteria provided, multiple submitters, no conflicts	2	178735576	GRCh38	46594	55759
NM_133378.4(TTN):c.11033G>A (p.Ser3678Asn)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GMAF:0.00400(T), GO-ESP:0.00422(T)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178735681	GRCh38	46592	55757
NM_133378.4(TTN):c.10969A>G (p.Ile3657Val)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	2	178735745	GRCh38	263532	258160
NM_133378.4(TTN):c.10966G>A (p.Ala3656Thr)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00234(T), GMAF:0.00180(T), GO-ESP:0.00342(T)	Benign/Likely benign, not provided(Last reviewed: Oct 15, 2015)	criteria provided, multiple submitters, no conflicts	2	178735748	GRCh38	46591	55756
NM_133378.4(TTN):c.10907C>T (p.Ala3636Val)	TTN	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	2	178735807	GRCh38	263756	258172
NM_133378.4(TTN):c.10878C>T (p.Ser3626=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.98103(A), GMAF:0.01820(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178735836	GRCh38	46590	55755
NM_133378.4(TTN):c.10793G>A (p.Arg3598Lys)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.09744(T), GMAF:0.14480(T), GO-ESP:0.09586(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178735921	GRCh38	46586	55751
NM_003319.4(TTN):c.13250G>A (p.Ser4417Asn)	TTN	Dilated cardiomyopathy 1G	GMAF:0.00020(T), GO-ESP:0.00013(T)	Pathogenic(Last reviewed: Feb 22, 2002)	no assertion criteria provided	2	178738114	GRCh38	12658	27697
NM_003319.4(TTN):c.12788C>A (p.Thr4263Lys)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 3, 2015)	criteria provided, single submitter	2	178739356	GRCh38	264459	258167
NM_133379.4(TTN):c.*265+5374T>C	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00146(G), GMAF:0.00140(G), GO-ESP:0.00039(G)	Benign/Likely benign(Last reviewed: Sep 17, 2015)	criteria provided, multiple submitters, no conflicts	2	178739946	GRCh38	47837	57001
NM_001256850.1(TTN):c.12251G>A (p.Arg4084Gln)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00185(T), GMAF:0.00160(T), GO-ESP:0.00052(T)	Likely benign(Last reviewed: Sep 17, 2015)	criteria provided, multiple submitters, no conflicts	2	178740031	GRCh38	47835	56999
NM_133379.4(TTN):c.*265+5281A>G	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00151(C), GMAF:0.00140(C), GO-ESP:0.00039(C)	Benign/Likely benign(Last reviewed: Sep 17, 2015)	criteria provided, multiple submitters, no conflicts	2	178740039	GRCh38	47834	56998
NM_001256850.1(TTN):c.12157C>T (p.Gln4053Ter)	TTN	Dilated cardiomyopathy 1G		Pathogenic(Last reviewed: Feb 22, 2002)	no assertion criteria provided	2	178740125	GRCh38	12657	27696
NM_001256850.1(TTN):c.12035G>A (p.Arg4012Lys)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00149(T), GMAF:0.00140(T), GO-ESP:0.00039(T)	Likely benign(Last reviewed: Sep 17, 2015)	criteria provided, multiple submitters, no conflicts	2	178740247	GRCh38	47832	56996
NM_001267550.2(TTN):c.12870dupA (p.Val4291Serfs)	TTN	Primary dilated cardiomyopathy|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, multiple submitters, no conflicts	2	178740363	GRCh38	222876	224240
NM_001256850.1(TTN):c.11782A>C (p.Asn3928His)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00148(G), GMAF:0.00140(G), GO-ESP:0.00039(G)	Likely benign(Last reviewed: Sep 17, 2015)	criteria provided, multiple submitters, no conflicts	2	178740500	GRCh38	47829	56993
NM_133378.4(TTN):c.10361-2877A>G	TTN	not provided|Cardiovascular phenotype	GO-ESP:0.00013(C)	Uncertain significance(Last reviewed: Aug 6, 2015)	criteria provided, multiple submitters, no conflicts	2	178741237	GRCh38	192039	189705
NM_003319.4(TTN):c.10870A>G (p.Ile3624Val)	TTN	Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00023(C)	Uncertain significance(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	2	178741274	GRCh38	264496	258163
NM_001267550.2(TTN):c.11254+2T>C	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified	GMAF:0.00060(G), GO-ESP:0.00040(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 2, 2016)	criteria provided, conflicting interpretations	2	178756220	GRCh38	178264	173438
NM_001256850.1(TTN):c.10303+2739C>G	TTN	not specified		Uncertain significance(Last reviewed: Sep 23, 2014)	criteria provided, single submitter	2	178756245	GRCh38	202532	199660
NM_133437.4(TTN):c.10670dupG (p.Leu3558Thrfs)	TTN	Primary dilated cardiomyopathy|not provided		Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, multiple submitters, no conflicts	2	178756293	GRCh38	202507	199661
NM_001267550.2(TTN):c.11113delA (p.Arg3705Aspfs)	TTN	Primary dilated cardiomyopathy	GO-ESP:0.00002(-)	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178756363	GRCh38	223346	225075
NM_001267550.2(TTN):c.10852C>T (p.Gln3618Ter)	TTN	Primary dilated cardiomyopathy	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178756624	GRCh38	223254	224985
NM_001267550.2(TTN):c.10799C>A (p.Ser3600Ter)	TTN	Primary dilated cardiomyopathy	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178756677	GRCh38	223253	224984
NM_001267550.2(TTN):c.10592C>G (p.Ser3531Ter)	TTN	Primary dilated cardiomyopathy	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	178757628	GRCh38	223345	225074
NM_133378.4(TTN):c.10256G>A (p.Ser3419Asn)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.90235(T), GMAF:0.19110(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178759031	GRCh38	46582	55747
NM_133378.4(TTN):c.10242C>T (p.Tyr3414=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00607(A), GMAF:0.00260(A), GO-ESP:0.00501(A)	Benign/Likely benign(Last reviewed: Feb 26, 2016)	criteria provided, multiple submitters, no conflicts	2	178759045	GRCh38	46581	55746
NM_133378.4(TTN):c.10114+5G>A	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00338(T), GMAF:0.00340(T), GO-ESP:0.00131(T)	Benign/Likely benign(Last reviewed: Jan 30, 2016)	criteria provided, multiple submitters, no conflicts	2	178764172	GRCh38	46579	55744
TTN:c.10100G>A (p.Arg3367Gln)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.01207(T), GMAF:0.00380(T), GO-ESP:0.00996(T)	Benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	2	178764191	GRCh38	46578	55743
NM_133378.4(TTN):c.10032A>C (p.Pro3344=)	TTN	Cardiovascular phenotype	GO-ESP:0.00002(G)	Likely benign(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	2	178764259	GRCh38	263366	258164
NM_133378.4(TTN):c.9879A>G (p.Glu3293=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.97032(C), GMAF:0.02640(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178764636	GRCh38	47707	56871
NM_133378.4(TTN):c.9812C>T (p.Ser3271Phe)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 1, 2013)	criteria provided, single submitter	2	178764703	GRCh38	263487	258173
NM_133378.4(TTN):c.9781G>A (p.Val3261Met)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.89651(T), GMAF:0.19510(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178764734	GRCh38	47692	56856
NM_133378.4(TTN):c.9669A>G (p.Gly3223=)	TTN	Cardiovascular phenotype	GO-ESP:0.00002(C)	Likely benign(Last reviewed: Aug 15, 2012)	criteria provided, single submitter	2	178766415	GRCh38	263368	258168
TTN:c.9597A>G (p.Glu3199=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.07358(C), GMAF:0.16770(C), GO-ESP:0.14188(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178766487	GRCh38	47661	56825
NM_001256850.1(TTN):c.9571C>G (p.Gln3191Glu)	TTN	not specified|not provided|Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00007(C)	Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, multiple submitters, no conflicts	2	178766513	GRCh38	47660	56824
NM_133378.4(TTN):c.9519C>T (p.Asp3173=)	TTN	not specified|Cardiovascular phenotype	GMAF:0.00080(A), GO-ESP:0.00033(A)	Likely benign(Last reviewed: Mar 18, 2015)	criteria provided, multiple submitters, no conflicts	2	178766565	GRCh38	228178	228875
NM_133378.4(TTN):c.9512A>G (p.Asn3171Ser)	TTN	Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00007(C)	Uncertain significance(Last reviewed: Nov 25, 2013)	criteria provided, single submitter	2	178766572	GRCh38	263726	258165
NM_133378.4(TTN):c.9461A>G (p.Lys3154Arg)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03837(C), GMAF:0.08610(C), GO-ESP:0.06589(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178767769	GRCh38	47648	56812
NM_133378.4(TTN):c.9359G>A (p.Arg3120Gln)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00323(T), GMAF:0.00160(T), GO-ESP:0.00440(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178767871	GRCh38	47636	56800
NM_001256850.1(TTN):c.9150A>G (p.Thr3050=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00392(C), GMAF:0.00180(C), GO-ESP:0.00087(C)	Benign/Likely benign(Last reviewed: Sep 6, 2016)	criteria provided, multiple submitters, no conflicts	2	178768686	GRCh38	47614	56778
NM_133378.4(TTN):c.9129A>G (p.Gly3043=)	TTN	Cardiovascular phenotype	GO-ESP:0.00160(C)	Likely benign(Last reviewed: Aug 15, 2012)	criteria provided, single submitter	2	178768707	GRCh38	263377	258166
NM_133378.4(TTN):c.8919C>G (p.Ser2973=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03883(C), GMAF:0.08670(C), GO-ESP:0.06599(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178768917	GRCh38	47571	56735
NM_003319.4(TTN):c.8514T>A (p.Ile2838=)	TTN	Cardiovascular phenotype		Likely benign(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	2	178769929	GRCh38	264315	258174
TTN:c.8492G>A (p.Ser2831Asn)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03437(T), GMAF:0.08130(T), GO-ESP:0.07594(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178770209	GRCh38	47527	56691
NM_133378.4(TTN):c.8467G>T (p.Val2823Phe)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.01545(A), GMAF:0.00760(A), GO-ESP:0.01443(A)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	2	178770234	GRCh38	47523	56687
NM_001256850.1(TTN):c.8434G>C (p.Val2812Leu)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(G)	Uncertain significance(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	2	178770267	GRCh38	178268	173591
NM_001267550.2(TTN):c.8223_8224delCAinsTC (p.Lys2742Gln)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	2	178770568 - 178770569	GRCh38	263691	258170
NM_133378.4(TTN):c.8043C>T (p.Thr2681=)	TTN	Cardiovascular phenotype	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Jul 22, 2013)	criteria provided, single submitter	2	178771284	GRCh38	263649	258171
NM_003319.4(TTN):c.7819T>C (p.Leu2607=)	TTN	Cardiovascular phenotype	GO-ESP:0.00013(G)	Likely benign(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	2	178771370	GRCh38	264293	258169
TTN:c.7830G>C (p.Met2610Ile)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03300(G), GMAF:0.07550(G), GO-ESP:0.07135(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178773134	GRCh38	47451	56615
NM_133378.4(TTN):c.7619G>A (p.Arg2540His)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178773345	GRCh38	47431	56595
NM_133378.4(TTN):c.7545C>T (p.Tyr2515=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.10180(A), GMAF:0.07550(A), GO-ESP:0.09155(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178773511	GRCh38	47420	56585
NM_133378.4(TTN):c.7174G>A (p.Gly2392Ser)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.04682(T), GMAF:0.08750(T), GO-ESP:0.06532(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178773994	GRCh38	47377	56542
NM_133378.4(TTN):c.7157G>A (p.Gly2386Asp)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 30, 2014)	criteria provided, multiple submitters, no conflicts	2	178774011	GRCh38	178270	173456
NM_001256850.1(TTN):c.7061G>A (p.Arg2354His)	TTN	not specified|Cardiovascular phenotype	GO-ESP:0.00331(T), GMAF:0.00280(T), GO-ESP:0.00091(T)	Benign/Likely benign(Last reviewed: Jul 14, 2015)	criteria provided, multiple submitters, no conflicts	2	178774107	GRCh38	47365	56530
NM_133378.4(TTN):c.6941T>C (p.Ile2314Thr)	TTN	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Sep 24, 2012)	criteria provided, single submitter	2	178774323	GRCh38	47354	56519
NM_003319.4(TTN):c.6682C>G (p.Gln2228Glu)	TTN	Cardiovascular phenotype	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	2	178774444	GRCh38	264475	258175
NM_133378.4(TTN):c.6727G>T (p.Asp2243Tyr)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01076(A), GMAF:0.00840(A), GO-ESP:0.00272(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178774984	GRCh38	47334	56499
NM_003319.4(TTN):c.6576G>A (p.Thr2192=)	TTN	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: May 21, 2015)	criteria provided, single submitter	2	178774997	GRCh38	264009	258176
NM_133378.4(TTN):c.6593C>T (p.Thr2198Ile)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 19, 2013)	criteria provided, single submitter	2	178775118	GRCh38	263666	258177
TTN:c.6353T>C (p.Ile2118Thr)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00600(G), GMAF:0.00420(G), GO-ESP:0.00149(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178775511	GRCh38	47297	56462
NM_133378.4(TTN):c.6321C>T (p.Pro2107=)	TTN	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Feb 6, 2013)	criteria provided, single submitter	2	178775543	GRCh38	263548	258178
NM_001267550.2(TTN):c.6162C>T (p.Ala2054=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Dec 8, 2015)	criteria provided, multiple submitters, no conflicts	2	178775702	GRCh38	166313	173597
NM_133378.4(TTN):c.5993G>A (p.Arg1998His)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00077(T), GMAF:0.00160(T), GO-ESP:0.00176(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Nov 5, 2015)	criteria provided, conflicting interpretations	2	178775871	GRCh38	47256	56421
NM_133378.4(TTN):c.5917A>G (p.Thr1973Ala)	TTN	not specified		Uncertain significance(Last reviewed: Dec 16, 2011)	criteria provided, single submitter	2	178775947	GRCh38	47242	56407
NM_003319.4(TTN):c.5438G>T (p.Arg1813Met)	TTN	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	2	178776288	GRCh38	264326	258179
NM_003319.4(TTN):c.5301A>G (p.Leu1767=)	TTN	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	2	178776425	GRCh38	264323	258180
NM_133378.4(TTN):c.5268A>G (p.Glu1756=)	TTN	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 10, 2013)	criteria provided, single submitter	2	178776596	GRCh38	263762	258181
NM_133378.4(TTN):c.5198C>T (p.Thr1733Met)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00024(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178776666	GRCh38	166316	173599
NM_003319.4(TTN):c.4714G>T (p.Asp1572Tyr)	TTN|LOC101927055	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 1, 2015)	criteria provided, multiple submitters, no conflicts	2	178777012	GRCh38	196143	193304
NM_133378.4(TTN):c.4739C>T (p.Thr1580Met)	TTN|LOC101927055	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00554(A), GMAF:0.00560(A), GO-ESP:0.00174(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178777224	GRCh38	47100	56265
TTN:c.4715G>A (p.Arg1572Gln)	TTN|LOC101927055	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03298(T), GMAF:0.07530(T), GO-ESP:0.07112(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178777248	GRCh38	47098	56263
NM_133378.4(TTN):c.4630A>G (p.Ile1544Val)	TTN|LOC101927055	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01115(C), GMAF:0.01200(C), GO-ESP:0.00527(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178777435	GRCh38	47078	56243
NM_001256850.1(TTN):c.4359A>T (p.Arg1453Ser)	TTN|LOC101927055	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(A), GMAF:0.00140(A), GO-ESP:0.00047(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Dec 2, 2015)	criteria provided, conflicting interpretations	2	178777825	GRCh38	47051	56216
NM_133378.4(TTN):c.4328T>C (p.Leu1443Pro)	TTN|LOC101927055	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00031(G), GMAF:0.00380(G), GO-ESP:0.00435(G)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178777856	GRCh38	47049	56214
NM_133378.4(TTN):c.4322G>C (p.Arg1441Pro)	TTN|LOC101927055	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|Cardiovascular phenotype	GO-ESP:0.00577(G), GMAF:0.01040(G), GO-ESP:0.01113(G)	Benign/Likely benign(Last reviewed: Feb 26, 2016)	criteria provided, multiple submitters, no conflicts	2	178777862	GRCh38	47046	56211
TTN:c.4246C>T (p.Arg1416Cys)	TTN|LOC101927055	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01776(A), GMAF:0.01480(A), GO-ESP:0.00499(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178777938	GRCh38	47040	56205
NM_133378.4(TTN):c.4177A>G (p.Ile1393Val)	TTN|LOC101927055	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.04475(C), GMAF:0.03910(C), GO-ESP:0.01217(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178778905	GRCh38	47032	56197
NM_133378.4(TTN):c.4034G>A (p.Gly1345Asp)	TTN|LOC101927055	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00507(T), GMAF:0.00380(T), GO-ESP:0.00993(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178779048	GRCh38	47018	56183
NM_133378.4(TTN):c.3940A>G (p.Met1314Val)	TTN|LOC101927055	Cardiovascular phenotype	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	2	178779252	GRCh38	263594	258182
NM_133378.4(TTN):c.3884C>T (p.Ser1295Leu)	TTN|LOC101927055	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.95086(A), GMAF:0.07990(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178779308	GRCh38	47001	56166
NM_003319.4(TTN):c.3730G>A (p.Glu1244Lys)	TTN|LOC101927055	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	2	178779324	GRCh38	264610	258184
TTN:c.3759A>G (p.Arg1253=)	TTN|LOC101927055	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03239(C), GMAF:0.07570(C), GO-ESP:0.08582(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178779433	GRCh38	46985	56150
TTN:c.3668C>T (p.Ala1223Val)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00446(A), GMAF:0.00380(A), GO-ESP:0.00121(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178780061	GRCh38	46978	56143
NM_133378.4(TTN):c.3601A>G (p.Lys1201Glu)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.73489(C), GMAF:0.49980(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178780128	GRCh38	46973	56138
NM_133378.4(TTN):c.3409G>C (p.Gly1137Arg)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00300(G), GMAF:0.00100(G), GO-ESP:0.00212(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 28, 2016)	criteria provided, conflicting interpretations	2	178781235	GRCh38	46949	56114
NM_133378.4(TTN):c.3241G>A (p.Ala1081Thr)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00085(T), GMAF:0.00060(T), GO-ESP:0.00068(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 19, 2016)	criteria provided, conflicting interpretations	2	178782351	GRCh38	46931	56096
NM_003319.4(TTN):c.3019G>A (p.Glu1007Lys)	TTN	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 13, 2015)	criteria provided, single submitter	2	178782546	GRCh38	264052	258188
NM_133378.4(TTN):c.3100G>A (p.Val1034Met)	TTN	Primary dilated cardiomyopathy|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00077(T), GMAF:0.00040(T), GO-ESP:0.00095(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178782806	GRCh38	46910	56075
TTN:c.3087T>C (p.Tyr1029=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.03629(G), GMAF:0.07770(G), GO-ESP:0.07451(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178782819	GRCh38	46907	56072
TTN:c.2949C>T (p.Ile983=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01392(A), GMAF:0.01260(A), GO-ESP:0.00417(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178782957	GRCh38	46885	56050
NM_001256850.1(TTN):c.2926T>C (p.Trp976Arg)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G		Pathogenic(Last reviewed: Oct 6, 2015)	criteria provided, single submitter	2	178782980	GRCh38	12651	27690
NM_001256850.1(TTN):c.2764C>T (p.Arg922Cys)	TTN	not specified|not provided|Cardiovascular phenotype	GMAF:0.00180(A), GO-ESP:0.00040(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Oct 28, 2015)	criteria provided, conflicting interpretations	2	178784081	GRCh38	202868	199749
NM_133378.4(TTN):c.2760C>T (p.His920=)	TTN	Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00003(A)	Likely benign(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	2	178784085	GRCh38	263753	258183
NM_001267550.2(TTN):c.2744G>A (p.Arg915His)	TTN	not specified|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Jul 8, 2013)	criteria provided, conflicting interpretations	2	178784101	GRCh38	202328	199750
NM_133378.4(TTN):c.2629C>A (p.Pro877Thr)	TTN	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 4, 2015)	criteria provided, multiple submitters, no conflicts	2	178784216	GRCh38	263452	258186
NM_133378.4(TTN):c.2599A>G (p.Ser867Gly)	TTN	Cardiovascular phenotype	GO-ESP:0.00011(C)	Uncertain significance(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	2	178784246	GRCh38	263595	258191
NM_133378.4(TTN):c.2432C>T (p.Thr811Ile)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.18968(A), GMAF:0.10040(A), GO-ESP:0.16907(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178785681	GRCh38	46805	55970
TTN:c.2244G>A (p.Glu748=)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.33600(T), GMAF:0.20470(T), GO-ESP:0.31922(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178785974	GRCh38	46774	55939
NM_001256850.1(TTN):c.2228C>T (p.Ala743Val)	TTN	Dilated cardiomyopathy 1G		Pathogenic(Last reviewed: Feb 22, 2002)	no assertion criteria provided	2	178785990	GRCh38	12655	27694
NM_133378.4(TTN):c.1492G>A (p.Val498Ile)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01753(T), GMAF:0.00760(T), GO-ESP:0.01484(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178793448	GRCh38	46641	55806
NM_133378.4(TTN):c.1421C>T (p.Thr474Ile)	TTN	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	2	178793519	GRCh38	263780	258190
NM_001256850.1(TTN):c.1137A>G (p.Arg379=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00161(C), GMAF:0.00600(C), GO-ESP:0.00478(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 7, 2016)	criteria provided, conflicting interpretations	2	178795030	GRCh38	46597	55762
NM_133378.4(TTN):c.1079G>C (p.Arg360Thr)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00623(G), GMAF:0.01200(G), GO-ESP:0.00620(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178795088	GRCh38	46587	55752
TTN:c.1003G>A (p.Val335Met)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.01384(T), GMAF:0.01400(T), GO-ESP:0.00391(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178795164	GRCh38	46576	55741
NM_133378.4(TTN):c.982C>T (p.Arg328Cys)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.08811(A), GMAF:0.23600(A), GO-ESP:0.12379(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178795185	GRCh38	47703	56867
NM_133378.4(TTN):c.970C>T (p.Pro324Ser)	TTN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00346(A), GMAF:0.00160(A), GO-ESP:0.00071(A)	Benign/Likely benign(Last reviewed: Sep 6, 2016)	criteria provided, multiple submitters, no conflicts	2	178795197	GRCh38	47678	56842
NM_133378.4(TTN):c.542G>A (p.Ser181Asn)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02130(T), GMAF:0.01820(T), GO-ESP:0.00553(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178800436	GRCh38	47178	56343
NM_133378.4(TTN):c.454A>G (p.Ile152Val)	TTN	not provided|Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 30, 2015)	criteria provided, multiple submitters, no conflicts	2	178800524	GRCh38	192098	189768
NM_001256850.1(TTN):c.426C>T (p.Ala142=)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00161(A), GMAF:0.00600(A), GO-ESP:0.00476(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	178800552	GRCh38	47044	56209
NM_133378.4(TTN):c.204C>T (p.Pro68=)	TTN	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00006(A)	Likely benign(Last reviewed: Oct 3, 2013)	criteria provided, single submitter	2	178802229	GRCh38	263700	258185
NM_133378.4(TTN):c.178G>T (p.Asp60Tyr)	TTN	Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.02583(A), GMAF:0.02900(A), GO-ESP:0.01389(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	178802255	GRCh38	46687	55852
NM_000090.3(COL3A1):c.52C>T (p.Pro18Ser)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	2	188974541	GRCh38	263853	258187
NM_000090.3(COL3A1):c.121G>A (p.Asp41Asn)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 17, 2015)	criteria provided, single submitter	2	188984801	GRCh38	264258	258192
NM_000090.3(COL3A1):c.130G>A (p.Val44Ile)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00120(A), GO-ESP:0.00041(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2016)	criteria provided, conflicting interpretations	2	188984810	GRCh38	199707	196763
NM_000090.3(COL3A1):c.198A>G (p.Ile66Met)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(G)	Likely benign(Last reviewed: Oct 6, 2015)	criteria provided, single submitter	2	188984878	GRCh38	263619	258198
NM_000090.3(COL3A1):c.217G>C (p.Asp73His)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00015(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	188984897	GRCh38	263844	258189
NM_000090.3(COL3A1):c.266C>T (p.Pro89Leu)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: May 6, 2014)	criteria provided, single submitter	2	188984946	GRCh38	263835	258195
NM_000090.3(COL3A1):c.505C>T (p.Leu169Phe)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified|Aortic aneurysm	GO-ESP:0.00055(T)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 16, 2016)	criteria provided, conflicting interpretations	2	188987116	GRCh38	161216	171072
NM_000090.3(COL3A1):c.508G>A (p.Ala170Thr)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(A), GO-ESP:0.00007(A)	Uncertain significance(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	2	188987119	GRCh38	263818	258196
NM_000090.3(COL3A1):c.515A>C (p.Tyr172Ser)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00011(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	188987126	GRCh38	263946	258199
NM_000090.3(COL3A1):c.528+5G>A	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	2	188987144	GRCh38	263523	258193
NM_000090.3(COL3A1):c.531C>A (p.Gly177=)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Jun 14, 2013)	criteria provided, single submitter	2	188988083	GRCh38	263640	258197
NM_000090.3(COL3A1):c.554C>G (p.Pro185Arg)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	2	188988106	GRCh38	263923	258204
NM_000090.3(COL3A1):c.812G>A (p.Arg271Gln)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(A), GO-ESP:0.00136(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	188991017	GRCh38	161215	171073
NM_000090.3(COL3A1):c.897+4A>G	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 20, 2015)	criteria provided, single submitter	2	188991535	GRCh38	264567	258203
NM_000090.3(COL3A1):c.970G>A (p.Gly324Ser)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection		Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	2	188992202	GRCh38	101388	107134
NM_000090.3(COL3A1):c.1156C>T (p.Pro386Ser)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Feb 4, 2014)	criteria provided, single submitter	2	188994044	GRCh38	263816	258194
NM_000090.3(COL3A1):c.1165A>T (p.Asn389Tyr)	COL3A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Dec 29, 2015)	criteria provided, multiple submitters, no conflicts	2	188994053	GRCh38	199718	196776
NM_000090.3(COL3A1):c.1232G>A (p.Gly411Glu)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 21, 2012)	criteria provided, single submitter	2	188994271	GRCh38	263468	258200
NM_000090.3(COL3A1):c.1241G>A (p.Gly414Asp)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	2	188994280	GRCh38	263829	258205
NM_000090.3(COL3A1):c.1257C>T (p.Ala419=)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.02200(T), GO-ESP:0.00584(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	188994296	GRCh38	136843	140546
NM_000090.3(COL3A1):c.1303G>A (p.Gly435Ser)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	2	188994550	GRCh38	263854	258207
NM_000090.3(COL3A1):c.1348-5_1348-4delTT	COL3A1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Dec 18, 2012)	criteria provided, single submitter	2	188994719 - 188994720	GRCh38	263466	258201
NM_000090.3(COL3A1):c.1348-4delT	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection		Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	188994720	GRCh38	199694	196782
NM_000090.3(COL3A1):c.1424C>T (p.Ala475Val)	COL3A1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00001(T)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 19, 2014)	criteria provided, conflicting interpretations	2	188994800	GRCh38	199695	196783
NM_000090.3(COL3A1):c.1476A>C (p.Gly492=)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(C), GO-ESP:0.00009(C)	Likely benign(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	2	188995066	GRCh38	263861	258202
NM_000090.3(COL3A1):c.1659T>A (p.Pro553=)	COL3A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00360(A), GO-ESP:0.00127(A)	Benign(Last reviewed: Oct 20, 2014)	criteria provided, multiple submitters, no conflicts	2	188996175	GRCh38	199696	196786
NM_000090.3(COL3A1):c.1662+1G>A (p.Gly537_Pro554del)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not provided	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, multiple submitters, no conflicts	2	188996179	GRCh38	101269	107015
NM_000090.3(COL3A1):c.1727G>A (p.Gly576Asp)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	2	188996462	GRCh38	263581	258206
NM_000090.3(COL3A1):c.1770T>C (p.Pro590=)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.01280(C), GO-ESP:0.00410(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	188997173	GRCh38	136844	140547
NM_000090.3(COL3A1):c.1804C>A (p.Pro602Thr)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00460(A), GO-ESP:0.00440(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	188997207	GRCh38	136845	140548
NM_000090.3(COL3A1):c.1813C>G (p.Gln605Glu)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Oct 3, 2015)	criteria provided, single submitter	2	188997216	GRCh38	264434	258212
NM_000090.3(COL3A1):c.1851G>A (p.Gln617=)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.12900(A), GO-ESP:0.12605(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	188997371	GRCh38	136848	140551
NM_000090.3(COL3A1):c.2002C>T (p.Pro668Ser)	COL3A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00220(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 16, 2015)	criteria provided, conflicting interpretations	2	188998698	GRCh38	199727	196790
NM_000090.3(COL3A1):c.2002C>A (p.Pro668Thr)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00220(A), GO-ESP:0.00174(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	188998698	GRCh38	199726	196789
NM_000090.3(COL3A1):c.2022+4G>A	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 30, 2013)	criteria provided, single submitter	2	188998722	GRCh38	263630	258211
NM_000090.3(COL3A1):c.2022+5T>C	COL3A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00380(C), GO-ESP:0.00130(C)	Benign(Last reviewed: Oct 20, 2014)	criteria provided, multiple submitters, no conflicts	2	188998723	GRCh38	199697	196791
NM_000090.3(COL3A1):c.2035G>A (p.Ala679Thr)	COL3A1	Ehlers-Danlos syndrome, type 4|Familial aortopathy|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00508(A), GMAF:0.00180(A), GO-ESP:0.01369(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	188999297	GRCh38	35964	44628
NM_000090.3(COL3A1):c.2056C>G (p.Pro686Ala)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00100(G), GO-ESP:0.00091(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2015)	criteria provided, conflicting interpretations	2	188999318	GRCh38	199698	196792
NM_000090.3(COL3A1):c.2092G>A (p.Ala698Thr)	COL3A1	Ehlers-Danlos syndrome, type 4|COLLAGEN TYPE III POLYMORPHISM|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.21390(A), GMAF:0.21850(A), GO-ESP:0.32041(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	188999354	GRCh38	17205	32244
NM_000090.3(COL3A1):c.2096G>A (p.Gly699Asp)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	2	188999358	GRCh38	101471	107218
NM_000090.3(COL3A1):c.2244T>C (p.Gly748=)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.21210(C), GO-ESP:0.31376(C)	Benign(Last reviewed: Aug 5, 2016)	criteria provided, multiple submitters, no conflicts	2	188999856	GRCh38	136853	140556
NM_000090.3(COL3A1):c.2394T>C (p.Gly798=)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Mar 18, 2015)	criteria provided, single submitter	2	189002300	GRCh38	263931	258214
NM_000090.3(COL3A1):c.2489C>T (p.Pro830Leu)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	2	189002998	GRCh38	263573	258208
NM_000090.3(COL3A1):c.2519G>T (p.Gly840Val)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jul 12, 2013)	criteria provided, single submitter	2	189003028	GRCh38	263689	258217
NM_000090.3(COL3A1):c.2607T>A (p.Pro869=)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Dec 6, 2012)	criteria provided, single submitter	2	189003464	GRCh38	263465	258213
NM_000090.3(COL3A1):c.2642delC (p.Pro881Leufs)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	2	189003768	GRCh38	263774	258220
NM_000090.3(COL3A1):c.2801C>T (p.Ser934Leu)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	2	189004121	GRCh38	263987	258209
NM_000090.3(COL3A1):c.2802G>A (p.Ser934=)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(A), GO-ESP:0.00002(A)	Likely benign(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	2	189004122	GRCh38	263809	258219
NM_000090.3(COL3A1):c.2927T>C (p.Val976Ala)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	2	189004360	GRCh38	263828	258215
NM_000090.3(COL3A1):c.2959G>A (p.Gly987Ser)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection		Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2014)	criteria provided, conflicting interpretations	2	189005377	GRCh38	101296	107042
NM_000090.3(COL3A1):c.3200G>A (p.Ser1067Asn)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	2	189006451	GRCh38	264159	258223
NM_000090.3(COL3A1):c.3205C>T (p.Pro1069Ser)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 14, 2013)	criteria provided, single submitter	2	189006940	GRCh38	263586	258210
NM_000090.3(COL3A1):c.3229G>A (p.Gly1077Ser)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Jun 24, 2013)	criteria provided, single submitter	2	189006964	GRCh38	263685	258221
NM_000090.3(COL3A1):c.3325C>G (p.Arg1109Gly)	COL3A1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00006(G)	Uncertain significance(Last reviewed: Nov 17, 2015)	criteria provided, multiple submitters, no conflicts	2	189007569	GRCh38	199742	196812
NM_000090.3(COL3A1):c.3500_3501delGTinsAA (p.Gly1167Glu)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	2	189008117 - 189008118	GRCh38	263793	258218
NM_000090.3(COL3A1):c.3642C>A (p.Gly1214=)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(A), GO-ESP:0.00041(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	189009040	GRCh38	136857	140560
NM_000090.3(COL3A1):c.3654G>T (p.Pro1218=)	COL3A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00400(T), GO-ESP:0.00137(T)	Benign(Last reviewed: Oct 20, 2014)	criteria provided, multiple submitters, no conflicts	2	189009052	GRCh38	199706	196816
NM_000090.3(COL3A1):c.3775G>A (p.Ala1259Thr)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00008(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	189009173	GRCh38	263915	258225
NM_000090.3(COL3A1):c.3777T>C (p.Ala1259=)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00053(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	189009175	GRCh38	263324	258216
NM_000090.3(COL3A1):c.3806A>G (p.His1269Arg)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Jan 23, 2013)	criteria provided, single submitter	2	189009204	GRCh38	263525	258224
NM_000090.3(COL3A1):c.3818A>G (p.Lys1273Arg)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(G), GO-ESP:0.00008(G)	Uncertain significance(Last reviewed: Sep 20, 2016)	criteria provided, multiple submitters, no conflicts	2	189009216	GRCh38	199744	196817
NM_000090.3(COL3A1):c.3859T>C (p.Leu1287=)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(C)	Likely benign(Last reviewed: Jun 14, 2013)	criteria provided, single submitter	2	189010213	GRCh38	263683	258228
NM_000090.3(COL3A1):c.3937A>C (p.Lys1313Gln)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 12, 2015)	criteria provided, single submitter	2	189010291	GRCh38	263935	258226
NM_000090.3(COL3A1):c.3938A>G (p.Lys1313Arg)	COL3A1	Ehlers-Danlos syndrome, type 4|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00080(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	189010292	GRCh38	161218	171075
NM_000090.3(COL3A1):c.4003G>A (p.Gly1335Ser)	COL3A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	2	189010357	GRCh38	264160	258222
NM_000090.3(COL3A1):c.4073G>A (p.Arg1358Gln)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Feb 12, 2013)	criteria provided, single submitter	2	189010709	GRCh38	263557	258229
NM_000090.3(COL3A1):c.4080C>G (p.Leu1360=)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(G)	Likely benign(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	2	189010716	GRCh38	263925	258236
NM_000090.3(COL3A1):c.4086C>T (p.Ser1362=)	COL3A1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00004(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 6, 2015)	criteria provided, conflicting interpretations	2	189010722	GRCh38	197910	195071
NM_000090.3(COL3A1):c.4300C>T (p.Arg1434Cys)	COL3A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	2	189011673	GRCh38	263882	258230
NM_000393.3(COL5A2):c.4470C>T (p.Gly1490=)	COL5A2	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Dec 2, 2015)	criteria provided, multiple submitters, no conflicts	2	189034100	GRCh38	237778	238580
NM_000393.3(COL5A2):c.4451G>A (p.Gly1484Asp)	COL5A2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Dec 16, 2015)	criteria provided, multiple submitters, no conflicts	2	189034119	GRCh38	213132	209494
NM_000393.3(COL5A2):c.4423A>G (p.Ile1475Val)	COL5A2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	2	189034147	GRCh38	264167	258227
NM_000393.3(COL5A2):c.4409C>T (p.Ala1470Val)	COL5A2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	2	189034161	GRCh38	264358	258234
NM_000393.3(COL5A2):c.4389A>G (p.Glu1463=)	COL5A2	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(C), GO-ESP:0.00203(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	189034181	GRCh38	136957	140660
NM_000393.3(COL5A2):c.4316T>C (p.Ile1439Thr)	COL5A2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Oct 13, 2015)	criteria provided, single submitter	2	189034953	GRCh38	264388	258240
NM_000393.3(COL5A2):c.4173C>G (p.Arg1391=)	COL5A2	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(C), GO-ESP:0.00017(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	189035096	GRCh38	213084	209502
NM_000393.3(COL5A2):c.3837T>C (p.Ile1279=)	COL5A2	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(G), GO-ESP:0.00032(G)	Benign/Likely benign(Last reviewed: Aug 14, 2015)	criteria provided, multiple submitters, no conflicts	2	189039360	GRCh38	136955	140658
NM_000393.3(COL5A2):c.3222G>A (p.Gly1074=)	COL5A2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00005(T)	Likely benign(Last reviewed: Nov 22, 2015)	criteria provided, single submitter	2	189045887	GRCh38	264502	258231
NM_000393.3(COL5A2):c.2988C>T (p.Gly996=)	COL5A2	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00060(A), GO-ESP:0.00005(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	189050620	GRCh38	264616	258233
NM_000393.3(COL5A2):c.2884C>A (p.Pro962Thr)	COL5A2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00017(T)	Uncertain significance(Last reviewed: Feb 19, 2015)	criteria provided, single submitter	2	189051367	GRCh38	263921	258235
NM_000393.3(COL5A2):c.2741C>T (p.Ala914Val)	COL5A2	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00011(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	189052200	GRCh38	213092	209533
NM_000393.3(COL5A2):c.2562C>T (p.Asp854=)	COL5A2	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00180(A), GO-ESP:0.00246(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	189053010	GRCh38	136946	140649
NM_000393.3(COL5A2):c.2533G>A (p.Val845Ile)	COL5A2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Apr 12, 2016)	criteria provided, multiple submitters, no conflicts	2	189053444	GRCh38	213107	209538
NM_000393.3(COL5A2):c.2291C>G (p.Pro764Arg)	COL5A2	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(C), GO-ESP:0.00055(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	189057366	GRCh38	213106	209541
NM_000393.3(COL5A2):c.1976C>T (p.Pro659Leu)	COL5A2	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(A), GO-ESP:0.00048(A)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 13, 2015)	criteria provided, conflicting interpretations	2	189062866	GRCh38	155777	165529
NM_000393.3(COL5A2):c.1454C>A (p.Pro485Gln)	COL5A2	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00120(T), GO-ESP:0.00055(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	189066730	GRCh38	213074	209560
NM_000393.3(COL5A2):c.1400C>T (p.Pro467Leu)	COL5A2	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00860(A), GO-ESP:0.00278(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	189068016	GRCh38	136940	140643
NM_000393.3(COL5A2):c.1394G>T (p.Gly465Val)	COL5A2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	2	189068022	GRCh38	264206	258241
NM_000393.3(COL5A2):c.1073C>T (p.Ala358Val)	COL5A2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	2	189075424	GRCh38	264579	258232
NM_000393.3(COL5A2):c.1035G>C (p.Gly345=)	COL5A2	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00420(G), GO-ESP:0.00163(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	189078540	GRCh38	136934	140637
NM_000393.3(COL5A2):c.894G>C (p.Leu298=)	COL5A2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T)	Likely benign(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	2	189081002	GRCh38	264063	258238
NM_000393.3(COL5A2):c.750G>A (p.Pro250=)	COL5A2	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00029(T)	Benign/Likely benign(Last reviewed: Feb 15, 2016)	criteria provided, multiple submitters, no conflicts	2	189085208	GRCh38	237779	238585
NM_000393.3(COL5A2):c.587C>A (p.Ala196Asp)	COL5A2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	2	189088753	GRCh38	264413	258237
NM_000393.3(COL5A2):c.33C>T (p.Leu11=)	COL5A2	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(A), GO-ESP:0.00090(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	189179572	GRCh38	213089	209580
NM_000393.3(COL5A2):c.5T>C (p.Met2Thr)	COL5A2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00004(G)	Uncertain significance(Last reviewed: Jun 24, 2016)	criteria provided, multiple submitters, no conflicts	2	189179600	GRCh38	213138	209581
NM_001204.6(BMPR2):c.295T>C (p.Cys99Arg)	BMPR2	not provided		Pathogenic(Last reviewed: Oct 9, 2014)	criteria provided, single submitter	2	202467566	GRCh38	212816	209584
NM_001204.6(BMPR2):c.377A>G (p.Asn126Ser)	BMPR2	not provided		Pathogenic(Last reviewed: Sep 3, 2014)	criteria provided, single submitter	2	202467648	GRCh38	212817	209585
NM_001204.6(BMPR2):c.797G>C (p.Arg266Thr)	BMPR2	not provided	GO-ESP:0.00004(C)	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	2	202518997	GRCh38	212810	209586
NM_001204.6(BMPR2):c.846T>G (p.Tyr282Ter)	BMPR2	not provided		Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	2	202519046	GRCh38	212809	209587
NM_001204.6(BMPR2):c.1128+1G>A	BMPR2	Primary pulmonary hypertension|not provided		Pathogenic(Last reviewed: Sep 15, 2015)	criteria provided, multiple submitters, no conflicts	2	202530955	GRCh38	212811	209589
NM_001204.6(BMPR2):c.1426_1450del25 (p.Leu476Glyfs)	BMPR2	not provided		Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	2	202552728 - 202552752	GRCh38	212813	209590
NM_001204.6(BMPR2):c.1459G>T (p.Asp487Tyr)	BMPR2	not provided		Likely pathogenic(Last reviewed: Jun 30, 2014)	criteria provided, single submitter	2	202552761	GRCh38	212812	209591
NM_001927.3(DES):c.38C>T (p.Ser13Phe)	DES	Primary dilated cardiomyopathy|Myofibrillar myopathy 1|not provided		Pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, multiple submitters, no conflicts	2	219418500	GRCh38	44260	53427
NM_001927.3(DES):c.75A>G (p.Pro25=)	DES	Myofibrillar myopathy 1|Cardiomyopathy|not specified|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.89723(G), GMAF:0.11380(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219418537	GRCh38	36002	44666
NM_001927.3(DES):c.93T>C (p.Ser31=)	DES	Myofibrillar myopathy 1|Cardiomyopathy|not specified|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.87939(C), GMAF:0.13400(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219418555	GRCh38	36003	44667
NM_001927.3(DES):c.109C>T (p.Arg37Trp)	DES	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	2	219418571	GRCh38	264441	258243
NM_001927.3(DES):c.154C>A (p.Arg52Ser)	DES	Myofibrillar myopathy 1|not specified|Muscular dystrophy, limb-girdle, type 2r|Cardiovascular phenotype		Uncertain significance(Last reviewed: Mar 8, 2016)	criteria provided, multiple submitters, no conflicts	2	219418616	GRCh38	201712	198111
NM_001927.3(DES):c.286G>T (p.Ala96Ser)	DES	Cardiovascular phenotype	GMAF:0.00020(T)	Uncertain significance(Last reviewed: Mar 11, 2013)	criteria provided, single submitter	2	219418748	GRCh38	263554	258239
NM_001927.3(DES):c.324G>A (p.Glu108=)	DES	Myofibrillar myopathy 1|not specified|Muscular dystrophy, limb-girdle, type 2r|Cardiovascular phenotype	GMAF:0.00240(A), GO-ESP:0.00160(A)	Benign/Likely benign(Last reviewed: Mar 13, 2016)	criteria provided, multiple submitters, no conflicts	2	219418786	GRCh38	137077	140780
NM_001927.3(DES):c.358G>C (p.Ala120Pro)	DES	not provided		Pathogenic(Last reviewed: Oct 24, 2014)	criteria provided, single submitter	2	219418820	GRCh38	201726	198117
NM_001927.3(DES):c.372G>A (p.Glu124=)	DES	Myofibrillar myopathy 1|not specified|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.01779(A), GMAF:0.01720(A), GO-ESP:0.01205(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219418834	GRCh38	44258	53425
NM_001927.3(DES):c.408C>T (p.Leu136=)	DES	Myofibrillar myopathy 1|not specified|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.02553(T), GMAF:0.01240(T), GO-ESP:0.04124(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219418870	GRCh38	44262	53429
NM_001927.3(DES):c.438C>G (p.Arg146=)	DES	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00053(G)	Likely benign(Last reviewed: Aug 9, 2012)	criteria provided, single submitter	2	219418900	GRCh38	263361	258249
NM_001927.3(DES):c.517_537del21 (p.Ala174_Arg180del)	DES	Myofibrillar myopathy 1|not provided		Pathogenic(Last reviewed: Oct 29, 2012)	no assertion criteria provided	2	219418979 - 219418999	GRCh38	16823	31862
NM_001927.3(DES):c.609A>C (p.Glu203Asp)	DES	Cardiovascular phenotype	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	2	219420125	GRCh38	264129	258242
NM_001927.3(DES):c.638C>T (p.Ala213Val)	DES	Myofibrillar myopathy 1|Congenital diaphragmatic hernia|Myofibrillar myopathy|not specified|not provided|Muscular dystrophy, limb-girdle, type 2r|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.01053(T), GMAF:0.00560(T), GO-ESP:0.01015(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Aug 16, 2016)	criteria provided, conflicting interpretations	2	219420154	GRCh38	44265	53432
NM_001927.3(DES):c.669T>C (p.Ile223=)	DES	Myofibrillar myopathy 1|Cardiomyopathy|not specified|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.02653(C), GMAF:0.02940(C), GO-ESP:0.00857(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219420280	GRCh38	36001	44665
NM_001927.3(DES):c.792C>T (p.Asp264=)	DES	Myofibrillar myopathy 1|not specified|Muscular dystrophy, limb-girdle, type 2r|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.00077(T), GMAF:0.00420(T), GO-ESP:0.00394(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219420551	GRCh38	44271	53438
NM_001927.3(DES):c.828C>T (p.Asp276=)	DES	Myofibrillar myopathy 1|not specified|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.38451(T), GMAF:0.33750(T), GO-ESP:0.33626(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219420587	GRCh38	44272	53439
NM_001927.3(DES):c.934G>A (p.Asp312Asn)	DES	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00054(A), GMAF:0.00120(A), GO-ESP:0.00018(A)	Uncertain significance(Last reviewed: Mar 16, 2016)	criteria provided, multiple submitters, no conflicts	2	219420864	GRCh38	44274	53441
NM_001927.3(DES):c.935A>C (p.Asp312Ala)	DES	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00100(C), GMAF:0.00140(C), GO-ESP:0.00039(C)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2015)	criteria provided, conflicting interpretations	2	219420865	GRCh38	44275	53442
NM_001927.3(DES):c.1009G>C (p.Ala337Pro)	DES	Myofibrillar myopathy 1|not provided		Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	2	219420939	GRCh38	16820	31859
NM_001927.3(DES):c.1014G>C (p.Leu338=)	DES	Myofibrillar myopathy 1|not specified|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.38659(C), GMAF:0.33770(C), GO-ESP:0.34141(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219420944	GRCh38	44242	53409
NM_001927.3(DES):c.1026C>T (p.Asn342=)	DES	Myofibrillar myopathy 1|not specified|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.02291(T), GMAF:0.02320(T), GO-ESP:0.00650(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219421342	GRCh38	44243	53410
NM_001927.3(DES):c.1048C>T (p.Arg350Trp)	DES	Primary dilated cardiomyopathy|not specified|not provided	GO-ESP:0.00008(T), GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Sep 29, 2014)	criteria provided, conflicting interpretations	2	219421364	GRCh38	44244	53411
NM_001927.3(DES):c.1096_1098delAAC (p.Asn366del)	DES	Myofibrillar myopathy 1|not provided		Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	2	219421412 - 219421414	GRCh38	16832	31871
NM_001927.3(DES):c.1104G>A (p.Ala368=)	DES	Myofibrillar myopathy 1|not specified|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.38444(A), GMAF:0.33370(A), GO-ESP:0.33618(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219421420	GRCh38	44245	53412
NM_001927.3(DES):c.1166A>C (p.Gln389Pro)	DES	Myofibrillar myopathy 1|not provided		Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	2	219421482	GRCh38	16830	31869
NM_001927.3(DES):c.1189G>A (p.Ala397Thr)	DES	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Nov 24, 2014)	criteria provided, single submitter	2	219421505	GRCh38	163028	173495
NM_001927.3(DES):c.1216C>T (p.Arg406Trp)	DES	Myofibrillar myopathy 1|not provided		Pathogenic/Likely pathogenic, not provided(Last reviewed: Sep 22, 2016)	criteria provided, multiple submitters, no conflicts	2	219421532	GRCh38	16826	31865
NM_001927.3(DES):c.1245-3T>G	DES	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 31, 2015)	criteria provided, multiple submitters, no conflicts	2	219423774	GRCh38	198476	195637
NM_001927.3(DES):c.1353C>T (p.Ile451=)	DES	not specified|Cardiovascular phenotype	GMAF:0.00220(T), GO-ESP:0.00085(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2015)	criteria provided, conflicting interpretations	2	219425727	GRCh38	226559	228924
NM_001927.3(DES):c.1353C>G (p.Ile451Met)	DES	Dilated cardiomyopathy 1I|not specified|not provided	GMAF:0.00220(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Aug 12, 2016)	criteria provided, conflicting interpretations	2	219425727	GRCh38	16824	31863
NM_001927.3(DES):c.1360C>T (p.Arg454Trp)	DES	Dilated cardiomyopathy 1I|Myofibrillar myopathy 1|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic, not provided(Last reviewed: May 5, 2016)	criteria provided, multiple submitters, no conflicts	2	219425734	GRCh38	66402	77299
NM_001927.3(DES):c.1375G>A (p.Val459Ile)	DES	Myofibrillar myopathy 1|not specified|not provided|Muscular dystrophy, limb-girdle, type 2r|Dilated cardiomyopathy|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.01215(A), GMAF:0.00980(A), GO-ESP:0.00303(A)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	219425952	GRCh38	44252	53419
NM_004544.3(NDUFA10):c.1A>G (p.Met1Val)	NDUFA10	Leigh syndrome due to mitochondrial complex I deficiency	GO-ESP:0.00009(C)	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	2	240025301	GRCh38	30392	39349
GRCh38/hg38 2p25.3(chr2:12770-4318861)x3	ACP1|RPS7|TPO|TSSC1|PXDN|MYT1L|SH3YL1|TRAPPC12|SNTG2|ADI1|ALLC|COLEC11|TMEM18|RNASEH1|FAM150B|LINC01115|FAM110C|DCDC2C|MYT1L-AS1|LINC01304|RNASEH1-AS1|LOC101060385|LOC101060391|LINC01250|LOC105373352|LOC105373394|LOC107985837	See cases		Uncertain significance(Last reviewed: Mar 18, 2014)	no assertion criteria provided	2	12770 - 4318861	GRCh38	155714	165468
GRCh38/hg38 2p11.2(chr2:87472053-87705910)x3	CYTOR|MIR4435-1	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	2	87472053 - 87705910	GRCh38	155011	164765
GRCh38/hg38 2p16.3(chr2:50794296-50839976)x1	NRXN1	See cases		Uncertain significance(Last reviewed: Sep 21, 2012)	no assertion criteria provided	2	50794296 - 50839976	GRCh38	154805	164559
GRCh38/hg38 2p16.3(chr2:48581695-49195508)x3	FSHR|LHCGR|GTF2A1L|STON1|STON1-GTF2A1L|MIR548BA	See cases		Uncertain significance(Last reviewed: Jan 24, 2011)	no assertion criteria provided	2	48581695 - 49195508	GRCh38	154470	164224
GRCh38/hg38 2q14.2(chr2:118783531-118995100)x1	EN1|MARCO	See cases		Uncertain significance(Last reviewed: Dec 13, 2010)	no assertion criteria provided	2	118783531 - 118995100	GRCh38	154450	164204
GRCh38/hg38 2q37.3(chr2:241914448-242126251)x1	LOC728323|LINC01237|LOC102723927	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	2	241914448 - 242126251	GRCh38	154414	164168
GRCh38/hg38 2q24.1-24.2(chr2:158655460-159251819)x3	PKP4|TANC1|DAPL1|WDSUB1|LOC100129029|MIR6888	See cases		Uncertain significance(Last reviewed: Jan 14, 2013)	no assertion criteria provided	2	158655460 - 159251819	GRCh38	152747	162498
GRCh38/hg38 2p15(chr2:62031155-62779065)x3	B3GNT2|EHBP1|COMMD1|TMEM17|MIR5192	See cases		Uncertain significance(Last reviewed: Dec 17, 2012)	no assertion criteria provided	2	62031155 - 62779065	GRCh38	152565	162316
GRCh38/hg38 2q37.3(chr2:241914448-242065306)x1	LINC01237|LOC102723927	See cases		Benign(Last reviewed: Nov 30, 2010)	no assertion criteria provided	2	241914448 - 242065306	GRCh38	144562	154313
GRCh38/hg38 2q13(chr2:110104897-110207198)x3	NPHP1|MALL	See cases		conflicting data from submitters(Last reviewed: Sep 21, 2012)	no assertion criteria provided	2	110104897 - 110207198	GRCh38	144557	154308
GRCh38/hg38 2p16.1-15(chr2:56738054-62473668)x1	PEX13|REL|VRK2|XPO1|USP34|CCT4|B3GNT2|BCL11A|FANCL|PAPOLG|FAM161A|KIAA1841|AHSA2|COMMD1|PUS10|TMEM17|LOC339803|C2orf74|LINC01122|LINC01185|SNORA70B|MIR4432|MIR5192|LINC01793|MIR4432HG	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	2	56738054 - 62473668	GRCh38	60146	74741
GRCh38/hg38 2p16.3(chr2:50485201-50531213)x1	NRXN1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	2	50485201 - 50531213	GRCh38	60110	74705
GRCh38/hg38 2q13(chr2:110084138-110212693)x1	NPHP1|MALL|LINC00116|MIR4436B1	See cases		Benign(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	2	110084138 - 110212693	GRCh38	59743	74338
GRCh38/hg38 2p22.1(chr2:39036084-39379226)x3	SOS1|MAP4K3|CDKL4	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	2	39036084 - 39379226	GRCh38	58841	73436
GRCh38/hg38 2q31.1-31.2(chr2:173408061-177702487)x1	ATP5G3|CHN1|CHRNA1|ATF2|HOXD1|HOXD3|HOXD4|HOXD8|HOXD9|HOXD10|HOXD11|HOXD12|HOXD13|NFE2L2|SP3|WIPF1|AGPS|CIR1|MTX2|OLA1|PDE11A|SCRN3|LNPK|TTC30A|TTC30B|GPR155|HNRNPA3|LINC01305|EVX2|LINC01116|HAGLR|MIR10B|MIR933|LOC100128905|LOC100130691|SP9|MIR1246|MIR3128|HOXD-AS2|MIR4444-1|MIR6512|MIR7704|LINC01117|HAGLROS|LOC105373764	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	2	173408061 - 177702487	GRCh38	58767	73362
GRCh38/hg38 2q13-14.1(chr2:110638242-112317901)x1	BUB1|BCL2L11|MERTK|ACOXL|ANAPC1|ZC3H8|TMEM87B|FBLN7|ZC3H6|ACOXL-AS1|MIR4435-2HG|MIR4771-2|MIR4435-2|SNORD132	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	2	110638242 - 112317901	GRCh38	57564	72159
GRCh38/hg38 2p11.2(chr2:87148954-87705899)x1	CYTOR|MIR4771-1|MIR4435-1	See cases		Benign(Last reviewed: Sep 18, 2013)	no assertion criteria provided	2	87148954 - 87705899	GRCh38	33823	42488
NM_002222.5(ITPR1):c.805C>T (p.Arg269Trp)	ITPR1	not provided		Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	3	4645678	GRCh38	265201	259766
NM_033337.2(CAV3):c.27C>T (p.Leu9=)	CAV3|SSUH2	Caveolinopathy|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	GO-ESP:0.09150(T), GMAF:0.04250(T), GO-ESP:0.08729(T)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	8733903	GRCh38	31716	40376
NM_033337.2(CAV3):c.99C>T (p.Asn33=)	CAV3|SSUH2	Caveolinopathy|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	GO-ESP:0.34315(T), GMAF:0.37100(T), GO-ESP:0.30104(T)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	8733975	GRCh38	31709	40369
NM_033337.2(CAV3):c.110T>C (p.Val37Ala)	CAV3|SSUH2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	3	8733986	GRCh38	264147	258330
NM_033337.2(CAV3):c.123T>C (p.Phe41=)	CAV3	Caveolinopathy|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	GO-ESP:0.25557(C), GMAF:0.15300(C), GO-ESP:0.18859(C)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	8745534	GRCh38	31717	40377
NM_033337.2(CAV3):c.166G>A (p.Gly56Ser)	CAV3	Limb-girdle muscular dystrophy, type 1C|Limb-girdle muscular dystrophy|not specified|not provided|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	GO-ESP:0.03729(A), GMAF:0.04090(A), GO-ESP:0.01073(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	8745577	GRCh38	8278	23317
NM_033337.2(CAV3):c.171G>A (p.Val57=)	CAV3	Caveolinopathy|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	GO-ESP:0.01853(A), GMAF:0.02100(A), GO-ESP:0.00505(A)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	8745582	GRCh38	31714	40374
NM_033337.2(CAV3):c.201C>A (p.Val67=)	CAV3	not specified|Cardiovascular phenotype	GO-ESP:0.00005(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 14, 2015)	criteria provided, conflicting interpretations	3	8745612	GRCh38	136659	140362
NM_033337.2(CAV3):c.216C>G (p.Cys72Trp)	CAV3	Limb-girdle muscular dystrophy, type 1C|Limb-girdle muscular dystrophy|Long QT syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00138(G), GMAF:0.00100(G), GO-ESP:0.00113(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Apr 11, 2016)	criteria provided, conflicting interpretations	3	8745627	GRCh38	8279	23318
NM_033337.2(CAV3):c.233C>T (p.Thr78Met)	CAV3	Long QT syndrome 9|Long QT syndrome 2/9, digenic|Long QT syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00431(T), GMAF:0.00200(T), GO-ESP:0.00304(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 7, 2016)	criteria provided, conflicting interpretations	3	8745644	GRCh38	8293	23332
NM_033337.2(CAV3):c.234G>A (p.Thr78=)	CAV3	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00014(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 5, 2016)	criteria provided, conflicting interpretations	3	8745645	GRCh38	241747	239294
NM_033337.2(CAV3):c.244G>A (p.Val82Ile)	CAV3	not specified	GMAF:0.00020(A), GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	3	8745655	GRCh38	279733	264150
NM_033337.2(CAV3):c.251T>C (p.Leu84Pro)	CAV3	not provided		Likely pathogenic(Last reviewed: Aug 15, 2014)	criteria provided, single submitter	3	8745662	GRCh38	180797	179087
NM_033337.2(CAV3):c.253G>A (p.Ala85Thr)	CAV3	Long QT syndrome 9|not provided		Pathogenic(Last reviewed: Nov 14, 2006)	no assertion criteria provided	3	8745664	GRCh38	8294	23333
NM_033337.2(CAV3):c.277G>A (p.Ala93Thr)	CAV3	Rippling muscle disease 2, autosomal recessive|Long QT syndrome|not provided	GMAF:0.00020(T), GO-ESP:0.00014(A)	Pathogenic/Likely pathogenic, not provided(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	3	8745688	GRCh38	8285	23324
NM_033337.2(CAV3):c.336C>T (p.Ile112=)	CAV3	Long QT syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00169(T), GMAF:0.00100(T), GO-ESP:0.00190(T)	Benign/Likely benign(Last reviewed: Mar 24, 2016)	criteria provided, multiple submitters, no conflicts	3	8745747	GRCh38	46536	55701
NM_033337.2(CAV3):c.442C>T (p.Arg148Trp)	CAV3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jun 25, 2014)	criteria provided, conflicting interpretations	3	8745853	GRCh38	180801	179092
NM_033337.2(CAV3):c.449A>T (p.Glu150Val)	CAV3	not specified		Uncertain significance(Last reviewed: Nov 13, 2013)	criteria provided, single submitter	3	8745860	GRCh38	180802	179093
NM_001031717.3(CRELD1):c.320G>A (p.Arg107His)	CRELD1	Atrioventricular septal defect, partial, with heterotaxy syndrome|not specified	GO-ESP:0.00108(A), GMAF:0.00160(A), GO-ESP:0.00058(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2016)	criteria provided, conflicting interpretations	3	9937624	GRCh38	3429	18468
NM_001031717.3(CRELD1):c.383C>G (p.Pro128Arg)	CRELD1	Atrioventricular septal defect 2	GMAF:0.01220(G), GO-ESP:0.00418(G)	Benign(Last reviewed: Jan 25, 2016)	criteria provided, single submitter	3	9938029	GRCh38	238217	239295
NM_001031717.3(CRELD1):c.484C>G (p.Pro162Ala)	CRELD1	Atrioventricular septal defect 2		risk factor(Last reviewed: Jun 1, 2005)	no assertion criteria provided	3	9940873	GRCh38	3430	18469
NM_001031717.3(CRELD1):c.575G>A (p.Cys192Tyr)	CRELD1	Atrioventricular septal defect 2	GO-ESP:0.00018(A)	Uncertain significance(Last reviewed: Jan 25, 2016)	criteria provided, single submitter	3	9940964	GRCh38	238218	239296
NM_001031717.3(CRELD1):c.932C>T (p.Thr311Ile)	CRELD1	Atrioventricular septal defect 2	GO-ESP:0.00077(T), GMAF:0.00060(T), GO-ESP:0.00040(T)	risk factor(Last reviewed: Apr 1, 2003)	no assertion criteria provided	3	9943399	GRCh38	3428	18467
NM_015513.4(CRELD1):c.945G>A (p.Pro315=)	CRELD1	Atrioventricular septal defect 2|not specified	GMAF:0.00360(A), GO-ESP:0.01190(A)	Benign(Last reviewed: Jan 19, 2016)	criteria provided, multiple submitters, no conflicts	3	9943412	GRCh38	137029	140732
NM_001031717.3(CRELD1):c.985C>T (p.Arg329Cys)	CRELD1	Atrioventricular septal defect 2	GO-ESP:0.00131(T), GMAF:0.00080(T), GO-ESP:0.00064(T)	risk factor(Last reviewed: Mar 31, 2014)	no assertion criteria provided	3	9943452	GRCh38	3427	18466
NM_001077415.2(CRELD1):c.1240G>A (p.Glu414Lys)	CRELD1	Atrioventricular septal defect 2		risk factor(Last reviewed: Oct 5, 2012)	no assertion criteria provided	3	9944556	GRCh38	3431	18470
NM_002880.3(RAF1):c.1941C>T (p.Val647=)	RAF1	not specified|Rasopathy|Cardiovascular phenotype	GO-ESP:0.00830(A), GMAF:0.00440(A), GO-ESP:0.00708(A)	Benign(Last reviewed: Feb 24, 2016)	criteria provided, multiple submitters, no conflicts	3	12584520	GRCh38	44623	53790
NM_002880.3(RAF1):c.1914G>A (p.Thr638=)	RAF1	Noonan syndrome|not specified|Cardiovascular phenotype|LEOPARD Syndrome	GMAF:0.00360(T), GO-ESP:0.00147(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	12584547	GRCh38	40628	49098
NM_002880.3(RAF1):c.1879C>T (p.Arg627Trp)	RAF1	not specified|Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jul 17, 2015)	criteria provided, multiple submitters, no conflicts	3	12584582	GRCh38	181513	179045
NM_002880.3(RAF1):c.1830A>G (p.Gln610=)	RAF1	Noonan syndrome|not specified|Rasopathy|Cardiovascular phenotype|LEOPARD Syndrome	GO-ESP:0.00069(C), GMAF:0.00080(C), GO-ESP:0.00076(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	12584631	GRCh38	40627	49097
NM_002880.3(RAF1):c.1814C>T (p.Ser605Phe)	RAF1	not specified|Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Jun 27, 2016)	criteria provided, multiple submitters, no conflicts	3	12584647	GRCh38	181512	179046
NM_002880.3(RAF1):c.1808T>C (p.Leu603Pro)	RAF1	Cardiomyopathy, dilated, 1NN		Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	12584653	GRCh38	142296	152010
NM_002880.3(RAF1):c.1755A>G (p.Val585=)	RAF1	Noonan syndrome|not specified|Rasopathy|Cardiovascular phenotype|LEOPARD Syndrome	GO-ESP:0.02191(C), GMAF:0.01960(C), GO-ESP:0.00616(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	12584895	GRCh38	40626	49096
NM_002880.3(RAF1):c.1710T>C (p.Leu570=)	RAF1	Cardiovascular phenotype		Likely benign(Last reviewed: May 26, 2013)	criteria provided, single submitter	3	12584940	GRCh38	263637	258278
NM_002880.3(RAF1):c.1611A>G (p.Val537=)	RAF1	Cardiovascular phenotype	GO-ESP:0.00001(C)	Likely benign(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	3	12585179	GRCh38	264563	258282
NM_002880.3(RAF1):c.1334T>G (p.Leu445Arg)	RAF1	not specified|Cardiovascular phenotype	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Nov 20, 2013)	criteria provided, single submitter	3	12590834	GRCh38	235047	236756
NM_002880.3(RAF1):c.935T>C (p.Val312Ala)	RAF1	not specified|Cardiovascular phenotype	GO-ESP:0.00016(G)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 7, 2014)	criteria provided, conflicting interpretations	3	12600207	GRCh38	40612	49082
NM_002880.3(RAF1):c.853A>G (p.Ser285Gly)	RAF1	Cardiovascular phenotype	GMAF:0.00040(C), GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: May 10, 2013)	criteria provided, single submitter	3	12600397	GRCh38	263589	258290
NM_002880.3(RAF1):c.770C>T (p.Ser257Leu)	RAF1	LEOPARD syndrome 2|Noonan syndrome 5|Noonan syndrome with multiple lentigines|Noonan syndrome|not provided|Rasopathy		Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, multiple submitters, no conflicts	3	12604200	GRCh38	13957	28996
NM_002880.3(RAF1):c.576A>G (p.Gln192=)	RAF1	not specified|Cardiovascular phenotype	GO-ESP:0.00031(C), GO-ESP:0.00013(C)	Likely benign(Last reviewed: Jun 10, 2015)	criteria provided, multiple submitters, no conflicts	3	12608771	GRCh38	40597	49067
NM_002880.3(RAF1):c.142C>G (p.Leu48Val)	RAF1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	3	12618580	GRCh38	264142	258287
NM_002880.3(RAF1):c.122G>A (p.Arg41Gln)	RAF1	not specified|Rasopathy|Cardiovascular phenotype	GO-ESP:0.00023(T), GMAF:0.00040(T), GO-ESP:0.00018(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2015)	criteria provided, conflicting interpretations	3	12618600	GRCh38	40586	49056
NM_024334.2(TMEM43):c.-4C>T	TMEM43	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	3	14125190	GRCh38	264209	258280
NM_024334.2(TMEM43):c.82C>T (p.Arg28Trp)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00669(T), GMAF:0.00840(T), GO-ESP:0.00289(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14129481	GRCh38	46153	55318
NM_024334.2(TMEM43):c.91G>A (p.Glu31Lys)	TMEM43	Cardiovascular phenotype	GO-ESP:0.00007(A)	Uncertain significance(Last reviewed: May 17, 2013)	criteria provided, single submitter	3	14129490	GRCh38	263617	258285
NM_024334.2(TMEM43):c.222C>T (p.Pro74=)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00900(T), GMAF:0.00400(T), GO-ESP:0.00804(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	14130881	GRCh38	46141	55306
NM_024334.2(TMEM43):c.244C>G (p.Pro82Ala)	TMEM43	not specified	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	3	14130903	GRCh38	202126	198142
NM_024334.2(TMEM43):c.271A>G (p.Ile91Val)	TMEM43	not specified|Emery-Dreifuss muscular dystrophy 7, autosomal dominant	GO-ESP:0.00015(G), GMAF:0.00020(G), GO-ESP:0.00006(G)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 14, 2016)	criteria provided, conflicting interpretations	3	14130930	GRCh38	40871	49357
NM_024334.2(TMEM43):c.337G>A (p.Val113Met)	TMEM43	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Nov 25, 2013)	criteria provided, single submitter	3	14131619	GRCh38	202128	198145
NM_024334.2(TMEM43):c.347G>A (p.Arg116Gln)	TMEM43	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Dec 9, 2015)	criteria provided, single submitter	3	14131629	GRCh38	264584	258292
NM_024334.2(TMEM43):c.410G>C (p.Gly137Ala)	TMEM43	not specified	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Nov 25, 2013)	criteria provided, single submitter	3	14132563	GRCh38	202130	198147
NM_024334.2(TMEM43):c.424G>C (p.Glu142Gln)	TMEM43	not specified	GMAF:0.00080(A)	Uncertain significance(Last reviewed: Jun 1, 2015)	criteria provided, single submitter	3	14132577	GRCh38	202133	198149
NM_024334.2(TMEM43):c.424G>A (p.Glu142Lys)	TMEM43	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00131(A), GMAF:0.00080(A), GO-ESP:0.00049(A)	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2016)	criteria provided, conflicting interpretations	3	14132577	GRCh38	46147	55312
NM_024334.2(TMEM43):c.428C>T (p.Thr143Met)	TMEM43	not specified|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Sep 10, 2015)	criteria provided, multiple submitters, no conflicts	3	14132581	GRCh38	179489	173894
NM_024334.2(TMEM43):c.484G>A (p.Asp162Asn)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|not specified|Cardiovascular phenotype	GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Nov 25, 2015)	criteria provided, multiple submitters, no conflicts	3	14132907	GRCh38	178140	173895
NM_024334.2(TMEM43):c.504A>T (p.Lys168Asn)	TMEM43	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.28756(T), GMAF:0.35260(T), GO-ESP:0.32087(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14132927	GRCh38	46148	55313
NM_024334.2(TMEM43):c.509C>G (p.Pro170Arg)	TMEM43	not specified		Uncertain significance(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	3	14132932	GRCh38	202134	198150
NM_024334.2(TMEM43):c.536T>C (p.Met179Thr)	TMEM43	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.33277(C), GMAF:0.46330(C), GO-ESP:0.37237(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14133762	GRCh38	46150	55315
NM_024334.2(TMEM43):c.564C>T (p.Gly188=)	TMEM43	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00005(T)	Likely benign(Last reviewed: May 27, 2015)	criteria provided, single submitter	3	14133790	GRCh38	264054	258288
NM_024334.2(TMEM43):c.659G>A (p.Arg220His)	TMEM43	not specified	GMAF:0.00020(T), GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Feb 19, 2014)	criteria provided, single submitter	3	14134845	GRCh38	202117	198152
NM_024334.2(TMEM43):c.698A>G (p.Tyr233Cys)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GMAF:0.00520(G), GO-ESP:0.00204(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14134884	GRCh38	177840	173755
NM_024334.2(TMEM43):c.861C>G (p.His287Gln)	TMEM43	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	3	14135887	GRCh38	264109	258291
NM_024334.2(TMEM43):c.896G>C (p.Arg299Thr)	TMEM43	not provided	GMAF:0.00120(C), GO-ESP:0.00053(C)	Likely benign(Last reviewed: Oct 31, 2014)	criteria provided, single submitter	3	14139193	GRCh38	202109	198157
NM_024334.2(TMEM43):c.909C>T (p.Ser303=)	TMEM43	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.02130(T), GMAF:0.02140(T), GO-ESP:0.01996(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14139206	GRCh38	46154	55319
NM_024334.2(TMEM43):c.934C>T (p.Arg312Trp)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|Cardiomyopathy|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00984(T), GMAF:0.00380(T), GO-ESP:0.00905(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14139231	GRCh38	36873	45534
NM_024334.2(TMEM43):c.953C>T (p.Ala318Val)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00800(T), GMAF:0.00420(T), GO-ESP:0.00185(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	14139250	GRCh38	46156	55321
NM_024334.2(TMEM43):c.980C>G (p.Thr327Arg)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	3	14139277	GRCh38	241470	239112
NM_024334.2(TMEM43):c.1061G>C (p.Cys354Ser)	TMEM43	not specified|Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00046(C)	Uncertain significance(Last reviewed: Dec 11, 2012)	criteria provided, single submitter	3	14141653	GRCh38	235059	236758
NM_024334.2(TMEM43):c.1073C>T (p.Ser358Leu)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|Arrhythmogenic right ventricular cardiomyopathy|not provided		Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, multiple submitters, no conflicts	3	14141665	GRCh38	734	15773
NM_024334.2(TMEM43):c.1095G>A (p.Ala365=)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|not specified|Cardiovascular phenotype	GO-ESP:0.00019(A)	Likely benign(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	3	14141687	GRCh38	165458	173757
NM_024334.2(TMEM43):c.1096G>A (p.Ala366Thr)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|not specified|Cardiovascular phenotype	GO-ESP:0.00646(A), GMAF:0.00560(A), GO-ESP:0.00168(A)	Benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	3	14141688	GRCh38	46138	55303
NM_024334.2(TMEM43):c.1105C>T (p.Leu369Phe)	TMEM43	not specified|not provided	GO-ESP:0.00062(T), GMAF:0.00020(T), GO-ESP:0.00011(T)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 7, 2016)	criteria provided, conflicting interpretations	3	14141697	GRCh38	46139	55304
NM_022340.3(RBSN):c.1273G>A (p.Gly425Arg)	RBSN	not provided	GMAF:0.00260(T), GO-ESP:0.00552(T)	Uncertain significance(Last reviewed: Sep 20, 2014)	no assertion criteria provided	3	15074864	GRCh38	156371	166150
NM_000965.4(RARB):c.355C>T (p.Arg119Ter)	RARB	Microphthalmia, syndromic 12		Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	3	25501230	GRCh38	88760	94341
NM_003242.5(TGFBR2):c.106A>G (p.Met36Val)	TGFBR2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(G), GO-ESP:0.00021(G)	Uncertain significance(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	3	30644758	GRCh38	264100	258286
NM_003242.5(TGFBR2):c.367A>T (p.Met123Leu)	TGFBR2	Marfan syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00007(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	30650373	GRCh38	213939	209597
NM_003242.5(TGFBR2):c.455-4T>A	TGFBR2	Marfan syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.25550(A), GMAF:0.27200(A), GO-ESP:0.29277(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	30671634	GRCh38	44658	53825
NM_003242.5(TGFBR2):c.571G>A (p.Val191Ile)	TGFBR2	Marfan syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00400(A), GO-ESP:0.00161(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	30671754	GRCh38	137635	141338
NM_003242.5(TGFBR2):c.594T>C (p.Ser198=)	TGFBR2	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: May 13, 2014)	criteria provided, single submitter	3	30671777	GRCh38	263842	258296
NM_003242.5(TGFBR2):c.649G>C (p.Ala217Pro)	TGFBR2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(C), GO-ESP:0.00011(C)	Uncertain significance(Last reviewed: Feb 10, 2015)	criteria provided, single submitter	3	30671832	GRCh38	263839	258289
NM_003242.5(TGFBR2):c.678C>T (p.Asp226=)	TGFBR2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00005(T)	Likely benign(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	3	30671861	GRCh38	263936	258293
NM_001024847.2(TGFBR2):c.822G>A (p.Leu274=)	TGFBR2	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	3	30671930	GRCh38	263908	258298
NM_003242.5(TGFBR2):c.831G>T (p.Lys277Asn)	TGFBR2	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Apr 30, 2013)	criteria provided, single submitter	3	30672014	GRCh38	263412	258297
NM_003242.5(TGFBR2):c.902A>G (p.His301Arg)	TGFBR2	Thoracic aortic aneurysm and aortic dissection|not specified		Uncertain significance(Last reviewed: Jul 26, 2016)	criteria provided, multiple submitters, no conflicts	3	30672085	GRCh38	213943	209606
NM_003242.5(TGFBR2):c.927G>A (p.Thr309=)	TGFBR2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00007(A)	Likely benign(Last reviewed: Dec 9, 2015)	criteria provided, single submitter	3	30672110	GRCh38	263881	258294
NM_003242.5(TGFBR2):c.944C>T (p.Thr315Met)	TGFBR2	Marfan syndrome|Hereditary nonpolyposis colorectal cancer type 6|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00008(T), GMAF:0.00300(T), GO-ESP:0.00101(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	30672127	GRCh38	12502	27541
NM_003242.5(TGFBR2):c.984C>T (p.His328=)	TGFBR2	Marfan syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00017(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	30672167	GRCh38	36869	45530
NM_003242.5(TGFBR2):c.999A>G (p.Leu333=)	TGFBR2	Marfan syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.02691(G), GMAF:0.02320(G), GO-ESP:0.00764(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	30672182	GRCh38	44661	53828
NM_003242.5(TGFBR2):c.1062C>T (p.Leu354=)	TGFBR2	Marfan syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00380(T), GO-ESP:0.00394(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	30672245	GRCh38	137636	141339
NM_003242.5(TGFBR2):c.1116G>A (p.Lys372=)	TGFBR2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00004(A)	Likely benign(Last reviewed: Mar 11, 2013)	criteria provided, single submitter	3	30672299	GRCh38	263567	258295
NM_003242.5(TGFBR2):c.1119G>A (p.Met373Ile)	TGFBR2	Marfan syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00115(A), GMAF:0.00120(A), GO-ESP:0.00139(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	30672302	GRCh38	36859	45520
NM_003242.5(TGFBR2):c.1125C>T (p.Ile375=)	TGFBR2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00007(T)	Benign/Likely benign(Last reviewed: Sep 8, 2015)	criteria provided, multiple submitters, no conflicts	3	30672308	GRCh38	213907	209615
NM_003242.5(TGFBR2):c.1136A>T (p.Asp379Val)	TGFBR2	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	3	30672319	GRCh38	263559	258300
NM_003242.5(TGFBR2):c.1153A>G (p.Ile385Val)	TGFBR2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	3	30672336	GRCh38	263878	258302
NM_003242.5(TGFBR2):c.1159G>A (p.Val387Met)	TGFBR2	Marfan syndrome|Congenital aneurysm of ascending aorta|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00231(A), GMAF:0.00020(A), GO-ESP:0.00116(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	30672342	GRCh38	44651	53818
NM_003242.5(TGFBR2):c.1159G>T (p.Val387Leu)	TGFBR2	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 28, 2015)	criteria provided, conflicting interpretations	3	30672342	GRCh38	36862	45523
NM_003242.5(TGFBR2):c.1167C>T (p.Asn389=)	TGFBR2	Marfan syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.01830(T), GMAF:0.10340(T), GO-ESP:0.05509(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	30672350	GRCh38	44652	53819
NM_003242.5(TGFBR2):c.1178G>A (p.Cys393Tyr)	TGFBR2	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Nov 11, 2015)	criteria provided, single submitter	3	30672361	GRCh38	264260	258303
NM_003242.5(TGFBR2):c.1189G>A (p.Asp397Asn)	TGFBR2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	3	30672372	GRCh38	264397	258299
NM_001024847.2(TGFBR2):c.1282C>T (p.Arg428Cys)	TGFBR2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 29, 2014)	criteria provided, single submitter	3	30672390	GRCh38	263867	258306
NM_003242.5(TGFBR2):c.1261A>G (p.Thr421Ala)	TGFBR2	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jul 1, 2013)	criteria provided, single submitter	3	30674111	GRCh38	263399	258304
NM_003242.5(TGFBR2):c.1266A>G (p.Ala422=)	TGFBR2	Marfan syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.03160(G), GMAF:0.03120(G), GO-ESP:0.00878(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	30674116	GRCh38	36865	45526
NM_003242.5(TGFBR2):c.1334C>A (p.Thr445Asn)	TGFBR2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 5, 2014)	criteria provided, single submitter	3	30674184	GRCh38	263822	258305
NM_003242.5(TGFBR2):c.1378C>T (p.Arg460Cys)	TGFBR2	Loeys-Dietz syndrome 2|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Aug 6, 2013)	criteria provided, multiple submitters, no conflicts	3	30674228	GRCh38	12514	27553
NM_003242.5(TGFBR2):c.1408T>G (p.Tyr470Asp)	TGFBR2	Loeys-Dietz syndrome 2|Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, multiple submitters, no conflicts	3	30688395	GRCh38	217016	213550
NM_003242.5(TGFBR2):c.1458C>T (p.Ser486=)	TGFBR2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00060(T), GO-ESP:0.00026(T)	Uncertain significance(Last reviewed: Oct 1, 2012)	criteria provided, single submitter	3	30688445	GRCh38	263413	258301
NM_003242.5(TGFBR2):c.1483C>T (p.Arg495Ter)	TGFBR2	Loeys-Dietz syndrome 2|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2015)	criteria provided, multiple submitters, no conflicts	3	30688470	GRCh38	12519	27558
NM_003242.5(TGFBR2):c.1489C>T (p.Arg497Ter)	TGFBR2	Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, multiple submitters, no conflicts	3	30688476	GRCh38	213934	209628
NM_003242.5(TGFBR2):c.1548G>A (p.Thr516=)	TGFBR2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00015(A)	Likely benign(Last reviewed: Jan 30, 2016)	criteria provided, multiple submitters, no conflicts	3	30691443	GRCh38	239530	239137
NM_003242.5(TGFBR2):c.1565A>T (p.Asp522Val)	TGFBR2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	3	30691460	GRCh38	263334	258308
NM_003242.5(TGFBR2):c.1582C>T (p.Arg528Cys)	TGFBR2	Loeys-Dietz syndrome 2|not provided		Pathogenic(Last reviewed: Jan 11, 2014)	criteria provided, single submitter	3	30691477	GRCh38	12512	27551
NM_003242.5(TGFBR2):c.1602G>A (p.Val534=)	TGFBR2	Marfan syndrome|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00100(A), GO-ESP:0.00122(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	30691497	GRCh38	137637	141340
NM_001024847.2(TGFBR2):c.1732T>A (p.Ser578Thr)	TGFBR2	Marfan syndrome|Congenital aneurysm of ascending aorta|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00140(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	30691552	GRCh38	161394	171083
NM_015141.3(GPD1L):c.247G>A (p.Glu83Lys)	GPD1L	Brugada syndrome 2	GMAF:0.00020(A), GO-ESP:0.00017(A)	Pathogenic(Last reviewed: Apr 10, 2014)	no assertion criteria provided	3	32138608	GRCh38	787	15826
NM_015141.3(GPD1L):c.408C>T (p.Asp136=)	GPD1L	Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.14980(T), GO-ESP:0.12859(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	32140269	GRCh38	260571	251091
NM_015141.3(GPD1L):c.465C>T (p.Ala155=)	GPD1L	Cardiovascular phenotype	GMAF:0.00100(T), GO-ESP:0.00137(T)	Likely benign(Last reviewed: Sep 3, 2013)	criteria provided, single submitter	3	32140326	GRCh38	263656	258307
NM_015141.3(GPD1L):c.520G>A (p.Glu174Lys)	GPD1L	Sudden cardiac death|Brugada syndrome|not specified|not provided	GO-ESP:0.00015(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	32146636	GRCh38	180369	178515
NM_015141.3(GPD1L):c.651C>T (p.Asp217=)	GPD1L	Brugada syndrome|Cardiovascular phenotype	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	32158908	GRCh38	264629	258314
NM_015141.3(GPD1L):c.659G>A (p.Arg220His)	GPD1L	not specified|not provided|Cardiovascular phenotype	GMAF:0.00180(A), GO-ESP:0.00035(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2015)	criteria provided, conflicting interpretations	3	32158916	GRCh38	190764	188327
NM_015141.3(GPD1L):c.691C>T (p.Arg231Cys)	GPD1L	not specified	GO-ESP:0.00014(T)	Uncertain significance(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	3	32158948	GRCh38	190766	188328
NM_015141.3(GPD1L):c.839C>T (p.Ala280Val)	GPD1L	Brugada syndrome 2|not provided|Death in infancy|Cardiovascular phenotype	GO-ESP:0.00008(T), GMAF:0.00040(T), GO-ESP:0.00010(T)	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, multiple submitters, no conflicts	3	32159096	GRCh38	786	15825
NM_000404.3(GLB1):c.1772A>G (p.Tyr591Cys)	GLB1	Gm1-gangliosidosis, type I, with cardiac involvement	GO-ESP:0.00002(C)	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	3	32997307	GRCh38	948	15987
NM_000404.3(GLB1):c.1771T>A (p.Tyr591Asn)	GLB1	Gm1-gangliosidosis, type I, with cardiac involvement	GMAF:0.00020(G)	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	3	32997308	GRCh38	947	15986
NM_000404.3(GLB1):c.1480-2A>G	GLB1	Gm1-gangliosidosis, type I, with cardiac involvement	GO-ESP:0.00001(C)	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	3	33014312	GRCh38	946	15985
NM_000404.3(GLB1):c.1051C>T (p.Arg351Ter)	GLB1	Gm1-gangliosidosis, type I, with cardiac involvement	GO-ESP:0.00002(A)	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	3	33046137	GRCh38	941	15980
NM_000404.3(GLB1):c.176G>A (p.Arg59His)	GLB1	GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|Gm1-gangliosidosis, type I, with cardiac involvement|not provided	GO-ESP:0.00016(T), GO-ESP:0.00004(T)	Pathogenic(Last reviewed: Feb 18, 2013)	criteria provided, single submitter	3	33072613	GRCh38	945	15984
NM_006371.4(CRTAP):c.826C>T (p.Gln276Ter)	CRTAP	Osteogenesis imperfecta type 7	GO-ESP:0.00008(T), GMAF:0.00020(T), GO-ESP:0.00003(T)	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	3	33129971	GRCh38	4950	19989
NM_198056.2(SCN5A):c.6016C>G (p.Pro2006Ala)	SCN5A	Brugada syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00113(C), GMAF:0.00040(C), GO-ESP:0.00134(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Aug 15, 2016)	criteria provided, conflicting interpretations	3	38550356	GRCh38	68024	78916
NM_198056.2(SCN5A):c.6010T>C (p.Phe2004Leu)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00226(G), GMAF:0.00100(G), GO-ESP:0.00202(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 15, 2016)	criteria provided, conflicting interpretations	3	38550362	GRCh38	48315	57478
NM_198056.2(SCN5A):c.5935A>T (p.Ser1979Cys)	SCN5A	not provided		Likely pathogenic(Last reviewed: May 16, 2014)	criteria provided, single submitter	3	38550437	GRCh38	201548	196830
NM_198056.2(SCN5A):c.5904C>G (p.Ile1968Met)	SCN5A	not specified|not provided	GO-ESP:0.00008(C), GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Aug 7, 2014)	criteria provided, multiple submitters, no conflicts	3	38550468	GRCh38	68018	78910
NM_198056.2(SCN5A):c.5872C>T (p.Arg1958Ter)	SCN5A	not provided	GO-ESP:0.00007(A)	Likely pathogenic(Last reviewed: May 18, 2016)	criteria provided, multiple submitters, no conflicts	3	38550500	GRCh38	201546	196831
NM_198056.2(SCN5A):c.5860G>A (p.Glu1954Lys)	SCN5A	Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	3	38550512	GRCh38	48312	57475
NM_198056.2(SCN5A):c.5851G>A (p.Val1951Met)	SCN5A	Long QT syndrome 2|not provided|Atrial fibrillation|Cardiovascular phenotype	GMAF:0.00840(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Nov 19, 2015)	criteria provided, conflicting interpretations	3	38550521	GRCh38	68014	78906
NM_000335.4(SCN5A):c.5848G>T (p.Val1950Leu)	SCN5A	Atrial fibrillation|Long QT syndrome|Brugada syndrome|not specified|not provided|Ventricular tachycardia|Ventricular tachycardia|Pulmonary valve stenosis (rare)|Cardiovascular phenotype	GO-ESP:0.00191(A), GMAF:0.00840(A), GO-ESP:0.00541(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 10, 2016)	criteria provided, conflicting interpretations	3	38550521	GRCh38	36765	45426
NM_000335.4(SCN5A):c.5841C>T (p.Ile1947=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.06962(A), GMAF:0.06750(A), GO-ESP:0.01940(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38550528	GRCh38	48311	57474
NM_198056.2(SCN5A):c.5830C>T (p.Arg1944Ter)	SCN5A	not provided|SCN5A-Related Disorders		Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2016)	criteria provided, conflicting interpretations	3	38550542	GRCh38	201596	196833
NM_198056.2(SCN5A):c.5796G>C (p.Ala1932=)	SCN5A	Cardiovascular phenotype	GMAF:0.00120(T)	Likely benign(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	3	38550576	GRCh38	263948	258309
NM_198056.2(SCN5A):c.5796G>A (p.Ala1932=)	SCN5A	not specified|Cardiovascular phenotype	GMAF:0.00120(T), GO-ESP:0.00039(T)	Benign/Likely benign(Last reviewed: Oct 27, 2015)	criteria provided, multiple submitters, no conflicts	3	38550576	GRCh38	139067	142770
NM_198056.2(SCN5A):c.5726A>G (p.Gln1909Arg)	SCN5A	not provided|Congenital long QT syndrome|Cardiovascular phenotype		Conflicting interpretations of pathogenicity, not provided(Last reviewed: Nov 9, 2015)	criteria provided, conflicting interpretations	3	38550646	GRCh38	68008	78900
NM_000335.4(SCN5A):c.5690G>A (p.Arg1897His)	SCN5A	Long QT syndrome 3|not specified|Cardiovascular phenotype	GO-ESP:0.00007(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2015)	criteria provided, conflicting interpretations	3	38550679	GRCh38	207974	204196
NM_000335.4(SCN5A):c.5686C>T (p.Arg1896Trp)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided	GO-ESP:0.00024(A), GMAF:0.00060(A)	Uncertain significance(Last reviewed: Jan 5, 2016)	criteria provided, multiple submitters, no conflicts	3	38550683	GRCh38	68003	78895
NM_198056.2(SCN5A):c.5658G>T (p.Lys1886Asn)	SCN5A	not provided		Uncertain significance(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	3	38550714	GRCh38	201543	196836
NM_198056.2(SCN5A):c.5626G>A (p.Glu1876Lys)	SCN5A	not provided		Likely pathogenic(Last reviewed: Dec 6, 2012)	criteria provided, single submitter	3	38550746	GRCh38	201542	196837
NM_198056.2(SCN5A):c.5624T>C (p.Met1875Thr)	SCN5A	not provided|Atrial fibrillation		Likely pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	3	38550748	GRCh38	68002	78894
NM_198056.2(SCN5A):c.5546A>G (p.His1849Arg)	SCN5A	Brugada syndrome|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2016)	criteria provided, conflicting interpretations	3	38550826	GRCh38	201540	196840
NM_198056.2(SCN5A):c.5529_5543delGAGTGGGGACCGCAT (p.Ser1844_Ile1848del)	SCN5A	Brugada syndrome|not specified		Uncertain significance(Last reviewed: Feb 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38550829 - 38550843	GRCh38	201563	196841
NM_000335.4(SCN5A):c.5504T>C (p.Ile1835Thr)	SCN5A	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1E|not specified|not provided	GO-ESP:0.00086(G), GMAF:0.00160(G), GO-ESP:0.00023(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Oct 20, 2014)	criteria provided, conflicting interpretations	3	38550865	GRCh38	39445	48044
NM_198056.2(SCN5A):c.5494C>G (p.Gln1832Glu)	SCN5A	Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00008(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 26, 2016)	criteria provided, conflicting interpretations	3	38550878	GRCh38	48308	57471
NM_000335.4(SCN5A):c.5474G>A (p.Arg1825His)	SCN5A	Long QT syndrome 3|SUDDEN INFANT DEATH SYNDROME|not specified|not provided|Congenital long QT syndrome	GO-ESP:0.00016(T), GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Apr 21, 2016)	criteria provided, conflicting interpretations	3	38550895	GRCh38	9389	24428
NM_198056.2(SCN5A):c.5464_5467delTCTG (p.Glu1823Hisfs)	SCN5A	not provided|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, multiple submitters, no conflicts	3	38550905 - 38550908	GRCh38	201573	196843
NM_198056.2(SCN5A):c.5458G>A (p.Ala1820Thr)	SCN5A	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Feb 17, 2012)	criteria provided, single submitter	3	38550914	GRCh38	201594	196844
NM_198056.2(SCN5A):c.5457T>C (p.Asp1819=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.43144(G), GMAF:0.49240(G), GO-ESP:0.38781(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38550915	GRCh38	48307	57470
NM_198056.2(SCN5A):c.5455G>A (p.Asp1819Asn)	SCN5A	Long QT syndrome 2/3, digenic|Long QT syndrome|Brugada syndrome|not specified|Congenital long QT syndrome	GO-ESP:0.00031(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: May 11, 2016)	criteria provided, conflicting interpretations	3	38550917	GRCh38	9402	24441
NM_198056.2(SCN5A):c.5454C>T (p.Ala1818=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00011(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	38550918	GRCh38	242203	239196
NM_198056.2(SCN5A):c.5435C>T (p.Ser1812Leu)	SCN5A	not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Oct 10, 2012)	criteria provided, single submitter	3	38550937	GRCh38	201538	196845
NM_000335.4(SCN5A):c.5382_5384dupTGA (p.Tyr1794_Glu1795insAsp)	SCN5A	Brugada syndrome 1|Long QT syndrome 3		Pathogenic(Last reviewed: Mar 12, 2002)	no assertion criteria provided	3	38550985 - 38550987	GRCh38	9382	24421
NM_198056.2(SCN5A):c.5378T>A (p.Met1793Lys)	SCN5A	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2013)	criteria provided, conflicting interpretations	3	38550994	GRCh38	201537	196846
NM_198056.2(SCN5A):c.5374G>A (p.Asp1792Asn)	SCN5A	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	3	38550998	GRCh38	178858	173919
NM_198056.2(SCN5A):c.5367C>T (p.Asp1789=)	SCN5A	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00011(A)	Benign/Likely benign(Last reviewed: Oct 23, 2015)	criteria provided, multiple submitters, no conflicts	3	38551005	GRCh38	139066	142769
NM_198056.2(SCN5A):c.5360G>C (p.Ser1787Thr)	SCN5A	not specified		Uncertain significance(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	3	38551012	GRCh38	201536	196847
NM_000335.4(SCN5A):c.5357G>A (p.Ser1786Asn)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided	GO-ESP:0.00069(T), GO-ESP:0.00061(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 5, 2016)	criteria provided, conflicting interpretations	3	38551012	GRCh38	67988	78880
NM_198056.2(SCN5A):c.5350G>A (p.Glu1784Lys)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Sinus node disease|Brugada syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype		Pathogenic(Last reviewed: May 31, 2016)	criteria provided, multiple submitters, no conflicts	3	38551022	GRCh38	9377	24416
NM_198056.2(SCN5A):c.5348C>G (p.Thr1783Ser)	SCN5A	not specified		Uncertain significance(Last reviewed: Jan 13, 2014)	criteria provided, single submitter	3	38551024	GRCh38	201535	196848
NM_198056.2(SCN5A):c.5302A>G (p.Ile1768Val)	SCN5A	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	3	38551070	GRCh38	67980	78872
NM_198056.2(SCN5A):c.5297T>A (p.Met1766Lys)	SCN5A	not provided		Pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	3	38551075	GRCh38	201534	196849
NM_198056.2(SCN5A):c.5287G>A (p.Val1763Met)	SCN5A	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	3	38551085	GRCh38	67974	78866
NM_198056.2(SCN5A):c.5231G>T (p.Ser1744Ile)	SCN5A	not provided		Likely pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	3	38551141	GRCh38	201533	196850
NM_198056.2(SCN5A):c.5227G>A (p.Gly1743Arg)	SCN5A	Brugada syndrome|not provided		Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	3	38551145	GRCh38	67967	78859
NM_198056.2(SCN5A):c.5185G>A (p.Asp1729Asn)	SCN5A	not provided	GO-ESP:0.00001(T)	Likely pathogenic(Last reviewed: May 17, 2014)	criteria provided, single submitter	3	38551187	GRCh38	201531	196852
NM_198056.2(SCN5A):c.5168C>A (p.Thr1723Asn)	SCN5A	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Dec 12, 2012)	criteria provided, single submitter	3	38551204	GRCh38	67961	78853
NM_198056.2(SCN5A):c.5144G>C (p.Gly1715Ala)	SCN5A	not specified		Uncertain significance(Last reviewed: Mar 6, 2013)	criteria provided, single submitter	3	38551228	GRCh38	201530	196853
NM_000335.4(SCN5A):c.5128delG (p.Ala1710Profs)	SCN5A	Heart block, nonprogressive		Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	3	38551241	GRCh38	9379	24418
NM_000335.4(SCN5A):c.5126C>T (p.Ser1709Leu)	SCN5A	Brugada syndrome 1|Paroxysmal familial ventricular fibrillation 1|not provided|Ventricular fibrillation|Cardiovascular phenotype	GO-ESP:0.00001(A)	Pathogenic/Likely pathogenic, not provided(Last reviewed: Oct 11, 2016)	criteria provided, multiple submitters, no conflicts	3	38551243	GRCh38	9383	24422
NM_001099404.1(SCN5A):c.5075T>C (p.Phe1692Ser)	SCN5A	Cardiac arrest		Uncertain significance(Last reviewed: May 27, 2015)	criteria provided, single submitter	3	38551297	GRCh38	222813	224265
NM_198056.2(SCN5A):c.5038G>A (p.Ala1680Thr)	SCN5A	Sudden cardiac death|Brugada syndrome|not specified	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 27, 2016)	criteria provided, conflicting interpretations	3	38551334	GRCh38	67952	78844
NM_198056.2(SCN5A):c.5027T>C (p.Met1676Thr)	SCN5A	not provided	GO-ESP:0.00001(G)	Likely pathogenic(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	3	38551345	GRCh38	201526	196857
NM_198056.2(SCN5A):c.4999G>C (p.Val1667Leu)	SCN5A	not provided		Pathogenic(Last reviewed: Nov 25, 2013)	criteria provided, single submitter	3	38551373	GRCh38	201524	196859
NM_198056.2(SCN5A):c.4981G>A (p.Gly1661Arg)	SCN5A	not specified		Uncertain significance(Last reviewed: Oct 14, 2015)	criteria provided, single submitter	3	38551391	GRCh38	201523	196860
NM_198056.2(SCN5A):c.4978A>G (p.Ile1660Val)	SCN5A	not provided|Congenital long QT syndrome	GO-ESP:0.00003(C)	Likely pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	3	38551394	GRCh38	67947	78839
NM_198056.2(SCN5A):c.4934C>T (p.Thr1645Met)	SCN5A	not provided|Congenital long QT syndrome	GO-ESP:0.00003(A)	Pathogenic(Last reviewed: Mar 14, 2014)	criteria provided, single submitter	3	38551438	GRCh38	67942	78834
NM_198056.2(SCN5A):c.4931G>A (p.Arg1644His)	SCN5A	Long QT syndrome 3|not provided|Congenital long QT syndrome|Cardiovascular phenotype		Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, multiple submitters, no conflicts	3	38551441	GRCh38	9369	24408
NM_000335.4(SCN5A):c.4892G>A (p.Arg1631His)	SCN5A	Cardiac conduction defect, nonspecific	GO-ESP:0.00001(T)	not provided	no assertion provided	3	38551477	GRCh38	67939	78831
NM_198056.2(SCN5A):c.4885C>T (p.Arg1629Ter)	SCN5A	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	3	38551487	GRCh38	264276	258311
NM_198056.2(SCN5A):c.4877G>A (p.Arg1626His)	SCN5A	not provided|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00007(T)	Likely pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, multiple submitters, no conflicts	3	38551495	GRCh38	67934	78826
NM_198056.2(SCN5A):c.4870G>A (p.Val1624Ile)	SCN5A	not specified		Uncertain significance(Last reviewed: Apr 24, 2013)	criteria provided, single submitter	3	38551502	GRCh38	201521	196863
NM_000335.4(SCN5A):c.4865G>A (p.Arg1622Gln)	SCN5A	Long QT syndrome 3|Long qt syndrome 3/6, digenic|Congenital long QT syndrome		Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	3	38551504	GRCh38	9376	24415
NM_198056.2(SCN5A):c.4867C>T (p.Arg1623Ter)	SCN5A	Sick sinus syndrome 1, autosomal recessive|not provided		Pathogenic(Last reviewed: Jul 31, 2016)	criteria provided, multiple submitters, no conflicts	3	38551505	GRCh38	9374	24413
NM_000335.4(SCN5A):c.4856C>A (p.Thr1619Lys)	SCN5A	Cardiac conduction defect, nonspecific		not provided	no assertion provided	3	38551513	GRCh38	67931	78824
NM_198056.2(SCN5A):c.4850_4852delTCT (p.Phe1617del)	SCN5A	Long QT syndrome 3|Long QT syndrome|not provided	GO-ESP:0.00001(-)	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, multiple submitters, no conflicts	3	38551520 - 38551522	GRCh38	201572	196864
NM_000335.4(SCN5A):c.4845C>T (p.Phe1615=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.05374(A), GMAF:0.05590(A), GO-ESP:0.01587(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38551524	GRCh38	48304	57467
NM_198056.2(SCN5A):c.4813G>C (p.Gly1605Arg)	SCN5A	not provided		Pathogenic(Last reviewed: Sep 2, 2011)	criteria provided, single submitter	3	38554279	GRCh38	201593	196865
NM_198056.2(SCN5A):c.4786T>A (p.Phe1596Ile)	SCN5A	Brugada syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Jun 9, 2016)	criteria provided, multiple submitters, no conflicts	3	38554306	GRCh38	67924	78817
NM_198056.2(SCN5A):c.4783G>A (p.Asp1595Asn)	SCN5A	Progressive familial heart block type 1A|not provided|Atrioventricular block		Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	3	38554309	GRCh38	9385	24424
NM_198056.2(SCN5A):c.4719C>T (p.Gly1573=)	SCN5A	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely pathogenic(Last reviewed: Nov 2, 2012)	criteria provided, single submitter	3	38554373	GRCh38	263423	258310
NM_000335.4(SCN5A):c.4591G>A (p.Val1531Ile)	SCN5A	Long QT syndrome|not specified|Congenital long QT syndrome	GO-ESP:0.00056(T), GMAF:0.00060(T), GO-ESP:0.00034(T)	Uncertain significance(Last reviewed: Sep 26, 2014)	criteria provided, single submitter	3	38554498	GRCh38	67912	78805
NM_000335.4(SCN5A):c.4531C>T (p.Arg1511Trp)	SCN5A	Brugada syndrome 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided	GO-ESP:0.00007(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	3	38555664	GRCh38	9380	24419
NM_198056.2(SCN5A):c.4519_4527delCAGAAGCCC (p.Gln1507_Pro1509del)	SCN5A	Long QT syndrome 3|not provided		Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	3	38555671 - 38555679	GRCh38	201571	196868
NM_198056.2(SCN5A):c.4509C>T (p.Ser1503=)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00308(A), GMAF:0.00120(A), GO-ESP:0.00315(A)	Benign/Likely benign(Last reviewed: Mar 21, 2016)	criteria provided, multiple submitters, no conflicts	3	38555689	GRCh38	36763	45424
NM_198056.2(SCN5A):c.4493T>C (p.Met1498Thr)	SCN5A	not provided|Congenital long QT syndrome		Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	3	38555705	GRCh38	67902	78795
NM_198056.2(SCN5A):c.4437+13C>T	SCN5A	Cardiac arrhythmia|Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00285(A), GMAF:0.00260(A), GO-ESP:0.00190(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	38556428	GRCh38	36762	45423
NM_198056.2(SCN5A):c.4423delC (p.Gln1475Asnfs)	SCN5A	Cardiovascular phenotype		Pathogenic(Last reviewed: May 15, 2015)	criteria provided, single submitter	3	38556455	GRCh38	264039	258316
NM_198056.2(SCN5A):c.4405A>T (p.Ile1469Phe)	SCN5A	not specified		Uncertain significance(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	3	38556473	GRCh38	201592	196875
NM_198056.2(SCN5A):c.4404C>T (p.Val1468=)	SCN5A	Cardiovascular phenotype	GO-ESP:0.00020(A)	Likely benign(Last reviewed: Mar 23, 2015)	criteria provided, single submitter	3	38556474	GRCh38	263970	258313
NM_198056.2(SCN5A):c.4403T>C (p.Val1468Ala)	SCN5A	not provided		Likely pathogenic(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	3	38556475	GRCh38	201514	196876
NM_198056.2(SCN5A):c.4396A>G (p.Ile1466Val)	SCN5A	not specified		Uncertain significance(Last reviewed: Nov 8, 2013)	criteria provided, single submitter	3	38556482	GRCh38	201512	196878
NM_198056.2(SCN5A):c.4373C>A (p.Ser1458Tyr)	SCN5A	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Oct 19, 2012)	criteria provided, single submitter	3	38556505	GRCh38	67887	78780
NM_198056.2(SCN5A):c.4346A>G (p.Tyr1449Cys)	SCN5A	Brugada syndrome|not provided		Likely pathogenic(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	3	38556532	GRCh38	67884	78777
NM_198056.2(SCN5A):c.4342A>C (p.Ile1448Leu)	SCN5A	Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Aug 19, 2015)	criteria provided, multiple submitters, no conflicts	3	38556536	GRCh38	67882	78775
NM_198056.2(SCN5A):c.4321G>C (p.Glu1441Gln)	SCN5A	Brugada syndrome|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	3	38556557	GRCh38	67881	78774
NM_000335.4(SCN5A):c.4259G>A (p.Trp1420Ter)	SCN5A	Brugada syndrome 1		Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	3	38557268	GRCh38	9403	24442
NM_198056.2(SCN5A):c.4245+1G>C	SCN5A	not provided		Likely pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	3	38560146	GRCh38	201508	196886
NM_198056.2(SCN5A):c.4229T>C (p.Leu1410Pro)	SCN5A	not specified		Uncertain significance(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	3	38560163	GRCh38	201507	196887
NM_198056.2(SCN5A):c.4222G>A (p.Gly1408Arg)	SCN5A	Brugada syndrome 1|Sick sinus syndrome 1, autosomal recessive|Cardiac conduction defect, nonspecific|Brugada syndrome|not provided		Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	3	38560170	GRCh38	9395	24434
NM_198056.2(SCN5A):c.4218G>A (p.Gly1406=)	SCN5A	Cardiomyopathy|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.01034(T), GMAF:0.00360(T), GO-ESP:0.00880(T)	Benign/Likely benign(Last reviewed: Mar 19, 2016)	criteria provided, multiple submitters, no conflicts	3	38560174	GRCh38	36761	45422
NM_198056.2(SCN5A):c.4212C>T (p.Asn1404=)	SCN5A	not specified|Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Nov 30, 2015)	criteria provided, multiple submitters, no conflicts	3	38560180	GRCh38	48303	57466
NM_000335.4(SCN5A):c.4187delA (p.Lys1396Argfs)	SCN5A	Brugada syndrome 1		Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	3	38560202	GRCh38	9373	24412
NM_198056.2(SCN5A):c.4109A>G (p.Asp1370Gly)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00007(C)	Uncertain significance(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	3	38560283	GRCh38	201506	196890
NM_198056.2(SCN5A):c.4018G>C (p.Val1340Leu)	SCN5A	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	3	38560374	GRCh38	264236	258312
NM_198056.2(SCN5A):c.4018G>A (p.Val1340Ile)	SCN5A	Brugada syndrome|not provided	GO-ESP:0.00005(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jul 16, 2015)	criteria provided, conflicting interpretations	3	38560374	GRCh38	67849	78742
NM_198056.2(SCN5A):c.3995delC (p.Pro1332Argfs)	SCN5A	Brugada syndrome		Pathogenic(Last reviewed: Oct 21, 2013)	criteria provided, single submitter	3	38560397	GRCh38	179338	173922
NM_198056.2(SCN5A):c.3976G>T (p.Ala1326Ser)	SCN5A	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Oct 2, 2014)	criteria provided, single submitter	3	38560416	GRCh38	67840	78733
NM_198056.2(SCN5A):c.3964-2_3964delAGG	SCN5A	not provided		Pathogenic(Last reviewed: Jul 16, 2012)	criteria provided, single submitter	3	38560428 - 38560430	GRCh38	201569	196895
NM_198056.2(SCN5A):c.3956G>T (p.Gly1319Val)	SCN5A	Brugada syndrome|Cardiovascular phenotype	GO-ESP:0.00008(A), GO-ESP:0.00001(A)	Likely pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, multiple submitters, no conflicts	3	38562422	GRCh38	67838	78731
NM_198056.2(SCN5A):c.3925C>T (p.Arg1309Cys)	SCN5A	not provided		Likely pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	3	38562453	GRCh38	265302	259763
NM_000335.4(SCN5A):c.3919C>T (p.Leu1307Phe)	SCN5A	not specified|not provided|Brugada syndrome, lidocaine-induced|Cardiovascular phenotype	GO-ESP:0.00134(A), GMAF:0.00240(A), GO-ESP:0.00055(A)	Benign/Likely benign, not provided(Last reviewed: Oct 20, 2015)	criteria provided, multiple submitters, no conflicts	3	38562456	GRCh38	67836	38448
NM_000335.4(SCN5A):c.3914G>A (p.Arg1305His)	SCN5A	Brugada syndrome|not provided	GO-ESP:0.00001(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 22, 2014)	criteria provided, conflicting interpretations	3	38562461	GRCh38	180516	178518
NM_198056.2(SCN5A):c.3873G>A (p.Leu1291=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(T), GO-ESP:0.00080(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	38562505	GRCh38	139061	142764
NM_198056.2(SCN5A):c.3840+5G>A	SCN5A	not specified		Uncertain significance(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	3	38566404	GRCh38	201587	196898
NM_000335.4(SCN5A):c.3832G>A (p.Val1278Ile)	SCN5A	Primary dilated cardiomyopathy|not specified|Dilated cardiomyopathy	GO-ESP:0.00008(T), GO-ESP:0.00017(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 16, 2016)	criteria provided, conflicting interpretations	3	38566414	GRCh38	67829	78723
NM_198056.2(SCN5A):c.3823G>T (p.Asp1275Tyr)	SCN5A	not provided		Pathogenic(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	3	38566426	GRCh38	201500	196899
NM_198056.2(SCN5A):c.3823G>A (p.Asp1275Asn)	SCN5A	Dilated cardiomyopathy 1E|Atrial fibrillation, familial, 10|Brugada syndrome|not provided|Atrial standstill 1, digenic		Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	3	38566426	GRCh38	9401	24440
NM_198056.2(SCN5A):c.3709G>A (p.Val1237Ile)	SCN5A	not specified		Uncertain significance(Last reviewed: Nov 28, 2011)	criteria provided, single submitter	3	38566540	GRCh38	201586	196900
NM_198056.2(SCN5A):c.3695G>A (p.Arg1232Gln)	SCN5A	Brugada syndrome|not provided	GO-ESP:0.00002(T)	Likely pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	3	38566554	GRCh38	67814	78708
NM_198056.2(SCN5A):c.[3694C>T;4859C>T]	SCN5A	Brugada syndrome 1	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	3|3	38566555	GRCh38	9371	24410|38446
NM_198056.2(SCN5A):c.3691G>A (p.Glu1231Lys)	SCN5A	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Nov 11, 2011)	criteria provided, single submitter	3	38566558	GRCh38	67812	78707
NM_198056.2(SCN5A):c.3629T>C (p.Phe1210Ser)	SCN5A	not provided		Likely pathogenic(Last reviewed: May 3, 2013)	criteria provided, single submitter	3	38575334	GRCh38	201498	196903
NM_198056.2(SCN5A):c.3622G>T (p.Glu1208Ter)	SCN5A	not provided		Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	3	38575341	GRCh38	280012	264166
NM_000335.4(SCN5A):c.3575G>A (p.Arg1192Gln)	SCN5A	Brugada syndrome 1|Primary familial hypertrophic cardiomyopathy|Long qt syndrome 3, acquired, susceptibility to|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00085(T), GMAF:0.01240(T), GO-ESP:0.00622(T)	Conflicting interpretations of pathogenicity, not provided, risk factor(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	38575385	GRCh38	9392	24431
NM_198056.2(SCN5A):c.3577C>T (p.Arg1193Trp)	SCN5A	Long QT syndrome 3|Brugada syndrome|not specified	GMAF:0.00040(A), GO-ESP:0.00010(A)	Uncertain significance(Last reviewed: Feb 1, 2016)	criteria provided, multiple submitters, no conflicts	3	38575386	GRCh38	201497	196904
NM_198056.2(SCN5A):c.3575G>A (p.Trp1192Ter)	SCN5A	not provided		Pathogenic(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	3	38575388	GRCh38	201585	196905
NM_198056.2(SCN5A):c.3491dupC (p.Glu1165Argfs)	SCN5A	not provided		Pathogenic(Last reviewed: Dec 21, 2012)	criteria provided, single submitter	3	38576681	GRCh38	201566	196910
NM_198056.2(SCN5A):c.3467A>G (p.Asp1156Gly)	SCN5A	not specified	GO-ESP:0.00004(C)	Uncertain significance(Last reviewed: Apr 16, 2014)	criteria provided, single submitter	3	38576705	GRCh38	201495	196911
NM_198056.2(SCN5A):c.3439A>G (p.Thr1147Ala)	SCN5A	not specified		Uncertain significance(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	3	38576733	GRCh38	201584	196912
NM_198056.2(SCN5A):c.3413A>C (p.Glu1138Ala)	SCN5A	not provided|Congenital long QT syndrome		Likely pathogenic(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	3	38576759	GRCh38	67796	78691
NM_198056.2(SCN5A):c.3404G>T (p.Ser1135Ile)	SCN5A	not provided	GO-ESP:0.00005(A)	Likely pathogenic(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	3	38576768	GRCh38	201494	196913
NM_198056.2(SCN5A):c.3394C>T (p.Pro1132Ser)	SCN5A	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	3	38576778	GRCh38	201493	196914
NM_198056.2(SCN5A):c.3392C>T (p.Thr1131Ile)	SCN5A	not specified|Atrial fibrillation	GO-ESP:0.00008(A), GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	3	38576780	GRCh38	67795	78690
NM_198056.2(SCN5A):c.3363G>A (p.Ala1121=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00428(T), GMAF:0.00620(T), GO-ESP:0.00287(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	38579361	GRCh38	48300	57463
NM_198056.2(SCN5A):c.3318C>T (p.Ala1106=)	SCN5A	Cardiovascular phenotype	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Jan 2, 2016)	criteria provided, single submitter	3	38579406	GRCh38	264627	258319
NM_198056.2(SCN5A):c.3308C>A (p.Ser1103Tyr)	SCN5A	Cardiac arrhythmia|SUDDEN INFANT DEATH SYNDROME|Long qt syndrome 3, acquired, susceptibility to|Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|not provided|Sick sinus syndrome|Progressive familial heart block|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02433(T), GMAF:0.02400(T), GO-ESP:0.00799(T)	Conflicting interpretations of pathogenicity, not provided, risk factor(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	38579416	GRCh38	9393	24432
NM_198056.2(SCN5A):c.3269C>T (p.Pro1090Leu)	SCN5A	Brugada syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(A), GMAF:0.00440(A), GO-ESP:0.00172(A)	Benign/Likely benign, not provided(Last reviewed: Feb 29, 2016)	criteria provided, multiple submitters, no conflicts	3	38579455	GRCh38	48298	57461
NM_198056.2(SCN5A):c.3235T>A (p.Ser1079Thr)	SCN5A	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jun 1, 2012)	criteria provided, single submitter	3	38579489	GRCh38	201491	196916
NM_198056.2(SCN5A):c.3206C>T (p.Thr1069Met)	SCN5A	not specified|Congenital long QT syndrome	GMAF:0.00020(A), GO-ESP:0.00012(A)	Uncertain significance(Last reviewed: Nov 3, 2015)	criteria provided, single submitter	3	38580953	GRCh38	67782	78677
NM_198056.2(SCN5A):c.3192G>A (p.Glu1064=)	SCN5A	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	3	38580967	GRCh38	264329	258318
NM_198056.2(SCN5A):c.3183A>G (p.Glu1061=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.88497(C), GMAF:0.07690(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38580976	GRCh38	48297	57460
NM_000335.4(SCN5A):c.3157G>A (p.Glu1053Lys)	SCN5A	Brugada syndrome 1|Atrial fibrillation, familial, 10|Congenital long QT syndrome	GO-ESP:0.00010(T)	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	3	38581002	GRCh38	9400	24439
NM_198056.2(SCN5A):c.3142_3153delCCCATCGCTGTGinsTCTGACTGTGT (p.Pro1048Serfs)	SCN5A	not provided		Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, single submitter	3	38581006 - 38581017	GRCh38	201564	196918
NM_000335.4(SCN5A):c.3112delAinsCCC (p.Thr1038Profs)	SCN5A	not provided		Pathogenic(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	3	38581047	GRCh38	201562	196920
NM_198056.2(SCN5A):c.3094G>A (p.Glu1032Lys)	SCN5A	not specified	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Dec 18, 2012)	criteria provided, single submitter	3	38581065	GRCh38	201490	196921
NM_198056.2(SCN5A):c.3068G>A (p.Arg1023His)	SCN5A	Brugada syndrome|not specified	GMAF:0.00020(T), GO-ESP:0.00036(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 15, 2016)	criteria provided, conflicting interpretations	3	38581091	GRCh38	67775	78670
NM_000335.4(SCN5A):c.3022C>T (p.Pro1008Ser)	SCN5A	Cardiac conduction defect, nonspecific		not provided	no assertion provided	3	38581137	GRCh38	67773	78668
NM_198056.2(SCN5A):c.2976C>T (p.Pro992=)	SCN5A	Cardiac arrhythmia	GO-ESP:0.00011(A)	Likely benign(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	3	38581183	GRCh38	36759	45420
NM_198056.2(SCN5A):c.2963G>A (p.Arg988Gln)	SCN5A	not specified	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	3	38581196	GRCh38	201551	196926
NM_198056.2(SCN5A):c.2962C>T (p.Arg988Trp)	SCN5A	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	3	38581197	GRCh38	201486	196927
NM_198056.2(SCN5A):c.2956C>T (p.Arg986Trp)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38581203	GRCh38	201485	196928
NM_000335.4(SCN5A):c.2944T>C (p.Cys982Arg)	SCN5A	Sudden cardiac death|not specified	GO-ESP:0.00041(G), GMAF:0.00020(G), GO-ESP:0.00009(G)	Uncertain significance(Last reviewed: Feb 15, 2016)	criteria provided, multiple submitters, no conflicts	3	38581215	GRCh38	67769	78664
NM_198056.2(SCN5A):c.2924G>A (p.Arg975Gln)	SCN5A	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Aug 29, 2014)	criteria provided, single submitter	3	38581235	GRCh38	201483	196929
NM_198056.2(SCN5A):c.2893C>T (p.Arg965Cys)	SCN5A	Brugada syndrome|not provided	GMAF:0.00020(A), GO-ESP:0.00007(A)	Likely pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, single submitter	3	38581266	GRCh38	67763	78658
NM_198056.2(SCN5A):c.2788-2A>G	SCN5A	not provided		Pathogenic(Last reviewed: Jul 10, 2013)	criteria provided, single submitter	3	38581373	GRCh38	201465	196933
NM_198056.2(SCN5A):c.2770G>A (p.Val924Ile)	SCN5A	Long QT syndrome 3|Brugada syndrome|not specified|not provided|Ventricular tachycardia|Ventricular tachycardia	GO-ESP:0.00014(T)	Uncertain significance(Last reviewed: Aug 24, 2015)	criteria provided, multiple submitters, no conflicts	3	38585708	GRCh38	48295	57458
NM_198056.2(SCN5A):c.2678G>T (p.Arg893Leu)	SCN5A	not provided		Pathogenic(Last reviewed: Jul 18, 2011)	criteria provided, single submitter	3	38585800	GRCh38	201582	196938
NM_198056.2(SCN5A):c.2632C>T (p.Arg878Cys)	SCN5A	Brugada syndrome|not provided		Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	3	38585846	GRCh38	67744	78639
NM_198056.2(SCN5A):c.2582_2583delTT (p.Phe861Trpfs)	SCN5A	Brugada syndrome|not provided		Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, multiple submitters, no conflicts	3	38585895 - 38585896	GRCh38	201561	196941
NM_198056.2(SCN5A):c.2550_2551dupGT (p.Phe851Cysfs)	SCN5A	Dilated cardiomyopathy 1E|not provided		Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	3	38585927 - 38585928	GRCh38	201560	196943
NM_198056.2(SCN5A):c.2527A>G (p.Thr843Ala)	SCN5A	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Sep 14, 2011)	criteria provided, single submitter	3	38585951	GRCh38	67739	78634
NM_198056.2(SCN5A):c.2441G>A (p.Arg814Gln)	SCN5A	Brugada syndrome|not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Feb 16, 2016)	criteria provided, multiple submitters, no conflicts	3	38586037	GRCh38	67732	78627
NM_198056.2(SCN5A):c.2440C>T (p.Arg814Trp)	SCN5A	Primary dilated cardiomyopathy|not provided|Dilated cardiomyopathy		Pathogenic/Likely pathogenic, not provided(Last reviewed: Feb 22, 2016)	criteria provided, multiple submitters, no conflicts	3	38586038	GRCh38	67731	78626
NM_198056.2(SCN5A):c.2437-5C>A	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(T), GO-ESP:0.00035(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	38586046	GRCh38	139054	142757
NM_198056.2(SCN5A):c.2343delG (p.Trp781Terfs)	SCN5A	not provided		Pathogenic(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	3	38587493	GRCh38	201556	196947
NM_198056.2(SCN5A):c.2291T>C (p.Met764Thr)	SCN5A	not provided		Pathogenic(Last reviewed: Nov 16, 2012)	criteria provided, single submitter	3	38587545	GRCh38	201472	196949
NM_198056.2(SCN5A):c.2254G>A (p.Gly752Arg)	SCN5A	Brugada syndrome|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic, not provided(Last reviewed: Jan 21, 2016)	criteria provided, multiple submitters, no conflicts	3	38597737	GRCh38	67723	78618
NM_198056.2(SCN5A):c.2209G>A (p.Glu737Lys)	SCN5A	not specified		Uncertain significance(Last reviewed: May 17, 2014)	criteria provided, single submitter	3	38597782	GRCh38	201471	196951
NM_198056.2(SCN5A):c.2184A>T (p.Val728=)	SCN5A	Cardiovascular phenotype		Likely benign(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	3	38597807	GRCh38	264393	258326
NM_198056.2(SCN5A):c.2177G>A (p.Cys726Tyr)	SCN5A	not specified		Uncertain significance(Last reviewed: Jan 7, 2013)	criteria provided, single submitter	3	38597814	GRCh38	201470	196952
NM_000335.4(SCN5A):c.2074C>A (p.Gln692Lys)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided	GO-ESP:0.00016(T), GMAF:0.00020(T), GO-ESP:0.00028(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Aug 8, 2016)	criteria provided, conflicting interpretations	3	38597917	GRCh38	67712	78607
NM_000335.4(SCN5A):c.2066G>A (p.Arg689His)	SCN5A	Long QT syndrome|not specified|not provided	GO-ESP:0.00008(T), GMAF:0.00020(T), GO-ESP:0.00012(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 13, 2016)	criteria provided, conflicting interpretations	3	38597925	GRCh38	67710	78605
NM_198056.2(SCN5A):c.2048G>C (p.Cys683Ser)	SCN5A	not specified		Uncertain significance(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	3	38597943	GRCh38	201469	196954
NM_198056.2(SCN5A):c.2014G>A (p.Ala672Thr)	SCN5A	not specified|not provided	GO-ESP:0.00008(T), GMAF:0.00180(T), GO-ESP:0.00089(T)	Uncertain significance(Last reviewed: May 21, 2014)	criteria provided, single submitter	3	38598927	GRCh38	67704	78599
NM_198056.2(SCN5A):c.2001C>T (p.Ser667=)	SCN5A	not specified|Cardiovascular phenotype	GO-ESP:0.00001(A)	Benign/Likely benign(Last reviewed: Aug 29, 2013)	criteria provided, multiple submitters, no conflicts	3	38598940	GRCh38	139053	142756
NM_198056.2(SCN5A):c.1967C>T (p.Pro656Leu)	SCN5A	not specified|not provided	GO-ESP:0.00116(A), GMAF:0.00300(A), GO-ESP:0.00039(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 5, 2015)	criteria provided, conflicting interpretations	3	38598974	GRCh38	48293	57456
NM_000335.4(SCN5A):c.1963G>A (p.Glu655Lys)	SCN5A	Atrial fibrillation, familial, 10|Atrial fibrillation		Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	3	38598978	GRCh38	30049	39004
NM_198056.2(SCN5A):c.1951G>C (p.Asp651His)	SCN5A	not provided		Uncertain significance(Last reviewed: Nov 7, 2011)	criteria provided, single submitter	3	38598990	GRCh38	201578	196959
NM_198056.2(SCN5A):c.1943C>T (p.Pro648Leu)	SCN5A	not specified|not provided|Congenital long QT syndrome	GO-ESP:0.00003(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 22, 2016)	criteria provided, conflicting interpretations	3	38598998	GRCh38	48292	57455
NM_198056.2(SCN5A):c.1939G>T (p.Ala647Ser)	SCN5A	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Apr 12, 2014)	criteria provided, single submitter	3	38599002	GRCh38	201466	196960
NM_198056.2(SCN5A):c.1936delC (p.Gln646Argfs)	SCN5A	Brugada syndrome|not provided		Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, multiple submitters, no conflicts	3	38599005	GRCh38	179829	173788
NM_198056.2(SCN5A):c.1902G>A (p.Ser634=)	SCN5A	Cardiovascular phenotype	GO-ESP:0.00004(T)	Likely benign(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	3	38599039	GRCh38	263971	258315
NM_198056.2(SCN5A):c.1889C>T (p.Thr630Met)	SCN5A	Brugada syndrome|not specified	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	3	38603713	GRCh38	201462	196963
NM_198056.2(SCN5A):c.1880C>T (p.Pro627Leu)	SCN5A	not specified|not provided	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 10, 2014)	criteria provided, conflicting interpretations	3	38603722	GRCh38	201577	196964
NM_198056.2(SCN5A):c.1820G>T (p.Gly607Val)	SCN5A	not specified|Cardiovascular phenotype	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Apr 1, 2016)	criteria provided, multiple submitters, no conflicts	3	38603782	GRCh38	201461	196967
NM_198056.2(SCN5A):c.1743G>A (p.Ser581=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GMAF:0.00560(T), GO-ESP:0.00140(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	38603859	GRCh38	139051	142754
NM_000335.4(SCN5A):c.1714_1715delGCinsTT (p.Ala572Phe)	SCN5A	Primary familial hypertrophic cardiomyopathy|Brugada syndrome|not specified		Uncertain significance(Last reviewed: Jun 20, 2016)	criteria provided, multiple submitters, no conflicts	3	38603887 - 38603888	GRCh38	180521	178522
NM_198056.2(SCN5A):c.1715C>A (p.Ala572Asp)	SCN5A	Paroxysmal familial ventricular fibrillation 1|Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|not provided|Congenital long QT syndrome|Sick sinus syndrome|Cardiac arrest|Left ventricular noncompaction cardiomyopathy|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00168(T), GMAF:0.00180(T), GO-ESP:0.00430(T)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38603887	GRCh38	67683	78578
NM_198056.2(SCN5A):c.1706G>A (p.Arg569Gln)	SCN5A	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	3	38603896	GRCh38	201459	196971
NM_198056.2(SCN5A):c.1705C>G (p.Arg569Gly)	SCN5A	not provided		Pathogenic(Last reviewed: Jan 19, 2012)	criteria provided, single submitter	3	38603897	GRCh38	201576	196972
NM_198056.2(SCN5A):c.1681C>T (p.Leu561=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00207(A), GMAF:0.00080(A), GO-ESP:0.00205(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	38603921	GRCh38	48290	57453
NM_198056.2(SCN5A):c.1673A>G (p.His558Arg)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|not provided|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.24628(C), GMAF:0.23040(C), GO-ESP:0.22174(C)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38603929	GRCh38	48289	38447
NM_198056.2(SCN5A):c.1654G>T (p.Gly552Trp)	SCN5A	not specified	GO-ESP:0.00008(A), GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	3	38603948	GRCh38	201458	196973
NM_001099404.1(SCN5A):c.1598G>A (p.Arg533His)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GMAF:0.00020(T), GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Jul 13, 2016)	criteria provided, multiple submitters, no conflicts	3	38604004	GRCh38	180512	178523
NM_198056.2(SCN5A):c.1595T>G (p.Phe532Cys)	SCN5A	Brugada syndrome|not provided	GO-ESP:0.00002(C)	Likely pathogenic(Last reviewed: Dec 6, 2012)	criteria provided, single submitter	3	38604007	GRCh38	67671	78566
NM_198056.2(SCN5A):c.1587T>C (p.Ile529=)	SCN5A	Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00600(G), GMAF:0.00200(G), GO-ESP:0.00657(G)	Benign(Last reviewed: Feb 23, 2016)	criteria provided, multiple submitters, no conflicts	3	38604015	GRCh38	48287	57451
NM_000335.4(SCN5A):c.1583_1584delGC (p.Ser528Asnfs)	SCN5A	not provided		Pathogenic(Last reviewed: Jul 24, 2012)	criteria provided, single submitter	3	38604018 - 38604019	GRCh38	201554	196975
NM_198056.2(SCN5A):c.1571C>A (p.Ser524Tyr)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.01139(T), GMAF:0.01140(T), GO-ESP:0.00512(T)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38604031	GRCh38	48286	57450
NM_198056.2(SCN5A):c.1567C>T (p.Arg523Cys)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Progressive familial heart block type 1A|Paroxysmal familial ventricular fibrillation 1|Dilated cardiomyopathy 1E|Atrial fibrillation, familial, 10|not specified|Congenital long QT syndrome		Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 28, 2016)	criteria provided, conflicting interpretations	3	38604035	GRCh38	67667	78562
NM_000335.4(SCN5A):c.1540G>T (p.Gly514Cys)	SCN5A	Cardiac conduction defect, nonprogressive|Cardiac conduction defect, nonspecific		Pathogenic(Last reviewed: Feb 22, 2001)	no assertion criteria provided	3	38604062	GRCh38	9386	24425
NM_198056.2(SCN5A):c.1537C>T (p.Arg513Cys)	SCN5A	not specified	GMAF:0.00040(A), GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Oct 11, 2013)	criteria provided, single submitter	3	38604065	GRCh38	201456	196976
NM_198056.2(SCN5A):c.1535C>T (p.Thr512Ile)	SCN5A	Brugada syndrome 1|Cardiac conduction defect, nonspecific|Brugada syndrome	GO-ESP:0.00002(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 27, 2016)	criteria provided, conflicting interpretations	3	38604067	GRCh38	67665	24437
NM_198056.2(SCN5A):c.[1535C>T;1673A>G]	SCN5A	Progressive familial heart block type 1A	GO-ESP:0.00002(A), GO-ESP:0.24628(C), GMAF:0.23040(C), GO-ESP:0.22174(C)	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	3|3	38604067	GRCh38	9398	24437|38447
NM_001099404.1(SCN5A):c.1441C>T (p.Arg481Trp)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00320(A), GMAF:0.00280(A), GO-ESP:0.00113(A)	Benign/Likely benign, not provided(Last reviewed: Jul 30, 2015)	criteria provided, multiple submitters, no conflicts	3	38604806	GRCh38	48284	57448
NM_198056.2(SCN5A):c.1428_1431delCAAG (p.Ser476Argfs)	SCN5A	not provided		Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	3	38604816 - 38604819	GRCh38	201553	196978
NM_000335.4(SCN5A):c.1410C>G (p.Asn470Lys)	SCN5A	Atrial fibrillation, familial, 10|Atrial fibrillation		Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	3	38604837	GRCh38	30047	39002
NM_198056.2(SCN5A):c.1399G>T (p.Ala467Ser)	SCN5A	not specified		Uncertain significance(Last reviewed: May 31, 2012)	criteria provided, single submitter	3	38604848	GRCh38	201454	196979
NM_198056.2(SCN5A):c.1398G>T (p.Leu466Phe)	SCN5A	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Jun 4, 2014)	criteria provided, single submitter	3	38604849	GRCh38	201453	196980
NM_198056.2(SCN5A):c.1385A>C (p.Glu462Ala)	SCN5A	not specified|not provided|Congenital long QT syndrome		Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 10, 2015)	criteria provided, conflicting interpretations	3	38604862	GRCh38	67661	78557
NM_198056.2(SCN5A):c.1381T>G (p.Leu461Val)	SCN5A	Sudden cardiac death|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00294(C), GMAF:0.00440(C), GO-ESP:0.00116(C)	Benign(Last reviewed: Sep 28, 2015)	criteria provided, multiple submitters, no conflicts	3	38604866	GRCh38	67659	78555
NM_198056.2(SCN5A):c.1338+2T>A	SCN5A	not provided|Cardiovascular phenotype		Pathogenic(Last reviewed: Aug 4, 2016)	criteria provided, multiple submitters, no conflicts	3	38605949	GRCh38	189324	187213
NM_198056.2(SCN5A):c.1335C>T (p.His445=)	SCN5A	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00020(A)	Likely benign(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	3	38605954	GRCh38	264144	258321
NM_000335.4(SCN5A):c.1333C>G (p.His445Asp)	SCN5A	Atrial fibrillation, familial, 10|Atrial fibrillation	GO-ESP:0.00005(C)	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	3	38605956	GRCh38	30046	39001
NM_198056.2(SCN5A):c.1302C>T (p.Phe434=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01407(A), GMAF:0.01100(A), GO-ESP:0.00403(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38605987	GRCh38	48282	57446
NM_000335.4(SCN5A):c.1282G>A (p.Glu428Lys)	SCN5A	Atrial fibrillation|Atrial fibrillation, familial, 10|not specified|Atrial fibrillation	GO-ESP:0.00005(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Sep 8, 2016)	criteria provided, conflicting interpretations	3	38606007	GRCh38	30048	39003
NM_198056.2(SCN5A):c.1273G>A (p.Ala425Thr)	SCN5A	not provided		Likely pathogenic(Last reviewed: Dec 12, 2013)	criteria provided, single submitter	3	38606016	GRCh38	201450	196984
NM_198056.2(SCN5A):c.1272C>T (p.Ile424=)	SCN5A	Cardiovascular phenotype	GO-ESP:0.00008(A)	Likely benign(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	3	38606017	GRCh38	75060	85951
NM_000335.4(SCN5A):c.1231G>A (p.Val411Met)	SCN5A	Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: May 23, 2016)	criteria provided, multiple submitters, no conflicts	3	38606058	GRCh38	67651	78547
NM_198056.2(SCN5A):c.1167C>A (p.Tyr389Ter)	SCN5A	not provided		Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	3	38606122	GRCh38	201448	196986
NM_198056.2(SCN5A):c.1141-3C>A	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.16642(T), GMAF:0.15120(T), GO-ESP:0.17223(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38606151	GRCh38	48280	57444
NM_198056.2(SCN5A):c.1134T>A (p.Tyr378Ter)	SCN5A	not provided		Pathogenic(Last reviewed: Feb 4, 2014)	criteria provided, single submitter	3	38606675	GRCh38	201447	196988
NM_198056.2(SCN5A):c.1127G>A (p.Arg376His)	SCN5A	Brugada syndrome|not provided	GO-ESP:0.00008(T)	Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, single submitter	3	38606682	GRCh38	67639	78535
NM_198056.2(SCN5A):c.1122G>A (p.Trp374Ter)	SCN5A	not provided		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	3	38606687	GRCh38	201575	196989
NM_198056.2(SCN5A):c.1100G>A (p.Arg367His)	SCN5A	Brugada syndrome 1|Brugada syndrome|not provided		Pathogenic(Last reviewed: May 1, 2014)	criteria provided, single submitter	3	38606709	GRCh38	9390	24429
NM_198056.2(SCN5A):c.1099C>T (p.Arg367Cys)	SCN5A	not provided|Congenital long QT syndrome	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: May 14, 2014)	criteria provided, single submitter	3	38606710	GRCh38	67633	78529
NM_198056.2(SCN5A):c.1080G>A (p.Trp360Ter)	SCN5A	not provided		Pathogenic(Last reviewed: Aug 4, 2013)	criteria provided, single submitter	3	38606729	GRCh38	201443	196990
NM_198056.2(SCN5A):c.1073T>C (p.Phe358Ser)	SCN5A	not specified		Uncertain significance(Last reviewed: Feb 25, 2011)	no assertion criteria provided	3	38606736	GRCh38	235057	236760
NM_198056.2(SCN5A):c.1066G>A (p.Asp356Asn)	SCN5A	Brugada syndrome|not provided		Likely pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	3	38606743	GRCh38	67632	78528
NM_198056.2(SCN5A):c.1035C>T (p.Gly345=)	SCN5A	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	3	38606774	GRCh38	264022	258322
NM_198056.2(SCN5A):c.1017C>T (p.Tyr339=)	SCN5A	not specified|Cardiovascular phenotype	GMAF:0.00480(A), GO-ESP:0.00098(A)	Benign/Likely benign(Last reviewed: Dec 3, 2012)	criteria provided, multiple submitters, no conflicts	3	38606792	GRCh38	227057	229059
NM_198056.2(SCN5A):c.998+5G>A	SCN5A	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00018(T)	Uncertain significance(Last reviewed: Oct 21, 2015)	criteria provided, multiple submitters, no conflicts	3	38608146	GRCh38	165158	173932
NM_198056.2(SCN5A):c.944T>C (p.Leu315Pro)	SCN5A	Brugada syndrome|not specified		Uncertain significance(Last reviewed: Oct 15, 2015)	criteria provided, multiple submitters, no conflicts	3	38608205	GRCh38	68058	78949
NM_198056.2(SCN5A):c.895T>A (p.Leu299Met)	SCN5A	Brugada syndrome|not provided|Cardiovascular phenotype	GO-ESP:0.00063(T), GMAF:0.00140(T), GO-ESP:0.00016(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Nov 24, 2015)	criteria provided, conflicting interpretations	3	38609773	GRCh38	68055	78946
NM_000335.4(SCN5A):c.892G>A (p.Gly298Ser)	SCN5A	Progressive familial heart block type 1A|not specified|Atrioventricular block	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Dec 29, 2014)	criteria provided, conflicting interpretations	3	38609776	GRCh38	9387	24426
NM_198056.2(SCN5A):c.871A>C (p.Asn291His)	SCN5A	Brugada syndrome|not specified|Torsades de pointes		Uncertain significance(Last reviewed: May 31, 2016)	criteria provided, multiple submitters, no conflicts	3	38609797	GRCh38	68051	78942
NM_198056.2(SCN5A):c.844C>T (p.Arg282Cys)	SCN5A	Brugada syndrome 1|Brugada syndrome|not provided		Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	3	38609824	GRCh38	68047	78938
NM_198056.2(SCN5A):c.820G>A (p.Gly274Ser)	SCN5A	Brugada syndrome|not specified		Uncertain significance(Last reviewed: May 25, 2016)	criteria provided, multiple submitters, no conflicts	3	38609848	GRCh38	201445	196994
NM_198056.2(SCN5A):c.787G>A (p.Val263Ile)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not provided|Sick sinus syndrome|Progressive familial heart block|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	38609881	GRCh38	201444	196995
NM_198056.2(SCN5A):c.717C>T (p.Ile239=)	SCN5A	Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00473(A), GMAF:0.00140(A), GO-ESP:0.00394(A)	Benign/Likely benign(Last reviewed: Feb 23, 2016)	criteria provided, multiple submitters, no conflicts	3	38609951	GRCh38	48316	57479
NM_198056.2(SCN5A):c.702A>C (p.Ser234=)	SCN5A	not provided		Pathogenic(Last reviewed: Dec 14, 2012)	criteria provided, single submitter	3	38613744	GRCh38	201442	196996
NM_000335.4(SCN5A):c.694G>A (p.Val232Ile)	SCN5A	Brugada syndrome|not specified|Brugada syndrome, lidocaine-induced|Cardiovascular phenotype	GO-ESP:0.00025(T), GMAF:0.00040(T), GO-ESP:0.00031(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	3	38613752	GRCh38	68037	24446
NM_198056.2(SCN5A):c.[694G>A;3922C>T]	SCN5A	Brugada syndrome 1	GO-ESP:0.00025(T), GMAF:0.00040(T), GO-ESP:0.00031(T), GO-ESP:0.00134(A), GMAF:0.00240(A), GO-ESP:0.00055(A)	Pathogenic(Last reviewed: Aug 15, 2008)	no assertion criteria provided	3|3	38613752	GRCh38	9407	24446|38448
NM_000335.4(SCN5A):c.689T>C (p.Ile230Thr)	SCN5A	Cardiac conduction defect, nonspecific		not provided	no assertion provided	3	38613757	GRCh38	68036	78928
NM_198056.2(SCN5A):c.681G>A (p.Leu227=)	SCN5A	Cardiovascular phenotype	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	3	38613765	GRCh38	264406	258328
NM_198056.2(SCN5A):c.680T>C (p.Leu227Pro)	SCN5A	Brugada syndrome|not specified|not provided	GO-ESP:0.00002(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	3	38613766	GRCh38	201441	196997
NM_000335.4(SCN5A):c.673C>T (p.Arg225Trp)	SCN5A	Cardiac conduction defect, nonspecific|not provided|Congenital long QT syndrome	GO-ESP:0.00008(A), GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 27, 2016)	criteria provided, conflicting interpretations	3	38613773	GRCh38	68032	78924
NM_198056.2(SCN5A):c.665G>A (p.Arg222Gln)	SCN5A	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1E|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, multiple submitters, no conflicts	3	38613781	GRCh38	39444	48043
NM_000335.4(SCN5A):c.659C>T (p.Thr220Ile)	SCN5A	Sick sinus syndrome 1, autosomal recessive|Dilated cardiomyopathy 1E|Brugada syndrome|not specified|Nodal rhythm|Cardiovascular phenotype	GO-ESP:0.00032(A), GMAF:0.00020(A), GO-ESP:0.00101(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Dec 28, 2015)	criteria provided, conflicting interpretations	3	38613787	GRCh38	9396	24435
NM_198056.2(SCN5A):c.647C>T (p.Ser216Leu)	SCN5A	Cardiomyopathy|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00096(A), GMAF:0.00080(A), GO-ESP:0.00100(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jul 26, 2016)	criteria provided, conflicting interpretations	3	38613799	GRCh38	36767	45428
NM_000335.4(SCN5A):c.635T>C (p.Leu212Pro)	SCN5A	Atrial standstill 1, digenic|Congenital long QT syndrome		Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	3	38613811	GRCh38	68030	78922
NM_198056.2(SCN5A):c.611C>A (p.Ala204Glu)	SCN5A	not provided		Likely pathogenic(Last reviewed: Dec 3, 2012)	criteria provided, single submitter	3	38620843	GRCh38	201436	197004
NM_198056.2(SCN5A):c.589G>T (p.Asp197Tyr)	SCN5A	not provided		Likely pathogenic(Last reviewed: Oct 23, 2013)	criteria provided, single submitter	3	38620865	GRCh38	201435	197005
NM_198056.2(SCN5A):c.559A>G (p.Thr187Ala)	SCN5A	Cardiac arrest		Uncertain significance(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	3	38620895	GRCh38	222801	224279
NM_198056.2(SCN5A):c.552C>G (p.His184Gln)	SCN5A	not provided		Uncertain significance(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	3	38620902	GRCh38	201434	197006
NM_198056.2(SCN5A):c.539G>T (p.Gly180Val)	SCN5A	not provided		Likely pathogenic(Last reviewed: Mar 25, 2013)	criteria provided, single submitter	3	38620915	GRCh38	201433	197007
NM_198056.2(SCN5A):c.359T>C (p.Ile120Thr)	SCN5A	not specified		Uncertain significance(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	3	38630344	GRCh38	201430	197010
NM_198056.2(SCN5A):c.354C>T (p.His118=)	SCN5A	Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00204(A), GMAF:0.00540(A), GO-ESP:0.00440(A)	Benign(Last reviewed: Dec 16, 2015)	criteria provided, multiple submitters, no conflicts	3	38630349	GRCh38	48301	57464
NM_198056.2(SCN5A):c.311G>A (p.Arg104Gln)	SCN5A	Brugada syndrome|not provided		Pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	3	38630392	GRCh38	67780	78675
NM_198056.2(SCN5A):c.283G>A (p.Val95Ile)	SCN5A	Brugada syndrome|not provided	GMAF:0.00020(T), GO-ESP:0.00003(T)	Likely pathogenic(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	3	38630420	GRCh38	67761	78656
NM_198056.2(SCN5A):c.255delC (p.Phe86Serfs)	SCN5A	Brugada syndrome		Likely pathogenic(Last reviewed: Jan 31, 2014)	criteria provided, single submitter	3	38633053	GRCh38	165160	173793
NM_198056.2(SCN5A):c.142G>A (p.Glu48Lys)	SCN5A	not specified|Congenital long QT syndrome	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 22, 2016)	criteria provided, single submitter	3	38633166	GRCh38	67663	78559
NM_198056.2(SCN5A):c.100C>T (p.Arg34Cys)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|not provided|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02963(A), GMAF:0.03710(A), GO-ESP:0.00946(A)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38633208	GRCh38	48279	57443
NM_198056.2(SCN5A):c.86_87invCA (p.Ala29Val)	SCN5A	Brugada syndrome|not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 15, 2016)	criteria provided, multiple submitters, no conflicts	3	38633221 - 38633222	GRCh38	242209	239213
NM_198056.2(SCN5A):c.87A>G (p.Ala29=)	SCN5A	Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|Sick sinus syndrome|Progressive familial heart block|Cardiovascular phenotype|Paroxysmal familial ventricular fibrillation|Dilated Cardiomyopathy, Dominant	GO-ESP:0.83596(C), GMAF:0.21830(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	38633221	GRCh38	48318	57481
NM_198056.2(SCN5A):c.86C>T (p.Ala29Val)	SCN5A	not specified	GMAF:0.00020(A), GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: May 4, 2012)	criteria provided, single submitter	3	38633222	GRCh38	201428	197014
NM_198056.2(SCN5A):c.80G>A (p.Arg27His)	SCN5A	Brugada syndrome|not specified|Congenital long QT syndrome|Death in infancy	GMAF:0.00040(T), GO-ESP:0.00023(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 24, 2016)	criteria provided, conflicting interpretations	3	38633228	GRCh38	68043	78934
NM_000258.2(MYL3):c.477G>A (p.Thr159=)	MYL3	Cardiovascular phenotype	GO-ESP:0.00004(T)	Likely benign(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	3	46859479	GRCh38	263711	258317
NM_000258.2(MYL3):c.461G>A (p.Arg154His)	MYL3	Familial hypertrophic cardiomyopathy 8|Familial hypertrophic cardiomyopathy 1|not specified|Cardiovascular phenotype	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Oct 15, 2015)	criteria provided, conflicting interpretations	3	46859495	GRCh38	14062	29101
NM_000258.2(MYL3):c.445A>G (p.Met149Val)	MYL3	Familial hypertrophic cardiomyopathy 8|not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, multiple submitters, no conflicts	3	46859511	GRCh38	14061	29100
NM_000258.2(MYL3):c.427G>A (p.Glu143Lys)	MYL3	Familial hypertrophic cardiomyopathy 8|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 31, 2016)	criteria provided, conflicting interpretations	3	46859529	GRCh38	14063	29102
NM_000258.2(MYL3):c.400G>A (p.Val134Met)	MYL3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	3	46859556	GRCh38	264162	258323
NM_000258.2(MYL3):c.286C>T (p.Leu96=)	MYL3	Cardiovascular phenotype	GO-ESP:0.00017(A)	Likely benign(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	3	46860697	GRCh38	264378	258325
NM_000258.2(MYL3):c.170C>G (p.Ala57Gly)	MYL3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GMAF:0.00020(T)	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, multiple submitters, no conflicts	3	46860813	GRCh38	31780	40440
NM_000258.2(MYL3):c.81T>C (p.Pro27=)	MYL3	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00146(G), GMAF:0.00140(G), GO-ESP:0.00037(G)	Benign/Likely benign(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	3	46863310	GRCh38	43130	52300
NM_000258.2(MYL3):c.69C>T (p.Pro23=)	MYL3	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.01668(A), GMAF:0.03710(A), GO-ESP:0.01835(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	46863322	GRCh38	43129	52299
NM_000387.5(SLC25A20):c.897dupC (p.Asn300Glnfs)	SLC25A20	Carnitine acylcarnitine translocase deficiency		Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	3	48857719	GRCh38	12132	27171
NM_000387.5(SLC25A20):c.713A>G (p.Gln238Arg)	SLC25A20	Carnitine acylcarnitine translocase deficiency|not provided		Pathogenic(Last reviewed: Dec 17, 2013)	criteria provided, single submitter	3	48859097	GRCh38	12138	27177
NM_000387.5(SLC25A20):c.199_326del128 (p.Gly67Leufs)	SLC25A20	Carnitine acylcarnitine translocase deficiency		Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	3	48883997 - 48884124	GRCh38	12133	27172
NM_002070.3(GNAI2):c.600T>A (p.Phe200Leu)	GNAI2	Ventricular tachycardia, somatic		Pathogenic(Last reviewed: Jun 15, 1998)	no assertion criteria provided	3	50256729	GRCh38	15906	30945
NG_008963.1:g.7894C>T	TNNC1	Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	52451148	GRCh38	346128	291189
NG_008963.1:g.7850A>C	TNNC1	Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.01480(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	52451192	GRCh38	346129	292148
NG_008963.1:g.7842G>A	TNNC1	Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	52451200	GRCh38	346130	295592
NM_003280.2(TNNC1):c.480G>A (p.Val160=)	TNNC1	not specified		Likely benign(Last reviewed: Jan 24, 2014)	criteria provided, single submitter	3	52451281	GRCh38	179485	173941
NM_003280.2(TNNC1):c.476G>A (p.Gly159Asp)	TNNC1	Dilated cardiomyopathy 1Z		Pathogenic(Last reviewed: Nov 16, 2004)	no assertion criteria provided	3	52451285	GRCh38	12441	27480
NM_003280.2(TNNC1):c.469A>C (p.Met157Leu)	TNNC1	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	3	52451292	GRCh38	181569	179069
NM_003280.2(TNNC1):c.469A>T (p.Met157Leu)	TNNC1	Primary dilated cardiomyopathy		Uncertain significance(Last reviewed: Sep 29, 2014)	no assertion criteria provided	3	52451292	GRCh38	180550	178531
NM_003280.2(TNNC1):c.456G>A (p.Glu152=)	TNNC1	Dilated cardiomyopathy 1Z|Familial hypertrophic cardiomyopathy 13	GMAF:0.00020(T), GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	3	52451305	GRCh38	239537	239288
NM_003280.2(TNNC1):c.455-14C>A	TNNC1	not specified		Benign(Last reviewed: Jul 5, 2011)	criteria provided, single submitter	3	52451320	GRCh38	137683	141386
NM_003280.2(TNNC1):c.454+6C>G	TNNC1	not specified		Uncertain significance(Last reviewed: May 18, 2015)	criteria provided, single submitter	3	52451385	GRCh38	229326	229104
NM_003280.2(TNNC1):c.446A>G (p.Asp149Gly)	TNNC1	not provided		Likely pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	3	52451399	GRCh38	181568	179070
NM_003280.2(TNNC1):c.445G>A (p.Asp149Asn)	TNNC1	not specified		Uncertain significance(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	3	52451400	GRCh38	44683	53850
NM_003280.2(TNNC1):c.442A>G (p.Ile148Val)	TNNC1	Primary dilated cardiomyopathy|not specified	GO-ESP:0.00001(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2013)	criteria provided, conflicting interpretations	3	52451403	GRCh38	44682	53849
NM_003280.2(TNNC1):c.435C>T (p.Asp145=)	TNNC1	not specified		Likely benign(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	3	52451410	GRCh38	228016	229105
NM_003280.2(TNNC1):c.435C>A (p.Asp145Glu)	TNNC1	Dilated cardiomyopathy 1Z|Familial hypertrophic cardiomyopathy 13|not specified|not provided	GO-ESP:0.00023(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2016)	criteria provided, conflicting interpretations	3	52451410	GRCh38	12445	27484
NM_003280.2(TNNC1):c.431A>G (p.Asn144Ser)	TNNC1	not specified	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Feb 7, 2013)	no assertion criteria provided	3	52451414	GRCh38	235061	236761
NM_003280.2(TNNC1):c.430A>G (p.Asn144Asp)	TNNC1	not specified		Uncertain significance(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	3	52451415	GRCh38	181567	179071
NM_003280.2(TNNC1):c.402G>T (p.Glu134Asp)	TNNC1	not specified		Uncertain significance(Last reviewed: Jan 21, 2013)	criteria provided, multiple submitters, no conflicts	3	52451443	GRCh38	44681	53848
NM_003280.2(TNNC1):c.394G>A (p.Asp132Asn)	TNNC1	not specified		Uncertain significance(Last reviewed: Jul 6, 2012)	criteria provided, single submitter	3	52451451	GRCh38	44680	53847
NM_003280.2(TNNC1):c.387G>C (p.Thr129=)	TNNC1	not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00020(G), GO-ESP:0.00024(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	52451458	GRCh38	44679	53846
NM_003280.2(TNNC1):c.376G>A (p.Glu126Lys)	TNNC1	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	3	52451469	GRCh38	181566	179072
NM_003280.2(TNNC1):c.336C>T (p.Ile112=)	TNNC1	Dilated cardiomyopathy 1Z|Familial hypertrophic cardiomyopathy 13	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	3	52451509	GRCh38	220797	221423
NM_003280.2(TNNC1):c.324T>C (p.Ala108=)	TNNC1	not specified	GO-ESP:0.00015(G), GO-ESP:0.00005(G)	Likely benign(Last reviewed: Mar 6, 2013)	criteria provided, single submitter	3	52451521	GRCh38	44678	53845
NM_003280.2(TNNC1):c.304C>T (p.Arg102Cys)	TNNC1	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	3	52451757	GRCh38	181565	179073
NM_003280.2(TNNC1):c.290T>A (p.Leu97Gln)	TNNC1	not provided		Likely pathogenic(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	3	52451771	GRCh38	181564	179074
NM_003280.2(TNNC1):c.262G>A (p.Asp88Asn)	TNNC1	not provided		Likely pathogenic(Last reviewed: Sep 11, 2013)	criteria provided, single submitter	3	52451799	GRCh38	181563	179075
NM_003280.2(TNNC1):c.251G>A (p.Cys84Tyr)	TNNC1	Familial hypertrophic cardiomyopathy 13		Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	3	52451810	GRCh38	12444	27483
NM_003280.2(TNNC1):c.242T>C (p.Met81Thr)	TNNC1	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	3	52451819	GRCh38	281574	265811
NM_003280.2(TNNC1):c.210C>T (p.Gly70=)	TNNC1	not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00015(A), GO-ESP:0.00007(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	52451851	GRCh38	44677	53844
NM_003280.2(TNNC1):c.203-5C>T	TNNC1	Dilated cardiomyopathy 1Z|Familial hypertrophic cardiomyopathy 13|not specified|Cardiovascular phenotype	GMAF:0.00160(A), GO-ESP:0.00046(A)	Benign/Likely benign(Last reviewed: Feb 23, 2016)	criteria provided, multiple submitters, no conflicts	3	52451863	GRCh38	165493	173801
NM_003280.2(TNNC1):c.203-10C>G	TNNC1	not specified		Uncertain significance(Last reviewed: Dec 31, 2014)	criteria provided, single submitter	3	52451868	GRCh38	179947	173942
NM_003280.2(TNNC1):c.201C>T (p.Asp67=)	TNNC1	Dilated cardiomyopathy 1Z|Familial hypertrophic cardiomyopathy 13|not specified	GMAF:0.00020(A), GO-ESP:0.00020(A)	Benign/Likely benign(Last reviewed: Feb 10, 2016)	criteria provided, multiple submitters, no conflicts	3	52452107	GRCh38	178145	173802
NM_003280.2(TNNC1):c.191T>C (p.Val64Ala)	TNNC1	not specified		Uncertain significance(Last reviewed: Mar 7, 2016)	criteria provided, single submitter	3	52452117	GRCh38	181562	179076
NM_003280.2(TNNC1):c.189G>T (p.Glu63Asp)	TNNC1	Dilated cardiomyopathy 1Z|Familial hypertrophic cardiomyopathy 13		Uncertain significance(Last reviewed: Nov 2, 2015)	criteria provided, single submitter	3	52452119	GRCh38	221030	221424
NM_003280.2(TNNC1):c.161C>A (p.Pro54His)	TNNC1	not specified		Uncertain significance(Last reviewed: May 23, 2013)	no assertion criteria provided	3	52452147	GRCh38	235060	236762
NM_003280.2(TNNC1):c.141G>T (p.Met47Ile)	TNNC1	not provided		Likely pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	3	52452167	GRCh38	265272	259776
NM_003280.2(TNNC1):c.108C>A (p.Ile36=)	TNNC1	not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00120(T), GO-ESP:0.00066(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	52452200	GRCh38	179034	173943
NM_003280.2(TNNC1):c.97G>A (p.Asp33Asn)	TNNC1	not specified		Uncertain significance(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	3	52452211	GRCh38	165497	173803
NM_003280.2(TNNC1):c.91G>A (p.Ala31Thr)	TNNC1	not provided		Pathogenic(Last reviewed: May 15, 2013)	criteria provided, single submitter	3	52452217	GRCh38	181561	179078
NM_003280.2(TNNC1):c.91G>T (p.Ala31Ser)	TNNC1	Familial hypertrophic cardiomyopathy 13		Pathogenic(Last reviewed: Sep 14, 2012)	no assertion criteria provided	3	52452217	GRCh38	39832	48431
NM_003280.2(TNNC1):c.86T>A (p.Leu29Gln)	TNNC1	Familial hypertrophic cardiomyopathy 13|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Mar 11, 2015)	criteria provided, conflicting interpretations	3	52452222	GRCh38	12442	27481
NM_003280.2(TNNC1):c.74_82delACATCTTCG (p.Asp25_Phe27del)	TNNC1	not specified		Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	3	52452226 - 52452234	GRCh38	165499	173944
NG_008963.1:g.6815C>T	TNNC1	Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	52452227	GRCh38	346131	291190
NM_003280.2(TNNC1):c.73G>A (p.Asp25Asn)	TNNC1	not specified		Uncertain significance(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	3	52452235	GRCh38	181571	179079
NM_003280.2(TNNC1):c.72C>T (p.Phe24=)	TNNC1	Dilated cardiomyopathy 1Z|Familial hypertrophic cardiomyopathy 13	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	3	52452236	GRCh38	239536	239289
NM_003280.2(TNNC1):c.56-8G>A	TNNC1	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	3	52452260	GRCh38	165498	173804
NM_003280.2(TNNC1):c.56-9T>C	TNNC1	not specified	GO-ESP:0.00003(G)	Likely benign(Last reviewed: Mar 12, 2014)	criteria provided, single submitter	3	52452261	GRCh38	165500	173945
NG_008963.1:g.6568C>A	TNNC1	Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	52452474	GRCh38	346132	292151
NM_003280.2(TNNC1):c.26T>G (p.Val9Gly)	TNNC1	not specified		Uncertain significance(Last reviewed: May 28, 2014)	criteria provided, single submitter	3	52452512	GRCh38	181560	179080
NM_003280.2(TNNC1):c.24+13G>T	TNNC1	not specified		Likely benign(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	3	52453979	GRCh38	228015	229106
NM_003280.2(TNNC1):c.24+1G>A	TNNC1	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Aug 11, 2013)	criteria provided, single submitter	3	52453991	GRCh38	165501	173805
NM_003280.2(TNNC1):c.23C>T (p.Ala8Val)	TNNC1	Familial hypertrophic cardiomyopathy 13|not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2015)	criteria provided, conflicting interpretations	3	52453993	GRCh38	12443	27482
NM_003280.2(TNNC1):c.8A>T (p.Asp3Val)	TNNC1	not provided		Likely pathogenic(Last reviewed: May 2, 2014)	criteria provided, single submitter	3	52454008	GRCh38	181570	179081
NM_003280.2(TNNC1):c.5A>G (p.Asp2Gly)	TNNC1	not specified		Uncertain significance(Last reviewed: Mar 9, 2012)	criteria provided, single submitter	3	52454011	GRCh38	44684	53851
NG_008963.1:g.5030G>A	TNNC1	Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	52454012	GRCh38	346133	295721
NM_007159.4(SLMAP):c.1918+1G>A	SLMAP	Cardiac arrest		Uncertain significance(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	3	57912702	GRCh38	222824	224285
NM_001278689.1(EOGT):c.1130G>A (p.Arg377Gln)	EOGT	Adams-Oliver syndrome 4	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	3	68987467	GRCh38	55818	70474
NM_032682.5(FOXP1):c.1702C>T (p.Pro568Ser)	FOXP1	Atrioventricular septal defect|Hypoplastic left heart syndrome|Pulmonary atresia with ventricular septal defect|Heterotaxy syndrome|not specified|Congenital atresia of aortic valve|Congenital atresia of mitral valve|Single Ventricle Defect|Intellectual Disability with Language Impairment and Autistic Features	GO-ESP:0.00208(A), GMAF:0.00080(A), GO-ESP:0.00043(A)	Benign/Likely benign, association(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	70970756	GRCh38	55847	70500
NM_000158.3(GBE1):c.708G>C (p.Gln236His)	GBE1	Glycogen storage disease IV, congenital neuromuscular	GO-ESP:0.00003(G)	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	3	81646466	GRCh38	2790	17829
NM_198196.2(CD96):c.839C>T (p.Thr280Met)	CD96	C syndrome	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	3	111585362	GRCh38	4640	19679
NM_053025.3(MYLK):c.4915G>C (p.Gly1639Arg)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00060(T)	Uncertain significance(Last reviewed: Oct 13, 2015)	criteria provided, single submitter	3	123638117	GRCh38	264399	258246
NM_053025.3(MYLK):c.4764G>A (p.Pro1588=)	MYLK	Aortic aneurysm, familial thoracic 7|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00340(T), GO-ESP:0.00442(T)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	3	123640360	GRCh38	196142	193303
NM_053025.3(MYLK):c.4645C>T (p.Arg1549Cys)	MYLK	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	3	123640479	GRCh38	264543	258245
NM_053025.3(MYLK):c.4620-4G>A	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00013(T)	Uncertain significance(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	3	123640508	GRCh38	264335	258256
NM_053025.3(MYLK):c.4520G>A (p.Arg1507Gln)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T)	Uncertain significance(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	3	123647323	GRCh38	264262	258244
NM_053025.3(MYLK):c.4349G>A (p.Arg1450Gln)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00520(T), GO-ESP:0.00133(T)	Benign(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	3	123649037	GRCh38	264291	258248
NM_053025.3(MYLK):c.4336G>A (p.Glu1446Lys)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00013(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	123649050	GRCh38	263899	258250
NM_053025.3(MYLK):c.4293G>A (p.Pro1431=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00008(T)	Likely benign(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	3	123649190	GRCh38	263960	258257
NM_053025.3(MYLK):c.4119A>G (p.Ser1373=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00017(C)	Likely benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	3	123657295	GRCh38	263932	258247
NM_053025.3(MYLK):c.4082G>A (p.Ser1361Asn)	MYLK	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 13, 2015)	criteria provided, single submitter	3	123657332	GRCh38	264396	258253
NM_053025.3(MYLK):c.4026C>T (p.Asp1342=)	MYLK	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Aug 30, 2015)	criteria provided, single submitter	3	123657388	GRCh38	264287	258252
NM_053025.3(MYLK):c.3969C>T (p.Val1323=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00060(A), GO-ESP:0.00003(A)	Likely benign(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	3	123664121	GRCh38	264126	258258
NM_053025.3(MYLK):c.3755G>A (p.Gly1252Glu)	MYLK	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	3	123666295	GRCh38	264105	258251
NM_053025.3(MYLK):c.3750C>T (p.Arg1250=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00024(A)	Likely benign(Last reviewed: May 13, 2015)	criteria provided, single submitter	3	123666300	GRCh38	264013	258255
NM_053025.3(MYLK):c.3681C>T (p.Ala1227=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00017(A)	Likely benign(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	3	123667159	GRCh38	264548	258254
NM_053025.3(MYLK):c.3611G>A (p.Arg1204Gln)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00009(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	123682265	GRCh38	263940	258259
NM_053025.3(MYLK):c.3253A>G (p.Thr1085Ala)	MYLK	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.06310(C), GO-ESP:0.01858(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	123700215	GRCh38	226761	228995
NM_053025.3(MYLK):c.3242A>G (p.His1081Arg)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00300(C), GO-ESP:0.00068(C)	Likely benign(Last reviewed: Dec 26, 2015)	criteria provided, single submitter	3	123700226	GRCh38	264565	258260
NM_053025.3(MYLK):c.3183C>T (p.Ser1061=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(A), GO-ESP:0.00017(A)	Likely benign(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	3	123700285	GRCh38	264198	258261
NM_053025.3(MYLK):c.3048T>C (p.Asn1016=)	MYLK	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Sep 7, 2015)	criteria provided, single submitter	3	123700420	GRCh38	264352	258263
NM_053025.3(MYLK):c.2799G>A (p.Val933=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00004(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	123700669	GRCh38	264305	258262
NM_053027.3(MYLK):c.2596G>A (p.Gly866Ser)	MYLK	Thoracic aortic aneurysm and aortic dissection|Disproportionate tall stature	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	3	123700872	GRCh38	155819	165571
NM_053025.3(MYLK):c.2533C>T (p.Arg845Cys)	MYLK	Aortic aneurysm, familial thoracic 6|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.04510(A), GO-ESP:0.02736(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	123700935	GRCh38	226038	227843
NM_053025.3(MYLK):c.2474C>T (p.Pro825Leu)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00013(A)	Uncertain significance(Last reviewed: Sep 7, 2015)	criteria provided, single submitter	3	123700994	GRCh38	264351	258264
NM_053025.3(MYLK):c.1991A>G (p.Gln664Arg)	MYLK	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(C), GO-ESP:0.00045(C)	Uncertain significance(Last reviewed: Aug 13, 2015)	criteria provided, multiple submitters, no conflicts	3	123708847	GRCh38	228937	228999
NM_053025.3(MYLK):c.1802A>C (p.His601Pro)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00011(G)	Uncertain significance(Last reviewed: May 11, 2015)	criteria provided, single submitter	3	123722130	GRCh38	264001	258265
NM_053025.3(MYLK):c.1496G>C (p.Ser499Thr)	MYLK	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 8, 2015)	criteria provided, single submitter	3	123732916	GRCh38	264553	258267
NM_053025.3(MYLK):c.1314C>T (p.Ser438=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(A), GO-ESP:0.00007(A)	Likely benign(Last reviewed: Sep 7, 2015)	criteria provided, single submitter	3	123733098	GRCh38	264383	258266
NM_053025.3(MYLK):c.1219G>T (p.Gly407Cys)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00009(A)	Uncertain significance(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	3	123733777	GRCh38	264402	258268
NM_053025.3(MYLK):c.1134T>C (p.Arg378=)	MYLK	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	3	123733862	GRCh38	264322	258269
NM_053025.3(MYLK):c.1133G>A (p.Arg378His)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00014(T)	Uncertain significance(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	3	123733863	GRCh38	264282	258270
NM_053025.3(MYLK):c.1110G>A (p.Glu370=)	MYLK	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Mar 27, 2015)	criteria provided, single submitter	3	123733886	GRCh38	263952	258271
NM_053025.3(MYLK):c.1075C>A (p.Pro359Thr)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	3	123733921	GRCh38	264267	258272
NM_053025.3(MYLK):c.1007C>T (p.Pro336Leu)	MYLK	Aortic aneurysm, familial thoracic 7|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00140(A), GO-ESP:0.00167(A)	Benign/Likely benign(Last reviewed: Feb 12, 2016)	criteria provided, multiple submitters, no conflicts	3	123733989	GRCh38	193752	190915
NM_053025.3(MYLK):c.999G>A (p.Pro333=)	MYLK	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(A), GO-ESP:0.00037(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	123733997	GRCh38	262298	250878
NM_053025.3(MYLK):c.993G>A (p.Thr331=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00018(T)	Likely benign(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	3	123734003	GRCh38	263916	258273
NM_053025.3(MYLK):c.652C>T (p.Leu218=)	MYLK	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00460(A), GO-ESP:0.00138(A)	Benign(Last reviewed: Feb 11, 2015)	criteria provided, multiple submitters, no conflicts	3	123737480	GRCh38	262295	250881
NM_053025.3(MYLK):c.639C>T (p.Asn213=)	MYLK	Thoracic aortic aneurysm and aortic dissection|not specified		Likely benign(Last reviewed: Sep 6, 2015)	criteria provided, multiple submitters, no conflicts	3	123737493	GRCh38	262294	250882
NM_053025.3(MYLK):c.619G>A (p.Val207Met)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	123737513	GRCh38	264468	258274
NM_053025.3(MYLK):c.479C>G (p.Pro160Arg)	MYLK	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00460(C), GO-ESP:0.00143(C)	Benign(Last reviewed: Feb 11, 2015)	criteria provided, multiple submitters, no conflicts	3	123739006	GRCh38	262287	250885
NM_053025.3(MYLK):c.455G>A (p.Arg152His)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00040(T)	Uncertain significance(Last reviewed: Aug 24, 2015)	criteria provided, single submitter	3	123739030	GRCh38	264312	258277
NM_053025.3(MYLK):c.435A>C (p.Ser145=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Likely benign(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	3	123739050	GRCh38	263951	258275
NM_053025.3(MYLK):c.399G>T (p.Gln133His)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00060(A), GO-ESP:0.00173(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	123739976	GRCh38	263911	258283
NM_053025.3(MYLK):c.382G>A (p.Ala128Thr)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00360(T), GO-ESP:0.00148(T)	Likely benign(Last reviewed: Aug 30, 2015)	criteria provided, single submitter	3	123739993	GRCh38	264342	258276
NM_053025.3(MYLK):c.333C>T (p.Gly111=)	MYLK	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	3	123752371	GRCh38	264012	258279
NM_053025.3(MYLK):c.257G>A (p.Arg86Gln)	MYLK	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	123752447	GRCh38	264174	258281
NM_053025.3(MYLK):c.24C>G (p.Ala8=)	MYLK	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00180(C), GO-ESP:0.00075(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	123793818	GRCh38	263976	258284
NM_014049.4(ACAD9):c.[1A>G];[796C>T]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	GO-ESP:0.00002(T)	Pathogenic(Last reviewed: Aug 30, 2015)	no assertion criteria provided	3|3	128879692	GRCh38	217744	214380|214383
NM_014049.4(ACAD9):c.[2T>G];[1015T>G]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of		Pathogenic(Last reviewed: Aug 25, 2015)	no assertion criteria provided	3|3	128879693	GRCh38	217738	214381|214384
NM_014049.4(ACAD9):c.[151-2A>G];[1298G>A]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	GO-ESP:0.00003(A)	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	3|3	128884651	GRCh38	217741	214382|214387
NM_014049.4(ACAD9):c.[976G>A];[1595G>A]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	GO-ESP:0.01522(A), GMAF:0.00780(A), GO-ESP:0.01823(A), GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Aug 26, 2015)	no assertion criteria provided	3|3	128904079	GRCh38	217740	139956|214390
NM_014049.4(ACAD9):c.[1237G>A];[1552C>T]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	GMAF:0.00020(A), GO-ESP:0.00003(A), GMAF:0.00020(T), GO-ESP:0.00011(T)	Pathogenic(Last reviewed: Aug 28, 2015)	no assertion criteria provided	3|3	128906208	GRCh38	217742	214386|214388
NM_014049.4(ACAD9):c.[1249C>T];[1030-1G>T]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	GO-ESP:0.00008(T), GO-ESP:0.00001(T), GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Aug 25, 2015)	no assertion criteria provided	3|3	128906220	GRCh38	217737	39837|214385
NM_014049.4(ACAD9):c.[1552C>T];[1564-6_1569del]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	GMAF:0.00020(T), GO-ESP:0.00011(T)	Pathogenic(Last reviewed: Aug 29, 2015)	no assertion criteria provided	3|3	128909410	GRCh38	217743	214388|214389
NM_014049.4(ACAD9):c.[359delT];[1594C>T]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	GO-ESP:0.00008(T), GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Aug 25, 2015)	no assertion criteria provided	3|3	128910051	GRCh38	217739	39841|213547
NM_153240.4(NPHP3):c.1729C>T (p.Arg577Ter)	NPHP3|NPHP3-ACAD11	Renal-hepatic-pancreatic dysplasia|Adolescent nephronophthisis|Meckel syndrome type 7|not provided		Pathogenic(Last reviewed: Sep 19, 2014)	criteria provided, single submitter	3	132700348	GRCh38	2636	17675
NM_003722.4(TP63):c.1010G>A (p.Arg337Gln)	TP63	ADULT syndrome		Pathogenic(Last reviewed: Jun 8, 2010)	no assertion criteria provided	3	189868597	GRCh38	6540	21579
NC_000003.11:g.(?_52086599)_(59689209_?)del	ALAS1|ARF4|CACNA1D|DNASE1L3|DUSP7|FLNB|ITIH1|ITIH3|ITIH4|PDHB|PRKCD|NEK4|TKT|TNNC1|WNT5A|SLMAP|ACOX2|BAP1|HESX1|RPP14|FAM107A|NISCH|TWF2|STAB1|FAM208A|POC1A|DNAH1|ERC2|APPL1|GNL3|SPCS1|ARHGEF3|SFMBT1|PHF7|TLR9|IL17RD|PXK|PBRM1|CHDH|IL17RB|CACNA2D3|DCP1A|GLT8D1|SEMA3G|ABHD6|LRTM1|SELENOK|NT5DC2|WDR82|RFT1|ACTR8|FAM3D|GLYCTK|PPM1M|ASB14|C3orf67|KCTD6|DNAH12|PDE12|DENND6A|CCDC66|SPATA12|TMEM110|MUSTN1|MIRLET7G|SMIM4|ESRG|TMEM110-MUSTN1	See cases		Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter			GRCh38	253632	248080
NM_002880.3(RAF1):c.(?_-26)-50_(1370_?)+72dup	RAF1	not specified		Uncertain significance(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	3	12590726 - 12618797	GRCh38	229174	228971
NC_000003.11:g.(?_73524387)_(73613399_?)del	PDZRN3	See cases		Uncertain significance(Last reviewed: Apr 7, 2015)	criteria provided, single submitter			GRCh38	202232	198673
GRCh38/hg38 3p21.2-14.3(chr3:51394434-55064449)x1	ACY1|ALAS1|CACNA1D|DUSP7|GRM2|ITIH1|ITIH3|ITIH4|PRKCD|RPL29|NEK4|TKT|TNNC1|BAP1|RRP9|DCAF1|PARP3|NISCH|TWF2|RAD54L2|STAB1|ABHD14A|POC1A|DNAH1|GNL3|SPCS1|RBM15B|TEX264|SFMBT1|PHF7|TLR9|PBRM1|CHDH|IL17RB|CACNA2D3|DCP1A|GLT8D1|SEMA3G|PCBP4|LRTM1|SELENOK|NT5DC2|WDR82|ABHD14B|RFT1|ACTR8|GPR62|IQCF1|GLYCTK|PPM1M|TMEM110|IQCF2|IQCF5|MUSTN1|IQCF3|MIRLET7G|MIR135A1|IQCF6|SMIM4|SNORD19|SNORD69|ESRG|SNORD19B|LINC00696|ABHD14A-ACY1|TMEM110-MUSTN1|ITIH4-AS1|GLYCTK-AS1|CACNA2D3-AS1|IQCF5-AS1|LOC101929054|MIR8064|SNORD136	See cases		Likely pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	3	51394434 - 55064449	GRCh38	155564	165318
GRCh38/hg38 3p21.31(chr3:49171381-49474635)x3	AMT|RHOA|DAG1|GPX1|TCTA|USP4|NICN1|KLHDC8B|CCDC36|C3orf62|C3orf84|MIR4271	See cases		Uncertain significance(Last reviewed: Jul 16, 2013)	no assertion criteria provided	3	49171381 - 49474635	GRCh38	155444	165198
GRCh38/hg38 3p21.31(chr3:48950685-49171381)x4	IMPDH2|LAMB2|QARS|ARIH2|USP19|WDR6|NDUFAF3|P4HTM|QRICH1|DALRD3|CCDC71|KLHDC8B|MIR191|MIR425|MIR6890	See cases		Uncertain significance(Last reviewed: Jul 16, 2013)	no assertion criteria provided	3	48950685 - 49171381	GRCh38	155443	165197
GRCh38/hg38 3p14.2(chr3:60855679-61139521)x1	FHIT	See cases		Uncertain significance(Last reviewed: Sep 21, 2012)	no assertion criteria provided	3	60855679 - 61139521	GRCh38	154804	164558
GRCh38/hg38 3p22.2(chr3:36935294-37058124)x3	MLH1|LRRFIP2|EPM2AIP1|TRANK1	See cases		Benign(Last reviewed: Oct 20, 2010)	no assertion criteria provided	3	36935294 - 37058124	GRCh38	154691	164445
GRCh38/hg38 3p26.3(chr3:1091885-1880834)x3	CNTN6	See cases		Uncertain significance(Last reviewed: Dec 22, 2010)	no assertion criteria provided	3	1091885 - 1880834	GRCh38	154613	164367
GRCh38/hg38 3p26.3(chr3:1780588-2221008)x3	CNTN4|CNTN4-AS2	See cases		Uncertain significance(Last reviewed: Jan 14, 2011)	no assertion criteria provided	3	1780588 - 2221008	GRCh38	154508	164262
GRCh38/hg38 3q23(chr3:139466635-140108900)x3	RBP1|RBP2|CLSTN2|NMNAT3|LOC100507291	See cases		Uncertain significance(Last reviewed: Mar 18, 2014)	no assertion criteria provided	3	139466635 - 140108900	GRCh38	154230	163981
GRCh38/hg38 3q29(chr3:196035777-197625573)x1	BDH1|DLG1|MELTF|PAK2|PCYT1A|TFRC|NCBP2|UBXN7|PIGX|PIGZ|CEP19|TM4SF19|ZDHHC19|NCBP2-AS2|RNF168|SLC51A|FBXO45|SENP5|TCTEX1D2|SMCO1|WDR53|NRROS|LINC00885|RNU6-42P|MFI2-AS1|DLG1-AS1|TM4SF19-TCTEX1D2|MIR4797|UBXN7-AS1|TM4SF19-AS1|LINC01063	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	3	196035777 - 197625573	GRCh38	59289	73884
GRCh38/hg38 3q25.32-26.31(chr3:158141556-172788324)x3	BCHE|ECT2|MECOM|GHSR|IL12A|KPNA4|MLF1|CLDN11|SERPINI1|SERPINI2|PLD1|PRKCI|RARRES1|SI|SKIL|SLC2A2|TERC|SEC62|B3GALNT1|TNFSF10|SMC4|PDCD10|SLITRK3|TNIK|GPR160|GOLIM4|SCHIP1|NMD3|RSRC1|MYNN|EIF5A2|LXN|NCEH1|IFT80|SLC7A14|MFSD1|FNDC3B|ZBBX|LRRC31|PHC3|ARL14|ACTRT3|GFM1|OTOL1|PPM1L|WDR49|LRRC34|SPTSSB|RPL22L1|TRIM59|LRRIQ4|SAMD7|TMEM212|C3orf80|MIR15B|MIR16-2|LINC01192|IQCJ|SCARNA7|MIR551B|MIR569|LINC01100|TRV-AAC1-1|LOC100287290|MIR1263|MIR3919|IQCJ-SCHIP1|LOC100507661|TMEM212-AS1|IQCJ-SCHIP1-AS1|LOC100996447|LOC101243545|IL12A-AS1|LOC101928583|MIR6828|LINC01322|LINC01327|LINC01324|LOC105374194|LOC105374205	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	3	158141556 - 172788324	GRCh38	57993	72588
GRCh38/hg38 3q24-29(chr3:147521892-198096565)x3	AADAC|ACTL6A|AGTR1|AHSG|APOD|BCHE|BCL6|BDH1|AP2M1|CLCN2|CP|CPA3|CPB1|CPN2|CRYGS|DGKG|DLG1|DVL3|ECT2|EHHADH|EIF4A2|EIF4G1|EPHB3|ETV5|MECOM|FGF12|GHSR|GP5|GYG1|HRG|HES1|IL1RAP|IL12A|KNG1|KPNA4|LPP|TM4SF1|MBNL1|MELTF|MLF1|MME|MUC4|NDUFB5|OPA1|CLDN11|P2RY1|PAK2|PCYT1A|PFN2|SERPINI1|SERPINI2|PIK3CA|PLD1|POLR2H|PPP1R2|PRKCI|MASP1|PSMD2|PTX3|RAP2B|RARRES1|RFC4|SNORA63|RPL35A|TRA2B|SHOX2|SI|SIAH2|ST6GAL1|SKIL|SLC2A2|HLTF|SOX2|SSR3|SST|TERC|TFRC|THPO|SEC62|TM4SF4|CLRN1|KCNAB1|FXR1|TP63|CHRD|B3GALNT1|TNFSF10|GMPS|EIF2B5|USP13|CLDN1|MAP3K13|SLC33A1|ADIPOQ|RUBCN|ECE2|TSC22D2|P2RY14|SMC4|ABCC5|TNK2|ALG3|KCNMB2|IGF2BP2|CLDN16|PDCD10|RNF13|SLITRK3|NLGN1|NCBP2|PLCH1|TNIK|MCF2L2|ATP11B|VPS8|ACAP2|WWTR1|TIPARP|UBXN7|ARHGEF26|GPR160|FETUB|LAMP3|KCNMB3|SERP1|GOLIM4|GPR171|SCHIP1|NMD3|COMMD2|ZNF639|RSRC1|PEX5L|SELENOT|DNAJB11|P2RY13|GPR87|DCUN1D1|KLHL24|PIGX|TBCCD1|P3H2|ABCF3|LSG1|PARL|MFN1|YEATS2|MYNN|EIF5A2|SUCNR1|MCCC1|LXN|CCNL1|HRASLS|MRPL47|NCEH1|IFT80|SLC7A14|SENP2|GNB4|RTP4|MAGEF1|ZMAT3|MFSD1|FNDC3B|P2RY12|ATP13A3|VEPH1|TBL1XR1|ZBBX|LRRC31|MAP6D1|PHC3|ARL14|PIGZ|SPATA16|EIF2A|B3GNT5|IQCG|ATP13A4|FYTTD1|HPS3|ACTRT3|MGC2889|LRCH3|CEP19|GFM1|LMLN|KLHL6|VWA5B2|TMEM41A|TMEM44|CAMK2N2|TM4SF19|TM4SF18|RPL39L|MED12L|DNAJC19|OTOL1|FAM131A|ZDHHC19|LRRC15|FAM43A|ERICH6|TMEM207|RTP1|TTC14|PPM1L|WDR49|LRRC34|MB21D2|XXYLT1|PQLC2L|C3orf79|CCDC50|PYDC2|NCBP2-AS2|SPTSSB|RNF168|DHX36|HTR3C|LIPH|HTR3D|RPL22L1|SLC51A|FBXO45|MUC20|SENP5|LOC253573|NAALADL2|TCTEX1D2|SMCO1|UTS2B|HTR3E|IGSF10|PABPC1P10|C3orf33|C3orf70|TPRG1|LOC285389|TRIM59|CCDC39|LINC00880|EHHADH-AS1|LPP-AS2|LRRIQ4|SAMD7|AADACL2|GPR149|RTP2|OSTN|ATP13A5|SOX2-OT|WDR53|NRROS|ANKUB1|LEKR1|TMEM212|MBNL1-AS1|C3orf80|FLJ46066|FLJ42393|LINC00884|LINC00885|MIR15B|MIR16-2|MIR28|LINC00969|SNORD2|SNORA4|TMEM14E|IGF2BP2-AS1|LOC646903|FAM188B2|LINC01192|GMNC|LOC647323|TMEM183B|IQCJ|SCARNA7|SNORA81|SNORD66|MIR551B|MIR569|MIR570|LINC00886|LINC01100|MIR922|MIR944|WWTR1-AS1|TNK2-AS1|LINC00887|LOC100131635|SNAR-I|MIR1224|TRV-AAC1-1|TIPARP-AS1|LOC100287290|MIR1248|MIR1263|RNU6-42P|MIR3137|LINC00881|MIR3919|IQCJ-SCHIP1|LINC01208|LINC00578|LOC100505609|LINC00888|LOC100505920|MELTF-AS1|DLG1-AS1|TMEM44-AS1|LOC100507391|LOC100507461|ARHGEF26-AS1|LOC100507537|LOC100507661|TM4SF19-TCTEX1D2|MIR4448|MIR4797|MIR4789|LINC00501|MIR5186|MIR5588|MIR548AQ|NAALADL2-AS3|LPP-AS1|OPA1-AS1|HLTF-AS1|LMLN-AS1|ABCC5-AS1|FGF12-AS1|FGF12-AS3|NLGN1-AS1|KLHL6-AS1|TPRG1-AS2|UBXN7-AS1|PLCH1-AS1|PLCH1-AS2|TPRG1-AS1|EIF2B5-AS1|KCNAB1-AS2|KCNAB1-AS1|TM4SF1-AS1|ADIPOQ-AS1|TM4SF19-AS1|ATP13A5-AS1|TMEM212-AS1|NAALADL2-AS2|NAALADL2-AS1|LINC01014|IQCJ-SCHIP1-AS1|XXYLT1-AS1|LOC100996447|LINC01206|LOC101243545|XXYLT1-AS2|LINC01213|LINC01214|ERICH6-AS1|LOC101928105|AADACL2-AS1|LOC101928166|LINC01487|IL12A-AS1|LOC101928583|LINC01209|LOC101928739|PEX5L-AS2|LOC101928882|LOC101928992|LOC101929106|LOC101929130|P3H2-AS1|ATP13A4-AS1|LOC101929337|LOC101929697|LINC01063|MIR6828|MIR7977|MIR6829|KCCAT211|LOC102724604|LOC102724699|LINCR-0002|LINC01322|LINC01327|LINC01324|KCNMB2-AS1|LOC105374177|LOC105374194|LOC105374205|LOC105374244|LOC105374250|LOC105374266|LOC105374297|LOC105374313|HTR3E-AS1|OSTN-AS1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	3	147521892 - 198096565	GRCh38	57983	72578
GRCh38/hg38 3q27.2-29(chr3:185485849-198110178)x1	AHSG|APOD|BCL6|BDH1|CPN2|CRYGS|DGKG|DLG1|EIF4A2|ETV5|FGF12|GP5|HRG|HES1|IL1RAP|KNG1|LPP|MELTF|MUC4|OPA1|PAK2|PCYT1A|PPP1R2|MASP1|RFC4|SNORA63|RPL35A|TRA2B|ST6GAL1|SST|TFRC|TP63|CLDN1|MAP3K13|ADIPOQ|RUBCN|TNK2|IGF2BP2|CLDN16|NCBP2|ACAP2|UBXN7|FETUB|DNAJB11|PIGX|TBCCD1|P3H2|LSG1|HRASLS|SENP2|RTP4|ATP13A3|PIGZ|IQCG|ATP13A4|FYTTD1|MGC2889|LRCH3|CEP19|LMLN|TMEM41A|TMEM44|TM4SF19|RPL39L|ZDHHC19|LRRC15|FAM43A|TMEM207|RTP1|MB21D2|XXYLT1|CCDC50|PYDC2|NCBP2-AS2|RNF168|LIPH|SLC51A|FBXO45|MUC20|SENP5|LOC253573|TCTEX1D2|SMCO1|UTS2B|TPRG1|LOC285389|LPP-AS2|RTP2|OSTN|ATP13A5|WDR53|NRROS|FLJ42393|LINC00884|LINC00885|MIR28|LINC00969|SNORD2|SNORA4|IGF2BP2-AS1|GMNC|LOC647323|SNORA81|MIR570|MIR922|MIR944|TNK2-AS1|LINC00887|LOC100131635|SNAR-I|MIR1248|RNU6-42P|MIR3137|LOC100505920|MELTF-AS1|DLG1-AS1|TMEM44-AS1|LOC100507391|TM4SF19-TCTEX1D2|MIR4797|MIR548AQ|LPP-AS1|OPA1-AS1|LMLN-AS1|FGF12-AS1|FGF12-AS3|TPRG1-AS2|UBXN7-AS1|TPRG1-AS1|ADIPOQ-AS1|TM4SF19-AS1|ATP13A5-AS1|XXYLT1-AS1|XXYLT1-AS2|LOC101929106|LOC101929130|P3H2-AS1|ATP13A4-AS1|LOC101929337|LOC101929697|LINC01063|MIR6829|LOC102724699|LINCR-0002|LOC105374266|LOC105374297|OSTN-AS1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	3	185485849 - 198110178	GRCh38	57868	72463
GRCh38/hg38 3q11.1-21.1(chr3:93886671-123216683)x1	ADPRH|ALCAM|ATP6V1A|CASR|CBLB|CD80|CD86|CD47|COL8A1|CPOX|CSTA|DRD3|GAP43|GOLGB1|GPR15|GSK3B|GTF2E1|HCLS1|HGD|KPNA1|LSAMP|CD200|NDUFB4|PROS1|RPL24|SLC15A2|UPK1B|ZNF80|B4GALT4|NR1I2|STXBP5L|GUCA1C|IQCB1|DZIP3|TOMM70|COX17|CD96|TFG|ST3GAL6|POLQ|PDIA5|HHLA2|FSTL1|FILIP1L|MYH15|NEPRO|ABI3BP|NECTIN3|ZBTB20|OR5K1|OR5H1|FAM162A|SEC22A|ZBTB11|MORC1|GTPBP8|TAGLN3|TRAT1|IMPG2|TIMMDC1|PLA1A|FBXO40|SEMA5B|WDR5B|PARP14|GRAMD1C|SIDT1|TRMT10C|SLC35A5|TMEM45A|IFT57|DPPA4|TMEM39A|ABHD10|TBC1D23|CFAP44|EAF2|CLDND1|NIT2|POGLUT1|BBX|PCNP|SENP7|ARHGAP31|CCDC191|KIAA1524|NSUN3|POPDC2|NFKBIZ|ATG3|OR5H6|OR5H2|ZBED2|CEP97|HSPBAP1|C3orf52|QTRT2|NAA50|OR5AC2|PARP9|ARL6|CMSS1|RETNLB|CCDC54|MINA|ADGRG7|DIRC2|MAATS1|PHLDB2|BOC|NXPE3|LRRC58|CCDC58|ZPLD1|CD200R1|CRYBG3|DCBLD2|DTX3L|LINC00635|DPPA2|CCDC80|BTLA|SPICE1|LOC152225|IGSF11|C3orf30|PARP15|GPR156|ARL13B|DHFR2|GABRR3|TIGIT|USF3|ZDHHC23|LINC00879|PLCXD2|GCSAM|TUSC7|LINC00636|EPHA6|RABL3|SLC9C1|ILDR1|DUBR|TMPRSS7|CD200R1L|LNP1|FLJ22763|LINC01205|OR5K2|OR5H14|OR5H15|OR5K3|OR5K4|MIR198|STX19|ARGFX|TMEM30CP|LINC00488|MIR567|MIR568|ZBTB11-AS1|LOC100129550|ZBTB20-AS1|LINC00882|MIR3921|PVRL3-AS1|LINC01279|LINC00901|IGSF11-AS1|MIR4445|MIR4796|MIR548AB|MIR4446|MIR4447|MIR5682|RNU6-26P|CFAP44-AS1|PLCXD2-AS1|ZBTB20-AS4|B4GALT4-AS1|ST3GAL6-AS1|ARHGAP31-AS1|LSAMP-AS1|LOC101926968|LOC101926983|HP09053|LOC101929411|LOC101929579|LOC101929607|LINC01215|LOC101929694|LOC101929717|LOC101929754|MIR7110|MIR8060|MIR8076|LOC102723582|ZBTB20-AS3|LOC105374060	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	3	93886671 - 123216683	GRCh38	57803	72398
GRCh38/hg38 3q22.1(chr3:132662034-133263499)x3	NPHP3|TMEM108|UBA5|NPHP3-AS1|NPHP3-ACAD11|TMEM108-AS1	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	3	132662034 - 133263499	GRCh38	57793	72388
GRCh38/hg38 3q21.3(chr3:128735053-128967179)x3	RAB7A|ACAD9|KIAA1257	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	3	128735053 - 128967179	GRCh38	57792	72387
GRCh38/hg38 3p21.31-14.3(chr3:49461000-55314500)x1	ACY1|ALAS1|APEH|CACNA1D|CISH|DAG1|DOCK3|DUSP7|GNAI2|GNAT1|GRM2|HYAL1|ITIH1|ITIH3|ITIH4|MST1|MST1R|PRKCD|RPL29|SEMA3F|NEK4|TKT|TNNC1|UBA7|IFRD2|MAPKAPK3|SEMA3B|MANF|BAP1|HYAL3|HYAL2|BSN|RRP9|CACNA2D2|DCAF1|IP6K1|PARP3|RBM6|RBM5|TRAIP|NPRL2|SLC38A3|CYB561D2|TMEM115|RASSF1|NISCH|TUSC2|TWF2|RAD54L2|STAB1|NAT6|ABHD14A|POC1A|DNAH1|GNL3|SPCS1|RBM15B|GMPPB|C3orf18|ZMYND10|TEX264|HEMK1|SFMBT1|PHF7|TLR9|PBRM1|CHDH|IL17RB|CACNA2D3|DCP1A|GLT8D1|SEMA3G|PCBP4|LRTM1|SELENOK|RNF123|NT5DC2|CAMKV|WDR82|MON1A|ABHD14B|RFT1|ACTR8|GPR62|IQCF1|GLYCTK|PPM1M|LSMEM2|TMEM110|AMIGO3|CDHR4|FAM212A|IQCF2|IQCF5|MUSTN1|IQCF3|MIRLET7G|MIR135A1|IQCF6|SMIM4|SNORD19|SNORD69|MIR566|ESRG|SNORD19B|LINC00696|SEMA3F-AS1|BSN-AS2|ABHD14A-ACY1|TMEM110-MUSTN1|MIR4787|RBM5-AS1|MIR5193|ITIH4-AS1|GLYCTK-AS1|CACNA2D3-AS1|SEMA3B-AS1|IQCF5-AS1|LOC101929054|RASSF1-AS1|MIR5787|MIR6872|MIR8064|SNORD136	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	3	49461000 - 55314500	GRCh38	57771	72366
GRCh38/hg38 3p25.3(chr3:9393349-9956171)x1	OGG1|BRPF1|CAMK1|ARPC4|TADA3|TTLL3|SETD5|CIDEC|MTMR14|CRELD1|JAGN1|IL17RC|IL17RE|CPNE9|RPUSD3|PRRT3|LHFPL4|THUMPD3-AS1|ARPC4-TTLL3|PRRT3-AS1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	3	9393349 - 9956171	GRCh38	57741	72336
NM_153717.2(EVC):c.1328G>A (p.Arg443Gln)	EVC	Chondroectodermal dysplasia|not specified|Ellis-van Creveld Syndrome	GO-ESP:0.07681(A), GMAF:0.07290(A), GO-ESP:0.02103(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	5753797	GRCh38	5342	20381
NM_001148.4(ANK2):c.-131714G>A	ANK2	Cardiac arrhythmia		Uncertain significance(Last reviewed: Apr 30, 2013)	criteria provided, single submitter	4	112918015	GRCh38	190536	188329
NM_001148.4(ANK2):c.130C>G (p.Leu44Val)	ANK2	Cardiovascular phenotype	GMAF:0.00040(G), GO-ESP:0.00014(G)	Uncertain significance(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	4	113174461	GRCh38	264251	258320
NM_001148.4(ANK2):c.261G>A (p.Gly87=)	ANK2	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00015(A)	Benign/Likely benign(Last reviewed: Jun 29, 2015)	criteria provided, multiple submitters, no conflicts	4	113196442	GRCh38	136381	140084
NM_001148.4(ANK2):c.297C>T (p.Thr99=)	ANK2	Cardiac arrhythmia	GO-ESP:0.00001(T)	Benign(Last reviewed: Jul 18, 2011)	criteria provided, single submitter	4	113199022	GRCh38	136382	140085
NM_001127493.1(ANK2):c.321+19C>T	ANK2	Cardiac arrhythmia	GO-ESP:0.02122(T), GMAF:0.02540(T), GO-ESP:0.03029(T)	Benign(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	4	113199128	GRCh38	35688	44353
NM_001148.4(ANK2):c.645C>T (p.Asp215=)	ANK2	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00002(T)	Likely benign(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	4	113237148	GRCh38	264493	258324
NM_001148.4(ANK2):c.962G>A (p.Arg321Gln)	ANK2	Long QT syndrome|not specified|not provided	GO-ESP:0.00065(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 4, 2016)	criteria provided, conflicting interpretations	4	113249834	GRCh38	190540	188336
NM_001148.4(ANK2):c.997C>T (p.Leu333=)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00018(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	113255741	GRCh38	264488	258327
NM_001148.4(ANK2):c.1118C>T (p.Ala373Val)	ANK2	not specified	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	4	113255862	GRCh38	190541	188337
NM_001148.4(ANK2):c.1173G>A (p.Pro391=)	ANK2	Cardiovascular phenotype	GO-ESP:0.00003(A)	Likely benign(Last reviewed: May 26, 2015)	criteria provided, single submitter	4	113255917	GRCh38	264074	258336
NM_001148.4(ANK2):c.1189-5C>T	ANK2	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Jan 18, 2016)	criteria provided, single submitter	4	113258045	GRCh38	234488	231638
NM_001148.4(ANK2):c.1245A>G (p.Glu415=)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00700(G), GO-ESP:0.00168(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113258106	GRCh38	238569	239301
NM_001148.4(ANK2):c.1554A>T (p.Gln518His)	ANK2	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: May 7, 2014)	criteria provided, single submitter	4	113274520	GRCh38	190547	188345
NM_001148.4(ANK2):c.1615C>T (p.Arg539Trp)	ANK2	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: May 14, 2015)	criteria provided, single submitter	4	113274581	GRCh38	190549	188347
NM_001148.4(ANK2):c.1899A>G (p.Leu633=)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00007(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	113282692	GRCh38	136384	140087
NM_001148.4(ANK2):c.1995A>G (p.Pro665=)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00680(G), GO-ESP:0.00166(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113282788	GRCh38	264372	258329
NM_001148.4(ANK2):c.2060A>G (p.Asn687Ser)	ANK2	not specified	GO-ESP:0.00007(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2015)	criteria provided, conflicting interpretations	4	113282853	GRCh38	190594	188353
NM_001148.4(ANK2):c.2063T>A (p.Ile688Asn)	ANK2	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Oct 3, 2015)	criteria provided, single submitter	4	113282856	GRCh38	264395	258331
NM_001148.4(ANK2):c.2110C>G (p.Gln704Glu)	ANK2	not provided|Cardiovascular phenotype	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Dec 19, 2015)	criteria provided, multiple submitters, no conflicts	4	113287635	GRCh38	191399	189222
NM_001148.4(ANK2):c.2127T>C (p.Asn709=)	ANK2	Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00007(C)	Likely benign(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	4	113287652	GRCh38	264571	258332
NM_001148.4(ANK2):c.2337C>T (p.Val779=)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.02160(T), GO-ESP:0.03634(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113292475	GRCh38	263475	258338
NM_001148.4(ANK2):c.2424C>T (p.Ser808=)	ANK2	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00008(T)	Likely benign(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	4	113293487	GRCh38	264458	258333
NM_001148.4(ANK2):c.2712C>T (p.Ser904=)	ANK2	Cardiovascular phenotype	GO-ESP:0.00007(T)	Likely benign(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	4	113317725	GRCh38	264572	258335
NM_001148.4(ANK2):c.2713G>A (p.Asp905Asn)	ANK2	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	4	113317726	GRCh38	190596	188362
NM_001148.4(ANK2):c.2807T>C (p.Leu936Pro)	ANK2	not specified		Uncertain significance(Last reviewed: Dec 8, 2014)	criteria provided, single submitter	4	113318527	GRCh38	190597	188364
NM_001148.4(ANK2):c.2825G>C (p.Arg942Thr)	ANK2	not specified		Uncertain significance(Last reviewed: Jul 8, 2014)	criteria provided, single submitter	4	113318545	GRCh38	190556	188366
NM_001148.4(ANK2):c.2987G>A (p.Arg996Gln)	ANK2	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	4	113330332	GRCh38	234979	236763
NM_001148.4(ANK2):c.3067G>A (p.Gly1023Arg)	ANK2	Long QT syndrome|not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113330412	GRCh38	190561	188374
NM_001148.4(ANK2):c.3085C>T (p.Arg1029Cys)	ANK2	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	4	113330430	GRCh38	190564	188377
NM_001148.4(ANK2):c.3136C>T (p.Leu1046=)	ANK2	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00011(T)	Likely benign(Last reviewed: Jan 4, 2013)	criteria provided, single submitter	4	113331982	GRCh38	263473	258337
NM_001148.4(ANK2):c.3255G>T (p.Ala1085=)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00113(T)	Benign/Likely benign(Last reviewed: Aug 14, 2015)	criteria provided, multiple submitters, no conflicts	4	113333084	GRCh38	219766	221429
NM_001127493.1(ANK2):c.3483A>G (p.Val1161=)	ANK2	Cardiac arrhythmia|Long QT syndrome	GO-ESP:0.03391(G), GMAF:0.03340(G), GO-ESP:0.00968(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113335976	GRCh38	35686	44351
NM_001148.4(ANK2):c.3579C>T (p.Arg1193=)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.26040(T), GO-ESP:0.14599(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113336045	GRCh38	136390	140093
NM_001127493.1(ANK2):c.3769+18G>A	ANK2	Cardiac arrhythmia	GO-ESP:0.02760(A), GMAF:0.02800(A), GO-ESP:0.00717(A)	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	4	113336799	GRCh38	35687	44352
NM_001148.4(ANK2):c.3979A>G (p.Met1327Val)	ANK2	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Mar 29, 2014)	criteria provided, single submitter	4	113341773	GRCh38	190569	188386
NM_001148.4(ANK2):c.4310C>T (p.Thr1437Met)	ANK2	not provided|Cardiovascular phenotype	GO-ESP:0.00012(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 4, 2014)	criteria provided, conflicting interpretations	4	113345961	GRCh38	190571	188388
NM_001148.4(ANK2):c.4315G>T (p.Gly1439Cys)	ANK2	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00031(T), GMAF:0.00020(T), GO-ESP:0.00029(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	113345966	GRCh38	67606	78502
NM_001148.4(ANK2):c.4373A>G (p.Glu1458Gly)	ANK2	Cardiac arrhythmia, ankyrin B-related|Long QT syndrome 4|Long QT syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00015(G), GMAF:0.00100(G), GO-ESP:0.00042(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Nov 9, 2015)	criteria provided, conflicting interpretations	4	113348277	GRCh38	18056	33095
NM_001148.4(ANK2):c.4456G>C (p.Val1486Leu)	ANK2	Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00015(C)	Uncertain significance(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	4	113353074	GRCh38	263709	258339
NM_001148.4(ANK2):c.4745G>A (p.Arg1582Gln)	ANK2	Long QT syndrome|not provided|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00064(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	113353363	GRCh38	191535	189229
NM_001148.4(ANK2):c.4835C>T (p.Thr1612Ile)	ANK2	Cardiac arrhythmia|not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jul 10, 2015)	criteria provided, multiple submitters, no conflicts	4	113353453	GRCh38	190572	188391
NM_001148.4(ANK2):c.4883A>G (p.Lys1628Arg)	ANK2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	4	113353501	GRCh38	263741	258334
NM_001148.4(ANK2):c.5017A>G (p.Arg1673Gly)	ANK2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Apr 11, 2013)	criteria provided, single submitter	4	113353635	GRCh38	263620	258348
NM_001148.4(ANK2):c.5231C>A (p.Ala1744Asp)	ANK2	Cardiovascular phenotype	GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	4	113353849	GRCh38	264303	258340
NM_001148.4(ANK2):c.5240C>G (p.Pro1747Arg)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00025(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113353858	GRCh38	263614	258341
NM_001148.4(ANK2):c.5313G>A (p.Lys1771=)	ANK2	Cardiovascular phenotype	GO-ESP:0.00007(A)	Likely benign(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	4	113353931	GRCh38	264575	258343
NM_001148.4(ANK2):c.5469C>T (p.Pro1823=)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.03890(T), GO-ESP:0.07960(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113354087	GRCh38	257580	251312
NM_001148.4(ANK2):c.5509G>A (p.Ala1837Thr)	ANK2	Cardiac arrest	GO-ESP:0.00020(A)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	4	113354127	GRCh38	222498	224288
NM_001148.4(ANK2):c.5607G>A (p.Ala1869=)	ANK2	Long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00012(A)	Likely benign(Last reviewed: Sep 4, 2015)	criteria provided, multiple submitters, no conflicts	4	113354225	GRCh38	219513	221430
NM_001127493.1(ANK2):c.4399+4084G>A	ANK2	Cardiac arrhythmia|Long QT syndrome	GMAF:0.00600(A), GO-ESP:0.00304(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113354333	GRCh38	35689	44354
NM_001148.4(ANK2):c.5754C>T (p.Pro1918=)	ANK2	Cardiovascular phenotype		Likely benign(Last reviewed: Oct 7, 2015)	criteria provided, single submitter	4	113354372	GRCh38	264392	258349
NM_001148.4(ANK2):c.5985G>A (p.Lys1995=)	ANK2	Cardiovascular phenotype	GMAF:0.00140(A), GO-ESP:0.00024(A)	Likely benign(Last reviewed: May 27, 2013)	criteria provided, single submitter	4	113354603	GRCh38	263628	258342
NM_001148.4(ANK2):c.6168C>G (p.Leu2056=)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.11880(G), GO-ESP:0.04917(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113354786	GRCh38	257581	251313
NM_001148.4(ANK2):c.6206G>A (p.Arg2069His)	ANK2	Long QT syndrome|Cardiac arrest|Cardiovascular phenotype	GMAF:0.00100(A), GO-ESP:0.00086(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2016)	criteria provided, conflicting interpretations	4	113354824	GRCh38	180270	178534
NM_001148.4(ANK2):c.6398C>T (p.Ser2133Phe)	ANK2	Cardiac arrhythmia, ankyrin B-related		Uncertain significance(Last reviewed: Apr 1, 2016)	criteria provided, single submitter	4	113355016	GRCh38	242915	244014
NM_001148.4(ANK2):c.6629T>G (p.Val2210Gly)	ANK2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 11, 2013)	criteria provided, single submitter	4	113355247	GRCh38	263680	258344
NM_001148.4(ANK2):c.6648C>G (p.Gly2216=)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00140(G), GO-ESP:0.00229(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	113355266	GRCh38	238585	239317
NM_001148.4(ANK2):c.6906C>T (p.Thr2302=)	ANK2	Cardiovascular phenotype	GMAF:0.00120(T), GO-ESP:0.00041(T)	Likely benign(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	4	113355524	GRCh38	263766	258345
NM_001148.4(ANK2):c.6912T>C (p.Thr2304=)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00051(C)	Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	4	113355530	GRCh38	238586	239318
NM_001148.4(ANK2):c.7106T>C (p.Val2369Ala)	ANK2	Cardiac arrhythmia|Long QT syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.13986(C), GMAF:0.09210(C), GO-ESP:0.09797(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113355724	GRCh38	35690	44355
NM_001148.4(ANK2):c.7110A>G (p.Gln2370=)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.28490(G), GO-ESP:0.19022(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113355728	GRCh38	257582	251314
NM_001148.4(ANK2):c.7117A>G (p.Thr2373Ala)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00140(G), GO-ESP:0.00048(G)	Benign(Last reviewed: Feb 24, 2016)	criteria provided, multiple submitters, no conflicts	4	113355735	GRCh38	238588	239320
NM_001148.4(ANK2):c.7245C>T (p.Ser2415=)	ANK2	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	4	113355863	GRCh38	264281	258351
NM_001148.4(ANK2):c.7458C>G (p.His2486Gln)	ANK2	Cardiac arrest	GO-ESP:0.00006(G)	Uncertain significance(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	4	113356076	GRCh38	222502	224292
NM_001148.4(ANK2):c.7577C>T (p.Ser2526Leu)	ANK2	Cardiac arrest	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	4	113356195	GRCh38	222503	224293
NM_001148.4(ANK2):c.7685C>T (p.Pro2562Leu)	ANK2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	4	113356303	GRCh38	264526	258346
NM_001148.4(ANK2):c.7834A>G (p.Lys2612Glu)	ANK2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	4	113356452	GRCh38	263654	258350
NM_001148.4(ANK2):c.7902G>A (p.Val2634=)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00131(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	113356520	GRCh38	215488	212344
NM_001127493.1(ANK2):c.4400-4039G>A	ANK2	Cardiac arrhythmia	GO-ESP:0.00003(A)	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	4	113356784	GRCh38	35691	44356
NM_001148.4(ANK2):c.8354C>T (p.Ser2785Leu)	ANK2	Long QT syndrome|not provided|Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00187(T)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2015)	criteria provided, conflicting interpretations	4	113356972	GRCh38	191540	189244
NM_001148.4(ANK2):c.8503C>T (p.Pro2835Ser)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.18790(T), GO-ESP:0.09004(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113357121	GRCh38	191560	189247
NM_001148.4(ANK2):c.8658A>G (p.Leu2886=)	ANK2	Cardiovascular phenotype	GMAF:0.00100(G), GO-ESP:0.00040(G)	Likely benign(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	4	113357276	GRCh38	263767	258347
NM_001148.4(ANK2):c.8727C>T (p.Pro2909=)	ANK2	Cardiovascular phenotype	GO-ESP:0.00011(T)	Likely benign(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	4	113357345	GRCh38	264511	258352
NM_001148.4(ANK2):c.8892C>G (p.Ile2964Met)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00014(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113357510	GRCh38	264239	258353
NM_001148.4(ANK2):c.9173G>A (p.Arg3058His)	ANK2	Sudden cardiac death	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Aug 26, 2014)	no assertion criteria provided	4	113357791	GRCh38	180273	178537
NM_001148.4(ANK2):c.9427C>G (p.Leu3143Val)	ANK2	not specified|Cardiovascular phenotype	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Nov 13, 2013)	criteria provided, single submitter	4	113358045	GRCh38	234980	236764
NM_001148.4(ANK2):c.9438T>C (p.Asp3146=)	ANK2	Cardiovascular phenotype	GO-ESP:0.00002(C)	Likely benign(Last reviewed: Jan 22, 2013)	criteria provided, single submitter	4	113358056	GRCh38	263514	258357
NM_001148.4(ANK2):c.9526G>T (p.Asp3176Tyr)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00018(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113358144	GRCh38	234981	236765
NM_001148.4(ANK2):c.9598C>T (p.Leu3200Phe)	ANK2	Long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00020(T)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2015)	criteria provided, conflicting interpretations	4	113358216	GRCh38	238596	239327
NM_001148.4(ANK2):c.9648A>G (p.Glu3216=)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.09210(G), GO-ESP:0.09821(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113358266	GRCh38	257583	251315
NM_001148.4(ANK2):c.9704C>T (p.Pro3235Leu)	ANK2	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	4	113358322	GRCh38	263786	258354
NM_001148.4(ANK2):c.9825T>G (p.Asp3275Glu)	ANK2	Cardiovascular phenotype	GO-ESP:0.00036(G)	Uncertain significance(Last reviewed: May 27, 2013)	criteria provided, single submitter	4	113358443	GRCh38	263634	258355
NM_001148.4(ANK2):c.9854T>C (p.Ile3285Thr)	ANK2	Cardiac arrhythmia|Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.00400(C), GO-ESP:0.00823(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113358472	GRCh38	190528	188392
NM_001148.4(ANK2):c.9900C>A (p.Ser3300Arg)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.01000(A), GO-ESP:0.01883(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113358518	GRCh38	191563	189251
NM_001148.4(ANK2):c.9968G>A (p.Ser3323Asn)	ANK2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Mar 11, 2013)	criteria provided, single submitter	4	113358586	GRCh38	263533	258356
NM_001148.4(ANK2):c.10243A>G (p.Thr3415Ala)	ANK2	Congenital long QT syndrome		Uncertain significance	criteria provided, single submitter	4	113358861	GRCh38	219174	217191
NM_001148.4(ANK2):c.10310T>C (p.Ile3437Thr)	ANK2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	4	113358928	GRCh38	264478	258358
NM_001148.4(ANK2):c.10395G>A (p.Glu3465=)	ANK2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00181(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	113359013	GRCh38	220622	221432
NM_001148.4(ANK2):c.10693G>A (p.Glu3565Lys)	ANK2	not specified		Uncertain significance(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	4	113360834	GRCh38	190573	188393
NM_001148.4(ANK2):c.10702C>T (p.Arg3568Trp)	ANK2	not specified	GMAF:0.00040(T), GO-ESP:0.00017(T)	Uncertain significance(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	4	113360843	GRCh38	190574	188394
NM_001148.4(ANK2):c.10805G>A (p.Arg3602Gln)	ANK2	Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	4	113363386	GRCh38	264145	258359
NM_001148.4(ANK2):c.10825C>T (p.Leu3609Phe)	ANK2	not specified		Uncertain significance(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	4	113363406	GRCh38	190606	188397
NM_001148.4(ANK2):c.10889-17T>A	ANK2	Cardiac arrhythmia	GO-ESP:0.00005(A)	Benign(Last reviewed: Jul 15, 2011)	criteria provided, single submitter	4	113365022	GRCh38	190530	188398
NM_001148.4(ANK2):c.10901T>A (p.Val3634Asp)	ANK2	Cardiac arrhythmia|Long QT syndrome|not specified|Arrhythmia	GO-ESP:0.00238(A), GMAF:0.00200(A), GO-ESP:0.00274(A)	Benign/Likely benign, not provided(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	4	113365051	GRCh38	67599	78495
NM_001127493.1(ANK2):c.4764delT (p.Gln1589Lysfs)	ANK2	Cardiac arrhythmia, ankyrin B-related		Uncertain significance(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	4	113367579	GRCh38	235896	237531
NM_001148.4(ANK2):c.11218C>A (p.Leu3740Ile)	ANK2	Cardiac arrhythmia|Cardiac arrhythmia, ankyrin B-related|Long QT syndrome|not provided|Cardiovascular phenotype	GO-ESP:0.01261(A), GMAF:0.01000(A), GO-ESP:0.00326(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	113367751	GRCh38	18058	33097
NM_001148.4(ANK2):c.11230A>C (p.Thr3744Pro)	ANK2	not specified	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Apr 3, 2014)	criteria provided, single submitter	4	113367763	GRCh38	190579	188404
NM_001148.4(ANK2):c.11231C>A (p.Thr3744Asn)	ANK2	Cardiac arrhythmia|Cardiac arrhythmia, ankyrin B-related|Long QT syndrome|not specified|Arrhythmia	GO-ESP:0.00085(A), GO-ESP:0.00062(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 31, 2016)	criteria provided, conflicting interpretations	4	113367764	GRCh38	18057	33096
NM_001148.4(ANK2):c.11354A>G (p.Gln3785Arg)	ANK2	not specified|Cardiovascular phenotype	GO-ESP:0.00005(G)	Uncertain significance(Last reviewed: Aug 9, 2016)	criteria provided, multiple submitters, no conflicts	4	113369549	GRCh38	190580	188405
NM_001148.4(ANK2):c.11453G>A (p.Ser3818Asn)	ANK2	not specified		Uncertain significance(Last reviewed: May 9, 2014)	criteria provided, single submitter	4	113369648	GRCh38	190581	188406
NM_001148.4(ANK2):c.11465G>C (p.Gly3822Ala)	ANK2	Cardiac arrhythmia	GMAF:0.00160(C), GO-ESP:0.00066(C)	Likely benign(Last reviewed: Oct 10, 2012)	criteria provided, single submitter	4	113369660	GRCh38	190532	188407
NM_001148.4(ANK2):c.11509G>C (p.Glu3837Gln)	ANK2	Cardiac arrhythmia		Uncertain significance(Last reviewed: Jan 24, 2014)	criteria provided, single submitter	4	113369704	GRCh38	190584	188411
NM_001148.4(ANK2):c.11538C>T (p.Leu3846=)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00039(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	113369733	GRCh38	197480	194641
NM_001148.4(ANK2):c.11548G>A (p.Glu3850Lys)	ANK2	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Oct 3, 2014)	criteria provided, single submitter	4	113369743	GRCh38	190608	188413
NM_001148.4(ANK2):c.11587G>A (p.Asp3863Asn)	ANK2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	4	113369782	GRCh38	264094	258360
NM_001148.4(ANK2):c.11594A>G (p.Asp3865Gly)	ANK2	not specified|not provided	GO-ESP:0.00004(G)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2014)	criteria provided, conflicting interpretations	4	113369789	GRCh38	190610	188416
NM_001148.4(ANK2):c.11650G>A (p.Glu3884Lys)	ANK2	not specified	GMAF:0.00020(A), GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	4	113373129	GRCh38	190587	188418
NM_001148.4(ANK2):c.11673T>C (p.His3891=)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.31330(C), GO-ESP:0.19738(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113373152	GRCh38	136397	140100
NM_001148.4(ANK2):c.11683G>C (p.Val3895Leu)	ANK2	Cardiac arrhythmia	GMAF:0.00040(A)	Uncertain significance(Last reviewed: Jun 24, 2013)	criteria provided, single submitter	4	113373162	GRCh38	191416	189253
NM_001148.4(ANK2):c.11683G>A (p.Val3895Met)	ANK2	not specified|Arrhythmia	GMAF:0.00040(A), GO-ESP:0.00034(A)	Uncertain significance(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	4	113373162	GRCh38	67603	78499
NM_001148.4(ANK2):c.11716C>T (p.Arg3906Trp)	ANK2	Cardiac arrhythmia|Long QT syndrome 4|not specified|Arrhythmia|Death in infancy	GO-ESP:0.00123(T), GMAF:0.00060(T), GO-ESP:0.00112(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Aug 8, 2016)	criteria provided, conflicting interpretations	4	113373306	GRCh38	18059	33098
NM_001148.4(ANK2):c.11790C>T (p.Ile3930=)	ANK2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.01180(T), GO-ESP:0.00424(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	113373380	GRCh38	136398	140101
NM_001148.4(ANK2):c.11791G>A (p.Glu3931Lys)	ANK2	Cardiac arrhythmia|Cardiac arrhythmia, ankyrin B-related|Long QT syndrome|not specified|Arrhythmia	GO-ESP:0.00308(A), GMAF:0.00080(A), GO-ESP:0.00267(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 1, 2016)	criteria provided, conflicting interpretations	4	113373381	GRCh38	18060	33099
NM_016599.4(MYOZ2):c.29A>C (p.Gln10Pro)	MYOZ2	not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00015(C), GMAF:0.00660(C), GO-ESP:0.00270(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	119136554	GRCh38	45780	54945
NM_016599.4(MYOZ2):c.142T>C (p.Ser48Pro)	MYOZ2	Familial hypertrophic cardiomyopathy 16|not provided		Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	4	119150937	GRCh38	30508	39465
NM_016599.4(MYOZ2):c.237A>G (p.Ala79=)	MYOZ2	not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00961(G), GMAF:0.00380(G), GO-ESP:0.00992(G)	Benign(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	4	119151032	GRCh38	31788	40448
NM_016599.4(MYOZ2):c.302C>A (p.Ser101Ter)	MYOZ2	not specified|not provided	GMAF:0.00020(T)	Uncertain significance(Last reviewed: Apr 15, 2014)	criteria provided, multiple submitters, no conflicts	4	119158077	GRCh38	191742	189781
NM_016599.4(MYOZ2):c.360A>G (p.Pro120=)	MYOZ2	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00015(G), GMAF:0.00680(G), GO-ESP:0.00267(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	119158135	GRCh38	45782	54947
NM_016599.4(MYOZ2):c.459A>G (p.Glu153=)	MYOZ2	not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.07312(G), GMAF:0.08390(G), GO-ESP:0.04434(G)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	119164293	GRCh38	31786	40446
NM_016599.4(MYOZ2):c.488T>C (p.Leu163Ser)	MYOZ2	not specified|Cardiovascular phenotype	GO-ESP:0.00085(C), GMAF:0.00040(C), GO-ESP:0.00015(C)	Uncertain significance(Last reviewed: Jul 8, 2016)	criteria provided, multiple submitters, no conflicts	4	119164322	GRCh38	45784	54949
NM_016599.4(MYOZ2):c.738A>G (p.Ile246Met)	MYOZ2	Familial hypertrophic cardiomyopathy 16|not specified|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00023(G), GMAF:0.00080(G), GO-ESP:0.00190(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	4	119186143	GRCh38	30509	39466
NM_016599.4(MYOZ2):c.750C>T (p.Thr250=)	MYOZ2	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00838(T), GMAF:0.00880(T), GO-ESP:0.00254(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	119186155	GRCh38	45787	54952
NM_000508.4(FGA):c.1634A>T (p.Glu545Val)	FGA	Familial visceral amyloidosis, Ostertag type		Pathogenic(Last reviewed: Dec 25, 2008)	no assertion criteria provided	4	154585795	GRCh38	16410	31449
NM_000128.3(F11):c.1378T>G (p.Phe460Val)	F11	Hereditary factor XI deficiency disease	GO-ESP:0.00001(G)	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	4	186285711	GRCh38	11895	26934
GRCh38/hg38 4q21.21(chr4:79621254-79898438)x1	PCAT4	See cases		Uncertain significance(Last reviewed: Jul 1, 2013)	no assertion criteria provided	4	79621254 - 79898438	GRCh38	155427	165181
GRCh38/hg38 4q33-35.2(chr4:170899124-190036318)x1	AGA|SLC25A4|CASP3|DCTD|F11|ACSL1|FAT1|FRG1|GPM6A|HMGB2|HPGD|ING2|IRF2|KLKB1|MTNR1A|TLR3|VEGFC|GLRA3|SORBS2|SAP30|HAND2|MORF4|ADAM29|SCRG1|FAM149A|FBXO8|PDLIM3|GALNT7|CLDN22|NEIL3|UFSP2|CDKN2AIP|TENM3|LRP2BP|STOX2|CFAP97|SPCS3|TRAPPC11|CENPU|HAND2-AS1|WWC2|CEP44|SNX25|LOC90768|WDR17|ZFP42|SPATA4|ENPP6|ASB5|WWC2-AS2|RWDD4|PRIMPOL|TRIML2|CCDC110|CYP4V2|F11-AS1|LINC01098|LOC339975|TRIML1|ANKRD37|LOC389247|HELT|LINC01060|LOC441052|C4orf47|GALNTL6|FRG2|FLJ38576|LINC00290|LOC728175|MIR3945HG|CLDN24|DUX4L9|MIR1305|MIR548T|MIR4276|MIR3945|LOC100506122|LINC01093|LOC100506272|MIR4455|LOC101928314|LOC101928509|LOC101928551|LOC101928590|LINC01099|WWC2-AS1|LINC01262|LOC101930370|MIR6082|LOC102723766|LVCAT8|LOC105377590|LINC01596	See cases		Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	4	170899124 - 190036318	GRCh38	155165	164919
GRCh38/hg38 4q32.3-33(chr4:167469096-170889588)x3	CLCN3|NEK1|MFAP3L|ANXA10|PALLD|AADAT|HPF1|DDX60|SH3RF1|CBR4|DDX60L|LOC100506085|LOC100506107|LINC01612	See cases		Uncertain significance(Last reviewed: Mar 4, 2013)	no assertion criteria provided	4	167469096 - 170889588	GRCh38	155164	164918
GRCh38/hg38 4q34.3(chr4:180608484-181096608)x1	LINC00290	See cases		Uncertain significance(Last reviewed: Dec 10, 2012)	no assertion criteria provided	4	180608484 - 181096608	GRCh38	154873	164627
GRCh38/hg38 4q22.2(chr4:93343337-93541770)x3	GRID2	See cases		Uncertain significance(Last reviewed: Dec 22, 2010)	no assertion criteria provided	4	93343337 - 93541770	GRCh38	154589	164343
GRCh38/hg38 4p16.3(chr4:72428-146077)x3	ZNF595|ZNF718	See cases		Benign(Last reviewed: Jun 30, 2010)	no assertion criteria provided	4	72428 - 146077	GRCh38	154349	164103
GRCh38/hg38 4q25(chr4:110818535-111610698)x1	MIR297	See cases		Uncertain significance(Last reviewed: May 27, 2010)	no assertion criteria provided	4	110818535 - 111610698	GRCh38	144212	153963
GRCh38/hg38 4p16.1-15.33(chr4:10746202-11703880)x1	HS3ST1|MIR572	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	4	10746202 - 11703880	GRCh38	60165	74760
GRCh38/hg38 4q34.1-35.2(chr4:172356988-189975519)x1	AGA|SLC25A4|CASP3|DCTD|F11|ACSL1|FAT1|FRG1|GPM6A|HMGB2|HPGD|ING2|IRF2|KLKB1|MTNR1A|TLR3|VEGFC|GLRA3|SORBS2|SAP30|HAND2|MORF4|ADAM29|SCRG1|FAM149A|FBXO8|PDLIM3|GALNT7|CLDN22|NEIL3|UFSP2|CDKN2AIP|TENM3|LRP2BP|STOX2|CFAP97|SPCS3|TRAPPC11|CENPU|HAND2-AS1|WWC2|CEP44|SNX25|LOC90768|WDR17|ZFP42|SPATA4|ENPP6|ASB5|WWC2-AS2|RWDD4|PRIMPOL|TRIML2|CCDC110|CYP4V2|F11-AS1|LINC01098|LOC339975|TRIML1|ANKRD37|LOC389247|HELT|LINC01060|C4orf47|GALNTL6|FLJ38576|LINC00290|LOC728175|MIR3945HG|CLDN24|MIR1305|MIR548T|MIR4276|MIR3945|LINC01093|LOC100506272|MIR4455|LOC101928314|LOC101928509|LOC101928551|LOC101928590|LINC01099|WWC2-AS1|LINC01262|LOC101930370|LOC102723766|LVCAT8|LOC105377590|LINC01596	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	4	172356988 - 189975519	GRCh38	59510	74105
GRCh38/hg38 4q12-13.1(chr4:54198601-62270115)x1	IGFBP7|KDR|KIT|PDGFRA|POLR2B|PPAT|REST|SPINK2|SRP72|CLOCK|CEP135|PAICS|NMU|ADGRL3|EXOC1|TMEM165|KIAA1211|SRD5A3|NOA1|HOPX|ARL9|AASDH|PDCL2|IGFBP7-AS1|LOC339978|SRD5A3-AS1|THEGL|MIR548AG1|ADGRL3-AS1|LOC101928851|LOC105377245|LOC105377247|LOC105377671	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	4	54198601 - 62270115	GRCh38	59424	74019
GRCh38/hg38 4q27-35.2(chr4:121518223-190062270)x3	AGA|SLC25A4|ANXA5|CASP3|CCNA2|LRBA|CLGN|CLCN3|CPE|CTSO|DCTD|EDNRA|ELF2|ETFDH|F11|ACSL1|FAT1|FGA|FGB|FGF2|FGG|FRG1|GAB1|GK3P|GLRB|GPM6A|GRIA2|GUCY1A3|GUCY1B3|GYPA|GYPB|GYPE|HMGB2|HPGD|IL2|IL15|ING2|IRF2|KLKB1|SMAD1|MGST2|NR3C2|MTNR1A|NDUFC1|NEK1|NPY1R|NPY2R|NPY5R|GATB|PLRG1|EXOSC9|POU4F2|PPID|ABCE1|RPS3A|MSMO1|SFRP2|TDO2|TLL1|TLR2|TLR3|TRPC3|UCP1|VEGFC|GLRA3|SMARCA5|SORBS2|SAP30|INPP4B|SNORD73A|LRAT|HAND2|RAPGEF2|MFAP3L|SPRY1|ANAPC10|PGRMC2|MAB21L2|PLK4|MORF4|ADAM29|LSM6|NUDT6|ANXA10|KLHL2|SCRG1|HSPA4L|PALLD|TBC1D9|KIAA0922|TRIM2|ANP32C|SLC7A11|NOCT|FAM149A|FBXO8|INTU|ARFIP1|PDLIM3|ZNF330|SPOCK3|AADAT|FAM198B|ASIC5|GALNT7|CLDN22|PCDH18|DKFZP434I0714|OTUD4|DCHS2|HPF1|MARCH1|LARP1B|BBS7|NEIL3|FBXW7|TMEM144|TMA16|UFSP2|MAML3|DDX60|CDKN2AIP|TENM3|TMEM184C|LRP2BP|PDGFC|FSTL5|STOX2|ANKRD50|RNF150|PCDH10|CFAP97|FNIP2|SH3RF1|IL21|RXFP1|SPCS3|SCOC|TRAPPC11|HHIP|FAT4|ARHGAP10|CENPU|HAND2-AS1|MAP9|JADE1|WWC2|NAA15|ABHD18|CEP44|SETD7|SLC25A31|RAB33B|SNX25|TTC29|MND1|SLC10A7|TKTL2|KIAA1109|USP38|MGARP|CBR4|FHDC1|LOC90768|PRMT9|DDX60L|NAF1|WDR17|SCLT1|C4orf33|TMEM155|PABPC4L|ADAD1|ZFP42|SPATA4|ENPP6|ASB5|ZNF827|SH3D19|MGAT4D|WWC2-AS2|FAM218A|C4orf45|SPATA5|BBS12|DCLK2|TRIM60|FREM3|MMAA|RBM46|C4orf46|TIGD4|TMEM154|TMEM192|RWDD4|PRIMPOL|TRIML2|ELMOD2|CCDC110|MFSD8|LINC01091|LOC285423|CYP4V2|F11-AS1|LINC01098|RNF175|LOC339975|TRIML1|LOC340017|PRSS48|ANKRD37|LOC389247|TRIM61|HELT|LINC01060|LOC441052|C4orf47|GALNTL6|FRG2|SLC7A11-AS1|LINC00616|HHIP-AS1|C4orf51|FLJ38576|MIR578|LINC00290|LOC728175|LOC729307|FAM160A1|LOC729870|MIR3945HG|SMARCA5-AS1|SCOC-AS1|CLDN24|TRC-GCA2-1|PP12613|DUX4L9|MIR2054|MIR1305|MIR548G|MIR548T|MIR3140|MIR3139|MIR4276|MIR3945|MIR3688-1|LINC01095|LINC01207|APELA|LOC100506085|LOC100506107|LOC100506122|LINC01093|LOC100506272|LOC100507487|LINC00613|LOC100507639|MIR4455|MIR4453|MIR4454|MIR4799|MIR3688-2|LINC00499|LOC100996286|IL21-AS1|LOC101927087|LOC101927282|LOC101927305|LOC101927359|LOC101927636|SMAD1-AS2|LOC101927849|LOC101928052|LOC101928131|LINC01179|LINC01612|LOC101928314|LOC101928509|LOC101928551|LOC101928590|LINC01099|WWC2-AS1|LINC01262|LOC101930370|MIR7849|MIR6082|LOC102723766|LOC102724776|SMAD1-AS1|LINC01256|LOC105377448|LOC105377458|LOC105377480|LVCAT8|LOC105377590|LINC01596|LOC105377623	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	4	121518223 - 190062270	GRCh38	58043	72638
GRCh38/hg38 4q31.23(chr4:149956405-150119840)x3	DCLK2	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	4	149956405 - 150119840	GRCh38	57895	72490
GRCh38/hg38 4p16.2(chr4:4791822-5811236)x3	EVC|MSX1|LINC01587|CYTL1|STK32B|EVC2|LOC101928306|LINC01396	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	4	4791822 - 5811236	GRCh38	57826	72421
GRCh38/hg38 4p16.3-16.1(chr4:51519-8222798)x3	ADD1|ADRA2C|ATP5I|CRMP1|CTBP1|DGKQ|EVC|FGFR3|GAK|GRK4|HTT|HGFAC|IDUA|LETM1|LRPAP1|MSX1|MYL5|PDE6B|PPP2R2C|RGS12|RNF4|S100P|SH3BP2|WFS1|WHSC1|NELFA|ZNF141|SLBP|NOP14|FAM193A|KIAA0232|LINC01587|MFSD10|MAEA|PCGF3|SPON2|TACC3|MXD4|CPLX1|SLC26A1|MAN2B2|NSG1|STX18|FGFRL1|CYTL1|SH3TC1|NKX1-1|PIGG|BLOC1S4|STK32B|LYAR|TBC1D14|SORCS2|UVSSA|ZFYVE28|AFAP1|TNIP2|HAUS3|GRPEL1|MFSD7|TMEM175|ABLIM2|AFAP1-AS1|TMEM128|CTBP1-AS2|TMEM129|MRFAP1|TADA2B|MRFAP1L1|EVC2|OTOP1|ZNF595|JAKMIP1|FAM53A|ZBTB49|ZNF721|ZNF718|CCDC96|CTBP1-AS|CRIPAK|LOC285484|DOK7|LINC00955|RNF212|NOP14-AS1|NAT8L|MSANTD1|POLN|C4orf50|LOC389199|C4orf48|CFAP99|MIR95|ZNF732|SCARNA22|MIR571|FLJ36777|PSAPL1|MIR943|LOC100129917|LOC100129931|LOC100130872|LOC100133461|MIR4274|STX18-AS1|MIR378D1|MIR4800|MIR4798|HTT-AS|LOC101928279|LOC101928306|LINC01396|STX18-IT1|LOC105374344|LOC105374366|LOC107986211	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	4	51519 - 8222798	GRCh38	57239	71834
NM_198253.2(TERT):c.1892G>A (p.Arg631Gln)	TERT	Idiopathic fibrosing alveolitis, chronic form|Dyskeratosis congenita, autosomal dominant, 2		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	5	1280216	GRCh38	29899	38854
NM_002495.3(NDUFS4):c.316C>T (p.Arg106Ter)	NDUFS4	Leigh syndrome due to mitochondrial complex I deficiency		Pathogenic(Last reviewed: Aug 18, 2000)	no assertion criteria provided	5	53646371	GRCh38	6889	21928
NM_002890.2(RASA1):c.1619G>A (p.Cys540Tyr)	CCNH|RASA1	Capillary malformation-arteriovenous malformation		Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	5	87369821	GRCh38	16000	31039
NM_002890.2(RASA1):c.2131C>T (p.Arg711Ter)	CCNH|RASA1	not provided		Pathogenic(Last reviewed: Mar 24, 2015)	criteria provided, single submitter	5	87376512	GRCh38	213660	209861
NM_002890.2(RASA1):c.2184+9_2184+10insGTTAAA	CCNH|RASA1	not specified		Benign(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	5	87376574 - 87376575	GRCh38	213653	209862
NM_002890.2(RASA1):c.2690+1G>A	CCNH|RASA1	not provided		Pathogenic(Last reviewed: Feb 18, 2015)	criteria provided, single submitter	5	87380596	GRCh38	213661	209863
NM_001999.3(FBN2):c.8733C>G (p.Leu2911=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.02760(C), GO-ESP:0.00771(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128259461	GRCh38	137357	141060
NM_001999.3(FBN2):c.8597G>T (p.Gly2866Val)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 20, 2012)	criteria provided, single submitter	5	128259597	GRCh38	263471	258361
NM_001999.3(FBN2):c.8589C>T (p.Leu2863=)	FBN2	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Sep 24, 2012)	criteria provided, single submitter	5	128259605	GRCh38	263395	258363
NM_001999.3(FBN2):c.8513A>G (p.Gln2838Arg)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Jan 16, 2014)	criteria provided, single submitter	5	128259681	GRCh38	263810	258362
NM_001999.3(FBN2):c.8498G>A (p.Arg2833His)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Sep 7, 2015)	criteria provided, multiple submitters, no conflicts	5	128259696	GRCh38	213375	209648
NM_001999.3(FBN2):c.8481C>G (p.Pro2827=)	FBN2	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	5	128259713	GRCh38	263929	258364
NM_001999.3(FBN2):c.8351C>T (p.Pro2784Leu)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.01000(A), GO-ESP:0.00625(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128261749	GRCh38	258529	251642
NM_001999.3(FBN2):c.8347G>C (p.Glu2783Gln)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00600(G), GMAF:0.00640(G), GO-ESP:0.00177(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128261753	GRCh38	129054	134500
NM_001999.3(FBN2):c.8332A>C (p.Lys2778Gln)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00200(G), GO-ESP:0.00148(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128261768	GRCh38	213371	209653
NM_001999.3(FBN2):c.8304C>T (p.Asn2768=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00180(A), GO-ESP:0.00082(A)	Benign/Likely benign(Last reviewed: Dec 28, 2015)	criteria provided, multiple submitters, no conflicts	5	128261796	GRCh38	137354	141057
NM_001999.3(FBN2):c.8274C>T (p.Ser2758=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.13855(A), GMAF:0.11280(A), GO-ESP:0.10425(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128261826	GRCh38	129053	134499
NM_001999.3(FBN2):c.8257G>A (p.Glu2753Lys)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00050(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2016)	criteria provided, conflicting interpretations	5	128261843	GRCh38	213256	209656
NM_001999.3(FBN2):c.8247A>G (p.Thr2749=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00100(C), GO-ESP:0.00071(C)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2016)	criteria provided, conflicting interpretations	5	128261853	GRCh38	211002	207155
NM_001999.3(FBN2):c.8239C>G (p.Leu2747Val)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00003(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128261861	GRCh38	213255	209657
NM_001999.3(FBN2):c.8196C>T (p.His2732=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	5	128261904	GRCh38	264120	258365
NM_001999.3(FBN2):c.8193-4A>G	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	5	128261911	GRCh38	264027	258367
NM_001999.3(FBN2):c.8154C>T (p.Leu2718=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00638(A), GMAF:0.00600(A), GO-ESP:0.00189(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128263463	GRCh38	129052	134498
NM_001999.3(FBN2):c.8119A>C (p.Asn2707His)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	5	128263498	GRCh38	264179	258366
NM_001999.3(FBN2):c.8082C>A (p.His2694Gln)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00037(T)	Uncertain significance(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	5	128263535	GRCh38	213254	209661
NM_001999.3(FBN2):c.8035G>T (p.Ala2679Ser)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 6, 2013)	criteria provided, single submitter	5	128263582	GRCh38	263329	258368
NM_001999.3(FBN2):c.7963G>A (p.Glu2655Lys)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	5	128263654	GRCh38	264359	258369
NM_001999.3(FBN2):c.7938C>T (p.His2646=)	FBN2	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Jan 22, 2013)	criteria provided, single submitter	5	128272021	GRCh38	263521	258370
NM_001999.3(FBN2):c.7879G>A (p.Gly2627Ser)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Aug 30, 2015)	criteria provided, single submitter	5	128272080	GRCh38	264343	258371
NM_001999.3(FBN2):c.7824C>T (p.Thr2608=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00460(A), GO-ESP:0.00126(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128273856	GRCh38	264176	258374
NM_001999.3(FBN2):c.7739C>T (p.Ser2580Leu)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.07804(A), GMAF:0.07570(A), GO-ESP:0.07441(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128273941	GRCh38	129051	134497
NM_001999.3(FBN2):c.7653G>C (p.Leu2551=)	FBN2	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	5	128274625	GRCh38	263687	258372
NM_001999.3(FBN2):c.7593A>G (p.Lys2531=)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00054(C)	Benign/Likely benign(Last reviewed: Jun 23, 2015)	criteria provided, multiple submitters, no conflicts	5	128276039	GRCh38	213252	209670
NM_001999.3(FBN2):c.7565T>C (p.Val2522Ala)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 25, 2015)	criteria provided, single submitter	5	128276067	GRCh38	263995	258378
NM_001999.3(FBN2):c.7418G>A (p.Arg2473Gln)	FBN2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A)	Uncertain significance(Last reviewed: Jan 2, 2015)	criteria provided, single submitter	5	128277933	GRCh38	263894	258373
NM_001999.3(FBN2):c.7380C>T (p.Cys2460=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(A), GO-ESP:0.00117(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2016)	criteria provided, conflicting interpretations	5	128277971	GRCh38	137349	141052
NM_001999.3(FBN2):c.7296G>T (p.Gln2432His)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00907(A), GMAF:0.00700(A), GO-ESP:0.00268(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128278684	GRCh38	129050	134496
NM_001999.3(FBN2):c.7250G>T (p.Gly2417Val)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 13, 2014)	criteria provided, single submitter	5	128278730	GRCh38	263827	258376
NM_001999.3(FBN2):c.7212C>T (p.Leu2404=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00005(A)	Likely benign(Last reviewed: Feb 27, 2015)	criteria provided, single submitter	5	128278768	GRCh38	263569	258377
NM_001999.3(FBN2):c.7200T>C (p.Ser2400=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.67792(G), GMAF:0.27340(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128278780	GRCh38	129049	134495
NM_001999.3(FBN2):c.7181T>C (p.Ile2394Thr)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(G), GO-ESP:0.00232(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128278799	GRCh38	210999	207158
NM_001999.3(FBN2):c.7013-5T>C	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.07736(G), GMAF:0.08050(G), GO-ESP:0.07665(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128280322	GRCh38	129048	134494
NM_001999.3(FBN2):c.6990G>A (p.Arg2330=)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(T), GO-ESP:0.00013(T)	Likely benign(Last reviewed: Oct 1, 2013)	criteria provided, multiple submitters, no conflicts	5	128286740	GRCh38	258526	251645
NM_001999.3(FBN2):c.6989G>A (p.Arg2330Lys)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 21, 2015)	criteria provided, single submitter	5	128286741	GRCh38	263964	258380
NM_001999.3(FBN2):c.6948C>A (p.Ile2316=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.01399(T), GMAF:0.01020(T), GO-ESP:0.01857(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128286782	GRCh38	129047	134493
NM_001999.3(FBN2):c.6946A>T (p.Ile2316Phe)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00018(A)	Uncertain significance(Last reviewed: Oct 3, 2016)	criteria provided, multiple submitters, no conflicts	5	128286784	GRCh38	213423	209687
NM_001999.3(FBN2):c.6931A>G (p.Met2311Val)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.09780(C), GMAF:0.23280(C), GO-ESP:0.11513(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128286799	GRCh38	129046	134492
NM_001999.3(FBN2):c.6903G>T (p.Gly2301=)	FBN2	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Sep 7, 2015)	criteria provided, single submitter	5	128286827	GRCh38	264344	258375
NM_001999.3(FBN2):c.6834G>A (p.Thr2278=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Jan 23, 2013)	criteria provided, single submitter	5	128287354	GRCh38	263522	258383
NM_001999.3(FBN2):c.6764A>G (p.Asn2255Ser)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	5	128287424	GRCh38	264412	258387
NM_001999.3(FBN2):c.6687C>T (p.Thr2229=)	FBN2	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	5	128288508	GRCh38	264615	258381
NM_001999.3(FBN2):c.6681A>G (p.Thr2227=)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00004(C)	Uncertain significance(Last reviewed: Nov 21, 2014)	criteria provided, multiple submitters, no conflicts	5	128288514	GRCh38	213350	209693
NM_001999.3(FBN2):c.6655A>G (p.Ile2219Val)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00120(C), GO-ESP:0.00031(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128288540	GRCh38	213246	209697
NM_001999.3(FBN2):c.6638-2A>C	FBN2	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	5	128288559	GRCh38	264587	258379
NM_001999.3(FBN2):c.6615C>T (p.Asp2205=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00580(A), GO-ESP:0.00140(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128289149	GRCh38	213245	209698
NM_001999.3(FBN2):c.6511+5G>A	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(T), GO-ESP:0.00497(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128289877	GRCh38	137344	141047
NM_001999.3(FBN2):c.6253C>G (p.Pro2085Ala)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00017(C)	Uncertain significance(Last reviewed: Aug 15, 2016)	criteria provided, multiple submitters, no conflicts	5	128291568	GRCh38	213344	209705
NM_001999.3(FBN2):c.6118A>G (p.Arg2040Gly)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 27, 2012)	criteria provided, single submitter	5	128300865	GRCh38	263464	258385
NM_001999.3(FBN2):c.6077C>T (p.Ser2026Phe)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Sep 25, 2012)	criteria provided, single submitter	5	128300906	GRCh38	263401	258390
NM_001999.3(FBN2):c.6000A>G (p.Leu2000=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00580(C), GO-ESP:0.00146(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128301428	GRCh38	213241	209710
NM_001999.3(FBN2):c.5834A>G (p.Asn1945Ser)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified		Uncertain significance(Last reviewed: Nov 13, 2015)	criteria provided, multiple submitters, no conflicts	5	128303056	GRCh38	213341	209713
NM_001999.3(FBN2):c.5823T>C (p.His1941=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.10411(G), GMAF:0.09290(G), GO-ESP:0.09488(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128303067	GRCh38	129044	134490
NM_001999.3(FBN2):c.5787G>A (p.Gln1929=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Oct 4, 2015)	criteria provided, single submitter	5	128304970	GRCh38	264450	258382
NM_001999.3(FBN2):c.5670T>C (p.Cys1890=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00140(G), GO-ESP:0.00081(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128305515	GRCh38	213238	209717
NM_001999.3(FBN2):c.5531T>C (p.Leu1844Pro)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	5	128305840	GRCh38	263328	258388
NM_001999.3(FBN2):c.5496C>T (p.Arg1832=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00120(A), GO-ESP:0.00384(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128305875	GRCh38	137341	141044
NM_001999.3(FBN2):c.5448A>G (p.Pro1816=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00200(C), GO-ESP:0.00098(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128305923	GRCh38	137340	141043
NM_001999.3(FBN2):c.4994A>G (p.Asn1665Ser)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	5	128311380	GRCh38	263342	258386
NM_001999.3(FBN2):c.4983C>T (p.Cys1661=)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(A), GO-ESP:0.00021(A)	Benign/Likely benign(Last reviewed: Dec 17, 2014)	criteria provided, multiple submitters, no conflicts	5	128311391	GRCh38	137336	141039
NM_001999.3(FBN2):c.4938C>T (p.Ile1646=)	FBN2	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Mar 25, 2013)	criteria provided, single submitter	5	128311895	GRCh38	263579	258394
NM_001999.3(FBN2):c.4829T>C (p.Leu1610Pro)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 14, 2013)	criteria provided, single submitter	5	128312684	GRCh38	263684	258384
NM_001999.3(FBN2):c.4801G>A (p.Val1601Ile)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128312712	GRCh38	213334	209731
NM_001999.3(FBN2):c.4791C>T (p.Ile1597=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(A), GO-ESP:0.00077(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128312722	GRCh38	137335	141038
NM_001999.3(FBN2):c.4757G>A (p.Arg1586Gln)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: May 24, 2016)	criteria provided, multiple submitters, no conflicts	5	128312756	GRCh38	213333	209732
NM_001999.3(FBN2):c.4647C>T (p.Asn1549=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(A), GO-ESP:0.00076(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128318219	GRCh38	137333	141036
NM_001999.3(FBN2):c.4559G>T (p.Gly1520Val)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	5	128318914	GRCh38	263332	258392
NM_001999.3(FBN2):c.4495A>C (p.Asn1499His)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Sep 18, 2013)	criteria provided, single submitter	5	128318978	GRCh38	263771	258389
NM_001999.3(FBN2):c.4454A>G (p.Asp1485Gly)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00030(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128328713	GRCh38	213328	209741
NM_001999.3(FBN2):c.4407G>A (p.Pro1469=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	5	128328760	GRCh38	263838	258397
NM_001999.3(FBN2):c.4402G>A (p.Val1468Ile)	FBN2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	5	128328765	GRCh38	264519	258391
NM_001999.3(FBN2):c.4346-2A>T	FBN2	Congenital contractural arachnodactyly		Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	5	128328823	GRCh38	522	15561
NM_001999.3(FBN2):c.4316G>A (p.Gly1439Asp)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 3, 2015)	criteria provided, single submitter	5	128330602	GRCh38	264422	258393
NM_001999.3(FBN2):c.4312G>A (p.Glu1438Lys)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00360(T), GO-ESP:0.00795(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128330606	GRCh38	137330	141033
NM_001999.3(FBN2):c.4311C>T (p.Ser1437=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00004(A)	Likely benign(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	5	128330607	GRCh38	264532	258396
NM_001999.3(FBN2):c.4206C>T (p.Asn1402=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00269(A), GMAF:0.00320(A), GO-ESP:0.00138(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128332928	GRCh38	129042	134488
NM_001999.3(FBN2):c.4184G>T (p.Cys1395Phe)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Feb 21, 2014)	criteria provided, single submitter	5	128332950	GRCh38	263821	258400
NM_001999.3(FBN2):c.4141C>A (p.His1381Asn)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00368(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128332993	GRCh38	210996	207161
NM_001999.3(FBN2):c.4098A>C (p.Thr1366=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.02568(G), GMAF:0.01960(G), GO-ESP:0.00664(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128334720	GRCh38	129041	134487
NM_001999.3(FBN2):c.3958A>G (p.Met1320Val)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: May 31, 2013)	criteria provided, single submitter	5	128335185	GRCh38	263631	258399
NM_001999.3(FBN2):c.3884A>G (p.Asp1295Gly)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	5	128335259	GRCh38	264121	258395
NM_001999.3(FBN2):c.3767A>G (p.Gln1256Arg)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00140(C), GO-ESP:0.00028(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128335535	GRCh38	213230	209759
NM_001999.3(FBN2):c.3762C>T (p.Asp1254=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00680(A), GO-ESP:0.00700(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128335540	GRCh38	137325	141028
NM_001999.3(FBN2):c.3702G>A (p.Thr1234=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00004(T)	Likely benign(Last reviewed: May 15, 2015)	criteria provided, single submitter	5	128336010	GRCh38	264004	258404
NM_001999.3(FBN2):c.3490C>T (p.Arg1164Cys)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	5	128338105	GRCh38	264140	258403
NM_001999.3(FBN2):c.3430G>A (p.Glu1144Lys)	FBN2	Thoracic aortic aneurysm and aortic dissection|Macular degeneration, early-onset	GO-ESP:0.00004(T)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2015)	criteria provided, conflicting interpretations	5	128338975	GRCh38	161445	171281
NM_001999.3(FBN2):c.3394G>A (p.Val1132Ile)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00017(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128339011	GRCh38	213228	209778
NM_001999.3(FBN2):c.3351C>T (p.Asp1117=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(A), GO-ESP:0.00041(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 9, 2016)	criteria provided, conflicting interpretations	5	128339054	GRCh38	239082	239657
NM_001999.3(FBN2):c.3342G>A (p.Thr1114=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00002(T)	Likely benign(Last reviewed: May 5, 2014)	criteria provided, single submitter	5	128344386	GRCh38	263840	258407
NM_001999.3(FBN2):c.3296G>A (p.Arg1099His)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00009(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128344432	GRCh38	213305	209781
NM_001999.3(FBN2):c.3166G>T (p.Ala1056Ser)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00900(A), GO-ESP:0.00228(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128345408	GRCh38	137324	141027
NM_001999.3(FBN2):c.3144C>T (p.Tyr1048=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00160(A), GO-ESP:0.00032(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128345430	GRCh38	263905	258398
NM_001999.3(FBN2):c.3015G>A (p.Leu1005=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.02153(T), GMAF:0.01320(T), GO-ESP:0.01468(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128345559	GRCh38	129040	134486
NM_001999.3(FBN2):c.2978G>A (p.Arg993His)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	5	128349358	GRCh38	263966	258405
NM_001999.3(FBN2):c.2940C>T (p.Cys980=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00200(A), GO-ESP:0.00099(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128349396	GRCh38	137322	141025
NM_001999.3(FBN2):c.2893G>A (p.Val965Ile)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.66216(T), GMAF:0.26900(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128349443	GRCh38	129039	134485
NM_001999.3(FBN2):c.2856G>A (p.Thr952=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(T)	Likely benign(Last reviewed: Jun 12, 2014)	criteria provided, single submitter	5	128349962	GRCh38	263830	258406
NM_001999.3(FBN2):c.2836G>T (p.Ala946Ser)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 18, 2014)	criteria provided, single submitter	5	128349982	GRCh38	263852	258414
NM_001999.3(FBN2):c.2778C>T (p.Ala926=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.01023(A), GMAF:0.00800(A), GO-ESP:0.00300(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128350902	GRCh38	129038	134484
NM_001999.3(FBN2):c.2777C>A (p.Ala926Asp)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	5	128350903	GRCh38	263934	258401
NM_001999.3(FBN2):c.2651G>C (p.Ser884Thr)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00005(G)	Uncertain significance(Last reviewed: May 28, 2014)	criteria provided, multiple submitters, no conflicts	5	128357299	GRCh38	213288	209805
NM_001999.3(FBN2):c.2557A>C (p.Ile853Leu)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00009(G)	Uncertain significance(Last reviewed: Oct 3, 2015)	criteria provided, single submitter	5	128357393	GRCh38	264426	258408
NM_001999.3(FBN2):c.2508G>A (p.Thr836=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00007(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128361769	GRCh38	137320	141023
NM_001999.3(FBN2):c.2480G>A (p.Arg827Gln)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, multiple submitters, no conflicts	5	128361797	GRCh38	213287	209808
NM_001999.3(FBN2):c.2427T>A (p.Ile809=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(T), GO-ESP:0.00077(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128364601	GRCh38	137319	141022
NM_001999.3(FBN2):c.2365G>A (p.Gly789Ser)	FBN2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	5	128364663	GRCh38	263906	258412
NM_001999.3(FBN2):c.2260G>A (p.Gly754Ser)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00140(T), GO-ESP:0.00161(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 23, 2016)	criteria provided, conflicting interpretations	5	128366419	GRCh38	213286	209809
NM_001999.3(FBN2):c.2042G>A (p.Arg681His)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00260(T), GO-ESP:0.00139(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128374681	GRCh38	213283	209813
NM_001999.3(FBN2):c.1885A>G (p.Asn629Asp)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified		Uncertain significance(Last reviewed: Aug 12, 2015)	criteria provided, multiple submitters, no conflicts	5	128376818	GRCh38	213280	209818
NM_001999.3(FBN2):c.1804delT (p.Cys602Alafs)	FBN2	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Dec 20, 2012)	criteria provided, single submitter	5	128377797	GRCh38	263489	258416
NM_001999.3(FBN2):c.1720A>G (p.Ile574Val)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Sep 3, 2014)	criteria provided, single submitter	5	128378774	GRCh38	263857	258402
NM_001999.3(FBN2):c.1592G>C (p.Gly531Ala)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(G), GO-ESP:0.00128(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128392029	GRCh38	213263	209826
NM_001999.3(FBN2):c.1526G>T (p.Arg509Leu)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Aug 7, 2015)	criteria provided, multiple submitters, no conflicts	5	128392095	GRCh38	213274	209828
NM_001999.3(FBN2):c.1466-4G>A	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00022(T)	Benign(Last reviewed: Feb 20, 2014)	criteria provided, single submitter	5	128392159	GRCh38	263817	258410
NM_001999.3(FBN2):c.1466-5C>T	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.01038(A), GMAF:0.00940(A), GO-ESP:0.00259(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128392160	GRCh38	129035	134481
NM_001999.3(FBN2):c.1435G>A (p.Gly479Arg)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(T), GO-ESP:0.00013(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128393165	GRCh38	213272	209830
NM_001999.3(FBN2):c.1423G>A (p.Gly475Ser)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128393177	GRCh38	264520	258413
NM_001999.3(FBN2):c.1285A>G (p.Ser429Gly)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00720(C), GO-ESP:0.00160(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128393315	GRCh38	137317	141020
NM_001999.3(FBN2):c.1194C>T (p.Ile398=)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2016)	criteria provided, conflicting interpretations	5	128395159	GRCh38	264225	258419
NM_001999.3(FBN2):c.1180C>T (p.Arg394Cys)	FBN2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	5	128395173	GRCh38	263337	258409
NM_001999.3(FBN2):c.1040G>A (p.Arg347His)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00120(T), GO-ESP:0.00451(T)	Benign/Likely benign(Last reviewed: Aug 26, 2016)	criteria provided, multiple submitters, no conflicts	5	128408712	GRCh38	210993	207163
NM_001999.3(FBN2):c.976C>T (p.Pro326Ser)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00320(A), GO-ESP:0.00656(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128408776	GRCh38	137316	141019
NM_001999.3(FBN2):c.891C>A (p.Gly297=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00002(T)	Likely benign(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	5	128446542	GRCh38	263387	258411
NM_001999.3(FBN2):c.829G>A (p.Val277Ile)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00100(T), GO-ESP:0.00181(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 8, 2016)	criteria provided, conflicting interpretations	5	128446604	GRCh38	213259	209841
NM_001999.3(FBN2):c.761G>C (p.Cys254Ser)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	5	128464789	GRCh38	264096	258415
NM_001999.3(FBN2):c.756G>T (p.Glu252Asp)	FBN2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T)	Uncertain significance(Last reviewed: Jun 13, 2013)	criteria provided, single submitter	5	128464794	GRCh38	263643	258422
NM_001999.3(FBN2):c.738G>A (p.Ala246=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(T), GO-ESP:0.00154(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128464812	GRCh38	137359	141062
NM_001999.3(FBN2):c.728T>C (p.Ile243Thr)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.01400(G), GO-ESP:0.00948(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128464822	GRCh38	137358	141061
NM_001999.3(FBN2):c.671T>C (p.Met224Thr)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128464879	GRCh38	263417	258417
NM_001999.3(FBN2):c.523T>C (p.Cys175Arg)	FBN2	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: May 23, 2014)	criteria provided, single submitter	5	128527881	GRCh38	263836	258420
NM_001999.3(FBN2):c.518C>T (p.Thr173Ile)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(A), GO-ESP:0.00137(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128527886	GRCh38	155796	165548
NM_001999.3(FBN2):c.460A>G (p.Met154Val)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	5	128527944	GRCh38	239085	239661
NM_001999.3(FBN2):c.362A>G (p.Asp121Gly)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	5	128530669	GRCh38	264204	258418
NM_001999.3(FBN2):c.297T>C (p.Pro99=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00300(G), GO-ESP:0.00102(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128536442	GRCh38	213232	209849
NM_001999.3(FBN2):c.294C>T (p.Cys98=)	FBN2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Jul 12, 2015)	criteria provided, single submitter	5	128536445	GRCh38	264165	258425
NM_001999.3(FBN2):c.287_289delACT (p.Tyr96del)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00100(-), GO-ESP:0.00019(-)	Uncertain significance(Last reviewed: Sep 23, 2014)	criteria provided, multiple submitters, no conflicts	5	128536450 - 128536452	GRCh38	213385	209850
NM_001999.3(FBN2):c.244G>A (p.Val82Met)	FBN2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(G)	Uncertain significance(Last reviewed: Sep 27, 2015)	criteria provided, single submitter	5	128537360	GRCh38	264428	258421
NM_001999.3(FBN2):c.217C>A (p.Arg73Ser)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Feb 3, 2015)	criteria provided, multiple submitters, no conflicts	5	128537387	GRCh38	213266	209851
NM_001999.3(FBN2):c.203C>T (p.Ala68Val)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.03554(A), GMAF:0.01480(A), GO-ESP:0.03314(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128537401	GRCh38	94020	99922
NM_001999.3(FBN2):c.183C>G (p.Pro61=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.11449(C), GMAF:0.09940(C), GO-ESP:0.09200(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128537421	GRCh38	129036	134482
NM_001999.3(FBN2):c.111G>A (p.Pro37=)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.14494(T), GMAF:0.13780(T), GO-ESP:0.11743(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128537493	GRCh38	129034	134480
NM_001999.3(FBN2):c.110C>A (p.Pro37Gln)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(T), GO-ESP:0.00031(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	128537494	GRCh38	193220	190385
NM_001999.3(FBN2):c.76A>G (p.Thr26Ala)	FBN2	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00028(C)	Uncertain significance(Last reviewed: Sep 28, 2015)	criteria provided, multiple submitters, no conflicts	5	128537528	GRCh38	213260	209856
NM_001999.3(FBN2):c.68C>G (p.Ala23Gly)	FBN2	Congenital contractural arachnodactyly|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00038(C)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	128537536	GRCh38	213218	209857
NM_003060.3(SLC22A5):c.396G>A (p.Trp132Ter)	SLC22A5	Renal carnitine transport defect	GO-ESP:0.00001(A)	Pathogenic/Likely pathogenic, not provided(Last reviewed: Jun 22, 2014)	criteria provided, single submitter	5	132378380	GRCh38	6411	21450
NM_003060.3(SLC22A5):c.424G>T (p.Ala142Ser)	SLC22A5	Renal carnitine transport defect	GO-ESP:0.00038(T), GO-ESP:0.00005(T)	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	5	132378408	GRCh38	25372	36706
NM_003060.3(SLC22A5):c.632A>G (p.Tyr211Cys)	SLC22A5	Renal carnitine transport defect|not provided		Pathogenic/Likely pathogenic, not provided(Last reviewed: Jul 7, 2016)	criteria provided, multiple submitters, no conflicts	5	132384281	GRCh38	6420	21459
NM_003060.3(SLC22A5):c.1463G>A (p.Arg488His)	SLC22A5	Renal carnitine transport defect	GO-ESP:0.00408(A), GMAF:0.00140(A), GO-ESP:0.00326(A)	Pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	5	132393688	GRCh38	38794	47399
NM_003060.3(SLC22A5):c.1586+1G>T	SLC22A5	Renal carnitine transport defect		not provided	no assertion provided	5	132393812	GRCh38	25430	36764
NM_000337.5(SGCD):c.451T>G (p.Ser151Ala)	SGCD	Dilated cardiomyopathy 1L|Muscular dystrophy, limb-girdle, type 2F, digenic|not specified	GO-ESP:0.00026(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2016)	criteria provided, conflicting interpretations	5	156595000	GRCh38	8176	23215
NM_000337.5(SGCD):c.699+18C>G	SGCD	not specified|not provided	GMAF:0.00240(G), GO-ESP:0.00097(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2015)	criteria provided, conflicting interpretations	5	156757722	GRCh38	48123	57287
NM_004387.3(NKX2-5):c.896A>G (p.Asp299Gly)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects|Atrioventricular septal defect, somatic		Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	5	173232648	GRCh38	9014	24053
NM_004387.3(NKX2-5):c.861C>T (p.Ala287=)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects|not specified	GMAF:0.01000(A), GO-ESP:0.00239(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 27, 2016)	criteria provided, conflicting interpretations	5	173232683	GRCh38	138525	142228
NM_004387.3(NKX2-5):c.809G>A (p.Cys270Tyr)	NKX2-5	Single ventricle|small Atrial septal defect	GO-ESP:0.00007(T)	Likely benign(Last reviewed: Jan 1, 2014)	no assertion criteria provided	5	173232735	GRCh38	156161	165960
NM_004387.3(NKX2-5):c.768T>G (p.Tyr256Ter)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	5	173232776	GRCh38	254163	248630
NM_004387.3(NKX2-5):c.768T>A (p.Tyr256Ter)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	5	173232776	GRCh38	9017	24056
NM_004387.3(NKX2-5):c.751delA (p.Asn251Thrfs)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Likely pathogenic(Last reviewed: Feb 23, 2016)	no assertion criteria provided	5	173232793	GRCh38	242906	244012
NM_004387.3(NKX2-5):c.721_728delTACGGCGT (p.Tyr241Glyfs)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	5	173232816 - 173232823	GRCh38	156160	165959
NM_004387.3(NKX2-5):c.618delG (p.Leu207Cysfs)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	5	173232926	GRCh38	156159	165958
NM_004387.3(NKX2-5):c.592C>T (p.Gln198Ter)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	5	173232952	GRCh38	9006	24045
NM_004387.3(NKX2-5):c.590G>C (p.Arg197Pro)	NKX2-5	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	5	173232954	GRCh38	190835	188422
NM_004387.3(NKX2-5):c.568C>T (p.Arg190Cys)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: May 15, 2005)	no assertion criteria provided	5	173232976	GRCh38	9016	24055
NM_004387.3(NKX2-5):c.566G>C (p.Arg189Pro)	NKX2-5	not provided		Pathogenic(Last reviewed: Jan 23, 2013)	criteria provided, single submitter	5	173232978	GRCh38	190834	188423
NM_004387.3(NKX2-5):c.554_555insC (p.Trp185Cysfs)	NKX2-5	not provided		Pathogenic(Last reviewed: Apr 2, 2014)	criteria provided, single submitter	5	173232989 - 173232990	GRCh38	190839	188424
NM_004387.3(NKX2-5):c.547A>G (p.Lys183Glu)	NKX2-5	Atrioventricular septal defect, somatic		Pathogenic(Last reviewed: Jul 15, 2005)	no assertion criteria provided	5	173232997	GRCh38	9020	24059
NM_004387.3(NKX2-5):c.543G>C (p.Gln181His)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects	GMAF:0.00480(T)	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	5	173233001	GRCh38	36659	45321
NM_004387.3(NKX2-5):c.543G>A (p.Gln181=)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects|Atrial septal defect|not specified	GO-ESP:0.00538(T), GMAF:0.00480(T), GO-ESP:0.00927(T)	Benign(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	5	173233001	GRCh38	36658	45320
NM_004387.3(NKX2-5):c.533C>T (p.Thr178Met)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Jul 15, 2005)	no assertion criteria provided	5	173233011	GRCh38	9004	24043
NM_004387.3(NKX2-5):c.514G>A (p.Ala172Thr)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	5	173233030	GRCh38	239930	239785
NM_004387.3(NKX2-5):c.508C>T (p.Gln170Ter)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	5	173233036	GRCh38	9005	24044
NM_004387.3(NKX2-5):c.482G>C (p.Arg161Pro)	NKX2-5	Hypothyroidism, congenital, nongoitrous, 5	GMAF:0.00020(G), GO-ESP:0.00001(G)	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	5	173233062	GRCh38	9019	24058
NM_004387.3(NKX2-5):c.461A>G (p.Glu154Gly)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	5	173233083	GRCh38	156158	165957
NM_004387.3(NKX2-5):c.380C>A (p.Ala127Glu)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Nov 5, 2003)	no assertion criteria provided	5	173233164	GRCh38	30113	39068
NM_004387.3(NKX2-5):c.355G>T (p.Ala119Ser)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects|Hypothyroidism, congenital, nongoitrous, 5|not specified	GO-ESP:0.00054(A), GMAF:0.00060(A), GO-ESP:0.00123(A)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2016)	criteria provided, conflicting interpretations	5	173233189	GRCh38	9018	24057
NM_004387.3(NKX2-5):c.298C>G (p.Pro100Ala)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects	GO-ESP:0.00016(C)	Likely benign(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	5	173234786	GRCh38	239929	239786
NM_004387.3(NKX2-5):c.262delG (p.Ala88Profs)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: May 15, 2005)	no assertion criteria provided	5	173234822	GRCh38	9015	24054
NM_004387.3(NKX2-5):c.237G>C (p.Pro79=)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects|not specified	GO-ESP:0.00131(G), GMAF:0.00020(G), GO-ESP:0.00113(G)	Benign/Likely benign(Last reviewed: Jul 7, 2016)	criteria provided, multiple submitters, no conflicts	5	173234847	GRCh38	36657	45319
NM_004387.3(NKX2-5):c.237G>A (p.Pro79=)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects	GMAF:0.00020(G)	Likely benign(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	5	173234847	GRCh38	36656	45318
NM_004387.3(NKX2-5):c.228_229delGC (p.Pro77Phefs)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	5	173234855 - 173234856	GRCh38	9013	24052
NM_004387.3(NKX2-5):c.215_221delAGCTGGG (p.Glu72Alafs)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	5	173234863 - 173234869	GRCh38	9012	24051
NM_004387.3(NKX2-5):c.175C>G (p.Pro59Ala)	NKX2-5	Ventricular septal defect 3		Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	5	173234909	GRCh38	30116	39071
NM_004387.3(NKX2-5):c.124G>C (p.Ala42Pro)	NKX2-5	not specified	GMAF:0.00040(G), GO-ESP:0.00016(G)	Uncertain significance(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	5	173234960	GRCh38	190837	188427
NM_004387.3(NKX2-5):c.73C>T (p.Arg25Cys)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects|Hypothyroidism, congenital, nongoitrous, 5|Tetralogy of Fallot|Congenital heart disease|not specified|Hypoplastic left heart syndrome 2|Interrupted aortic arch|not provided|Malformation of the heart and great vessels|TRUNCUS ARTERIOSUS	GO-ESP:0.00955(A), GMAF:0.01020(A), GO-ESP:0.00363(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2016)	criteria provided, conflicting interpretations	5	173235011	GRCh38	9008	24047
NM_004387.3(NKX2-5):c.65A>G (p.Gln22Arg)	NKX2-5	not specified|Malformation of the heart and great vessels|Malformation of the heart and great vessels	GO-ESP:0.00018(C)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2016)	criteria provided, conflicting interpretations	5	173235019	GRCh38	190840	188428
NM_004387.3(NKX2-5):c.61G>C (p.Glu21Gln)	NKX2-5	Tetralogy of Fallot|Congenital heart disease|not specified	GO-ESP:0.00062(G), GO-ESP:0.00081(G)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 27, 2016)	criteria provided, conflicting interpretations	5	173235023	GRCh38	9009	24048
NM_004387.3(NKX2-5):c.44A>T (p.Lys15Ile)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects		Pathogenic(Last reviewed: Nov 5, 2003)	no assertion criteria provided	5	173235040	GRCh38	30112	39067
NC_000005.9:g.(?_94319893)_(95158593_?)dup	GLRX|TTC37|RHOBTB3|MCTP1|SPATA9|ARSK|FAM81B|GPR150|RFESD	See cases		Uncertain significance(Last reviewed: Jan 20, 2016)	criteria provided, single submitter			GRCh38	253708	248156
GRCh38/hg38 5q13.2(chr5:69942850-71291191)x1	GTF2H2|NAIP|SMN1|SMN2|SERF1A|SERF1B	See cases		Benign(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	5	69942850 - 71291191	GRCh38	161045	170889
GRCh38/hg38 5p15.33(chr5:574789-759113)x1	TPPP|CEP72|ZDHHC11B|LOC100996325	See cases		Benign(Last reviewed: Oct 19, 2010)	no assertion criteria provided	5	574789 - 759113	GRCh38	154678	164432
GRCh38/hg38 5p15.33(chr5:79031-138331)x3	PLEKHG4B	See cases		Benign(Last reviewed: Oct 19, 2010)	no assertion criteria provided	5	79031 - 138331	GRCh38	154676	164430
GRCh38/hg38 5q35.2-35.3(chr5:176700128-181269805)x1	CANX|DBN1|F12|FGFR4|FLT4|GRK6|GRM6|HK3|HNRNPAB|HNRNPH1|LTC4S|MGAT1|MAPK9|PROP1|SLC34A1|ZNF354A|TRP-TGG3-1|TRT-TGT6-1|TRV-AAC1-4|TRV-CAC1-2|TRV-AAC1-3|SQSTM1|PDLIM7|ADAMTS2|MAML1|GFPT2|RACK1|RGS14|BTNL3|LMAN2|MGAT4B|B4GALT7|TBC1D9B|N4BP3|ZNF346|OR2V1|PRELID1|ZNF354C|MRNIP|DDX41|UIMC1|RAB24|FAM193B|TMED9|NHP2|RNF130|CLK4|CNOT6|NSD1|RMND5B|BTNL8|DOK3|ZFP2|RUFY1|PRR7|TRIM7|MXD3|TRIM52|PHYKPL|UNC5A|TRIM41|COL23A1|SCGB3A1|ZNF354B|OR2Y1|BTNL9|RASGEF1C|FAM153A|OR2V2|ZNF454|C5orf60|PRR7-AS1|PFN3|ZNF879|MIR340|SNORD95|SNORD96A|ZFP62|CBY3|LINC00847|TRK-CTT2-3|TRV-CAC1-3|TRV-CAC1-5|LOC100130798|TRV-AAC1-2|TRV-AAC2-1|TRL-AAG1-3|TRL-AAG1-2|TRA-TGC3-1|TRL-AAG2-1|TRL-AAG1-1|TRK-CTT2-2|TRV-CAC1-4|MIR1229|TRIM52-AS1|MIR4638|HEIH|LOC100996419|LOC101928445|CTC-338M12.4|MIR8089|LINC01574|LOC102577426|LOC105377752|LOC105377763	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	5	176700128 - 181269805	GRCh38	154581	164335
GRCh38/hg38 5q35.1-35.2(chr5:173237772-176614618)x3	CLTB|DRD1|HRH2|MSX2|STC2|CPLX2|RNF44|FAF2|NOP16|HMP19|CDHR2|KIAA1191|CPEB4|THOC3|BOD1|SFXN1|GPRIN1|C5orf47|HIGD2A|FAM153B|LOC285593|ARL10|SIMC1|FLJ16171|MIR1271|LOC100507387|MIR4634|LOC100996385|LINC01484|LINC01485|LINC01411|MIR8056	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	5	173237772 - 176614618	GRCh38	154580	164334
GRCh38/hg38 5p15.33(chr5:22149-1659135)x3	SDHA|SLC6A3|SLC9A3|TERT|TRIP13|PDCD6|SLC12A7|TPPP|EXOC3|PP7080|CEP72|AHRR|BRD9|ZDHHC11|LPCAT1|CLPTM1L|NKD2|EXOC3-AS1|CCDC127|PLEKHG4B|SLC6A19|SLC6A18|LRRC14B|ZDHHC11B|LOC100288152|LOC100506688|LINC01511|MIR4457|MIR4456|MIR4635|LOC100996325|CTD-3080P12.3|MIR6075|HRAT5	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	5	22149 - 1659135	GRCh38	154579	164333
GRCh38/hg38 5p15.2(chr5:12513493-13227648)x1	LINC01194	See cases		Uncertain significance(Last reviewed: Jan 27, 2011)	no assertion criteria provided	5	12513493 - 13227648	GRCh38	154491	164245
GRCh38/hg38 5p15.33(chr5:629140-820501)x3	TPPP|CEP72|ZDHHC11|ZDHHC11B	See cases		Benign(Last reviewed: Jul 30, 2009)	no assertion criteria provided	5	629140 - 820501	GRCh38	154477	164231
GRCh38/hg38 5q35.2-35.3(chr5:176517339-177709289)x1	DBN1|F12|FGFR4|GRK6|HK3|SLC34A1|SNCB|PDLIM7|RGS14|LMAN2|B4GALT7|RNF44|ZNF346|TSPAN17|PRELID1|DDX41|UIMC1|RAB24|FAM193B|TMED9|CDHR2|NSD1|DOK3|PRR7|MXD3|UNC5A|GPRIN1|EIF4E1B|FAM153A|PRR7-AS1|PFN3|MIR4281|LINC01574	See cases		Pathogenic(Last reviewed: Jan 27, 2011)	no assertion criteria provided	5	176517339 - 177709289	GRCh38	154471	164225
GRCh38/hg38 5q31.3-32(chr5:141089988-149530678)x3	ADRB2|CSNK1A1|DIAPH1|DPYSL3|FGF1|NR3C1|HTR4|PCDH1|PCDHGC3|POU4F3|PPP2R2B|SPINK1|TAF7|PCDHGB4|HDAC3|RNF14|PCDHGA8|KIAA0141|JAKMIP2|GNPDA1|TCERG1|SPINK5|ABLIM3|ARHGAP26|PCDHGA12|PCDHB5|IL17B|PCDH12|LARS|RBM27|PCDHGC5|PCDHGC4|PCDHGB7|PCDHGB6|PCDHGB5|PCDHGB3|PCDHGB2|PCDHGB1|PCDHGA11|PCDHGA10|PCDHGA9|PCDHGA7|PCDHGA6|PCDHGA5|PCDHGA4|PCDHGA3|PCDHGA2|PCDHGA1|PCDHG@|PCDHB@|PCDHB15|PCDHB14|PCDHB13|PCDHB12|PCDHB11|PCDHB10|PCDHB9|PCDHB8|PCDHB7|PCDHB6|PCDHB4|PCDHB3|PCDHB2|KCTD16|PCDHB16|HMHB1|ARAP3|PCYOX1L|SH3TC2|NDFIP1|FBXO38|YIPF5|SPRY4|SLC25A2|SPINK7|FCHSD1|SCGB3A2|AFAP1L1|GRPEL2|GPR151|SPINK13|JAKMIP2-AS1|PRELID2|SH3RF2|PLAC8L1|STK32A|LOC255187|RELL2|C5orf46|SPINK6|MIR143|MIR145|SPINK14|GRXCR2|SPINK9|MIR584|CARMN|LOC100505658|SPRY4-IT1|MIR5197|ARHGAP26-AS1|PPP2R2B-IT1|ARHGAP26-IT1|LOC101926941|LOC101926975|LOC102546294|LOC105378220|GRPEL2-AS1	See cases		Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	5	141089988 - 149530678	GRCh38	150685	160436
GRCh38/hg38 5p15.33(chr5:22149-90168)x3	PLEKHG4B	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	5	22149 - 90168	GRCh38	150471	160222
GRCh38/hg38 5p12-11(chr5:45273484-46114984)x3	HCN1	See cases		Uncertain significance(Last reviewed: Dec 22, 2010)	no assertion criteria provided	5	45273484 - 46114984	GRCh38	149913	159664
GRCh38/hg38 5q23.3-33.2(chr5:129847794-153353546)x3	ADRB2|ANXA6|ATOX1|CAMK2A|CAMLG|CD14|CD74|CDC25C|CDX1|CSF1R|CSF2|CSNK1A1|CTNNA1|DIAPH1|DPYSL3|SLC26A2|HBEGF|EGR1|ETF1|FAT2|FGF1|GDF9|GFRA3|GLRA1|GM2A|GPX3|NR3C1|HARS|HINT1|HSPA4|HSPA9|NDST1|HTR4|IK|IL3|IL4|IL5|IL9|IL13|IRF1|LECT2|SMAD5|NDUFA2|NEUROG1|NPY6R|PCDH1|PCDHGC3|PDE6A|PDGFRB|PFDN1|PITX1|POU4F3|PPP2CA|PPP2R2B|PURA|RPS14|RPS20P4|SKP1|SLC6A7|SLC22A4|SLC22A5|SPARC|SPINK1|SPOCK1|TAF7|TCF7|TCOF1|TGFBI|UBE2B|UBE2D2|VDAC1|WNT8A|NME5|PDLIM4|EIF4EBP3|PCDHGB4|CDC23|HDAC3|P4HA2|MYOT|NRG2|CXCL14|H2AFY|SMAD5-AS1|RNF14|PCDHGA8|PCDHA9|MATR3|KIAA0141|JAKMIP2|DDX46|SLC23A1|GNPDA1|SRA1|RAD50|KIF20A|G3BP1|APBB3|TNIP1|SEC24A|BRD8|TCERG1|HNRNPA0|SPINK5|KIF3A|SYNPO|ABLIM3|HMGXB3|ARHGAP26|FSTL4|SEPT8|ACSL6|JADE2|HARS2|PCDHGA12|LRRTM2|CCDC69|PCDHB5|FBXL21|KLHL3|SNORD63|SNORA74A|PKD2L2|UQCRQ|AFF4|IL17B|PCDHB1|SAR1B|DCTN4|MZB1|PAIP2|CDKL3|PCDH12|FAM13B|FAM53C|REEP2|LARS|CXXC5|RAPGEF6|KDM3B|RBM27|ZCCHC10|WDR55|ANKHD1|TMCO6|RBM22|PCDHGC5|PCDHGC4|PCDHGB7|PCDHGB6|PCDHGB5|PCDHGB3|PCDHGB2|PCDHGB1|PCDHGA11|PCDHGA10|PCDHGA9|PCDHGA7|PCDHGA6|PCDHGA5|PCDHGA4|PCDHGA3|PCDHGA2|PCDHGA1|PCDHG@|PCDHB@|PCDHA@|PCDHACT|PCDHB15|PCDHB14|PCDHB13|PCDHB12|PCDHB11|PCDHB10|PCDHB9|PCDHB8|PCDHB7|PCDHB6|PCDHB4|PCDHB3|PCDHB2|PCDHAC2|PCDHAC1|PCDHA13|PCDHA12|PCDHA11|PCDHA10|PCDHA8|PCDHA7|PCDHA6|PCDHA5|PCDHA4|PCDHA3|PCDHA2|PCDHA1|VTRNA1-3|VTRNA1-2|VTRNA1-1|NMUR2|C5orf15|CDC42SE2|TRPC7|KCTD16|PCDHB16|HMHB1|SIL1|ARAP3|PCYOX1L|SH3TC2|TXNDC15|NDFIP1|FBXO38|YIPF5|TIGD6|SPRY4|SLC4A9|SLC25A2|PCBD2|PSD2|CYSTM1|SPINK7|SMIM3|FCHSD1|LYRM7|CDKN2AIPNL|ZNF300|MYOZ3|FNIP1|SLC35A4|LEAP2|SCGB3A2|PPARGC1B|AFAP1L1|GRPEL2|GPR151|SOWAHA|SHROOM1|C5orf24|DCANP1|SLC36A2|SPINK13|SLC25A48|JAKMIP2-AS1|ZMAT2|PRELID2|SH3RF2|PLAC8L1|SPATA24|DNAJC18|STK32A|SLC36A1|LOC255187|RELL2|SLC36A3|CHSY3|TMEM173|C5orf66-AS2|LOC340074|ARSI|IRGM|CATSPER3|DND1|LOC389332|PROB1|C5orf46|ARHGEF37|SPINK6|ANKHD1-EIF4EBP3|MIR143|MIR145|SPINK14|C5orf56|IGIP|MIR378A|TIFAB|LOC553103|ECSCR|GRXCR2|SPINK9|CCNI2|MIR584|SNHG4|CARMN|MEIKIN|VTRNA2-1|MIR874|LOC100130172|MIR1289-2|MIR3655|MIR3936|MIR3661|LINC01024|LOC100505658|MIR4461|SPRY4-IT1|LOC100652758|MIR5197|MIR5692C1|P4HA2-AS1|ARHGAP26-AS1|PPP2R2B-IT1|ARHGAP26-IT1|C5orf66|LOC101926905|LOC101926941|LOC101926975|CTB-113P19.1|CTB-12O2.1|LINC01470|TH2LCRR|LOC101927934|C5orf66-AS1|LOC101929696|LOC101929719|MIR6499|MIR6830|MIR6831|LOC102546229|LOC102546294|LOC102546298|LOC105378220|LOC105379176|LOC105379183|LOC105379192|LOC105379194|WSPAR|GRPEL2-AS1|TRPC7-AS2|LOC107986453	See cases		Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	5	129847794 - 153353546	GRCh38	149858	159609
GRCh38/hg38 5q13.2(chr5:69942850-71032915)x3	NAIP|SMN1|SMN2|SERF1A|SERF1B	See cases		Benign(Last reviewed: Apr 30, 2010)	no assertion criteria provided	5	69942850 - 71032915	GRCh38	144511	154262
GRCh38/hg38 5q21.3-33.2(chr5:106619588-156124387)x1	ADRB2|ANXA6|APC|ATOX1|ALDH7A1|CAMK4|CAMK2A|CAMLG|CD14|CD74|CDC25C|CDO1|CDX1|AP3S1|CSF1R|CSF2|CSNK1A1|CSNK1G3|CTNNA1|DMXL1|DIAPH1|DPYSL3|SLC26A2|HBEGF|EFNA5|EGR1|ETF1|FAT2|FBN2|FER|FGF1|GDF9|GFRA3|GLRA1|GM2A|GPX3|GRIA1|NR3C1|HARS|HINT1|HSD17B4|HSPA4|HSPA9|NDST1|HTR4|IK|IL3|IL4|IL5|IL9|IL13|IRF1|KCNN2|LECT2|LMNB1|LOX|SMAD5|MAN2A1|MCC|MFAP3|NDUFA2|NEUROG1|NPY6R|PCDH1|PCDHGC3|PDE6A|PDGFRB|PFDN1|PGGT1B|PITX1|POU4F3|PPIC|PPP2CA|PPP2R2B|PURA|RPS14|RPS20P3|RPS20P4|SGCD|SKP1|SLC6A7|SLC12A2|SLC22A4|SLC22A5|SNX2|SPARC|SPINK1|SPOCK1|SRP19|TAF7|TCF7|TCOF1|TGFBI|ZRSR1|UBE2B|UBE2D2|VDAC1|WNT8A|REEP5|NME5|PDLIM4|EIF4EBP3|PCDHGB4|CDC23|HDAC3|P4HA2|ATG12|NREP|CNOT8|HAND1|MYOT|NRG2|CXCL14|H2AFY|SMAD5-AS1|RNF14|SNCAIP|PCDHGA8|PCDHA9|MATR3|KIAA0141|JAKMIP2|PJA2|DDX46|SLC23A1|GNPDA1|SRA1|RAD50|KIF20A|G3BP1|APBB3|TNIP1|SEC24A|FAXDC2|FAM114A2|BRD8|TCERG1|HNRNPA0|SPINK5|KIF3A|SYNPO|ABLIM3|HMGXB3|ARHGAP26|FSTL4|SEPT8|ACSL6|JADE2|LARP1|HARS2|TNFAIP8|GEMIN5|PCDHGA12|LRRTM2|CCDC69|PCDHB5|FBXL21|KLHL3|SNORD63|SNORA74A|PKD2L2|UQCRQ|AFF4|IL17B|SLC27A6|SNX24|MRPL22|PCDHB1|TMED7|ISOC1|SAR1B|DCTN4|MZB1|PAIP2|CDKL3|PCDH12|FAM13B|FAM53C|REEP2|PRR16|COMMD10|LARS|CXXC5|RAPGEF6|KDM3B|PHAX|RBM27|EPB41L4A-AS2|ZCCHC10|WDR55|ANKHD1|TMCO6|TRIM36|GALNT10|RBM22|PCDHGC5|PCDHGC4|PCDHGB7|PCDHGB6|PCDHGB5|PCDHGB3|PCDHGB2|PCDHGB1|PCDHGA11|PCDHGA10|PCDHGA9|PCDHGA7|PCDHGA6|PCDHGA5|PCDHGA4|PCDHGA3|PCDHGA2|PCDHGA1|PCDHG@|PCDHB@|PCDHA@|PCDHACT|PCDHB15|PCDHB14|PCDHB13|PCDHB12|PCDHB11|PCDHB10|PCDHB9|PCDHB8|PCDHB7|PCDHB6|PCDHB4|PCDHB3|PCDHB2|PCDHAC2|PCDHAC1|PCDHA13|PCDHA12|PCDHA11|PCDHA10|PCDHA8|PCDHA7|PCDHA6|PCDHA5|PCDHA4|PCDHA3|PCDHA2|PCDHA1|VTRNA1-3|VTRNA1-2|VTRNA1-1|NMUR2|FEM1C|C5orf15|CDC42SE2|TRPC7|ZNF608|KCTD16|SEMA6A|PCDHB16|HMHB1|EPB41L4A|SIL1|ARAP3|FBXL17|YTHDC2|GRAMD3|PCYOX1L|SH3TC2|SAP30L|TXNDC15|NDFIP1|FBXO38|YIPF5|TIGD6|SPRY4|SLC4A9|SLC25A2|TSSK1B|PCBD2|PSD2|CYSTM1|MEGF10|SPINK7|SMIM3|TSLP|FCHSD1|LYRM7|SLC25A46|CDKN2AIPNL|ZNF300|MYOZ3|PRDM6|FTMT|FNIP1|SLC35A4|EPB41L4A-AS1|MARCH3|LEAP2|SCGB3A2|PPARGC1B|PRRC1|ZNF474|AFAP1L1|GRPEL2|GPR151|STARD4|WDR36|SOWAHA|SHROOM1|C5orf24|DCANP1|MGC32805|SLC36A2|SPINK13|CEP120|SLC25A48|SRFBP1|JAKMIP2-AS1|ZMAT2|CCDC112|PRELID2|SH3RF2|PLAC8L1|DCP2|ADAMTS19|SPATA24|DNAJC18|STK32A|LVRN|SLC36A1|LOC255187|DTWD2|RELL2|SLC36A3|KIF4B|CHSY3|TMEM173|FAM170A|C5orf66-AS2|LOC340074|ARSI|IRGM|CATSPER3|TICAM2|DND1|SAP30L-AS1|TEX43|LOC389332|PROB1|C5orf46|ARHGEF37|C5orf63|SPINK6|ANKHD1-EIF4EBP3|MIR143|MIR145|SPINK14|C5orf56|IGIP|MIR378A|TIFAB|LOC553103|CTXN3|ECSCR|TMEM232|GRXCR2|SPINK9|ARL14EPL|LINC01184|CCNI2|SNORA13|MIR584|SNHG4|CARMN|LINC00992|CCDC192|MEIKIN|VTRNA2-1|MIR874|KIAA1024L|LOC100130172|MIR1289-2|MIR548F3|MIR1294|MIR1303|TMED7-TICAM2|MIR1244-2|MIR3141|MIR3655|MIR3936|MIR3661|LINC01024|LOC100505658|STARD4-AS1|HNCAT21|LOC100505841|MIR4633|MIR4461|MIR378H|MIR4460|SPRY4-IT1|LOC100652758|LINC01023|MIR5197|MIR5692C1|MIR5706|P4HA2-AS1|NREP-AS1|ARHGAP26-AS1|PPP2R2B-IT1|ARHGAP26-IT1|C5orf66|LOC101926905|LOC101926941|LOC101926975|LOC101927023|LOC101927059|LOC101927078|CTB-113P19.1|LOC101927100|CTB-12O2.1|LINC01470|LOC101927190|SEMA6A-AS1|HRAT56|LOC101927357|LOC101927379|LOC101927421|LOC101927460|LOC101927488|TH2LCRR|LOC101927934|C5orf66-AS1|LOC101929696|LOC101929719|MIR6499|MIR6830|MIR6831|LOC102467213|LOC102467214|LOC102467216|LOC102467217|LOC102467223|LOC102467224|LOC102467225|LOC102467226|LOC102546228|LOC102546229|LOC102546294|LOC102546298|LOC102723557|ADAMTS19-AS1|LINC01170|LOC105378220|LOC105379143|LOC105379176|LOC105379183|LOC105379192|LOC105379194|WSPAR|GRPEL2-AS1|TRPC7-AS2|LOC107986453	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	5	106619588 - 156124387	GRCh38	59672	74267
GRCh38/hg38 5p15.33-15.2(chr5:22149-12004091)x1	ADCY2|CTNND2|DAP|MTRR|NDUFS6|SDHA|SLC6A3|SLC9A3|SRD5A1|TERT|SEMA5A|TRIP13|PDCD6|MARCH6|SLC12A7|PAPD7|TPPP|EXOC3|CCT5|ICE1|PP7080|IRX4|TAS2R1|NSUN2|CEP72|AHRR|MRPL36|BRD9|FASTKD3|IRX1|ZDHHC11|LPCAT1|CLPTM1L|ROPN1L|MED10|NKD2|EXOC3-AS1|CCDC127|UBE2QL1|C5orf49|FAM173B|CMBL|PLEKHG4B|C5orf38|IRX2|ADAMTS16|LINC01018|LINC01019|LOC285692|SLC6A19|LINC01020|SLC6A18|LRRC14B|LOC389273|FLJ33360|ANKRD33B|ZDHHC11B|LOC729506|SNORD123|LOC100288152|MIR4277|MIR4278|LOC100505625|MIR4458HG|SNHG18|ROPN1L-AS1|LOC100506688|LINC01511|LOC100506858|MIR4458|MIR4457|MIR4636|MIR4456|MIR4635|LOC100996325|CTD-3080P12.3|LOC101929034|CTD-2194D22.4|LOC101929153|CTD-2297D10.2|LOC101929261|LOC101929284|CTD-2201E9.1|LOC101929412|MIR6131|MIR6075|HRAT5|LINC01377|LINC01017|LOC105374620|LOC105374631	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	5	22149 - 12004091	GRCh38	59556	74151
GRCh38/hg38 5q14.3(chr5:90590733-90849185)x3	ADGRV1	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	5	90590733 - 90849185	GRCh38	59442	74037
GRCh38/hg38 5p13.2-12(chr5:35700480-45260029)x3	C6|C7|C9|DAB2|FGF10|FYB|GDNF|GHR|HMGCS1|IL7R|LIFR|OXCT1|PRKAA1|PTGER4|RPL37|SELENOP|SKP2|SLC1A3|ZNF131|OSMR|NUP155|PAIP1|MRPS30|NNT|TTC33|NIPBL|FBXO4|WDR70|CCL28|TMEM267|C5orf42|SPEF2|CARD6|LMBRD2|MROH2B|EGFLAM|NADK2|UGT3A1|CAPSL|LOC153684|UGT3A2|NIM1K|RANBP3L|RICTOR|C5orf51|PLCXD3|HCN1|C5orf34|ANXA2R|SNORD72|FLJ32255|NIPBL-AS1|LOC648987|MIR580|CCDC152|LOC100132356|MIR3650|LOC100506406|EGFLAM-AS2|LIFR-AS1|LOC100506548|LOC100506639|BRCAT54|NNT-AS1|EGFLAM-AS4|GDNF-AS1|OXCT1-AS1|LINC01265|LOC101926940|LOC101926960|FGF10-AS1|LOC101929745|OSMR-AS1|LINC00603|BRCAT107|LOC105374727|LOC105374729	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	5	35700480 - 45260029	GRCh38	58092	72687
GRCh38/hg38 5q23.3-33.2(chr5:130860928-155321811)x3	ADRB2|ANXA6|ATOX1|CAMK2A|CAMLG|CD14|CD74|CDC25C|CDX1|CSF1R|CSF2|CSNK1A1|CTNNA1|DIAPH1|DPYSL3|SLC26A2|HBEGF|EGR1|ETF1|FAT2|FGF1|GDF9|GFRA3|GLRA1|GM2A|GPX3|GRIA1|NR3C1|HARS|HINT1|HSPA4|HSPA9|NDST1|HTR4|IK|IL3|IL4|IL5|IL9|IL13|IRF1|LECT2|SMAD5|MFAP3|NDUFA2|NEUROG1|NPY6R|PCDH1|PCDHGC3|PDE6A|PDGFRB|PFDN1|PITX1|POU4F3|PPP2CA|PPP2R2B|PURA|RPS14|RPS20P4|SKP1|SLC6A7|SLC22A4|SLC22A5|SPARC|SPINK1|SPOCK1|TAF7|TCF7|TCOF1|TGFBI|UBE2B|UBE2D2|VDAC1|WNT8A|NME5|PDLIM4|EIF4EBP3|PCDHGB4|CDC23|HDAC3|P4HA2|CNOT8|HAND1|MYOT|NRG2|CXCL14|H2AFY|SMAD5-AS1|RNF14|PCDHGA8|PCDHA9|MATR3|KIAA0141|JAKMIP2|DDX46|SLC23A1|GNPDA1|SRA1|RAD50|KIF20A|G3BP1|APBB3|TNIP1|SEC24A|FAXDC2|FAM114A2|BRD8|TCERG1|HNRNPA0|SPINK5|KIF3A|SYNPO|ABLIM3|HMGXB3|ARHGAP26|FSTL4|SEPT8|ACSL6|JADE2|LARP1|HARS2|GEMIN5|PCDHGA12|LRRTM2|CCDC69|PCDHB5|FBXL21|KLHL3|SNORD63|SNORA74A|PKD2L2|UQCRQ|AFF4|IL17B|MRPL22|PCDHB1|SAR1B|DCTN4|MZB1|PAIP2|CDKL3|PCDH12|FAM13B|FAM53C|REEP2|LARS|CXXC5|RAPGEF6|KDM3B|RBM27|ZCCHC10|WDR55|ANKHD1|TMCO6|GALNT10|RBM22|PCDHGC5|PCDHGC4|PCDHGB7|PCDHGB6|PCDHGB5|PCDHGB3|PCDHGB2|PCDHGB1|PCDHGA11|PCDHGA10|PCDHGA9|PCDHGA7|PCDHGA6|PCDHGA5|PCDHGA4|PCDHGA3|PCDHGA2|PCDHGA1|PCDHG@|PCDHB@|PCDHA@|PCDHACT|PCDHB15|PCDHB14|PCDHB13|PCDHB12|PCDHB11|PCDHB10|PCDHB9|PCDHB8|PCDHB7|PCDHB6|PCDHB4|PCDHB3|PCDHB2|PCDHAC2|PCDHAC1|PCDHA13|PCDHA12|PCDHA11|PCDHA10|PCDHA8|PCDHA7|PCDHA6|PCDHA5|PCDHA4|PCDHA3|PCDHA2|PCDHA1|VTRNA1-3|VTRNA1-2|VTRNA1-1|NMUR2|C5orf15|CDC42SE2|TRPC7|KCTD16|PCDHB16|HMHB1|SIL1|ARAP3|PCYOX1L|SH3TC2|SAP30L|TXNDC15|NDFIP1|FBXO38|YIPF5|TIGD6|SPRY4|SLC4A9|SLC25A2|PCBD2|PSD2|CYSTM1|SPINK7|SMIM3|FCHSD1|LYRM7|CDKN2AIPNL|ZNF300|MYOZ3|FNIP1|SLC35A4|LEAP2|SCGB3A2|PPARGC1B|AFAP1L1|GRPEL2|GPR151|SOWAHA|SHROOM1|C5orf24|DCANP1|SLC36A2|SPINK13|SLC25A48|JAKMIP2-AS1|ZMAT2|PRELID2|SH3RF2|PLAC8L1|SPATA24|DNAJC18|STK32A|SLC36A1|LOC255187|RELL2|SLC36A3|KIF4B|TMEM173|C5orf66-AS2|LOC340074|ARSI|IRGM|CATSPER3|DND1|SAP30L-AS1|LOC389332|PROB1|C5orf46|ARHGEF37|SPINK6|ANKHD1-EIF4EBP3|MIR143|MIR145|SPINK14|C5orf56|IGIP|MIR378A|TIFAB|LOC553103|ECSCR|GRXCR2|SPINK9|CCNI2|MIR584|SNHG4|CARMN|MEIKIN|VTRNA2-1|MIR874|LOC100130172|MIR1289-2|MIR1294|MIR1303|MIR3141|MIR3655|MIR3936|MIR3661|LINC01024|LOC100505658|MIR4461|MIR378H|SPRY4-IT1|LOC100652758|MIR5197|MIR5692C1|P4HA2-AS1|ARHGAP26-AS1|PPP2R2B-IT1|ARHGAP26-IT1|C5orf66|LOC101926905|LOC101926941|LOC101926975|CTB-113P19.1|CTB-12O2.1|LINC01470|TH2LCRR|LOC101927934|C5orf66-AS1|LOC101929696|LOC101929719|MIR6499|MIR6830|MIR6831|LOC102546229|LOC102546294|LOC102546298|LOC105378220|LOC105379176|LOC105379183|LOC105379192|LOC105379194|WSPAR|GRPEL2-AS1|TRPC7-AS2|LOC107986453	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	5	130860928 - 155321811	GRCh38	57483	72078
GRCh38/hg38 5q13.2(chr5:69942850-71291191)x1	GTF2H2|NAIP|SMN1|SMN2|SERF1A|SERF1B	See cases		Benign(Last reviewed: Jul 1, 2013)	no assertion criteria provided	5	69942850 - 71291191	GRCh38	32259	40924
NM_001453.2(FOXC1):c.67C>T (p.Gln23Ter)	FOXC1	Axenfeld-Rieger syndrome type 3		Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	6	1610512	GRCh38	8455	23494
NM_004415.3(DSP):c.12C>G (p.Asn4Lys)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GMAF:0.00200(G), GO-ESP:0.00497(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7541927	GRCh38	44858	54025
NM_004415.3(DSP):c.88G>A (p.Val30Met)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiomyopathy|Cardiomyopathy, ARVC	GO-ESP:0.00124(A), GMAF:0.00220(A), GO-ESP:0.00311(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7542003	GRCh38	16846	31885
NM_004415.3(DSP):c.478C>T (p.Arg160Ter)	DSP	Arrhythmogenic right ventricular cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, multiple submitters, no conflicts	6	7559281	GRCh38	44922	54089
NM_004415.3(DSP):c.522T>C (p.Cys174=)	DSP	not specified|Cardiovascular phenotype	GMAF:0.00060(C), GO-ESP:0.00035(C)	Benign/Likely benign(Last reviewed: Jan 25, 2013)	criteria provided, multiple submitters, no conflicts	6	7559325	GRCh38	163239	174384
NM_004415.3(DSP):c.667G>A (p.Gly223Ser)	DSP	Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00005(A)	Likely benign(Last reviewed: Jun 26, 2015)	criteria provided, single submitter	6	7562721	GRCh38	264110	258442
NM_004415.3(DSP):c.688G>A (p.Asp230Asn)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|not specified|not provided	GO-ESP:0.00038(A), GO-ESP:0.00040(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2016)	criteria provided, conflicting interpretations	6	7562742	GRCh38	44945	54112
NM_004415.3(DSP):c.774G>C (p.Leu258=)	DSP	Cardiovascular phenotype	GO-ESP:0.00001(C)	Likely benign(Last reviewed: Jul 31, 2015)	criteria provided, single submitter	6	7563783	GRCh38	264203	258443
NM_004415.3(DSP):c.782C>T (p.Ala261Val)	DSP	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00038(T), GMAF:0.00040(T), GO-ESP:0.00015(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2015)	criteria provided, conflicting interpretations	6	7565363	GRCh38	44956	54123
NM_004415.3(DSP):c.852G>A (p.Met284Ile)	DSP	not specified		Uncertain significance(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	6	7565433	GRCh38	199854	197030
NM_004415.3(DSP):c.888C>G (p.Tyr296Ter)	DSP	not provided	GMAF:0.00020(T)	Pathogenic(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	6	7565469	GRCh38	199855	197032
NM_004415.3(DSP):c.913A>T (p.Ile305Phe)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.02968(T), GMAF:0.01840(T), GO-ESP:0.02993(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7565494	GRCh38	36026	44690
NM_004415.3(DSP):c.928dupG (p.Glu310Glyfs)	DSP	not provided		Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	6	7565509	GRCh38	199916	197033
NM_004415.3(DSP):c.939+1G>A	DSP	Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, multiple submitters, no conflicts	6	7565521	GRCh38	178282	173844
NM_004415.3(DSP):c.943C>T (p.Arg315Cys)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiomyopathy, ARVC	GMAF:0.00020(T), GO-ESP:0.00008(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7566380	GRCh38	44982	54149
NM_004415.3(DSP):c.1090A>G (p.Ile364Val)	DSP	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	6	7567399	GRCh38	263729	258438
NM_004415.3(DSP):c.1206G>A (p.Lys402=)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GMAF:0.00100(A), GO-ESP:0.00124(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7567846	GRCh38	137168	140871
NM_004415.3(DSP):c.1264G>A (p.Glu422Lys)	DSP	not specified|not provided		Uncertain significance(Last reviewed: Dec 18, 2013)	criteria provided, single submitter	6	7567904	GRCh38	44853	54020
NM_004415.3(DSP):c.1274G>A (p.Arg425Gln)	DSP	not specified|Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Dec 14, 2015)	criteria provided, multiple submitters, no conflicts	6	7568444	GRCh38	44857	54024
NM_004415.3(DSP):c.1468C>T (p.Arg490Cys)	DSP	not specified	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	6	7569234	GRCh38	199861	197041
NM_004415.3(DSP):c.1481A>T (p.Tyr494Phe)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00054(T), GMAF:0.01780(T), GO-ESP:0.01176(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7569247	GRCh38	44860	54027
NM_004415.3(DSP):c.1482C>T (p.Tyr494=)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Mar 11, 2016)	criteria provided, multiple submitters, no conflicts	6	7569248	GRCh38	246659	245265
NM_004415.3(DSP):c.1488G>A (p.Thr496=)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00215(A), GMAF:0.00240(A), GO-ESP:0.00109(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7569254	GRCh38	44861	54028
NM_004415.3(DSP):c.1778A>G (p.Asn593Ser)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00085(G), GMAF:0.00020(G), GO-ESP:0.00051(G)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 12, 2016)	criteria provided, conflicting interpretations	6	7571459	GRCh38	44867	54034
NM_004415.3(DSP):c.1920C>T (p.Ile640=)	DSP	not specified|Cardiovascular phenotype	GMAF:0.00100(T), GO-ESP:0.00047(T)	Benign/Likely benign(Last reviewed: Feb 26, 2013)	criteria provided, multiple submitters, no conflicts	6	7571858	GRCh38	178027	173990
NM_004415.3(DSP):c.2027G>A (p.Arg676His)	DSP	not provided	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	6	7571965	GRCh38	199865	197046
NM_004415.3(DSP):c.2047G>A (p.Glu683Lys)	DSP	Cardiac arrest	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	6	7571985	GRCh38	222574	224322
NM_004415.3(DSP):c.2122G>A (p.Glu708Lys)	DSP	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: May 22, 2015)	criteria provided, single submitter	6	7572060	GRCh38	264019	258445
NM_004415.3(DSP):c.2131_2132delAG (p.Ser711Cysfs)	DSP	Primary dilated cardiomyopathy|not provided|Ventricular tachycardia|Left ventricular noncompaction cardiomyopathy|Ventricular tachycardia|Left ventricular noncompaction cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	6	7574086 - 7574087	GRCh38	143947	153685
NM_004415.3(DSP):c.2182G>C (p.Asp728His)	DSP	not specified		Uncertain significance(Last reviewed: Aug 20, 2014)	criteria provided, single submitter	6	7574137	GRCh38	199866	197047
NM_004415.3(DSP):c.2260G>A (p.Glu754Lys)	DSP	Cardiac arrest	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Sep 4, 2014)	no assertion criteria provided	6	7574215	GRCh38	180323	178550
NM_004415.3(DSP):c.2346C>T (p.Asp782=)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00146(T), GMAF:0.00040(T), GO-ESP:0.00146(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7574705	GRCh38	44873	54040
NM_004415.3(DSP):c.2468C>T (p.Ser823Leu)	DSP	not specified	GMAF:0.00020(T), GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	6	7575326	GRCh38	199869	197050
NM_004415.3(DSP):c.2552T>A (p.Leu851Gln)	DSP	not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	6	7575410	GRCh38	199870	197051
NM_004415.3(DSP):c.2596C>T (p.Arg866Cys)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00208(T), GMAF:0.00160(T), GO-ESP:0.00061(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7575454	GRCh38	44876	54043
NM_004415.3(DSP):c.2631G>A (p.Arg877=)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.74812(A), GMAF:0.26460(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7576294	GRCh38	44877	54044
NM_004415.3(DSP):c.2708A>G (p.Tyr903Cys)	DSP	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Oct 14, 2014)	criteria provided, single submitter	6	7576371	GRCh38	199933	197055
NM_004415.3(DSP):c.2723G>A (p.Arg908His)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|not provided|Cardiomyopathy, ARVC	GO-ESP:0.00112(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7576386	GRCh38	177781	173850
NM_004415.3(DSP):c.2815G>A (p.Gly939Ser)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.01330(A), GMAF:0.01060(A), GO-ESP:0.00369(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7576980	GRCh38	36020	44684
NM_004415.3(DSP):c.2821C>T (p.Arg941Ter)	DSP	Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiac arrest		Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, multiple submitters, no conflicts	6	7576986	GRCh38	180326	178554
NM_004415.3(DSP):c.2866A>T (p.Asn956Tyr)	DSP	not specified|Cardiovascular phenotype	GMAF:0.00100(T), GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Dec 24, 2015)	criteria provided, multiple submitters, no conflicts	6	7577031	GRCh38	44887	54054
NM_004415.3(DSP):c.2985G>A (p.Glu995=)	DSP	not provided	GO-ESP:0.00002(A)	Likely pathogenic(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	6	7577886	GRCh38	199877	197059
NM_004415.3(DSP):c.3195C>G (p.Tyr1065Ter)	DSP	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	6	7579385	GRCh38	264512	258450
NM_004415.3(DSP):c.3303C>T (p.Tyr1101=)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00007(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7579493	GRCh38	227342	229496
NM_004415.3(DSP):c.3510G>A (p.Glu1170=)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.01092(A), GMAF:0.00820(A), GO-ESP:0.00303(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7579700	GRCh38	44893	54060
NM_004415.3(DSP):c.3646A>G (p.Ile1216Val)	DSP	not specified|not provided|Cardiovascular phenotype	GMAF:0.00060(G), GO-ESP:0.00017(G)	Uncertain significance(Last reviewed: Sep 30, 2015)	criteria provided, multiple submitters, no conflicts	6	7579836	GRCh38	44894	54061
NM_004415.3(DSP):c.3661A>G (p.Ile1221Val)	DSP	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 7, 2015)	criteria provided, multiple submitters, no conflicts	6	7579851	GRCh38	199878	197065
NM_004415.3(DSP):c.3800G>A (p.Arg1267Gln)	DSP	not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	6	7579990	GRCh38	199934	197070
NM_004415.3(DSP):c.3877A>G (p.Ile1293Val)	DSP	Cardiovascular phenotype	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Sep 3, 2013)	criteria provided, single submitter	6	7580067	GRCh38	263657	258452
NM_004415.3(DSP):c.3922C>T (p.Arg1308Trp)	DSP	Cardiovascular phenotype	GO-ESP:0.00012(T)	Uncertain significance(Last reviewed: May 11, 2015)	criteria provided, single submitter	6	7580112	GRCh38	264035	258446
NM_004415.3(DSP):c.3963G>A (p.Gln1321=)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.01138(A), GMAF:0.00580(A), GO-ESP:0.01385(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7580153	GRCh38	44897	54064
NM_004415.3(DSP):c.3971A>T (p.Asn1324Ile)	DSP	not specified|Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Dec 1, 2015)	criteria provided, multiple submitters, no conflicts	6	7580161	GRCh38	199935	197073
NM_004415.3(DSP):c.4065T>C (p.Tyr1355=)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00108(C), GO-ESP:0.00109(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7580255	GRCh38	44899	54066
NM_004415.3(DSP):c.4198C>T (p.Arg1400Ter)	DSP	not provided	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: May 2, 2014)	criteria provided, single submitter	6	7580388	GRCh38	199884	197076
NM_004415.3(DSP):c.4353_4357delGAGAC (p.Arg1452Serfs)	DSP	Cardiovascular phenotype		Likely pathogenic(Last reviewed: May 20, 2015)	criteria provided, single submitter	6	7580543 - 7580547	GRCh38	264015	258447
NM_004415.3(DSP):c.4372C>G (p.Arg1458Gly)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Left ventricular noncompaction cardiomyopathy|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiomyopathy, ARVC	GO-ESP:0.00169(G), GMAF:0.00180(G), GO-ESP:0.00174(G)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2016)	criteria provided, conflicting interpretations	6	7580562	GRCh38	44906	54073
NM_004415.3(DSP):c.4401A>G (p.Gln1467=)	DSP	Cardiovascular phenotype	GMAF:0.00100(G), GO-ESP:0.00010(G)	Likely benign(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	6	7580591	GRCh38	263576	258456
NM_004415.3(DSP):c.4535A>G (p.Tyr1512Cys)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.12094(G), GMAF:0.20330(G), GO-ESP:0.11560(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7580725	GRCh38	44915	54082
NM_004415.3(DSP):c.4578C>A (p.Asn1526Lys)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.05159(A), GMAF:0.05110(A), GO-ESP:0.01352(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7580768	GRCh38	44919	54086
NM_004415.3(DSP):c.4752G>A (p.Ala1584=)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Cardiovascular phenotype|Cardiomyopathy, ARVC	GMAF:0.00020(A), GO-ESP:0.00008(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7580942	GRCh38	264550	258459
NM_004415.3(DSP):c.4773G>A (p.Arg1591=)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Cardiomyopathy|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.01307(A), GMAF:0.00720(A), GO-ESP:0.01347(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7580963	GRCh38	36021	44685
NM_004415.3(DSP):c.4836C>T (p.Ile1612=)	DSP	Cardiovascular phenotype		Likely benign(Last reviewed: Jun 26, 2015)	criteria provided, single submitter	6	7581026	GRCh38	264133	258448
NM_004415.3(DSP):c.5035C>T (p.His1679Tyr)	DSP	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	6	7581225	GRCh38	199888	197083
NM_004415.3(DSP):c.5108T>A (p.Ile1703Asn)	DSP	not provided		Uncertain significance(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	6	7581298	GRCh38	199889	197085
NM_004415.3(DSP):c.5167G>C (p.Glu1723Gln)	DSP	not specified|not provided	GO-ESP:0.00100(C), GMAF:0.00020(C), GO-ESP:0.00022(C)	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2016)	criteria provided, conflicting interpretations	6	7581357	GRCh38	44924	54091
NM_004415.3(DSP):c.5178C>A (p.Asn1726Lys)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|not provided|Cardiomyopathy, ARVC	GMAF:0.00040(A), GO-ESP:0.00086(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7581368	GRCh38	178032	174000
NM_004415.3(DSP):c.5218G>A (p.Glu1740Lys)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|not provided|Cardiomyopathy, ARVC	GO-ESP:0.00092(A), GMAF:0.00040(A), GO-ESP:0.00124(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7581408	GRCh38	44926	54093
NM_004415.3(DSP):c.5324G>T (p.Arg1775Ile)	DSP	Arrhythmogenic right ventricular cardiomyopathy|not specified	GMAF:0.00020(T), GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Jun 24, 2016)	criteria provided, multiple submitters, no conflicts	6	7581514	GRCh38	161227	171103
NM_004415.3(DSP):c.5513G>A (p.Arg1838His)	DSP	Primary dilated cardiomyopathy|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiomyopathy, ARVC	GMAF:0.00020(A), GO-ESP:0.00006(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7582775	GRCh38	161225	171104
NM_004415.3(DSP):c.5542A>G (p.Arg1848Gly)	DSP	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 28, 2012)	criteria provided, single submitter	6	7582804	GRCh38	263436	258451
NM_004415.3(DSP):c.5984T>C (p.Leu1995Ser)	DSP	not specified		Uncertain significance(Last reviewed: Mar 25, 2014)	criteria provided, single submitter	6	7583246	GRCh38	199897	197097
NM_004415.3(DSP):c.5991G>A (p.Gly1997=)	DSP	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00004(A)	Likely benign(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	6	7583253	GRCh38	264254	258457
NM_004415.3(DSP):c.6179A>G (p.Asp2060Gly)	DSP	not specified		Uncertain significance(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	6	7583441	GRCh38	199898	197099
NM_004415.3(DSP):c.6208G>A (p.Asp2070Asn)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|not provided|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00331(A), GMAF:0.00260(A), GO-ESP:0.00392(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7583470	GRCh38	44936	54103
NM_004415.3(DSP):c.6307A>G (p.Lys2103Glu)	DSP	Primary dilated cardiomyopathy|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiomyopathy, ARVC	GO-ESP:0.00012(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7583569	GRCh38	180336	178566
NM_004415.3(DSP):c.6441C>T (p.Val2147=)	DSP	Cardiovascular phenotype	GO-ESP:0.00004(T)	Likely benign(Last reviewed: Sep 6, 2013)	criteria provided, single submitter	6	7583703	GRCh38	263733	258460
NM_004415.3(DSP):c.6496C>A (p.Arg2166=)	DSP	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	6	7583758	GRCh38	264195	258449
NM_004415.3(DSP):c.6772A>G (p.Ser2258Gly)	DSP	Cardiovascular phenotype		Uncertain significance(Last reviewed: Mar 11, 2013)	criteria provided, single submitter	6	7584034	GRCh38	263534	258453
NM_004415.3(DSP):c.6902T>C (p.Ile2301Thr)	DSP	Cardiovascular phenotype	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Mar 7, 2013)	criteria provided, single submitter	6	7584164	GRCh38	263528	258458
NM_004415.3(DSP):c.6907G>C (p.Asp2303His)	DSP	not provided		Likely pathogenic(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	6	7584169	GRCh38	199906	197113
NM_004415.3(DSP):c.6927G>A (p.Arg2309=)	DSP	Cardiovascular phenotype	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	6	7584189	GRCh38	264265	258462
NM_004415.3(DSP):c.7097G>A (p.Arg2366His)	DSP	Skin fragility woolly hair syndrome		Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	6	7584359	GRCh38	29672	38627
NM_004415.3(DSP):c.7249G>T (p.Asp2417Tyr)	DSP	Cardiac arrest	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	6	7584511	GRCh38	222585	224335
NM_004415.3(DSP):c.7622G>A (p.Arg2541Lys)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiomyopathy, ARVC	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7584884	GRCh38	228649	229517
NM_004415.3(DSP):c.7644A>T (p.Arg2548=)	DSP	Cardiovascular phenotype		Likely benign(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	6	7584906	GRCh38	264442	258454
NM_004415.3(DSP):c.7738G>T (p.Asp2580Tyr)	DSP	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	6	7585000	GRCh38	264394	258455
NM_004415.3(DSP):c.7780delT (p.Ser2594Profs)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma		Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	6	7585042	GRCh38	60561	75137
NM_004415.3(DSP):c.7916G>A (p.Arg2639Gln)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype|Dysplasia, arrhythmogenic right ventricular|Cardiomyopathy, ARVC	GMAF:0.00360(A), GO-ESP:0.00098(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7585178	GRCh38	163287	174142
NM_004415.3(DSP):c.8019C>T (p.Asp2673=)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00022(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7585281	GRCh38	246675	245281
NM_004415.3(DSP):c.8117_8119delAGA (p.Lys2706del)	DSP	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	6	7585379 - 7585381	GRCh38	44960	54127
NM_004415.3(DSP):c.8175C>A (p.Arg2725=)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.04606(A), GMAF:0.02400(A), GO-ESP:0.04600(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7585437	GRCh38	44961	54128
NM_004415.3(DSP):c.8188delC (p.Gln2730Serfs)	DSP	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	6	7585450	GRCh38	263803	258461
NM_004415.3(DSP):c.8191T>C (p.Tyr2731His)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|not provided|Cardiomyopathy, ARVC	GMAF:0.00500(C), GO-ESP:0.00281(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	7585453	GRCh38	163289	174143
NM_004415.3(DSP):c.8301C>G (p.Thr2767=)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Cardiomyopathy|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00038(G), GMAF:0.00080(G), GO-ESP:0.00056(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7585563	GRCh38	36025	44689
NM_004415.3(DSP):c.8472G>C (p.Gly2824=)	DSP	Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.68807(C), GMAF:0.29050(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7585734	GRCh38	44967	54134
NM_004415.3(DSP):c.8476C>T (p.Arg2826Cys)	DSP	not provided	GO-ESP:0.00001(T)	Likely pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	6	7585738	GRCh38	199911	197125
NM_004415.3(DSP):c.8531G>T (p.Gly2844Val)	DSP	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: May 8, 2014)	criteria provided, single submitter	6	7585793	GRCh38	199912	197127
NM_004415.3(DSP):c.8605A>G (p.Ile2869Val)	DSP	Cardiomyopathy dilated with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GMAF:0.00460(G), GO-ESP:0.00216(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	7585867	GRCh38	137173	140876
NM_181336.3(LEMD2):c.38T>G (p.Leu13Arg)	LEMD2	Cataract Hutterite type		Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	6	33789079	GRCh38	235192	236890
NM_004999.3(MYO6):c.737A>G (p.His246Arg)	MYO6	Sensorineural deafness with hypertrophic cardiomyopathy|Non-syndromic genetic deafness		Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	6	75841299	GRCh38	8581	23620
NM_012160.4(FBXL4):c.64C>T (p.Arg22Ter)	FBXL4	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	GO-ESP:0.00004(A)	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, multiple submitters, no conflicts	6	98926925	GRCh38	209153	205749
NM_001199563.1(BVES):c.602C>T (p.Ser201Phe)	BVES	Muscular dystrophy, limb-girdle, type 2X		Pathogenic(Last reviewed: Aug 9, 2016)	no assertion criteria provided	6	105124593	GRCh38	222033	223742
NM_002290.4(LAMA4):c.5384C>A (p.Pro1795Gln)	LAMA4	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	6	112109504	GRCh38	264038	258423
NM_002290.4(LAMA4):c.4801-3C>T	LAMA4	not specified|Dilated cardiomyopathy 1JJ|Cardiovascular phenotype	GO-ESP:0.00231(A), GMAF:0.00080(A), GO-ESP:0.00051(A)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	6	112117901	GRCh38	44397	53564
NM_002290.4(LAMA4):c.4657C>A (p.Arg1553=)	LAMA4	not specified|Cardiovascular phenotype	GMAF:0.00160(T), GO-ESP:0.00022(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2015)	criteria provided, conflicting interpretations	6	112119299	GRCh38	196891	194052
NM_002290.4(LAMA4):c.4214T>C (p.Leu1405Pro)	LAMA4	Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	6	112128974	GRCh38	264264	258424
NM_002290.4(LAMA4):c.4113-1G>A	LAMA4	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 23, 2015)	criteria provided, single submitter	6	112129076	GRCh38	264298	258427
NM_002290.4(LAMA4):c.3922G>A (p.Val1308Ile)	LAMA4	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00015(T), GMAF:0.00320(T), GO-ESP:0.00117(T)	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2015)	criteria provided, conflicting interpretations	6	112130993	GRCh38	44380	53547
NM_002290.4(LAMA4):c.3683G>C (p.Arg1228Pro)	LAMA4	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 19, 2015)	criteria provided, single submitter	6	112132883	GRCh38	264592	258426
NM_002290.4(LAMA4):c.3573C>A (p.Phe1191Leu)	LAMA4	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	6	112133451	GRCh38	264250	258429
NM_002290.4(LAMA4):c.3351T>C (p.Asp1117=)	LAMA4	Cardiovascular phenotype	GO-ESP:0.00001(G)	Likely benign(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	6	112136165	GRCh38	264319	258433
NM_002290.4(LAMA4):c.3033G>T (p.Leu1011Phe)	LAMA4	not specified|Dilated cardiomyopathy 1JJ|Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00054(A)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 23, 2016)	criteria provided, conflicting interpretations	6	112139808	GRCh38	213589	209879
NM_002290.4(LAMA4):c.2789A>G (p.Glu930Gly)	LAMA4	not specified|Cardiovascular phenotype	GO-ESP:0.00277(C), GMAF:0.00520(C), GO-ESP:0.00119(C)	Benign/Likely benign(Last reviewed: Oct 28, 2015)	criteria provided, multiple submitters, no conflicts	6	112141361	GRCh38	44366	53533
NM_002290.4(LAMA4):c.2634C>T (p.Leu878=)	LAMA4	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00049(A)	Benign/Likely benign(Last reviewed: Nov 4, 2015)	criteria provided, multiple submitters, no conflicts	6	112142131	GRCh38	163788	176848
NM_002290.4(LAMA4):c.2382G>A (p.Thr794=)	LAMA4	not specified|Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00022(T)	Likely benign(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	6	112144884	GRCh38	163789	176849
NM_002290.4(LAMA4):c.1938T>C (p.Asp646=)	LAMA4	not specified	GO-ESP:0.00103(G)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 28, 2015)	criteria provided, conflicting interpretations	6	112155565	GRCh38	177973	178203
NM_002290.4(LAMA4):c.1179C>T (p.Asn393=)	LAMA4	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	6	112175470	GRCh38	264217	258428
NM_002290.4(LAMA4):c.853G>A (p.Glu285Lys)	LAMA4	Cardiovascular phenotype	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	6	112187542	GRCh38	264484	258435
NM_002290.4(LAMA4):c.514G>A (p.Gly172Ser)	LAMA4	not specified|Cardiovascular phenotype	GO-ESP:0.00108(T), GMAF:0.00040(T), GO-ESP:0.00023(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2015)	criteria provided, conflicting interpretations	6	112191840	GRCh38	44402	53569
NM_002667.4(PLN):c.25C>T (p.Arg9Cys)	PLN|CEP85L	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1P|not provided		Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, multiple submitters, no conflicts	6	118558946	GRCh38	13636	28675
NM_002667.4(PLN):c.40_42delAGA (p.Arg14del)	PLN|CEP85L	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1P|Cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, multiple submitters, no conflicts	6	118558961 - 118558963	GRCh38	44580	53747
NM_002667.4(PLN):c.116T>G (p.Leu39Ter)	PLN|CEP85L	Dilated cardiomyopathy 1P|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 18|Sudden cardiac death|Dilated cardiomyopathy|Cardiac arrest	GO-ESP:0.00001(G)	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, multiple submitters, no conflicts	6	118559037	GRCh38	13637	28676
NM_000165.4(GJA1):c.1085G>A (p.Arg362Gln)	GJA1	Atrioventricular septal defect and common atrioventricular junction|Hypoplastic left heart syndrome	GMAF:0.00020(A), GO-ESP:0.00025(A)	Pathogenic(Last reviewed: Aug 8, 2001)	no assertion criteria provided	6	121447932	GRCh38	16990	32029
NM_000165.4(GJA1):c.1127G>A (p.Arg376Gln)	GJA1	Atrioventricular septal defect and common atrioventricular junction|Hypoplastic left heart syndrome	GO-ESP:0.00031(A), GO-ESP:0.00019(A)	Pathogenic(Last reviewed: Aug 8, 2001)	no assertion criteria provided	6	121447974	GRCh38	16991	32030
NM_006073.3(TRDN):c.1721-4A>G	TRDN	not specified|Cardiovascular phenotype	GMAF:0.00640(C), GO-ESP:0.00123(C)	Benign(Last reviewed: May 11, 2015)	criteria provided, multiple submitters, no conflicts	6	123269870	GRCh38	227116	229389
NM_006073.3(TRDN):c.1282C>G (p.Arg428Gly)	TRDN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	6	123366174	GRCh38	264241	258430
NM_006073.3(TRDN):c.1011G>A (p.Lys337=)	TRDN	Cardiovascular phenotype		Likely benign(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	6	123438103	GRCh38	264151	258437
NM_006073.3(TRDN):c.911C>T (p.Pro304Leu)	TRDN|HRAT13	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	6	123464926	GRCh38	264327	258431
NM_006073.3(TRDN):c.482A>G (p.Lys161Arg)	TRDN	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 7, 2015)	criteria provided, single submitter	6	123530508	GRCh38	263984	258440
NM_006073.3(TRDN):c.375C>T (p.Asp125=)	TRDN	Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GMAF:0.00040(A), GO-ESP:0.00014(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	123548470	GRCh38	264376	258432
NM_006073.3(TRDN):c.367G>A (p.Asp123Asn)	TRDN	Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	GO-ESP:0.00070(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	123548478	GRCh38	264130	258439
NM_006073.3(TRDN):c.176C>G (p.Thr59Arg)	TRDN	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness		Pathogenic(Last reviewed: Jun 15, 2012)	no assertion criteria provided	6	123570979	GRCh38	66017	76927
NM_006073.3(TRDN):c.53_56delACAG (p.Asp18Alafs)	TRDN	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness		Pathogenic(Last reviewed: Jun 15, 2012)	no assertion criteria provided	6	123571099 - 123571102	GRCh38	66015	76925
NM_006208.2(ENPP1):c.783C>G (p.Tyr261Ter)	ENPP1	Arterial calcification of infancy		Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	6	131858735	GRCh38	13597	28636
NM_004100.4(EYA4):c.131G>A (p.Gly44Asp)	EYA4	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	6	133446677	GRCh38	264447	258436
NM_004100.4(EYA4):c.179G>T (p.Ser60Ile)	EYA4	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 26, 2012)	criteria provided, single submitter	6	133446725	GRCh38	263420	258441
NM_004100.4(EYA4):c.550A>G (p.Thr184Ala)	EYA4	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	6	133462447	GRCh38	264605	258434
NM_004100.4(EYA4):c.783G>A (p.Thr261=)	EYA4	not specified|Cardiovascular phenotype	GO-ESP:0.00139(A), GMAF:0.00100(A), GO-ESP:0.00132(A)	Likely benign(Last reviewed: Sep 19, 2012)	criteria provided, multiple submitters, no conflicts	6	133464837	GRCh38	44772	53939
NM_004100.4(EYA4):c.829G>A (p.Gly277Ser)	EYA4	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Nonsyndromic Hearing Loss, Dominant	GO-ESP:0.38298(A), GMAF:0.40950(A), GO-ESP:0.34169(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	133468590	GRCh38	44773	53940
NM_004100.4(EYA4):c.1078C>A (p.Pro360Thr)	EYA4	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	6	133481570	GRCh38	264336	258444
NM_004100.4(EYA4):c.1845C>T (p.Asn615=)	EYA4|TARID	Dilated cardiomyopathy 1J|Cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.01000(T), GMAF:0.00820(T), GO-ESP:0.01241(T)	Benign(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	6	133528730	GRCh38	36031	44695
NM_003206.3(TCF21):c.63C>G (p.Asp21Glu)	TCF21	not provided	GMAF:0.00320(G), GO-ESP:0.00570(G)	Uncertain significance(Last reviewed: Dec 1, 2014)	no assertion criteria provided	6	133889460	GRCh38	167872	178172
NM_015093.5(TAB2):c.688C>A (p.Gln230Lys)	TAB2	Congenital heart defects, multiple types, 2	GO-ESP:0.00002(A)	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	6	149378603	GRCh38	5212	20251
NM_017909.3(RMND1):c.1349G>C (p.Ter450Ser)	RMND1	Mitochondrial diseases|Combined oxidative phosphorylation deficiency 11	GMAF:0.01600(T)	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	6	151405236	GRCh38	143051	152761
NM_033071.3(SYNE1):c.24071G>A (p.Arg8024His)	SYNE1	Emery-Dreifuss muscular dystrophy 4, autosomal dominant		Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	6	152151987	GRCh38	2332	17371
NM_020732.3(ARID1B):c.2692C>T (p.Arg898Ter)	ARID1B	Mental retardation, autosomal dominant 12|not provided		Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, multiple submitters, no conflicts	6	157148764	GRCh38	199160	196319
NC_000006.11:g.(?_10490144)_(10724301_?)del	GCNT2|TMEM14C|PAK1IP1|C6orf52|GCNT6	See cases		Uncertain significance(Last reviewed: Sep 21, 2015)	criteria provided, single submitter			GRCh38	219036	216087
GRCh38/hg38 6p25.3(chr6:259528-293493)x3	DUSP22	See cases		Benign(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	6	259528 - 293493	GRCh38	160993	170837
GRCh38/hg38 6p25.3-23(chr6:156974-13855925)x1	BMP6|BPHL|DSP|EDN1|SERPINB1|F13A1|FOXF2|FOXC1|GCNT2|GMDS|HIVEP1|IRF4|MAK|NEDD9|NQO2|SERPINB6|SERPINB9|RREB1|SSR1|TFAP2A|TUBB2A|RIPK1|PRPF4B|GCM2|CDYL|LY86|EEF1E1|RANBP9|ECI2|FARS2|RPP40|SIRT5|FAM50B|SLC35B3|TBC1D7|NRN1|NOL7|TMEM14C|GFOD1|ELOVL2|PAK1IP1|EXOC2|WRNIP1|DUSP22|LYRM4|SLC22A23|BLOC1S5|MCUR1|TXNDC5|TMEM14B|RIOK1|ADTRP|FOXQ1|HUS1B|SNRNP48|LINC01600|PHACTR1|SMIM13|SYCP2L|LINC00518|PXDC1|FAM217A|OFCC1|LOC285766|LINC01622|LY86-AS1|CAGE1|MYLK4|TUBB2B|C6orf52|PSMG4|LINC01011|C6orf201|ERVFRD-1|KU-MEL-3|GCNT6|PPP1R3G|HULC|TMEM170B|SCARNA27|LYRM4-AS1|TFAP2A-AS1|LOC100130357|MIR3691|LOC100506207|ELOVL2-AS1|LOC100507194|LOC100507506|GMDS-AS1|BLOC1S5-TXNDC5|EEF1E1-BLOC1S5|MIR4645|MIR5689|MIR5683|LOC101927691|FOXCUT|LOC101927730|LOC101927759|LOC101927950|LOC101927972|LOC101928191|LOC101928253|MIR6720|MIR7853|LOC102724096|OFCC1|LINC01394|MIR5689HG|TBC1D7-LOC100130357	See cases		Pathogenic(Last reviewed: Mar 18, 2014)	no assertion criteria provided	6	156974 - 13855925	GRCh38	155715	165469
GRCh38/hg38 6q23.1(chr6:130040763-130549075)x3	L3MBTL3|TMEM200A|SAMD3	See cases		Uncertain significance(Last reviewed: Mar 4, 2013)	no assertion criteria provided	6	130040763 - 130549075	GRCh38	155166	164920
GRCh38/hg38 6q26(chr6:162232971-162629368)x3	PARK2	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	6	162232971 - 162629368	GRCh38	154967	164721
GRCh38/hg38 6q16.1-16.2(chr6:98770647-99813111)x1	CCNC|POU3F2|PNISR|FBXL4|COQ3|PRDM13|FAXC|USP45|TSTD3|MIR548AI|LOC101927365	See cases		Uncertain significance(Last reviewed: Oct 19, 2010)	no assertion criteria provided	6	98770647 - 99813111	GRCh38	154571	164325
GRCh38/hg38 6q11.1(chr6:61468685-62167348)x3	KHDRBS2|MTRNR2L9	See cases		Conflicting interpretations of pathogenicity(Last reviewed: Jan 14, 2011)	no assertion criteria provided	6	61468685 - 62167348	GRCh38	154481	164235
GRCh38/hg38 6p25.3(chr6:164360-293497)x3	DUSP22|LOC285766	See cases		Benign(Last reviewed: Jun 30, 2010)	no assertion criteria provided	6	164360 - 293497	GRCh38	154371	164125
GRCh38/hg38 6p25.3(chr6:259531-339797)x1	DUSP22	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	6	259531 - 339797	GRCh38	154339	164093
GRCh38/hg38 6p25.3(chr6:259531-339797)x3	DUSP22	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	6	259531 - 339797	GRCh38	154338	164092
GRCh38/hg38 6p25.3(chr6:279208-339797)x3	DUSP22	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	6	279208 - 339797	GRCh38	154325	164079
GRCh38/hg38 6q14.1(chr6:75655832-76509933)x3	IMPG1|MYO6|SENP6	See cases		Uncertain significance(Last reviewed: Feb 4, 2013)	no assertion criteria provided	6	75655832 - 76509933	GRCh38	152284	162035
GRCh38/hg38 6q26(chr6:162579229-163529838)x3	PARK2|QKI|PACRG|PACRG-AS1|DKFZp451B082|PACRG-AS3|CAHM|PACRG-AS2	See cases		Uncertain significance(Last reviewed: Dec 17, 2012)	no assertion criteria provided	6	162579229 - 163529838	GRCh38	152216	161967
GRCh38/hg38 6q27(chr6:167896913-170714507)x1	KIF25|AFDN|PDCD2|PSMB1|TBP|TCTE3|THBS2|DLL1|PHF10|ERMARD|SMOC2|FRMD1|LINC00574|FAM120B|LOC154449|DACT2|WDR27|LOC285804|C6orf120|LINC00242|LINC01624|HGC6.3|LOC100131532|KIF25-AS1|MIR4644|LOC101929420|LOC101929460|LINC01615|LOC101929504|LOC101929523|LOC101929692|LOC102724357|LOC102724511|LOC105378137|LOC105378146	See cases		Pathogenic(Last reviewed: Dec 17, 2012)	no assertion criteria provided	6	167896913 - 170714507	GRCh38	152206	161957
GRCh38/hg38 6p25.3(chr6:259531-293497)x1	DUSP22	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	6	259531 - 293497	GRCh38	144532	154283
GRCh38/hg38 6p25.3(chr6:259531-293497)x3	DUSP22	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	6	259531 - 293497	GRCh38	144531	154282
GRCh38/hg38 6q23.3(chr6:135397890-135406717)x1	AHI1	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	6	135397890 - 135406717	GRCh38	58830	73425
GRCh38/hg38 6q23.3(chr6:135249940-136439720)x1	MAP7|BCLAF1|PDE7B|AHI1|MTFR2|LINC00271	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	6	135249940 - 136439720	GRCh38	58446	73041
GRCh38/hg38 6q22.1(chr6:115220054-117196371)x1	COL10A1|FRK|KPNA5|TSPYL1|TSPYL4|DSE|RWDD1|NT5DC1|FAM26D|ZUFSP|FAM162B|GPRC6A|RFX6|FAM26E|RSPH4A|FAM26F|TRAPPC3L|LOC105377962	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	6	115220054 - 117196371	GRCh38	58441	73036
GRCh38/hg38 6p21.2-21.1(chr6:37777369-45653843)x1	BYSL|RUNX2|CCND3|CDC5L|DNAH8|SLC29A1|GLO1|GLP1R|GUCA1A|GUCA1B|HSP90AB1|MDFI|MEA1|MOCS1|NFKBIE|NFYA|PEX6|PGC|POLH|PPP2R5D|PTK7|PRPH2|SRF|TBCC|VEGFA|TFEB|SUPT3H|KCNK5|NCR2|MED20|POLR1C|MAD2L1BP|CUL7|DNPH1|CNPY3|FRS3|SLC22A7|APOBEC2|CAPN11|CUL9|UBR2|DAAM2|GLTSCR1L|ZNF318|YIPF3|USP49|GNMT|PRICKLE4|MRPL2|TREM2|TREM1|GTPBP2|MRPS18A|MRPS10|TMEM63B|SAYSD1|TRERF1|LRFN2|AARS2|XPO5|ZFAND3|MRPL14|DLK2|TREML2|KCNK16|TTBK1|RRP36|KCNK17|ABCC10|KLC4|TJAP1|BTBD9|FOXP4|KLHDC3|TAF8|PTCRA|TCTE1|SPATS1|C6orf223|RSPH9|LRRC73|OARD1|KIF6|TSPO2|UNC5CL|TREML4|RPL7L1|TREML1|TREML3P|SLC35B2|LINC00951|LOC401261|CRIP3|C6orf226|TMEM151B|C6orf132|MIR586|TDRG1|LOC100131047|LINC01512|TOMM6|LOC100505635|MIR4647|MIR4641|MIR4642|FOXP4-AS1|LOC101929555|LOC101929705|LOC101929726|MIR6780B|LINC01276|LOC105375075|CNPY3-GNMT	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	6	37777369 - 45653843	GRCh38	58427	73022
GRCh38/hg38 6p25.1-24.3(chr6:4427090-8391140)x1	BMP6|DSP|F13A1|RREB1|SSR1|CDYL|LY86|EEF1E1|FARS2|RPP40|NRN1|LYRM4|BLOC1S5|TXNDC5|RIOK1|SNRNP48|LY86-AS1|CAGE1|KU-MEL-3|PPP1R3G|SCARNA27|LYRM4-AS1|MIR3691|BLOC1S5-TXNDC5|EEF1E1-BLOC1S5|MIR5683|LOC101927950|LOC101927972|MIR7853	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	6	4427090 - 8391140	GRCh38	58423	73018
GRCh38/hg38 6p25.3(chr6:259528-339802)x1	DUSP22	See cases		Benign(Last reviewed: Oct 22, 2013)	no assertion criteria provided	6	259528 - 339802	GRCh38	32267	40932
GRCh38/hg38 6p25.3(chr6:259528-293493)x3	DUSP22	See cases		Benign(Last reviewed: Aug 2, 2013)	no assertion criteria provided	6	259528 - 293493	GRCh38	32174	40839
GRCh38/hg38 6p25.3(chr6:259528-293493)x1	DUSP22	See cases		Benign(Last reviewed: Sep 23, 2013)	no assertion criteria provided	6	259528 - 293493	GRCh38	32165	40830
NM_005522.4(HOXA1):c.76C>T (p.Arg26Ter)	HOXA1	Athabaskan brainstem dysgenesis		Pathogenic(Last reviewed: May 15, 2008)	no assertion criteria provided	7	27095837	GRCh38	14900	29939
NM_001077653.2(TBX20):c.583C>T (p.Gln195Ter)	TBX20	Atrial septal defect 4		Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	7	35245020	GRCh38	4633	19672
NM_001077653.2(TBX20):c.456C>G (p.Ile152Met)	TBX20	Atrial septal defect 4	GO-ESP:0.00003(C)	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	7	35248766	GRCh38	4632	19671
NM_001077653.2(TBX20):c.414G>A (p.Ser138=)	TBX20	Cardiovascular phenotype	GO-ESP:0.00014(T)	Likely benign(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	7	35248808	GRCh38	264385	258476
NM_138295.3(PKD1L1):c.6473+2_6473+3delTG	PKD1L1	Situs inversus totalis|Situs ambiguus	GO-ESP:0.00038(-)	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	7	47831214 - 47831215	GRCh38	235796	236891
NM_000181.3(GUSB):c.1050G>C (p.Lys350Asn)	GUSB	Mucopolysaccharidosis type VII	GMAF:0.00040(T)	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	7	65974934	GRCh38	906	15945
NM_000501.3(ELN):c.1324C>T (p.Gln442Ter)	ELN	Supravalvar aortic stenosis|not provided		Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, multiple submitters, no conflicts	7	74056680	GRCh38	16722	31761
NM_000722.3(CACNA2D1):c.3218T>C (p.Ile1073Thr)	CACNA2D1	Cardiovascular phenotype	GO-ESP:0.00006(G)	Uncertain significance(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	7	81950450	GRCh38	264507	258474
NM_000722.3(CACNA2D1):c.3134A>C (p.Asp1045Ala)	CACNA2D1	Cardiovascular phenotype	GMAF:0.00180(G), GO-ESP:0.00281(G)	Benign(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	7	81959300	GRCh38	263797	258473
NM_000722.3(CACNA2D1):c.3114C>T (p.Pro1038=)	CACNA2D1	not specified|Cardiovascular phenotype	GMAF:0.22260(A), GO-ESP:0.28586(A)	Benign(Last reviewed: Jun 19, 2015)	criteria provided, multiple submitters, no conflicts	7	81959320	GRCh38	256767	252942
NM_000722.3(CACNA2D1):c.2673A>G (p.Val891=)	CACNA2D1	Cardiovascular phenotype	GMAF:0.00120(C), GO-ESP:0.00052(C)	Likely benign(Last reviewed: May 17, 2013)	criteria provided, single submitter	7	81964261	GRCh38	263618	258478
NM_000722.3(CACNA2D1):c.2333C>T (p.Ser778Leu)	CACNA2D1	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	7	81968949	GRCh38	264556	258486
NM_000722.3(CACNA2D1):c.2264G>C (p.Ser755Thr)	CACNA2D1	Cardiac arrest|Cardiovascular phenotype	GO-ESP:0.00077(G)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 21, 2015)	criteria provided, conflicting interpretations	7	81969925	GRCh38	180288	178582
NM_000722.3(CACNA2D1):c.1983G>A (p.Ser661=)	CACNA2D1	Brugada syndrome|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00201(T)	Benign/Likely benign(Last reviewed: Feb 24, 2016)	criteria provided, multiple submitters, no conflicts	7	81974525	GRCh38	238180	240181
NM_000722.3(CACNA2D1):c.1956-5_1956-4dupTT	CACNA2D1	Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.09690(AA)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	7	81974556 - 81974557	GRCh38	215475	212616
NM_000722.3(CACNA2D1):c.1919A>G (p.Asn640Ser)	CACNA2D1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	7	81982603	GRCh38	263754	258475
NM_000722.3(CACNA2D1):c.1416A>G (p.Gln472=)	CACNA2D1	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	7	82007703	GRCh38	264191	258477
NM_000722.3(CACNA2D1):c.1332C>T (p.Val444=)	CACNA2D1|LOC101927356	Brugada syndrome|Cardiovascular phenotype	GMAF:0.00320(A), GO-ESP:0.00876(A)	Benign(Last reviewed: Nov 15, 2015)	criteria provided, multiple submitters, no conflicts	7	82012184	GRCh38	238179	240182
NM_000722.3(CACNA2D1):c.1259G>A (p.Arg420Lys)	CACNA2D1|LOC101927356	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	7	82013474	GRCh38	264275	258479
NM_000722.3(CACNA2D1):c.1141A>G (p.Lys381Glu)	CACNA2D1	Cardiovascular phenotype	GO-ESP:0.00005(C)	Uncertain significance(Last reviewed: Oct 15, 2013)	criteria provided, single submitter	7	82032799	GRCh38	263722	258487
NM_000722.3(CACNA2D1):c.963G>A (p.Ala321=)	CACNA2D1	not specified|Cardiovascular phenotype	GMAF:0.01940(T), GO-ESP:0.03851(T)	Benign(Last reviewed: Jun 11, 2015)	criteria provided, multiple submitters, no conflicts	7	82038152	GRCh38	256769	252943
NM_000722.3(CACNA2D1):c.960C>T (p.Asp320=)	CACNA2D1	Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00041(A)	Likely benign(Last reviewed: Oct 6, 2015)	criteria provided, single submitter	7	82038155	GRCh38	264371	258483
NM_005751.4(AKAP9):c.109A>G (p.Lys37Glu)	AKAP9	not specified	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	7	91973771	GRCh38	190516	188429
NM_005751.4(AKAP9):c.139C>T (p.His47Tyr)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.00220(T), GO-ESP:0.00814(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	91973801	GRCh38	191549	189264
NM_005751.4(AKAP9):c.510G>C (p.Glu170Asp)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Cardiovascular phenotype	GMAF:0.00120(C), GO-ESP:0.00180(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	91992989	GRCh38	190518	188434
NM_005751.4(AKAP9):c.610G>A (p.Asp204Asn)	AKAP9	not provided|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00054(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 31, 2013)	criteria provided, conflicting interpretations	7	91994654	GRCh38	190513	188435
NM_005751.4(AKAP9):c.747A>G (p.Glu249=)	AKAP9	Long QT syndrome|Romano-Ward syndrome|Cardiovascular phenotype	GMAF:0.01100(G), GO-ESP:0.00313(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	91995617	GRCh38	219401	221743
NM_005751.4(AKAP9):c.872_874delAAG (p.Glu292del)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00001(-)	Uncertain significance(Last reviewed: Sep 25, 2012)	criteria provided, single submitter	7	91995742 - 91995744	GRCh38	263356	258481
NM_005751.4(AKAP9):c.876_878delAGA (p.Glu292del)	AKAP9	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 25, 2012)	criteria provided, single submitter	7	91995746 - 91995748	GRCh38	263381	258480
NM_005751.4(AKAP9):c.948A>G (p.Val316=)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00071(G)	Likely benign(Last reviewed: Nov 21, 2013)	criteria provided, single submitter	7	92000865	GRCh38	263785	258488
NM_005751.4(AKAP9):c.1067A>T (p.Asp356Val)	AKAP9	Cardiac arrest	GMAF:0.00020(T), GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	7	92000984	GRCh38	222487	224356
NM_005751.4(AKAP9):c.1099G>A (p.Val367Met)	AKAP9	Long QT syndrome 2|not specified|not provided|Cardiac arrest	GMAF:0.00020(A), GO-ESP:0.00072(A)	Conflicting interpretations of pathogenicity(Last reviewed: May 26, 2014)	criteria provided, conflicting interpretations	7	92001016	GRCh38	180260	178585
NM_005751.4(AKAP9):c.1389G>T (p.Met463Ile)	AKAP9	Long QT syndrome|not specified|Colorectal cancer|Cardiovascular phenotype	GMAF:0.37220(T), GO-ESP:0.38290(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92001306	GRCh38	136347	140050
NM_005751.4(AKAP9):c.1651A>G (p.Ile551Val)	AKAP9	not specified|Cardiovascular phenotype	GMAF:0.00120(G), GO-ESP:0.00028(G)	Likely benign(Last reviewed: Nov 17, 2015)	criteria provided, multiple submitters, no conflicts	7	92001568	GRCh38	264510	258485
NM_005751.4(AKAP9):c.1890A>G (p.Leu630=)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00004(G)	Likely benign(Last reviewed: Dec 10, 2012)	criteria provided, single submitter	7	92001807	GRCh38	263455	258484
NM_005751.4(AKAP9):c.2301A>G (p.Gln767=)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00003(G)	Likely benign(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	7	92002218	GRCh38	264506	258482
NM_005751.4(AKAP9):c.2475T>G (p.Leu825=)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00006(G)	Likely benign(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	7	92002392	GRCh38	264418	258489
NM_005751.4(AKAP9):c.2477T>C (p.Ile826Thr)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.00080(C), GO-ESP:0.00060(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	92002394	GRCh38	190507	188440
NM_005751.4(AKAP9):c.2782T>C (p.Leu928=)	AKAP9	Long QT syndrome|Romano-Ward syndrome|Cardiovascular phenotype	GMAF:0.01440(C), GO-ESP:0.00455(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92002699	GRCh38	263768	258490
NM_005751.4(AKAP9):c.2793T>A (p.Gly931=)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	7	92002710	GRCh38	264338	258491
NM_005751.4(AKAP9):c.2865G>A (p.Leu955=)	AKAP9	Cardiovascular phenotype		Likely benign(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	7	92002782	GRCh38	264113	258492
NM_005751.4(AKAP9):c.3068T>A (p.Val1023Asp)	AKAP9	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 27, 2015)	criteria provided, single submitter	7	92002985	GRCh38	264595	258494
NM_005751.4(AKAP9):c.3075C>T (p.Thr1025=)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.06410(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92002992	GRCh38	136349	140052
NM_005751.4(AKAP9):c.3504A>G (p.Glu1168=)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.37380(G), GO-ESP:0.38378(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92012614	GRCh38	136350	140053
NM_005751.4(AKAP9):c.3827G>A (p.Arg1276Gln)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.01100(A), GO-ESP:0.01548(A)	Benign/Likely benign(Last reviewed: Aug 4, 2016)	criteria provided, multiple submitters, no conflicts	7	92017092	GRCh38	191552	189273
NM_005751.4(AKAP9):c.4003_4004insAAC (p.Lys1335_Leu1336insGln)	AKAP9	Cardiovascular phenotype	GMAF:0.42470(AAC), GO-ESP:0.39892(AAC)	Benign(Last reviewed: Sep 17, 2012)	criteria provided, single submitter	7	92022864 - 92022865	GRCh38	263353	258493
NM_005751.4(AKAP9):c.4004_4006dupAAC (p.Lys1335_Leu1336insGln)	AKAP9	Cardiac arrhythmia|Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype		Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92022865 - 92022867	GRCh38	190508	188441
NM_005751.4(AKAP9):c.4190A>G (p.Gln1397Arg)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not provided|Cardiovascular phenotype	GO-ESP:0.00042(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	92029936	GRCh38	191516	189276
NM_005751.4(AKAP9):c.4199T>C (p.Met1400Thr)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.05050(C), GO-ESP:0.01463(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92029945	GRCh38	191553	189277
NM_005751.4(AKAP9):c.4342A>G (p.Ile1448Val)	AKAP9	not provided|Cardiovascular phenotype	GMAF:0.00040(G), GO-ESP:0.00055(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 11, 2015)	criteria provided, conflicting interpretations	7	92038422	GRCh38	191517	189278
NM_005751.4(AKAP9):c.4360G>A (p.Ala1454Thr)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	7	92038440	GRCh38	264112	258495
NM_005751.4(AKAP9):c.4396G>A (p.Gly1466Arg)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Nov 15, 2013)	criteria provided, single submitter	7	92038476	GRCh38	263742	258496
NM_005751.4(AKAP9):c.4693-11delT	AKAP9	Cardiac arrhythmia		Benign(Last reviewed: Apr 24, 2012)	criteria provided, single submitter	7	92040663	GRCh38	190482	188443
NM_005751.4(AKAP9):c.4696C>A (p.His1566Asn)	AKAP9	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	7	92040677	GRCh38	264084	258497
NM_005751.4(AKAP9):c.4724A>T (p.Asp1575Val)	AKAP9	Cardiovascular phenotype		Uncertain significance(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	7	92040705	GRCh38	263600	258498
NM_147185.2(AKAP9):c.4837A>G (p.Met1613Val)	AKAP9	Cardiac arrhythmia|not specified	GO-ESP:0.00001(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 10, 2015)	criteria provided, conflicting interpretations	7	92040818	GRCh38	35670	44335
NM_005751.4(AKAP9):c.4841G>A (p.Arg1614Gln)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.00900(A), GO-ESP:0.00227(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92040822	GRCh38	136330	140033
NM_005751.4(AKAP9):c.5271A>G (p.Leu1757=)	AKAP9	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	7	92045116	GRCh38	264308	258499
NM_005751.4(AKAP9):c.5369T>G (p.Val1790Gly)	AKAP9	Sudden cardiac death|Long QT syndrome|Romano-Ward syndrome|not specified|not provided	GMAF:0.00080(G), GO-ESP:0.00094(G)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2016)	criteria provided, conflicting interpretations	7	92052726	GRCh38	180263	178589
NM_005751.4(AKAP9):c.5568A>T (p.Lys1856Asn)	AKAP9	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	7	92052925	GRCh38	264569	258500
NM_005751.4(AKAP9):c.5616A>G (p.Lys1872=)	AKAP9	Cardiovascular phenotype		Likely benign(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	7	92061274	GRCh38	263999	258501
NM_005751.4(AKAP9):c.5778C>T (p.Gly1926=)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.35980(T), GO-ESP:0.37946(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92062287	GRCh38	136333	140036
NM_005751.4(AKAP9):c.5911G>A (p.Glu1971Lys)	AKAP9	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 18, 2013)	criteria provided, single submitter	7	92062420	GRCh38	263749	258502
NM_005751.4(AKAP9):c.5977C>T (p.Gln1993Ter)	AKAP9	Cardiac arrhythmia		Uncertain significance(Last reviewed: Jul 21, 2014)	criteria provided, single submitter	7	92062486	GRCh38	190515	188450
NM_005751.4(AKAP9):c.5978-4A>G	AKAP9	Long QT syndrome|Romano-Ward syndrome|Cardiovascular phenotype	GMAF:0.00080(G), GO-ESP:0.00260(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	92065227	GRCh38	220501	221747
NM_005751.4(AKAP9):c.6037G>A (p.Glu2013Lys)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00117(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	92065290	GRCh38	191518	189285
NM_005751.4(AKAP9):c.6176A>G (p.Glu2059Gly)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not provided|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00056(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	92065429	GRCh38	191519	189286
NM_005751.4(AKAP9):c.6249C>T (p.Phe2083=)	AKAP9	Long QT syndrome|Romano-Ward syndrome|Cardiovascular phenotype	GO-ESP:0.00089(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	92066465	GRCh38	215513	212621
NM_005751.4(AKAP9):c.6556T>C (p.Ser2186Pro)	AKAP9	Long QT syndrome|not provided|Cardiovascular phenotype	GMAF:0.00200(C), GO-ESP:0.00378(C)	Benign/Likely benign(Last reviewed: Dec 21, 2015)	criteria provided, multiple submitters, no conflicts	7	92070953	GRCh38	191520	189287
NM_005751.4(AKAP9):c.6696A>G (p.Gln2232=)	AKAP9	Cardiovascular phenotype	GMAF:0.00100(G), GO-ESP:0.00082(G)	Likely benign(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	7	92076938	GRCh38	264046	258503
NM_005751.4(AKAP9):c.6921A>G (p.Gln2307=)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00152(G)	Likely benign(Last reviewed: Oct 15, 2015)	criteria provided, single submitter	7	92077851	GRCh38	263446	258504
NM_005751.4(AKAP9):c.7034_7036delGAG (p.Arg2345_Glu2346delinsLys)	AKAP9	Cardiac arrhythmia		Likely benign(Last reviewed: Nov 4, 2011)	criteria provided, single submitter	7	92079167 - 92079169	GRCh38	190490	188452
NM_005751.4(AKAP9):c.7074A>G (p.Lys2358=)	AKAP9	Cardiac arrhythmia	GMAF:0.00020(G), GO-ESP:0.00004(G)	Benign(Last reviewed: Jul 15, 2011)	criteria provided, single submitter	7	92079207	GRCh38	136336	140039
NM_005751.4(AKAP9):c.7243G>A (p.Val2415Ile)	AKAP9	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 27, 2013)	criteria provided, single submitter	7	92079376	GRCh38	263540	258505
NM_005751.4(AKAP9):c.7275G>A (p.Gln2425=)	AKAP9	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.00160(A), GO-ESP:0.00280(A)	Benign(Last reviewed: Mar 5, 2016)	criteria provided, multiple submitters, no conflicts	7	92079408	GRCh38	136337	140040
NM_005751.4(AKAP9):c.7451A>G (p.Lys2484Arg)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.06550(G), GO-ESP:0.10900(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92079584	GRCh38	136338	140041
NM_005751.4(AKAP9):c.7486A>G (p.Asn2496Asp)	AKAP9	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 15, 2013)	criteria provided, single submitter	7	92079619	GRCh38	263743	258506
NM_005751.4(AKAP9):c.7488T>G (p.Asn2496Lys)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not provided|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00031(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	92079621	GRCh38	191521	189288
NM_005751.4(AKAP9):c.7628T>C (p.Leu2543Pro)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Jan 13, 2013)	criteria provided, single submitter	7	92079761	GRCh38	263437	258507
NM_005751.4(AKAP9):c.7775T>A (p.Leu2592Gln)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: May 7, 2015)	criteria provided, single submitter	7	92079908	GRCh38	263985	258508
NM_005751.4(AKAP9):c.8189A>G (p.Gln2730Arg)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.00040(G), GO-ESP:0.00013(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92083198	GRCh38	234978	236772
NM_005751.4(AKAP9):c.8286A>C (p.Lys2762Asn)	AKAP9	not specified|not provided|Cardiovascular phenotype	GMAF:0.00080(C), GO-ESP:0.00126(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2015)	criteria provided, conflicting interpretations	7	92083295	GRCh38	191522	189291
NM_005751.4(AKAP9):c.8336C>T (p.Ala2779Val)	AKAP9	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	7	92083345	GRCh38	263787	258509
NM_005751.4(AKAP9):c.8375A>G (p.Asn2792Ser)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.29590(G), GO-ESP:0.35934(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92083384	GRCh38	136340	140043
NM_005751.4(AKAP9):c.8485G>A (p.Glu2829Lys)	AKAP9	Cardiovascular phenotype	GMAF:0.00300(A), GO-ESP:0.00094(A)	Benign(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	7	92083494	GRCh38	263541	258510
NM_005751.4(AKAP9):c.8665C>T (p.Leu2889=)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.37380(T), GO-ESP:0.38317(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92084658	GRCh38	136341	140044
NM_005751.4(AKAP9):c.8688G>A (p.Gln2896=)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Nov 11, 2015)	criteria provided, single submitter	7	92084681	GRCh38	264513	258511
NM_005751.4(AKAP9):c.8935C>T (p.Pro2979Ser)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Cardiovascular phenotype	GMAF:0.00120(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92085597	GRCh38	136342	140045
NM_005751.4(AKAP9):c.9145C>T (p.Leu3049=)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.29570(T), GO-ESP:0.35888(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92086348	GRCh38	136343	140046
NM_005751.4(AKAP9):c.9929G>A (p.Arg3310Gln)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not provided|Cardiovascular phenotype	GMAF:0.00760(A), GO-ESP:0.00199(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92096888	GRCh38	191524	189297
NM_005751.4(AKAP9):c.10197T>C (p.Thr3399=)	AKAP9	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00100(C), GO-ESP:0.00136(C)	Benign/Likely benign(Last reviewed: Feb 17, 2016)	criteria provided, multiple submitters, no conflicts	7	92097156	GRCh38	215511	212622
NM_005751.4(AKAP9):c.10331A>G (p.Gln3444Arg)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.01340(G), GO-ESP:0.00435(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92097290	GRCh38	191556	189299
NM_005751.4(AKAP9):c.10406C>T (p.Thr3469Met)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00026(T)	Uncertain significance(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	7	92097593	GRCh38	264086	258512
NM_005751.4(AKAP9):c.10426A>C (p.Arg3476=)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.37740(C), GO-ESP:0.38459(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92097613	GRCh38	136344	140047
NM_005751.4(AKAP9):c.10459G>A (p.Glu3487Lys)	AKAP9	Long QT syndrome 11|Long QT syndrome|Romano-Ward syndrome|not provided|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00054(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	92097646	GRCh38	191526	189300
NM_005751.4(AKAP9):c.10664A>T (p.Asp3555Val)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00087(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	92098165	GRCh38	190514	188463
NM_005751.4(AKAP9):c.10714-3C>T	AKAP9	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	7	92099684	GRCh38	264457	258513
NM_005751.4(AKAP9):c.10840A>G (p.Met3614Val)	AKAP9	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.00680(G), GO-ESP:0.00718(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	92099813	GRCh38	136345	140048
NM_005751.4(AKAP9):c.10880G>A (p.Gly3627Glu)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jan 10, 2013)	criteria provided, single submitter	7	92099853	GRCh38	263485	258514
NM_005751.4(AKAP9):c.11225G>C (p.Arg3742Pro)	AKAP9	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.00220(C), GO-ESP:0.00070(C)	Benign/Likely benign(Last reviewed: Oct 17, 2016)	criteria provided, multiple submitters, no conflicts	7	92102721	GRCh38	190497	188464
NM_005751.4(AKAP9):c.11234G>A (p.Gly3745Glu)	AKAP9	Cardiovascular phenotype	GMAF:0.00040(A)	Uncertain significance(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	7	92102730	GRCh38	264384	258515
NM_005751.4(AKAP9):c.11273G>A (p.Arg3758His)	AKAP9	not provided|Cardiovascular phenotype	GMAF:0.00160(A), GO-ESP:0.00156(A)	Likely benign(Last reviewed: Jun 11, 2015)	criteria provided, multiple submitters, no conflicts	7	92102769	GRCh38	191531	189307
NM_005751.4(AKAP9):c.11276C>T (p.Pro3759Leu)	AKAP9	Cardiac arrest		Uncertain significance(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	7	92102772	GRCh38	222492	224362
NM_005751.4(AKAP9):c.11378C>G (p.Ser3793Cys)	AKAP9	Cardiac arrest		Uncertain significance(Last reviewed: Mar 13, 2014)	no assertion criteria provided	7	92105725	GRCh38	180266	178592
NM_005751.4(AKAP9):c.11580T>G (p.Gly3860=)	AKAP9	Long QT syndrome|Romano-Ward syndrome|Cardiovascular phenotype	GO-ESP:0.00014(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	92108527	GRCh38	263701	258516
NM_005751.4(AKAP9):c.11617G>A (p.Asp3873Asn)	AKAP9	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	7	92108564	GRCh38	264495	258518
NM_021167.4(GATAD1):c.304T>C (p.Ser102Pro)	GATAD1	Cardiomyopathy, dilated, 2b		Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	7	92448806	GRCh38	31656	40332
NM_021167.4(GATAD1):c.431A>G (p.Tyr144Cys)	GATAD1	Cardiovascular phenotype	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	7	92450756	GRCh38	264373	258517
NM_021167.4(GATAD1):c.558G>A (p.Thr186=)	GATAD1	not specified|Cardiovascular phenotype	GO-ESP:0.00015(A), GMAF:0.00720(A), GO-ESP:0.00375(A)	Benign/Likely benign(Last reviewed: Jun 10, 2015)	criteria provided, multiple submitters, no conflicts	7	92454624	GRCh38	45828	54993
NM_000089.3(COL1A2):c.70+717A>G	COL1A2	Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form		Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	7	94395818	GRCh38	17276	32315
NM_000089.3(COL1A2):c.293dupC (p.Arg99Terfs)	COL1A2	Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form		Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	7	94404569	GRCh38	17280	32319
NM_000089.3(COL1A2):c.1404+1G>A	COL1A2	Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form	GO-ESP:0.00002(A)	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	7	94412122	GRCh38	17275	32314
NM_000089.3(COL1A2):c.2123G>A (p.Arg708Gln)	COL1A2	Marfan syndrome, atypical	GO-ESP:0.00077(A), GO-ESP:0.00069(A)	Uncertain significance(Last reviewed: Jun 1, 2004)	no assertion criteria provided	7	94420276	GRCh38	17250	32289
NM_000089.3(COL1A2):c.3601G>T (p.Glu1201Ter)	COL1A2	Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form		Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	7	94428367	GRCh38	17279	32318
NM_003227.3(TFR2):c.515T>A (p.Met172Lys)	TFR2	Hemochromatosis type 3	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	7	100633515	GRCh38	5382	20421
NM_001753.4(CAV1):c.30+19dupG	CAV1	not specified		Benign(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	7	116525111	GRCh38	212818	209905
NM_001458.4(FLNC):c.4871C>T (p.Ser1624Leu)	FLNC	Cardiomyopathy, familial restrictive, 5		Pathogenic(Last reviewed: Jul 21, 2016)	no assertion criteria provided	7	128848926	GRCh38	253126	247538
NM_001458.4(FLNC):c.6478A>T (p.Ile2160Phe)	FLNC	Cardiomyopathy, familial restrictive, 5		Pathogenic(Last reviewed: Jul 21, 2016)	no assertion criteria provided	7	128853831	GRCh38	253127	247539
NM_001006630.1(CHRM2):c.1189A>G (p.Ile397Val)	CHRM2|LOC349160	Cardiomyopathy	GO-ESP:0.00003(G)	Uncertain significance	criteria provided, single submitter	7	137016054	GRCh38	219175	217192
NG_007873.3:g.195555G>A	BRAF	Noonan syndrome|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GMAF:0.00880(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	140734210	GRCh38	359041	310006
NG_007873.3:g.195279C>T	BRAF	Noonan syndrome|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GMAF:0.00080(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	140734486	GRCh38	359042	301991
NM_004333.4(BRAF):c.*7T>C	BRAF	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome		Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	140734590	GRCh38	162794	174040
NG_007873.3:g.195171C>T	BRAF	Noonan syndrome|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	140734594	GRCh38	359043	310007
NM_004333.4(BRAF):c.2235A>G (p.Leu745=)	BRAF	Noonan syndrome|not specified|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GMAF:0.00160(C), GO-ESP:0.00096(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140734663	GRCh38	40399	48869
NG_007873.3:g.194991delG	BRAF	Noonan syndrome|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	140734774	GRCh38	359044	310013
NM_004333.4(BRAF):c.2128-5delT	BRAF	Noonan syndrome|not specified|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.02998(-)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140734775	GRCh38	44821	53988
NM_004333.4(BRAF):c.2128-5dupT	BRAF	Noonan syndrome|not specified|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome		Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	140734775	GRCh38	44820	53987
NG_007873.3:g.194979_194980delCT	BRAF	Noonan syndrome|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	140734785 - 140734786	GRCh38	359045	309875
NG_007873.3:g.194968_194979delCTTTTTTTTTTCinsTCT	BRAF	Noonan syndrome|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	140734786 - 140734797	GRCh38	359046	301998
NG_007873.3:g.194967dupT	BRAF	Noonan syndrome|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	140734798	GRCh38	359047	302001
NM_004333.4(BRAF):c.2126A>G (p.Gln709Arg)	BRAF	Rasopathy		Pathogenic	criteria provided, single submitter	7	140739813	GRCh38	40397	48867
NM_004333.4(BRAF):c.1929A>G (p.Gly643=)	BRAF	Noonan syndrome|not specified|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.32001(C), GMAF:0.35100(C), GO-ESP:0.21236(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140749350	GRCh38	40391	48861
NM_004333.4(BRAF):c.1914T>G (p.Asp638Glu)	BRAF	not provided|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Sep 11, 2014)	criteria provided, multiple submitters, no conflicts	7	140749365	GRCh38	162797	174176
NM_004333.4(BRAF):c.1914T>A (p.Asp638Glu)	BRAF	Cardiofaciocutaneous syndrome 1|not provided		Pathogenic(Last reviewed: Feb 16, 2015)	criteria provided, single submitter	7	140749365	GRCh38	13981	29020
NM_004333.4(BRAF):c.1802A>C (p.Lys601Thr)	BRAF	Rasopathy		Pathogenic(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	7	140753333	GRCh38	44818	53985
NM_004333.4(BRAF):c.1802A>T (p.Lys601Ile)	BRAF	Rasopathy		Pathogenic/Likely pathogenic	criteria provided, single submitter	7	140753333	GRCh38	40390	48860
NM_004333.4(BRAF):c.1801A>C (p.Lys601Gln)	BRAF	not provided|Rasopathy		Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, multiple submitters, no conflicts	7	140753334	GRCh38	41446	49884
NM_004333.4(BRAF):c.1799T>G (p.Val600Gly)	BRAF	Rasopathy|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	7	140753336	GRCh38	40389	48859
NM_004333.4(BRAF):c.1799T>A (p.Val600Glu)	BRAF	Papillary thyroid carcinoma|Non-small cell lung cancer|Carcinoma of colon|Astrocytoma, low-grade, somatic|Germ cell tumor, nonseminomatous|NONSEMINOMATOUS GERM CELL TUMORS, SOMATIC|not provided|Malignant melanoma|Cardio-facio-cutaneous syndrome	GO-ESP:0.00002(T)	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	7	140753336	GRCh38	13961	29000
NM_004333.4(BRAF):c.1796C>G (p.Thr599Arg)	BRAF	not provided		Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	7	140753339	GRCh38	280033	264307
NM_004333.4(BRAF):c.1796C>T (p.Thr599Ile)	BRAF	not provided		Pathogenic(Last reviewed: Feb 1, 2014)	criteria provided, single submitter	7	140753339	GRCh38	40388	48858
NM_004333.4(BRAF):c.1787G>T (p.Gly596Val)	BRAF	not provided|Rasopathy|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	7	140753348	GRCh38	40387	48857
NM_004333.4(BRAF):c.1785T>A (p.Phe595Leu)	BRAF	not provided		Pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, single submitter	7	140753350	GRCh38	180789	179094
NM_004333.4(BRAF):c.1785T>G (p.Phe595Leu)	BRAF	not provided|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Jan 18, 2016)	criteria provided, multiple submitters, no conflicts	7	140753350	GRCh38	177672	174042
NM_004333.4(BRAF):c.1743T>A (p.Asn581Lys)	BRAF	Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 24, 2011)	criteria provided, single submitter	7	140753392	GRCh38	44811	53978
NM_004333.4(BRAF):c.1741A>C (p.Asn581His)	BRAF	Rasopathy		Pathogenic(Last reviewed: May 20, 2009)	criteria provided, single submitter	7	140754187	GRCh38	55794	70450
NM_004333.4(BRAF):c.1741A>G (p.Asn581Asp)	BRAF	Cardiofaciocutaneous syndrome 1|not provided|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Jan 6, 2015)	criteria provided, multiple submitters, no conflicts	7	140754187	GRCh38	13979	29018
NM_004333.4(BRAF):c.1722C>G (p.His574Gln)	BRAF	not provided		Pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, single submitter	7	140754206	GRCh38	40384	48854
NM_004333.4(BRAF):c.1720C>T (p.His574Tyr)	BRAF	Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	7	140754208	GRCh38	44810	53977
NM_004333.4(BRAF):c.1695T>G (p.Asp565Glu)	BRAF	not provided|Rasopathy|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, multiple submitters, no conflicts	7	140754233	GRCh38	40383	48853
NM_004333.4(BRAF):c.1694+14G>A	BRAF	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.00015(T), GMAF:0.00080(T), GO-ESP:0.00030(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140776898	GRCh38	44809	53976
NM_004333.4(BRAF):c.1600G>C (p.Gly534Arg)	BRAF	Cardiofaciocutaneous syndrome 1|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	7	140777006	GRCh38	13980	29019
NM_004333.4(BRAF):c.1595G>A (p.Cys532Tyr)	BRAF	not specified|not provided|Cardio-facio-cutaneous syndrome		Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2016)	criteria provided, conflicting interpretations	7	140777011	GRCh38	40380	48850
NM_004333.4(BRAF):c.1593G>T (p.Trp531Cys)	BRAF	not provided		Pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	7	140777013	GRCh38	265358	259851
NM_004333.4(BRAF):c.1513C>T (p.Leu505Phe)	BRAF	not provided		Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	7	140777995	GRCh38	40375	48845
NM_004333.4(BRAF):c.1502A>T (p.Glu501Val)	BRAF	not provided|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, multiple submitters, no conflicts	7	140778006	GRCh38	40374	48844
NM_004333.4(BRAF):c.1502A>C (p.Glu501Ala)	BRAF	not provided		Pathogenic(Last reviewed: Mar 10, 2014)	criteria provided, single submitter	7	140778006	GRCh38	40373	48843
NM_004333.4(BRAF):c.1502A>G (p.Glu501Gly)	BRAF	Cardiofaciocutaneous syndrome 1|not provided|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, multiple submitters, no conflicts	7	140778006	GRCh38	13978	29017
NM_004333.4(BRAF):c.1501G>C (p.Glu501Gln)	BRAF	Cardio-facio-cutaneous syndrome		Likely pathogenic(Last reviewed: Apr 23, 2010)	criteria provided, single submitter	7	140778007	GRCh38	44807	53974
NM_004333.4(BRAF):c.1501G>A (p.Glu501Lys)	BRAF	Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|not provided|Rasopathy		Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, multiple submitters, no conflicts	7	140778007	GRCh38	13977	29016
NM_004333.4(BRAF):c.1497A>T (p.Lys499Asn)	BRAF	Rasopathy		Pathogenic	criteria provided, single submitter	7	140778011	GRCh38	40372	48842
NM_004333.4(BRAF):c.1497A>C (p.Lys499Asn)	BRAF	not provided		Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, multiple submitters, no conflicts	7	140778011	GRCh38	40371	48841
NM_004333.4(BRAF):c.1495A>G (p.Lys499Glu)	BRAF	Cardiofaciocutaneous syndrome 1|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, multiple submitters, no conflicts	7	140778013	GRCh38	13976	29015
NM_004333.4(BRAF):c.1493T>A (p.Phe498Tyr)	BRAF	not provided		Likely pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	7	140778015	GRCh38	279935	264228
NM_004333.4(BRAF):c.1460T>G (p.Val487Gly)	BRAF	Cardio-facio-cutaneous syndrome		Likely pathogenic(Last reviewed: Apr 13, 2012)	criteria provided, single submitter	7	140778048	GRCh38	44806	53973
NM_004333.4(BRAF):c.1455G>T (p.Leu485Phe)	BRAF	Rasopathy		Pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	7	140778053	GRCh38	177844	174043
NM_004333.4(BRAF):c.1455G>C (p.Leu485Phe)	BRAF	Cardiofaciocutaneous syndrome 1|Rasopathy|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	7	140778053	GRCh38	13975	29014
NM_004333.4(BRAF):c.1454T>C (p.Leu485Ser)	BRAF	not provided|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2014)	criteria provided, multiple submitters, no conflicts	7	140778054	GRCh38	40370	48840
NM_004333.4(BRAF):c.1447A>C (p.Lys483Gln)	BRAF	Rasopathy|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2014)	criteria provided, multiple submitters, no conflicts	7	140778061	GRCh38	40369	48839
NM_004333.4(BRAF):c.1442C>A (p.Ala481Glu)	BRAF	Cardio-facio-cutaneous syndrome		Likely pathogenic(Last reviewed: Feb 29, 2012)	criteria provided, single submitter	7	140778066	GRCh38	44805	53972
NM_004333.4(BRAF):c.1411G>A (p.Val471Ile)	BRAF	not provided		Likely pathogenic(Last reviewed: Aug 30, 2012)	criteria provided, single submitter	7	140781597	GRCh38	40368	48838
NM_004333.4(BRAF):c.1411G>T (p.Val471Phe)	BRAF	not provided		Likely pathogenic(Last reviewed: May 29, 2012)	criteria provided, single submitter	7	140781597	GRCh38	40367	48837
NM_004333.4(BRAF):c.1408_1410delACA (p.Thr470del)	BRAF	Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	7	140781598 - 140781600	GRCh38	223139	224864
NM_004333.4(BRAF):c.1406G>A (p.Gly469Glu)	BRAF	Cardiofaciocutaneous syndrome 1|not provided|Rasopathy|Cardio-facio-cutaneous syndrome	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Oct 13, 2014)	criteria provided, multiple submitters, no conflicts	7	140781602	GRCh38	13974	29013
NM_004333.4(BRAF):c.1405G>C (p.Gly469Arg)	BRAF	Malignant lymphoma, non-Hodgkin|not provided		Pathogenic(Last reviewed: Dec 17, 2012)	criteria provided, single submitter	7	140781603	GRCh38	13970	29009
NM_004333.4(BRAF):c.1403T>C (p.Phe468Ser)	BRAF	not provided|Cardio-facio-cutaneous syndrome	GO-ESP:0.00001(G)	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, multiple submitters, no conflicts	7	140781605	GRCh38	40366	48836
NM_004333.4(BRAF):c.1399T>G (p.Ser467Ala)	BRAF	not provided|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	7	140781609	GRCh38	223138	224865
NM_004333.4(BRAF):c.1391G>T (p.Gly464Val)	BRAF	Non-small cell lung cancer|Rasopathy		Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	7	140781617	GRCh38	40364	48834
NM_004333.4(BRAF):c.1390G>C (p.Gly464Arg)	BRAF	not provided		Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	7	140781618	GRCh38	279992	264230
NM_004333.4(BRAF):c.1383A>G (p.Gln461=)	BRAF	Noonan syndrome|not specified|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.00315(C), GMAF:0.00540(C), GO-ESP:0.00108(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140781625	GRCh38	40363	48833
NM_004333.4(BRAF):c.1332G>A (p.Arg444=)	BRAF	Noonan syndrome|not specified|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.00115(T), GMAF:0.00020(T), GO-ESP:0.00059(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140781676	GRCh38	40362	48832
NM_004333.4(BRAF):c.1227A>G (p.Ser409=)	BRAF	Noonan syndrome|not specified|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.00215(C), GMAF:0.00060(C), GO-ESP:0.00291(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140783108	GRCh38	40360	48830
NM_004333.4(BRAF):c.1068A>G (p.Gln356=)	BRAF	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.00015(C), GMAF:0.00080(C), GO-ESP:0.00030(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140794380	GRCh38	44788	53955
NG_007873.3:g.135341A>G	BRAF	Noonan syndrome|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GMAF:0.00020(C), GO-ESP:0.00003(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	140794424	GRCh38	359048	302003
NG_007873.3:g.135284C>A	BRAF	Noonan syndrome|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	140794481	GRCh38	359049	309876
NM_004333.4(BRAF):c.785A>G (p.Gln262Arg)	BRAF	not provided|Rasopathy		Likely pathogenic(Last reviewed: Aug 8, 2015)	criteria provided, single submitter	7	140801487	GRCh38	180723	178882
NM_004333.4(BRAF):c.785A>C (p.Gln262Pro)	BRAF	not provided|Cardio-facio-cutaneous syndrome		Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140801487	GRCh38	44831	53998
NM_004333.4(BRAF):c.784C>A (p.Gln262Lys)	BRAF	not provided		Pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	7	140801488	GRCh38	40352	48822
NM_004333.4(BRAF):c.770A>G (p.Gln257Arg)	BRAF	Cardiofaciocutaneous syndrome 1|not provided|Rasopathy|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	7	140801502	GRCh38	13973	29012
NM_004333.4(BRAF):c.769C>A (p.Gln257Lys)	BRAF	not provided|Rasopathy		Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2015)	criteria provided, multiple submitters, no conflicts	7	140801503	GRCh38	40351	48821
NM_004333.4(BRAF):c.740T>C (p.Phe247Ser)	BRAF	Rasopathy		Likely pathogenic(Last reviewed: Jun 29, 2011)	criteria provided, single submitter	7	140801532	GRCh38	40349	48819
NM_004333.4(BRAF):c.739T>G (p.Phe247Val)	BRAF	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Mar 11, 2016)	criteria provided, conflicting interpretations	7	140801533	GRCh38	44830	53997
NM_004333.4(BRAF):c.736G>C (p.Ala246Pro)	BRAF	Cardiofaciocutaneous syndrome 1|not provided|Rasopathy|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, multiple submitters, no conflicts	7	140801536	GRCh38	13965	29004
NM_004333.4(BRAF):c.735A>T (p.Leu245Phe)	BRAF	Noonan syndrome with multiple lentigines|not provided|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2012)	criteria provided, multiple submitters, no conflicts	7	140801537	GRCh38	40348	48818
NM_004333.4(BRAF):c.735A>C (p.Leu245Phe)	BRAF	LEOPARD syndrome 3|not provided|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2015)	criteria provided, multiple submitters, no conflicts	7	140801537	GRCh38	40347	48817
NM_004333.4(BRAF):c.730A>C (p.Thr244Pro)	BRAF	not provided|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Nov 19, 2014)	criteria provided, multiple submitters, no conflicts	7	140801542	GRCh38	40346	48816
NM_004333.4(BRAF):c.722C>A (p.Thr241Lys)	BRAF	Noonan syndrome		Pathogenic(Last reviewed: Jun 7, 2013)	criteria provided, single submitter	7	140801550	GRCh38	44829	53996
NM_004333.4(BRAF):c.722C>T (p.Thr241Met)	BRAF	Noonan syndrome 1|Noonan syndrome 7|Noonan syndrome|not provided		Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, multiple submitters, no conflicts	7	140801550	GRCh38	29805	38760
NM_004333.4(BRAF):c.721A>C (p.Thr241Pro)	BRAF	Cardiofaciocutaneous syndrome 1|Noonan syndrome with multiple lentigines|LEOPARD syndrome 3|not provided|Rasopathy|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2016)	criteria provided, multiple submitters, no conflicts	7	140801551	GRCh38	29807	38762
NM_004333.4(BRAF):c.708C>T (p.Asn236=)	BRAF	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.00015(A), GMAF:0.00080(A), GO-ESP:0.00030(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140807963	GRCh38	44827	53994
NM_004333.4(BRAF):c.375T>G (p.Ser125=)	BRAF	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GMAF:0.00060(C), GO-ESP:0.00012(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140834738	GRCh38	44825	53992
NM_004333.4(BRAF):c.78G>T (p.Glu26Asp)	BRAF	Noonan syndrome|not specified|not provided|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.00494(A), GMAF:0.00920(A), GO-ESP:0.00057(A)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140924626	GRCh38	40337	48807
NM_004333.4(BRAF):c.36G>A (p.Ala12=)	BRAF	Noonan syndrome|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GO-ESP:0.00145(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140924668	GRCh38	40333	48803
NM_004333.4(BRAF):c.-5A>G	BRAF	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GMAF:0.00200(C), GO-ESP:0.00029(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140924708	GRCh38	136536	140239
NM_004333.4(BRAF):c.-19C>T	BRAF	Noonan syndrome|not specified|Rasopathy|Cardio-facio-cutaneous syndrome|LEOPARD Syndrome	GMAF:0.01540(A), GO-ESP:0.00029(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	140924722	GRCh38	41445	49883
NM_000083.2(CLCN1):c.501C>G (p.Phe167Leu)	CLCN1	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Myotonia congenita	GMAF:0.00080(G), GO-ESP:0.00109(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	143321432	GRCh38	209138	205752
NM_000083.2(CLCN1):c.568_569delGGinsTC (p.Gly190Ser)	CLCN1	Congenital myotonia, autosomal recessive form		Likely pathogenic(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	7	143321720 - 143321721	GRCh38	209139	205753
NM_000238.3(KCNH2):c.3470dupC (p.Ser1159Glnfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: May 13, 2014)	criteria provided, single submitter	7	150945375	GRCh38	200713	197128
NM_000238.3(KCNH2):c.3470C>T (p.Pro1157Leu)	KCNH2	SUDDEN INFANT DEATH SYNDROME|not specified	GO-ESP:0.00008(A), GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Nov 4, 2015)	criteria provided, single submitter	7	150945375	GRCh38	67499	78395
NM_000238.3(KCNH2):c.3365C>G (p.Pro1122Arg)	KCNH2	not specified		Uncertain significance(Last reviewed: Jul 3, 2014)	no assertion criteria provided	7	150945480	GRCh38	234998	236768
NM_000238.3(KCNH2):c.3331-9_3331-8delGT	KCNH2	Cardiac arrhythmia|Long QT syndrome		Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	150945522 - 150945523	GRCh38	200266	197131
NM_000238.3(KCNH2):c.3331-13delG	KCNH2	Cardiac arrhythmia		Benign(Last reviewed: Apr 18, 2012)	criteria provided, single submitter	7	150945527	GRCh38	200264	197133
NM_000238.3(KCNH2):c.3331-14delT	KCNH2	Cardiac arrhythmia		Benign(Last reviewed: Jun 18, 2012)	criteria provided, single submitter	7	150945528	GRCh38	200260	197134
NM_000238.3(KCNH2):c.3251dupC (p.Pro1086Alafs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jun 20, 2014)	criteria provided, single submitter	7	150946956	GRCh38	200711	197136
NM_000238.3(KCNH2):c.3247A>G (p.Thr1083Ala)	KCNH2	not specified	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	7	150946960	GRCh38	200529	197137
NM_000238.3(KCNH2):c.3164G>A (p.Arg1055Gln)	KCNH2	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(T), GMAF:0.00040(T), GO-ESP:0.00011(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	150947043	GRCh38	67475	78371
NM_000238.3(KCNH2):c.3140G>T (p.Arg1047Leu)	KCNH2	Cardiac arrhythmia|Long QT syndrome 2|Long QT syndrome|not provided|Torsades de pointes|Cardiovascular phenotype|Sudden unexplained death	GO-ESP:0.01334(A), GMAF:0.00900(A), GO-ESP:0.00879(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	150947340	GRCh38	36429	45092
NM_000238.3(KCNH2):c.3136delC (p.Gln1046Serfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Sep 29, 2014)	criteria provided, single submitter	7	150947344	GRCh38	200709	197139
NM_000238.3(KCNH2):c.3112_3129del18insCA (p.Val1038Glnfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jul 8, 2014)	criteria provided, single submitter	7	150947351 - 150947368	GRCh38	200707	197140
NM_000238.3(KCNH2):c.3125T>C (p.Leu1042Pro)	KCNH2	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	7	150947355	GRCh38	264155	258465
NM_000238.3(KCNH2):c.3119G>A (p.Ser1040Asn)	KCNH2	not specified		Uncertain significance(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	7	150947361	GRCh38	200526	197141
NM_000238.3(KCNH2):c.3105_3112dupGGGCGACG (p.Val1038Glyfs)	KCNH2	Cardiac arrhythmia|Long QT syndrome		Pathogenic(Last reviewed: Feb 18, 2016)	criteria provided, multiple submitters, no conflicts	7	150947368 - 150947375	GRCh38	200705	197142
NM_000238.3(KCNH2):c.3107dupG (p.Asp1037Argfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jun 25, 2013)	criteria provided, single submitter	7	150947373	GRCh38	200803	197146
NM_000238.3(KCNH2):c.3104_3107dupGGGG (p.Asp1037Glyfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Mar 20, 2013)	criteria provided, single submitter	7	150947373 - 150947376	GRCh38	200703	197144
NM_000238.3(KCNH2):c.3096_3099dupGCGG (p.Pro1034Alafs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Mar 1, 2012)	criteria provided, single submitter	7	150947381 - 150947384	GRCh38	200699	197148
NM_000238.3(KCNH2):c.3079dupC (p.Leu1027Profs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	7	150947401	GRCh38	200695	197151
NM_000238.3(KCNH2):c.3079C>A (p.Leu1027Ile)	KCNH2	Cardiac arrhythmia		Likely benign(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	7	150947401	GRCh38	200254	197150
NM_000238.3(KCNH2):c.2987A>T (p.Asn996Ile)	KCNH2	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Apr 27, 2012)	criteria provided, single submitter	7	150947493	GRCh38	67458	78354
NM_000238.3(KCNH2):c.2966-2_2967dupAGGC	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	7	150947513 - 150947516	GRCh38	200691	197158
NM_000238.3(KCNH2):c.2959_2960delCT (p.Leu987Valfs)	KCNH2	not provided|Cardiovascular phenotype	GO-ESP:0.00002(-)	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, multiple submitters, no conflicts	7	150947611 - 150947612	GRCh38	200693	197159
NM_000238.3(KCNH2):c.2944G>A (p.Asp982Asn)	KCNH2	Long QT syndrome	GMAF:0.00040(T), GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	7	150947627	GRCh38	237299	239993
NM_000238.3(KCNH2):c.2916_2917dupCC (p.Leu973Profs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Mar 26, 2014)	criteria provided, single submitter	7	150947654 - 150947655	GRCh38	200689	197162
NM_000238.3(KCNH2):c.2906delG (p.Gly969Valfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Dec 30, 2013)	criteria provided, single submitter	7	150947665	GRCh38	200680	197163
NM_000238.3(KCNH2):c.2900dupC (p.Pro968Alafs)	KCNH2	Cardiac arrhythmia|Long QT syndrome		Pathogenic(Last reviewed: Oct 11, 2014)	criteria provided, multiple submitters, no conflicts	7	150947671	GRCh38	188144	186073
NM_000238.3(KCNH2):c.2900C>T (p.Pro967Leu)	KCNH2	not provided|Cardiovascular phenotype	GO-ESP:0.00031(A), GMAF:0.00020(A), GO-ESP:0.00015(A)	Likely benign(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	7	150947671	GRCh38	67451	78347
NM_000238.3(KCNH2):c.2892dupC (p.Gly965Argfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: May 7, 2012)	criteria provided, single submitter	7	150947679	GRCh38	200686	197165
NM_000238.3(KCNH2):c.2860C>T (p.Arg954Cys)	KCNH2	SUDDEN INFANT DEATH SYNDROME|not provided	GO-ESP:0.00008(A)	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	7	150947711	GRCh38	67444	78340
NM_000238.3(KCNH2):c.2857delC (p.Leu953Serfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jul 15, 2011)	criteria provided, single submitter	7	150947714	GRCh38	200797	197166
NM_000238.3(KCNH2):c.2797dupA (p.Ser933Lysfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Dec 12, 2012)	criteria provided, single submitter	7	150947774	GRCh38	200684	197167
NM_000238.3(KCNH2):c.2783_2789delGGGAGAG (p.Gly928Alafs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jul 3, 2012)	criteria provided, single submitter	7	150947782 - 150947788	GRCh38	200676	197169
NM_000238.3(KCNH2):c.2785dupG (p.Glu929Glyfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	7	150947786	GRCh38	200678	197171
NM_000238.3(KCNH2):c.2780G>A (p.Trp927Ter)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Oct 6, 2014)	criteria provided, single submitter	7	150947791	GRCh38	200499	197173
NM_000238.3(KCNH2):c.2777delC (p.Pro926Argfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Sep 27, 2012)	criteria provided, single submitter	7	150947794	GRCh38	200674	197174
NM_000238.3(KCNH2):c.2775dupG (p.Pro926Alafs)	KCNH2	Cardiac arrhythmia|Long QT syndrome|Cardiovascular phenotype		Pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	7	150947796	GRCh38	200672	197175
NM_000238.3(KCNH2):c.2771G>A (p.Gly924Glu)	KCNH2	not provided|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00011(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 23, 2015)	criteria provided, conflicting interpretations	7	150947800	GRCh38	67437	78333
NM_000238.3(KCNH2):c.2770G>A (p.Gly924Arg)	KCNH2	not specified		Uncertain significance(Last reviewed: Jun 26, 2015)	criteria provided, single submitter	7	150947801	GRCh38	200492	197178
NM_000238.3(KCNH2):c.2764delC (p.Arg922Glyfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Dec 12, 2012)	criteria provided, single submitter	7	150947807	GRCh38	200668	197180
NM_000238.3(KCNH2):c.2734_2738dupCGGGC (p.Ala915Argfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	7	150947833 - 150947837	GRCh38	200795	197182
NM_000238.3(KCNH2):c.2731_2732dupGG (p.Arg912Alafs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jun 19, 2012)	criteria provided, single submitter	7	150947839 - 150947840	GRCh38	200666	197183
NM_000238.3(KCNH2):c.2732delG (p.Gly911Alafs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Aug 1, 2012)	criteria provided, single submitter	7	150947839	GRCh38	200664	197184
NM_000238.3(KCNH2):c.2724_2728dupGGGGC (p.Pro910Argfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Apr 8, 2014)	criteria provided, single submitter	7	150947843 - 150947847	GRCh38	200660	197185
NM_000238.3(KCNH2):c.2719G>A (p.Ala907Thr)	KCNH2	not specified		Uncertain significance(Last reviewed: May 14, 2014)	criteria provided, single submitter	7	150947852	GRCh38	200486	197187
NM_000238.3(KCNH2):c.2690_2691delAGinsC (p.Lys897Thrfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Feb 20, 2013)	criteria provided, single submitter	7	150948445 - 150948446	GRCh38	200658	197189
NM_000238.3(KCNH2):c.2690A>C (p.Lys897Thr)	KCNH2	Atrial fibrillation|Long QT syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.16908(G), GMAF:0.13620(G), GO-ESP:0.18715(G)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	150948446	GRCh38	67427	78323
NM_000238.3(KCNH2):c.2684_2685insCC (p.Asp896Argfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Dec 20, 2013)	criteria provided, single submitter	7	150948451 - 150948452	GRCh38	200656	197191
NM_000238.3(KCNH2):c.2681G>T (p.Arg894Leu)	KCNH2	Cardiac arrhythmia|Congenital long QT syndrome		Pathogenic(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	7	150948455	GRCh38	67425	78321
NM_000238.3(KCNH2):c.2606C>T (p.Pro869Leu)	KCNH2	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jun 10, 2013)	criteria provided, single submitter	7	150948530	GRCh38	200473	197194
NM_000238.3(KCNH2):c.2595C>T (p.Thr865=)	KCNH2	Cardiovascular phenotype	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Oct 8, 2013)	criteria provided, single submitter	7	150948541	GRCh38	263736	258463
NM_000238.3(KCNH2):c.2582A>T (p.Asn861Ile)	KCNH2	Long QT syndrome 2|Long QT syndrome 2/5|Congenital long QT syndrome		Pathogenic(Last reviewed: Apr 20, 2004)	no assertion criteria provided	7	150948866	GRCh38	14440	29479
NM_000238.3(KCNH2):c.2504G>A (p.Arg835Gln)	KCNH2	not provided		Likely pathogenic(Last reviewed: Jun 25, 2014)	criteria provided, single submitter	7	150948944	GRCh38	200464	197197
NM_000238.3(KCNH2):c.2464G>A (p.Val822Met)	KCNH2	Long QT syndrome 2|Congenital long QT syndrome|Cardiovascular phenotype		Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	7	150948984	GRCh38	14424	29463
NM_000238.3(KCNH2):c.2456delA (p.Asn819Thrfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: May 24, 2012)	criteria provided, single submitter	7	150948992	GRCh38	200654	197200
NM_000238.3(KCNH2):c.2454G>A (p.Ser818=)	KCNH2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00025(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	150948994	GRCh38	200245	197201
NM_000238.3(KCNH2):c.2419delG (p.Glu807Serfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jun 12, 2012)	criteria provided, single submitter	7	150949029	GRCh38	200652	197202
NM_172056.2(KCNH2):c.2632C>T (p.Arg878Cys)	KCNH2	Cardiac arrhythmia	GO-ESP:0.00024(A)	Likely benign(Last reviewed: Sep 16, 2014)	criteria provided, single submitter	7	150949934	GRCh38	200243	197204
NM_172056.2(KCNH2):c.2503delC (p.Leu835Cysfs)	KCNH2	Cardiac arrhythmia	GMAF:0.00100(-), GO-ESP:0.00023(-)	Likely benign(Last reviewed: Sep 19, 2014)	criteria provided, single submitter	7	150950063	GRCh38	200237	197207
NM_000238.3(KCNH2):c.2390C>A (p.Ala797Asp)	KCNH2	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jul 23, 2013)	criteria provided, conflicting interpretations	7	150950176	GRCh38	200440	197215
NM_000238.3(KCNH2):c.2366T>C (p.Ile789Thr)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jun 30, 2014)	criteria provided, single submitter	7	150950200	GRCh38	200431	197219
NM_000238.3(KCNH2):c.2343C>G (p.Phe781Leu)	KCNH2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	7	150950223	GRCh38	264633	258469
NM_000238.3(KCNH2):c.2320G>T (p.Asp774Tyr)	KCNH2	Long QT syndrome 2|not provided|Congenital long QT syndrome		Pathogenic/Likely pathogenic, not provided(Last reviewed: Oct 20, 2015)	criteria provided, multiple submitters, no conflicts	7	150950246	GRCh38	67385	78281
NM_000238.3(KCNH2):c.2204C>T (p.Ser735Leu)	KCNH2	Cardiac arrhythmia|Long QT syndrome|Congenital long QT syndrome	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 15, 2015)	criteria provided, conflicting interpretations	7	150950362	GRCh38	67374	78270
NM_000238.3(KCNH2):c.2144C>T (p.Ala715Val)	KCNH2	Cardiac arrhythmia	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Jun 30, 2014)	criteria provided, single submitter	7	150950922	GRCh38	200413	197228
NM_000238.3(KCNH2):c.2084delA (p.Gln695Argfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Mar 1, 2012)	criteria provided, single submitter	7	150950982	GRCh38	200793	197231
NM_000238.3(KCNH2):c.2053delC (p.Arg685Alafs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Feb 10, 2012)	criteria provided, single submitter	7	150951013	GRCh38	200791	197233
NM_000238.3(KCNH2):c.1954_1956delTATinsCAC (p.Tyr652His)	KCNH2	Cardiac arrhythmia		Likely pathogenic(Last reviewed: Dec 19, 2011)	criteria provided, single submitter	7	150951110 - 150951112	GRCh38	200761	197237
NM_000238.3(KCNH2):c.1956T>C (p.Tyr652=)	KCNH2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.22780(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	150951110	GRCh38	200230	197235
NM_000238.3(KCNH2):c.1920C>A (p.Phe640Leu)	KCNH2	Long QT syndrome 2|Congenital long QT syndrome		Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	7	150951473	GRCh38	67336	78232
NM_000238.3(KCNH2):c.1898A>G (p.Asn633Ser)	KCNH2	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	7	150951495	GRCh38	67323	78219
NM_000238.3(KCNH2):c.1882G>A (p.Gly628Ser)	KCNH2	Long QT syndrome 2|not provided|Congenital long QT syndrome		Pathogenic/Likely pathogenic, not provided(Last reviewed: Nov 15, 2013)	no assertion criteria provided	7	150951511	GRCh38	14427	29466
NM_000238.3(KCNH2):c.1841C>T (p.Ala614Val)	KCNH2	Long QT syndrome 2|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, multiple submitters, no conflicts	7	150951552	GRCh38	29777	38732
NM_000238.3(KCNH2):c.1838C>T (p.Thr613Met)	KCNH2	not provided|Congenital long QT syndrome|Cardiovascular phenotype		Pathogenic/Likely pathogenic, not provided(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	7	150951555	GRCh38	67292	78188
NM_000238.3(KCNH2):c.1815delC (p.Ser606Profs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jan 24, 2012)	criteria provided, single submitter	7	150951578	GRCh38	200789	197253
NM_000238.3(KCNH2):c.1764C>G (p.Asn588Lys)	KCNH2	Short QT syndrome 1|short QT syndrome		Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	7	150951629	GRCh38	14436	29475
NM_000238.3(KCNH2):c.1692A>G (p.Leu564=)	KCNH2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.39160(T), GO-ESP:0.47859(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	150951701	GRCh38	200228	197263
NM_000238.3(KCNH2):c.1682C>T (p.Ala561Val)	KCNH2	Long QT syndrome 2|Long QT syndrome|not provided|Congenital long QT syndrome		Pathogenic/Likely pathogenic, not provided(Last reviewed: Dec 19, 2015)	criteria provided, multiple submitters, no conflicts	7	150951711	GRCh38	14420	29459
NM_000238.3(KCNH2):c.1681G>C (p.Ala561Pro)	KCNH2	Congenital long QT syndrome|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	7	150951712	GRCh38	67230	78126
NM_000238.3(KCNH2):c.1681G>A (p.Ala561Thr)	KCNH2	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	7	150951712	GRCh38	67229	78125
NM_000238.3(KCNH2):c.1676delT (p.Leu559Profs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: May 11, 2012)	criteria provided, single submitter	7	150951717	GRCh38	200640	197267
NM_000238.3(KCNH2):c.1655T>C (p.Leu552Ser)	KCNH2	Long QT syndrome 2|not provided|Congenital long QT syndrome|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00004(G)	Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, multiple submitters, no conflicts	7	150951738	GRCh38	67225	78121
NM_000238.3(KCNH2):c.1609C>T (p.Arg537Trp)	KCNH2	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	7	150951784	GRCh38	67222	78118
NM_000238.3(KCNH2):c.1583G>A (p.Arg528Gln)	KCNH2	Cardiac arrhythmia		Likely pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	7	150951810	GRCh38	200356	197271
NM_000238.3(KCNH2):c.1581G>A (p.Ala527=)	KCNH2	not specified|Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00025(T)	Benign/Likely benign(Last reviewed: Jun 29, 2015)	criteria provided, multiple submitters, no conflicts	7	150951812	GRCh38	200224	197272
NM_000238.3(KCNH2):c.1563C>T (p.Ile521=)	KCNH2	Long QT syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00077(A), GMAF:0.00160(A), GO-ESP:0.00118(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 4, 2016)	criteria provided, conflicting interpretations	7	150951830	GRCh38	70633	81524
NM_000238.3(KCNH2):c.1558-5C>T	KCNH2	Long QT syndrome 2|Long QT syndrome|Cardiovascular phenotype	GMAF:0.00720(A), GO-ESP:0.00202(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	150951840	GRCh38	218433	215355
NM_000238.3(KCNH2):c.1557+1G>A	KCNH2	Cardiovascular phenotype		Pathogenic(Last reviewed: Jun 1, 2015)	criteria provided, single submitter	7	150952424	GRCh38	264098	258466
NM_000238.3(KCNH2):c.1539C>T (p.Phe513=)	KCNH2	Cardiac arrhythmia|Long QT syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.22636(A), GMAF:0.34170(A), GO-ESP:0.29345(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	150952443	GRCh38	36428	45091
NM_000238.3(KCNH2):c.1528C>T (p.Leu510=)	KCNH2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00159(A)	Benign/Likely benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	7	150952454	GRCh38	237292	239999
NM_000238.3(KCNH2):c.1468G>A (p.Ala490Thr)	KCNH2	Long QT syndrome, bradycardia-induced|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Jan 23, 2012)	criteria provided, single submitter	7	150952514	GRCh38	14430	29469
NM_000238.3(KCNH2):c.1467C>T (p.Ile489=)	KCNH2	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.34270(A), GO-ESP:0.29287(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	150952515	GRCh38	255614	252648
NM_000238.3(KCNH2):c.1320G>T (p.Pro440=)	KCNH2	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00034(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	150952662	GRCh38	215441	212569
NM_000238.3(KCNH2):c.1319dupC (p.Pro441Alafs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Dec 6, 2013)	criteria provided, single submitter	7	150952663	GRCh38	200634	197284
NM_000238.3(KCNH2):c.1285delG (p.Ala429Leufs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Feb 22, 2012)	criteria provided, single submitter	7	150952697	GRCh38	200787	197286
NM_000238.3(KCNH2):c.1282T>C (p.Ser428Pro)	KCNH2	not provided		Likely pathogenic(Last reviewed: Mar 26, 2014)	criteria provided, single submitter	7	150952700	GRCh38	200335	197287
NM_000238.3(KCNH2):c.1280A>C (p.Tyr427Ser)	KCNH2	Congenital long QT syndrome|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	7	150952702	GRCh38	67178	78074
NM_000238.3(KCNH2):c.1201_1204dupCTGC (p.His402Profs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Aug 29, 2014)	criteria provided, single submitter	7	150952778 - 150952781	GRCh38	200630	197290
NM_000238.3(KCNH2):c.1150dupG (p.Val384Glyfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Mar 26, 2012)	criteria provided, single submitter	7	150952832	GRCh38	200628	197292
NM_000238.3(KCNH2):c.1142delG (p.Gly381Alafs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Aug 16, 2011)	criteria provided, single submitter	7	150952840	GRCh38	200785	197294
NM_000238.3(KCNH2):c.1132dupC (p.Leu378Profs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	7	150952850	GRCh38	200626	197295
NM_000238.3(KCNH2):c.1067G>A (p.Arg356His)	KCNH2	Long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: May 28, 2014)	criteria provided, single submitter	7	150957352	GRCh38	180382	178575
NM_000238.3(KCNH2):c.982C>T (p.Arg328Cys)	KCNH2	Long QT syndrome|not specified|not provided	GMAF:0.00080(A), GO-ESP:0.00053(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 25, 2016)	criteria provided, conflicting interpretations	7	150957437	GRCh38	67552	78448
NM_000238.3(KCNH2):c.980A>G (p.Tyr327Cys)	KCNH2	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 8, 2015)	criteria provided, single submitter	7	150957439	GRCh38	264025	258467
NM_000238.3(KCNH2):c.959C>G (p.Ser320Trp)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	7	150957460	GRCh38	200312	197304
NM_000238.3(KCNH2):c.934C>T (p.Arg312Cys)	KCNH2	Long QT syndrome|Congenital long QT syndrome	GO-ESP:0.00004(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 14, 2016)	criteria provided, conflicting interpretations	7	150957485	GRCh38	67547	78443
NM_000238.3(KCNH2):c.877G>T (p.Ala293Ser)	KCNH2	not specified		Uncertain significance(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	7	150958098	GRCh38	200308	197307
NM_000238.3(KCNH2):c.853_859delGCCGACG (p.Ala285Thrfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Dec 1, 2013)	criteria provided, single submitter	7	150958116 - 150958122	GRCh38	200618	197310
NM_000238.3(KCNH2):c.809_812delCGCGinsAAAAGC (p.Thr270Lysfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	7	150958163 - 150958166	GRCh38	200614	197313
NM_000238.3(KCNH2):c.735_754dup20 (p.Arg252Profs)	KCNH2	Cardiac arrhythmia|Long QT syndrome		Pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, multiple submitters, no conflicts	7	150958221 - 150958240	GRCh38	200612	197315
NM_000238.3(KCNH2):c.719C>T (p.Pro240Leu)	KCNH2	not specified		Uncertain significance(Last reviewed: May 30, 2014)	criteria provided, single submitter	7	150958256	GRCh38	200299	197318
NM_000238.3(KCNH2):c.695G>T (p.Arg232Leu)	KCNH2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	7	150958280	GRCh38	264446	258464
NM_000238.3(KCNH2):c.560_568dupGCGCGGGCG (p.Gly189_Ala190insGlyAlaGly)	KCNH2	Cardiac arrhythmia		Uncertain significance(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	7	150958407 - 150958415	GRCh38	200604	197325
NM_000238.3(KCNH2):c.560_568delGCGCGGGCG (p.Gly187_Gly189del)	KCNH2	Cardiac arrhythmia|Long QT syndrome 2|Cardiovascular phenotype	GMAF:0.00280(-), GO-ESP:0.00131(-)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2015)	criteria provided, conflicting interpretations	7	150958407 - 150958415	GRCh38	200600	197324
NM_000238.3(KCNH2):c.542G>A (p.Arg181Gln)	KCNH2	Cardiac arrhythmia|Long QT syndrome|not provided	GMAF:0.00260(T), GO-ESP:0.00012(T)	Benign(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	7	150958433	GRCh38	67510	78406
NM_000238.3(KCNH2):c.526C>T (p.Arg176Trp)	KCNH2	Long QT syndrome 2|Long QT syndrome|not specified|not provided		Conflicting interpretations of pathogenicity, not provided, risk factor(Last reviewed: May 20, 2016)	criteria provided, conflicting interpretations	7	150958449	GRCh38	67509	78405
NM_000238.3(KCNH2):c.472+1G>C	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jul 19, 2011)	criteria provided, single submitter	7	150959571	GRCh38	200719	197330
NM_000238.3(KCNH2):c.442C>T (p.Arg148Trp)	KCNH2	Cardiac arrhythmia|Long QT syndrome|not specified|not provided	GO-ESP:0.00123(A), GMAF:0.00060(A), GO-ESP:0.00106(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 19, 2016)	criteria provided, conflicting interpretations	7	150959602	GRCh38	67505	78401
NM_000238.3(KCNH2):c.373_374insGTGG (p.Phe125Cysfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Aug 14, 2011)	criteria provided, single submitter	7	150959670 - 150959671	GRCh38	200759	197337
NM_000238.3(KCNH2):c.374T>G (p.Phe125Cys)	KCNH2	Congenital long QT syndrome|Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	7	150959670	GRCh38	67502	78398
NM_000238.3(KCNH2):c.298C>G (p.Arg100Gly)	KCNH2	Long QT syndrome 2/3, digenic|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Apr 25, 2012)	criteria provided, single submitter	7	150974720	GRCh38	14442	29481
NM_000238.3(KCNH2):c.266C>T (p.Ala89Val)	KCNH2	Cardiac arrhythmia		Likely pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	7	150974752	GRCh38	200571	197349
NM_000238.3(KCNH2):c.244_252dupATCGCGCAG (p.Gln84_Ala85insIleAlaGln)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Dec 23, 2013)	criteria provided, single submitter	7	150974766 - 150974774	GRCh38	200717	197350
NM_000238.3(KCNH2):c.247G>C (p.Ala83Pro)	KCNH2	Cardiac arrhythmia		Uncertain significance(Last reviewed: Dec 17, 2013)	criteria provided, single submitter	7	150974771	GRCh38	200569	197351
NM_000238.3(KCNH2):c.234_241delTGCCGCGC (p.Ala79Aspfs)	KCNH2	Cardiovascular phenotype		Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	7	150974777 - 150974784	GRCh38	264104	258472
NM_000238.3(KCNH2):c.239C>T (p.Ala80Val)	KCNH2	Sudden cardiac death		not provided	no assertion provided	7	150974779	GRCh38	67395	78291
NM_000238.3(KCNH2):c.212G>A (p.Gly71Glu)	KCNH2	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	7	150974806	GRCh38	264521	258468
NM_000238.3(KCNH2):c.209A>G (p.His70Arg)	KCNH2	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Jul 25, 2016)	criteria provided, single submitter	7	150974809	GRCh38	67363	78259
NM_000238.3(KCNH2):c.167G>T (p.Arg56Leu)	KCNH2	not provided		Pathogenic(Last reviewed: Jul 7, 2014)	criteria provided, single submitter	7	150974851	GRCh38	200557	197356
NM_000238.3(KCNH2):c.156C>T (p.Cys52=)	KCNH2	Cardiovascular phenotype	GO-ESP:0.00006(A)	Likely benign(Last reviewed: Sep 14, 2013)	criteria provided, single submitter	7	150974862	GRCh38	263739	258471
NM_000238.3(KCNH2):c.156C>A (p.Cys52Ter)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Aug 23, 2011)	criteria provided, single submitter	7	150974862	GRCh38	200772	197357
NM_000238.3(KCNH2):c.154delT (p.Cys52Alafs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Feb 17, 2012)	criteria provided, single submitter	7	150974864	GRCh38	200809	197358
NM_000238.3(KCNH2):c.106delG (p.Val36Trpfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Oct 20, 2011)	criteria provided, single submitter	7	150974912	GRCh38	200807	197365
NM_000238.3(KCNH2):c.100delG (p.Ala34Leufs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: Oct 16, 2011)	criteria provided, single submitter	7	150974918	GRCh38	200805	197366
NM_000238.3(KCNH2):c.81dupT (p.Lys28Terfs)	KCNH2	Cardiac arrhythmia		Pathogenic(Last reviewed: May 24, 2013)	criteria provided, single submitter	7	150974937	GRCh38	200715	197367
NM_000238.3(KCNH2):c.-13-7_-12delGGCCCGCCC	KCNH2	Cardiac arrhythmia	GO-ESP:0.00006(-)	Benign(Last reviewed: Aug 23, 2014)	criteria provided, single submitter	7	150977925 - 150977933	GRCh38	200270	197375
NM_016203.3(PRKAG2):c.*3G>A	PRKAG2	Glycogen storage disease of heart, lethal congenital|not specified|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.01176(T), GMAF:0.00900(T), GO-ESP:0.00283(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	151557198	GRCh38	45684	54849
NM_016203.3(PRKAG2):c.1704G>A (p.Thr568=)	PRKAG2	Glycogen storage disease of heart, lethal congenital|not specified|Cardiovascular phenotype	GO-ESP:0.00131(T), GMAF:0.00360(T), GO-ESP:0.00053(T)	Benign(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	7	151557207	GRCh38	45706	54871
NM_016203.3(PRKAG2):c.1623T>C (p.Ile541=)	PRKAG2	Glycogen storage disease of heart, lethal congenital|not specified|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.04060(G), GMAF:0.04390(G), GO-ESP:0.01167(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	151560579	GRCh38	45702	54867
NM_016203.3(PRKAG2):c.1593G>A (p.Arg531=)	PRKAG2	Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|not specified|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.00354(T), GMAF:0.00140(T), GO-ESP:0.00312(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	151560609	GRCh38	36696	45357
NM_016203.3(PRKAG2):c.1589A>G (p.His530Arg)	PRKAG2	Familial hypertrophic cardiomyopathy 6|not provided		Pathogenic(Last reviewed: Mar 8, 2012)	criteria provided, single submitter	7	151560613	GRCh38	6854	21893
NM_016203.3(PRKAG2):c.1516G>C (p.Glu506Gln)	PRKAG2	Familial hypertrophic cardiomyopathy 6|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2013)	criteria provided, multiple submitters, no conflicts	7	151564146	GRCh38	6855	21894
NM_016203.3(PRKAG2):c.1463A>T (p.Asn488Ile)	PRKAG2	Familial hypertrophic cardiomyopathy 6		Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	7	151564199	GRCh38	6850	21889
NM_016203.3(PRKAG2):c.1459T>C (p.Tyr487His)	PRKAG2	Familial hypertrophic cardiomyopathy 6|not provided		Pathogenic(Last reviewed: Feb 26, 2015)	criteria provided, single submitter	7	151564203	GRCh38	6853	21892
NM_016203.3(PRKAG2):c.1296G>A (p.Thr432=)	PRKAG2	not specified|Cardiovascular phenotype	GMAF:0.00280(T), GO-ESP:0.00081(T)	Benign/Likely benign(Last reviewed: Dec 29, 2014)	criteria provided, multiple submitters, no conflicts	7	151565823	GRCh38	177715	174048
NM_016203.3(PRKAG2):c.1199C>A (p.Thr400Asn)	PRKAG2	Familial hypertrophic cardiomyopathy 6|Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2012)	criteria provided, single submitter	7	151568750	GRCh38	6849	21888
NM_016203.3(PRKAG2):c.1151G>C (p.Arg384Thr)	PRKAG2	Glycogen storage disease of heart, lethal congenital		Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	7	151568798	GRCh38	183142	181278
NM_016203.3(PRKAG2):c.1148A>G (p.His383Arg)	PRKAG2	Familial hypertrophic cardiomyopathy 6		Pathogenic(Last reviewed: May 15, 2001)	no assertion criteria provided	7	151568801	GRCh38	6847	21886
NM_016203.3(PRKAG2):c.1098A>G (p.Pro366=)	PRKAG2	Glycogen storage disease of heart, lethal congenital|not specified|Cardiovascular phenotype	GO-ESP:0.00216(C), GMAF:0.00180(C), GO-ESP:0.00055(C)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2016)	criteria provided, conflicting interpretations	7	151570179	GRCh38	45686	54851
NM_016203.3(PRKAG2):c.1050_1051insTTA (p.Arg350_Glu351insLeu)	PRKAG2	Familial hypertrophic cardiomyopathy 6		Pathogenic(Last reviewed: May 15, 2001)	no assertion criteria provided	7	151572664 - 151572665	GRCh38	6848	21887
NM_016203.3(PRKAG2):c.905G>A (p.Arg302Gln)	PRKAG2	Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, multiple submitters, no conflicts	7	151576412	GRCh38	6846	21885
NM_016203.3(PRKAG2):c.639C>T (p.Thr213=)	PRKAG2	Glycogen storage disease of heart, lethal congenital|not specified|Cardiovascular phenotype	GO-ESP:0.00623(A), GMAF:0.00380(A), GO-ESP:0.00158(A)	Benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	7	151675465	GRCh38	45730	54895
NM_016203.3(PRKAG2):c.471C>T (p.Ser157=)	PRKAG2	not specified|Cardiovascular phenotype	GO-ESP:0.00023(A), GO-ESP:0.00027(A)	Benign/Likely benign(Last reviewed: May 8, 2014)	criteria provided, multiple submitters, no conflicts	7	151675633	GRCh38	45721	54886
NM_016203.3(PRKAG2):c.356G>A (p.Arg119Gln)	PRKAG2	not specified	GO-ESP:0.00008(T), GMAF:0.00020(T), GO-ESP:0.00012(T)	Uncertain significance(Last reviewed: Oct 4, 2012)	criteria provided, multiple submitters, no conflicts	7	151781262	GRCh38	45716	54881
NM_016203.3(PRKAG2):c.325T>G (p.Ser109Ala)	PRKAG2	not specified	GO-ESP:0.00015(C), GMAF:0.00040(C), GO-ESP:0.00007(C)	Uncertain significance(Last reviewed: Aug 13, 2015)	criteria provided, multiple submitters, no conflicts	7	151781293	GRCh38	45715	54880
NM_016203.3(PRKAG2):c.298G>A (p.Gly100Ser)	PRKAG2	Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|not specified|Wolff-Parkinson-White syndrome|PRKAG2 cardiac syndrome|Cardiovascular phenotype|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.00085(T), GMAF:0.01460(T), GO-ESP:0.00813(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	151781320	GRCh38	36697	45358
NM_016203.3(PRKAG2):c.207G>A (p.Pro69=)	PRKAG2	Glycogen storage disease of heart, lethal congenital|not specified|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.00031(T), GMAF:0.01300(T), GO-ESP:0.00955(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	151781411	GRCh38	45709	54874
NM_016203.3(PRKAG2):c.111T>A (p.Ile37=)	PRKAG2	Glycogen storage disease of heart, lethal congenital|not specified|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.00392(T), GMAF:0.00100(T), GO-ESP:0.00197(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	151876510	GRCh38	45688	54853
NM_016203.3(PRKAG2):c.66C>G (p.Gly22=)	PRKAG2	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 13, 2012)	criteria provided, single submitter	7	151876555	GRCh38	263384	258470
NM_016203.3(PRKAG2):c.59G>T (p.Ser20Ile)	PRKAG2	Glycogen storage disease of heart, lethal congenital|not specified|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.02414(A), GMAF:0.02100(A), GO-ESP:0.00648(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	151876562	GRCh38	45727	54892
NM_001039350.2(DPP6):c.52-141059C>T	DPP6	Ventricular fibrillation, paroxysmal familial, 2		Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	7	154305155	GRCh38	16794	31833
NM_001039350.2(DPP6):c.482C>T (p.Pro161Leu)	DPP6	Sudden cardiac death		Uncertain significance(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	7	154637867	GRCh38	222553	224352
NM_001039350.2(DPP6):c.847G>A (p.Ala283Thr)	DPP6	Cardiac arrest		Uncertain significance(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	7	154772845	GRCh38	222554	224353
NM_058246.3(DNAJB6):c.277T>C (p.Phe93Leu)	DNAJB6	Limb-girdle muscular dystrophy, type 1E		Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	7	157367414	GRCh38	30904	39861
NM_058246.3(DNAJB6):c.287C>G (p.Pro96Arg)	DNAJB6	Limb-girdle muscular dystrophy, type 1E		Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	7	157367424	GRCh38	30905	39862
NC_000007.13:g.(?_72722981)_(74217390_?)del	CLDN4|CLDN3|ELN|GTF2I|LIMK1|RFC2|STX1A|EIF4H|CLIP2|LAT2|FZD9|FKBP6|BAZ1B|BCL7B|GTF2IRD1|TBL2|MLXIPL|ABHD11|GTF2IRD2|DNAJC30|WBSCR22|WBSCR28|TRIM50|WBSCR27|VPS37D|ABHD11-AS1|NCF1|MIR590	See cases		Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter			GRCh38	268059	263500
NC_000007.13:g.(?_72722981)_(74141840_?)del	CLDN4|CLDN3|ELN|GTF2I|LIMK1|RFC2|STX1A|EIF4H|CLIP2|LAT2|FZD9|FKBP6|BAZ1B|BCL7B|GTF2IRD1|TBL2|MLXIPL|ABHD11|DNAJC30|WBSCR22|WBSCR28|TRIM50|WBSCR27|VPS37D|ABHD11-AS1|MIR590	See cases		Pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, single submitter			GRCh38	221994	223682
GRCh38/hg38 7q32.3-36.3(chr7:131171478-159327017)x3	AOC1|AKR1B1|BPGM|BRAF|CALD1|CASP2|CDK5|CHRM2|CLCN1|DPP6|EN2|EPHA1|EPHB6|EZH2|GBX1|MNX1|HTR5A|INSIG1|KCNH2|KEL|MKLN1|NDUFB2|NOS3|CNOT4|PIP|PODXL|PRSS1|PRSS2|TAS2R38|PTN|PTPRN2|RARRES2|RHEB|RNY1|RNY3|RNY4|RNY5|SHH|SLC4A2|SMARCD3|AKR1D1|SSBP1|TBXAS1|TRB|VIPR2|XRCC2|ZYX|ARHGEF5|ZNF212|ZNF282|CUL1|TRIM24|MGAM|DGKI|ASIC3|PDIA4|UBE3C|FAM131B|TCAF1|DNAJB6|ABCF2|FASTK|ABCB8|PAXIP1|SSPO|NUP205|CLEC5A|MKRN1|CNTNAP2|GIMAP2|OR2F1|SLC13A4|TPK1|DENND2A|ZNF777|TRBV30|TRBV29-1|TRBV28|TRBV27|TRBV25-1|TRBV24-1|TRBV20-1|TRBV19|TRBV18|TRBV17|TRBV15|TRBV14|TRBV13|TRBV12-5|TRBV12-4|TRBV12-3|TRBV11-3|TRBV11-2|TRBV11-1|TRBV10-3|TRBV10-2|TRBV10-1|TRBV9|TRBV7-9|TRBV7-7|TRBV7-6|TRBV7-4|TRBV7-3|TRBV7-2|TRBV6-8|TRBV6-7|TRBV6-6|TRBV6-5|TRBV6-4|TRBV6-2|TRBV6-1|TRBV5-7|TRBV5-6|TRBV5-5|TRBV5-4|TRBV5-1|TRBV4-2|TRBV4-1|TRBV3-1|TRBV2|TRBJ2-7|TRBJ2-6|TRBJ2-5|TRBJ2-4|TRBJ2-3|TRBJ2-2|TRBJ2-1|TRBJ1-6|TRBJ1-5|TRBJ1-4|TRBJ1-3|TRBJ1-2|TRBJ1-1|TRBD2|TRBD1|TRBC2|TRBC1|TMEM176B|HIPK2|WDR91|REPIN1|ATP6V0A4|TAS2R3|TAS2R4|PRKAG2|LUC7L2|MRPS33|NUB1|TAS2R5|CHPF2|NCAPG2|CHCHD3|WDR60|TMEM140|GIMAP4|GIMAP5|TMEM176A|TRPV6|AGK|TRPV5|ZC3HAV1|AKR1B10|ACTR3B|KIAA1147|ESYT2|ZNF398|KIAA1549|KMT2C|EXOC4|GALNT11|LMBR1|LINC00244|NOM1|PARP12|CREB3L2|LRRC61|C7orf49|TTC26|KDM7A|TMUB1|SLC37A3|KRBA1|SLC35B4|ADCK2|PLXNA4|ZC3HAV1L|MGAM2|ZBED6CL|AGAP3|C7orf13|OR9A4|OR9A2|C7orf34|TMEM139|NOBOX|OR2A14|OR6B1|OR2F2|ZNF786|PRSS37|SVOPL|MTPN|LRGUK|ASB10|PRSS58|RNF32|CLEC2L|FMC1|LINC00689|TMEM213|GIMAP8|CRYGN|ZNF425|ZNF746|ATP6V0E2|RBM33|GALNTL5|GIMAP7|ZNF467|GIMAP1|PAXIP1-AS1|C7orf33|UBN2|TAS2R39|TAS2R40|TAS2R41|CNPY1|LOC285889|WEE2-AS1|EPHA1-AS1|TCAF2|ZNF775|LINC00996|ATG9B|FLJ40288|TAS2R60|BLACE|CTAGE6|AGBL3|OR6V1|OR2A12|OR2A1|STRA8|KLRG2|WDR86|LOC349160|GSTK1|FAM180A|LOC389602|OR2A25|IQCA1L|OR2A5|RAB19|OR2A7|ATP6V0E2-AS1|OR2A42|MIR153-2|AKR1B15|CTAGE15|OR2A2|ARHGEF35|GIMAP6|WEE2|MIR490|ZNF862|MNX1-AS1|C7orf73|ACTR3C|MIR595|LUZP6|MIR671|HTR5A-AS1|CTAGE4|LINC01003|LOC100129148|LOC100130880|WDR86-AS1|PAXIP1-AS2|LOC100134040|JHDM1D-AS1|NDUFB2-AS1|CTAGE8|TRC-GCA11-1|TRC-GCA22-1|TRC-GCA18-1|TRC-GCA12-1|TRC-GCA3-1|TRC-GCA1-1|TRC-GCA16-1|TRC-GCA19-1|TRC-GCA23-1|TRC-GCA15-1|TRC-GCA17-1|TRC-GCA10-1|TRC-GCA20-1|TRC-GCA13-1|TRC-GCA21-1|TRC-GCA9-3|TRC-GCA9-4|TRR-CCT4-1|TRC-GCA9-2|TRS-AGA5-1|ZNF783|MIR548F4|MTRNR2L6|MIR3654|MIR3907|PRKAG2-AS1|LOC100506302|LINC01006|LOC100506585|MKLN1-AS|LOC100506937|TMEM178B|LOC100507507|GIMAP1-GIMAP5|MIR4468|MIR5707|C7orf55-LUC7L2|LOC101927914|OR2A1-AS1|LOC101928605|LOC101928700|LOC101928782|LOC101928807|LOC101928861|LOC101929998|MIR6133|MIR6509|MIR6892|GHET1|LINC01287|LOC105375512|LOC105375545|LOC105375556|MNX1-AS2|LINC01022	See cases		Pathogenic(Last reviewed: Mar 18, 2014)	no assertion criteria provided	7	131171478 - 159327017	GRCh38	155687	165441
GRCh38/hg38 7q34(chr7:142750220-142753076)x1	PRSS1|TRB	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	7	142750220 - 142753076	GRCh38	154818	164572
GRCh38/hg38 7p22.3(chr7:94063-227860)x3	FAM20C|LOC100507642|LOC102723672|LOC105375115	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	7	94063 - 227860	GRCh38	154753	164507
GRCh38/hg38 7q34(chr7:142749675-142753076)x1	PRSS1|TRB	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	7	142749675 - 142753076	GRCh38	154751	164505
GRCh38/hg38 7q11.23(chr7:73352304-75065728)x3	CLDN4|CLDN3|ELN|GTF2I|LIMK1|RFC2|STX1A|EIF4H|CLIP2|LAT2|FZD9|FKBP6|BAZ1B|BCL7B|GTF2IRD1|TBL2|MLXIPL|RCC1L|ABHD11|GTF2IRD2|DNAJC30|WBSCR22|WBSCR28|WBSCR27|VPS37D|ABHD11-AS1|NCF1|MIR590|GATSL2|MIR4284|LOC101926943	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	7	73352304 - 75065728	GRCh38	154623	164377
GRCh38/hg38 7q11.23(chr7:76584501-76928848)x1	POMZP3|LOC100133091	See cases		Benign(Last reviewed: Jul 30, 2009)	no assertion criteria provided	7	76584501 - 76928848	GRCh38	154476	164230
GRCh38/hg38 7q31.1(chr7:111199777-111693903)x1	IMMP2L	See cases		Uncertain significance(Last reviewed: Aug 19, 2010)	no assertion criteria provided	7	111199777 - 111693903	GRCh38	154399	164153
GRCh38/hg38 7q11.23(chr7:73755831-74131326)x1	CLDN4|CLDN3|ELN|LIMK1|WBSCR28|WBSCR27	See cases		Pathogenic(Last reviewed: Jun 30, 2010)	no assertion criteria provided	7	73755831 - 74131326	GRCh38	154350	164104
GRCh38/hg38 7q34(chr7:142728507-142753745)x3	PRSS1|TRB|TRBV29-1	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	7	142728507 - 142753745	GRCh38	149890	159641
GRCh38/hg38 7q11.1-11.21(chr7:61006478-62410831)x3	TRH-GTG2-1	See cases		Benign/Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	7	61006478 - 62410831	GRCh38	146847	156598
GRCh38/hg38 7q34-36.3(chr7:140754198-159307523)x1	AOC1|BRAF|CASP2|CDK5|CLCN1|DPP6|EN2|EPHA1|EPHB6|EZH2|GBX1|MNX1|HTR5A|INSIG1|KCNH2|KEL|NOS3|PIP|PRSS1|PRSS2|TAS2R38|PTPRN2|RARRES2|RHEB|RNY1|RNY3|RNY4|RNY5|SHH|SLC4A2|SMARCD3|SSBP1|TRB|VIPR2|XRCC2|ZYX|ARHGEF5|ZNF212|ZNF282|CUL1|MGAM|ASIC3|PDIA4|UBE3C|FAM131B|TCAF1|DNAJB6|ABCF2|FASTK|ABCB8|PAXIP1|SSPO|CLEC5A|CNTNAP2|GIMAP2|OR2F1|TPK1|ZNF777|TRBV30|TRBV29-1|TRBV28|TRBV27|TRBV25-1|TRBV24-1|TRBV20-1|TRBV19|TRBV18|TRBV17|TRBV15|TRBV14|TRBV13|TRBV12-5|TRBV12-4|TRBV12-3|TRBV11-3|TRBV11-2|TRBV11-1|TRBV10-3|TRBV10-2|TRBV10-1|TRBV9|TRBV7-9|TRBV7-7|TRBV7-6|TRBV7-4|TRBV7-3|TRBV7-2|TRBV6-8|TRBV6-7|TRBV6-6|TRBV6-5|TRBV6-4|TRBV6-2|TRBV6-1|TRBV5-7|TRBV5-6|TRBV5-5|TRBV5-4|TRBV5-1|TRBV4-2|TRBV4-1|TRBV3-1|TRBV2|TRBJ2-7|TRBJ2-6|TRBJ2-5|TRBJ2-4|TRBJ2-3|TRBJ2-2|TRBJ2-1|TRBJ1-6|TRBJ1-5|TRBJ1-4|TRBJ1-3|TRBJ1-2|TRBJ1-1|TRBD2|TRBD1|TRBC2|TRBC1|TMEM176B|REPIN1|TAS2R3|TAS2R4|PRKAG2|MRPS33|NUB1|TAS2R5|CHPF2|NCAPG2|WDR60|GIMAP4|GIMAP5|TMEM176A|TRPV6|AGK|TRPV5|ACTR3B|KIAA1147|ESYT2|ZNF398|KMT2C|GALNT11|LMBR1|LINC00244|NOM1|LRRC61|TMUB1|KRBA1|MGAM2|ZBED6CL|AGAP3|C7orf13|OR9A4|OR9A2|C7orf34|TMEM139|NOBOX|OR2A14|OR6B1|OR2F2|ZNF786|PRSS37|ASB10|PRSS58|RNF32|LINC00689|GIMAP8|CRYGN|ZNF425|ZNF746|ATP6V0E2|RBM33|GALNTL5|GIMAP7|ZNF467|GIMAP1|PAXIP1-AS1|C7orf33|TAS2R39|TAS2R40|TAS2R41|CNPY1|LOC285889|WEE2-AS1|EPHA1-AS1|TCAF2|ZNF775|LINC00996|ATG9B|TAS2R60|BLACE|CTAGE6|OR6V1|OR2A12|OR2A1|WDR86|GSTK1|LOC389602|OR2A25|IQCA1L|OR2A5|OR2A7|ATP6V0E2-AS1|OR2A42|MIR153-2|CTAGE15|OR2A2|ARHGEF35|GIMAP6|WEE2|ZNF862|MNX1-AS1|ACTR3C|MIR595|MIR671|HTR5A-AS1|CTAGE4|LINC01003|WDR86-AS1|PAXIP1-AS2|LOC100134040|CTAGE8|TRC-GCA11-1|TRC-GCA22-1|TRC-GCA18-1|TRC-GCA12-1|TRC-GCA3-1|TRC-GCA1-1|TRC-GCA16-1|TRC-GCA19-1|TRC-GCA23-1|TRC-GCA15-1|TRC-GCA17-1|TRC-GCA10-1|TRC-GCA20-1|TRC-GCA13-1|TRC-GCA21-1|TRC-GCA9-3|TRC-GCA9-4|TRC-GCA9-2|TRS-AGA5-1|ZNF783|MIR548F4|MTRNR2L6|MIR3907|PRKAG2-AS1|LOC100506302|LINC01006|LOC100506585|TMEM178B|LOC100507507|GIMAP1-GIMAP5|MIR5707|LOC101927914|OR2A1-AS1|LOC101928605|LOC101928700|LOC101929998|MIR6892|GHET1|LINC01287|LOC105375545|LOC105375556|MNX1-AS2|LINC01022	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	7	140754198 - 159307523	GRCh38	60300	74895
GRCh38/hg38 7q33-34(chr7:137741740-139688885)x1	AKR1D1|TRIM24|DGKI|HIPK2|ATP6V0A4|LUC7L2|ZC3HAV1|KIAA1549|CREB3L2|TTC26|ZC3HAV1L|SVOPL|CLEC2L|FMC1|TMEM213|UBN2|KLRG2|LOC100129148|LOC100130880|TRR-CCT4-1|MIR4468|C7orf55-LUC7L2	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	7	137741740 - 139688885	GRCh38	60298	74893
GRCh38/hg38 7q11.23(chr7:73286412-74707848)x1	CLDN4|CLDN3|ELN|GTF2I|LIMK1|RFC2|STX1A|EIF4H|CLIP2|LAT2|FZD9|FKBP6|BAZ1B|BCL7B|GTF2IRD1|TBL2|MLXIPL|NSUN5|ABHD11|DNAJC30|WBSCR22|WBSCR28|TRIM50|WBSCR27|VPS37D|ABHD11-AS1|MIR590|MIR4284|LOC101926943	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	7	73286412 - 74707848	GRCh38	59319	73914
GRCh38/hg38 7q11.23(chr7:73352304-74719013)x1	CLDN4|CLDN3|ELN|GTF2I|LIMK1|RFC2|STX1A|EIF4H|CLIP2|LAT2|FZD9|FKBP6|BAZ1B|BCL7B|GTF2IRD1|TBL2|MLXIPL|ABHD11|DNAJC30|WBSCR22|WBSCR28|WBSCR27|VPS37D|ABHD11-AS1|MIR590|MIR4284|LOC101926943	See cases		Pathogenic(Last reviewed: Jan 27, 2011)	no assertion criteria provided	7	73352304 - 74719013	GRCh38	32643	41308
GRCh38/hg38 7q11.23(chr7:73352304-74719013)x3	CLDN4|CLDN3|ELN|GTF2I|LIMK1|RFC2|STX1A|EIF4H|CLIP2|LAT2|FZD9|FKBP6|BAZ1B|BCL7B|GTF2IRD1|TBL2|MLXIPL|ABHD11|DNAJC30|WBSCR22|WBSCR28|WBSCR27|VPS37D|ABHD11-AS1|MIR590|MIR4284|LOC101926943	See cases		Pathogenic(Last reviewed: Jan 27, 2011)	no assertion criteria provided	7	73352304 - 74719013	GRCh38	32380	41045
NM_002052.4(GATA4):c.27C>A (p.Ala9=)	GATA4	Congenital heart disease		Pathogenic(Last reviewed: May 15, 2013)	no assertion criteria provided	8	11708339	GRCh38	219231	217249
NM_002052.4(GATA4):c.99G>T (p.Ala33=)	GATA4	Atrioventricular septal defect 4	GMAF:0.00420(T), GO-ESP:0.00447(T)	Benign(Last reviewed: Oct 31, 2015)	criteria provided, single submitter	8	11708411	GRCh38	220979	221750
NM_002052.4(GATA4):c.127C>T (p.Arg43Trp)	GATA4	Ventricular septal defect 1		Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	8	11708439	GRCh38	30107	39062
NM_002052.4(GATA4):c.348C>T (p.Ser116=)	GATA4	Atrioventricular septal defect 4	GO-ESP:0.00056(T)	Likely benign(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	8	11708660	GRCh38	239100	240222
NM_002052.4(GATA4):c.420T>G (p.Gly140=)	GATA4	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 8, 2012)	criteria provided, single submitter	8	11708732	GRCh38	263447	258520
NM_002052.4(GATA4):c.487C>T (p.Pro163Ser)	GATA4	Tetralogy of Fallot|Ventricular septal defect 1|Atrioventricular septal defect 4	GMAF:0.00020(T), GO-ESP:0.00017(T)	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	8	11708799	GRCh38	30099	39054
NM_002052.4(GATA4):c.627C>T (p.Asp209=)	GATA4	Atrioventricular septal defect 4	GMAF:0.00040(T), GO-ESP:0.00035(T)	Benign(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	8	11748929	GRCh38	239101	240223
NM_002052.4(GATA4):c.628G>T (p.Asp210Tyr)	GATA4	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 11, 2015)	criteria provided, single submitter	8	11748930	GRCh38	264472	258519
NM_002052.4(GATA4):c.723C>T (p.Cys241=)	GATA4	Cardiovascular phenotype	GMAF:0.00120(T), GO-ESP:0.00039(T)	Likely benign(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	8	11749025	GRCh38	264047	258522
NM_002052.4(GATA4):c.732C>T (p.Tyr244=)	GATA4	not specified|Cardiovascular phenotype	GMAF:0.00180(T), GO-ESP:0.00045(T)	Benign/Likely benign(Last reviewed: Oct 23, 2015)	criteria provided, multiple submitters, no conflicts	8	11749034	GRCh38	178691	174532
NM_002052.4(GATA4):c.822C>T (p.Cys274=)	GATA4	not specified|Atrioventricular septal defect 4|Cardiovascular phenotype	GO-ESP:0.00308(T), GMAF:0.00180(T), GO-ESP:0.00224(T)	Benign/Likely benign(Last reviewed: Apr 7, 2016)	criteria provided, multiple submitters, no conflicts	8	11750149	GRCh38	44336	53503
NM_002052.4(GATA4):c.886G>C (p.Gly296Arg)	GATA4	Ventricular septal defect 1		Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	8	11750213	GRCh38	30106	39061
NM_002052.4(GATA4):c.886G>A (p.Gly296Ser)	GATA4	Atrial septal defect 2		Pathogenic(Last reviewed: Jul 24, 2003)	no assertion criteria provided	8	11750213	GRCh38	9030	24069
NM_002052.4(GATA4):c.1023T>C (p.Pro341=)	GATA4	Atrioventricular septal defect 4|Cardiovascular phenotype	GMAF:0.00760(C), GO-ESP:0.00284(C)	Benign/Likely benign(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	8	11756960	GRCh38	239095	240224
NM_002052.4(GATA4):c.1037C>T (p.Ala346Val)	GATA4	Atrioventricular septal defect 4	GO-ESP:0.00238(T), GMAF:0.00060(T), GO-ESP:0.00178(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 24, 2016)	criteria provided, conflicting interpretations	8	11756974	GRCh38	30100	39055
NM_002052.4(GATA4):c.1113A>G (p.Ser371=)	GATA4	Atrioventricular septal defect 4	GMAF:0.01020(G), GO-ESP:0.00248(G)	Benign(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	8	11757050	GRCh38	239096	240225
NM_002052.4(GATA4):c.1133G>T (p.Ser378Ile)	GATA4	Atrioventricular septal defect 4		Uncertain significance(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	8	11757070	GRCh38	239097	240226
NM_002052.4(GATA4):c.1221A>C (p.Pro407=)	GATA4	Atrioventricular septal defect 4	GMAF:0.00320(C), GO-ESP:0.00097(C)	Benign(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	8	11758367	GRCh38	239098	240227
NM_002052.4(GATA4):c.1232C>T (p.Ala411Val)	GATA4	Atrioventricular septal defect 4	GMAF:0.00120(T), GO-ESP:0.00360(T)	Benign(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	8	11758378	GRCh38	239099	240228
NM_006766.4(KAT6A):c.4292dupT (p.Leu1431Phefs)	KAT6A	not provided		Uncertain significance(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	8	41933928	GRCh38	162182	171893
NM_006766.4(KAT6A):c.4108G>T (p.Glu1370Ter)	KAT6A	not provided|Mental retardation, autosomal dominant 32		Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2015)	criteria provided, conflicting interpretations	8	41934112	GRCh38	162180	171894
NM_006766.4(KAT6A):c.3879dupA (p.Glu1294Argfs)	KAT6A	Intellectual disability syndrome|Mental retardation, autosomal dominant 32		Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	8	41934341	GRCh38	180678	178847
NM_006766.4(KAT6A):c.3830_3831insTT (p.Arg1278Serfs)	KAT6A	not provided		Uncertain significance(Last reviewed: May 5, 2014)	criteria provided, single submitter	8	41934389 - 41934390	GRCh38	162181	171895
NM_000930.4(PLAT):c.102_103delCA (p.Arg35Ilefs)	PLAT	not provided		Uncertain significance(Last reviewed: Nov 10, 2016)	no assertion criteria provided	8	42191384 - 42191385	GRCh38	268128	263654
NM_012082.3(ZFPM2):c.89A>G (p.Glu30Gly)	ZFPM2	Diaphragmatic hernia 3|Tetralogy of Fallot|Double outlet right ventricle	GO-ESP:0.00453(G), GMAF:0.00180(G), GO-ESP:0.00271(G)	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	8	105419192	GRCh38	6128	21167
NM_012082.3(ZFPM2):c.681T>G (p.Ile227Met)	ZFPM2|ZFPM2-AS1	Double outlet right ventricle		Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	8	105788866	GRCh38	39517	48116
NM_012082.3(ZFPM2):c.1632G>A (p.Met544Ile)	ZFPM2|ZFPM2-AS1	Tetralogy of Fallot|46,XY sex reversal 9	GMAF:0.00100(A), GO-ESP:0.00345(A)	Pathogenic(Last reviewed: Jul 15, 2014)	no assertion criteria provided	8	105801714	GRCh38	39518	48117
NM_012082.3(ZFPM2):c.2107A>C (p.Met703Leu)	ZFPM2|ZFPM2-AS1	Diaphragmatic hernia 3|Double outlet right ventricle	GMAF:0.00080(C), GO-ESP:0.00041(C)	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	8	105802189	GRCh38	6130	21169
NM_012082.3(ZFPM2):c.2209A>G (p.Lys737Glu)	ZFPM2|ZFPM2-AS1	Double outlet right ventricle		Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	8	105802291	GRCh38	39519	48118
NM_014846.3(WASHC5):c.3335+2T>A	WASHC5	Dandy-Walker like malformation with atrioventricular septal defect		Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	8	125032239	GRCh38	92129	97556
NM_201384.2(PLEC):c.46C>T (p.Arg16Ter)	PLEC	Epidermolysis bullosa simplex with nail dystrophy	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	8	143939416	GRCh38	204402	200792
NC_000008.10:g.(?_8127723)_(11858461_?)del	BLK|CTSB|FDFT1|GATA4|MSRA|TNKS|MFHAS1|PINX1|MTMR9|PPP1R3B|SOX7|FAM167A|SLC35G5|ERI1|RP1L1|CLDN23|TDH|PRSS55|C8orf74|NEIL2|XKR6|PRSS51|MIR124-1|DEFB135|DEFB136|DEFB134	See cases		Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter			GRCh38	219040	216091
NC_000008.10:g.(?_145600952)_(145834119_?)dup	GPT|TONSL|FOXH1|RECQL4|LRRC14|CPSF1|CYHR1|VPS28|SLC39A4|ARHGAP39|PPP1R16A|KIFC2|MFSD3|ADCK5|C8orf82|LRRC24|MIR1234	See cases		Uncertain significance(Last reviewed: Sep 21, 2015)	criteria provided, single submitter			GRCh38	219037	216088
GRCh38/hg38 8p23.1(chr8:7514108-8222398)x3	DEFB4A|DEFB104A|DEFB105A|DEFB106A|DEFB107A|USP17L8|DEFB103A|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|FAM90A14P|USP17L3|FAM90A12P|SPAG11A|FAM90A19P|PRR23D1|FAM66E|ZNF705B|PRR23D2|MIR548I3	See cases		Benign(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	7514108 - 8222398	GRCh38	161070	170914
GRCh38/hg38 8q11.1(chr8:46031334-46662449)x1		See cases		Benign(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	46031334 - 46662449	GRCh38	161000	170844
GRCh38/hg38 8p23.3-23.1(chr8:208048-7186524)x4	ANGPT2|DEFA1|DEFA3|DEFA4|DEFA5|DEFA6|DEFB1|CLN8|MYOM2|DLGAP2|ARHGEF10|KBTBD11|FBXO25|AGPAT5|CSMD1|MCPH1|FAM87A|TDRP|ERICH1|ZNF596|LOC286083|XKR5|LOC401442|ERICH1-AS1|MIR596|DEFA1B|LOC100287015|MIR3674|DLGAP2-AS1|MCPH1-AS1|MIR4659A|MIR4659B|GS1-24F4.2|LOC101927752|LOC101927815|LOC101928058|MIR7160|MIR8055|KBTBD11-OT1	See cases		Pathogenic(Last reviewed: Mar 18, 2014)	no assertion criteria provided	8	208048 - 7186524	GRCh38	155691	165445
GRCh38/hg38 8p23.3(chr8:208048-1576545)x3	DLGAP2|FBXO25|FAM87A|TDRP|ERICH1|ZNF596|LOC286083|LOC401442|ERICH1-AS1|DLGAP2-AS1	See cases		Uncertain significance(Last reviewed: Jul 16, 2013)	no assertion criteria provided	8	208048 - 1576545	GRCh38	155445	165199
GRCh38/hg38 8p23.1(chr8:8235647-12077956)x1	BLK|CTSB|FDFT1|GATA4|MSRA|TNKS|MFHAS1|PINX1|MTMR9|PPP1R3B|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|ERI1|RP1L1|CLDN23|LOC157273|SGK223|LINC00599|TDH|PRSS55|C8orf74|NEIL2|XKR6|PRSS51|MIR124-1|C8orf49|DEFB135|DEFB136|DEFB134|MIR597|MIR598|LOC100133267|MIR1322|MIR4286|MIR4660|LOC101929128|LINCR-0001|LOC101929229|LOC101929269|SNORA99	See cases		Pathogenic(Last reviewed: Apr 16, 2013)	no assertion criteria provided	8	8235647 - 12077956	GRCh38	155289	165043
GRCh38/hg38 8p23.1(chr8:8235544-12088347)x3	BLK|CTSB|FDFT1|GATA4|MSRA|TNKS|MFHAS1|PINX1|MTMR9|PPP1R3B|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|ERI1|RP1L1|CLDN23|LOC157273|SGK223|LINC00599|TDH|PRSS55|C8orf74|NEIL2|XKR6|PRSS51|MIR124-1|C8orf49|DEFB135|DEFB136|DEFB134|MIR597|MIR598|LOC100133267|MIR1322|MIR4286|MIR4660|LOC101929128|LINCR-0001|LOC101929229|LOC101929269|SNORA99	See cases		Pathogenic(Last reviewed: Mar 11, 2013)	no assertion criteria provided	8	8235544 - 12088347	GRCh38	155213	164967
GRCh38/hg38 8q11.23-12.3(chr8:53325389-61863018)x1	ASPH|CA8|CYP7A1|LYN|MOS|PENK|PLAG1|RAB2A|RP1|RPS20|SDCBP|TCEA1|NSMAF|RGS20|TOX|LYPLA1|LINC00588|RNU105C|SNORD54|MRPL15|ATP6V1H|IMPAD1|CHD7|SOX17|CHCHD7|FAM110B|TGS1|XKR4|TMEM68|UBXN2B|CLVS1|SDR16C5|LOC286177|LOC286178|LOC100129098|LOC100130298|LINC01602|LINC01301|LINC00968|LINC01606|MIR4470|LOC101929415|LOC101929488|LOC101929528|LOC105375843	See cases		Pathogenic(Last reviewed: Jan 9, 2013)	no assertion criteria provided	8	53325389 - 61863018	GRCh38	155115	164869
GRCh38/hg38 8p22-12(chr8:18972996-33619264)x1	ADRA1A|ATP6V1B2|BMP1|POLR3D|BNIP3L|CHRNA2|CLU|DPYSL2|DUSP4|EGR3|DMTN|EPHX2|EXTL3|PTK2B|GFRA2|GNRH1|GSR|GTF2E2|GULOP|NRG1|LOXL2|LPL|NEFM|NEFL|NKX3-1|PNOC|PPP2CB|PPP2R2A|PPP3CC|SFTPC|SLC18A1|STC1|WRN|FZD3|UBXN8|ADAM7|TNFRSF10D|TNFRSF10C|TNFRSF10B|TNFRSF10A|FGF17|DOK2|ENTPD4|PHYHIP|SORBS3|NPM2|DCTN6|PNMA2|ADAM28|RBPMS|LZTS1|XPO7|TRIM35|RHOBTB2|KIF13B|PSD3|LEPROTL1|SLC39A14|ADAMDEC1|PURG|SLC25A37|SCARA3|SARAF|KCTD9|PIWIL2|ELP3|INTS10|CCDC25|INTS9|CSGALNACT1|HR|PBK|ZNF395|BIN3|TEX15|CCAR2|SH2D4A|PDLIM2|EBF2|FAM160B2|DUSP26|HMBOX1|RNF122|NUDT18|DOCK5|BIN3-IT1|TTI2|REEP4|STMN4|MAK16|FUT10|CHMP7|NKX2-6|PEBP4|CDCA2|ESCO2|FBXO16|R3HCC1|LGI3|LOC254896|LOC286114|SCARA5|FAM183CP|LOC389641|NUGGC|MIR320A|C8orf58|LINC00589|MBOAT4|SNORD13|RBPMS-AS1|LOC100128993|MIR548H4|MIR4287|MIR3148|MIR4288|MIR3622A|MIR3622B|LOC100507071|LOC100507156|SMIM18|NRG1-IT1|LZTS1-AS1|NRG1-IT3|LOC101929172|LOC101929237|LOC101929294|LOC101929315|EXTL3-AS1|LOC101929450|LOC101929470|MIR6841|MIR6842|MIR6843|MIR6876|LOC102467222	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	8	18972996 - 33619264	GRCh38	154680	164434
GRCh38/hg38 8p23.1(chr8:8273108-12610034)x1	BLK|CTSB|FDFT1|GATA4|MSRA|TNKS|MFHAS1|PINX1|MTMR9|PPP1R3B|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|FAM86B1|ERI1|RP1L1|CLDN23|LOC157273|SGK223|LINC00599|TDH|PRSS55|C8orf74|DEFB130|NEIL2|XKR6|PRSS51|USP17L2|USP17L7|MIR124-1|C8orf49|DEFB135|DEFB136|DEFB134|FAM85A|FAM86B2|MIR597|MIR598|ZNF705D|LOC729732|FAM66D|FAM66A|LOC100133267|MIR1322|MIR4286|LOC100506990|MIR4660|LOC101929128|LINCR-0001|LOC101929229|LOC101929269|SNORA99	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	8	8273108 - 12610034	GRCh38	154643	164397
GRCh38/hg38 8q23.3-24.11(chr8:116497730-117379167)x1	RAD21|EIF3H|UTP23|SLC30A8|AARD|RAD21-AS1|MIR3610|LOC105375713	See cases		Uncertain significance(Last reviewed: Jan 27, 2011)	no assertion criteria provided	8	116497730 - 117379167	GRCh38	154486	164240
GRCh38/hg38 8p23.1(chr8:7311988-8273109)x3	DEFB4A|SPAG11B|DEFB103B|DEFB104A|DEFB105A|DEFB106A|DEFB107A|USP17L8|USP17L1|DEFB103A|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|DEFB107B|DEFB104B|DEFB106B|DEFB105B|USP17L4|FAM90A14P|USP17L3|FAM90A12P|SPAG11A|FAM90A19P|FAM66B|PRR23D1|ZNF705G|FAM66E|ZNF705B|PRR23D2|DEFB4B|MIR548I3	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	8	7311988 - 8273109	GRCh38	154431	164185
GRCh38/hg38 8p23.1(chr8:7195674-7948705)x1	DEFB4A|SPAG11B|DEFB103B|DEFB104A|DEFB105A|DEFB106A|DEFB107A|LINC00965|FAM90A3P|FAM90A15P|USP17L1|DEFB103A|FAM90A13P|FAM90A5P|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|DEFB107B|DEFB104B|DEFB106B|DEFB105B|USP17L4|FAM90A14P|SPAG11A|FAM90A20P|FAM90A19P|FAM66B|PRR23D1|ZNF705G|ZNF705B|PRR23D2|DEFB4B	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	8	7195674 - 7948705	GRCh38	154409	164163
GRCh38/hg38 8p23.1(chr8:7311988-7948705)x1	DEFB4A|SPAG11B|DEFB103B|DEFB104A|DEFB105A|DEFB106A|DEFB107A|USP17L1|DEFB103A|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|DEFB107B|DEFB104B|DEFB106B|DEFB105B|USP17L4|FAM90A14P|SPAG11A|FAM90A19P|FAM66B|PRR23D1|ZNF705G|ZNF705B|PRR23D2|DEFB4B	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	8	7311988 - 7948705	GRCh38	154404	164158
GRCh38/hg38 8p23.1(chr8:7311988-7948705)x3	DEFB4A|SPAG11B|DEFB103B|DEFB104A|DEFB105A|DEFB106A|DEFB107A|USP17L1|DEFB103A|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|DEFB107B|DEFB104B|DEFB106B|DEFB105B|USP17L4|FAM90A14P|SPAG11A|FAM90A19P|FAM66B|PRR23D1|ZNF705G|ZNF705B|PRR23D2|DEFB4B	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	8	7311988 - 7948705	GRCh38	154403	164157
GRCh38/hg38 8p23.1(chr8:7311988-8222390)x1	DEFB4A|SPAG11B|DEFB103B|DEFB104A|DEFB105A|DEFB106A|DEFB107A|USP17L8|USP17L1|DEFB103A|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|DEFB107B|DEFB104B|DEFB106B|DEFB105B|USP17L4|FAM90A14P|USP17L3|FAM90A12P|SPAG11A|FAM90A19P|FAM66B|PRR23D1|ZNF705G|FAM66E|ZNF705B|PRR23D2|DEFB4B|MIR548I3	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	8	7311988 - 8222390	GRCh38	154363	164117
GRCh38/hg38 8q24.12(chr8:118626991-119703035)x3	NOV|TNFRSF11B|ENPP2|COLEC10|MAL2|SAMD12-AS1|LOC101927513|MIR548AZ	See cases		Uncertain significance(Last reviewed: Feb 20, 2013)	no assertion criteria provided	8	118626991 - 119703035	GRCh38	151127	160878
GRCh38/hg38 8q11.21(chr8:49294687-49796726)x1	LOC100507464	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	8	49294687 - 49796726	GRCh38	150742	160493
GRCh38/hg38 8p23.1(chr8:7381949-8273109)x3	DEFB4A|SPAG11B|DEFB103B|DEFB104A|DEFB105A|DEFB106A|DEFB107A|USP17L8|DEFB103A|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|DEFB107B|DEFB104B|DEFB106B|DEFB105B|FAM90A14P|USP17L3|FAM90A12P|SPAG11A|FAM90A19P|PRR23D1|FAM66E|ZNF705B|PRR23D2|DEFB4B|MIR548I3	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	8	7381949 - 8273109	GRCh38	149988	159739
GRCh38/hg38 8p11.1(chr8:43516300-43528060)x3		See cases		Benign/Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	8	43516300 - 43528060	GRCh38	149665	159416
GRCh38/hg38 8p23.1(chr8:8273108-12383643)x1	BLK|CTSB|FDFT1|GATA4|MSRA|TNKS|MFHAS1|PINX1|MTMR9|PPP1R3B|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|FAM86B1|ERI1|RP1L1|CLDN23|LOC157273|SGK223|LINC00599|TDH|PRSS55|C8orf74|DEFB130|NEIL2|XKR6|PRSS51|USP17L2|USP17L7|MIR124-1|C8orf49|DEFB135|DEFB136|DEFB134|FAM85A|MIR597|MIR598|ZNF705D|FAM66D|FAM66A|LOC100133267|MIR1322|MIR4286|MIR4660|LOC101929128|LINCR-0001|LOC101929229|LOC101929269|SNORA99	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	8	8273108 - 12383643	GRCh38	146493	156244
GRCh38/hg38 8p23.1(chr8:8273108-12546553)x3	BLK|CTSB|FDFT1|GATA4|MSRA|TNKS|MFHAS1|PINX1|MTMR9|PPP1R3B|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|FAM86B1|ERI1|RP1L1|CLDN23|LOC157273|SGK223|LINC00599|TDH|PRSS55|C8orf74|DEFB130|NEIL2|XKR6|PRSS51|USP17L2|USP17L7|MIR124-1|C8orf49|DEFB135|DEFB136|DEFB134|FAM85A|FAM86B2|MIR597|MIR598|ZNF705D|LOC729732|FAM66D|FAM66A|LOC100133267|MIR1322|MIR4286|LOC100506990|MIR4660|LOC101929128|LINCR-0001|LOC101929229|LOC101929269|SNORA99	See cases		Pathogenic(Last reviewed: Jan 14, 2011)	no assertion criteria provided	8	8273108 - 12546553	GRCh38	145585	155336
GRCh38/hg38 8q12.2-13.1(chr8:60816393-65117062)x1	ASPH|TTPA|GGH|CYP7B1|BHLHE22|CHD7|CLVS1|YTHDF3|NKAIN3|LINC01289|LOC401463|MIR124-2|UG0898H09|MIR124-2HG|LOC100130298|MIR4470|YTHDF3-AS1|LOC102724612|LOC102724623	See cases		Pathogenic(Last reviewed: Sep 18, 2013)	no assertion criteria provided	8	60816393 - 65117062	GRCh38	144167	153918
GRCh38/hg38 8q21.13-22.1(chr8:78672463-95366868)x1	OSGIN2|CA1|CA2|CA3|CALB1|RUNX1T1|CDH17|DECR1|E2F5|FABP4|FABP5|GEM|IL7|IMPA1|MMP16|NBN|PMP2|TPD52|RIPK2|CPNE3|CCNE2|WWP1|STMN2|HEY1|RAD54B|KIAA1429|MRPS28|ZC2HC1A|RMDN1|OTUD6B|PDP1|CNGB3|ESRP1|RBM12B-AS1|TMEM55A|INTS8|PAG1|SNX16|NECAB1|ZBTB10|PLEKHF2|ZFAND1|LRRCC1|PSKH2|TMEM67|CHMP4C|TP53INP1|SLC26A7|FAM92A|NDUFAF6|DCAF4L2|RALYL|C8orf37|SLC7A13|CNBD1|TMEM64|ATP6V0D2|TRIQK|DPY19L4|SLC10A5|CA13|C8orf87|RBM12B|C8orf59|FLJ46284|ZNF704|LINC01298|LINC00535|FABP9|FABP12|C8orf88|LRRC69|TRS-AGA2-5|LOC100288748|MIR3150A|MIR3150B|OTUD6B-AS1|MIR378D2|MIR4661|C8orf37-AS1|MIR5708|FSBP|LINC00534|CA3-AS1|LOC101927040|LINC01607|LOC101927141|LOC101929709|LINC01030|MIR8084|LOC102723322|LOC102724710|LINC01419|LOC105375650	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	78672463 - 95366868	GRCh38	60380	74975
GRCh38/hg38 8q13.3(chr8:71278615-71962825)x1	EYA1|MSC|MSC-AS1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	71278615 - 71962825	GRCh38	60373	74968
GRCh38/hg38 8p11.21(chr8:41690724-41867446)x1	ANK1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	41690724 - 41867446	GRCh38	60361	74956
GRCh38/hg38 8p23.3(chr8:241330-1847998)x1	CLN8|DLGAP2|ARHGEF10|FBXO25|FAM87A|TDRP|ERICH1|ZNF596|LOC286083|LOC401442|ERICH1-AS1|MIR596|MIR3674|DLGAP2-AS1|LOC101927752	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	241330 - 1847998	GRCh38	60331	74926
GRCh38/hg38 8p23.3-22(chr8:241530-17678697)x3	ANGPT2|BLK|CTSB|DEFA1|DEFA3|DEFA4|DEFA5|DEFA6|DEFB1|DEFB4A|CLN8|FDFT1|GATA4|MSR1|MSRA|PDGFRL|SLC7A2|TUSC3|TNKS|MTMR7|MYOM2|DLGAP2|MFHAS1|ARHGEF10|KBTBD11|DLC1|SPAG11B|FBXO25|FGF20|CNOT7|ZDHHC2|PINX1|AGPAT5|DEFB103B|MTUS1|KIAA1456|CSMD1|MTMR9|MCPH1|PPP1R3B|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|FAM86B1|ERI1|LONRF1|RP1L1|CLDN23|VPS37A|SGCZ|DEFB104A|LOC157273|SGK223|LINC00599|FAM87A|TDRP|ERICH1|TDH|C8orf48|ZNF596|PRSS55|C8orf74|DEFB105A|DEFB106A|DEFB107A|DEFB130|NEIL2|XKR6|LOC286083|MICU3|LOC340357|PRSS51|LINC00965|USP17L2|XKR5|FAM90A3P|FAM90A15P|USP17L8|USP17L7|LOC401442|USP17L1|MIR124-1|DEFB103A|FAM90A13P|FAM90A5P|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|MIR383|DEFB107B|DEFB104B|DEFB106B|DEFB105B|C8orf49|DEFB135|DEFB136|DEFB134|ERICH1-AS1|FAM85A|USP17L4|FAM90A14P|USP17L3|FAM90A12P|FAM86B2|SPAG11A|MIR596|MIR597|MIR598|DEFA1B|FAM90A20P|FAM90A19P|ZNF705D|LOC729732|FAM66B|PRR23D1|ZNF705G|FAM66E|ZNF705B|FAM66D|FAM66A|PRR23D2|LOC100133267|LOC100287015|DEFB4B|MIR1322|MIR548I3|MIR4286|MIR3926-2|MIR3926-1|MIR3674|LOC100506990|DLGAP2-AS1|MCPH1-AS1|MIR4659A|MIR4660|MIR4659B|GS1-24F4.2|MIR5692A2|LINC00681|LOC101927752|LOC101927815|LOC101928058|LOC101929128|LINCR-0001|LOC101929229|LOC101929269|MIR7160|MIR8055|LOC102725080|KBTBD11-OT1|SNORA99	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	241530 - 17678697	GRCh38	59739	74334
GRCh38/hg38 8p23.3-12(chr8:96310-30614703)x3	NAT1|NAT2|ADRA1A|ANGPT2|ASAH1|ATP6V1B2|BLK|BMP1|POLR3D|BNIP3L|CHRNA2|CLU|CTSB|DEFA1|DEFA3|DEFA4|DEFA5|DEFA6|DEFB1|DEFB4A|DPYSL2|DUSP4|EGR3|DMTN|EPHX2|CLN8|EXTL3|PTK2B|FDFT1|FGL1|GATA4|GFRA2|GNRH1|GTF2E2|GULOP|LOXL2|LPL|MSR1|MSRA|NEFM|NEFL|NKX3-1|PCM1|PDGFRL|PNOC|PPP2R2A|PPP3CC|SFTPC|SLC7A2|SLC18A1|STC1|FZD3|TUSC3|TNKS|ADAM7|TNFRSF10D|TNFRSF10C|TNFRSF10B|TNFRSF10A|FGF17|DOK2|MTMR7|MYOM2|DLGAP2|MFHAS1|ENTPD4|ARHGEF10|PHYHIP|KBTBD11|SORBS3|NPM2|DLC1|SPAG11B|DCTN6|PNMA2|ADAM28|RBPMS|LZTS1|XPO7|TRIM35|RHOBTB2|KIF13B|PSD3|LEPROTL1|SLC39A14|FBXO25|FGF20|ADAMDEC1|CNOT7|ZDHHC2|SLC25A37|SCARA3|SARAF|KCTD9|PINX1|PIWIL2|ELP3|INTS10|CCDC25|AGPAT5|INTS9|CSGALNACT1|HR|PBK|ZNF395|DEFB103B|BIN3|MTUS1|KIAA1456|CCAR2|SH2D4A|PDLIM2|CSMD1|EBF2|FAM160B2|MTMR9|HMBOX1|MCPH1|PPP1R3B|NUDT18|DOCK5|BIN3-IT1|REEP4|STMN4|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|FAM86B1|ERI1|LONRF1|CHMP7|RP1L1|CLDN23|VPS37A|NKX2-6|SGCZ|DEFB104A|LOC157273|PRAG1|PEBP4|CDCA2|ESCO2|FBXO16|LINC00599|FAM87A|TDRP|ERICH1|TDH|C8orf48|ZNF596|R3HCC1|PRSS55|C8orf74|LGI3|DEFB105A|DEFB106A|DEFB107A|DEFB130|NEIL2|LOC254896|XKR6|LOC286083|MICU3|LOC286114|SCARA5|FAM183CP|LOC340357|PRSS51|LINC00965|USP17L2|XKR5|FAM90A3P|FAM90A15P|LOC389641|NUGGC|USP17L8|USP17L7|LOC401442|USP17L1|MIR124-1|MIR320A|DEFB103A|OR4F21|FAM90A13P|FAM90A5P|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|MIR383|DEFB107B|DEFB104B|DEFB106B|DEFB105B|C8orf58|C8orf49|DEFB135|DEFB136|DEFB134|ERICH1-AS1|LINC00589|MBOAT4|FAM85A|USP17L4|FAM90A14P|USP17L3|FAM90A12P|FAM86B2|SPAG11A|MIR596|MIR597|MIR598|DEFA1B|FAM90A20P|FAM90A19P|ZNF705D|LOC729732|RBPMS-AS1|FAM66B|LOC100128993|PRR23D1|ZNF705G|FAM66E|ZNF705B|FAM66D|FAM66A|PRR23D2|LOC100133267|LOC100287015|DEFB4B|MIR1322|MIR548I3|MIR548H4|MIR4287|MIR548V|MIR3148|MIR4288|MIR4286|MIR3926-2|MIR3622A|MIR3926-1|MIR3622B|MIR3674|LOC100506990|LOC100507071|LOC100507156|DLGAP2-AS1|MCPH1-AS1|MIR4659A|MIR4660|MIR4659B|GS1-24F4.2|MIR5692A2|LZTS1-AS1|LINC00681|LOC101927752|LOC101927815|LOC101928058|LOC101929066|LOC101929128|LOC101929172|LINCR-0001|LOC101929229|LOC101929237|LOC101929269|LOC101929294|LOC101929315|EXTL3-AS1|LOC101929450|LOC101929470|MIR6841|MIR6842|MIR6843|MIR6876|MIR7160|MIR8055|LOC102467222|LOC102725080|KBTBD11-OT1|SNORA99	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	96310 - 30614703	GRCh38	59735	74330
GRCh38/hg38 8p23.1(chr8:8336212-11984392)x1	BLK|CTSB|FDFT1|GATA4|MSRA|TNKS|MFHAS1|PINX1|MTMR9|PPP1R3B|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|ERI1|RP1L1|CLDN23|LOC157273|PRAG1|LINC00599|TDH|PRSS55|C8orf74|NEIL2|XKR6|PRSS51|MIR124-1|C8orf49|DEFB135|DEFB136|MIR597|MIR598|MIR1322|MIR4286|MIR4660|LOC101929128|LINCR-0001|LOC101929229|LOC101929269|SNORA99	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	8336212 - 11984392	GRCh38	59639	74234
GRCh38/hg38 8p23.1(chr8:7411297-11961807)x1	BLK|CTSB|DEFB4A|FDFT1|GATA4|MSRA|TNKS|MFHAS1|SPAG11B|PINX1|DEFB103B|MTMR9|PPP1R3B|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|ERI1|RP1L1|CLDN23|DEFB104A|LOC157273|PRAG1|LINC00599|TDH|PRSS55|C8orf74|DEFB105A|DEFB106A|DEFB107A|NEIL2|XKR6|PRSS51|USP17L8|MIR124-1|DEFB103A|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|DEFB107B|DEFB104B|DEFB106B|DEFB105B|C8orf49|FAM90A14P|USP17L3|FAM90A12P|SPAG11A|MIR597|MIR598|FAM90A19P|PRR23D1|FAM66E|ZNF705B|PRR23D2|DEFB4B|MIR1322|MIR548I3|MIR4286|MIR4660|LOC101929128|LINCR-0001|LOC101929229|LOC101929269|SNORA99	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	7411297 - 11961807	GRCh38	59334	73929
GRCh38/hg38 8p23.1(chr8:7234837-12514815)x1	BLK|CTSB|DEFB4A|FDFT1|GATA4|MSRA|TNKS|MFHAS1|SPAG11B|PINX1|DEFB103B|MTMR9|PPP1R3B|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|FAM86B1|ERI1|RP1L1|CLDN23|DEFB104A|LOC157273|PRAG1|LINC00599|TDH|PRSS55|C8orf74|DEFB105A|DEFB106A|DEFB107A|DEFB130|NEIL2|XKR6|PRSS51|LINC00965|USP17L2|FAM90A3P|FAM90A15P|USP17L8|USP17L7|USP17L1|MIR124-1|DEFB103A|FAM90A13P|FAM90A5P|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|DEFB107B|DEFB104B|DEFB106B|DEFB105B|C8orf49|DEFB135|DEFB136|DEFB134|FAM85A|USP17L4|FAM90A14P|USP17L3|FAM90A12P|FAM86B2|SPAG11A|MIR597|MIR598|FAM90A20P|FAM90A19P|ZNF705D|FAM66B|PRR23D1|ZNF705G|FAM66E|ZNF705B|FAM66D|FAM66A|PRR23D2|LOC100133267|DEFB4B|MIR1322|MIR548I3|MIR4286|LOC100506990|MIR4660|LOC101929128|LINCR-0001|LOC101929229|LOC101929269|SNORA99	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	7234837 - 12514815	GRCh38	59332	73927
GRCh38/hg38 8p23.2(chr8:2475295-3082171)x3	CSMD1|LOC101927815	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	2475295 - 3082171	GRCh38	57082	71677
GRCh38/hg38 8p23.1(chr8:8222339-12383643)x1	BLK|CTSB|FDFT1|GATA4|MSRA|TNKS|MFHAS1|PINX1|MTMR9|PPP1R3B|SOX7|FAM167A|SLC35G5|LINC00208|FAM167A-AS1|FAM86B1|ERI1|RP1L1|CLDN23|LOC157273|SGK223|LINC00599|TDH|PRSS55|C8orf74|DEFB130|NEIL2|XKR6|PRSS51|USP17L2|USP17L7|MIR124-1|C8orf49|DEFB135|DEFB136|DEFB134|FAM85A|MIR597|MIR598|ZNF705D|FAM66D|FAM66A|LOC100133267|MIR1322|MIR4286|MIR4660|LOC101929128|LINCR-0001|LOC101929229|LOC101929269|SNORA99	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	8	8222339 - 12383643	GRCh38	57060	71655
GRCh38/hg38 8p23.1(chr8:7411297-7895064)x1	DEFB4A|SPAG11B|DEFB103B|DEFB104A|DEFB105A|DEFB106A|DEFB107A|DEFB103A|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|DEFB107B|DEFB104B|DEFB106B|DEFB105B|FAM90A14P|SPAG11A|FAM90A19P|PRR23D1|PRR23D2|DEFB4B	See cases		Benign(Last reviewed: Sep 18, 2013)	no assertion criteria provided	8	7411297 - 7895064	GRCh38	32138	40803
GRCh38/hg38 8p23.1(chr8:7411297-8222398)x1	DEFB4A|SPAG11B|DEFB103B|DEFB104A|DEFB105A|DEFB106A|DEFB107A|USP17L8|DEFB103A|FAM90A7P|FAM90A8P|FAM90A18P|FAM90A9P|FAM90A10P|DEFB107B|DEFB104B|DEFB106B|DEFB105B|FAM90A14P|USP17L3|FAM90A12P|SPAG11A|FAM90A19P|PRR23D1|FAM66E|ZNF705B|PRR23D2|DEFB4B|MIR548I3	See cases		Benign(Last reviewed: Oct 22, 2013)	no assertion criteria provided	8	7411297 - 8222398	GRCh38	32007	40672
NM_003289.3(TPM2):c.415_417delGAG (p.Glu139del)	TPM2	not provided|Cap myopathy 2		Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	9	35685509 - 35685511	GRCh38	12465	27504
NM_003289.3(TPM2):c.397C>T (p.Arg133Trp)	TPM2	Distal arthrogryposis type 2B|not provided		Pathogenic(Last reviewed: Mar 6, 2007)	no assertion criteria provided	9	35685529	GRCh38	12463	27502
NM_000144.4(FXN):c.11_12delTC (p.Leu4Argfs)	FXN	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	9	69035793 - 69035794	GRCh38	263606	258601
NM_000144.4(FXN):c.54A>G (p.Pro18=)	FXN	not specified|Cardiovascular phenotype	GMAF:0.01520(A)	Benign/Likely benign(Last reviewed: Mar 18, 2016)	criteria provided, multiple submitters, no conflicts	9	69035836	GRCh38	129120	134566
NM_000144.4(FXN):c.118C>T (p.Arg40Cys)	FXN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	9	69035900	GRCh38	264451	258604
NM_000144.4(FXN):c.179G>A (p.Arg60His)	FXN	not specified|Cardiovascular phenotype	GMAF:0.00180(A), GO-ESP:0.00031(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 31, 2015)	criteria provided, conflicting interpretations	9	69046398	GRCh38	211055	207727
NM_000144.4(FXN):c.226A>G (p.Met76Val)	FXN	Cardiovascular phenotype	GMAF:0.01280(G), GO-ESP:0.00462(G)	Benign(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	9	69046445	GRCh38	263542	258611
NM_000144.4(FXN):c.389G>T (p.Gly130Val)	FXN	Friedreich's ataxia	GO-ESP:0.00005(T)	Pathogenic(Last reviewed: Apr 15, 2007)	no assertion criteria provided	9	69064942	GRCh38	3982	19021
NM_000144.4(FXN):c.534C>T (p.Asp178=)	FXN	Cardiovascular phenotype	GO-ESP:0.00021(T)	Likely benign(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	9	69072663	GRCh38	264460	258603
NG_008089.1:g.218534_227384del8851	ROR2	Robinow syndrome, autosomal recessive		Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	9	91727779 - 91736629	GRCh38	7315	22354
NM_004612.3(TGFBR1):c.32G>C (p.Arg11Pro)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	9	99105237	GRCh38	263928	258606
NM_004612.3(TGFBR1):c.51_59delGGCGGCGGC (p.Ala24_Ala26del)	TGFBR1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.05130(-)	Benign(Last reviewed: Feb 21, 2013)	criteria provided, single submitter	9	99105256 - 99105264	GRCh38	263558	258607
NM_004612.3(TGFBR1):c.70_74delGCGGC (p.Ala24Glyfs)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 26, 2012)	criteria provided, single submitter	9	99105275 - 99105279	GRCh38	263391	258612
NM_004612.3(TGFBR1):c.70_78delGCGGCGGCG (p.Ala24_Ala26del)	TGFBR1	Loeys-Dietz syndrome 1|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified		Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	99105275 - 99105283	GRCh38	165381	174853
NM_004612.3(TGFBR1):c.73_78delGCGGCG (p.Ala25_Ala26del)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Benign(Last reviewed: Mar 19, 2015)	criteria provided, single submitter	9	99105278 - 99105283	GRCh38	263873	258605
NM_004612.3(TGFBR1):c.76_78delGCG (p.Ala26del)	TGFBR1	Thoracic aortic aneurysm and aortic dissection|not specified		Benign/Likely benign(Last reviewed: Sep 10, 2015)	criteria provided, multiple submitters, no conflicts	9	99105281 - 99105283	GRCh38	213863	210154
NM_004612.3(TGFBR1):c.120C>T (p.Leu40=)	TGFBR1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00009(T)	Likely benign(Last reviewed: Aug 1, 2014)	criteria provided, multiple submitters, no conflicts	9	99128877	GRCh38	178135	174577
NM_004612.3(TGFBR1):c.192A>G (p.Lys64=)	TGFBR1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(G), GO-ESP:0.00025(G)	Benign/Likely benign(Last reviewed: Apr 19, 2016)	criteria provided, multiple submitters, no conflicts	9	99128949	GRCh38	213853	210156
NM_004612.3(TGFBR1):c.282T>C (p.Ser94=)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Apr 29, 2013)	criteria provided, single submitter	9	99129039	GRCh38	263584	258608
NM_004612.3(TGFBR1):c.457G>A (p.Val153Ile)	TGFBR1	Loeys-Dietz syndrome 1|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(A), GO-ESP:0.00110(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	99132622	GRCh38	213868	210162
NM_004612.3(TGFBR1):c.528G>A (p.Thr176=)	TGFBR1	Loeys-Dietz syndrome 1|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00008(A), GMAF:0.00020(A), GO-ESP:0.00019(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	99132693	GRCh38	45097	54264
NM_004612.3(TGFBR1):c.587T>G (p.Leu196Arg)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	9	99137871	GRCh38	263978	258609
NM_004612.3(TGFBR1):c.611C>T (p.Thr204Ile)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	9	99137895	GRCh38	264166	258613
NM_004612.3(TGFBR1):c.722C>T (p.Ser241Leu)	TGFBR1	Loeys-Dietz syndrome 1|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection		Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	9	99138006	GRCh38	12524	27563
NM_004612.3(TGFBR1):c.757A>G (p.Met253Val)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	9	99138041	GRCh38	263773	258614
NM_004612.3(TGFBR1):c.835G>C (p.Val279Leu)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 4, 2015)	criteria provided, single submitter	9	99142565	GRCh38	264407	258615
NM_004612.3(TGFBR1):c.934G>A (p.Gly312Ser)	TGFBR1	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not provided	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 7, 2015)	criteria provided, conflicting interpretations	9	99142664	GRCh38	213882	210182
NM_004612.3(TGFBR1):c.1032T>C (p.Asn344=)	TGFBR1	Loeys-Dietz syndrome 1|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00015(C), GMAF:0.00140(C), GO-ESP:0.00061(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	99144790	GRCh38	45093	54260
NM_004612.3(TGFBR1):c.1041C>G (p.Cys347Trp)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 25, 2015)	criteria provided, single submitter	9	99144799	GRCh38	264034	258616
NM_004612.3(TGFBR1):c.1125A>C (p.Thr375=)	TGFBR1	Loeys-Dietz syndrome 1|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00300(C), GMAF:0.00220(C), GO-ESP:0.00413(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	99144883	GRCh38	36857	45518
NM_004612.3(TGFBR1):c.1136T>C (p.Met379Thr)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 3, 2015)	criteria provided, single submitter	9	99146490	GRCh38	263993	258617
NM_004612.3(TGFBR1):c.1152C>T (p.Leu384=)	TGFBR1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00346(T), GMAF:0.00420(T), GO-ESP:0.00090(T)	Benign(Last reviewed: Dec 2, 2015)	criteria provided, multiple submitters, no conflicts	9	99146506	GRCh38	45094	54261
NM_004612.3(TGFBR1):c.1216T>C (p.Leu406=)	TGFBR1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(C), GO-ESP:0.00023(C)	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, multiple submitters, no conflicts	9	99146570	GRCh38	45095	54262
NM_004612.3(TGFBR1):c.1301C>G (p.Ser434Cys)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	9	99147699	GRCh38	264193	258618
NM_004612.3(TGFBR1):c.1302_1303dupTG (p.Asp435Valfs)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	9	99147700 - 99147701	GRCh38	263856	258619
NM_004612.3(TGFBR1):c.1433A>G (p.Asn478Ser)	TGFBR1	Loeys-Dietz syndrome 1|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00028(G)	Uncertain significance(Last reviewed: Jan 6, 2016)	criteria provided, multiple submitters, no conflicts	9	99149226	GRCh38	161393	171117
NM_004612.3(TGFBR1):c.1457T>G (p.Leu486Trp)	TGFBR1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	9	99149250	GRCh38	264499	258620
NM_004612.3(TGFBR1):c.1459C>T (p.Arg487Trp)	TGFBR1	Loeys-Dietz syndrome 1|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, multiple submitters, no conflicts	9	99149252	GRCh38	12526	27565
NM_001079802.1(FKTN):c.22G>T (p.Val8Leu)	FKTN	Cardiovascular phenotype	GMAF:0.00020(T)	Uncertain significance(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	9	105575054	GRCh38	264150	258521
NM_001079802.1(FKTN):c.167G>A (p.Arg56His)	FKTN	not specified|not provided|Cardiovascular phenotype|Walker-Warburg congenital muscular dystrophy	GO-ESP:0.00208(A), GMAF:0.00240(A), GO-ESP:0.00090(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 16, 2016)	criteria provided, conflicting interpretations	9	105601146	GRCh38	93518	99423
NM_001079802.1(FKTN):c.340G>A (p.Ala114Thr)	FKTN	Limb-girdle muscular dystrophy-dystroglycanopathy, type C4		Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	9	105601319	GRCh38	3213	18252
NM_001079802.1(FKTN):c.382C>T (p.Arg128Trp)	FKTN	not specified|Cardiovascular phenotype	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Sep 14, 2015)	criteria provided, multiple submitters, no conflicts	9	105604227	GRCh38	264196	258525
NM_001079802.1(FKTN):c.625C>T (p.Arg209Cys)	FKTN	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 21, 2015)	criteria provided, single submitter	9	105604470	GRCh38	264093	258528
NM_001079802.1(FKTN):c.668C>T (p.Thr223Ile)	FKTN	not specified|not provided|Cardiovascular phenotype|Walker-Warburg congenital muscular dystrophy	GMAF:0.00420(T), GO-ESP:0.00078(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2015)	criteria provided, conflicting interpretations	9	105607839	GRCh38	162568	172238
NM_001079802.1(FKTN):c.681G>A (p.Leu227=)	FKTN	Fukuyama congenital muscular dystrophy|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Recessive	GMAF:0.00040(A), GO-ESP:0.00021(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	105607852	GRCh38	264299	258524
NM_001079802.1(FKTN):c.895A>C (p.Ser299Arg)	FKTN	Cardiovascular phenotype	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	9	105615392	GRCh38	264590	258523
NM_001079802.1(FKTN):c.1073A>C (p.Gln358Pro)	FKTN	Dilated cardiomyopathy 1X		Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	9	105619962	GRCh38	3209	18248
NM_001079802.1(FKTN):c.1249G>A (p.Glu417Lys)	FKTN	Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	9	105635127	GRCh38	264522	258527
NM_001127666.1(GSN):c.520G>A (p.Asp174Asn)	GSN	Meretoja syndrome		Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	9	121310819	GRCh38	16180	31219
NM_000118.3(ENG):c.1428+2T>C	ENG|LOC102723566	not provided		Pathogenic(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	9	127818714	GRCh38	213217	209947
NM_000118.3(ENG):c.1428+1G>A	ENG|LOC102723566	not provided		Pathogenic(Last reviewed: Oct 23, 2014)	criteria provided, single submitter	9	127818715	GRCh38	213216	209948
NM_000118.3(ENG):c.1312A>T (p.Lys438Ter)	ENG|LOC102723566	not provided		Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	9	127818832	GRCh38	213210	209950
NM_000118.3(ENG):c.991+26_991+27insCCTCCC	ENG	not specified	GO-ESP:0.22487(GGGAGG)	Benign(Last reviewed: May 4, 2015)	criteria provided, single submitter	9	127824773 - 127824774	GRCh38	213201	209953
NM_000118.3(ENG):c.572G>A (p.Gly191Asp)	ENG	Osler hemorrhagic telangiectasia syndrome|not specified|Juvenile Polyposis	GMAF:0.00320(T), GO-ESP:0.01522(T)	Benign/Likely benign(Last reviewed: Jul 21, 2016)	criteria provided, multiple submitters, no conflicts	9	127825812	GRCh38	213200	209955
NM_000118.3(ENG):c.446G>A (p.Trp149Ter)	ENG	not provided		Pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	9	127826587	GRCh38	213207	209957
NM_000118.3(ENG):c.247C>T (p.Gln83Ter)	ENG	not provided		Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	9	127829800	GRCh38	213205	209960
NM_000118.3(ENG):c.98A>C (p.Gln33Pro)	ENG	not specified		Uncertain significance(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	9	127843215	GRCh38	213204	209961
NM_014908.3(DOLK):c.1222C>G (p.His408Asp)	DOLK	Congenital disorder of glycosylation type 1M		Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	9	128946082	GRCh38	30850	39807
NM_014908.3(DOLK):c.2T>C (p.Met1Thr)	DOLK	Congenital disorder of glycosylation type 1M		Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	9	128947302	GRCh38	100664	106536
NM_000368.4(TSC1):c.1680_1702del23 (p.Ser561Argfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome		Pathogenic(Last reviewed: Jun 4, 1999)	no assertion criteria provided	9	132905876 - 132905898	GRCh38	64763	75692
NM_000093.4(COL5A1):c.126C>T (p.Leu42=)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00046(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	134690928	GRCh38	212915	209966
NM_000093.4(COL5A1):c.193C>T (p.Arg65Trp)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(T), GO-ESP:0.00195(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	134690995	GRCh38	213006	209971
NM_000093.4(COL5A1):c.194G>A (p.Arg65Gln)	COL5A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00220(A), GO-ESP:0.00054(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2016)	criteria provided, conflicting interpretations	9	134690996	GRCh38	213007	209972
NM_000093.4(COL5A1):c.295G>T (p.Asp99Tyr)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Apr 10, 2015)	criteria provided, single submitter	9	134699926	GRCh38	263968	258532
NM_000093.4(COL5A1):c.573C>T (p.Leu191=)	COL5A1	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00260(T), GO-ESP:0.00197(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	134701252	GRCh38	136919	140622
NM_000093.4(COL5A1):c.761C>T (p.Ser254Leu)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00240(T), GO-ESP:0.00105(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	134727372	GRCh38	237008	240514
NM_000093.4(COL5A1):c.805G>A (p.Glu269Lys)	COL5A1	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00021(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	134728688	GRCh38	198041	195202
NM_000093.4(COL5A1):c.825C>T (p.Tyr275=)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00004(T)	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	9	134728708	GRCh38	264205	258526
NM_000093.4(COL5A1):c.996C>T (p.Asp332=)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00120(T), GO-ESP:0.00022(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	134730307	GRCh38	212924	209995
NM_000093.4(COL5A1):c.1024C>T (p.Pro342Ser)	COL5A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 28, 2015)	criteria provided, single submitter	9	134730335	GRCh38	264049	258531
NM_000093.4(COL5A1):c.1140C>T (p.Thr380=)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Mar 18, 2015)	criteria provided, single submitter	9	134730451	GRCh38	263930	258529
NM_000093.4(COL5A1):c.1158C>T (p.Ser386=)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00160(T), GO-ESP:0.00066(T)	Benign/Likely benign(Last reviewed: Aug 19, 2016)	criteria provided, multiple submitters, no conflicts	9	134730469	GRCh38	212926	209998
NM_000093.4(COL5A1):c.1281G>A (p.Pro427=)	COL5A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(A), GO-ESP:0.00015(A)	Benign/Likely benign(Last reviewed: Sep 9, 2015)	criteria provided, multiple submitters, no conflicts	9	134731612	GRCh38	212927	210000
NM_000093.4(COL5A1):c.1333-3dupC	COL5A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	9	134732068	GRCh38	264321	258534
NM_000093.4(COL5A1):c.1350C>T (p.Gly450=)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00016(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	134732088	GRCh38	212929	210006
NM_000093.4(COL5A1):c.1430C>T (p.Ala477Val)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Aug 24, 2015)	criteria provided, single submitter	9	134738514	GRCh38	264313	258536
NM_000093.4(COL5A1):c.1754C>T (p.Pro585Leu)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	9	134753884	GRCh38	264062	258537
NM_000093.4(COL5A1):c.2058G>A (p.Pro686=)	COL5A1	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00320(A), GO-ESP:0.00091(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	134765704	GRCh38	212890	210035
NM_000093.4(COL5A1):c.2088C>T (p.Pro696=)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Dec 6, 2015)	criteria provided, single submitter	9	134765734	GRCh38	264547	258530
NM_000093.4(COL5A1):c.2238C>T (p.Pro746=)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(T)	Likely benign(Last reviewed: May 22, 2015)	criteria provided, single submitter	9	134768415	GRCh38	264028	258538
NM_000093.4(COL5A1):c.2588A>T (p.Glu863Val)	COL5A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(T), GO-ESP:0.00045(T)	Uncertain significance(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	9	134785092	GRCh38	213044	210053
NM_000093.4(COL5A1):c.2799+4T>C	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.01300(C), GO-ESP:0.00388(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	134795319	GRCh38	136871	140574
NM_000093.4(COL5A1):c.2991C>T (p.Gly997=)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00004(T)	Likely benign(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	9	134801992	GRCh38	264527	258542
NM_000093.4(COL5A1):c.3014C>T (p.Thr1005Met)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	9	134802895	GRCh38	264088	258544
NM_000093.4(COL5A1):c.3087G>A (p.Pro1029=)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00008(A)	Likely benign(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	9	134802968	GRCh38	264078	258533
NM_000093.4(COL5A1):c.3096T>A (p.Ala1032=)	COL5A1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	9	134802977	GRCh38	264099	258539
NM_000093.4(COL5A1):c.3291C>T (p.Ala1097=)	COL5A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00015(T)	Benign/Likely benign(Last reviewed: Dec 20, 2015)	criteria provided, multiple submitters, no conflicts	9	134806221	GRCh38	212898	210069
NM_000093.4(COL5A1):c.3303C>T (p.Ile1101=)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00005(T)	Likely benign(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	9	134806233	GRCh38	264544	258545
NM_000093.4(COL5A1):c.3418G>A (p.Val1140Met)	COL5A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(A), GO-ESP:0.00077(A)	Uncertain significance(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	9	134809234	GRCh38	213048	210076
NM_000093.4(COL5A1):c.3428C>T (p.Pro1143Leu)	COL5A1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Mar 18, 2016)	criteria provided, multiple submitters, no conflicts	9	134809244	GRCh38	264045	258548
NM_000093.4(COL5A1):c.3591C>T (p.Asp1197=)	COL5A1	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00024(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	134811500	GRCh38	136880	140583
NM_000093.4(COL5A1):c.3600G>A (p.Pro1200=)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(A), GO-ESP:0.00007(A)	Likely benign(Last reviewed: Jul 9, 2015)	criteria provided, single submitter	9	134811509	GRCh38	264164	258535
NM_000093.4(COL5A1):c.3649C>T (p.Pro1217Ser)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00022(T)	Uncertain significance(Last reviewed: Nov 2, 2015)	criteria provided, single submitter	9	134811558	GRCh38	264411	258541
NM_000093.4(COL5A1):c.3698C>T (p.Pro1233Leu)	COL5A1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	9	134812456	GRCh38	264234	258547
NM_000093.4(COL5A1):c.3753G>A (p.Pro1251=)	COL5A1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00004(A)	Likely benign(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	9	134812613	GRCh38	264190	258551
NM_000093.4(COL5A1):c.3855C>T (p.Gly1285=)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(T), GO-ESP:0.00143(T)	Benign/Likely benign(Last reviewed: Jan 19, 2016)	criteria provided, multiple submitters, no conflicts	9	134813985	GRCh38	136882	140585
NM_000093.4(COL5A1):c.3868G>A (p.Ala1290Thr)	COL5A1	Thoracic aortic aneurysm and aortic dissection|not specified		Uncertain significance(Last reviewed: Jul 12, 2015)	criteria provided, multiple submitters, no conflicts	9	134813998	GRCh38	212967	210083
NM_000093.4(COL5A1):c.3906+3G>T	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type		Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	9	134814039	GRCh38	17183	32222
NM_000093.4(COL5A1):c.3987C>T (p.Pro1329=)	COL5A1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: May 15, 2015)	criteria provided, single submitter	9	134814877	GRCh38	264002	258540
NM_000093.4(COL5A1):c.4066G>A (p.Ala1356Thr)	COL5A1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00100(A), GO-ESP:0.00036(A)	Uncertain significance(Last reviewed: Jul 7, 2015)	criteria provided, multiple submitters, no conflicts	9	134815627	GRCh38	212970	210089
NM_000093.4(COL5A1):c.4135C>T (p.Pro1379Ser)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00400(T), GO-ESP:0.00742(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	134817038	GRCh38	136890	140593
NM_000093.4(COL5A1):c.4554+3G>A	COL5A1|LOC101448202	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Mar 24, 2015)	criteria provided, single submitter	9	134820226	GRCh38	263949	258543
NM_000093.4(COL5A1):c.4683A>C (p.Gly1561=)	COL5A1|LOC101448202	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00280(C), GO-ESP:0.00147(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	134823454	GRCh38	136902	140605
NM_000093.4(COL5A1):c.4782C>T (p.Asp1594=)	COL5A1|LOC101448202	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Nov 4, 2015)	criteria provided, single submitter	9	134824683	GRCh38	264439	258555
NM_000093.4(COL5A1):c.4814C>T (p.Ala1605Val)	COL5A1|LOC101448202	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00012(T)	Uncertain significance(Last reviewed: Jan 15, 2016)	criteria provided, multiple submitters, no conflicts	9	134824715	GRCh38	212992	210125
NM_000093.4(COL5A1):c.5034G>A (p.Ser1678=)	COL5A1|LOC101448202	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00010(A)	Benign/Likely benign(Last reviewed: Oct 16, 2015)	criteria provided, multiple submitters, no conflicts	9	134825871	GRCh38	136906	140609
NM_000093.4(COL5A1):c.5151C>T (p.Asp1717=)	COL5A1|LOC101448202	Ehlers-Danlos syndrome, type 7A|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00640(T), GO-ESP:0.00244(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	134834985	GRCh38	136911	140614
NM_000093.4(COL5A1):c.5154C>T (p.Ala1718=)	COL5A1|LOC101448202	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00006(T)	Benign/Likely benign(Last reviewed: Mar 19, 2015)	criteria provided, multiple submitters, no conflicts	9	134834988	GRCh38	212910	210137
NM_000093.4(COL5A1):c.5223C>T (p.Asn1741=)	COL5A1|LOC101448202	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	9	134835057	GRCh38	264007	258558
NM_000093.4(COL5A1):c.5280C>T (p.Tyr1760=)	COL5A1|LOC101448202	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00011(T)	Likely benign(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	9	134835114	GRCh38	263994	258549
NM_000093.4(COL5A1):c.5407G>A (p.Asp1803Asn)	COL5A1|LOC101448202	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00420(A), GO-ESP:0.00110(A)	Benign(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	9	134842193	GRCh38	136915	140618
NM_017617.4(NOTCH1):c.*5C>T	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00025(A)	Uncertain significance(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	9	136496066	GRCh38	264503	258546
NM_017617.4(NOTCH1):c.7363A>G (p.Thr2455Ala)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00004(C)	Uncertain significance(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	9	136496376	GRCh38	264349	258556
NM_017617.4(NOTCH1):c.7311G>T (p.Glu2437Asp)	NOTCH1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	9	136496428	GRCh38	264070	258560
NM_017617.4(NOTCH1):c.7291C>T (p.Arg2431Trp)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Apr 23, 2015)	criteria provided, single submitter	9	136496448	GRCh38	263974	258552
NM_017617.4(NOTCH1):c.7289G>C (p.Gly2430Ala)	NOTCH1	Cardiovascular phenotype	GMAF:0.00220(G), GO-ESP:0.00043(G)	Likely benign(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	9	136496450	GRCh38	264535	258550
NM_017617.4(NOTCH1):c.7150C>G (p.Gln2384Glu)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Oct 4, 2015)	criteria provided, single submitter	9	136496589	GRCh38	264454	258557
NM_017617.4(NOTCH1):c.6991G>A (p.Ala2331Thr)	NOTCH1	not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00760(T), GO-ESP:0.00153(T)	Benign(Last reviewed: Jan 14, 2016)	criteria provided, multiple submitters, no conflicts	9	136496748	GRCh38	134957	138696
NM_017617.4(NOTCH1):c.6960G>A (p.Pro2320=)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: May 19, 2015)	criteria provided, single submitter	9	136496779	GRCh38	264006	258565
NM_017617.4(NOTCH1):c.6870C>T (p.Ser2290=)	NOTCH1	Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00440(A), GO-ESP:0.00279(A)	Benign/Likely benign(Last reviewed: Feb 12, 2016)	criteria provided, multiple submitters, no conflicts	9	136496869	GRCh38	241163	240540
NM_017617.4(NOTCH1):c.6685G>A (p.Val2229Met)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00014(T)	Uncertain significance(Last reviewed: Dec 9, 2015)	criteria provided, single submitter	9	136497054	GRCh38	264594	258553
NM_017617.4(NOTCH1):c.6636C>T (p.Asp2212=)	NOTCH1	Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00023(A)	Likely benign(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	9	136497103	GRCh38	264082	258554
NM_017617.4(NOTCH1):c.6521A>G (p.Lys2174Arg)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: May 15, 2015)	criteria provided, single submitter	9	136497218	GRCh38	264003	258559
NM_017617.4(NOTCH1):c.6429C>T (p.Asn2143=)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00012(A)	Likely benign(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	9	136497310	GRCh38	264443	258567
NM_017617.4(NOTCH1):c.6397C>T (p.Pro2133Ser)	NOTCH1	Cardiovascular phenotype	GMAF:0.00460(A), GO-ESP:0.00134(A)	Benign(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	9	136497342	GRCh38	264614	258561
NM_017617.4(NOTCH1):c.6228C>T (p.Thr2076=)	NOTCH1	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00017(A)	Likely benign(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	9	136497511	GRCh38	264243	258562
NM_017617.4(NOTCH1):c.6222C>T (p.Tyr2074=)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00002(A)	Likely benign(Last reviewed: May 28, 2015)	criteria provided, single submitter	9	136497517	GRCh38	264050	258563
NM_017617.4(NOTCH1):c.6130G>A (p.Ala2044Thr)	NOTCH1	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Feb 9, 2015)	criteria provided, single submitter	9	136498949	GRCh38	263917	258570
NM_017617.4(NOTCH1):c.6054C>T (p.His2018=)	NOTCH1	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00003(A)	Likely benign(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	9	136499140	GRCh38	264290	258564
NM_017617.4(NOTCH1):c.5967T>C (p.Asp1989=)	NOTCH1	Cardiovascular phenotype	GMAF:0.00120(G), GO-ESP:0.00012(G)	Likely benign(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	9	136499227	GRCh38	264008	258566
NM_017617.4(NOTCH1):c.5776C>T (p.Arg1926Cys)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00007(A)	Uncertain significance(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	9	136500710	GRCh38	264419	258568
NM_017617.4(NOTCH1):c.5723C>T (p.Ala1908Val)	NOTCH1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	9	136500763	GRCh38	264552	258571
NM_017617.4(NOTCH1):c.5690C>T (p.Thr1897Met)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	9	136500796	GRCh38	263950	258569
NM_017617.4(NOTCH1):c.5673C>T (p.Ser1891=)	NOTCH1	Cardiovascular phenotype	GMAF:0.00180(A), GO-ESP:0.00079(A)	Likely benign(Last reviewed: May 21, 2015)	criteria provided, single submitter	9	136500813	GRCh38	264030	258576
NM_017617.4(NOTCH1):c.5500C>T (p.Leu1834=)	NOTCH1	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00019(A)	Likely benign(Last reviewed: May 21, 2015)	criteria provided, single submitter	9	136501886	GRCh38	264031	258572
NM_017617.4(NOTCH1):c.5281delC (p.Arg1761Glyfs)	NOTCH1	Heart, malformation of		Likely pathogenic	no assertion criteria provided	9	136502375	GRCh38	139666	150130
NM_017617.4(NOTCH1):c.5073G>A (p.Gln1691=)	NOTCH1	Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00325(T)	Benign/Likely benign(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	9	136503276	GRCh38	241146	240555
NM_017617.4(NOTCH1):c.5061G>T (p.Gln1687His)	NOTCH1	Heart, malformation of		Likely pathogenic	no assertion criteria provided	9	136503288	GRCh38	139665	150129
NM_017617.4(NOTCH1):c.4917C>T (p.Ala1639=)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00066(A)	Likely benign(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	9	136504774	GRCh38	263870	258573
NM_017617.4(NOTCH1):c.4887C>T (p.His1629=)	NOTCH1	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00270(A)	Likely benign(Last reviewed: Feb 6, 2015)	criteria provided, single submitter	9	136504804	GRCh38	263902	258578
NM_017617.4(NOTCH1):c.4823G>A (p.Arg1608His)	NOTCH1	not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00700(T), GO-ESP:0.01301(T)	Benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	9	136504868	GRCh38	134939	138678
NM_017617.4(NOTCH1):c.4746G>A (p.Pro1582=)	NOTCH1	Cardiovascular phenotype		Likely benign(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	9	136504945	GRCh38	263919	258580
NM_017617.4(NOTCH1):c.4652G>T (p.Ser1551Ile)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00014(A)	Uncertain significance(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	9	136505039	GRCh38	264333	258574
NM_017617.4(NOTCH1):c.4626C>T (p.Asp1542=)	NOTCH1	Cardiovascular phenotype	GMAF:0.00260(A), GO-ESP:0.00053(A)	Likely benign(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	9	136505065	GRCh38	264538	258575
NM_017617.4(NOTCH1):c.4551C>T (p.Asp1517=)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00011(A)	Likely benign(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	9	136505345	GRCh38	264398	258584
NM_017617.4(NOTCH1):c.4512delC (p.Cys1505Valfs)	NOTCH1	Aortic valve disorder		Pathogenic(Last reviewed: Sep 8, 2005)	no assertion criteria provided	9	136505384	GRCh38	12477	27516
NM_017617.4(NOTCH1):c.4487G>A (p.Cys1496Tyr)	NOTCH1	Adams-Oliver syndrome 5		Pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	9	136505409	GRCh38	156007	165811
NM_017617.4(NOTCH1):c.4238G>A (p.Arg1413His)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	9	136505658	GRCh38	264469	258583
NM_017617.4(NOTCH1):c.4168C>A (p.Pro1390Thr)	NOTCH1	not specified|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00062(T)	Uncertain significance(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	9	136505728	GRCh38	134935	138674
NM_017617.4(NOTCH1):c.4078G>A (p.Gly1360Ser)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	9	136505818	GRCh38	263913	258579
NM_017617.4(NOTCH1):c.4028C>T (p.Ala1343Val)	NOTCH1	not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00188(A)	Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	9	136505868	GRCh38	134932	138671
NM_017617.4(NOTCH1):c.4024G>A (p.Gly1342Ser)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	9	136505872	GRCh38	264014	258577
NM_017617.4(NOTCH1):c.3970G>A (p.Val1324Met)	NOTCH1	Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00024(T)	Uncertain significance(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	9	136506571	GRCh38	264613	258587
NM_017617.4(NOTCH1):c.3835C>T (p.Arg1279Cys)	NOTCH1	Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00032(A)	Uncertain significance(Last reviewed: Mar 31, 2016)	criteria provided, multiple submitters, no conflicts	9	136506782	GRCh38	241139	240561
NM_017617.4(NOTCH1):c.3638C>G (p.Thr1213Ser)	NOTCH1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 9, 2015)	criteria provided, single submitter	9	136507310	GRCh38	264061	258585
NM_017617.4(NOTCH1):c.3597C>T (p.Leu1199=)	NOTCH1	Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00010(A)	Likely benign(Last reviewed: Dec 5, 2015)	criteria provided, single submitter	9	136507351	GRCh38	264557	258581
NM_017617.4(NOTCH1):c.3319C>T (p.Arg1107Ter)	NOTCH1	Aortic valve disorder		Pathogenic(Last reviewed: Sep 8, 2005)	no assertion criteria provided	9	136508238	GRCh38	12476	27515
NM_017617.4(NOTCH1):c.3315G>T (p.Ala1105=)	NOTCH1	Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00580(A), GO-ESP:0.00265(A)	Benign/Likely benign(Last reviewed: Nov 5, 2015)	criteria provided, multiple submitters, no conflicts	9	136508242	GRCh38	221096	221810
NM_017617.4(NOTCH1):c.3294C>T (p.Ser1098=)	NOTCH1	Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00160(A), GO-ESP:0.00304(A)	Benign/Likely benign(Last reviewed: Oct 28, 2015)	criteria provided, multiple submitters, no conflicts	9	136508263	GRCh38	220792	221811
NM_017617.4(NOTCH1):c.3198G>A (p.Ser1066=)	NOTCH1	Adams-Oliver syndrome 5|Cardiovascular phenotype	GO-ESP:0.00025(T)	Likely benign(Last reviewed: Dec 25, 2015)	criteria provided, multiple submitters, no conflicts	9	136508359	GRCh38	241134	240566
NM_017617.4(NOTCH1):c.3115G>A (p.Gly1039Ser)	NOTCH1	Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00035(T)	Likely benign(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	9	136508926	GRCh38	264180	258586
NM_017617.4(NOTCH1):c.3104C>T (p.Thr1035Ile)	NOTCH1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	9	136508937	GRCh38	264380	258591
NM_017617.4(NOTCH1):c.2813G>A (p.Arg938Gln)	NOTCH1	Cardiovascular phenotype	GMAF:0.00280(T), GO-ESP:0.00049(T)	Benign(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	9	136509889	GRCh38	264537	258595
NM_017617.4(NOTCH1):c.2734C>T (p.Arg912Trp)	NOTCH1	Thoracic aortic aneurysm and aortic dissection|not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00195(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 15, 2016)	criteria provided, conflicting interpretations	9	136510659	GRCh38	134921	138660
NM_017617.4(NOTCH1):c.2691C>T (p.Ala897=)	NOTCH1	not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00500(A), GO-ESP:0.01348(A)	Benign(Last reviewed: Jun 27, 2016)	criteria provided, multiple submitters, no conflicts	9	136510702	GRCh38	220988	221813
NM_017617.4(NOTCH1):c.2664C>T (p.His888=)	NOTCH1	not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00500(A), GO-ESP:0.01341(A)	Benign(Last reviewed: Mar 31, 2016)	criteria provided, multiple submitters, no conflicts	9	136510729	GRCh38	220987	221814
NM_017617.4(NOTCH1):c.2542G>A (p.Glu848Lys)	NOTCH1	not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00140(T), GO-ESP:0.00270(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 17, 2016)	criteria provided, conflicting interpretations	9	136511197	GRCh38	134919	138658
NM_017617.4(NOTCH1):c.2495C>T (p.Pro832Leu)	NOTCH1	not specified|Cardiovascular phenotype	GMAF:0.00100(A), GO-ESP:0.00039(A)	Uncertain significance(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	9	136511244	GRCh38	134918	138657
NM_017617.4(NOTCH1):c.2441A>G (p.Lys814Arg)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	9	136513047	GRCh38	264173	258582
NM_017617.4(NOTCH1):c.2205C>T (p.Asn735=)	NOTCH1	Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.01760(A), GO-ESP:0.01171(A)	Benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	9	136514512	GRCh38	241122	240577
NM_017617.4(NOTCH1):c.2068G>A (p.Gly690Arg)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	9	136514649	GRCh38	263986	258589
NM_017617.4(NOTCH1):c.2014+1G>A	NOTCH1	Heart, malformation of		Likely pathogenic	no assertion criteria provided	9	136515289	GRCh38	139664	150128
NM_017617.4(NOTCH1):c.1981G>A (p.Gly661Ser)	NOTCH1	Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00038(T)	Uncertain significance(Last reviewed: Dec 4, 2015)	criteria provided, single submitter	9	136515323	GRCh38	264541	258593
NM_017617.4(NOTCH1):c.1962C>T (p.Thr654=)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00075(A)	Likely benign(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	9	136515342	GRCh38	264178	258597
NM_017617.4(NOTCH1):c.1950C>T (p.Cys650=)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00005(A)	Likely benign(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	9	136515354	GRCh38	264403	258588
NM_017617.4(NOTCH1):c.1914C>T (p.Cys638=)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00008(A)	Likely benign(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	9	136515390	GRCh38	264540	258592
NM_017617.4(NOTCH1):c.1862G>A (p.Arg621His)	NOTCH1	not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00120(T)	Likely benign(Last reviewed: Mar 22, 2016)	criteria provided, multiple submitters, no conflicts	9	136515524	GRCh38	134910	138649
NM_017617.4(NOTCH1):c.1787C>T (p.Thr596Met)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00021(A)	Uncertain significance(Last reviewed: Nov 27, 2015)	criteria provided, single submitter	9	136515599	GRCh38	264528	258594
NM_017617.4(NOTCH1):c.1778C>T (p.Pro593Leu)	NOTCH1	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 21, 2015)	criteria provided, single submitter	9	136515608	GRCh38	264032	258599
NM_017617.4(NOTCH1):c.1775G>A (p.Arg592His)	NOTCH1	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Oct 3, 2015)	criteria provided, single submitter	9	136515611	GRCh38	264433	258590
NM_017617.4(NOTCH1):c.1701C>G (p.Ile567Met)	NOTCH1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	9	136515685	GRCh38	263914	258598
NM_017617.4(NOTCH1):c.1635C>T (p.Asp545=)	NOTCH1	Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00380(A), GO-ESP:0.00749(A)	Benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	9	136516015	GRCh38	220907	221815
NM_017617.4(NOTCH1):c.1374G>A (p.Ser458=)	NOTCH1	Cardiovascular phenotype		Likely benign(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	9	136517819	GRCh38	264037	258596
NM_017617.4(NOTCH1):c.1038C>T (p.His346=)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00015(A)	Likely benign(Last reviewed: Dec 4, 2015)	criteria provided, single submitter	9	136518652	GRCh38	264564	258600
NM_017617.4(NOTCH1):c.775G>A (p.Asp259Asn)	NOTCH1	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: May 22, 2015)	criteria provided, single submitter	9	136519533	GRCh38	264044	258610
NM_017617.4(NOTCH1):c.711C>T (p.Gly237=)	NOTCH1	not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.02040(A), GO-ESP:0.02168(A)	Benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	9	136522881	GRCh38	197310	194471
NM_017617.4(NOTCH1):c.558C>T (p.Pro186=)	NOTCH1	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 16, 2015)	criteria provided, single submitter	9	136523034	GRCh38	264263	258602
NM_017617.4(NOTCH1):c.368C>T (p.Thr123Met)	NOTCH1	not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00093(A)	Likely benign(Last reviewed: Jan 7, 2016)	criteria provided, multiple submitters, no conflicts	9	136523752	GRCh38	134944	138683
NM_017617.4(NOTCH1):c.64C>T (p.Pro22Ser)	NOTCH1	not specified|Adams-Oliver syndrome 5|Cardiovascular phenotype	GMAF:0.00700(A), GO-ESP:0.00372(A)	Benign/Likely benign, not provided(Last reviewed: Feb 23, 2016)	criteria provided, multiple submitters, no conflicts	9	136544100	GRCh38	134923	138662
NM_007327.3(GRIN1):c.1858G>C (p.Gly620Arg)	GRIN1	Mental retardation, autosomal dominant 8		Likely pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	9	137162510	GRCh38	209159	205760
NM_000718.3(CACNA1B):c.4166G>A (p.Arg1389His)	CACNA1B	Dystonia 23	GMAF:0.00080(A), GO-ESP:0.00038(A)	Pathogenic(Last reviewed: Feb 15, 2015)	no assertion criteria provided	9	138058108	GRCh38	189196	187087
GRCh38/hg38 9p24.3(chr9:254654-399596)x4	DOCK8	See cases		Uncertain significance(Last reviewed: Jan 28, 2013)	no assertion criteria provided	9	254654 - 399596	GRCh38	155146	164900
GRCh38/hg38 9q21.11-21.12(chr9:68802194-69342807)x3	FXN|PRKACG|PIP5K1B|FAM189A2|TJP2|BANCR|LOC101927069	See cases		Uncertain significance(Last reviewed: Nov 27, 2012)	no assertion criteria provided	9	68802194 - 69342807	GRCh38	155100	164854
GRCh38/hg38 9p24.3-q21.31(chr9:193412-79877816)x3	ACO1|PLIN2|ALDH1A1|ALDH1B1|ANXA1|NUDT2|APBA1|AQP3|AQP7|BAG1|KLF9|CA9|CCIN|CD72|CDKN2A|CDKN2B|CLTA|CNTFR|DMRT1|ELAVL2|FANCG|MLANA|FXN|GALT|GCNT1|B4GALT1|GLDC|GNAQ|DNAJA1|IFNA1|IFNA2|IFNA4|IFNA5|IFNA6|IFNA7|IFNA8|IFNA10|IFNA13|IFNA14|IFNA16|IFNA17|IFNA21|IFNB1|IFNW1|IL11RA|INSL4|JAK2|MLLT3|MTAP|NDUFB6|NFIB|NFX1|NPR2|PAX5|PCSK5|PGM5|PRKACG|PRSS3|PTPRD|RFX3|RLN1|RLN2|RMRP|RORB|RPS6|CCL19|CCL21|SH3GL2|SHB|SLC1A1|SMARCA2|SNAPC3|TEK|TESK1|TLE4|TLN1|TPM2|TYRP1|VCP|VLDLR|ZFAND5|PIP5K1B|RECK|MPDZ|CER1|PLAA|GRHPR|FAM189A2|TJP2|GDA|GNA14|RGP1|MELK|RUSC2|ZBTB5|PUM3|GNE|RCL1|TOPORS|SIGMAR1|CREB3|UNC13B|DMRT2|RRAGA|CCL27|PSIP1|INSL6|PTENP1|DCTN3|FRMPD1|KDM4C|SMC5|KANK1|VPS13A|PHF24|DDX58|TMEM2|SLC24A2|DNAJB5|DCAF12|ZNF658|SPATA31A7|SPAG8|FBXO10|OSTF1|RANBP6|DNAI1|SIT1|SPINK4|CD274|PSAT1|STOML2|PCA3|AK3|EXOSC3|ABHD17B|CDKN2A-AS1|UBAP1|CHMP5|TMEM8B|EQTN|BNC2|HAUS6|APTX|CNTLN|FOCAD|UBE2R2|NMRK1|SPATA6L|C9orf40|SMU1|RFK|CDC37L1|DENND4C|UBAP2|PLGRKT|KLHL9|OR2S2|IFNK|KIAA1161|RIC1|GBA2|DMRT3|DMRTA1|POLR1E|LRRC19|NOL6|DCAF10|MOB3B|CAAP1|CNTNAP3|ERMP1|TRPM3|IFT74|FAM214B|PDCD1LG2|DOCK8|CEP78|ZCCHC7|ANKRD20A1|HINT2|C9orf24|PIGO|GLIS3-AS1|ARHGEF39|TPD52L3|IL33|TMEM261|SLC25A51|ADAMTSL1|LINC00950|UHRF2|FAM122A|TMC1|CARNMT1|C9orf57|C9orf85|C9orf135|TAF1L|ARID3C|RPP25L|C9orf131|TRPM6|RNF38|GLIPR2|C9orf66|LINC00032|LINGO2|TTC39B|FAM201A|TRMT10B|SAXO1|FREM1|KIAA2026|LINC00961|PRUNE2|KCNV2|TMEM252|GLIS3|C9orf72|CCDC171|FAM219A|CCDC107|LINC00537|CBWD5|ANKRD18A|MAMDC2|FAM205A|LOC286297|TUSC1|LURAP1L|FOXD4L3|IFNE|ZDHHC21|ACER2|KIF24|IGFBPL1|FOXD4L4|ENHO|PTAR1|SPATA31A6|GLIDR|FAM221B|OR13J1|VLDLR-AS1|LINC01235|HACD4|LINC01242|TMEM215|TOMM5|FAM74A1|FAM74A4|PLPP6|LOC403323|MIR101-2|MIR204|MIR31|CNTFR-AS1|LOC440896|LINC01239|ANKRD20A3|ANKRD20A2|ANKRD18B|FOXB2|CBWD3|C9orf135-AS1|MIR31HG|LOC554249|PGM5-AS1|MIR491|LINC01189|CBWD6|HRCT1|SPATA31A1|FAM74A6|FOXD4L6|FOXD4L5|SCARNA8|MSMP|FAM27D1|SPATA31A3|SPATA31A5|CBWD7|FAM74A3|CNTNAP3B|LOC728673|ANKRD20A4|LOC730098|FAM166B|TRH-GTG1-6|CDKN2B-AS1|SNORD121A|LINC00583|MIR876|MIR873|TOPORS-AS1|C9orf92|IZUMO3|FAM205C|FAM27E3|LOC100132249|FAM27C|FAM95B1|FAM27B|VPS13A-AS1|FAM27E2|FAM95C|LOC100289279|MIR1299|PIRC43|MIR3152|LOC100506422|MAMDC2-AS1|SMC5-AS1|LINC01504|MIR4477A|MIR4477B|MIR4667|MIR4473|MIR4540|MIR4665|MIR4475|MIR4474|MIR4476|RNU6-14P|BANCR|FAM74A7|PTENP1-AS|SNORD121B|DNAJB5-AS1|LOC101926948|LINC01506|LOC101927069|LINC01474|LOC101927358|C9orf41-AS1|GNA14-AS1|LOC101927450|LINC01507|LOC101927827|LOC101928381|LINC01231|RFX3-AS1|CDC37L1-AS1|PTPRD-AS1|PTPRD-AS2|LURAP1L-AS1|FOCAD-AS1|LOC101929563|LINC01241|IFT74-AS1|LINC01243|B4GALT1-AS1|UBE2R2-AS1|LINC01251|MIR6851|MIR6852|MIR6853|LOC102723709|LOC102724238|LINC01230|LINC01410|RORB-AS1|LOC103908605|LOC105375972|LOC105376064|LOC105379252|LOC105379450|XLOC_007697|SNORD137	See cases		Pathogenic(Last reviewed: Aug 20, 2012)	no assertion criteria provided	9	193412 - 79877816	GRCh38	154945	164699
GRCh38/hg38 9q34.3(chr9:137092629-137270028)x3	GRIN1|SSNA1|TUBB4B|MAN1B1|NELFB|NDOR1|ANAPC2|DPP7|TMEM203|SLC34A3|TPRN|CYSRT1|LRRC26|FAM166A|STPG3|RNF224|RNF208|STPG3-AS1|MIR3621|TMEM210	See cases		Benign(Last reviewed: Oct 19, 2010)	no assertion criteria provided	9	137092629 - 137270028	GRCh38	154677	164431
GRCh38/hg38 9p24.3-24.1(chr9:220253-7733826)x1	DMRT1|MLANA|GLDC|INSL4|JAK2|RFX3|RLN1|RLN2|SLC1A1|SMARCA2|VLDLR|PUM3|RCL1|DMRT2|INSL6|KDM4C|KANK1|RANBP6|CD274|AK3|SPATA6L|CDC37L1|PLGRKT|RIC1|DMRT3|ERMP1|PDCD1LG2|DOCK8|GLIS3-AS1|TPD52L3|IL33|UHRF2|KIAA2026|KCNV2|GLIS3|VLDLR-AS1|PLPP6|MIR101-2|MIR4665|LINC01231|RFX3-AS1|CDC37L1-AS1|LINC01230	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	9	220253 - 7733826	GRCh38	154621	164375
GRCh38/hg38 9p21.3(chr9:24386548-24942409)x3	IZUMO3	See cases		Uncertain significance(Last reviewed: Nov 30, 2009)	no assertion criteria provided	9	24386548 - 24942409	GRCh38	154549	164303
GRCh38/hg38 9q34.3(chr9:137215877-138138735)x1	CACNA1B|TUBB4B|NOXA1|NELFB|NSMF|NDOR1|TOR4A|EXD3|MRPL41|EHMT1|ARRDC1-AS1|ARRDC1|DPH7|ZMYND19|SLC34A3|PNPLA7|CYSRT1|ENTPD8|FAM166A|STPG3|NRARP|EHMT1-IT1|RNF224|MIR602|RNF208|STPG3-AS1|LOC100133077|LOC101928786|MIR7114|LOC105376331	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	9	137215877 - 138138735	GRCh38	59141	73736
GRCh38/hg38 9q34.2-34.3(chr9:134428674-138154922)x1	ABCA2|C8G|CACNA1B|ENTPD2|COL5A1|FCN1|FCN2|FUT7|GRIN1|LCN1|NOTCH1|PAEP|PTGDS|RXRA|SNAPC4|TRAF2|LHX3|SSNA1|EDF1|CLIC3|PPP1R26|SEC16A|TUBB4B|UBAC1|OLFM1|AGPAT2|SDCCAG3|NOXA1|MAN1B1|PMPCA|NELFB|NSMF|GPSM1|DKFZP434A062|NDOR1|PHPT1|ANAPC2|DPP7|OBP2A|MRPS2|EGFL7|FBXW5|TOR4A|EXD3|RABL6|INPP5E|NPDC1|KCNT1|CARD9|MRPL41|EHMT1|CCDC183|SNHG7|TMEM141|ARRDC1-AS1|SAPCD2|C9orf69|UAP1L1|ARRDC1|DPH7|TMEM203|ZMYND19|NACC2|C9orf116|LCN8|FAM69B|SLC34A3|CAMSAP1|C9orf62|C9orf163|MAMDC4|LCN6|QSOX2|LCN12|C9orf142|TPRN|GLT6D1|PNPLA7|CYSRT1|ENTPD8|LCN15|C9orf172|LRRC26|LCN9|CCDC187|LOC401557|LINC01451|LCNL1|C9orf139|FAM166A|SOHLH1|MIR126|COL5A1-AS1|LCN10|STPG3|NRARP|EHMT1-IT1|RNF224|SNORA17A|SNORA17B|MIR602|RNF208|DNLZ|LOC100128593|STPG3-AS1|LINC01502|CCDC183-AS1|LOC100133077|MAN1B1-AS1|MIR4292|MIR3621|MIR3689A|MIR3689B|TMEM210|PPP1R26-AS1|MIR3689D1|MIR3689F|MIR4673|MIR4674|MIR3689C|MIR3689D2|MIR3689E|MIR4479|LOC101448202|NALT1|LOC101928525|HSPC324|PRR31|LOC101928786|MIR6722|MIR7114|LOC102723971|LOC105376331	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	9	134428674 - 138154922	GRCh38	59136	73731
GRCh38/hg38 9p24.3-24.1(chr9:220253-6968724)x1	DMRT1|MLANA|GLDC|INSL4|JAK2|RFX3|RLN1|RLN2|SLC1A1|SMARCA2|VLDLR|PUM3|RCL1|DMRT2|INSL6|KDM4C|KANK1|RANBP6|CD274|AK3|SPATA6L|CDC37L1|PLGRKT|RIC1|DMRT3|ERMP1|PDCD1LG2|DOCK8|GLIS3-AS1|TPD52L3|IL33|UHRF2|KIAA2026|KCNV2|GLIS3|VLDLR-AS1|PLPP6|MIR101-2|MIR4665|LINC01231|RFX3-AS1|CDC37L1-AS1|LINC01230	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	9	220253 - 6968724	GRCh38	59065	73660
GRCh38/hg38 9q31.2(chr9:106998471-107651321)x3	RAD23B|KLF4|ZNF462|LOC340512|LINC01509	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	9	106998471 - 107651321	GRCh38	58480	73075
NM_014241.3(HACD1):c.744C>A (p.Tyr248Ter)	HACD1	not provided		Uncertain significance(Last reviewed: Dec 20, 2013)	no assertion criteria provided	10	17594245	GRCh38	157511	167372
NM_201593.2(CACNB2):c.17delT (p.Met6Serfs)	CACNB2	not specified		Uncertain significance(Last reviewed: Jul 10, 2014)	criteria provided, single submitter	10	18140753	GRCh38	190734	188469
NM_201590.2(CACNB2):c.-200138C>T	CACNB2	not specified		Uncertain significance(Last reviewed: Oct 27, 2014)	criteria provided, single submitter	10	18140789	GRCh38	190738	188470
NM_000724.3(CACNB2):c.-110391_-110390insG	CACNB2	Cardiac arrhythmia		Benign(Last reviewed: Apr 16, 2012)	criteria provided, single submitter	10	18150879 - 18150880	GRCh38	190712	188472
NM_201597.2(CACNB2):c.209G>A (p.Arg70His)	CACNB2	not specified|not provided	GMAF:0.00060(A), GO-ESP:0.00088(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2015)	criteria provided, conflicting interpretations	10	18150971	GRCh38	190713	188474
NM_201590.2(CACNB2):c.57G>A (p.Ser19=)	CACNB2	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	10	18401929	GRCh38	263347	258635
NM_000724.3(CACNB2):c.215C>T (p.Ala72Val)	CACNB2	Ventricular fibrillation, idiopathic|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00010(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	10	18498401	GRCh38	161209	171118
NM_201590.2(CACNB2):c.253G>T (p.Ala85Ser)	CACNB2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	10	18498436	GRCh38	264132	258636
NM_000724.3(CACNB2):c.425C>T (p.Ser142Phe)	CACNB2	Brugada syndrome 4|Brugada syndrome|not specified|not provided	GMAF:0.00040(T), GO-ESP:0.00051(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 16, 2015)	criteria provided, conflicting interpretations	10	18500945	GRCh38	161210	171119
NM_201590.2(CACNB2):c.460T>C (p.Leu154=)	CACNB2	Cardiovascular phenotype	GMAF:0.00080(C), GO-ESP:0.00068(C)	Likely benign(Last reviewed: Aug 17, 2015)	criteria provided, single submitter	10	18506499	GRCh38	264257	258637
NM_201590.2(CACNB2):c.503C>T (p.Ser168Leu)	CACNB2	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jun 12, 2014)	criteria provided, single submitter	10	18506542	GRCh38	190723	188476
NM_201590.2(CACNB2):c.711G>A (p.Leu237=)	CACNB2|NSUN6	Brugada syndrome 4|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00080(A), GO-ESP:0.00352(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	18518404	GRCh38	198635	195796
NM_201590.2(CACNB2):c.831G>A (p.Ser277=)	CACNB2|NSUN6	Brugada syndrome 4|Brugada syndrome|Cardiovascular phenotype	GMAF:0.00360(A), GO-ESP:0.00729(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	18527636	GRCh38	242263	240754
NM_201590.2(CACNB2):c.847A>G (p.Ser283Gly)	CACNB2|NSUN6	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	10	18527652	GRCh38	263499	258638
NM_201590.2(CACNB2):c.978T>C (p.His326=)	CACNB2|NSUN6	Brugada syndrome|Cardiovascular phenotype	GMAF:0.00040(C), GO-ESP:0.00004(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	18534161	GRCh38	264300	258639
NM_201571.3(CACNB2):c.1122+3A>T	CACNB2|NSUN6	Cardiac arrest|Cardiovascular phenotype	GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	10	18534230	GRCh38	180291	178613
NM_201590.2(CACNB2):c.1044+4_1044+7dupAGTA	CACNB2|NSUN6	Cardiac arrhythmia|Long QT syndrome|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2015)	criteria provided, conflicting interpretations	10	18534231 - 18534234	GRCh38	191435	189317
NM_201596.2(CACNB2):c.1399C>T (p.Pro467Ser)	CACNB2|NSUN6	Cardiac conduction defect, nonspecific		Uncertain significance(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	10	18538276	GRCh38	222519	224386
NM_201590.2(CACNB2):c.1337G>A (p.Gly446Asp)	CACNB2|NSUN6	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Mar 26, 2014)	criteria provided, single submitter	10	18539240	GRCh38	190726	188482
NM_000724.3(CACNB2):c.1346C>T (p.Thr449Ile)	CACNB2|NSUN6	Brugada syndrome 4|Cardiac arrhythmia|Brugada syndrome|not provided|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00158(T)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 7, 2016)	criteria provided, conflicting interpretations	10	18539252	GRCh38	161212	171122
NM_201590.2(CACNB2):c.1359C>T (p.Ser453=)	CACNB2|NSUN6	Brugada syndrome 4|Cardiovascular phenotype	GMAF:0.00280(T), GO-ESP:0.00447(T)	Benign/Likely benign(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	10	18539262	GRCh38	242261	240757
NM_201590.2(CACNB2):c.1391A>C (p.Glu464Ala)	CACNB2|NSUN6	not specified|Cardiovascular phenotype	GMAF:0.00060(C), GO-ESP:0.00023(C)	Uncertain significance(Last reviewed: Oct 23, 2015)	criteria provided, multiple submitters, no conflicts	10	18539294	GRCh38	190728	188484
NM_201590.2(CACNB2):c.1398T>C (p.Pro466=)	CACNB2|NSUN6	Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00100(C), GO-ESP:0.00092(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	18539301	GRCh38	136647	140350
NM_201590.2(CACNB2):c.1430G>A (p.Arg477His)	CACNB2|NSUN6	not provided	GMAF:0.00040(A), GO-ESP:0.00007(A)	Likely pathogenic(Last reviewed: Mar 26, 2014)	criteria provided, single submitter	10	18539333	GRCh38	190729	188485
NM_000724.3(CACNB2):c.1429T>G (p.Ser477Ala)	CACNB2|NSUN6	Cardiac arrest		Uncertain significance(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	10	18539335	GRCh38	222520	224387
NM_201571.3(CACNB2):c.1558G>A (p.Gly520Ser)	CACNB2|NSUN6	not provided|Cardiac arrest	GO-ESP:0.00005(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 18, 2014)	criteria provided, conflicting interpretations	10	18539383	GRCh38	180290	178614
NM_201590.2(CACNB2):c.1508C>G (p.Ser503Trp)	CACNB2|NSUN6	Cardiovascular phenotype	GMAF:0.00140(T)	Uncertain significance(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	10	18539411	GRCh38	264509	258640
NM_201590.2(CACNB2):c.1508C>T (p.Ser503Leu)	CACNB2|NSUN6	Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00140(T), GO-ESP:0.00116(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	18539411	GRCh38	190730	188486
NM_201590.2(CACNB2):c.1534G>A (p.Ala512Thr)	CACNB2|NSUN6	not specified|not provided	GMAF:0.00100(A), GO-ESP:0.00082(A)	Uncertain significance(Last reviewed: Jun 13, 2016)	criteria provided, multiple submitters, no conflicts	10	18539437	GRCh38	190731	188487
NM_201590.2(CACNB2):c.1539C>T (p.Tyr513=)	CACNB2|NSUN6	Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.23720(T), GO-ESP:0.21286(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	18539442	GRCh38	263261	253717
NM_000724.3(CACNB2):c.1611C>A (p.Asp537Glu)	CACNB2|NSUN6	Brugada syndrome 4|Brugada syndrome|not specified|not provided	GMAF:0.00020(G), GO-ESP:0.00064(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 12, 2016)	criteria provided, conflicting interpretations	10	18539517	GRCh38	161213	171123
NM_201590.2(CACNB2):c.1679G>A (p.Arg560Gln)	CACNB2|NSUN6	not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Nov 18, 2014)	criteria provided, single submitter	10	18539582	GRCh38	190737	188490
NM_201590.2(CACNB2):c.1759G>A (p.Val587Met)	CACNB2|NSUN6	not specified		Uncertain significance(Last reviewed: Jun 27, 2015)	criteria provided, single submitter	10	18539662	GRCh38	190732	188491
NM_201590.2(CACNB2):c.1803T>G (p.Asp601Glu)	CACNB2|NSUN6	Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.09700(G), GO-ESP:0.13817(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	18539706	GRCh38	136649	140352
NM_000724.3(CACNB2):c.1810C>T (p.Arg604Cys)	CACNB2|NSUN6	Cardiac arrhythmia	GMAF:0.00100(T), GO-ESP:0.00033(T)	Likely benign(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	10	18539716	GRCh38	190718	188492
NM_006393.2(NEBL):c.2616G>T (p.Lys872Asn)	NEBL	Sudden cardiac death		Uncertain significance(Last reviewed: Jan 28, 2015)	criteria provided, single submitter	10	20808655	GRCh38	222752	224388
NM_006393.2(NEBL):c.2260C>G (p.His754Asp)	NEBL	not specified		Uncertain significance(Last reviewed: Jul 1, 2015)	no assertion criteria provided	10	20814025	GRCh38	235040	236777
NM_006393.2(NEBL):c.1775C>A (p.Ala592Glu)	NEBL	Primary dilated cardiomyopathy|not specified	GO-ESP:0.00131(T), GMAF:0.00040(T), GO-ESP:0.00026(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 7, 2016)	criteria provided, conflicting interpretations	10	20828531	GRCh38	45485	54651
NM_006393.2(NEBL):c.604G>A (p.Gly202Arg)	NEBL	not specified	GO-ESP:0.00177(T), GMAF:0.00140(T), GO-ESP:0.00213(T)	Uncertain significance(Last reviewed: Sep 23, 2016)	criteria provided, multiple submitters, no conflicts	10	20868744	GRCh38	45499	54665
NM_006393.2(NEBL):c.180G>C (p.Lys60Asn)	NEBL	Primary dilated cardiomyopathy|not specified	GO-ESP:0.00515(G), GMAF:0.00140(G), GO-ESP:0.00386(G)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2016)	criteria provided, conflicting interpretations	10	20889923	GRCh38	45486	54652
NM_006393.2(NEBL):c.82-4A>G	NEBL	not specified	GO-ESP:0.00023(C)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2015)	criteria provided, conflicting interpretations	10	20897033	GRCh38	164771	174919
NM_014317.4(PDSS1):c.924T>G (p.Asp308Glu)	PDSS1	Coenzyme Q10 deficiency, primary, 2		Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	10	26735477	GRCh38	3237	18276
NM_006258.3(PRKG1):c.426C>T (p.Asp142=)	PRKG1	Thoracic aortic aneurysm and aortic dissection|Aortic aneurysm, familial thoracic 8	GMAF:0.00100(T), GO-ESP:0.00389(T)	Benign/Likely benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	10	51153278	GRCh38	240642	240817
NM_001098512.2(PRKG1):c.530G>A (p.Arg177Gln)	PRKG1	Thoracic aortic aneurysm and aortic dissection|Aortic aneurysm, familial thoracic 8		Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, multiple submitters, no conflicts	10	51467819	GRCh38	65477	76388
NM_006258.3(PRKG1):c.676G>A (p.Glu226Lys)	PRKG1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Feb 6, 2015)	criteria provided, single submitter	10	51804668	GRCh38	263903	258641
NM_006258.3(PRKG1):c.888T>C (p.Leu296=)	PRKG1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.02120(C), GO-ESP:0.00637(C)	Benign(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	10	52062584	GRCh38	263893	258642
NM_006258.3(PRKG1):c.1008T>C (p.Phe336=)	PRKG1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.07130(C), GO-ESP:0.02418(C)	Benign(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	10	52161895	GRCh38	263888	258643
NM_006258.3(PRKG1):c.1071A>G (p.Lys357=)	PRKG1	Thoracic aortic aneurysm and aortic dissection|Aortic aneurysm, familial thoracic 8	GMAF:0.00020(G), GO-ESP:0.00075(G)	Benign/Likely benign(Last reviewed: Dec 21, 2015)	criteria provided, multiple submitters, no conflicts	10	52161958	GRCh38	240638	240818
NM_006258.3(PRKG1):c.1173+4G>A	PRKG1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	10	52251670	GRCh38	264425	258644
NM_006258.3(PRKG1):c.1299C>T (p.Ser433=)	PRKG1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00180(T), GO-ESP:0.00037(T)	Likely benign(Last reviewed: May 21, 2015)	criteria provided, single submitter	10	52271475	GRCh38	264029	258652
NM_001098512.2(PRKG1):c.1421A>T (p.Tyr474Phe)	PRKG1	Thoracic aortic aneurysm and aortic dissection|Aortic aneurysm, familial thoracic 8	GMAF:0.00020(T), GO-ESP:0.00025(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 14, 2015)	criteria provided, conflicting interpretations	10	52280851	GRCh38	210010	206601
NM_006258.3(PRKG1):c.1811A>C (p.Asn604Thr)	PRKG1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	10	52288827	GRCh38	264097	258647
NM_032578.3(MYPN):c.59A>G (p.Tyr20Cys)	MYPN	Primary dilated cardiomyopathy|not specified|not provided|Dilated cardiomyopathy 1KK|Familial hypertrophic cardiomyopathy 22|Cardiovascular phenotype	GO-ESP:0.00092(G), GMAF:0.00100(G), GO-ESP:0.00092(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: May 31, 2016)	criteria provided, conflicting interpretations	10	68121497	GRCh38	31811	40471
NM_032578.3(MYPN):c.65C>G (p.Ala22Gly)	MYPN	not specified|Cardiovascular phenotype	GMAF:0.00040(G), GO-ESP:0.00020(G)	Uncertain significance(Last reviewed: Apr 13, 2015)	criteria provided, multiple submitters, no conflicts	10	68121503	GRCh38	229037	229826
NM_032578.3(MYPN):c.628_630delTCT (p.Ser210del)	MYPN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	10	68122066 - 68122068	GRCh38	264245	258645
NM_032578.3(MYPN):c.734C>G (p.Ala245Gly)	MYPN	not specified|Dilated cardiomyopathy 1KK|Cardiovascular phenotype	GMAF:0.00100(G), GO-ESP:0.00024(G)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2015)	criteria provided, conflicting interpretations	10	68122172	GRCh38	227722	229828
NM_032578.3(MYPN):c.843A>G (p.Pro281=)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.03514(G), GMAF:0.03690(G), GO-ESP:0.01037(G)	Benign(Last reviewed: Jul 8, 2015)	criteria provided, multiple submitters, no conflicts	10	68122281	GRCh38	31826	40486
NM_032578.3(MYPN):c.845A>G (p.Glu282Gly)	MYPN	Cardiomyopathy|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00016(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2014)	criteria provided, conflicting interpretations	10	68122283	GRCh38	201881	198262
NM_032578.3(MYPN):c.903-4G>T	MYPN	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 21, 2015)	criteria provided, single submitter	10	68142936	GRCh38	264092	258646
NM_032578.3(MYPN):c.1122G>A (p.Glu374=)	MYPN	not specified|Cardiovascular phenotype	GMAF:0.00120(A), GO-ESP:0.00031(A)	Benign/Likely benign(Last reviewed: Jul 1, 2015)	criteria provided, multiple submitters, no conflicts	10	68145518	GRCh38	226840	229830
NM_032578.3(MYPN):c.1130G>A (p.Arg377Gln)	MYPN	not specified|not provided|Dilated cardiomyopathy 1KK|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00049(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 11, 2016)	criteria provided, conflicting interpretations	10	68145526	GRCh38	191749	189847
NM_032578.3(MYPN):c.1178T>C (p.Val393Ala)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.12225(C), GMAF:0.12060(C), GO-ESP:0.04524(C)	Benign(Last reviewed: Jun 19, 2015)	criteria provided, multiple submitters, no conflicts	10	68148400	GRCh38	31793	40453
NM_032578.3(MYPN):c.1251G>A (p.Gln417=)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.10857(A), GMAF:0.08430(A), GO-ESP:0.08446(A)	Benign(Last reviewed: Jun 12, 2015)	criteria provided, multiple submitters, no conflicts	10	68150045	GRCh38	31794	40454
NM_032578.3(MYPN):c.1293C>A (p.Ile431=)	MYPN	not specified|Cardiovascular phenotype	GMAF:0.00200(A), GO-ESP:0.00078(A)	Likely benign(Last reviewed: Sep 25, 2015)	criteria provided, multiple submitters, no conflicts	10	68150087	GRCh38	198273	195434
NM_032578.3(MYPN):c.1399G>A (p.Glu467Lys)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.04936(A), GMAF:0.04850(A), GO-ESP:0.01370(A)	Benign(Last reviewed: Jun 26, 2015)	criteria provided, multiple submitters, no conflicts	10	68158567	GRCh38	31827	40487
NM_032578.3(MYPN):c.1585C>T (p.Gln529Ter)	MYPN	not provided|Cardiomyopathy, familial restrictive, 4		Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	10	68165803	GRCh38	31816	40476
NM_032578.3(MYPN):c.1647T>C (p.Ser549=)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.57866(C), GMAF:0.48260(C)	Benign(Last reviewed: Jun 12, 2015)	criteria provided, multiple submitters, no conflicts	10	68166340	GRCh38	31795	40455
NM_032578.3(MYPN):c.1790G>A (p.Arg597His)	MYPN	not specified|not provided|Dilated cardiomyopathy 1KK	GMAF:0.00160(A), GO-ESP:0.00045(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2016)	criteria provided, conflicting interpretations	10	68166483	GRCh38	192125	189849
NM_032578.3(MYPN):c.1869C>A (p.Thr623=)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.12610(A), GMAF:0.11660(A), GO-ESP:0.15649(A)	Benign(Last reviewed: Jun 12, 2015)	criteria provided, multiple submitters, no conflicts	10	68166562	GRCh38	31803	40463
NM_032578.3(MYPN):c.1875C>T (p.Pro625=)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.17231(T), GMAF:0.15780(T), GO-ESP:0.18091(T)	Benign(Last reviewed: Jun 12, 2015)	criteria provided, multiple submitters, no conflicts	10	68166568	GRCh38	31796	40456
NM_032578.3(MYPN):c.1884C>G (p.Phe628Leu)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.39597(G), GMAF:0.31650(G), GO-ESP:0.43825(G)	Benign(Last reviewed: Jun 16, 2015)	criteria provided, multiple submitters, no conflicts	10	68166577	GRCh38	31804	40464
NM_032578.3(MYPN):c.1935C>T (p.Pro645=)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00054(T), GMAF:0.00060(T), GO-ESP:0.00074(T)	Likely benign(Last reviewed: Oct 20, 2015)	criteria provided, multiple submitters, no conflicts	10	68166628	GRCh38	31805	40465
NM_032578.3(MYPN):c.1977T>C (p.Asp659=)	MYPN	Cardiovascular phenotype		Likely benign(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	10	68174069	GRCh38	264514	258658
NM_032578.3(MYPN):c.2072G>A (p.Ser691Asn)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.39243(A), GMAF:0.33590(A), GO-ESP:0.43077(A)	Benign(Last reviewed: Jun 16, 2015)	criteria provided, multiple submitters, no conflicts	10	68174164	GRCh38	31797	40457
NM_032578.3(MYPN):c.2120G>A (p.Ser707Asn)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.39236(A), GMAF:0.32510(A), GO-ESP:0.42584(A)	Benign(Last reviewed: Jun 16, 2015)	criteria provided, multiple submitters, no conflicts	10	68174212	GRCh38	31798	40458
NM_032578.3(MYPN):c.2163C>A (p.Ala721=)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.04336(A), GMAF:0.04290(A), GO-ESP:0.02384(A)	Benign(Last reviewed: Jun 19, 2015)	criteria provided, multiple submitters, no conflicts	10	68174255	GRCh38	31806	40466
NM_032578.3(MYPN):c.2409C>G (p.Ser803Arg)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.52299(G), GMAF:0.47150(G)	Benign(Last reviewed: Jun 12, 2015)	criteria provided, multiple submitters, no conflicts	10	68174501	GRCh38	31808	40468
NM_032578.3(MYPN):c.2410G>A (p.Gly804Arg)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.02453(A), GMAF:0.01040(A), GO-ESP:0.01838(A)	Benign(Last reviewed: Jul 15, 2015)	criteria provided, multiple submitters, no conflicts	10	68174502	GRCh38	31809	40469
NM_032578.3(MYPN):c.2550A>G (p.Arg850=)	MYPN	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	10	68174642	GRCh38	264273	258650
NM_032578.3(MYPN):c.2654G>A (p.Arg885Gln)	MYPN	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	10	68175412	GRCh38	264161	258648
NM_032578.3(MYPN):c.2802T>A (p.His934Gln)	MYPN	Cardiovascular phenotype	GO-ESP:0.00022(A)	Uncertain significance(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	10	68189003	GRCh38	263796	258649
NM_032578.3(MYPN):c.2863C>T (p.Arg955Trp)	MYPN	not specified|not provided|Dilated cardiomyopathy 1KK	GMAF:0.00020(T), GO-ESP:0.00043(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 2, 2016)	criteria provided, conflicting interpretations	10	68189064	GRCh38	192126	189855
NM_032578.3(MYPN):c.2864G>A (p.Arg955Gln)	MYPN	not specified|not provided	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Dec 8, 2015)	criteria provided, multiple submitters, no conflicts	10	68189065	GRCh38	31831	40491
NM_032578.3(MYPN):c.2880T>G (p.Ser960=)	MYPN	not specified|Dilated cardiomyopathy 1KK|Cardiovascular phenotype	GMAF:0.00060(G), GO-ESP:0.00031(G)	Benign/Likely benign(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	10	68189081	GRCh38	227718	229839
NM_032578.3(MYPN):c.2882C>T (p.Pro961Leu)	MYPN	Dilated cardiomyopathy 1KK		Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2013)	no assertion criteria provided	10	68189083	GRCh38	50512	59549
NM_032578.3(MYPN):c.3017T>G (p.Ile1006Ser)	MYPN	Dilated cardiomyopathy 1KK|Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	10	68194454	GRCh38	220980	221986
NM_032578.3(MYPN):c.3086G>T (p.Ser1029Ile)	MYPN	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	10	68195460	GRCh38	264524	258659
NM_001256267.1(MYPN):c.3124C>T (p.Arg1042Cys)	MYPN	Primary familial hypertrophic cardiomyopathy|Dilated cardiomyopathy 1KK|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00040(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2015)	criteria provided, conflicting interpretations	10	68195498	GRCh38	155824	165576
NM_032578.3(MYPN):c.3146G>A (p.Gly1049Asp)	MYPN	Dilated cardiomyopathy 1KK|Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 1, 2016)	criteria provided, multiple submitters, no conflicts	10	68195520	GRCh38	241709	240837
NM_032578.3(MYPN):c.3263G>A (p.Arg1088His)	MYPN	not provided|Dilated cardiomyopathy 1KK	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	10	68197456	GRCh38	31790	40450
NM_032578.3(MYPN):c.3335C>T (p.Pro1112Leu)	MYPN	Primary dilated cardiomyopathy|not specified|not provided|Dilated cardiomyopathy 1KK|Familial hypertrophic cardiomyopathy 22|Dilated cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00208(T), GMAF:0.00260(T), GO-ESP:0.00303(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 29, 2016)	criteria provided, conflicting interpretations	10	68199417	GRCh38	31791	40451
NM_032578.3(MYPN):c.3403C>A (p.Pro1135Thr)	MYPN	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.40589(A), GMAF:0.34030(A), GO-ESP:0.43228(A)	Benign(Last reviewed: Jun 16, 2015)	criteria provided, multiple submitters, no conflicts	10	68199485	GRCh38	31800	40460
NM_032578.3(MYPN):c.3417C>T (p.Arg1139=)	MYPN	not specified|Cardiovascular phenotype	GO-ESP:0.00008(T), GMAF:0.00180(G)	Benign/Likely benign(Last reviewed: Jun 26, 2015)	criteria provided, multiple submitters, no conflicts	10	68199499	GRCh38	194792	191955
NM_032578.3(MYPN):c.3481C>A (p.Leu1161Ile)	MYPN	Cardiomyopathy|not specified|not provided|Dilated cardiomyopathy 1KK|Cardiovascular phenotype	GO-ESP:0.00023(A), GMAF:0.00220(A), GO-ESP:0.00330(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 11, 2016)	criteria provided, conflicting interpretations	10	68199563	GRCh38	31819	40479
NM_001256267.1(MYPN):c.3580C>T (p.Arg1194Cys)	MYPN	not specified|Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Oct 16, 2013)	criteria provided, single submitter	10	68201915	GRCh38	235039	236778
NM_032578.3(MYPN):c.3653G>A (p.Arg1218Lys)	MYPN	Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Sep 10, 2013)	criteria provided, single submitter	10	68201988	GRCh38	263734	258653
NM_032578.3(MYPN):c.3833G>A (p.Arg1278Gln)	MYPN	not specified|not provided|Dilated cardiomyopathy 1KK|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00046(A)	Uncertain significance(Last reviewed: Dec 1, 2015)	criteria provided, multiple submitters, no conflicts	10	68210325	GRCh38	191759	189860
NM_032578.3(MYPN):c.3935G>A (p.Arg1312Gln)	MYPN	Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	10	68210427	GRCh38	264277	258651
NM_018055.4(NODAL):c.891+1G>A	NODAL	Visceral heterotaxy 5, autosomal		Likely pathogenic(Last reviewed: Mar 5, 2016)	criteria provided, single submitter	10	70435285	GRCh38	241245	240839
NM_018055.4(NODAL):c.778G>A (p.Gly260Arg)	NODAL	Visceral heterotaxy 5, autosomal	GO-ESP:0.00035(T)	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	10	70435399	GRCh38	8269	23308
NM_004273.4(CHST3):c.475T>A (p.Phe159Ile)	CHST3	Spondyloepiphyseal dysplasia with congenital joint dislocations	GO-ESP:0.00008(A), GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	10	72007506	GRCh38	6049	21088
NM_014000.2(VCL):c.339G>A (p.Arg113=)	VCL	Cardiomyopathy|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.07389(A), GMAF:0.07170(A), GO-ESP:0.02056(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	74070769	GRCh38	36897	45558
NM_014000.2(VCL):c.492T>G (p.Leu164=)	VCL	Dilated cardiomyopathy 1W|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00026(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	74071076	GRCh38	166536	175290
NM_014000.2(VCL):c.590C>T (p.Thr197Ile)	VCL	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00023(T), GMAF:0.00020(T), GO-ESP:0.00023(T)	Uncertain significance(Last reviewed: Dec 8, 2015)	criteria provided, multiple submitters, no conflicts	10	74072820	GRCh38	45617	54783
NM_014000.2(VCL):c.731T>A (p.Ile244Lys)	VCL	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 21, 2012)	criteria provided, single submitter	10	74074851	GRCh38	263474	258654
NM_014000.2(VCL):c.768T>C (p.Asp256=)	VCL	Cardiomyopathy|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.07412(C), GMAF:0.07250(C), GO-ESP:0.02066(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	74074888	GRCh38	36898	45559
NM_014000.2(VCL):c.945C>A (p.Gly315=)	VCL	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.03060(A), GMAF:0.02740(A), GO-ESP:0.00861(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	74083436	GRCh38	45622	54788
NM_014000.2(VCL):c.1223T>C (p.Ile408Thr)	VCL	Dilated cardiomyopathy 1W|Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 1, 2016)	criteria provided, multiple submitters, no conflicts	10	74090069	GRCh38	240876	240843
NM_014000.2(VCL):c.1237G>A (p.Ala413Thr)	VCL	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00023(A), GMAF:0.00020(A), GO-ESP:0.00024(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2015)	criteria provided, conflicting interpretations	10	74090083	GRCh38	45575	54741
NM_014000.2(VCL):c.1317T>C (p.Ser439=)	VCL	Dilated cardiomyopathy 1W|not specified|Cardiovascular phenotype	GO-ESP:0.00392(C), GMAF:0.00200(C), GO-ESP:0.00419(C)	Benign(Last reviewed: Mar 13, 2016)	criteria provided, multiple submitters, no conflicts	10	74090163	GRCh38	45577	54743
NM_014000.2(VCL):c.1382C>G (p.Ala461Gly)	VCL	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 26, 2012)	criteria provided, single submitter	10	74094300	GRCh38	263421	258660
NM_014000.2(VCL):c.1407C>T (p.Ala469=)	VCL	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.07312(T), GMAF:0.06970(T), GO-ESP:0.02304(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	74094325	GRCh38	45579	54745
NM_014000.2(VCL):c.1506G>A (p.Arg502=)	VCL	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.07297(A), GMAF:0.06950(A), GO-ESP:0.02362(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	74094424	GRCh38	45580	54746
NM_014000.2(VCL):c.1555A>C (p.Ile519Leu)	VCL	Cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00115(C), GMAF:0.00020(C), GO-ESP:0.00072(C)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2016)	criteria provided, conflicting interpretations	10	74095667	GRCh38	45582	54748
NM_014000.2(VCL):c.1557C>A (p.Ile519=)	VCL	Dilated cardiomyopathy 1W|not specified|Cardiovascular phenotype	GO-ESP:0.00438(A), GMAF:0.00680(A), GO-ESP:0.00143(A)	Benign(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	10	74095669	GRCh38	45583	54749
NM_014000.2(VCL):c.1621C>G (p.Leu541Val)	VCL	Cardiovascular phenotype	GO-ESP:0.00009(G)	Uncertain significance(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	10	74095733	GRCh38	263345	258656
NM_014000.2(VCL):c.1671C>T (p.Asp557=)	VCL	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00100(T), GMAF:0.00320(T), GO-ESP:0.00511(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	74095783	GRCh38	45587	54753
NM_014000.2(VCL):c.1716T>G (p.Leu572=)	VCL	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(G), GO-ESP:0.00061(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	74095828	GRCh38	45588	54754
NM_014000.2(VCL):c.1856C>A (p.Ala619Glu)	VCL	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	10	74097316	GRCh38	264420	258655
NM_014000.2(VCL):c.1907A>G (p.His636Arg)	VCL	Dilated cardiomyopathy 1W|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00092(G), GMAF:0.00040(G), GO-ESP:0.00149(G)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 10, 2016)	criteria provided, conflicting interpretations	10	74100982	GRCh38	45594	54760
NM_014000.2(VCL):c.2000C>T (p.Thr667Met)	VCL	not specified		Uncertain significance(Last reviewed: Nov 12, 2012)	criteria provided, single submitter	10	74101075	GRCh38	202146	198300
NM_014000.2(VCL):c.2025G>A (p.Val675=)	VCL	Dilated cardiomyopathy 1W|Cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00300(A), GMAF:0.00020(A), GO-ESP:0.00254(A)	Benign/Likely benign(Last reviewed: Feb 9, 2016)	criteria provided, multiple submitters, no conflicts	10	74103822	GRCh38	36896	45557
NM_014000.2(VCL):c.2046A>T (p.Leu682Phe)	VCL	not specified|Cardiovascular phenotype	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Jul 20, 2015)	criteria provided, multiple submitters, no conflicts	10	74103843	GRCh38	166551	175019
NM_014000.2(VCL):c.2388G>A (p.Pro796=)	VCL	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.43872(A), GMAF:0.32470(A), GO-ESP:0.47612(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	74105307	GRCh38	45595	54761
NM_014000.2(VCL):c.2418A>G (p.Gly806=)	VCL	Cardiovascular phenotype	GMAF:0.03650(G), GO-ESP:0.00007(G)	Likely benign(Last reviewed: Aug 15, 2012)	criteria provided, single submitter	10	74105337	GRCh38	263378	258657
NM_014000.2(VCL):c.2521G>C (p.Asp841His)	VCL	not specified|not provided|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00400(C), GO-ESP:0.00099(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	74107316	GRCh38	192106	189869
NM_014000.2(VCL):c.2801C>T (p.Ala934Val)	VCL	not specified|not provided|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00046(T), GMAF:0.02180(T), GO-ESP:0.01213(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	74111964	GRCh38	45599	54765
NM_014000.2(VCL):c.2814C>G (p.Gly938=)	VCL	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.76242(G), GMAF:0.37700(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	74111977	GRCh38	45600	54766
NM_014000.2(VCL):c.2827C>G (p.Pro943Ala)	VCL	Dilated cardiomyopathy 1W|not provided|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2016)	criteria provided, conflicting interpretations	10	74111990	GRCh38	192181	189870
NM_014000.2(VCL):c.2875A>C (p.Asn959His)	VCL	Cardiovascular phenotype	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Apr 23, 2015)	criteria provided, single submitter	10	74112038	GRCh38	263962	258661
NM_014000.2(VCL):c.2923C>T (p.Arg975Trp)	VCL	Dilated cardiomyopathy 1W|Familial hypertrophic cardiomyopathy 15	GO-ESP:0.00008(T), GMAF:0.00020(T), GO-ESP:0.00013(T)	Pathogenic(Last reviewed: Oct 20, 2006)	no assertion criteria provided	10	74112086	GRCh38	12197	27236
NM_014000.2(VCL):c.2969C>T (p.Ala990Val)	VCL	not specified|Cardiovascular phenotype	GO-ESP:0.00031(T), GO-ESP:0.00041(T)	Uncertain significance(Last reviewed: Jul 21, 2016)	criteria provided, multiple submitters, no conflicts	10	74114203	GRCh38	45603	54769
NM_014000.2(VCL):c.3333T>C (p.Ala1111=)	VCL	not specified|Cardiovascular phenotype	GMAF:0.00040(C), GO-ESP:0.00064(C)	Benign/Likely benign(Last reviewed: Jul 15, 2015)	criteria provided, multiple submitters, no conflicts	10	74118097	GRCh38	137901	141604
NM_007078.2(LDB3):c.529dupG (p.Ala177Glyfs)	LDB3	not specified|not provided		Uncertain significance(Last reviewed: Aug 11, 2014)	criteria provided, multiple submitters, no conflicts	10	86681643	GRCh38	178668	175311
NM_001080116.1(LDB3):c.321+1523C>T	LDB3	Dilated cardiomyopathy 1C|Myofibrillar myopathy, ZASP-related|not specified|not provided|Familial hypertrophic cardiomyopathy 24	GO-ESP:0.00015(T), GMAF:0.00060(T), GO-ESP:0.00057(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 2, 2016)	criteria provided, conflicting interpretations	10	86681680	GRCh38	4731	19770
NM_001080116.1(LDB3):c.349G>A (p.Asp117Asn)	LDB3	Dilated cardiomyopathy 1C|Myofibrillar myopathy, ZASP-related|not specified|not provided|Dilated cardiomyopathy	GO-ESP:0.00677(A), GMAF:0.00780(A), GO-ESP:0.00455(A)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2016)	criteria provided, conflicting interpretations	10	86687073	GRCh38	4733	19772
NM_007078.2(LDB3):c.690-4733G>A	LDB3	Myofibrillar myopathy, ZASP-related|not provided		Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	10	86687163	GRCh38	4727	19766
NM_001080114.1(LDB3):c.494C>T (p.Ala165Val)	LDB3	Primary dilated cardiomyopathy|Myofibrillar myopathy, ZASP-related|Myofibrillar myopathy	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Aug 16, 2016)	no assertion criteria provided	10	86687218	GRCh38	4728	19767
NM_001080116.1(LDB3):c.802C>T (p.Arg268Cys)	LDB3	Myofibrillar myopathy, ZASP-related|not specified	GO-ESP:0.00008(T), GO-ESP:0.00007(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 10, 2014)	criteria provided, conflicting interpretations	10	86699324	GRCh38	4729	19768
NM_007078.2(LDB3):c.1609delC (p.Gln537Argfs)	LDB3	not specified		Uncertain significance(Last reviewed: Dec 18, 2013)	criteria provided, single submitter	10	86716704	GRCh38	163850	175323
NM_007078.2(LDB3):c.1823C>T (p.Pro608Leu)	LDB3	not specified|Familial hypertrophic cardiomyopathy 24	GO-ESP:0.00023(T), GO-ESP:0.00009(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2014)	criteria provided, conflicting interpretations	10	86718110	GRCh38	45533	54699
NM_007078.2(LDB3):c.2017G>A (p.Asp673Asn)	LDB3	Dilated cardiomyopathy 1C|Left ventricular noncompaction 3	GMAF:0.00060(A), GO-ESP:0.00017(A)	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	10	86726175	GRCh38	4735	19774
NM_004329.2(BMPR1A):c.1433G>A (p.Arg478His)	BMPR1A	Juvenile polyposis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	GO-ESP:0.00023(A), GO-ESP:0.00014(A)	Uncertain significance(Last reviewed: Oct 5, 2016)	criteria provided, multiple submitters, no conflicts	10	86923466	GRCh38	41780	50219
NM_001613.2(ACTA2):c.977C>A (p.Thr326Asn)	ACTA2|ACTA2-AS1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00013(T)	Uncertain significance(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	10	88938074	GRCh38	263430	258662
NM_001613.2(ACTA2):c.940C>T (p.Arg314Ter)	ACTA2|ACTA2-AS1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	10	88938111	GRCh38	263926	258663
NM_001613.2(ACTA2):c.936C>T (p.Ala312=)	ACTA2|ACTA2-AS1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00016(A)	Likely benign(Last reviewed: Oct 3, 2014)	criteria provided, single submitter	10	88938115	GRCh38	263863	258664
NM_001613.2(ACTA2):c.896A>G (p.Asn299Ser)	ACTA2|ACTA2-AS1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jul 2, 2014)	criteria provided, single submitter	10	88938155	GRCh38	263843	258665
NM_001613.2(ACTA2):c.772C>T (p.Arg258Cys)	ACTA2|ACTA2-AS1	Aortic aneurysm, familial thoracic 6|Moyamoya disease 5|Thoracic aortic aneurysm and aortic dissection		Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	10	88939543	GRCh38	18278	33317
NM_001613.2(ACTA2):c.767G>A (p.Arg256His)	ACTA2|ACTA2-AS1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 7, 2015)	criteria provided, single submitter	10	88939548	GRCh38	264363	258666
NM_001613.2(ACTA2):c.766C>T (p.Arg256Cys)	ACTA2|ACTA2-AS1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 29, 2013)	criteria provided, single submitter	10	88939549	GRCh38	263578	258667
NM_001613.2(ACTA2):c.593G>A (p.Arg198His)	ACTA2	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	10	88941252	GRCh38	264311	258668
NM_001613.2(ACTA2):c.592C>T (p.Arg198Cys)	ACTA2	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	10	88941253	GRCh38	263819	258670
NM_001613.2(ACTA2):c.591G>T (p.Glu197Asp)	ACTA2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	10	88941254	GRCh38	264095	258669
NM_001613.2(ACTA2):c.536G>A (p.Arg179His)	ACTA2	Aortic aneurysm, familial thoracic 6|Multisystemic smooth muscle dysfunction syndrome|Moyamoya disease 5|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, multiple submitters, no conflicts	10	88941309	GRCh38	29598	38552
NM_001613.2(ACTA2):c.496C>A (p.Pro166Thr)	ACTA2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	10	88941349	GRCh38	263639	258671
NM_001613.2(ACTA2):c.445C>T (p.Arg149Cys)	ACTA2	Aortic aneurysm, familial thoracic 6|Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jul 14, 2014)	criteria provided, single submitter	10	88941794	GRCh38	18276	33315
NM_001613.2(ACTA2):c.420G>A (p.Ala140=)	ACTA2	Multisystemic smooth muscle dysfunction syndrome|Thoracic aortic aneurysm and aortic dissection|Moyamoya disease	GO-ESP:0.00006(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	88941819	GRCh38	264091	258672
NM_001613.2(ACTA2):c.323C>T (p.Thr108Met)	ACTA2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 24, 2012)	criteria provided, single submitter	10	88943843	GRCh38	263402	258673
NM_001613.2(ACTA2):c.83C>T (p.Ala28Val)	ACTA2	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 2, 2013)	criteria provided, single submitter	10	88948848	GRCh38	263583	258674
NM_001613.2(ACTA2):c.78C>T (p.Asp26=)	ACTA2	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00016(A)	Likely benign(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	10	88948853	GRCh38	263386	258675
NM_014391.2(ANKRD1):c.949G>C (p.Ala317Pro)	ANKRD1	Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: May 20, 2015)	criteria provided, single submitter	10	90912877	GRCh38	264067	258676
NM_014391.2(ANKRD1):c.827C>T (p.Ala276Val)	ANKRD1	Cardiomyopathy|not specified|Dilated cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00415(A), GMAF:0.00020(A), GO-ESP:0.00286(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 25, 2015)	criteria provided, conflicting interpretations	10	90915565	GRCh38	45639	54804
NM_014391.2(ANKRD1):c.751-4C>A	ANKRD1	Cardiovascular phenotype	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	10	90915645	GRCh38	264542	258677
NM_014391.2(ANKRD1):c.651+4T>A	ANKRD1	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Dec 4, 2015)	criteria provided, single submitter	10	90916167	GRCh38	264598	258678
NM_014391.2(ANKRD1):c.348G>A (p.Thr116=)	ANKRD1	ANKRD1-related dilated cardiomyopathy|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00023(T), GMAF:0.01420(T), GO-ESP:0.01246(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	90918970	GRCh38	45633	54798
NM_014391.2(ANKRD1):c.347C>T (p.Thr116Met)	ANKRD1	not specified|Cardiovascular phenotype	GMAF:0.00080(A), GO-ESP:0.00015(A)	Uncertain significance(Last reviewed: Sep 9, 2015)	criteria provided, multiple submitters, no conflicts	10	90918971	GRCh38	228439	229953
NM_014391.2(ANKRD1):c.222dupA (p.Leu75Thrfs)	ANKRD1	ANKRD1-related dilated cardiomyopathy|not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 2, 2016)	criteria provided, multiple submitters, no conflicts	10	90919254	GRCh38	201670	198351
NM_014391.2(ANKRD1):c.197G>A (p.Arg66Gln)	ANKRD1	ANKRD1-related dilated cardiomyopathy|not specified|Dilated cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00069(T), GMAF:0.00040(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2016)	criteria provided, conflicting interpretations	10	90920179	GRCh38	45628	54793
NM_014391.2(ANKRD1):c.154C>G (p.Pro52Ala)	ANKRD1	Cardiovascular phenotype	GO-ESP:0.00011(C)	Uncertain significance(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	10	90920222	GRCh38	263990	258679
NM_014391.2(ANKRD1):c.150C>G (p.Ala50=)	ANKRD1	ANKRD1-related dilated cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00200(C), GO-ESP:0.00170(C)	Benign/Likely benign(Last reviewed: Mar 8, 2016)	criteria provided, multiple submitters, no conflicts	10	90920226	GRCh38	178005	175330
NM_014391.2(ANKRD1):c.148G>C (p.Ala50Pro)	ANKRD1	ANKRD1-related dilated cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00346(G), GMAF:0.00360(G), GO-ESP:0.00110(G)	Benign(Last reviewed: Feb 24, 2016)	criteria provided, multiple submitters, no conflicts	10	90920228	GRCh38	45625	54790
NM_004376.6(COX15):c.649C>T (p.Arg217Trp)	COX15	Congenital myasthenic syndrome, acetazolamide-responsive|Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	GO-ESP:0.00008(A), GO-ESP:0.00003(A)	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	10	99724057	GRCh38	6175	21214
NM_021830.4(TWNK):c.1001G>A (p.Arg334Gln)	TWNK	Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic		Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	10	100989211	GRCh38	4623	19662
NM_001134363.2(RBM20):c.90G>A (p.Arg30=)	RBM20	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.22220(A), GO-ESP:0.15223(A)	Benign/Likely benign(Last reviewed: Jun 16, 2016)	criteria provided, multiple submitters, no conflicts	10	110644544	GRCh38	44029	53197
NM_001134363.2(RBM20):c.517C>A (p.Pro173Thr)	RBM20	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02146(A), GMAF:0.02700(A), GO-ESP:0.00727(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	110781126	GRCh38	44020	53188
NM_001134363.2(RBM20):c.532C>T (p.Arg178Ter)	RBM20	not specified		Uncertain significance(Last reviewed: Oct 10, 2014)	criteria provided, single submitter	10	110781141	GRCh38	202080	198190
NM_001134363.2(RBM20):c.533G>C (p.Arg178Pro)	RBM20	not specified|Cardiovascular phenotype	GMAF:0.00040(A)	Uncertain significance(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	10	110781142	GRCh38	235049	236774
NM_001134363.2(RBM20):c.695G>A (p.Gly232Asp)	RBM20	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02124(A), GMAF:0.02720(A), GO-ESP:0.00856(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	110781304	GRCh38	44025	53193
NM_001134363.2(RBM20):c.1183C>T (p.Gln395Ter)	RBM20	not provided		Pathogenic(Last reviewed: Jul 9, 2013)	criteria provided, single submitter	10	110781792	GRCh38	202056	198196
NM_001134363.2(RBM20):c.1348C>T (p.Arg450Trp)	RBM20	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	10	110784351	GRCh38	264341	258621
NM_001134363.2(RBM20):c.1364C>T (p.Ser455Leu)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|Cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00723(T), GMAF:0.00200(T), GO-ESP:0.00483(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 3, 2016)	criteria provided, conflicting interpretations	10	110784367	GRCh38	43971	53139
NM_001134363.2(RBM20):c.1455A>G (p.Ser485=)	RBM20	Cardiovascular phenotype	GO-ESP:0.00010(G)	Likely benign(Last reviewed: Mar 29, 2016)	criteria provided, single submitter	10	110784817	GRCh38	263443	258622
NM_001134363.2(RBM20):c.1807G>A (p.Gly603Arg)	RBM20	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Sep 10, 2013)	criteria provided, single submitter	10	110810389	GRCh38	263763	258623
NM_001134363.2(RBM20):c.1881-3C>T	RBM20	Dilated cardiomyopathy 1DD|not specified|Cardiovascular phenotype	GO-ESP:0.00571(T), GMAF:0.00480(T), GO-ESP:0.00218(T)	Benign/Likely benign(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	10	110812275	GRCh38	43979	53147
NM_001134363.2(RBM20):c.1901G>A (p.Arg634Gln)	RBM20	Dilated cardiomyopathy 1DD|not provided		Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, multiple submitters, no conflicts	10	110812298	GRCh38	269	15308
NM_001134363.2(RBM20):c.1914G>A (p.Pro638=)	RBM20	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.02000(A), GO-ESP:0.00721(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	110812311	GRCh38	43981	53149
NM_001134363.2(RBM20):c.1986G>A (p.Pro662=)	RBM20	Dilated cardiomyopathy 1DD|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00100(A), GO-ESP:0.00229(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	110812383	GRCh38	138900	142603
NM_001134363.2(RBM20):c.2131C>T (p.Arg711Cys)	RBM20	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 22, 2013)	criteria provided, single submitter	10	110812528	GRCh38	263478	258624
NM_001134363.2(RBM20):c.2201G>A (p.Arg734Gln)	RBM20	not specified|Cardiovascular phenotype	GO-ESP:0.00020(A)	Uncertain significance(Last reviewed: Jun 29, 2015)	criteria provided, multiple submitters, no conflicts	10	110812598	GRCh38	178112	174598
NM_001134363.2(RBM20):c.2303C= (p.Ser768=)	RBM20	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.99365(C), GMAF:0.00520(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	110812700	GRCh38	138901	142604
NM_001134363.2(RBM20):c.2303C>T (p.Ser768Leu)	RBM20	not specified|Cardiovascular phenotype	GO-ESP:0.00635(T), GMAF:0.00520(T), GO-ESP:0.00202(T)	Benign(Last reviewed: Sep 17, 2015)	criteria provided, multiple submitters, no conflicts	10	110812700	GRCh38	43988	53156
NM_001134363.2(RBM20):c.2318A>G (p.Lys773Arg)	RBM20	not specified|Cardiovascular phenotype	GMAF:0.00580(G), GO-ESP:0.00102(G)	Conflicting interpretations of pathogenicity(Last reviewed: May 27, 2015)	criteria provided, conflicting interpretations	10	110812715	GRCh38	199060	196219
NM_001134363.2(RBM20):c.2359G>A (p.Glu787Lys)	RBM20	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 9, 2013)	criteria provided, single submitter	10	110812756	GRCh38	263676	258625
NM_001134363.2(RBM20):c.2662G>A (p.Asp888Asn)	RBM20	Dilated cardiomyopathy 1DD|not specified|Dilated cardiomyopathy	GMAF:0.00080(A), GO-ESP:0.00284(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2016)	criteria provided, conflicting interpretations	10	110821281	GRCh38	43995	53163
NM_001134363.2(RBM20):c.2664T>C (p.Asp888=)	RBM20	not specified|Cardiovascular phenotype		Likely benign(Last reviewed: Dec 11, 2015)	criteria provided, multiple submitters, no conflicts	10	110821283	GRCh38	43996	53164
NM_001134363.2(RBM20):c.3023G>C (p.Arg1008Pro)	RBM20	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 10, 2013)	criteria provided, single submitter	10	110821642	GRCh38	263590	258626
NM_001134363.2(RBM20):c.3144C>T (p.Ser1048=)	RBM20	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01270(T), GMAF:0.01820(T), GO-ESP:0.00565(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	110821763	GRCh38	44003	53171
NM_001134363.2(RBM20):c.3171G>T (p.Arg1057=)	RBM20	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	10	110821790	GRCh38	263655	258627
NM_001134363.2(RBM20):c.3265C>G (p.Pro1089Ala)	RBM20	Cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00260(G), GO-ESP:0.00088(G)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 12, 2015)	criteria provided, conflicting interpretations	10	110821884	GRCh38	44006	53174
NM_001134363.2(RBM20):c.3373G>A (p.Glu1125Lys)	RBM20	Dilated cardiomyopathy 1DD|Cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00372(A), GMAF:0.00200(A), GO-ESP:0.00373(A)	Benign/Likely benign(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	10	110823536	GRCh38	44009	53177
NM_001134363.2(RBM20):c.3595G>A (p.Glu1199Lys)	RBM20	Cardiovascular phenotype	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	10	110835889	GRCh38	264207	258628
NM_001134363.2(RBM20):c.3648C>T (p.Ser1216=)	RBM20	Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(T), GO-ESP:0.00010(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	110835942	GRCh38	264328	258629
NM_001134363.2(RBM20):c.3667G>C (p.Glu1223Gln)	RBM20	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.75843(C), GMAF:0.30290(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	110835961	GRCh38	44016	53184
NM_007373.3(SHOC2):c.4A>G (p.Ser2Gly)	SHOC2	Noonan-like syndrome with loose anagen hair|Noonan syndrome|not provided|Rasopathy		Pathogenic/Likely pathogenic, not provided(Last reviewed: May 28, 2016)	criteria provided, multiple submitters, no conflicts	10	110964362	GRCh38	6821	21860
NM_004281.3(BAG3):c.212G>A (p.Arg71Gln)	BAG3	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.02299(A), GMAF:0.00740(A), GO-ESP:0.02012(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	119669882	GRCh38	44780	53947
NM_004281.3(BAG3):c.367C>T (p.Arg123Ter)	BAG3	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1HH|not provided|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00002(T)	Pathogenic/Likely pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, multiple submitters, no conflicts	10	119670037	GRCh38	30397	39354
NM_004281.3(BAG3):c.451T>C (p.Cys151Arg)	BAG3	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.15112(C), GMAF:0.09650(C), GO-ESP:0.17674(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	119670121	GRCh38	44783	53950
NM_004281.3(BAG3):c.463G>A (p.Ala155Thr)	BAG3	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not specified|not provided|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GMAF:0.00180(A), GO-ESP:0.00296(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	119670133	GRCh38	44784	53951
NM_004281.3(BAG3):c.481C>T (p.Gln161Ter)	BAG3	Cardiovascular phenotype		Pathogenic(Last reviewed: Jun 19, 2015)	criteria provided, single submitter	10	119670151	GRCh38	264102	258630
NM_004281.3(BAG3):c.626C>A (p.Pro209Gln)	BAG3	Myofibrillar myopathy, BAG3-related		Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	10	119672373	GRCh38	156530	166295
NM_004281.3(BAG3):c.626C>T (p.Pro209Leu)	BAG3	Myofibrillar myopathy, BAG3-related|not provided		Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	10	119672373	GRCh38	5981	21020
NM_004281.3(BAG3):c.653G>A (p.Arg218Gln)	BAG3	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00020(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 5, 2015)	criteria provided, conflicting interpretations	10	119672400	GRCh38	179009	174890
NM_004281.3(BAG3):c.679C>G (p.Gln227Glu)	BAG3	Cardiovascular phenotype	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	10	119672426	GRCh38	264497	258632
NM_004281.3(BAG3):c.772C>T (p.Arg258Trp)	BAG3	Myofibrillar myopathy|Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not specified|Myofibrillar Myopathy, Dominant	GMAF:0.00420(T), GO-ESP:0.00117(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	119672519	GRCh38	39466	48065
NM_004281.3(BAG3):c.785C>T (p.Ala262Val)	BAG3	not specified|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Sep 24, 2015)	criteria provided, multiple submitters, no conflicts	10	119672532	GRCh38	44789	53956
NM_004281.3(BAG3):c.892G>A (p.Val298Met)	BAG3	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not specified|Cardiovascular phenotype	GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Dec 16, 2015)	criteria provided, multiple submitters, no conflicts	10	119672639	GRCh38	196379	193540
NM_004281.3(BAG3):c.898G>A (p.Asp300Asn)	BAG3	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GMAF:0.00080(A), GO-ESP:0.00086(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	119672645	GRCh38	201676	198236
NM_004281.3(BAG3):c.1002T>G (p.Pro334=)	BAG3	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.11610(G), GMAF:0.15580(G), GO-ESP:0.11440(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	119676556	GRCh38	44774	53941
NM_004281.3(BAG3):c.1220C>T (p.Pro407Leu)	BAG3	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.11572(T), GMAF:0.15560(T), GO-ESP:0.11406(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	119676774	GRCh38	44776	53943
NM_004281.3(BAG3):c.1262G>A (p.Gly421Glu)	BAG3	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 20, 2015)	criteria provided, single submitter	10	119676816	GRCh38	264058	258631
NM_004281.3(BAG3):c.1292dupA (p.Val432Glyfs)	BAG3	Cardiovascular phenotype		Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	10	119676846	GRCh38	264518	258633
NM_004281.3(BAG3):c.1296A>G (p.Val432=)	BAG3	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	GO-ESP:0.77034(G), GMAF:0.29350(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	119676850	GRCh38	44777	53944
NM_004281.3(BAG3):c.1362C>T (p.Ile454=)	BAG3	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00006(T)	Likely benign(Last reviewed: Jul 9, 2015)	criteria provided, single submitter	10	119676916	GRCh38	264169	258634
NC_000010.10:g.(?_124593422)_(125010666_?)dup	ACADSB|HMX2|BUB3|CUZD1|IKZF5|C10orf88|FAM24A|PSTK|FAM24B|HMX3	See cases		Uncertain significance(Last reviewed: Jan 20, 2016)	criteria provided, single submitter			GRCh38	253890	248338
GRCh38/hg38 10q11.22(chr10:46157935-47923579)x3	GDF2|GDF10|NPY4R|RBP3|GPRIN2|PTPN20|SYT15|ZNF488|ANTXRL|AGAP9|LINC00842|ANXA8|ANXA8L1|AGAP10|FAM25G|CH17-360D5.1|LOC102724593|LOC105378292|LOC105378577|LOC107001062	See cases		Benign(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	10	46157935 - 47923579	GRCh38	160950	170794
GRCh38/hg38 10q11.22(chr10:46154949-46706745)x3		See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided			GRCh38	154361	164115
GRCh38/hg38 10q26.3(chr10:133429127-133563886)x3	CYP2E1|SYCE1	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	10	133429127 - 133563886	GRCh38	154345	164099
GRCh38/hg38 10p15.1(chr10:5161663-5599060)x1	CALML3|AKR1C4|NET1|CALML5|TUBAL3|UCN3|CALML3-AS1|LOC105376382	See cases		Uncertain significance(Last reviewed: Dec 10, 2012)	no assertion criteria provided	10	5161663 - 5599060	GRCh38	152194	161945
GRCh38/hg38 10q11.22(chr10:46157935-47923579)x3	GDF2|GDF10|NPY4R|RBP3|GPRIN2|PTPN20|SYT15|ZNF488|ANTXRL|AGAP9|LINC00842|ANXA8|ANXA8L1|AGAP10|FAM25G|CH17-360D5.1|LOC102724593|LOC105378292|LOC105378577|LOC107001062	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	10	46157935 - 47923579	GRCh38	150472	160223
GRCh38/hg38 10q25.1-26.3(chr10:108102587-133620674)x3	ACADSB|ADAM8|ADD3|ADRA2A|ADRB1|BNIP3|CASP7|CTBP2|CYP2E1|DMBT1|DOCK1|DUSP5|ECHS1|EMX2|FGFR2|GFRA1|PRLHR|GPR26|GRK5|HABP2|HMX2|INPP5A|ABLIM1|MGMT|MKI67|MXI1|NRAP|OAT|PNLIP|PNLIPRP1|PNLIPRP2|HTRA1|PTPRE|RGS10|SLC18A2|TCF7L2|TECTB|TIAL1|UROS|XPNPEP1|SHOC2|ADAM12|UTF1|EIF3A|SMC3|BUB3|BAG3|FAM53B|DCLRE1A|SMNDC1|GLRX3|DPYSL4|TACC2|TUBGCP2|PRDX3|VAX1|ATE1|SEC23IP|RAB11FIP2|INPP5F|FAM175B|ATRNL1|EDRF1|PDCD4|VENTX|CUZD1|CALY|CHST15|ACSL5|ZRANB1|CFAP46|NSMCE4A|CCDC186|WDR11|DHX32|PPP2R2D|TDRD1|BCCIP|GPAM|SHTN1|FAM160B1|PLEKHA1|FAM204A|LHPP|IKZF5|ZDHHC6|MCMBP|PLEKHS1|C10orf88|LRRC27|ADGRA1|NKX6-2|AFAP1L2|KNDC1|MTG1|BBIP1|FANK1|SYCE1|PRAP1|ZNF511|C10orf90|BTBD16|FAM24A|PSTK|MMP21|PDZD8|CLRN3|PNLIPRP3|SFXN4|CPXM2|TRUB1|VTI1A|C10orf82|CACUL1|C10orf91|PWWP2B|EMX2OS|PLPP4|PAOX|FAM24B|EBF3|CASC2|TCERG1L|HSPA12A|FUOM|JAKMIP3|STK32C|RBM20|PDCD4-AS1|LOC283038|WDR11-AS1|KCNK18|VWA2|NANOS1|HMX3|NHLRC2|CCDC172|ENO4|ARMS2|TEX36|LINC00959|NKX1-2|C10orf120|METTL10|FLJ37035|FOXI2|LINC01164|LINC01168|LINC01561|FAM45A|SPRN|MIR202|NPS|SNORA19|FAM196A|ADGRA1-AS1|LINC01165|ATE1-AS1|TEX36-AS1|MIR2110|MIR548E|MIR378C|MIR4297|MIR4295|MIR4296|MIR3941|MIR3663|MIR3944|ADD3-AS1|LINC00867|FAM24B-CUZD1|MIR4680|MIR4483|MIR4682|MIR4484|MIR4681|LINC00601|FANK1-AS1|LINC01163|TCERG1L-AS1|LINC01166|MIR202HG|LOC101927692|MIR3663HG|GRK5-IT1|LINC01153|FAM53B-AS1|EDRF1-AS1|MIR6715B|MIR6715A|LOC102724589|LOC103344931|LINC01167|AS-PTPRE|SNORA87	See cases		Pathogenic(Last reviewed: May 27, 2010)	no assertion criteria provided	10	108102587 - 133620674	GRCh38	144206	153957
GRCh38/hg38 10q21.1-22.2(chr10:58436466-74415216)x1	ADK|ANK3|ANXA7|CAMK2G|CDK1|COL13A1|DNA2|EGR2|EIF4EBP2|HK1|HNRNPH3|NODAL|P4HA1|PCBD1|PLAU|PPA1|PPP3CB|PRF1|SRGN|PSAP|SUPV3L1|TACR2|VCL|CCDC6|SLC25A16|NDST2|SGPL1|DDX21|CHST3|VPS26A|SEC24C|SPOCK2|RHOBTB1|MICU1|ECD|ZNF365|ZSWIM8|DNAJC9|SIRT1|TSPAN15|NUDT13|HERC4|KIF1BP|AP3M1|PALD1|CTNNA3|NRBF2|NEUROG3|ASCC1|MRPS16|DDIT4|DNAJB12|LRRC20|SLC29A3|H2AFY2|RUFY2|CCAR1|DNAJC12|SAR1A|MYOZ1|CDH23|PBLD|NPFFR1|C10orf54|DDX50|SYNPO2L|BICC1|HKDC1|TET1|ARID5B|PHYHIPL|PLA2G12B|MYPN|AIFM2|ADO|JMJD1C-AS1|MCU|CHCHD1|MSS51|CFAP70|ANAPC16|ADAMTS14|USP54|FUT11|OIT3|C10orf107|TMEM26|UNC5B|STOX1|C10orf35|TYSND1|RTKN2|TBATA|ATOH7|SLC16A9|FAM13C|REEP3|JMJD1C|LINC01553|LOC283045|FAM149B1|LRRTM3|C10orf105|C10orf55|DNAJC9-AS1|SNORD98|UNC5B-AS1|AGAP5|TRS-TGA1-1|MIR1296|MIR1254-1|LINC00844|MRLN|LINC00845|ZSWIM8-AS1|MIR4676|TMEM26-AS1|LOC101928887|LINC01515|LOC101928961|LOC101928994|PPP3CB-AS1|MIR7152|MIR7151|CDH23-AS1|LOC105378330|LOC105378349|CCEPR	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	10	58436466 - 74415216	GRCh38	58726	73321
GRCh38/hg38 10q24.2-24.31(chr10:99333940-100475567)x3	CHUK|ABCC2|COX15|CPN1|GOT1|SCD|WNT8B|PKD2L1|ERLIN1|DNMBP|CNNM1|CUTC|CWF19L1|ENTPD7|SLC25A28|OLMALINC|NKX2-3|BLOC1S2|SNORA12|DNMBP-AS1|LINC01475	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	10	99333940 - 100475567	GRCh38	57907	72502
GRCh38/hg38 10q26.3(chr10:133440535-133564028)x1	CYP2E1|SYCE1	See cases		Benign(Last reviewed: Jul 10, 2013)	no assertion criteria provided	10	133440535 - 133564028	GRCh38	32439	41104
NM_005343.3(HRAS):c.350A>G (p.Lys117Arg)	HRAS|LRRC56	Costello syndrome|not provided		Pathogenic(Last reviewed: Feb 3, 2016)	criteria provided, multiple submitters, no conflicts	11	533553	GRCh38	12605	27644
NM_005343.3(HRAS):c.317C>G (p.Ser106Trp)	HRAS|LRRC56	not specified		Uncertain significance(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	11	533586	GRCh38	180850	179416
NM_005343.3(HRAS):c.35G>A (p.Gly12Asp)	HRAS|LRRC56	Costello syndrome|Costello syndrome, severe|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Rasopathy		Pathogenic(Last reviewed: Dec 11, 2015)	criteria provided, multiple submitters, no conflicts	11	534288	GRCh38	12612	27651
NM_005343.3(HRAS):c.35G>T (p.Gly12Val)	HRAS|LRRC56	Malignant tumor of urinary bladder|Costello syndrome|Epidermal nevus|Myopathy, congenital, with excess of muscle spindles|not provided		Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	11	534288	GRCh38	12600	27639
NM_005343.3(HRAS):c.34G>T (p.Gly12Cys)	HRAS|LRRC56	Costello syndrome|Epidermal nevus|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Rasopathy		Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	11	534289	GRCh38	12613	27652
NM_020376.3(PNPLA2):c.475_478dupCTCC (p.Gln160Profs)	PNPLA2	Neutral lipid storage disease with myopathy		Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	11	822012 - 822015	GRCh38	65421	76351
NM_020376.3(PNPLA2):c.543delC (p.Ile182Serfs)	PNPLA2	Neutral lipid storage disease with myopathy		Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	11	822453	GRCh38	65420	76350
NM_020376.3(PNPLA2):c.613dupC (p.Leu205Profs)	PNPLA2	Neutral lipid storage disease with myopathy		Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	11	822523	GRCh38	65419	76349
NM_006757.3(TNNT3):c.188G>A (p.Arg63His)	TNNT3	Distal arthrogryposis type 2B|not provided|Arthyrgryposis, distal, type 2B		Pathogenic(Last reviewed: Mar 5, 2015)	criteria provided, single submitter	11	1933737	GRCh38	8913	23952
NM_000218.2(KCNQ1):c.-5T>C	KCNQ1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GMAF:0.00020(C), GO-ESP:0.01471(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	2445094	GRCh38	138009	141712
NM_000218.2(KCNQ1):c.5C>T (p.Ala2Val)	KCNQ1	not specified|Congenital long QT syndrome		Uncertain significance(Last reviewed: May 27, 2014)	criteria provided, single submitter	11	2445103	GRCh38	67091	77987
NM_000218.2(KCNQ1):c.152_153insCGCGCCCAT (p.Pro56_Gly57insIleAlaPro)	KCNQ1	Cardiovascular phenotype	GMAF:0.00880(CGCGCCCAT)	Uncertain significance(Last reviewed: Feb 27, 2013)	criteria provided, single submitter	11	2445250 - 2445251	GRCh38	263545	258688
NM_000218.2(KCNQ1):c.160_168dupATCGCGCCC (p.Pro56_Gly57insIleAlaPro)	KCNQ1	Atrial fibrillation, familial, 3|Long QT syndrome|not specified|Long QT syndrome, LQT1 subtype|Cardiovascular phenotype	GMAF:0.00880(CGCGCCCAT)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Aug 17, 2016)	criteria provided, conflicting interpretations	11	2445258 - 2445266	GRCh38	42487	51657
NM_000218.2(KCNQ1):c.165_187del23 (p.Gly57Cysfs)	KCNQ1	Cardiac arrhythmia		Pathogenic(Last reviewed: Sep 27, 2012)	criteria provided, single submitter	11	2445263 - 2445285	GRCh38	200889	197410
NM_000218.2(KCNQ1):c.321G>T (p.Gln107His)	KCNQ1	Cardiac arrhythmia		Likely pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	11	2445419	GRCh38	200878	197417
NM_000218.2(KCNQ1):c.345G>A (p.Glu115=)	KCNQ1	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	11	2445443	GRCh38	264125	258689
NM_000218.2(KCNQ1):c.425delT (p.Leu142Argfs)	KCNQ1	Cardiac arrhythmia		Pathogenic(Last reviewed: Jul 26, 2012)	criteria provided, single submitter	11	2527966	GRCh38	200892	197425
NM_000218.2(KCNQ1):c.435C>T (p.Ile145=)	KCNQ1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GMAF:0.00900(T), GO-ESP:0.00434(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2527976	GRCh38	163734	175699
NM_000218.2(KCNQ1):c.443delA (p.Tyr148Leufs)	KCNQ1	Long QT syndrome 1		Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	11	2527984	GRCh38	207969	204197
NM_000218.2(KCNQ1):c.447C>T (p.Ala149=)	KCNQ1	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.00160(T), GO-ESP:0.00042(T)	Benign/Likely benign(Last reviewed: Jul 19, 2016)	criteria provided, multiple submitters, no conflicts	11	2527988	GRCh38	138011	141714
NM_000218.2(KCNQ1):c.477+1G>A	KCNQ1	not provided	GO-ESP:0.00002(A)	Pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, single submitter	11	2528019	GRCh38	200874	197427
NM_000218.2(KCNQ1):c.477+5G>A	KCNQ1	not provided|Long QT syndrome, LQT1 subtype	GO-ESP:0.00002(A)	Pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, single submitter	11	2528023	GRCh38	53047	67715
NM_000218.2(KCNQ1):c.499_501delTTC (p.Phe167del)	KCNQ1	Cardiac arrhythmia		Pathogenic(Last reviewed: Jun 23, 2014)	criteria provided, single submitter	11	2570649 - 2570651	GRCh38	200881	197428
NM_000218.2(KCNQ1):c.502G>A (p.Gly168Arg)	KCNQ1	Long QT syndrome 1|not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome		Pathogenic(Last reviewed: Nov 13, 2013)	criteria provided, single submitter	11	2570652	GRCh38	53052	67720
NM_000218.2(KCNQ1):c.513C>T (p.Tyr171=)	KCNQ1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GO-ESP:0.00108(T), GMAF:0.00020(T), GO-ESP:0.00102(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2570663	GRCh38	178385	175700
NM_000218.2(KCNQ1):c.524_534dupTCTGGTCCGCC (p.Gly179Serfs)	KCNQ1	Long QT syndrome 1		Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	11	2570674 - 2570684	GRCh38	253221	247639
NM_000218.2(KCNQ1):c.532G>A (p.Ala178Thr)	KCNQ1	Long QT syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00008(A), GO-ESP:0.00002(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 24, 2016)	criteria provided, conflicting interpretations	11	2570682	GRCh38	53061	67729
NM_000218.2(KCNQ1):c.535G>A (p.Gly179Ser)	KCNQ1	Long QT syndrome 1|Long QT syndrome|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome	GO-ESP:0.00008(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 1, 2014)	criteria provided, conflicting interpretations	11	2570685	GRCh38	53063	67731
NM_000218.2(KCNQ1):c.551dupA (p.Tyr184Terfs)	KCNQ1	Cardiac arrhythmia		Pathogenic(Last reviewed: Oct 9, 2014)	criteria provided, single submitter	11	2570701	GRCh38	200870	197431
NM_000218.2(KCNQ1):c.557G>A (p.Gly186Asp)	KCNQ1	Long QT syndrome 1		Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	11	2570707	GRCh38	207967	204198
NM_000218.2(KCNQ1):c.560T>C (p.Leu187Pro)	KCNQ1	Long QT syndrome|not provided|Congenital long QT syndrome	GO-ESP:0.00001(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jul 23, 2015)	criteria provided, conflicting interpretations	11	2570710	GRCh38	53066	67734
NM_000218.2(KCNQ1):c.564G>A (p.Trp188Ter)	KCNQ1	Cardiovascular phenotype	GMAF:0.00020(C)	Pathogenic(Last reviewed: Mar 23, 2015)	criteria provided, single submitter	11	2570714	GRCh38	263738	258690
NM_000218.2(KCNQ1):c.567dupG (p.Arg190Alafs)	KCNQ1	Jervell and Lange-Nielsen syndrome 1|Long QT syndrome|not provided		Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	11	2570717	GRCh38	53069	67737
NM_000218.2(KCNQ1):c.568C>T (p.Arg190Trp)	KCNQ1	not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00001(T)	Likely pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, multiple submitters, no conflicts	11	2570718	GRCh38	53070	67738
NM_000218.2(KCNQ1):c.569G>A (p.Arg190Gln)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	11	2570719	GRCh38	3117	18156
NM_000218.2(KCNQ1):c.575G>A (p.Arg192His)	KCNQ1	not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Oct 9, 2014)	criteria provided, single submitter	11	2570725	GRCh38	67085	77981
NM_000218.2(KCNQ1):c.603_604+9delCGGTGAGTCAT	KCNQ1	Cardiac arrhythmia		Pathogenic(Last reviewed: Nov 10, 2011)	criteria provided, single submitter	11	2570753 - 2570763	GRCh38	200912	197436
NM_000218.2(KCNQ1):c.604G>A (p.Asp202Asn)	KCNQ1	Jervell and Lange-Nielsen syndrome 1|not provided|Congenital long QT syndrome	GO-ESP:0.00002(A)	Pathogenic(Last reviewed: Dec 17, 2015)	criteria provided, single submitter	11	2570754	GRCh38	53077	67745
NM_000218.2(KCNQ1):c.608T>C (p.Leu203Pro)	KCNQ1	Cardiac arrhythmia|Congenital long QT syndrome		Pathogenic(Last reviewed: Sep 27, 2013)	criteria provided, single submitter	11	2571328	GRCh38	67093	77989
NM_000218.2(KCNQ1):c.613G>A (p.Val205Met)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, multiple submitters, no conflicts	11	2571333	GRCh38	37255	45847
NM_000218.2(KCNQ1):c.629T>C (p.Met210Thr)	KCNQ1	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 6, 2015)	criteria provided, single submitter	11	2571349	GRCh38	263972	258691
NM_000218.2(KCNQ1):c.642C>T (p.Cys214=)	KCNQ1	Cardiovascular phenotype	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	11	2571362	GRCh38	264508	258692
NM_000218.2(KCNQ1):c.692G>A (p.Arg231His)	KCNQ1	Atrial fibrillation, familial, 3|Long QT syndrome 1|Long QT syndrome|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2572021	GRCh38	53087	67755
NM_000218.2(KCNQ1):c.720C>T (p.His240=)	KCNQ1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GO-ESP:0.00454(T), GMAF:0.00520(T), GO-ESP:0.00184(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2572049	GRCh38	42493	51663
NM_000218.2(KCNQ1):c.724G>T (p.Asp242Tyr)	KCNQ1	not provided|Congenital long QT syndrome		Likely pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	11	2572053	GRCh38	67099	77995
NM_000218.2(KCNQ1):c.758C>G (p.Ser253Cys)	KCNQ1	Long QT syndrome 1		Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	11	2572087	GRCh38	207971	204199
NM_000218.2(KCNQ1):c.760_768delGTGGTCTTC (p.Val254_Phe256del)	KCNQ1	Cardiac arrhythmia|Long QT syndrome, LQT1 subtype		Pathogenic(Last reviewed: Nov 28, 2011)	criteria provided, single submitter	11	2572089 - 2572097	GRCh38	53097	67765
NM_000218.2(KCNQ1):c.760G>T (p.Val254Leu)	KCNQ1	Cardiac arrhythmia|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome		Pathogenic(Last reviewed: Sep 17, 2013)	criteria provided, single submitter	11	2572089	GRCh38	53096	67764
NM_000218.2(KCNQ1):c.760G>A (p.Val254Met)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not provided|Congenital long QT syndrome		Pathogenic/Likely pathogenic, not provided(Last reviewed: Oct 3, 2016)	criteria provided, multiple submitters, no conflicts	11	2572089	GRCh38	3118	18157
NM_000218.2(KCNQ1):c.775C>T (p.Arg259Cys)	KCNQ1	Long QT syndrome|not provided|Congenital long QT syndrome		Pathogenic/Likely pathogenic, not provided(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	11	2572104	GRCh38	53100	67768
NM_000218.2(KCNQ1):c.781-14_781-13delGT	KCNQ1	Cardiac arrhythmia|not specified		Benign/Likely benign(Last reviewed: Jul 25, 2014)	criteria provided, multiple submitters, no conflicts	11	2572832 - 2572833	GRCh38	163739	175842
NM_000218.2(KCNQ1):c.797T>C (p.Leu266Pro)	KCNQ1	Long QT syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype		Pathogenic/Likely pathogenic, not provided(Last reviewed: Aug 1, 2016)	criteria provided, multiple submitters, no conflicts	11	2572862	GRCh38	53108	67776
NM_000218.2(KCNQ1):c.800A>T (p.Tyr267Phe)	KCNQ1	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 1, 2015)	criteria provided, single submitter	11	2572865	GRCh38	264075	258693
NM_000218.2(KCNQ1):c.805G>A (p.Gly269Ser)	KCNQ1	Long QT syndrome 1|not provided|Congenital long QT syndrome	GMAF:0.00020(A), GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	11	2572870	GRCh38	3144	18183
NM_000218.2(KCNQ1):c.820A>G (p.Ile274Val)	KCNQ1	SUDDEN INFANT DEATH SYNDROME|not specified|not provided|Congenital long QT syndrome	GO-ESP:0.00008(G), GO-ESP:0.00026(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Sep 19, 2016)	criteria provided, conflicting interpretations	11	2572885	GRCh38	67109	78005
NM_000218.2(KCNQ1):c.824_826delTCT (p.Phe275del)	KCNQ1	Long QT syndrome 1|Long QT syndrome, LQT1 subtype		Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	11	2572889 - 2572891	GRCh38	53112	67780
NM_000218.2(KCNQ1):c.828_830delCTC (p.Ser277del)	KCNQ1	Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|not provided|Long QT syndrome, LQT1 subtype		Pathogenic(Last reviewed: Jan 8, 2015)	criteria provided, single submitter	11	2572893 - 2572895	GRCh38	53114	67782
NM_000218.2(KCNQ1):c.914G>C (p.Trp305Ser)	KCNQ1	Jervell and Lange-Nielsen syndrome 1|not provided|Congenital long QT syndrome	GO-ESP:0.00001(C)	Pathogenic(Last reviewed: Oct 2, 2014)	criteria provided, single submitter	11	2572979	GRCh38	3127	18166
NM_000218.2(KCNQ1):c.935C>T (p.Thr312Ile)	KCNQ1	Long QT syndrome 1|not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome		Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	11	2583448	GRCh38	3116	18155
NM_000218.2(KCNQ1):c.949G>A (p.Asp317Asn)	KCNQ1	not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome		Pathogenic(Last reviewed: Jan 16, 2012)	criteria provided, single submitter	11	2583462	GRCh38	53145	67813
NM_000218.2(KCNQ1):c.964A>G (p.Thr322Ala)	KCNQ1	not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome		Pathogenic(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	11	2583477	GRCh38	53149	67817
NM_000218.2(KCNQ1):c.965C>T (p.Thr322Met)	KCNQ1	Long QT syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype		Pathogenic/Likely pathogenic, not provided(Last reviewed: Oct 23, 2015)	criteria provided, multiple submitters, no conflicts	11	2583478	GRCh38	53151	67819
NM_000218.2(KCNQ1):c.969G>A (p.Trp323Ter)	KCNQ1	not provided		Pathogenic(Last reviewed: Jan 6, 2012)	criteria provided, single submitter	11	2583482	GRCh38	200893	197456
NM_000218.2(KCNQ1):c.984C>T (p.Ile328=)	KCNQ1	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00038(T)	Likely benign(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	11	2583497	GRCh38	264431	258694
NM_000218.2(KCNQ1):c.1004_1005delTT (p.Phe335Cysfs)	KCNQ1	Cardiac arrhythmia		Pathogenic(Last reviewed: Oct 3, 2014)	criteria provided, single submitter	11	2583517 - 2583518	GRCh38	200913	197458
NM_000218.2(KCNQ1):c.1029_1031dupAGC (p.Ala344_Gly345insAla)	KCNQ1	Cardiac arrhythmia		Likely pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	11	2583542 - 2583544	GRCh38	200885	197462
NM_000218.2(KCNQ1):c.1031C>G (p.Ala344Gly)	KCNQ1	not provided		Likely pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	11	2583544	GRCh38	200900	197463
NM_000218.2(KCNQ1):c.1031C>T (p.Ala344Val)	KCNQ1	not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome		Pathogenic(Last reviewed: Jul 16, 2015)	no assertion criteria provided	11	2583544	GRCh38	52936	67604
NM_000218.2(KCNQ1):c.1032G>A (p.Ala344=)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not provided		Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, multiple submitters, no conflicts	11	2583545	GRCh38	3135	18174
NM_000218.2(KCNQ1):c.1032+5dupG	KCNQ1	Cardiac arrhythmia		Uncertain significance(Last reviewed: Aug 25, 2014)	criteria provided, single submitter	11	2583550	GRCh38	200886	197464
NM_000218.2(KCNQ1):c.1046C>G (p.Ser349Trp)	KCNQ1	not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome		Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	11	2585225	GRCh38	52942	67610
NM_000218.2(KCNQ1):c.1051T>C (p.Phe351Leu)	KCNQ1	Long QT syndrome 1	GO-ESP:0.00001(C)	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	11	2585230	GRCh38	207968	204200
NM_000218.2(KCNQ1):c.1070A>G (p.Gln357Arg)	KCNQ1	Cardiac arrhythmia|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome		Pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	11	2585249	GRCh38	52948	67616
NM_000218.2(KCNQ1):c.1081C>T (p.Gln361Ter)	KCNQ1	Cardiac arrhythmia		Pathogenic(Last reviewed: Jul 25, 2011)	criteria provided, single submitter	11	2585260	GRCh38	200901	197471
NM_000218.2(KCNQ1):c.1135T>C (p.Trp379Arg)	KCNQ1	Cardiac arrhythmia|SUDDEN INFANT DEATH SYNDROME		Pathogenic(Last reviewed: Oct 20, 2014)	criteria provided, single submitter	11	2587576	GRCh38	67013	77909
NM_000218.2(KCNQ1):c.1189C>T (p.Arg397Trp)	KCNQ1	Long QT syndrome 1|short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome|Familial atrial fibrillation|Jervell and Lange-Nielsen syndrome	GO-ESP:0.00038(T), GMAF:0.00020(T), GO-ESP:0.00017(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	2587630	GRCh38	52970	67638
NM_000218.2(KCNQ1):c.1201dupC (p.Arg401Profs)	KCNQ1	not provided|Long QT syndrome, LQT1 subtype|Cardiovascular phenotype		Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, multiple submitters, no conflicts	11	2587642	GRCh38	52972	67640
NM_000218.2(KCNQ1):c.1222C>G (p.Pro408Ala)	KCNQ1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GO-ESP:0.00385(G), GMAF:0.00540(G), GO-ESP:0.00129(G)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2587663	GRCh38	42484	51654
NM_000218.2(KCNQ1):c.1251+2T>C	KCNQ1	Cardiac arrhythmia		Pathogenic(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	11	2587694	GRCh38	200845	197479
NM_000218.2(KCNQ1):c.1252delG (p.Val418Terfs)	KCNQ1	Cardiac arrhythmia		Pathogenic(Last reviewed: Sep 23, 2011)	criteria provided, single submitter	11	2588713	GRCh38	200914	197480
NM_000218.2(KCNQ1):c.1340C>A (p.Pro447His)	KCNQ1	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	11	2588801	GRCh38	264157	258695
NM_000218.2(KCNQ1):c.1343C>T (p.Pro448Leu)	KCNQ1	Cardiac arrhythmia|Congenital long QT syndrome	GMAF:0.02260(G)	Uncertain significance(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	11	2588804	GRCh38	67027	77923
NM_000218.2(KCNQ1):c.1343C>G (p.Pro448Arg)	KCNQ1	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(G), GMAF:0.02260(G), GO-ESP:0.00761(G)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2588804	GRCh38	67026	77922
NM_000218.2(KCNQ1):c.1343dupC (p.Glu449Argfs)	KCNQ1	Cardiac arrhythmia|Long QT syndrome, LQT1 subtype		Pathogenic(Last reviewed: Apr 29, 2013)	criteria provided, single submitter	11	2588804	GRCh38	52978	67646
NM_000218.2(KCNQ1):c.1343delC (p.Pro448Glnfs)	KCNQ1	Cardiac arrhythmia|Long QT syndrome, LQT1 subtype		Pathogenic(Last reviewed: Sep 25, 2013)	criteria provided, single submitter	11	2588804	GRCh38	52977	67645
NM_000218.2(KCNQ1):c.1355G>A (p.Arg452Gln)	KCNQ1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GO-ESP:0.00015(A), GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Oct 4, 2016)	criteria provided, multiple submitters, no conflicts	11	2588816	GRCh38	67030	77926
NM_000218.2(KCNQ1):c.1426A>G (p.Met476Val)	KCNQ1|KCNQ1OT1	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 10, 2015)	criteria provided, multiple submitters, no conflicts	11	2661993	GRCh38	200848	197485
NM_000218.2(KCNQ1):c.1455C>T (p.Phe485=)	KCNQ1|KCNQ1OT1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GO-ESP:0.01677(T), GMAF:0.01560(T), GO-ESP:0.00607(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2662022	GRCh38	42486	51656
NM_000218.2(KCNQ1):c.1464C>A (p.Asp488Glu)	KCNQ1|KCNQ1OT1	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Apr 23, 2014)	criteria provided, single submitter	11	2662031	GRCh38	200849	197487
NM_000218.2(KCNQ1):c.1480dupG (p.Glu494Glyfs)	KCNQ1|KCNQ1OT1	Long QT syndrome 1		Pathogenic(Last reviewed: Jan 1, 2012)	criteria provided, single submitter	11	2662047	GRCh38	207972	204201
NM_000218.2(KCNQ1):c.1514+18C>T	KCNQ1|KCNQ1OT1	Cardiac arrhythmia	GO-ESP:0.00285(T), GMAF:0.01920(T), GO-ESP:0.01016(T)	Benign(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	2662099	GRCh38	36435	45098
NM_000218.2(KCNQ1):c.1552C>T (p.Arg518Ter)	KCNQ1	Long QT syndrome 1, recessive|Long QT syndrome|not provided|Cardiovascular phenotype	GO-ESP:0.00008(T), GO-ESP:0.00017(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2016)	criteria provided, conflicting interpretations	11	2768881	GRCh38	3131	18170
NM_000218.2(KCNQ1):c.1590+14T>C	KCNQ1	Cardiac arrhythmia|short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Familial atrial fibrillation|Jervell and Lange-Nielsen syndrome	GO-ESP:0.08599(C), GMAF:0.04610(C), GO-ESP:0.08683(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2768933	GRCh38	36436	45099
NM_000218.2(KCNQ1):c.1597C>T (p.Arg533Trp)	KCNQ1	Long QT syndrome 1|Congenital long QT syndrome		Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	11	2775966	GRCh38	67041	77937
NM_000218.2(KCNQ1):c.1615C>T (p.Arg539Trp)	KCNQ1	Long QT syndrome|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	11	2775984	GRCh38	52998	67666
NM_000218.2(KCNQ1):c.1638G>A (p.Ser546=)	KCNQ1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GO-ESP:0.14351(A), GMAF:0.18090(A), GO-ESP:0.25844(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2776007	GRCh38	42488	51658
NM_000218.2(KCNQ1):c.1660delG (p.Val554Cysfs)	KCNQ1	Cardiac arrhythmia		Pathogenic(Last reviewed: Apr 3, 2014)	criteria provided, single submitter	11	2776029	GRCh38	200887	197494
NM_000218.2(KCNQ1):c.1663C>T (p.Arg555Cys)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not provided|Congenital long QT syndrome	GO-ESP:0.00004(T)	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, multiple submitters, no conflicts	11	2776032	GRCh38	3126	18165
NM_000218.2(KCNQ1):c.1669A>G (p.Lys557Glu)	KCNQ1	Congenital long QT syndrome|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	11	2776038	GRCh38	67047	77943
NM_000218.2(KCNQ1):c.1686-2A>G	KCNQ1	Long QT syndrome 1		Pathogenic(Last reviewed: Jan 1, 2011)	criteria provided, single submitter	11	2776984	GRCh38	207973	204202
NM_000218.2(KCNQ1):c.1702G>A (p.Gly568Arg)	KCNQ1	Long QT syndrome, LQT1 subtype|Congenital long QT syndrome|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Aug 1, 2015)	criteria provided, single submitter	11	2777002	GRCh38	53009	67677
NM_000218.2(KCNQ1):c.1703G>C (p.Gly568Ala)	KCNQ1	Long QT syndrome 1|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome		Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	11	2777003	GRCh38	53010	67678
NM_000218.2(KCNQ1):c.1706A>G (p.Lys569Arg)	KCNQ1	Cardiac arrhythmia		Likely pathogenic(Last reviewed: Nov 22, 2011)	criteria provided, single submitter	11	2777006	GRCh38	200907	197499
NM_000218.2(KCNQ1):c.1716G>A (p.Leu572=)	KCNQ1	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	11	2777016	GRCh38	264237	258696
NM_000218.2(KCNQ1):c.1733-1G>C	KCNQ1	Long QT syndrome 1		Pathogenic(Last reviewed: Jan 1, 2012)	criteria provided, single submitter	11	2777975	GRCh38	207970	204203
NM_000218.2(KCNQ1):c.1762A>T (p.Ile588Phe)	KCNQ1	Long QT syndrome 1|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2014)	criteria provided, multiple submitters, no conflicts	11	2778005	GRCh38	200856	197501
NM_000218.2(KCNQ1):c.1768G>A (p.Ala590Thr)	KCNQ1	not specified|not provided|Long QT syndrome, LQT1 subtype|Congenital long QT syndrome		Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 24, 2016)	criteria provided, conflicting interpretations	11	2778011	GRCh38	53015	67683
NM_000218.2(KCNQ1):c.1781G>A (p.Arg594Gln)	KCNQ1	Long QT syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00003(A)	Pathogenic/Likely pathogenic, not provided(Last reviewed: Aug 4, 2016)	criteria provided, multiple submitters, no conflicts	11	2778024	GRCh38	53018	67686
NM_000218.2(KCNQ1):c.1799C>T (p.Thr600Met)	KCNQ1|KCNQ1-AS1	Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00054(T), GMAF:0.00020(T), GO-ESP:0.00034(T)	Uncertain significance(Last reviewed: Jul 28, 2015)	criteria provided, multiple submitters, no conflicts	11	2847771	GRCh38	67057	77953
NM_000218.2(KCNQ1):c.1800G>A (p.Thr600=)	KCNQ1|KCNQ1-AS1	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00056(A)	Benign/Likely benign(Last reviewed: Dec 7, 2015)	criteria provided, multiple submitters, no conflicts	11	2847772	GRCh38	163744	174724
NM_000218.2(KCNQ1):c.1842_1844delCCA (p.His614del)	KCNQ1|KCNQ1-AS1	Cardiac arrhythmia|Long QT syndrome, LQT1 subtype		Pathogenic(Last reviewed: Apr 8, 2014)	criteria provided, single submitter	11	2847814 - 2847816	GRCh38	53020	67688
NM_000218.2(KCNQ1):c.1860C>T (p.His620=)	KCNQ1|KCNQ1-AS1	Long QT syndrome|not specified|Cardiovascular phenotype	GMAF:0.00200(T), GO-ESP:0.00123(T)	Benign/Likely benign(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	11	2847832	GRCh38	138007	141710
NM_000218.2(KCNQ1):c.1875C>T (p.Pro625=)	KCNQ1|KCNQ1-AS1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GMAF:0.00020(T), GO-ESP:0.00055(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	2847847	GRCh38	237226	241093
NM_000218.2(KCNQ1):c.1892_1911del20 (p.Pro631Hisfs)	KCNQ1|KCNQ1-AS1	Cardiac arrhythmia|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome, LQT1 subtype		Pathogenic(Last reviewed: May 6, 2014)	criteria provided, single submitter	11	2847864 - 2847883	GRCh38	53025	67693
NM_000218.2(KCNQ1):c.1927G>A (p.Gly643Ser)	KCNQ1|KCNQ1-AS1	Cardiac arrhythmia|short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Familial atrial fibrillation|Jervell and Lange-Nielsen syndrome	GO-ESP:0.00689(A), GMAF:0.01660(A), GO-ESP:0.01667(A)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2847899	GRCh38	36437	45100
NM_000218.2(KCNQ1):c.1942G>A (p.Val648Ile)	KCNQ1|KCNQ1-AS1	Cardiac arrhythmia|short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Familial atrial fibrillation|Jervell and Lange-Nielsen syndrome	GO-ESP:0.00613(A), GMAF:0.00740(A), GO-ESP:0.00370(A)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2847914	GRCh38	36438	45101
NM_000218.2(KCNQ1):c.1986C>T (p.Tyr662=)	KCNQ1|KCNQ1-AS1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GO-ESP:0.17342(T), GMAF:0.08330(T), GO-ESP:0.26074(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	2847958	GRCh38	42489	51659
NM_000218.2(KCNQ1):c.1999G>A (p.Val667Met)	KCNQ1|KCNQ1-AS1	not specified	GO-ESP:0.00014(A)	Uncertain significance(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	11	2847971	GRCh38	200865	197511
NM_000218.2(KCNQ1):c.2025dupG (p.Ser676Valfs)	KCNQ1|KCNQ1-AS1	Cardiac arrhythmia|Long QT syndrome, LQT1 subtype		Pathogenic(Last reviewed: Jan 5, 2014)	criteria provided, single submitter	11	2847997	GRCh38	53029	67697
NM_000518.4(HBB):c.125T>G (p.Phe42Cys)	HBB	HEMOGLOBIN ILMENAU		other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	11	5226767	GRCh38	15598	30637
NM_004517.3(ILK):c.211delC (p.Leu71Cysfs)	ILK	not specified		Uncertain significance(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	11	6608167	GRCh38	208590	205169
NM_003737.3(DCHS1):c.7538G>A (p.Arg2513His)	DCHS1	Mitral valve prolapse 2	GMAF:0.00040(T), GO-ESP:0.00051(T)	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	11	6624138	GRCh38	217870	214526
NM_003737.3(DCHS1):c.6988C>T (p.Arg2330Cys)	DCHS1	Mitral valve prolapse 2	GO-ESP:0.00003(A)	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	11	6625356	GRCh38	217871	214527
NM_003476.4(CSRP3):c.575delA (p.Lys192Argfs)	CSRP3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	11	19182680	GRCh38	263453	258686
NM_003476.4(CSRP3):c.572delA (p.Lys192Argfs)	CSRP3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	11	19182683	GRCh38	263450	258687
NM_003476.4(CSRP3):c.336G>A (p.Ala112=)	CSRP3	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.07748(T), GMAF:0.04270(T), GO-ESP:0.08189(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	19186294	GRCh38	44696	53863
NM_003476.4(CSRP3):c.312C>G (p.Thr104=)	CSRP3	Familial hypertrophic cardiomyopathy 12|Dilated cardiomyopathy 1M|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01987(C), GMAF:0.01360(C), GO-ESP:0.00474(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	19186318	GRCh38	44695	53862
NM_003476.4(CSRP3):c.213C>T (p.Ile71=)	CSRP3	Familial hypertrophic cardiomyopathy 12|Dilated cardiomyopathy 1M|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00539(A), GMAF:0.00240(A), GO-ESP:0.00458(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	19188204	GRCh38	44692	53859
NM_003476.4(CSRP3):c.206A>G (p.Lys69Arg)	CSRP3	Familial hypertrophic cardiomyopathy 12|Dilated cardiomyopathy 1M|Cardiovascular phenotype	GO-ESP:0.00008(C), GO-ESP:0.00002(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2015)	criteria provided, conflicting interpretations	11	19188211	GRCh38	8780	23819
NM_003476.4(CSRP3):c.150G>A (p.Ala50=)	CSRP3	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.03474(T), GMAF:0.03200(T), GO-ESP:0.01004(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	19188267	GRCh38	44688	53855
NM_003476.4(CSRP3):c.10T>C (p.Trp4Arg)	CSRP3	Familial hypertrophic cardiomyopathy 12|Dilated cardiomyopathy 1M|Cardiomyopathy|not specified|Dilated cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00370(G), GMAF:0.00180(G), GO-ESP:0.00237(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 25, 2016)	criteria provided, conflicting interpretations	11	19192439	GRCh38	8776	23815
NM_000256.3(MYBPC3):c.-2053_*2307del	MYBPC3|MADD	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	11	47329436 - 47354700	GRCh38	188592	186342
NG_007667.1:g.26287C>A	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331416	GRCh38	304934	320886
NG_007667.1:g.26253A>G	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331450	GRCh38	304935	326913
NG_007667.1:g.26196G>A	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.01880(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331507	GRCh38	304936	314276
NG_007667.1:g.26190delA	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00920(-)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331513	GRCh38	304937	326925
NG_007667.1:g.26123C>A	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331580	GRCh38	304938	320887
NG_007667.1:g.26091T>C	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00060(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331612	GRCh38	304939	326929
NG_007667.1:g.26087G>A	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00020(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331616	GRCh38	304940	327964
NG_007667.1:g.26079C>A	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331624	GRCh38	304941	326930
NG_007667.1:g.26076T>C	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331627	GRCh38	304942	320888
NG_007667.1:g.26073G>T	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00260(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331630	GRCh38	304943	326931
NG_007667.1:g.26055G>T	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331648	GRCh38	304944	320892
NM_000256.3(MYBPC3):c.*26+14G>A	MYBPC3	not specified	GO-ESP:0.00007(T)	Benign(Last reviewed: Oct 25, 2013)	criteria provided, single submitter	11	47331831	GRCh38	138320	142023
NG_007667.1:g.25861A>G	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47331842	GRCh38	304945	314279
NM_000256.3(MYBPC3):c.*6_*16delCTGGCTCCTGG	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 2, 2009)	no assertion criteria provided	11	47331855 - 47331865	GRCh38	177853	175136
NM_000256.3(MYBPC3):c.3825A>G (p.Ter1275Trp)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 12, 2013)	no assertion criteria provided	11	47331871	GRCh38	177888	174725
NM_000256.3(MYBPC3):c.3815-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2015)	criteria provided, multiple submitters, no conflicts	11	47331882	GRCh38	42746	51916
NM_000256.3(MYBPC3):c.3815-10T>G	MYBPC3	not specified|Hypertrophic cardiomyopathy		Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2015)	criteria provided, conflicting interpretations	11	47331891	GRCh38	42745	51915
NM_000256.3(MYBPC3):c.3814+14G>A	MYBPC3	not specified	GO-ESP:0.00011(T)	Likely benign(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	11	47332058	GRCh38	179135	175137
NM_000256.3(MYBPC3):c.3814+2T>C	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Nov 2, 2015)	criteria provided, single submitter	11	47332070	GRCh38	222711	224421
NM_000256.3(MYBPC3):c.3814G>A (p.Val1272Met)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jul 2, 2012)	criteria provided, single submitter	11	47332072	GRCh38	181029	179168
NM_000256.3(MYBPC3):c.3811C>T (p.Arg1271Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00003(A)	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, multiple submitters, no conflicts	11	47332075	GRCh38	42744	51914
NM_000256.3(MYBPC3):c.3803T>C (p.Leu1268Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47332083	GRCh38	188591	186343
NM_000256.3(MYBPC3):c.3800_3802delGCC (p.Arg1267del)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 27, 2014)	criteria provided, single submitter	11	47332084 - 47332086	GRCh38	179534	174726
NM_000256.3(MYBPC3):c.3800G>A (p.Arg1267His)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Nov 11, 2015)	criteria provided, single submitter	11	47332086	GRCh38	180415	178638
NM_000256.3(MYBPC3):c.3797G>A (p.Cys1266Tyr)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Sep 22, 2009)	no assertion criteria provided	11	47332089	GRCh38	42743	51913
NM_000256.3(MYBPC3):c.3796T>C (p.Cys1266Arg)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	11	47332090	GRCh38	181028	179169
NM_000256.3(MYBPC3):c.3794A>T (p.Glu1265Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	11	47332092	GRCh38	181027	179170
NM_000256.3(MYBPC3):c.3791G>T (p.Cys1264Phe)	MYBPC3	not provided|Left ventricular noncompaction 10		Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2014)	criteria provided, single submitter	11	47332095	GRCh38	64613	75576
NM_000256.3(MYBPC3):c.3791G>A (p.Cys1264Tyr)	MYBPC3	not specified|not provided	GO-ESP:0.00001(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 11, 2015)	criteria provided, conflicting interpretations	11	47332095	GRCh38	42742	51912
NM_000256.3(MYBPC3):c.3787C>T (p.Arg1263Trp)	MYBPC3	not specified|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Aug 21, 2015)	criteria provided, multiple submitters, no conflicts	11	47332099	GRCh38	181026	179171
NM_000256.3(MYBPC3):c.3781G>A (p.Glu1261Lys)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Nov 11, 2014)	no assertion criteria provided	11	47332105	GRCh38	180414	178639
NM_000256.3(MYBPC3):c.3779G>A (p.Gly1260Asp)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 11, 2014)	criteria provided, single submitter	11	47332107	GRCh38	181025	179172
NM_000256.3(MYBPC3):c.3777G>A (p.Gln1259=)	MYBPC3	not specified	GO-ESP:0.00006(T)	Likely benign(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	11	47332109	GRCh38	227570	230200
NM_000256.3(MYBPC3):c.3776delA (p.Gln1259Argfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47332110	GRCh38	164021	175138
NM_000256.3(MYBPC3):c.3775C>T (p.Gln1259Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Feb 28, 2013)	criteria provided, single submitter	11	47332111	GRCh38	181024	179173
NM_000256.3(MYBPC3):c.3771C>A (p.Asn1257Lys)	MYBPC3	not specified|Hypertrophic cardiomyopathy		Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2016)	criteria provided, conflicting interpretations	11	47332115	GRCh38	181022	179175
NM_000256.3(MYBPC3):c.3767_3769delCCA (p.Thr1256del)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Likely pathogenic(Last reviewed: May 16, 2016)	criteria provided, multiple submitters, no conflicts	11	47332117 - 47332119	GRCh38	42741	51911
NM_000256.3(MYBPC3):c.3764C>A (p.Ala1255Asp)	MYBPC3	not specified		Uncertain significance(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	11	47332122	GRCh38	179227	174727
NM_000256.3(MYBPC3):c.3763delG (p.Ala1255Profs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	11	47332123	GRCh38	188590	186344
NM_000256.3(MYBPC3):c.3763G>A (p.Ala1255Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00008(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 2, 2016)	criteria provided, conflicting interpretations	11	47332123	GRCh38	164023	175139
NM_000256.3(MYBPC3):c.3742_3759dup18 (p.Cys1253_Arg1254insGlyGlyIleTyrValCys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, multiple submitters, no conflicts	11	47332127 - 47332144	GRCh38	8603	23642
NM_000256.3(MYBPC3):c.3744_3758delGGGCATCTATGTCTG (p.Gly1249_Cys1253del)	MYBPC3	Cardiomyopathy		Uncertain significance(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	11	47332128 - 47332142	GRCh38	181104	179176
NM_000256.3(MYBPC3):c.3753T>G (p.Tyr1251Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GMAF:0.00020(G)	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47332133	GRCh38	177818	174728
NM_000256.3(MYBPC3):c.3753T>C (p.Tyr1251=)	MYBPC3	not specified	GMAF:0.00020(G), GO-ESP:0.00013(G)	Likely benign(Last reviewed: Dec 28, 2010)	criteria provided, single submitter	11	47332133	GRCh38	42740	51910
NM_000256.3(MYBPC3):c.3752A>G (p.Tyr1251Cys)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 30, 2015)	criteria provided, multiple submitters, no conflicts	11	47332134	GRCh38	181021	179177
NM_000256.3(MYBPC3):c.3751T>C (p.Tyr1251His)	MYBPC3	not specified		Uncertain significance(Last reviewed: May 12, 2016)	criteria provided, single submitter	11	47332135	GRCh38	181020	179178
NM_000256.3(MYBPC3):c.3746G>T (p.Gly1249Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: May 23, 2012)	no assertion criteria provided	11	47332140	GRCh38	177653	175140
NM_000256.3(MYBPC3):c.3742G>A (p.Gly1248Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	11	47332144	GRCh38	42739	51909
NM_000256.3(MYBPC3):c.3741C>T (p.Asp1247=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00020(A), GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47332145	GRCh38	188589	186345
NM_000256.3(MYBPC3):c.3737T>C (p.Phe1246Ser)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47332149	GRCh38	188588	186346
NM_000256.3(MYBPC3):c.3735delC (p.Phe1246Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	11	47332151	GRCh38	42737	51907
NM_000256.3(MYBPC3):c.3732C>A (p.Cys1244Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	11	47332154	GRCh38	181019	179179
NM_000256.3(MYBPC3):c.3728C>G (p.Pro1243Arg)	MYBPC3	Familial hypertrophic cardiomyopathy 1		Uncertain significance(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	11	47332158	GRCh38	217829	214488
NM_000256.3(MYBPC3):c.3712_3713delCT (p.Leu1238Glyfs)	MYBPC3	Familial hypertrophic cardiomyopathy 1		Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	11	47332173 - 47332174	GRCh38	217836	214489
NM_000256.3(MYBPC3):c.3713T>C (p.Leu1238Pro)	MYBPC3	not provided		Pathogenic(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	11	47332173	GRCh38	181136	179180
NM_000256.3(MYBPC3):c.3709A>C (p.Thr1237Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47332177	GRCh38	164026	174729
NM_000256.3(MYBPC3):c.3705G>A (p.Val1235=)	MYBPC3	not specified	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2015)	criteria provided, conflicting interpretations	11	47332181	GRCh38	42734	51904
NM_000256.3(MYBPC3):c.3699G>A (p.Gln1233=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00008(T), GMAF:0.00160(T), GO-ESP:0.00081(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47332187	GRCh38	42736	51906
NM_000256.3(MYBPC3):c.3697C>T (p.Gln1233Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00001(A)	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, multiple submitters, no conflicts	11	47332189	GRCh38	42735	51905
NM_000256.3(MYBPC3):c.3694A>T (p.Lys1232Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Sep 28, 2011)	criteria provided, single submitter	11	47332192	GRCh38	42733	51903
NM_000256.3(MYBPC3):c.3690_3691delCA (p.Phe1230Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	11	47332195 - 47332196	GRCh38	177899	175141
NM_000256.3(MYBPC3):c.3685A>G (p.Met1229Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	11	47332201	GRCh38	164028	174730
NM_000256.3(MYBPC3):c.3683G>C (p.Arg1228Pro)	MYBPC3	not specified	GMAF:0.00020(T)	Uncertain significance(Last reviewed: Mar 23, 2015)	criteria provided, multiple submitters, no conflicts	11	47332203	GRCh38	181018	179181
NM_000256.3(MYBPC3):c.3682C>T (p.Arg1228Cys)	MYBPC3	Primary dilated cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00022(A)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2016)	criteria provided, conflicting interpretations	11	47332204	GRCh38	161306	171133
NM_000256.3(MYBPC3):c.3679T>A (p.Phe1227Ile)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 7, 2012)	criteria provided, single submitter	11	47332207	GRCh38	181017	179182
NM_000256.3(MYBPC3):c.3677G>T (p.Arg1226Leu)	MYBPC3	not specified		Uncertain significance(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	11	47332209	GRCh38	42732	51902
NM_000256.3(MYBPC3):c.3676C>T (p.Arg1226Cys)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Nov 10, 2015)	criteria provided, multiple submitters, no conflicts	11	47332210	GRCh38	42731	51901
NM_000256.3(MYBPC3):c.3672C>T (p.Asp1224=)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00025(A), GMAF:0.00020(A), GO-ESP:0.00011(A)	Benign/Likely benign(Last reviewed: Aug 19, 2015)	criteria provided, multiple submitters, no conflicts	11	47332214	GRCh38	42730	51900
NM_000256.3(MYBPC3):c.3664G>T (p.Gly1222Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Jun 23, 2014)	criteria provided, single submitter	11	47332222	GRCh38	181016	179183
NM_000256.3(MYBPC3):c.3662delT (p.Leu1221Argfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic	criteria provided, single submitter	11	47332224	GRCh38	217479	214109
NM_000256.3(MYBPC3):c.3659_3662delACCTinsTTCAAGAATGGC (p.Asp1220Valfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	11	47332224 - 47332227	GRCh38	8612	23651
NM_000256.3(MYBPC3):c.3651T>C (p.Asn1217=)	MYBPC3	not specified	GMAF:0.00040(G), GO-ESP:0.00001(G)	Likely benign(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	11	47332235	GRCh38	227569	230201
NM_000256.3(MYBPC3):c.3644dupT (p.Lys1216Glnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	11	47332242	GRCh38	179527	175142
NM_000256.3(MYBPC3):c.3642G>A (p.Trp1214Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00001(T)	Pathogenic/Likely pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, multiple submitters, no conflicts	11	47332244	GRCh38	162506	172177
NM_000256.3(MYBPC3):c.3641G>A (p.Trp1214Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, multiple submitters, no conflicts	11	47332245	GRCh38	181015	179184
NM_000256.3(MYBPC3):c.3628-34_3628-10del	MYBPC3	Cardiomyopathy, familial hypertrophic, 4, susceptibility to		risk factor(Last reviewed: Feb 1, 2009)	no assertion criteria provided	11	47332268 - 47332292	GRCh38	8620	23659
NM_000256.3(MYBPC3):c.3628-41_3628-17del25	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GMAF:0.00640(-), GO-ESP:0.00441(-)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 16, 2016)	criteria provided, conflicting interpretations	11	47332275 - 47332299	GRCh38	177677	174731
NM_000256.3(MYBPC3):c.3627+49C>T	MYBPC3	not specified	GMAF:0.34150(A), GO-ESP:0.25288(A)	Benign	criteria provided, single submitter	11	47332517	GRCh38	255625	254187
NM_000256.3(MYBPC3):c.3627+30G>A	MYBPC3	not specified	GMAF:0.00380(T), GO-ESP:0.00198(T)	Likely benign(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47332536	GRCh38	188586	186347
NM_000256.3(MYBPC3):c.3627+12delT	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 14, 2015)	criteria provided, single submitter	11	47332554	GRCh38	188587	186348
NG_007667.1:g.25143G>T	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47332560	GRCh38	304946	320893
NM_000256.3(MYBPC3):c.3627+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, multiple submitters, no conflicts	11	47332565	GRCh38	42728	51898
NM_000256.3(MYBPC3):c.3624delC (p.Lys1209Serfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, multiple submitters, no conflicts	11	47332569	GRCh38	42727	51897
NM_000256.3(MYBPC3):c.3624dupC (p.Lys1209Glnfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47332569	GRCh38	42726	51896
NM_000256.3(MYBPC3):c.3614G>A (p.Arg1205Gln)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Aug 5, 2016)	criteria provided, multiple submitters, no conflicts	11	47332579	GRCh38	181014	179185
NM_000256.3(MYBPC3):c.3613C>T (p.Arg1205Trp)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00002(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2016)	criteria provided, conflicting interpretations	11	47332580	GRCh38	164032	175143
NM_000256.3(MYBPC3):c.3611T>C (p.Val1204Ala)	MYBPC3	not provided		Likely pathogenic	criteria provided, single submitter	11	47332582	GRCh38	191020	188826
NM_000256.3(MYBPC3):c.3600_3609delCTGCTGTGCT (p.Cys1201Serfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	11	47332584 - 47332593	GRCh38	177670	174732
NM_000256.3(MYBPC3):c.3605G>A (p.Cys1202Tyr)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47332588	GRCh38	164029	175144
NM_000256.3(MYBPC3):c.3599T>C (p.Leu1200Pro)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 4		Likely pathogenic(Last reviewed: Jan 31, 2011)	criteria provided, multiple submitters, no conflicts	11	47332594	GRCh38	42725	51895
NM_000256.3(MYBPC3):c.3593C>T (p.Ala1198Val)	MYBPC3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	11	47332600	GRCh38	237429	241141
NM_000256.3(MYBPC3):c.3585C>A (p.Gly1195=)	MYBPC3	not specified		Likely benign(Last reviewed: Apr 5, 2012)	criteria provided, single submitter	11	47332608	GRCh38	42724	51894
NM_000256.3(MYBPC3):c.3584G>T (p.Gly1195Val)	MYBPC3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2014)	criteria provided, conflicting interpretations	11	47332609	GRCh38	181013	179186
NM_000256.3(MYBPC3):c.3581C>T (p.Ala1194Val)	MYBPC3	not specified|not provided	GO-ESP:0.00008(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2013)	criteria provided, conflicting interpretations	11	47332612	GRCh38	181012	179187
NM_000256.3(MYBPC3):c.3580G>A (p.Ala1194Thr)	MYBPC3	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Nov 5, 2009)	no assertion criteria provided	11	47332613	GRCh38	42723	51893
NM_000256.3(MYBPC3):c.3569G>A (p.Arg1190His)	MYBPC3	not specified|Cardiovascular phenotype	GO-ESP:0.00008(T), GMAF:0.00020(T), GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: May 13, 2015)	criteria provided, multiple submitters, no conflicts	11	47332624	GRCh38	42722	51892
NM_000256.3(MYBPC3):c.3553C>T (p.Gln1185Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	11	47332640	GRCh38	181133	179188
NM_000256.3(MYBPC3):c.3548T>G (p.Phe1183Cys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2013)	criteria provided, conflicting interpretations	11	47332645	GRCh38	42720	51890
NM_000256.3(MYBPC3):c.3547T>C (p.Phe1183Leu)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47332646	GRCh38	188585	186349
NM_000256.3(MYBPC3):c.3541C>G (p.Pro1181Ala)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Mar 6, 2012)	criteria provided, single submitter	11	47332652	GRCh38	181011	179189
NM_000256.3(MYBPC3):c.3535G>A (p.Glu1179Lys)	MYBPC3	not specified|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00049(T), GO-ESP:0.00046(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2016)	criteria provided, conflicting interpretations	11	47332658	GRCh38	42719	51889
NM_000256.3(MYBPC3):c.3512delA (p.Asn1171Thrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	11	47332681	GRCh38	228371	230202
NM_000256.3(MYBPC3):c.3491-2A>G	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47332704	GRCh38	188584	186350
NM_000256.3(MYBPC3):c.3491-2A>T	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47332704	GRCh38	42717	51887
NM_000256.3(MYBPC3):c.3491-3C>G	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jun 4, 2013)	criteria provided, single submitter	11	47332705	GRCh38	181010	179190
NM_000256.3(MYBPC3):c.3491-3C>A	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jan 31, 2013)	criteria provided, single submitter	11	47332705	GRCh38	181009	179191
NM_000256.3(MYBPC3):c.3490+6G>A	MYBPC3	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Aug 31, 2009)	no assertion criteria provided	11	47332808	GRCh38	42716	51886
NM_000256.3(MYBPC3):c.3490+1G>T	MYBPC3	not provided		Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	11	47332813	GRCh38	181008	179192
NM_000256.3(MYBPC3):c.3490+1G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Sep 10, 2012)	criteria provided, single submitter	11	47332813	GRCh38	42715	51885
NM_000256.3(MYBPC3):c.3486A>T (p.Arg1162Ser)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47332818	GRCh38	188583	186351
NM_000256.3(MYBPC3):c.3472_3481delGTCTTTATCC (p.Val1158Profs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	11	47332823 - 47332832	GRCh38	181103	179193
NM_000256.3(MYBPC3):c.3476_3479dupTTAT (p.Pro1161Tyrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy		Pathogenic(Last reviewed: May 29, 2013)	criteria provided, multiple submitters, no conflicts	11	47332825 - 47332828	GRCh38	42714	51884
NM_000256.3(MYBPC3):c.3477T>C (p.Phe1159=)	MYBPC3	not specified		Likely benign(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	11	47332827	GRCh38	227568	230203
NM_000256.3(MYBPC3):c.3476_3477delTT (p.Phe1159Tyrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	11	47332827 - 47332828	GRCh38	177784	174733
NM_000256.3(MYBPC3):c.3472G>A (p.Val1158Ile)	MYBPC3	not specified	GMAF:0.00020(T), GO-ESP:0.00015(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2013)	criteria provided, conflicting interpretations	11	47332832	GRCh38	177812	175145
NM_000256.3(MYBPC3):c.3469C>G (p.Pro1157Ala)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 26, 2014)	criteria provided, single submitter	11	47332835	GRCh38	180012	174734
NM_000256.3(MYBPC3):c.3467dupA (p.Pro1157Alafs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Sep 16, 2014)	criteria provided, single submitter	11	47332837	GRCh38	181156	179194
NM_000256.3(MYBPC3):c.3431T>C (p.Met1144Thr)	MYBPC3	not specified		Likely benign(Last reviewed: Aug 2, 2012)	criteria provided, single submitter	11	47332873	GRCh38	180920	179195
NM_000256.3(MYBPC3):c.3415G>A (p.Val1139Ile)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00016(T), GMAF:0.00040(T), GO-ESP:0.00009(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47332889	GRCh38	42713	51883
NM_000256.3(MYBPC3):c.3414dupC (p.Val1139Argfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic	criteria provided, single submitter	11	47332890	GRCh38	217486	214110
NM_000256.3(MYBPC3):c.3414C>T (p.Arg1138=)	MYBPC3	not specified	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47332890	GRCh38	188582	186352
NM_000256.3(MYBPC3):c.3413G>A (p.Arg1138His)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified	GMAF:0.00040(T), GO-ESP:0.00130(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2015)	criteria provided, conflicting interpretations	11	47332891	GRCh38	177689	175146
NM_000256.3(MYBPC3):c.3413G>C (p.Arg1138Pro)	MYBPC3	not specified	GMAF:0.00040(T)	Uncertain significance(Last reviewed: Jun 29, 2015)	criteria provided, multiple submitters, no conflicts	11	47332891	GRCh38	42712	51882
NM_000256.3(MYBPC3):c.3412C>T (p.Arg1138Cys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	11	47332892	GRCh38	161307	171134
NM_000256.3(MYBPC3):c.3407_3409delACT (p.Tyr1136del)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2015)	criteria provided, conflicting interpretations	11	47332895 - 47332897	GRCh38	181102	179196
NM_000256.3(MYBPC3):c.3408C>A (p.Tyr1136Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype		Pathogenic(Last reviewed: May 26, 2015)	criteria provided, multiple submitters, no conflicts	11	47332896	GRCh38	36611	45273
NM_000256.3(MYBPC3):c.3392T>C (p.Ile1131Thr)	MYBPC3	not specified|Cardiac arrest|Cardiovascular phenotype	GO-ESP:0.00057(G), GO-ESP:0.00106(G)	Likely benign(Last reviewed: Jan 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47332912	GRCh38	42711	51881
NM_000256.3(MYBPC3):c.3384G>C (p.Glu1128Asp)	MYBPC3	not specified	GO-ESP:0.00016(G), GO-ESP:0.00013(G)	Uncertain significance(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	11	47332920	GRCh38	42710	51880
NM_000256.3(MYBPC3):c.3373G>T (p.Val1125Leu)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47332931	GRCh38	188581	186353
NM_000256.3(MYBPC3):c.3373G>A (p.Val1125Met)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not specified	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 16, 2016)	criteria provided, conflicting interpretations	11	47332931	GRCh38	8604	23643
NM_000256.3(MYBPC3):c.3372C>A (p.Cys1124Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00002(T)	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	11	47332932	GRCh38	177701	174735
NM_000256.3(MYBPC3):c.3362G>A (p.Arg1121His)	MYBPC3	not specified	GMAF:0.00020(T), GO-ESP:0.00013(T)	Uncertain significance(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	11	47332942	GRCh38	42709	51879
NM_000256.3(MYBPC3):c.3347T>C (p.Leu1116Ser)	MYBPC3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	11	47332957	GRCh38	263510	258697
NM_000256.3(MYBPC3):c.3335_3337dupGGT (p.Trp1112_Phe1113insTrp)	MYBPC3	Cardiomyopathy		Uncertain significance(Last reviewed: Sep 19, 2012)	criteria provided, single submitter	11	47332967 - 47332969	GRCh38	181101	179197
NM_000256.3(MYBPC3):c.3332_3335dupAGTG (p.Trp1112Terfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47332969 - 47332972	GRCh38	177718	178184
NM_000256.3(MYBPC3):c.3335G>A (p.Trp1112Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47332969	GRCh38	177680	175147
NM_000256.3(MYBPC3):c.3331-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Aug 29, 2013)	criteria provided, single submitter	11	47332974	GRCh38	177742	174736
NM_000256.3(MYBPC3):c.3331-2A>C	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, multiple submitters, no conflicts	11	47332975	GRCh38	222710	224422
NM_000256.3(MYBPC3):c.3330+5G>T	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2015)	criteria provided, multiple submitters, no conflicts	11	47333189	GRCh38	42707	51877
NM_000256.3(MYBPC3):c.3330+5G>C	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00008(G), GO-ESP:0.00003(G)	Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, multiple submitters, no conflicts	11	47333189	GRCh38	42706	51876
NM_000256.3(MYBPC3):c.3330+5G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|not provided		Pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	11	47333189	GRCh38	8602	23641
NM_000256.3(MYBPC3):c.3330+2T>C	MYBPC3	not provided		Pathogenic(Last reviewed: Aug 22, 2012)	criteria provided, single submitter	11	47333192	GRCh38	181007	179198
NM_000256.3(MYBPC3):c.3330+2T>G	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Inborn genetic diseases		Pathogenic/Likely pathogenic(Last reviewed: May 2, 2016)	criteria provided, multiple submitters, no conflicts	11	47333192	GRCh38	8621	23660
NM_000256.3(MYBPC3):c.3327delC (p.Met1110Trpfs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Dec 20, 2011)	criteria provided, single submitter	11	47333197	GRCh38	181155	179199
NM_000256.3(MYBPC3):c.3326C>T (p.Thr1109Ile)	MYBPC3	not specified|not provided	GMAF:0.00020(A)	Uncertain significance(Last reviewed: Jun 24, 2013)	criteria provided, multiple submitters, no conflicts	11	47333198	GRCh38	42705	51875
NM_000256.3(MYBPC3):c.3323A>C (p.Lys1108Thr)	MYBPC3	not specified|not provided	GO-ESP:0.00005(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2015)	criteria provided, conflicting interpretations	11	47333201	GRCh38	42704	51874
NM_000256.3(MYBPC3):c.3321dupG (p.Lys1108Glufs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Feb 15, 2014)	criteria provided, single submitter	11	47333203	GRCh38	181100	179200
NM_000256.3(MYBPC3):c.3315C>T (p.Ala1105=)	MYBPC3	not specified	GMAF:0.00020(A)	Likely benign(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	11	47333209	GRCh38	178872	175148
NM_000256.3(MYBPC3):c.3315C>A (p.Ala1105=)	MYBPC3	not specified	GO-ESP:0.00016(T), GMAF:0.00020(A), GO-ESP:0.00029(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2013)	criteria provided, conflicting interpretations	11	47333209	GRCh38	42703	51873
NM_000256.3(MYBPC3):c.3314C>G (p.Ala1105Gly)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47333210	GRCh38	188580	186354
NM_000256.3(MYBPC3):c.3308A>C (p.Gln1103Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: May 28, 2014)	criteria provided, single submitter	11	47333216	GRCh38	181006	179201
NM_000256.3(MYBPC3):c.3305T>A (p.Val1102Glu)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jun 12, 2014)	criteria provided, single submitter	11	47333219	GRCh38	181005	179202
NM_000256.3(MYBPC3):c.3302_3303delCA (p.Thr1101Serfs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Dec 19, 2012)	criteria provided, single submitter	11	47333221 - 47333222	GRCh38	181098	179203
NM_000256.3(MYBPC3):c.3300C>A (p.Tyr1100Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic	criteria provided, single submitter	11	47333224	GRCh38	217485	214111
NM_000256.3(MYBPC3):c.3297dupG (p.Tyr1100Valfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2014)	criteria provided, single submitter	11	47333227	GRCh38	42702	51872
NM_000256.3(MYBPC3):c.3293G>T (p.Trp1098Leu)	MYBPC3	not specified		Uncertain significance(Last reviewed: Dec 6, 2012)	criteria provided, single submitter	11	47333231	GRCh38	181004	179205
NM_000256.3(MYBPC3):c.3293G>A (p.Trp1098Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Sep 20, 2011)	criteria provided, single submitter	11	47333231	GRCh38	42701	51871
NM_000256.3(MYBPC3):c.3288delG (p.Glu1096Aspfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, multiple submitters, no conflicts	11	47333236	GRCh38	164042	174737
NM_000256.3(MYBPC3):c.3288G>A (p.Glu1096=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.35504(T), GMAF:0.47620(T), GO-ESP:0.47070(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47333236	GRCh38	42700	51870
NM_000256.3(MYBPC3):c.3286G>T (p.Glu1096Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: May 23, 2016)	criteria provided, multiple submitters, no conflicts	11	47333238	GRCh38	8616	23655
NM_000256.3(MYBPC3):c.3285G>A (p.Thr1095=)	MYBPC3	not specified	GO-ESP:0.00024(T), GMAF:0.00020(T), GO-ESP:0.00021(T)	Benign/Likely benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	11	47333239	GRCh38	138319	142022
NM_000256.3(MYBPC3):c.3285G>C (p.Thr1095=)	MYBPC3	not specified	GMAF:0.00020(T)	Likely benign(Last reviewed: Nov 15, 2010)	criteria provided, single submitter	11	47333239	GRCh38	42699	51869
NM_000256.3(MYBPC3):c.3281A>T (p.Asn1094Ile)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47333243	GRCh38	42698	51868
NM_000256.3(MYBPC3):c.3279C>T (p.Gly1093=)	MYBPC3	not specified	GMAF:0.00060(A), GO-ESP:0.00016(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2014)	criteria provided, conflicting interpretations	11	47333245	GRCh38	188579	186355
NM_000256.3(MYBPC3):c.3277G>T (p.Gly1093Cys)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Apr 10, 2015)	criteria provided, multiple submitters, no conflicts	11	47333247	GRCh38	164043	175149
NM_000256.3(MYBPC3):c.3276C>T (p.Val1092=)	MYBPC3	not specified	GO-ESP:0.00013(A)	Benign/Likely benign(Last reviewed: Aug 13, 2014)	criteria provided, multiple submitters, no conflicts	11	47333248	GRCh38	178063	174738
NM_000256.3(MYBPC3):c.3253G>T (p.Glu1085Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2016)	criteria provided, multiple submitters, no conflicts	11	47333271	GRCh38	42696	51866
NM_000256.3(MYBPC3):c.3233G>A (p.Trp1078Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00002(T)	Pathogenic(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	11	47333291	GRCh38	42692	51862
NM_000256.3(MYBPC3):c.3229G>A (p.Ala1077Thr)	MYBPC3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2013)	criteria provided, conflicting interpretations	11	47333295	GRCh38	42695	51865
NM_000256.3(MYBPC3):c.3227A>G (p.Asp1076Gly)	MYBPC3	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Sep 29, 2014)	no assertion criteria provided	11	47333297	GRCh38	180413	178640
NM_000256.3(MYBPC3):c.3226_3227insT (p.Asp1076Valfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, multiple submitters, no conflicts	11	47333297 - 47333298	GRCh38	42694	51864
NM_000256.3(MYBPC3):c.3217dupC (p.Arg1073Profs)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Aug 17, 2012)	no assertion criteria provided	11	47333307	GRCh38	181096	179207
NM_000256.3(MYBPC3):c.3217delC (p.Arg1073Glyfs)	MYBPC3	not provided		Pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	11	47333307	GRCh38	181095	179206
NM_000256.3(MYBPC3):c.3192dupC (p.Lys1065Glnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, multiple submitters, no conflicts	11	47333332	GRCh38	42693	51863
NG_007667.1:g.24363C>T	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47333340	GRCh38	304947	314281
NM_000256.3(MYBPC3):c.3191-21A>G	MYBPC3	not specified	GMAF:0.03300(C), GO-ESP:0.10692(C)	Benign(Last reviewed: Feb 23, 2012)	criteria provided, multiple submitters, no conflicts	11	47333354	GRCh38	188578	186356
NM_000256.3(MYBPC3):c.3190+5G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00002(T)	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	11	47333552	GRCh38	155808	165560
NM_000256.3(MYBPC3):c.3182_3190+4del	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Feb 7, 2012)	criteria provided, single submitter	11	47333553 - 47333565	GRCh38	181154	179209
NM_000256.3(MYBPC3):c.3190+4C>T	MYBPC3	not specified	GMAF:0.00020(A), GO-ESP:0.00009(A)	Uncertain significance(Last reviewed: Oct 28, 2015)	criteria provided, multiple submitters, no conflicts	11	47333553	GRCh38	181003	179208
NM_000256.3(MYBPC3):c.3190+3delG	MYBPC3	not provided		Pathogenic(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	11	47333554	GRCh38	181094	179210
NM_000256.3(MYBPC3):c.3190+2T>G	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00002(C)	Pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, multiple submitters, no conflicts	11	47333555	GRCh38	42691	51861
NM_000256.3(MYBPC3):c.3190+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, multiple submitters, no conflicts	11	47333556	GRCh38	177837	175150
NM_000256.3(MYBPC3):c.3190G>A (p.Asp1064Asn)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	11	47333557	GRCh38	179881	174739
NM_000256.3(MYBPC3):c.3181C>T (p.Gln1061Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00002(A)	Pathogenic(Last reviewed: Dec 8, 2015)	criteria provided, multiple submitters, no conflicts	11	47333566	GRCh38	42690	51860
NM_000256.3(MYBPC3):c.3171G>A (p.Thr1057=)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Feb 10, 2016)	criteria provided, multiple submitters, no conflicts	11	47333576	GRCh38	42689	51859
NM_000256.3(MYBPC3):c.3169A>G (p.Thr1057Ala)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47333578	GRCh38	188577	186357
NM_000256.3(MYBPC3):c.3166dupG (p.Ala1056Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47333581	GRCh38	164047	175151
NM_000256.3(MYBPC3):c.3163A>T (p.Lys1055Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	11	47333584	GRCh38	222702	224423
NM_000256.3(MYBPC3):c.3154A>G (p.Met1052Val)	MYBPC3	not specified	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	11	47333593	GRCh38	181002	179211
NM_000256.3(MYBPC3):c.3148G>A (p.Glu1050Lys)	MYBPC3	not provided	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Jun 24, 2013)	criteria provided, single submitter	11	47333599	GRCh38	191703	189887
NM_000256.3(MYBPC3):c.3143G>A (p.Arg1048His)	MYBPC3	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	11	47333604	GRCh38	188576	186358
NM_000256.3(MYBPC3):c.3137C>T (p.Thr1046Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	GMAF:0.00040(A), GO-ESP:0.00006(A)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 16, 2015)	criteria provided, conflicting interpretations	11	47333610	GRCh38	161301	171135
NM_000256.3(MYBPC3):c.3129C>A (p.Tyr1043Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GMAF:0.00020(A)	Pathogenic(Last reviewed: Jan 4, 2013)	criteria provided, single submitter	11	47333618	GRCh38	164048	174740
NM_000256.3(MYBPC3):c.3123C>T (p.Gly1041=)	MYBPC3	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	11	47333624	GRCh38	181001	179212
NM_000256.3(MYBPC3):c.3118T>G (p.Ser1040Ala)	MYBPC3	Ventricular tachycardia, catecholaminergic polymorphic, 1		Uncertain significance(Last reviewed: Aug 22, 2014)	no assertion criteria provided	11	47333629	GRCh38	180412	178641
NM_000256.3(MYBPC3):c.3107G>A (p.Arg1036His)	MYBPC3	not specified	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	11	47333640	GRCh38	181000	179213
NM_000256.3(MYBPC3):c.3106C>T (p.Arg1036Cys)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00209(A), GMAF:0.00260(A), GO-ESP:0.00052(A)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 24, 2016)	criteria provided, conflicting interpretations	11	47333641	GRCh38	42688	51858
NM_000256.3(MYBPC3):c.3103G>A (p.Ala1035Thr)	MYBPC3	not specified	GMAF:0.00020(T), GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47333644	GRCh38	188575	186359
NM_000256.3(MYBPC3):c.3102C>T (p.Ala1034=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00080(A), GO-ESP:0.00054(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47333645	GRCh38	42687	51857
NM_000256.3(MYBPC3):c.3089_3101delTGTTCATCCGGGC (p.Leu1030Profs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47333646 - 47333658	GRCh38	164049	175152
NM_000256.3(MYBPC3):c.3098G>A (p.Arg1033Gln)	MYBPC3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2013)	criteria provided, conflicting interpretations	11	47333649	GRCh38	42686	51856
NM_000256.3(MYBPC3):c.3089T>C (p.Leu1030Pro)	MYBPC3	Cardiomyopathy		Likely pathogenic(Last reviewed: Jul 3, 2012)	criteria provided, single submitter	11	47333658	GRCh38	180999	179214
NM_000256.3(MYBPC3):c.3087C>T (p.Ile1029=)	MYBPC3	not specified		Likely benign(Last reviewed: Mar 27, 2015)	criteria provided, single submitter	11	47333660	GRCh38	42685	51855
NM_000256.3(MYBPC3):c.3086T>A (p.Ile1029Asn)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jan 27, 2014)	criteria provided, single submitter	11	47333661	GRCh38	180998	179215
NM_000256.3(MYBPC3):c.3083C>T (p.Thr1028Ile)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 25, 2015)	criteria provided, multiple submitters, no conflicts	11	47333664	GRCh38	164050	174741
NM_000256.3(MYBPC3):c.3083C>G (p.Thr1028Ser)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47333664	GRCh38	42684	51854
NM_000256.3(MYBPC3):c.3079delGinsAA (p.Asp1027Lysfs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Aug 11, 2014)	criteria provided, single submitter	11	47333668	GRCh38	181093	179216
NM_000256.3(MYBPC3):c.3068dupA (p.Asn1023Lysfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Feb 17, 2011)	criteria provided, single submitter	11	47333679	GRCh38	42683	51853
NM_000256.3(MYBPC3):c.3065G>C (p.Arg1022Pro)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	GMAF:0.00020(G), GO-ESP:0.00003(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2015)	criteria provided, conflicting interpretations	11	47333682	GRCh38	42682	51852
NM_000256.3(MYBPC3):c.3065G>A (p.Arg1022His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|not specified	GMAF:0.00020(G)	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, multiple submitters, no conflicts	11	47333682	GRCh38	42681	51851
NM_000256.3(MYBPC3):c.3064C>T (p.Arg1022Cys)	MYBPC3	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Apr 11, 2013)	criteria provided, single submitter	11	47333683	GRCh38	42680	51850
NM_000256.3(MYBPC3):c.3049G>A (p.Glu1017Lys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00008(T), GO-ESP:0.00009(T)	Uncertain significance(Last reviewed: Mar 24, 2016)	criteria provided, multiple submitters, no conflicts	11	47333698	GRCh38	42679	51849
NM_000256.3(MYBPC3):c.3048C>T (p.Gly1016=)	MYBPC3	not specified	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Dec 28, 2010)	criteria provided, single submitter	11	47333699	GRCh38	42678	51848
NM_000256.3(MYBPC3):c.3043dupG (p.Ala1015Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Nov 4, 2015)	criteria provided, single submitter	11	47333704	GRCh38	222709	224424
NM_000256.3(MYBPC3):c.3040delC (p.Leu1014Trpfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2012)	criteria provided, multiple submitters, no conflicts	11	47333707	GRCh38	42677	51847
NM_000256.3(MYBPC3):c.3034C>T (p.Gln1012Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	11	47333713	GRCh38	180997	179217
NM_000256.3(MYBPC3):c.3029_3030delAG (p.Glu1010Glyfs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: May 29, 2014)	criteria provided, single submitter	11	47333717 - 47333718	GRCh38	181092	179218
NM_000256.3(MYBPC3):c.3021G>A (p.Trp1007Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	11	47333726	GRCh38	181135	179219
NM_000256.3(MYBPC3):c.3019T>C (p.Trp1007Arg)	MYBPC3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2014)	criteria provided, conflicting interpretations	11	47333728	GRCh38	180996	179220
NM_000256.3(MYBPC3):c.3017C>A (p.Thr1006Asn)	MYBPC3	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47333730	GRCh38	188574	186360
NM_000256.3(MYBPC3):c.3005G>A (p.Arg1002Gln)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00005(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2015)	criteria provided, conflicting interpretations	11	47333742	GRCh38	177622	175153
NM_000256.3(MYBPC3):c.3004C>T (p.Arg1002Trp)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00162(A), GMAF:0.00300(A), GO-ESP:0.00067(A)	Benign/Likely benign(Last reviewed: Jan 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47333743	GRCh38	42676	51846
NM_000256.3(MYBPC3):c.3003C>T (p.Pro1001=)	MYBPC3	not specified	GMAF:0.00060(A), GO-ESP:0.00006(A)	Likely benign(Last reviewed: Feb 8, 2007)	criteria provided, single submitter	11	47333744	GRCh38	42675	51845
NM_000256.3(MYBPC3):c.2997C>T (p.Gly999=)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00024(A), GMAF:0.00020(A), GO-ESP:0.00009(A)	Benign/Likely benign(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	11	47333750	GRCh38	42674	51844
NM_000256.3(MYBPC3):c.2995-1G>A	MYBPC3	not provided		Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	11	47333753	GRCh38	180995	179221
NM_000256.3(MYBPC3):c.2995-5C>G	MYBPC3	not specified	GO-ESP:0.00006(C)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2015)	criteria provided, conflicting interpretations	11	47333757	GRCh38	42673	51843
NM_000256.3(MYBPC3):c.2994+2T>C	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	11	47333920	GRCh38	164051	174742
NM_000256.3(MYBPC3):c.2993A>G (p.Gln998Arg)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 11, 2013)	no assertion criteria provided	11	47333923	GRCh38	164052	175154
NM_000256.3(MYBPC3):c.2992C>T (p.Gln998Ter)	MYBPC3	not provided	GMAF:0.00620(C)	Pathogenic(Last reviewed: Apr 21, 2014)	criteria provided, single submitter	11	47333924	GRCh38	180993	179222
NM_000256.3(MYBPC3):c.2992C>G (p.Gln998Glu)	MYBPC3	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00620(C), GO-ESP:0.00524(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47333924	GRCh38	36610	45272
NM_000256.3(MYBPC3):c.2980C>T (p.Leu994Phe)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00021(A)	Uncertain significance(Last reviewed: May 17, 2016)	criteria provided, multiple submitters, no conflicts	11	47333936	GRCh38	180992	179223
NM_000256.3(MYBPC3):c.2965G>T (p.Glu989Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47333951	GRCh38	164053	174743
NM_000256.3(MYBPC3):c.2963G>T (p.Gly988Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 30, 2014)	criteria provided, single submitter	11	47333953	GRCh38	179550	175155
NM_000256.3(MYBPC3):c.2961C>T (p.Val987=)	MYBPC3	Cardiovascular phenotype	GO-ESP:0.00019(A)	Likely benign(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	11	47333955	GRCh38	263598	258698
NM_000256.3(MYBPC3):c.2956A>G (p.Lys986Glu)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 12, 2015)	criteria provided, single submitter	11	47333960	GRCh38	228868	230204
NM_000256.3(MYBPC3):c.2953A>T (p.Lys985Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	11	47333963	GRCh38	177956	174744
NM_000256.3(MYBPC3):c.2943_2947delGACCA (p.Gln981Hisfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 5, 2012)	criteria provided, single submitter	11	47333969 - 47333973	GRCh38	42672	51842
NM_000256.3(MYBPC3):c.2942A>C (p.Gln981Pro)	MYBPC3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2014)	criteria provided, conflicting interpretations	11	47333974	GRCh38	180991	179224
NM_000256.3(MYBPC3):c.2939G>A (p.Arg980His)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jul 17, 2013)	criteria provided, single submitter	11	47333977	GRCh38	164054	175156
NM_000256.3(MYBPC3):c.2938C>T (p.Arg980Cys)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Paroxysmal atrial fibrillation|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47333978	GRCh38	42671	51841
NM_000256.3(MYBPC3):c.2920C>T (p.Gln974Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Sep 23, 2013)	criteria provided, multiple submitters, no conflicts	11	47333996	GRCh38	164055	174745
NM_000256.3(MYBPC3):c.2914C>T (p.Arg972Trp)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00100(A), GO-ESP:0.00043(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2015)	criteria provided, conflicting interpretations	11	47334002	GRCh38	36609	45271
NM_000256.3(MYBPC3):c.2909G>A (p.Arg970Gln)	MYBPC3	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Feb 19, 2015)	criteria provided, multiple submitters, no conflicts	11	47334007	GRCh38	177832	175157
NM_000256.3(MYBPC3):c.2908C>T (p.Arg970Trp)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00007(A)	Likely pathogenic(Last reviewed: Apr 11, 2014)	no assertion criteria provided	11	47334008	GRCh38	180411	178642
NM_000256.3(MYBPC3):c.2906-2A>G	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47334012	GRCh38	177811	174746
NM_000256.3(MYBPC3):c.2906-7C>T	MYBPC3	not specified		Likely benign(Last reviewed: Dec 29, 2014)	criteria provided, single submitter	11	47334017	GRCh38	227567	230205
NG_007667.1:g.22668G>C	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47335035	GRCh38	304948	314284
NM_000256.3(MYBPC3):c.2905+5G>T	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 10, 2011)	criteria provided, single submitter	11	47335037	GRCh38	42668	51838
NM_000256.3(MYBPC3):c.2905+5G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	47335037	GRCh38	36608	45270
NM_000256.3(MYBPC3):c.2894_2905+4del	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	11	47335038 - 47335053	GRCh38	181153	179225
NM_000256.3(MYBPC3):c.2905+1G>C	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Aug 30, 2012)	criteria provided, single submitter	11	47335041	GRCh38	42667	51837
NM_000256.3(MYBPC3):c.2905+1G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Conflicting interpretations of pathogenicity(Last reviewed: Mar 16, 2016)	criteria provided, conflicting interpretations	11	47335041	GRCh38	42666	51836
NM_000256.3(MYBPC3):c.2905C>T (p.Gln969Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, multiple submitters, no conflicts	11	47335042	GRCh38	42669	51839
NM_000256.3(MYBPC3):c.2904G>C (p.Leu968=)	MYBPC3	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	11	47335043	GRCh38	228867	230206
NM_000256.3(MYBPC3):c.2897A>T (p.Glu966Val)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Mar 30, 2014)	criteria provided, single submitter	11	47335050	GRCh38	180987	179226
NM_000256.3(MYBPC3):c.2893C>T (p.Gln965Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: May 10, 2013)	criteria provided, single submitter	11	47335054	GRCh38	180986	179227
NG_007667.1:g.22648G>T	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47335055	GRCh38	304949	326939
NM_000256.3(MYBPC3):c.2882C>T (p.Pro961Leu)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00008(A), GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Dec 29, 2015)	criteria provided, multiple submitters, no conflicts	11	47335065	GRCh38	42665	51835
NM_000256.3(MYBPC3):c.2877G>A (p.Thr959=)	MYBPC3	not specified	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	11	47335070	GRCh38	164058	175158
NM_000256.3(MYBPC3):c.2876C>T (p.Thr959Met)	MYBPC3	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Sep 23, 2014)	criteria provided, single submitter	11	47335071	GRCh38	181131	179228
NM_000256.3(MYBPC3):c.2875_2876delAC (p.Thr959Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy		Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	11	47335071 - 47335072	GRCh38	164059	174747
NM_000256.3(MYBPC3):c.2873C>T (p.Thr958Ile)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00016(A), GO-ESP:0.00007(A)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2015)	criteria provided, conflicting interpretations	11	47335074	GRCh38	42664	51834
NM_000256.3(MYBPC3):c.2870C>G (p.Thr957Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Cardiomyopathy|Hypertrophic cardiomyopathy	GMAF:0.00040(C), GO-ESP:0.00109(C)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2015)	criteria provided, conflicting interpretations	11	47335077	GRCh38	36607	45269
NM_000256.3(MYBPC3):c.2869dupA (p.Thr957Asnfs)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jun 20, 2012)	no assertion criteria provided	11	47335078	GRCh38	235020	236782
NM_000256.3(MYBPC3):c.2864_2865delCT (p.Pro955Argfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: May 18, 2016)	criteria provided, multiple submitters, no conflicts	11	47335082 - 47335083	GRCh38	42663	51833
NM_000256.3(MYBPC3):c.2860G>A (p.Ala954Thr)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47335087	GRCh38	188573	186361
NM_000256.3(MYBPC3):c.2859A>G (p.Gly953=)	MYBPC3	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 13, 2012)	criteria provided, single submitter	11	47335088	GRCh38	263373	258699
NM_000256.3(MYBPC3):c.2856T>G (p.Pro952=)	MYBPC3	not specified|Cardiovascular phenotype	GO-ESP:0.00002(C)	Likely benign(Last reviewed: Aug 9, 2012)	criteria provided, multiple submitters, no conflicts	11	47335091	GRCh38	42662	51832
NG_007667.1:g.22610C>G	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.02400(C), GO-ESP:0.00004(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47335093	GRCh38	304950	314287
NM_000256.3(MYBPC3):c.2849C>T (p.Ala950Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Oct 13, 2015)	criteria provided, single submitter	11	47335098	GRCh38	180985	179229
NM_000256.3(MYBPC3):c.2846dupT (p.Met949Ilefs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47335101	GRCh38	188572	186362
NM_000256.3(MYBPC3):c.2843A>C (p.Asn948Thr)	MYBPC3	Left ventricular noncompaction 10		Pathogenic(Last reviewed: Oct 18, 2002)	no assertion criteria provided	11	47335104	GRCh38	8615	23654
NM_000256.3(MYBPC3):c.2839C>A (p.His947Asn)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 30, 2010)	criteria provided, single submitter	11	47335108	GRCh38	42661	51831
NM_000256.3(MYBPC3):c.2833_2834delCG (p.Arg945Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	11	47335113 - 47335114	GRCh38	42660	51830
NM_000256.3(MYBPC3):c.2833C>T (p.Arg945Trp)	MYBPC3	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jul 21, 2014)	criteria provided, single submitter	11	47335114	GRCh38	164060	175159
NM_000256.3(MYBPC3):c.2828G>A (p.Arg943Gln)	MYBPC3	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	11	47335119	GRCh38	42659	51829
NM_000256.3(MYBPC3):c.2827C>T (p.Arg943Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	GO-ESP:0.00002(A)	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, multiple submitters, no conflicts	11	47335120	GRCh38	37039	45725
NM_000256.3(MYBPC3):c.2808G>A (p.Thr936=)	MYBPC3	not specified	GO-ESP:0.00013(T)	Uncertain significance(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	11	47335139	GRCh38	188571	186363
NM_000256.3(MYBPC3):c.2807C>T (p.Thr936Met)	MYBPC3	not specified	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	11	47335140	GRCh38	181130	179230
NM_000256.3(MYBPC3):c.2805C>T (p.Pro935=)	MYBPC3	Hypertrophic cardiomyopathy		Likely benign(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	11	47335142	GRCh38	237428	241142
NM_000256.3(MYBPC3):c.2800C>T (p.Leu934=)	MYBPC3	not specified|Cardiomyopathy	GO-ESP:0.00008(A), GO-ESP:0.00006(A)	Benign/Likely benign(Last reviewed: Jul 24, 2012)	criteria provided, multiple submitters, no conflicts	11	47335147	GRCh38	42658	51828
NM_000256.3(MYBPC3):c.2792dupT (p.Lys932Glufs)	MYBPC3	not provided		Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	11	47335155	GRCh38	181152	179231
NM_000256.3(MYBPC3):c.2789delT (p.Leu930Argfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	11	47335158	GRCh38	228370	230207
NM_000256.3(MYBPC3):c.2784G>A (p.Ser928=)	MYBPC3	not specified	GMAF:0.00040(G)	Likely benign(Last reviewed: Apr 9, 2010)	criteria provided, single submitter	11	47335163	GRCh38	42657	51827
NM_000256.3(MYBPC3):c.2780_2781delCA (p.Thr927Ilefs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Nov 17, 2015)	criteria provided, multiple submitters, no conflicts	11	47335166 - 47335167	GRCh38	177660	174748
NM_000256.3(MYBPC3):c.2771C>T (p.Thr924Ile)	MYBPC3	not specified|not provided	GO-ESP:0.00009(A)	Uncertain significance(Last reviewed: Feb 17, 2016)	criteria provided, multiple submitters, no conflicts	11	47335176	GRCh38	181129	179232
NM_000256.3(MYBPC3):c.2761C>G (p.Gln921Glu)	MYBPC3	not specified|Cardiomyopathy	GMAF:0.00120(C), GO-ESP:0.00018(C)	Uncertain significance(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	11	47335186	GRCh38	180983	179233
NM_000256.3(MYBPC3):c.2748G>A (p.Trp916Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Jul 13, 2012)	criteria provided, single submitter	11	47335199	GRCh38	180982	179234
NM_000256.3(MYBPC3):c.2747G>A (p.Trp916Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	11	47335200	GRCh38	177835	175160
NM_000256.3(MYBPC3):c.2744delA (p.Glu915Glyfs)	MYBPC3	not provided		Pathogenic(Last reviewed: Jan 19, 2014)	criteria provided, single submitter	11	47335203	GRCh38	181088	179235
NM_000256.3(MYBPC3):c.2739delC (p.Ser914Glnfs)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	11	47335208	GRCh38	181087	179236
NG_007667.1:g.21840C>A	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47335863	GRCh38	304951	326940
NM_000256.3(MYBPC3):c.2737+13G>A	MYBPC3	not specified	GO-ESP:0.00027(T)	Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47335864	GRCh38	188570	186364
NM_000256.3(MYBPC3):c.2737+12C>T	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.03383(A), GMAF:0.05470(A), GO-ESP:0.10086(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47335865	GRCh38	42653	51823
NM_000256.3(MYBPC3):c.2737+5G>A	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	11	47335872	GRCh38	92690	98597
NM_000256.3(MYBPC3):c.2737+2T>A	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: May 14, 2015)	criteria provided, single submitter	11	47335875	GRCh38	164063	174749
NM_000256.3(MYBPC3):c.2737+1G>C	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47335876	GRCh38	177766	175161
NM_000256.3(MYBPC3):c.2737delT (p.Cys913Alafs)	MYBPC3	not provided		Pathogenic(Last reviewed: May 11, 2016)	criteria provided, single submitter	11	47335877	GRCh38	181085	179237
NM_000256.3(MYBPC3):c.2728C>A (p.Pro910Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Brugada syndrome|not specified	GMAF:0.00020(T), GO-ESP:0.00039(T)	Uncertain significance(Last reviewed: Mar 21, 2016)	criteria provided, multiple submitters, no conflicts	11	47335886	GRCh38	42656	51826
NM_000256.3(MYBPC3):c.2727C>A (p.Cys909Ter)	MYBPC3	Cardiovascular phenotype		Pathogenic(Last reviewed: Jan 15, 2013)	criteria provided, single submitter	11	47335887	GRCh38	263484	258700
NM_000256.3(MYBPC3):c.2723A>G (p.Tyr908Cys)	MYBPC3	not specified	GO-ESP:0.00006(C)	Uncertain significance(Last reviewed: Feb 4, 2013)	criteria provided, single submitter	11	47335891	GRCh38	42655	51825
NM_000256.3(MYBPC3):c.2709_2719delCTACAGCGTGG (p.Tyr904Valfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, multiple submitters, no conflicts	11	47335895 - 47335905	GRCh38	181084	179238
NM_000256.3(MYBPC3):c.2716delG (p.Val906Trpfs)	MYBPC3	not provided		Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	11	47335898	GRCh38	280011	264551
NM_000256.3(MYBPC3):c.2714G>A (p.Ser905Asn)	MYBPC3	not specified		Uncertain significance(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	11	47335900	GRCh38	42654	51824
NM_000256.3(MYBPC3):c.2686G>A (p.Val896Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00375(T), GMAF:0.00160(T), GO-ESP:0.01275(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47335928	GRCh38	42652	51822
NM_000256.3(MYBPC3):c.2684G>A (p.Arg895His)	MYBPC3	not specified	GO-ESP:0.00033(T), GMAF:0.00020(T), GO-ESP:0.00017(T)	Uncertain significance(Last reviewed: Aug 6, 2015)	criteria provided, multiple submitters, no conflicts	11	47335930	GRCh38	42651	51821
NM_000256.3(MYBPC3):c.2672G>A (p.Arg891Gln)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00010(T)	Uncertain significance(Last reviewed: Nov 9, 2015)	criteria provided, multiple submitters, no conflicts	11	47335942	GRCh38	177884	174750
NM_000256.3(MYBPC3):c.2671C>T (p.Arg891Trp)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00003(A)	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	11	47335943	GRCh38	177949	175162
NM_000256.3(MYBPC3):c.2670dupG (p.Arg891Alafs)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic	criteria provided, single submitter	11	47335944	GRCh38	217476	214112
NM_000256.3(MYBPC3):c.2670G>A (p.Trp890Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, multiple submitters, no conflicts	11	47335944	GRCh38	42650	51820
NM_000256.3(MYBPC3):c.2654C>T (p.Thr885Met)	MYBPC3	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47335960	GRCh38	42649	51819
NM_000256.3(MYBPC3):c.2641G>A (p.Val881Ile)	MYBPC3	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Jan 23, 2009)	no assertion criteria provided	11	47335973	GRCh38	177854	174751
NM_000256.3(MYBPC3):c.2640C>T (p.Asp880=)	MYBPC3	not specified	GMAF:0.00020(A), GO-ESP:0.00004(A)	Likely benign(Last reviewed: May 13, 2011)	criteria provided, single submitter	11	47335974	GRCh38	42648	51818
NG_007667.1:g.21728A>C	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47335975	GRCh38	304952	326941
NM_000256.3(MYBPC3):c.2632G>A (p.Val878Ile)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 20, 2014)	criteria provided, single submitter	11	47335982	GRCh38	180980	179239
NG_007667.1:g.21711C>A	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47335992	GRCh38	304953	314289
NM_000256.3(MYBPC3):c.2618C>T (p.Pro873Leu)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10	GMAF:0.00020(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2015)	criteria provided, conflicting interpretations	11	47335996	GRCh38	64615	75578
NM_000256.3(MYBPC3):c.2618C>A (p.Pro873His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00008(T), GMAF:0.00020(A), GO-ESP:0.00020(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2016)	criteria provided, conflicting interpretations	11	47335996	GRCh38	30143	39099
NM_000256.3(MYBPC3):c.2614G>A (p.Glu872Lys)	MYBPC3	not specified	GMAF:0.00020(T), GO-ESP:0.00059(T)	Uncertain significance(Last reviewed: Aug 20, 2014)	criteria provided, multiple submitters, no conflicts	11	47336000	GRCh38	42647	51817
NM_000256.3(MYBPC3):c.2610delC (p.Ser871Alafs)	MYBPC3	not provided		Pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	11	47336004	GRCh38	181083	179240
NM_000256.3(MYBPC3):c.2610dupC (p.Ser871Glnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy		Pathogenic(Last reviewed: May 23, 2012)	criteria provided, multiple submitters, no conflicts	11	47336004	GRCh38	42646	51816
NM_000256.3(MYBPC3):c.2604_2605delTCinsA (p.Ser871Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	11	47336009 - 47336010	GRCh38	177870	175163
NM_000256.3(MYBPC3):c.2604delT (p.Ser871Alafs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Aug 14, 2014)	criteria provided, single submitter	11	47336010	GRCh38	181082	179241
NG_007667.1:g.21692G>T	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47336011	GRCh38	304954	327968
NG_007667.1:g.21688C>A	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47336015	GRCh38	304955	327969
NM_000256.3(MYBPC3):c.2603-10C>T	MYBPC3	Hypertrophic cardiomyopathy	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Jan 16, 2016)	criteria provided, single submitter	11	47336021	GRCh38	237427	241143
NM_000256.3(MYBPC3):c.2603-11C>T	MYBPC3	not specified	GO-ESP:0.00006(A)	Likely benign(Last reviewed: Nov 18, 2014)	criteria provided, single submitter	11	47336022	GRCh38	178064	174752
NM_000256.3(MYBPC3):c.2601C>T (p.Ile867=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01594(A), GMAF:0.01600(A), GO-ESP:0.00463(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47337392	GRCh38	42645	51815
NM_000256.3(MYBPC3):c.2573G>A (p.Ser858Asn)	MYBPC3	not specified|Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Feb 18, 2016)	criteria provided, multiple submitters, no conflicts	11	47337420	GRCh38	164070	175164
NM_000256.3(MYBPC3):c.2562G>A (p.Met854Ile)	MYBPC3	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	11	47337431	GRCh38	180978	179242
NM_000256.3(MYBPC3):c.2560A>G (p.Met854Val)	MYBPC3	not specified	GO-ESP:0.00008(C)	Uncertain significance(Last reviewed: Jan 27, 2010)	criteria provided, single submitter	11	47337433	GRCh38	42642	51812
NM_000256.3(MYBPC3):c.2558delG (p.Gly853Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, multiple submitters, no conflicts	11	47337435	GRCh38	42641	51811
NM_000256.3(MYBPC3):c.2557G>A (p.Gly853Ser)	MYBPC3	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: May 4, 2012)	criteria provided, single submitter	11	47337436	GRCh38	42640	51810
NM_000256.3(MYBPC3):c.2556_2557delCGinsTCT (p.Gly853Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Sep 22, 2015)	criteria provided, multiple submitters, no conflicts	11	47337436 - 47337437	GRCh38	42639	51809
NM_000256.3(MYBPC3):c.2556delC (p.Ile852Metfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy		Pathogenic(Last reviewed: May 16, 2013)	criteria provided, multiple submitters, no conflicts	11	47337437	GRCh38	164071	174753
NM_000256.3(MYBPC3):c.2552C>T (p.Ala851Val)	MYBPC3	Familial hypertrophic cardiomyopathy 1	GO-ESP:0.00007(A)	Uncertain significance(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	11	47337441	GRCh38	217837	214490
NM_000256.3(MYBPC3):c.2551G>A (p.Ala851Thr)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Mar 15, 2014)	criteria provided, single submitter	11	47337442	GRCh38	180977	179243
NM_000256.3(MYBPC3):c.2550delC (p.Asn850Lysfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic	criteria provided, single submitter	11	47337443	GRCh38	217477	214113
NM_000256.3(MYBPC3):c.2549A>T (p.Asn850Ile)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	11	47337444	GRCh38	180976	179244
NM_000256.3(MYBPC3):c.2547C>T (p.Val849=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.03004(A), GMAF:0.04810(A), GO-ESP:0.04644(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47337446	GRCh38	42638	51808
NM_000256.3(MYBPC3):c.2544G>A (p.Ala848=)	MYBPC3	not specified	GO-ESP:0.00008(T), GO-ESP:0.00001(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2015)	criteria provided, conflicting interpretations	11	47337449	GRCh38	42637	51807
NM_000256.3(MYBPC3):c.2543C>A (p.Ala848Glu)	MYBPC3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	11	47337450	GRCh38	220872	222142
NM_000256.3(MYBPC3):c.2543delC (p.Ala848Glyfs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Dec 13, 2011)	criteria provided, single submitter	11	47337450	GRCh38	181151	179246
NM_000256.3(MYBPC3):c.2543C>G (p.Ala848Gly)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 25, 2013)	criteria provided, single submitter	11	47337450	GRCh38	180975	179245
NM_000256.3(MYBPC3):c.2541C>A (p.Tyr847Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	11	47337452	GRCh38	177852	175165
NM_000256.3(MYBPC3):c.2541C>G (p.Tyr847Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, multiple submitters, no conflicts	11	47337452	GRCh38	42636	51806
NM_000256.3(MYBPC3):c.2540A>C (p.Tyr847Ser)	MYBPC3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	11	47337453	GRCh38	219400	222143
NM_000256.3(MYBPC3):c.2532_2538delGCGCGTC (p.Met844Ilefs)	MYBPC3	not provided		Pathogenic(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	11	47337455 - 47337461	GRCh38	181081	179247
NM_000256.3(MYBPC3):c.2517_2538del22 (p.Val840Thrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	11	47337455 - 47337476	GRCh38	164073	174754
NM_000256.3(MYBPC3):c.2534_2538delGCGTC (p.Arg845Leufs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy		Pathogenic(Last reviewed: Feb 10, 2012)	criteria provided, multiple submitters, no conflicts	11	47337455 - 47337459	GRCh38	42635	51805
NM_000256.3(MYBPC3):c.2537T>A (p.Val846Asp)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	47337456	GRCh38	36606	45268
NM_000256.3(MYBPC3):c.2528_2536delAGATGCGCG (p.Glu843_Arg845del)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 21, 2012)	criteria provided, single submitter	11	47337457 - 47337465	GRCh38	42634	51804
NM_000256.3(MYBPC3):c.2534G>C (p.Arg845Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	11	47337459	GRCh38	181128	179248
NM_000256.3(MYBPC3):c.2534G>A (p.Arg845His)	MYBPC3	not provided	GO-ESP:0.00001(T)	Likely pathogenic(Last reviewed: May 21, 2014)	criteria provided, single submitter	11	47337459	GRCh38	180974	179249
NM_000256.3(MYBPC3):c.2533C>G (p.Arg845Gly)	MYBPC3	Cardiomyopathy		Likely pathogenic(Last reviewed: Dec 31, 2013)	criteria provided, single submitter	11	47337460	GRCh38	180973	179250
NM_000256.3(MYBPC3):c.2533C>T (p.Arg845Cys)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 29, 2013)	no assertion criteria provided	11	47337460	GRCh38	177830	175166
NM_000256.3(MYBPC3):c.2525A>G (p.Tyr842Cys)	MYBPC3	not specified		Uncertain significance(Last reviewed: Dec 2, 2011)	criteria provided, single submitter	11	47337468	GRCh38	42633	51803
NM_000256.3(MYBPC3):c.2524dupT (p.Tyr842Leufs)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: May 30, 2015)	criteria provided, multiple submitters, no conflicts	11	47337469	GRCh38	42632	51802
NM_000256.3(MYBPC3):c.2518G>A (p.Val840Met)	MYBPC3	not specified	GO-ESP:0.00008(T), GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: May 26, 2010)	criteria provided, single submitter	11	47337475	GRCh38	42631	51801
NM_000256.3(MYBPC3):c.2517C>T (p.Gly839=)	MYBPC3	not specified	GO-ESP:0.00006(A)	Likely benign(Last reviewed: Dec 24, 2013)	criteria provided, single submitter	11	47337476	GRCh38	164075	174755
NM_000256.3(MYBPC3):c.2512G>C (p.Glu838Gln)	MYBPC3	not specified	GMAF:0.00020(G), GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Dec 11, 2013)	criteria provided, single submitter	11	47337481	GRCh38	179456	175167
NM_000256.3(MYBPC3):c.2512G>A (p.Glu838Lys)	MYBPC3	not specified	GMAF:0.00020(G)	Uncertain significance(Last reviewed: Nov 20, 2012)	criteria provided, single submitter	11	47337481	GRCh38	42630	51800
NM_000256.3(MYBPC3):c.2511delC (p.Ile837Metfs)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	11	47337482	GRCh38	181080	179252
NM_000256.3(MYBPC3):c.2504delG (p.Arg835Profs)	MYBPC3	Primary dilated cardiomyopathy		Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	11	47337489	GRCh38	228369	230208
NM_000256.3(MYBPC3):c.2499G>A (p.Ala833=)	MYBPC3	not specified		Likely benign(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	11	47337494	GRCh38	42628	51798
NM_000256.3(MYBPC3):c.2498C>T (p.Ala833Val)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00770(A), GMAF:0.01020(A), GO-ESP:0.00222(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47337495	GRCh38	42627	51797
NM_000256.3(MYBPC3):c.2497G>A (p.Ala833Thr)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10|Cardiomyopathy|Hypertrophic cardiomyopathy|Paroxysmal atrial fibrillation	GO-ESP:0.00117(T), GO-ESP:0.00168(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2016)	criteria provided, conflicting interpretations	11	47337496	GRCh38	42626	51796
NM_000256.3(MYBPC3):c.2490dupT (p.His831Serfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, multiple submitters, no conflicts	11	47337503	GRCh38	42625	51795
NM_000256.3(MYBPC3):c.2487G>T (p.Leu829=)	MYBPC3	not specified	GO-ESP:0.00023(A), GO-ESP:0.00006(A)	Benign/Likely benign(Last reviewed: Jun 23, 2014)	criteria provided, multiple submitters, no conflicts	11	47337506	GRCh38	42624	51794
NM_000256.3(MYBPC3):c.2479C>A (p.Gln827Lys)	MYBPC3	not specified		Uncertain significance(Last reviewed: Apr 22, 2014)	criteria provided, single submitter	11	47337514	GRCh38	180971	179253
NM_000256.3(MYBPC3):c.2460G>A (p.Arg820=)	MYBPC3	not specified	GMAF:0.00080(T), GO-ESP:0.00031(T)	Likely benign(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	11	47337533	GRCh38	177877	174756
NM_000256.3(MYBPC3):c.2455_2459delATGCG (p.Met819Alafs)	MYBPC3	not provided		Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	11	47337534 - 47337538	GRCh38	181079	179255
NM_000256.3(MYBPC3):c.2459G>C (p.Arg820Pro)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	11	47337534	GRCh38	180970	179254
NM_000256.3(MYBPC3):c.2459G>A (p.Arg820Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2016)	criteria provided, conflicting interpretations	11	47337534	GRCh38	8617	23656
NM_000256.3(MYBPC3):c.2458C>T (p.Arg820Trp)	MYBPC3	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: May 4, 2015)	criteria provided, single submitter	11	47337535	GRCh38	195850	193011
NM_000256.3(MYBPC3):c.2456T>C (p.Met819Thr)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	11	47337537	GRCh38	228866	230209
NM_000256.3(MYBPC3):c.2454G>A (p.Trp818Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, multiple submitters, no conflicts	11	47337539	GRCh38	42622	51792
NM_000256.3(MYBPC3):c.2450G>A (p.Arg817Gln)	MYBPC3	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Aug 14, 2013)	criteria provided, multiple submitters, no conflicts	11	47337543	GRCh38	42621	51791
NM_000256.3(MYBPC3):c.2449C>T (p.Arg817Trp)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 30, 2013)	no assertion criteria provided	11	47337544	GRCh38	164078	175168
NM_000256.3(MYBPC3):c.2441_2443delAGA (p.Lys814del)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00032(-)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 11, 2016)	criteria provided, conflicting interpretations	11	47337550 - 47337552	GRCh38	177700	174757
NM_000256.3(MYBPC3):c.2439G>C (p.Lys813Asn)	MYBPC3	not specified	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	11	47337554	GRCh38	179986	175169
NM_000256.3(MYBPC3):c.2437A>T (p.Lys813Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47337556	GRCh38	177641	174758
NM_000256.3(MYBPC3):c.2436G>T (p.Lys812Asn)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47337557	GRCh38	177640	175170
NM_000256.3(MYBPC3):c.2435A>G (p.Lys812Arg)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47337558	GRCh38	188569	186365
NM_000256.3(MYBPC3):c.2429G>T (p.Arg810Leu)	MYBPC3	not provided		Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	11	47337564	GRCh38	181127	179256
NM_000256.3(MYBPC3):c.2429G>A (p.Arg810His)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00008(T), GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2016)	criteria provided, conflicting interpretations	11	47337564	GRCh38	42620	51790
NM_000256.3(MYBPC3):c.2414G>A (p.Gly805Asp)	MYBPC3	not provided		Pathogenic(Last reviewed: Apr 5, 2013)	criteria provided, single submitter	11	47337579	GRCh38	180969	179257
NM_000256.3(MYBPC3):c.2414-1G>A	MYBPC3	Dilated cardiomyopathy 1A|Familial hypertrophic cardiomyopathy 4		Likely pathogenic(Last reviewed: Sep 18, 2012)	criteria provided, single submitter	11	47337580	GRCh38	216967	213610
NM_000256.3(MYBPC3):c.2413+2dupT	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47337688	GRCh38	188568	186366
NM_000256.3(MYBPC3):c.2398G>A (p.Gly800Arg)	MYBPC3	not specified	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: May 30, 2013)	criteria provided, single submitter	11	47337705	GRCh38	178966	174759
NM_000256.3(MYBPC3):c.2394dupT (p.Gly799Trpfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2015)	criteria provided, multiple submitters, no conflicts	11	47337709	GRCh38	177862	175171
NM_000256.3(MYBPC3):c.2391C>A (p.Tyr797Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47337712	GRCh38	179435	174760
NM_000256.3(MYBPC3):c.2382delG (p.Pro795Leufs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Oct 17, 2011)	criteria provided, single submitter	11	47337721	GRCh38	181150	179258
NM_000256.3(MYBPC3):c.2381C>T (p.Pro794Leu)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00022(A)	Likely pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, multiple submitters, no conflicts	11	47337722	GRCh38	180968	179259
NM_000256.3(MYBPC3):c.2376G>A (p.Trp792Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic	criteria provided, single submitter	11	47337727	GRCh38	217484	214115
NM_000256.3(MYBPC3):c.2374T>C (p.Trp792Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, multiple submitters, no conflicts	11	47337729	GRCh38	36605	45267
NM_000256.3(MYBPC3):c.2373dupG (p.Trp792Valfs)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, multiple submitters, no conflicts	11	47337730	GRCh38	42619	51789
NM_000256.3(MYBPC3):c.2371C>T (p.Gln791Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic	criteria provided, single submitter	11	47337732	GRCh38	217478	214116
NM_000256.3(MYBPC3):c.2324C>G (p.Pro775Arg)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Mar 15, 2014)	criteria provided, single submitter	11	47337779	GRCh38	180967	179260
NM_000256.3(MYBPC3):c.2320G>A (p.Ala774Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	11	47337783	GRCh38	42618	51788
NM_000256.3(MYBPC3):c.2319C>T (p.Asp773=)	MYBPC3	not specified		Likely benign(Last reviewed: Dec 28, 2010)	criteria provided, single submitter	11	47337784	GRCh38	42617	51787
NM_000256.3(MYBPC3):c.2312T>C (p.Val771Ala)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	11	47337791	GRCh38	42616	51786
NM_000256.3(MYBPC3):c.2311G>A (p.Val771Met)	MYBPC3	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00006(T)	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2015)	criteria provided, conflicting interpretations	11	47337792	GRCh38	161308	171136
NM_000256.3(MYBPC3):c.2311dupG (p.Val771Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype		Pathogenic(Last reviewed: Jun 16, 2014)	criteria provided, multiple submitters, no conflicts	11	47337792	GRCh38	42615	51785
NM_000256.3(MYBPC3):c.2310C>T (p.Asp770=)	MYBPC3	not specified		Likely benign(Last reviewed: Mar 20, 2012)	criteria provided, single submitter	11	47337793	GRCh38	42614	51784
NM_000256.3(MYBPC3):c.2309-2A>G	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	11	47337796	GRCh38	42613	51783
NM_000256.3(MYBPC3):c.2309-9C>A	MYBPC3	not specified		Likely benign(Last reviewed: Mar 23, 2012)	criteria provided, single submitter	11	47337803	GRCh38	180919	179261
NM_000256.3(MYBPC3):c.2309-20G>A	MYBPC3	not specified		Likely benign(Last reviewed: May 7, 2008)	no assertion criteria provided	11	47337814	GRCh38	42612	51782
NM_000256.3(MYBPC3):c.2309-21G>A	MYBPC3	not specified		Uncertain significance(Last reviewed: Oct 10, 2014)	criteria provided, single submitter	11	47337815	GRCh38	180013	175172
NM_000256.3(MYBPC3):c.2309-26A>G	MYBPC3	Familial hypertrophic cardiomyopathy 4		Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	11	47337820	GRCh38	8610	23649
NM_000256.3(MYBPC3):c.2309-27G>A	MYBPC3	not specified	GMAF:0.00280(T), GO-ESP:0.00069(T)	Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47337821	GRCh38	188567	186367
NM_000256.3(MYBPC3):c.2308+18C>G	MYBPC3	not specified	GMAF:0.06950(C), GO-ESP:0.05221(C)	Benign(Last reviewed: Feb 23, 2012)	criteria provided, multiple submitters, no conflicts	11	47338502	GRCh38	188566	186368
NM_000256.3(MYBPC3):c.2308+12C>T	MYBPC3	not specified	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Nov 5, 2014)	criteria provided, single submitter	11	47338508	GRCh38	180082	174761
NM_000256.3(MYBPC3):c.2308+9G>A	MYBPC3	Hypertrophic cardiomyopathy	GO-ESP:0.00004(T)	Likely benign(Last reviewed: Nov 15, 2015)	criteria provided, single submitter	11	47338511	GRCh38	237426	241144
NM_000256.3(MYBPC3):c.2308+1G>T	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 13, 2016)	criteria provided, multiple submitters, no conflicts	11	47338519	GRCh38	42611	51781
NM_000256.3(MYBPC3):c.2308+1G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00008(T)	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, multiple submitters, no conflicts	11	47338519	GRCh38	42610	51780
NM_000256.3(MYBPC3):c.2308G>A (p.Asp770Asn)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00001(T)	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	11	47338520	GRCh38	36604	45266
NM_000256.3(MYBPC3):c.2288A>G (p.Asn763Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified		Uncertain significance(Last reviewed: Apr 26, 2016)	criteria provided, multiple submitters, no conflicts	11	47338540	GRCh38	180918	179262
NM_000256.3(MYBPC3):c.2274C>T (p.Gly758=)	MYBPC3	not specified	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Mar 1, 2008)	criteria provided, single submitter	11	47338554	GRCh38	42609	51779
NM_000256.3(MYBPC3):c.2269G>A (p.Val757Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	11	47338559	GRCh38	161309	171137
NM_000256.3(MYBPC3):c.2267delC (p.Pro756Leufs)	MYBPC3	not provided		Pathogenic(Last reviewed: May 16, 2014)	criteria provided, single submitter	11	47338561	GRCh38	181078	179263
NM_000256.3(MYBPC3):c.2249C>T (p.Thr750Met)	MYBPC3	not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	11	47338579	GRCh38	164086	175173
NM_000256.3(MYBPC3):c.2242G>A (p.Val748Ile)	MYBPC3	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	11	47338586	GRCh38	180966	179264
NM_000256.3(MYBPC3):c.2234A>G (p.Asp745Gly)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2015)	criteria provided, conflicting interpretations	11	47338594	GRCh38	30142	39098
NM_000256.3(MYBPC3):c.2221delG (p.Ala741Glnfs)	MYBPC3	not provided		Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	11	47338607	GRCh38	181077	179265
NM_000256.3(MYBPC3):c.2217G>T (p.Glu739Asp)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47338611	GRCh38	188565	186369
NM_000256.3(MYBPC3):c.2210C>T (p.Thr737Met)	MYBPC3	not specified|not provided	GO-ESP:0.00016(A), GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Feb 23, 2016)	criteria provided, multiple submitters, no conflicts	11	47338618	GRCh38	42608	51778
NM_000256.3(MYBPC3):c.2200A>G (p.Ser734Gly)	MYBPC3	not specified	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47338628	GRCh38	188564	186370
NM_000256.3(MYBPC3):c.2198G>A (p.Arg733His)	MYBPC3	not provided	GMAF:0.00020(T), GO-ESP:0.00003(T)	Pathogenic(Last reviewed: Aug 29, 2011)	criteria provided, single submitter	11	47338630	GRCh38	181126	179266
NM_000256.3(MYBPC3):c.2197C>A (p.Arg733Ser)	MYBPC3	not specified	GMAF:0.00060(A)	Uncertain significance(Last reviewed: Aug 1, 2012)	criteria provided, single submitter	11	47338631	GRCh38	180965	179267
NM_000256.3(MYBPC3):c.2197C>T (p.Arg733Cys)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GMAF:0.00060(A), GO-ESP:0.00009(A)	Uncertain significance(Last reviewed: Nov 6, 2015)	criteria provided, multiple submitters, no conflicts	11	47338631	GRCh38	42607	51777
NM_000256.3(MYBPC3):c.2196C>T (p.Asp732=)	MYBPC3	not specified		Likely benign(Last reviewed: Mar 1, 2008)	criteria provided, single submitter	11	47338632	GRCh38	42606	51776
NM_000256.3(MYBPC3):c.2190C>A (p.Thr730=)	MYBPC3	Hypertrophic cardiomyopathy		Likely benign(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	11	47338638	GRCh38	237425	241145
NM_000256.3(MYBPC3):c.2189C>T (p.Thr730Ile)	MYBPC3	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47338639	GRCh38	188563	186371
NM_000256.3(MYBPC3):c.2182G>T (p.Glu728Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, multiple submitters, no conflicts	11	47338646	GRCh38	42605	51775
NM_000256.3(MYBPC3):c.2179G>A (p.Val727Met)	MYBPC3	not provided	GO-ESP:0.00004(T)	Likely pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	11	47338649	GRCh38	180964	179268
NM_000256.3(MYBPC3):c.2178C>T (p.Arg726=)	MYBPC3	not specified	GO-ESP:0.00008(A), GO-ESP:0.00004(A)	Likely benign(Last reviewed: Apr 29, 2010)	criteria provided, single submitter	11	47338650	GRCh38	42604	51774
NM_000256.3(MYBPC3):c.2177G>A (p.Arg726His)	MYBPC3	not specified	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Sep 26, 2012)	criteria provided, single submitter	11	47338651	GRCh38	42603	51773
NM_000256.3(MYBPC3):c.2170C>T (p.Arg724Trp)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00002(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2013)	criteria provided, conflicting interpretations	11	47338658	GRCh38	177901	175174
NM_000256.3(MYBPC3):c.2164G>A (p.Glu722Lys)	MYBPC3	not provided	GO-ESP:0.00003(T)	Likely pathogenic(Last reviewed: Jan 3, 2012)	criteria provided, single submitter	11	47338664	GRCh38	181125	179269
NM_000256.3(MYBPC3):c.2163delC (p.Glu722Argfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jun 19, 2012)	criteria provided, multiple submitters, no conflicts	11	47338665	GRCh38	42602	51772
NM_000256.3(MYBPC3):c.2163C>T (p.Thr721=)	MYBPC3	not specified	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Mar 1, 2008)	criteria provided, single submitter	11	47338665	GRCh38	42601	51771
NM_000256.3(MYBPC3):c.2158G>T (p.Glu720Ter)	MYBPC3	Cardiovascular phenotype		Pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	11	47338670	GRCh38	264065	258701
NM_000256.3(MYBPC3):c.2149-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47338680	GRCh38	177814	174763
NM_000256.3(MYBPC3):c.2149-5C>T	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00140(A), GO-ESP:0.00128(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47338684	GRCh38	42599	51769
NM_000256.3(MYBPC3):c.2149-8C>G	MYBPC3	not specified	GO-ESP:0.00006(C)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 2, 2015)	criteria provided, conflicting interpretations	11	47338687	GRCh38	42600	51770
NM_000256.3(MYBPC3):c.2148+6_2148+9delTGAG	MYBPC3	not specified|not provided	GO-ESP:0.00003(-)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47339315 - 47339318	GRCh38	42598	51768
NM_000256.3(MYBPC3):c.2136G>A (p.Val712=)	MYBPC3	not specified		Likely benign(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	11	47339336	GRCh38	227565	230210
NM_000256.3(MYBPC3):c.2125G>A (p.Asp709Asn)	MYBPC3	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 20, 2015)	criteria provided, single submitter	11	47339347	GRCh38	264066	258702
NM_000256.3(MYBPC3):c.2113dupA (p.Thr705Asnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, multiple submitters, no conflicts	11	47339359	GRCh38	42597	51767
NM_000256.3(MYBPC3):c.2097delA (p.Asp700Metfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Dec 18, 2014)	criteria provided, single submitter	11	47339375	GRCh38	222701	224425
NM_000256.3(MYBPC3):c.2096delC (p.Pro699Glnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, multiple submitters, no conflicts	11	47339376	GRCh38	42596	51766
NM_000256.3(MYBPC3):c.2074A>C (p.Lys692Gln)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 27, 2013)	criteria provided, single submitter	11	47339398	GRCh38	180963	179270
NM_000256.3(MYBPC3):c.2065C>T (p.Gln689Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: May 2, 2015)	criteria provided, multiple submitters, no conflicts	11	47339653	GRCh38	216055	212928
NM_000256.3(MYBPC3):c.2064G>A (p.Thr688=)	MYBPC3	Cardiovascular phenotype	GO-ESP:0.00012(T)	Likely benign(Last reviewed: Dec 11, 2015)	criteria provided, single submitter	11	47339654	GRCh38	264604	258703
NM_000256.3(MYBPC3):c.2063C>A (p.Thr688Lys)	MYBPC3	not specified	GMAF:0.00020(T), GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: May 29, 2014)	criteria provided, single submitter	11	47339655	GRCh38	180962	179271
NM_000256.3(MYBPC3):c.2048G>A (p.Trp683Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, multiple submitters, no conflicts	11	47339670	GRCh38	42591	51761
NM_000256.3(MYBPC3):c.2040dupT (p.Val681Cysfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: May 10, 2012)	criteria provided, single submitter	11	47339678	GRCh38	42593	51763
NM_000256.3(MYBPC3):c.2035C>T (p.Pro679Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	47339683	GRCh38	161302	171138
NM_000256.3(MYBPC3):c.2030C>T (p.Pro677Leu)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47339688	GRCh38	188562	186372
NM_000256.3(MYBPC3):c.2013_2016delCCCTinsGG (p.Pro672Aspfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Nov 23, 2012)	criteria provided, single submitter	11	47339702 - 47339705	GRCh38	42592	51762
NM_000256.3(MYBPC3):c.2011G>A (p.Val671Ile)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 16, 2015)	criteria provided, single submitter	11	47339707	GRCh38	228865	230211
NM_000256.3(MYBPC3):c.2003G>A (p.Arg668His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|not specified	GO-ESP:0.00027(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 21, 2015)	criteria provided, conflicting interpretations	11	47339715	GRCh38	164090	175175
NM_000256.3(MYBPC3):c.1999_2000delCTinsA (p.Leu667Asnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Nov 18, 2011)	criteria provided, single submitter	11	47339718 - 47339719	GRCh38	188561	186373
NM_000256.3(MYBPC3):c.1999_2000delCTinsG (p.Leu667Aspfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47339718 - 47339719	GRCh38	164091	174764
NM_000256.3(MYBPC3):c.1989T>A (p.Ala663=)	MYBPC3	not specified	GO-ESP:0.00006(T)	Benign(Last reviewed: Jul 13, 2011)	criteria provided, single submitter	11	47339729	GRCh38	138318	142021
NM_000256.3(MYBPC3):c.1978G>A (p.Val660Met)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jun 1, 2012)	criteria provided, single submitter	11	47339740	GRCh38	180960	179273
NM_000256.3(MYBPC3):c.1976T>C (p.Ile659Thr)	MYBPC3	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 19, 2013)	criteria provided, multiple submitters, no conflicts	11	47339742	GRCh38	42590	51760
NM_000256.3(MYBPC3):c.1968A>G (p.Pro656=)	MYBPC3	not specified	GO-ESP:0.00002(C)	Likely benign(Last reviewed: Aug 4, 2010)	criteria provided, single submitter	11	47339750	GRCh38	42589	51759
NM_000256.3(MYBPC3):c.1961G>A (p.Arg654His)	MYBPC3	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 24, 2015)	criteria provided, multiple submitters, no conflicts	11	47339757	GRCh38	42588	51758
NM_000256.3(MYBPC3):c.1960C>G (p.Arg654Gly)	MYBPC3	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: Oct 31, 2014)	no assertion criteria provided	11	47339758	GRCh38	180410	178643
NM_000256.3(MYBPC3):c.1960C>T (p.Arg654Cys)	MYBPC3	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47339758	GRCh38	42587	51757
NM_000256.3(MYBPC3):c.1950C>G (p.Asp650Glu)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47339768	GRCh38	177639	175176
NM_000256.3(MYBPC3):c.1944C>T (p.His648=)	MYBPC3	not specified	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	11	47339774	GRCh38	227564	230212
NM_000256.3(MYBPC3):c.1935C>T (p.Pro645=)	MYBPC3	not specified	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	11	47339783	GRCh38	164093	174765
NM_000256.3(MYBPC3):c.1934C>T (p.Pro645Leu)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2015)	criteria provided, conflicting interpretations	11	47339784	GRCh38	42586	51756
NM_000256.3(MYBPC3):c.1928-2A>G	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, multiple submitters, no conflicts	11	47339792	GRCh38	42585	51755
NM_000256.3(MYBPC3):c.1927+3A>C	MYBPC3	not specified		Uncertain significance(Last reviewed: Jun 21, 2012)	criteria provided, single submitter	11	47341000	GRCh38	180959	179274
NM_000256.3(MYBPC3):c.1927+2T>C	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 16, 2015)	criteria provided, single submitter	11	47341001	GRCh38	222708	224426
NM_000256.3(MYBPC3):c.1924C>T (p.Gln642Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47341006	GRCh38	177705	175177
NM_000256.3(MYBPC3):c.1914C>T (p.Phe638=)	MYBPC3	not specified	GO-ESP:0.00008(A), GO-ESP:0.00011(A)	Likely benign(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	11	47341016	GRCh38	42584	51754
NM_000256.3(MYBPC3):c.1898-1G>A	MYBPC3	not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2012)	criteria provided, single submitter	11	47341033	GRCh38	180958	179275
NM_000256.3(MYBPC3):c.1897+47G>A	MYBPC3	not specified	GMAF:0.00900(T), GO-ESP:0.01846(T)	Benign(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	11	47341091	GRCh38	188559	186374
NM_000256.3(MYBPC3):c.1897+28C>T	MYBPC3	not specified	GO-ESP:0.00035(A)	Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47341110	GRCh38	188560	186375
NM_000256.3(MYBPC3):c.1897+15G>C	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47341123	GRCh38	188558	186376
NM_000256.3(MYBPC3):c.1897+5G>A	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 3, 2012)	criteria provided, single submitter	11	47341133	GRCh38	42583	51753
NM_000256.3(MYBPC3):c.1897+4A>C	MYBPC3	not provided		Likely pathogenic(Last reviewed: Sep 20, 2012)	criteria provided, single submitter	11	47341134	GRCh38	180957	179276
NM_000256.3(MYBPC3):c.1897+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Sep 30, 2015)	criteria provided, multiple submitters, no conflicts	11	47341137	GRCh38	42582	51752
NM_000256.3(MYBPC3):c.1895delT (p.Met632Argfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Jul 23, 2014)	criteria provided, multiple submitters, no conflicts	11	47341140	GRCh38	42581	51751
NM_000256.3(MYBPC3):c.1892delT (p.Phe631Serfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Dec 27, 2011)	criteria provided, single submitter	11	47341143	GRCh38	42580	51750
NM_000256.3(MYBPC3):c.1886T>C (p.Leu629Pro)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Mar 3, 2014)	no assertion criteria provided	11	47341149	GRCh38	180409	178644
NM_000256.3(MYBPC3):c.1869C>A (p.Cys623Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47341166	GRCh38	164095	174766
NM_000256.3(MYBPC3):c.1869C>T (p.Cys623=)	MYBPC3	not specified	GO-ESP:0.00006(A)	Likely benign(Last reviewed: Oct 24, 2012)	criteria provided, single submitter	11	47341166	GRCh38	42579	51749
NM_000256.3(MYBPC3):c.1863delC (p.Phe621Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	11	47341172	GRCh38	42578	51748
NM_000256.3(MYBPC3):c.1863C>T (p.Phe621=)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00024(A)	Benign/Likely benign(Last reviewed: Nov 11, 2015)	criteria provided, multiple submitters, no conflicts	11	47341172	GRCh38	36603	45265
NM_000256.3(MYBPC3):c.1859G>T (p.Gly620Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	11	47341176	GRCh38	180956	179277
NM_000256.3(MYBPC3):c.1855G>A (p.Glu619Lys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00079(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 14, 2015)	criteria provided, conflicting interpretations	11	47341180	GRCh38	161303	171139
NM_000256.3(MYBPC3):c.1841A>G (p.Tyr614Cys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Sep 7, 2015)	criteria provided, conflicting interpretations	11	47341194	GRCh38	164096	175178
NM_000256.3(MYBPC3):c.1838dupA (p.Asp613Glufs)	MYBPC3	Familial hypertrophic cardiomyopathy 1|not provided|Cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2015)	criteria provided, multiple submitters, no conflicts	11	47341197	GRCh38	181076	179278
NM_000256.3(MYBPC3):c.1831G>A (p.Glu611Lys)	MYBPC3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 15, 2012)	criteria provided, single submitter	11	47341204	GRCh38	180955	179279
NM_000256.3(MYBPC3):c.1829A>T (p.Asp610Val)	MYBPC3	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Mar 3, 2016)	criteria provided, conflicting interpretations	11	47341206	GRCh38	180954	179280
NM_000256.3(MYBPC3):c.1828G>C (p.Asp610His)	MYBPC3	not specified|Inborn genetic diseases	GO-ESP:0.00006(G)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2015)	criteria provided, conflicting interpretations	11	47341207	GRCh38	42576	51746
NM_000256.3(MYBPC3):c.1828G>A (p.Asp610Asn)	MYBPC3	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00008(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2015)	criteria provided, conflicting interpretations	11	47341207	GRCh38	42575	51745
NM_000256.3(MYBPC3):c.1826C>T (p.Ala609Val)	MYBPC3	Primary dilated cardiomyopathy|not provided	GO-ESP:0.00004(A)	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2015)	criteria provided, conflicting interpretations	11	47341209	GRCh38	180953	179281
NM_000256.3(MYBPC3):c.1822C>T (p.Pro608Ser)	MYBPC3	not specified	GO-ESP:0.00014(A)	Uncertain significance(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	11	47341213	GRCh38	180952	179282
NM_000256.3(MYBPC3):c.1816G>A (p.Val606Ile)	MYBPC3	not specified	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Jan 17, 2014)	criteria provided, single submitter	11	47341219	GRCh38	180951	179283
NM_000256.3(MYBPC3):c.1814_1816delACG (p.Asp605del)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 14, 2013)	no assertion criteria provided	11	47341219 - 47341221	GRCh38	42574	51744
NM_000256.3(MYBPC3):c.1814A>G (p.Asp605Gly)	MYBPC3	Primary dilated cardiomyopathy|not specified	GO-ESP:0.00008(C), GO-ESP:0.00015(C)	Uncertain significance(Last reviewed: Feb 5, 2016)	criteria provided, multiple submitters, no conflicts	11	47341221	GRCh38	42573	51743
NM_000256.3(MYBPC3):c.1813G>A (p.Asp605Asn)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00032(T), GO-ESP:0.00019(T)	Uncertain significance(Last reviewed: Mar 22, 2016)	criteria provided, multiple submitters, no conflicts	11	47341222	GRCh38	42572	51742
NM_000256.3(MYBPC3):c.1812C>T (p.Asp604=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00160(A), GO-ESP:0.00150(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47341223	GRCh38	42571	51741
NM_000256.3(MYBPC3):c.1808T>C (p.Ile603Thr)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jun 26, 2012)	criteria provided, single submitter	11	47341227	GRCh38	42570	51740
NM_000256.3(MYBPC3):c.1806delC (p.Ile603Leufs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	11	47341229	GRCh38	181075	179284
NM_000256.3(MYBPC3):c.1805C>T (p.Thr602Ile)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	11	47341230	GRCh38	180950	179285
NM_000256.3(MYBPC3):c.1803G>A (p.Leu601=)	MYBPC3	not specified		Likely benign(Last reviewed: Feb 26, 2010)	criteria provided, single submitter	11	47341232	GRCh38	42569	51739
NM_000256.3(MYBPC3):c.1800delA (p.Lys600Asnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00002(-)	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, multiple submitters, no conflicts	11	47341235	GRCh38	42568	51738
NM_000256.3(MYBPC3):c.1792delG (p.Val598Serfs)	MYBPC3	not provided		Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	11	47341243	GRCh38	181074	179286
NM_000256.3(MYBPC3):c.1791-2A>C	MYBPC3	not provided		Pathogenic(Last reviewed: Aug 15, 2014)	criteria provided, single submitter	11	47341246	GRCh38	180949	179287
NM_000256.3(MYBPC3):c.1791-10_1791-8delinsCCT	MYBPC3	not specified		Likely benign(Last reviewed: Mar 23, 2015)	criteria provided, single submitter	11	47341252 - 47341254	GRCh38	227563	230213
NM_000256.3(MYBPC3):c.1791-15A>G	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47341259	GRCh38	188557	186377
NM_000256.3(MYBPC3):c.1790+7G>A	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00008(T), GMAF:0.00400(T), GO-ESP:0.00602(T)	Benign(Last reviewed: Oct 20, 2015)	criteria provided, multiple submitters, no conflicts	11	47341984	GRCh38	42567	51737
NM_000256.3(MYBPC3):c.1790+5G>A	MYBPC3	not specified		Uncertain significance(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	11	47341986	GRCh38	178851	174767
NM_000256.3(MYBPC3):c.1790G>A (p.Arg597Gln)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Mar 4, 2016)	criteria provided, conflicting interpretations	11	47341991	GRCh38	164098	175179
NM_000256.3(MYBPC3):c.1789C>T (p.Arg597Trp)	MYBPC3	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Feb 24, 2016)	criteria provided, multiple submitters, no conflicts	11	47341992	GRCh38	179549	174768
NM_000256.3(MYBPC3):c.1786G>A (p.Gly596Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00026(T)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2016)	criteria provided, conflicting interpretations	11	47341995	GRCh38	42566	51736
NM_000256.3(MYBPC3):c.1783A>G (p.Ile595Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Dec 4, 2014)	criteria provided, single submitter	11	47341998	GRCh38	180948	179288
NM_000256.3(MYBPC3):c.1778C>T (p.Ser593Phe)	MYBPC3	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Jul 15, 2016)	criteria provided, multiple submitters, no conflicts	11	47342003	GRCh38	42564	51734
NM_000256.3(MYBPC3):c.1776_1777delGT (p.Ser593Profs)	MYBPC3	not provided		Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	11	47342004 - 47342005	GRCh38	181149	179289
NM_000256.3(MYBPC3):c.1776G>A (p.Val592=)	MYBPC3	not specified		Likely benign(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	11	47342005	GRCh38	164100	175180
NM_000256.3(MYBPC3):c.1775T>C (p.Val592Ala)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 18, 2014)	no assertion criteria provided	11	47342006	GRCh38	235019	236783
NM_000256.3(MYBPC3):c.1766G>A (p.Arg589His)	MYBPC3	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 2, 2016)	criteria provided, multiple submitters, no conflicts	11	47342015	GRCh38	42563	51733
NM_000256.3(MYBPC3):c.1759G>A (p.Asp587Asn)	MYBPC3	not specified		Likely benign(Last reviewed: Jul 23, 2014)	criteria provided, single submitter	11	47342022	GRCh38	180917	179290
NM_000256.3(MYBPC3):c.1758C>T (p.Pro586=)	MYBPC3	not specified	GO-ESP:0.00007(A)	Likely benign(Last reviewed: Jul 24, 2014)	criteria provided, single submitter	11	47342023	GRCh38	179895	174769
NM_000256.3(MYBPC3):c.1734delG (p.Lys579Argfs)	MYBPC3	not provided		Pathogenic(Last reviewed: Sep 2, 2014)	criteria provided, single submitter	11	47342047	GRCh38	181073	179291
NM_000256.3(MYBPC3):c.1731G>A (p.Trp577Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Dec 5, 2014)	criteria provided, single submitter	11	47342050	GRCh38	180943	179292
NM_000256.3(MYBPC3):c.1721G>A (p.Arg574Gln)	MYBPC3	Primary dilated cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00020(T), GO-ESP:0.00012(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47342060	GRCh38	42562	51732
NM_000256.3(MYBPC3):c.1720C>T (p.Arg574Trp)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	11	47342061	GRCh38	180947	179293
NM_000256.3(MYBPC3):c.1720C>A (p.Arg574=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00011(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47342061	GRCh38	138317	142020
NM_000256.3(MYBPC3):c.1719T>A (p.Val573=)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47342062	GRCh38	188556	186378
NM_000256.3(MYBPC3):c.1719T>G (p.Val573=)	MYBPC3	not specified		Likely benign(Last reviewed: Jun 25, 2010)	criteria provided, single submitter	11	47342062	GRCh38	42561	51731
NM_000256.3(MYBPC3):c.1700_1701delAG (p.Glu567Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Dec 29, 2014)	criteria provided, single submitter	11	47342080 - 47342081	GRCh38	181072	179294
NM_000256.3(MYBPC3):c.1696T>C (p.Cys566Arg)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, single submitter	11	47342085	GRCh38	181124	179295
NM_000256.3(MYBPC3):c.1693A>T (p.Lys565Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: May 21, 2012)	criteria provided, single submitter	11	47342088	GRCh38	42560	51730
NM_000256.3(MYBPC3):c.1625-27_1691del	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Nov 14, 2012)	criteria provided, single submitter	11	47342090 - 47342183	GRCh38	188554	186379
NM_000256.3(MYBPC3):c.1687delG (p.Val563Cysfs)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Dec 9, 2013)	no assertion criteria provided	11	47342094	GRCh38	235018	236784
NM_000256.3(MYBPC3):c.1685C>A (p.Ala562Glu)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jan 20, 2012)	criteria provided, single submitter	11	47342096	GRCh38	181123	179296
NM_000256.3(MYBPC3):c.1684G>A (p.Ala562Thr)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jun 22, 2012)	criteria provided, single submitter	11	47342097	GRCh38	42559	51729
NM_000256.3(MYBPC3):c.1678delG (p.Asp560Thrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	11	47342103	GRCh38	177864	174770
NM_000256.3(MYBPC3):c.1672G>A (p.Ala558Thr)	MYBPC3	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jan 28, 2013)	no assertion criteria provided	11	47342109	GRCh38	164102	175182
NM_000256.3(MYBPC3):c.1670G>A (p.Gly557Asp)	MYBPC3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Dec 10, 2015)	criteria provided, conflicting interpretations	11	47342111	GRCh38	180946	179297
NM_000256.3(MYBPC3):c.1669G>A (p.Gly557Ser)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Aug 30, 2011)	criteria provided, single submitter	11	47342112	GRCh38	181122	179298
NM_000256.3(MYBPC3):c.1664T>C (p.Met555Thr)	MYBPC3	not specified	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	11	47342117	GRCh38	181121	179299
NM_000256.3(MYBPC3):c.1652_1656delTCGCA (p.Ile551Argfs)	MYBPC3	not provided		Pathogenic(Last reviewed: Jul 17, 2013)	criteria provided, single submitter	11	47342125 - 47342129	GRCh38	181071	179300
NM_000256.3(MYBPC3):c.1654G>T (p.Ala552Ser)	MYBPC3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2013)	criteria provided, conflicting interpretations	11	47342127	GRCh38	179473	174771
NM_000256.3(MYBPC3):c.1641_1642delGT (p.Tyr548Profs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	11	47342139 - 47342140	GRCh38	92689	98596
NM_000256.3(MYBPC3):c.1641G>A (p.Val547=)	MYBPC3	not specified		Likely benign(Last reviewed: Dec 28, 2010)	criteria provided, single submitter	11	47342140	GRCh38	42555	51725
NM_000256.3(MYBPC3):c.1633_1640delCTGGAGGT (p.Leu545Valfs)	MYBPC3	Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	11	47342141 - 47342148	GRCh38	237424	241146
NM_000256.3(MYBPC3):c.1633C>A (p.Leu545Met)	MYBPC3	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 28, 2016)	criteria provided, multiple submitters, no conflicts	11	47342148	GRCh38	164105	175183
NM_000256.3(MYBPC3):c.1628delA (p.Lys543Argfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47342153	GRCh38	177637	174772
NM_000256.3(MYBPC3):c.1625-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	11	47342157	GRCh38	222707	224427
NM_000256.3(MYBPC3):c.1625-12C>T	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47342168	GRCh38	188555	186380
NM_000256.3(MYBPC3):c.1624+14_1624+15insA	MYBPC3	not specified	GMAF:0.00060(T), GO-ESP:0.00014(T)	Likely benign(Last reviewed: Jan 14, 2015)	criteria provided, single submitter	11	47342563 - 47342564	GRCh38	42554	51724
NM_000256.3(MYBPC3):c.1624+14G>C	MYBPC3	not specified		Likely benign(Last reviewed: Nov 21, 2012)	criteria provided, single submitter	11	47342564	GRCh38	42553	51723
NM_000256.3(MYBPC3):c.1624+13G>A	MYBPC3	not specified	GMAF:0.00040(T), GO-ESP:0.00035(T)	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	11	47342565	GRCh38	42552	51722
NM_000256.3(MYBPC3):c.1624+9G>A	MYBPC3	not specified		Likely benign(Last reviewed: Oct 2, 2008)	criteria provided, single submitter	11	47342569	GRCh38	42557	51727
NM_000256.3(MYBPC3):c.1624+5G>A	MYBPC3	not provided		Pathogenic(Last reviewed: Aug 8, 2011)	criteria provided, single submitter	11	47342573	GRCh38	181120	179301
NM_000256.3(MYBPC3):c.1624+4A>T	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00001(A)	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2016)	criteria provided, multiple submitters, no conflicts	11	47342574	GRCh38	42556	51726
NM_000256.3(MYBPC3):c.1624+3G>C	MYBPC3	not provided		Likely pathogenic(Last reviewed: Nov 15, 2011)	criteria provided, single submitter	11	47342575	GRCh38	181119	179302
NM_000256.3(MYBPC3):c.1624+2T>C	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, multiple submitters, no conflicts	11	47342576	GRCh38	164107	175184
NM_000256.3(MYBPC3):c.1624G>C (p.Glu542Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00008(G), GO-ESP:0.00003(G)	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	11	47342578	GRCh38	8608	23647
NM_000256.3(MYBPC3):c.1608T>A (p.Ala536=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00221(T), GO-ESP:0.00140(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 7, 2016)	criteria provided, conflicting interpretations	11	47342594	GRCh38	42549	51719
NM_000256.3(MYBPC3):c.1604T>C (p.Leu535Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 18, 2014)	criteria provided, single submitter	11	47342598	GRCh38	180945	179303
NM_000256.3(MYBPC3):c.1602G>A (p.Ala534=)	MYBPC3	not specified|Cardiovascular phenotype	GO-ESP:0.00008(T), GO-ESP:0.00020(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 26, 2013)	criteria provided, conflicting interpretations	11	47342600	GRCh38	42551	51721
NM_000256.3(MYBPC3):c.1595delG (p.Gly532Alafs)	MYBPC3	not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, multiple submitters, no conflicts	11	47342607	GRCh38	181067	179305
NM_000256.3(MYBPC3):c.1595G>T (p.Gly532Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Apr 24, 2013)	criteria provided, single submitter	11	47342607	GRCh38	180944	179304
NM_000256.3(MYBPC3):c.1593G>A (p.Gly531=)	MYBPC3	not specified	GO-ESP:0.00002(T)	Likely benign(Last reviewed: May 31, 2013)	criteria provided, single submitter	11	47342609	GRCh38	164108	174773
NM_000256.3(MYBPC3):c.1591G>A (p.Gly531Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 3, 2016)	criteria provided, conflicting interpretations	11	47342611	GRCh38	164109	175185
NM_000256.3(MYBPC3):c.1591G>C (p.Gly531Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GMAF:0.00020(G), GO-ESP:0.00002(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2015)	criteria provided, conflicting interpretations	11	47342611	GRCh38	42550	51720
NM_000256.3(MYBPC3):c.1586C>G (p.Thr529Ser)	MYBPC3	not specified		Uncertain significance(Last reviewed: Dec 27, 2011)	criteria provided, single submitter	11	47342616	GRCh38	42548	51718
NM_000256.3(MYBPC3):c.1577_1580dupCACT (p.Cys528Thrfs)	MYBPC3	not provided		Pathogenic/Likely pathogenic(Last reviewed: Apr 23, 2015)	criteria provided, single submitter	11	47342622 - 47342625	GRCh38	181148	179306
NM_000256.3(MYBPC3):c.1575T>A (p.Tyr525Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 24, 2015)	criteria provided, single submitter	11	47342627	GRCh38	222700	224428
NM_000256.3(MYBPC3):c.1575T>G (p.Tyr525Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, multiple submitters, no conflicts	11	47342627	GRCh38	42547	51717
NM_000256.3(MYBPC3):c.1566G>A (p.Ala522=)	MYBPC3	not specified	GO-ESP:0.00008(T), GMAF:0.00020(T), GO-ESP:0.00024(T)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2015)	criteria provided, conflicting interpretations	11	47342636	GRCh38	42546	51716
NM_000256.3(MYBPC3):c.1565C>T (p.Ala522Val)	MYBPC3	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	11	47342637	GRCh38	264356	258704
NM_000256.3(MYBPC3):c.1564G>A (p.Ala522Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00171(T), GMAF:0.00180(T), GO-ESP:0.00039(T)	Benign/Likely benign(Last reviewed: Feb 6, 2016)	criteria provided, multiple submitters, no conflicts	11	47342638	GRCh38	42545	51715
NG_007667.1:g.15054T>C	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47342649	GRCh38	304956	326942
NM_000256.3(MYBPC3):c.1547_1549delAGG (p.Glu516del)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 9, 2012)	criteria provided, single submitter	11	47342653 - 47342655	GRCh38	188553	186381
NM_000256.3(MYBPC3):c.1546G>A (p.Glu516Lys)	MYBPC3	not specified		Uncertain significance(Last reviewed: May 13, 2014)	criteria provided, single submitter	11	47342656	GRCh38	180942	179307
NM_000256.3(MYBPC3):c.1543_1545delAAC (p.Asn515del)	MYBPC3	not provided	GO-ESP:0.00001(-)	Likely pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	11	47342657 - 47342659	GRCh38	181070	179308
NM_000256.3(MYBPC3):c.1544A>G (p.Asn515Ser)	MYBPC3	Primary dilated cardiomyopathy|not specified	GO-ESP:0.00023(C), GMAF:0.00120(C), GO-ESP:0.00014(C)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 25, 2016)	criteria provided, conflicting interpretations	11	47342658	GRCh38	36602	45264
NM_000256.3(MYBPC3):c.1540A>G (p.Ile514Val)	MYBPC3	not specified	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Jan 30, 2013)	no assertion criteria provided	11	47342662	GRCh38	164110	174774
NM_000256.3(MYBPC3):c.1535T>C (p.Leu512Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	11	47342667	GRCh38	164111	175186
NM_000256.3(MYBPC3):c.1535T>A (p.Leu512Gln)	MYBPC3	not specified		Uncertain significance(Last reviewed: Apr 7, 2011)	criteria provided, single submitter	11	47342667	GRCh38	42544	51714
NM_000256.3(MYBPC3):c.1522C>T (p.Gln508Ter)	MYBPC3	not provided		Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	11	47342680	GRCh38	180941	179309
NM_000256.3(MYBPC3):c.1519G>A (p.Gly507Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00132(T), GMAF:0.00260(T), GO-ESP:0.00068(T)	Benign/Likely benign(Last reviewed: Feb 18, 2016)	criteria provided, multiple submitters, no conflicts	11	47342683	GRCh38	42543	51713
NM_000256.3(MYBPC3):c.1518C>T (p.Asp506=)	MYBPC3	not specified	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Dec 28, 2010)	criteria provided, single submitter	11	47342684	GRCh38	42542	51712
NM_000256.3(MYBPC3):c.1513_1515delAAG (p.Lys505del)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not specified	GO-ESP:0.00001(-)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2013)	criteria provided, conflicting interpretations	11	47342687 - 47342689	GRCh38	177699	174775
NM_000256.3(MYBPC3):c.1513A>T (p.Lys505Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47342689	GRCh38	188552	186382
NM_000256.3(MYBPC3):c.1505_1509delGGTTC (p.Arg502Glnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 11, 2014)	no assertion criteria provided	11	47342693 - 47342697	GRCh38	155807	165559
NM_000256.3(MYBPC3):c.1505G>T (p.Arg502Leu)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 11, 2013)	no assertion criteria provided	11	47342697	GRCh38	164112	175187
NM_000256.3(MYBPC3):c.1505G>A (p.Arg502Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: May 12, 2016)	criteria provided, multiple submitters, no conflicts	11	47342697	GRCh38	42541	51711
NM_000256.3(MYBPC3):c.1504C>T (p.Arg502Trp)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00008(A), GO-ESP:0.00003(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2016)	criteria provided, conflicting interpretations	11	47342698	GRCh38	42540	51710
NM_000256.3(MYBPC3):c.1494C>G (p.Thr498=)	MYBPC3	not specified	GO-ESP:0.00007(C)	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	11	47342708	GRCh38	42539	51709
NM_000256.3(MYBPC3):c.1484G>A (p.Arg495Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|MYBPC3-Related Disorders	GO-ESP:0.00001(T)	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47342718	GRCh38	164113	174776
NM_000256.3(MYBPC3):c.1483C>T (p.Arg495Trp)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 24, 2014)	criteria provided, single submitter	11	47342719	GRCh38	164114	175188
NM_000256.3(MYBPC3):c.1483C>G (p.Arg495Gly)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	11	47342719	GRCh38	42537	51707
NM_000256.3(MYBPC3):c.1471G>A (p.Val491Met)	MYBPC3	not provided|Cardiovascular phenotype	GO-ESP:0.00006(T)	Conflicting interpretations of pathogenicity(Last reviewed: May 19, 2014)	criteria provided, conflicting interpretations	11	47342731	GRCh38	180940	179310
NM_000256.3(MYBPC3):c.1469G>T (p.Gly490Val)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Pathogenic(Last reviewed: Jun 28, 2013)	no assertion criteria provided	11	47342733	GRCh38	64617	75580
NM_000256.3(MYBPC3):c.1468G>A (p.Gly490Arg)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy	GO-ESP:0.00021(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2016)	criteria provided, conflicting interpretations	11	47342734	GRCh38	42536	51706
NM_000256.3(MYBPC3):c.1467C>G (p.Asp489Glu)	MYBPC3	not specified	GMAF:0.00040(A)	Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47342735	GRCh38	188551	186383
NM_000256.3(MYBPC3):c.1467C>T (p.Asp489=)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00016(A), GMAF:0.00040(A), GO-ESP:0.00029(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2016)	criteria provided, conflicting interpretations	11	47342735	GRCh38	42535	51705
NM_000256.3(MYBPC3):c.1458-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Aug 24, 2015)	criteria provided, multiple submitters, no conflicts	11	47342745	GRCh38	42532	51702
NM_000256.3(MYBPC3):c.1458-6G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Cardiomyopathy|Hypertrophic cardiomyopathy	GO-ESP:0.00008(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2016)	criteria provided, conflicting interpretations	11	47342750	GRCh38	42533	51703
NM_000256.3(MYBPC3):c.1458-7C>T	MYBPC3	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47342751	GRCh38	42534	51704
NG_007667.1:g.14950C>T	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47342753	GRCh38	304957	327974
NM_000256.3(MYBPC3):c.1458-17C>T	MYBPC3	not specified	GMAF:0.00280(A), GO-ESP:0.00051(A)	Uncertain significance(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47342761	GRCh38	188549	186384
NM_000256.3(MYBPC3):c.1458-26C>G	MYBPC3	not specified	GMAF:0.00240(C), GO-ESP:0.00087(C)	Likely benign(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47342770	GRCh38	188550	186385
NM_000256.3(MYBPC3):c.1457+6_1457+25del	MYBPC3	not specified		Uncertain significance(Last reviewed: Apr 19, 2012)	criteria provided, multiple submitters, no conflicts	11	47342805 - 47342824	GRCh38	164115	174777
NM_000256.3(MYBPC3):c.1457+20G>T	MYBPC3	not specified	GMAF:0.00040(A), GO-ESP:0.00128(A)	Benign(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	11	47342810	GRCh38	138316	142019
NM_000256.3(MYBPC3):c.1457+5G>A	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 27, 2014)	criteria provided, single submitter	11	47342825	GRCh38	180939	179311
NM_000256.3(MYBPC3):c.1457+5G>C	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 30, 2013)	no assertion criteria provided	11	47342825	GRCh38	164116	175189
NM_000256.3(MYBPC3):c.1457+4A>G	MYBPC3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	11	47342826	GRCh38	264307	258705
NM_000256.3(MYBPC3):c.1457G>A (p.Trp486Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	11	47342830	GRCh38	180937	179312
NM_000256.3(MYBPC3):c.1456T>C (p.Trp486Arg)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 9, 2015)	criteria provided, single submitter	11	47342831	GRCh38	180938	179313
NM_000256.3(MYBPC3):c.1456T>G (p.Trp486Gly)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2013)	criteria provided, conflicting interpretations	11	47342831	GRCh38	42531	51701
NM_000256.3(MYBPC3):c.1447C>T (p.Gln483Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Jun 14, 2013)	criteria provided, single submitter	11	47342840	GRCh38	180936	179314
NM_000256.3(MYBPC3):c.1445C>T (p.Ala482Val)	MYBPC3	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Sep 4, 2014)	criteria provided, multiple submitters, no conflicts	11	47342842	GRCh38	164117	174778
NM_000256.3(MYBPC3):c.1444dupG (p.Ala482Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: May 1, 2015)	criteria provided, single submitter	11	47342843	GRCh38	228368	230214
NM_000256.3(MYBPC3):c.1433C>T (p.Ser478Leu)	MYBPC3	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	11	47342854	GRCh38	180935	179315
NM_000256.3(MYBPC3):c.1431A>G (p.Val477=)	MYBPC3	not specified		Benign(Last reviewed: Jul 15, 2011)	criteria provided, single submitter	11	47342856	GRCh38	138315	142018
NM_000256.3(MYBPC3):c.1422G>C (p.Glu474Asp)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jul 21, 2009)	no assertion criteria provided	11	47342865	GRCh38	42530	51700
NM_000256.3(MYBPC3):c.1418T>C (p.Phe473Ser)	MYBPC3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2014)	criteria provided, conflicting interpretations	11	47342869	GRCh38	42529	51699
NM_000256.3(MYBPC3):c.1410_1411delGG (p.Val471Glyfs)	MYBPC3	not provided		Pathogenic(Last reviewed: Feb 22, 2013)	criteria provided, single submitter	11	47342876 - 47342877	GRCh38	181069	179316
NM_000256.3(MYBPC3):c.1405C>T (p.Gln469Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	11	47342882	GRCh38	180934	179317
NM_000256.3(MYBPC3):c.1404delG (p.Gln469Serfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	11	47342883	GRCh38	254153	248633
NM_000256.3(MYBPC3):c.1397T>A (p.Met466Lys)	MYBPC3	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Mar 19, 2013)	criteria provided, single submitter	11	47342890	GRCh38	42528	51698
NM_000256.3(MYBPC3):c.1387C>T (p.Gln463Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	11	47342900	GRCh38	180933	179318
NM_000256.3(MYBPC3):c.1381G>T (p.Glu461Ter)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	11	47342906	GRCh38	180932	179319
NM_000256.3(MYBPC3):c.1377delC (p.Leu460Trpfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47342910	GRCh38	188548	186386
NM_000256.3(MYBPC3):c.1373G>A (p.Arg458His)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00016(T), GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	11	47342914	GRCh38	42527	51697
NM_000256.3(MYBPC3):c.1372C>T (p.Arg458Cys)	MYBPC3	not specified	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	11	47342915	GRCh38	180931	179320
NM_000256.3(MYBPC3):c.1370C>T (p.Thr457Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00020(A)	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	47342917	GRCh38	161314	171140
NM_000256.3(MYBPC3):c.1359delT (p.Val454Cysfs)	MYBPC3	Familial hypertrophic cardiomyopathy 1		Pathogenic(Last reviewed: May 1, 2015)	criteria provided, single submitter	11	47342928	GRCh38	217835	214491
NM_000256.3(MYBPC3):c.1358dupC (p.Val454Cysfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2011)	criteria provided, multiple submitters, no conflicts	11	47342929	GRCh38	181147	179321
NM_000256.3(MYBPC3):c.1357_1358delCC (p.Pro453Cysfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Sep 23, 2013)	criteria provided, single submitter	11	47342929 - 47342930	GRCh38	164118	175190
NM_000256.3(MYBPC3):c.1358C>T (p.Pro453Leu)	MYBPC3	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47342929	GRCh38	42526	51696
NM_000256.3(MYBPC3):c.1357C>T (p.Pro453Ser)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic	criteria provided, single submitter	11	47342930	GRCh38	217475	214117
NM_000256.3(MYBPC3):c.1355C>A (p.Pro452His)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jan 17, 2014)	criteria provided, single submitter	11	47342932	GRCh38	180930	179322
NM_000256.3(MYBPC3):c.1352-16C>T	MYBPC3	not specified		Likely benign	criteria provided, single submitter	11	47342951	GRCh38	255624	254188
NM_000256.3(MYBPC3):c.1351+2T>C	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Jan 31, 2013)	criteria provided, multiple submitters, no conflicts	11	47343019	GRCh38	42525	51695
NM_000256.3(MYBPC3):c.1351+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: May 4, 2015)	criteria provided, multiple submitters, no conflicts	11	47343020	GRCh38	164119	174779
NM_000256.3(MYBPC3):c.1351G>T (p.Glu451Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47343021	GRCh38	188547	186387
NM_000256.3(MYBPC3):c.1343T>C (p.Phe448Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 12, 2013)	criteria provided, single submitter	11	47343029	GRCh38	177685	175191
NM_000256.3(MYBPC3):c.1335G>A (p.Thr445=)	MYBPC3	not specified	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	11	47343037	GRCh38	164121	174780
NM_000256.3(MYBPC3):c.1330delA (p.Ser444Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	11	47343042	GRCh38	179821	175192
NM_000256.3(MYBPC3):c.1321G>A (p.Glu441Lys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GMAF:0.00020(T), GO-ESP:0.00016(T)	Uncertain significance(Last reviewed: Aug 22, 2016)	criteria provided, multiple submitters, no conflicts	11	47343051	GRCh38	36601	45263
NM_000256.3(MYBPC3):c.1320C>T (p.Gly440=)	MYBPC3	not specified	GO-ESP:0.00016(A), GO-ESP:0.00005(A)	Likely benign(Last reviewed: Dec 28, 2010)	criteria provided, single submitter	11	47343052	GRCh38	42523	51693
NM_000256.3(MYBPC3):c.1316delG (p.Gly439Valfs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Sep 30, 2011)	criteria provided, single submitter	11	47343056	GRCh38	181146	179323
NM_000256.3(MYBPC3):c.1310delT (p.Val437Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Feb 17, 2011)	criteria provided, single submitter	11	47343062	GRCh38	42522	51692
NM_000256.3(MYBPC3):c.1309G>A (p.Val437Met)	MYBPC3	not specified|Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	11	47343063	GRCh38	180929	179324
NM_000256.3(MYBPC3):c.1308C>T (p.Cys436=)	MYBPC3	not specified	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	11	47343064	GRCh38	227562	230215
NM_000256.3(MYBPC3):c.1302C>A (p.Tyr434Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 1	GMAF:0.00040(A)	Pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	11	47343070	GRCh38	217827	214492
NM_000256.3(MYBPC3):c.1294G>A (p.Ala432Thr)	MYBPC3	not specified	GO-ESP:0.00008(T), GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Aug 24, 2012)	criteria provided, single submitter	11	47343078	GRCh38	42520	51690
NM_000256.3(MYBPC3):c.1290C>T (p.Asp430=)	MYBPC3	not specified	GO-ESP:0.00008(A), GO-ESP:0.00002(A)	Likely benign(Last reviewed: Aug 10, 2009)	criteria provided, single submitter	11	47343082	GRCh38	42519	51689
NM_000256.3(MYBPC3):c.1288G>A (p.Asp430Asn)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	11	47343084	GRCh38	180928	179325
NM_000256.3(MYBPC3):c.1286C>A (p.Ala429Glu)	MYBPC3	not specified	GMAF:0.00040(A)	Uncertain significance(Last reviewed: Jul 31, 2011)	criteria provided, single submitter	11	47343086	GRCh38	181118	179326
NM_000256.3(MYBPC3):c.1286C>T (p.Ala429Val)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00039(A), GMAF:0.00040(A), GO-ESP:0.00021(A)	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2016)	criteria provided, conflicting interpretations	11	47343086	GRCh38	42518	51688
NM_000256.3(MYBPC3):c.1282T>C (p.Leu428=)	MYBPC3	Hypertrophic cardiomyopathy	GO-ESP:0.00005(G)	Likely benign(Last reviewed: Feb 17, 2016)	criteria provided, single submitter	11	47343090	GRCh38	237423	241147
NM_000256.3(MYBPC3):c.1273C>T (p.Gln425Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	11	47343099	GRCh38	42517	51687
NM_000256.3(MYBPC3):c.1264A>C (p.Thr422Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 8, 2013)	criteria provided, single submitter	11	47343108	GRCh38	164123	174781
NM_000256.3(MYBPC3):c.1255C>T (p.Arg419Cys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: May 17, 2016)	criteria provided, multiple submitters, no conflicts	11	47343117	GRCh38	42516	51686
NM_000256.3(MYBPC3):c.1252A>T (p.Lys418Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	11	47343120	GRCh38	180927	179327
NM_000256.3(MYBPC3):c.1246G>A (p.Gly416Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00024(T), GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 8, 2016)	criteria provided, conflicting interpretations	11	47343126	GRCh38	42515	51685
NM_000256.3(MYBPC3):c.1238A>G (p.Glu413Gly)	MYBPC3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2014)	criteria provided, conflicting interpretations	11	47343134	GRCh38	180926	179328
NM_000256.3(MYBPC3):c.1236dupT (p.Glu413Terfs)	MYBPC3	Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	11	47343136	GRCh38	237422	241148
NM_000256.3(MYBPC3):c.1235_1236delTT (p.Phe412Terfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: May 10, 2016)	criteria provided, multiple submitters, no conflicts	11	47343136 - 47343137	GRCh38	42514	51684
NM_000256.3(MYBPC3):c.1227-2A>G	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, multiple submitters, no conflicts	11	47343147	GRCh38	180925	179329
NM_000256.3(MYBPC3):c.1227-10C>T	MYBPC3	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	11	47343155	GRCh38	178934	175193
NM_000256.3(MYBPC3):c.1227-13G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00001(T)	Likely pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	11	47343158	GRCh38	42513	51683
NM_000256.3(MYBPC3):c.1226+54C>T	MYBPC3	not specified		Likely benign(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	11	47343206	GRCh38	188546	186388
NM_000256.3(MYBPC3):c.1226+49T>C	MYBPC3	not specified	GMAF:0.03590(A)	Benign(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	11	47343211	GRCh38	188545	186389
NM_000256.3(MYBPC3):c.1226+6T>C	MYBPC3	not specified	GMAF:0.00020(G), GO-ESP:0.00006(G)	Uncertain significance(Last reviewed: Mar 16, 2010)	criteria provided, single submitter	11	47343254	GRCh38	42512	51682
NM_000256.3(MYBPC3):c.1224-2A>G	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	11	47343264	GRCh38	42511	51681
NM_000256.3(MYBPC3):c.1224-19G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|not specified	GO-ESP:0.00004(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2013)	criteria provided, conflicting interpretations	11	47343281	GRCh38	138326	142029
NM_000256.3(MYBPC3):c.1224-52G>A	MYBPC3	not specified		Likely benign(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	11	47343314	GRCh38	188544	186390
NM_000256.3(MYBPC3):c.1223+29G>A	MYBPC3	not specified	GMAF:0.07830(T), GO-ESP:0.14446(T)	Benign(Last reviewed: Feb 23, 2012)	criteria provided, multiple submitters, no conflicts	11	47343463	GRCh38	188543	186391
NM_000256.3(MYBPC3):c.1223+14T>G	MYBPC3	not specified		Benign(Last reviewed: Apr 15, 2013)	criteria provided, single submitter	11	47343478	GRCh38	138325	142028
NM_000256.3(MYBPC3):c.1223+2T>G	MYBPC3	not provided	GO-ESP:0.00054(C)	Pathogenic(Last reviewed: Jan 18, 2014)	criteria provided, single submitter	11	47343490	GRCh38	181068	179330
NM_000256.3(MYBPC3):c.1223+1G>A	MYBPC3	not provided		Pathogenic(Last reviewed: Jan 15, 2013)	criteria provided, single submitter	11	47343491	GRCh38	181066	179331
NM_000256.3(MYBPC3):c.1222A>C (p.Ser408Arg)	MYBPC3	not specified		Uncertain significance(Last reviewed: May 14, 2014)	criteria provided, single submitter	11	47343493	GRCh38	181065	179332
NM_000256.3(MYBPC3):c.1219G>A (p.Gly407Ser)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 1, 2014)	criteria provided, single submitter	11	47343496	GRCh38	179988	174782
NM_000256.3(MYBPC3):c.1213A>G (p.Met405Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 29, 2014)	criteria provided, multiple submitters, no conflicts	11	47343502	GRCh38	164126	175194
NM_000256.3(MYBPC3):c.1210C>T (p.Gln404Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: May 18, 2016)	criteria provided, multiple submitters, no conflicts	11	47343505	GRCh38	177796	174783
NM_000256.3(MYBPC3):c.1201C>T (p.Gln401Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Feb 14, 2013)	criteria provided, single submitter	11	47343514	GRCh38	181064	179333
NM_000256.3(MYBPC3):c.1188G>A (p.Trp396Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Aug 31, 2011)	criteria provided, single submitter	11	47343527	GRCh38	181141	179334
NM_000256.3(MYBPC3):c.1188G>T (p.Trp396Cys)	MYBPC3	not specified		Uncertain significance(Last reviewed: Aug 13, 2010)	criteria provided, single submitter	11	47343527	GRCh38	42509	51679
NM_000256.3(MYBPC3):c.1182C>A (p.Val394=)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	11	47343533	GRCh38	181063	179335
NM_000256.3(MYBPC3):c.1156_1171dup16 (p.Asp391Glyfs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Mar 29, 2012)	criteria provided, single submitter	11	47343544 - 47343559	GRCh38	181117	179336
NM_000256.3(MYBPC3):c.1153_1168del16 (p.Val385Metfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Nov 26, 2015)	criteria provided, single submitter	11	47343547 - 47343562	GRCh38	222706	224429
NM_000256.3(MYBPC3):c.1168delC (p.His390Metfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy		Pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, multiple submitters, no conflicts	11	47343547	GRCh38	42508	51678
NM_000256.3(MYBPC3):c.1162dupG (p.Ala388Glyfs)	MYBPC3	not provided		Likely pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	11	47343553	GRCh38	181160	179337
NM_000256.3(MYBPC3):c.1156G>T (p.Glu386Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Aug 13, 2010)	criteria provided, single submitter	11	47343559	GRCh38	42507	51677
NM_000256.3(MYBPC3):c.1153G>A (p.Val385Met)	MYBPC3	Hypertrophic cardiomyopathy	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	11	47343562	GRCh38	219403	222144
NM_000256.3(MYBPC3):c.1147C>G (p.Leu383Val)	MYBPC3	not provided	GO-ESP:0.00009(C)	Likely pathogenic(Last reviewed: Oct 21, 2013)	criteria provided, single submitter	11	47343568	GRCh38	181062	179338
NM_000256.3(MYBPC3):c.1144C>T (p.Arg382Trp)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01028(A), GMAF:0.01260(A), GO-ESP:0.00422(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47343571	GRCh38	42506	51676
NM_000256.3(MYBPC3):c.1123G>A (p.Val375Met)	MYBPC3	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Aug 18, 2014)	criteria provided, multiple submitters, no conflicts	11	47343592	GRCh38	164128	175195
NM_000256.3(MYBPC3):c.1120dupC (p.Gln374Profs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	11	47343595	GRCh38	181116	179339
NM_000256.3(MYBPC3):c.1120C>T (p.Gln374Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Mar 12, 2012)	criteria provided, single submitter	11	47343595	GRCh38	181061	179340
NG_007667.1:g.14101G>A	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47343602	GRCh38	304958	326949
NM_000256.3(MYBPC3):c.1112C>T (p.Pro371Leu)	MYBPC3	not specified	GMAF:0.00020(A), GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Feb 26, 2014)	criteria provided, single submitter	11	47343603	GRCh38	181060	179341
NM_000256.3(MYBPC3):c.1112C>G (p.Pro371Arg)	MYBPC3	not specified	GMAF:0.00020(A)	Uncertain significance(Last reviewed: May 5, 2011)	criteria provided, single submitter	11	47343603	GRCh38	42505	51675
NM_000256.3(MYBPC3):c.1091-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Oct 27, 2014)	no assertion criteria provided	11	47343625	GRCh38	180416	178645
NM_000256.3(MYBPC3):c.1091-18_1091-8del	MYBPC3	not specified		Uncertain significance(Last reviewed: Oct 3, 2014)	criteria provided, single submitter	11	47343632 - 47343642	GRCh38	42504	51674
NM_000256.3(MYBPC3):c.1091-24C>T	MYBPC3	not specified	GMAF:0.24960(A), GO-ESP:0.31591(A)	Benign(Last reviewed: Feb 23, 2012)	criteria provided, multiple submitters, no conflicts	11	47343648	GRCh38	188541	186392
NM_000256.3(MYBPC3):c.1091-31G>A	MYBPC3	not specified	GMAF:0.05890(T), GO-ESP:0.01635(T)	Benign	criteria provided, single submitter	11	47343655	GRCh38	255623	254189
NM_000256.3(MYBPC3):c.1091-39C>T	MYBPC3	not specified	GMAF:0.01480(A), GO-ESP:0.02936(A)	Benign(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	11	47343663	GRCh38	188542	186393
NM_000256.3(MYBPC3):c.1090+2T>G	MYBPC3	not provided		Pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	11	47346205	GRCh38	181059	179342
NM_000256.3(MYBPC3):c.1090+1G>T	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, multiple submitters, no conflicts	11	47346206	GRCh38	177686	174784
NM_000256.3(MYBPC3):c.1090+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, multiple submitters, no conflicts	11	47346206	GRCh38	177668	175196
NM_000256.3(MYBPC3):c.1090G>C (p.Ala364Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47346207	GRCh38	193980	191143
NM_000256.3(MYBPC3):c.1084dupA (p.Ser362Lysfs)	MYBPC3	not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	11	47346213	GRCh38	181159	179344
NM_000256.3(MYBPC3):c.1084A>G (p.Ser362Gly)	MYBPC3	not provided	GO-ESP:0.00001(C)	Likely pathogenic(Last reviewed: Feb 9, 2014)	criteria provided, single submitter	11	47346213	GRCh38	181058	179343
NM_000256.3(MYBPC3):c.1080G>C (p.Lys360Asn)	MYBPC3	not provided	GO-ESP:0.00001(G)	Likely pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, single submitter	11	47346217	GRCh38	181057	179345
NM_000256.3(MYBPC3):c.1075G>T (p.Glu359Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	11	47346222	GRCh38	228367	230216
NM_000256.3(MYBPC3):c.1069_1072delCGCGinsGC (p.Arg357Alafs)	MYBPC3	not provided		Pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	11	47346225 - 47346228	GRCh38	181115	179346
NM_000256.3(MYBPC3):c.1070G>A (p.Arg357His)	MYBPC3	not specified|not provided	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2014)	criteria provided, conflicting interpretations	11	47346227	GRCh38	181145	179347
NG_007667.1:g.11462C>G	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47346241	GRCh38	304959	327975
NM_000256.3(MYBPC3):c.984_1054del71 (p.Pro329Glnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Sep 17, 2010)	criteria provided, single submitter	11	47346243 - 47346313	GRCh38	42814	51984
NM_000256.3(MYBPC3):c.1038_1042dupCGGCA (p.Met348Thrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy		Pathogenic(Last reviewed: Sep 20, 2013)	criteria provided, multiple submitters, no conflicts	11	47346255 - 47346259	GRCh38	177698	178182
NM_000256.3(MYBPC3):c.1039G>A (p.Gly347Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: May 22, 2014)	criteria provided, conflicting interpretations	11	47346258	GRCh38	42502	51672
NM_000256.3(MYBPC3):c.1038C>T (p.Arg346=)	MYBPC3	Hypertrophic cardiomyopathy	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Feb 25, 2016)	criteria provided, single submitter	11	47346259	GRCh38	237420	241149
NM_000256.3(MYBPC3):c.1037G>A (p.Arg346His)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jul 14, 2015)	criteria provided, multiple submitters, no conflicts	11	47346260	GRCh38	42501	51671
NM_000256.3(MYBPC3):c.1028delC (p.Thr343Metfs)	MYBPC3	not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, multiple submitters, no conflicts	11	47346269	GRCh38	181114	179348
NM_000256.3(MYBPC3):c.1025T>A (p.Val342Asp)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Aug 9, 2011)	criteria provided, single submitter	11	47346272	GRCh38	181144	179349
NM_000256.3(MYBPC3):c.1024G>A (p.Val342Ile)	MYBPC3	not specified	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	11	47346273	GRCh38	42500	51670
NM_000256.3(MYBPC3):c.1021G>A (p.Gly341Ser)	MYBPC3	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Mar 10, 2011)	criteria provided, single submitter	11	47346276	GRCh38	42499	51669
NM_000256.3(MYBPC3):c.1020C>T (p.Tyr340=)	MYBPC3	Hypertrophic cardiomyopathy	GMAF:0.00020(A), GO-ESP:0.00004(A)	Likely benign(Last reviewed: Nov 2, 2015)	criteria provided, single submitter	11	47346277	GRCh38	221024	222145
NM_000256.3(MYBPC3):c.1015C>T (p.Gln339Ter)	MYBPC3	not provided		Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, single submitter	11	47346282	GRCh38	181056	179350
NM_000256.3(MYBPC3):c.1008C>T (p.Ile336=)	MYBPC3	not specified|Cardiovascular phenotype		Likely benign(Last reviewed: Dec 6, 2012)	criteria provided, multiple submitters, no conflicts	11	47346289	GRCh38	42498	51668
NM_000256.3(MYBPC3):c.1003C>T (p.Arg335Cys)	MYBPC3	not provided|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00002(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47346294	GRCh38	181055	179351
NM_000256.3(MYBPC3):c.1000G>A (p.Glu334Lys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00100(T), GO-ESP:0.00034(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47346297	GRCh38	177902	175197
NM_000256.3(MYBPC3):c.1000G>T (p.Glu334Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GMAF:0.00100(T)	Pathogenic/Likely pathogenic(Last reviewed: Jan 11, 2016)	criteria provided, multiple submitters, no conflicts	11	47346297	GRCh38	177850	174785
NM_000256.3(MYBPC3):c.999C>G (p.Tyr333Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype		Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, multiple submitters, no conflicts	11	47346298	GRCh38	177706	174786
NM_000256.3(MYBPC3):c.994G>A (p.Glu332Lys)	MYBPC3	not specified|not provided	GMAF:0.00020(T), GO-ESP:0.00001(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2014)	criteria provided, conflicting interpretations	11	47346303	GRCh38	42815	51985
NM_000256.3(MYBPC3):c.993dupT (p.Glu332Terfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	11	47346304	GRCh38	164134	175198
NM_000256.3(MYBPC3):c.979C>T (p.Gln327Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	11	47346318	GRCh38	164135	174787
NM_000256.3(MYBPC3):c.977G>A (p.Arg326Gln)	MYBPC3	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00249(T), GMAF:0.00080(T), GO-ESP:0.00551(T)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	11	47346320	GRCh38	42813	51983
NM_000256.3(MYBPC3):c.966G>A (p.Trp322Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Aug 4, 2016)	criteria provided, multiple submitters, no conflicts	11	47346331	GRCh38	164136	175199
NM_000256.3(MYBPC3):c.964T>C (p.Trp322Arg)	MYBPC3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2014)	criteria provided, conflicting interpretations	11	47346333	GRCh38	181143	179352
NM_000256.3(MYBPC3):c.961G>A (p.Val321Met)	MYBPC3	Primary dilated cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00046(T)	Uncertain significance(Last reviewed: Aug 30, 2016)	criteria provided, multiple submitters, no conflicts	11	47346336	GRCh38	161310	171141
NM_000256.3(MYBPC3):c.960C>T (p.Asp320=)	MYBPC3	not specified	GO-ESP:0.00008(A), GO-ESP:0.00001(A)	Likely benign(Last reviewed: Mar 1, 2008)	criteria provided, single submitter	11	47346337	GRCh38	42812	51982
NM_000256.3(MYBPC3):c.933G>C (p.Ser311=)	MYBPC3	not specified	GO-ESP:0.00016(G), GMAF:0.00020(G), GO-ESP:0.00029(G)	Benign/Likely benign(Last reviewed: May 2, 2014)	criteria provided, multiple submitters, no conflicts	11	47346364	GRCh38	42810	51980
NM_000256.3(MYBPC3):c.933G>A (p.Ser311=)	MYBPC3	not specified	GMAF:0.00020(G)	Likely benign(Last reviewed: Dec 28, 2010)	criteria provided, single submitter	11	47346364	GRCh38	42809	51979
NM_000256.3(MYBPC3):c.932C>T (p.Ser311Leu)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	11	47346365	GRCh38	177928	174788
NM_000256.3(MYBPC3):c.932C>A (p.Ser311Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, multiple submitters, no conflicts	11	47346365	GRCh38	36615	45277
NM_000256.3(MYBPC3):c.931T>A (p.Ser311Thr)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47346366	GRCh38	42808	51978
NM_000256.3(MYBPC3):c.927_928delGG (p.Asp310Leufs)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	11	47346369 - 47346370	GRCh38	254155	248634
NM_000256.3(MYBPC3):c.927-2A>G	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, multiple submitters, no conflicts	11	47346372	GRCh38	42806	51976
NG_007667.1:g.11326G>T	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47346377	GRCh38	304960	326951
NM_000256.3(MYBPC3):c.927-9G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, multiple submitters, no conflicts	11	47346379	GRCh38	42807	51977
NG_007667.1:g.11323C>T	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47346380	GRCh38	304961	314290
NM_000256.3(MYBPC3):c.927-10C>A	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	11	47346380	GRCh38	42805	51975
NM_000256.3(MYBPC3):c.927-28C>T	MYBPC3	not specified	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	11	47346398	GRCh38	188540	186394
NM_000256.3(MYBPC3):c.926+25C>A	MYBPC3	not specified	GMAF:0.00840(T), GO-ESP:0.01886(T)	Benign(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	11	47346602	GRCh38	188539	186395
NM_000256.3(MYBPC3):c.926+8C>T	MYBPC3	not specified	GO-ESP:0.00073(A), GMAF:0.00040(A), GO-ESP:0.00035(A)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 9, 2015)	criteria provided, conflicting interpretations	11	47346619	GRCh38	42804	51974
NM_000256.3(MYBPC3):c.926+4A>G	MYBPC3	not specified	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: May 18, 2009)	no assertion criteria provided	11	47346623	GRCh38	42803	51973
NM_000256.3(MYBPC3):c.923_924insAACT (p.Arg309Thrfs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	11	47346629 - 47346630	GRCh38	181106	179353
NM_000256.3(MYBPC3):c.917G>A (p.Arg306Gln)	MYBPC3	not specified	GO-ESP:0.00008(T), GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Feb 11, 2014)	criteria provided, multiple submitters, no conflicts	11	47346636	GRCh38	42802	51972
NM_000256.3(MYBPC3):c.913_914delTT (p.Phe305Profs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2015)	criteria provided, multiple submitters, no conflicts	11	47346639 - 47346640	GRCh38	42801	51971
NM_000256.3(MYBPC3):c.909C>T (p.Asp303=)	MYBPC3	not specified	GMAF:0.00100(A), GO-ESP:0.00061(A)	Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	11	47346644	GRCh38	188538	186396
NM_000256.3(MYBPC3):c.909-13A>C	MYBPC3	not specified	GO-ESP:0.00006(G)	Benign(Last reviewed: May 24, 2012)	criteria provided, single submitter	11	47346657	GRCh38	138324	142027
NM_000256.3(MYBPC3):c.909-19A>C	MYBPC3	not specified		Benign(Last reviewed: May 24, 2012)	criteria provided, single submitter	11	47346663	GRCh38	138323	142026
NM_000256.3(MYBPC3):c.909-20C>T	MYBPC3	not specified	GO-ESP:0.00003(A)	Benign(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	11	47346664	GRCh38	138322	142025
NM_000256.3(MYBPC3):c.906-1G>A	MYBPC3	not provided		Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	11	47347030	GRCh38	279971	264553
NM_000256.3(MYBPC3):c.906-1G>C	MYBPC3	Familial hypertrophic cardiomyopathy 4|not provided	GO-ESP:0.00001(G)	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	11	47347030	GRCh38	8619	23658
NM_000256.3(MYBPC3):c.906-7G>T	MYBPC3	not specified	GMAF:0.00020(A), GO-ESP:0.00028(A)	Uncertain significance(Last reviewed: Jul 10, 2015)	criteria provided, multiple submitters, no conflicts	11	47347036	GRCh38	42800	51970
NM_000256.3(MYBPC3):c.906-13T>A	MYBPC3	not specified		Uncertain significance(Last reviewed: Jul 23, 2012)	criteria provided, single submitter	11	47347042	GRCh38	181764	179355
NM_000256.3(MYBPC3):c.906-36G>A	MYBPC3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Dec 19, 2015)	criteria provided, single submitter	11	47347065	GRCh38	219660	222146
NM_000256.3(MYBPC3):c.901A>T (p.Lys301Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	11	47347430	GRCh38	181054	179356
NM_000256.3(MYBPC3):c.884T>C (p.Phe295Ser)	MYBPC3	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 10, 2013)	criteria provided, single submitter	11	47347447	GRCh38	235024	236785
NM_000256.3(MYBPC3):c.884delT (p.Phe295Serfs)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, single submitter	11	47347447	GRCh38	181112	179357
NM_000256.3(MYBPC3):c.853G>A (p.Asp285Asn)	MYBPC3	not specified		Uncertain significance(Last reviewed: Apr 12, 2013)	criteria provided, single submitter	11	47347478	GRCh38	178898	175200
NM_000256.3(MYBPC3):c.852-1G>A	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Jan 14, 2014)	criteria provided, single submitter	11	47347480	GRCh38	181053	179358
NM_000256.3(MYBPC3):c.852-1G>T	MYBPC3	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00002(A)	Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	47347480	GRCh38	162500	172178
NM_000256.3(MYBPC3):c.852-6C>T	MYBPC3	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: May 5, 2010)	criteria provided, single submitter	11	47347485	GRCh38	42799	51969
NM_000256.3(MYBPC3):c.852-10C>G	MYBPC3	not specified	GO-ESP:0.00004(C)	Uncertain significance(Last reviewed: Oct 1, 2015)	criteria provided, multiple submitters, no conflicts	11	47347489	GRCh38	188537	186397
NM_000256.3(MYBPC3):c.851+1G>A	MYBPC3	not provided		Likely pathogenic(Last reviewed: Oct 19, 2015)	no assertion criteria provided	11	47347650	GRCh38	235023	236786
NM_000256.3(MYBPC3):c.844C>T (p.Arg282Trp)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2013)	criteria provided, conflicting interpretations	11	47347658	GRCh38	177621	174789
NM_000256.3(MYBPC3):c.841C>T (p.Arg281Trp)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	11	47347661	GRCh38	181052	179359
NM_000256.3(MYBPC3):c.836G>C (p.Gly279Ala)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00008(G)	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, multiple submitters, no conflicts	11	47347666	GRCh38	42798	51968
NM_000256.3(MYBPC3):c.833delG (p.Gly278Glufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, multiple submitters, no conflicts	11	47347669	GRCh38	164140	175201
NM_000256.3(MYBPC3):c.833G>A (p.Gly278Glu)	MYBPC3	not specified	GO-ESP:0.00518(T), GMAF:0.00380(T), GO-ESP:0.00295(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2014)	criteria provided, conflicting interpretations	11	47347669	GRCh38	42797	51967
NM_000256.3(MYBPC3):c.822-3C>T	MYBPC3	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	11	47347683	GRCh38	181051	179360
NM_000256.3(MYBPC3):c.822-5C>G	MYBPC3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Feb 6, 2016)	criteria provided, single submitter	11	47347685	GRCh38	237431	241150
NM_000256.3(MYBPC3):c.821+5G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	11	47347852	GRCh38	42796	51966
NM_000256.3(MYBPC3):c.821+3G>T	MYBPC3	not specified		Uncertain significance(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	11	47347854	GRCh38	228869	230217
NM_000256.3(MYBPC3):c.821+3G>C	MYBPC3	not specified		Uncertain significance(Last reviewed: Dec 5, 2013)	criteria provided, single submitter	11	47347854	GRCh38	164141	174790
NM_000256.3(MYBPC3):c.821+2T>C	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2015)	criteria provided, conflicting interpretations	11	47347855	GRCh38	42795	51965
NM_000256.3(MYBPC3):c.821+1G>C	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47347856	GRCh38	178946	175202
NM_000256.3(MYBPC3):c.821+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00004(T)	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2016)	criteria provided, multiple submitters, no conflicts	11	47347856	GRCh38	42791	51961
NM_000256.3(MYBPC3):c.818G>A (p.Arg273His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47347860	GRCh38	161312	171142
NM_000256.3(MYBPC3):c.814C>T (p.Arg272Cys)	MYBPC3	not specified	GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47347864	GRCh38	42794	51964
NM_000256.3(MYBPC3):c.790dupG (p.Asp264Glyfs)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47347888	GRCh38	188536	186398
NM_000256.3(MYBPC3):c.787G>A (p.Gly263Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00023(T)	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	47347891	GRCh38	161315	171143
NM_000256.3(MYBPC3):c.786C>T (p.Thr262=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.09332(A), GMAF:0.06110(A), GO-ESP:0.15423(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47347892	GRCh38	42793	51963
NM_000256.3(MYBPC3):c.785C>G (p.Thr262Ser)	MYBPC3	Cardiomyopathy		Uncertain significance(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	11	47347893	GRCh38	181050	179361
NM_000256.3(MYBPC3):c.779delT (p.Met260Argfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Jan 14, 2015)	criteria provided, single submitter	11	47347899	GRCh38	188535	186399
NM_000256.3(MYBPC3):c.772+10C>T	MYBPC3	not specified	GO-ESP:0.00024(A), GO-ESP:0.00008(A)	Likely benign(Last reviewed: Feb 25, 2013)	criteria provided, single submitter	11	47348414	GRCh38	42789	51959
NM_000256.3(MYBPC3):c.772+5G>A	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	11	47348419	GRCh38	181049	179362
NM_000256.3(MYBPC3):c.772+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Oct 28, 2015)	criteria provided, multiple submitters, no conflicts	11	47348423	GRCh38	42790	51960
NM_000256.3(MYBPC3):c.772G>A (p.Glu258Lys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00004(T)	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, multiple submitters, no conflicts	11	47348424	GRCh38	42792	51962
NG_007667.1:g.9275C>A	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47348428	GRCh38	304962	327976
NM_000256.3(MYBPC3):c.758A>G (p.Asn253Ser)	MYBPC3	not specified		Uncertain significance(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	11	47348438	GRCh38	164143	174791
NM_000256.3(MYBPC3):c.756C>A (p.Phe252Leu)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 9, 2011)	no assertion criteria provided	11	47348440	GRCh38	235022	236787
NM_000256.3(MYBPC3):c.745T>C (p.Cys249Arg)	MYBPC3	not specified|Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Nov 11, 2015)	criteria provided, multiple submitters, no conflicts	11	47348451	GRCh38	42788	51958
NM_000256.3(MYBPC3):c.727A>C (p.Thr243Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 22, 2012)	criteria provided, single submitter	11	47348469	GRCh38	181048	179363
NM_000256.3(MYBPC3):c.722dupT (p.Ser242Valfs)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Sep 30, 2013)	criteria provided, single submitter	11	47348474	GRCh38	181111	179364
NM_000256.3(MYBPC3):c.721G>C (p.Val241Leu)	MYBPC3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	11	47348475	GRCh38	263980	258706
NM_000256.3(MYBPC3):c.713G>A (p.Arg238His)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Sep 7, 2016)	criteria provided, multiple submitters, no conflicts	11	47348483	GRCh38	177910	175203
NM_000256.3(MYBPC3):c.710A>C (p.Tyr237Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jul 6, 2016)	criteria provided, conflicting interpretations	11	47348486	GRCh38	42787	51957
NM_000256.3(MYBPC3):c.709T>C (p.Tyr237His)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	11	47348487	GRCh38	181047	179365
NM_000256.3(MYBPC3):c.706A>G (p.Ser236Gly)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.10344(C), GMAF:0.06710(C), GO-ESP:0.10790(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47348490	GRCh38	42786	51956
NM_000256.3(MYBPC3):c.676_701dup26 (p.Gly235Serfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	11	47348495 - 47348520	GRCh38	188532	186400
NM_000256.3(MYBPC3):c.700A>C (p.Thr234Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	11	47348496	GRCh38	188534	186401
NM_000256.3(MYBPC3):c.682G>A (p.Asp228Asn)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GMAF:0.00020(T), GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	11	47348514	GRCh38	161304	171144
NM_000256.3(MYBPC3):c.681C>T (p.Thr227=)	MYBPC3	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47348515	GRCh38	188533	186402
NM_000256.3(MYBPC3):c.667G>A (p.Glu223Lys)	MYBPC3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00012(T)	Uncertain significance(Last reviewed: Mar 7, 2016)	criteria provided, multiple submitters, no conflicts	11	47348529	GRCh38	42785	51955
NM_000256.3(MYBPC3):c.655G>T (p.Val219Phe)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00001(A)	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, multiple submitters, no conflicts	11	47348541	GRCh38	188531	186403
NM_000256.3(MYBPC3):c.655G>C (p.Val219Leu)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: May 10, 2016)	criteria provided, multiple submitters, no conflicts	11	47348541	GRCh38	42784	51954
NM_000256.3(MYBPC3):c.655-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	11	47348542	GRCh38	42783	51953
NM_000256.3(MYBPC3):c.655-18G>A	MYBPC3	not specified	GMAF:0.01020(T)	Benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	11	47348559	GRCh38	188530	186404
NM_000256.3(MYBPC3):c.654+18G>A	MYBPC3	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	11	47349756	GRCh38	188529	186405
NM_000256.3(MYBPC3):c.654+12G>A	MYBPC3	not specified	GO-ESP:0.00006(T)	Likely benign(Last reviewed: Feb 7, 2013)	criteria provided, single submitter	11	47349762	GRCh38	42781	51951
NM_000256.3(MYBPC3):c.654+5G>C	MYBPC3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	11	47349769	GRCh38	263572	258707
NM_000256.3(MYBPC3):c.654+5G>A	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 15, 2013)	criteria provided, single submitter	11	47349769	GRCh38	42782	51952
NM_000256.3(MYBPC3):c.654+2_654+4dupTGG	MYBPC3	Cardiomyopathy		Uncertain significance(Last reviewed: Jul 29, 2013)	criteria provided, single submitter	11	47349770 - 47349772	GRCh38	181110	179366
NM_000256.3(MYBPC3):c.653A>G (p.Lys218Arg)	MYBPC3	not specified		Uncertain significance(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	11	47349775	GRCh38	181142	179368
NM_000256.3(MYBPC3):c.649A>G (p.Ser217Gly)	MYBPC3	not specified|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00096(C), GMAF:0.00180(C), GO-ESP:0.00227(C)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 20, 2015)	criteria provided, conflicting interpretations	11	47349779	GRCh38	42780	51950
NM_000256.3(MYBPC3):c.646G>A (p.Ala216Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00056(T), GMAF:0.00100(T), GO-ESP:0.00037(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2016)	criteria provided, conflicting interpretations	11	47349782	GRCh38	42779	51949
NM_000256.3(MYBPC3):c.645C>T (p.Arg215=)	MYBPC3	not specified	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	11	47349783	GRCh38	42778	51948
NM_000256.3(MYBPC3):c.643C>T (p.Arg215Cys)	MYBPC3	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00016(A)	Uncertain significance(Last reviewed: Sep 16, 2015)	criteria provided, multiple submitters, no conflicts	11	47349785	GRCh38	42777	51947
NM_000256.3(MYBPC3):c.640G>A (p.Asp214Asn)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not provided	GO-ESP:0.00004(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2013)	criteria provided, conflicting interpretations	11	47349788	GRCh38	191705	189889
NM_000256.3(MYBPC3):c.639C>T (p.Tyr213=)	MYBPC3	not specified	GO-ESP:0.00025(A)	Likely benign(Last reviewed: Nov 12, 2013)	criteria provided, single submitter	11	47349789	GRCh38	179421	174792
NM_000256.3(MYBPC3):c.636C>G (p.Ser212Arg)	MYBPC3	not specified|not provided		Uncertain significance(Last reviewed: Mar 13, 2015)	criteria provided, multiple submitters, no conflicts	11	47349792	GRCh38	42776	51946
NM_000256.3(MYBPC3):c.631G>A (p.Asp211Asn)	MYBPC3	not provided	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jun 24, 2013)	criteria provided, single submitter	11	47349797	GRCh38	191706	189890
NM_000256.3(MYBPC3):c.624G>C (p.Gln208His)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00039(G), GO-ESP:0.00016(G)	Uncertain significance(Last reviewed: Apr 8, 2016)	criteria provided, multiple submitters, no conflicts	11	47349804	GRCh38	42775	51945
NM_000256.3(MYBPC3):c.613C>T (p.Gln205Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, multiple submitters, no conflicts	11	47349815	GRCh38	42774	51944
NM_000256.3(MYBPC3):c.604A>C (p.Lys202Gln)	MYBPC3	Dilated cardiomyopathy 1A|not specified|not provided	GO-ESP:0.00005(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2016)	criteria provided, conflicting interpretations	11	47349824	GRCh38	181046	179369
NM_000256.3(MYBPC3):c.596T>C (p.Leu199Pro)	MYBPC3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Nov 21, 2015)	criteria provided, single submitter	11	47349832	GRCh38	237430	241151
NM_000256.3(MYBPC3):c.588G>C (p.Trp196Cys)	MYBPC3	not specified		Uncertain significance(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	11	47349840	GRCh38	164146	175204
NM_000256.3(MYBPC3):c.586delT (p.Trp196Glyfs)	MYBPC3	not provided		Pathogenic(Last reviewed: May 28, 2014)	criteria provided, single submitter	11	47349842	GRCh38	181109	179370
NM_000256.3(MYBPC3):c.571T>C (p.Trp191Arg)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	11	47349857	GRCh38	181045	179371
NM_000256.3(MYBPC3):c.566T>A (p.Val189Asp)	MYBPC3	not specified		Uncertain significance(Last reviewed: Dec 7, 2012)	criteria provided, single submitter	11	47349862	GRCh38	42773	51943
NM_000256.3(MYBPC3):c.565G>A (p.Val189Ile)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00239(T), GMAF:0.00200(T), GO-ESP:0.00280(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 2, 2016)	criteria provided, conflicting interpretations	11	47349863	GRCh38	36614	45276
NM_000256.3(MYBPC3):c.540_559del20 (p.Ala181Cysfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Nov 30, 2010)	criteria provided, single submitter	11	47349869 - 47349888	GRCh38	42770	51940
NM_000256.3(MYBPC3):c.558G>T (p.Pro186=)	MYBPC3	not specified	GMAF:0.00160(A), GO-ESP:0.00096(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2015)	criteria provided, conflicting interpretations	11	47349870	GRCh38	42772	51942
NM_000256.3(MYBPC3):c.557C>T (p.Pro186Leu)	MYBPC3	not specified	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Sep 16, 2014)	criteria provided, single submitter	11	47349871	GRCh38	164147	174793
NM_000256.3(MYBPC3):c.553A>T (p.Lys185Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Dec 19, 2012)	criteria provided, single submitter	11	47349875	GRCh38	181044	179372
NM_000256.3(MYBPC3):c.551dupT (p.Lys185Glufs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, multiple submitters, no conflicts	11	47349877	GRCh38	42771	51941
NM_000256.3(MYBPC3):c.541_542dupGC (p.Ser182Profs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47349886 - 47349887	GRCh38	188528	186406
NM_000256.3(MYBPC3):c.540C>T (p.Gly180=)	MYBPC3	not specified	GO-ESP:0.00008(A), GO-ESP:0.00004(A)	Likely benign(Last reviewed: Nov 17, 2011)	criteria provided, single submitter	11	47349888	GRCh38	42769	51939
NM_000256.3(MYBPC3):c.537C>T (p.Ala179=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.03406(A), GMAF:0.02500(A), GO-ESP:0.04545(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47349891	GRCh38	42768	51938
NM_000256.3(MYBPC3):c.533delT (p.Val178Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	11	47349895	GRCh38	164148	175205
NM_000256.3(MYBPC3):c.532G>A (p.Val178Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2013)	criteria provided, conflicting interpretations	11	47349896	GRCh38	164149	174794
NM_000256.3(MYBPC3):c.531C>T (p.Arg177=)	MYBPC3	not specified	GO-ESP:0.00021(A)	Benign(Last reviewed: Apr 14, 2014)	criteria provided, single submitter	11	47349897	GRCh38	180923	179373
NM_000256.3(MYBPC3):c.530G>C (p.Arg177Pro)	MYBPC3	not specified	GMAF:0.00300(T)	Benign(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47349898	GRCh38	197649	194810
NM_000256.3(MYBPC3):c.530G>A (p.Arg177His)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00343(T), GMAF:0.00300(T), GO-ESP:0.00095(T)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 8, 2016)	criteria provided, conflicting interpretations	11	47349898	GRCh38	42767	51937
NM_000256.3(MYBPC3):c.529C>T (p.Arg177Cys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00006(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 23, 2016)	criteria provided, conflicting interpretations	11	47349899	GRCh38	36613	45275
NM_000256.3(MYBPC3):c.521_523delTCT (p.Phe174del)	MYBPC3	not specified		Uncertain significance(Last reviewed: Oct 24, 2014)	criteria provided, single submitter	11	47349905 - 47349907	GRCh38	181158	179374
NM_000256.3(MYBPC3):c.518C>T (p.Thr173Ile)	MYBPC3	not specified		Uncertain significance(Last reviewed: May 2, 2014)	criteria provided, single submitter	11	47349910	GRCh38	181043	179375
NM_000256.3(MYBPC3):c.518C>A (p.Thr173Asn)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 16, 2010)	criteria provided, single submitter	11	47349910	GRCh38	42766	51936
NM_000256.3(MYBPC3):c.517A>G (p.Thr173Ala)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jul 9, 2014)	criteria provided, single submitter	11	47349911	GRCh38	179848	175206
NM_000256.3(MYBPC3):c.506-1G>C	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47349923	GRCh38	188526	186407
NM_000256.3(MYBPC3):c.506-1G>T	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	11	47349923	GRCh38	42764	51934
NM_000256.3(MYBPC3):c.506-2A>C	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 1, 2013)	criteria provided, single submitter	11	47349924	GRCh38	42765	51935
NM_000256.3(MYBPC3):c.506-13_506-11delCCTinsCCT	MYBPC3	not specified		Benign(Last reviewed: Mar 1, 2008)	criteria provided, single submitter	11	47349933 - 47349935	GRCh38	177688	174795
NM_000256.3(MYBPC3):c.506-12delC	MYBPC3	not specified|Cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.62003(-), GMAF:0.38920(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47349937	GRCh38	42763	51933
NM_000256.3(MYBPC3):c.506-17C>T	MYBPC3	not specified	GMAF:0.00020(C), GO-ESP:0.00018(A)	Benign(Last reviewed: Mar 15, 2014)	criteria provided, single submitter	11	47349939	GRCh38	138321	142024
NM_000256.3(MYBPC3):c.506-24G>A	MYBPC3	not specified	GMAF:0.00020(T), GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47349946	GRCh38	188527	186408
NM_000256.3(MYBPC3):c.505+6T>G	MYBPC3	not specified		Uncertain significance(Last reviewed: May 16, 2011)	criteria provided, single submitter	11	47350008	GRCh38	42762	51932
NM_000256.3(MYBPC3):c.505+5G>C	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Feb 12, 2013)	no assertion criteria provided	11	47350009	GRCh38	164151	175207
NM_000256.3(MYBPC3):c.505+1G>A	MYBPC3	not provided		Pathogenic(Last reviewed: May 13, 2014)	criteria provided, single submitter	11	47350013	GRCh38	181041	179377
NM_000256.3(MYBPC3):c.505G>A (p.Gly169Ser)	MYBPC3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 31, 2015)	criteria provided, single submitter	11	47350014	GRCh38	264628	258708
NM_000256.3(MYBPC3):c.503T>C (p.Val168Ala)	MYBPC3	Ventricular tachycardia, catecholaminergic polymorphic, 1|not specified	GO-ESP:0.00008(G)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2014)	criteria provided, conflicting interpretations	11	47350016	GRCh38	179989	174796
NM_000256.3(MYBPC3):c.502G>A (p.Val168Met)	MYBPC3	not specified	GMAF:0.00060(T), GO-ESP:0.00047(T)	Uncertain significance(Last reviewed: Apr 27, 2014)	criteria provided, multiple submitters, no conflicts	11	47350017	GRCh38	181040	179378
NM_000256.3(MYBPC3):c.501C>T (p.Thr167=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00021(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47350018	GRCh38	42761	51931
NM_000256.3(MYBPC3):c.497T>G (p.Val166Gly)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 8, 2013)	no assertion criteria provided	11	47350022	GRCh38	235021	236788
NM_000256.3(MYBPC3):c.495G>C (p.Glu165Asp)	MYBPC3	not provided	GO-ESP:0.00034(G)	Likely pathogenic(Last reviewed: Dec 26, 2014)	criteria provided, single submitter	11	47350024	GRCh38	181039	179379
NM_000256.3(MYBPC3):c.492C>T (p.Gly164=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02240(A), GMAF:0.00840(A), GO-ESP:0.02879(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47350027	GRCh38	42760	51930
NM_000256.3(MYBPC3):c.484C>T (p.Gln162Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	11	47350035	GRCh38	181038	179380
NM_000256.3(MYBPC3):c.481C>A (p.Pro161Thr)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00004(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 21, 2016)	criteria provided, conflicting interpretations	11	47350038	GRCh38	42759	51929
NM_000256.3(MYBPC3):c.479G>A (p.Arg160Gln)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jun 9, 2014)	criteria provided, single submitter	11	47350040	GRCh38	181037	179381
NM_000256.3(MYBPC3):c.478C>T (p.Arg160Trp)	MYBPC3	Dilated cardiomyopathy 1A|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00060(A), GO-ESP:0.00162(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47350041	GRCh38	161311	171145
NM_000256.3(MYBPC3):c.477G>A (p.Met159Ile)	MYBPC3	not specified		Uncertain significance(Last reviewed: Mar 13, 2012)	criteria provided, single submitter	11	47350042	GRCh38	181140	179382
NM_000256.3(MYBPC3):c.472G>A (p.Val158Met)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.06368(T), GMAF:0.03300(T), GO-ESP:0.09043(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47350047	GRCh38	42758	51928
NM_000256.3(MYBPC3):c.471C>T (p.Phe157=)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(A), GO-ESP:0.00040(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47350048	GRCh38	42757	51927
NM_000256.3(MYBPC3):c.466dupC (p.Leu156Profs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	11	47350053	GRCh38	179709	175208
NM_000256.3(MYBPC3):c.461T>C (p.Ile154Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00016(G), GMAF:0.00100(G), GO-ESP:0.00020(G)	Uncertain significance(Last reviewed: Jan 5, 2016)	criteria provided, multiple submitters, no conflicts	11	47350058	GRCh38	42756	51926
NM_000256.3(MYBPC3):c.459delC (p.Ile154Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, multiple submitters, no conflicts	11	47350060	GRCh38	42755	51925
NM_000256.3(MYBPC3):c.455_456delAC (p.Asp152Alafs)	MYBPC3	not provided		Pathogenic(Last reviewed: Jul 24, 2013)	criteria provided, single submitter	11	47350063 - 47350064	GRCh38	181108	179384
NM_000256.3(MYBPC3):c.453delT (p.Asp151Glufs)	MYBPC3	not provided		Pathogenic(Last reviewed: May 10, 2013)	criteria provided, single submitter	11	47350066	GRCh38	181107	179385
NM_000256.3(MYBPC3):c.451G>A (p.Asp151Asn)	MYBPC3	not specified	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	11	47350068	GRCh38	42754	51924
NM_000256.3(MYBPC3):c.450delC (p.Asp151Metfs)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	11	47350069	GRCh38	181105	179386
NM_000256.3(MYBPC3):c.450C>T (p.Pro150=)	MYBPC3	not specified	GO-ESP:0.00016(A), GO-ESP:0.00025(A)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 20, 2014)	criteria provided, conflicting interpretations	11	47350069	GRCh38	42753	51923
NM_000256.3(MYBPC3):c.446C>T (p.Ala149Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47350073	GRCh38	188525	186409
NM_000256.3(MYBPC3):c.441_442delTG (p.Gly148Serfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	11	47350077 - 47350078	GRCh38	222705	224430
NM_000256.3(MYBPC3):c.442G>A (p.Gly148Arg)	MYBPC3	not specified|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Feb 29, 2016)	criteria provided, multiple submitters, no conflicts	11	47350077	GRCh38	42752	51922
NM_000256.3(MYBPC3):c.440C>T (p.Pro147Leu)	MYBPC3	not specified	GO-ESP:0.00038(A)	Uncertain significance(Last reviewed: Oct 28, 2013)	criteria provided, single submitter	11	47350079	GRCh38	181035	179387
NM_000256.3(MYBPC3):c.436dupA (p.Thr146Asnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Aug 2, 2013)	criteria provided, single submitter	11	47350083	GRCh38	42751	51921
NM_000256.3(MYBPC3):c.436A>C (p.Thr146Pro)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GMAF:0.00020(C)	Uncertain significance(Last reviewed: Mar 18, 2015)	criteria provided, single submitter	11	47350083	GRCh38	42750	51920
NM_000256.3(MYBPC3):c.431_432delGT (p.Gly144Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: May 10, 2012)	criteria provided, single submitter	11	47350087 - 47350088	GRCh38	42749	51919
NM_000256.3(MYBPC3):c.428A>G (p.Asn143Ser)	MYBPC3	not specified		Uncertain significance(Last reviewed: Dec 12, 2011)	criteria provided, single submitter	11	47350091	GRCh38	181139	179388
NM_000256.3(MYBPC3):c.419C>T (p.Ala140Val)	MYBPC3	not provided		Uncertain significance(Last reviewed: Jun 24, 2013)	criteria provided, single submitter	11	47350100	GRCh38	191707	189891
NM_000256.3(MYBPC3):c.418G>C (p.Ala140Pro)	MYBPC3	Cardiomyopathy		Pathogenic(Last reviewed: Aug 1, 2014)	criteria provided, single submitter	11	47350101	GRCh38	181034	179389
NM_000256.3(MYBPC3):c.416C>G (p.Ser139Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	11	47350103	GRCh38	181138	179390
NM_000256.3(MYBPC3):c.410C>G (p.Ser137Ter)	MYBPC3	not provided		Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	11	47350109	GRCh38	181137	179391
NM_000256.3(MYBPC3):c.406G>A (p.Gly136Arg)	MYBPC3	not specified		Uncertain significance(Last reviewed: May 15, 2014)	criteria provided, single submitter	11	47350502	GRCh38	181033	179392
NM_000256.3(MYBPC3):c.405A>G (p.Lys135=)	MYBPC3	not specified	GO-ESP:0.00008(C)	Uncertain significance(Last reviewed: Apr 19, 2012)	criteria provided, single submitter	11	47350503	GRCh38	177780	174797
NM_000256.3(MYBPC3):c.402C>T (p.Pro134=)	MYBPC3	not specified		Likely benign(Last reviewed: Dec 28, 2010)	criteria provided, single submitter	11	47350506	GRCh38	42748	51918
NM_000256.3(MYBPC3):c.373G>T (p.Ala125Ser)	MYBPC3	not specified	GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	11	47350535	GRCh38	42738	51908
NM_000256.3(MYBPC3):c.362delC (p.Pro121Argfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jun 22, 2012)	criteria provided, single submitter	11	47350546	GRCh38	42729	51899
NM_000256.3(MYBPC3):c.357delA (p.Ala120Profs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	11	47350551	GRCh38	222704	224431
NM_000256.3(MYBPC3):c.355G>A (p.Glu119Lys)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 18, 2016)	criteria provided, single submitter	11	47350553	GRCh38	42721	51891
NM_000256.3(MYBPC3):c.350delC (p.Pro117Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Oct 12, 2011)	criteria provided, single submitter	11	47350558	GRCh38	42718	51888
NM_000256.3(MYBPC3):c.348C>A (p.Ala116=)	MYBPC3	Cardiovascular phenotype		Likely benign(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	11	47350560	GRCh38	264580	258709
NM_000256.3(MYBPC3):c.343G>T (p.Gly115Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47350565	GRCh38	164155	175209
NM_000256.3(MYBPC3):c.340A>G (p.Thr114Ala)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 3, 2014)	criteria provided, single submitter	11	47350568	GRCh38	181032	179393
NM_000256.3(MYBPC3):c.339C>T (p.Ala113=)	MYBPC3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47350569	GRCh38	188524	186410
NM_000256.3(MYBPC3):c.338C>A (p.Ala113Asp)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jun 17, 2013)	criteria provided, single submitter	11	47350570	GRCh38	181031	179394
NM_000256.3(MYBPC3):c.332_335dupCTGA (p.Glu112Aspfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	11	47350573 - 47350576	GRCh38	254154	248635
NM_000256.3(MYBPC3):c.333dupT (p.Glu112Terfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47350575	GRCh38	177675	174798
NM_000256.3(MYBPC3):c.333T>C (p.Ala111=)	MYBPC3	not specified		Likely benign(Last reviewed: Jul 10, 2012)	criteria provided, single submitter	11	47350575	GRCh38	42708	51878
NM_000256.3(MYBPC3):c.332C>T (p.Ala111Val)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	47350576	GRCh38	180921	179395
NM_000256.3(MYBPC3):c.326C>T (p.Ala109Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Nov 27, 2012)	criteria provided, single submitter	11	47350582	GRCh38	42697	51867
NM_000256.3(MYBPC3):c.324delT (p.Ala109Profs)	MYBPC3	not provided		Pathogenic(Last reviewed: Aug 24, 2015)	criteria provided, single submitter	11	47350584	GRCh38	181157	179396
NM_000256.3(MYBPC3):c.306delC (p.Met103Cysfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic	criteria provided, single submitter	11	47350602	GRCh38	217481	214119
NM_000256.3(MYBPC3):c.305C>T (p.Pro102Leu)	MYBPC3	not specified	GO-ESP:0.00010(A)	Uncertain significance(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	11	47350603	GRCh38	181030	179397
NM_000256.3(MYBPC3):c.292+41G>C	MYBPC3	not specified	GMAF:0.06070(G), GO-ESP:0.04596(G)	Benign(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	11	47351198	GRCh38	188523	186411
NM_000256.3(MYBPC3):c.290C>T (p.Ala97Val)	MYBPC3	not specified		Uncertain significance(Last reviewed: Oct 26, 2011)	criteria provided, single submitter	11	47351241	GRCh38	42670	51840
NM_000256.3(MYBPC3):c.284T>C (p.Ile95Thr)	MYBPC3	not specified		Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2015)	criteria provided, conflicting interpretations	11	47351247	GRCh38	179554	175210
NM_000256.3(MYBPC3):c.270C>G (p.Phe90Leu)	MYBPC3	not provided		Likely pathogenic	criteria provided, single submitter	11	47351261	GRCh38	191021	188827
NM_000256.3(MYBPC3):c.263T>A (p.Val88Asp)	MYBPC3	not specified		Uncertain significance(Last reviewed: May 2, 2012)	criteria provided, single submitter	11	47351268	GRCh38	180994	179398
NM_000256.3(MYBPC3):c.246T>C (p.Ile82=)	MYBPC3	not specified	GO-ESP:0.00016(G), GO-ESP:0.00014(G)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2015)	criteria provided, conflicting interpretations	11	47351285	GRCh38	42623	51793
NM_000256.3(MYBPC3):c.239delCinsGAGG (p.Ala80delinsGlyGly)	MYBPC3	not specified		Uncertain significance(Last reviewed: Jan 23, 2013)	no assertion criteria provided	11	47351292	GRCh38	177816	174799
NM_000256.3(MYBPC3):c.238G>A (p.Ala80Thr)	MYBPC3	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Feb 25, 2016)	criteria provided, single submitter	11	47351293	GRCh38	181134	179399
NM_000256.3(MYBPC3):c.237C>G (p.Tyr79Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, multiple submitters, no conflicts	11	47351294	GRCh38	181132	179400
NM_000256.3(MYBPC3):c.237delC (p.Tyr79Terfs)	MYBPC3	not provided		Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	11	47351294	GRCh38	181091	179401
NM_000256.3(MYBPC3):c.235T>A (p.Tyr79Asn)	MYBPC3	not provided		Likely pathogenic(Last reviewed: Nov 19, 2012)	criteria provided, single submitter	11	47351296	GRCh38	180990	179402
NM_000256.3(MYBPC3):c.230G>A (p.Gly77Glu)	MYBPC3	not provided		Likely pathogenic(Last reviewed: May 23, 2013)	criteria provided, single submitter	11	47351301	GRCh38	180989	179403
NM_000256.3(MYBPC3):c.229G>T (p.Gly77Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	11	47351302	GRCh38	222699	224432
NM_000256.3(MYBPC3):c.227dupA (p.Ser78Ilefs)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Likely pathogenic	criteria provided, single submitter	11	47351304	GRCh38	217483	214120
NM_000256.3(MYBPC3):c.223G>A (p.Asp75Asn)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00009(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	criteria provided, conflicting interpretations	11	47351308	GRCh38	161313	171146
NM_000256.3(MYBPC3):c.216C>A (p.Gly72=)	MYBPC3	not specified	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	11	47351315	GRCh38	227566	230218
NM_000256.3(MYBPC3):c.214_215dupGG (p.Pro73Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	11	47351316 - 47351317	GRCh38	179537	178284
NM_000256.3(MYBPC3):c.207G>C (p.Arg69=)	MYBPC3	not specified	GMAF:0.00020(G), GO-ESP:0.00005(G)	Likely benign(Last reviewed: May 7, 2010)	criteria provided, single submitter	11	47351324	GRCh38	42595	51765
NM_000256.3(MYBPC3):c.206G>A (p.Arg69Gln)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2015)	criteria provided, conflicting interpretations	11	47351325	GRCh38	42594	51764
NM_000256.3(MYBPC3):c.188G>A (p.Arg63Gln)	MYBPC3	not specified	GMAF:0.00020(T), GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	11	47351343	GRCh38	188522	186412
NM_000256.3(MYBPC3):c.177_187delAGAGGGCACAC (p.Glu60Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, multiple submitters, no conflicts	11	47351344 - 47351354	GRCh38	42565	51735
NM_000256.3(MYBPC3):c.184A>C (p.Thr62Pro)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00023(G), GO-ESP:0.00026(G)	Uncertain significance(Last reviewed: Jun 27, 2016)	criteria provided, multiple submitters, no conflicts	11	47351347	GRCh38	42577	51747
NM_000256.3(MYBPC3):c.182delG (p.Gly61Alafs)	MYBPC3	not provided		Pathogenic(Last reviewed: May 14, 2013)	criteria provided, single submitter	11	47351349	GRCh38	181090	179404
NM_000256.3(MYBPC3):c.179_180delAG (p.Glu60Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Nov 18, 2011)	criteria provided, single submitter	11	47351351 - 47351352	GRCh38	188521	186413
NM_000256.3(MYBPC3):c.175A>G (p.Thr59Ala)	MYBPC3	Familial hypertrophic cardiomyopathy 4		Pathogenic(Last reviewed: Jan 29, 2002)	no assertion criteria provided	11	47351356	GRCh38	8614	23653
NM_000256.3(MYBPC3):c.172delG (p.Ala58Profs)	MYBPC3	not provided		Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	11	47351359	GRCh38	181089	179405
NM_000256.3(MYBPC3):c.166G>A (p.Gly56Ser)	MYBPC3	not specified	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Nov 12, 2014)	criteria provided, single submitter	11	47351365	GRCh38	42558	51728
NM_000256.3(MYBPC3):c.162delG (p.Lys54Asnfs)	MYBPC3	Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	11	47351369	GRCh38	219730	222147
NM_000256.3(MYBPC3):c.151G>T (p.Ala51Ser)	MYBPC3	not specified|not provided	GMAF:0.00020(T), GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jun 3, 2014)	criteria provided, multiple submitters, no conflicts	11	47351380	GRCh38	180988	179406
NM_000256.3(MYBPC3):c.145_150delATCAGCinsTGATGAG (p.Ile49Terfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, single submitter	11	47351381 - 47351386	GRCh38	222703	224433
NM_000256.3(MYBPC3):c.148A>G (p.Ser50Gly)	MYBPC3	not specified	GO-ESP:0.00008(C), GO-ESP:0.00004(C)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2015)	criteria provided, conflicting interpretations	11	47351383	GRCh38	42538	51708
NM_000256.3(MYBPC3):c.132C>T (p.Arg44=)	MYBPC3	not specified	GO-ESP:0.00008(A), GO-ESP:0.00009(A)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2015)	criteria provided, conflicting interpretations	11	47351399	GRCh38	42524	51694
NM_000256.3(MYBPC3):c.131G>A (p.Arg44His)	MYBPC3	not specified	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Aug 14, 2013)	criteria provided, single submitter	11	47351400	GRCh38	180984	179407
NM_000256.3(MYBPC3):c.122G>A (p.Arg41His)	MYBPC3	Hypertrophic cardiomyopathy	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	11	47351409	GRCh38	237421	241152
NM_000256.3(MYBPC3):c.121C>T (p.Arg41Cys)	MYBPC3	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Dec 24, 2013)	criteria provided, single submitter	11	47351410	GRCh38	42510	51680
NM_000256.3(MYBPC3):c.104G>A (p.Arg35Gln)	MYBPC3	not specified|Cardiomyopathy	GMAF:0.00020(T), GO-ESP:0.00008(T)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 9, 2014)	criteria provided, conflicting interpretations	11	47351427	GRCh38	42503	51673
NM_000256.3(MYBPC3):c.103C>A (p.Arg35=)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	11	47351428	GRCh38	188520	186414
NM_000256.3(MYBPC3):c.103C>T (p.Arg35Trp)	MYBPC3	not specified	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Mar 19, 2014)	criteria provided, single submitter	11	47351428	GRCh38	177638	175211
NM_000256.3(MYBPC3):c.94G>A (p.Glu32Lys)	MYBPC3	not specified	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Jul 5, 2014)	no assertion criteria provided	11	47351437	GRCh38	180981	179409
NM_000256.3(MYBPC3):c.93C>T (p.Ala31=)	MYBPC3	not specified	GO-ESP:0.00026(A)	Likely benign(Last reviewed: Jun 14, 2010)	criteria provided, single submitter	11	47351438	GRCh38	42811	51981
NM_000256.3(MYBPC3):c.88G>A (p.Glu30Lys)	MYBPC3	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47351443	GRCh38	188519	186415
NM_000256.3(MYBPC3):c.82G>A (p.Val28Met)	MYBPC3	Hypertrophic cardiomyopathy	GO-ESP:0.00020(T)	Likely benign(Last reviewed: Jun 21, 2015)	criteria provided, single submitter	11	47351449	GRCh38	215678	212929
NM_000256.3(MYBPC3):c.74G>A (p.Ser25Asn)	MYBPC3	not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(T), GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47351457	GRCh38	164159	174800
NM_000256.3(MYBPC3):c.67G>C (p.Ala23Pro)	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	11	47351464	GRCh38	188518	186416
NM_000256.3(MYBPC3):c.50G>A (p.Arg17Gln)	MYBPC3	not specified	GO-ESP:0.00014(T)	Uncertain significance(Last reviewed: Oct 20, 2014)	criteria provided, multiple submitters, no conflicts	11	47351481	GRCh38	164160	175212
NM_000256.3(MYBPC3):c.46C>T (p.Pro16Ser)	MYBPC3	not provided	GO-ESP:0.00002(A)	Likely pathogenic(Last reviewed: Apr 24, 2014)	criteria provided, single submitter	11	47351485	GRCh38	180979	179410
NM_000256.3(MYBPC3):c.39C>G (p.Ser13Arg)	MYBPC3	Long QT syndrome		Uncertain significance(Last reviewed: Oct 6, 2014)	no assertion criteria provided	11	47351492	GRCh38	180408	178646
NM_000256.3(MYBPC3):c.26-2A>G	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00008(C), GO-ESP:0.00005(C)	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2015)	criteria provided, multiple submitters, no conflicts	11	47351507	GRCh38	42644	51814
NM_000256.3(MYBPC3):c.26-10G>A	MYBPC3	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Aug 3, 2012)	criteria provided, single submitter	11	47351515	GRCh38	42643	51813
NM_000256.3(MYBPC3):c.26-27C>T	MYBPC3	not specified	GMAF:0.00060(A), GO-ESP:0.00014(A)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	11	47351532	GRCh38	188517	186417
NM_000256.3(MYBPC3):c.25+3A>C	MYBPC3	not specified		Uncertain significance(Last reviewed: Sep 30, 2008)	no assertion criteria provided	11	47352620	GRCh38	42629	51799
NM_000256.3(MYBPC3):c.13G>T (p.Gly5Trp)	MYBPC3	Familial hypertrophic cardiomyopathy 1	GMAF:0.00020(G)	Uncertain significance(Last reviewed: Jul 3, 2015)	criteria provided, single submitter	11	47352635	GRCh38	217839	214493
NM_000256.3(MYBPC3):c.13G>C (p.Gly5Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular hypertrophy	GMAF:0.00020(G), GO-ESP:0.00030(G)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 30, 2016)	criteria provided, conflicting interpretations	11	47352635	GRCh38	161305	171147
NM_000256.3(MYBPC3):c.12G>A (p.Pro4=)	MYBPC3	not specified	GO-ESP:0.00024(T), GO-ESP:0.00009(T)	Likely benign(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	11	47352636	GRCh38	42521	51691
NM_000256.3(MYBPC3):c.3G>C (p.Met1Ile)	MYBPC3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Jan 4, 2013)	criteria provided, single submitter	11	47352645	GRCh38	42747	51917
NG_007667.1:g.5051T>G	MYBPC3	Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	47352652	GRCh38	304963	327977
NM_000256.3(MYBPC3):c.-10G>A	MYBPC3	not specified	GMAF:0.00020(T), GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	11	47352657	GRCh38	228864	230219
NM_012200.3(B3GAT3):c.830G>A (p.Arg277Gln)	B3GAT3	Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects|MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH CONGENITAL HEART DEFECTS	GO-ESP:0.00003(T)	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	11	62616585	GRCh38	30573	39530
NM_032667.6(BSCL2):c.565G>T (p.Glu189Ter)	BSCL2|HNRNPUL2-BSCL2	Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease, type 2	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	11	62692671	GRCh38	4546	19585
NM_032667.6(BSCL2):c.325dupA (p.Thr109Asnfs)	BSCL2|HNRNPUL2-BSCL2	Congenital generalized lipodystrophy type 2		Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	11	62694681	GRCh38	4536	19575
NM_001130144.2(LTBP3):c.1859dupG (p.Cys620Trpfs)	LTBP3	Verloes Bourguignon syndrome		Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	11	65547809	GRCh38	204492	200879
NM_022172.2(PC):c.[2095G>T];[2095G>A]	PC	Pyruvate carboxylase deficiency	GO-ESP:0.00008(T)	Likely pathogenic(Last reviewed: Nov 5, 2014)	no assertion criteria provided	11|11	66851168	GRCh38	221279	222990|222991
NM_002496.3(NDUFS8):c.236C>T (p.Pro79Leu)	NDUFS8	Mitochondrial complex I deficiency	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	11	68033147	GRCh38	7511	22550
NM_005472.4(KCNE3):c.296G>A (p.Arg99His)	KCNE3	Brugada syndrome 6|Brugada syndrome|not provided	GMAF:0.00060(T), GO-ESP:0.00009(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2013)	criteria provided, conflicting interpretations	11	74457268	GRCh38	5542	20581
NM_005472.4(KCNE3):c.263G>A (p.Arg88His)	KCNE3	not specified	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Feb 28, 2014)	criteria provided, single submitter	11	74457301	GRCh38	190801	188516
NM_005472.4(KCNE3):c.248G>A (p.Arg83His)	KCNE3	Cardiac arrhythmia|not specified|not provided|Cardiovascular phenotype|Periodic paralysis	GO-ESP:0.00508(T), GMAF:0.00100(T), GO-ESP:0.00297(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2015)	criteria provided, conflicting interpretations	11	74457316	GRCh38	5541	20580
NM_005472.4(KCNE3):c.198T>C (p.Phe66=)	KCNE3	Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.14120(G), GO-ESP:0.13359(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	74457366	GRCh38	259778	254321
NM_005472.4(KCNE3):c.26C>T (p.Thr9Ile)	KCNE3	Cardiovascular phenotype	GO-ESP:0.00017(A)	Uncertain significance(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	11	74457538	GRCh38	264211	258710
NM_005472.4(KCNE3):c.20C>T (p.Thr7Met)	KCNE3	not specified	GMAF:0.00060(A), GO-ESP:0.00007(A)	Uncertain significance(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	11	74457544	GRCh38	190800	188517
NM_005472.4(KCNE3):c.10A>G (p.Thr4Ala)	KCNE3	not provided	GMAF:0.00060(C), GO-ESP:0.00007(C)	Uncertain significance(Last reviewed: Jan 1, 2012)	no assertion criteria provided	11	74457554	GRCh38	126426	131959
NM_014679.4(CEP57):c.241C>T (p.Arg81Ter)	CEP57	Mosaic variegated aneuploidy syndrome 2	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	11	95812970	GRCh38	30692	39649
NM_001885.2(CRYAB):c.470G>A (p.Arg157His)	CRYAB	Dilated cardiomyopathy 1II	GO-ESP:0.00015(T), GMAF:0.00020(T), GO-ESP:0.00009(T)	Pathogenic(Last reviewed: Apr 7, 2006)	no assertion criteria provided	11	111908822	GRCh38	41925	51094
NM_001885.2(CRYAB):c.324+4T>G	CRYAB	Alpha-B crystallinopathy|not specified|Posterior polar cataract|Cardiovascular phenotype|Myofibrillar Myopathy, Dominant	GO-ESP:0.27239(C), GMAF:0.23980(C), GO-ESP:0.26953(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	111910323	GRCh38	44234	53401
NM_001885.2(CRYAB):c.324G>C (p.Gln108His)	CRYAB	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	11	111910327	GRCh38	264247	258680
NM_001885.2(CRYAB):c.165G>A (p.Leu55=)	CRYAB	Alpha-B crystallinopathy|not specified|Dilated cardiomyopathy 1II|Posterior polar cataract|Cardiovascular phenotype|Myofibrillar Myopathy, Dominant	GO-ESP:0.01647(T), GMAF:0.00920(T), GO-ESP:0.01935(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	111911560	GRCh38	44233	53400
NM_000039.2(APOA1):c.518G>C (p.Arg173Pro)	APOA1	Amyloidosis, cardiac and cutaneous		Pathogenic(Last reviewed: Apr 13, 1999)	no assertion criteria provided	11	116836094	GRCh38	17932	32971
NM_000039.2(APOA1):c.341T>C (p.Leu114Pro)	APOA1|APOA1-AS	Amyloidosis, cardiac and cutaneous		Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	11	116836271	GRCh38	17931	32970
NM_174934.3(SCN4B):c.594-2A>G	SCN4B	Cardiovascular phenotype	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	11	118137122	GRCh38	264183	258681
NM_174934.3(SCN4B):c.174C>T (p.Cys58=)	SCN4B	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.03490(A), GO-ESP:0.03491(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	118145117	GRCh38	139037	142740
NM_174934.3(SCN4B):c.34G>A (p.Ala12Thr)	SCN4B	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Mar 26, 2014)	criteria provided, single submitter	11	118152640	GRCh38	190897	188499
NM_004588.4(SCN2B):c.632A>G (p.Asp211Gly)	SCN2B	Variant of unknown significance	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Jul 1, 2013)	no assertion criteria provided	11	118166903	GRCh38	60776	75315
NM_004588.4(SCN2B):c.478G>A (p.Val160Met)	SCN2B	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	11	118167057	GRCh38	264461	258682
NM_005188.3(CBL):c.1100A>C (p.Gln367Pro)	CBL	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|not provided		Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, multiple submitters, no conflicts	11	119278170	GRCh38	13807	28846
NM_005188.3(CBL):c.1111T>A (p.Tyr371Asn)	CBL	Rasopathy		Pathogenic(Last reviewed: Nov 5, 2014)	criteria provided, single submitter	11	119278181	GRCh38	180827	179157
NM_018400.3(SCN3B):c.587C>G (p.Ser196Cys)	SCN3B	Sudden cardiac death	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Feb 10, 2015)	criteria provided, single submitter	11	123634204	GRCh38	222800	224414
NM_018400.3(SCN3B):c.438C>T (p.Thr146=)	SCN3B	Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.08210(A), GO-ESP:0.08960(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	123642453	GRCh38	261028	254022
NM_018400.3(SCN3B):c.423C>G (p.Ile141Met)	SCN3B	Arrhythmia		Pathogenic(Last reviewed: Mar 27, 2015)	no assertion criteria provided	11	123642468	GRCh38	224720	226503
NM_018400.3(SCN3B):c.416G>A (p.Arg139Gln)	SCN3B	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Dec 18, 2014)	criteria provided, single submitter	11	123642475	GRCh38	190888	188505
NM_018400.3(SCN3B):c.390G>T (p.Ala130=)	SCN3B	Cardiovascular phenotype	GMAF:0.00080(A), GO-ESP:0.00140(A)	Benign(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	11	123642501	GRCh38	264285	258683
NM_018400.3(SCN3B):c.390G>A (p.Ala130=)	SCN3B	not specified|Cardiovascular phenotype	GMAF:0.00080(A)	Benign/Likely benign(Last reviewed: Oct 28, 2015)	criteria provided, multiple submitters, no conflicts	11	123642501	GRCh38	139033	142736
NM_018400.3(SCN3B):c.389C>T (p.Ala130Val)	SCN3B	Atrial fibrillation, familial, 16	GO-ESP:0.00002(A)	Pathogenic(Last reviewed: Jul 16, 2010)	no assertion criteria provided	11	123642502	GRCh38	140597	150289
NM_018400.3(SCN3B):c.363T>C (p.Asn121=)	SCN3B	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 26, 2013)	criteria provided, single submitter	11	123642528	GRCh38	263670	258684
NM_018400.3(SCN3B):c.198C>T (p.Pro66=)	SCN3B	Brugada syndrome 7|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00920(A), GO-ESP:0.00265(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	123645608	GRCh38	190885	188507
NM_018400.3(SCN3B):c.161T>G (p.Val54Gly)	SCN3B	not provided	GO-ESP:0.00002(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2015)	criteria provided, conflicting interpretations	11	123645645	GRCh38	140596	150288
NM_018400.3(SCN3B):c.105C>T (p.Ala35=)	SCN3B	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00007(A)	Likely benign(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	11	123645701	GRCh38	263681	258685
NM_018400.3(SCN3B):c.29T>C (p.Leu10Pro)	SCN3B	Brugada syndrome 7|Brugada syndrome|not specified|not provided|Atrial fibrillation, familial, 16|Cardiovascular phenotype	GO-ESP:0.00008(G), GO-ESP:0.00017(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	123653773	GRCh38	2470	17509
NM_000890.3(KCNJ5):c.10G>A (p.Asp4Asn)	KCNJ5	not specified	GMAF:0.00020(A), GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jun 20, 2014)	criteria provided, single submitter	11	128911283	GRCh38	190824	188509
NM_000890.3(KCNJ5):c.121C>T (p.Arg41Cys)	KCNJ5	Long QT syndrome|Romano-Ward syndrome|Familial hyperaldosteronism|Cardiovascular phenotype	GMAF:0.00500(T), GO-ESP:0.00150(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	128911394	GRCh38	188315	186151
NM_000890.3(KCNJ5):c.133G>A (p.Glu45Lys)	KCNJ5	not specified	GO-ESP:0.00011(A)	Uncertain significance(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	11	128911406	GRCh38	190825	188510
NM_000890.3(KCNJ5):c.314G>C (p.Gly105Ala)	KCNJ5	not specified	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Oct 15, 2013)	criteria provided, single submitter	11	128911587	GRCh38	190826	188511
NM_000890.3(KCNJ5):c.344G>A (p.Arg115Gln)	KCNJ5	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jun 18, 2014)	criteria provided, single submitter	11	128911617	GRCh38	190827	188512
NM_000890.3(KCNJ5):c.634G>A (p.Asp212Asn)	KCNJ5	Cardiac arrhythmia		Uncertain significance(Last reviewed: May 27, 2014)	criteria provided, single submitter	11	128911907	GRCh38	190828	188513
NM_000890.3(KCNJ5):c.703C>T (p.Arg235Trp)	KCNJ5	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	11	128911976	GRCh38	190829	188514
NM_000890.3(KCNJ5):c.1159G>C (p.Gly387Arg)	KCNJ5	Andersen Tawil syndrome|Long QT syndrome 13|Romano-Ward syndrome|Familial hyperaldosteronism	GMAF:0.00020(C), GO-ESP:0.00014(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	128916630	GRCh38	8856	23895
NC_000011.10:g.(?_47332566)_(47334010_?)del	MYBPC3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	11	47332566 - 47334010	GRCh38	228366	229955
NC_000011.10:g.(?_532631)_(534375_?)dup	HRAS|LRRC56	not specified		Uncertain significance(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	11	532631 - 534375	GRCh38	179613	175336
GRCh38/hg38 11q24.3-25(chr11:127915964-135068576)x1	APLP2|ETS1|FLI1|KCNJ1|KCNJ5|NFRKB|OPCML|ST14|BARX2|ARHGAP32|ADAMTS8|IGSF9B|NCAPD3|ACAD8|B3GAT1|ZBTB44|THYN1|NTM|PRDM10|TP53AIP1|JAM3|GLB1L2|VPS26B|GLB1L3|TMEM45B|ADAMTS15|C11orf45|SPATA19|C11orf44|MIR4697HG|LOC283177|SNX19|LINC00167|LOC646522|LOC100128239|ZNF123P|SENCR|LOC100507431|LOC100507548|MIR4697|NTM-IT|LOC101929517|LOC101929538|LINC01395|NTM-AS1|LOC101929653|MIR6090|MIR8052|LOC103611081	See cases		Pathogenic(Last reviewed: Mar 18, 2014)	no assertion criteria provided	11	127915964 - 135068576	GRCh38	155688	165442
GRCh38/hg38 11p12-11.12(chr11:42727555-49135735)x3	ACP2|ARHGAP1|CHRM4|CRY2|DDB2|EXT2|F2|CD82|LRP4|MDK|MYBPC3|NDUFS3|PSMC3|PTPRJ|RAPSN|SPI1|DGKZ|CHST1|API5|MADD|PEX16|MAPK8IP1|TP53I11|ATG13|CKAP5|NR1H3|CELF1|NUP160|FNBP4|MTCH2|PACSIN3|HSD17B12|PHF21A|SLC35C1|AMBRA1|KBTBD4|TTC17|PRDM11|SYT13|ALX4|C11orf49|ZNF408|AGBL2|ARFGAP2|ACCS|TSPAN18|CREB3L1|SLC39A13|C1QTNF4|PTPMT1|OR4X2|OR4B1|LARGE2|C11orf94|ALKBH3|LOC221122|OR4C3|OR4S1|TRIM49B|HARBI1|DKFZp779M0652|C11orf96|ACCSL|OR4X1|LOC399886|FAM180B|OR4A47|MIR129-2|TRIM64C|SNORD67|MIR670|MIR3160-2|MIR3160-1|MIR3161|MIR670HG|ALKBH3-AS1|LOC100507384|LRP4-AS1|MIR4487|MIR4688|MIR5582|LOC101928812|LOC101928894|LOC101928943|MIR7154|MIR6745	See cases		Likely pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	11	42727555 - 49135735	GRCh38	150595	160346
GRCh38/hg38 11p12-11.12(chr11:39179252-49135735)x1	ACP2|ARHGAP1|CHRM4|CRY2|DDB2|EXT2|F2|CD82|LRP4|MDK|MYBPC3|NDUFS3|PSMC3|PTPRJ|RAPSN|SPI1|DGKZ|CHST1|API5|MADD|PEX16|MAPK8IP1|TP53I11|ATG13|CKAP5|NR1H3|CELF1|NUP160|FNBP4|MTCH2|PACSIN3|HSD17B12|PHF21A|SLC35C1|AMBRA1|KBTBD4|TTC17|PRDM11|SYT13|LRRC4C|ALX4|C11orf49|ZNF408|AGBL2|ARFGAP2|ACCS|TSPAN18|CREB3L1|SLC39A13|C1QTNF4|PTPMT1|OR4X2|OR4B1|LARGE2|C11orf94|ALKBH3|LOC221122|OR4C3|OR4S1|TRIM49B|HARBI1|DKFZp779M0652|C11orf96|ACCSL|OR4X1|LOC399886|FAM180B|OR4A47|MIR129-2|TRIM64C|SNORD67|MIR670|MIR3160-2|MIR3160-1|MIR3161|LOC100507205|MIR670HG|ALKBH3-AS1|LOC100507384|LRP4-AS1|MIR4487|MIR4688|MIR5582|LOC101928591|LOC101928812|LOC101928894|LOC101928943|MIR7154|MIR6745|LINC01499	See cases		Pathogenic(Last reviewed: Feb 8, 2011)	no assertion criteria provided	11	39179252 - 49135735	GRCh38	148316	158067
GRCh38/hg38 11p15.4(chr11:2883714-2883812)x3	CDKN1C	See cases		conflicting data from submitters(Last reviewed: Oct 20, 2010)	no assertion criteria provided	11	2883714 - 2883812	GRCh38	146916	156667
GRCh38/hg38 11p12-11.2(chr11:41118322-48643003)x1	ACP2|ARHGAP1|CHRM4|CRY2|DDB2|EXT2|F2|CD82|LRP4|MDK|MYBPC3|NDUFS3|PSMC3|PTPRJ|RAPSN|SPI1|DGKZ|CHST1|API5|MADD|PEX16|MAPK8IP1|TP53I11|ATG13|CKAP5|NR1H3|CELF1|NUP160|FNBP4|MTCH2|PACSIN3|HSD17B12|PHF21A|SLC35C1|AMBRA1|KBTBD4|TTC17|PRDM11|SYT13|LRRC4C|ALX4|C11orf49|ZNF408|AGBL2|ARFGAP2|ACCS|TSPAN18|CREB3L1|SLC39A13|C1QTNF4|PTPMT1|OR4X2|OR4B1|LARGE2|C11orf94|ALKBH3|LOC221122|OR4C3|OR4S1|HARBI1|DKFZp779M0652|C11orf96|ACCSL|OR4X1|LOC399886|FAM180B|OR4A47|MIR129-2|SNORD67|MIR670|MIR3160-2|MIR3160-1|MIR3161|LOC100507205|MIR670HG|ALKBH3-AS1|LOC100507384|LRP4-AS1|MIR4487|MIR4688|MIR5582|LOC101928591|LOC101928812|LOC101928894|LOC101928943|MIR7154|MIR6745|LINC01499	See cases		Pathogenic(Last reviewed: Jul 30, 2009)	no assertion criteria provided	11	41118322 - 48643003	GRCh38	146079	155830
GRCh38/hg38 11p12-11.2(chr11:40688674-44913409)x3	EXT2|CD82|API5|HSD17B12|TTC17|LRRC4C|ALX4|ACCS|TSPAN18|ALKBH3|C11orf96|ACCSL|MIR129-2|MIR670|LOC100507205|MIR670HG|ALKBH3-AS1|LOC101928591|LINC01499	See cases		Uncertain significance(Last reviewed: Feb 28, 2010)	no assertion criteria provided	11	40688674 - 44913409	GRCh38	144293	154044
GRCh38/hg38 11q25(chr11:131311972-134998654)x3	OPCML|IGSF9B|NCAPD3|ACAD8|B3GAT1|THYN1|NTM|JAM3|GLB1L2|VPS26B|GLB1L3|SPATA19|MIR4697HG|LOC283177|LOC646522|LOC100128239|LOC100507548|MIR4697|NTM-IT|NTM-AS1|LOC101929653	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	11	131311972 - 134998654	GRCh38	59793	74388
GRCh38/hg38 11q23.3-25(chr11:120236432-135040246)x3	ACRV1|APLP2|CHEK1|ETS1|FLI1|GRIK4|HSPA8|STT3A|KCNJ1|KCNJ5|VWA5A|NFRKB|NRGN|OPCML|SC5D|ST3GAL4|SORL1|SRPRA|ST14|TECTA|ZNF202|BARX2|EI24|FEZ1|ARHGAP32|ADAMTS8|IGSF9B|NCAPD3|ARHGEF12|VSIG2|POU2F3|OR8G2|OR8B8|OR8G1|OR8B2|ACAD8|B3GAT1|DCPS|ZBTB44|THYN1|DDX25|NTM|CDON|SPA17|SIAE|ROBO4|FOXRED1|SCN3B|CRTAM|PRDM10|GRAMD1B|PKNOX2|TP53AIP1|ROBO3|FAM118B|MSANTD2|CLMP|C11orf63|CCDC15|PUS3|JAM3|KIRREL3|RPUSD4|TBRG1|UBASH3B|SNORD14C|SNORD14D|SNORD14E|GLB1L2|ESAM|VPS26B|GLB1L3|TIRAP|PANX3|TMEM45B|PATE1|ADAMTS15|C11orf45|HYLS1|TMEM218|SLC37A2|OR8B12|OR8G5|OR10G8|OR10G9|OR10S1|OR6T1|OR4D5|TBCEL|TMEM136|SPATA19|HEPACAM|OR8D1|OR8D2|OR8B4|KIRREL3-AS3|C11orf44|MIR4697HG|LOC283177|TMEM225|OR8D4|BSX|OR6X1|OR6M1|OR10G4|OR10G7|OR8B3|OR8A1|MIR100HG|PATE2|PATE4|ST3GAL4-AS1|SNX19|LOC403312|MIRLET7A2|MIR100|MIR125B1|BLID|LINC00167|HEPN1|LOC646522|LOC649133|LOC100128239|PATE3|ZNF123P|TRK-TTT2-1|MIR3167|LOC100507283|SENCR|LOC100507431|LOC100507548|MIR4697|MIR4493|KIRREL3-AS2|NTM-IT|LOC101929208|LOC101929227|LOC101929340|LOC101929427|LOC101929473|LOC101929497|LOC101929517|LOC101929538|LINC01395|NTM-AS1|LOC101929653|MIR6090|MIR8052|LOC103611081|PKNOX2-AS1|LOC105369532|STT3A-AS1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	11	120236432 - 135040246	GRCh38	59777	74372
GRCh38/hg38 11q24.3-25(chr11:130060292-135040246)x1	APLP2|OPCML|ST14|ADAMTS8|IGSF9B|NCAPD3|ACAD8|B3GAT1|ZBTB44|THYN1|NTM|JAM3|GLB1L2|VPS26B|GLB1L3|ADAMTS15|SPATA19|C11orf44|MIR4697HG|LOC283177|SNX19|LOC646522|LOC100128239|LOC100507431|LOC100507548|MIR4697|NTM-IT|NTM-AS1|LOC101929653|MIR8052|LOC103611081	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	11	130060292 - 135040246	GRCh38	58950	73545
GRCh38/hg38 11p12-11.2(chr11:36508280-48643003)x1	ACP2|ARHGAP1|CHRM4|CRY2|DDB2|EXT2|F2|CD82|LRP4|MDK|MYBPC3|NDUFS3|PSMC3|PTPRJ|RAG1|RAG2|RAPSN|SPI1|TRAF6|DGKZ|CHST1|API5|MADD|PEX16|MAPK8IP1|TP53I11|ATG13|CKAP5|NR1H3|CELF1|NUP160|FNBP4|MTCH2|PACSIN3|HSD17B12|PHF21A|SLC35C1|AMBRA1|KBTBD4|TTC17|PRDM11|SYT13|LRRC4C|ALX4|C11orf49|ZNF408|AGBL2|ARFGAP2|ACCS|TSPAN18|CREB3L1|SLC39A13|C1QTNF4|PTPMT1|C11orf74|OR4X2|OR4B1|LARGE2|C11orf94|ALKBH3|LOC221122|OR4C3|OR4S1|HARBI1|DKFZp779M0652|C11orf96|ACCSL|OR4X1|LOC399886|FAM180B|OR4A47|MIR129-2|SNORD67|MIR670|MIR3160-2|MIR3160-1|MIR3161|LOC100507205|MIR670HG|ALKBH3-AS1|LOC100507384|LRP4-AS1|MIR4487|MIR4688|MIR5582|LINC01493|LOC101928591|LOC101928812|LOC101928894|LOC101928943|MIR7154|MIR6745|LINC01499|LOC103312105|LOC105376633	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	11	36508280 - 48643003	GRCh38	58890	73485
GRCh38/hg38 11p11.2(chr11:46840454-48643003)x1	ACP2|DDB2|LRP4|MYBPC3|NDUFS3|PSMC3|PTPRJ|RAPSN|SPI1|MADD|CKAP5|NR1H3|CELF1|NUP160|FNBP4|MTCH2|PACSIN3|KBTBD4|C11orf49|AGBL2|ARFGAP2|SLC39A13|C1QTNF4|PTPMT1|OR4X2|OR4B1|OR4C3|OR4S1|OR4X1|FAM180B|OR4A47|MIR3161|LRP4-AS1|MIR4487|LOC101928943|MIR6745	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	11	46840454 - 48643003	GRCh38	57329	71924
GRCh38/hg38 11q23.3-25(chr11:119433909-134998513)x1	ACRV1|APLP2|CHEK1|ETS1|FLI1|GRIK4|HSPA8|STT3A|KCNJ1|KCNJ5|VWA5A|NFRKB|NRGN|OPCML|NECTIN1|SC5D|ST3GAL4|SORL1|SRPRA|ST14|TECTA|ZNF202|BARX2|EI24|FEZ1|ARHGAP32|ADAMTS8|IGSF9B|NCAPD3|ARHGEF12|VSIG2|TRIM29|POU2F3|OR8G2|OR8B8|OR8G1|OR8B2|ACAD8|B3GAT1|DCPS|ZBTB44|THYN1|DDX25|NTM|CDON|SPA17|SIAE|ROBO4|FOXRED1|SCN3B|CRTAM|PRDM10|GRAMD1B|PKNOX2|TP53AIP1|ROBO3|FAM118B|MSANTD2|CLMP|C11orf63|CCDC15|PUS3|JAM3|KIRREL3|RPUSD4|TBRG1|UBASH3B|SNORD14C|SNORD14D|SNORD14E|GLB1L2|ESAM|VPS26B|GLB1L3|TIRAP|PANX3|TMEM45B|PATE1|ADAMTS15|C11orf45|HYLS1|TMEM218|SLC37A2|OR8B12|OR8G5|OR10G8|OR10G9|OR10S1|OR6T1|OR4D5|TBCEL|TMEM136|SPATA19|HEPACAM|OAF|OR8D1|OR8D2|OR8B4|KIRREL3-AS3|C11orf44|MIR4697HG|LOC283177|TMEM225|OR8D4|BSX|OR6X1|OR6M1|OR10G4|OR10G7|OR8B3|OR8A1|MIR100HG|PATE2|PATE4|ST3GAL4-AS1|SNX19|LOC403312|MIRLET7A2|MIR100|MIR125B1|BLID|LINC00167|HEPN1|LOC646522|LOC649133|LOC100128239|PATE3|ZNF123P|TRK-TTT2-1|MIR3167|USP2-AS1|LOC100507283|SENCR|LOC100507431|LOC100507548|MIR4697|MIR4493|KIRREL3-AS2|NTM-IT|LOC101929208|LOC101929227|LOC101929340|LOC101929427|LOC101929473|LOC101929497|LOC101929517|LOC101929538|LINC01395|NTM-AS1|LOC101929653|MIR6090|MIR8052|LOC102724301|LOC103611081|PKNOX2-AS1|LOC105369532|STT3A-AS1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	11	119433909 - 134998513	GRCh38	57238	71833
GRCh38/hg38 11q25(chr11:134511738-134841778)x3		See cases		Benign(Last reviewed: Jul 16, 2013)	no assertion criteria provided	11	134511738 - 134841778	GRCh38	33072	41737
NM_000719.6(CACNA1C):c.2T>C (p.Met1Thr)	CACNA1C	not specified	GO-ESP:0.00004(C)	Uncertain significance(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	12	2053564	GRCh38	190710	188519
NM_000719.6(CACNA1C):c.107C>T (p.Ala36Val)	CACNA1C	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	12	2115281	GRCh38	264470	258719
NM_000719.6(CACNA1C):c.171C>T (p.Asp57=)	CACNA1C	Cardiac arrhythmia|Timothy syndrome|Long QT syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.01723(T), GMAF:0.01180(T), GO-ESP:0.03236(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2115345	GRCh38	35767	44431
NM_000719.6(CACNA1C):c.213G>A (p.Ala71=)	CACNA1C	Timothy syndrome|Long QT syndrome|Brugada syndrome|Cardiovascular phenotype	GMAF:0.01380(A), GO-ESP:0.00490(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2115387	GRCh38	238171	241530
NM_000719.6(CACNA1C):c.247C>T (p.Arg83Trp)	CACNA1C	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	12	2115421	GRCh38	264632	258720
NM_000719.6(CACNA1C):c.372-15G>A	CACNA1C	Cardiac arrhythmia|Timothy syndrome|Brugada syndrome|not specified	GMAF:0.02540(A), GO-ESP:0.02550(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2120310	GRCh38	35768	44432
NM_000719.6(CACNA1C):c.459C>T (p.Asn153=)	CACNA1C	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	12	2120412	GRCh38	264525	258721
NM_000719.6(CACNA1C):c.522G>A (p.Ala174=)	CACNA1C	Timothy syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.17570(A), GMAF:0.12040(A), GO-ESP:0.20737(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2449020	GRCh38	93412	99319
NM_000719.6(CACNA1C):c.535A>G (p.Ile179Val)	CACNA1C	not provided		Uncertain significance(Last reviewed: May 20, 2014)	criteria provided, single submitter	12	2449033	GRCh38	190630	188537
NM_000719.6(CACNA1C):c.538G>A (p.Ala180Thr)	CACNA1C	not specified		Uncertain significance(Last reviewed: Jun 30, 2011)	criteria provided, single submitter	12	2449036	GRCh38	190690	188538
NM_000719.6(CACNA1C):c.724C>T (p.Leu242=)	CACNA1C	not specified|Cardiovascular phenotype	GMAF:0.00180(T), GO-ESP:0.00035(T)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2016)	criteria provided, conflicting interpretations	12	2457673	GRCh38	264146	258730
NM_000719.6(CACNA1C):c.771C>T (p.Val257=)	CACNA1C	Long QT syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00946(T), GMAF:0.01340(T), GO-ESP:0.00312(T)	Benign(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	12	2486117	GRCh38	93423	99330
NM_000719.6(CACNA1C):c.911T>C (p.Ile304Thr)	CACNA1C	Timothy syndrome|Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00050(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	2486257	GRCh38	190631	188539
NM_000719.6(CACNA1C):c.985G>A (p.Gly329Ser)	CACNA1C	Sudden cardiac death|not specified		Uncertain significance(Last reviewed: Sep 10, 2015)	criteria provided, multiple submitters, no conflicts	12	2493258	GRCh38	190632	188540
NM_001167623.1(CACNA1C):c.1204G>A (p.Gly402Ser)	CACNA1C	Paroxysmal familial ventricular fibrillation 1|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	12	2504526	GRCh38	155775	165527
NM_001167625.1(CACNA1C):c.1216G>A (p.Gly406Arg)	CACNA1C	Timothy syndrome|not provided		Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	12	2504538	GRCh38	190633	188541
NM_000719.6(CACNA1C):c.1176G>T (p.Gly392=)	CACNA1C	Timothy syndrome|Long QT syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00222(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	2504904	GRCh38	166767	177533
NM_000719.6(CACNA1C):c.1204G>A (p.Gly402Ser)	CACNA1C	Timothy syndrome|Congenital long QT syndrome		Pathogenic(Last reviewed: Apr 21, 2011)	no assertion criteria provided	12	2504932	GRCh38	17633	32672
NM_000719.6(CACNA1C):c.1216G>A (p.Gly406Arg)	CACNA1C	Timothy syndrome|Long QT syndrome|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, multiple submitters, no conflicts	12	2504944	GRCh38	17632	32671
NM_000719.6(CACNA1C):c.1290A>G (p.Leu430=)	CACNA1C	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	12	2512884	GRCh38	263798	258729
NM_000719.6(CACNA1C):c.1359C>T (p.Asp453=)	CACNA1C	Long QT syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00039(T), GMAF:0.00060(T), GO-ESP:0.00019(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2016)	criteria provided, conflicting interpretations	12	2512953	GRCh38	93393	99300
NM_000719.6(CACNA1C):c.1419C>T (p.Ser473=)	CACNA1C	Cardiovascular phenotype	GO-ESP:0.00042(T)	Likely benign(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	12	2549971	GRCh38	263744	258731
NM_000719.6(CACNA1C):c.1420G>A (p.Val474Ile)	CACNA1C	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 31, 2015)	criteria provided, single submitter	12	2549972	GRCh38	264623	258732
NM_000719.6(CACNA1C):c.1420G>T (p.Val474Phe)	CACNA1C	not specified	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	12	2549972	GRCh38	190698	188547
NM_000719.6(CACNA1C):c.1481C>T (p.Ala494Val)	CACNA1C	not specified		Uncertain significance(Last reviewed: Jun 10, 2013)	criteria provided, single submitter	12	2550033	GRCh38	190638	188549
NM_000719.6(CACNA1C):c.1485C>A (p.His495Gln)	CACNA1C	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Nov 25, 2013)	criteria provided, single submitter	12	2556954	GRCh38	190639	188550
NM_000719.6(CACNA1C):c.1486C>T (p.Arg496Trp)	CACNA1C	Timothy syndrome|Brugada syndrome|not specified	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Oct 20, 2016)	criteria provided, multiple submitters, no conflicts	12	2556955	GRCh38	190699	188551
NM_000719.6(CACNA1C):c.1794C>T (p.Gly598=)	CACNA1C	Timothy syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00200(T), GO-ESP:0.00056(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2567693	GRCh38	136615	140318
NM_000719.6(CACNA1C):c.2427C>T (p.Ile809=)	CACNA1C	Cardiovascular phenotype		Likely benign(Last reviewed: Oct 16, 2013)	criteria provided, single submitter	12	2585463	GRCh38	263710	258733
NM_000719.6(CACNA1C):c.2436C>T (p.Asp812=)	CACNA1C	Timothy syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.07914(T), GMAF:0.14560(T), GO-ESP:0.16213(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2585472	GRCh38	93398	99305
NM_000719.6(CACNA1C):c.2467A>G (p.Met823Val)	CACNA1C	not specified		Uncertain significance(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	12	2585841	GRCh38	190650	188569
NM_000719.6(CACNA1C):c.2988C>T (p.Ile996=)	CACNA1C	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	12	2605108	GRCh38	264156	258734
NM_000719.6(CACNA1C):c.3114G>C (p.Leu1038=)	CACNA1C	Timothy syndrome|Long QT syndrome|Brugada syndrome|Cardiovascular phenotype	GMAF:0.01020(C), GO-ESP:0.00175(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2605744	GRCh38	220348	222248
NM_000719.6(CACNA1C):c.3234C>T (p.Asp1078=)	CACNA1C	Timothy syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00097(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	2607008	GRCh38	195932	193093
NM_000719.6(CACNA1C):c.3387G>A (p.Thr1129=)	CACNA1C	Timothy syndrome|Long QT syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00569(A), GMAF:0.00320(A), GO-ESP:0.00235(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2608541	GRCh38	78960	89851
NM_000719.6(CACNA1C):c.3736C>T (p.Leu1246=)	CACNA1C	Cardiovascular phenotype	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Nov 20, 2013)	criteria provided, single submitter	12	2611921	GRCh38	263778	258735
NM_000719.6(CACNA1C):c.3786C>T (p.Phe1262=)	CACNA1C	Timothy syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.25920(T), GO-ESP:0.20951(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2611971	GRCh38	93404	99311
NM_000719.6(CACNA1C):c.3829-626G>A	CACNA1C	not specified		Uncertain significance(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	12	2633671	GRCh38	190662	188585
NM_000719.6(CACNA1C):c.3862G>A (p.Ala1288Thr)	CACNA1C	Timothy syndrome|Brugada syndrome|not specified	GO-ESP:0.00022(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2634330	GRCh38	190664	188588
NM_000719.6(CACNA1C):c.3874G>T (p.Val1292Leu)	CACNA1C	not specified		Uncertain significance(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	12	2634342	GRCh38	190665	188589
NM_000719.6(CACNA1C):c.3904G>A (p.Glu1302Lys)	CACNA1C	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 11, 2013)	criteria provided, single submitter	12	2634372	GRCh38	263682	258736
NM_000719.6(CACNA1C):c.3930A>T (p.Gln1310His)	CACNA1C	not specified		Uncertain significance(Last reviewed: Jun 18, 2013)	criteria provided, single submitter	12	2648492	GRCh38	190666	188590
NM_000719.6(CACNA1C):c.3946-45C>G	CACNA1C	not specified	GMAF:0.00020(G), GO-ESP:0.00007(G)	Uncertain significance(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	12	2651595	GRCh38	190667	188593
NM_000719.6(CACNA1C):c.4038C>T (p.Ile1346=)	CACNA1C	Timothy syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.02380(T), GO-ESP:0.04888(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2651732	GRCh38	136623	140326
NM_000719.6(CACNA1C):c.4040G>A (p.Arg1347Gln)	CACNA1C	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Apr 25, 2012)	criteria provided, single submitter	12	2651734	GRCh38	190669	188596
NM_000719.6(CACNA1C):c.4075-4C>A	CACNA1C	Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Oct 6, 2015)	criteria provided, single submitter	12	2653831	GRCh38	263448	258740
NM_000719.6(CACNA1C):c.4393T>C (p.Phe1465Leu)	CACNA1C	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	12	2664985	GRCh38	263449	258737
NM_000719.6(CACNA1C):c.4485T>C (p.Asp1495=)	CACNA1C	Timothy syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.04114(C), GMAF:0.03850(C), GO-ESP:0.01449(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2665667	GRCh38	93407	99314
NM_000719.6(CACNA1C):c.4761G>A (p.Ala1587=)	CACNA1C	Timothy syndrome|Brugada syndrome|Cardiovascular phenotype	GO-ESP:0.00015(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	2674575	GRCh38	264555	258742
NM_000719.6(CACNA1C):c.4927C>T (p.Pro1643Ser)	CACNA1C|CACNA1C-AS1	not specified		Uncertain significance(Last reviewed: Apr 22, 2013)	criteria provided, single submitter	12	2677192	GRCh38	190674	188604
NM_000719.6(CACNA1C):c.4984G>A (p.Gly1662Arg)	CACNA1C|CACNA1C-AS1	not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Dec 9, 2013)	criteria provided, single submitter	12	2677760	GRCh38	190676	188605
NM_000719.6(CACNA1C):c.5064C>T (p.Ser1688=)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00360(T), GO-ESP:0.00134(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2677840	GRCh38	136630	140333
NM_000719.6(CACNA1C):c.5097C>T (p.Ala1699=)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Long QT syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00547(T), GMAF:0.00300(T), GO-ESP:0.02201(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2679449	GRCh38	93409	99316
NM_000719.6(CACNA1C):c.5120T>C (p.Val1707Ala)	CACNA1C|CACNA1C-AS1	not specified	GMAF:0.00100(C), GO-ESP:0.00008(C)	Uncertain significance(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	12	2679472	GRCh38	190622	188610
NM_000719.6(CACNA1C):c.5198C>T (p.Ala1733Val)	CACNA1C|CACNA1C-AS1	not specified	GMAF:0.00020(T), GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Jul 21, 2014)	criteria provided, single submitter	12	2679550	GRCh38	190686	188613
NM_000719.6(CACNA1C):c.5214C>A (p.Gly1738=)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Long QT syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00100(A), GO-ESP:0.00145(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	2679566	GRCh38	136632	140335
NM_000719.6(CACNA1C):c.5292C>T (p.Asn1764=)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.01940(T), GO-ESP:0.04543(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2679644	GRCh38	136633	140336
NM_000719.6(CACNA1C):c.5361G>A (p.Thr1787=)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.58112(A), GMAF:0.47360(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2679713	GRCh38	93413	99320
NM_000719.6(CACNA1C):c.5478G>A (p.Ala1826=)	CACNA1C|CACNA1C-AS1	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00028(A)	Likely benign(Last reviewed: Apr 16, 2015)	criteria provided, multiple submitters, no conflicts	12	2682583	GRCh38	190625	188616
NM_000719.6(CACNA1C):c.5499G>A (p.Gln1833=)	CACNA1C|CACNA1C-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	12	2682604	GRCh38	264240	258739
NM_000719.6(CACNA1C):c.5529T>C (p.His1843=)	CACNA1C|CACNA1C-AS1	not specified|Cardiovascular phenotype	GO-ESP:0.00010(C)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 22, 2015)	criteria provided, conflicting interpretations	12	2682634	GRCh38	136641	140344
NM_000719.6(CACNA1C):c.5604A>G (p.Gln1868=)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Long QT syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00899(G), GMAF:0.00940(G), GO-ESP:0.00278(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2685766	GRCh38	93415	99322
NM_000719.6(CACNA1C):c.5626A>G (p.Lys1876Glu)	CACNA1C|CACNA1C-AS1	Sudden cardiac death		Uncertain significance(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	12	2685788	GRCh38	222517	224445
NM_000719.6(CACNA1C):c.5639G>A (p.Arg1880Gln)	CACNA1C|CACNA1C-AS1	Brugada syndrome|not provided|Brugada syndrome (shorter-than-normal QT interval)	GO-ESP:0.00057(A), GMAF:0.00040(A), GO-ESP:0.00049(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2685801	GRCh38	67555	78451
NM_000719.6(CACNA1C):c.5649G>A (p.Pro1883=)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Long QT syndrome|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.03590(A), GO-ESP:0.02804(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2685811	GRCh38	93416	99323
NM_000719.6(CACNA1C):c.5680+15C>T	CACNA1C|CACNA1C-AS1	Cardiac arrhythmia|Timothy syndrome|Brugada syndrome|not specified	GO-ESP:0.01724(T), GMAF:0.01600(T), GO-ESP:0.00507(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2685857	GRCh38	35769	44433
NM_000719.6(CACNA1C):c.5747A>G (p.Gln1916Arg)	CACNA1C|CACNA1C-AS1	Cardiovascular phenotype	GMAF:0.00080(G), GO-ESP:0.00015(G)	Likely benign(Last reviewed: Oct 7, 2015)	criteria provided, single submitter	12	2686232	GRCh38	263515	258741
NM_000719.6(CACNA1C):c.5865A>C (p.Pro1955=)	CACNA1C|CACNA1C-AS1	Cardiovascular phenotype	GO-ESP:0.05024(C)	Likely benign(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	12	2688527	GRCh38	263422	258738
NM_000719.6(CACNA1C):c.5873C>T (p.Thr1958Ile)	CACNA1C|CACNA1C-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	12	2688535	GRCh38	264630	258749
NM_000719.6(CACNA1C):c.5898A>C (p.Pro1966=)	CACNA1C|CACNA1C-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	12	2688560	GRCh38	263379	258744
NM_000719.6(CACNA1C):c.5918G>A (p.Arg1973Gln)	CACNA1C|CACNA1C-AS1	Timothy syndrome|short QT syndrome|Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00165(A), GMAF:0.00320(A), GO-ESP:0.00359(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2016)	criteria provided, conflicting interpretations	12	2688580	GRCh38	93419	99326
NM_000719.6(CACNA1C):c.6007G>A (p.Gly2003Arg)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Brugada syndrome|Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	2688669	GRCh38	263770	258745
NM_000719.6(CACNA1C):c.6031G>A (p.Val2011Ile)	CACNA1C|CACNA1C-AS1	Cardiac arrhythmia	GO-ESP:0.00001(A)	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	2688693	GRCh38	35770	44434
NM_000719.6(CACNA1C):c.6213A>T (p.Ile2071=)	CACNA1C|CACNA1C-AS1	Cardiovascular phenotype	GO-ESP:0.00015(T)	Likely benign(Last reviewed: May 24, 2013)	criteria provided, single submitter	12	2690995	GRCh38	263604	258743
NM_000719.6(CACNA1C):c.6307G>T (p.Ala2103Ser)	CACNA1C|CACNA1C-AS1	Cardiac arrhythmia|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Apr 10, 2013)	criteria provided, conflicting interpretations	12	2691089	GRCh38	35771	44435
NM_144670.5(A2ML1):c.1775G>T (p.Arg592Leu)	A2ML1	not specified|not provided	GO-ESP:0.00043(T)	Uncertain significance(Last reviewed: Feb 4, 2016)	criteria provided, single submitter	12	8847640	GRCh38	203521	199921
NM_004982.3(KCNJ8):c.1265C>T (p.Ser422Leu)	KCNJ8	not provided	GMAF:0.00020(A), GO-ESP:0.00165(A)	Uncertain significance(Last reviewed: Jul 1, 2014)	no assertion criteria provided	12	21765733	GRCh38	157543	167406
NM_004982.3(KCNJ8):c.1182G>C (p.Arg394Ser)	KCNJ8	Cardiac arrhythmia		Uncertain significance(Last reviewed: Nov 13, 2014)	no assertion criteria provided	12	21765816	GRCh38	180388	178650
NM_004982.3(KCNJ8):c.855G>A (p.Leu285=)	KCNJ8	Brugada syndrome|Cardiovascular phenotype	GMAF:0.01240(T), GO-ESP:0.00298(T)	Benign(Last reviewed: Nov 2, 2015)	criteria provided, multiple submitters, no conflicts	12	21766143	GRCh38	221023	222246
NM_004982.3(KCNJ8):c.471G>C (p.Thr157=)	KCNJ8	not specified|Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00038(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 16, 2016)	criteria provided, conflicting interpretations	12	21766527	GRCh38	264182	258722
NM_004982.3(KCNJ8):c.263C>G (p.Ala88Gly)	KCNJ8	not specified	GMAF:0.00020(C), GO-ESP:0.00031(C)	Uncertain significance(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	12	21773354	GRCh38	190832	188534
NM_004982.3(KCNJ8):c.83G>C (p.Arg28Pro)	KCNJ8	Cardiac arrest		Uncertain significance(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	12	21773534	GRCh38	222678	224437
NM_004982.3(KCNJ8):c.6G>T (p.Leu2Phe)	KCNJ8	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 2, 2013)	criteria provided, single submitter	12	21773611	GRCh38	263769	258723
NM_005691.3(ABCC9):c.3460C>T (p.Arg1154Trp)	ABCC9	Hypertrichotic osteochondrodysplasia		Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	12	21842327	GRCh38	31946	40611
NM_005691.3(ABCC9):c.3321C>T (p.Ile1107=)	ABCC9	Dilated cardiomyopathy 1O|Cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.01492(A), GMAF:0.01240(A), GO-ESP:0.00369(A)	Benign(Last reviewed: Nov 2, 2015)	criteria provided, multiple submitters, no conflicts	12	21842466	GRCh38	35632	44297
NM_005691.3(ABCC9):c.3076A>G (p.Asn1026Asp)	ABCC9	Cardiovascular phenotype	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Mar 27, 2013)	criteria provided, single submitter	12	21845623	GRCh38	263571	258724
NM_005691.3(ABCC9):c.3057A>G (p.Thr1019=)	ABCC9	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	12	21845642	GRCh38	263708	258725
NM_005691.3(ABCC9):c.3030T>C (p.Ala1010=)	ABCC9	not specified|Cardiovascular phenotype	GMAF:0.00140(G), GO-ESP:0.00014(G)	Likely benign(Last reviewed: Dec 2, 2015)	criteria provided, multiple submitters, no conflicts	12	21845669	GRCh38	227159	230297
NM_005691.3(ABCC9):c.2631G>A (p.Thr877=)	ABCC9	Hypertrichotic osteochondrodysplasia|Dilated cardiomyopathy 1O|Cardiomyopathy|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00123(T), GMAF:0.00920(T), GO-ESP:0.00950(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	21852380	GRCh38	35630	44295
NM_005691.3(ABCC9):c.2523C>T (p.Ala841=)	ABCC9	Primary dilated cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00507(A), GMAF:0.00160(A), GO-ESP:0.00356(A)	Benign(Last reviewed: Jun 19, 2015)	criteria provided, multiple submitters, no conflicts	12	21852488	GRCh38	35628	44293
NM_005691.3(ABCC9):c.2238-1G>A	ABCC9	not specified|not provided	GMAF:0.00180(T), GO-ESP:0.00162(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 16, 2016)	criteria provided, conflicting interpretations	12	21863055	GRCh38	162688	175405
NM_005691.3(ABCC9):c.2238-4T>C	ABCC9	Cardiovascular phenotype	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Nov 8, 2013)	criteria provided, single submitter	12	21863058	GRCh38	263712	258726
NM_005691.3(ABCC9):c.2200G>A (p.Val734Ile)	ABCC9	Dilated cardiomyopathy 1O|Myocardial infarction|Cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00924(T), GMAF:0.00400(T), GO-ESP:0.00702(T)	Benign/Likely benign(Last reviewed: Nov 2, 2015)	criteria provided, multiple submitters, no conflicts	12	21864476	GRCh38	35627	44292
NM_020297.3(ABCC9):c.1848C>T (p.Asp616=)	ABCC9	Hypertrichotic osteochondrodysplasia|Dilated cardiomyopathy 1O|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01622(A), GMAF:0.01520(A), GO-ESP:0.00425(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	21887889	GRCh38	45391	54558
NM_005691.3(ABCC9):c.1320+1G>A	ABCC9	Cardiovascular phenotype	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	12	21910156	GRCh38	264611	258727
NM_020297.3(ABCC9):c.1296C= (p.Pro432=)	ABCC9	Hypertrichotic osteochondrodysplasia|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.99646(G), GMAF:0.00280(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	21910181	GRCh38	45386	54553
NM_005691.3(ABCC9):c.1043T>G (p.Leu348Arg)	ABCC9	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 16, 2013)	criteria provided, single submitter	12	21910947	GRCh38	234973	236792
NM_005691.3(ABCC9):c.971G>A (p.Arg324His)	ABCC9	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	12	21912912	GRCh38	264317	258728
NM_005691.3(ABCC9):c.826G>A (p.Ala276Thr)	ABCC9	not specified|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	12	21913057	GRCh38	234974	236793
NM_020297.3(ABCC9):c.574-5C>A	ABCC9	Hypertrichotic osteochondrodysplasia|not specified|Familial atrial fibrillation|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.58794(T), GMAF:0.35520(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	21915915	GRCh38	45419	54586
NG_007524.1:g.50648G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205273	GRCh38	308053	331599
NG_007524.1:g.50624T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205297	GRCh38	308054	324159
NG_007524.1:g.50609G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00120(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205312	GRCh38	308055	331605
NG_007524.1:g.50554G>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00180(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205367	GRCh38	308056	324166
NG_007524.1:g.50437A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.01720(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205484	GRCh38	308057	331606
NG_007524.1:g.50431_50432dupTT	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205489 - 25205490	GRCh38	308058	316684
NG_007524.1:g.50205T>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.45170(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205716	GRCh38	308059	331607
NG_007524.1:g.50200G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205721	GRCh38	308060	330198
NG_007524.1:g.50191_50192delAA	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.45360(TT)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205729 - 25205730	GRCh38	308062	316688
NG_007524.1:g.50192delA	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205729	GRCh38	308061	331617
NG_007524.1:g.50041A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205880	GRCh38	308063	331618
NG_007524.1:g.50027A>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.45170(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25205894	GRCh38	308064	324167
NG_007524.1:g.49912A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.45150(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206009	GRCh38	308065	330205
NG_007524.1:g.49886A>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.43330(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206035	GRCh38	308066	316694
NG_007524.1:g.49880_49883delATCT	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206038 - 25206041	GRCh38	308067	324168
NG_007524.1:g.49808_49809dupTT	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206112 - 25206113	GRCh38	308069	331620
NG_007524.1:g.49809dupT	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206112	GRCh38	308068	331623
NG_007524.1:g.49771A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00040(C)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206150	GRCh38	308070	316695
NG_007524.1:g.49677C>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00200(C)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206244	GRCh38	308071	331624
NG_007524.1:g.49628T>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.03360(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206293	GRCh38	308072	324169
NG_007524.1:g.49625C>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206296	GRCh38	308073	324181
NG_007524.1:g.49580T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206341	GRCh38	308074	330208
NG_007524.1:g.49527T>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.45190(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206394	GRCh38	308075	316697
NG_007524.1:g.49503C>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.45150(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206418	GRCh38	308076	324182
NG_007524.1:g.49390delT	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.45150(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206531	GRCh38	308077	331627
NG_007524.1:g.49328T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206593	GRCh38	308078	330209
NG_007524.1:g.49278G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.01520(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206643	GRCh38	308079	331629
NG_007524.1:g.49274C>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206647	GRCh38	308080	330210
NG_007524.1:g.49097_49100delGTAA	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206821 - 25206824	GRCh38	308081	330211
NG_007524.1:g.49014A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.47440(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25206907	GRCh38	308082	316700
NG_007524.1:g.48820C>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207101	GRCh38	308083	324186
NG_007524.1:g.48631T>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.03470(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207290	GRCh38	308084	324191
NG_007524.1:g.48610G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207311	GRCh38	308085	324195
NG_007524.1:g.48582G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207339	GRCh38	308086	331631
NG_007524.1:g.48497C>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00480(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207424	GRCh38	308087	316701
NG_007524.1:g.48451G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207470	GRCh38	308088	316702
NG_007524.1:g.48405dupT	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207516	GRCh38	308089	316706
NG_007524.1:g.48396_48397insC	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207524 - 25207525	GRCh38	308090	330214
NG_007524.1:g.48365A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207556	GRCh38	308091	316707
NG_007524.1:g.48310A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.04590(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207611	GRCh38	308092	330219
NG_007524.1:g.48017T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207904	GRCh38	308093	324199
NG_007524.1:g.47972delA	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25207949	GRCh38	308094	331632
NG_007524.1:g.47898A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208023	GRCh38	308095	331633
NG_007524.1:g.47891T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.01540(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208030	GRCh38	308096	324206
NG_007524.1:g.47836G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00020(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208085	GRCh38	308097	331635
NG_007524.1:g.47831C>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00020(C)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208090	GRCh38	308098	330228
NG_007524.1:g.47782A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208139	GRCh38	308099	316713
NG_007524.1:g.47781C>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.15840(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208140	GRCh38	308100	331642
NG_007524.1:g.47764A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00260(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208157	GRCh38	308102	330231
NG_007524.1:g.47763_47764delTA	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00440(-)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208157 - 25208158	GRCh38	308101	316714
NG_007524.1:g.47757A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208164	GRCh38	308103	324208
NG_007524.1:g.47753dupT	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208168	GRCh38	308104	316716
NG_007524.1:g.47713T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.17530(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208208	GRCh38	308105	330232
NG_007524.1:g.47666T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00500(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208255	GRCh38	308106	330245
NG_007524.1:g.47627G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208294	GRCh38	308107	316719
NG_007524.1:g.47544_47546delAAA	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00700(-)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208375 - 25208377	GRCh38	308108	316720
NG_007524.1:g.47331C>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00080(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208590	GRCh38	308109	324210
NG_007524.1:g.47209A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.15990(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208712	GRCh38	308110	330251
NG_007524.1:g.47188G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.01120(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208733	GRCh38	308111	324211
NG_007524.1:g.47099G>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.05230(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208822	GRCh38	308112	331657
NG_007524.1:g.46991T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00180(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208930	GRCh38	308113	316721
NG_007524.1:g.46950T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.01820(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25208971	GRCh38	308114	316725
NG_007524.1:g.46891A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209030	GRCh38	308115	331660
NG_007524.1:g.46676C>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00080(A), GO-ESP:0.00344(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209245	GRCh38	308116	330256
NG_007524.1:g.46664delA	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GO-ESP:0.00045(-)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209257	GRCh38	308117	331661
NG_007524.1:g.46638T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.45090(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209283	GRCh38	308118	324217
NG_007524.1:g.46530T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00920(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209391	GRCh38	308119	316726
NG_007524.1:g.46496C>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209425	GRCh38	308120	330259
NG_007524.1:g.46319C>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00100(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209602	GRCh38	308121	324220
NM_004985.4(KRAS):c.*177T>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.47940(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209618	GRCh38	40467	48937
NG_007524.1:g.46302C>T	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209619	GRCh38	308122	316728
NG_007524.1:g.46185A>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209736	GRCh38	308123	330260
NM_004985.4(KRAS):c.519T>C (p.Asp173=)	KRAS	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GO-ESP:0.20077(G), GMAF:0.17550(G), GO-ESP:0.19690(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	25209843	GRCh38	41449	49887
NM_004985.4(KRAS):c.468C>G (p.Phe156Leu)	KRAS	not provided|Cardiofaciocutaneous syndrome 2		Pathogenic(Last reviewed: Nov 16, 2012)	criteria provided, single submitter	12	25209894	GRCh38	12595	27634
NG_007524.1:g.46021T>C	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome	GO-ESP:0.00004(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25209900	GRCh38	308124	330264
NM_004985.4(KRAS):c.458A>G (p.Asp153Gly)	KRAS	Noonan syndrome|not provided		Pathogenic/Likely pathogenic(Last reviewed: May 8, 2012)	criteria provided, multiple submitters, no conflicts	12	25209904	GRCh38	40465	48935
NM_004985.4(KRAS):c.458A>T (p.Asp153Val)	KRAS	Noonan syndrome 3|not provided|Rasopathy|Cardiofaciocutaneous syndrome 2		Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, multiple submitters, no conflicts	12	25209904	GRCh38	12587	27626
NM_004985.4(KRAS):c.451-9G>A	KRAS	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GO-ESP:0.08748(T), GMAF:0.08370(T), GO-ESP:0.02809(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	25209920	GRCh38	40464	48934
NM_033360.3(KRAS):c.535G>A (p.Gly179Ser)	KRAS	not specified	GO-ESP:0.00008(T), GMAF:0.00020(T), GO-ESP:0.00036(T)	Likely benign(Last reviewed: Dec 3, 2010)	criteria provided, single submitter	12	25215476	GRCh38	46540	55705
NM_004985.4(KRAS):c.389C>T (p.Ala130Val)	KRAS	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	25225675	GRCh38	180861	179459
NM_004985.4(KRAS):c.264A>G (p.Lys88=)	KRAS	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GO-ESP:0.00017(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	25227260	GRCh38	227471	230307
NM_033360.3(KRAS):c.211T>C (p.Tyr71His)	KRAS	Cardiofaciocutaneous syndrome 2		Pathogenic(Last reviewed: Jan 15, 2013)	no assertion criteria provided	12	25227313	GRCh38	31940	40605
NM_004985.4(KRAS):c.198A>G (p.Ala66=)	KRAS	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GO-ESP:0.00008(C), GMAF:0.00020(C), GO-ESP:0.00011(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	25227326	GRCh38	45118	54285
NM_004985.4(KRAS):c.187_189delGAG (p.Glu63del)	KRAS	Rasopathy		Likely pathogenic(Last reviewed: Oct 18, 2012)	criteria provided, single submitter	12	25227335 - 25227337	GRCh38	180857	179460
NM_004985.4(KRAS):c.179G>T (p.Gly60Val)	KRAS	Non-small cell lung cancer|not provided|Rasopathy		Pathogenic/Likely pathogenic(Last reviewed: May 13, 2014)	criteria provided, multiple submitters, no conflicts	12	25227345	GRCh38	163766	175855
NM_004985.4(KRAS):c.178G>C (p.Gly60Arg)	KRAS	not provided|Rasopathy|Cardiofaciocutaneous syndrome 2		Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, multiple submitters, no conflicts	12	25227346	GRCh38	12586	27625
NM_004985.4(KRAS):c.173C>T (p.Thr58Ile)	KRAS	Noonan syndrome 3|Noonan syndrome|not provided		Pathogenic(Last reviewed: May 18, 2016)	criteria provided, multiple submitters, no conflicts	12	25227351	GRCh38	12588	27627
NM_004985.4(KRAS):c.101C>T (p.Pro34Leu)	KRAS	Noonan syndrome|not provided|Rasopathy		Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, multiple submitters, no conflicts	12	25245284	GRCh38	40454	48924
NM_004985.4(KRAS):c.101C>G (p.Pro34Arg)	KRAS	not provided|Rasopathy|Cardiofaciocutaneous syndrome 2		Pathogenic/Likely pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, multiple submitters, no conflicts	12	25245284	GRCh38	12590	27629
NM_004985.4(KRAS):c.68T>G (p.Leu23Arg)	KRAS	not provided		Likely pathogenic(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	12	25245317	GRCh38	180860	179462
NM_004985.4(KRAS):c.65A>T (p.Gln22Leu)	KRAS	not provided		Pathogenic(Last reviewed: Dec 20, 2013)	criteria provided, single submitter	12	25245320	GRCh38	40453	48923
NM_004985.4(KRAS):c.65A>G (p.Gln22Arg)	KRAS	Noonan syndrome|not provided|Rasopathy		Pathogenic/Likely pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, multiple submitters, no conflicts	12	25245320	GRCh38	40452	48922
NM_004985.4(KRAS):c.40G>A (p.Val14Ile)	KRAS	Endometrial carcinoma|Noonan syndrome 3|not provided|Rasopathy	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, multiple submitters, no conflicts	12	25245345	GRCh38	12589	27628
NG_007524.1:g.5054C>G	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25250867	GRCh38	308125	324221
NM_004985.4(KRAS):c.-160A>G	KRAS	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome		Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	25250899	GRCh38	163771	175718
NG_007524.1:g.5012_5014dupCGG	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25250907 - 25250909	GRCh38	308126	330268
NG_007524.1:g.5002G>A	KRAS	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	25250919	GRCh38	308127	330274
NM_001040436.2(YARS2):c.572G>A (p.Gly191Asp)	YARS2	Myopathy, lactic acidosis, and sideroblastic anemia 2	GMAF:0.12660(A)	Pathogenic(Last reviewed: Dec 17, 2013)	no assertion criteria provided	12	32755303	GRCh38	102434	108176
NM_004572.3(PKP2):c.2561A>T (p.His854Leu)	PKP2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	12	32792660	GRCh38	264570	258752
NM_004572.3(PKP2):c.2509delA (p.Ser837Valfs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, multiple submitters, no conflicts	12	32792712	GRCh38	177995	175861
NM_004572.3(PKP2):c.2489+1G>A	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided	GMAF:0.00020(T), GO-ESP:0.00003(T)	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2016)	criteria provided, multiple submitters, no conflicts	12	32796108	GRCh38	6757	21796
NM_004572.3(PKP2):c.2431C>A (p.Arg811Ser)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not specified|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00038(T), GMAF:0.00060(T), GO-ESP:0.00087(T)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2015)	criteria provided, conflicting interpretations	12	32796167	GRCh38	45068	54235
NM_004572.3(PKP2):c.2197_2202delCACACCinsG (p.His733Alafs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, multiple submitters, no conflicts	12	32802500 - 32802505	GRCh38	45063	54230
NM_004572.3(PKP2):c.2146-1G>C	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	GO-ESP:0.00005(G)	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2016)	criteria provided, multiple submitters, no conflicts	12	32802557	GRCh38	6756	21795
NM_004572.3(PKP2):c.1821dupT (p.Val608Cysfs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2016)	criteria provided, multiple submitters, no conflicts	12	32822617	GRCh38	45047	54214
NM_004572.3(PKP2):c.1759G>A (p.Val587Ile)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00323(T), GMAF:0.00060(T), GO-ESP:0.00237(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2016)	criteria provided, conflicting interpretations	12	32824092	GRCh38	36681	45342
NM_004572.3(PKP2):c.1672G>A (p.Val558Ile)	PKP2	Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Nov 9, 2013)	criteria provided, single submitter	12	32841044	GRCh38	263765	258746
NM_004572.3(PKP2):c.1636G>A (p.Ala546Thr)	PKP2	not specified|Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00021(T)	Uncertain significance(Last reviewed: Oct 8, 2015)	criteria provided, multiple submitters, no conflicts	12	32841080	GRCh38	178106	175726
NM_004572.3(PKP2):c.1592T>G (p.Ile531Ser)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00323(C), GMAF:0.00140(C), GO-ESP:0.00472(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	32841124	GRCh38	45035	54202
NM_004572.3(PKP2):c.1550A>G (p.Asn517Ser)	PKP2	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00023(C), GO-ESP:0.00042(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 9, 2015)	criteria provided, conflicting interpretations	12	32841166	GRCh38	45029	54196
NM_004572.3(PKP2):c.1547A>G (p.Lys516Arg)	PKP2	not provided		Likely pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	12	32841169	GRCh38	201985	198421
NM_004572.3(PKP2):c.1419_1421delCGCinsTGT (p.Ala474Val)	PKP2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 8, 2013)	criteria provided, single submitter	12	32843271 - 32843273	GRCh38	263794	258748
NM_004572.3(PKP2):c.1378+1G>C	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, multiple submitters, no conflicts	12	32850765	GRCh38	45022	54189
NM_004572.3(PKP2):c.1378G>C (p.Asp460His)	PKP2	not provided		Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	12	32850766	GRCh38	201983	198424
NM_004572.3(PKP2):c.1372A>G (p.Ile458Val)	PKP2	not specified|not provided	GMAF:0.00160(C), GO-ESP:0.00130(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 14, 2015)	criteria provided, conflicting interpretations	12	32850772	GRCh38	45021	54188
NM_004572.3(PKP2):c.1237C>T (p.Arg413Ter)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not provided	GO-ESP:0.00008(A), GO-ESP:0.00002(A)	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2016)	criteria provided, multiple submitters, no conflicts	12	32850907	GRCh38	45016	54183
NM_004572.3(PKP2):c.1125_1132delTTTCATAC (p.Phe376Alafs)	PKP2	not provided		Pathogenic(Last reviewed: Oct 10, 2012)	criteria provided, single submitter	12	32868965 - 32868972	GRCh38	202016	198431
NM_004572.3(PKP2):c.1097T>C (p.Leu366Pro)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.22005(G), GMAF:0.15140(G), GO-ESP:0.18002(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	32869000	GRCh38	45006	54173
NM_004572.3(PKP2):c.964G>T (p.Gly322Cys)	PKP2	not specified|Ventricular fibrillation|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Jan 4, 2016)	criteria provided, multiple submitters, no conflicts	12	32877916	GRCh38	201978	198436
NM_004572.3(PKP2):c.826C>T (p.Pro276Ser)	PKP2	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00016(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 8, 2014)	criteria provided, conflicting interpretations	12	32878054	GRCh38	178107	175869
NM_004572.3(PKP2):c.819G>A (p.Pro273=)	PKP2	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00008(T), GMAF:0.01880(T), GO-ESP:0.00813(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	32878061	GRCh38	45086	54253
NM_004572.3(PKP2):c.761A>C (p.Asn254Thr)	PKP2	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Oct 10, 2014)	criteria provided, single submitter	12	32878119	GRCh38	202028	198439
NM_004572.3(PKP2):c.730C>G (p.Pro244Ala)	PKP2	not specified|Cardiovascular phenotype	GO-ESP:0.00010(C)	Uncertain significance(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	12	32878150	GRCh38	235044	236795
NM_004572.3(PKP2):c.533dupT (p.His179Alafs)	PKP2	not provided		Pathogenic(Last reviewed: May 29, 2013)	criteria provided, single submitter	12	32878347	GRCh38	202012	198446
NM_004572.3(PKP2):c.505A>G (p.Ser169Gly)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided	GO-ESP:0.00162(C), GMAF:0.00020(C), GO-ESP:0.00122(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2015)	criteria provided, conflicting interpretations	12	32878375	GRCh38	45081	54248
NM_004572.3(PKP2):c.467C>T (p.Pro156Leu)	PKP2	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	12	32878413	GRCh38	264387	258751
NM_004572.3(PKP2):c.464G>C (p.Ser155Thr)	PKP2	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00008(G), GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: May 7, 2015)	criteria provided, multiple submitters, no conflicts	12	32878416	GRCh38	45079	54246
NM_004572.3(PKP2):c.419C>T (p.Ser140Phe)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype|Dysplasia, arrhythmogenic right ventricular	GO-ESP:0.00200(A), GMAF:0.00120(A), GO-ESP:0.00232(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2015)	criteria provided, conflicting interpretations	12	32878461	GRCh38	45077	54244
NM_004572.3(PKP2):c.369G>A (p.Trp123Ter)	PKP2	not provided	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Aug 30, 2012)	criteria provided, single submitter	12	32878511	GRCh38	201970	198452
NM_004572.3(PKP2):c.337-2A>T	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, multiple submitters, no conflicts	12	32878545	GRCh38	188654	186427
NM_004572.3(PKP2):c.302G>A (p.Arg101His)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00038(T), GO-ESP:0.00012(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2016)	criteria provided, conflicting interpretations	12	32878954	GRCh38	45076	54243
NM_004572.3(PKP2):c.256dupT (p.Tyr86Leufs)	PKP2	not provided		Pathogenic(Last reviewed: May 28, 2014)	criteria provided, single submitter	12	32879000	GRCh38	202010	198455
NM_004572.3(PKP2):c.235C>T (p.Arg79Ter)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, multiple submitters, no conflicts	12	32879021	GRCh38	6754	21793
NM_004572.3(PKP2):c.209G>T (p.Ser70Ile)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.01862(A), GMAF:0.01320(A), GO-ESP:0.02423(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	32896523	GRCh38	45057	54224
NM_001005242.2(PKP2):c.184C>A (p.Gln62Lys)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified	GO-ESP:0.00017(T)	Uncertain significance(Last reviewed: May 23, 2016)	criteria provided, multiple submitters, no conflicts	12	32896548	GRCh38	161332	171151
NM_004572.3(PKP2):c.174G>T (p.Glu58Asp)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00191(A), GMAF:0.00320(A), GO-ESP:0.00754(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	32896558	GRCh38	45043	54210
NM_001005242.2(PKP2):c.156G>A (p.Lys52=)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|not specified|Cardiovascular phenotype	GMAF:0.00220(T), GO-ESP:0.00130(T)	Benign/Likely benign(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	12	32896576	GRCh38	45030	54197
NM_004572.3(PKP2):c.76G>A (p.Asp26Asn)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype|Dysplasia, arrhythmogenic right ventricular|Cardiomyopathy, ARVC	GO-ESP:0.00486(T), GMAF:0.00300(T), GO-ESP:0.01400(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	32896656	GRCh38	45084	54251
NM_004572.3(PKP2):c.14G>A (p.Gly5Asp)	PKP2	not specified|Cardiovascular phenotype	GO-ESP:0.00024(T)	Uncertain significance(Last reviewed: Jul 17, 2015)	criteria provided, multiple submitters, no conflicts	12	32896718	GRCh38	201991	198459
NM_006009.3(TUBA1A):c.13A>C (p.Ile5Leu)	TUBA1A	Lissencephaly 3		Pathogenic(Last reviewed: Mar 15, 2011)	no assertion criteria provided	12	49186824	GRCh38	30268	39224
NM_000020.2(ACVRL1):c.152G>A (p.Cys51Tyr)	ACVRL1	not provided		Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	12	51913189	GRCh38	212797	210223
NM_000020.2(ACVRL1):c.269G>A (p.Cys90Tyr)	ACVRL1	not provided		Pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	12	51913306	GRCh38	212798	210225
NM_000020.2(ACVRL1):c.920C>A (p.Ala307Glu)	ACVRL1	not provided		Likely pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	12	51915372	GRCh38	212800	210231
NM_000020.2(ACVRL1):c.998G>T (p.Ser333Ile)	ACVRL1	not provided		Pathogenic(Last reviewed: Jun 11, 2014)	criteria provided, single submitter	12	51915450	GRCh38	212802	210233
NM_000020.2(ACVRL1):c.1231C>T (p.Arg411Trp)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided		Pathogenic(Last reviewed: Feb 12, 2015)	criteria provided, single submitter	12	51916218	GRCh38	8251	23290
NM_000020.2(ACVRL1):c.1377+1G>A	ACVRL1	not provided		Pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, single submitter	12	51919116	GRCh38	212794	210236
NM_000020.2(ACVRL1):c.1445C>T (p.Ala482Val)	ACVRL1	not specified|Haemorrhagic telangiectasia 2	GMAF:0.00020(T), GO-ESP:0.00167(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 18, 2014)	criteria provided, conflicting interpretations	12	51920826	GRCh38	161201	171155
NM_000020.2(ACVRL1):c.1451G>A (p.Arg484Gln)	ACVRL1	not provided		Pathogenic(Last reviewed: Feb 18, 2015)	criteria provided, single submitter	12	51920832	GRCh38	212796	210238
NM_003276.2(TMPO):c.24C>T (p.Pro8=)	TMPO|TMPO-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Dec 10, 2012)	criteria provided, single submitter	12	98515891	GRCh38	263441	258753
NM_003276.2(TMPO):c.264A>C (p.Arg88=)	TMPO|TMPO-AS1	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 15, 2012)	criteria provided, single submitter	12	98516131	GRCh38	263367	258747
NM_003276.2(TMPO):c.713T>G (p.Leu238Arg)	TMPO	Cardiomyopathy|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01907(G), GMAF:0.01920(G), GO-ESP:0.00561(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	98532970	GRCh38	36875	45536
NM_003276.2(TMPO):c.821G>A (p.Arg274Lys)	TMPO	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00292(A), GMAF:0.00180(A), GO-ESP:0.00235(A)	Likely benign(Last reviewed: Feb 23, 2016)	criteria provided, multiple submitters, no conflicts	12	98533078	GRCh38	44673	53840
NM_003276.2(TMPO):c.877T>G (p.Ser293Ala)	TMPO	Cardiomyopathy|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01907(G), GMAF:0.01920(G), GO-ESP:0.00562(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	98533134	GRCh38	36876	45537
NM_003276.2(TMPO):c.925G>C (p.Ala309Pro)	TMPO	Loeys-Dietz syndrome 2|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01492(C), GMAF:0.01320(C), GO-ESP:0.00382(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	98533182	GRCh38	44676	53843
NM_003276.2(TMPO):c.950C>G (p.Thr317Ser)	TMPO	Cardiomyopathy|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.03860(G), GMAF:0.03000(G), GO-ESP:0.01058(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	98533207	GRCh38	36877	45538
NM_003276.2(TMPO):c.977T>C (p.Val326Ala)	TMPO	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 25, 2012)	criteria provided, single submitter	12	98533234	GRCh38	263354	258750
NM_003276.2(TMPO):c.1074A>G (p.Lys358=)	TMPO	Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00010(G)	Likely benign(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	12	98533331	GRCh38	264391	258760
NM_003276.2(TMPO):c.1246A>G (p.Lys416Glu)	TMPO	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02299(G), GMAF:0.02460(G), GO-ESP:0.00667(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	98533503	GRCh38	44662	53829
NM_003276.2(TMPO):c.1309G>C (p.Val437Leu)	TMPO	Loeys-Dietz syndrome 2|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00160(C), GO-ESP:0.00053(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	98533566	GRCh38	178143	175756
NM_003276.2(TMPO):c.1434G>C (p.Lys478Asn)	TMPO	Cardiomyopathy|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01907(C), GMAF:0.01920(C), GO-ESP:0.00561(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	98533691	GRCh38	36874	45535
NM_003276.2(TMPO):c.1471T>G (p.Ser491Ala)	TMPO	Loeys-Dietz syndrome 2|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01492(G), GMAF:0.01320(G), GO-ESP:0.00381(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	98533728	GRCh38	44663	53830
NM_003276.2(TMPO):c.1632T>A (p.Ile544=)	TMPO	Loeys-Dietz syndrome 2|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01707(A), GMAF:0.01580(A), GO-ESP:0.00435(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	98533889	GRCh38	44666	53833
NM_003276.2(TMPO):c.1795C>G (p.Gln599Glu)	TMPO	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.07112(G), GMAF:0.05890(G), GO-ESP:0.08753(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	98534052	GRCh38	44667	53834
NM_003276.2(TMPO):c.1805A>G (p.Gln602Arg)	TMPO	not specified|Cardiovascular phenotype	GMAF:0.00120(G), GO-ESP:0.00033(G)	Likely benign(Last reviewed: Nov 11, 2015)	criteria provided, multiple submitters, no conflicts	12	98534062	GRCh38	178144	175898
NM_003276.2(TMPO):c.1892C>T (p.Ala631Val)	TMPO	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	12	98534149	GRCh38	264477	258756
NM_003276.2(TMPO):c.1949G>A (p.Arg650His)	TMPO	not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00038(A), GMAF:0.00060(A), GO-ESP:0.00020(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	98534206	GRCh38	44669	53836
NM_003276.2(TMPO):c.2068C>T (p.Arg690Cys)	TMPO	Loeys-Dietz syndrome 2|Dilated cardiomyopathy 1T|not specified|Dilated cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00062(T), GMAF:0.01140(T), GO-ESP:0.01508(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	98534325	GRCh38	12707	27746
NM_024312.4(GNPTAB):c.310C>T (p.Gln104Ter)	GNPTAB	I cell disease	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	12	101789951	GRCh38	2763	17802
NM_001111284.1(IGF1):c.226G>A (p.Val76Met)	IGF1	Insulin-like growth factor I deficiency		Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	12	102419637	GRCh38	14789	29828
NM_213595.3(ISCU):c.149G>A (p.Gly50Glu)	ISCU	Myopathy with lactic acidosis, hereditary	GO-ESP:0.00003(A)	Pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	12	108564313	GRCh38	783	15822
NM_000431.3(MVK):c.59A>C (p.His20Pro)	MVK	Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever		Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	12	109574881	GRCh38	11931	26970
NM_000432.3(MYL2):c.496G>T (p.Asp166Tyr)	MYL2	not provided		Likely pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	12	110911082	GRCh38	181436	179421
NM_000432.3(MYL2):c.484G>A (p.Gly162Arg)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not provided		Conflicting interpretations of pathogenicity, not provided(Last reviewed: Apr 5, 2016)	criteria provided, conflicting interpretations	12	110911094	GRCh38	132976	136725
NM_000432.3(MYL2):c.483C>A (p.His161Gln)	MYL2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	12	110911095	GRCh38	264266	258711
NM_000432.3(MYL2):c.456C>T (p.Tyr152=)	MYL2	Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00014(A)	Likely benign(Last reviewed: Feb 4, 2013)	criteria provided, single submitter	12	110911122	GRCh38	263505	258712
NM_000432.3(MYL2):c.401A>C (p.Glu134Ala)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00038(G), GO-ESP:0.00016(G)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 1, 2016)	criteria provided, conflicting interpretations	12	110913097	GRCh38	43475	52645
NM_000432.3(MYL2):c.381G>A (p.Ala127=)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00615(T), GMAF:0.00500(T), GO-ESP:0.00152(T)	Benign(Last reviewed: Dec 22, 2015)	criteria provided, multiple submitters, no conflicts	12	110913117	GRCh38	36646	45308
NM_000432.3(MYL2):c.279G>A (p.Ala93=)	MYL2	not specified|Cardiovascular phenotype	GMAF:0.00100(T), GO-ESP:0.00035(T)	Benign/Likely benign(Last reviewed: Oct 31, 2015)	criteria provided, multiple submitters, no conflicts	12	110913320	GRCh38	138399	142102
NM_000432.3(MYL2):c.173G>A (p.Arg58Gln)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00001(T)	Pathogenic/Likely pathogenic, not provided(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	12	110914287	GRCh38	14067	29106
NM_000432.3(MYL2):c.141C>A (p.Asn47Lys)	MYL2	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Death in infancy|Ventricular extrasystoles|Cardiovascular phenotype	GO-ESP:0.00018(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Mar 27, 2015)	criteria provided, conflicting interpretations	12	110915743	GRCh38	31766	40426
NM_000432.3(MYL2):c.132T>C (p.Ile44=)	MYL2	not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.07643(G), GMAF:0.11520(G), GO-ESP:0.10247(G)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	110915752	GRCh38	31771	40431
NM_000432.3(MYL2):c.52T>C (p.Phe18Leu)	MYL2	Familial hypertrophic cardiomyopathy 10|Cardiovascular phenotype		Pathogenic/Likely pathogenic, not provided(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	12	110919145	GRCh38	14068	29107
NM_000432.3(MYL2):c.49G>A (p.Val17Met)	MYL2	not specified|Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, multiple submitters, no conflicts	12	110919148	GRCh38	181424	179436
NM_000432.3(MYL2):c.37G>A (p.Ala13Thr)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00046(T), GMAF:0.00020(T), GO-ESP:0.00031(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 5, 2016)	criteria provided, conflicting interpretations	12	110919160	GRCh38	14064	29103
NM_000432.3(MYL2):c.23A>G (p.Lys8Arg)	MYL2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 11, 2015)	criteria provided, single submitter	12	110919174	GRCh38	264577	258713
NM_002834.4(PTPN11):c.172A>C (p.Asn58His)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided		Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, multiple submitters, no conflicts	12	112450352	GRCh38	40486	48956
NM_002834.4(PTPN11):c.218C>T (p.Thr73Ile)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy		Pathogenic(Last reviewed: May 19, 2016)	criteria provided, multiple submitters, no conflicts	12	112450398	GRCh38	13334	28373
NM_002834.4(PTPN11):c.255C>T (p.His85=)	PTPN11	Metachondromatosis|Noonan syndrome|not specified|Rasopathy|Cardiovascular phenotype|LEOPARD Syndrome	GO-ESP:0.02814(T), GMAF:0.02440(T), GO-ESP:0.00718(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	112450435	GRCh38	36708	45369
NM_002834.4(PTPN11):c.486C>T (p.Asp162=)	PTPN11	Rasopathy|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00007(T)	Benign/Likely benign(Last reviewed: Oct 22, 2015)	criteria provided, multiple submitters, no conflicts	12	112453348	GRCh38	40515	48985
NM_002834.4(PTPN11):c.642G>A (p.Gln214=)	PTPN11	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 1, 2013)	criteria provided, single submitter	12	112454680	GRCh38	235046	236790
NM_002834.4(PTPN11):c.893A>G (p.Asn298Ser)	PTPN11	not specified|Cardio-facio-cutaneous syndrome	GO-ESP:0.00004(G)	Uncertain significance(Last reviewed: Jan 23, 2015)	criteria provided, multiple submitters, no conflicts	12	112477690	GRCh38	181500	179450
NM_002834.4(PTPN11):c.925A>G (p.Ile309Val)	PTPN11	not specified|Cardiovascular phenotype	GO-ESP:0.00023(G), GO-ESP:0.00041(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2016)	criteria provided, conflicting interpretations	12	112477722	GRCh38	40536	49006
NM_002834.4(PTPN11):c.1190C>T (p.Thr397Met)	PTPN11	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: May 18, 2016)	criteria provided, single submitter	12	112482171	GRCh38	279919	264459
NM_002834.4(PTPN11):c.1391G>C (p.Gly464Ala)	PTPN11	LEOPARD syndrome 1|not provided|Rasopathy		Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, multiple submitters, no conflicts	12	112488454	GRCh38	13343	28382
NM_002834.4(PTPN11):c.1403C>T (p.Thr468Met)	PTPN11	Noonan syndrome 1|Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy|Cardiovascular phenotype	GO-ESP:0.00001(T)	Pathogenic/Likely pathogenic, not provided(Last reviewed: May 6, 2016)	criteria provided, multiple submitters, no conflicts	12	112488466	GRCh38	13331	28370
NM_002834.4(PTPN11):c.1404G>A (p.Thr468=)	PTPN11	Cardiovascular phenotype		Likely benign(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	12	112488467	GRCh38	264357	258714
NM_002834.4(PTPN11):c.1510A>G (p.Met504Val)	PTPN11	Noonan syndrome|not provided|Rasopathy|Cardiovascular phenotype		Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	12	112489086	GRCh38	40562	49032
NM_002834.4(PTPN11):c.1650G>A (p.Ala550=)	PTPN11	Metachondromatosis|Noonan syndrome|not specified|Cardiovascular phenotype|LEOPARD Syndrome	GO-ESP:0.00013(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	112502194	GRCh38	138843	142546
NM_002834.4(PTPN11):c.1658C>T (p.Thr553Met)	PTPN11	Noonan syndrome|not specified|not provided|Rasopathy|Cardiovascular phenotype	GO-ESP:0.00046(T), GMAF:0.00020(T), GO-ESP:0.00049(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2016)	criteria provided, conflicting interpretations	12	112502202	GRCh38	40570	49040
NM_000192.3(TBX5):c.836G>A (p.Arg279Gln)	TBX5	Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00025(T)	Uncertain significance(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	12	114366311	GRCh38	264163	258715
NM_000192.3(TBX5):c.710G>A (p.Arg237Gln)	TBX5	Holt-Oram syndrome|not provided		Pathogenic/Likely pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, multiple submitters, no conflicts	12	114385521	GRCh38	7993	23032
NM_000192.3(TBX5):c.709C>T (p.Arg237Trp)	TBX5	Holt-Oram syndrome|Heart, malformation of|not provided		Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	12	114385522	GRCh38	7995	23034
NM_000192.3(TBX5):c.576T>C (p.Asn192=)	TBX5	Cardiovascular phenotype	GO-ESP:0.00002(G)	Likely benign(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	12	114394828	GRCh38	264278	258716
NM_000192.3(TBX5):c.331G>T (p.Asp111Tyr)	TBX5	Holt-Oram syndrome|not specified|Cardiovascular phenotype	GMAF:0.00220(A), GO-ESP:0.00340(A)	Benign/Likely benign(Last reviewed: Sep 1, 2016)	criteria provided, multiple submitters, no conflicts	12	114399544	GRCh38	213813	210214
NM_000192.3(TBX5):c.301A>T (p.Ile101Phe)	TBX5	Heart, malformation of		Likely pathogenic	no assertion criteria provided	12	114399574	GRCh38	139662	150126
NM_000192.3(TBX5):c.260A>G (p.Tyr87Cys)	TBX5	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	12	114399615	GRCh38	264346	258717
NM_000192.3(TBX5):c.238G>A (p.Gly80Arg)	TBX5	Holt-Oram syndrome		Pathogenic(Last reviewed: Mar 16, 1999)	no assertion criteria provided	12	114401830	GRCh38	7994	23033
NM_000192.3(TBX5):c.55G>T (p.Ala19Ser)	TBX5	Holt-Oram syndrome|Cardiovascular phenotype	GMAF:0.00140(A), GO-ESP:0.00027(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	114403844	GRCh38	264111	258718
NM_016569.3(TBX3):c.1051C>T (p.Gln351Ter)	TBX3	Ulnar-mammary syndrome		Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	12	114676361	GRCh38	31909	40565
NM_015335.4(MED13L):c.6485C>T (p.Thr2162Met)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects		Pathogenic(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	12	115963422	GRCh38	224153	225881
NM_015335.4(MED13L):c.6118_6125delGGCATATT (p.Gly2040Asnfs)	MED13L	Intellectual disability|Mental retardation and distinctive facial features with or without cardiac defects		Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	12	115969040 - 115969047	GRCh38	221556	223285
NM_015335.4(MED13L):c.5949_5950delTC (p.Gln1984Alafs)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects		Pathogenic(Last reviewed: Feb 5, 2016)	no assertion criteria provided	12	115970711 - 115970712	GRCh38	221560	223289
NM_015335.4(MED13L):c.3765delC (p.Cys1256Valfs)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects		Pathogenic(Last reviewed: Feb 5, 2016)	no assertion criteria provided	12	115991189	GRCh38	221561	223290
NM_015335.4(MED13L):c.1708_1709delAG (p.Ser570Phefs)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects		Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	12	116008704 - 116008705	GRCh38	221555	223284
NM_015335.4(MED13L):c.607dupT (p.Ser203Phefs)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects		Pathogenic(Last reviewed: Feb 5, 2016)	no assertion criteria provided	12	116022474	GRCh38	221562	223291
NM_015335.4(MED13L):c.480-1G>T	MED13L	Mental retardation and distinctive facial features with or without cardiac defects		Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	12	116022602	GRCh38	221557	223286
NM_015335.4(MED13L):c.124dupG (p.Asp42Glyfs)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects		Pathogenic(Last reviewed: Feb 10, 2015)	criteria provided, single submitter	12	116237654	GRCh38	224115	225845
NC_000012.12:g.(116046494_116060176)_(116243744_116257969)dup	MED13L|MIR620	Mental retardation and distinctive facial features with or without cardiac defects		Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	12	116046494 - 116257969	GRCh38	221559	223288
NC_000012.12:g.(?_115982183)_(116022795_?)del	MED13L	Mental retardation and distinctive facial features with or without cardiac defects		Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	12	115982183 - 116022795	GRCh38	221558	223287
GRCh38/hg38 12q14.1(chr12:61201517-62266814)x3	USP15|FAM19A2|MIR6125	See cases		Uncertain significance(Last reviewed: Jul 22, 2013)	no assertion criteria provided	12	61201517 - 62266814	GRCh38	155464	165218
GRCh38/hg38 12q24.21(chr12:116103617-116165654)x1	MED13L|MIR620	See cases		Likely pathogenic(Last reviewed: Apr 9, 2013)	no assertion criteria provided	12	116103617 - 116165654	GRCh38	155068	164822
GRCh38/hg38 12q21.31(chr12:80195590-80500002)x1	OTOGL|PTPRQ	See cases		Uncertain significance(Last reviewed: Dec 22, 2010)	no assertion criteria provided	12	80195590 - 80500002	GRCh38	154657	164411
GRCh38/hg38 12q24.33(chr12:129318948-130000929)x3	TMEM132D	See cases		Uncertain significance(Last reviewed: Mar 24, 2014)	no assertion criteria provided	12	129318948 - 130000929	GRCh38	153212	162963
GRCh38/hg38 12p13.33-12.1(chr12:80412-25470329)x3	A2M|APOBEC1|ARHGDIB|ART4|BCAT1|C1R|C1S|C3AR1|CACNA1C|CCND2|CD4|CD9|CD27|CD69|CDKN1B|CHD4|CREBL2|ATN1|PHC1|EMP1|ENO2|EPS8|ETV6|FGF6|FKBP4|FOXM1|GAPDH|GNAI2P1|GNB3|GPR19|GRIN2B|GUCY2C|GYS2|IAPP|KCNA1|KCNA5|KCNA6|KCNJ8|KLRB1|KLRC1|KLRC2|KLRC3|KLRD1|KRAS|LAG3|LDHB|LRMP|LRP6|LTBR|M6PR|MGP|MGST1|NDUFA9|NINJ2|NOP2|NTF3|OLR1|PDE3A|PDE6H|PIK3C2G|PRB1|PRB3|PRB4|PRH1|PRH2|PTMS|PTPN6|PTPRO|PEX5|PZP|RAD52|KDM5A|RECQL|SCNN1A|ST8SIA1|SLC2A3|SLC6A12|SLC6A13|SLCO1A2|SOX5|VAMP1|TEAD4|TNFRSF1A|TPI1|TULP3|VWF|FGF23|MFAP5|USP5|MLF2|KLRC4|YBX3|DYRK4|GPRC5A|CD163|GDF3|CLSTN3|C2CD5|NCAPD2|CLEC2B|ABCC9|LPCAT3|KLRG1|LRRC23|EMG1|P3H3|AKAP3|SLCO1B1|RAD51AP1|KLRA1P|TSPAN9|STRAP|PRR4|PHB2|KLRK1|ERC1|GABARAPL1|IFFO1|NECAP1|CLEC4E|GALNT8|GPR162|SLCO1B3|CLEC2D|COPS7A|TAS2R9|TAS2R8|TAS2R7|TAS2R13|TAS2R10|TAS2R14|CLEC4A|HEBP1|GOLT1B|DERA|ING4|DDX47|MRPL51|CLEC1B|CLEC1A|C1RL|KLRF1|WBP11|SLCO1C1|PLEKHA5|MANSC1|TAPBPL|MAGOHB|FAM90A1|PLEKHG6|CASC1|STYK1|ETNK1|GPRC5D|ATF7IP|H2AFJ|FOXJ2|ITFG2|LMO3|CMAS|DAD1P1|PRMT8|PARP11|ANO2|C12orf4|TIGAR|LPAR5|AICDA|RIMKLB|FAM234B|CLEC7A|WNK1|BCL2L14|ADIPOR2|RERGL|PLBD1|PYROXD1|NANOG|SPX|DUSP16|WNT5B|APOLD1|GSG1|CDCA3|RHNO1|NRIP2|RBP5|CCDC77|ACRBP|SPSB2|CRACR2A|RERG|PLCZ1|CACNA2D4|CAPZA3|CLEC6A|C12orf57|BORCS5|TMEM52B|HIST4H4|ERP27|AEBP2|SLC2A14|LINC00477|ETFRF1|A2ML1|A2M-AS1|C12orf60|FBXL14|CLEC12A|CLECL1|CLEC4C|ZNF384|C12orf77|PIANP|DCP1B|LINC00612|TAS2R43|TAS2R31|TAS2R46|TAS2R30|TAS2R19|TAS2R20|TAS2R50|C1RL-AS1|CD163L1|B4GALNT3|CLEC9A|LINC01559|LOC283440|CLEC4D|LINC01252|SLCO1B7|ACSM4|TAS2R42|DPPA3|NANOGNB|CLEC2A|CLEC12B|LINC00937|LOC400002|MIR141|MIR200C|OVOS|IQSEC3|ZNF705A|FAM66C|DDX12P|SMCO3|LOH12CR2|LOC574538|LOC642846|LOC645177|PRB2|LRTM2|SCARNA12|SCARNA11|CD27-AS1|SCARNA10|MIR613|MIR614|SKP1P2|LOC728715|SLC15A5|LOC100049716|MIR920|THCAT155|SMIM10L1|RNU7-1|LINC00940|LINC00942|MIR1244-3|KLRF2|LINC00987|MIR3649|LOC100506159|LOC100506314|LOC100506393|LOC100507424|KLRC4-KLRK1|PRH1-PRR4|MIR3974|CACNA1C-AS1|RERG-AS1|CACNA1C-AS4|CACNA1C-AS2|CACNA1C-IT2|CACNA1C-IT3|LOC101927905|LOC101928030|LOC101928100|LOC101928162|PLBD1-AS1|LINC01489|LOC101928441|LOC101928471|LOC101929384|LOC101929549|LOC101929584|LOC101930452|LOC102723544|LOC102724020|MIR1244-4|CCND2-AS1|LOC105369595|LOC105369632|LOC105369635|LOC105369691|LOC105369728|PRH1-TAS2R14	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	12	80412 - 25470329	GRCh38	59795	74390
GRCh38/hg38 12p13.33-11.1(chr12:77187-34380176)x3	A2M|APOBEC1|ARHGDIB|ART4|BCAT1|BICD1|C1R|C1S|C3AR1|CACNA1C|CCND2|CD4|CD9|CD27|CD69|CDKN1B|CHD4|CREBL2|DDX11|ATN1|PHC1|EMP1|ENO2|EPS8|ETV6|FGF6|FKBP4|FOXM1|GAPDH|GNAI2P1|GNB3|GPR19|GRIN2B|GUCY2C|GYS2|IAPP|ITPR2|KCNA1|KCNA5|KCNA6|KCNJ8|KLRB1|KLRC1|KLRC2|KLRC3|KLRD1|KRAS|LAG3|LDHB|LRMP|LRP6|LTBR|M6PR|MGP|MGST1|NDUFA9|NINJ2|NOP2|NTF3|OLR1|PDE3A|PDE6H|PIK3C2G|PKP2|PRB1|PRB3|PRB4|PRH1|PRH2|PTHLH|PTMS|PTPN6|PTPRO|PEX5|PZP|RAD52|KDM5A|RECQL|SCNN1A|ST8SIA1|SLC2A3|SLC6A12|SLC6A13|SLCO1A2|SOX5|VAMP1|TEAD4|TNFRSF1A|TPI1|TULP3|VWF|FGF23|MFAP5|USP5|MLF2|SSPN|KLRC4|PPFIBP1|YBX3|DYRK4|GPRC5A|CD163|MED21|GDF3|CLSTN3|C2CD5|NCAPD2|CLEC2B|DNM1L|ABCC9|LPCAT3|KLRG1|LRRC23|EMG1|IPO8|P3H3|AKAP3|SLCO1B1|RAD51AP1|KLRA1P|TSPAN9|STRAP|RASSF8|PRR4|PHB2|KLRK1|STK38L|ERC1|GABARAPL1|IFFO1|NECAP1|FGFR1OP2|CLEC4E|GALNT8|GPR162|SLCO1B3|CLEC2D|COPS7A|TAS2R9|TAS2R8|TAS2R7|TAS2R13|TAS2R10|TAS2R14|CLEC4A|HEBP1|GOLT1B|YARS2|DERA|ING4|DDX47|MRPL51|CLEC1B|CLEC1A|C1RL|ERGIC2|KLRF1|WBP11|TM7SF3|SLCO1C1|PLEKHA5|MANSC1|TAPBPL|MAGOHB|FAM90A1|KIAA1551|PLEKHG6|CASC1|CCDC91|STYK1|ETNK1|GPRC5D|FAR2|ASUN|ATF7IP|H2AFJ|FOXJ2|ITFG2|LMO3|CMAS|DAD1P1|PRMT8|ARNTL2|PARP11|ANO2|C12orf4|TIGAR|LPAR5|AICDA|RIMKLB|KLHL42|FAM234B|FAM60A|MRPS35|CLEC7A|WNK1|CAPRIN2|BHLHE41|BCL2L14|ADIPOR2|RERGL|FLJ13224|PLBD1|PYROXD1|NANOG|SPX|DUSP16|WNT5B|APOLD1|GSG1|CDCA3|RHNO1|NRIP2|RBP5|TMTC1|CCDC77|ACRBP|SPSB2|CRACR2A|ALG10|RERG|PLCZ1|CACNA2D4|CAPZA3|CLEC6A|C12orf57|BORCS5|TMEM52B|HIST4H4|ERP27|FGD4|AEBP2|SLC2A14|OVOS2|LINC00477|ETFRF1|A2ML1|A2M-AS1|C12orf60|FBXL14|CLEC12A|CLECL1|LMNTD1|DENND5B|CLEC4C|ZNF384|AMN1|C12orf77|PIANP|DCP1B|LINC00612|ETFBKMT|TAS2R43|TAS2R31|TAS2R46|TAS2R30|TAS2R19|TAS2R20|TAS2R50|C1RL-AS1|CD163L1|B4GALNT3|CLEC9A|LINC01559|LOC283440|CLEC4D|LINC01252|SLCO1B7|SMCO2|OVCH1|SYT10|ACSM4|TAS2R42|DPPA3|NANOGNB|CLEC2A|CLEC12B|REP15|LINC00937|LOC400002|MIR141|MIR200C|OVOS|IQSEC3|ZNF705A|FAM66C|DDX12P|SMCO3|H3F3C|TSPAN11|LOH12CR2|LOC574538|LOC642846|LOC645177|LOC645485|PRB2|LRTM2|SCARNA12|SCARNA11|CD27-AS1|SCARNA10|MIR613|MIR614|SKP1P2|LOC728715|C12orf71|SLC15A5|LOC100049716|MIR920|THCAT155|SMIM10L1|RNU7-1|LINC00940|MANSC4|LINC00941|LINC00942|MIR1244-3|MIR4302|KLRF2|LINC00987|MIR3649|LOC100506159|LOC100506314|LOC100506393|RASSF8-AS1|LOC100506606|DDX11-AS1|LOC100507424|KLRC4-KLRK1|PRH1-PRR4|MIR3974|CACNA1C-AS1|RERG-AS1|CACNA1C-AS4|CACNA1C-AS2|DENND5B-AS1|CACNA1C-IT2|CACNA1C-IT3|OVCH1-AS1|LOC101927905|LOC101928030|LOC101928100|LOC101928162|PLBD1-AS1|LINC01489|LOC101928441|LOC101928471|ARNTL2-AS1|LOC101929384|LOC101929549|LOC101929584|LOC101930452|LOC102723544|LOC102724020|MIR1244-4|CCND2-AS1|LOC105369595|LOC105369632|LOC105369635|LOC105369691|LOC105369723|LOC105369728|PRH1-TAS2R14	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	12	77187 - 34380176	GRCh38	59794	74389
GRCh38/hg38 12q21.31(chr12:80530108-80719071)x1	MYF5|MYF6|PTPRQ	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	12	80530108 - 80719071	GRCh38	57588	72183
GRCh38/hg38 12q15-21.1(chr12:70051305-71116195)x1	CNOT2|PTPRB|PTPRR|KCNMB4|LINC01481	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	12	70051305 - 71116195	GRCh38	57583	72178
NM_001127217.2(SMAD9):c.880C>T (p.Arg294Ter)	SMAD9	not provided|Primary pulmonary hypertension 2	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Oct 9, 2014)	criteria provided, single submitter	13	36865660	GRCh38	56970	71565
NM_001127217.2(SMAD9):c.65T>C (p.Leu22Pro)	SMAD9	Primary pulmonary hypertension|not specified	GMAF:0.00100(G), GO-ESP:0.00139(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	13	36879625	GRCh38	213811	210242
NM_001845.5(COL4A1):c.1583G>A (p.Gly528Glu)	COL4A1	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps		Pathogenic(Last reviewed: Mar 8, 2011)	no assertion criteria provided	13	110187283	GRCh38	17420	32459
NM_001845.5(COL4A1):c.1493G>T (p.Gly498Val)	COL4A1	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps		Pathogenic(Last reviewed: Mar 8, 2011)	no assertion criteria provided	13	110192257	GRCh38	17418	32457
NM_001846.3(COL4A2):c.3110G>A (p.Gly1037Glu)	COL4A2	Porencephaly 2		Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	13	110485739	GRCh38	29628	38582
NM_001846.3(COL4A2):c.3455G>A (p.Gly1152Asp)	COL4A2	Porencephaly 2		Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	13	110492070	GRCh38	29627	38581
GRCh38/hg38 13q12.11(chr13:20234428-20504762)x1	CRYL1|MIR4499	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	13	20234428 - 20504762	GRCh38	154752	164506
GRCh38/hg38 13q12.12(chr13:22943845-24355293)x3	MIPEP|SGCG|SACS|TNFRSF19|SPATA13|C1QTNF9|C1QTNF9B|C1QTNF9B-AS1|MIR2276|SACS-AS1|LINC00327|LINC00566|RNU6-58P|SPATA13-AS1	See cases		Uncertain significance(Last reviewed: Nov 27, 2012)	no assertion criteria provided	13	22943845 - 24355293	GRCh38	149939	159690
GRCh38/hg38 13q32.3-34(chr13:100039860-114327173)x3	ATP4B|COL4A1|COL4A2|EFNB2|ERCC5|F7|F10|FGF14|GAS6|ING1|LAMP1|LIG4|PCCA|GRK1|SLC10A2|SOX1|TFDP1|TPP2|CUL4A|IRS2|PROZ|ARHGEF7|CDC16|ITGBL1|TUBGCP3|TNFSF13B|RASA3|MYO16|ATP11A|MCF2L|BIVM|TMCO3|ARGLU1|DCUN1D2|ANKRD10|RAB20|NAXD|PCID2|UPF3A|KDELC1|CARS2|GRTP1|TMTC4|ABHD13|GGACT|TEX30|ADPRHL1|TEX29|SPACA7|LINC00343|METTL21C|NALCN|DAOA|DAOA-AS1|FGF14-IT1|FGF14-AS2|LINC00551|LINC00567|LINC00346|CHAMP1|TMEM255B|ATP11AUN|LINC00452|CCDC168|GAS6-AS1|LINC00460|FAM155A|COL4A2-AS2|LINC00552|MCF2L-AS1|MIR1267|ANKRD10-IT1|LINC00403|LOC100506016|GAS6-AS2|BIVM-ERCC5|MIR2681|MIR4502|MIR4705|MIR548AR|LINC00565|GRTP1-AS1|FGF14-AS1|LINC00411|LINC00443|LINC00454|COL4A2-AS1|ATP11A-AS1|ARHGEF7-AS1|ARHGEF7-AS2|FAM155A-IT1|PCCA-AS1|NALCN-AS1|MYO16-AS1|LOC101060553|LINC00676|LINC00368|LINC00354|LINC01070|LOC101928730|LINC01043|LOC101928841|MIR8073|MIR8075|LINC01044|LINC00399|LINC01309|LINC00431|LINC00396|F10-AS1|LOC105370333|LINC00370|LOC105370369	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	13	100039860 - 114327173	GRCh38	59924	74519
GRCh38/hg38 13q13.3-14.11(chr13:35232476-41375955)x1	ELF1|FOXO1|MAB21L1|SMAD9|RFXAP|TRPC4|CCNA1|DCLK1|MTRF1|SLC25A15|LHFP|MRPS31|POSTN|WBP4|EXOSC8|SPG20|NBEA|ALG5|UFM1|SOHLH2|SUPT20H|COG6|NAA16|PROSER1|KBTBD7|KBTBD6|CSNK1A1L|STOML3|FREM2|NHLRC3|SERTM1|LINC00547|LINC00548|LINC00598|MIR621|CCDC169|TRE-TTC1-2|MIR320D1|MIR3168|MIR4305|LINC00445|SPG20-AS1|CCDC169-SOHLH2|RNU6-56P|RNU6-57P|RNU6-71P|FREM2-AS1|LINC00332|LINC00366|LINC00571|LINC00437|LOC101929140|LINC01048	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	13	35232476 - 41375955	GRCh38	57640	72235
NM_002471.3(MYH6):c.5809G>A (p.Asp1937Asn)	MYH6	Familial hypertrophic cardiomyopathy 14|Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 1, 2016)	criteria provided, multiple submitters, no conflicts	14	23382051	GRCh38	239180	241796
NM_002471.3(MYH6):c.5767C>T (p.Arg1923Ter)	MYH6	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	14	23382457	GRCh38	264622	258754
NM_002471.3(MYH6):c.5692T>G (p.Phe1898Val)	MYH6	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 15, 2013)	criteria provided, single submitter	14	23382532	GRCh38	263719	258755
NM_002471.3(MYH6):c.5601G>A (p.Gln1867=)	MYH6	Cardiovascular phenotype	GO-ESP:0.00011(T)	Likely benign(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	14	23383285	GRCh38	263989	258761
NM_002471.3(MYH6):c.5598A>G (p.Leu1866=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.08490(C), GO-ESP:0.02667(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23383288	GRCh38	258715	254914
NM_002471.3(MYH6):c.5540G>A (p.Arg1847Gln)	MYH6	Cardiovascular phenotype	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	14	23384467	GRCh38	264189	258758
NM_002471.3(MYH6):c.5519A>G (p.Lys1840Arg)	MYH6	Cardiovascular phenotype	GO-ESP:0.00008(C)	Uncertain significance(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	14	23384488	GRCh38	264214	258757
NM_002471.3(MYH6):c.5476_5477delGGinsAA (p.Gly1826Asn)	MYH6	Familial hypertrophic cardiomyopathy 14|Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	14	23384530 - 23384531	GRCh38	239179	241797
NM_002471.3(MYH6):c.5475G>A (p.Glu1825=)	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00031(T), GMAF:0.01140(T), GO-ESP:0.00728(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23384532	GRCh38	44537	53704
NM_002471.3(MYH6):c.5348G>A (p.Arg1783His)	MYH6	Cardiovascular phenotype	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Jan 24, 2013)	criteria provided, single submitter	14	23384659	GRCh38	263508	258759
NM_002471.3(MYH6):c.5259C>T (p.Ala1753=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.08734(A), GMAF:0.03630(A), GO-ESP:0.07485(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23384946	GRCh38	44532	53699
NM_002471.3(MYH6):c.5192_5194delAGA (p.Lys1731del)	MYH6	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	14	23385011 - 23385013	GRCh38	264294	258769
NM_002471.3(MYH6):c.5137G>A (p.Glu1713Lys)	MYH6	Cardiovascular phenotype	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	14	23385954	GRCh38	263451	258764
NM_002471.3(MYH6):c.4986G>A (p.Ala1662=)	MYH6	not specified|Cardiovascular phenotype	GO-ESP:0.00015(T), GMAF:0.00340(T), GO-ESP:0.00141(T)	Likely benign(Last reviewed: Jan 28, 2013)	criteria provided, multiple submitters, no conflicts	14	23386105	GRCh38	44529	53696
NM_002471.3(MYH6):c.4980C>T (p.Asp1660=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.08765(A), GMAF:0.03650(A), GO-ESP:0.07504(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23386111	GRCh38	44528	53695
NM_002471.3(MYH6):c.4914T>C (p.Ala1638=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.55321(G), GMAF:0.49280(G), GO-ESP:0.46489(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23386360	GRCh38	44526	53693
NM_002471.3(MYH6):c.4907G>A (p.Arg1636His)	MYH6	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Sep 12, 2013)	criteria provided, single submitter	14	23386367	GRCh38	263746	258763
NM_002471.3(MYH6):c.4906C>T (p.Arg1636Cys)	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00138(A), GMAF:0.00240(A), GO-ESP:0.00042(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23386368	GRCh38	44525	53692
NM_002471.3(MYH6):c.4899C>T (p.His1633=)	MYH6	Familial hypertrophic cardiomyopathy 14|not specified|Cardiovascular phenotype	GO-ESP:0.00438(A), GMAF:0.00360(A), GO-ESP:0.00154(A)	Benign(Last reviewed: Nov 21, 2015)	criteria provided, multiple submitters, no conflicts	14	23386375	GRCh38	44524	53691
NM_002471.3(MYH6):c.4838T>C (p.Val1613Ala)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01545(G), GMAF:0.04870(G), GO-ESP:0.01463(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23386436	GRCh38	44522	53689
NM_002471.3(MYH6):c.4782G>A (p.Arg1594=)	MYH6	Familial hypertrophic cardiomyopathy 14|not specified|Cardiovascular phenotype	GO-ESP:0.00138(T), GMAF:0.00220(T), GO-ESP:0.00040(T)	Benign/Likely benign(Last reviewed: Jan 29, 2016)	criteria provided, multiple submitters, no conflicts	14	23386492	GRCh38	44521	53688
NM_002471.3(MYH6):c.4778A>T (p.Gln1593Leu)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02153(A), GMAF:0.04910(A), GO-ESP:0.01470(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23386496	GRCh38	44520	53687
NM_002471.3(MYH6):c.4713G>T (p.Lys1571Asn)	MYH6	Cardiac arrest	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jun 23, 2014)	no assertion criteria provided	14	23386561	GRCh38	180427	178665
NM_002471.3(MYH6):c.4685G>A (p.Arg1562Gln)	MYH6	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	14	23386589	GRCh38	263944	258762
NM_002471.3(MYH6):c.4651-4C>A	MYH6	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Oct 7, 2013)	criteria provided, single submitter	14	23386627	GRCh38	263704	258771
NM_002471.3(MYH6):c.4604T>G (p.Leu1535Arg)	MYH6	Cardiovascular phenotype		Uncertain significance(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	14	23387575	GRCh38	263983	258770
NM_002471.3(MYH6):c.4527G>A (p.Glu1509=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02891(T), GMAF:0.03260(T), GO-ESP:0.01138(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23387652	GRCh38	44515	53682
NM_002471.3(MYH6):c.4416A>G (p.Ser1472=)	MYH6	not specified|Cardiovascular phenotype	GMAF:0.00200(C), GO-ESP:0.00065(C)	Benign/Likely benign(Last reviewed: Apr 8, 2015)	criteria provided, multiple submitters, no conflicts	14	23387867	GRCh38	177963	175413
NM_002471.3(MYH6):c.4401T>G (p.Ser1467=)	MYH6	Cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00177(C), GMAF:0.00220(C), GO-ESP:0.00073(C)	Likely benign(Last reviewed: Oct 30, 2015)	criteria provided, multiple submitters, no conflicts	14	23387882	GRCh38	36629	45291
NM_002471.3(MYH6):c.4365G>T (p.Leu1455=)	MYH6	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Aug 31, 2015)	criteria provided, single submitter	14	23387918	GRCh38	264332	258765
NM_002471.3(MYH6):c.4293G>A (p.Met1431Ile)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(T), GO-ESP:0.00175(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23388221	GRCh38	179022	175415
NM_002471.3(MYH6):c.4206C>T (p.Ala1402=)	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00884(A), GMAF:0.00780(A), GO-ESP:0.00219(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23388308	GRCh38	44506	53673
NM_002471.3(MYH6):c.4193G>A (p.Arg1398Gln)	MYH6	Atrial septal defect|not specified|not provided|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00039(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23388321	GRCh38	191712	189933
NM_002471.3(MYH6):c.4047C>T (p.Tyr1349=)	MYH6	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00002(A)	Likely benign(Last reviewed: May 21, 2015)	criteria provided, single submitter	14	23388987	GRCh38	264064	258767
NM_002471.3(MYH6):c.4026C>T (p.Cys1342=)	MYH6	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00010(A)	Likely benign(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	14	23389008	GRCh38	263527	258772
NM_002471.3(MYH6):c.4011G>A (p.Ser1337=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.08588(T), GMAF:0.03470(T), GO-ESP:0.07657(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23389023	GRCh38	44501	53668
NM_002471.3(MYH6):c.3980C>T (p.Ala1327Val)	MYH6	Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00017(A)	Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	14	23389054	GRCh38	264465	258773
NM_002471.3(MYH6):c.3883G>C (p.Glu1295Gln)	MYH6	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00300(G), GMAF:0.00420(G), GO-ESP:0.00325(G)	Benign/Likely benign(Last reviewed: Oct 27, 2015)	criteria provided, multiple submitters, no conflicts	14	23389488	GRCh38	44492	53659
NM_002471.3(MYH6):c.3627C>T (p.Ile1209=)	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01173(A), GMAF:0.00760(A), GO-ESP:0.00300(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23390162	GRCh38	44489	53656
NM_002471.3(MYH6):c.3612G>C (p.Glu1204Asp)	MYH6	Cardiovascular phenotype	GO-ESP:0.00006(G)	Uncertain significance(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	14	23390177	GRCh38	264374	258766
NM_002471.3(MYH6):c.3609C>G (p.Ala1203=)	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01158(C), GO-ESP:0.00306(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23390180	GRCh38	44487	53654
NM_002471.3(MYH6):c.3591G>A (p.Lys1197=)	MYH6	Cardiovascular phenotype		Likely benign(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	14	23390198	GRCh38	263646	258768
NM_002471.3(MYH6):c.3573C>T (p.Ala1191=)	MYH6	not specified|Cardiovascular phenotype		Likely benign(Last reviewed: Nov 4, 2015)	criteria provided, multiple submitters, no conflicts	14	23390216	GRCh38	180116	175419
NM_002471.3(MYH6):c.3532C>T (p.Arg1178Trp)	MYH6	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	14	23390257	GRCh38	264515	258777
NM_002471.3(MYH6):c.3480C>T (p.Ser1160=)	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00837(A), GMAF:0.00760(A), GO-ESP:0.00294(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23390309	GRCh38	44486	53653
NM_002471.3(MYH6):c.3408G>A (p.Lys1136=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01586(T), GMAF:0.01720(T), GO-ESP:0.00518(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23390381	GRCh38	44484	53651
NM_002471.3(MYH6):c.3388G>A (p.Ala1130Thr)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.07290(T), GO-ESP:0.10033(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23390401	GRCh38	44483	53650
NM_002471.3(MYH6):c.3347G>A (p.Arg1116His)	MYH6	Familial hypertrophic cardiomyopathy 14|Cardiovascular phenotype	GO-ESP:0.00009(T)	Uncertain significance(Last reviewed: Nov 5, 2015)	criteria provided, multiple submitters, no conflicts	14	23390442	GRCh38	239166	241808
NM_002471.3(MYH6):c.3302T>C (p.Val1101Ala)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.45564(G), GMAF:0.37480(G), GO-ESP:0.34610(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23392602	GRCh38	44480	53647
NM_002471.3(MYH6):c.3177C>T (p.Gly1059=)	MYH6	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00012(A)	Likely benign(Last reviewed: Nov 20, 2013)	criteria provided, single submitter	14	23392986	GRCh38	263779	258779
NM_002471.3(MYH6):c.3140G>A (p.Arg1047His)	MYH6	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	14	23393023	GRCh38	264390	258774
NM_002471.3(MYH6):c.3010G>T (p.Ala1004Ser)	MYH6	Dilated cardiomyopathy 1EE|Familial hypertrophic cardiomyopathy 14|not specified|Dilated cardiomyopathy|Sudden cardiac death|Cardiovascular phenotype	GO-ESP:0.00092(A), GMAF:0.00060(A), GO-ESP:0.00098(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 4, 2016)	criteria provided, conflicting interpretations	14	23393437	GRCh38	14151	29190
NM_002471.3(MYH6):c.2946G>A (p.Glu982=)	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00861(T), GMAF:0.00420(T), GO-ESP:0.00985(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23393501	GRCh38	44475	53642
NM_002471.3(MYH6):c.2928+5G>A	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00185(T), GMAF:0.00020(T), GO-ESP:0.00176(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23393661	GRCh38	44473	53640
NM_002471.3(MYH6):c.2928G>A (p.Lys976=)	MYH6	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	14	23393666	GRCh38	264562	258775
NM_002471.3(MYH6):c.2771T>A (p.Met924Lys)	MYH6	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 19, 2013)	criteria provided, single submitter	14	23393823	GRCh38	263550	258781
NM_002471.3(MYH6):c.2597A>G (p.Glu866Gly)	MYH6	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	14	23394156	GRCh38	264480	258780
NM_002471.3(MYH6):c.2579G>A (p.Arg860His)	MYH6	Familial hypertrophic cardiomyopathy 14|not specified|Cardiovascular phenotype	GO-ESP:0.00577(T), GMAF:0.00320(T), GO-ESP:0.00166(T)	Benign(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	14	23394174	GRCh38	44467	53634
NM_002471.3(MYH6):c.2574C>T (p.Phe858=)	MYH6	Cardiovascular phenotype	GO-ESP:0.00004(A)	Likely benign(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	14	23394179	GRCh38	264432	258776
NM_002471.3(MYH6):c.2554G>A (p.Ala852Thr)	MYH6	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	14	23394199	GRCh38	263991	258778
NM_002471.3(MYH6):c.2459T>A (p.Ile820Asn)	MYH6	Atrial septal defect 3		Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	14	23394294	GRCh38	14148	29187
NM_002471.3(MYH6):c.2430-4C>A	MYH6	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	14	23394327	GRCh38	263988	258783
NM_002471.3(MYH6):c.2273A>G (p.Tyr758Cys)	MYH6	Cardiovascular phenotype	GMAF:0.00040(C), GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	14	23396713	GRCh38	264481	258785
NM_002471.3(MYH6):c.2151C>T (p.Tyr717=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01061(A), GMAF:0.03400(A), GO-ESP:0.02363(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23396980	GRCh38	44461	53628
NM_002471.3(MYH6):c.2033A>G (p.Asn678Ser)	MYH6	Heart, malformation of	GO-ESP:0.00001(C)	Likely pathogenic	no assertion criteria provided	14	23397187	GRCh38	139663	150127
NM_002471.3(MYH6):c.1989C>T (p.Asn663=)	MYH6	Familial hypertrophic cardiomyopathy 14|not specified|Cardiovascular phenotype	GO-ESP:0.00569(A), GMAF:0.00100(A), GO-ESP:0.00518(A)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	14	23397231	GRCh38	44460	53627
NM_002471.3(MYH6):c.1763A>C (p.Asp588Ala)	MYH6	Familial hypertrophic cardiomyopathy 14|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GMAF:0.00060(G), GO-ESP:0.00213(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 25, 2016)	criteria provided, conflicting interpretations	14	23398856	GRCh38	155811	165563
NM_002471.3(MYH6):c.1753G>A (p.Gly585Ser)	MYH6	Atrial septal defect|Cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00023(T), GO-ESP:0.00016(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23398866	GRCh38	36627	45289
NM_002471.3(MYH6):c.1628A>G (p.Lys543Arg)	MYH6	not specified	GO-ESP:0.00005(C)	Uncertain significance(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	14	23398991	GRCh38	228888	230477
NM_002471.3(MYH6):c.1520T>C (p.Ile507Thr)	MYH6	Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	14	23400317	GRCh38	264253	258782
NM_002471.3(MYH6):c.1410C>T (p.Asp470=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00020(A), GO-ESP:0.00019(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23400709	GRCh38	178073	175573
NM_002471.3(MYH6):c.1408G>A (p.Asp470Asn)	MYH6	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Mar 19, 2013)	criteria provided, single submitter	14	23400711	GRCh38	263566	258784
NM_002471.3(MYH6):c.1336G>A (p.Ala446Thr)	MYH6	not specified|Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Oct 1, 2015)	criteria provided, multiple submitters, no conflicts	14	23400783	GRCh38	228886	230479
NM_002471.3(MYH6):c.1335C>T (p.Asn445=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.04467(A), GMAF:0.03220(A), GO-ESP:0.05441(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23400784	GRCh38	44451	53618
NM_002471.3(MYH6):c.1275C>T (p.Ile425=)	MYH6	Familial hypertrophic cardiomyopathy 14|not specified|Cardiovascular phenotype	GO-ESP:0.00246(A), GMAF:0.00020(A), GO-ESP:0.00232(A)	Benign/Likely benign(Last reviewed: Mar 7, 2016)	criteria provided, multiple submitters, no conflicts	14	23400844	GRCh38	44450	53617
NM_002471.3(MYH6):c.1252G>A (p.Val418Met)	MYH6	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00015(T), GMAF:0.00060(T), GO-ESP:0.00023(T)	Uncertain significance(Last reviewed: May 20, 2015)	criteria provided, multiple submitters, no conflicts	14	23400867	GRCh38	44449	53616
NM_002471.3(MYH6):c.1185C>T (p.Asp395=)	MYH6	Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00012(A)	Likely benign(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	14	23400934	GRCh38	263945	258788
NM_002471.3(MYH6):c.1132G>A (p.Gly378Ser)	MYH6	not specified|Cardiovascular phenotype	GMAF:0.00260(T), GO-ESP:0.00088(T)	Likely benign(Last reviewed: May 21, 2015)	criteria provided, multiple submitters, no conflicts	14	23402473	GRCh38	178075	175429
NM_002471.3(MYH6):c.1131C>T (p.Asp377=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00220(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23402474	GRCh38	227584	230481
NM_002471.3(MYH6):c.1083G>T (p.Gly361=)	MYH6	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00021(A)	Likely benign(Last reviewed: Apr 7, 2015)	criteria provided, multiple submitters, no conflicts	14	23402522	GRCh38	178077	175430
NM_002471.3(MYH6):c.999C>T (p.Thr333=)	MYH6	Atrial septal defect|Cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.04006(A), GMAF:0.04230(A), GO-ESP:0.02025(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23402700	GRCh38	36634	45296
NM_002471.3(MYH6):c.909G>A (p.Leu303=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02952(T), GMAF:0.03120(T), GO-ESP:0.00973(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23402790	GRCh38	44546	53713
NM_002471.3(MYH6):c.679G>A (p.Ala227Thr)	MYH6	not specified|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2013)	criteria provided, conflicting interpretations	14	23404352	GRCh38	164254	175433
NM_002471.3(MYH6):c.643-3T>C	MYH6	Cardiovascular phenotype	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	14	23404391	GRCh38	264560	258793
NM_002471.3(MYH6):c.643-5C>T	MYH6	Familial hypertrophic cardiomyopathy 14|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00054(A), GO-ESP:0.00039(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 10, 2015)	criteria provided, conflicting interpretations	14	23404393	GRCh38	44542	53709
NM_002471.3(MYH6):c.633T>A (p.Asn211Lys)	MYH6	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	14	23404720	GRCh38	264090	258787
NM_002471.3(MYH6):c.427C>A (p.Arg143=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.08089(T), GMAF:0.07770(T), GO-ESP:0.09507(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23405298	GRCh38	44507	53674
NM_002471.3(MYH6):c.411G>A (p.Glu137=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.22843(T), GMAF:0.15440(T), GO-ESP:0.21033(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23405314	GRCh38	44504	53671
NM_002471.3(MYH6):c.399G>A (p.Val133=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01407(T), GMAF:0.01340(T), GO-ESP:0.00404(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23405326	GRCh38	44500	53667
NM_002471.3(MYH6):c.393G>A (p.Leu131=)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.08027(T), GMAF:0.05710(T), GO-ESP:0.06986(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23405332	GRCh38	44495	53662
NM_002471.3(MYH6):c.330G>A (p.Ala110=)	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00423(T), GMAF:0.00140(T), GO-ESP:0.00355(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23405642	GRCh38	44481	53648
NM_002471.3(MYH6):c.292G>A (p.Glu98Lys)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00062(T), GMAF:0.00060(T), GO-ESP:0.00023(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23405680	GRCh38	44474	53641
NM_002471.3(MYH6):c.166G>A (p.Gly56Arg)	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.08019(T), GMAF:0.05670(T), GO-ESP:0.06980(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23407058	GRCh38	44455	53622
NM_002471.3(MYH6):c.86G>A (p.Arg29Gln)	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00420(T), GO-ESP:0.00150(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23407138	GRCh38	164258	175581
NM_002471.3(MYH6):c.36G>A (p.Ala12=)	MYH6	Familial hypertrophic cardiomyopathy 14|Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00380(T), GO-ESP:0.00150(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23407188	GRCh38	164259	175582
NM_002471.3(MYH6):c.-5C>A	MYH6	Atrial septal defect|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00380(T), GO-ESP:0.00141(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23407228	GRCh38	164261	175437
NM_000257.3(MYH7):c.5786C>T (p.Thr1929Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Oct 15, 2015)	criteria provided, multiple submitters, no conflicts	14	23413763	GRCh38	181397	179464
NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)	MYH7	Left ventricular noncompaction 5	GMAF:0.00020(A)	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	14	23413795	GRCh38	66082	76984
NM_000257.3(MYH7):c.5749G>T (p.Val1917Phe)	MYH7	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: May 24, 2013)	criteria provided, multiple submitters, no conflicts	14	23413800	GRCh38	43089	52259
NM_000257.3(MYH7):c.5727G>A (p.Arg1909=)	MYH7	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Oct 7, 2013)	criteria provided, single submitter	14	23413822	GRCh38	263705	258786
NM_000257.3(MYH7):c.5704G>C (p.Glu1902Gln)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(G), GO-ESP:0.00007(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23413845	GRCh38	43082	52252
NM_000257.3(MYH7):c.5702A>T (p.His1901Leu)	MYH7	Myosin storage myopathy		Pathogenic(Last reviewed: Apr 14, 2009)	no assertion criteria provided	14	23413847	GRCh38	14117	29156
NM_000257.3(MYH7):c.5647G>A (p.Glu1883Lys)	MYH7	Myopathy, myosin storage, autosomal recessive|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Aug 7, 2014)	criteria provided, conflicting interpretations	14	23414015	GRCh38	14121	29160
NM_000257.3(MYH7):c.5624T>C (p.Val1875Ala)	MYH7	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 14, 2013)	criteria provided, single submitter	14	23414038	GRCh38	263507	258789
NM_000257.3(MYH7):c.5481G>A (p.Glu1827=)	MYH7	Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	14	23415073	GRCh38	237440	241816
NM_000257.3(MYH7):c.5458C>T (p.Arg1820Trp)	MYH7	Myopathy, myosin storage, autosomal recessive|not specified|not provided	GO-ESP:0.00003(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2016)	criteria provided, conflicting interpretations	14	23415096	GRCh38	181282	179477
NM_000257.3(MYH7):c.5452C>T (p.Arg1818Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Aug 18, 2016)	criteria provided, multiple submitters, no conflicts	14	23415102	GRCh38	217826	214496
NM_000257.3(MYH7):c.5399C>T (p.Ala1800Val)	MYH7	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jul 16, 2015)	criteria provided, conflicting interpretations	14	23415155	GRCh38	181279	179480
NM_000257.3(MYH7):c.5378T>C (p.Leu1793Pro)	MYH7	Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Left ventricular noncompaction 5|not provided		Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	14	23415176	GRCh38	14123	29162
NM_000257.3(MYH7):c.5329G>A (p.Ala1777Thr)	MYH7	Primary familial hypertrophic cardiomyopathy|Camptocormism|not specified	GO-ESP:0.00004(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2016)	criteria provided, conflicting interpretations	14	23415225	GRCh38	177697	175587
NM_000257.3(MYH7):c.5245A>C (p.Arg1749=)	MYH7	Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00002(G)	Likely benign(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	14	23415419	GRCh38	264079	258799
NM_000257.3(MYH7):c.5186_5188delAGA (p.Lys1729del)	MYH7|MHRT	Congenital myopathy with fiber type disproportion|Myopathy, distal, 1|Laing distal myopathy		Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23415476 - 23415478	GRCh38	42096	51262
NM_000257.3(MYH7):c.5135G>A (p.Arg1712Gln)	MYH7|MHRT	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00001(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 29, 2016)	criteria provided, conflicting interpretations	14	23415651	GRCh38	36642	45304
NM_000257.3(MYH7):c.5106G>A (p.Ala1702=)	MYH7|MHRT	Myosin storage myopathy|Myopathy, distal, 1|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.16062(T), GMAF:0.11760(T), GO-ESP:0.10702(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23415680	GRCh38	43056	52226
NM_000257.3(MYH7):c.4965T>C (p.Ile1655=)	MYH7|MHRT	Cardiovascular phenotype		Likely benign(Last reviewed: May 22, 2015)	criteria provided, single submitter	14	23415821	GRCh38	264017	258790
NM_000257.3(MYH7):c.4717G>A (p.Glu1573Lys)	MYH7|MHRT	First degree atrioventricular block	GO-ESP:0.00008(T)	Uncertain significance(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	14	23416240	GRCh38	222729	224461
NM_000257.3(MYH7):c.4716C>T (p.Ile1572=)	MYH7|MHRT	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01738(A), GMAF:0.01820(A), GO-ESP:0.00459(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23416241	GRCh38	43032	52202
NM_000257.3(MYH7):c.4588C>T (p.Arg1530Ter)	MYH7|MHRT	not specified|Cardiovascular phenotype	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 8, 2015)	criteria provided, conflicting interpretations	14	23416924	GRCh38	43029	52199
NM_000257.3(MYH7):c.4566T>C (p.Thr1522=)	MYH7|MHRT	Myosin storage myopathy|Myopathy, distal, 1|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00538(G), GMAF:0.01120(G), GO-ESP:0.01271(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23416946	GRCh38	43027	52197
NM_000257.3(MYH7):c.4499G>A (p.Arg1500Gln)	MYH7|MHRT	Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23417173	GRCh38	180439	178673
NM_000257.3(MYH7):c.4472C>G (p.Ser1491Cys)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00861(C), GMAF:0.00520(C), GO-ESP:0.00746(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23417200	GRCh38	43020	52190
NM_000257.3(MYH7):c.4423C>T (p.Arg1475Cys)	MYH7|MHRT	not specified	GO-ESP:0.00008(A)	Uncertain significance(Last reviewed: Mar 9, 2014)	criteria provided, single submitter	14	23417249	GRCh38	181256	179512
NM_000257.3(MYH7):c.4402G>A (p.Glu1468Lys)	MYH7|MHRT	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	14	23417270	GRCh38	235033	236797
NM_000257.3(MYH7):c.4377G>T (p.Lys1459Asn)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00031(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 19, 2016)	criteria provided, conflicting interpretations	14	23417295	GRCh38	43012	52182
NM_000257.3(MYH7):c.4347C>T (p.Phe1449=)	MYH7|MHRT	Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00054(A)	Likely benign(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	14	23417509	GRCh38	263348	258792
NM_000257.3(MYH7):c.4341G>A (p.Arg1447=)	MYH7|MHRT	Cardiovascular phenotype	GO-ESP:0.00049(T)	Likely benign(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	14	23417515	GRCh38	263349	258791
NM_000257.3(MYH7):c.4276G>A (p.Glu1426Lys)	MYH7|MHRT	not specified		Uncertain significance(Last reviewed: Jan 18, 2016)	criteria provided, multiple submitters, no conflicts	14	23417580	GRCh38	43005	52175
NM_000257.3(MYH7):c.4134C>T (p.Asp1378=)	MYH7	Cardiovascular phenotype	GO-ESP:0.00013(A)	Likely benign(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	14	23418245	GRCh38	264306	258801
NM_000257.3(MYH7):c.3982G>A (p.Ala1328Thr)	MYH7	not specified|Cardiovascular phenotype	GO-ESP:0.00008(T), GMAF:0.00040(T), GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Nov 16, 2015)	criteria provided, multiple submitters, no conflicts	14	23418397	GRCh38	42985	52155
NM_000257.3(MYH7):c.3981C>A (p.Asn1327Lys)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00008(T), GO-ESP:0.00010(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2016)	criteria provided, conflicting interpretations	14	23418398	GRCh38	36641	45303
NM_000257.3(MYH7):c.3961_3963delGAGinsAAA (p.Glu1321Lys)	MYH7	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 28, 2013)	criteria provided, single submitter	14	23419186 - 23419188	GRCh38	263629	258798
NM_000257.3(MYH7):c.3853+1G>A	MYH7	Sudden cardiac death	GMAF:0.00020(T), GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	14	23419482	GRCh38	222733	224464
NM_000257.3(MYH7):c.3658_3660delGAG (p.Glu1220del)	MYH7	Primary dilated cardiomyopathy|Cardiovascular phenotype		Likely pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, multiple submitters, no conflicts	14	23419911 - 23419913	GRCh38	42968	52138
NM_000257.3(MYH7):c.3577C>A (p.Arg1193Ser)	MYH7	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	14	23419994	GRCh38	264233	258794
NM_000257.3(MYH7):c.3373G>A (p.Glu1125Lys)	MYH7	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	14	23420198	GRCh38	264365	258795
NM_000257.3(MYH7):c.3351G>A (p.Glu1117=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00278(T), GMAF:0.00120(T), GO-ESP:0.00237(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23420220	GRCh38	42957	52127
NM_000257.3(MYH7):c.3337-3dupC	MYH7	Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Paroxysmal familial ventricular fibrillation 1|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.04030(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23420237	GRCh38	42956	52126
NM_000257.3(MYH7):c.3320A>C (p.Lys1107Thr)	MYH7	Cardiovascular phenotype		Uncertain significance(Last reviewed: Mar 17, 2015)	criteria provided, single submitter	14	23420974	GRCh38	263955	258802
NM_000257.3(MYH7):c.3301G>A (p.Gly1101Ser)	MYH7	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	14	23420993	GRCh38	161325	171162
NM_000257.3(MYH7):c.3286G>T (p.Asp1096Tyr)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	GO-ESP:0.00015(A), GO-ESP:0.00016(A)	Uncertain significance(Last reviewed: Feb 2, 2016)	criteria provided, multiple submitters, no conflicts	14	23421008	GRCh38	42953	52123
NM_000257.3(MYH7):c.3261G>A (p.Leu1087=)	MYH7	Cardiovascular phenotype	GO-ESP:0.00006(T)	Likely benign(Last reviewed: May 21, 2015)	criteria provided, single submitter	14	23421033	GRCh38	264011	258800
NM_000257.3(MYH7):c.3169G>A (p.Gly1057Ser)	MYH7	not specified|Cardiovascular phenotype	GO-ESP:0.00001(T)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 8, 2016)	criteria provided, conflicting interpretations	14	23422256	GRCh38	42950	52120
NM_000257.3(MYH7):c.3153G>A (p.Ala1051=)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00554(T), GMAF:0.00320(T), GO-ESP:0.00498(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23422272	GRCh38	42946	52116
NM_000257.3(MYH7):c.3036C>T (p.Ala1012=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00008(A), GMAF:0.00260(A), GO-ESP:0.00152(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23423610	GRCh38	42945	52115
NM_000257.3(MYH7):c.2967T>C (p.Ile989=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.45471(G), GMAF:0.37640(G), GO-ESP:0.32119(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23423679	GRCh38	42942	52112
NM_000257.3(MYH7):c.2945T>C (p.Met982Thr)	MYH7	Myosin storage myopathy|Primary familial hypertrophic cardiomyopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Increased left ventricular wall thickness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00169(G), GMAF:0.00040(G), GO-ESP:0.00091(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23423701	GRCh38	42941	52111
NM_000257.3(MYH7):c.2890G>C (p.Val964Leu)	MYH7	Primary dilated cardiomyopathy|Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00046(G), GMAF:0.00020(G), GO-ESP:0.00042(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23423939	GRCh38	42938	52108
NM_000257.3(MYH7):c.2886delC (p.Val964Trpfs)	MYH7	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Oct 9, 2013)	criteria provided, single submitter	14	23423943	GRCh38	263706	258796
NM_000257.3(MYH7):c.2882T>G (p.Leu961Arg)	MYH7	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 7, 2015)	criteria provided, single submitter	14	23423947	GRCh38	264501	258797
NM_000257.3(MYH7):c.2877G>A (p.Leu959=)	MYH7	Cardiovascular phenotype		Likely benign(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	14	23423952	GRCh38	264448	258803
NM_000257.3(MYH7):c.2863G>A (p.Asp955Asn)	MYH7	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	14	23423966	GRCh38	264608	258804
NM_000257.3(MYH7):c.2803G>A (p.Glu935Lys)	MYH7	Familial hypertrophic cardiomyopathy 1		Pathogenic(Last reviewed: Apr 15, 1994)	no assertion criteria provided	14	23424026	GRCh38	14106	29145
NM_000257.3(MYH7):c.2788G>A (p.Glu930Lys)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2015)	criteria provided, multiple submitters, no conflicts	14	23424041	GRCh38	42933	52103
NM_000257.3(MYH7):c.2783A>T (p.Asp928Val)	MYH7	not provided		Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	14	23424046	GRCh38	181379	179578
NM_000257.3(MYH7):c.2770G>A (p.Glu924Lys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, multiple submitters, no conflicts	14	23424059	GRCh38	14092	29131
NM_000257.3(MYH7):c.2769C>T (p.Asn923=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00038(A), GMAF:0.00060(A), GO-ESP:0.00069(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23424060	GRCh38	42931	52101
NM_000257.3(MYH7):c.2722C>G (p.Leu908Val)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, multiple submitters, no conflicts	14	23424107	GRCh38	14097	29136
NM_000257.3(MYH7):c.2681A>G (p.Glu894Gly)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Jul 28, 2016)	criteria provided, conflicting interpretations	14	23424148	GRCh38	42922	52092
NM_000257.3(MYH7):c.2666T>A (p.Leu889His)	MYH7	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 13, 2012)	criteria provided, single submitter	14	23424782	GRCh38	263460	258805
NM_000257.3(MYH7):c.2609G>A (p.Arg870His)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00001(T)	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2016)	criteria provided, multiple submitters, no conflicts	14	23424839	GRCh38	14120	29159
NM_000257.3(MYH7):c.2608C>T (p.Arg870Cys)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2016)	criteria provided, conflicting interpretations	14	23424840	GRCh38	161326	171163
NM_000257.3(MYH7):c.2602G>C (p.Ala868Pro)	MYH7	not specified		Uncertain significance(Last reviewed: Apr 8, 2016)	criteria provided, single submitter	14	23424846	GRCh38	177847	175470
NM_000257.3(MYH7):c.2578A>G (p.Lys860Glu)	MYH7	Familial hypertrophic cardiomyopathy 1		Uncertain significance(Last reviewed: Feb 25, 2015)	criteria provided, single submitter	14	23424870	GRCh38	192312	190102
NM_000257.3(MYH7):c.2539_2541delAAG (p.Lys847del)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2014)	criteria provided, conflicting interpretations	14	23424907 - 23424909	GRCh38	42913	52083
NM_000257.3(MYH7):c.2536G>C (p.Glu846Gln)	MYH7	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Jun 16, 2015)	criteria provided, conflicting interpretations	14	23424912	GRCh38	181194	179597
NM_000257.3(MYH7):c.2526T>C (p.Ser842=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(G), GO-ESP:0.00015(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23424922	GRCh38	181161	179598
NM_000257.3(MYH7):c.2508C>G (p.Ile836Met)	MYH7	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 25, 2015)	criteria provided, multiple submitters, no conflicts	14	23424940	GRCh38	235030	236800
NM_000257.3(MYH7):c.2360G>A (p.Arg787His)	MYH7	Myosin storage myopathy|Primary familial hypertrophic cardiomyopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00008(T), GMAF:0.00020(T), GO-ESP:0.00022(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	23425345	GRCh38	42900	52070
NM_000257.3(MYH7):c.2358G>T (p.Thr786=)	MYH7	not specified|Cardiovascular phenotype	GMAF:0.00120(T)	Benign/Likely benign(Last reviewed: Aug 31, 2015)	criteria provided, multiple submitters, no conflicts	14	23425347	GRCh38	164334	175477
NM_000257.3(MYH7):c.2345G>A (p.Ser782Asn)	MYH7	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	14	23425360	GRCh38	264539	258811
NM_000257.3(MYH7):c.2334C>G (p.Asp778Glu)	MYH7	not provided		Pathogenic(Last reviewed: Oct 9, 2016)	criteria provided, single submitter	14	23425371	GRCh38	265252	260053
NM_000257.3(MYH7):c.2334C>T (p.Asp778=)	MYH7	not specified|Cardiovascular phenotype	GO-ESP:0.00046(A), GO-ESP:0.00028(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2015)	criteria provided, conflicting interpretations	14	23425371	GRCh38	42894	52064
NM_000257.3(MYH7):c.2292C>G (p.Phe764Leu)	MYH7	Dilated cardiomyopathy 1S		Pathogenic(Last reviewed: Dec 7, 2000)	no assertion criteria provided	14	23425413	GRCh38	14109	29148
NM_000257.3(MYH7):c.2288T>G (p.Val763Gly)	MYH7	not provided		Pathogenic(Last reviewed: May 2, 2013)	criteria provided, single submitter	14	23425417	GRCh38	181179	179618
NM_000257.3(MYH7):c.2221G>A (p.Gly741Arg)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, multiple submitters, no conflicts	14	23425760	GRCh38	42890	52060
NM_000257.3(MYH7):c.2206A>G (p.Ile736Val)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|not provided	GO-ESP:0.00001(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2016)	criteria provided, conflicting interpretations	14	23425775	GRCh38	42889	52059
NM_000257.3(MYH7):c.2167C>G (p.Arg723Gly)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, multiple submitters, no conflicts	14	23425814	GRCh38	42885	52055
NM_000257.3(MYH7):c.2167C>T (p.Arg723Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	GO-ESP:0.00003(A)	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, multiple submitters, no conflicts	14	23425814	GRCh38	14095	29134
NM_000257.3(MYH7):c.2156G>A (p.Arg719Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	14	23425970	GRCh38	14107	29146
NM_000257.3(MYH7):c.2155C>T (p.Arg719Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic(Last reviewed: May 24, 2016)	criteria provided, multiple submitters, no conflicts	14	23425971	GRCh38	14104	29143
NM_000257.3(MYH7):c.2146G>A (p.Gly716Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy		Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2016)	criteria provided, conflicting interpretations	14	23425980	GRCh38	14105	29144
NM_000257.3(MYH7):c.2091T>C (p.Gly697=)	MYH7	not specified|Cardiovascular phenotype	GO-ESP:0.00012(G)	Likely benign(Last reviewed: Sep 10, 2015)	criteria provided, multiple submitters, no conflicts	14	23426035	GRCh38	177756	175484
NM_000257.3(MYH7):c.2081G>A (p.Arg694His)	MYH7	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 20, 2015)	criteria provided, single submitter	14	23426045	GRCh38	264068	258806
NM_000257.3(MYH7):c.1988G>A (p.Arg663His)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00008(T), GO-ESP:0.00002(T)	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, multiple submitters, no conflicts	14	23426833	GRCh38	42875	52045
NM_000257.3(MYH7):c.1876G>A (p.Gly626Arg)	MYH7	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	14	23427597	GRCh38	235027	236803
NM_000257.3(MYH7):c.1816G>A (p.Val606Met)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, multiple submitters, no conflicts	14	23427657	GRCh38	14091	29130
NM_000257.3(MYH7):c.1767C>T (p.Asn589=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01392(A), GMAF:0.01300(A), GO-ESP:0.00375(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23427706	GRCh38	42864	52034
NM_000257.3(MYH7):c.1753A>T (p.Ile585Phe)	MYH7	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	14	23427720	GRCh38	263549	258807
NM_000257.3(MYH7):c.1750G>A (p.Gly584Ser)	MYH7	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2016)	criteria provided, conflicting interpretations	14	23427723	GRCh38	42862	52032
NM_000257.3(MYH7):c.1727A>G (p.His576Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00001(C)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 23, 2016)	criteria provided, conflicting interpretations	14	23427746	GRCh38	177625	175490
NM_000257.3(MYH7):c.1681G>A (p.Ala561Thr)	MYH7	not provided|Cardiovascular phenotype	GO-ESP:0.00004(T)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2015)	criteria provided, conflicting interpretations	14	23427792	GRCh38	181352	179640
NM_000257.3(MYH7):c.1633G>A (p.Asp545Asn)	MYH7	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	14	23427840	GRCh38	264607	258810
NM_000257.3(MYH7):c.1605A>G (p.Glu535=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.03414(C), GMAF:0.03300(C), GO-ESP:0.01053(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23427868	GRCh38	42853	52023
NM_000257.3(MYH7):c.1594T>C (p.Ser532Pro)	MYH7	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S		Pathogenic(Last reviewed: Aug 21, 2014)	criteria provided, single submitter	14	23427879	GRCh38	14108	29147
NM_000257.3(MYH7):c.1491G>T (p.Glu497Asp)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2016)	criteria provided, conflicting interpretations	14	23428587	GRCh38	14124	29163
NM_000257.3(MYH7):c.1478T>A (p.Met493Lys)	MYH7	Familial hypertrophic cardiomyopathy 1		Likely pathogenic(Last reviewed: Dec 5, 2014)	criteria provided, single submitter	14	23428600	GRCh38	192308	190104
NM_000257.3(MYH7):c.1395C>G (p.Phe465Leu)	MYH7	Cardiovascular phenotype	GMAF:0.00060(A)	Uncertain significance(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	14	23428967	GRCh38	264231	258813
NM_000257.3(MYH7):c.1357C>A (p.Arg453Ser)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2013)	no assertion criteria provided	14	23429005	GRCh38	14129	29168
NM_000257.3(MYH7):c.1357C>T (p.Arg453Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, multiple submitters, no conflicts	14	23429005	GRCh38	14089	29128
NM_000257.3(MYH7):c.1334C>T (p.Ala445Val)	MYH7	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Dec 5, 2015)	criteria provided, single submitter	14	23429028	GRCh38	264593	258808
NM_000257.3(MYH7):c.1322C>T (p.Thr441Met)	MYH7	Myopathy, distal, 1|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00013(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2015)	criteria provided, conflicting interpretations	14	23429040	GRCh38	14122	29161
NM_000257.3(MYH7):c.1230C>T (p.Tyr410=)	MYH7	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00031(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2013)	criteria provided, conflicting interpretations	14	23429256	GRCh38	138392	142095
NM_000257.3(MYH7):c.1208G>T (p.Arg403Leu)	MYH7	Familial hypertrophic cardiomyopathy 1|not provided		Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	14	23429278	GRCh38	14101	29140
NM_000257.3(MYH7):c.1208G>A (p.Arg403Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, multiple submitters, no conflicts	14	23429278	GRCh38	14087	29126
NM_000257.3(MYH7):c.1128C>T (p.Asp376=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.18445(A), GMAF:0.15620(A), GO-ESP:0.09607(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23429785	GRCh38	42823	51993
NM_000257.3(MYH7):c.1106G>A (p.Arg369Gln)	MYH7	Cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, multiple submitters, no conflicts	14	23429807	GRCh38	42822	51992
NM_000257.3(MYH7):c.1095G>A (p.Lys365=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.14885(T), GMAF:0.07970(T), GO-ESP:0.11586(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23429818	GRCh38	42821	51991
NM_000257.3(MYH7):c.1062C>T (p.Gly354=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.06259(A), GMAF:0.06390(A), GO-ESP:0.07043(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23429851	GRCh38	42819	51989
NM_000257.3(MYH7):c.1051A>G (p.Lys351Glu)	MYH7	not specified|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2015)	criteria provided, conflicting interpretations	14	23429862	GRCh38	181335	179665
NM_000257.3(MYH7):c.1002C>T (p.Asn334=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01607(A), GMAF:0.01240(A), GO-ESP:0.00426(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23429911	GRCh38	42817	51987
NM_000257.3(MYH7):c.975C>T (p.Asp325=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02099(A), GMAF:0.01460(A), GO-ESP:0.02085(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23430584	GRCh38	43116	52286
NM_000257.3(MYH7):c.968T>C (p.Ile323Thr)	MYH7	not specified|Cardiovascular phenotype	GO-ESP:0.00008(G)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2016)	criteria provided, conflicting interpretations	14	23430591	GRCh38	43115	52285
NM_000257.3(MYH7):c.957C>T (p.Thr319=)	MYH7	not specified|Cardiovascular phenotype	GO-ESP:0.00008(A), GMAF:0.00040(A), GO-ESP:0.00013(A)	Likely benign(Last reviewed: Apr 5, 2016)	criteria provided, multiple submitters, no conflicts	14	23430602	GRCh38	43113	52283
NM_000257.3(MYH7):c.847T>G (p.Tyr283Asp)	MYH7	Left ventricular noncompaction 5		Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	14	23430949	GRCh38	66081	76983
NM_000257.3(MYH7):c.842G>C (p.Arg281Thr)	MYH7	Primary dilated cardiomyopathy|not provided		Pathogenic(Last reviewed: May 20, 2015)	criteria provided, multiple submitters, no conflicts	14	23430954	GRCh38	181327	179675
NM_000257.3(MYH7):c.746G>A (p.Arg249Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, multiple submitters, no conflicts	14	23431468	GRCh38	14088	29127
NM_000257.3(MYH7):c.732C>T (p.Phe244=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.28894(A), GMAF:0.26380(A), GO-ESP:0.18365(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23431585	GRCh38	43103	52273
NM_000257.3(MYH7):c.728G>A (p.Arg243His)	MYH7	Familial hypertrophic cardiomyopathy 1|Left ventricular noncompaction 5|not specified	GO-ESP:0.00001(T)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 13, 2015)	criteria provided, conflicting interpretations	14	23431589	GRCh38	14126	29165
NM_000257.3(MYH7):c.709C>T (p.Arg237Trp)	MYH7	Primary dilated cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2015)	criteria provided, conflicting interpretations	14	23431608	GRCh38	43098	52268
NM_000257.3(MYH7):c.689T>C (p.Phe230Ser)	MYH7	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 27, 2013)	criteria provided, single submitter	14	23431628	GRCh38	263543	258809
NM_000257.3(MYH7):c.619A>C (p.Lys207Gln)	MYH7	not specified|Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, multiple submitters, no conflicts	14	23431781	GRCh38	177674	175510
NM_000257.3(MYH7):c.597A>G (p.Ala199=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01076(C), GMAF:0.00580(C), GO-ESP:0.01092(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23431803	GRCh38	43092	52262
NM_000257.3(MYH7):c.556G>C (p.Val186Leu)	MYH7	Familial hypertrophic cardiomyopathy 1		Uncertain significance(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	14	23431844	GRCh38	192309	190105
NM_000257.3(MYH7):c.189C>T (p.Thr63=)	MYH7	Myosin storage myopathy|Laing distal myopathy|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.52753(A), GMAF:0.47960(G), GO-ESP:0.48885(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23433544	GRCh38	42869	52039
NM_182914.2(SYNE2):c.18632C>T (p.Thr6211Met)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	GO-ESP:0.00423(T), GMAF:0.00360(T), GO-ESP:0.00509(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	64210033	GRCh38	2324	17363
NM_000021.3(PSEN1):c.998A>G (p.Asp333Gly)	PSEN1	Primary dilated cardiomyopathy|Cardiomyopathy, dilated, 1u|Heart failure	GO-ESP:0.00015(G), GMAF:0.00040(G), GO-ESP:0.00012(G)	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2013)	criteria provided, single submitter	14	73211811	GRCh38	18156	33195
NM_003239.4(TGFB3):c.1122C>G (p.Ala374=)	TGFB3	Loeys-Dietz syndrome 4|Cardiovascular phenotype|Cardiomyopathy, ARVC	GMAF:0.01380(C), GO-ESP:0.00356(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	75959304	GRCh38	239516	241889
NM_003239.4(TGFB3):c.787G>C (p.Asp263His)	TGFB3	Loeys-Dietz syndrome 5		Pathogenic(Last reviewed: Apr 7, 2015)	no assertion criteria provided	14	75963455	GRCh38	203492	199892
NM_003239.4(TGFB3):c.744C>A (p.Ile248=)	TGFB3	Loeys-Dietz syndrome 4|Cardiovascular phenotype|Cardiomyopathy, ARVC	GMAF:0.00060(T), GO-ESP:0.00138(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	14	75965598	GRCh38	239522	241891
NM_003239.4(TGFB3):c.293C>T (p.Ser98Leu)	TGFB3	not provided|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00074(A)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2015)	criteria provided, conflicting interpretations	14	75980601	GRCh38	192131	189962
NM_000369.2(TSHR):c.1915C>T (p.Pro639Ser)	TSHR	Hyperthyroidism, nonautoimmune		Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	14	81143973	GRCh38	6454	21493
NM_006888.4(CALM1):c.293A>G (p.Asn98Ser)	CALM1	Ventricular tachycardia, catecholaminergic polymorphic, 1|Ventricular tachycardia, catecholaminergic polymorphic, 4		Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	14	90404386	GRCh38	39758	48357
NM_006888.4(CALM1):c.426C>G (p.Phe142Leu)	CALM1	Long QT syndrome 14	GMAF:0.00020(T)	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	14	90404693	GRCh38	183231	181364
NM_006329.3(FBLN5):c.1171G>T (p.Glu391Ter)	FBLN5	Autosomal recessive cutis laxa type IA		Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	14	91877501	GRCh38	21451	34303
GRCh38/hg38 14q31.1(chr14:80621095-80870127)x1	CEP128	See cases		Uncertain significance(Last reviewed: Jul 1, 2013)	no assertion criteria provided	14	80621095 - 80870127	GRCh38	155428	165182
GRCh38/hg38 14q32.33(chr14:106689633-106774412)x3	IGH|IGHV2-70|IGHV1-69-2|IGHV1-69|IGHV2-70D|IGHV1-69D	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	14	106689633 - 106774412	GRCh38	154405	164159
GRCh38/hg38 14q32.31-32.33(chr14:101665602-106855263)x1	AKT1|CKB|CRIP1|CRIP2|DYNC1H1|EIF5|BRF1|HSP90AA1|IGH|IGHA1|IGHA2|IGHD|IGHE|IGHG1|IGHG2|IGHG3|IGHG4|IGHM|JAG2|KLC1|MARK3|PPP2R5C|MOK|TNFAIP2|TRAF3|XRCC3|MTA1|BAG5|C14orf2|CDC42BPB|KIAA0125|TECPR2|SIVA1|RCOR1|PACS2|PPP1R13B|KIF26A|IGHV6-1|IGHV5-51|IGHV4-61|IGHV4-59|IGHV4-39|IGHV4-34|IGHV4-31|IGHV4-30-2|IGHV4-28|IGHV4-4|IGHV3-74|IGHV3-73|IGHV3-72|IGHV3-66|IGHV3-64|IGHV3-53|IGHV3-49|IGHV3-48|IGHV3-43|IGHV3-38|IGHV3-35|IGHV3-33|IGHV3-30|IGHV3-23|IGHV3-21|IGHV3-20|IGHV3-16|IGHV3-15|IGHV3-13|IGHV3-11|IGHV3-7|IGHV2-70|IGHV2-26|IGHV2-5|IGHV1-69-2|IGHV1-69|IGHV1-58|IGHV1-46|IGHV1-45|IGHV1-24|IGHV1-18|IGHV1-3|IGHV1-2|IGHJ6|IGHJ5|IGHJ4|IGHJ3|IGHJ2|IGHJ1|IGHD7-27|IGHD6-25|IGHD6-19|IGHD6-13|IGHD6-6|IGHD5-24|IGHD5-18|IGHD5-12|IGHD5-5|IGHD4-23|IGHD4-17|IGHD4-11|IGHD4-4|IGHD3-22|IGHD3-16|IGHD3-10|IGHD3-9|IGHD3-3|IGHD2-21|IGHD2-15|IGHD2-8|IGHD2-2|IGHD1-26|IGHD1-20|IGHD1-14|IGHD1-7|IGHD1-1|GPR132|CINP|CDCA4|ZNF839|INF2|ZFYVE21|TMEM121|AMN|APOPT1|BTBD6|EXOC3L4|WDR20|AHNAK2|TRMT61A|TDRD9|ANKRD9|C14orf79|PLD4|ADSSL1|LINC00239|LINC00637|LINC00638|NUDT14|CEP170B|C14orf80|C14orf99|LINC00226|LINC00221|ASPG|TMEM179|C14orf180|MIR203A|RD3L|TEX22|SNORA28|ZBTB42|LINC00605|TRI-AAT5-4|MIR4309|LOC100507437|MIR4507|MIR203B|MIR4538|MIR4710|MIR4539|MIR4537|MIR5195|LOC101929634|MIR6765|MIR8071-1|MIR8071-2|IGHV2-70D|IGHV1-69D|IGHV3-64D|LOC102723354|LINC00677|LOC105370687|LOC105370697|LOC105370708|LOC105378183	See cases		Pathogenic(Last reviewed: Nov 30, 2010)	no assertion criteria provided	14	101665602 - 106855263	GRCh38	154386	164140
GRCh38/hg38 14q13.3(chr14:36191711-37228500)x3	PAX9|NKX2-1|NKX2-8|MBIP|SLC25A21|MIPOL1|SFTA3|SLC25A21-AS1|NKX2-1-AS1|MIR4503	See cases		Pathogenic(Last reviewed: Jun 30, 2010)	no assertion criteria provided	14	36191711 - 37228500	GRCh38	154357	164111
GRCh38/hg38 14q21.1-21.2(chr14:40490718-43709934)x3	LRFN5|LOC644919	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	14	40490718 - 43709934	GRCh38	150156	159907
GRCh38/hg38 14q32.33(chr14:106704829-106774412)x1	IGH|IGHV2-70|IGHV1-69-2|IGHV1-69|IGHV2-70D|IGHV1-69D	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	14	106704829 - 106774412	GRCh38	144680	154431
GRCh38/hg38 14q32.33(chr14:106692695-106774412)x3	IGH|IGHV2-70|IGHV1-69-2|IGHV1-69|IGHV2-70D|IGHV1-69D	See cases		Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	14	106692695 - 106774412	GRCh38	144547	154298
NG_007553.1:g.12607C>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788120	GRCh38	315643	338516
NG_007553.1:g.12590C>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00020(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788137	GRCh38	315644	322265
NG_007553.1:g.12521C>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788206	GRCh38	315645	322269
NG_007553.1:g.12483G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788244	GRCh38	315646	340274
NG_007553.1:g.12405A>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.39260(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788322	GRCh38	315647	322277
NG_007553.1:g.12302G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788425	GRCh38	315648	340276
NG_007553.1:g.12208C>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00220(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788519	GRCh38	315649	338517
NG_007553.1:g.12112C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788615	GRCh38	315650	340279
NG_007553.1:g.12096C>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00060(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788631	GRCh38	315651	322278
NG_007553.1:g.12068G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788659	GRCh38	315652	331578
NG_007553.1:g.11997A>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.45370(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788730	GRCh38	315653	338520
NG_007553.1:g.11989C>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.01860(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788738	GRCh38	315654	322280
NG_007553.1:g.11828T>C	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00480(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788899	GRCh38	315655	338523
NG_007553.1:g.11817G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788910	GRCh38	315656	322281
NG_007553.1:g.11797G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788930	GRCh38	315657	331581
NG_007553.1:g.11786G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788941	GRCh38	315658	338524
NG_007553.1:g.11760C>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.23060(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34788967	GRCh38	315659	340281
NG_007553.1:g.11633T>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789094	GRCh38	315660	331583
NG_007553.1:g.11536A>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789191	GRCh38	315661	322282
NG_007553.1:g.11534C>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00340(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789193	GRCh38	315662	322283
NG_007553.1:g.11448G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789279	GRCh38	315663	331584
NG_007553.1:g.11430A>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789297	GRCh38	315664	322290
NG_007553.1:g.11405A>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789322	GRCh38	315665	338527
NG_007553.1:g.11385A>C	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789342	GRCh38	315666	338558
NG_007553.1:g.11377G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789350	GRCh38	315667	322292
NG_007553.1:g.11354G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.34410(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789373	GRCh38	315668	338564
NG_007553.1:g.11319A>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00480(C)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789408	GRCh38	315669	338580
NG_007553.1:g.11298C>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00040(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789429	GRCh38	315670	340282
NG_007553.1:g.11250G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789477	GRCh38	315671	331587
NG_007553.1:g.11233delA	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.14540(-)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789494	GRCh38	315672	338581
NG_007553.1:g.11190G>C	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.02280(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789537	GRCh38	315673	322294
NG_007553.1:g.11183T>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.01880(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789544	GRCh38	315674	322300
NG_007553.1:g.11180T>C	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789547	GRCh38	315675	331588
NG_007553.1:g.11161G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00960(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789566	GRCh38	315676	331590
NG_007553.1:g.11092C>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789635	GRCh38	315677	340298
NG_007553.1:g.11090C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789637	GRCh38	315678	340299
NG_007553.1:g.11072G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00460(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789655	GRCh38	315679	331592
NG_007553.1:g.11057C>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789670	GRCh38	315680	331593
NG_007553.1:g.11054G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789673	GRCh38	315681	331597
NG_007553.1:g.11052C>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789675	GRCh38	315682	340305
NG_007553.1:g.11023G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789704	GRCh38	315683	338582
NG_007553.1:g.10994C>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789733	GRCh38	315684	340306
NG_007553.1:g.10989C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789738	GRCh38	315685	340308
NG_007553.1:g.10961C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789766	GRCh38	315686	340311
NG_007553.1:g.10958C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789769	GRCh38	315687	338583
NG_007553.1:g.10934A>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789793	GRCh38	315688	338586
NG_007553.1:g.10876C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789851	GRCh38	315689	338588
NG_007553.1:g.10833A>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00500(C)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789894	GRCh38	315690	322301
NG_007553.1:g.10787T>C	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.11760(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789940	GRCh38	315691	340312
NG_007553.1:g.10737T>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34789990	GRCh38	315692	340314
NG_007553.1:g.10708G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34790019	GRCh38	315693	322304
NG_007553.1:g.10703G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.27860(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34790024	GRCh38	315694	338595
NG_007553.1:g.10622T>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34790105	GRCh38	315695	322305
NG_007553.1:g.10599G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34790128	GRCh38	315696	340316
NG_007553.1:g.10584C>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.02080(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34790143	GRCh38	315697	338606
NG_007553.1:g.10562G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34790165	GRCh38	315698	338608
NG_007553.1:g.10539G>C	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00020(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34790188	GRCh38	315699	340327
NG_007553.1:g.10355G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00022(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34790372	GRCh38	315700	322310
NG_007553.1:g.10350A>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34790377	GRCh38	315701	331602
NM_005159.4(ACTC1):c.*3T>C	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Dec 17, 2010)	criteria provided, single submitter	15	34790409	GRCh38	177944	176097
NM_005159.4(ACTC1):c.1124A>G (p.Lys375Arg)	ACTC1|LOC101928174	Primary familial hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	15	34790422	GRCh38	222483	224476
NM_005159.4(ACTC1):c.1112T>C (p.Ile371Thr)	ACTC1|LOC101928174	not provided|Cardiovascular phenotype	GO-ESP:0.00001(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 25, 2014)	criteria provided, conflicting interpretations	15	34790434	GRCh38	180774	179717
NM_005159.4(ACTC1):c.1092C>T (p.Tyr364=)	ACTC1|LOC101928174	not specified	GO-ESP:0.00008(A), GO-ESP:0.00004(A)	Likely benign(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	15	34790454	GRCh38	45171	54338
NM_005159.4(ACTC1):c.1088A>G (p.Glu363Gly)	ACTC1|LOC101928174	Dilated cardiomyopathy 1R		Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	15	34790458	GRCh38	18324	33363
NM_005159.4(ACTC1):c.1084C>T (p.Gln362Ter)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	15	34790462	GRCh38	228427	230557
NG_007553.1:g.10234G>C	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00020(G), GO-ESP:0.00004(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34790493	GRCh38	315702	322312
NM_005159.4(ACTC1):c.1053G>A (p.Leu351=)	ACTC1|LOC101928174	not specified	GMAF:0.00020(G)	Likely benign(Last reviewed: Apr 30, 2009)	criteria provided, single submitter	15	34790493	GRCh38	45170	54337
NM_005159.4(ACTC1):c.1039A>G (p.Ile347Val)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jul 14, 2014)	criteria provided, single submitter	15	34790507	GRCh38	179882	175954
NM_005159.4(ACTC1):c.998C>T (p.Ala333Val)	ACTC1|LOC101928174	not provided		Likely pathogenic(Last reviewed: Sep 4, 2012)	criteria provided, single submitter	15	34790548	GRCh38	180773	179718
NM_005159.4(ACTC1):c.997G>C (p.Ala333Pro)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	15	34790549	GRCh38	18329	33368
NM_005159.4(ACTC1):c.991A>T (p.Ile331Phe)	ACTC1|LOC101928174	Cardiomyopathy		Uncertain significance(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	15	34790555	GRCh38	180772	179719
NM_005159.4(ACTC1):c.986T>C (p.Ile329Thr)	ACTC1|LOC101928174	not provided		Likely pathogenic(Last reviewed: Jan 23, 2012)	criteria provided, single submitter	15	34791118	GRCh38	180778	179720
NG_007553.1:g.9601C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34791126	GRCh38	315703	331610
NM_005159.4(ACTC1):c.970C>T (p.Pro324Ser)	ACTC1|LOC101928174	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	15	34791134	GRCh38	263668	258812
NM_005159.4(ACTC1):c.968C>T (p.Ala323Val)	ACTC1|LOC101928174	not provided		Pathogenic(Last reviewed: Jan 26, 2014)	criteria provided, single submitter	15	34791136	GRCh38	180771	179721
NM_005159.4(ACTC1):c.952G>A (p.Glu318Lys)	ACTC1|LOC101928174	not provided		Likely pathogenic(Last reviewed: Oct 8, 2013)	criteria provided, single submitter	15	34791152	GRCh38	180770	179722
NM_005159.4(ACTC1):c.941G>A (p.Arg314His)	ACTC1|LOC101928174	Dilated cardiomyopathy 1R		Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	15	34791163	GRCh38	18323	33362
NM_005159.4(ACTC1):c.927T>C (p.Pro309=)	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.02593(G), GMAF:0.02860(G), GO-ESP:0.00983(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	34791177	GRCh38	45194	54361
NM_005159.4(ACTC1):c.918T>A (p.Thr306=)	ACTC1|LOC101928174	not specified		Likely benign(Last reviewed: Oct 7, 2008)	criteria provided, single submitter	15	34791186	GRCh38	45193	54360
NM_005159.4(ACTC1):c.903A>G (p.Leu301=)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5|not specified	GO-ESP:0.00008(C), GO-ESP:0.00002(C)	Likely benign(Last reviewed: Jan 21, 2016)	criteria provided, multiple submitters, no conflicts	15	34791201	GRCh38	45192	54359
NM_005159.4(ACTC1):c.894C>G (p.Asn298Lys)	ACTC1|LOC101928174	Dilated cardiomyopathy 1R		Pathogenic(Last reviewed: Nov 15, 2014)	no assertion criteria provided	15	34791210	GRCh38	217889	214543
NM_005159.4(ACTC1):c.889G>T (p.Ala297Ser)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Cardiomyopathy		Pathogenic(Last reviewed: Aug 20, 2013)	criteria provided, single submitter	15	34791215	GRCh38	18325	33364
NM_005159.4(ACTC1):c.886T>C (p.Tyr296His)	ACTC1|LOC101928174	not provided		Likely pathogenic(Last reviewed: Nov 20, 2013)	criteria provided, single submitter	15	34791218	GRCh38	180769	179723
NM_005159.4(ACTC1):c.886T>A (p.Tyr296Asn)	ACTC1|LOC101928174	Cardiomyopathy		Likely pathogenic(Last reviewed: Feb 19, 2014)	criteria provided, single submitter	15	34791218	GRCh38	180768	179724
NM_005159.4(ACTC1):c.866T>C (p.Ile289Thr)	ACTC1|LOC101928174	Cardiomyopathy|not provided		Likely pathogenic(Last reviewed: Sep 22, 2011)	criteria provided, multiple submitters, no conflicts	15	34791238	GRCh38	177886	176098
NM_005159.4(ACTC1):c.854T>C (p.Met285Thr)	ACTC1|LOC101928174	Primary familial hypertrophic cardiomyopathy|not specified		Uncertain significance(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	15	34791250	GRCh38	222482	224477
NM_005159.4(ACTC1):c.850A>T (p.Ile284Phe)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: May 15, 2014)	criteria provided, single submitter	15	34791254	GRCh38	45191	54358
NM_005159.4(ACTC1):c.812T>C (p.Met271Thr)	ACTC1|LOC101928174	not provided		Likely pathogenic(Last reviewed: Feb 20, 2014)	criteria provided, single submitter	15	34791292	GRCh38	180767	179725
NG_007553.1:g.9420_9421insGT	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34791306 - 34791307	GRCh38	315704	331619
NM_005159.4(ACTC1):c.809-12A>G	ACTC1|LOC101928174	not specified		Benign(Last reviewed: Aug 29, 2013)	criteria provided, single submitter	15	34791307	GRCh38	136281	139984
NG_007553.1:g.9416_9419dupTGTG	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34791308 - 34791311	GRCh38	315710	340328
NG_007553.1:g.9408_9419delTGTGTGTGTGTG	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34791308 - 34791319	GRCh38	315709	331630
NG_007553.1:g.9416_9419delTGTG	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.24480(-)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	34791308 - 34791311	GRCh38	315708	322319
NG_007553.1:g.9418_9419delTG	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34791308 - 34791309	GRCh38	315707	331628
NG_007553.1:g.9414_9419dupTGTGTG	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34791308 - 34791313	GRCh38	315706	340329
NG_007553.1:g.9418_9419dupTG	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34791308 - 34791309	GRCh38	315705	322315
NM_005159.4(ACTC1):c.808+3G>A	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jan 27, 2011)	criteria provided, single submitter	15	34792087	GRCh38	45189	54356
NM_005159.4(ACTC1):c.808+1G>C	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jul 9, 2012)	criteria provided, single submitter	15	34792089	GRCh38	180766	179726
NM_005159.4(ACTC1):c.806T>C (p.Ile269Thr)	ACTC1|LOC101928174	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Feb 11, 2014)	criteria provided, conflicting interpretations	15	34792092	GRCh38	45190	54357
NM_005159.4(ACTC1):c.798C>T (p.Pro266=)	ACTC1|LOC101928174	not specified		Likely benign(Last reviewed: Mar 1, 2008)	criteria provided, single submitter	15	34792100	GRCh38	45187	54354
NM_005159.4(ACTC1):c.793C>G (p.Gln265Glu)	ACTC1|LOC101928174	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Mar 4, 2015)	criteria provided, conflicting interpretations	15	34792105	GRCh38	177786	175955
NM_005159.4(ACTC1):c.769T>C (p.Phe257Leu)	ACTC1|LOC101928174	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 11, 2015)	criteria provided, multiple submitters, no conflicts	15	34792129	GRCh38	180765	179728
NM_005159.4(ACTC1):c.756T>G (p.Ile252Met)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jan 23, 2013)	no assertion criteria provided	15	34792142	GRCh38	162706	176099
NM_005159.4(ACTC1):c.755T>C (p.Ile252Thr)	ACTC1|LOC101928174	not provided		Pathogenic(Last reviewed: Aug 1, 2014)	criteria provided, single submitter	15	34792143	GRCh38	180763	179729
NM_005159.4(ACTC1):c.751A>G (p.Thr251Ala)	ACTC1|LOC101928174	Primary familial hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Oct 6, 2014)	no assertion criteria provided	15	34792147	GRCh38	180256	178687
NM_005159.4(ACTC1):c.739G>A (p.Gly247Ser)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Oct 22, 2014)	criteria provided, single submitter	15	34792159	GRCh38	180075	175956
NM_005159.4(ACTC1):c.700T>C (p.Ser234Pro)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Mar 15, 2014)	criteria provided, single submitter	15	34792198	GRCh38	180762	179730
NM_005159.4(ACTC1):c.695C>T (p.Ala232Val)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	15	34792203	GRCh38	180761	179731
NM_005159.4(ACTC1):c.635G>A (p.Arg212His)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	15	34792263	GRCh38	45186	54353
NM_005159.4(ACTC1):c.622C>T (p.Arg208Cys)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	15	34792276	GRCh38	179863	176100
NM_005159.4(ACTC1):c.616+8T>C	ACTC1|LOC101928174	not specified	GO-ESP:0.00001(G)	Likely benign(Last reviewed: Sep 17, 2010)	criteria provided, single submitter	15	34792400	GRCh38	45185	54352
NM_005159.4(ACTC1):c.616+1G>A	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Nov 3, 2010)	criteria provided, single submitter	15	34792407	GRCh38	45184	54351
NM_005159.4(ACTC1):c.602C>T (p.Ser201Phe)	ACTC1|LOC101928174	Primary dilated cardiomyopathy		Uncertain significance(Last reviewed: Jul 16, 2014)	no assertion criteria provided	15	34792422	GRCh38	180255	178688
NM_005159.4(ACTC1):c.579G>T (p.Lys193Asn)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	15	34792445	GRCh38	180760	179732
NM_005159.4(ACTC1):c.563C>T (p.Thr188Ile)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	15	34792461	GRCh38	180759	179733
NM_005159.4(ACTC1):c.553C>T (p.Arg185Trp)	ACTC1|LOC101928174	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: May 20, 2010)	criteria provided, single submitter	15	34792471	GRCh38	45183	54350
NM_005159.4(ACTC1):c.541G>C (p.Asp181His)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Oct 11, 2012)	criteria provided, single submitter	15	34792483	GRCh38	180758	179734
NG_007553.1:g.8240T>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34792487	GRCh38	315711	340332
NM_005159.4(ACTC1):c.529A>G (p.Ile177Val)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jul 5, 2014)	no assertion criteria provided	15	34792495	GRCh38	180757	179735
NM_005159.4(ACTC1):c.523dupC (p.His175Profs)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Aug 6, 2013)	criteria provided, single submitter	15	34792501	GRCh38	180754	179736
NM_005159.4(ACTC1):c.516T>C (p.Ala172=)	ACTC1|LOC101928174	not specified		Likely benign(Last reviewed: Apr 16, 2010)	criteria provided, single submitter	15	34792508	GRCh38	45182	54349
NM_005159.4(ACTC1):c.514G>A (p.Ala172Thr)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Dec 28, 2011)	no assertion criteria provided	15	34792510	GRCh38	234976	236809
NM_005159.4(ACTC1):c.513C>T (p.Tyr171=)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5|not specified	GO-ESP:0.00062(A), GO-ESP:0.00007(A)	Benign/Likely benign(Last reviewed: Dec 29, 2015)	criteria provided, multiple submitters, no conflicts	15	34792511	GRCh38	45181	54348
NM_005159.4(ACTC1):c.500T>C (p.Ile167Thr)	ACTC1|LOC101928174	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jul 24, 2013)	criteria provided, conflicting interpretations	15	34792524	GRCh38	180776	179737
NM_005159.4(ACTC1):c.496C>G (p.Pro166Ala)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	15	34792528	GRCh38	18330	33369
NM_005159.4(ACTC1):c.477T>G (p.Asp159Glu)	ACTC1|LOC101928174	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	15	34792547	GRCh38	264401	258814
NM_005159.4(ACTC1):c.475G>A (p.Asp159Asn)	ACTC1|LOC101928174	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jul 9, 2014)	criteria provided, conflicting interpretations	15	34792549	GRCh38	45180	54347
NM_005159.4(ACTC1):c.465G>A (p.Leu155=)	ACTC1|LOC101928174	not specified	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Sep 2, 2010)	criteria provided, single submitter	15	34792559	GRCh38	45179	54346
NM_005159.4(ACTC1):c.456C>T (p.Gly152=)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	15	34792568	GRCh38	240100	242030
NM_005159.4(ACTC1):c.454+9G>A	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5|not specified	GO-ESP:0.00231(T), GMAF:0.00400(T), GO-ESP:0.00082(T)	Benign(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	15	34793236	GRCh38	45178	54345
NM_005159.4(ACTC1):c.383C>T (p.Thr128Ile)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jan 23, 2013)	no assertion criteria provided	15	34793316	GRCh38	177748	175957
NM_005159.4(ACTC1):c.373A>G (p.Met125Val)	ACTC1|LOC101928174	Atrial septal defect 5		Pathogenic(Last reviewed: Jan 15, 2008)	no assertion criteria provided	15	34793326	GRCh38	18327	33366
NM_005159.4(ACTC1):c.372C>G (p.Ile124Met)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jan 22, 2013)	criteria provided, single submitter	15	34793327	GRCh38	45177	54344
NM_005159.4(ACTC1):c.355G>C (p.Glu119Gln)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	15	34793344	GRCh38	45176	54343
NM_005159.4(ACTC1):c.342C>T (p.Pro114=)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5		Likely benign(Last reviewed: Jan 9, 2016)	criteria provided, single submitter	15	34793357	GRCh38	240099	242031
NM_005159.4(ACTC1):c.333G>A (p.Pro111=)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5|Cardiovascular phenotype	GO-ESP:0.00006(T)	Likely benign(Last reviewed: Nov 25, 2015)	criteria provided, multiple submitters, no conflicts	15	34793366	GRCh38	220307	222416
NM_005159.4(ACTC1):c.310C>T (p.Pro104Ser)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	15	34793389	GRCh38	45175	54342
NM_005159.4(ACTC1):c.301G>A (p.Glu101Lys)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Primary familial hypertrophic cardiomyopathy|Left ventricular noncompaction 4|not provided	GO-ESP:0.00001(T)	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2016)	criteria provided, multiple submitters, no conflicts	15	34793398	GRCh38	18331	33370
NM_005159.4(ACTC1):c.299C>T (p.Pro100Leu)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	15	34793400	GRCh38	234748	231921
NM_005159.4(ACTC1):c.294G>A (p.Val98=)	ACTC1|LOC101928174	not specified	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Sep 18, 2009)	criteria provided, single submitter	15	34793405	GRCh38	45174	54341
NM_005159.4(ACTC1):c.281A>G (p.Asn94Ser)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11	GO-ESP:0.00001(C)	Likely pathogenic	criteria provided, single submitter	15	34793418	GRCh38	217487	214137
NM_005159.4(ACTC1):c.275_277delTCT (p.Phe92del)	ACTC1|LOC101928174	not provided		Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2014)	criteria provided, single submitter	15	34793422 - 34793424	GRCh38	180753	179738
NM_005159.4(ACTC1):c.272C>A (p.Thr91Asn)	ACTC1|LOC101928174	Primary familial hypertrophic cardiomyopathy		Likely benign(Last reviewed: Sep 17, 2014)	no assertion criteria provided	15	34793427	GRCh38	180254	178689
NM_005159.4(ACTC1):c.270C>T (p.His90=)	ACTC1|LOC101928174	not specified	GO-ESP:0.00003(A)	Benign(Last reviewed: Mar 16, 2014)	criteria provided, single submitter	15	34793429	GRCh38	136280	139983
NM_005159.4(ACTC1):c.268C>T (p.His90Tyr)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|not specified	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 19, 2016)	criteria provided, conflicting interpretations	15	34793431	GRCh38	18326	33365
NM_005159.4(ACTC1):c.214_230del17 (p.Pro72Hisfs)	ACTC1|LOC101928174	Atrial septal defect 5		Pathogenic(Last reviewed: Jan 15, 2008)	no assertion criteria provided	15	34793469 - 34793485	GRCh38	18328	33367
NM_005159.4(ACTC1):c.229A>G (p.Ile77Val)	ACTC1|LOC101928174	not specified	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Dec 27, 2011)	criteria provided, single submitter	15	34793470	GRCh38	45173	54340
NM_005159.4(ACTC1):c.219C>T (p.Ile73=)	ACTC1|LOC101928174	not specified	GO-ESP:0.00008(A), GMAF:0.00020(A), GO-ESP:0.00011(A)	Likely benign(Last reviewed: Jun 3, 2009)	criteria provided, single submitter	15	34793480	GRCh38	45172	54339
NM_005159.4(ACTC1):c.217A>G (p.Ile73Val)	ACTC1|LOC101928174	not specified	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	15	34793482	GRCh38	228429	230558
NM_005159.4(ACTC1):c.191G>A (p.Arg64Lys)	ACTC1|LOC101928174	Left ventricular noncompaction cardiomyopathy		Uncertain significance(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	15	34793508	GRCh38	222481	224478
NM_005159.4(ACTC1):c.188A>G (p.Lys63Arg)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Feb 19, 2015)	criteria provided, single submitter	15	34793511	GRCh38	196406	193567
NM_005159.4(ACTC1):c.186delC (p.Ser62Argfs)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	15	34793513	GRCh38	228428	230559
NM_005159.4(ACTC1):c.165C>T (p.Tyr55=)	ACTC1|LOC101928174	not specified	GO-ESP:0.00008(A)	Likely benign(Last reviewed: Mar 19, 2012)	criteria provided, single submitter	15	34793534	GRCh38	162708	176101
NM_005159.4(ACTC1):c.161C>T (p.Ser54Phe)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	15	34793538	GRCh38	180756	179739
NM_005159.4(ACTC1):c.129+32C>A	ACTC1|LOC101928174	not specified	GMAF:0.00920(T), GO-ESP:0.00315(T)	Benign	criteria provided, single submitter	15	34794648	GRCh38	259653	255155
NM_005159.4(ACTC1):c.129+23dupC	ACTC1|LOC101928174	Primary familial hypertrophic cardiomyopathy|not specified	GMAF:0.02980(GGGGG)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2011)	criteria provided, conflicting interpretations	15	34794657	GRCh38	35646	44311
NM_005159.4(ACTC1):c.129+19_129+20insT	ACTC1|LOC101928174	Primary familial hypertrophic cardiomyopathy	GO-ESP:0.00154(A)	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	15	34794660 - 34794661	GRCh38	35645	44310
NM_005159.4(ACTC1):c.129+17delG	ACTC1|LOC101928174	Cardiomyopathy		Benign(Last reviewed: Dec 27, 2012)	criteria provided, single submitter	15	34794663	GRCh38	180749	179740
NM_005159.4(ACTC1):c.129G>A (p.Gln43=)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5		Uncertain significance(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	15	34794680	GRCh38	240098	242032
NM_005159.4(ACTC1):c.83C>T (p.Ala28Val)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, multiple submitters, no conflicts	15	34794726	GRCh38	50937	65598
NM_005159.4(ACTC1):c.76G>A (p.Asp26Asn)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Dec 23, 2014)	criteria provided, multiple submitters, no conflicts	15	34794733	GRCh38	177917	175958
NM_005159.4(ACTC1):c.67T>C (p.Phe23Leu)	ACTC1|LOC101928174	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	15	34794742	GRCh38	35647	44312
NM_005159.4(ACTC1):c.28C>A (p.Leu10Met)	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	34794781	GRCh38	50936	65597
NM_005159.4(ACTC1):c.22A>G (p.Thr8Ala)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Mar 12, 2012)	criteria provided, single submitter	15	34794787	GRCh38	180755	179742
NM_005159.4(ACTC1):c.10G>C (p.Asp4His)	ACTC1|LOC101928174	not provided		Likely pathogenic(Last reviewed: Nov 2, 2011)	criteria provided, single submitter	15	34794799	GRCh38	180775	179743
NM_005159.4(ACTC1):c.7G>C (p.Asp3His)	ACTC1|LOC101928174	not specified		Uncertain significance(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	15	34794802	GRCh38	45188	54355
NM_005159.4(ACTC1):c.-22-15C>G	ACTC1|LOC101928174	not specified	GO-ESP:0.00038(C), GMAF:0.00020(C), GO-ESP:0.00009(C)	Benign/Likely benign(Last reviewed: Sep 22, 2014)	criteria provided, multiple submitters, no conflicts	15	34794845	GRCh38	45169	54336
NG_007553.1:g.5236G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00220(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795491	GRCh38	315712	340333
NG_007553.1:g.5208C>G	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795519	GRCh38	315713	338610
NG_007553.1:g.5192_5194dupCCG	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795533 - 34795535	GRCh38	315714	338614
NG_007553.1:g.5189C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795538	GRCh38	315715	338623
NG_007553.1:g.5187T>C	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.08250(G)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795540	GRCh38	315716	331634
NG_007553.1:g.5165G>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795562	GRCh38	315717	331640
NG_007553.1:g.5143G>T	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795584	GRCh38	315718	331646
NG_007553.1:g.5139C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795588	GRCh38	315719	322320
NG_007553.1:g.5135C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795592	GRCh38	315720	340336
NG_007553.1:g.5069C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795658	GRCh38	315721	340337
NG_007553.1:g.5050C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795677	GRCh38	315722	322321
NG_007553.1:g.5016C>A	ACTC1|LOC101928174	Atrial septal defect|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	GMAF:0.00100(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	34795711	GRCh38	315723	331647
NM_002399.3(MEIS2):c.959_961delGAA (p.Arg320del)	MEIS2	not provided		Uncertain significance(Last reviewed: Apr 6, 2016)	no assertion criteria provided	15	36896664 - 36896666	GRCh38	224962	226843
NM_019074.3(DLL4):c.1660C>T (p.Gln554Ter)	DLL4	Adams-Oliver syndrome|Adams-Oliver syndrome 6		Pathogenic(Last reviewed: Aug 19, 2015)	criteria provided, single submitter	15	40936647	GRCh38	204368	200769
NM_016013.3(NDUFAF1):c.619A>C (p.Thr207Pro)	NDUFAF1	Mitochondrial complex I deficiency		Pathogenic(Last reviewed: Jul 11, 2007)	no assertion criteria provided	15	41394999	GRCh38	30622	39579
NM_000138.4(FBN1):c.8502T>C (p.Thr2834=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00239(G), GMAF:0.00060(G), GO-ESP:0.00100(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48411104	GRCh38	36132	44796
NM_000138.4(FBN1):c.8488C>T (p.Gln2830Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Sep 24, 2012)	criteria provided, single submitter	15	48411118	GRCh38	263414	258815
NM_000138.4(FBN1):c.8433G>A (p.Gly2811=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	15	48411173	GRCh38	263910	258818
NM_000138.4(FBN1):c.8385C>T (p.Ile2795=)	FBN1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00054(A), GMAF:0.00040(A), GO-ESP:0.00012(A)	Likely benign(Last reviewed: Aug 28, 2012)	criteria provided, multiple submitters, no conflicts	15	48411221	GRCh38	42444	51614
NM_000138.4(FBN1):c.8363C>T (p.Thr2788Met)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|Geleophysic dysplasia|Ectopia lentis	GMAF:0.00060(A), GO-ESP:0.00011(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48411243	GRCh38	263832	258816
NM_000138.4(FBN1):c.8326C>T (p.Arg2776Ter)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	15	48411280	GRCh38	16439	31478
NM_000138.4(FBN1):c.8311G>A (p.Val2771Ile)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Feb 10, 2014)	criteria provided, multiple submitters, no conflicts	15	48411295	GRCh38	36129	44793
NM_000138.4(FBN1):c.8189G>A (p.Arg2730Gln)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: May 25, 2015)	criteria provided, single submitter	15	48412606	GRCh38	264033	258827
NM_000138.4(FBN1):c.8176C>T (p.Arg2726Trp)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00108(A), GMAF:0.00020(A), GO-ESP:0.00073(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2016)	criteria provided, conflicting interpretations	15	48412619	GRCh38	16445	31484
NM_000138.4(FBN1):c.8149G>T (p.Glu2717Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T)	Pathogenic(Last reviewed: Nov 8, 2012)	criteria provided, single submitter	15	48412646	GRCh38	263433	258819
NM_000138.4(FBN1):c.8130C>T (p.Leu2710=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	15	48412665	GRCh38	264444	258824
NM_000138.4(FBN1):c.8099C>T (p.Pro2700Leu)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 27, 2012)	criteria provided, single submitter	15	48412696	GRCh38	263390	258817
NM_000138.4(FBN1):c.8080C>G (p.Arg2694Gly)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	15	48412715	GRCh38	263562	258828
NM_000138.4(FBN1):c.8038C>T (p.Arg2680Cys)	FBN1	Thoracic aortic aneurysm and aortic dissection|not provided		Likely pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, multiple submitters, no conflicts	15	48415549	GRCh38	200127	197585
NM_000138.4(FBN1):c.8006G>T (p.Gly2669Val)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Jun 4, 2013)	criteria provided, single submitter	15	48415581	GRCh38	263642	258821
NM_000138.4(FBN1):c.7949A>G (p.Asn2650Ser)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Jul 25, 2013)	criteria provided, single submitter	15	48415638	GRCh38	263693	258825
NM_000138.4(FBN1):c.7939C>T (p.Gln2647Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: May 28, 2013)	criteria provided, single submitter	15	48415648	GRCh38	263644	258820
NM_000138.4(FBN1):c.7902C>T (p.Pro2634=)	FBN1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(A), GO-ESP:0.00021(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 31, 2016)	criteria provided, conflicting interpretations	15	48415685	GRCh38	263699	258829
NM_000138.4(FBN1):c.7881G>A (p.Gly2627=)	FBN1	Thoracic aortic aneurysm and aortic dissection|not specified		Likely benign(Last reviewed: Nov 20, 2014)	criteria provided, multiple submitters, no conflicts	15	48415706	GRCh38	42435	51605
NM_000138.4(FBN1):c.7879G>A (p.Gly2627Arg)	FBN1	Marfan syndrome		Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	15	48415708	GRCh38	36122	44786
NM_000138.4(FBN1):c.7852G>A (p.Gly2618Arg)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00015(T), GMAF:0.00020(T), GO-ESP:0.00025(T)	Uncertain significance(Last reviewed: Apr 5, 2016)	criteria provided, multiple submitters, no conflicts	15	48415735	GRCh38	42434	51604
NM_000138.4(FBN1):c.7828G>A (p.Glu2610Lys)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	15	48415759	GRCh38	264272	258823
NM_000138.4(FBN1):c.7820-3C>A	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 21, 2012)	criteria provided, single submitter	15	48415770	GRCh38	263432	258826
NM_000138.4(FBN1):c.7792C>T (p.Gln2598Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	15	48420714	GRCh38	263920	258822
NM_000138.4(FBN1):c.7754T>C (p.Ile2585Thr)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, multiple submitters, no conflicts	15	48420752	GRCh38	163462	175979
NM_000138.4(FBN1):c.7726C>T (p.Arg2576Cys)	FBN1	Marfan syndrome|Marfan syndrome, autosomal recessive	GO-ESP:0.00001(A)	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2015)	no assertion criteria provided	15	48420780	GRCh38	36118	44782
NM_000138.4(FBN1):c.7708G>A (p.Glu2570Lys)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	15	48420798	GRCh38	263398	258830
NM_000138.4(FBN1):c.7540G>A (p.Gly2514Arg)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2015)	criteria provided, conflicting interpretations	15	48421982	GRCh38	178034	176123
NM_000138.4(FBN1):c.7530A>G (p.Lys2510=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(C)	Likely benign(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	15	48421992	GRCh38	263330	258831
NM_000138.4(FBN1):c.7497A>G (p.Leu2499=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GMAF:0.00180(C), GO-ESP:0.00075(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48422025	GRCh38	137313	141016
NM_000138.4(FBN1):c.7363T>C (p.Cys2455Arg)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	15	48425459	GRCh38	263805	258834
NM_000138.4(FBN1):c.7167_7168delCT (p.Cys2390Serfs)	FBN1	Marfan syndrome|not provided		Pathogenic(Last reviewed: Mar 12, 2014)	criteria provided, multiple submitters, no conflicts	15	48427603 - 48427604	GRCh38	42420	51590
NM_000138.4(FBN1):c.7113G>T (p.Trp2371Cys)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	15	48427658	GRCh38	264152	258835
NM_000138.4(FBN1):c.7098C>T (p.Asp2366=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GMAF:0.00080(A), GO-ESP:0.00189(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48427673	GRCh38	199952	197615
NM_000138.4(FBN1):c.7092_7093delCT (p.Cys2364Trpfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Sep 22, 2014)	criteria provided, single submitter	15	48427678 - 48427679	GRCh38	263859	258832
NM_000138.4(FBN1):c.7071C>T (p.Pro2357=)	FBN1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Jun 9, 2015)	criteria provided, multiple submitters, no conflicts	15	48427700	GRCh38	42417	51587
NM_000138.4(FBN1):c.7067A>G (p.Asn2356Ser)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jan 30, 2015)	criteria provided, single submitter	15	48427704	GRCh38	263901	258833
NM_000138.4(FBN1):c.7056C>T (p.Ser2352=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00007(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	48427715	GRCh38	263431	258836
NM_000138.4(FBN1):c.6991T>A (p.Cys2331Ser)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jul 8, 2013)	criteria provided, single submitter	15	48428352	GRCh38	263688	258841
NM_000138.4(FBN1):c.6942C>T (p.Tyr2314=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	15	48428401	GRCh38	263695	258837
NM_000138.4(FBN1):c.6932G>A (p.Arg2311His)	FBN1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2014)	criteria provided, conflicting interpretations	15	48428411	GRCh38	200197	197622
NM_000138.4(FBN1):c.6904T>A (p.Cys2302Ser)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 16, 2015)	criteria provided, single submitter	15	48428439	GRCh38	264235	258839
NM_000138.4(FBN1):c.6888G>A (p.Gln2296=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.02633(T), GMAF:0.05090(T), GO-ESP:0.02964(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48428455	GRCh38	42413	51583
NM_000138.4(FBN1):c.6884G>A (p.Cys2295Tyr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jul 14, 2014)	criteria provided, single submitter	15	48428459	GRCh38	263849	258845
NM_000138.4(FBN1):c.6855T>C (p.Asp2285=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.02633(G), GMAF:0.05110(G), GO-ESP:0.02966(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48430687	GRCh38	42412	51582
NM_000138.4(FBN1):c.6832C>T (p.Pro2278Ser)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.01193(A), GMAF:0.01360(A), GO-ESP:0.00335(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48430710	GRCh38	36108	44772
NM_000138.4(FBN1):c.6806T>C (p.Ile2269Thr)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, multiple submitters, no conflicts	15	48430736	GRCh38	36107	44771
NM_000138.4(FBN1):c.6773G>A (p.Cys2258Tyr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	15	48430769	GRCh38	264106	258848
NM_000138.4(FBN1):c.6707A>G (p.Tyr2236Cys)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	15	48432898	GRCh38	264354	258838
NM_000138.4(FBN1):c.6700G>A (p.Val2234Met)	FBN1	Marfan syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00062(T), GMAF:0.00020(T), GO-ESP:0.00079(T)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 15, 2016)	criteria provided, conflicting interpretations	15	48432905	GRCh38	36104	44768
NM_000138.4(FBN1):c.6681A>C (p.Ser2227=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00100(G), GMAF:0.00080(G), GO-ESP:0.00112(G)	Benign/Likely benign(Last reviewed: Jul 7, 2016)	criteria provided, multiple submitters, no conflicts	15	48432924	GRCh38	42408	51578
NM_000138.4(FBN1):c.6611G>A (p.Cys2204Tyr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	15	48434599	GRCh38	264438	258840
NM_000138.4(FBN1):c.6594C>T (p.Pro2198=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00531(A), GMAF:0.00200(A), GO-ESP:0.00289(A)	Benign/Likely benign(Last reviewed: Jul 12, 2016)	criteria provided, multiple submitters, no conflicts	15	48434616	GRCh38	36103	44767
NM_000138.4(FBN1):c.6583G>A (p.Gly2195Arg)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Feb 26, 2015)	criteria provided, single submitter	15	48434627	GRCh38	263922	258847
NM_000138.4(FBN1):c.6492T>A (p.Cys2164Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Sep 29, 2014)	criteria provided, single submitter	15	48436965	GRCh38	263864	258850
NM_000138.4(FBN1):c.6448C>T (p.Arg2150Cys)	FBN1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(A), GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Nov 18, 2015)	criteria provided, multiple submitters, no conflicts	15	48437009	GRCh38	200084	197644
NM_000138.4(FBN1):c.6431A>G (p.Asn2144Ser)	FBN1	Marfan syndrome		Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	15	48437026	GRCh38	16431	31470
NM_000138.4(FBN1):c.6430A>C (p.Asn2144His)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: May 7, 2014)	criteria provided, single submitter	15	48437027	GRCh38	263837	258843
NM_000138.4(FBN1):c.6393C>T (p.Cys2131=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GMAF:0.00700(A), GO-ESP:0.00154(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48437064	GRCh38	137311	141014
NM_000138.4(FBN1):c.6388G>A (p.Glu2130Lys)	FBN1	not provided		Pathogenic(Last reviewed: Sep 23, 2014)	criteria provided, single submitter	15	48437069	GRCh38	200191	197650
NM_000138.4(FBN1):c.6354C>T (p.Ile2118=)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection		Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2014)	criteria provided, multiple submitters, no conflicts	15	48437347	GRCh38	16449	31488
NM_000138.4(FBN1):c.6302C>T (p.Thr2101Met)	FBN1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00060(A), GO-ESP:0.00020(A)	Uncertain significance(Last reviewed: Dec 29, 2015)	criteria provided, single submitter	15	48437779	GRCh38	264000	258842
NM_000138.4(FBN1):c.6169C>T (p.Arg2057Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: May 13, 2016)	criteria provided, multiple submitters, no conflicts	15	48437912	GRCh38	200076	197655
NM_000138.4(FBN1):c.6129G>C (p.Gly2043=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Likely benign(Last reviewed: Dec 10, 2012)	criteria provided, single submitter	15	48441755	GRCh38	263463	258849
NM_000138.4(FBN1):c.6080G>T (p.Gly2027Val)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	15	48441804	GRCh38	263865	258852
NM_000138.4(FBN1):c.6068T>C (p.Ile2023Thr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 5, 2014)	criteria provided, single submitter	15	48441816	GRCh38	263823	258844
NM_000138.4(FBN1):c.6032G>A (p.Cys2011Tyr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 19, 2015)	criteria provided, single submitter	15	48444546	GRCh38	263898	258846
NM_000138.4(FBN1):c.6025G>A (p.Glu2009Lys)	FBN1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Nov 20, 2014)	criteria provided, multiple submitters, no conflicts	15	48444553	GRCh38	200190	197661
NM_000138.4(FBN1):c.5921T>C (p.Ile1974Thr)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Nov 14, 2015)	criteria provided, single submitter	15	48444657	GRCh38	264487	258851
NM_000138.4(FBN1):c.5825G>C (p.Cys1942Ser)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	15	48445468	GRCh38	263804	258853
NM_000138.4(FBN1):c.5789-2A>G	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Sep 7, 2012)	criteria provided, single submitter	15	48445506	GRCh38	263403	258858
NM_000138.4(FBN1):c.5776_5778delAAT (p.Asn1926del)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	15	48446716 - 48446718	GRCh38	263883	258857
NM_000138.4(FBN1):c.5726T>C (p.Ile1909Thr)	FBN1	Thoracic aortic aneurysm and aortic dissection|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2015)	criteria provided, conflicting interpretations	15	48446768	GRCh38	200189	197672
NM_000138.4(FBN1):c.5725A>C (p.Ile1909Leu)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 27, 2012)	criteria provided, single submitter	15	48446769	GRCh38	263396	258855
NM_000138.4(FBN1):c.5720delA (p.Asn1907Thrfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Oct 1, 2014)	criteria provided, single submitter	15	48446774	GRCh38	263866	258854
NM_000138.4(FBN1):c.5699G>A (p.Cys1900Tyr)	FBN1	not provided		Pathogenic(Last reviewed: Aug 14, 2014)	criteria provided, single submitter	15	48446795	GRCh38	200066	197674
NM_000138.4(FBN1):c.5619T>G (p.Tyr1873Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	15	48448820	GRCh38	263340	258860
NM_000138.4(FBN1):c.5536delC (p.Gln1846Serfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	15	48452571	GRCh38	264473	258861
NM_000138.4(FBN1):c.5372G>A (p.Cys1791Tyr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	15	48456687	GRCh38	263568	258859
NM_000138.4(FBN1):c.5368C>T (p.Arg1790Ter)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Jun 12, 2014)	criteria provided, multiple submitters, no conflicts	15	48456691	GRCh38	42382	51552
NM_000138.4(FBN1):c.5343G>A (p.Val1781=)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)	GO-ESP:0.00678(T), GMAF:0.00260(T), GO-ESP:0.00484(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48456716	GRCh38	42381	51551
NM_000138.4(FBN1):c.5301T>C (p.Ile1767=)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Oct 2, 2012)	criteria provided, single submitter	15	48456758	GRCh38	263415	258856
NM_000138.4(FBN1):c.5155T>C (p.Cys1719Arg)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	15	48463151	GRCh38	263524	258862
NM_000138.4(FBN1):c.5142G>A (p.Met1714Ile)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2016)	criteria provided, conflicting interpretations	15	48463164	GRCh38	237096	242066
NM_000138.4(FBN1):c.5087A>G (p.Tyr1696Cys)	FBN1	Geleophysic dysplasia 2		Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	15	48463219	GRCh38	29699	38654
NM_000138.4(FBN1):c.5067_5073delTATGAGA (p.Asp1689Glufs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Dec 19, 2012)	criteria provided, single submitter	15	48463233 - 48463239	GRCh38	263488	258863
NM_000138.4(FBN1):c.4985C>A (p.Thr1662Lys)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 27, 2013)	criteria provided, single submitter	15	48463979	GRCh38	263788	258867
NM_000138.4(FBN1):c.4956delT (p.Cys1652Trpfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	15	48464008	GRCh38	263927	258864
NM_000138.4(FBN1):c.4951G>A (p.Glu1651Lys)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	15	48464013	GRCh38	264424	258874
NM_000138.4(FBN1):c.4935G>A (p.Val1645=)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Aug 1, 2013)	criteria provided, single submitter	15	48465575	GRCh38	263692	258865
NM_000138.4(FBN1):c.4930C>T (p.Arg1644Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection|not provided	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Sep 15, 2015)	criteria provided, multiple submitters, no conflicts	15	48465580	GRCh38	200186	197685
NM_000138.4(FBN1):c.4905C>T (p.Thr1635=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00200(C)	Likely benign(Last reviewed: Nov 19, 2014)	criteria provided, single submitter	15	48465605	GRCh38	263869	258869
NM_000138.4(FBN1):c.4905C>G (p.Thr1635=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00531(C), GMAF:0.00200(C), GO-ESP:0.00290(C)	Benign/Likely benign(Last reviewed: Jul 12, 2016)	criteria provided, multiple submitters, no conflicts	15	48465605	GRCh38	36084	44748
NM_000138.4(FBN1):c.4750G>A (p.Glu1584Lys)	FBN1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00008(T), GMAF:0.00100(T), GO-ESP:0.00017(T)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 25, 2014)	criteria provided, conflicting interpretations	15	48465856	GRCh38	42370	51540
NM_000138.4(FBN1):c.4615C>T (p.Arg1539Ter)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Oct 6, 2016)	criteria provided, multiple submitters, no conflicts	15	48468070	GRCh38	42366	51536
NM_000138.4(FBN1):c.4588C>T (p.Arg1530Cys)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Aortic aneurysm, ascending, and dissection		Pathogenic(Last reviewed: Jul 9, 2015)	criteria provided, multiple submitters, no conflicts	15	48468097	GRCh38	36078	44742
NM_000138.4(FBN1):c.4577G>A (p.Cys1526Tyr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	15	48468417	GRCh38	264314	258870
NM_000138.4(FBN1):c.4562delC (p.Pro1521Glnfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jun 1, 2015)	criteria provided, single submitter	15	48468432	GRCh38	264077	258876
NM_000138.4(FBN1):c.4460-8G>A	FBN1	Marfan syndrome		Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, multiple submitters, no conflicts	15	48468542	GRCh38	36075	44739
NM_000138.4(FBN1):c.4412_4415delAGTG (p.Glu1471Valfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	15	48470678 - 48470681	GRCh38	263556	258866
NM_000138.4(FBN1):c.4337-3A>C	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Nov 19, 2014)	criteria provided, single submitter	15	48470759	GRCh38	263868	258871
NM_000138.4(FBN1):c.4331G>A (p.Cys1444Tyr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	15	48472556	GRCh38	263831	258873
NM_000138.4(FBN1):c.4316C>T (p.Ala1439Val)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	15	48472571	GRCh38	264533	258877
NM_000138.4(FBN1):c.4270C>G (p.Pro1424Ala)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)	GO-ESP:0.00031(C), GO-ESP:0.00018(C)	Uncertain significance(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48472617	GRCh38	42355	51525
NM_000138.4(FBN1):c.4209A>G (p.Thr1403=)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Nov 21, 2013)	criteria provided, single submitter	15	48474256	GRCh38	263806	258868
NM_000138.4(FBN1):c.4135_4141delGACTGCA (p.Asp1379Argfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	15	48474324 - 48474330	GRCh38	263907	258872
NM_000138.4(FBN1):c.4096G>C (p.Glu1366Gln)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Likely pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, single submitter	15	48474369	GRCh38	263872	258875
NM_000138.4(FBN1):c.4096G>A (p.Glu1366Lys)	FBN1	not provided		Likely pathogenic(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	15	48474369	GRCh38	200036	197710
NM_000138.4(FBN1):c.4087+1G>A	FBN1	Marfan syndrome, neonatal		Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	15	48474527	GRCh38	16442	31481
NM_000138.4(FBN1):c.4007A>G (p.His1336Arg)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	15	48474608	GRCh38	263388	258880
NM_000138.4(FBN1):c.3965-2A>T	FBN1	Marfan syndrome, neonatal		Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	15	48474652	GRCh38	16441	31480
NM_000138.4(FBN1):c.3964+1G>A	FBN1	not provided		Pathogenic(Last reviewed: Mar 30, 2014)	criteria provided, single submitter	15	48481654	GRCh38	200028	197716
NM_000138.4(FBN1):c.3962C>T (p.Thr1321Ile)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	15	48481657	GRCh38	263875	258878
NM_000138.4(FBN1):c.3936C>T (p.Ser1312=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00019(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48481683	GRCh38	237089	242072
NM_000138.4(FBN1):c.3765_3767delAAAinsCTGTAC (p.Asn1256delinsCysThr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	15	48483889 - 48483891	GRCh38	264549	258879
NM_000138.4(FBN1):c.3746G>C (p.Cys1249Ser)	FBN1	Marfan syndrome		Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	15	48483910	GRCh38	16425	31464
NM_000138.4(FBN1):c.3689T>C (p.Met1230Thr)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Oct 23, 2013)	criteria provided, single submitter	15	48485397	GRCh38	263789	258890
NM_000138.4(FBN1):c.3675G>A (p.Pro1225=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00377(T), GMAF:0.00460(T), GO-ESP:0.00112(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48485411	GRCh38	36071	44735
NM_000138.4(FBN1):c.3669T>A (p.Cys1223Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Dec 25, 2015)	criteria provided, single submitter	15	48485417	GRCh38	264578	258881
NM_000138.4(FBN1):c.3668G>A (p.Cys1223Tyr)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Nov 9, 2012)	criteria provided, single submitter	15	48485418	GRCh38	16444	31483
NM_000138.4(FBN1):c.3662G>A (p.Cys1221Tyr)	FBN1	Marfan syndrome		Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	15	48485424	GRCh38	16464	31503
NM_000138.4(FBN1):c.3584G>A (p.Cys1195Tyr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	15	48487080	GRCh38	263427	258882
NM_000138.4(FBN1):c.3509G>A (p.Arg1170His)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Marfan syndrome, subdiagnostic variant of|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Marfanoid habitus|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00192(T), GMAF:0.00080(T), GO-ESP:0.00117(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	48487155	GRCh38	16451	31490
NM_000138.4(FBN1):c.3503A>G (p.Asn1168Ser)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00005(C)	Uncertain significance(Last reviewed: Mar 27, 2015)	criteria provided, single submitter	15	48487161	GRCh38	263998	258883
NM_000138.4(FBN1):c.3464-5G>A	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GMAF:0.19650(T), GO-ESP:0.17090(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48487205	GRCh38	137305	141008
NM_000138.4(FBN1):c.3463+3A>G	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00008(C), GMAF:0.01080(C), GO-ESP:0.00311(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48487309	GRCh38	42337	51507
NM_000138.4(FBN1):c.3457T>C (p.Cys1153Arg)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Jun 25, 2013)	criteria provided, single submitter	15	48487318	GRCh38	263660	258891
NM_000138.4(FBN1):c.3442C>G (p.Pro1148Ala)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|FNB1 POLYMORPHISM	GO-ESP:0.00362(C), GMAF:0.05970(C), GO-ESP:0.02880(C)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48487333	GRCh38	36065	44729
NM_000138.4(FBN1):c.3422C>T (p.Pro1141Leu)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00108(A), GMAF:0.00040(A), GO-ESP:0.00073(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	48487353	GRCh38	42334	51504
NM_000138.4(FBN1):c.3379G>A (p.Gly1127Ser)	FBN1	Marfan syndrome|Marfan syndrome, mild		Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2015)	no assertion criteria provided	15	48487396	GRCh38	16443	31482
NM_000138.4(FBN1):c.3344A>G (p.Asp1115Gly)	FBN1	Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic/Likely pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, multiple submitters, no conflicts	15	48487431	GRCh38	200015	197735
NM_000138.4(FBN1):c.3294C>T (p.Asp1098=)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	GO-ESP:0.00547(A), GMAF:0.00220(A), GO-ESP:0.00797(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48488156	GRCh38	42330	51500
NM_000138.4(FBN1):c.3217G>A (p.Glu1073Lys)	FBN1	Marfan syndrome|Marfan syndrome, neonatal|not provided		Pathogenic(Last reviewed: Nov 30, 2015)	criteria provided, multiple submitters, no conflicts	15	48488233	GRCh38	16457	31496
NM_000138.4(FBN1):c.3209-1G>C	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Sep 22, 2014)	criteria provided, single submitter	15	48488242	GRCh38	263860	258884
NM_000138.4(FBN1):c.3197G>C (p.Arg1066Thr)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	15	48488379	GRCh38	263470	258885
NM_000138.4(FBN1):c.3172G>A (p.Gly1058Ser)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	15	48488404	GRCh38	264619	258886
NM_000138.4(FBN1):c.3159C>A (p.Cys1053Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	15	48488417	GRCh38	264131	258892
NM_000138.4(FBN1):c.3128A>G (p.Lys1043Arg)	FBN1	Marfan syndrome, neonatal	GO-ESP:0.00002(C)	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	15	48488448	GRCh38	16446	31485
NM_000138.4(FBN1):c.3123C>G (p.His1041Gln)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	15	48488453	GRCh38	264289	258888
NM_000138.4(FBN1):c.3095G>A (p.Cys1032Tyr)	FBN1	Marfan syndrome, neonatal		Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	15	48488481	GRCh38	16462	31501
NM_000138.4(FBN1):c.3089A>G (p.Asn1030Ser)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|Geleophysic dysplasia|Ectopia lentis	GMAF:0.00100(C), GO-ESP:0.00028(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	48488487	GRCh38	263632	258887
NM_000138.4(FBN1):c.3082+1G>C	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	15	48489850	GRCh38	263975	258889
NM_000138.4(FBN1):c.3058A>G (p.Thr1020Ala)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)	GO-ESP:0.00023(C), GMAF:0.00060(C), GO-ESP:0.00046(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2016)	criteria provided, conflicting interpretations	15	48489875	GRCh38	42325	51495
NM_000138.4(FBN1):c.3043G>A (p.Ala1015Thr)	FBN1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	15	48489890	GRCh38	225356	227370
NM_000138.4(FBN1):c.2956G>A (p.Ala986Thr)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00131(T), GMAF:0.00020(T), GO-ESP:0.00151(T)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 15, 2016)	criteria provided, conflicting interpretations	15	48489977	GRCh38	36060	44724
NM_000138.4(FBN1):c.2954G>A (p.Gly985Glu)	FBN1	Marfan syndrome, atypical		Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	15	48489979	GRCh38	16453	31492
NM_000138.4(FBN1):c.2953G>A (p.Gly985Arg)	FBN1	Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, multiple submitters, no conflicts	15	48489980	GRCh38	200008	197742
NM_000138.4(FBN1):c.2934C>G (p.Asp978Glu)	FBN1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00120(C), GO-ESP:0.00042(C)	Uncertain significance(Last reviewed: Mar 2, 2016)	criteria provided, multiple submitters, no conflicts	15	48489999	GRCh38	199947	197743
NM_000138.4(FBN1):c.2906delT (p.Leu969Argfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	15	48490027	GRCh38	264427	258893
NM_000138.4(FBN1):c.2883G>A (p.Arg961=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00001(T)	Likely benign(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	15	48490050	GRCh38	264117	258894
NM_000138.4(FBN1):c.2882G>A (p.Arg961Lys)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 24, 2015)	criteria provided, single submitter	15	48490051	GRCh38	264248	258895
NM_000138.4(FBN1):c.2861G>A (p.Arg954His)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2015)	criteria provided, conflicting interpretations	15	48490072	GRCh38	200005	197746
NM_000138.4(FBN1):c.2728+2T>C	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Jul 26, 2013)	criteria provided, single submitter	15	48494202	GRCh38	263694	258896
NM_000138.4(FBN1):c.2725delG (p.Glu909Lysfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Nov 5, 2012)	criteria provided, single submitter	15	48494207	GRCh38	263434	258897
NM_000138.4(FBN1):c.2639G>A (p.Gly880Asp)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	15	48495161	GRCh38	263855	258898
NM_000138.4(FBN1):c.2624G>A (p.Cys875Tyr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: May 27, 2015)	criteria provided, single submitter	15	48495176	GRCh38	264089	258899
NM_000138.4(FBN1):c.2524A>T (p.Lys842Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: May 2, 2014)	criteria provided, single submitter	15	48495484	GRCh38	263834	258900
NM_000138.4(FBN1):c.2433C>A (p.Cys811Ter)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection		Pathogenic/Likely pathogenic(Last reviewed: May 29, 2014)	criteria provided, multiple submitters, no conflicts	15	48495575	GRCh38	36049	44713
NM_000138.4(FBN1):c.2375G>T (p.Cys792Phe)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	15	48496144	GRCh38	263937	258901
NM_000138.4(FBN1):c.2343T>C (p.Cys781=)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Oct 1, 2012)	criteria provided, single submitter	15	48496176	GRCh38	263418	258902
NM_000138.4(FBN1):c.2339A>T (p.Gln780Leu)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	15	48496180	GRCh38	264139	258904
NM_000138.4(FBN1):c.2227delC (p.Arg743Valfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	15	48497332	GRCh38	263335	258903
NM_000138.4(FBN1):c.2201G>A (p.Cys734Tyr)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	15	48497358	GRCh38	263790	258906
NM_000138.4(FBN1):c.2175T>C (p.Asn725=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00039(G), GMAF:0.00040(G), GO-ESP:0.00028(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48497384	GRCh38	42298	51468
NM_000138.4(FBN1):c.2127_2130delACTCins11 (p.?)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jan 6, 2015)	criteria provided, single submitter	15	48499022 - 48499025	GRCh38	263918	258908
NM_000138.4(FBN1):c.2127A>C (p.Ala709=)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	15	48499025	GRCh38	263959	258905
NM_000138.4(FBN1):c.2094G>T (p.Pro698=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00012(A)	Likely benign(Last reviewed: Nov 27, 2015)	criteria provided, single submitter	15	48503806	GRCh38	264529	258909
NM_000138.4(FBN1):c.2093C>T (p.Pro698Leu)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	15	48503807	GRCh38	264197	258907
NM_000138.4(FBN1):c.1908A>G (p.Arg636=)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	15	48505077	GRCh38	264230	258910
NM_000138.4(FBN1):c.1876G>A (p.Gly626Arg)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	15	48505109	GRCh38	263953	258912
NM_000138.4(FBN1):c.1875T>C (p.Asn625=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.24442(G), GMAF:0.29690(G), GO-ESP:0.20059(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48505110	GRCh38	42297	51467
NM_000138.4(FBN1):c.1807C>T (p.Gln603Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	15	48508612	GRCh38	263880	258920
NM_000138.4(FBN1):c.1746C>T (p.Cys582=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00531(A), GMAF:0.00200(A), GO-ESP:0.00292(A)	Benign/Likely benign(Last reviewed: Jul 12, 2016)	criteria provided, multiple submitters, no conflicts	15	48508673	GRCh38	36041	44705
NM_000138.4(FBN1):c.1693C>T (p.Arg565Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, multiple submitters, no conflicts	15	48510065	GRCh38	199975	197789
NM_000138.4(FBN1):c.1571delC (p.Thr524Serfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Dec 14, 2012)	criteria provided, single submitter	15	48513566	GRCh38	263469	258914
NM_000138.4(FBN1):c.1546C>T (p.Arg516Ter)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, multiple submitters, no conflicts	15	48513591	GRCh38	42285	51455
NM_000138.4(FBN1):c.1530G>T (p.Ser510=)	FBN1	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	15	48513607	GRCh38	263696	258911
NM_000138.4(FBN1):c.1468+5G>A	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	15	48515382	GRCh38	42284	51454
NM_000138.4(FBN1):c.1285C>T (p.Arg429Ter)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Sep 19, 2016)	criteria provided, multiple submitters, no conflicts	15	48516225	GRCh38	180351	178700
NM_000138.4(FBN1):c.1211dupC (p.Pro405Thrfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: May 2, 2013)	criteria provided, single submitter	15	48516299	GRCh38	263585	258913
NM_000138.4(FBN1):c.1195C>G (p.Pro399Ala)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	15	48516315	GRCh38	264435	258922
NM_000138.4(FBN1):c.1191dupG (p.Arg398Glufs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Feb 16, 2015)	criteria provided, single submitter	15	48516319	GRCh38	263912	258916
NM_000138.4(FBN1):c.1167C>T (p.Cys389=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Oct 3, 2015)	criteria provided, single submitter	15	48516343	GRCh38	264430	258915
NM_000138.4(FBN1):c.1158C>G (p.Asn386Lys)	FBN1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(C), GO-ESP:0.00007(C)	Likely benign(Last reviewed: Apr 20, 2016)	criteria provided, single submitter	15	48516352	GRCh38	263638	258919
NM_000138.4(FBN1):c.1129T>C (p.Cys377Arg)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	15	48520677	GRCh38	264158	258929
NM_000138.4(FBN1):c.1029G>A (p.Gly343=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GMAF:0.00840(T), GO-ESP:0.00195(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48520777	GRCh38	137299	141002
NM_000138.4(FBN1):c.986T>C (p.Ile329Thr)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.00793(G), GMAF:0.00820(G), GO-ESP:0.00229(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48526132	GRCh38	36133	44797
NM_000138.4(FBN1):c.902G>T (p.Gly301Val)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GMAF:0.00020(A), GO-ESP:0.00017(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	48526216	GRCh38	199960	197811
NM_000138.4(FBN1):c.841_842insT (p.Glu281Valfs)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	15	48534100 - 48534101	GRCh38	264076	258918
NM_000138.4(FBN1):c.783T>C (p.Asn261=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GMAF:0.00060(G), GO-ESP:0.00086(G)	Benign/Likely benign(Last reviewed: Jul 7, 2016)	criteria provided, multiple submitters, no conflicts	15	48534159	GRCh38	237105	242082
NM_000138.4(FBN1):c.762C>T (p.Pro254=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00004(A)	Likely benign(Last reviewed: Aug 16, 2015)	criteria provided, single submitter	15	48534180	GRCh38	264227	258917
NM_000138.4(FBN1):c.643C>T (p.Arg215Ter)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, multiple submitters, no conflicts	15	48537704	GRCh38	42401	51571
NM_000138.4(FBN1):c.526C>T (p.Gln176Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Feb 1, 2013)	criteria provided, single submitter	15	48596295	GRCh38	263325	258921
NM_000138.4(FBN1):c.492T>C (p.Asn164=)	FBN1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(G)	Likely benign(Last reviewed: Mar 23, 2015)	criteria provided, single submitter	15	48596329	GRCh38	263939	258930
NM_000138.4(FBN1):c.439C>T (p.Gln147Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	15	48600142	GRCh38	264081	258925
NM_000138.4(FBN1):c.412A>C (p.Lys138Gln)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 19, 2014)	criteria provided, single submitter	15	48600169	GRCh38	263825	258923
NM_000138.4(FBN1):c.364C>T (p.Arg122Cys)	FBN1	Marfan syndrome|Marfan syndrome, atypical|not provided		Pathogenic(Last reviewed: May 20, 2014)	criteria provided, multiple submitters, no conflicts	15	48600217	GRCh38	16440	31479
NM_000138.4(FBN1):c.306C>T (p.Cys102=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Geleophysic dysplasia|Ectopia lentis	GMAF:0.00080(A), GO-ESP:0.00409(A)	Benign/Likely benign(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	15	48610768	GRCh38	137314	141017
NM_000138.4(FBN1):c.287G>C (p.Arg96Thr)	FBN1	Thoracic aortic aneurysm and aortic dissection|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jul 29, 2014)	criteria provided, conflicting interpretations	15	48610787	GRCh38	200142	197822
NM_000138.4(FBN1):c.156G>T (p.Ala52=)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GO-ESP:0.07693(A), GMAF:0.07010(A), GO-ESP:0.02077(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48644614	GRCh38	42287	51457
NM_000138.4(FBN1):c.149A>T (p.His50Leu)	FBN1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	15	48644621	GRCh38	264355	258924
NM_000138.4(FBN1):c.79G>A (p.Ala27Thr)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Geleophysic dysplasia|Ectopia lentis	GMAF:0.00120(T), GO-ESP:0.00044(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	48644691	GRCh38	163486	175991
NM_000138.4(FBN1):c.7C>T (p.Arg3Ter)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Oct 2, 2012)	criteria provided, single submitter	15	48644763	GRCh38	263416	258931
NM_000138.4(FBN1):c.3G>T (p.Met1Ile)	FBN1	Thoracic aortic aneurysm and aortic dissection		Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	15	48644767	GRCh38	264175	258926
NM_006578.3(GNB5):c.994C>T (p.Arg332Ter)	GNB5	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	15	52124529	GRCh38	268099	263625
NM_006578.3(GNB5):c.906C>G (p.Tyr302Ter)	GNB5	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	GO-ESP:0.00001(C)	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	15	52124617	GRCh38	268102	263628
NM_006578.3(GNB5):c.249+3A>G	GNB5	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA		Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	15	52153937	GRCh38	268101	263627
NM_006578.3(GNB5):c.249+1G>T	GNB5	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA		Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	15	52153939	GRCh38	268100	263626
NM_006578.3(GNB5):c.249G>A (p.Gln83=)	GNB5	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA		Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	15	52153940	GRCh38	268098	263624
NM_006578.3(GNB5):c.242C>T (p.Ser81Leu)	GNB5	Delayed speech and language development|Global developmental delay|Attention deficit hyperactivity disorder|LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA	GO-ESP:0.00005(A)	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	15	52153947	GRCh38	254029	248477
NM_001018005.1(TPM1):c.27G>A (p.Gln9=)	TPM1	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00006(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	63042856	GRCh38	43410	52580
NM_001018005.1(TPM1):c.62G>T (p.Arg21Leu)	TPM1	Familial hypertrophic cardiomyopathy 3|not specified|Cardiovascular phenotype	GO-ESP:0.00001(T)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 29, 2015)	criteria provided, conflicting interpretations	15	63042891	GRCh38	181678	179749
NM_001018005.1(TPM1):c.115-275A>T	TPM1	not specified		Uncertain significance(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	15	63043752	GRCh38	181659	179751
NM_001018005.1(TPM1):c.118G>A (p.Glu40Lys)	TPM1	Dilated cardiomyopathy 1Y		Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	15	63044030	GRCh38	12459	27498
NM_001018005.1(TPM1):c.160G>A (p.Glu54Lys)	TPM1	Dilated cardiomyopathy 1Y|not provided		Pathogenic(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	15	63044072	GRCh38	12458	27497
NM_001018005.1(TPM1):c.180C>T (p.Tyr60=)	TPM1	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00292(T), GMAF:0.00260(T), GO-ESP:0.00088(T)	Benign/Likely benign(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	15	63044092	GRCh38	43405	52575
NM_001018005.1(TPM1):c.188C>T (p.Ala63Val)	TPM1	not provided|Hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	15	63044100	GRCh38	31877	40537
NM_001018005.1(TPM1):c.250G>A (p.Asp84Asn)	TPM1	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	15	63056994	GRCh38	264474	258928
NM_001018005.1(TPM1):c.453C>A (p.Ala151=)	TPM1	not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.63571(A), GMAF:0.29430(C)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	63059641	GRCh38	31888	40548
NM_001018005.1(TPM1):c.486T>C (p.Tyr162=)	TPM1	not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	GO-ESP:0.05090(C), GMAF:0.02420(C), GO-ESP:0.05331(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	63059674	GRCh38	31889	40549
NM_001018005.1(TPM1):c.515T>C (p.Ile172Thr)	TPM1	Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00001(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jun 1, 2014)	criteria provided, conflicting interpretations	15	63060891	GRCh38	31879	40539
NM_001018005.1(TPM1):c.523G>A (p.Asp175Asn)	TPM1	Familial hypertrophic cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, multiple submitters, no conflicts	15	63060899	GRCh38	12456	27495
NM_001018005.1(TPM1):c.524A>G (p.Asp175Gly)	TPM1	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 12, 2015)	criteria provided, single submitter	15	63060900	GRCh38	264053	258927
NM_001018005.1(TPM1):c.555C>T (p.Leu185=)	TPM1	Cardiovascular phenotype	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Feb 26, 2013)	criteria provided, single submitter	15	63060931	GRCh38	263544	258932
NM_001018005.1(TPM1):c.560A>T (p.Glu187Val)	TPM1	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, multiple submitters, no conflicts	15	63060936	GRCh38	188697	186522
NM_001018005.1(TPM1):c.742A>G (p.Lys248Glu)	TPM1	not provided|Left ventricular noncompaction 9		Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	15	63062615	GRCh38	31901	40561
NM_139242.3(MTFMT):c.626C>T (p.Ser209Leu)	MTFMT	Leigh syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Combined oxidative phosphorylation deficiency 15|not provided	GO-ESP:0.00075(A), GO-ESP:0.00036(A)	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, multiple submitters, no conflicts	15	65021533	GRCh38	39827	48426
NG_008305.1:g.5015C>T	MAP2K1	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66386887	GRCh38	316829	323106
NG_008305.1:g.5020C>G	MAP2K1	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66386892	GRCh38	316830	341098
NG_008305.1:g.5028C>T	MAP2K1	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00480(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66386900	GRCh38	316831	323117
NG_008305.1:g.5068G>T	MAP2K1	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00600(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66386940	GRCh38	316832	341099
NG_008305.1:g.5071T>G	MAP2K1	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66386943	GRCh38	316833	339712
NG_008305.1:g.5256C>T	MAP2K1	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66387128	GRCh38	316835	341104
NG_008305.1:g.5260_5261dupCG	MAP2K1	Noonan syndrome|Cardio-facio-cutaneous syndrome		Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66387132 - 66387133	GRCh38	316834	332754
NM_002755.3(MAP2K1):c.-85G>C	MAP2K1	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.16370(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66387263	GRCh38	40704	49174
NM_002755.3(MAP2K1):c.-31dupC	MAP2K1	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome		Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	66387317	GRCh38	40710	49180
NM_002755.3(MAP2K1):c.-2A>G	MAP2K1	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GO-ESP:0.00378(G), GMAF:0.01320(G), GO-ESP:0.01471(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	66387346	GRCh38	40738	49208
NM_002755.3(MAP2K1):c.124C>T (p.Leu42Phe)	MAP2K1	Cardio-facio-cutaneous syndrome		Likely pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	15	66435070	GRCh38	44587	53754
NM_002755.3(MAP2K1):c.158T>C (p.Phe53Ser)	MAP2K1	not provided|Cardiofaciocutaneous syndrome 3		Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	15	66435104	GRCh38	13350	28389
NM_002755.3(MAP2K1):c.169A>C (p.Lys57Gln)	MAP2K1	Rasopathy|Cardio-facio-cutaneous syndrome		Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2015)	criteria provided, conflicting interpretations	15	66435115	GRCh38	40779	49249
NM_002755.3(MAP2K1):c.171G>T (p.Lys57Asn)	MAP2K1	Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	15	66435117	GRCh38	223140	224866
NM_002755.3(MAP2K1):c.199G>A (p.Asp67Asn)	MAP2K1	not provided|Rasopathy|Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	15	66435145	GRCh38	40781	49251
NM_002755.3(MAP2K1):c.355C>T (p.His119Tyr)	MAP2K1	Rasopathy		Pathogenic(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	15	66436809	GRCh38	40741	49211
NM_002755.3(MAP2K1):c.371C>T (p.Pro124Leu)	MAP2K1	Cardio-facio-cutaneous syndrome		Likely pathogenic(Last reviewed: Sep 2, 2010)	criteria provided, single submitter	15	66436825	GRCh38	40744	49214
NM_002755.3(MAP2K1):c.383_384delGCinsTT (p.Gly128Val)	MAP2K1	Rasopathy		Pathogenic(Last reviewed: Nov 4, 2012)	criteria provided, single submitter	15	66436837 - 66436838	GRCh38	40745	49215
NM_002755.3(MAP2K1):c.383G>T (p.Gly128Val)	MAP2K1	not provided|Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Jul 21, 2015)	criteria provided, multiple submitters, no conflicts	15	66436837	GRCh38	13352	28391
NM_002755.3(MAP2K1):c.388T>C (p.Tyr130His)	MAP2K1	Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 7, 2012)	criteria provided, single submitter	15	66436842	GRCh38	40747	49217
NM_002755.3(MAP2K1):c.389A>G (p.Tyr130Cys)	MAP2K1	not provided|Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: May 19, 2016)	criteria provided, multiple submitters, no conflicts	15	66436843	GRCh38	13351	28390
NG_008305.1:g.61472A>G	MAP2K1	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66443344	GRCh38	316836	341106
NM_002755.3(MAP2K1):c.657G>C (p.Met219Ile)	MAP2K1	not specified		Uncertain significance(Last reviewed: Apr 22, 2012)	criteria provided, single submitter	15	66481843	GRCh38	40752	49222
NM_002755.3(MAP2K1):c.694-8_694-7dupTC	MAP2K1	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GMAF:0.01680(TC)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	66484982 - 66484983	GRCh38	94082	99984
NM_002755.3(MAP2K1):c.927A>T (p.Ala309=)	MAP2K1	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GMAF:0.00500(T), GO-ESP:0.00132(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	66487259	GRCh38	40758	49228
NM_002755.3(MAP2K1):c.1023-8C>T	MAP2K1	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GO-ESP:0.09177(T), GMAF:0.08930(T), GO-ESP:0.08434(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	66489710	GRCh38	40760	49230
NM_002755.3(MAP2K1):c.1068+9A>G	MAP2K1	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GO-ESP:0.00019(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	66489772	GRCh38	180895	179789
NM_002755.3(MAP2K1):c.1068+12_1068+15delTATT	MAP2K1	Noonan syndrome|not specified|Rasopathy|Cardio-facio-cutaneous syndrome	GMAF:0.00120(-), GO-ESP:0.00201(-)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	66489775 - 66489778	GRCh38	44586	53753
NG_008305.1:g.108618C>A	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66490490	GRCh38	316837	339717
NG_008305.1:g.108691C>T	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66490563	GRCh38	316838	339723
NM_002755.3(MAP2K1):c.1137C>T (p.Ile379=)	MAP2K1|SNAPC5	Noonan syndrome|not specified|Cardio-facio-cutaneous syndrome	GO-ESP:0.00092(T), GMAF:0.00140(T), GO-ESP:0.00039(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	66490570	GRCh38	40762	49232
NG_008305.1:g.108891_108892delTT	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome	GO-ESP:0.00008(-)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66490763 - 66490764	GRCh38	316839	332756
NG_008305.1:g.108988G>A	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66490860	GRCh38	316840	323119
NG_008305.1:g.109051C>A	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.18310(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66490923	GRCh38	316841	332760
NG_008305.1:g.109168G>T	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.01720(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66491040	GRCh38	316842	339726
NG_008305.1:g.109357G>T	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66491229	GRCh38	316843	323120
NG_008305.1:g.109358G>T	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66491230	GRCh38	316844	323121
NG_008305.1:g.109400G>A	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.03610(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66491272	GRCh38	316845	341107
NG_008305.1:g.109523T>C	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66491395	GRCh38	316846	341111
NG_008305.1:g.109633A>G	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00080(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66491505	GRCh38	316847	332762
NG_008305.1:g.109640T>C	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome	GMAF:0.00080(C)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66491512	GRCh38	316848	332765
NG_008305.1:g.109660delA	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66491532	GRCh38	316850	323126
NG_008305.1:g.109660dupA	MAP2K1|SNAPC5	Noonan syndrome|Cardio-facio-cutaneous syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	66491532	GRCh38	316849	323128
NM_005585.4(SMAD6):c.1244C>T (p.Pro415Leu)	SMAD6	Aortic valve disease 2		Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	15	66781288	GRCh38	37112	45782
NM_005585.4(SMAD6):c.1451G>T (p.Cys484Phe)	SMAD6	Aortic valve disease 2		Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	15	66781495	GRCh38	37111	45781
NM_005902.3(SMAD3):c.9C>T (p.Ser3=)	SMAD3	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(T)	Likely benign(Last reviewed: Jan 27, 2014)	criteria provided, single submitter	15	67066163	GRCh38	263814	258933
NM_005902.3(SMAD3):c.48G>A (p.Leu16=)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Dec 13, 2015)	criteria provided, single submitter	15	67066202	GRCh38	264624	258934
NM_005902.3(SMAD3):c.66G>A (p.Glu22=)	SMAD3	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00240(A), GO-ESP:0.00156(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	67066220	GRCh38	213757	210245
NM_005902.3(SMAD3):c.269G>A (p.Arg90His)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 12, 2012)	criteria provided, single submitter	15	67164957	GRCh38	263428	258935
NM_005902.3(SMAD3):c.309A>G (p.Leu103=)	SMAD3	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.16590(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	67164997	GRCh38	139217	142920
NM_005902.3(SMAD3):c.316A>G (p.Met106Val)	SMAD3	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(G), GO-ESP:0.00028(G)	Uncertain significance(Last reviewed: Nov 18, 2015)	criteria provided, multiple submitters, no conflicts	15	67165004	GRCh38	213801	210259
NM_005902.3(SMAD3):c.333C>T (p.Phe111=)	SMAD3	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00004(T)	Likely benign(Last reviewed: Sep 27, 2015)	criteria provided, single submitter	15	67165021	GRCh38	264429	258936
NM_005902.3(SMAD3):c.371C>T (p.Pro124Leu)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	15	67165059	GRCh38	264116	258941
NM_005902.3(SMAD3):c.376C>T (p.His126Tyr)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 20, 2013)	criteria provided, single submitter	15	67165064	GRCh38	263339	258937
NM_005902.3(SMAD3):c.381C>T (p.Tyr127=)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	15	67165069	GRCh38	263909	258938
NM_005902.3(SMAD3):c.414G>A (p.Val138=)	SMAD3	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	15	67165266	GRCh38	263331	258939
NM_005902.3(SMAD3):c.508A>G (p.Ile170Val)	SMAD3	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.01900(G), GO-ESP:0.04028(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	67165360	GRCh38	139212	142915
NM_005902.3(SMAD3):c.723C>T (p.Asn241=)	SMAD3	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00006(T)	Likely benign(Last reviewed: Nov 2, 2015)	criteria provided, single submitter	15	67181305	GRCh38	264410	258942
NM_005902.3(SMAD3):c.727C>T (p.Arg243Cys)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	15	67181309	GRCh38	264379	258940
NM_005902.3(SMAD3):c.733G>A (p.Gly245Arg)	SMAD3	Thoracic aortic aneurysm and aortic dissection|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Apr 3, 2015)	criteria provided, conflicting interpretations	15	67181315	GRCh38	213762	210278
NM_005902.3(SMAD3):c.764T>G (p.Met255Arg)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 16, 2013)	criteria provided, single submitter	15	67181346	GRCh38	263697	258943
NM_005902.3(SMAD3):c.850G>C (p.Glu284Gln)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 2, 2015)	criteria provided, single submitter	15	67181432	GRCh38	263961	258944
NM_005902.3(SMAD3):c.870C>T (p.Ile290=)	SMAD3	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00840(T), GO-ESP:0.01646(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	67181452	GRCh38	139213	142916
NM_005902.3(SMAD3):c.885G>A (p.Arg295=)	SMAD3	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00007(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	67184740	GRCh38	198533	195694
NM_005902.3(SMAD3):c.1009+5A>C	SMAD3	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(C)	Uncertain significance(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	15	67184869	GRCh38	264568	258950
NM_005902.3(SMAD3):c.1070A>G (p.Asn357Ser)	SMAD3	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Mar 30, 2014)	criteria provided, multiple submitters, no conflicts	15	67187425	GRCh38	213773	210293
NM_005902.3(SMAD3):c.1091A>G (p.Tyr364Cys)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 11, 2015)	criteria provided, single submitter	15	67187446	GRCh38	264500	258945
NM_005902.3(SMAD3):c.1102C>A (p.Arg368=)	SMAD3	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00007(A)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	67187457	GRCh38	264036	258946
NM_005902.3(SMAD3):c.1153A>G (p.Arg385Gly)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	15	67187508	GRCh38	263520	258947
NM_005902.3(SMAD3):c.1154G>C (p.Arg385Thr)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Likely pathogenic(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	15	67187509	GRCh38	263338	258951
NM_005902.3(SMAD3):c.1243G>C (p.Gly415Arg)	SMAD3	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	15	67190501	GRCh38	263871	258948
NM_005477.2(HCN4):c.3512G>T (p.Arg1171Ile)	HCN4	not specified	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Mar 26, 2014)	criteria provided, single submitter	15	73322581	GRCh38	190790	188623
NM_005477.2(HCN4):c.3497_3500delCTTT (p.Ser1166Cysfs)	HCN4	not specified	GO-ESP:0.00001(-)	Uncertain significance(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	15	73322593 - 73322596	GRCh38	190785	188624
NM_005477.2(HCN4):c.3448G>A (p.Val1150Ile)	HCN4	not specified		Uncertain significance(Last reviewed: Jan 18, 2016)	criteria provided, single submitter	15	73322645	GRCh38	234777	231928
NM_005477.2(HCN4):c.3077G>A (p.Ser1026Asn)	HCN4	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	15	73323016	GRCh38	264302	258949
NM_005477.2(HCN4):c.2804C>T (p.Ser935Phe)	HCN4	not specified|not provided	GO-ESP:0.00032(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2016)	criteria provided, conflicting interpretations	15	73323289	GRCh38	190784	188627
NM_005477.2(HCN4):c.2800C>T (p.Arg934Cys)	HCN4	not specified	GMAF:0.00080(A), GO-ESP:0.00061(A)	Uncertain significance(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	15	73323293	GRCh38	190774	188628
NM_005477.2(HCN4):c.2730C>A (p.Phe910Leu)	HCN4	Cardiovascular phenotype	GO-ESP:0.00017(T)	Uncertain significance(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	15	73323363	GRCh38	264440	258952
NM_005477.2(HCN4):c.2700C>A (p.Ala900=)	HCN4	Cardiovascular phenotype	GO-ESP:0.00210(T)	Benign(Last reviewed: Oct 13, 2015)	criteria provided, single submitter	15	73323393	GRCh38	264375	258953
NM_005477.2(HCN4):c.2527G>A (p.Ala843Thr)	HCN4	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	15	73323566	GRCh38	190783	188630
NM_005477.2(HCN4):c.2458G>A (p.Gly820Arg)	HCN4	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Oct 2, 2014)	criteria provided, single submitter	15	73323635	GRCh38	190789	188632
NM_005477.2(HCN4):c.2275G>A (p.Val759Ile)	HCN4	Brugada syndrome 8|not specified|not provided|Sudden cardiac death	GMAF:0.00140(T), GO-ESP:0.00353(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 8, 2016)	criteria provided, conflicting interpretations	15	73323818	GRCh38	190772	188633
NM_005477.2(HCN4):c.2197G>A (p.Val733Ile)	HCN4	not specified|Cardiac arrest	GMAF:0.00020(T), GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Nov 16, 2015)	criteria provided, multiple submitters, no conflicts	15	73323896	GRCh38	222648	224510
NM_005477.2(HCN4):c.2064C>T (p.Asn688=)	HCN4	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	15	73324168	GRCh38	264581	258954
NM_005477.2(HCN4):c.1703G>C (p.Ser568Thr)	HCN4	Brugada syndrome 8|not specified	GMAF:0.00020(G), GO-ESP:0.00109(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2016)	criteria provided, conflicting interpretations	15	73325332	GRCh38	190770	188635
NM_005477.2(HCN4):c.1653C>A (p.Ile551=)	HCN4	Cardiovascular phenotype	GMAF:0.00140(T), GO-ESP:0.00035(T)	Likely benign(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	15	73325382	GRCh38	264494	258960
NM_005477.2(HCN4):c.1346G>C (p.Cys449Ser)	HCN4	not specified		Uncertain significance(Last reviewed: May 19, 2014)	criteria provided, single submitter	15	73332156	GRCh38	190781	188638
NM_005477.2(HCN4):c.1178G>A (p.Arg393His)	HCN4	not specified		Uncertain significance(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	15	73343416	GRCh38	190780	188639
NM_005477.2(HCN4):c.1155C>T (p.Leu385=)	HCN4	Cardiovascular phenotype		Likely benign(Last reviewed: May 15, 2015)	criteria provided, single submitter	15	73343439	GRCh38	264040	258955
NM_005477.2(HCN4):c.1132C>T (p.Arg378Cys)	HCN4	not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: May 1, 2014)	criteria provided, single submitter	15	73343462	GRCh38	190779	188640
NM_005477.2(HCN4):c.621C>G (p.Arg207=)	HCN4	Brugada syndrome 8|not specified|Cardiovascular phenotype	GO-ESP:0.00010(C)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2015)	criteria provided, conflicting interpretations	15	73367650	GRCh38	167172	177766
NM_005477.2(HCN4):c.584C>T (p.Ala195Val)	HCN4	not specified|not provided	GMAF:0.00080(A), GO-ESP:0.00038(A)	Uncertain significance(Last reviewed: Oct 31, 2014)	criteria provided, multiple submitters, no conflicts	15	73367687	GRCh38	190788	188641
NM_005477.2(HCN4):c.520C>T (p.Pro174Ser)	HCN4	not specified	GMAF:0.00020(A), GO-ESP:0.00013(A)	Uncertain significance(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	15	73367751	GRCh38	190787	188642
NM_005477.2(HCN4):c.418G>A (p.Gly140Ser)	HCN4	not specified	GO-ESP:0.00067(T)	Uncertain significance(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	15	73367853	GRCh38	190786	188643
NM_005477.2(HCN4):c.196G>A (p.Glu66Lys)	HCN4	not specified		Uncertain significance(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	15	73368075	GRCh38	190778	188645
NM_005477.2(HCN4):c.106G>A (p.Gly36Arg)	HCN4	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 4, 2015)	criteria provided, single submitter	15	73368165	GRCh38	263981	258957
NM_005477.2(HCN4):c.88G>A (p.Glu30Lys)	HCN4	Cardiac arrhythmia		Uncertain significance(Last reviewed: May 8, 2013)	criteria provided, single submitter	15	73368183	GRCh38	190777	188646
NM_001142617.1(STRA6):c.1521-1G>A	STRA6	Microphthalmia syndromic 9		Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	15	74181459	GRCh38	88764	94345
NM_001142617.1(STRA6):c.878C>T (p.Pro293Leu)	STRA6	Microphthalmia syndromic 9	GO-ESP:0.00008(A), GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	15	74190889	GRCh38	1133	16172
NM_021005.3(NR2F2):c.222_224dupGCA (p.Gln75_His76insGln)	NR2F2	Congenital heart defects, multiple types, 4		Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	15	96332327 - 96332329	GRCh38	128234	133689
NM_001145155.1(NR2F2):c.215A>T (p.Asn72Ile)	NR2F2	Congenital heart defects, multiple types, 4		Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	15	96334247	GRCh38	128233	133688
NM_001145155.1(NR2F2):c.623C>A (p.Ser208Tyr)	NR2F2	Congenital heart defects, multiple types, 4		Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	15	96337399	GRCh38	128232	133687
GRCh38/hg38 15q11.2-14(chr15:25033869-37204304)x1	ACTC1|APBA2|CHRM5|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|MEIS2|TRPM1|OCA2|RYR3|SCG5|TJP1|UBE3A|HERC2|AQR|ARHGAP11A|SLC12A6|FAN1|GOLGA8A|FAM189A1|DKFZP434L187|GREM1|EMC4|KLF13|MTMR10|ZNF770|NOP10|NSMCE3|EMC7|AVEN|ATP10A|GJD2|KATNBL1|C15orf41|CHRFAM7A|ARHGAP11B|DPH6|PWAR1|LOC145845|OTUD7A|PGBD4|LPCAT4|NUTM1|LOC283710|SNORD109A|SNORD109B|SNORD115-1|FMN1|PWAR4|MIR211|GOLGA8B|LINC00929|GOLGA8N|LOC645202|GOLGA8J|GOLGA8K|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|GOLGA8O|GOLGA8H|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LOC100128714|LOC100130111|LOC100131315|TRE-TTC2-2|MIR1233-1|MIR1233-2|MIR3942|PWAR6|DPH6-AS1|MIR4509-2|MIR4510|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|LOC100996255|GOLGA8R|LOC101927579|LOC101928042|LOC101928134|LOC101928174|GABRG3-AS1|MIR8063|LOC102725022|LOC105370757	See cases		Pathogenic(Last reviewed: Jan 28, 2013)	no assertion criteria provided	15	25033869 - 37204304	GRCh38	155138	164892
GRCh38/hg38 15q13.2-13.3(chr15:30629714-32569425)x3	CHRNA7|TRPM1|FAN1|KLF13|MTMR10|ARHGAP11B|OTUD7A|LOC283710|MIR211|GOLGA8K|GOLGA8O|LOC100996255|LOC102725022	See cases		Pathogenic(Last reviewed: Nov 14, 2012)	no assertion criteria provided	15	30629714 - 32569425	GRCh38	154725	164479
GRCh38/hg38 15q11.2-13.2(chr15:23319714-30527306)x4	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAM189A1|NPAP1|DKFZP434L187|MAGEL2|NSMCE3|ATP10A|CHRFAM7A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8J|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LOC100128714|LOC100130111|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|GOLGA8R|PWRN3|GABRG3-AS1	See cases		Pathogenic(Last reviewed: Nov 14, 2012)	no assertion criteria provided	15	23319714 - 30527306	GRCh38	154724	164478
GRCh38/hg38 15q26.3(chr15:99338283-101843270)x3	ALDH1A3|MEF2A|PCSK6|SNRPA1|CHSY1|LINS1|SELENOS|LRRK1|TM2D3|TARSL2|LRRC28|ASB7|LYSMD4|ADAMTS17|CERS3|SPATA41|OR4F6|OR4F15|LOC100128108|LOC100507472|LOC101927751|CERS3-AS1|LOC102723335|PCSK6-AS1	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	15	99338283 - 101843270	GRCh38	154512	164266
GRCh38/hg38 15q26.1(chr15:89738724-89788051)x1	ANPEP|MESP1|WDR93|MESP2	See cases		Uncertain significance(Last reviewed: Nov 27, 2013)	no assertion criteria provided	15	89738724 - 89788051	GRCh38	154044	163795
GRCh38/hg38 15q11.2-14(chr15:23319714-38545325)x3	ACTC1|APBA2|CHRM5|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|MEIS2|TRPM1|NDN|OCA2|RYR3|SCG5|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|AQR|ARHGAP11A|SLC12A6|RASGRP1|FAN1|GOLGA8A|FAM189A1|NPAP1|DKFZP434L187|GREM1|EMC4|KLF13|MAGEL2|MTMR10|ZNF770|NOP10|NSMCE3|EMC7|AVEN|ATP10A|GJD2|KATNBL1|C15orf41|CHRFAM7A|ARHGAP11B|DPH6|SNORD107|PWAR1|LOC145845|TMCO5A|OTUD7A|SPRED1|PGBD4|LPCAT4|NUTM1|GOLGA6L2|LOC283710|FAM98B|SNORD108|SNORD109A|SNORD109B|SNORD115-1|FMN1|SNORD64|PWAR4|PWARSN|MIR211|GOLGA8B|LINC00929|GOLGA8N|LOC645202|GOLGA8J|GOLGA8K|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|GOLGA8O|GOLGA8H|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LOC100128714|LOC100130111|LOC100131315|TRE-TTC2-2|MIR1233-1|MIR1233-2|MIR3942|PWAR6|DPH6-AS1|MIR4509-2|MIR4508|MIR4510|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|LOC100996255|GOLGA8R|LOC101927579|LOC101928042|LOC101928134|LOC101928174|LOC101928227|PWRN3|GABRG3-AS1|MIR8063|LOC102725022|LOC105370757	See cases		Pathogenic(Last reviewed: Aug 13, 2012)	no assertion criteria provided	15	23319714 - 38545325	GRCh38	149530	159281
GRCh38/hg38 15q11.2-14(chr15:23319714-38089582)x1	ACTC1|APBA2|CHRM5|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|MEIS2|TRPM1|NDN|OCA2|RYR3|SCG5|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|AQR|ARHGAP11A|SLC12A6|FAN1|GOLGA8A|FAM189A1|NPAP1|DKFZP434L187|GREM1|EMC4|KLF13|MAGEL2|MTMR10|ZNF770|NOP10|NSMCE3|EMC7|AVEN|ATP10A|GJD2|KATNBL1|C15orf41|CHRFAM7A|ARHGAP11B|DPH6|SNORD107|PWAR1|LOC145845|TMCO5A|OTUD7A|PGBD4|LPCAT4|NUTM1|GOLGA6L2|LOC283710|SNORD108|SNORD109A|SNORD109B|SNORD115-1|FMN1|SNORD64|PWAR4|PWARSN|MIR211|GOLGA8B|LINC00929|GOLGA8N|LOC645202|GOLGA8J|GOLGA8K|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|GOLGA8O|GOLGA8H|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LOC100128714|LOC100130111|LOC100131315|TRE-TTC2-2|MIR1233-1|MIR1233-2|MIR3942|PWAR6|DPH6-AS1|MIR4509-2|MIR4508|MIR4510|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|LOC100996255|GOLGA8R|LOC101927579|LOC101928042|LOC101928134|LOC101928174|LOC101928227|PWRN3|GABRG3-AS1|MIR8063|LOC102725022|LOC105370757	See cases		Pathogenic(Last reviewed: Nov 30, 2009)	no assertion criteria provided	15	23319714 - 38089582	GRCh38	146702	156453
GRCh38/hg38 15q13.3(chr15:31729530-32149250)x3	CHRNA7	See cases		Benign(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	15	31729530 - 32149250	GRCh38	59710	74305
GRCh38/hg38 15q21.3(chr15:55279032-55622007)x3	RAB27A|CCPG1|PIGB|PYGO1|C15orf65|DYX1C1|PRTG|MIR628|DYX1C1-CCPG1|PIGBOS1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	15	55279032 - 55622007	GRCh38	58571	73166
GRCh38/hg38 15q14(chr15:34588015-39280404)x1	ACTC1|MEIS2|AQR|RASGRP1|ZNF770|GJD2|C15orf41|DPH6|LOC145845|TMCO5A|SPRED1|FAM98B|C15orf53|C15orf54|MIR3942|DPH6-AS1|MIR4510|LOC101928174|LOC101928227|MIR8063	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	15	34588015 - 39280404	GRCh38	57878	72473
GRCh38/hg38 15q13.3-15.1(chr15:32635803-40233825)x1	ACTC1|BUB1B|CHRM5|MEIS2|RYR3|SCG5|SRP14|THBS1|AQR|ARHGAP11A|SLC12A6|RASGRP1|GPR176|GOLGA8A|GREM1|EMC4|ZNF770|NOP10|EMC7|AVEN|GJD2|KATNBL1|C15orf41|DPH6|BMF|LOC145845|TMCO5A|SPRED1|PGBD4|FSIP1|LPCAT4|NUTM1|FAM98B|FMN1|C15orf53|C15orf54|GOLGA8B|EIF2AK4|SRP14-AS1|LOC100131315|MIR1233-1|MIR1233-2|MIR3942|DPH6-AS1|MIR4510|LOC101928134|LOC101928174|LOC101928227|MIR8063|LOC105370757|LOC105370941|BUB1B-PAK6	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	15	32635803 - 40233825	GRCh38	57877	72472
GRCh38/hg38 15q13.3-14(chr15:32326136-39394068)x1	ACTC1|CHRM5|MEIS2|RYR3|SCG5|AQR|ARHGAP11A|SLC12A6|RASGRP1|GOLGA8A|GREM1|EMC4|ZNF770|NOP10|EMC7|AVEN|GJD2|KATNBL1|C15orf41|DPH6|LOC145845|TMCO5A|SPRED1|PGBD4|LPCAT4|NUTM1|FAM98B|FMN1|C15orf53|C15orf54|GOLGA8B|GOLGA8N|GOLGA8K|GOLGA8O|LOC100131315|MIR1233-1|MIR1233-2|MIR3942|DPH6-AS1|MIR4510|LOC100996255|LOC101928042|LOC101928134|LOC101928174|LOC101928227|MIR8063|LOC105370757	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	15	32326136 - 39394068	GRCh38	57876	72471
GRCh38/hg38 15q13.3-14(chr15:32607298-35200429)x3	ACTC1|CHRM5|RYR3|SCG5|AQR|ARHGAP11A|SLC12A6|GOLGA8A|GREM1|EMC4|ZNF770|NOP10|EMC7|AVEN|GJD2|KATNBL1|PGBD4|LPCAT4|NUTM1|FMN1|GOLGA8B|GOLGA8N|LOC100131315|MIR1233-1|MIR1233-2|LOC101928042|LOC101928134|LOC101928174|LOC105370757	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	15	32607298 - 35200429	GRCh38	57451	72046
GRCh38/hg38 15q11.2-13.1(chr15:23462305-28275167)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LOC100128714|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1	See cases		Pathogenic(Last reviewed: Jan 27, 2011)	no assertion criteria provided	15	23462305 - 28275167	GRCh38	33733	42398
GRCh38/hg38 15q13.2-13.3(chr15:30361674-32607357)x3	CHRNA7|TRPM1|FAN1|KLF13|MTMR10|CHRFAM7A|ARHGAP11B|OTUD7A|LOC283710|MIR211|GOLGA8N|GOLGA8K|GOLGA8O|GOLGA8H|LOC100996255|GOLGA8R|LOC101927579|LOC101928042|LOC102725022	See cases		conflicting data from submitters(Last reviewed: Dec 22, 2010)	no assertion criteria provided	15	30361674 - 32607357	GRCh38	32396	41061
NM_000548.4(TSC2):c.34A>T (p.Lys12Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome		Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	16	2048649	GRCh38	12394	27433
NM_000548.4(TSC2):c.223G>A (p.Glu75Lys)	TSC2	Tuberous sclerosis syndrome|not specified	GO-ESP:0.00012(A)	Uncertain significance(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	16	2050484	GRCh38	161399	171187
NM_000548.4(TSC2):c.1258G>T (p.Glu420Ter)	TSC2	not provided		Pathogenic(Last reviewed: May 21, 2012)	criteria provided, single submitter	16	2062497	GRCh38	207712	203108
NM_000548.4(TSC2):c.4829G>A (p.Trp1610Ter)	TSC2	Tuberous sclerosis syndrome|not provided		Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	16	2086359	GRCh38	49323	58485
NM_000548.4(TSC2):c.5150T>C (p.Leu1717Pro)	TSC2	Tuberous sclerosis syndrome|not provided		Pathogenic(Last reviewed: Feb 21, 2014)	criteria provided, single submitter	16	2088129	GRCh38	49352	58514
NM_000548.4(TSC2):c.5238_5255del18 (p.His1746_Arg1751del)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome		Pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, single submitter	16	2088304 - 2088321	GRCh38	12402	27441
NM_024339.3(THOC6):c.136G>A (p.Gly46Arg)	THOC6	Beaulieu-Boycott-Innes syndrome	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: Apr 26, 2013)	no assertion criteria provided	16	3025804	GRCh38	64681	75616
NM_022844.2(MYH11):c.*146C>G	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.03060(C), GO-ESP:0.00855(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15703986	GRCh38	192314	190107
NM_001040113.1(MYH11):c.*22A>T	MYH11|NDE1	Aortic aneurysm, familial thoracic 6|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(A), GO-ESP:0.00124(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15704110	GRCh38	201044	197832
NM_002474.2(MYH11):c.5796C>T (p.Asn1932=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00260(A), GO-ESP:0.00069(A)	Benign/Likely benign(Last reviewed: Aug 28, 2015)	criteria provided, multiple submitters, no conflicts	16	15704114	GRCh38	201043	197833
NM_002474.2(MYH11):c.5757C>T (p.Arg1919=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.00420(A), GO-ESP:0.00099(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15714938	GRCh38	138360	142063
NM_002474.2(MYH11):c.5742C>T (p.Asn1914=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	16	15714953	GRCh38	264107	258956
NM_002474.2(MYH11):c.5691C>T (p.Asn1897=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00200(A), GO-ESP:0.00101(A)	Benign/Likely benign(Last reviewed: May 15, 2014)	criteria provided, multiple submitters, no conflicts	16	15715004	GRCh38	138359	142062
NM_002474.2(MYH11):c.5676G>C (p.Glu1892Asp)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00340(G), GO-ESP:0.00514(G)	Benign(Last reviewed: Dec 11, 2015)	criteria provided, multiple submitters, no conflicts	16	15715019	GRCh38	138358	142061
NM_002474.2(MYH11):c.5666C>T (p.Ala1889Val)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Oct 8, 2015)	criteria provided, multiple submitters, no conflicts	16	15715029	GRCh38	201090	197841
NM_002474.2(MYH11):c.5652G>A (p.Arg1884=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	16	15715043	GRCh38	264071	258965
NM_002474.2(MYH11):c.5596G>A (p.Glu1866Lys)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	16	15715181	GRCh38	263884	258961
NM_002474.2(MYH11):c.5595C>T (p.Ala1865=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00007(A)	Likely benign(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	16	15715182	GRCh38	264414	258958
NM_002474.2(MYH11):c.5566C>T (p.Leu1856=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GO-ESP:0.00134(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15715211	GRCh38	138357	142060
NM_002474.2(MYH11):c.5529G>A (p.Ser1843=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.00020(T), GO-ESP:0.00050(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15715248	GRCh38	197068	194229
NM_002474.2(MYH11):c.5528C>T (p.Ser1843Leu)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00060(A), GO-ESP:0.00009(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 7, 2015)	criteria provided, conflicting interpretations	16	15715249	GRCh38	201039	197845
NM_002474.2(MYH11):c.5517G>A (p.Ala1839=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.09210(T), GO-ESP:0.03764(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15715260	GRCh38	138356	142059
NM_002474.2(MYH11):c.5516C>T (p.Ala1839Val)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.00020(A), GO-ESP:0.00022(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15715261	GRCh38	197069	194230
NM_002474.2(MYH11):c.5511A>G (p.Lys1837=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(C)	Likely benign(Last reviewed: Oct 1, 2012)	criteria provided, single submitter	16	15715266	GRCh38	263419	258962
NM_002474.2(MYH11):c.5499G>C (p.Glu1833Asp)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00031(G)	Uncertain significance(Last reviewed: Feb 5, 2016)	criteria provided, multiple submitters, no conflicts	16	15717145	GRCh38	201086	197846
NM_001143979.1(NDE1):c.948-7025C>T	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.39620(T), GO-ESP:0.48179(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15717166	GRCh38	138354	142057
NM_001143979.1(NDE1):c.948-6986C>T	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.39680(T), GO-ESP:0.48230(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15717205	GRCh38	138353	142056
NM_002474.2(MYH11):c.5393G>A (p.Arg1798Gln)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(T), GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Mar 4, 2015)	criteria provided, multiple submitters, no conflicts	16	15717251	GRCh38	201116	197849
NM_001143979.1(NDE1):c.948-6917G>A	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.04710(A), GO-ESP:0.01708(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15717274	GRCh38	138351	142054
NM_002474.2(MYH11):c.5360G>A (p.Arg1787Gln)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 11, 2015)	criteria provided, single submitter	16	15717284	GRCh38	264024	258968
NM_001040113.1(MYH11):c.5317-4C>T	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.00240(A), GO-ESP:0.00620(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15717352	GRCh38	138350	142053
NM_002474.2(MYH11):c.5275G>A (p.Val1759Ile)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GO-ESP:0.00019(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15718335	GRCh38	201037	197852
NM_002474.2(MYH11):c.5160C>T (p.Ser1720=)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(A), GO-ESP:0.00012(A)	Benign/Likely benign(Last reviewed: Mar 11, 2016)	criteria provided, multiple submitters, no conflicts	16	15719231	GRCh38	138349	142052
NM_002474.2(MYH11):c.4920G>A (p.Arg1640=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Apr 23, 2014)	criteria provided, single submitter	16	15720184	GRCh38	263826	258963
NM_002474.2(MYH11):c.4884C>T (p.Asp1628=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Feb 25, 2014)	criteria provided, single submitter	16	15720220	GRCh38	263812	258959
NM_002474.2(MYH11):c.4791+4C>T	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00600(A), GO-ESP:0.00218(A)	Benign(Last reviewed: Oct 21, 2015)	criteria provided, multiple submitters, no conflicts	16	15720835	GRCh38	138348	142051
NM_002474.2(MYH11):c.4774A>C (p.Arg1592=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00160(G), GO-ESP:0.00031(G)	Likely benign(Last reviewed: Nov 2, 2015)	criteria provided, single submitter	16	15720856	GRCh38	264409	258969
NM_001040113.1(MYH11):c.4791G>A (p.Lys1597=)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Familial aortopathy|Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GO-ESP:0.01485(T), GMAF:0.00480(T), GO-ESP:0.01427(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15720860	GRCh38	36621	45283
NM_002474.2(MYH11):c.4681G>A (p.Ala1561Thr)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|Lissencephaly, Recessive	GO-ESP:0.00012(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15720949	GRCh38	263877	258971
NM_001040113.1(MYH11):c.4625G>A (p.Arg1542Gln)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00140(T), GO-ESP:0.00234(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2016)	criteria provided, conflicting interpretations	16	15721026	GRCh38	180418	178711
NM_002474.2(MYH11):c.4578+3A>G	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00180(C), GO-ESP:0.00145(C)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 25, 2015)	criteria provided, conflicting interpretations	16	15721419	GRCh38	138346	142049
NM_002474.2(MYH11):c.4543G>A (p.Asp1515Asn)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: May 26, 2015)	criteria provided, single submitter	16	15721457	GRCh38	264056	258964
NM_002474.2(MYH11):c.4522A>G (p.Met1508Val)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00260(C), GO-ESP:0.00143(C)	Benign(Last reviewed: Jul 20, 2015)	criteria provided, multiple submitters, no conflicts	16	15721478	GRCh38	138345	142048
NM_002474.2(MYH11):c.4506C>T (p.Leu1502=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00600(A), GO-ESP:0.00274(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15721494	GRCh38	138344	142047
NM_002474.2(MYH11):c.4433C>G (p.Ala1478Gly)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	16	15721567	GRCh38	264436	258966
NM_001040113.1(MYH11):c.4422C>T (p.Tyr1474=)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.00960(A), GO-ESP:0.00303(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15721599	GRCh38	138343	142046
NM_002474.2(MYH11):c.4372G>A (p.Ala1458Thr)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	16	15721628	GRCh38	263876	258974
NM_002474.2(MYH11):c.4240_4242delGCTinsACG (p.Ala1414Thr)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified		Uncertain significance(Last reviewed: Jun 27, 2016)	criteria provided, multiple submitters, no conflicts	16	15724284 - 15724286	GRCh38	201110	197868
NM_002474.2(MYH11):c.4242T>G (p.Ala1414=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.41010(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15724284	GRCh38	138342	142045
NM_002474.2(MYH11):c.4240G>A (p.Ala1414Thr)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(T), GO-ESP:0.00036(T)	Uncertain significance(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	16	15724286	GRCh38	201073	197869
NM_002474.2(MYH11):c.4239C>T (p.Ala1413=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00240(A), GO-ESP:0.00066(A)	Benign/Likely benign(Last reviewed: Aug 28, 2015)	criteria provided, multiple submitters, no conflicts	16	15724287	GRCh38	263393	258979
NM_001040113.1(MYH11):c.4218G>A (p.Lys1406=)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(T), GO-ESP:0.00026(T)	Benign/Likely benign(Last reviewed: Nov 2, 2015)	criteria provided, multiple submitters, no conflicts	16	15724329	GRCh38	221033	222447
NM_002474.2(MYH11):c.4158C>T (p.Thr1386=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00440(A), GO-ESP:0.00886(A)	Benign(Last reviewed: Jun 19, 2015)	criteria provided, multiple submitters, no conflicts	16	15724368	GRCh38	138341	142044
NM_002474.2(MYH11):c.4135A>C (p.Lys1379Gln)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	16	15724391	GRCh38	263874	258967
NM_002474.2(MYH11):c.4000G>C (p.Val1334Leu)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	16	15724763	GRCh38	263992	258970
NM_002474.2(MYH11):c.3973C>G (p.Gln1325Glu)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00063(C)	Uncertain significance(Last reviewed: Dec 17, 2015)	criteria provided, multiple submitters, no conflicts	16	15724790	GRCh38	201070	197876
NM_001040113.1(MYH11):c.3988C>T (p.Leu1330=)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.10160(A), GO-ESP:0.03945(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15724796	GRCh38	138338	142041
NM_002474.2(MYH11):c.3949C>A (p.Leu1317Ile)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.00520(T), GO-ESP:0.00172(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15724902	GRCh38	201031	197877
NM_002474.2(MYH11):c.3928G>A (p.Val1310Met)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|Lissencephaly, Recessive	GMAF:0.00120(T), GO-ESP:0.00070(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15724923	GRCh38	201068	197879
NM_002474.2(MYH11):c.3910A>C (p.Ile1304Leu)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00032(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15724941	GRCh38	263686	258975
NM_002474.2(MYH11):c.3866T>C (p.Val1289Ala)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.02020(G), GO-ESP:0.03976(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15724985	GRCh38	138337	142040
NM_002474.2(MYH11):c.3828G>A (p.Ala1276=)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00100(T), GO-ESP:0.00269(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15726878	GRCh38	138335	142038
NM_001040113.1(MYH11):c.3845G>T (p.Arg1282Leu)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection		Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2013)	criteria provided, conflicting interpretations	16	15726882	GRCh38	14134	29173
NM_002474.2(MYH11):c.3816G>A (p.Glu1272=)	MYH11	Familial aortopathy|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00038(T), GO-ESP:0.00034(T)	Benign/Likely benign(Last reviewed: Jul 10, 2015)	criteria provided, multiple submitters, no conflicts	16	15726890	GRCh38	36620	45282
NM_002474.2(MYH11):c.3791T>C (p.Leu1264Pro)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not provided	GMAF:0.00020(T)	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, multiple submitters, no conflicts	16	15726915	GRCh38	88953	94510
NM_002474.2(MYH11):c.3776C>T (p.Ala1259Val)	MYH11	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00011(A)	Likely benign(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	16	15726930	GRCh38	264118	258980
NM_001040114.1(MYH11):c.3787_3789delAAG (p.Lys1263del)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00006(-)	Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, multiple submitters, no conflicts	16	15726938 - 15726940	GRCh38	180420	178712
NM_002474.2(MYH11):c.3766A>C (p.Lys1256Gln)	MYH11	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(G), GO-ESP:0.00039(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15726940	GRCh38	263518	258972
NM_001040113.1(MYH11):c.3721G>A (p.Ala1241Thr)	MYH11|NDE1	Thoracic aortic aneurysm and aortic dissection|not specified|Lissencephaly, Recessive	GMAF:0.20390(T), GO-ESP:0.24569(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15727006	GRCh38	138334	142037
NM_001040113.1(MYH11):c.3672+5_3672+11delTGCTTTTinsG	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection		Conflicting interpretations of pathogenicity(Last reviewed: Jan 14, 2016)	criteria provided, conflicting interpretations	16	15732553 - 15732559	GRCh38	201029	197882
NM_002474.2(MYH11):c.3651+5delT	MYH11	Thoracic aortic aneurysm and aortic dissection	GMAF:0.01280(-), GO-ESP:0.00222(-)	Benign(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	16	15732559	GRCh38	264115	258973
NM_002474.2(MYH11):c.3619G>A (p.Glu1207Lys)	MYH11	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Sep 16, 2013)	criteria provided, single submitter	16	15732596	GRCh38	263772	258978
NM_002474.2(MYH11):c.3432C>T (p.Leu1144=)	MYH11	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Dec 5, 2012)	criteria provided, single submitter	16	15735440	GRCh38	263462	258982
NM_002474.2(MYH11):c.3409G>T (p.Ala1137Ser)	MYH11	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Aug 11, 2014)	criteria provided, single submitter	16	15735463	GRCh38	263850	258976
NM_002474.2(MYH11):c.3379C>T (p.Leu1127=)	MYH11	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	16	15735493	GRCh38	263582	258977
NM_002474.2(MYH11):c.3358A>G (p.Ile1120Val)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 27, 2012)	criteria provided, single submitter	16	15735514	GRCh38	263400	258981
NM_002474.2(MYH11):c.3310G>A (p.Ala1104Thr)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.01400(T), GO-ESP:0.00386(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15735562	GRCh38	138333	142036
NM_002474.2(MYH11):c.3291C>T (p.Ala1097=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00012(A)	Uncertain significance(Last reviewed: Aug 18, 2016)	criteria provided, multiple submitters, no conflicts	16	15737451	GRCh38	201061	197890
NM_002474.2(MYH11):c.3286C>A (p.Leu1096Met)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 11, 2015)	criteria provided, single submitter	16	15737456	GRCh38	264200	258985
NM_002474.2(MYH11):c.3235G>T (p.Ala1079Ser)	MYH11	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00060(T)	Uncertain significance(Last reviewed: Dec 8, 2015)	criteria provided, single submitter	16	15737507	GRCh38	264554	258983
NM_001040113.1(MYH11):c.3123T>C (p.Ser1041=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(G), GO-ESP:0.00104(G)	Likely benign(Last reviewed: Apr 10, 2015)	criteria provided, multiple submitters, no conflicts	16	15738584	GRCh38	257257	255477
NM_002474.2(MYH11):c.3031T>C (p.Leu1011=)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00059(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15738655	GRCh38	201026	197893
NM_001040113.1(MYH11):c.2914G>T (p.Ala972Ser)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00040(A)	Uncertain significance(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	16	15740155	GRCh38	201058	197894
NM_002474.2(MYH11):c.2692G>A (p.Ala898Thr)	MYH11	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	16	15741630	GRCh38	263641	258987
NM_002474.2(MYH11):c.2649G>A (p.Ser883=)	MYH11	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00140(T), GO-ESP:0.00020(T)	Likely benign(Last reviewed: Sep 6, 2012)	criteria provided, single submitter	16	15741763	GRCh38	263394	258984
NM_002474.2(MYH11):c.2648C>T (p.Ser883Leu)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(A), GO-ESP:0.00027(A)	Uncertain significance(Last reviewed: Aug 8, 2016)	criteria provided, multiple submitters, no conflicts	16	15741764	GRCh38	201056	197896
NM_002474.2(MYH11):c.2562G>A (p.Met854Ile)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	16	15741850	GRCh38	264463	258988
NM_001040113.1(MYH11):c.2496C>T (p.Ala832=)	MYH11	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Jul 8, 2014)	criteria provided, single submitter	16	15745174	GRCh38	263848	258986
NM_002474.2(MYH11):c.2472C>T (p.Ala824=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.25360(A), GO-ESP:0.29752(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15745177	GRCh38	138330	142033
NM_001040113.1(MYH11):c.2229C>T (p.Ile743=)	MYH11	Familial aortopathy|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.07273(A), GMAF:0.09670(A), GO-ESP:0.05616(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15747916	GRCh38	36616	45278
NM_022844.2(MYH11):c.2135G>A (p.Arg712Gln)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection		Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	16	15748092	GRCh38	14135	29174
NM_002474.2(MYH11):c.2098C>T (p.Arg700Trp)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 21, 2013)	criteria provided, single submitter	16	15748129	GRCh38	263807	258991
NM_002474.2(MYH11):c.2079C>T (p.Phe693=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.07170(A), GO-ESP:0.01984(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15748148	GRCh38	138329	142032
NM_002474.2(MYH11):c.2061C>T (p.Ser687=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.08390(A), GO-ESP:0.06475(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15748166	GRCh38	138328	142031
NM_001040113.1(MYH11):c.2070C>T (p.His690=)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(A), GO-ESP:0.00046(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15750147	GRCh38	220799	222449
NM_001040113.1(MYH11):c.2026C>T (p.Arg676Cys)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00058(A)	Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, multiple submitters, no conflicts	16	15750191	GRCh38	161319	171184
NM_002474.2(MYH11):c.2000C>T (p.Thr667Met)	MYH11	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Dec 27, 2012)	criteria provided, single submitter	16	15750196	GRCh38	263472	258999
NM_002474.2(MYH11):c.1749+4C>G	MYH11	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Apr 7, 2014)	criteria provided, single submitter	16	15756337	GRCh38	263833	258993
NM_002474.2(MYH11):c.1743T>C (p.Ala581=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.45190(A), GO-ESP:0.44370(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15756347	GRCh38	138327	142030
NM_002474.2(MYH11):c.1732A>G (p.Ile578Val)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(C), GO-ESP:0.00080(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15756358	GRCh38	201024	197902
NM_001040113.1(MYH11):c.1701C>T (p.His567=)	MYH11	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	16	15756410	GRCh38	263847	258989
NM_002474.2(MYH11):c.1512C>T (p.Ile504=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00100(A), GO-ESP:0.00021(A)	Benign/Likely benign(Last reviewed: Jul 12, 2015)	criteria provided, multiple submitters, no conflicts	16	15757890	GRCh38	138373	142076
NM_002474.2(MYH11):c.1502G>A (p.Arg501His)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(T), GO-ESP:0.00019(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 29, 2016)	criteria provided, conflicting interpretations	16	15757900	GRCh38	201108	197907
NM_002474.2(MYH11):c.1434C>T (p.Tyr478=)	MYH11	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00014(A)	Likely benign(Last reviewed: Aug 28, 2012)	criteria provided, single submitter	16	15757968	GRCh38	263397	258996
NM_002474.2(MYH11):c.1419G>A (p.Gln473=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00360(T), GO-ESP:0.00166(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15757983	GRCh38	138372	142075
NM_002474.2(MYH11):c.1318G>A (p.Val440Met)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Aug 5, 2013)	criteria provided, single submitter	16	15759659	GRCh38	263698	259000
NM_002474.2(MYH11):c.1220T>C (p.Val407Ala)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15760568	GRCh38	263969	258994
NM_002474.2(MYH11):c.1212G>C (p.Gly404=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00019(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15760576	GRCh38	138370	142073
NM_002474.2(MYH11):c.1115T>C (p.Met372Thr)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jan 23, 2013)	criteria provided, single submitter	16	15763810	GRCh38	263516	258990
NM_002474.2(MYH11):c.1056G>A (p.Ser352=)	MYH11	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00026(T)	Likely benign(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	16	15763869	GRCh38	263333	258997
NM_002474.2(MYH11):c.1017C>T (p.Ser339=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(A), GO-ESP:0.00024(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2015)	criteria provided, conflicting interpretations	16	15771585	GRCh38	199079	196238
NM_002474.2(MYH11):c.987C>T (p.Thr329=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.05730(A), GO-ESP:0.10258(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15771615	GRCh38	138369	142072
NM_002474.2(MYH11):c.914A>G (p.Asn305Ser)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00300(C), GO-ESP:0.00057(C)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 24, 2016)	criteria provided, conflicting interpretations	16	15771688	GRCh38	201103	197914
NM_002474.2(MYH11):c.811G>A (p.Ala271Thr)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Mar 29, 2013)	criteria provided, single submitter	16	15776156	GRCh38	263577	259001
NM_002474.2(MYH11):c.792T>C (p.Tyr264=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.01180(G), GO-ESP:0.03071(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15776175	GRCh38	138368	142071
NM_002474.2(MYH11):c.758C>T (p.Thr253Met)	MYH11	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	16	15778812	GRCh38	263519	258995
NM_001040113.1(MYH11):c.760C>T (p.Arg254Cys)	MYH11	Aortic aneurysm, familial thoracic 4|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|Altered myosin contractile function	GMAF:0.00060(A), GO-ESP:0.00194(A)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2016)	criteria provided, conflicting interpretations	16	15778831	GRCh38	161317	171185
NM_002474.2(MYH11):c.546C>T (p.Ala182=)	MYH11	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00003(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15786717	GRCh38	263526	258992
NM_002474.2(MYH11):c.472G>A (p.Ala158Thr)	MYH11	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00014(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15823285	GRCh38	263862	258998
NM_002474.2(MYH11):c.471C>T (p.Ile157=)	MYH11	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00026(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15823286	GRCh38	263341	259003
NM_002474.2(MYH11):c.453G>A (p.Pro151=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00180(T), GO-ESP:0.00086(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15823304	GRCh38	201046	197922
NM_001040113.1(MYH11):c.429G>A (p.Lys143=)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00046(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15823328	GRCh38	238261	242203
NM_002474.2(MYH11):c.417C>T (p.Val139=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.07530(A), GO-ESP:0.09912(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15823340	GRCh38	138366	142069
NM_002474.2(MYH11):c.412A>T (p.Ile138Phe)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	16	15823345	GRCh38	264360	259002
NM_002474.2(MYH11):c.387A>G (p.Lys129=)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.01160(C), GO-ESP:0.00299(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15823370	GRCh38	138365	142068
NM_002474.2(MYH11):c.291C>T (p.Asn97=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00360(A), GO-ESP:0.00194(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	15837962	GRCh38	138364	142067
NM_002474.2(MYH11):c.217A>C (p.Lys73Gln)	MYH11	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00026(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15838036	GRCh38	201095	197926
NM_002474.2(MYH11):c.190G>C (p.Glu64Gln)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	16	15838063	GRCh38	263977	259004
NM_002474.2(MYH11):c.135C>T (p.Phe45=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.04390(A), GO-ESP:0.01454(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	15838118	GRCh38	138363	142066
NM_002474.2(MYH11):c.99G>C (p.Lys33Asn)	MYH11	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	16	15838154	GRCh38	263841	259006
NM_002474.2(MYH11):c.12G>A (p.Lys4=)	MYH11	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(T), GO-ESP:0.00059(T)	Benign/Likely benign(Last reviewed: Jul 28, 2015)	criteria provided, multiple submitters, no conflicts	16	15838241	GRCh38	138362	142065
NM_001171.5(ABCC6):c.3940C>T (p.Arg1314Trp)	ABCC6	Pseudoxanthoma elasticum|Generalized arterial calcification of infancy 2|not provided	GO-ESP:0.00023(A), GMAF:0.00020(A), GO-ESP:0.00048(A)	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	16	16154974	GRCh38	6564	21603
NM_001083614.1(EARS2):c.193A>G (p.Lys65Glu)	EARS2	Combined oxidative phosphorylation deficiency 12	GO-ESP:0.00001(C)	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	16	23552251	GRCh38	39793	48392
NM_001080432.2(FTO):c.956C>T (p.Ser319Phe)	FTO	Growth retardation, developmental delay, coarse facies, and early death		Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2015)	no assertion criteria provided	16	53873846	GRCh38	208336	204571
NM_004614.4(TK2):c.323C>T (p.Thr108Met)	TK2	Mitochondrial DNA depletion syndrome 2|not provided	GO-ESP:0.00003(A)	Pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, single submitter	16	66531432	GRCh38	12710	27749
NM_001451.2(FOXF1):c.225C>A (p.Tyr75Ter)	FOXF1	Alveolar capillary dysplasia with misalignment of pulmonary veins		Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	16	86510794	GRCh38	8462	23501
NC_000016.9:g.(?_15494600)_(16327230_?)dup	ABCC6|ABCC1|MYH11|KIAA0430|NDE1|C16orf45|FOPNL|MPV17L|NOMO3	See cases		Uncertain significance(Last reviewed: Jan 20, 2016)	criteria provided, single submitter			GRCh38	253709	248157
NC_000016.9:g.(?_21313377)_(21947230_?)del	CRYM|IGSF6|NPIPB3|METTL9|OTOA|NPIPB4	See cases		Uncertain significance(Last reviewed: Jun 24, 2016)	criteria provided, single submitter			GRCh38	252982	247385
GRCh38/hg38 16p11.2(chr16:29568699-30228906)x3	ALDOA|KIF22|MAZ|PPP4C|MAPK3|SPN|SULT1A3|TBX6|DOC2A|HIRIP3|TAOK2|MVP|CDIPT|CORO1A|QPRT|SEZ6L2|GDPD3|PAGR1|YPEL3|FAM57B|PRRT2|TMEM219|C16orf92|KCTD13|ASPHD1|C16orf54|INO80E|CDIPT-AS1|SLX1A|NPIPB13|ZG16|BOLA2B|SLX1A-SULT1A3|MIR3680-2|LOC101928595	See cases		Likely pathogenic(Last reviewed: May 14, 2013)	no assertion criteria provided	16	29568699 - 30228906	GRCh38	155364	165118
GRCh38/hg38 16p13.3(chr16:984540-986105)x3	SOX8	See cases		Benign(Last reviewed: Oct 19, 2010)	no assertion criteria provided	16	984540 - 986105	GRCh38	154570	164324
GRCh38/hg38 16q24.2(chr16:87766820-88391819)x3	CA5A|SLC7A5|BANP|LOC400553|LOC101928880|MIR6775|LOC102724467	See cases		Uncertain significance(Last reviewed: Dec 22, 2010)	no assertion criteria provided	16	87766820 - 88391819	GRCh38	154521	164275
GRCh38/hg38 16q12.1(chr16:47224376-47628637)x1	PHKB|ITFG1	See cases		Likely benign(Last reviewed: Mar 10, 2014)	no assertion criteria provided	16	47224376 - 47628637	GRCh38	154127	163878
GRCh38/hg38 16p13.11-12.3(chr16:15184811-18535419)x3	ABCC6|ABCC1|MYH11|KIAA0430|NDE1|XYLT1|C16orf45|FOPNL|MPV17L|NOMO2|NOMO3|MIR484|NPIPA5|MIR3180-3|MIR3179-2|MIR3180-2|MIR3179-3|MIR3670-2|NPIPA7|NPIPA8|MIR6506|MIR6511A3|MIR6511A4|MIR6770-2|MIR6770-3|MIR6511A2|LOC102723692|MIR3670-3|MIR3179-4|MIR3670-4	See cases		Uncertain significance(Last reviewed: Sep 21, 2012)	no assertion criteria provided	16	15184811 - 18535419	GRCh38	150157	159908
GRCh38/hg38 16p11.2(chr16:28832433-29019750)x3	ATP2A1|CD19|TUFM|ATXN2L|SH2B1|LAT|RABEP2|SPNS1|NFATC2IP|ATP2A1-AS1|MIR4721|MIR4517	See cases		Uncertain significance(Last reviewed: Sep 21, 2012)	no assertion criteria provided	16	28832433 - 29019750	GRCh38	149863	159614
GRCh38/hg38 16p13.3(chr16:3726714-3759009)x1	CREBBP	See cases		Pathogenic(Last reviewed: Dec 13, 2010)	no assertion criteria provided	16	3726714 - 3759009	GRCh38	145541	155292
GRCh38/hg38 16p11.2(chr16:29808232-30162533)x1	ALDOA|MAZ|PPP4C|MAPK3|TBX6|DOC2A|HIRIP3|TAOK2|MVP|CDIPT|SEZ6L2|GDPD3|PAGR1|YPEL3|FAM57B|PRRT2|TMEM219|C16orf92|KCTD13|ASPHD1|INO80E|CDIPT-AS1|LOC101928595	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	16	29808232 - 30162533	GRCh38	60410	75005
GRCh38/hg38 16p11.2(chr16:29662433-30179388)x1	ALDOA|KIF22|MAZ|PPP4C|MAPK3|SPN|TBX6|DOC2A|HIRIP3|TAOK2|MVP|CDIPT|QPRT|SEZ6L2|GDPD3|PAGR1|YPEL3|FAM57B|PRRT2|TMEM219|C16orf92|KCTD13|ASPHD1|C16orf54|INO80E|CDIPT-AS1|ZG16|LOC101928595	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, multiple submitters, no conflicts	16	29662433 - 30179388	GRCh38	60400	74995
GRCh38/hg38 16q23.1(chr16:75485676-75603079)x3	CHST6|GABARAPL2|ADAT1|CHST5|TMEM231	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	16	75485676 - 75603079	GRCh38	60022	74617
GRCh38/hg38 16q22.3-23.1(chr16:73917167-75319927)x3	CTRB1|GLG1|PSMD7|BCAR1|CFDP1|RFWD3|FA2H|WDR59|ZNRF1|ZFP1|LDHD|MLKL|NPIPB15|CTRB2|CLEC18B|LOC100506281|LOC101928035|LOC105376772	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	16	73917167 - 75319927	GRCh38	59996	74591
GRCh38/hg38 16q22.1-23.1(chr16:69918076-76723348)x1	AARS|AP1G1|ZFHX3|CALB2|CTRB1|DHODH|GLG1|HP|HPR|KARS|CHST6|PSMD7|ST3GAL2|TAT|TRG-GCC3-1|ZNF19|ZNF23|BCAR1|DHX38|IST1|CHST4|CFDP1|WWP2|DDX19B|GABARAPL2|PHLPP2|SF3B3|ADAT1|CHST5|COG4|TERF2IP|HYDIN|TXNL4B|PDPR|RFWD3|DDX19A|ZNF821|VAC14|CMTR2|FA2H|TMEM231|WDR59|PMFBP1|ZNRF1|CNTNAP4|MARVELD3|MTSS1L|EXOSC6|TMEM170A|IL34|ZFP1|LDHD|FUK|MLKL|HCCAT5|CLEC18C|ATXN1L|PKD1L3|CLEC18A|C16orf47|LOC400541|MIR140|NPIPB15|CTRB2|CLEC18B|SNORD71|SNORD111|DUXB|SNORD111B|VAC14-AS1|TAT-AS1|TRG-GCC2-4|TRK-TTT1-1|TRM-CAT2-1|TRG-GCC2-5|TRG-GCC5-1|SNORA70D|MIR1972-2|LOC100506083|LINC01568|LOC100506281|RNU6-23P|LINC01572|LOC101928035|LOC101928203|LOC105371328|LOC105371335|LOC105376772	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	16	69918076 - 76723348	GRCh38	59514	74109
GRCh38/hg38 16p13.3(chr16:6717241-7051313)x1	RBFOX1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	16	6717241 - 7051313	GRCh38	59465	74060
GRCh38/hg38 16p13.3(chr16:2850734-7110697)x1	ADCY9|CREBBP|DNASE1|HMOX2|MEFV|OR1F1|OR2C1|PPL|SRL|TFAP4|ZNF75A|ZNF174|ZNF200|ZNF205|ZNF213|CLDN6|CLDN9|PKMYT1|DNAJA3|IL32|SEC14L5|ZNF263|TRAP1|CLUAP1|MGRN1|ZNF500|UBN1|CDIP1|PAM16|NAGPA|TNFRSF12A|RBFOX1|ZSCAN32|HCFC1R1|ALG1|NMRAL1|PRSS22|MMP25|THOC6|KREMEN2|CORO7|ROGDI|NAA60|ZNF205-AS1|FLYWCH1|NUDT16L1|SLX4|GLYR1|GLIS2|ZSCAN10|TIGD7|FLYWCH2|VASN|PAQR4|ANKS3|UBALD1|SEPT12|ZNF597|BICDL2|C16orf89|C16orf71|EEF2KMT|CASP16|NLRC3|LINC00514|LINC00921|C16orf96|SMIM22|C16orf90|LOC100128770|TRP-AGG1-1|TRK-CTT4-1|TRK-CTT3-1|TRP-AGG2-7|TRR-CCT3-1|TRR-CCG1-3|TRK-CTT5-1|TRP-CGG1-2|TRR-CCT5-1|TRP-TGG3-5|TRK-CTT2-5|TRP-AGG2-8|TRP-TGG3-3|TRP-TGG3-4|MTRNR2L4|MMP25-AS1|ZNF213-AS1|LINC01569|NAGPA-AS1|CORO7-PAM16|GLIS2-AS1|LINC01570|LOC101929613|MIR6126|MIR8065|MIR6769A|LOC102724927	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	16	2850734 - 7110697	GRCh38	59428	74023
GRCh38/hg38 16p13.3-13.13(chr16:23141-11296695)x3	ABAT|ABCA3|ADCY9|ARHGDIG|ATP6V0C|CCNF|CLCN7|CREBBP|ECI1|DNASE1|DNASE1L2|E4F1|EMP2|GFER|GRIN2A|HAGH|HBA1|HBA2|HBM|HBQ1|HBZ|HMOX2|IGFALS|MEFV|CIITA|MPG|NUBP1|NDUFB10|NME3|NME4|NTHL1|NTN3|OR1F1|OR2C1|PDPK1|PKD1|PMM2|PPL|PRM1|PRM2|RPL3L|RPS2|SRL|CAPN15|SSTR5|ELOB|TFAP4|TNP2|TPSAB1|TSC2|UBE2I|ZNF75A|ZNF174|ZNF200|ZNF205|ZNF213|USP7|NPRL3|AXIN1|SOCS1|RGS11|CACNA1H|BAIAP3|RHBDL1|CLDN6|CLDN9|PKMYT1|PIGQ|DNAJA3|SYNGR3|IL32|SLC9A3R2|SEC14L5|RAB11FIP3|IFT140|TELO2|NUBP2|ZNF263|TRAP1|MSLN|STUB1|MRPL28|TBL3|RNPS1|PRSS21|CLUAP1|MAPK8IP3|CLEC16A|MGRN1|TPSD1|SRRM2|CARHSP1|TPSG1|RAB26|TMEM186|ZNF500|DECR2|SNORA64|SNORD60|DEXI|C16orf72|UBN1|CDIP1|SOX8|AMDHD2|PAM16|NAGPA|TNFRSF12A|POLR3K|MSRB1|GNG13|KCTD5|RBFOX1|ZSCAN32|HCFC1R1|LUC7L|ALG1|NMRAL1|TBC1D24|CASKIN1|CRAMP1|RAB40C|PRM3|TMEM8A|CHTF18|PRSS22|MLST8|RHBDF1|MMP25|NARFL|LINC00235|TPSB2|HS3ST6|PDIA2|TRG-CCC2-2|UNKL|LINC00254|LMF1|FAM173A|MRPS34|METRN|METTL22|THOC6|KREMEN2|CORO7|SNRNP25|ROGDI|TMEM204|NAA60|ATF7IP2|C16orf59|ZNF205-AS1|FAHD1|PRSS27|FAM234A|WDR24|TRAF7|FLYWCH1|HAGHL|NUDT16L1|METTL26|MCRIP2|SLX4|GNPTG|GLYR1|GLIS2|ZSCAN10|RHOT2|ZNF598|HN1L|SPSB3|TIGD7|RPUSD1|FLYWCH2|VASN|TSR3|WFIKKN1|NOXO1|CCDC78|ZG16B|PAQR4|ANKS3|UBALD1|SEPT12|TEKT5|RNF151|PRR35|FBXL16|SSTR5-AS1|ZNF597|BICDL2|C16orf89|C16orf71|EEF2KMT|WDR90|EME2|CASP16|NLRC3|MEIOB|PRSS33|NPW|BRICD5|PGP|LINC00514|LINC00921|NHLRC4|C16orf91|TMEM114|JMJD8|C16orf96|PRSS41|PRR25|C1QTNF8|PTX4|SMIM22|SNORA10|FLJ42627|CCDC154|C16orf90|SNORA78|MIR662|LOC729652|SNHG9|CEMP1|TVP23A|MIR940|LOC100128770|SRRM2-AS1|WASIR2|LOC100134368|MIR1225|TRP-AGG1-1|TRK-CTT4-1|TRK-CTT3-1|TRP-AGG2-7|TRR-CCT3-1|TRR-CCG1-3|TRK-CTT5-1|TRP-CGG1-2|TRR-CCT5-1|TRP-TGG3-5|TRK-CTT2-5|TRP-AGG2-8|TRP-TGG3-3|TRP-TGG3-4|MIR3178|MIR3177|MIR3176|MTRNR2L4|MIR3677|MIR3180-5|SNHG19|ERVK13-1|MMP25-AS1|ZNF213-AS1|LINC01569|NAGPA-AS1|CORO7-PAM16|MIR4717|MIR4516|MIR5587|GLIS2-AS1|LINC01570|LOC101927009|LMF1-AS1|LOC101929613|MIR6126|MIR6511B1|MIR6767|MIR6768|MIR8065|MIR6769A|LOC102724927|LINC01195|LINC01177|LOC105371038|LOC105371046|LOC105371049|LOC106660606	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	16	23141 - 11296695	GRCh38	58594	73189
GRCh38/hg38 16q24.3(chr16:89730086-90081985)x1	AFG3L1P|GAS8-AS1|FANCA|GAS8|MC1R|TUBB3|PRDM7|TCF25|DEF8|DBNDD1|SPIRE2|CENPBD1|ZNF276|URAHP	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	16	89730086 - 90081985	GRCh38	58271	72866
GRCh38/hg38 16q23.2(chr16:81083563-81219270)x1	GCSH|PKD1L2	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	16	81083563 - 81219270	GRCh38	58252	72847
NM_000546.5(TP53):c.848G>A (p.Arg283His)	TP53	not provided|Astrocytoma|Hereditary cancer-predisposing syndrome	GO-ESP:0.00007(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 7, 2016)	criteria provided, conflicting interpretations	17	7673772	GRCh38	142324	152038
NM_016492.4(RANGRF):c.81C>T (p.Asp27=)	RANGRF|SLC25A35	Cardiac arrhythmia	GMAF:0.00340(T), GO-ESP:0.00418(T)	Benign(Last reviewed: Nov 15, 2015)	criteria provided, single submitter	17	8288959	GRCh38	241109	243021
NM_016492.4(RANGRF):c.151C>G (p.Leu51Val)	RANGRF|SLC25A35	not specified		Uncertain significance(Last reviewed: May 23, 2016)	criteria provided, single submitter	17	8289029	GRCh38	190844	188669
NM_016492.4(RANGRF):c.249G>C (p.Glu83Asp)	RANGRF|SLC25A35	not specified	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	17	8289312	GRCh38	190842	188671
NM_016492.4(RANGRF):c.364G>A (p.Val122Met)	RANGRF|SLC25A35	not specified	GMAF:0.00040(A), GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jan 16, 2014)	criteria provided, single submitter	17	8289515	GRCh38	190843	188672
NM_016492.4(RANGRF):c.510G>A (p.Gln170=)	RANGRF|SLC25A35	Cardiac arrhythmia|not specified	GMAF:0.00120(A), GO-ESP:0.00241(A)	Benign(Last reviewed: Jan 10, 2016)	criteria provided, multiple submitters, no conflicts	17	8289885	GRCh38	138889	142592
NM_001256012.1(MYH10):c.838C>T (p.Arg280Cys)	MYH10	not provided		Uncertain significance(Last reviewed: Oct 1, 2014)	no assertion criteria provided	17	8552127	GRCh38	167870	178170
NM_002472.2(MYH8):c.2021G>A (p.Arg674Gln)	MYH8|MYHAS	Carney complex variant|Hecht syndrome		Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	17	10406924	GRCh38	14136	29175
NM_004589.3(SCO1):c.394G>A (p.Gly132Ser)	SCO1	Cytochrome-c oxidase deficiency	GO-ESP:0.00002(T)	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	17	10692932	GRCh38	120177	125785
NM_007202.3(AKAP10):c.1936A>G (p.Ile646Val)	AKAP10	Cardiac conduction defect, susceptibility to	GO-ESP:0.45041(C), GMAF:0.39400(C), GO-ESP:0.37365(C)	risk factor(Last reviewed: May 15, 2007)	no assertion criteria provided	17	19909228	GRCh38	5404	20443
NM_178170.2(NEK8):c.47+1delG	NEK8	not specified		Uncertain significance(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	17	28728861	GRCh38	189238	187127
NM_178170.2(NEK8):c.1795C>T (p.Arg599Ter)	NEK8	Renal-hepatic-pancreatic dysplasia 2	GO-ESP:0.00008(T), GO-ESP:0.00004(T)	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	17	28741140	GRCh38	65408	76339
NM_000267.3(NF1):c.2531T>G (p.Leu844Arg)	NF1	Neurofibromatosis, type 1		Pathogenic(Last reviewed: Jul 30, 2005)	no assertion criteria provided	17	31229146	GRCh38	373	15412
NM_000267.3(NF1):c.3104T>G (p.Met1035Arg)	NF1	Neurofibromatosis, type 1		Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	17	31230373	GRCh38	347	15386
NM_013975.3(LIG3):c.1440T>C (p.Pro480=)	LIG3	Cardiac arrhythmia	GO-ESP:0.00002(C)	Likely benign(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	17	34992677	GRCh38	36472	45134
NM_003673.3(TCAP):c.32C>T (p.Ser11Leu)	TCAP	Dilated cardiomyopathy 1N|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00080(T)	Likely benign(Last reviewed: Jan 27, 2016)	criteria provided, multiple submitters, no conflicts	17	39665391	GRCh38	177939	176490
NM_003673.3(TCAP):c.52C>T (p.Arg18Trp)	TCAP	Cardiovascular phenotype		Uncertain significance(Last reviewed: Mar 17, 2015)	criteria provided, single submitter	17	39665411	GRCh38	263956	259005
NM_003673.3(TCAP):c.60C>G (p.Ala20=)	TCAP	Dilated cardiomyopathy 1N|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.00046(G), GO-ESP:0.00029(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	17	39665419	GRCh38	44714	53881
NM_003673.3(TCAP):c.191C>T (p.Ser64Leu)	TCAP	Dilated cardiomyopathy 1N|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00354(T), GMAF:0.00260(T), GO-ESP:0.00111(T)	Benign(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	17	39665796	GRCh38	44705	53872
NM_003673.3(TCAP):c.208C>T (p.Arg70Trp)	TCAP	Dilated cardiomyopathy 1N|not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2016)	criteria provided, conflicting interpretations	17	39665813	GRCh38	189789	187659
NM_003673.3(TCAP):c.300C>T (p.Gly100=)	TCAP	Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00002(T)	Likely benign(Last reviewed: Oct 18, 2013)	criteria provided, single submitter	17	39665905	GRCh38	263750	259007
NM_003673.3(TCAP):c.313G>C (p.Glu105Gln)	TCAP	Dilated cardiomyopathy 1N|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GMAF:0.00060(C), GO-ESP:0.00037(C)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2016)	criteria provided, conflicting interpretations	17	39665918	GRCh38	191776	189965
NM_003673.3(TCAP):c.316C>T (p.Arg106Cys)	TCAP	Dilated cardiomyopathy 1N|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00361(T), GMAF:0.00840(T), GO-ESP:0.01958(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	39665921	GRCh38	44706	53873
NM_003673.3(TCAP):c.448G>A (p.Gly150Ser)	TCAP	Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Aug 25, 2015)	criteria provided, multiple submitters, no conflicts	17	39666053	GRCh38	222831	224515
NM_003673.3(TCAP):c.453A>C (p.Ala151=)	TCAP	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	GO-ESP:0.61834(C), GMAF:0.45030(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	39666058	GRCh38	44709	53876
NM_002230.2(JUP):c.*2C>T	JUP	not specified|Cardiovascular phenotype	GMAF:0.00640(A), GO-ESP:0.00200(A)	Benign(Last reviewed: Feb 2, 2016)	criteria provided, multiple submitters, no conflicts	17	41755742	GRCh38	163706	176810
NM_002230.2(JUP):c.2089A>T (p.Met697Leu)	JUP	Naxos disease|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.69699(A), GMAF:0.41270(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	41755893	GRCh38	21304	34156
NM_002230.2(JUP):c.2069A>G (p.Asn690Ser)	JUP	Naxos disease|Paroxysmal familial ventricular fibrillation 1|Arrhythmogenic right ventricular cardiomyopathy, type 12|not specified	GO-ESP:0.00008(C)	Uncertain significance(Last reviewed: Jan 4, 2016)	criteria provided, multiple submitters, no conflicts	17	41756192	GRCh38	163710	176814
NM_002230.2(JUP):c.2046T>A (p.Ala682=)	JUP	Cardiovascular phenotype	GO-ESP:0.00011(T)	Likely benign(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	17	41757415	GRCh38	263755	259008
NM_021991.2(JUP):c.2038_2039delTG (p.Trp680Glyfs)	JUP	Naxos disease		Pathogenic(Last reviewed: Jul 10, 2008)	no assertion criteria provided	17	41757422 - 41757423	GRCh38	13599	28638
NM_002230.2(JUP):c.2025T>C (p.His675=)	JUP	Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12|not specified|Cardiovascular phenotype	GMAF:0.00420(G), GO-ESP:0.00082(G)	Benign/Likely benign(Last reviewed: Feb 15, 2016)	criteria provided, multiple submitters, no conflicts	17	41757436	GRCh38	137960	141663
NM_002230.2(JUP):c.1959C>T (p.Ser653=)	JUP	not specified|Cardiovascular phenotype	GO-ESP:0.00005(A)	Likely benign(Last reviewed: May 3, 2013)	criteria provided, multiple submitters, no conflicts	17	41757502	GRCh38	178040	178212
NM_002230.2(JUP):c.1942G>A (p.Val648Ile)	JUP	Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12|not specified|Cardiovascular phenotype	GO-ESP:0.00677(T), GMAF:0.00260(T), GO-ESP:0.00743(T)	Benign(Last reviewed: Mar 18, 2016)	criteria provided, multiple submitters, no conflicts	17	41757519	GRCh38	45842	55007
NM_002230.2(JUP):c.1824G>A (p.Leu608=)	JUP	Naxos disease|Cardiovascular phenotype|Cardiomyopathy, ARVC		Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	17	41757734	GRCh38	264280	259010
NM_002230.2(JUP):c.1807G>T (p.Val603Leu)	JUP	Paroxysmal familial ventricular fibrillation 1|not specified	GMAF:0.00120(A), GO-ESP:0.00066(A)	Uncertain significance(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	17	41757751	GRCh38	180376	178718
NM_002230.2(JUP):c.1774-13C>T	JUP	Cardiac arrhythmia|Naxos disease|not specified|Cardiomyopathy, ARVC	GO-ESP:0.02286(A), GMAF:0.02540(A), GO-ESP:0.00691(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	41757797	GRCh38	36424	45087
NM_002230.2(JUP):c.1702C>T (p.His568Tyr)	JUP	Cardiac arrhythmia		Likely pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	17	41758470	GRCh38	201826	198485
NM_002230.2(JUP):c.1582G>A (p.Val528Ile)	JUP	not specified	GMAF:0.00020(T), GO-ESP:0.00010(T)	Uncertain significance(Last reviewed: May 27, 2015)	criteria provided, multiple submitters, no conflicts	17	41758786	GRCh38	201825	198486
NM_002230.2(JUP):c.1563A>G (p.Ala521=)	JUP	Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00292(C), GMAF:0.00240(C), GO-ESP:0.00627(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	41758805	GRCh38	45837	55002
NM_002230.2(JUP):c.1366G>A (p.Val456Ile)	JUP	Cardiac arrhythmia|Naxos disease|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiomyopathy, ARVC	GMAF:0.00080(T), GO-ESP:0.00030(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	17	41763114	GRCh38	180375	178719
NM_002230.2(JUP):c.1355C>T (p.Thr452Met)	JUP	not specified	GO-ESP:0.00007(A)	Uncertain significance(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	17	41763125	GRCh38	201824	198487
NM_002230.2(JUP):c.1354A>T (p.Thr452Ser)	JUP	not specified		Uncertain significance(Last reviewed: May 6, 2015)	criteria provided, single submitter	17	41763126	GRCh38	201823	198488
NM_002230.2(JUP):c.1333G>C (p.Ala445Pro)	JUP	Cardiovascular phenotype	GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	17	41763147	GRCh38	264551	259009
NM_002230.2(JUP):c.1296C>T (p.Asn432=)	JUP	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00003(A)	Likely benign(Last reviewed: Jul 12, 2013)	criteria provided, single submitter	17	41763184	GRCh38	263664	259011
NM_002230.2(JUP):c.1224C>T (p.Leu408=)	JUP	Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00692(A), GMAF:0.00740(A), GO-ESP:0.00162(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	41763256	GRCh38	45832	54997
NM_002230.2(JUP):c.1130G>A (p.Arg377His)	JUP	Cardiac arrhythmia	GMAF:0.00020(T), GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Jul 29, 2012)	criteria provided, single submitter	17	41764741	GRCh38	201822	198489
NM_002230.2(JUP):c.958C>T (p.Arg320Cys)	JUP	not specified	GMAF:0.00060(A), GO-ESP:0.00019(A)	Uncertain significance(Last reviewed: Oct 31, 2014)	criteria provided, single submitter	17	41765019	GRCh38	201833	198492
NM_002230.2(JUP):c.909+6C>T	JUP	Cardiac arrhythmia|Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12|not specified|Cardiomyopathy, ARVC	GO-ESP:0.00178(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	17	41767373	GRCh38	36426	45089
NM_002230.2(JUP):c.892G>A (p.Gly298Ser)	JUP	not specified|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Jun 26, 2015)	criteria provided, multiple submitters, no conflicts	17	41767396	GRCh38	201819	198493
NM_002230.2(JUP):c.867C>T (p.Thr289=)	JUP	Cardiac arrhythmia|Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.01653(A), GMAF:0.01480(A), GO-ESP:0.00464(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	41767421	GRCh38	36425	45088
NM_002230.2(JUP):c.818T>C (p.Met273Thr)	JUP	Cardiac arrhythmia|Naxos disease|Cardiomyopathy, ARVC	GO-ESP:0.00003(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	17	41767470	GRCh38	201831	198495
NM_002230.2(JUP):c.568G>A (p.Val190Met)	JUP	not specified	GMAF:0.00020(T), GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Jul 10, 2014)	criteria provided, single submitter	17	41769108	GRCh38	201814	198501
NM_002230.2(JUP):c.567C>T (p.Val189=)	JUP	not specified|Cardiovascular phenotype	GO-ESP:0.00069(A), GMAF:0.00060(A), GO-ESP:0.00036(A)	Benign/Likely benign(Last reviewed: Mar 10, 2014)	criteria provided, multiple submitters, no conflicts	17	41769109	GRCh38	45854	55019
NM_002230.2(JUP):c.546G>A (p.Ser182=)	JUP	Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GMAF:0.00080(T), GO-ESP:0.00016(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	17	41769130	GRCh38	227451	231352
NM_002230.2(JUP):c.529C>T (p.Arg177Trp)	JUP	not specified	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Dec 28, 2015)	criteria provided, single submitter	17	41769147	GRCh38	201813	198502
NM_002230.2(JUP):c.526C>T (p.Arg176Trp)	JUP	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	GO-ESP:0.00007(A)	Uncertain significance(Last reviewed: Dec 19, 2015)	criteria provided, multiple submitters, no conflicts	17	41769150	GRCh38	191675	189972
NM_002230.2(JUP):c.521C>T (p.Ala174Val)	JUP	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	17	41769155	GRCh38	264367	259013
NM_002230.2(JUP):c.509C>T (p.Ser170Leu)	JUP	Naxos disease|not specified|Cardiomyopathy, ARVC	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	41769167	GRCh38	201812	198503
NM_002230.2(JUP):c.486G>A (p.Ala162=)	JUP	not specified|Cardiovascular phenotype	GO-ESP:0.00031(T), GMAF:0.00040(T), GO-ESP:0.00061(T)	Benign/Likely benign(Last reviewed: Nov 4, 2013)	criteria provided, multiple submitters, no conflicts	17	41769190	GRCh38	45852	55017
NM_002230.2(JUP):c.467C>T (p.Pro156Leu)	JUP	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Nov 18, 2013)	criteria provided, single submitter	17	41769419	GRCh38	263731	259018
NM_002230.2(JUP):c.427G>A (p.Ala143Thr)	JUP	not specified	GO-ESP:0.00011(T)	Uncertain significance(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	17	41769459	GRCh38	201811	198504
NM_002230.2(JUP):c.425G>A (p.Arg142His)	JUP	Naxos disease|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.04221(T), GMAF:0.02400(T), GO-ESP:0.04974(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	41769461	GRCh38	45851	55016
NM_002230.2(JUP):c.406G>C (p.Asp136His)	JUP	not provided		Likely pathogenic(Last reviewed: Nov 20, 2013)	criteria provided, single submitter	17	41769480	GRCh38	201810	198505
NM_002230.2(JUP):c.405C>T (p.Asp135=)	JUP	Naxos disease|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.03568(A), GMAF:0.02720(A), GO-ESP:0.01127(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	41769481	GRCh38	45850	55015
NM_002230.2(JUP):c.329C>T (p.Ala110Val)	JUP	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 6, 2015)	criteria provided, single submitter	17	41769557	GRCh38	264370	259012
NM_002230.2(JUP):c.213T>C (p.Asp71=)	JUP	Naxos disease|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.79556(G), GMAF:0.28440(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	41769673	GRCh38	45845	55010
NM_002230.2(JUP):c.209G>C (p.Gly70Ala)	JUP	not specified		Uncertain significance(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	17	41769677	GRCh38	201808	198507
NM_002230.2(JUP):c.100G>A (p.Val34Met)	JUP	Cardiac arrhythmia	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Apr 14, 2014)	criteria provided, single submitter	17	41771755	GRCh38	201807	198508
NM_002230.2(JUP):c.56C>T (p.Thr19Ile)	JUP	Naxos disease|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GMAF:0.00020(A), GO-ESP:0.00011(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	41771799	GRCh38	179756	178295
NM_138387.3(G6PC3):c.758G>A (p.Arg253His)	G6PC3	Severe congenital neutropenia 4, autosomal recessive	GO-ESP:0.00002(A)	Pathogenic(Last reviewed: Jan 18, 2015)	no assertion criteria provided	17	44075760	GRCh38	1037	16076
NM_000023.3(SGCA):c.410A>G (p.Glu137Gly)	SGCA	Limb-girdle muscular dystrophy, type 2D		Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	17	50168398	GRCh38	9438	24477
NM_004655.3(AXIN2):c.2051C>T (p.Ala684Val)	AXIN2	Oligodontia-colorectal cancer syndrome|not specified	GMAF:0.00040(A), GO-ESP:0.00188(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	17	65536410	GRCh38	127941	133398
NM_002734.4(PRKAR1A):c.220C>T (p.Arg74Cys)	PRKAR1A	Carney complex, type 1|Carney complex	GO-ESP:0.00008(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	17	68522798	GRCh38	12674	27713
NM_212472.2(PRKAR1A):c.618_621delTTAT (p.Ile206Metfs)	PRKAR1A	Atrial myxoma, familial		Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	17	68525822 - 68525825	GRCh38	12665	27704
NM_000891.2(KCNJ2):c.2T>C (p.Met1Thr)	KCNJ2	not specified		Uncertain significance(Last reviewed: May 11, 2015)	criteria provided, single submitter	17	70175041	GRCh38	190805	188647
NM_000891.2(KCNJ2):c.118C>T (p.Arg40Ter)	KCNJ2	not specified		Uncertain significance(Last reviewed: May 16, 2016)	criteria provided, single submitter	17	70175157	GRCh38	190806	188648
NM_000891.2(KCNJ2):c.161G>T (p.Cys54Phe)	KCNJ2	Andersen Tawil syndrome|Familial periodic paralysis		Pathogenic(Last reviewed: Apr 15, 2007)	no assertion criteria provided	17	70175200	GRCh38	30119	39075
NM_000891.2(KCNJ2):c.174C>T (p.Phe58=)	KCNJ2	not specified|Cardiovascular phenotype	GO-ESP:0.00009(T)	Benign/Likely benign(Last reviewed: Aug 8, 2013)	criteria provided, multiple submitters, no conflicts	17	70175213	GRCh38	137983	141686
NM_000891.2(KCNJ2):c.199C>T (p.Arg67Trp)	KCNJ2	Andersen Tawil syndrome|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	17	70175238	GRCh38	8923	23962
NM_000891.2(KCNJ2):c.200G>A (p.Arg67Gln)	KCNJ2	not provided|Congenital long QT syndrome	GO-ESP:0.00001(A)	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	17	70175239	GRCh38	67560	78456
NM_000891.2(KCNJ2):c.213C>T (p.Asp71=)	KCNJ2	Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00022(T)	Likely benign(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	17	70175252	GRCh38	263553	259015
NM_000891.2(KCNJ2):c.256G>T (p.Val86Phe)	KCNJ2	not specified		Uncertain significance(Last reviewed: Jan 31, 2013)	criteria provided, single submitter	17	70175295	GRCh38	190810	188652
NM_000891.2(KCNJ2):c.394_396dupGCC (p.Ala132_Phe133insAla)	KCNJ2	Cardiac arrhythmia		Uncertain significance(Last reviewed: Sep 26, 2014)	criteria provided, single submitter	17	70175433 - 70175435	GRCh38	190822	188654
NM_000891.2(KCNJ2):c.653G>A (p.Arg218Gln)	KCNJ2	Andersen Tawil syndrome|not provided|Congenital long QT syndrome		Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, multiple submitters, no conflicts	17	70175692	GRCh38	67585	78481
NM_000891.2(KCNJ2):c.660C>T (p.Ser220=)	KCNJ2	Andersen Tawil syndrome|Cardiac arrhythmia|short QT syndrome|not specified|Familial atrial fibrillation|Cardiovascular phenotype	GO-ESP:0.07604(T), GMAF:0.07290(T), GO-ESP:0.02084(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	70175699	GRCh38	36434	45097
NM_000891.2(KCNJ2):c.750C>A (p.Ile250=)	KCNJ2	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	17	70175789	GRCh38	264238	259016
NM_000891.2(KCNJ2):c.913A>G (p.Thr305Ala)	KCNJ2	Arrhythmia		not provided	no assertion provided	17	70175952	GRCh38	67591	78487
NM_000891.2(KCNJ2):c.913A>C (p.Thr305Pro)	KCNJ2	Andersen Tawil syndrome|Congenital long QT syndrome		Pathogenic(Last reviewed: Apr 15, 2007)	no assertion criteria provided	17	70175952	GRCh38	30120	39076
NM_000891.2(KCNJ2):c.916_918delGCC (p.Ala306del)	KCNJ2	Cardiac arrhythmia		Likely pathogenic(Last reviewed: Dec 19, 2011)	criteria provided, single submitter	17	70175955 - 70175957	GRCh38	190823	188660
NM_000891.2(KCNJ2):c.935G>A (p.Arg312His)	KCNJ2	Cardiac arrhythmia		Pathogenic(Last reviewed: Jul 25, 2011)	criteria provided, single submitter	17	70175974	GRCh38	190820	188661
NM_000891.2(KCNJ2):c.1045G>A (p.Glu349Lys)	KCNJ2	not provided	GO-ESP:0.00004(A)	Likely pathogenic(Last reviewed: Sep 16, 2014)	criteria provided, single submitter	17	70176084	GRCh38	190818	188664
NM_000891.2(KCNJ2):c.1065T>G (p.Leu355=)	KCNJ2	not specified|Cardiovascular phenotype	GMAF:0.00080(G), GO-ESP:0.00022(G)	Benign/Likely benign(Last reviewed: Jan 8, 2014)	criteria provided, multiple submitters, no conflicts	17	70176104	GRCh38	137987	141690
NM_000891.2(KCNJ2):c.1146C>T (p.Leu382=)	KCNJ2	Andersen Tawil syndrome|short QT syndrome|not specified|Familial atrial fibrillation|Cardiovascular phenotype	GMAF:0.15400(T), GO-ESP:0.13372(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	70176185	GRCh38	137988	141691
NM_000891.2(KCNJ2):c.1199C>T (p.Thr400Met)	KCNJ2	Long QT syndrome|not provided	GO-ESP:0.00008(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	criteria provided, conflicting interpretations	17	70176238	GRCh38	161258	171190
NM_000891.2(KCNJ2):c.1229A>G (p.Asn410Ser)	KCNJ2	Andersen Tawil syndrome|short QT syndrome|not specified|Familial atrial fibrillation	GMAF:0.00020(G), GO-ESP:0.00037(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	17	70176268	GRCh38	190804	188666
NM_000891.2(KCNJ2):c.1244C>T (p.Pro415Leu)	KCNJ2	not specified	GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	17	70176283	GRCh38	190819	188667
NM_000891.2(KCNJ2):c.1259C>T (p.Pro420Leu)	KCNJ2	Andersen Tawil syndrome|short QT syndrome|Familial atrial fibrillation|Cardiovascular phenotype	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	70176298	GRCh38	264482	259021
NM_000891.2(KCNJ2):c.*18T>C	KCNJ2	Cardiac arrhythmia		Benign(Last reviewed: Jul 15, 2011)	criteria provided, single submitter	17	70176341	GRCh38	137989	141692
GRCh38/hg38 17p11.2-11.1(chr17:22181582-22762465)x1	FAM27E5|FLJ36000|MTRNR2L1	See cases		Uncertain significance	no assertion criteria provided	17	22181582 - 22762465	GRCh38	155479	165233
GRCh38/hg38 17q23.3(chr17:63648253-63855879)x3	MAP3K3|PSMC5|SMARCD2|DDX42|CCDC47|LIMD2|STRADA|FTSJ3|LOC729683	See cases		Uncertain significance(Last reviewed: Sep 21, 2012)	no assertion criteria provided	17	63648253 - 63855879	GRCh38	150795	160546
GRCh38/hg38 17q22-23.1(chr17:59151705-59547602)x3	SMG8|PRR11|GDPD1|SKA2|YPEL2|MIR4729|LINC01476	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	17	59151705 - 59547602	GRCh38	150741	160492
GRCh38/hg38 17q21.31(chr17:43088882-43865172)x3	ARL4D|BRCA1|DHX8|DUSP3|ETV4|NBR1|MEOX1|MPP3|RNU2-1|NBR2|SOST|TMEM106A|CD300LG|C17orf105|LINC00910|MIR2117|LINC00854|LOC101929767	See cases		Uncertain significance(Last reviewed: Sep 21, 2012)	no assertion criteria provided	17	43088882 - 43865172	GRCh38	150167	159918
GRCh38/hg38 17p11.2(chr17:16117885-18362819)x1	DRG2|FLII|LLGL1|SHMT1|SREBF1|TOP3A|UBB|COPS3|PIGL|NCOR1|CCDC144A|PEMT|RAI1|MPRIP|TNFRSF13B|SNORD49A|MYO15A|TRPV2|RASD1|ALKBH5|MED9|NT5M|ZNF287|ZNF624|GID4|DRC3|ATPAF2|TBC1D27|LRRC75A-AS1|MIEF2|SMCR5|SMCR8|TOM1L2|CENPV|FLCN|PLD6|LRRC75A|SNORD49B|SNORD65|MIR33B|FAM106CP|MIR1288|RAI1-AS1|MIR6777|MIR6778|SMCR2	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	16117885 - 18362819	GRCh38	60433	75028
GRCh38/hg38 17p13.2(chr17:4201600-4574195)x3	UBE2G1|MYBBP1A|ANKFY1|GGT6|SPNS2|SPNS3	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	4201600 - 4574195	GRCh38	60131	74726
GRCh38/hg38 17p13.3(chr17:2490435-2638867)x3	PAFAH1B1|METTL16	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	2490435 - 2638867	GRCh38	60098	74693
GRCh38/hg38 17p13.3(chr17:2452259-2691244)x3	PAFAH1B1|CLUH|METTL16	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	2452259 - 2691244	GRCh38	60097	74692
GRCh38/hg38 17p13.1(chr17:7478195-8435524)x1	ALOX12B|ALOX15B|ATP1B2|CD68|CHD3|EFNB3|EIF4A1|GUCY2D|PER1|PFAS|POLR2A|RPL26|SHBG|SOX15|VAMP2|TP53|TRG-GCC2-6|TRK-TTT3-5|TRL-TAG1-1|TRQ-CTG1-5|TRR-TCT2-1|TNFSF13|TNFSF12|KCNAB3|AURKB|FXR2|MPDU1|ARHGEF15|KDM6B|SENP3|SNORA67|RANGRF|BORCS6|WRAP53|ZBTB4|TRAPPC1|ALOXE3|CTC1|TMEM107|NAA38|HES7|TMEM88|SAT2|CNTROB|CYB5D1|KRBA2|DNAH2|ODF4|LOC284023|LINC00324|SLC25A35|TNFSF12-TNFSF13|SLC35G6|RNF222|SNORA48|SNORD10|SCARNA21|SNORD118|LOC100128288|TRS-CGA1-1|TRW-CCA3-3|TRW-CCA1-1|TRP-CGG1-3|TRS-AGA2-6|TRT-AGT1-1|TRG-TCC3-1|TRT-AGT1-2|TRS-GCT4-3|TRD-GTC2-11|TRI-AAT5-5|TRI-AAT4-1|TRT-AGT5-1|MIR4314|SENP3-EIF4A1|MIR4521|LOC100996842|MIR6883	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	7478195 - 8435524	GRCh38	59583	74178
GRCh38/hg38 17p13.3(chr17:193307-1376276)x1	ABR|YWHAE|RPH3AL|TIMM22|GEMIN4|GLOD4|MRM3|VPS53|NXN|FAM57A|TUSC5|RFLNB|C17orf97|BHLHA9|MIR3183|LOC100506388|LOC101927727|LOC105371430	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	193307 - 1376276	GRCh38	59543	74138
GRCh38/hg38 17q11.2(chr17:30650145-31015565)x3	CRLF3|ADAP2|TEFM|ATAD5|RNF135	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	30650145 - 31015565	GRCh38	59306	73901
GRCh38/hg38 17q12(chr17:36180741-38169599)x3	ACACA|LHX1|CCL3|CCL4|CCL14|CCL15|CCL18|CCL23|TADA2A|HNF1B|ZNHIT3|CCL4L2|DDX52|DUSP14|SYNRG|AATF|DHRS11|GGNBP2|MRM1|MYO19|TBC1D3F|PIGW|C17orf78|CCL15-CCL14|TBC1D3B|CCL3L3|TBC1D3H|MIR2909|TBC1D3G|MIR378J|LOC102723471|TBC1D3I|SNORA90	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	218526 - 2142084	GRCh38	58166	72761
GRCh38/hg38 17p11.2(chr17:16760818-20504849)x3	ALDH3A1|ALDH3A2|DRG2|FLII|LLGL1|MFAP4|MAPK7|PRPSAP2|SHMT1|SREBF1|TOP3A|RNF112|COPS3|ULK2|CCDC144A|PEMT|FBXW10|RAI1|GRAP|AKAP10|EPN2|MPRIP|TNFRSF13B|SNORD3B-1|B9D1|TVP23B|MYO15A|RASD1|ALKBH5|MED9|SLC47A1|NT5M|GID4|LOC79999|FAM106A|DRC3|ATPAF2|SPECC1|TBC1D27|MIEF2|SLC5A10|SMCR5|SMCR8|TOM1L2|SLC47A2|TRIM16L|FLCN|PLD6|NOS2P2|TBC1D28|LGALS9B|LOC388436|FLJ35934|GRAPL|FAM83G|EVPLL|LGALS9C|SNORA59B|MIR33B|ZNF286B|SNORD3A|SNORD3B-2|SNORD3C|SNORD3D|FAM106CP|TRW-CCA2-1|TRG-CCC3-1|MIR1180|RAI1-AS1|EPN2-AS1|EPN2-IT1|FAM106B|MIR6777|MIR6778|SMCR2	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	16760818 - 20504849	GRCh38	58128	72723
GRCh38/hg38 17p12(chr17:14186983-15578926)x3	COX10|PMP22|HS3ST3B1|TEKT3|MGC12916|CDRT7|CDRT8|CDRT15|TVP23C|CDRT4|CDRT1|TVP23C-CDRT4|MIR4731|LOC101928475	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	14186983 - 15578926	GRCh38	58102	72697
GRCh38/hg38 17q21.31(chr17:45674308-46273786)x1	CRHR1|MAPT|LRRC37A|SPPL2C|STH|KANSL1|KANSL1-AS1|MAPT-AS1|MAPT-IT1|CRHR1-IT1-CRHR1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	45674308 - 46273786	GRCh38	57541	72136
GRCh38/hg38 17q21.31(chr17:45629520-46098805)x1	CRHR1|MAPT|CRHR1-IT1|SPPL2C|STH|KANSL1|MAPT-AS1|MAPT-IT1|CRHR1-IT1-CRHR1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	17	45629520 - 46098805	GRCh38	57538	72133
NM_003803.3(MYOM1):c.3708C>A (p.Ser1236Arg)	MYOM1	Cardiac arrest		Uncertain significance(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	18	3100178	GRCh38	222745	224527
NM_003803.3(MYOM1):c.3190C>T (p.His1064Tyr)	MYOM1	Sudden cardiac death	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	18	3116444	GRCh38	222744	224533
NM_021074.4(NDUFV2):c.120+5_120+8delGTAA	NDUFV2	not provided		Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	18	9117908 - 9117911	GRCh38	279920	264825
NM_005257.5(GATA6):c.222G>A (p.Pro74=)	GATA6	Atrioventricular septal defect 5	GMAF:0.00260(A), GO-ESP:0.00070(A)	Benign(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	18	22171366	GRCh38	240130	243031
NM_005257.5(GATA6):c.533C>T (p.Ala178Val)	GATA6	Atrioventricular septal defect 5	GMAF:0.00080(T), GO-ESP:0.00041(T)	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	18	22171677	GRCh38	30209	39165
NM_005257.5(GATA6):c.551G>A (p.Ser184Asn)	GATA6	Tetralogy of Fallot|Atrial septal defect 9	GMAF:0.00100(A), GO-ESP:0.00084(A)	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	18	22171695	GRCh38	30210	39166
NM_005257.5(GATA6):c.993_998delCCACCA (p.His332_His333del)	GATA6	Atrioventricular septal defect 5		Uncertain significance(Last reviewed: Mar 27, 2016)	criteria provided, single submitter	18	22172137 - 22172142	GRCh38	240131	243032
NM_005257.5(GATA6):c.1374C>T (p.Asn458=)	GATA6	Atrioventricular septal defect 5	GMAF:0.00100(T), GO-ESP:0.00199(T)	Benign(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	18	22181524	GRCh38	240127	243033
NM_005257.5(GATA6):c.1396A>C (p.Asn466His)	GATA6	Persistent truncus arteriosus		Pathogenic(Last reviewed: Aug 18, 2009)	no assertion criteria provided	18	22181546	GRCh38	30207	39163
NM_005257.5(GATA6):c.1448_1455delTGAAAAAA (p.Met483Argfs)	GATA6	Pancreatic agenesis and congenital heart disease		Pathogenic(Last reviewed: Dec 11, 2011)	no assertion criteria provided	18	22182776 - 22182783	GRCh38	30212	39168
NM_005257.5(GATA6):c.1602A>G (p.Thr534=)	GATA6	Atrioventricular septal defect 5	GMAF:0.00120(G), GO-ESP:0.00342(G)	Benign(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	18	22183025	GRCh38	240128	243034
NM_005257.5(GATA6):c.1605A>G (p.Gln535=)	GATA6	not specified|Atrioventricular septal defect 5	GMAF:0.00060(G), GO-ESP:0.00147(G)	Benign(Last reviewed: Mar 13, 2016)	criteria provided, multiple submitters, no conflicts	18	22183028	GRCh38	240129	243035
NM_024422.4(DSC2):c.2686_2687dupGA (p.Ala897Lysfs)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|Arrhythmogenic right ventricular cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00360(TC)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 19, 2016)	criteria provided, conflicting interpretations	18	31068034 - 31068035	GRCh38	46186	55351
NM_024422.4(DSC2):c.2587G>A (p.Gly863Arg)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|not specified|Cardiovascular phenotype	GO-ESP:0.00046(T), GMAF:0.00040(T), GO-ESP:0.00027(T)	Uncertain significance(Last reviewed: Jun 28, 2016)	criteria provided, multiple submitters, no conflicts	18	31068134	GRCh38	46183	55348
NM_024422.4(DSC2):c.2498G>A (p.Arg833His)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|not specified|Cardiovascular phenotype	GO-ESP:0.00031(T), GMAF:0.00020(T), GO-ESP:0.00017(T)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2015)	criteria provided, conflicting interpretations	18	31068904	GRCh38	46182	55347
NM_024422.4(DSC2):c.2393G>A (p.Arg798Gln)	DSC2	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.03421(T), GMAF:0.02760(T), GO-ESP:0.04949(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31069009	GRCh38	36006	44670
NM_024422.4(DSC2):c.2368_2370delGGA (p.Gly790del)	DSC2	Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00440(-), GO-ESP:0.00138(-)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2015)	criteria provided, conflicting interpretations	18	31069032 - 31069034	GRCh38	180319	178726
NM_024422.4(DSC2):c.2353G>A (p.Glu785Lys)	DSC2	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Mar 14, 2013)	criteria provided, single submitter	18	31069049	GRCh38	263563	259014
NM_024422.4(DSC2):c.2335G>A (p.Gly779Arg)	DSC2	not specified|not provided	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Jul 5, 2016)	criteria provided, multiple submitters, no conflicts	18	31069067	GRCh38	191619	189979
NM_024422.4(DSC2):c.2326A>G (p.Ile776Val)	DSC2	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.19122(C), GMAF:0.19650(C), GO-ESP:0.11901(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31069076	GRCh38	46178	55343
NM_024422.4(DSC2):c.2314G>A (p.Val772Met)	DSC2	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00007(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 22, 2015)	criteria provided, conflicting interpretations	18	31069088	GRCh38	191620	189980
NM_024422.4(DSC2):c.2245A>C (p.Lys749Gln)	DSC2	not specified	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	18	31070731	GRCh38	199771	197937
NM_024422.4(DSC2):c.2244C>T (p.Asp748=)	DSC2	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	18	31070732	GRCh38	264255	259019
NM_024422.4(DSC2):c.2202G>A (p.Gln734=)	DSC2	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Oct 6, 2015)	criteria provided, single submitter	18	31070774	GRCh38	264369	259020
NM_024422.4(DSC2):c.1914G>C (p.Gln638His)	DSC2	not specified|not provided	GO-ESP:0.00069(G), GO-ESP:0.00042(G)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 10, 2015)	criteria provided, conflicting interpretations	18	31071816	GRCh38	46173	55338
NM_024422.4(DSC2):c.1787C>T (p.Ala596Val)	DSC2	Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00092(A), GMAF:0.00220(A), GO-ESP:0.00125(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2016)	criteria provided, conflicting interpretations	18	31074784	GRCh38	46171	55336
NM_024422.4(DSC2):c.1729A>G (p.Ile577Val)	DSC2	not specified|not provided	GO-ESP:0.00008(C), GO-ESP:0.00034(C)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31074842	GRCh38	46170	55335
NM_024422.4(DSC2):c.1721G>A (p.Ser574Asn)	DSC2	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Sep 26, 2016)	criteria provided, multiple submitters, no conflicts	18	31074850	GRCh38	178018	176654
NM_024422.4(DSC2):c.1521-1G>A	DSC2	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	18	31079990	GRCh38	264340	259025
NM_024422.4(DSC2):c.1350A>G (p.Arg450=)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|Cardiomyopathy|not specified	GO-ESP:0.00300(C), GMAF:0.00020(C), GO-ESP:0.00322(C)	Benign/Likely benign(Last reviewed: Nov 3, 2015)	criteria provided, multiple submitters, no conflicts	18	31080266	GRCh38	36004	44668
NM_024422.4(DSC2):c.1264-5C>T	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|not specified|Cardiovascular phenotype	GO-ESP:0.00369(A), GMAF:0.00260(A), GO-ESP:0.00090(A)	Benign(Last reviewed: Nov 25, 2015)	criteria provided, multiple submitters, no conflicts	18	31080357	GRCh38	46165	55330
NM_024422.4(DSC2):c.1231A>G (p.Lys411Glu)	DSC2	not specified	GO-ESP:0.00005(C)	Uncertain significance(Last reviewed: May 14, 2015)	criteria provided, single submitter	18	31082270	GRCh38	199766	197947
NM_004949.4(DSC2):c.1073C>T (p.Thr358Ile)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiac arrest|Cardiovascular phenotype	GO-ESP:0.00092(A), GMAF:0.00060(A), GO-ESP:0.00145(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 21, 2016)	criteria provided, conflicting interpretations	18	31082930	GRCh38	46160	55325
NM_024422.4(DSC2):c.870A>G (p.Pro290=)	DSC2	Cardiovascular phenotype	GO-ESP:0.00002(C)	Likely benign(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	18	31086648	GRCh38	264606	259017
NM_024422.4(DSC2):c.802A>G (p.Thr268Ala)	DSC2	not specified|Cardiovascular phenotype	GO-ESP:0.00017(C)	Uncertain significance(Last reviewed: Jul 3, 2014)	criteria provided, multiple submitters, no conflicts	18	31086716	GRCh38	178019	176519
NM_024422.4(DSC2):c.754A>G (p.Ile252Val)	DSC2	Cardiovascular phenotype	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: May 18, 2015)	criteria provided, single submitter	18	31087690	GRCh38	264041	259022
NM_024422.4(DSC2):c.697A>G (p.Ile233Val)	DSC2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	18	31087747	GRCh38	264192	259024
NM_024422.4(DSC2):c.536A>G (p.Asp179Gly)	DSC2	not specified	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Mar 26, 2014)	criteria provided, single submitter	18	31089533	GRCh38	199761	197954
NM_024422.4(DSC2):c.408A>G (p.Arg136=)	DSC2	not specified|Cardiovascular phenotype	GMAF:0.00060(C), GO-ESP:0.00004(C)	Uncertain significance(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	18	31091094	GRCh38	234987	236814
NM_024422.4(DSC2):c.351A>G (p.Thr117=)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00816(C), GMAF:0.00380(C), GO-ESP:0.00883(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	18	31092104	GRCh38	46188	55353
NM_024422.4(DSC2):c.348A>G (p.Gln116=)	DSC2	not specified|Cardiovascular phenotype	GO-ESP:0.00024(C)	Likely benign(Last reviewed: Aug 11, 2014)	criteria provided, multiple submitters, no conflicts	18	31092107	GRCh38	163192	176658
NM_024422.4(DSC2):c.321G>T (p.Lys107Asn)	DSC2	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Oct 4, 2013)	criteria provided, single submitter	18	31092134	GRCh38	263702	259029
NM_004949.4(DSC2):c.304G>A (p.Glu102Lys)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|not specified|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00077(T), GO-ESP:0.00074(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 28, 2016)	criteria provided, conflicting interpretations	18	31092151	GRCh38	46189	55354
NM_024422.4(DSC2):c.270G>A (p.Glu90=)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.00054(T), GO-ESP:0.00041(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	18	31092185	GRCh38	46187	55352
NM_024422.4(DSC2):c.236T>G (p.Val79Gly)	DSC2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 18, 2013)	criteria provided, single submitter	18	31092219	GRCh38	263500	259023
NM_024422.4(DSC2):c.111A>G (p.Leu37=)	DSC2	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.10710(C), GMAF:0.12360(C), GO-ESP:0.11273(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31093602	GRCh38	46163	55328
NM_024422.4(DSC2):c.82G>T (p.Ala28Ser)	DSC2	not specified|Cardiovascular phenotype	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Jan 7, 2013)	criteria provided, single submitter	18	31093631	GRCh38	234988	236815
NM_024422.4(DSC2):c.32A>G (p.Asn11Ser)	DSC2|DSCAS	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GMAF:0.08550(C), GO-ESP:0.01005(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31101940	GRCh38	46191	55356
NM_024422.4(DSC2):c.4G>A (p.Glu2Lys)	DSC2|DSCAS	not specified	GO-ESP:0.00040(T)	Uncertain significance(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	18	31101968	GRCh38	199776	197962
NM_001943.4(DSG2):c.6G>A (p.Ala2=)	DSG2	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC|Dilated Cardiomyopathy, Dominant	GMAF:0.00060(A), GO-ESP:0.00476(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	18	31498257	GRCh38	137166	140869
NM_001943.4(DSG2):c.44T>A (p.Leu15Gln)	DSG2	not specified|Cardiovascular phenotype	GO-ESP:0.00017(A), GO-ESP:0.00215(A)	Uncertain significance(Last reviewed: Oct 22, 2015)	criteria provided, multiple submitters, no conflicts	18	31498295	GRCh38	44318	53485
NM_001943.4(DSG2):c.86_87delTAinsATTCTATTGTTGTGCTATTGTTAT (p.Leu29Tyrfs)	DSG2	Cardiomyopathy		Pathogenic(Last reviewed: Dec 12, 2011)	criteria provided, single submitter	18	31519807 - 31519808	GRCh38	199834	197963
NM_001943.4(DSG2):c.166G>A (p.Val56Met)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Ventricular tachycardia, catecholaminergic polymorphic, 1|Arrhythmogenic right ventricular cardiomyopathy|Dilated cardiomyopathy 1BB|Primary familial hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00259(A), GMAF:0.00020(A), GO-ESP:0.00187(A)	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Nov 19, 2015)	criteria provided, conflicting interpretations	18	31519887	GRCh38	16818	31857
NM_001943.4(DSG2):c.208A>G (p.Ile70Val)	DSG2	Cardiovascular phenotype	GO-ESP:0.00005(G)	Uncertain significance(Last reviewed: Feb 18, 2013)	criteria provided, single submitter	18	31519929	GRCh38	263501	259026
NM_001943.4(DSG2):c.217-5G>T	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01135(T), GMAF:0.01300(T), GO-ESP:0.00362(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31520798	GRCh38	44296	53463
NM_001943.4(DSG2):c.220C>A (p.His74Asn)	DSG2	not specified		Uncertain significance(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	18	31520806	GRCh38	199798	197967
NM_001943.4(DSG2):c.221A>G (p.His74Arg)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|not specified|Cardiovascular phenotype	GMAF:0.00100(G), GO-ESP:0.00024(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 15, 2016)	criteria provided, conflicting interpretations	18	31520807	GRCh38	227340	230862
NM_001943.4(DSG2):c.273A>G (p.Gly91=)	DSG2	Cardiovascular phenotype	GMAF:0.00080(G), GO-ESP:0.00018(G)	Likely benign(Last reviewed: Sep 14, 2013)	criteria provided, single submitter	18	31520859	GRCh38	263740	259033
NM_001943.4(DSG2):c.437G>T (p.Arg146Leu)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|not specified|not provided|Cardiac arrest|Cardiovascular phenotype|Cardiomyopathy, ARVC|Dilated Cardiomyopathy, Dominant	GO-ESP:0.00075(T), GO-ESP:0.00031(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	18	31521157	GRCh38	44317	53484
NM_001943.4(DSG2):c.445G>A (p.Val149Ile)	DSG2	Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Sep 4, 2015)	criteria provided, multiple submitters, no conflicts	18	31521165	GRCh38	218601	215553
NM_001943.4(DSG2):c.473T>G (p.Val158Gly)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular dysplasia, familial 1|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	GMAF:0.00140(G), GO-ESP:0.00538(G)	Benign/Likely benign(Last reviewed: Mar 6, 2016)	criteria provided, multiple submitters, no conflicts	18	31521193	GRCh38	44319	53486
NM_001943.4(DSG2):c.523+2T>C	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, multiple submitters, no conflicts	18	31521245	GRCh38	44321	53488
NM_001943.4(DSG2):c.829_840delCTTGAAGGGATG (p.Leu277_Met280del)	DSG2	not provided		Pathogenic(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	18	31524703 - 31524714	GRCh38	199824	197973
NM_001943.4(DSG2):c.861C>T (p.Asn287=)	DSG2	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC|Dilated Cardiomyopathy, Dominant	GO-ESP:0.50588(T), GMAF:0.47340(C), GO-ESP:0.41164(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31524735	GRCh38	44329	53496
NM_001943.4(DSG2):c.862G>A (p.Val288Ile)	DSG2	not specified|Cardiovascular phenotype	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Jan 4, 2016)	criteria provided, multiple submitters, no conflicts	18	31524736	GRCh38	199829	197974
NM_001943.4(DSG2):c.873G>A (p.Thr291=)	DSG2	Cardiovascular phenotype	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	18	31524747	GRCh38	263760	259030
NM_001943.4(DSG2):c.877A>G (p.Ile293Val)	DSG2	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC|Dilated Cardiomyopathy, Dominant	GO-ESP:0.06360(G), GMAF:0.03240(G), GO-ESP:0.06867(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31524751	GRCh38	44331	53498
NM_001943.4(DSG2):c.918G>A (p.Trp306Ter)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|not provided		Pathogenic(Last reviewed: Oct 5, 2011)	criteria provided, single submitter	18	31524792	GRCh38	16811	31850
NM_001943.4(DSG2):c.967A>G (p.Ile323Val)	DSG2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	18	31524841	GRCh38	264242	259027
NM_001943.4(DSG2):c.1003A>G (p.Thr335Ala)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00042(G), GMAF:0.00020(G), GO-ESP:0.00056(G)	Conflicting interpretations of pathogenicity(Last reviewed: May 5, 2016)	criteria provided, conflicting interpretations	18	31524877	GRCh38	44278	53445
NM_001943.4(DSG2):c.1051A>G (p.Ser351Gly)	DSG2	not specified|Cardiovascular phenotype	GO-ESP:0.00203(G), GMAF:0.00220(G), GO-ESP:0.00073(G)	Benign/Likely benign(Last reviewed: Nov 11, 2015)	criteria provided, multiple submitters, no conflicts	18	31531023	GRCh38	44277	53444
NM_001943.4(DSG2):c.1063G>A (p.Ala355Thr)	DSG2	not provided|Cardiac arrest		Uncertain significance(Last reviewed: Nov 18, 2015)	criteria provided, multiple submitters, no conflicts	18	31531035	GRCh38	191629	189989
NM_001943.4(DSG2):c.1159C>G (p.His387Asp)	DSG2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	18	31531131	GRCh38	264490	259031
NM_001943.4(DSG2):c.1174G>A (p.Val392Ile)	DSG2	Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|not specified	GMAF:0.00100(A), GO-ESP:0.00257(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2015)	criteria provided, conflicting interpretations	18	31531146	GRCh38	36009	44673
NM_001943.4(DSG2):c.1303G>A (p.Asp435Asn)	DSG2	not specified|not provided	GMAF:0.00060(A), GO-ESP:0.00121(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 4, 2015)	criteria provided, conflicting interpretations	18	31535292	GRCh38	179011	176667
NM_001943.4(DSG2):c.1355T>G (p.Leu452Arg)	DSG2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	18	31535344	GRCh38	264366	259036
NM_001943.4(DSG2):c.1478A>G (p.Asn493Ser)	DSG2	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00004(G)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2015)	criteria provided, conflicting interpretations	18	31536256	GRCh38	163212	176531
NM_001943.4(DSG2):c.1491C>T (p.Pro497=)	DSG2	not specified|Cardiovascular phenotype	GO-ESP:0.00003(T)	Benign/Likely benign(Last reviewed: Dec 30, 2015)	criteria provided, multiple submitters, no conflicts	18	31536269	GRCh38	137164	140867
NM_001943.4(DSG2):c.1550C>T (p.Ala517Val)	DSG2	not specified|Cardiovascular phenotype	GMAF:0.00180(T), GO-ESP:0.00057(T)	Benign/Likely benign(Last reviewed: Sep 2, 2016)	criteria provided, multiple submitters, no conflicts	18	31536328	GRCh38	163210	176532
NM_001943.4(DSG2):c.1847C>T (p.Ala616Val)	DSG2	Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00022(T)	Uncertain significance(Last reviewed: Feb 11, 2013)	criteria provided, single submitter	18	31538946	GRCh38	263502	259038
NM_001943.4(DSG2):c.1885C>T (p.Pro629Ser)	DSG2	not specified|not provided	GO-ESP:0.00002(T)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 14, 2014)	criteria provided, conflicting interpretations	18	31541198	GRCh38	199813	197990
NM_001943.4(DSG2):c.1959G>A (p.Met653Ile)	DSG2	not specified		Uncertain significance(Last reviewed: Jun 19, 2014)	criteria provided, single submitter	18	31541272	GRCh38	199814	197991
NM_001943.4(DSG2):c.2137G>A (p.Glu713Lys)	DSG2|DSG2-AS1	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC	GO-ESP:0.05843(A), GMAF:0.02600(A), GO-ESP:0.05186(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31542655	GRCh38	44295	53462
NM_001943.4(DSG2):c.2188A>G (p.Thr730Ala)	DSG2|DSG2-AS1	Cardiac arrest	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	18	31542706	GRCh38	222564	224538
NM_001943.4(DSG2):c.2318G>A (p.Arg773Lys)	DSG2|DSG2-AS1	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC|Dilated Cardiomyopathy, Dominant	GO-ESP:0.19729(A), GMAF:0.24000(A), GO-ESP:0.26757(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31542836	GRCh38	44300	53467
NM_001943.4(DSG2):c.2484T>C (p.Asp828=)	DSG2|DSG2-AS1	not specified|Cardiovascular phenotype	GMAF:0.00200(C), GO-ESP:0.00064(C)	Benign(Last reviewed: Jun 3, 2015)	criteria provided, multiple submitters, no conflicts	18	31545870	GRCh38	178020	176536
NM_001943.4(DSG2):c.2505A>G (p.Thr835=)	DSG2|DSG2-AS1	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC|Dilated Cardiomyopathy, Dominant	GO-ESP:0.18015(G), GMAF:0.19750(G), GO-ESP:0.12844(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31545891	GRCh38	44302	53469
NM_001943.4(DSG2):c.2548G>C (p.Glu850Gln)	DSG2|DSG2-AS1	not specified		Uncertain significance(Last reviewed: Jan 26, 2012)	criteria provided, single submitter	18	31545934	GRCh38	199833	197999
NM_001943.4(DSG2):c.2575A>G (p.Thr859Ala)	DSG2|DSG2-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: May 22, 2015)	criteria provided, single submitter	18	31545961	GRCh38	264018	259028
NM_001943.4(DSG2):c.2702A>G (p.Lys901Arg)	DSG2|DSG2-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	18	31546088	GRCh38	264559	259032
NM_001943.4(DSG2):c.2759T>G (p.Val920Gly)	DSG2|DSG2-AS1	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	GO-ESP:0.00386(G), GMAF:0.00320(G), GO-ESP:0.00323(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 25, 2016)	criteria provided, conflicting interpretations	18	31546145	GRCh38	44307	53474
NM_001943.4(DSG2):c.2780C>T (p.Pro927Leu)	DSG2|DSG2-AS1	not specified	GMAF:0.00040(T), GO-ESP:0.00027(T)	Uncertain significance(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	18	31546166	GRCh38	199819	198003
NM_001943.4(DSG2):c.2792G>A (p.Arg931Lys)	DSG2|DSG2-AS1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	18	31546178	GRCh38	264612	259039
NM_001943.4(DSG2):c.2906C>T (p.Ala969Val)	DSG2|DSG2-AS1	Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy	GMAF:0.00080(T), GO-ESP:0.00055(T)	Uncertain significance(Last reviewed: Jul 10, 2015)	criteria provided, multiple submitters, no conflicts	18	31546292	GRCh38	199820	198005
NM_001943.4(DSG2):c.3040G>A (p.Val1014Ile)	DSG2|DSG2-AS1	not specified|Dilated cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00024(A), GO-ESP:0.00005(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 29, 2015)	criteria provided, conflicting interpretations	18	31546426	GRCh38	44309	53476
NM_001943.4(DSG2):c.3059_3062delAGAG (p.Glu1020Alafs)	DSG2|DSG2-AS1	Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, multiple submitters, no conflicts	18	31546445 - 31546448	GRCh38	199827	198007
NM_001943.4(DSG2):c.3082G>A (p.Gly1028Ser)	DSG2|DSG2-AS1	Arrhythmogenic right ventricular cardiomyopathy, type 10|Cardiomyopathy|not specified	GMAF:0.00140(A), GO-ESP:0.00063(A)	Benign/Likely benign(Last reviewed: Mar 7, 2016)	criteria provided, multiple submitters, no conflicts	18	31546468	GRCh38	163221	176676
NM_001943.4(DSG2):c.3135A>C (p.Thr1045=)	DSG2|DSG2-AS1	Arrhythmogenic right ventricular cardiomyopathy, type 10|Cardiac arrhythmia|not specified	GO-ESP:0.00750(C), GMAF:0.00660(C), GO-ESP:0.00216(C)	Benign(Last reviewed: Mar 3, 2016)	criteria provided, multiple submitters, no conflicts	18	31546521	GRCh38	36013	44677
NM_001943.4(DSG2):c.3243C>T (p.Val1081=)	DSG2|DSG2-AS1	Arrhythmogenic right ventricular cardiomyopathy, type 10|not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC|Dilated Cardiomyopathy, Dominant	GO-ESP:0.01096(T), GMAF:0.01040(T), GO-ESP:0.00581(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31546629	GRCh38	44312	53479
NM_001943.4(DSG2):c.3266G>A (p.Gly1089Asp)	DSG2|DSG2-AS1	Cardiovascular phenotype	GO-ESP:0.00012(A)	Uncertain significance(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	18	31546652	GRCh38	264574	259043
NM_001943.4(DSG2):c.3321T>C (p.Val1107=)	DSG2|DSG2-AS1	not specified|Cardiovascular phenotype|Cardiomyopathy, ARVC|Dilated Cardiomyopathy, Dominant	GO-ESP:0.47309(C), GMAF:0.45710(T), GO-ESP:0.42332(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31546707	GRCh38	44315	53482
NM_001943.4(DSG2):c.*2C>T	DSG2|DSG2-AS1	not specified|Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00084(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jul 8, 2015)	criteria provided, conflicting interpretations	18	31546745	GRCh38	163229	176679
NM_000371.3(TTR):c.14G>A (p.Arg5His)	TTR	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00011(A)	Uncertain significance(Last reviewed: Apr 18, 2016)	criteria provided, multiple submitters, no conflicts	18	31591916	GRCh38	181697	179802
NM_000371.3(TTR):c.76G>A (p.Gly26Ser)	TTR	TRANSTHYRETIN POLYMORPHISM|not specified|Cardiovascular phenotype	GO-ESP:0.05736(A), GMAF:0.02340(A), GO-ESP:0.04953(A)	Benign(Last reviewed: Jun 21, 2015)	criteria provided, multiple submitters, no conflicts	18	31592902	GRCh38	13452	28491
NM_000371.3(TTR):c.118G>A (p.Val40Ile)	TTR	Amyloidogenic transthyretin amyloidosis|not provided		Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	18	31592944	GRCh38	13455	28494
NM_000371.3(TTR):c.130C>T (p.Pro44Ser)	TTR	not provided		Pathogenic/Likely pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	18	31592956	GRCh38	181693	179804
NM_000371.3(TTR):c.148G>A (p.Val50Met)	TTR	Amyloidogenic transthyretin amyloidosis|not provided	GO-ESP:0.00015(A)	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, multiple submitters, no conflicts	18	31592974	GRCh38	13417	28456
NM_000371.3(TTR):c.194C>A (p.Ala65Asp)	TTR	not provided		Pathogenic(Last reviewed: Jan 19, 2012)	criteria provided, single submitter	18	31593020	GRCh38	181702	179805
NM_000371.3(TTR):c.199G>A (p.Gly67Arg)	TTR	Amyloidogenic transthyretin amyloidosis		Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	18	31593025	GRCh38	13459	28498
NM_000371.3(TTR):c.199G>C (p.Gly67Arg)	TTR	Amyloidogenic transthyretin amyloidosis		Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	18	31593025	GRCh38	13436	28475
NM_000371.3(TTR):c.200G>C (p.Gly67Ala)	TTR	Amyloidogenic transthyretin amyloidosis		Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	18	31593026	GRCh38	13451	28490
NM_000371.3(TTR):c.209G>T (p.Ser70Ile)	TTR	Amyloidogenic transthyretin amyloidosis		Pathogenic(Last reviewed: Aug 31, 1992)	no assertion criteria provided	18	31595128	GRCh38	13439	28478
NM_000371.3(TTR):c.224T>C (p.Leu75Pro)	TTR	Amyloidogenic transthyretin amyloidosis		Pathogenic(Last reviewed: Jun 1, 1994)	no assertion criteria provided	18	31595143	GRCh38	13438	28477
NM_000371.3(TTR):c.236C>A (p.Thr79Lys)	TTR	not provided		Likely pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	18	31595155	GRCh38	181694	179807
NM_000371.3(TTR):c.238A>G (p.Thr80Ala)	TTR	Amyloidogenic transthyretin amyloidosis|not provided		Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, multiple submitters, no conflicts	18	31595157	GRCh38	13421	28460
NM_000371.3(TTR):c.262A>T (p.Ile88Leu)	TTR	Amyloidogenic transthyretin amyloidosis	GO-ESP:0.00015(T), GO-ESP:0.00004(T)	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	18	31595181	GRCh38	13446	28485
NM_000371.3(TTR):c.283A>T (p.Thr95Ser)	TTR	not specified		Uncertain significance(Last reviewed: Oct 15, 2014)	criteria provided, single submitter	18	31595202	GRCh38	181703	179809
NM_000371.3(TTR):c.290C>A (p.Ser97Tyr)	TTR	Amyloidogenic transthyretin amyloidosis		Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	18	31595209	GRCh38	13422	28461
NM_000371.3(TTR):c.301G>A (p.Ala101Thr)	TTR	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Nov 26, 2014)	criteria provided, multiple submitters, no conflicts	18	31595220	GRCh38	181696	179811
NM_000371.3(TTR):c.325G>C (p.Glu109Gln)	TTR	Amyloidogenic transthyretin amyloidosis|not provided		Pathogenic(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	18	31595244	GRCh38	13442	28481
NM_000371.3(TTR):c.327G>T (p.Glu109Asp)	TTR	not specified		Uncertain significance(Last reviewed: Sep 18, 2015)	no assertion criteria provided	18	31595246	GRCh38	235066	236816
NM_000371.3(TTR):c.349G>T (p.Ala117Ser)	TTR	Amyloidogenic transthyretin amyloidosis|not provided		Pathogenic(Last reviewed: Aug 10, 2010)	criteria provided, single submitter	18	31598580	GRCh38	13468	28507
NM_000371.3(TTR):c.350C>G (p.Ala117Gly)	TTR	Amyloidogenic transthyretin amyloidosis		Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	18	31598581	GRCh38	13448	28487
NM_000371.3(TTR):c.354C>T (p.Asn118=)	TTR	not specified|Cardiovascular phenotype	GO-ESP:0.00006(T)	Likely benign(Last reviewed: Nov 11, 2015)	criteria provided, multiple submitters, no conflicts	18	31598585	GRCh38	166364	176681
NM_000371.3(TTR):c.360C>T (p.Ser120=)	TTR	Amyloidogenic transthyretin amyloidosis|not specified|Cardiovascular phenotype	GO-ESP:0.00031(T), GMAF:0.00920(T), GO-ESP:0.00280(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	18	31598591	GRCh38	43453	52623
NM_000371.3(TTR):c.391C>A (p.Leu131Met)	TTR	Amyloidogenic transthyretin amyloidosis		Pathogenic(Last reviewed: Oct 1, 1993)	no assertion criteria provided	18	31598622	GRCh38	13424	28463
NM_000371.3(TTR):c.397C>T (p.Pro133Ser)	TTR	not provided		Likely pathogenic(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	18	31598628	GRCh38	181699	179814
NM_000371.3(TTR):c.417G>A (p.Thr139=)	TTR	Amyloidogenic transthyretin amyloidosis|not specified|Cardiovascular phenotype	GO-ESP:0.00008(A), GMAF:0.00360(A), GO-ESP:0.00279(A)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2016)	criteria provided, conflicting interpretations	18	31598648	GRCh38	43455	52625
NM_000371.3(TTR):c.424_426delGTC (p.Val142del)	TTR	Amyloidogenic transthyretin amyloidosis		Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2008)	no assertion criteria provided	18	31598655 - 31598657	GRCh38	13460	28499
NM_000371.3(TTR):c.424G>A (p.Val142Ile)	TTR	Amyloidogenic transthyretin amyloidosis|Amyloid Cardiomyopathy, Transthyretin-related|Cardiomyopathy|not provided|Cardiovascular phenotype	GO-ESP:0.00592(A), GMAF:0.00560(A), GO-ESP:0.00138(A)	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	31598655	GRCh38	13426	28465
NM_001001937.1(ATP5A1):c.985C>T (p.Arg329Cys)	ATP5A1	Mitochondrial complex v (atp synthase) deficiency, nuclear type 4	GO-ESP:0.00003(A)	Pathogenic(Last reviewed: May 15, 2013)	no assertion criteria provided	18	46087199	GRCh38	50353	59478
NM_004046.5(ATP5A1):c.962A>G (p.Tyr321Cys)	ATP5A1	Combined oxidative phosphorylation deficiency 22		Pathogenic(Last reviewed: May 7, 2013)	no assertion criteria provided	18	46087222	GRCh38	156426	166199
NM_001257335.1(ATP5A1):c.228G>T (p.Lys76Asn)	ATP5A1	not specified		Uncertain significance(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	18	46089928	GRCh38	218566	215557
NM_001135937.2(SMAD2):c.694+1G>A	SMAD2	Variant of unknown significance		Uncertain significance(Last reviewed: Jun 13, 2013)	no assertion criteria provided	18	47851273	GRCh38	56824	71447
NM_005359.5(SMAD4):c.1148T>A (p.Ile383Lys)	SMAD4	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome		Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	51067027	GRCh38	24840	36181
NM_005359.5(SMAD4):c.1333C>T (p.Arg445Ter)	SMAD4	Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Hereditary cancer-predisposing syndrome	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	18	51076662	GRCh38	24850	36191
NM_006701.4(TXNL4A):c.131delT (p.Val44Alafs)	TXNL4A	Burn-McKeown syndrome		Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	18	79988262	GRCh38	162206	171914
NC_000018.9:g.(?_18548019)_(77954165_?)dup	AQP4|ATP5A1|BCL2|CDH2|CDH7|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GRP|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC4R|ME2|MEP1B|MYO5B|NARS|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TTR|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|CTDP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|CTIF|TSHZ1|ACAA2|CD226|ZNF271P|MALT1|TXNL4A|MAPRE2|POLI|ADNP2|TRAPPC8|PHLPP1|NEDD4L|WDR7|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|ELOA2|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ZNF407|CNDP2|CELF4|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|CTAGE1|GAREM1|CCDC102B|RBFA|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|NETO1|KATNAL2|CHST9|C18orf21|MRO|HDHD2|ZNF397|PARD6G|CNDP1|TMEM241|SERPINB12|SERPINB11|SEC11C|CABLES1|DSEL|ESCO1|OSBPL1A|HAUS1|ALPK2|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|ANKRD29|C18orf54|TCEB3C|ABHD3|FBXO15|ZBTB7C|SKA1|CFAP53|DOK6|RNF152|ZNF396|KCTD1|DYNAP|BOD1L2|SIGLEC15|ZADH2|SMIM21|HMSD|CPLX4|CCDC178|ATP9B|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|C18orf32|C18orf63|SKOR2|ELOA3B|ZSCAN30|LINC01415|ELOA3D|RPL17-C18orf32|LINC-ROR	See cases		Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter			GRCh38	253620	248068
NC_000018.9:g.(?_163323)_(78005236_?)dup	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|ELOA2|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|ANKRD29|APCDD1|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|ZBTB7C|SKA1|CFAP53|DOK6|RNF152|ZNF396|LAMA1|KCTD1|DYNAP|BOD1L2|SIGLEC15|ZADH2|SMIM21|HMSD|LRRC30|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf32|AKAIN1|C18orf63|TMEM200C|SLC35G4|SKOR2|ELOA3B|ZSCAN30|LINC01415|ELOA3D|RPL17-C18orf32|LINC-ROR	See cases		Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter			GRCh38	253424	247872
GRCh38/hg38 18p11.32-q23(chr18:148963-80252149)x3	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|LINC00470|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|C18orf12|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|APCDD1|LINC00526|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|DLGAP1-AS3|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|DLGAP1-AS5|LAMA1|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LINC00667|LRRC30|LOC339298|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00668|LINC01443|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf61|C18orf32|KC6|AKAIN1|LOC643542|C18orf63|MIR3976HG|TMEM200C|SLC35G4|MIR924HG|DLGAP1-AS1|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01387|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LOC100192426|GACAT2|LINC01630|LDLRAD4-AS1|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4317|MIR4318|MIR4320|MIR3156-2|MIR3929|LINC01539|LOC100505549|GAPLINC|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4526|MIR4741|MIR4528|MIR3976|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR5190|MIR548AV|RNU6-39P|LINC-ROR|LOC100996324|LINC01544|LOC101060542|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|LOC101927229|LINC01416|NDUFV2-AS1|LOC101927322|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|LOC101927481|LOC101927571|LOC101927606|LINC01444|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR6718|MIR7153|MIR6788|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC104968399|LOC105371998|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LOC105376854|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, multiple submitters, no conflicts	18	148963 - 80252149	GRCh38	160810	170654
GRCh38/hg38 18p11.32-q23(chr18:136226-80256240)x3	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|LINC00470|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|C18orf12|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|APCDD1|LINC00526|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|DLGAP1-AS3|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|DLGAP1-AS5|LAMA1|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LINC00667|LRRC30|LOC339298|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00668|LINC01443|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf61|C18orf32|KC6|AKAIN1|LOC643542|C18orf63|MIR3976HG|TMEM200C|SLC35G4|MIR924HG|DLGAP1-AS1|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01387|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LOC100192426|GACAT2|LINC01630|LDLRAD4-AS1|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4317|MIR4318|MIR4320|MIR3156-2|MIR3929|LINC01539|LOC100505549|GAPLINC|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4526|MIR4741|MIR4528|MIR3976|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR5190|MIR548AV|RNU6-39P|LINC-ROR|LOC100996324|LINC01544|LOC101060542|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|LOC101927229|LINC01416|NDUFV2-AS1|LOC101927322|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|LOC101927481|LOC101927571|LOC101927606|LINC01444|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR6718|MIR7153|MIR6788|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC104968399|LOC105371998|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LOC105376854|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Apr 9, 2013)	no assertion criteria provided	18	136226 - 80256240	GRCh38	155151	164905
GRCh38/hg38 18q11.1-22.3(chr18:20962119-74691446)x3	AQP4|ATP5A1|BCL2|CDH2|CDH7|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALNT1|GATA6|GRP|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MC4R|ME2|MEP1B|MYO5B|NARS|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TTR|ZNF24|SLC14A2|SERPINB7|NOL4|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|CTIF|ACAA2|CD226|ZNF271P|MALT1|MAPRE2|POLI|TRAPPC8|PHLPP1|NEDD4L|WDR7|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|CABYR|SNORD58B|SNORD58A|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ZNF407|CNDP2|CELF4|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|CTAGE1|GAREM1|CCDC102B|GREB1L|FHOD3|CCDC68|ASXL3|NETO1|KATNAL2|CHST9|C18orf21|MRO|HDHD2|ZNF397|C18orf12|CNDP1|TMEM241|SERPINB12|SERPINB11|SEC11C|CABLES1|DSEL|ESCO1|OSBPL1A|HAUS1|ALPK2|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|C18orf54|TCEB3C|ABHD3|FBXO15|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|HMSD|LOC284294|CPLX4|CCDC178|LINC01538|LOC400655|LINC00909|MIR1-2|MIR122|MIR133A1|MIR187|RNF165|C18orf32|KC6|LOC643542|C18orf63|MIR924HG|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01415|TRK-CTT6-1|LINC01630|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4318|MIR4320|MIR3929|LINC01539|LOC100505549|LINC01541|LOC100505797|LOC100505817|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4741|MIR4528|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR548AV|RNU6-39P|LINC-ROR|LINC01544|LOC101060542|LOC101927229|LINC01416|LOC101927322|LOC101927481|LOC101927571|LOC101927606|DSCAS|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101928167|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	18	20962119 - 74691446	GRCh38	154990	164744
GRCh38/hg38 18q12.3-21.1(chr18:41722823-49043887)x1	ATP5A1|SMAD2|SMAD7|PIK3C3|RIT2|SLC14A1|SYT4|SLC14A2|PSTPIP2|PIAS2|CTIF|SETBP1|ST8SIA5|IER3IP1|TCEB3B|DYM|EPG5|KATNAL2|HDHD2|C18orf12|HAUS1|LOXHD1|C18orf25|TCEB3C|ZBTB7C|LINC00907|SIGLEC15|RNF165|SKOR2|TCEB3CL|LOC100129878|TRK-CTT6-1|MIR4319|TCEB3CL2|MIR4527|MIR4743|LINC01478|SLC14A2-AS1|LINC01601	See cases		Pathogenic(Last reviewed: Jan 30, 2010)	no assertion criteria provided	18	41722823 - 49043887	GRCh38	154629	164383
GRCh38/hg38 18q23(chr18:76635470-80252149)x1	GALR1|MBP|NFATC1|ZNF236|CTDP1|TXNL4A|ADNP2|KCNG2|SALL3|RBFA|PQLC1|PARD6G|LOC284241|ATP9B|LOC400661|HSBP1L1|PARD6G-AS1|LOC100131655|RBFADN|LOC101927651|LINC01029	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	18	76635470 - 80252149	GRCh38	154513	164267
GRCh38/hg38 18p11.31-11.22(chr18:6913068-9146867)x3	NDUFV2|PTPRM|ANKRD12|MTCL1|ARHGAP28|RAB12|LAMA1|LRRC30|LINC00668|LOC100192426|GACAT2|LOC101927188|NDUFV2-AS1	See cases		Uncertain significance(Last reviewed: Aug 30, 2010)	no assertion criteria provided	18	6913068 - 9146867	GRCh38	154424	164178
GRCh38/hg38 18p11.32-q23(chr18:136227-80256240)x3	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|LINC00470|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|C18orf12|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|APCDD1|LINC00526|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|DLGAP1-AS3|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|DLGAP1-AS5|LAMA1|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LINC00667|LRRC30|LOC339298|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00668|LINC01443|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf61|C18orf32|KC6|AKAIN1|LOC643542|C18orf63|MIR3976HG|TMEM200C|SLC35G4|MIR924HG|DLGAP1-AS1|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01387|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LOC100192426|GACAT2|LINC01630|LDLRAD4-AS1|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4317|MIR4318|MIR4320|MIR3156-2|MIR3929|LINC01539|LOC100505549|GAPLINC|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4526|MIR4741|MIR4528|MIR3976|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR5190|MIR548AV|RNU6-39P|LINC-ROR|LOC100996324|LINC01544|LOC101060542|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|LOC101927229|LINC01416|NDUFV2-AS1|LOC101927322|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|LOC101927481|LOC101927571|LOC101927606|LINC01444|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR6718|MIR7153|MIR6788|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC104968399|LOC105371998|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LOC105376854|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Mar 10, 2014)	no assertion criteria provided	18	136227 - 80256240	GRCh38	154106	163857
GRCh38/hg38 18q12.3-23(chr18:40367455-80256240)x3	ATP5A1|BCL2|CDH7|CYB5A|DCC|FECH|KDSR|GALR1|GRP|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC4R|ME2|MYO5B|NARS|NFATC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|RAB27B|RIT2|RPL17|SERPINB3|SERPINB4|SLC14A1|SYT4|TCF4|ZNF236|SLC14A2|SERPINB7|TNFRSF11A|MBD2|PSTPIP2|PIAS2|CTDP1|SOCS6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|CTIF|TSHZ1|ACAA2|CD226|MALT1|TXNL4A|POLI|ADNP2|PHLPP1|NEDD4L|WDR7|PIGN|RTTN|SETBP1|KCNG2|SNORD58B|SNORD58A|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|TMX3|DYM|ZCCHC2|ZNF532|ELAC1|ZNF407|CNDP2|KIAA1468|EPG5|CCDC102B|RBFA|PQLC1|CCDC68|NETO1|KATNAL2|MRO|HDHD2|C18orf12|PARD6G|CNDP1|SERPINB12|SERPINB11|SEC11C|DSEL|HAUS1|ALPK2|LOXHD1|FAM69C|STARD6|C18orf25|CCBE1|CBLN2|C18orf54|TCEB3C|FBXO15|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|LOC284241|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LOC339298|CPLX4|ATP9B|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR122|HSBP1L1|RNF165|C18orf32|KC6|LOC643542|C18orf63|SKOR2|SCARNA17|SNORA37|TCEB3CL|SNORD58C|LOC100129878|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LINC01630|MIR1539|MIR4319|MIR4320|LINC01539|LOC100505549|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|TCEB3CL2|RPL17-C18orf32|MIR4528|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|MIR5011|MIR548AV|RNU6-39P|LINC-ROR|LINC01544|LOC101060542|LOC101927229|LINC01416|LOC101927322|LOC101927481|LOC101927606|LOC101927651|LINC01029|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|LOC102724651|LOC102724913|SNHG22|TCF4-AS1|LOC105372179|LINC01601|SNORA108	See cases		Pathogenic(Last reviewed: Dec 3, 2013)	no assertion criteria provided	18	40367455 - 80256240	GRCh38	154074	163825
GRCh38/hg38 18q12.3-21.1(chr18:43833480-46144138)x1	ATP5A1|SLC14A1|SLC14A2|PSTPIP2|SETBP1|EPG5|HAUS1|SIGLEC15|TRK-CTT6-1|MIR4319|LINC01478|SLC14A2-AS1|LINC01601	See cases		Pathogenic(Last reviewed: Apr 30, 2011)	no assertion criteria provided	18	43833480 - 46144138	GRCh38	152556	162307
GRCh38/hg38 18p11.32-q23(chr18:149089-80254936)x3	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|LINC00470|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|C18orf12|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|APCDD1|LINC00526|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|DLGAP1-AS3|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|DLGAP1-AS5|LAMA1|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LINC00667|LRRC30|LOC339298|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00668|LINC01443|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf61|C18orf32|KC6|AKAIN1|LOC643542|C18orf63|MIR3976HG|TMEM200C|SLC35G4|MIR924HG|DLGAP1-AS1|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01387|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LOC100192426|GACAT2|LINC01630|LDLRAD4-AS1|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4317|MIR4318|MIR4320|MIR3156-2|MIR3929|LINC01539|LOC100505549|GAPLINC|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4526|MIR4741|MIR4528|MIR3976|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR5190|MIR548AV|RNU6-39P|LINC-ROR|LOC100996324|LINC01544|LOC101060542|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|LOC101927229|LINC01416|NDUFV2-AS1|LOC101927322|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|LOC101927481|LOC101927571|LOC101927606|LINC01444|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR6718|MIR7153|MIR6788|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC104968399|LOC105371998|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LOC105376854|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	18	149089 - 80254936	GRCh38	150559	160310
GRCh38/hg38 18p11.32-q23(chr18:118760-80254946)x3	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|LINC00470|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|C18orf12|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|APCDD1|LINC00526|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|DLGAP1-AS3|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|DLGAP1-AS5|LAMA1|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LINC00667|LRRC30|LOC339298|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00668|LINC01443|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf61|C18orf32|KC6|AKAIN1|LOC643542|C18orf63|MIR3976HG|TMEM200C|SLC35G4|MIR924HG|DLGAP1-AS1|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01387|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LOC100192426|GACAT2|LINC01630|LDLRAD4-AS1|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4317|MIR4318|MIR4320|MIR3156-2|MIR3929|LINC01539|LOC100505549|GAPLINC|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4526|MIR4741|MIR4528|MIR3976|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR5190|MIR548AV|RNU6-39P|LINC-ROR|LOC100996324|LINC01544|LOC101060542|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|LOC101927229|LINC01416|NDUFV2-AS1|LOC101927322|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|LOC101927481|LOC101927571|LOC101927606|LINC01444|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR6718|MIR7153|MIR6788|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC104968399|LOC105371998|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LOC105376854|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Jan 9, 2013)	no assertion criteria provided	18	118760 - 80254946	GRCh38	149674	159425
GRCh38/hg38 18q12.3-23(chr18:42651392-80254946)x3	ATP5A1|BCL2|CDH7|CYB5A|DCC|FECH|KDSR|GALR1|GRP|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC4R|ME2|MYO5B|NARS|NFATC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PMAIP1|MAPK4|RAB27B|RIT2|RPL17|SERPINB3|SERPINB4|SLC14A1|SYT4|TCF4|ZNF236|SLC14A2|SERPINB7|TNFRSF11A|MBD2|PSTPIP2|PIAS2|CTDP1|SOCS6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|CTIF|TSHZ1|ACAA2|CD226|MALT1|TXNL4A|POLI|ADNP2|PHLPP1|NEDD4L|WDR7|PIGN|RTTN|SETBP1|KCNG2|SNORD58B|SNORD58A|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|TMX3|DYM|ZCCHC2|ZNF532|ELAC1|ZNF407|CNDP2|KIAA1468|EPG5|CCDC102B|RBFA|PQLC1|CCDC68|NETO1|KATNAL2|MRO|HDHD2|C18orf12|PARD6G|CNDP1|SERPINB12|SERPINB11|SEC11C|DSEL|HAUS1|ALPK2|LOXHD1|FAM69C|STARD6|C18orf25|CCBE1|CBLN2|C18orf54|TCEB3C|FBXO15|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|LOC284241|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LOC339298|CPLX4|ATP9B|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR122|HSBP1L1|RNF165|C18orf32|LOC643542|C18orf63|SKOR2|SCARNA17|SNORA37|TCEB3CL|SNORD58C|LOC100129878|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LINC01630|MIR1539|MIR4319|MIR4320|LINC01539|LOC100505549|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|TCEB3CL2|RPL17-C18orf32|MIR4528|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|MIR5011|MIR548AV|RNU6-39P|LINC-ROR|LINC01544|LOC101060542|LOC101927229|LINC01416|LOC101927322|LOC101927481|LOC101927606|LOC101927651|LINC01029|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|LOC102724651|LOC102724913|SNHG22|TCF4-AS1|LOC105372179|LINC01601|SNORA108	See cases		Pathogenic(Last reviewed: Jan 3, 2012)	no assertion criteria provided	18	42651392 - 80254946	GRCh38	148972	158723
GRCh38/hg38 18q12.2-22.1(chr18:38794728-65632804)x3	ATP5A1|BCL2|DCC|FECH|KDSR|GRP|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MC4R|ME2|MYO5B|NARS|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|RAB27B|RIT2|RPL17|SERPINB3|SERPINB4|SLC14A1|SYT4|TCF4|SLC14A2|SERPINB7|TNFRSF11A|MBD2|PSTPIP2|PIAS2|TXNL1|LIPG|ONECUT2|VPS4B|CTIF|ACAA2|MALT1|POLI|PHLPP1|NEDD4L|WDR7|PIGN|SETBP1|SNORD58B|SNORD58A|CDH20|ST8SIA5|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|DYM|ZCCHC2|ZNF532|ELAC1|KIAA1468|EPG5|CCDC68|KATNAL2|MRO|HDHD2|C18orf12|SERPINB12|SERPINB11|SEC11C|HAUS1|ALPK2|LOXHD1|STARD6|C18orf25|CCBE1|C18orf54|TCEB3C|ZBTB7C|SKA1|CFAP53|RNF152|LINC00305|DYNAP|BOD1L2|LINC00907|SIGLEC15|HMSD|LOC284294|CPLX4|LINC01538|MIR122|RNF165|C18orf32|KC6|MIR924HG|SKOR2|SCARNA17|SNORA37|TCEB3CL|SNORD58C|MIR924|LOC100129878|LINC01415|TRK-CTT6-1|LINC01630|MIR1539|MIR4319|MIR4320|LINC01539|LOC100505549|TCEB3CL2|RPL17-C18orf32|MIR4528|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|MIR5583-2|MIR5583-1|LINC-ROR|LINC01544|LOC101927229|LINC01416|LOC101927322|LINC01477|LINC01478|SLC14A2-AS1|LOC101928167|LOC102724651|SNHG22|TCF4-AS1|LINC01601|SNORA108	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	18	38794728 - 65632804	GRCh38	147762	157513
GRCh38/hg38 18q12.1-23(chr18:32123105-80252149)x3	ATP5A1|BCL2|CDH7|CYB5A|DCC|DTNA|FECH|KDSR|GALR1|GALNT1|GRP|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC4R|ME2|MEP1B|MYO5B|NARS|NFATC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|RAB27B|RIT2|RPL17|SERPINB3|SERPINB4|SLC14A1|SYT4|TCF4|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|TNFRSF11A|MBD2|PSTPIP2|PIAS2|CTDP1|SOCS6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|CTIF|TSHZ1|ACAA2|CD226|ZNF271P|MALT1|TXNL4A|MAPRE2|POLI|ADNP2|PHLPP1|NEDD4L|WDR7|PIGN|SLC39A6|RTTN|TPGS2|SETBP1|KCNG2|SNORD58B|SNORD58A|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|MOCOS|RPRD1A|ZNF532|ELP2|ELAC1|ZNF407|CNDP2|CELF4|KIAA1328|KLHL14|KIAA1468|EPG5|GAREM1|CCDC102B|RBFA|PQLC1|FHOD3|CCDC68|ASXL3|NETO1|KATNAL2|C18orf21|MRO|HDHD2|ZNF397|C18orf12|PARD6G|CNDP1|SERPINB12|SERPINB11|SEC11C|DSEL|HAUS1|ALPK2|LOXHD1|INO80C|FAM69C|STARD6|C18orf25|CCBE1|CBLN2|C18orf54|TCEB3C|FBXO15|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|LOC284241|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LOC339298|CPLX4|CCDC178|ATP9B|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR122|MIR187|HSBP1L1|RNF165|C18orf32|KC6|LOC643542|C18orf63|MIR924HG|SKOR2|SCARNA17|SNORA37|TCEB3CL|ZSCAN30|SNORD58C|MIR924|LOC100129878|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LINC01630|MIR1539|MIR4319|MIR4318|MIR4320|MIR3929|LINC01539|LOC100505549|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|TCEB3CL2|RPL17-C18orf32|MIR4528|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|MIR5583-2|MIR5011|MIR5583-1|MIR548AV|RNU6-39P|LINC-ROR|LINC01544|LOC101060542|LOC101927229|LINC01416|LOC101927322|LOC101927481|LOC101927606|LOC101927651|LINC01029|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|LOC102724651|LOC102724913|SNHG22|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Oct 19, 2010)	no assertion criteria provided	18	32123105 - 80252149	GRCh38	147738	157489
GRCh38/hg38 18q12.3-21.1(chr18:42335174-46726460)x1	ATP5A1|RIT2|SLC14A1|SYT4|SLC14A2|PSTPIP2|SETBP1|ST8SIA5|EPG5|HAUS1|LOXHD1|C18orf25|LINC00907|SIGLEC15|RNF165|TRK-CTT6-1|MIR4319|LINC01478|SLC14A2-AS1|LINC01601	See cases		Pathogenic(Last reviewed: Jan 30, 2010)	no assertion criteria provided	18	42335174 - 46726460	GRCh38	147605	157356
GRCh38/hg38 18p11.32-q23(chr18:149089-80234391)x3	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|LINC00470|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|C18orf12|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|APCDD1|LINC00526|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|DLGAP1-AS3|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|DLGAP1-AS5|LAMA1|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LINC00667|LRRC30|LOC339298|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00668|LINC01443|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf61|C18orf32|KC6|AKAIN1|LOC643542|C18orf63|MIR3976HG|TMEM200C|SLC35G4|MIR924HG|DLGAP1-AS1|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01387|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LOC100192426|GACAT2|LINC01630|LDLRAD4-AS1|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4317|MIR4318|MIR4320|MIR3156-2|MIR3929|LINC01539|LOC100505549|GAPLINC|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4526|MIR4741|MIR4528|MIR3976|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR5190|MIR548AV|RNU6-39P|LINC-ROR|LOC100996324|LINC01544|LOC101060542|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|LOC101927229|LINC01416|NDUFV2-AS1|LOC101927322|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|LOC101927481|LOC101927571|LOC101927606|LINC01444|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR6718|MIR7153|MIR6788|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC104968399|LOC105371998|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LOC105376854|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Jun 30, 2010)	no assertion criteria provided	18	149089 - 80234391	GRCh38	144654	154405
GRCh38/hg38 18q21.32-23(chr18:59567681-80252149)x1	BCL2|CDH7|CYB5A|KDSR|GALR1|MBP|MC4R|NFATC1|SERPINB2|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PMAIP1|SERPINB3|SERPINB4|ZNF236|SERPINB7|TNFRSF11A|CTDP1|SOCS6|VPS4B|ZNF516|TSHZ1|CD226|TXNL4A|ADNP2|PHLPP1|PIGN|RTTN|KCNG2|SALL3|CDH20|CDH19|TIMM21|TMX3|ZCCHC2|ZNF407|CNDP2|KIAA1468|CCDC102B|RBFA|PQLC1|NETO1|PARD6G|CNDP1|SERPINB12|SERPINB11|DSEL|FAM69C|CCBE1|CBLN2|FBXO15|GTSCR1|DOK6|RNF152|LINC00305|LOC284241|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LOC339298|ATP9B|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|HSBP1L1|LOC643542|C18orf63|PARD6G-AS1|LOC100131655|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|MIR5011|MIR548AV|RNU6-39P|LINC01544|LOC101060542|LOC101927481|LOC101927606|LOC101927651|LINC01029|LOC101927989|LOC102724913|LOC105372179	See cases		Pathogenic(Last reviewed: May 27, 2010)	no assertion criteria provided	18	59567681 - 80252149	GRCh38	144207	153958
GRCh38/hg38 18q12.3-21.1(chr18:40718750-48354407)x1	ATP5A1|SMAD2|PIK3C3|RIT2|SLC14A1|SYT4|SLC14A2|PSTPIP2|PIAS2|SETBP1|ST8SIA5|IER3IP1|TCEB3B|EPG5|KATNAL2|HDHD2|C18orf12|HAUS1|LOXHD1|C18orf25|TCEB3C|ZBTB7C|LINC00907|SIGLEC15|RNF165|KC6|SKOR2|TCEB3CL|TRK-CTT6-1|MIR4319|TCEB3CL2|MIR4527|LINC01478|SLC14A2-AS1|LINC01601	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	40718750 - 48354407	GRCh38	59962	74557
GRCh38/hg38 18q12.3-21.1(chr18:40718750-47042515)x1	ATP5A1|PIK3C3|RIT2|SLC14A1|SYT4|SLC14A2|PSTPIP2|PIAS2|SETBP1|ST8SIA5|TCEB3B|EPG5|KATNAL2|HAUS1|LOXHD1|C18orf25|TCEB3C|LINC00907|SIGLEC15|RNF165|KC6|TCEB3CL|TRK-CTT6-1|MIR4319|TCEB3CL2|LINC01478|SLC14A2-AS1|LINC01601	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	40718750 - 47042515	GRCh38	59961	74556
GRCh38/hg38 18q12.2-21.1(chr18:36859191-47164436)x1	ATP5A1|PIK3C3|RIT2|SLC14A1|SYT4|SLC14A2|PSTPIP2|PIAS2|SETBP1|ST8SIA5|IER3IP1|ELOA2|CELF4|KIAA1328|EPG5|KATNAL2|HDHD2|HAUS1|LOXHD1|C18orf25|TCEB3C|LINC00907|SIGLEC15|RNF165|KC6|MIR924HG|ELOA3B|MIR924|TRK-CTT6-1|MIR4319|MIR4318|ELOA3D|MIR5583-2|MIR5583-1|LINC01477|LINC01478|SLC14A2-AS1|LOC105372068|LOC105372069|LINC01601|SNORA111	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	36859191 - 47164436	GRCh38	59960	74555
GRCh38/hg38 18p11.31-11.23(chr18:7115076-7608220)x3	PTPRM|LAMA1|LRRC30	See cases		Benign(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	7115076 - 7608220	GRCh38	59753	74348
GRCh38/hg38 18p11.32-11.22(chr18:112259-9135777)x1	ADCYAP1|CETN1|NDUFV2|PTPRM|TGIF1|TYMS|YES1|ZBTB14|MYOM1|USP14|DLGAP1|LPIN2|THOC1|NDC80|MYL12A|EPB41L3|MTCL1|SMCHD1|CLUL1|ENOSF1|LINC00470|METTL4|ARHGAP28|COLEC12|EMILIN2|DLGAP1-AS2|L3MBTL4|MYL12B|LINC00526|RAB12|DLGAP1-AS3|DLGAP1-AS5|LAMA1|LINC00667|LRRC30|LINC00668|TYMSOS|AKAIN1|MIR3976HG|TMEM200C|DLGAP1-AS1|LINC01387|LOC100192426|GACAT2|MIR4317|GAPLINC|MIR3976|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|NDUFV2-AS1|MIR6718|MIR8078|LOC104968399|LOC105376854	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	112259 - 9135777	GRCh38	59613	74208
GRCh38/hg38 18q12.3-21.1(chr18:45541699-46697357)x3	ATP5A1|SLC14A1|SLC14A2|PSTPIP2|ST8SIA5|EPG5|HAUS1|LOXHD1|C18orf25|SIGLEC15|RNF165|TRK-CTT6-1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	45541699 - 46697357	GRCh38	58781	73376
GRCh38/hg38 18q12.1-12.2(chr18:35097761-39379288)x3	GALNT1|ZNF24|ZNF271P|MAPRE2|SLC39A6|TPGS2|MOCOS|RPRD1A|ELP2|CELF4|KIAA1328|FHOD3|C18orf21|ZNF397|INO80C|ZNF396|MIR187|MIR924HG|ZSCAN30|MIR4318|MIR3929|MIR3975|LOC101927809|LOC105372068|LOC105372069|LOC105372071|SNORA111	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	35097761 - 39379288	GRCh38	58779	73374
GRCh38/hg38 18q12.1-22.1(chr18:29249202-65448117)x3	ATP5A1|BCL2|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALNT1|GRP|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MC4R|ME2|MEP1B|MYO5B|NARS|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|RAB27B|RIT2|RPL17|SERPINB3|SERPINB4|SLC14A1|SYT4|TCF4|TTR|ZNF24|SLC14A2|SERPINB7|NOL4|TNFRSF11A|MBD2|PSTPIP2|PIAS2|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|CTIF|ACAA2|ZNF271P|MALT1|MAPRE2|POLI|TRAPPC8|PHLPP1|NEDD4L|WDR7|PIGN|SLC39A6|TPGS2|SETBP1|SNORD58B|SNORD58A|CDH20|ST8SIA5|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|DYM|ZCCHC2|RNF125|MOCOS|RPRD1A|ZNF532|ELP2|ELAC1|CELF4|KIAA1328|KLHL14|KIAA1468|EPG5|GAREM1|FHOD3|CCDC68|ASXL3|KATNAL2|C18orf21|MRO|HDHD2|ZNF397|C18orf12|SERPINB12|SERPINB11|SEC11C|HAUS1|ALPK2|LOXHD1|INO80C|STARD6|C18orf25|CCBE1|SLC25A52|DSG4|C18orf54|TCEB3C|ZBTB7C|SKA1|CFAP53|RNF152|LINC00305|ZNF396|DYNAP|BOD1L2|LINC00907|SIGLEC15|HMSD|LOC284294|CPLX4|CCDC178|LINC01538|MIR122|MIR187|RNF165|C18orf32|KC6|MIR924HG|SKOR2|SCARNA17|SNORA37|TCEB3CL|ZSCAN30|SNORD58C|MIR924|LOC100129878|LINC01415|TRK-CTT6-1|LINC01630|MIR302F|MIR1539|MIR4319|MIR4318|MIR4320|MIR3929|LINC01539|LOC100505549|TCEB3CL2|RPL17-C18orf32|MIR4528|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5583-1|LINC-ROR|LINC01544|LOC101927229|LINC01416|LOC101927322|DSCAS|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101928167|LOC102724651|SNHG22|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	29249202 - 65448117	GRCh38	58775	73370
GRCh38/hg38 18q11.1-23(chr18:20989762-80209986)x3	AQP4|ATP5A1|BCL2|CDH2|CDH7|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GRP|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC4R|ME2|MEP1B|MYO5B|NARS|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TTR|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|CTDP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|CTIF|TSHZ1|ACAA2|CD226|ZNF271P|MALT1|TXNL4A|MAPRE2|POLI|ADNP2|TRAPPC8|PHLPP1|NEDD4L|WDR7|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ZNF407|CNDP2|CELF4|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|CTAGE1|GAREM1|CCDC102B|RBFA|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|NETO1|KATNAL2|CHST9|C18orf21|MRO|HDHD2|ZNF397|C18orf12|PARD6G|CNDP1|TMEM241|SERPINB12|SERPINB11|SEC11C|CABLES1|DSEL|ESCO1|OSBPL1A|HAUS1|ALPK2|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|C18orf54|TCEB3C|ABHD3|FBXO15|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LOC339298|CPLX4|CCDC178|ATP9B|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|C18orf32|KC6|LOC643542|C18orf63|MIR924HG|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LINC01630|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4318|MIR4320|MIR3929|LINC01539|LOC100505549|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4741|MIR4528|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR548AV|RNU6-39P|LINC-ROR|LINC01544|LOC101060542|LOC101927229|LINC01416|LOC101927322|LOC101927481|LOC101927571|LOC101927606|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	20989762 - 80209986	GRCh38	58762	73357
GRCh38/hg38 18q11.1-23(chr18:20960320-80234429)x3	AQP4|ATP5A1|BCL2|CDH2|CDH7|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GRP|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC4R|ME2|MEP1B|MYO5B|NARS|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TTR|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|CTDP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|CTIF|TSHZ1|ACAA2|CD226|ZNF271P|MALT1|TXNL4A|MAPRE2|POLI|ADNP2|TRAPPC8|PHLPP1|NEDD4L|WDR7|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ZNF407|CNDP2|CELF4|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|CTAGE1|GAREM1|CCDC102B|RBFA|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|NETO1|KATNAL2|CHST9|C18orf21|MRO|HDHD2|ZNF397|C18orf12|PARD6G|CNDP1|TMEM241|SERPINB12|SERPINB11|SEC11C|CABLES1|DSEL|ESCO1|OSBPL1A|HAUS1|ALPK2|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|C18orf54|TCEB3C|ABHD3|FBXO15|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LOC339298|CPLX4|CCDC178|ATP9B|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|C18orf32|KC6|LOC643542|C18orf63|MIR924HG|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LINC01630|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4318|MIR4320|MIR3929|LINC01539|LOC100505549|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4741|MIR4528|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR548AV|RNU6-39P|LINC-ROR|LINC01544|LOC101060542|LOC101927229|LINC01416|LOC101927322|LOC101927481|LOC101927571|LOC101927606|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	20960320 - 80234429	GRCh38	58756	73351
GRCh38/hg38 18p11.32-q23(chr18:148963-80244381)x3	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|LINC00470|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|C18orf12|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|APCDD1|LINC00526|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|DLGAP1-AS3|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|DLGAP1-AS5|LAMA1|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LINC00667|LRRC30|LOC339298|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00668|LINC01443|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf61|C18orf32|KC6|AKAIN1|LOC643542|C18orf63|MIR3976HG|TMEM200C|SLC35G4|MIR924HG|DLGAP1-AS1|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01387|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LOC100192426|GACAT2|LINC01630|LDLRAD4-AS1|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4317|MIR4318|MIR4320|MIR3156-2|MIR3929|LINC01539|LOC100505549|GAPLINC|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4526|MIR4741|MIR4528|MIR3976|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR5190|MIR548AV|RNU6-39P|LINC-ROR|LOC100996324|LINC01544|LOC101060542|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|LOC101927229|LINC01416|NDUFV2-AS1|LOC101927322|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|LOC101927481|LOC101927571|LOC101927606|LINC01444|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR6718|MIR7153|MIR6788|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC104968399|LOC105371998|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LOC105376854|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	148963 - 80244381	GRCh38	58729	73324
GRCh38/hg38 18p11.32-q23(chr18:148763-80252290)x3	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|LINC00470|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|C18orf12|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|APCDD1|LINC00526|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|DLGAP1-AS3|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|DLGAP1-AS5|LAMA1|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LINC00667|LRRC30|LOC339298|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00668|LINC01443|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf61|C18orf32|KC6|AKAIN1|LOC643542|C18orf63|MIR3976HG|TMEM200C|SLC35G4|MIR924HG|DLGAP1-AS1|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01387|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LOC100192426|GACAT2|LINC01630|LDLRAD4-AS1|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4317|MIR4318|MIR4320|MIR3156-2|MIR3929|LINC01539|LOC100505549|GAPLINC|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4526|MIR4741|MIR4528|MIR3976|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR5190|MIR548AV|RNU6-39P|LINC-ROR|LOC100996324|LINC01544|LOC101060542|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|LOC101927229|LINC01416|NDUFV2-AS1|LOC101927322|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|LOC101927481|LOC101927571|LOC101927606|LINC01444|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR6718|MIR7153|MIR6788|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC104968399|LOC105371998|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LOC105376854|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	148763 - 80252290	GRCh38	58723	73318
GRCh38/hg38 18p11.32-q23(chr18:53345-80209986)x3	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|LINC00470|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|C18orf12|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|APCDD1|LINC00526|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|DLGAP1-AS3|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|DLGAP1-AS5|LAMA1|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LINC00667|LRRC30|LOC339298|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00668|LINC01443|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf61|C18orf32|KC6|AKAIN1|LOC643542|C18orf63|MIR3976HG|TMEM200C|SLC35G4|MIR924HG|DLGAP1-AS1|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01387|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LOC100192426|GACAT2|LINC01630|LDLRAD4-AS1|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4317|MIR4318|MIR4320|MIR3156-2|MIR3929|LINC01539|LOC100505549|GAPLINC|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4526|MIR4741|MIR4528|MIR3976|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR5190|MIR548AV|RNU6-39P|LINC-ROR|LOC100996324|LINC01544|LOC101060542|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|LOC101927229|LINC01416|NDUFV2-AS1|LOC101927322|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|LOC101927481|LOC101927571|LOC101927606|LINC01444|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR6718|MIR7153|MIR6788|MIR8057|MIR8078|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC104968399|LOC105371998|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LOC105376854|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	18	53345 - 80209986	GRCh38	58718	73313
GRCh38/hg38 18p11.32-11.21(chr18:148963-14081888)x1	ADCYAP1|LDLRAD4|CETN1|CIDEA|GNAL|IMPA2|MC2R|MC5R|NDUFV2|PTPN2|PTPRM|TGIF1|TYMS|YES1|ZBTB14|RNMT|MYOM1|NAPG|USP14|VAPA|DLGAP1|LPIN2|THOC1|PPP4R1|NDC80|MYL12A|PRELID3A|RALBP1|AFG3L2|RAB31|EPB41L3|ANKRD12|MTCL1|SMCHD1|CLUL1|CEP192|ENOSF1|LINC00470|SPIRE1|PSMG2|TWSG1|CHMP1B|PIEZO2|METTL4|MPPE1|ARHGAP28|CEP76|COLEC12|SEH1L|EMILIN2|TXNDC2|TUBB6|DLGAP1-AS2|L3MBTL4|MYL12B|FAM210A|APCDD1|LINC00526|ZNF519|RAB12|DLGAP1-AS3|DLGAP1-AS5|LAMA1|LINC00667|LRRC30|ANKRD62|LINC00668|TYMSOS|C18orf61|AKAIN1|MIR3976HG|TMEM200C|SLC35G4|DLGAP1-AS1|LINC01387|LOC100192426|GACAT2|LDLRAD4-AS1|MIR4317|GAPLINC|MIR4526|MIR3976|MIR5190|LOC100996324|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|NDUFV2-AS1|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|MIR6718|MIR7153|MIR6788|LOC104968399|LOC105371998|LOC105376854	See cases		Pathogenic(Last reviewed: Jul 22, 2013)	no assertion criteria provided	18	148963 - 14081888	GRCh38	34384	43049
GRCh38/hg38 18p11.32-q23(chr18:148963-80252149)x3	ADCYAP1|AQP4|ATP5A1|BCL2|LDLRAD4|CDH2|CDH7|CETN1|CIDEA|CYB5A|DCC|DSC1|DSC2|DSC3|DSG1|DSG2|DSG3|DTNA|FECH|KDSR|GALR1|GALNT1|GATA6|GNAL|GRP|IMPA2|LAMA3|LMAN1|SMAD2|SMAD4|SMAD7|MBD1|MBP|MC2R|MC4R|MC5R|ME2|MEP1B|MYO5B|NARS|NDUFV2|NFATC1|NPC1|SERPINB2|ATP8B1|SERPINB5|SERPINB8|SERPINB10|SERPINB13|PIK3C3|PMAIP1|MAPK4|PTPN2|PTPRM|RAB27B|RBBP8|RIT2|ROCK1|RPL17|SERPINB3|SERPINB4|SLC14A1|SNRPD1|SS18|SYT4|TAF4B|TCF4|TGIF1|TTR|TYMS|YES1|ZBTB14|ZNF24|ZNF236|SLC14A2|SERPINB7|NOL4|RNMT|MYOM1|NAPG|RIOK3|TNFRSF11A|MBD2|PSTPIP2|PIAS2|USP14|CTDP1|VAPA|DLGAP1|SOCS6|B4GALT6|TXNL1|LIPG|ONECUT2|VPS4B|ZNF516|LPIN2|CTIF|THOC1|PPP4R1|TSHZ1|NDC80|ACAA2|MYL12A|PRELID3A|CD226|ZNF271P|MALT1|TXNL4A|RALBP1|AFG3L2|MAPRE2|RAB31|POLI|ADNP2|TRAPPC8|EPB41L3|PHLPP1|ANKRD12|MTCL1|NEDD4L|WDR7|SMCHD1|PIGN|SLC39A6|RTTN|ZNF521|TPGS2|SETBP1|KCNG2|CABYR|SNORD58B|SNORD58A|CLUL1|SALL3|CDH20|CDH19|TIMM21|ST8SIA5|C18orf8|RAX|CXXC1|ST8SIA3|IER3IP1|TCEB3B|MEX3C|RNF138|TMX3|DYM|ZCCHC2|RNF125|MOCOS|CEP192|RPRD1A|ZNF532|ELP2|IMPACT|ELAC1|ENOSF1|ZNF407|CNDP2|LINC00470|CELF4|SPIRE1|PSMG2|TWSG1|CHMP1B|MIB1|KIAA1328|KLHL14|KIAA1468|EPG5|HRH4|PIEZO2|CTAGE1|GAREM1|METTL4|MPPE1|ARHGAP28|CCDC102B|RBFA|CEP76|GREB1L|PQLC1|FHOD3|CCDC68|ASXL3|COLEC12|NETO1|SEH1L|KATNAL2|CHST9|C18orf21|MRO|EMILIN2|HDHD2|TXNDC2|ZNF397|C18orf12|PARD6G|TUBB6|CNDP1|DLGAP1-AS2|TMEM241|SERPINB12|SERPINB11|SEC11C|L3MBTL4|CABLES1|DSEL|MYL12B|ESCO1|OSBPL1A|HAUS1|ALPK2|FAM210A|LOXHD1|INO80C|TTC39C|FAM69C|PSMA8|STARD6|C18orf25|CCBE1|CBLN2|SLC25A52|DSG4|AQP4-AS1|ANKRD29|APCDD1|LINC00526|ZNF519|C18orf54|TCEB3C|ABHD3|FBXO15|RAB12|DLGAP1-AS3|ZBTB7C|SKA1|CFAP53|GTSCR1|DOK6|RNF152|LINC00305|ZNF396|DLGAP1-AS5|LAMA1|LOC284241|KCTD1|DYNAP|BOD1L2|LINC00907|SIGLEC15|ZADH2|SMIM21|LINC00908|HMSD|LOC284294|LINC00667|LRRC30|LOC339298|CPLX4|ANKRD62|ANKRD30B|CCDC178|ATP9B|POTEC|LINC00668|LINC01443|LINC01538|LOC400655|LINC00909|C18orf65|LINC00683|LOC400661|MIR1-2|MIR122|MIR133A1|MIR187|HSBP1L1|RNF165|TYMSOS|C18orf61|C18orf32|KC6|AKAIN1|LOC643542|C18orf63|MIR3976HG|TMEM200C|SLC35G4|MIR924HG|DLGAP1-AS1|SKOR2|SCARNA17|SNORA37|PCAT18|TCEB3CL|LOC729950|ZSCAN30|SNORD58C|MIR924|GATA6-AS1|LOC100129878|LINC01387|PARD6G-AS1|LOC100131655|LINC01415|TRK-CTT6-1|LOC100192426|GACAT2|LINC01630|LDLRAD4-AS1|MIR302F|MIR320C1|MIR320C2|MIR1539|MIR4319|MIR4317|MIR4318|MIR4320|MIR3156-2|MIR3929|LINC01539|LOC100505549|GAPLINC|LINC01541|LOC100505797|LOC100505817|LOC100505853|RBFADN|LINC01543|TCEB3CL2|RPL17-C18orf32|MIR4526|MIR4741|MIR4528|MIR3976|MIR3975|MIR4527|MIR4529|MIR3591|MIR4743|MIR4744|DSG2-AS1|MIR5583-2|MIR5011|MIR5583-1|MIR5190|MIR548AV|RNU6-39P|LINC-ROR|LOC100996324|LINC01544|LOC101060542|DLGAP1-AS4|L3MBTL4-AS1|LOC101927168|LOC101927188|LOC101927229|LINC01416|NDUFV2-AS1|LOC101927322|PPP4R1-AS1|LINC01254|LOC101927410|LINC01255|LOC101927481|LOC101927571|LOC101927606|LINC01444|LOC101927651|DSCAS|LINC01029|DSG1-AS1|LOC101927809|LINC01477|LINC01478|SLC14A2-AS1|LOC101927989|LOC101928167|MIR6718|MIR7153|MIR6788|MIR8057|MIR133A1HG|TTC39C-AS1|LOC102724651|LOC102724913|SNHG22|LOC104968399|LOC105371998|LOC105372028|LOC105372038|LOC105372068|LOC105372069|LOC105372071|TCF4-AS1|LOC105372179|LOC105376854|LINC01601|SNORA108|SNORA111	See cases		Pathogenic(Last reviewed: Jan 27, 2011)	no assertion criteria provided	18	148963 - 80252149	GRCh38	33085	41750
NM_030662.3(MAP2K2):c.806C>T (p.Pro269Leu)	MAP2K2	not specified	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	19	4099314	GRCh38	180906	179823
NM_030662.3(MAP2K2):c.619G>A (p.Glu207Lys)	MAP2K2	not provided|Rasopathy		Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2015)	criteria provided, multiple submitters, no conflicts	19	4101105	GRCh38	40813	49283
NM_030662.3(MAP2K2):c.401A>G (p.Tyr134Cys)	MAP2K2	Rasopathy|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	19	4110558	GRCh38	177868	176031
NM_030662.3(MAP2K2):c.400T>C (p.Tyr134His)	MAP2K2	not provided|Cardiofaciocutaneous syndrome 4|Cardio-facio-cutaneous syndrome		Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, multiple submitters, no conflicts	19	4110559	GRCh38	8274	23313
NM_030662.3(MAP2K2):c.383C>G (p.Pro128Arg)	MAP2K2	not specified		Uncertain significance(Last reviewed: Apr 7, 2014)	criteria provided, single submitter	19	4110576	GRCh38	40792	49262
NM_030662.3(MAP2K2):c.383C>A (p.Pro128Gln)	MAP2K2	not provided|Cardiofaciocutaneous syndrome 4|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	19	4110576	GRCh38	8275	23314
NM_030662.3(MAP2K2):c.181A>G (p.Lys61Glu)	MAP2K2	Cardiofaciocutaneous syndrome 1|not provided		Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2013)	criteria provided, multiple submitters, no conflicts	19	4117541	GRCh38	40769	49239
NM_030662.3(MAP2K2):c.170T>G (p.Phe57Cys)	MAP2K2	not provided|Cardiofaciocutaneous syndrome 4|Cardio-facio-cutaneous syndrome		Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	19	4117552	GRCh38	8272	23311
NM_030662.3(MAP2K2):c.169T>C (p.Phe57Leu)	MAP2K2	not provided		Pathogenic(Last reviewed: Oct 13, 2014)	criteria provided, single submitter	19	4117553	GRCh38	180911	179828
NM_030662.3(MAP2K2):c.169T>A (p.Phe57Ile)	MAP2K2	not specified		Uncertain significance(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	19	4117553	GRCh38	163960	176174
NM_032620.3(GTPBP3):c.32_33delAAinsGTG (p.Gln11Argfs)	GTPBP3	Combined oxidative phosphorylation deficiency 23		Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	19	17337643 - 17337644	GRCh38	180619	178785
NM_001492.5(GDF1):c.800G>A (p.Cys267Tyr)	GDF1|CERS1	Double outlet right ventricle		Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	19	18868916	GRCh38	6748	21787
NG_013359.1:g.5002C>G	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	35030689	GRCh38	328829	333128
NG_013359.1:g.5039C>T	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome	GMAF:0.00760(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	35030726	GRCh38	328830	333131
NG_013359.1:g.5041G>C	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	35030728	GRCh38	328831	348589
NG_013359.1:g.5046A>C	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	35030733	GRCh38	328832	349668
NG_013359.1:g.5107G>C	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome	GO-ESP:0.00108(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	35030794	GRCh38	328833	349669
NM_001037.4(SCN1B):c.-9C>A	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome|not specified	GMAF:0.00760(A), GO-ESP:0.00159(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	35030812	GRCh38	139002	142705
NM_001037.4(SCN1B):c.22G>C (p.Val8Leu)	SCN1B	not specified		Uncertain significance(Last reviewed: Aug 19, 2012)	criteria provided, single submitter	19	35030842	GRCh38	190867	188674
NM_001037.4(SCN1B):c.28G>A (p.Gly10Ser)	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00320(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	35030848	GRCh38	190869	188676
NM_001037.4(SCN1B):c.40+15G>T	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome|not specified	GMAF:0.14820(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	35030875	GRCh38	93481	99386
NM_001037.4(SCN1B):c.121A>G (p.Ile41Val)	SCN1B	not specified	GMAF:0.00020(G), GO-ESP:0.00004(G)	Uncertain significance(Last reviewed: Jul 22, 2014)	criteria provided, single submitter	19	35032608	GRCh38	190856	188681
NG_013359.1:g.6950C>T	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	35032637	GRCh38	328834	343244
NM_001037.4(SCN1B):c.207+14G>A	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome|not specified	GMAF:0.03240(A), GO-ESP:0.00913(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	35032708	GRCh38	138990	142693
NM_001037.4(SCN1B):c.259G>C (p.Glu87Gln)	SCN1B	Cardiac conduction defect, nonspecific		Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	19	35033550	GRCh38	9255	24294
NM_001037.4(SCN1B):c.351C>T (p.Gly117=)	SCN1B	Cardiac conduction defect, nonspecific|Brugada syndrome 5|Generalized epilepsy with febrile seizures plus|Brugada syndrome|not specified|Cardiovascular phenotype	GMAF:0.00540(T), GO-ESP:0.00236(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	35033642	GRCh38	138995	142698
NM_001037.4(SCN1B):c.352G>T (p.Asp118Tyr)	SCN1B	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: May 16, 2014)	criteria provided, single submitter	19	35033643	GRCh38	190861	188686
NM_001037.4(SCN1B):c.412G>A (p.Val138Ile)	SCN1B	Cardiac conduction defect, nonspecific|Brugada syndrome 5|Long QT syndrome|Generalized epilepsy with febrile seizures plus|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	GMAF:0.02100(A), GO-ESP:0.01168(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	35033703	GRCh38	180508	178737
NM_001037.4(SCN1B):c.448+88G>A	SCN1B	Brugada syndrome 5|not provided		Pathogenic(Last reviewed: Nov 7, 2011)	criteria provided, single submitter	19	35033827	GRCh38	9254	24293
NM_199037.4(SCN1B):c.537G>A (p.Trp179Ter)	SCN1B	Cardiac conduction defect, nonspecific		Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	19	35033828	GRCh38	9256	24295
NM_001037.4(SCN1B):c.448+144A>G	SCN1B	not specified	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Mar 29, 2014)	criteria provided, single submitter	19	35033883	GRCh38	190864	188690
NM_199037.3(SCN1B):c.749G>C (p.Arg250Thr)	SCN1B	Cardiac arrhythmia|not specified	GO-ESP:0.11644(C), GMAF:0.11920(C), GO-ESP:0.14273(C)	Benign(Last reviewed: Jul 22, 2013)	criteria provided, multiple submitters, no conflicts	19	35034040	GRCh38	36756	45417
NM_199037.3(SCN1B):c.751G>A (p.Val251Ile)	SCN1B	Cardiac arrhythmia	GO-ESP:0.00005(A)	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	19	35034042	GRCh38	36757	45418
NM_001037.4(SCN1B):c.501T>C (p.Ile167=)	SCN1B	Cardiac conduction defect, nonspecific|Generalized epilepsy with febrile seizures plus|Brugada syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.02368(C), GMAF:0.01560(C), GO-ESP:0.02399(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	35039169	GRCh38	130210	135657
NM_001037.4(SCN1B):c.590C>T (p.Ala197Val)	SCN1B	not specified	GMAF:0.00020(T), GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	19	35039258	GRCh38	190874	188704
NM_001037.4(SCN1B):c.632G>A (p.Cys211Tyr)	SCN1B	not specified|Cardiovascular phenotype	GMAF:0.00040(A), GO-ESP:0.00050(A)	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2016)	criteria provided, conflicting interpretations	19	35039676	GRCh38	190877	188707
NM_000540.2(RYR1):c.6838G>A (p.Val2280Ile)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	GO-ESP:0.00003(A)	Likely pathogenic(Last reviewed: Jul 17, 2014)	no assertion criteria provided	19	38496901	GRCh38	133172	136919
NM_001042544.1(LTBP4):c.4238dupC (p.Arg1414Alafs)	LTBP4	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities		Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	19	40627026	GRCh38	5399	20438
NM_006494.3(ERF):c.1270C>T (p.Gln424Ter)	ERF	Craniosynostosis 4		Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	19	42248842	GRCh38	55927	70569
NM_024301.4(FKRP):c.826C>A (p.Leu276Ile)	FKRP	Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|not provided|Walker-Warburg congenital muscular dystrophy	GO-ESP:0.00045(A), GMAF:0.00060(A), GO-ESP:0.00396(A)	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, multiple submitters, no conflicts	19	46756276	GRCh38	4221	19260
NM_024301.4(FKRP):c.1387A>G (p.Asn463Asp)	FKRP	Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B5|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|not provided|Muscular dystrophy	GO-ESP:0.00017(G)	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	19	46756837	GRCh38	4235	19274
NM_017636.3(TRPM4):c.19G>A (p.Glu7Lys)	TRPM4	Progressive familial heart block type 1B		Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	19	49157885	GRCh38	3770	18809
NM_017636.3(TRPM4):c.490C>T (p.Arg164Trp)	TRPM4	Progressive familial heart block type 1B	GO-ESP:0.00002(T)	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	19	49168301	GRCh38	35488	44161
NM_017636.3(TRPM4):c.597C>T (p.Thr199=)	TRPM4	Cardiovascular phenotype		Likely benign(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	19	49168408	GRCh38	264310	259035
NM_017636.3(TRPM4):c.618G>A (p.Ser206=)	TRPM4	Cardiovascular phenotype	GMAF:0.00960(A), GO-ESP:0.00472(A)	Benign(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	19	49168558	GRCh38	264212	259034
NM_017636.3(TRPM4):c.1069C>T (p.Arg357Trp)	TRPM4	Cardiac arrest	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	19	49172027	GRCh38	222852	224555
NM_017636.3(TRPM4):c.1119C>A (p.Phe373Leu)	TRPM4	Cardiovascular phenotype	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Dec 19, 2015)	criteria provided, single submitter	19	49172077	GRCh38	264591	259041
NM_017636.3(TRPM4):c.1294G>A (p.Ala432Thr)	TRPM4	Progressive familial heart block type 1B|Brugada syndrome	GO-ESP:0.00069(A), GMAF:0.00040(A), GO-ESP:0.00050(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2015)	criteria provided, conflicting interpretations	19	49182608	GRCh38	35487	44160
NM_017636.3(TRPM4):c.1323G>T (p.Val441=)	TRPM4	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	19	49182637	GRCh38	264216	259047
NM_017636.3(TRPM4):c.1575G>A (p.Trp525Ter)	TRPM4	Progressive familial heart block type 1B|Sudden cardiac death	GMAF:0.00040(A), GO-ESP:0.00157(A)	Conflicting interpretations of pathogenicity(Last reviewed: Oct 12, 2016)	criteria provided, conflicting interpretations	19	49182889	GRCh38	241176	243380
NM_017636.3(TRPM4):c.1744G>A (p.Gly582Ser)	TRPM4	Progressive familial heart block type 1B|Brugada syndrome	GMAF:0.00040(A), GO-ESP:0.00053(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2015)	criteria provided, conflicting interpretations	19	49188641	GRCh38	35486	44159
NM_017636.3(TRPM4):c.1826C>G (p.Ala609Gly)	TRPM4	Sudden cardiac death	GMAF:0.00020(G), GO-ESP:0.00002(G)	Uncertain significance(Last reviewed: May 4, 2015)	criteria provided, single submitter	19	49188723	GRCh38	222853	224556
NM_017636.3(TRPM4):c.2531G>A (p.Gly844Asp)	TRPM4	Progressive familial heart block type 1B|Cardiovascular phenotype	GO-ESP:0.00103(A), GMAF:0.00180(A), GO-ESP:0.00211(A)	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	19	49196760	GRCh38	35489	44162
NM_017636.3(TRPM4):c.2741A>G (p.Lys914Arg)	TRPM4	Progressive familial heart block type 1B		Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	19	49200395	GRCh38	35490	44163
NM_017636.3(TRPM4):c.2934T>C (p.Ile978=)	TRPM4	Progressive familial heart block|Cardiovascular phenotype	GMAF:0.02560(C), GO-ESP:0.00764(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	49200766	GRCh38	264108	259037
NM_017636.3(TRPM4):c.3337C>G (p.Leu1113Val)	TRPM4	Cardiac conduction defect, nonspecific		Uncertain significance(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	19	49210718	GRCh38	222855	224557
NM_003283.5(TNNT1):c.35A>G (p.Glu12Gly)	TNNI3|TNNT1	Familial restrictive cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.07051(C), GMAF:0.03590(C), GO-ESP:0.08147(C)	Benign/Likely benign, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55147019	GRCh38	31865	40525
NM_003283.5(TNNT1):c.33-8G>A	TNNI3|TNNT1	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Nemaline Myopathy, Recessive	GO-ESP:0.03822(T), GMAF:0.06870(T), GO-ESP:0.05254(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55147029	GRCh38	130603	136049
NM_003283.5(TNNT1):c.-20A>G	TNNI3|TNNT1	Familial restrictive cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Nemaline Myopathy, Recessive	GMAF:0.18990(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55149169	GRCh38	31855	40515
NM_000363.4(TNNI3):c.*35C>T	TNNI3	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.00760(A), GO-ESP:0.00364(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	55151799	GRCh38	188677	186575
NM_000363.4(TNNI3):c.632G>T (p.Ter211Leu)	TNNI3	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jul 29, 2013)	criteria provided, single submitter	19	55151835	GRCh38	181596	179832
NM_000363.4(TNNI3):c.625G>A (p.Glu209Lys)	TNNI3	not specified		Uncertain significance(Last reviewed: Mar 2, 2016)	criteria provided, multiple submitters, no conflicts	19	55151842	GRCh38	177666	176207
NM_000363.4(TNNI3):c.624T>G (p.Phe208Leu)	TNNI3	not specified		Uncertain significance(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	19	55151843	GRCh38	229335	231076
NM_000363.4(TNNI3):c.622T>A (p.Phe208Ile)	TNNI3	not specified		Uncertain significance(Last reviewed: Jul 6, 2015)	criteria provided, single submitter	19	55151845	GRCh38	229334	231077
NM_000363.4(TNNI3):c.617A>T (p.Lys206Ile)	TNNI3	not provided		Pathogenic(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	19	55151850	GRCh38	181594	179834
NM_000363.4(TNNI3):c.616A>G (p.Lys206Glu)	TNNI3	not provided		Pathogenic(Last reviewed: Jun 28, 2013)	criteria provided, single submitter	19	55151851	GRCh38	181593	179835
NM_000363.4(TNNI3):c.616A>C (p.Lys206Gln)	TNNI3	Familial hypertrophic cardiomyopathy 7		Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	19	55151851	GRCh38	12420	27459
NM_000363.4(TNNI3):c.613A>C (p.Lys205Gln)	TNNI3	not specified		Uncertain significance(Last reviewed: Nov 3, 2014)	criteria provided, single submitter	19	55151854	GRCh38	180077	176066
NM_000363.4(TNNI3):c.611G>A (p.Arg204His)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	19	55151856	GRCh38	177679	176208
NM_000363.4(TNNI3):c.610C>T (p.Arg204Cys)	TNNI3	Primary familial hypertrophic cardiomyopathy|not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2016)	criteria provided, conflicting interpretations	19	55151857	GRCh38	177631	176067
NM_000363.4(TNNI3):c.609C>T (p.Gly203=)	TNNI3	not specified		Benign(Last reviewed: May 23, 2014)	criteria provided, single submitter	19	55151858	GRCh38	137688	141391
NM_000363.4(TNNI3):c.607G>A (p.Gly203Ser)	TNNI3	Familial hypertrophic cardiomyopathy 7		Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	19	55151860	GRCh38	12432	27471
NM_000363.4(TNNI3):c.602T>C (p.Met201Thr)	TNNI3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 5, 2013)	no assertion criteria provided	19	55151865	GRCh38	177863	176209
NM_000363.4(TNNI3):c.599G>A (p.Gly200Glu)	TNNI3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	19	55151868	GRCh38	237692	243548
NM_000363.4(TNNI3):c.596G>A (p.Ser199Asn)	TNNI3	Familial hypertrophic cardiomyopathy 7|not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Nov 9, 2015)	criteria provided, conflicting interpretations	19	55151871	GRCh38	181603	179836
NM_000363.4(TNNI3):c.592C>G (p.Leu198Val)	TNNI3	not specified		Uncertain significance(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	19	55151875	GRCh38	177694	176068
NM_000363.4(TNNI3):c.586G>T (p.Asp196Tyr)	TNNI3	not specified		Uncertain significance(Last reviewed: Dec 26, 2013)	criteria provided, single submitter	19	55151881	GRCh38	179492	176210
NM_000363.4(TNNI3):c.586G>A (p.Asp196Asn)	TNNI3	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not specified|not provided	GO-ESP:0.00008(T), GO-ESP:0.00001(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 4, 2015)	criteria provided, conflicting interpretations	19	55151881	GRCh38	12422	27461
NM_000363.4(TNNI3):c.583A>C (p.Ile195Leu)	TNNI3	not specified		Uncertain significance(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	19	55151884	GRCh38	229333	231078
NM_000363.4(TNNI3):c.582C>G (p.Asn194Lys)	TNNI3	not provided		Pathogenic(Last reviewed: Dec 1, 2011)	criteria provided, single submitter	19	55151885	GRCh38	181602	179837
NM_000363.4(TNNI3):c.581A>G (p.Asn194Ser)	TNNI3	not provided		Likely pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, single submitter	19	55151886	GRCh38	181592	179838
NM_000363.4(TNNI3):c.579G>T (p.Lys193Asn)	TNNI3	not provided		Likely pathogenic(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	19	55151888	GRCh38	181591	179839
NM_000363.4(TNNI3):c.579G>C (p.Lys193Asn)	TNNI3	not specified|Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, multiple submitters, no conflicts	19	55151888	GRCh38	43396	52566
NM_000363.4(TNNI3):c.577A>G (p.Lys193Glu)	TNNI3	not specified		Uncertain significance(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	19	55151890	GRCh38	181590	179840
NM_000363.4(TNNI3):c.575G>C (p.Arg192Pro)	TNNI3	not specified		Uncertain significance(Last reviewed: Jan 22, 2014)	criteria provided, single submitter	19	55151892	GRCh38	179536	176211
NM_000363.4(TNNI3):c.575G>T (p.Arg192Leu)	TNNI3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Feb 13, 2013)	no assertion criteria provided	19	55151892	GRCh38	177831	176069
NM_000363.4(TNNI3):c.575G>A (p.Arg192His)	TNNI3	Familial restrictive cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, multiple submitters, no conflicts	19	55151892	GRCh38	12424	27463
NM_000363.4(TNNI3):c.574C>T (p.Arg192Cys)	TNNI3	Cardiomyopathy		Likely pathogenic(Last reviewed: Sep 21, 2012)	criteria provided, single submitter	19	55151893	GRCh38	165510	176070
NM_000363.4(TNNI3):c.569A>G (p.Asp190Gly)	TNNI3	Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7		Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	19	55151898	GRCh38	12423	27462
NM_000363.4(TNNI3):c.568G>T (p.Asp190Tyr)	TNNI3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	19	55151899	GRCh38	165511	176212
NM_000363.4(TNNI3):c.566G>A (p.Gly189Glu)	TNNI3	Primary familial hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Dec 20, 2013)	no assertion criteria provided	19	55151901	GRCh38	155841	165593
NM_000363.4(TNNI3):c.562G>T (p.Val188Leu)	TNNI3	not specified		Uncertain significance(Last reviewed: Feb 23, 2012)	criteria provided, single submitter	19	55151905	GRCh38	181589	179841
NM_000363.4(TNNI3):c.562G>A (p.Val188Met)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided		Likely pathogenic(Last reviewed: Dec 24, 2015)	criteria provided, multiple submitters, no conflicts	19	55151905	GRCh38	36883	45544
NM_000363.4(TNNI3):c.559G>A (p.Glu187Lys)	TNNI3	not specified		Uncertain significance(Last reviewed: Apr 24, 2014)	criteria provided, single submitter	19	55151908	GRCh38	179710	176071
NM_000363.4(TNNI3):c.557G>A (p.Arg186Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Oct 2, 2014)	criteria provided, multiple submitters, no conflicts	19	55151910	GRCh38	43395	52565
NM_000363.4(TNNI3):c.555C>G (p.Asn185Lys)	TNNI3	Dilated cardiomyopathy 1FF		Pathogenic(Last reviewed: Aug 14, 2009)	no assertion criteria provided	19	55151912	GRCh38	12431	27470
NM_000363.4(TNNI3):c.554A>G (p.Asn185Ser)	TNNI3	not provided		Likely pathogenic(Last reviewed: Jun 25, 2012)	criteria provided, single submitter	19	55151913	GRCh38	181588	179842
NM_000363.4(TNNI3):c.553A>T (p.Asn185Tyr)	TNNI3	not provided		Likely pathogenic(Last reviewed: Sep 10, 2014)	criteria provided, single submitter	19	55151914	GRCh38	181601	179843
NM_000363.4(TNNI3):c.550G>A (p.Glu184Lys)	TNNI3	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: Sep 6, 2013)	no assertion criteria provided	19	55151917	GRCh38	43394	52564
NM_000363.4(TNNI3):c.550-10C>T	TNNI3	not specified	GO-ESP:0.00195(A), GMAF:0.00280(A), GO-ESP:0.00057(A)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2015)	criteria provided, conflicting interpretations	19	55151927	GRCh38	43393	52563
NG_007866.2:g.10805C>T	TNNI3	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55151928	GRCh38	330198	344272
NM_000363.4(TNNI3):c.549+68_549+69insGCCTAG	TNNI3	Primary familial hypertrophic cardiomyopathy	GMAF:0.03470(CTAGGC)	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	19	55153961 - 55153962	GRCh38	36882	45543
NM_000363.4(TNNI3):c.549+16G>A	TNNI3	not specified		Uncertain significance(Last reviewed: Mar 13, 2012)	criteria provided, single submitter	19	55154014	GRCh38	188676	186576
NM_000363.4(TNNI3):c.548A>C (p.Lys183Thr)	TNNI3	not provided		Pathogenic(Last reviewed: Feb 15, 2014)	criteria provided, single submitter	19	55154031	GRCh38	181587	179844
NM_000363.4(TNNI3):c.547A>G (p.Lys183Glu)	TNNI3	not provided		Pathogenic(Last reviewed: Mar 30, 2013)	criteria provided, single submitter	19	55154032	GRCh38	181586	179845
NM_000363.4(TNNI3):c.544G>A (p.Glu182Lys)	TNNI3	Primary dilated cardiomyopathy|not provided		Pathogenic(Last reviewed: Sep 10, 2014)	criteria provided, multiple submitters, no conflicts	19	55154035	GRCh38	43392	52562
NM_000363.4(TNNI3):c.538delG (p.Asp180Thrfs)	TNNI3	not specified		Uncertain significance(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	19	55154041	GRCh38	229332	231079
NM_000363.4(TNNI3):c.537G>A (p.Glu179=)	TNNI3|DNAAF3	Primary ciliary dyskinesia|not specified|Cardiovascular phenotype	GO-ESP:0.04846(T), GMAF:0.04770(T), GO-ESP:0.06598(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55154042	GRCh38	43391	52561
NM_000363.4(TNNI3):c.532_534delAAG (p.Lys178del)	TNNI3	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Dec 2, 2009)	no assertion criteria provided	19	55154045 - 55154047	GRCh38	43386	52556
NM_000363.4(TNNI3):c.532A>G (p.Lys178Glu)	TNNI3	Familial restrictive cardiomyopathy 1		Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	19	55154047	GRCh38	12425	27464
NM_000363.4(TNNI3):c.526G>A (p.Val176Met)	TNNI3	Primary familial hypertrophic cardiomyopathy|not specified		Conflicting interpretations of pathogenicity(Last reviewed: May 5, 2014)	criteria provided, conflicting interpretations	19	55154053	GRCh38	165513	176213
NM_000363.4(TNNI3):c.525G>C (p.Gln175His)	TNNI3	not specified		Uncertain significance(Last reviewed: Jul 24, 2015)	criteria provided, single submitter	19	55154054	GRCh38	165514	176072
NM_000363.4(TNNI3):c.523C>T (p.Gln175Ter)	TNNI3	not provided|Cardiovascular phenotype		Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	19	55154056	GRCh38	235062	236817
NM_000363.4(TNNI3):c.522G>C (p.Lys174Asn)	TNNI3	Cardiomyopathy, restrictive		Pathogenic(Last reviewed: May 28, 2014)	no assertion criteria provided	19	55154057	GRCh38	180551	178749
NM_000363.4(TNNI3):c.521A>C (p.Lys174Thr)	TNNI3	not provided		Likely pathogenic(Last reviewed: May 24, 2013)	criteria provided, single submitter	19	55154058	GRCh38	181585	179846
NM_000363.4(TNNI3):c.514C>G (p.His172Asp)	TNNI3	not provided		Likely pathogenic(Last reviewed: Jan 13, 2012)	criteria provided, single submitter	19	55154065	GRCh38	181584	179847
NM_000363.4(TNNI3):c.511G>A (p.Ala171Thr)	TNNI3	Familial restrictive cardiomyopathy 1|not specified		Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2013)	criteria provided, conflicting interpretations	19	55154068	GRCh38	12429	27468
NM_000363.4(TNNI3):c.509G>A (p.Arg170Gln)	TNNI3	Cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, multiple submitters, no conflicts	19	55154070	GRCh38	165516	176214
NM_000363.4(TNNI3):c.508C>T (p.Arg170Trp)	TNNI3	Cardiomyopathy, restrictive|Familial restrictive cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, multiple submitters, no conflicts	19	55154071	GRCh38	179285	176073
NM_000363.4(TNNI3):c.508C>G (p.Arg170Gly)	TNNI3	Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 1FF|Familial hypertrophic cardiomyopathy 7|not specified		Conflicting interpretations of pathogenicity(Last reviewed: May 22, 2013)	criteria provided, conflicting interpretations	19	55154071	GRCh38	165517	176215
NM_000363.4(TNNI3):c.497C>T (p.Ser166Phe)	TNNI3	not specified|not provided	GO-ESP:0.00001(A)	Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2016)	criteria provided, conflicting interpretations	19	55154082	GRCh38	177630	176074
NM_000363.4(TNNI3):c.488C>T (p.Ala163Val)	TNNI3	not specified		Uncertain significance(Last reviewed: Jan 23, 2013)	no assertion criteria provided	19	55154091	GRCh38	177866	176216
NM_000363.4(TNNI3):c.485G>C (p.Arg162Pro)	TNNI3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	19	55154094	GRCh38	43390	52560
NM_000363.4(TNNI3):c.485G>A (p.Arg162Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00003(T)	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2016)	criteria provided, multiple submitters, no conflicts	19	55154094	GRCh38	43389	52559
NM_000363.4(TNNI3):c.484C>T (p.Arg162Trp)	TNNI3	Primary familial hypertrophic cardiomyopathy|not specified|not provided	GO-ESP:0.00003(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2016)	criteria provided, conflicting interpretations	19	55154095	GRCh38	161396	171245
NM_000363.4(TNNI3):c.471G>A (p.Ala157=)	TNNI3	not specified	GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	19	55154108	GRCh38	188675	186577
NM_000363.4(TNNI3):c.470C>T (p.Ala157Val)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, multiple submitters, no conflicts	19	55154109	GRCh38	43388	52558
NM_000363.4(TNNI3):c.464T>C (p.Met155Thr)	TNNI3	Primary dilated cardiomyopathy		Likely pathogenic(Last reviewed: Jun 16, 2011)	criteria provided, single submitter	19	55154115	GRCh38	43387	52557
NM_000363.4(TNNI3):c.463A>G (p.Met155Val)	TNNI3	not specified	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Aug 18, 2014)	criteria provided, single submitter	19	55154116	GRCh38	181583	179848
NM_000363.4(TNNI3):c.462G>A (p.Met154Ile)	TNNI3	not specified		Uncertain significance(Last reviewed: Sep 19, 2012)	criteria provided, single submitter	19	55154117	GRCh38	43385	52555
NM_000363.4(TNNI3):c.458C>A (p.Ala153Asp)	TNNI3	not specified		Uncertain significance(Last reviewed: Jun 18, 2013)	criteria provided, single submitter	19	55154121	GRCh38	181582	179849
NM_000363.4(TNNI3):c.451G>A (p.Ala151Thr)	TNNI3	not provided		Likely pathogenic(Last reviewed: Sep 26, 2013)	criteria provided, single submitter	19	55154128	GRCh38	181581	179850
NM_000363.4(TNNI3):c.439G>C (p.Val147Leu)	TNNI3	not specified	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	19	55154140	GRCh38	188674	186578
NM_000363.4(TNNI3):c.434G>A (p.Arg145Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00003(T)	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, multiple submitters, no conflicts	19	55154145	GRCh38	43384	52554
NM_000363.4(TNNI3):c.433C>T (p.Arg145Trp)	TNNI3	Familial restrictive cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided	GO-ESP:0.00001(A)	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, multiple submitters, no conflicts	19	55154146	GRCh38	12426	27465
NM_000363.4(TNNI3):c.433C>G (p.Arg145Gly)	TNNI3	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|Cardiovascular phenotype		Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	19	55154146	GRCh38	12419	27458
NM_000363.4(TNNI3):c.431T>C (p.Leu144Pro)	TNNI3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: May 14, 2015)	criteria provided, single submitter	19	55154148	GRCh38	43383	52553
NM_000363.4(TNNI3):c.431T>A (p.Leu144Gln)	TNNI3	Familial restrictive cardiomyopathy 1		Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	19	55154148	GRCh38	12428	27467
NM_000363.4(TNNI3):c.428C>A (p.Thr143Asn)	TNNI3	not specified|not provided	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2014)	criteria provided, conflicting interpretations	19	55154151	GRCh38	43382	52552
NM_000363.4(TNNI3):c.422G>A (p.Arg141Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided		Pathogenic/Likely pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	19	55154157	GRCh38	43381	52551
NM_000363.4(TNNI3):c.421C>T (p.Arg141Trp)	TNNI3	not provided	GO-ESP:0.00001(A)	Likely pathogenic(Last reviewed: Sep 19, 2016)	criteria provided, single submitter	19	55154158	GRCh38	181580	179851
NM_000363.4(TNNI3):c.407G>A (p.Arg136Gln)	TNNI3	not provided|Hypertrophic cardiomyopathy	GO-ESP:0.00001(T)	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2015)	criteria provided, multiple submitters, no conflicts	19	55154172	GRCh38	181576	179852
NM_000363.4(TNNI3):c.401A>G (p.Asp134Gly)	TNNI3	not specified		Uncertain significance(Last reviewed: Apr 21, 2013)	criteria provided, single submitter	19	55154178	GRCh38	165518	176075
NM_000363.4(TNNI3):c.384G>A (p.Leu128=)	TNNI3	not specified	GO-ESP:0.00008(T)	Likely benign(Last reviewed: May 3, 2010)	criteria provided, single submitter	19	55154195	GRCh38	43379	52549
NM_000363.4(TNNI3):c.374T>C (p.Ile125Thr)	TNNI3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	19	55154205	GRCh38	237691	243549
NM_000363.4(TNNI3):c.373-4C>G	TNNI3	not specified	GMAF:0.00020(C), GO-ESP:0.00009(C)	Likely benign(Last reviewed: Nov 5, 2008)	no assertion criteria provided	19	55154210	GRCh38	43378	52548
NM_000363.4(TNNI3):c.373-10G=	TNNI3|TNNT1|DNAAF3	Primary familial hypertrophic cardiomyopathy|Primary ciliary dyskinesia|not specified|Nemaline Myopathy, Recessive	GMAF:0.00000(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55154216	GRCh38	36881	45542
NM_000363.4(TNNI3):c.373-15C>G	TNNI3	not specified	GO-ESP:0.00105(C), GMAF:0.00080(C), GO-ESP:0.00033(C)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2015)	criteria provided, conflicting interpretations	19	55154221	GRCh38	43377	52547
NM_000363.4(TNNI3):c.373-60G>A	TNNI3	not specified	GMAF:0.00200(T)	Likely benign(Last reviewed: Mar 13, 2012)	criteria provided, single submitter	19	55154266	GRCh38	188673	186579
NM_000363.4(TNNI3):c.372+7C>T	TNNI3	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.00003(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	55154734	GRCh38	165519	176339
NM_000363.4(TNNI3):c.370G>C (p.Glu124Gln)	TNNI3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: May 23, 2016)	criteria provided, multiple submitters, no conflicts	19	55154743	GRCh38	165520	176076
NM_000363.4(TNNI3):c.368C>T (p.Thr123Met)	TNNI3	not specified|Cardiomyopathy	GO-ESP:0.00003(A)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2014)	criteria provided, conflicting interpretations	19	55154745	GRCh38	43376	52546
NM_000363.4(TNNI3):c.356C>T (p.Thr119Ile)	TNNI3	not specified|Hypertrophic cardiomyopathy	GMAF:0.00040(T)	Uncertain significance(Last reviewed: Feb 6, 2016)	criteria provided, multiple submitters, no conflicts	19	55154757	GRCh38	181579	179853
NM_000363.4(TNNI3):c.356C>A (p.Thr119Asn)	TNNI3	not specified|Cardiovascular phenotype	GMAF:0.00040(T), GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Sep 10, 2015)	criteria provided, multiple submitters, no conflicts	19	55154757	GRCh38	43375	52545
NM_000363.4(TNNI3):c.340A>G (p.Ile114Val)	TNNI3	not specified	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Apr 25, 2012)	criteria provided, single submitter	19	55154773	GRCh38	181578	179854
NM_000363.4(TNNI3):c.339C>T (p.Asp113=)	TNNI3	not specified		Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	19	55154774	GRCh38	188672	186580
NM_000363.4(TNNI3):c.336C>T (p.Tyr112=)	TNNI3	not specified	GMAF:0.00040(A), GO-ESP:0.00010(A)	Likely benign(Last reviewed: Feb 16, 2015)	criteria provided, single submitter	19	55154777	GRCh38	228018	231080
NM_000363.4(TNNI3):c.331A>G (p.Arg111Gly)	TNNI3	not specified	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	19	55154782	GRCh38	181600	179855
NM_000363.4(TNNI3):c.308G>A (p.Arg103His)	TNNI3	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Jun 9, 2014)	criteria provided, single submitter	19	55154805	GRCh38	181577	179856
NM_000363.4(TNNI3):c.307C>G (p.Arg103Gly)	TNNI3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Mar 15, 2015)	criteria provided, single submitter	19	55154806	GRCh38	216424	213465
NM_000363.4(TNNI3):c.307C>T (p.Arg103Cys)	TNNI3	not specified		Uncertain significance(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	19	55154806	GRCh38	43374	52544
NM_000363.4(TNNI3):c.304G>A (p.Ala102Thr)	TNNI3	not specified	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	19	55154809	GRCh38	165521	176340
NM_000363.4(TNNI3):c.303C>T (p.His101=)	TNNI3	not specified	GO-ESP:0.00016(A), GMAF:0.00020(A), GO-ESP:0.00011(A)	Likely benign(Last reviewed: Apr 22, 2011)	criteria provided, single submitter	19	55154810	GRCh38	43373	52543
NM_000363.4(TNNI3):c.302A>G (p.His101Arg)	TNNI3	not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2012)	criteria provided, conflicting interpretations	19	55154811	GRCh38	181599	179857
NM_000363.4(TNNI3):c.292C>T (p.Arg98Ter)	TNNI3	not specified	GO-ESP:0.00009(A)	Uncertain significance(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	19	55154821	GRCh38	181575	179858
NG_007866.2:g.7894C>T	TNNI3	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.00004(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55154839	GRCh38	330199	349397
NM_000363.4(TNNI3):c.282+5C>G	TNNI3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	19	55156196	GRCh38	237690	243550
NM_000363.4(TNNI3):c.273G>A (p.Ala91=)	TNNI3	not specified|Hypertrophic cardiomyopathy	GO-ESP:0.00151(T), GMAF:0.00200(T), GO-ESP:0.00042(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 3, 2016)	criteria provided, conflicting interpretations	19	55156210	GRCh38	43372	52542
NM_000363.4(TNNI3):c.258C>T (p.Ala86=)	TNNI3	not specified	GO-ESP:0.00002(A)	Likely benign(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	19	55156225	GRCh38	165523	176217
NM_000363.4(TNNI3):c.258delC (p.Leu88Trpfs)	TNNI3	not specified	GO-ESP:0.00001(-)	Uncertain significance(Last reviewed: Sep 10, 2014)	criteria provided, single submitter	19	55156225	GRCh38	165522	176341
NM_000363.4(TNNI3):c.250G>T (p.Glu84Ter)	TNNI3	Cardiovascular phenotype		Likely pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	19	55156233	GRCh38	264334	259045
NM_000363.4(TNNI3):c.246G>T (p.Pro82=)	TNNI3	not specified	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Jun 4, 2012)	criteria provided, single submitter	19	55156237	GRCh38	43369	52539
NM_000363.4(TNNI3):c.244C>T (p.Pro82Ser)	TNNI3	Familial hypertrophic cardiomyopathy 7|Cardiomyopathy|Familial restrictive cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.00643(A), GMAF:0.00460(A), GO-ESP:0.00169(A)	Benign/Likely benign, risk factor(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55156239	GRCh38	12421	27460
NM_000363.4(TNNI3):c.236G>T (p.Arg79Leu)	TNNI3	not specified	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	19	55156247	GRCh38	43368	52538
NM_000363.4(TNNI3):c.235C>T (p.Arg79Cys)	TNNI3	not specified|Cardiovascular phenotype	GMAF:0.00120(A), GO-ESP:0.00043(A)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 30, 2015)	criteria provided, conflicting interpretations	19	55156248	GRCh38	43367	52537
NM_000363.4(TNNI3):c.233C>T (p.Thr78Ile)	TNNI3	not specified		Uncertain significance(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	19	55156250	GRCh38	229331	231081
NM_000363.4(TNNI3):c.233C>G (p.Thr78Ser)	TNNI3	not provided		Uncertain significance(Last reviewed: Jun 24, 2013)	criteria provided, single submitter	19	55156250	GRCh38	191799	190010
NM_000363.4(TNNI3):c.232A>T (p.Thr78Ser)	TNNI3	not specified		Uncertain significance(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	19	55156251	GRCh38	188671	186581
NM_000363.4(TNNI3):c.221G>C (p.Arg74Pro)	TNNI3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	19	55156262	GRCh38	264048	259042
NM_000363.4(TNNI3):c.208G>A (p.Gly70Arg)	TNNI3	not specified		Uncertain significance(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	19	55156275	GRCh38	181574	179859
NM_000363.4(TNNI3):c.204delG (p.Arg69Alafs)	TNNI3	Cardiomyopathy|not specified|not provided	GO-ESP:0.00006(-)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2015)	criteria provided, conflicting interpretations	19	55156279	GRCh38	179447	176218
NM_000363.4(TNNI3):c.204G>T (p.Arg68=)	TNNI3|DNAAF3	Primary ciliary dyskinesia|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.03682(A), GMAF:0.02280(A), GO-ESP:0.04615(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55156279	GRCh38	43366	52536
NM_000363.4(TNNI3):c.198G>A (p.Glu66=)	TNNI3	Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.02441(T), GMAF:0.03610(T), GO-ESP:0.01041(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55156285	GRCh38	43364	52534
NM_000363.4(TNNI3):c.173A>G (p.Lys58Arg)	TNNI3	Hypertrophic cardiomyopathy|Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 29, 2016)	criteria provided, multiple submitters, no conflicts	19	55156310	GRCh38	237689	243551
NM_000363.4(TNNI3):c.168T>G (p.Ile56Met)	TNNI3	not specified		Uncertain significance(Last reviewed: Jan 29, 2015)	criteria provided, single submitter	19	55156315	GRCh38	165525	176342
NM_000363.4(TNNI3):c.167T>C (p.Ile56Thr)	TNNI3	not specified	GMAF:0.00020(G), GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Jan 30, 2013)	no assertion criteria provided	19	55156316	GRCh38	165526	176219
NG_007866.2:g.6407C>T	TNNI3	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55156326	GRCh38	330200	344273
NM_000363.4(TNNI3):c.151-6C>G	TNNI3	not specified	GO-ESP:0.00017(C), GO-ESP:0.00008(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jan 28, 2013)	criteria provided, conflicting interpretations	19	55156338	GRCh38	43363	52533
NM_000363.4(TNNI3):c.151-8C>T	TNNI3	not specified		Uncertain significance(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	19	55156340	GRCh38	188670	186582
NM_000363.4(TNNI3):c.150+13G>T	TNNI3	not specified	GMAF:0.07690(T)	Likely benign(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	19	55156590	GRCh38	228017	231082
NM_000363.4(TNNI3):c.150+13G>A	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.07156(T), GMAF:0.07690(T), GO-ESP:0.04019(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55156590	GRCh38	43362	52532
NM_000363.4(TNNI3):c.150G>A (p.Lys50=)	TNNI3	not provided	GO-ESP:0.00004(T)	Likely pathogenic(Last reviewed: Jan 19, 2012)	criteria provided, single submitter	19	55156603	GRCh38	181598	179860
NM_000363.4(TNNI3):c.143A>C (p.Gln48Pro)	TNNI3	Cardiovascular phenotype	GO-ESP:0.00013(G)	Uncertain significance(Last reviewed: Dec 4, 2015)	criteria provided, single submitter	19	55156610	GRCh38	264596	259051
NM_000363.4(TNNI3):c.139T>C (p.Leu47=)	TNNI3	not specified		Benign(Last reviewed: Jul 12, 2013)	criteria provided, single submitter	19	55156614	GRCh38	137685	141388
NM_000363.4(TNNI3):c.132G>C (p.Ser44=)	TNNI3	not specified	GO-ESP:0.00004(G)	Likely benign(Last reviewed: Feb 21, 2014)	criteria provided, single submitter	19	55156621	GRCh38	179548	176343
NM_000363.4(TNNI3):c.131C>G (p.Ser44Trp)	TNNI3	not provided		Likely pathogenic(Last reviewed: Nov 15, 2011)	criteria provided, single submitter	19	55156622	GRCh38	181597	179861
NM_000363.4(TNNI3):c.127G>T (p.Ala43Ser)	TNNI3	not specified		Uncertain significance(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	19	55156626	GRCh38	179652	176220
NM_000363.4(TNNI3):c.114A>T (p.Lys38Asn)	TNNI3	not provided		Likely pathogenic(Last reviewed: Sep 12, 2012)	criteria provided, single submitter	19	55156639	GRCh38	181573	179862
NM_000363.4(TNNI3):c.109-15A>G	TNNI3	not specified		Uncertain significance(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	19	55156659	GRCh38	229330	231083
NM_000363.4(TNNI3):c.109-17C>A	TNNI3	not specified	GMAF:0.00460(T), GO-ESP:0.00348(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2013)	criteria provided, conflicting interpretations	19	55156661	GRCh38	137684	141387
NM_000363.4(TNNI3):c.108+21G>A	TNNI3	not specified	GMAF:0.04770(T), GO-ESP:0.10438(T)	Benign	criteria provided, single submitter	19	55157029	GRCh38	255944	257236
NM_000363.4(TNNI3):c.108+4G>T	TNNI3	Hypertrophic cardiomyopathy		Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	19	55157046	GRCh38	237688	243552
NM_000363.4(TNNI3):c.107A>C (p.Lys36Thr)	TNNI3	not provided		Likely pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	19	55157051	GRCh38	265273	260215
NM_000363.4(TNNI3):c.106A>C (p.Lys36Gln)	TNNI3	Dilated cardiomyopathy 1FF		Pathogenic(Last reviewed: Aug 14, 2009)	no assertion criteria provided	19	55157052	GRCh38	12430	27469
NM_000363.4(TNNI3):c.105C>A (p.Ala35=)	TNNI3	not specified		Likely benign(Last reviewed: Jan 14, 2009)	criteria provided, single submitter	19	55157053	GRCh38	43359	52529
NM_000363.4(TNNI3):c.88G>A (p.Ala30Thr)	TNNI3	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 24, 2015)	criteria provided, single submitter	19	55157070	GRCh38	264087	259040
NM_000363.4(TNNI3):c.85T>G (p.Tyr29Asp)	TNNI3	not specified		Uncertain significance(Last reviewed: Aug 11, 2014)	criteria provided, single submitter	19	55157073	GRCh38	165529	176344
NM_000363.4(TNNI3):c.65G>A (p.Arg22His)	TNNI3	not specified		Uncertain significance(Last reviewed: Nov 10, 2010)	criteria provided, single submitter	19	55157093	GRCh38	43398	52568
NM_000363.4(TNNI3):c.61C>T (p.Arg21Cys)	TNNI3	Familial hypertrophic cardiomyopathy 7		Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	19	55157097	GRCh38	12434	27473
NM_000363.4(TNNI3):c.39C>G (p.Arg13=)	TNNI3	not specified|Hypertrophic cardiomyopathy		Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	19	55157119	GRCh38	43380	52550
NM_000363.4(TNNI3):c.25-4C>T	TNNI3	not specified	GO-ESP:0.00081(A), GMAF:0.00040(A), GO-ESP:0.00027(A)	Likely benign(Last reviewed: Dec 26, 2013)	criteria provided, single submitter	19	55157137	GRCh38	43370	52540
NM_000363.4(TNNI3):c.25-8T>A	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GO-ESP:0.31615(T), GMAF:0.45810(T), GO-ESP:0.35374(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55157141	GRCh38	43371	52541
NM_000363.4(TNNI3):c.12-1G>T	TNNI3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	19	55157309	GRCh38	43360	52530
NM_000363.4(TNNI3):c.12-7delC	TNNI3	Familial restrictive cardiomyopathy|not specified|Cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.00200(-), GO-ESP:0.00048(-)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	55157315	GRCh38	43361	52531
NM_000363.4(TNNI3):c.12-23C>G	TNNI3	not specified	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	19	55157331	GRCh38	188669	186583
NM_000363.4(TNNI3):c.12-52_12-49dupAGAC	TNNI3	not specified		Uncertain significance(Last reviewed: Mar 13, 2012)	criteria provided, single submitter	19	55157357 - 55157360	GRCh38	188668	186584
NM_000363.4(TNNI3):c.6G>A (p.Ala2=)	TNNI3	not specified	GO-ESP:0.00003(T)	Benign/Likely benign(Last reviewed: Sep 22, 2014)	criteria provided, multiple submitters, no conflicts	19	55157584	GRCh38	43399	52569
NM_000363.4(TNNI3):c.5C>T (p.Ala2Val)	TNNI3	not specified	GO-ESP:0.00003(A)	Uncertain significance(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	19	55157585	GRCh38	43397	52567
NM_000363.4(TNNI3):c.1A>G (p.Met1Val)	TNNI3	Primary familial hypertrophic cardiomyopathy		Likely pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	19	55157589	GRCh38	43365	52535
NM_000363.4(TNNI3):c.-35C>A	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.07690(T), GO-ESP:0.02340(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55157624	GRCh38	137687	141390
NM_000363.4(TNNI3):c.-47C>T	TNNI3	not specified	GMAF:0.00260(A), GO-ESP:0.00743(A)	Likely benign(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	19	55157636	GRCh38	188667	186585
NG_007866.2:g.5059A>C	TNNI3	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.00140(G), GO-ESP:0.00047(G)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55157674	GRCh38	330201	350406
NM_000363.4(TNNI3):c.-98C>A	TNNI3	not specified	GMAF:0.00520(T), GO-ESP:0.01166(T)	Uncertain significance(Last reviewed: Mar 13, 2012)	criteria provided, single submitter	19	55157687	GRCh38	188666	186586
NG_007866.2:g.5041C>T	TNNI3	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.00140(A), GO-ESP:0.00049(A)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55157692	GRCh38	330202	334391
NG_007866.2:g.5011G>T	TNNI3	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome		Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55157722	GRCh38	330203	350409
NG_007866.2:g.4996A>G	TNNI3	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.00460(C), GO-ESP:0.00277(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55157737	GRCh38	369294	353523
NG_007866.2:g.3450G>A	TNNI3|DNAAF3	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.00820(T), GO-ESP:0.00260(T)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55159283	GRCh38	369295	353524
NM_001256714.1(DNAAF3):c.1440-8A>G	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.46930(C), GO-ESP:0.32443(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55159457	GRCh38	257684	257238
NM_001256714.1(DNAAF3):c.1365-14C>T	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.13680(A), GO-ESP:0.09828(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55159621	GRCh38	257682	257239
NG_007866.2:g.2764G>A	TNNI3|DNAAF3	Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.00000(C)	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55159969	GRCh38	369296	353525
NM_001256714.1(DNAAF3):c.1257G>A (p.Pro419=)	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.33190(T), GO-ESP:0.22660(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55160006	GRCh38	257680	257242
NM_001256714.1(DNAAF3):c.1205T>C (p.Leu402Pro)	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.11720(G), GO-ESP:0.08639(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55160687	GRCh38	257679	257243
NM_001256714.1(DNAAF3):c.1079A>G (p.Glu360Gly)	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.22760(C), GO-ESP:0.19630(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55161102	GRCh38	257676	257246
NM_001256714.1(DNAAF3):c.994-14C>T	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.22720(A), GO-ESP:0.27667(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55161201	GRCh38	257695	257247
NM_001256714.1(DNAAF3):c.870T>C (p.Ala290=)	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.22700(G), GO-ESP:0.17260(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55161416	GRCh38	257694	257248
NG_007866.2:g.958C>T	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.00180(A), GO-ESP:0.00133(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	55161775	GRCh38	330217	334413
NM_001256714.1(DNAAF3):c.733G>A (p.Gly245Ser)	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.12880(T), GO-ESP:0.13530(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55161777	GRCh38	257691	257251
NM_001256714.1(DNAAF3):c.714A>G (p.Val238=)	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.13160(C), GO-ESP:0.14546(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55161796	GRCh38	257689	257252
NM_001256714.1(DNAAF3):c.531A>G (p.Arg177=)	TNNI3|DNAAF3	Primary ciliary dyskinesia|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	GMAF:0.12840(C), GO-ESP:0.06608(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55162286	GRCh38	257688	257253
NC_000019.9:g.(?_55665527)_(55692769_?)dup	PTPRH|SYT5|TNNI3|DNAAF3	See cases		Uncertain significance(Last reviewed: Jan 20, 2016)	criteria provided, single submitter			GRCh38	253851	248299
GRCh38/hg38 19q13.11(chr19:32312378-32535399)x1	ZNF507|DPY19L3|LOC400684	See cases		Uncertain significance(Last reviewed: Oct 17, 2013)	no assertion criteria provided	19	32312378 - 32535399	GRCh38	155573	165327
GRCh38/hg38 19q13.2-13.31(chr19:42850107-43141456)x1	PSG1|PSG2|PSG6|PSG7|PSG11|PSG10P	See cases		Benign(Last reviewed: Oct 19, 2010)	no assertion criteria provided	19	42850107 - 43141456	GRCh38	154675	164429
GRCh38/hg38 19p12(chr19:23441726-24128733)x1	ZNF254|ZNF681|ZNF675|ZNF726	See cases		Benign(Last reviewed: Jul 30, 2009)	no assertion criteria provided	19	23441726 - 24128733	GRCh38	154475	164229
GRCh38/hg38 19q13.42-13.43(chr19:55037146-56982033)x3	IL11|PEG3|PTPRH|RPL28|SYT5|TNNI3|TNNT1|U2AF2|PPP6R1|ZIM2|HSPBP1|UBE2S|CCDC106|EPN1|ZNF580|GP6|ZNF581|PPP1R12C|EPS8L1|ZNF444|NAT14|ZNF471|ZNF71|ZNF667|ZSCAN5A|ISOC2|BRSK1|KMT5C|FIZ1|GALP|ZNF628|ZNF835|RDH13|COX6B2|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|SMIM17|TMEM190|ZNF524|ZNF784|NLRP4|ZNF582|ZNF583|ZNF579|NLRP11|TMEM86B|SSC5D|TMEM150B|FAM71E2|NLRP9|RFPL4A|ZSCAN5B|DNAAF3|ZNF582-AS1|TMEM238|ZNF470|SBK2|ZSCAN5D|SHISA7|RFPL4AL1|MIMT1|ZNF667-AS1|SBK3|PEG3-AS1|ZNF865|LOC101928886|ZIM2-AS1|MIR6802|MIR6804|MIR6805|MIR6803|MIR7975	See cases		Uncertain significance(Last reviewed: Mar 10, 2014)	no assertion criteria provided	19	55037146 - 56982033	GRCh38	154108	163859
GRCh38/hg38 19q13.42(chr19:55066790-55789870)x3	IL11|PTPRH|RPL28|SYT5|TNNI3|TNNT1|U2AF2|PPP6R1|HSPBP1|UBE2S|CCDC106|EPN1|ZNF580|ZNF581|PPP1R12C|EPS8L1|NAT14|ISOC2|BRSK1|KMT5C|FIZ1|ZNF628|RDH13|COX6B2|TMEM190|ZNF524|ZNF784|ZNF579|NLRP11|TMEM86B|SSC5D|TMEM150B|FAM71E2|NLRP9|RFPL4A|DNAAF3|TMEM238|SBK2|SHISA7|RFPL4AL1|SBK3|ZNF865|MIR6802|MIR6804|MIR6805|MIR6803|MIR7975	See cases		Uncertain significance(Last reviewed: Sep 18, 2013)	no assertion criteria provided	19	55066790 - 55789870	GRCh38	153813	163564
GRCh38/hg38 19q13.41-13.43(chr19:52143873-58445521)x3	A1BG|FCAR|IL11|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|LAIR1|LAIR2|NDUFA3|CNOT3|PEG3|PPP2R1A|PRKCG|PTPRH|RPL28|RPS5|RPS9|AURKC|SYT5|TNNI3|TNNT1|ZNF8|ZNF17|ZNF28|ZNF132|ZNF134|ZNF135|ZNF137P|ZNF154|ZNF264|NCR1|ZNF256|LILRB2|ZNF211|ZNF274|ZNF460|LILRB1|LILRB5|LILRB4|LILRA1|LILRB3|LILRA2|U2AF2|PPP6R1|LILRA4|ZIM2|HSPBP1|PRPF31|ZNF544|UBE2S|TFPT|CCDC106|EPN1|ZNF580|GP6|ZNF581|PPP1R12C|ZNF586|EPS8L1|ZNF444|ZNF331|NLRP2|ZNF416|ZNF701|ZNF83|ZNF415|NAT14|VN1R1|ZNF304|TTYH1|ZNF471|USP29|ZNF71|CACNG8|CACNG7|CACNG6|ZNF667|ZSCAN18|TSEN34|MBOAT7|ZSCAN5A|LENG1|LILRA6|ZNF329|ZNF419|ISOC2|ZNF665|ZNF552|ZNF671|ZNF606|ZNF611|ZNF528|BRSK1|ZNF347|KMT5C|ZNF587|FIZ1|GALP|ZNF628|ZNF551|ZNF766|ZNF468|ZNF160|ZNF835|ZNF765|NLRP12|MYADM|ZNF845|LENG9|BIRC8|RDH13|ZIM3|LENG8|KIR3DL3|ZNF837|ZNF816|ZNF543|COX6B2|OSCAR|ZNF813|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|ZNF480|ZNF534|ZNF578|ERVV-1|SMIM17|C19orf18|ZNF418|ZNF417|ZNF548|TMEM190|TMC4|ZNF524|ZNF784|NLRP4|ZNF582|ZNF583|CDC42EP5|ZNF836|ZNF610|ZNF600|ZNF320|ZNF497|ZNF550|ZNF579|NLRP7|ZNF584|ZSCAN4|NLRP11|TMEM86B|ZNF549|SSC5D|ZNF547|ZIK1|ZNF776|ZSCAN1|VSTM1|TMEM150B|FAM71E2|VN1R2|VN1R4|NLRP9|ZNF677|RFPL4A|ZSCAN5B|ZSCAN22|ZNF530|DNAAF3|LILRA5|ZNF773|ZNF582-AS1|ZNF808|ZNF888|ZNF761|TMEM238|ZNF470|ZNF749|ZNF805|ZNF880|ZNF772|TARM1|MIR371A|MIR372|MIR373|A1BG-AS1|DPRX|DUXA|KIR3DP1|MIR512-1|MIR512-2|MIR498|MIR520E|MIR515-1|MIR519E|MIR520F|MIR515-2|MIR519C|MIR520A|MIR526B|MIR519B|MIR525|MIR523|MIR518F|MIR520B|MIR518B|MIR526A1|MIR520C|MIR518C|MIR524|MIR517A|MIR519D|MIR521-2|MIR520D|MIR517B|MIR520G|MIR516B2|MIR526A2|MIR518E|MIR518A1|MIR518D|MIR516B1|MIR518A2|MIR517C|MIR520H|MIR521-1|MIR522|MIR519A1|MIR527|MIR516A1|MIR516A2|MIR519A2|SBK2|ZSCAN5D|RNF225|MIR643|SHISA7|RFPL4AL1|ZNF814|MIMT1|MIR935|ZNF667-AS1|LOC100128398|SBK3|PEG3-AS1|ERVV-2|ZNF587B|MIR1283-2|MIR1323|MIR1283-1|ZNF865|ERVK3-1|ZNF816-ZNF321P|MIR4754|MIR4752|MIR371B|LOC101928804|LOC101928886|ZIM2-AS1|MIR6802|MIR6804|MIR6805|MIR6806|MIR8061|MIR6803|MIR7975|MIR6801|ZNF528-AS1|LENG8-AS1|LOC105372476|LOC105372483|LOC107985332	See cases		Pathogenic(Last reviewed: Aug 19, 2013)	no assertion criteria provided	19	52143873 - 58445521	GRCh38	153721	163472
GRCh38/hg38 19q13.42-13.43(chr19:55048514-56972458)x3	IL11|PEG3|PTPRH|RPL28|SYT5|TNNI3|TNNT1|U2AF2|PPP6R1|ZIM2|HSPBP1|UBE2S|CCDC106|EPN1|ZNF580|ZNF581|PPP1R12C|EPS8L1|ZNF444|NAT14|ZNF471|ZNF71|ZNF667|ZSCAN5A|ISOC2|BRSK1|KMT5C|FIZ1|GALP|ZNF628|ZNF835|RDH13|COX6B2|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|SMIM17|TMEM190|ZNF524|ZNF784|NLRP4|ZNF582|ZNF583|ZNF579|NLRP11|TMEM86B|SSC5D|TMEM150B|FAM71E2|NLRP9|RFPL4A|ZSCAN5B|DNAAF3|ZNF582-AS1|TMEM238|ZNF470|SBK2|ZSCAN5D|SHISA7|RFPL4AL1|MIMT1|ZNF667-AS1|SBK3|PEG3-AS1|ZNF865|LOC101928886|ZIM2-AS1|MIR6802|MIR6804|MIR6805|MIR6803|MIR7975	See cases		Likely pathogenic(Last reviewed: Jan 31, 2012)	no assertion criteria provided	19	55048514 - 56972458	GRCh38	149081	158832
GRCh38/hg38 19q13.33-13.43(chr19:50152520-58581203)x3	A1BG|KLK3|CD33|SIGLEC6|ETFB|FCAR|FPR1|FPR2|FPR3|GPR32|HAS1|IL11|KCNC3|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KLK1|KLK2|LAIR1|LAIR2|LIM2|MYBPC2|NDUFA3|NKG7|CNOT3|PEG3|POLD1|PPP2R1A|PRKCG|KLK7|KLK6|KLK10|PTPRH|RPL28|RPS5|RPS9|CLEC11A|SPIB|AURKC|SYT5|TNNI3|TNNT1|NR1H2|ZNF8|ZNF17|ZNF28|MZF1|ZNF132|ZNF134|ZNF135|ZNF137P|ZNF154|ZNF175|SIGLEC5|UBE2M|ZNF264|NCR1|NAPSA|KLK4|ZNF432|TRIM28|ZNF256|LILRB2|ZNF211|ZNF274|ZNF460|LILRB1|LILRB5|SLC27A5|LILRB4|KLK11|LILRA1|LILRB3|LILRA2|KLK8|U2AF2|PPP6R1|LILRA4|ZIM2|HSPBP1|ZNF324|KLK5|KLK13|PRPF31|SIGLEC7|SIGLEC9|SIGLEC8|CHMP2A|ZNF544|UBE2S|TFPT|CCDC106|EPN1|KLK14|KLK12|SHANK1|ZNF580|GP6|ZNF581|PPP1R12C|ZNF586|EPS8L1|ZNF444|ZNF331|KLK15|NLRP2|ZNF416|ZNF446|ZNF701|ZNF83|ZNF415|NAT14|VN1R1|ZNF304|TTYH1|ZNF471|USP29|ZNF71|CACNG8|CACNG7|CACNG6|ZNF350|ZNF667|ZNF649|ZSCAN18|TSEN34|MBOAT7|ZSCAN5A|LENG1|LILRA6|ZNF329|ZNF419|ISOC2|MYH14|ZNF665|ZNF552|ZNF671|ZNF613|ZNF606|ZNF614|ZNF611|SYT3|ZNF528|BRSK1|ZNF347|ZNF577|KMT5C|C19orf48|ZBTB45|ZNF587|FIZ1|GALP|SIGLEC10|SIGLEC12|ZNF628|ZNF551|ZNF616|ZNF766|ZNF468|ZNF160|CTU1|ZNF835|ZNF765|NLRP12|MYADM|ZNF845|ACPT|LRRC4B|LENG9|BIRC8|FAM71E1|RDH13|ZIM3|LENG8|KIR3DL3|ZNF837|CLDND2|ZNF816|ZNF543|COX6B2|OSCAR|ZNF813|JOSD2|IZUMO2|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|VSIG10L|C19orf84|SPACA6|ZNF480|ZNF534|ZNF578|ERVV-1|SMIM17|C19orf18|ZNF418|ZNF417|ZNF548|TMEM190|TMC4|ZNF524|ZNF784|NLRP4|ZNF582|ZNF583|CDC42EP5|ZNF836|ZNF610|ZNF600|ZNF320|ZNF497|ZNF550|ZNF579|NLRP7|ZNF584|ZSCAN4|NLRP11|TMEM86B|ZNF549|SSC5D|ZNF547|ZIK1|ZNF776|ZSCAN1|EMC10|MGC45922|KLK9|SIGLECL1|ZNF615|ZNF841|VSTM1|TMEM150B|FAM71E2|VN1R2|VN1R4|NLRP9|C19orf81|ZNF677|RFPL4A|ZSCAN5B|ZSCAN22|ZNF530|DNAAF3|LILRA5|ZNF773|ZNF582-AS1|ZNF808|ZNF888|ZNF761|TMEM238|ZNF470|ZNF749|ZNF324B|ZNF805|ZNF880|ZNF772|IGLON5|MIRLET7E|MIR125A|MIR99B|TARM1|MIR371A|MIR372|MIR373|A1BG-AS1|DPRX|DUXA|KIR3DP1|ASPDH|MIR512-1|MIR512-2|MIR498|MIR520E|MIR515-1|MIR519E|MIR520F|MIR515-2|MIR519C|MIR520A|MIR526B|MIR519B|MIR525|MIR523|MIR518F|MIR520B|MIR518B|MIR526A1|MIR520C|MIR518C|MIR524|MIR517A|MIR519D|MIR521-2|MIR520D|MIR517B|MIR520G|MIR516B2|MIR526A2|MIR518E|MIR518A1|MIR518D|MIR516B1|MIR518A2|MIR517C|MIR520H|MIR521-1|MIR522|MIR519A1|MIR527|MIR516A1|MIR516A2|MIR519A2|SBK2|ZSCAN5D|RNF225|SNORD88A|SNORD88B|SNORD88C|MIR643|CEACAM18|SHISA7|RFPL4AL1|LINC01530|ZNF814|SIGLEC14|MIMT1|MIR935|SNAR-F|ZNF667-AS1|LOC100128398|LOC100129083|SBK3|MZF1-AS1|PEG3-AS1|ERVV-2|ZNF587B|MIR1283-2|MIR1323|MIR1283-1|ZNF865|ERVK3-1|ZNF816-ZNF321P|MIR4754|MIR4752|MIR371B|ZNF350-AS1|LOC101928517|ZNF649-AS1|LOC101928804|LOC101928886|ZIM2-AS1|SPACA6P-AS|MIR6802|MIR6804|MIR6805|MIR6806|MIR8074|MIR6807|MIR8061|MIR6803|MIR7975|MIR6801|ZNF528-AS1|LENG8-AS1|LOC105372440|LOC105372441|LOC105372444|LOC105372476|LOC105372483|LOC107985332	See cases		Pathogenic(Last reviewed: Oct 19, 2010)	no assertion criteria provided	19	50152520 - 58581203	GRCh38	146579	156330
GRCh38/hg38 19q13.41-13.43(chr19:52612432-58581203)x3	A1BG|FCAR|IL11|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|LAIR1|LAIR2|NDUFA3|CNOT3|PEG3|PRKCG|PTPRH|RPL28|RPS5|RPS9|AURKC|SYT5|TNNI3|TNNT1|ZNF8|ZNF17|ZNF28|MZF1|ZNF132|ZNF134|ZNF135|ZNF154|UBE2M|ZNF264|NCR1|TRIM28|ZNF256|LILRB2|ZNF211|ZNF274|ZNF460|LILRB1|LILRB5|SLC27A5|LILRB4|LILRA1|LILRB3|LILRA2|U2AF2|PPP6R1|LILRA4|ZIM2|HSPBP1|ZNF324|PRPF31|CHMP2A|ZNF544|UBE2S|TFPT|CCDC106|EPN1|ZNF580|GP6|ZNF581|PPP1R12C|ZNF586|EPS8L1|ZNF444|ZNF331|NLRP2|ZNF416|ZNF446|ZNF701|ZNF83|ZNF415|NAT14|VN1R1|ZNF304|TTYH1|ZNF471|USP29|ZNF71|CACNG8|CACNG7|CACNG6|ZNF667|ZSCAN18|TSEN34|MBOAT7|ZSCAN5A|LENG1|LILRA6|ZNF329|ZNF419|ISOC2|ZNF665|ZNF552|ZNF671|ZNF606|ZNF611|BRSK1|ZNF347|KMT5C|ZBTB45|ZNF587|FIZ1|GALP|ZNF628|ZNF551|ZNF468|ZNF160|ZNF835|ZNF765|NLRP12|MYADM|ZNF845|LENG9|BIRC8|RDH13|ZIM3|LENG8|KIR3DL3|ZNF837|ZNF816|ZNF543|COX6B2|OSCAR|ZNF813|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|ERVV-1|SMIM17|C19orf18|ZNF418|ZNF417|ZNF548|TMEM190|TMC4|ZNF524|ZNF784|NLRP4|ZNF582|ZNF583|CDC42EP5|ZNF600|ZNF320|ZNF497|ZNF550|ZNF579|NLRP7|ZNF584|ZSCAN4|NLRP11|TMEM86B|ZNF549|SSC5D|ZNF547|ZIK1|ZNF776|ZSCAN1|VSTM1|TMEM150B|FAM71E2|VN1R2|VN1R4|NLRP9|ZNF677|RFPL4A|ZSCAN5B|ZSCAN22|ZNF530|DNAAF3|LILRA5|ZNF773|ZNF582-AS1|ZNF888|ZNF761|TMEM238|ZNF470|ZNF749|ZNF324B|ZNF805|ZNF772|TARM1|MIR371A|MIR372|MIR373|A1BG-AS1|DPRX|DUXA|KIR3DP1|MIR512-1|MIR512-2|MIR498|MIR520E|MIR515-1|MIR519E|MIR520F|MIR515-2|MIR519C|MIR520A|MIR526B|MIR519B|MIR525|MIR523|MIR518F|MIR520B|MIR518B|MIR526A1|MIR520C|MIR518C|MIR524|MIR517A|MIR519D|MIR521-2|MIR520D|MIR517B|MIR520G|MIR516B2|MIR526A2|MIR518E|MIR518A1|MIR518D|MIR516B1|MIR518A2|MIR517C|MIR520H|MIR521-1|MIR522|MIR519A1|MIR527|MIR516A1|MIR516A2|MIR519A2|SBK2|ZSCAN5D|RNF225|SHISA7|RFPL4AL1|ZNF814|MIMT1|MIR935|ZNF667-AS1|LOC100128398|SBK3|MZF1-AS1|PEG3-AS1|ERVV-2|ZNF587B|MIR1283-2|MIR1323|MIR1283-1|ZNF865|ERVK3-1|ZNF816-ZNF321P|MIR4754|MIR4752|MIR371B|LOC101928804|LOC101928886|ZIM2-AS1|MIR6802|MIR6804|MIR6805|MIR6806|MIR6807|MIR8061|MIR6803|MIR7975|LENG8-AS1|LOC105372476|LOC105372483|LOC107985332	See cases		Pathogenic(Last reviewed: Aug 19, 2010)	no assertion criteria provided	19	52612432 - 58581203	GRCh38	144762	154513
GRCh38/hg38 19q13.41-13.43(chr19:52955056-58581203)x3	A1BG|FCAR|IL11|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|LAIR1|LAIR2|NDUFA3|CNOT3|PEG3|PRKCG|PTPRH|RPL28|RPS5|RPS9|AURKC|SYT5|TNNI3|TNNT1|ZNF8|ZNF17|MZF1|ZNF132|ZNF134|ZNF135|ZNF154|UBE2M|ZNF264|NCR1|TRIM28|ZNF256|LILRB2|ZNF211|ZNF274|ZNF460|LILRB1|LILRB5|SLC27A5|LILRB4|LILRA1|LILRB3|LILRA2|U2AF2|PPP6R1|LILRA4|ZIM2|HSPBP1|ZNF324|PRPF31|CHMP2A|ZNF544|UBE2S|TFPT|CCDC106|EPN1|ZNF580|GP6|ZNF581|PPP1R12C|ZNF586|EPS8L1|ZNF444|ZNF331|NLRP2|ZNF416|ZNF446|ZNF415|NAT14|VN1R1|ZNF304|TTYH1|ZNF471|USP29|ZNF71|CACNG8|CACNG7|CACNG6|ZNF667|ZSCAN18|TSEN34|MBOAT7|ZSCAN5A|LENG1|LILRA6|ZNF329|ZNF419|ISOC2|ZNF665|ZNF552|ZNF671|ZNF606|BRSK1|ZNF347|KMT5C|ZBTB45|ZNF587|FIZ1|GALP|ZNF628|ZNF551|ZNF160|ZNF835|ZNF765|NLRP12|MYADM|ZNF845|LENG9|BIRC8|RDH13|ZIM3|LENG8|KIR3DL3|ZNF837|ZNF816|ZNF543|COX6B2|OSCAR|ZNF813|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|ERVV-1|SMIM17|C19orf18|ZNF418|ZNF417|ZNF548|TMEM190|TMC4|ZNF524|ZNF784|NLRP4|ZNF582|ZNF583|CDC42EP5|ZNF497|ZNF550|ZNF579|NLRP7|ZNF584|ZSCAN4|NLRP11|TMEM86B|ZNF549|SSC5D|ZNF547|ZIK1|ZNF776|ZSCAN1|VSTM1|TMEM150B|FAM71E2|VN1R2|VN1R4|NLRP9|ZNF677|RFPL4A|ZSCAN5B|ZSCAN22|ZNF530|DNAAF3|LILRA5|ZNF773|ZNF582-AS1|ZNF761|TMEM238|ZNF470|ZNF749|ZNF324B|ZNF805|ZNF772|TARM1|MIR371A|MIR372|MIR373|A1BG-AS1|DPRX|DUXA|KIR3DP1|MIR512-1|MIR512-2|MIR498|MIR520E|MIR515-1|MIR519E|MIR520F|MIR515-2|MIR519C|MIR520A|MIR526B|MIR519B|MIR525|MIR523|MIR518F|MIR520B|MIR518B|MIR526A1|MIR520C|MIR518C|MIR524|MIR517A|MIR519D|MIR521-2|MIR520D|MIR517B|MIR520G|MIR516B2|MIR526A2|MIR518E|MIR518A1|MIR518D|MIR516B1|MIR518A2|MIR517C|MIR520H|MIR521-1|MIR522|MIR519A1|MIR527|MIR516A1|MIR516A2|MIR519A2|SBK2|ZSCAN5D|RNF225|SHISA7|RFPL4AL1|ZNF814|MIMT1|MIR935|ZNF667-AS1|LOC100128398|SBK3|MZF1-AS1|PEG3-AS1|ERVV-2|ZNF587B|MIR1283-2|MIR1323|MIR1283-1|ZNF865|ERVK3-1|ZNF816-ZNF321P|MIR4754|MIR4752|MIR371B|LOC101928804|LOC101928886|ZIM2-AS1|MIR6802|MIR6804|MIR6805|MIR6806|MIR6807|MIR8061|MIR6803|MIR7975|LENG8-AS1|LOC105372476|LOC105372483|LOC107985332	See cases		Pathogenic(Last reviewed: Nov 30, 2010)	no assertion criteria provided	19	52955056 - 58581203	GRCh38	144709	154460
GRCh38/hg38 19q13.41-13.43(chr19:51141518-58539965)x3	A1BG|CD33|SIGLEC6|ETFB|FCAR|FPR1|FPR2|FPR3|HAS1|IL11|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|LAIR1|LAIR2|LIM2|NDUFA3|NKG7|CNOT3|PEG3|PPP2R1A|PRKCG|PTPRH|RPL28|RPS5|RPS9|AURKC|SYT5|TNNI3|TNNT1|ZNF8|ZNF17|ZNF28|ZNF132|ZNF134|ZNF135|ZNF137P|ZNF154|ZNF175|SIGLEC5|ZNF264|NCR1|ZNF432|ZNF256|LILRB2|ZNF211|ZNF274|ZNF460|LILRB1|LILRB5|SLC27A5|LILRB4|LILRA1|LILRB3|LILRA2|U2AF2|PPP6R1|LILRA4|ZIM2|HSPBP1|ZNF324|PRPF31|SIGLEC7|SIGLEC8|ZNF544|UBE2S|TFPT|CCDC106|EPN1|ZNF580|GP6|ZNF581|PPP1R12C|ZNF586|EPS8L1|ZNF444|ZNF331|NLRP2|ZNF416|ZNF446|ZNF701|ZNF83|ZNF415|NAT14|VN1R1|ZNF304|TTYH1|ZNF471|USP29|ZNF71|CACNG8|CACNG7|CACNG6|ZNF350|ZNF667|ZNF649|ZSCAN18|TSEN34|MBOAT7|ZSCAN5A|LENG1|LILRA6|ZNF329|ZNF419|ISOC2|ZNF665|ZNF552|ZNF671|ZNF613|ZNF606|ZNF614|ZNF611|ZNF528|BRSK1|ZNF347|ZNF577|KMT5C|ZBTB45|ZNF587|FIZ1|GALP|SIGLEC10|SIGLEC12|ZNF628|ZNF551|ZNF616|ZNF766|ZNF468|ZNF160|ZNF835|ZNF765|NLRP12|MYADM|ZNF845|LENG9|BIRC8|RDH13|ZIM3|LENG8|KIR3DL3|ZNF837|CLDND2|ZNF816|ZNF543|COX6B2|OSCAR|ZNF813|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|VSIG10L|C19orf84|SPACA6|ZNF480|ZNF534|ZNF578|ERVV-1|SMIM17|C19orf18|ZNF418|ZNF417|ZNF548|TMEM190|TMC4|ZNF524|ZNF784|NLRP4|ZNF582|ZNF583|CDC42EP5|ZNF836|ZNF610|ZNF600|ZNF320|ZNF497|ZNF550|ZNF579|NLRP7|ZNF584|ZSCAN4|NLRP11|TMEM86B|ZNF549|SSC5D|ZNF547|ZIK1|ZNF776|ZSCAN1|SIGLECL1|ZNF615|ZNF841|VSTM1|TMEM150B|FAM71E2|VN1R2|VN1R4|NLRP9|ZNF677|RFPL4A|ZSCAN5B|ZSCAN22|ZNF530|DNAAF3|LILRA5|ZNF773|ZNF582-AS1|ZNF808|ZNF888|ZNF761|TMEM238|ZNF470|ZNF749|ZNF324B|ZNF805|ZNF880|ZNF772|IGLON5|MIRLET7E|MIR125A|MIR99B|TARM1|MIR371A|MIR372|MIR373|A1BG-AS1|DPRX|DUXA|KIR3DP1|MIR512-1|MIR512-2|MIR498|MIR520E|MIR515-1|MIR519E|MIR520F|MIR515-2|MIR519C|MIR520A|MIR526B|MIR519B|MIR525|MIR523|MIR518F|MIR520B|MIR518B|MIR526A1|MIR520C|MIR518C|MIR524|MIR517A|MIR519D|MIR521-2|MIR520D|MIR517B|MIR520G|MIR516B2|MIR526A2|MIR518E|MIR518A1|MIR518D|MIR516B1|MIR518A2|MIR517C|MIR520H|MIR521-1|MIR522|MIR519A1|MIR527|MIR516A1|MIR516A2|MIR519A2|SBK2|ZSCAN5D|RNF225|MIR643|CEACAM18|SHISA7|RFPL4AL1|LINC01530|ZNF814|SIGLEC14|MIMT1|MIR935|ZNF667-AS1|LOC100128398|LOC100129083|SBK3|PEG3-AS1|ERVV-2|ZNF587B|MIR1283-2|MIR1323|MIR1283-1|ZNF865|ERVK3-1|ZNF816-ZNF321P|MIR4754|MIR4752|MIR371B|ZNF350-AS1|LOC101928517|ZNF649-AS1|LOC101928804|LOC101928886|ZIM2-AS1|SPACA6P-AS|MIR6802|MIR6804|MIR6805|MIR6806|MIR8074|MIR8061|MIR6803|MIR7975|MIR6801|ZNF528-AS1|LENG8-AS1|LOC105372444|LOC105372476|LOC105372483|LOC107985332	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	19	51141518 - 58539965	GRCh38	59127	73722
GRCh38/hg38 19q13.33-13.43(chr19:49907832-58557889)x3	A1BG|KLK3|CD33|SIGLEC6|ETFB|FCAR|FPR1|FPR2|FPR3|GPR32|HAS1|IL11|KCNC3|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KLK1|KLK2|LAIR1|LAIR2|LIM2|MYBPC2|NDUFA3|NKG7|CNOT3|PEG3|POLD1|PPP2R1A|PRKCG|KLK7|KLK6|KLK10|PTPRH|RPL28|RPS5|RPS9|CLEC11A|SPIB|AURKC|SYT5|TNNI3|TNNT1|NR1H2|ZNF8|ZNF17|ZNF28|ZNF132|ZNF134|ZNF135|ZNF137P|ZNF154|ZNF175|SIGLEC5|UBE2M|ZNF264|NCR1|NAPSA|KLK4|ZNF432|TRIM28|ZNF256|LILRB2|ZNF211|ZNF274|ZNF460|LILRB1|LILRB5|SLC27A5|LILRB4|KLK11|LILRA1|LILRB3|LILRA2|KLK8|U2AF2|ATF5|PPP6R1|LILRA4|ZIM2|NUP62|HSPBP1|ZNF324|KLK5|ZNF473|KLK13|PRPF31|SIGLEC7|SIGLEC9|SIGLEC8|CHMP2A|ZNF544|UBE2S|TFPT|CCDC106|EPN1|KLK14|KLK12|SHANK1|ZNF580|GP6|VRK3|ZNF581|PPP1R12C|ZNF586|EPS8L1|ZNF444|ZNF331|KLK15|NLRP2|ZNF416|ZNF446|ZNF701|ZNF83|ZNF415|NAT14|VN1R1|ZNF304|TTYH1|ZNF471|USP29|ZNF71|CACNG8|CACNG7|CACNG6|ZNF350|ZNF667|ZNF649|ZSCAN18|TSEN34|MBOAT7|ZSCAN5A|LENG1|LILRA6|ZNF329|ZNF419|ISOC2|MYH14|ZNF665|ZNF552|ZNF671|ZNF613|ZNF606|ZNF614|ZNF611|SYT3|ZNF528|BRSK1|ZNF347|ZNF577|KMT5C|C19orf48|ZBTB45|ZNF587|FIZ1|GALP|SIGLEC10|SIGLEC12|ZNF628|ZNF551|ZNF616|ZNF766|ZNF468|ZNF160|CTU1|ZNF835|ZNF765|NLRP12|MYADM|ZNF845|ACPT|LRRC4B|LENG9|BIRC8|FAM71E1|RDH13|ZIM3|SIGLEC11|LENG8|KIR3DL3|ZNF837|CLDND2|ZNF816|ZNF543|COX6B2|OSCAR|ZNF813|JOSD2|IZUMO2|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|VSIG10L|C19orf84|SPACA6|ZNF480|ZNF534|ZNF578|ERVV-1|SMIM17|C19orf18|ZNF418|ZNF417|ZNF548|TMEM190|TMC4|ZNF524|ZNF784|NLRP4|ZNF582|ZNF583|CDC42EP5|ZNF836|ZNF610|ZNF600|ZNF320|ZNF497|ZNF550|ZNF579|NLRP7|ZNF584|ZSCAN4|NLRP11|TMEM86B|ZNF549|IL4I1|SSC5D|ZNF547|ZIK1|ZNF776|ZSCAN1|EMC10|MGC45922|KLK9|SIGLECL1|ZNF615|ZNF841|VSTM1|TMEM150B|FAM71E2|VN1R2|VN1R4|NLRP9|C19orf81|ZNF677|RFPL4A|ZSCAN5B|ZSCAN22|ZNF530|DNAAF3|LILRA5|ZNF773|ZNF582-AS1|ZNF808|ZNF888|ZNF761|TMEM238|ZNF470|ZNF749|ZNF324B|ZNF805|LOC400710|ZNF880|ZNF772|IGLON5|MIRLET7E|MIR125A|MIR99B|TARM1|MIR371A|MIR372|MIR373|A1BG-AS1|DPRX|DUXA|KIR3DP1|ASPDH|MIR512-1|MIR512-2|MIR498|MIR520E|MIR515-1|MIR519E|MIR520F|MIR515-2|MIR519C|MIR520A|MIR526B|MIR519B|MIR525|MIR523|MIR518F|MIR520B|MIR518B|MIR526A1|MIR520C|MIR518C|MIR524|MIR517A|MIR519D|MIR521-2|MIR520D|MIR517B|MIR520G|MIR516B2|MIR526A2|MIR518E|MIR518A1|MIR518D|MIR516B1|MIR518A2|MIR517C|MIR520H|MIR521-1|MIR522|MIR519A1|MIR527|MIR516A1|MIR516A2|MIR519A2|SBK2|ZSCAN5D|RNF225|SNORD88A|SNORD88B|SNORD88C|MIR643|CEACAM18|SHISA7|RFPL4AL1|LINC01530|ZNF814|SIGLEC14|MIMT1|MIR935|SNAR-F|ZNF667-AS1|LOC100128398|LOC100129083|SBK3|PEG3-AS1|SNAR-A5|SNAR-A7|SNAR-A11|SNAR-A9|SNAR-A4|SNAR-A6|SNAR-A8|SNAR-A10|SNAR-B2|SNAR-B1|SNAR-D|SNAR-A14|ERVV-2|ZNF587B|MIR1283-2|MIR1323|MIR1283-1|ZNF865|ERVK3-1|ZNF816-ZNF321P|MIR4754|MIR4752|MIR371B|MIR4751|ZNF350-AS1|LOC101928517|ZNF649-AS1|LOC101928804|LOC101928886|ZIM2-AS1|SPACA6P-AS|MIR6802|MIR6804|MIR6805|MIR6806|MIR8074|MIR6807|MIR8061|MIR6803|MIR7975|MIR6801|ZNF528-AS1|LENG8-AS1|LOC105372440|LOC105372441|LOC105372444|LOC105372476|LOC105372483|LOC107985332	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	19	49907832 - 58557889	GRCh38	59126	73721
GRCh38/hg38 19q13.33-13.43(chr19:47929575-58572206)x3	A1BG|AP2A1|KLK3|BAX|BCAT2|CA11|CD33|SIGLEC6|CD37|CGB3|DBP|EMP3|ETFB|FCAR|FCGRT|FLT3LG|FPR1|FPR2|FPR3|FTL|FUT1|FUT2|GPR32|GRIN2D|GYS1|HAS1|HRC|PRMT1|IL11|IRF3|KCNA7|KCNC3|KCNJ14|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KLK1|KLK2|LAIR1|LAIR2|LHB|LIG1|LIM2|MYBPC2|NDUFA3|NKG7|CNOT3|NTF4|NUCB1|PEG3|POLD1|PPP2R1A|PRKCG|PRRG2|KLK7|KLK6|KLK10|PTPRH|RPL18|RPL28|RPS5|RPS9|RPS11|RRAS|CLEC11A|SNRNP70|SPIB|AURKC|SULT2B1|SYT5|TNNI3|TNNT1|TULP2|NR1H2|ZNF8|ZNF17|ZNF28|MZF1|ZNF132|ZNF134|ZNF135|ZNF137P|ZNF154|ZNF175|TEAD2|PPFIA3|PLA2G4C|SIGLEC5|UBE2M|CYTH2|ZNF264|NCR1|NAPSA|KLK4|ZNF432|TRIM28|ZNF256|LILRB2|ZNF211|ZNF274|ZNF460|RUVBL2|LILRB1|KDELR1|LILRB5|SLC27A5|LILRB4|KLK11|LILRA1|LILRB3|LILRA2|KLK8|PNKP|U2AF2|ATF5|PPP6R1|CARD8|RPL13A|SYNGR4|LILRA4|ZIM2|NUP62|HSPBP1|PPP1R15A|ZNF324|KLK5|ZNF473|KLK13|PRPF31|FGF21|SNORD35A|SNORD34|SNORD33|SNORD32A|SIGLEC7|DKKL1|SIGLEC9|SIGLEC8|CHMP2A|DHDH|ZNF544|UBE2S|SLC6A16|TFPT|CCDC106|EPN1|KLK14|KLK12|SHANK1|NOSIP|ZNF580|HSD17B14|GP6|VRK3|ZNF581|PTOV1|PPP1R12C|TRPM4|ZNF586|FAM83E|EPS8L1|RASIP1|PIH1D1|C19orf73|TMEM143|ZNF444|ZNF331|KLK15|NLRP2|ZNF416|ZNF446|ZNF701|ZNF83|ZNF415|CABP5|SPHK2|SLC17A7|NAT14|VN1R1|RCN3|ZNF304|TTYH1|PRR12|ZNF471|USP29|PLEKHA4|ZNF71|SCAF1|CACNG8|CACNG7|CACNG6|ZNF350|TSKS|ZNF667|ELSPBP1|LIN7B|ZNF649|ZSCAN18|TSEN34|MBOAT7|ZSCAN5A|LENG1|LILRA6|ZNF329|TBC1D17|ZNF419|ISOC2|MYH14|ZNF665|ZNF552|ZNF671|ZNF613|ZNF606|ZNF614|FUZ|ZNF611|MED25|BCL2L12|GRWD1|SYT3|AKT1S1|ZNF528|BRSK1|SNORD35B|ZNF347|ZNF577|KMT5C|C19orf48|ZBTB45|ZNF587|FIZ1|GALP|SIGLEC10|SIGLEC12|ZNF628|ZNF551|ZNF616|ZNF766|ZNF468|ZNF160|CTU1|ZNF835|ZNF765|NLRP12|MYADM|ZNF845|CCDC114|ACPT|CGB5|CGB7|LRRC4B|LENG9|CGB8|BIRC8|FAM71E1|RDH13|PTH2|ZIM3|SIGLEC11|CGB1|CGB2|LMTK3|LENG8|KIR3DL3|ZNF837|CLDND2|ZNF816|ZNF543|COX6B2|OSCAR|ZNF813|JOSD2|IZUMO2|CPT1C|ALDH16A1|NTN5|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|VSIG10L|C19orf84|SPACA6|ZNF480|ZNF534|ZNF578|ERVV-1|SMIM17|C19orf18|ZNF418|ZNF417|ZNF548|TMEM190|TMC4|ZNF524|ZNF784|CCDC155|NLRP4|ZNF582|ZNF583|CDC42EP5|ZNF836|ZNF610|ZNF600|ZNF320|ZNF497|ZNF550|ZNF579|ZNF114|SPACA4|NLRP7|ADM5|ZNF584|ZSCAN4|NLRP11|TMEM86B|ZNF549|IL4I1|SSC5D|ZNF547|ZIK1|ZNF776|ZSCAN1|MAMSTR|IZUMO1|EMC10|MGC45922|KLK9|SIGLECL1|ZNF615|ZNF841|VSTM1|TMEM150B|FAM71E2|VN1R2|VN1R4|NLRP9|C19orf81|ZNF677|RFPL4A|ZSCAN5B|ZSCAN22|ZNF530|DNAAF3|LILRA5|C19orf68|ZNF773|ZNF582-AS1|ZNF808|ZNF888|ZNF761|TMEM238|ZNF470|ZNF749|ZNF324B|ZNF805|LOC400710|ZNF880|ZNF772|IGLON5|MIRLET7E|MIR125A|MIR150|MIR99B|TARM1|MIR371A|MIR372|MIR373|A1BG-AS1|DPRX|DUXA|KIR3DP1|ASPDH|MIR512-1|MIR512-2|MIR498|MIR520E|MIR515-1|MIR519E|MIR520F|MIR515-2|MIR519C|MIR520A|MIR526B|MIR519B|MIR525|MIR523|MIR518F|MIR520B|MIR518B|MIR526A1|MIR520C|MIR518C|MIR524|MIR517A|MIR519D|MIR521-2|MIR520D|MIR517B|MIR520G|MIR516B2|MIR526A2|MIR518E|MIR518A1|MIR518D|MIR516B1|MIR518A2|MIR517C|MIR520H|MIR521-1|MIR522|MIR519A1|MIR527|MIR516A1|MIR516A2|MIR519A2|SBK2|ZSCAN5D|RNF225|SNORD88A|SNORD88B|SNORD88C|MIR643|CEACAM18|SHISA7|RFPL4AL1|LINC01530|ZNF814|SIGLEC14|MIMT1|MIR935|SNAR-G1|SNAR-F|SNAR-A2|ZNF667-AS1|LOC100128398|LOC100129083|SBK3|BSPH1|MZF1-AS1|PEG3-AS1|SNAR-A5|SNAR-A7|SNAR-A11|SNAR-A9|SNAR-A4|SNAR-A6|SNAR-A8|SNAR-A13|SNAR-A10|SNAR-B2|SNAR-C4|SNAR-B1|SNAR-C1|SNAR-C3|SNAR-D|SNAR-G2|SNAR-A14|ERVV-2|ZNF587B|MIR1283-2|MIR1323|MIR1283-1|MIR4324|CARD8-AS1|PTOV1-AS1|GFY|ZNF865|ERVK3-1|ZNF816-ZNF321P|MIR4754|MIR4752|MIR371B|MIR4749|MIR4750|MIR4751|MIR5088|NUCB1-AS1|LOC101059948|ZNF350-AS1|LOC101928295|PTOV1-AS2|LOC101928517|ZNF649-AS1|LOC101928804|LOC101928886|ZIM2-AS1|SPACA6P-AS|MIR6799|MIR6800|MIR6802|MIR6804|MIR6805|MIR6806|MIR8074|MIR6807|MIR8061|MIR6798|MIR6803|MIR7975|MIR6801|ZNF528-AS1|LENG8-AS1|LOC105372440|LOC105372441|LOC105372444|LOC105372476|LOC105372483|LOC105447645|PLA2G4C-AS1|LOC107985332	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	19	47929575 - 58572206	GRCh38	59117	73712
GRCh38/hg38 19q13.33-13.43(chr19:47908540-58539965)x3	A1BG|AP2A1|KLK3|BAX|BCAT2|CA11|CD33|SIGLEC6|CD37|CGB3|DBP|EMP3|ETFB|FCAR|FCGRT|FLT3LG|FPR1|FPR2|FPR3|FTL|FUT1|FUT2|GPR32|GRIN2D|GYS1|HAS1|HRC|PRMT1|IL11|IRF3|KCNA7|KCNC3|KCNJ14|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KLK1|KLK2|LAIR1|LAIR2|LHB|LIG1|LIM2|MYBPC2|NDUFA3|NKG7|CNOT3|NTF4|NUCB1|PEG3|POLD1|PPP2R1A|PRKCG|PRRG2|KLK7|KLK6|KLK10|PTPRH|RPL18|RPL28|RPS5|RPS9|RPS11|RRAS|CLEC11A|SNRNP70|SPIB|AURKC|SULT2B1|SYT5|TNNI3|TNNT1|TULP2|NR1H2|ZNF8|ZNF17|ZNF28|ZNF132|ZNF134|ZNF135|ZNF137P|ZNF154|ZNF175|TEAD2|PPFIA3|PLA2G4C|SIGLEC5|CYTH2|ZNF264|NCR1|NAPSA|KLK4|ZNF432|ZNF256|LILRB2|ZNF211|ZNF274|ZNF460|RUVBL2|LILRB1|KDELR1|LILRB5|SLC27A5|LILRB4|KLK11|LILRA1|LILRB3|LILRA2|KLK8|PNKP|U2AF2|ATF5|PPP6R1|CARD8|RPL13A|SYNGR4|LILRA4|ZIM2|NUP62|HSPBP1|PPP1R15A|ZNF324|KLK5|ZNF473|KLK13|PRPF31|FGF21|SNORD35A|SNORD34|SNORD33|SNORD32A|SIGLEC7|DKKL1|SIGLEC9|SIGLEC8|DHDH|ZNF544|UBE2S|SLC6A16|TFPT|CCDC106|EPN1|KLK14|KLK12|SHANK1|NOSIP|ZNF580|HSD17B14|GP6|VRK3|ZNF581|PTOV1|PPP1R12C|TRPM4|ZNF586|FAM83E|EPS8L1|RASIP1|PIH1D1|C19orf73|TMEM143|ZNF444|ZNF331|KLK15|NLRP2|ZNF416|ZNF446|ZNF701|ZNF83|ZNF415|CABP5|SPHK2|SLC17A7|NAT14|VN1R1|RCN3|ZNF304|TTYH1|PRR12|ZNF471|USP29|PLEKHA4|ZNF71|SCAF1|CACNG8|CACNG7|CACNG6|ZNF350|TSKS|ZNF667|ELSPBP1|LIN7B|ZNF649|ZSCAN18|TSEN34|MBOAT7|ZSCAN5A|LENG1|LILRA6|ZNF329|TBC1D17|ZNF419|ISOC2|MYH14|ZNF665|ZNF552|ZNF671|ZNF613|ZNF606|ZNF614|FUZ|ZNF611|MED25|BCL2L12|GRWD1|SYT3|AKT1S1|ZNF528|BRSK1|SNORD35B|ZNF347|ZNF577|KMT5C|C19orf48|ZBTB45|ZNF587|FIZ1|GALP|SIGLEC10|SIGLEC12|ZNF628|ZNF551|ZNF616|ZNF766|ZNF468|ZNF160|CTU1|ZNF835|ZNF765|NLRP12|MYADM|ZNF845|CCDC114|ACPT|CGB5|CGB7|LRRC4B|LENG9|CGB8|BIRC8|FAM71E1|RDH13|PTH2|ZIM3|SIGLEC11|CGB1|CGB2|LMTK3|LENG8|KIR3DL3|ZNF837|CLDND2|ZNF816|ZNF543|COX6B2|OSCAR|ZNF813|JOSD2|IZUMO2|CPT1C|ALDH16A1|NTN5|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|VSIG10L|C19orf84|SPACA6|ZNF480|ZNF534|ZNF578|ERVV-1|SMIM17|C19orf18|ZNF418|ZNF417|ZNF548|TMEM190|TMC4|ZNF524|ZNF784|CCDC155|NLRP4|ZNF582|ZNF583|CDC42EP5|ZNF836|ZNF610|ZNF600|ZNF320|ZNF497|ZNF550|ZNF579|ZNF114|SPACA4|NLRP7|ADM5|ZNF584|ZSCAN4|NLRP11|TMEM86B|ZNF549|IL4I1|SSC5D|ZNF547|ZIK1|ZNF776|ZSCAN1|MAMSTR|IZUMO1|EMC10|MGC45922|KLK9|SIGLECL1|ZNF615|ZNF841|VSTM1|TMEM150B|FAM71E2|VN1R2|VN1R4|NLRP9|C19orf81|ZNF677|RFPL4A|ZSCAN5B|ZSCAN22|ZNF530|DNAAF3|LILRA5|C19orf68|ZNF773|ZNF582-AS1|ZNF808|ZNF888|ZNF761|TMEM238|ZNF470|ZNF749|ZNF324B|ZNF805|LOC400710|ZNF880|ZNF772|IGLON5|MIRLET7E|MIR125A|MIR150|MIR99B|TARM1|MIR371A|MIR372|MIR373|A1BG-AS1|DPRX|DUXA|KIR3DP1|ASPDH|MIR512-1|MIR512-2|MIR498|MIR520E|MIR515-1|MIR519E|MIR520F|MIR515-2|MIR519C|MIR520A|MIR526B|MIR519B|MIR525|MIR523|MIR518F|MIR520B|MIR518B|MIR526A1|MIR520C|MIR518C|MIR524|MIR517A|MIR519D|MIR521-2|MIR520D|MIR517B|MIR520G|MIR516B2|MIR526A2|MIR518E|MIR518A1|MIR518D|MIR516B1|MIR518A2|MIR517C|MIR520H|MIR521-1|MIR522|MIR519A1|MIR527|MIR516A1|MIR516A2|MIR519A2|SBK2|ZSCAN5D|RNF225|SNORD88A|SNORD88B|SNORD88C|MIR643|CEACAM18|SHISA7|RFPL4AL1|LINC01530|ZNF814|SIGLEC14|MIMT1|MIR935|SNAR-G1|SNAR-F|SNAR-A1|SNAR-A2|ZNF667-AS1|LOC100128398|LOC100129083|SBK3|BSPH1|PEG3-AS1|SNAR-A3|SNAR-A5|SNAR-A7|SNAR-A11|SNAR-A9|SNAR-A4|SNAR-A6|SNAR-A8|SNAR-A13|SNAR-A10|SNAR-B2|SNAR-C2|SNAR-C4|SNAR-C5|SNAR-B1|SNAR-C1|SNAR-C3|SNAR-D|SNAR-G2|SNAR-A14|ERVV-2|ZNF587B|MIR1283-2|MIR1323|MIR1283-1|MIR4324|CARD8-AS1|PTOV1-AS1|GFY|ZNF865|ERVK3-1|ZNF816-ZNF321P|MIR4754|MIR4752|MIR371B|MIR4749|MIR4750|MIR4751|MIR5088|NUCB1-AS1|LOC101059948|ZNF350-AS1|LOC101928295|PTOV1-AS2|LOC101928517|ZNF649-AS1|LOC101928804|LOC101928886|ZIM2-AS1|SPACA6P-AS|MIR6799|MIR6800|MIR6802|MIR6804|MIR6805|MIR6806|MIR8074|MIR8061|MIR6798|MIR6803|MIR7975|MIR6801|ZNF528-AS1|LENG8-AS1|LOC105372440|LOC105372441|LOC105372444|LOC105372476|LOC105372483|LOC105447645|PLA2G4C-AS1|LOC107985332	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	19	47908540 - 58539965	GRCh38	59116	73711
GRCh38/hg38 19p13.3(chr19:1565575-4108128)x3	AES|AMH|CSNK1G2|DAPK3|EEF2|GNA11|GNA15|GNG7|MKNK2|MATK|GADD45B|NFIC|OAZ1|MAP2K2|SGTA|TBXA2R|TCF3|THOP1|TLE2|SF3A2|S1PR4|AP3D1|APBA3|HMG20B|UQCR11|ZFR2|PIP5K1C|TIMM13|SNORD37|TJP3|NMRK2|SLC39A3|ZBTB7A|FZR1|PIAS4|LSM7|MBD3|PLEKHJ1|BTBD2|NCLN|SPPL2B|REXO1|ZNF77|CACTIN|CELF5|TLE6|ZNF556|ABHD17A|DOHH|KLF16|DOT1L|LMNB2|RAX2|ATCAY|IZUMO4|SCAMP4|ADAT3|ZNF554|MRPL54|ZNF57|JSRP1|MOB3A|MFSD12|GIPC3|ATP8B3|DIRAS1|ZNF555|CSNK1G2-AS1|SMIM24|TMPRSS9|C19orf35|ONECUT3|MEX3D|CACTIN-AS1|LINGO3|MIR637|C19orf71|LOC100288123|MIR1909|MIR1227|MIR4321|LOC100996351|LINC01775|MIR7850|MIR6789|MIR7108	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	19	1565575 - 4108128	GRCh38	59081	73676
GRCh38/hg38 19q13.33-13.43(chr19:50191219-58535818)x3	A1BG|KLK3|CD33|SIGLEC6|ETFB|FCAR|FPR1|FPR2|FPR3|GPR32|HAS1|IL11|KCNC3|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KLK1|KLK2|LAIR1|LAIR2|LIM2|MYBPC2|NDUFA3|NKG7|CNOT3|PEG3|POLD1|PPP2R1A|PRKCG|KLK7|KLK6|KLK10|PTPRH|RPL28|RPS5|RPS9|CLEC11A|SPIB|AURKC|SYT5|TNNI3|TNNT1|NR1H2|ZNF8|ZNF17|ZNF28|ZNF132|ZNF134|ZNF135|ZNF137P|ZNF154|ZNF175|SIGLEC5|ZNF264|NCR1|NAPSA|KLK4|ZNF432|ZNF256|LILRB2|ZNF211|ZNF274|ZNF460|LILRB1|LILRB5|SLC27A5|LILRB4|KLK11|LILRA1|LILRB3|LILRA2|KLK8|U2AF2|PPP6R1|LILRA4|ZIM2|HSPBP1|ZNF324|KLK5|KLK13|PRPF31|SIGLEC7|SIGLEC9|SIGLEC8|ZNF544|UBE2S|TFPT|CCDC106|EPN1|KLK14|KLK12|SHANK1|ZNF580|GP6|ZNF581|PPP1R12C|ZNF586|EPS8L1|ZNF444|ZNF331|KLK15|NLRP2|ZNF416|ZNF446|ZNF701|ZNF83|ZNF415|NAT14|VN1R1|ZNF304|TTYH1|ZNF471|USP29|ZNF71|CACNG8|CACNG7|CACNG6|ZNF350|ZNF667|ZNF649|ZSCAN18|TSEN34|MBOAT7|ZSCAN5A|LENG1|LILRA6|ZNF329|ZNF419|ISOC2|MYH14|ZNF665|ZNF552|ZNF671|ZNF613|ZNF606|ZNF614|ZNF611|SYT3|ZNF528|BRSK1|ZNF347|ZNF577|KMT5C|C19orf48|ZBTB45|ZNF587|FIZ1|GALP|SIGLEC10|SIGLEC12|ZNF628|ZNF551|ZNF616|ZNF766|ZNF468|ZNF160|CTU1|ZNF835|ZNF765|NLRP12|MYADM|ZNF845|ACPT|LRRC4B|LENG9|BIRC8|FAM71E1|RDH13|ZIM3|LENG8|KIR3DL3|ZNF837|CLDND2|ZNF816|ZNF543|COX6B2|OSCAR|ZNF813|JOSD2|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|VSIG10L|C19orf84|SPACA6|ZNF480|ZNF534|ZNF578|ERVV-1|SMIM17|C19orf18|ZNF418|ZNF417|ZNF548|TMEM190|TMC4|ZNF524|ZNF784|NLRP4|ZNF582|ZNF583|CDC42EP5|ZNF836|ZNF610|ZNF600|ZNF320|ZNF497|ZNF550|ZNF579|NLRP7|ZNF584|ZSCAN4|NLRP11|TMEM86B|ZNF549|SSC5D|ZNF547|ZIK1|ZNF776|ZSCAN1|EMC10|MGC45922|KLK9|SIGLECL1|ZNF615|ZNF841|VSTM1|TMEM150B|FAM71E2|VN1R2|VN1R4|NLRP9|C19orf81|ZNF677|RFPL4A|ZSCAN5B|ZSCAN22|ZNF530|DNAAF3|LILRA5|ZNF773|ZNF582-AS1|ZNF808|ZNF888|ZNF761|TMEM238|ZNF470|ZNF749|ZNF324B|ZNF805|ZNF880|ZNF772|IGLON5|MIRLET7E|MIR125A|MIR99B|TARM1|MIR371A|MIR372|MIR373|A1BG-AS1|DPRX|DUXA|KIR3DP1|ASPDH|MIR512-1|MIR512-2|MIR498|MIR520E|MIR515-1|MIR519E|MIR520F|MIR515-2|MIR519C|MIR520A|MIR526B|MIR519B|MIR525|MIR523|MIR518F|MIR520B|MIR518B|MIR526A1|MIR520C|MIR518C|MIR524|MIR517A|MIR519D|MIR521-2|MIR520D|MIR517B|MIR520G|MIR516B2|MIR526A2|MIR518E|MIR518A1|MIR518D|MIR516B1|MIR518A2|MIR517C|MIR520H|MIR521-1|MIR522|MIR519A1|MIR527|MIR516A1|MIR516A2|MIR519A2|SBK2|ZSCAN5D|RNF225|SNORD88A|SNORD88B|SNORD88C|MIR643|CEACAM18|SHISA7|RFPL4AL1|LINC01530|ZNF814|SIGLEC14|MIMT1|MIR935|SNAR-F|ZNF667-AS1|LOC100128398|LOC100129083|SBK3|PEG3-AS1|ERVV-2|ZNF587B|MIR1283-2|MIR1323|MIR1283-1|ZNF865|ERVK3-1|ZNF816-ZNF321P|MIR4754|MIR4752|MIR371B|ZNF350-AS1|LOC101928517|ZNF649-AS1|LOC101928804|LOC101928886|ZIM2-AS1|SPACA6P-AS|MIR6802|MIR6804|MIR6805|MIR6806|MIR8074|MIR8061|MIR6803|MIR7975|MIR6801|ZNF528-AS1|LENG8-AS1|LOC105372440|LOC105372441|LOC105372444|LOC105372476|LOC105372483|LOC107985332	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	19	50191219 - 58535818	GRCh38	57219	71814
NM_000214.2(JAG1):c.3528C>T (p.Tyr1176=)	JAG1	Arteriohepatic dysplasia|not specified|Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease	GO-ESP:0.22813(A), GMAF:0.18010(A), GO-ESP:0.23829(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	10639627	GRCh38	42478	51648
NM_000214.2(JAG1):c.3417T>C (p.Tyr1139=)	JAG1	Arteriohepatic dysplasia|not specified|Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease	GMAF:0.28730(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	10639738	GRCh38	137595	141298
NM_000214.2(JAG1):c.2778C>T (p.Phe926=)	JAG1	not specified|Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00086(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 29, 2015)	criteria provided, conflicting interpretations	20	10641598	GRCh38	263781	259048
NM_000214.2(JAG1):c.2766C>T (p.Asp922=)	JAG1	Alagille syndrome 1|Arteriohepatic dysplasia|not specified|Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease	GMAF:0.01480(A), GO-ESP:0.00511(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	10641610	GRCh38	213526	210310
NM_000214.2(JAG1):c.2612C>G (p.Pro871Arg)	JAG1	Arteriohepatic dysplasia|not specified|Cardiovascular phenotype	GO-ESP:0.04813(C), GMAF:0.05290(C), GO-ESP:0.06618(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	10641853	GRCh38	42475	51645
NM_000214.2(JAG1):c.2286C>T (p.Asn762=)	JAG1	Cardiovascular phenotype	GO-ESP:0.00007(A)	Likely benign(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	20	10644921	GRCh38	263943	259044
NM_000214.2(JAG1):c.2214A>C (p.Thr738=)	JAG1	Arteriohepatic dysplasia|not specified|Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease	GO-ESP:0.07550(G), GMAF:0.10080(G), GO-ESP:0.10945(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	10645156	GRCh38	42473	51643
NM_000214.2(JAG1):c.924C>T (p.Asn308=)	JAG1	Arteriohepatic dysplasia|not specified|Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease	GO-ESP:0.01761(A), GMAF:0.03360(A), GO-ESP:0.03370(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	10652213	GRCh38	42483	51653
NM_000214.2(JAG1):c.909T>C (p.His303=)	JAG1	Arteriohepatic dysplasia|not specified|Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease	GMAF:0.00120(G), GO-ESP:0.00121(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	10652228	GRCh38	213525	210334
NM_000214.2(JAG1):c.821G>A (p.Gly274Asp)	JAG1	Tetralogy of Fallot		Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	20	10652533	GRCh38	7624	22663
NM_000214.2(JAG1):c.814G>A (p.Val272Ile)	JAG1	Cardiovascular phenotype	GMAF:0.00060(T), GO-ESP:0.00019(T)	Uncertain significance(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	20	10652540	GRCh38	264345	259057
NM_000214.2(JAG1):c.765C>T (p.Tyr255=)	JAG1	Arteriohepatic dysplasia|not specified|not provided|Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease	GMAF:0.42330(A), GO-ESP:0.45408(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	10652589	GRCh38	143063	152781
NM_000214.2(JAG1):c.588C>T (p.Cys196=)	JAG1	Arteriohepatic dysplasia|not specified|not provided|Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease	GO-ESP:0.10395(A), GMAF:0.18190(A), GO-ESP:0.10877(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	10658574	GRCh38	42481	51651
NM_033118.3(MYLK2):c.260C>T (p.Ala87Val)	MYLK2	Cardiomyopathy, hypertrophic, midventricular, digenic	GO-ESP:0.00008(T), GMAF:0.00060(T), GO-ESP:0.00014(T)	Pathogenic(Last reviewed: Nov 30, 2001)	no assertion criteria provided	20	31820333	GRCh38	4243	19282
NM_033118.3(MYLK2):c.344A>C (p.Gln115Pro)	MYLK2	not specified		Uncertain significance(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	20	31820417	GRCh38	179165	176224
NM_033118.3(MYLK2):c.463A>T (p.Ile155Phe)	MYLK2	not specified	GMAF:0.00040(G), GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	20	31820536	GRCh38	164499	176348
NM_003098.2(SNTA1):c.1377C>T (p.Asp459=)	SNTA1	Cardiac arrhythmia	GMAF:0.00040(A), GO-ESP:0.00012(A)	Benign(Last reviewed: Jun 26, 2011)	criteria provided, single submitter	20	33408749	GRCh38	139223	142926
NM_003098.2(SNTA1):c.1300T>C (p.Trp434Arg)	SNTA1	not specified	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	20	33408826	GRCh38	190923	188714
NM_003098.2(SNTA1):c.1244C>T (p.Thr415Met)	SNTA1	not specified	GMAF:0.00020(T), GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	20	33408882	GRCh38	190920	188717
NM_003098.2(SNTA1):c.1225G>C (p.Glu409Gln)	SNTA1	not specified		Uncertain significance(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	20	33410147	GRCh38	190937	188719
NM_003098.2(SNTA1):c.1204C>T (p.Arg402Trp)	SNTA1	Long QT syndrome 12	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Jul 17, 2014)	no assertion criteria provided	20	33410168	GRCh38	203366	199810
NM_003098.2(SNTA1):c.1169C>T (p.Ala390Val)	SNTA1	Long QT syndrome 12	GO-ESP:0.00008(A), GO-ESP:0.00002(A)	Pathogenic(Last reviewed: Jul 8, 2008)	no assertion criteria provided	20	33410203	GRCh38	8476	23515
NM_003098.2(SNTA1):c.1088A>C (p.Glu363Ala)	SNTA1	not specified|Cardiovascular phenotype	GMAF:0.00020(G), GO-ESP:0.00039(G)	Uncertain significance(Last reviewed: Feb 23, 2016)	criteria provided, multiple submitters, no conflicts	20	33410284	GRCh38	190918	188722
NM_003098.2(SNTA1):c.992G>A (p.Arg331His)	SNTA1	not specified	GMAF:0.00020(A), GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Jun 18, 2014)	criteria provided, single submitter	20	33412344	GRCh38	190917	188723
NM_003098.2(SNTA1):c.984C>T (p.Pro328=)	SNTA1	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GO-ESP:0.00111(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	20	33412352	GRCh38	139222	142925
NM_003098.2(SNTA1):c.828G>A (p.Lys276=)	SNTA1	Long QT syndrome|Romano-Ward syndrome|Cardiovascular phenotype	GMAF:0.00720(T), GO-ESP:0.01067(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	20	33412656	GRCh38	220958	222853
NM_003098.2(SNTA1):c.807T>C (p.Asn269=)	SNTA1	Long QT syndrome|Romano-Ward syndrome|Cardiovascular phenotype	GMAF:0.02500(G), GO-ESP:0.00601(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	33412677	GRCh38	263424	259046
NM_003098.2(SNTA1):c.770C>G (p.Ala257Gly)	SNTA1	Long QT syndrome 12|Long QT syndrome|Cardiovascular phenotype	GMAF:0.00100(C), GO-ESP:0.00202(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2013)	criteria provided, conflicting interpretations	20	33412714	GRCh38	191548	189373
NM_003098.2(SNTA1):c.620G>A (p.Arg207Gln)	SNTA1	Cardiovascular phenotype	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	20	33417800	GRCh38	264348	259052
NM_003098.2(SNTA1):c.619C>T (p.Arg207Trp)	SNTA1	Cardiovascular phenotype	GMAF:0.00120(A), GO-ESP:0.00022(A)	Uncertain significance(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	20	33417801	GRCh38	264288	259050
NM_003098.2(SNTA1):c.567A>C (p.Ser189=)	SNTA1	Cardiovascular phenotype	GMAF:0.00020(A)	Likely benign(Last reviewed: Aug 13, 2012)	criteria provided, single submitter	20	33417853	GRCh38	263382	259058
NM_003098.2(SNTA1):c.566C>T (p.Ser189Leu)	SNTA1	Cardiovascular phenotype	GO-ESP:0.00021(A)	Uncertain significance(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	20	33417854	GRCh38	263623	259049
NM_003098.2(SNTA1):c.555C>T (p.Val185=)	SNTA1	Long QT syndrome|Romano-Ward syndrome|Cardiovascular phenotype	GMAF:0.01140(A), GO-ESP:0.00274(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	33417865	GRCh38	263425	259054
NM_003098.2(SNTA1):c.388T>C (p.Phe130Leu)	SNTA1	Cardiac arrhythmia	GO-ESP:0.00003(G)	Uncertain significance(Last reviewed: Oct 6, 2014)	criteria provided, single submitter	20	33438949	GRCh38	190929	188736
NM_003098.2(SNTA1):c.317G>A (p.Arg106Gln)	SNTA1	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype	GMAF:0.00820(T), GO-ESP:0.00323(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	33439020	GRCh38	191576	189377
NM_003098.2(SNTA1):c.312C>T (p.Gly104=)	SNTA1	Cardiovascular phenotype	GMAF:0.00220(A), GO-ESP:0.00081(A)	Likely benign(Last reviewed: Feb 4, 2013)	criteria provided, single submitter	20	33439025	GRCh38	263506	259053
NM_003098.2(SNTA1):c.311-6G>C	SNTA1	Cardiac arrhythmia|Long QT syndrome	GO-ESP:0.00246(G), GMAF:0.00200(G), GO-ESP:0.00064(G)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2015)	criteria provided, conflicting interpretations	20	33439032	GRCh38	36777	45438
NM_003098.2(SNTA1):c.287G>C (p.Gly96Ala)	SNTA1	not specified	GO-ESP:0.00012(G)	Uncertain significance(Last reviewed: Aug 12, 2016)	criteria provided, multiple submitters, no conflicts	20	33443334	GRCh38	190907	188739
NM_003098.2(SNTA1):c.259C>A (p.Arg87Ser)	SNTA1	not specified		Uncertain significance(Last reviewed: Jul 2, 2014)	criteria provided, single submitter	20	33443362	GRCh38	190905	188741
NM_003098.2(SNTA1):c.221C>T (p.Pro74Leu)	SNTA1	Long QT syndrome|Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00097(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	20	33443400	GRCh38	263476	259063
NM_003098.2(SNTA1):c.40G>A (p.Glu14Lys)	SNTA1	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 16, 2016)	criteria provided, multiple submitters, no conflicts	20	33443581	GRCh38	190932	188746
NM_003098.2(SNTA1):c.25C>T (p.Arg9Cys)	SNTA1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	20	33443596	GRCh38	264021	259059
NM_020433.4(JPH2):c.2073T>C (p.Phe691=)	JPH2	not specified|Cardiovascular phenotype	GMAF:0.25740(G), GO-ESP:0.31197(G)	Benign(Last reviewed: Jun 15, 2015)	criteria provided, multiple submitters, no conflicts	20	44114814	GRCh38	137611	141314
NM_020433.4(JPH2):c.1990G>A (p.Ala664Thr)	JPH2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	20	44115685	GRCh38	264222	259055
NM_020433.4(JPH2):c.1987G>C (p.Glu663Gln)	JPH2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	20	44115688	GRCh38	264479	259056
NM_020433.4(JPH2):c.1896G>C (p.Glu632Asp)	JPH2	not specified|Cardiovascular phenotype	GO-ESP:0.00005(G)	Uncertain significance(Last reviewed: Dec 30, 2015)	criteria provided, multiple submitters, no conflicts	20	44115779	GRCh38	201804	198526
NM_020433.4(JPH2):c.1794C>A (p.Ser598=)	JPH2	Cardiovascular phenotype	GMAF:0.00180(T), GO-ESP:0.00070(T)	Benign(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	20	44115881	GRCh38	264143	259064
NM_020433.4(JPH2):c.1728C>G (p.Pro576=)	JPH2	not specified|Cardiovascular phenotype	GMAF:0.15300(C), GO-ESP:0.21320(C)	Benign(Last reviewed: Jun 18, 2015)	criteria provided, multiple submitters, no conflicts	20	44115947	GRCh38	137609	141312
NM_020433.4(JPH2):c.1589C>T (p.Ala530Val)	JPH2	Cardiovascular phenotype	GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	20	44116086	GRCh38	263783	259060
NM_020433.4(JPH2):c.1513G>A (p.Gly505Ser)	JPH2	Familial hypertrophic cardiomyopathy 17|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00705(T), GMAF:0.01540(T), GO-ESP:0.05298(T)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2016)	criteria provided, conflicting interpretations	20	44116162	GRCh38	30458	39415
NM_020433.4(JPH2):c.1424G>A (p.Arg475His)	JPH2	not specified	GO-ESP:0.00079(T)	Uncertain significance(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	20	44116251	GRCh38	201803	198529
NM_020433.4(JPH2):c.1357C>T (p.Pro453Ser)	JPH2	Cardiovascular phenotype	GMAF:0.00020(A)	Uncertain significance(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	20	44116318	GRCh38	264361	259061
NM_020433.4(JPH2):c.1344C>T (p.Ser448=)	JPH2	Cardiovascular phenotype		Likely benign(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	20	44116331	GRCh38	263599	259062
NM_020433.4(JPH2):c.1186G>A (p.Ala396Thr)	JPH2	not specified|Cardiovascular phenotype	GMAF:0.27040(T), GO-ESP:0.18458(T)	Benign(Last reviewed: Jun 15, 2015)	criteria provided, multiple submitters, no conflicts	20	44118607	GRCh38	137607	141310
NM_020433.4(JPH2):c.1179C>T (p.His393=)	JPH2	not specified|Cardiovascular phenotype	GMAF:0.04870(A), GO-ESP:0.07155(A)	Benign(Last reviewed: Jun 19, 2015)	criteria provided, multiple submitters, no conflicts	20	44118614	GRCh38	137606	141309
NM_020433.4(JPH2):c.1090C>T (p.Gln364Ter)	JPH2	not specified		Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	20	44159697	GRCh38	201800	198531
NM_020433.4(JPH2):c.972C>T (p.His324=)	JPH2	Cardiovascular phenotype	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	20	44159815	GRCh38	264400	259068
NM_020433.4(JPH2):c.856A>G (p.Thr286Ala)	JPH2	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GMAF:0.00040(C), GO-ESP:0.00127(C)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 24, 2016)	criteria provided, conflicting interpretations	20	44159931	GRCh38	201799	198532
NM_020433.4(JPH2):c.780C>T (p.Ala260=)	JPH2	not specified|Cardiovascular phenotype	GMAF:0.00200(A), GO-ESP:0.00199(A)	Benign/Likely benign(Last reviewed: Jun 25, 2015)	criteria provided, multiple submitters, no conflicts	20	44160007	GRCh38	226677	231101
NM_020433.4(JPH2):c.661T>C (p.Phe221Leu)	JPH2	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GMAF:0.00840(G), GO-ESP:0.00109(G)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 15, 2016)	criteria provided, conflicting interpretations	20	44160126	GRCh38	201798	198533
NM_020433.4(JPH2):c.648G>A (p.Lys216=)	JPH2	Cardiovascular phenotype		Likely benign(Last reviewed: May 20, 2015)	criteria provided, single submitter	20	44160139	GRCh38	264069	259066
NM_020433.4(JPH2):c.624C>T (p.Ala208=)	JPH2	Cardiovascular phenotype		Likely benign(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	20	44160163	GRCh38	264546	259071
NM_020433.4(JPH2):c.572C>G (p.Pro191Arg)	JPH2	not specified|Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00278(C)	Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2016)	criteria provided, conflicting interpretations	20	44160215	GRCh38	201796	198535
NM_020433.4(JPH2):c.562C>T (p.Pro188Ser)	JPH2	Hypertrophic cardiomyopathy|Cardiovascular phenotype	GMAF:0.00240(A), GO-ESP:0.00029(A)	Uncertain significance(Last reviewed: Oct 1, 2015)	criteria provided, multiple submitters, no conflicts	20	44160225	GRCh38	220441	222854
NM_020433.4(JPH2):c.537T>C (p.Ser179=)	JPH2	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	20	44160250	GRCh38	263380	259065
NM_020433.4(JPH2):c.494C>T (p.Ser165Phe)	JPH2	Familial hypertrophic cardiomyopathy 17		Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	20	44160293	GRCh38	30457	39414
NM_020433.4(JPH2):c.483G>A (p.Thr161=)	JPH2	Cardiovascular phenotype	GO-ESP:0.00084(T)	Likely benign(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	20	44160304	GRCh38	264268	259076
NM_020433.4(JPH2):c.476T>A (p.Leu159Gln)	JPH2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Feb 7, 2013)	criteria provided, single submitter	20	44160311	GRCh38	263513	259067
NM_020433.4(JPH2):c.421T>C (p.Tyr141His)	JPH2	Familial hypertrophic cardiomyopathy 17	GO-ESP:0.00002(G)	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	20	44160366	GRCh38	30456	39413
NM_020433.4(JPH2):c.156C>T (p.Tyr52=)	JPH2	not specified|Cardiovascular phenotype	GMAF:0.14580(G)	Benign(Last reviewed: Mar 11, 2015)	criteria provided, multiple submitters, no conflicts	20	44186550	GRCh38	137602	141305
NM_020433.4(JPH2):c.45C>T (p.Cys15=)	JPH2	Cardiovascular phenotype	GO-ESP:0.00003(A)	Likely benign(Last reviewed: May 21, 2013)	criteria provided, single submitter	20	44186661	GRCh38	263613	259074
NM_006282.3(STK4):c.349C>T (p.Arg117Ter)	STK4	T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations		Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	20	44981932	GRCh38	37323	45898
NM_030777.3(SLC2A10):c.119T>C (p.Phe40Ser)	SLC2A10	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(C)	Uncertain significance(Last reviewed: May 21, 2015)	criteria provided, single submitter	20	46725155	GRCh38	264055	259069
NM_030777.3(SLC2A10):c.144G>A (p.Glu48=)	SLC2A10	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	20	46725180	GRCh38	264215	259079
NM_030777.3(SLC2A10):c.313C>T (p.Arg105Cys)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 25, 2015)	criteria provided, conflicting interpretations	20	46725349	GRCh38	161104	170939
NM_030777.3(SLC2A10):c.315C>T (p.Arg105=)	SLC2A10	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00019(T)	Likely benign(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	20	46725351	GRCh38	263815	259070
NM_030777.3(SLC2A10):c.316G>T (p.Ala106Ser)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00900(T), GO-ESP:0.00276(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	46725352	GRCh38	139170	142873
NM_030777.3(SLC2A10):c.366C>T (p.Tyr122=)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00440(T), GO-ESP:0.00475(T)	Benign/Likely benign(Last reviewed: Apr 12, 2016)	criteria provided, multiple submitters, no conflicts	20	46725402	GRCh38	139171	142874
NM_030777.3(SLC2A10):c.367G>A (p.Val123Met)	SLC2A10	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	20	46725403	GRCh38	264583	259077
NM_030777.3(SLC2A10):c.515C>T (p.Thr172Ile)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00082(T)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 29, 2016)	criteria provided, conflicting interpretations	20	46725551	GRCh38	195383	192544
NM_030777.3(SLC2A10):c.581C>T (p.Thr194Ile)	SLC2A10	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00009(T)	Uncertain significance(Last reviewed: Jun 26, 2015)	criteria provided, single submitter	20	46725617	GRCh38	264101	259073
NM_030777.3(SLC2A10):c.610G>A (p.Gly204Ser)	SLC2A10	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Feb 28, 2013)	criteria provided, single submitter	20	46725646	GRCh38	263561	259086
NM_030777.3(SLC2A10):c.616G>A (p.Ala206Thr)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.17470(A), GO-ESP:0.10087(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	46725652	GRCh38	139172	142875
NM_030777.3(SLC2A10):c.674G>A (p.Arg225His)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00600(A), GO-ESP:0.00165(A)	Benign/Likely benign(Last reviewed: Jan 25, 2016)	criteria provided, multiple submitters, no conflicts	20	46725710	GRCh38	241606	243583
NM_030777.3(SLC2A10):c.685C>T (p.Arg229Ter)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(T)	Pathogenic(Last reviewed: Sep 10, 2014)	criteria provided, single submitter	20	46725721	GRCh38	161096	170942
NM_030777.3(SLC2A10):c.692G>A (p.Arg231Gln)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	20	46725728	GRCh38	161097	170944
NM_030777.3(SLC2A10):c.765C>T (p.Ser255=)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(T), GO-ESP:0.00053(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	20	46725801	GRCh38	213717	210362
NM_030777.3(SLC2A10):c.781G>A (p.Val261Ile)	SLC2A10	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(A), GO-ESP:0.00012(A)	Uncertain significance(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	20	46725817	GRCh38	263879	259072
NM_030777.3(SLC2A10):c.816C>G (p.Ala272=)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00040(G), GO-ESP:0.00078(G)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	20	46725852	GRCh38	139173	142876
NM_030777.3(SLC2A10):c.931G>A (p.Val311Ile)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(A), GO-ESP:0.00031(A)	Uncertain significance(Last reviewed: Jun 27, 2016)	criteria provided, multiple submitters, no conflicts	20	46725967	GRCh38	213720	210369
NM_030777.3(SLC2A10):c.1087C>G (p.Gln363Glu)	SLC2A10	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Feb 26, 2014)	criteria provided, single submitter	20	46726123	GRCh38	263820	259078
NM_030777.3(SLC2A10):c.1154C>G (p.Ala385Gly)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.02900(G), GO-ESP:0.01344(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	46726190	GRCh38	139174	142877
NM_030777.3(SLC2A10):c.1212G>T (p.Gly404=)	SLC2A10	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00400(T), GO-ESP:0.00113(T)	Benign(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	20	46726248	GRCh38	263336	259075
NM_030777.3(SLC2A10):c.1233C>T (p.Thr411=)	SLC2A10	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	20	46726269	GRCh38	263967	259087
NM_030777.3(SLC2A10):c.1274T>C (p.Phe425Ser)	SLC2A10	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(C)	Uncertain significance(Last reviewed: Mar 19, 2014)	criteria provided, single submitter	20	46726310	GRCh38	263824	259080
NM_030777.3(SLC2A10):c.1334delG (p.Gly445Glufs)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Sep 29, 2014)	criteria provided, multiple submitters, no conflicts	20	46726909	GRCh38	4587	19626
NM_030777.3(SLC2A10):c.1370C>T (p.Ala457Val)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00021(T)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	46726945	GRCh38	213737	210379
NM_030777.3(SLC2A10):c.1464C>T (p.Leu488=)	SLC2A10	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 8, 2015)	criteria provided, conflicting interpretations	20	46729405	GRCh38	197356	194517
NM_030777.3(SLC2A10):c.1512G>A (p.Ser504=)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00100(A), GO-ESP:0.00138(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	20	46729453	GRCh38	139176	142879
NM_030777.3(SLC2A10):c.1541A>G (p.Lys514Arg)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.06950(G), GO-ESP:0.01863(G)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	46729482	GRCh38	139177	142880
NM_030777.3(SLC2A10):c.1548G>T (p.Arg516=)	SLC2A10	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00320(T), GO-ESP:0.00069(T)	Likely benign(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	20	46733756	GRCh38	263890	259081
NM_030777.3(SLC2A10):c.1552A>G (p.Thr518Ala)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.02840(G), GO-ESP:0.00881(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	46733760	GRCh38	139181	142884
NM_030777.3(SLC2A10):c.1609A>G (p.Ile537Val)	SLC2A10	Arterial tortuosity syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.02080(G), GO-ESP:0.00705(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	46733817	GRCh38	139182	142885
NM_030777.3(SLC2A10):c.1616C>T (p.Ala539Val)	SLC2A10	Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Apr 17, 2015)	criteria provided, multiple submitters, no conflicts	20	46733824	GRCh38	213743	210389
NM_030777.3(SLC2A10):c.1617G>A (p.Ala539=)	SLC2A10	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00500(A), GO-ESP:0.00169(A)	Benign(Last reviewed: Apr 2, 2015)	criteria provided, multiple submitters, no conflicts	20	46733825	GRCh38	139183	142886
GRCh38/hg38 20p13-q11.1(chr20:80106-30227427)x3	ADRA1D|JAG1|AVP|BFSP1|BMP2|ENTPD6|CDC25B|CENPB|CHGB|CSNK2A1|CST1|CST2|CST3|CST4|CST5|FKBP1A|GNRH2|FOXA2|IDH3B|INSM1|ITPA|NKX2-2|OXT|PAX1|PCNA|PCSK2|PDYN|PLCB4|PRNP|PTPRA|PYGB|RRBP1|SIGLEC1|SNAP25|SNRPB|SNRPB2|SOX12|SSTR4|TCF15|TGM3|THBD|ZNF133|MKKS|ATRN|CST7|CDS2|PSMF1|SNPH|LZTS3|RASSF2|GINS1|SLC23A2|CST8|SIRPB1|SEC23B|NOP56|RBCK1|POLR3F|RBBP9|DSTN|RNF24|XRN2|UBOX5|BTBD3|CD93|NINL|PLCB1|PRND|FLRT3|LAMP5|SPEF1|C20orf194|CFAP61|ABHD12|ZNF337|RNU105B|SNORD57|SNORD56|SDCBP2|SNX5|TMEM230|LINC00652|NXT1|VSX1|NAA20|CRNKL1|ANGPT4|ESF1|TRMT6|HAO1|RIN2|SMOX|CRLS1|C20orf27|DZANK1|SPTLC3|AP5S1|TMEM74B|SIRPG|FERMT1|KIF16B|TASP1|KIZ|NSFL1C|TMX4|GPCPD1|CPXM1|OTOR|APMAP|PAK5|RALGAPA2|KAT14|SLC24A3|MAVS|EBF4|TRIB3|OVOL2|FASTKD5|NAPB|ANKEF1|GFRA4|GZF1|VPS16|PCED1A|MRPS26|DDRGK1|NDUFAF5|ZNF343|SYNDIG1|NRSN2|PANK2|ADAM33|SEL1L2|DEFB126|FAM110A|SLC4A11|MCM8|ACSS1|ZCCHC3|SCRT2|GGTLC1|MGME1|DTD1|SLC52A3|HSPA12B|TMC2|TBC1D20|SIRPD|C20orf141|PROKR2|SLX4IP|CSTL1|CST9L|CST9|C20orf96|MACROD2|SRXN1|LINC00261|BANF2|NANP|MACROD2-IT1|DEFB127|SCP2D1|ISM1|CST11|DEFB129|SIRPA|STK35|PRNT|LINC00654|C20orf196|LRRN4|LINC00656|DEFB125|DEFB128|SIRPB2|LOC284788|LOC284798|FAM182A|MIR663AHG|LOC339593|RSPO4|TGM6|LOC388780|LINC00493|DEFB132|C20orf202|FLJ33581|MIR103A2|LINC00851|LOC613266|RAD21L1|LOC643406|NKX2-4|SNORA51|SNORD17|SNORD86|SNORD110|MIR663A|LOC727993|LINC01433|C20orf187|LINC00687|FAM182B|SNORD119|C20orf78|LOC100130264|SNAP25-AS1|UBOX5-AS1|LOC100134868|LINC01432|LOC100270804|TMEM239|LOC100289097|MIR1292|MIR103B2|PCNA-AS1|PET117|MACROD2-AS1|MIR3192|LOC100505515|ISM1-AS1|LINC01431|NRSN2-AS1|SDCBP2-AS1|LINC00658|FKBP1A-SDCBP2|PLCB1-IT1|LOC101926889|LOC101926935|LOC101926955|SIRPG-AS1|LOC101929125|LOC101929207|MCM8-AS1|CASC20|LINC01428|LOC101929288|LOC101929312|LAMP5-AS1|LOC101929371|LOC101929395|LOC101929413|LOC101929486|LOC101929526|KIZ-AS1|LOC101929608|LOC101929625|LINC01427|LINC01384|MIR6869|MIR6870|MIR8062|LOC102606466|ZNF337-AS1|LOC105372493|LOC105372582|LOC105379477|LINC01598|LOC107987276	See cases		Pathogenic(Last reviewed: Apr 30, 2010)	no assertion criteria provided	20	80106 - 30227427	GRCh38	144514	154265
GRCh38/hg38 20q13.12-13.33(chr20:44787704-64277321)x3	ATP5E|BMP7|CD40|CDH4|CEBPB|CHRNA4|COL9A3|CSE1L|CSTF1|CTSZ|CYP24A1|EDN3|EEF1A2|EYA2|GNAS|NPBWR2|KCNB1|KCNG1|KCNQ2|KCNS1|LAMA5|MC3R|MMP9|MYT1|NFATC2|NTSR1|OPRL1|PCK1|PFDN4|PI3|PLTP|CTSA|PPP1R3D|PSMA7|PTGIS|PTK6|PTPN1|RPS21|SDC4|SEMG1|SEMG2|SLPI|SNAI1|SRMS|STAU1|STK4|AURKA|TAF4|TCEA2|TFAP2C|TNNC2|TPD52L2|UBE2V1|YWHAB|ZNF217|NCOA3|RAE1|BCAS1|STX16|TNFRSF6B|MATN4|DPM1|VAPB|B4GALT5|SPATA2|OSBPL2|ACOT8|ATP9A|ARFRP1|RGS19|SYCP2|WFDC2|ARFGEF2|TCFL5|SPINT3|TOMM34|ADRM1|OGFR|UBE2C|DIDO1|HRH3|RBPJL|SLC9A8|ADNP|ZMYND8|SPO11|PRPF6|SS18L1|MTG2|GMEB2|SNORD12C|TP53TG5|MOCS3|SLCO4A1|STMN3|SLC35C2|PRELID3B|NELFCD|RTFDC1|PIGT|RTEL1|SOX18|YTHDF1|LIME1|UCKL1|GID8|PCMTD2|MRGBP|RBM38|BCAS4|DDX27|ZNF334|ZFP64|ARFGAP1|DOK5|DBNDD2|RNF114|SULF2|SLC2A4RG|PMEPA1|CASS4|EPPIN|SALL4|ZNFX1|RAB22A|SLC12A5|ZNF512B|PREX1|COL20A1|NCOA5|CDH26|SLC17A9|ELMO2|ZNF335|LOC63930|PCIF1|FAM217B|CDH22|SLC13A3|FNDC11|PPDPF|LOC79160|BIRC7|NPEPL1|DNAJC5|PABPC1L|TUBB1|ZBP1|SLC2A10|CABLES2|PARD6B|ZGPAT|HELZ2|SYS1|WFDC8|SNX21|ZSWIM1|TP53RK|DNTTIP1|FAM210B|PHACTR3|BHLHE23|NKAIN4|WFDC12|SPATA25|OCSTAMP|TSHZ2|C20orf85|ZNF831|MIR1-1HG|GATA5|ZBTB46|WFDC3|GCNT7|CBLN4|CTCFL|SAMD10|ABHD16B|RIMS4|ANKRD60|NEURL2|ZSWIM3|WFDC10A|WFDC6|FAM65C|RBBP8NL|WFDC5|APCDD1L-AS1|GNAS-AS1|LSM14B|WFDC13|APCDD1L|LKAAEAR1|FAM209A|C20orf166-AS1|WFDC11|WFDC9|WFDC10B|LINC00176|LINC00494|LINC01270|C20orf197|MIR646HG|TMEM189|TMEM189-UBE2V1|FAM209B|SPINT4|MIR1-1|MIR124-3|MIR133A2|MIR296|ZFAS1|SNORD12|MIR645|MIR646|MIR647|LOC729296|SYS1-DBNDD2|HAR1A|HAR1B|UCKL1-AS1|SNORD12B|MIR298|MIR941-1|MIR941-4|MIR941-2|MIR941-3|SLCO4A1-AS1|LOC100128028|C20orf181|LOC100130587|ZNF840P|LOC100131496|DPH3P1|LINC00029|LINC01056|FLJ16779|MIR1914|MIR1302-5|MIR1257|MIR3195|MIR4325|MIR3194|MIR4326|MIR3196|MTRNR2L3|MIR3616|MIR3617|LOC100505771|STK4-AS1|LINC01272|LOC100506175|LOC100506384|LOC100506470|EPPIN-WFDC6|RTEL1-TNFRSF6B|SLMO2-ATP5E|STX16-NPEPL1|MIR4756|MIR4758|MIR4532|MIR4533|MIR548AG2|LINC00659|TRERNA1|LINC01523|OGFR-AS1|LOC101927377|LINC01522|LINC01273|CEBPB-AS1|LINC01271|ADNP-AS1|LINC01429|LINC01524|LOC101927770|LINC01441|LOC101927932|LOC101928048|LAMA5-AS1|ZBTB46-AS1|MIR6812|MIR6813|CSE1L-AS1|LINC01440|BMP7-AS1|MIR941-5|LOC105369209|LOC105372653|LOC105372672|LOC105372682|LOC105372695|NKILA	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, multiple submitters, no conflicts	20	44787704 - 64277321	GRCh38	59218	73813
GRCh38/hg38 20p13(chr20:89939-975656)x1	CSNK2A1|SOX12|TCF15|RBCK1|ANGPT4|TRIB3|NRSN2|DEFB126|FAM110A|ZCCHC3|SCRT2|SLC52A3|TBC1D20|C20orf96|SRXN1|DEFB127|DEFB129|DEFB125|DEFB128|RSPO4|DEFB132|NRSN2-AS1	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, multiple submitters, no conflicts	20	89939 - 975656	GRCh38	58941	73536
NM_172201.1(KCNE2):c.22A>G (p.Thr8Ala)	KCNE2	Long QT syndrome 6|not specified|not provided|Long QT syndrome, drug-associated|Cardiovascular phenotype	GO-ESP:0.00492(G), GMAF:0.00140(G), GO-ESP:0.00380(G)	Benign(Last reviewed: Sep 20, 2015)	criteria provided, multiple submitters, no conflicts	21	34370500	GRCh38	67615	78511
NM_172201.1(KCNE2):c.25C>G (p.Gln9Glu)	KCNE2	Long QT syndrome 6|Long QT syndrome 6, acquired, susceptibility to|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00561(G), GMAF:0.00480(G), GO-ESP:0.00145(G)	Benign, not provided, risk factor(Last reviewed: Jan 27, 2016)	criteria provided, multiple submitters, no conflicts	21	34370503	GRCh38	6052	21091
NM_172201.1(KCNE2):c.29C>T (p.Thr10Met)	KCNE2	Long QT syndrome|not specified|not provided|Congenital long QT syndrome	GO-ESP:0.00018(T)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: May 27, 2016)	criteria provided, conflicting interpretations	21	34370507	GRCh38	67619	78515
NM_172201.1(KCNE2):c.40G>A (p.Val14Ile)	KCNE2	Long QT syndrome 6|Long QT syndrome|not specified|not provided	GO-ESP:0.00085(A), GMAF:0.00120(A), GO-ESP:0.00024(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Jan 10, 2016)	criteria provided, conflicting interpretations	21	34370518	GRCh38	67621	78517
NM_172201.1(KCNE2):c.161T>C (p.Met54Thr)	KCNE2	Cardiac arrhythmia|Long QT syndrome 6|not provided|Congenital long QT syndrome|KCNE2-Related Disorders	GO-ESP:0.00023(C), GO-ESP:0.00024(C)	Pathogenic/Likely pathogenic, not provided(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	34370639	GRCh38	6053	21092
NM_172201.1(KCNE2):c.170T>C (p.Ile57Thr)	KCNE2	Cardiac arrhythmia|Long QT syndrome 6|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00038(C), GMAF:0.00080(C), GO-ESP:0.00088(C)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Sep 1, 2016)	criteria provided, conflicting interpretations	21	34370648	GRCh38	6054	21093
NM_172201.1(KCNE2):c.178T>C (p.Phe60Leu)	KCNE2	Long qt syndrome 3/6, digenic|Congenital long QT syndrome		Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	21	34370656	GRCh38	6056	21095
NM_172201.1(KCNE2):c.229C>T (p.Arg77Trp)	KCNE2	Long QT syndrome|not specified|Congenital long QT syndrome	GO-ESP:0.00015(T), GO-ESP:0.00007(T)	Uncertain significance(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	21	34370707	GRCh38	67614	78510
NM_172201.1(KCNE2):c.347C>T (p.Ala116Val)	KCNE2	not provided|Acquired long QT syndrome	GO-ESP:0.00002(T)	Likely pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	21	34370825	GRCh38	67620	78516
NM_172201.1(KCNE2):c.354G>A (p.Gly118=)	KCNE2	not specified|Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00026(A)	Benign/Likely benign(Last reviewed: Jun 9, 2015)	criteria provided, multiple submitters, no conflicts	21	34370832	GRCh38	190792	188753
NM_172201.1(KCNE2):c.362T>A (p.Met121Lys)	KCNE2	not provided		Likely pathogenic(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	21	34370840	GRCh38	190795	188754
NM_000219.5(KCNE1):c.253G>A (p.Asp85Asn)	KCNE1	Long QT syndrome 5, acquired, susceptibility to|Long QT syndrome 2/5|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GO-ESP:0.00877(T), GMAF:0.00380(T), GO-ESP:0.00916(T)	Conflicting interpretations of pathogenicity, not provided, risk factor(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	21	34449382	GRCh38	13479	28518
NM_000219.5(KCNE1):c.247G>A (p.Glu83Lys)	KCNE1	Congenital long QT syndrome|Cardiovascular phenotype	GMAF:0.00020(T), GO-ESP:0.00003(T)	Uncertain significance(Last reviewed: Oct 15, 2013)	criteria provided, single submitter	21	34449388	GRCh38	132673	136421
NM_000219.5(KCNE1):c.226G>A (p.Asp76Asn)	KCNE1	Jervell and Lange-Nielsen syndrome 2|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 5|not provided|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00008(T), GO-ESP:0.00003(T)	Pathogenic/Likely pathogenic, not provided(Last reviewed: Jul 25, 2016)	criteria provided, multiple submitters, no conflicts	21	34449409	GRCh38	13477	28516
NM_000219.5(KCNE1):c.200G>A (p.Arg67His)	KCNE1	Long QT syndrome|not specified|Congenital long QT syndrome	GO-ESP:0.00023(T), GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Nov 6, 2014)	no assertion criteria provided	21	34449435	GRCh38	132661	136409
NM_000219.5(KCNE1):c.199C>T (p.Arg67Cys)	KCNE1	not specified|Congenital long QT syndrome|Cardiovascular phenotype	GO-ESP:0.00003(A)	Conflicting interpretations of pathogenicity, not provided(Last reviewed: Sep 4, 2015)	criteria provided, conflicting interpretations	21	34449436	GRCh38	132660	136408
NM_000219.5(KCNE1):c.112A>G (p.Ser38Gly)	KCNE1	Hearing loss, noise-induced, susceptibility to|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GO-ESP:0.66193(C), GMAF:0.32610(T)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	34449523	GRCh38	132651	136399
NM_000219.5(KCNE1):c.84G>A (p.Ser28=)	KCNE1	Long QT syndrome|Romano-Ward syndrome|not specified|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	GMAF:0.00380(T), GO-ESP:0.00362(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	34449551	GRCh38	178611	176235
NM_000219.5(KCNE1):c.30G>T (p.Thr10=)	KCNE1	Cardiac arrhythmia	GMAF:0.00200(T)	Likely benign(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	21	34449605	GRCh38	36427	45090
NM_000071.2(CBS):c.1644G>C (p.Arg548=)	CBS	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00080(G), GO-ESP:0.00010(G)	Likely benign(Last reviewed: Sep 6, 2012)	criteria provided, single submitter	21	43053892	GRCh38	263392	259083
NM_000071.2(CBS):c.1643G>A (p.Arg548Gln)	CBS	Homocystinuria due to CBS deficiency|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00120(T), GO-ESP:0.00173(T)	Benign/Likely benign(Last reviewed: Nov 27, 2015)	criteria provided, multiple submitters, no conflicts	21	43053893	GRCh38	212869	210393
NM_000071.2(CBS):c.1563C>T (p.Thr521=)	CBS	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00001(A)	Likely benign(Last reviewed: Aug 21, 2012)	criteria provided, single submitter	21	43053973	GRCh38	263389	259088
NM_000071.2(CBS):c.1524C>T (p.Phe508=)	CBS	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Feb 22, 2013)	criteria provided, single submitter	21	43056831	GRCh38	263560	259082
NM_000071.2(CBS):c.1479G>A (p.Thr493=)	CBS	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00020(T), GO-ESP:0.00023(T)	Benign/Likely benign(Last reviewed: Aug 18, 2014)	criteria provided, multiple submitters, no conflicts	21	43056876	GRCh38	212834	210396
NM_000071.2(CBS):c.1472G>A (p.Arg491His)	CBS	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00009(T)	Uncertain significance(Last reviewed: Jun 17, 2013)	criteria provided, single submitter	21	43056883	GRCh38	263326	259085
NM_000071.2(CBS):c.1436T>C (p.Val479Ala)	CBS	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Jan 22, 2014)	criteria provided, single submitter	21	43058176	GRCh38	263813	259084
NM_000071.2(CBS):c.1358G>A (p.Gly453Glu)	CBS	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 2, 2015)	criteria provided, single submitter	21	43058834	GRCh38	264408	259091
NM_000071.2(CBS):c.1262C>A (p.Ala421Asp)	CBS	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: May 22, 2015)	criteria provided, single submitter	21	43058930	GRCh38	264043	259089
NM_000071.2(CBS):c.1161C>T (p.Ser387=)	CBS	Homocystinuria|Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	21	43059288	GRCh38	263900	259090
NM_000071.2(CBS):c.1105C>T (p.Arg369Cys)	CBS	Homocystinuria due to CBS deficiency|Thoracic aortic aneurysm and aortic dissection|not specified|not provided	GMAF:0.00120(A), GO-ESP:0.00328(A)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 12, 2016)	criteria provided, conflicting interpretations	21	43060481	GRCh38	212860	210412
NM_000071.2(CBS):c.1080C>T (p.Ala360=)	CBS	Homocystinuria|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.26269(A), GMAF:0.29550(A), GO-ESP:0.33815(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	43060506	GRCh38	92424	98335
NM_000071.2(CBS):c.1059G>A (p.Thr353=)	CBS	Homocystinuria due to CBS deficiency|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00220(T), GO-ESP:0.00061(T)	Benign/Likely benign(Last reviewed: Jan 7, 2016)	criteria provided, multiple submitters, no conflicts	21	43060527	GRCh38	212827	210415
NM_000071.2(CBS):c.1058C>T (p.Thr353Met)	CBS	Homocystinuria due to CBS deficiency|Homocystinuria, pyridoxine-nonresponsive|Thoracic aortic aneurysm and aortic dissection|not provided	GO-ESP:0.00008(A), GO-ESP:0.00001(A)	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, multiple submitters, no conflicts	21	43060528	GRCh38	131	15170
NM_000071.2(CBS):c.1009A>G (p.Met337Val)	CBS	Thoracic aortic aneurysm and aortic dissection|not specified		Uncertain significance(Last reviewed: Apr 22, 2015)	criteria provided, multiple submitters, no conflicts	21	43062341	GRCh38	212859	210418
NM_000071.2(CBS):c.981C>T (p.Asn327=)	CBS	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Jan 22, 2013)	criteria provided, single submitter	21	43062369	GRCh38	263517	259092
NM_000071.2(CBS):c.939G>A (p.Thr313=)	CBS	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00080(T), GO-ESP:0.00060(T)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2015)	criteria provided, conflicting interpretations	21	43062968	GRCh38	212824	210423
NM_000071.2(CBS):c.919G>A (p.Gly307Ser)	CBS	Homocystinuria due to CBS deficiency|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-nonresponsive|Homocystinuria|not provided	GO-ESP:0.00008(T), GO-ESP:0.00016(T)	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, multiple submitters, no conflicts	21	43062988	GRCh38	117	15156
NM_000071.2(CBS):c.844_845insCATCCAGGTGGGGCTTTTGCTGGGCTTGAGCCCTGAAGCCGCGCCCTCTGCAGATCATTGGGGTGGAT (p.Glu283Serfs)	CBS	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	21	43063062 - 43063063	GRCh38	264368	259093
NM_000071.2(CBS):c.844_845ins68 (p.?)	CBS	Thoracic aortic aneurysm and aortic dissection		Likely benign(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	21	43063062 - 43063063	GRCh38	263811	259096
NM_000071.2(CBS):c.833T>C (p.Ile278Thr)	CBS	Homocystinuria due to CBS deficiency|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Homocystinuria|Thoracic aortic aneurysm and aortic dissection|not provided	GO-ESP:0.00308(G), GMAF:0.00020(G)	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, multiple submitters, no conflicts	21	43063074	GRCh38	120	15159
NM_000071.2(CBS):c.786G>A (p.Thr262=)	CBS	Homocystinuria|Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(T), GO-ESP:0.00005(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	21	43063942	GRCh38	264505	259094
NM_000071.2(CBS):c.699C>T (p.Tyr233=)	CBS	Homocystinuria|Thoracic aortic aneurysm and aortic dissection|not specified	GO-ESP:0.30609(A), GMAF:0.19650(A), GO-ESP:0.27633(A)	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	43065240	GRCh38	92426	98337
NM_000071.2(CBS):c.670C>T (p.Arg224Cys)	CBS	Thoracic aortic aneurysm and aortic dissection|not specified|not provided	GMAF:0.00020(A), GO-ESP:0.00026(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 15, 2016)	criteria provided, conflicting interpretations	21	43065269	GRCh38	212851	210431
NM_000071.2(CBS):c.636C>T (p.Asn212=)	CBS	Homocystinuria|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00300(A), GO-ESP:0.00125(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	21	43065417	GRCh38	136668	140371
NM_000071.2(CBS):c.615G>C (p.Gly205=)	CBS	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00002(G)	Likely benign(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	21	43065438	GRCh38	264224	259095
NM_000071.2(CBS):c.612G>C (p.Val204=)	CBS	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00040(A)	Likely benign(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	21	43065441	GRCh38	264320	259101
NM_000071.2(CBS):c.609C>T (p.His203=)	CBS	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00003(A)	Likely benign(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	21	43065444	GRCh38	264194	259097
NM_000071.2(CBS):c.573G>A (p.Thr191=)	CBS	Homocystinuria due to CBS deficiency|Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00440(T), GO-ESP:0.00581(T)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	21	43065480	GRCh38	136667	140370
NM_000071.2(CBS):c.548C>T (p.Ala183Val)	CBS	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Nov 21, 2013)	criteria provided, single submitter	21	43065505	GRCh38	263808	259098
NM_000071.2(CBS):c.537C>T (p.Asp179=)	CBS	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00010(A)	Uncertain significance(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	21	43065516	GRCh38	263327	259099
NM_000071.2(CBS):c.502G>A (p.Val168Met)	CBS	Homocystinuria, pyridoxine-responsive|Thoracic aortic aneurysm and aortic dissection|not specified|not provided	GO-ESP:0.00003(T)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 29, 2015)	criteria provided, conflicting interpretations	21	43065645	GRCh38	127	15166
NM_000071.2(CBS):c.469G>A (p.Ala157Thr)	CBS	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T)	Uncertain significance(Last reviewed: Mar 4, 2016)	criteria provided, single submitter	21	43065678	GRCh38	263924	259104
NM_000071.2(CBS):c.441C>T (p.Ser147=)	CBS	Thoracic aortic aneurysm and aortic dissection	GO-ESP:0.00006(A)	Likely benign(Last reviewed: Aug 13, 2014)	criteria provided, single submitter	21	43066253	GRCh38	263851	259100
NM_000071.2(CBS):c.397G>A (p.Asp133Asn)	CBS	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00060(T), GO-ESP:0.00027(T)	Uncertain significance(Last reviewed: Jan 12, 2014)	criteria provided, multiple submitters, no conflicts	21	43066297	GRCh38	212844	210441
NM_000071.2(CBS):c.394C>A (p.Arg132Ser)	CBS	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	21	43066300	GRCh38	263891	259108
NM_000071.2(CBS):c.342G>A (p.Ala114=)	CBS	Thoracic aortic aneurysm and aortic dissection	GMAF:0.00020(T), GO-ESP:0.00008(T)	Likely benign(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	21	43066352	GRCh38	263580	259102
NM_000071.2(CBS):c.325T>C (p.Cys109Arg)	CBS	Thoracic aortic aneurysm and aortic dissection|not provided		Pathogenic(Last reviewed: Sep 9, 2014)	criteria provided, multiple submitters, no conflicts	21	43066369	GRCh38	212878	210444
NM_000071.2(CBS):c.210-3C>T	CBS	Thoracic aortic aneurysm and aortic dissection		Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	21	43068618	GRCh38	264609	259106
NM_000071.2(CBS):c.146C>T (p.Pro49Leu)	CBS	Thoracic aortic aneurysm and aortic dissection|not provided	GO-ESP:0.00018(A)	Pathogenic(Last reviewed: Aug 16, 2015)	criteria provided, multiple submitters, no conflicts	21	43072048	GRCh38	212872	210450
NM_000071.2(CBS):c.52C>T (p.Arg18Cys)	CBS	Thoracic aortic aneurysm and aortic dissection|not specified	GMAF:0.00260(A), GO-ESP:0.00086(A)	Benign/Likely benign(Last reviewed: Mar 14, 2016)	criteria provided, multiple submitters, no conflicts	21	43072142	GRCh38	263858	259103
NM_001848.2(COL6A1):c.850G>A (p.Gly284Arg)	COL6A1	Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|not provided|Ullrich congenital muscular dystrophy 1, autosomal dominant		Pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, multiple submitters, no conflicts	21	45989129	GRCh38	17180	32219
GRCh38/hg38 21q11.2-22.3(chr21:7749532-46677460)x3	ADARB1|AIRE|APP|ATP5J|ATP5O|BACH1|PTTG1IP|C21orf2|TMEM50B|RUNX1|CBR1|CBR3|CBS|COL6A1|COL6A2|CRYAA|CSTB|CXADR|DSCAM|RCAN1|DYRK1A|ERG|ETS2|GABPA|GART|GRIK1|HLCS|HMGN1|PRMT2|IFNAR1|IFNAR2|IFNGR2|IL10RB|ITGB2|KCNE1|KCNJ6|KCNJ15|LSS|MX1|MX2|NCAM2|NDUFV3|PCNT|PCP4|PDE9A|PFKL|PKNOX1|TMPRSS15|PWP2|S100B|SH3BGR|ITSN1|SIM2|SLC5A3|SLC19A1|SUMO3|SOD1|SON|HSPA13|TFF1|TFF2|TFF3|TIAM1|TRAPPC10|TMPRSS2|TPTE|TRPM2|TTC3|U2AF1|UBE2G2|WRB|NRIP1|CHAF1B|C21orf33|PDXK|RRP1|PSMG1|SYNJ1|MCM3AP|CLDN8|ADAMTS1|ABCG1|URB1|CRYZL1|DOPEY2|KCNE2|RWDD2B|OLIG2|DSCR4|DSCR3|B3GALT5|USP16|CCT8|WDR4|FTCD|BTG3|HSF2BP|ADAMTS5|RRP1B|DIP2A|POFUT2|ICOSLG|MORC3|CLDN14|BACE2|C2CD2|LTN1|CLDN17|N6AMT1|USP25|DNMT3L|DONSON|HUNK|ZBTB21|PIGP|UBASH3A|RIPPLY3|BRWD1|SLC37A1|RBM11|PCBP3|C21orf58|YBEY|LINC00160|SMIM11A|C21orf62-AS1|MIS18A|LINC00158|CHODL-AS1|TSPEAR-AS1|LRRC3DN|TSPEAR|LINC00113|LINC00112|LINC00111|SETD4|FAM3B|RIPK4|CLIC6|LINC00308|MRPL39|C21orf91|DNAJC28|C21orf62|MRAP|C21orf59|AGPAT3|MAP3K7CL|SCAF4|JAM2|EVA1C|PRDM15|SAMSN1|TMPRSS3|MRPS6|RUNX1-IT1|COL18A1|LRRC3|SPATC1L|LINC01547|DSCR8|URB1-AS1|BAGE2|FAM207A|RSPH1|UMODL1|ERVH48-1|PAXBP1|LINC00310|LINC00313|B3GALT5-AS1|LINC00334|TSPEAR-AS2|MCM3AP-AS1|MIR155HG|CYYR1|OLIG1|LINC00161|KRTAP13-1|TCP10L|CHODL|LIPI|ABCC13|LOC150051|LCA5L|IGSF5|SIK1|LINC00479|ZNF295-AS1|UMODL1-AS1|PLAC4|LINC00189|C21orf91-OT1|LINC00315|LINC00314|KRTAP15-1|DSCR9|DSCR10|D21S2088E|LINC00307|LINC00515|LOC284825|KRTAP13-4|LINC00323|LINC00319|AATBC|POTED|KRTAP7-1|KRTAP8-1|KRTAP11-1|KRTAP19-1|KRTAP13-2|KRTAP13-3|KRTAP23-1|KRTAP6-1|KRTAP6-2|KRTAP6-3|KRTAP19-2|KRTAP19-3|KRTAP19-4|KRTAP19-5|KRTAP19-6|KRTAP19-7|KRTAP20-1|KRTAP20-2|KRTAP21-1|KRTAP21-2|KRTAP22-1|KRTAP20-3|LOC339622|KRTAP12-2|KRTAP12-1|KRTAP10-10|PICSAR|LINC00317|COL18A1-AS1|KRTAP10-4|KRTAP10-6|KRTAP10-7|KRTAP10-9|KRTAP10-1|KRTAP10-11|KRTAP10-2|KRTAP10-5|KRTAP10-8|KRTAP10-3|KRTAP12-3|KRTAP12-4|KRTAP10-12|LINC00320|LOC388813|MIR99AHG|KRTAP26-1|LINC00316|LINC00649|LINC00114|LOC400867|MIRLET7C|MIR125B2|MIR155|MIR99A|MGC39584|LOC642852|GRIK1-AS1|KRTAP24-1|KRTAP27-1|SNORA80A|LINC00163|KRTAP19-8|LINC01548|MIR802|LINC00322|LOC100129027|KRTAP25-1|LOC100133286|KRTAP20-4|TRG-GCC1-5|KRTAP22-2|KRTAP21-3|IL10RB-AS1|GRIK1-AS2|MIR4327|MIR548X|MIR3118-1|MIR3156-3|MIR3197|MIR3687-1|MIR3648-1|ITGB2-AS1|LINC01549|PAXBP1-AS1|LINC00649|LINC01426|LOC100506403|CBR3-AS1|DSCAM-AS1|LINC00159|MIR4760|MIR4759|MIR5692B|LRRC3-AS1|DIP2A-IT1|TTC3-AS1|BRWD1-AS1|SAMSN1-AS1|COL18A1-AS2|BACH1-IT2|DSCAM-IT1|CYYR1-AS1|LINC01436|MIR548XHG|LINC01425|LOC101927843|LOC101927869|LOC101927973|LOC101928107|LOC101928126|C21orf140|LOC101928233|LOC101928269|LOC101928311|LOC101928398|TCONS_00029157|LOC101928435|TRPM2-AS|LINC01424|LOC101928796|LOC101930094|LINC00945|MIR6070|MIR6501|MIR6724-1|MIR6814|MIR6815|MIR6130|MIR6508|KCNE1B|LINC00205|SMIM11B|LOC102724188|LOC102724502|LINC01423|BRWD1-IT2|MIR6724-2|MIR3687-2|MIR3648-2|MIR6724-4|MIR8069-2|MIR6724-3|LOC105372751|LOC105372795|LOC105372833|LOC105377134|LOC105379514|FRGCA|SNORA91|WRB-SH3BGR	See cases		Pathogenic(Last reviewed: Mar 26, 2013)	no assertion criteria provided	21	7749532 - 46677460	GRCh38	155053	164807
GRCh38/hg38 21q22.2-22.3(chr21:39375937-44246148)x1	CBS|CRYAA|CSTB|DSCAM|MX1|MX2|NDUFV3|PCP4|PDE9A|PKNOX1|PWP2|SH3BGR|TFF1|TFF2|TFF3|TRAPPC10|TMPRSS2|U2AF1|WRB|C21orf33|PDXK|RRP1|ABCG1|B3GALT5|WDR4|HSF2BP|RRP1B|ICOSLG|BACE2|C2CD2|ZBTB21|UBASH3A|SLC37A1|LINC00112|LINC00111|FAM3B|RIPK4|AGPAT3|PRDM15|TMPRSS3|RSPH1|UMODL1|ERVH48-1|LINC00313|B3GALT5-AS1|LCA5L|IGSF5|SIK1|LINC00479|ZNF295-AS1|UMODL1-AS1|PLAC4|LINC00323|LINC00319|AATBC|LINC00322|MIR3197|DSCAM-AS1|MIR4760|MIR5692B|DSCAM-IT1|LOC101928233|LOC101928311|TCONS_00029157|LOC101930094|MIR6070|MIR6814|MIR6508|FRGCA|SNORA91|WRB-SH3BGR	See cases		Pathogenic(Last reviewed: Sep 16, 2011)	no assertion criteria provided	21	39375937 - 44246148	GRCh38	154583	164337
GRCh38/hg38 21p11.2-q22.3(chr21:7749532-46670440)x3	ADARB1|AIRE|APP|ATP5J|ATP5O|BACH1|PTTG1IP|C21orf2|TMEM50B|RUNX1|CBR1|CBR3|CBS|COL6A1|COL6A2|CRYAA|CSTB|CXADR|DSCAM|RCAN1|DYRK1A|ERG|ETS2|GABPA|GART|GRIK1|HLCS|HMGN1|PRMT2|IFNAR1|IFNAR2|IFNGR2|IL10RB|ITGB2|KCNE1|KCNJ6|KCNJ15|LSS|MX1|MX2|NCAM2|NDUFV3|PCNT|PCP4|PDE9A|PFKL|PKNOX1|TMPRSS15|PWP2|S100B|SH3BGR|ITSN1|SIM2|SLC5A3|SLC19A1|SUMO3|SOD1|SON|HSPA13|TFF1|TFF2|TFF3|TIAM1|TRAPPC10|TMPRSS2|TPTE|TRPM2|TTC3|U2AF1|UBE2G2|WRB|NRIP1|CHAF1B|C21orf33|PDXK|RRP1|PSMG1|SYNJ1|MCM3AP|CLDN8|ADAMTS1|ABCG1|URB1|CRYZL1|DOPEY2|KCNE2|RWDD2B|OLIG2|DSCR4|DSCR3|B3GALT5|USP16|CCT8|WDR4|FTCD|BTG3|HSF2BP|ADAMTS5|RRP1B|DIP2A|POFUT2|ICOSLG|MORC3|CLDN14|BACE2|C2CD2|LTN1|CLDN17|N6AMT1|USP25|DNMT3L|DONSON|HUNK|ZBTB21|PIGP|UBASH3A|RIPPLY3|BRWD1|SLC37A1|RBM11|PCBP3|C21orf58|YBEY|LINC00160|SMIM11A|C21orf62-AS1|MIS18A|LINC00158|CHODL-AS1|TSPEAR-AS1|LRRC3DN|TSPEAR|LINC00113|LINC00112|LINC00111|SETD4|FAM3B|RIPK4|CLIC6|LINC00308|MRPL39|C21orf91|DNAJC28|C21orf62|MRAP|C21orf59|AGPAT3|MAP3K7CL|SCAF4|JAM2|EVA1C|PRDM15|SAMSN1|TMPRSS3|MRPS6|RUNX1-IT1|COL18A1|LRRC3|SPATC1L|LINC01547|DSCR8|URB1-AS1|BAGE2|FAM207A|RSPH1|UMODL1|ERVH48-1|PAXBP1|LINC00310|LINC00313|B3GALT5-AS1|LINC00334|TSPEAR-AS2|MCM3AP-AS1|MIR155HG|CYYR1|OLIG1|LINC00161|KRTAP13-1|TCP10L|CHODL|LIPI|ABCC13|LOC150051|LCA5L|IGSF5|SIK1|LINC00479|ZNF295-AS1|UMODL1-AS1|PLAC4|LINC00189|C21orf91-OT1|LINC00315|LINC00314|KRTAP15-1|DSCR9|DSCR10|D21S2088E|LINC00307|LINC00515|LOC284825|KRTAP13-4|LINC00323|LINC00319|AATBC|POTED|KRTAP7-1|KRTAP8-1|KRTAP11-1|KRTAP19-1|KRTAP13-2|KRTAP13-3|KRTAP23-1|KRTAP6-1|KRTAP6-2|KRTAP6-3|KRTAP19-2|KRTAP19-3|KRTAP19-4|KRTAP19-5|KRTAP19-6|KRTAP19-7|KRTAP20-1|KRTAP20-2|KRTAP21-1|KRTAP21-2|KRTAP22-1|KRTAP20-3|LOC339622|KRTAP12-2|KRTAP12-1|KRTAP10-10|PICSAR|LINC00317|COL18A1-AS1|KRTAP10-4|KRTAP10-6|KRTAP10-7|KRTAP10-9|KRTAP10-1|KRTAP10-11|KRTAP10-2|KRTAP10-5|KRTAP10-8|KRTAP10-3|KRTAP12-3|KRTAP12-4|KRTAP10-12|LINC00320|LOC388813|MIR99AHG|KRTAP26-1|LINC00316|LINC00649|LINC00114|LOC400867|MIRLET7C|MIR125B2|MIR155|MIR99A|MGC39584|LOC642852|GRIK1-AS1|KRTAP24-1|KRTAP27-1|SNORA80A|LINC00163|KRTAP19-8|LINC01548|MIR802|LINC00322|LOC100129027|KRTAP25-1|LOC100133286|KRTAP20-4|TRG-GCC1-5|KRTAP22-2|KRTAP21-3|IL10RB-AS1|GRIK1-AS2|MIR4327|MIR548X|MIR3118-1|MIR3156-3|MIR3197|MIR3687-1|MIR3648-1|ITGB2-AS1|LINC01549|PAXBP1-AS1|LINC00649|LINC01426|LOC100506403|CBR3-AS1|DSCAM-AS1|LINC00159|MIR4760|MIR4759|MIR5692B|LRRC3-AS1|DIP2A-IT1|TTC3-AS1|BRWD1-AS1|SAMSN1-AS1|COL18A1-AS2|BACH1-IT2|DSCAM-IT1|CYYR1-AS1|LINC01436|MIR548XHG|LINC01425|LOC101927843|LOC101927869|LOC101927973|LOC101928107|LOC101928126|C21orf140|LOC101928233|LOC101928269|LOC101928311|LOC101928398|TCONS_00029157|LOC101928435|TRPM2-AS|LINC01424|LOC101928796|LOC101930094|LINC00945|MIR6070|MIR6501|MIR6724-1|MIR6814|MIR6815|MIR6130|MIR6508|KCNE1B|LINC00205|SMIM11B|LOC102724188|LOC102724502|LINC01423|BRWD1-IT2|MIR6724-2|MIR3687-2|MIR3648-2|MIR6724-4|MIR8069-2|MIR6724-3|LOC105372751|LOC105372795|LOC105372833|LOC105377134|LOC105379514|FRGCA|SNORA91|WRB-SH3BGR	See cases		Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	21	7749532 - 46670440	GRCh38	144677	154428
GRCh37/hg19 21q22.1(chr21:35292816-36834601)x3	RUNX1|RCAN1|KCNE1|SLC5A3|KCNE2|SMIM11A|CLIC6|MRPS6	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter			GRCh38	59248	73843
GRCh38/hg38 21p11.2-q22.3(chr21:7749532-46670546)x3	ADARB1|AIRE|APP|ATP5J|ATP5O|BACH1|PTTG1IP|C21orf2|TMEM50B|RUNX1|CBR1|CBR3|CBS|COL6A1|COL6A2|CRYAA|CSTB|CXADR|DSCAM|RCAN1|DYRK1A|ERG|ETS2|GABPA|GART|GRIK1|HLCS|HMGN1|PRMT2|IFNAR1|IFNAR2|IFNGR2|IL10RB|ITGB2|KCNE1|KCNJ6|KCNJ15|LSS|MX1|MX2|NCAM2|NDUFV3|PCNT|PCP4|PDE9A|PFKL|PKNOX1|TMPRSS15|PWP2|S100B|SH3BGR|ITSN1|SIM2|SLC5A3|SLC19A1|SUMO3|SOD1|SON|HSPA13|TFF1|TFF2|TFF3|TIAM1|TRAPPC10|TMPRSS2|TPTE|TRPM2|TTC3|U2AF1|UBE2G2|WRB|NRIP1|CHAF1B|C21orf33|PDXK|RRP1|PSMG1|SYNJ1|MCM3AP|CLDN8|ADAMTS1|ABCG1|URB1|CRYZL1|DOPEY2|KCNE2|RWDD2B|OLIG2|DSCR4|DSCR3|B3GALT5|USP16|CCT8|WDR4|FTCD|BTG3|HSF2BP|ADAMTS5|RRP1B|DIP2A|POFUT2|ICOSLG|MORC3|CLDN14|BACE2|C2CD2|LTN1|CLDN17|N6AMT1|USP25|DNMT3L|DONSON|HUNK|ZBTB21|PIGP|UBASH3A|RIPPLY3|BRWD1|SLC37A1|RBM11|PCBP3|C21orf58|YBEY|LINC00160|SMIM11A|C21orf62-AS1|MIS18A|LINC00158|CHODL-AS1|TSPEAR-AS1|LRRC3DN|TSPEAR|LINC00113|LINC00112|LINC00111|SETD4|FAM3B|RIPK4|CLIC6|LINC00308|MRPL39|C21orf91|DNAJC28|C21orf62|MRAP|C21orf59|AGPAT3|MAP3K7CL|SCAF4|JAM2|EVA1C|PRDM15|SAMSN1|TMPRSS3|MRPS6|RUNX1-IT1|COL18A1|LRRC3|SPATC1L|LINC01547|DSCR8|URB1-AS1|BAGE2|FAM207A|RSPH1|UMODL1|ERVH48-1|PAXBP1|LINC00310|LINC00313|B3GALT5-AS1|LINC00334|TSPEAR-AS2|MCM3AP-AS1|MIR155HG|CYYR1|OLIG1|LINC00161|KRTAP13-1|TCP10L|CHODL|LIPI|ABCC13|LOC150051|LCA5L|IGSF5|SIK1|LINC00479|ZNF295-AS1|UMODL1-AS1|PLAC4|LINC00189|C21orf91-OT1|LINC00315|LINC00314|KRTAP15-1|DSCR9|DSCR10|D21S2088E|LINC00307|LINC00515|LOC284825|KRTAP13-4|LINC00323|LINC00319|AATBC|POTED|KRTAP7-1|KRTAP8-1|KRTAP11-1|KRTAP19-1|KRTAP13-2|KRTAP13-3|KRTAP23-1|KRTAP6-1|KRTAP6-2|KRTAP6-3|KRTAP19-2|KRTAP19-3|KRTAP19-4|KRTAP19-5|KRTAP19-6|KRTAP19-7|KRTAP20-1|KRTAP20-2|KRTAP21-1|KRTAP21-2|KRTAP22-1|KRTAP20-3|LOC339622|KRTAP12-2|KRTAP12-1|KRTAP10-10|PICSAR|LINC00317|COL18A1-AS1|KRTAP10-4|KRTAP10-6|KRTAP10-7|KRTAP10-9|KRTAP10-1|KRTAP10-11|KRTAP10-2|KRTAP10-5|KRTAP10-8|KRTAP10-3|KRTAP12-3|KRTAP12-4|KRTAP10-12|LINC00320|LOC388813|MIR99AHG|KRTAP26-1|LINC00316|LINC00649|LINC00114|LOC400867|MIRLET7C|MIR125B2|MIR155|MIR99A|MGC39584|LOC642852|GRIK1-AS1|KRTAP24-1|KRTAP27-1|SNORA80A|LINC00163|KRTAP19-8|LINC01548|MIR802|LINC00322|LOC100129027|KRTAP25-1|LOC100133286|KRTAP20-4|TRG-GCC1-5|KRTAP22-2|KRTAP21-3|IL10RB-AS1|GRIK1-AS2|MIR4327|MIR548X|MIR3118-1|MIR3156-3|MIR3197|MIR3687-1|MIR3648-1|ITGB2-AS1|LINC01549|PAXBP1-AS1|LINC00649|LINC01426|LOC100506403|CBR3-AS1|DSCAM-AS1|LINC00159|MIR4760|MIR4759|MIR5692B|LRRC3-AS1|DIP2A-IT1|TTC3-AS1|BRWD1-AS1|SAMSN1-AS1|COL18A1-AS2|BACH1-IT2|DSCAM-IT1|CYYR1-AS1|LINC01436|MIR548XHG|LINC01425|LOC101927843|LOC101927869|LOC101927973|LOC101928107|LOC101928126|C21orf140|LOC101928233|LOC101928269|LOC101928311|LOC101928398|TCONS_00029157|LOC101928435|TRPM2-AS|LINC01424|LOC101928796|LOC101930094|LINC00945|MIR6070|MIR6501|MIR6724-1|MIR6814|MIR6815|MIR6130|MIR6508|KCNE1B|LINC00205|SMIM11B|LOC102724188|LOC102724502|LINC01423|BRWD1-IT2|MIR6724-2|MIR3687-2|MIR3648-2|MIR6724-4|MIR8069-2|MIR6724-3|LOC105372751|LOC105372795|LOC105372833|LOC105377134|LOC105379514|FRGCA|SNORA91|WRB-SH3BGR	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	21	7749532 - 46670546	GRCh38	59226	73821
GRCh38/hg38 21p11.2-q22.3(chr21:7749532-46653090)x3	ADARB1|AIRE|APP|ATP5J|ATP5O|BACH1|PTTG1IP|C21orf2|TMEM50B|RUNX1|CBR1|CBR3|CBS|COL6A1|COL6A2|CRYAA|CSTB|CXADR|DSCAM|RCAN1|DYRK1A|ERG|ETS2|GABPA|GART|GRIK1|HLCS|HMGN1|PRMT2|IFNAR1|IFNAR2|IFNGR2|IL10RB|ITGB2|KCNE1|KCNJ6|KCNJ15|LSS|MX1|MX2|NCAM2|NDUFV3|PCNT|PCP4|PDE9A|PFKL|PKNOX1|TMPRSS15|PWP2|S100B|SH3BGR|ITSN1|SIM2|SLC5A3|SLC19A1|SUMO3|SOD1|SON|HSPA13|TFF1|TFF2|TFF3|TIAM1|TRAPPC10|TMPRSS2|TPTE|TRPM2|TTC3|U2AF1|UBE2G2|WRB|NRIP1|CHAF1B|C21orf33|PDXK|RRP1|PSMG1|SYNJ1|MCM3AP|CLDN8|ADAMTS1|ABCG1|URB1|CRYZL1|DOPEY2|KCNE2|RWDD2B|OLIG2|DSCR4|DSCR3|B3GALT5|USP16|CCT8|WDR4|FTCD|BTG3|HSF2BP|ADAMTS5|RRP1B|DIP2A|POFUT2|ICOSLG|MORC3|CLDN14|BACE2|C2CD2|LTN1|CLDN17|N6AMT1|USP25|DNMT3L|DONSON|HUNK|ZBTB21|PIGP|UBASH3A|RIPPLY3|BRWD1|SLC37A1|RBM11|PCBP3|C21orf58|YBEY|LINC00160|SMIM11A|C21orf62-AS1|MIS18A|LINC00158|CHODL-AS1|TSPEAR-AS1|LRRC3DN|TSPEAR|LINC00113|LINC00112|LINC00111|SETD4|FAM3B|RIPK4|CLIC6|LINC00308|MRPL39|C21orf91|DNAJC28|C21orf62|MRAP|C21orf59|AGPAT3|MAP3K7CL|SCAF4|JAM2|EVA1C|PRDM15|SAMSN1|TMPRSS3|MRPS6|RUNX1-IT1|COL18A1|LRRC3|SPATC1L|LINC01547|DSCR8|URB1-AS1|BAGE2|FAM207A|RSPH1|UMODL1|ERVH48-1|PAXBP1|LINC00310|LINC00313|B3GALT5-AS1|LINC00334|TSPEAR-AS2|MCM3AP-AS1|MIR155HG|CYYR1|OLIG1|LINC00161|KRTAP13-1|TCP10L|CHODL|LIPI|ABCC13|LOC150051|LCA5L|IGSF5|SIK1|LINC00479|ZNF295-AS1|UMODL1-AS1|PLAC4|LINC00189|C21orf91-OT1|LINC00315|LINC00314|KRTAP15-1|DSCR9|DSCR10|D21S2088E|LINC00307|LINC00515|LOC284825|KRTAP13-4|LINC00323|LINC00319|AATBC|POTED|KRTAP7-1|KRTAP8-1|KRTAP11-1|KRTAP19-1|KRTAP13-2|KRTAP13-3|KRTAP23-1|KRTAP6-1|KRTAP6-2|KRTAP6-3|KRTAP19-2|KRTAP19-3|KRTAP19-4|KRTAP19-5|KRTAP19-6|KRTAP19-7|KRTAP20-1|KRTAP20-2|KRTAP21-1|KRTAP21-2|KRTAP22-1|KRTAP20-3|LOC339622|KRTAP12-2|KRTAP12-1|KRTAP10-10|PICSAR|LINC00317|COL18A1-AS1|KRTAP10-4|KRTAP10-6|KRTAP10-7|KRTAP10-9|KRTAP10-1|KRTAP10-11|KRTAP10-2|KRTAP10-5|KRTAP10-8|KRTAP10-3|KRTAP12-3|KRTAP12-4|KRTAP10-12|LINC00320|LOC388813|MIR99AHG|KRTAP26-1|LINC00316|LINC00649|LINC00114|LOC400867|MIRLET7C|MIR125B2|MIR155|MIR99A|MGC39584|LOC642852|GRIK1-AS1|KRTAP24-1|KRTAP27-1|SNORA80A|LINC00163|KRTAP19-8|LINC01548|MIR802|LINC00322|LOC100129027|KRTAP25-1|LOC100133286|KRTAP20-4|TRG-GCC1-5|KRTAP22-2|KRTAP21-3|IL10RB-AS1|GRIK1-AS2|MIR4327|MIR548X|MIR3118-1|MIR3156-3|MIR3197|MIR3687-1|MIR3648-1|ITGB2-AS1|LINC01549|PAXBP1-AS1|LINC00649|LINC01426|LOC100506403|CBR3-AS1|DSCAM-AS1|LINC00159|MIR4760|MIR4759|MIR5692B|LRRC3-AS1|DIP2A-IT1|TTC3-AS1|BRWD1-AS1|SAMSN1-AS1|COL18A1-AS2|BACH1-IT2|DSCAM-IT1|CYYR1-AS1|LINC01436|MIR548XHG|LINC01425|LOC101927843|LOC101927869|LOC101927973|LOC101928107|LOC101928126|C21orf140|LOC101928233|LOC101928269|LOC101928311|LOC101928398|TCONS_00029157|LOC101928435|TRPM2-AS|LINC01424|LOC101928796|LOC101930094|LINC00945|MIR6070|MIR6501|MIR6724-1|MIR6814|MIR6815|MIR6130|MIR6508|KCNE1B|LINC00205|SMIM11B|LOC102724188|LOC102724502|LINC01423|BRWD1-IT2|MIR6724-2|MIR3687-2|MIR3648-2|MIR6724-4|MIR8069-2|MIR6724-3|LOC105372751|LOC105372795|LOC105372833|LOC105377134|LOC105379514|FRGCA|SNORA91|WRB-SH3BGR	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	21	7749532 - 46653090	GRCh38	59222	73817
GRCh38/hg38 21q22.3(chr21:45278163-45430994)x3	POFUT2|COL18A1|LINC00315|COL18A1-AS1|LINC00316|LOC642852|COL18A1-AS2|LINC00205	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	21	45278163 - 45430994	GRCh38	59036	73631
GRCh38/hg38 21p11.2(chr21:7743711-7865746)x3	KCNE1B|SMIM11B	See cases		Uncertain significance(Last reviewed: May 27, 2010)	no assertion criteria provided	21	7743711 - 7865746	GRCh38	34363	43028
GRCh38/hg38 21p11.2-q22.3(chr21:7749532-46670405)x3	ADARB1|AIRE|APP|ATP5J|ATP5O|BACH1|PTTG1IP|C21orf2|TMEM50B|RUNX1|CBR1|CBR3|CBS|COL6A1|COL6A2|CRYAA|CSTB|CXADR|DSCAM|RCAN1|DYRK1A|ERG|ETS2|GABPA|GART|GRIK1|HLCS|HMGN1|PRMT2|IFNAR1|IFNAR2|IFNGR2|IL10RB|ITGB2|KCNE1|KCNJ6|KCNJ15|LSS|MX1|MX2|NCAM2|NDUFV3|PCNT|PCP4|PDE9A|PFKL|PKNOX1|TMPRSS15|PWP2|S100B|SH3BGR|ITSN1|SIM2|SLC5A3|SLC19A1|SUMO3|SOD1|SON|HSPA13|TFF1|TFF2|TFF3|TIAM1|TRAPPC10|TMPRSS2|TPTE|TRPM2|TTC3|U2AF1|UBE2G2|WRB|NRIP1|CHAF1B|C21orf33|PDXK|RRP1|PSMG1|SYNJ1|MCM3AP|CLDN8|ADAMTS1|ABCG1|URB1|CRYZL1|DOPEY2|KCNE2|RWDD2B|OLIG2|DSCR4|DSCR3|B3GALT5|USP16|CCT8|WDR4|FTCD|BTG3|HSF2BP|ADAMTS5|RRP1B|DIP2A|POFUT2|ICOSLG|MORC3|CLDN14|BACE2|C2CD2|LTN1|CLDN17|N6AMT1|USP25|DNMT3L|DONSON|HUNK|ZBTB21|PIGP|UBASH3A|RIPPLY3|BRWD1|SLC37A1|RBM11|PCBP3|C21orf58|YBEY|LINC00160|SMIM11A|C21orf62-AS1|MIS18A|LINC00158|CHODL-AS1|TSPEAR-AS1|LRRC3DN|TSPEAR|LINC00113|LINC00112|LINC00111|SETD4|FAM3B|RIPK4|CLIC6|LINC00308|MRPL39|C21orf91|DNAJC28|C21orf62|MRAP|C21orf59|AGPAT3|MAP3K7CL|SCAF4|JAM2|EVA1C|PRDM15|SAMSN1|TMPRSS3|MRPS6|RUNX1-IT1|COL18A1|LRRC3|SPATC1L|LINC01547|DSCR8|URB1-AS1|BAGE2|FAM207A|RSPH1|UMODL1|ERVH48-1|PAXBP1|LINC00310|LINC00313|B3GALT5-AS1|LINC00334|TSPEAR-AS2|MCM3AP-AS1|MIR155HG|CYYR1|OLIG1|LINC00161|KRTAP13-1|TCP10L|CHODL|LIPI|ABCC13|LOC150051|LCA5L|IGSF5|SIK1|LINC00479|ZNF295-AS1|UMODL1-AS1|PLAC4|LINC00189|C21orf91-OT1|LINC00315|LINC00314|KRTAP15-1|DSCR9|DSCR10|D21S2088E|LINC00307|LINC00515|LOC284825|KRTAP13-4|LINC00323|LINC00319|AATBC|POTED|KRTAP7-1|KRTAP8-1|KRTAP11-1|KRTAP19-1|KRTAP13-2|KRTAP13-3|KRTAP23-1|KRTAP6-1|KRTAP6-2|KRTAP6-3|KRTAP19-2|KRTAP19-3|KRTAP19-4|KRTAP19-5|KRTAP19-6|KRTAP19-7|KRTAP20-1|KRTAP20-2|KRTAP21-1|KRTAP21-2|KRTAP22-1|KRTAP20-3|LOC339622|KRTAP12-2|KRTAP12-1|KRTAP10-10|PICSAR|LINC00317|COL18A1-AS1|KRTAP10-4|KRTAP10-6|KRTAP10-7|KRTAP10-9|KRTAP10-1|KRTAP10-11|KRTAP10-2|KRTAP10-5|KRTAP10-8|KRTAP10-3|KRTAP12-3|KRTAP12-4|KRTAP10-12|LINC00320|LOC388813|MIR99AHG|KRTAP26-1|LINC00316|LINC00649|LINC00114|LOC400867|MIRLET7C|MIR125B2|MIR155|MIR99A|MGC39584|LOC642852|GRIK1-AS1|KRTAP24-1|KRTAP27-1|SNORA80A|LINC00163|KRTAP19-8|LINC01548|MIR802|LINC00322|LOC100129027|KRTAP25-1|LOC100133286|KRTAP20-4|TRG-GCC1-5|KRTAP22-2|KRTAP21-3|IL10RB-AS1|GRIK1-AS2|MIR4327|MIR548X|MIR3118-1|MIR3156-3|MIR3197|MIR3687-1|MIR3648-1|ITGB2-AS1|LINC01549|PAXBP1-AS1|LINC00649|LINC01426|LOC100506403|CBR3-AS1|DSCAM-AS1|LINC00159|MIR4760|MIR4759|MIR5692B|LRRC3-AS1|DIP2A-IT1|TTC3-AS1|BRWD1-AS1|SAMSN1-AS1|COL18A1-AS2|BACH1-IT2|DSCAM-IT1|CYYR1-AS1|LINC01436|MIR548XHG|LINC01425|LOC101927843|LOC101927869|LOC101927973|LOC101928107|LOC101928126|C21orf140|LOC101928233|LOC101928269|LOC101928311|LOC101928398|TCONS_00029157|LOC101928435|TRPM2-AS|LINC01424|LOC101928796|LOC101930094|LINC00945|MIR6070|MIR6501|MIR6724-1|MIR6814|MIR6815|MIR6130|MIR6508|KCNE1B|LINC00205|SMIM11B|LOC102724188|LOC102724502|LINC01423|BRWD1-IT2|MIR6724-2|MIR3687-2|MIR3648-2|MIR6724-4|MIR8069-2|MIR6724-3|LOC105372751|LOC105372795|LOC105372833|LOC105377134|LOC105379514|FRGCA|SNORA91|WRB-SH3BGR	See cases		Pathogenic(Last reviewed: Jul 10, 2013)	no assertion criteria provided	21	7749532 - 46670405	GRCh38	32099	40764
NM_003504.4(CDC45):c.1660C>T (p.Arg554Trp)	CDC45	Meier-gorlin syndrome 7	GO-ESP:0.00003(T)	Pathogenic(Last reviewed: Oct 20, 2016)	no assertion criteria provided	22	19518867	GRCh38	253101	247512
NM_080647.1(TBX1):c.143_145dupCGC (p.Pro48_Arg49insPro)	TBX1	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 26, 2012)	criteria provided, single submitter	22	19761013 - 19761015	GRCh38	263404	259112
NM_080647.1(TBX1):c.297G>A (p.Ala99=)	TBX1	Cardiovascular phenotype	GMAF:0.01040(A), GO-ESP:0.03337(A)	Benign(Last reviewed: Jun 19, 2015)	criteria provided, single submitter	22	19761167	GRCh38	263555	259105
NM_080647.1(TBX1):c.420T>C (p.Phe140=)	TBX1	Cardiovascular phenotype	GMAF:0.22820(C), GO-ESP:0.23525(C)	Benign(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	22	19763250	GRCh38	263350	259109
NM_080647.1(TBX1):c.664C>T (p.Leu222=)	TBX1	Cardiovascular phenotype	GMAF:0.34130(T), GO-ESP:0.28059(T)	Benign(Last reviewed: Jun 26, 2015)	criteria provided, single submitter	22	19764306	GRCh38	263383	259110
NM_080647.1(TBX1):c.933A>G (p.Ala311=)	TBX1	Cardiovascular phenotype	GMAF:0.23060(G), GO-ESP:0.22761(G)	Benign(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	22	19765926	GRCh38	263444	259115
NM_080647.1(TBX1):c.1059A>G (p.Ala353=)	TBX1	Cardiovascular phenotype	GMAF:0.07510(G), GO-ESP:0.07113(G)	Benign(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	22	19766438	GRCh38	263355	259107
NM_080647.1(TBX1):c.1189A>C (p.Asn397His)	TBX1	Cardiovascular phenotype	GMAF:0.23120(C), GO-ESP:0.31153(C)	Benign(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	22	19766568	GRCh38	263351	259113
NM_006440.4(TXNRD2):c.1523G>A (p.Arg508His)	TXNRD2	Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00033(T)	Likely benign(Last reviewed: Feb 3, 2016)	criteria provided, single submitter	22	19877157	GRCh38	263535	259114
NM_006440.4(TXNRD2):c.1514T>A (p.Val505Asp)	TXNRD2	Cardiovascular phenotype	GO-ESP:0.00004(T)	Uncertain significance(Last reviewed: Dec 20, 2015)	criteria provided, single submitter	22	19877166	GRCh38	264602	259116
NM_006440.4(TXNRD2):c.1511T>C (p.Val504Ala)	TXNRD2	Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: May 3, 2013)	criteria provided, single submitter	22	19877169	GRCh38	263607	259111
NM_006440.4(TXNRD2):c.1401C>T (p.Gly467=)	TXNRD2	Cardiovascular phenotype		Likely benign(Last reviewed: Jun 14, 2013)	criteria provided, single submitter	22	19878134	GRCh38	263650	259120
NM_006440.4(TXNRD2):c.1341T>G (p.Tyr447Ter)	TXNRD2	Cardiovascular phenotype	GMAF:0.00060(C), GO-ESP:0.00070(C)	Uncertain significance(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	22	19878372	GRCh38	264269	259117
NM_006440.4(TXNRD2):c.1233C>T (p.Ser411=)	TXNRD2	Primary dilated cardiomyopathy|Cardiovascular phenotype	GMAF:0.00860(A), GO-ESP:0.00274(A)	Benign(Last reviewed: Dec 29, 2015)	criteria provided, multiple submitters, no conflicts	22	19880221	GRCh38	240654	243643
NM_006440.4(TXNRD2):c.1206G>A (p.Pro402=)	TXNRD2	Cardiovascular phenotype	GMAF:0.26920(T), GO-ESP:0.18532(T)	Benign(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	22	19880248	GRCh38	263385	259119
NM_006440.4(TXNRD2):c.1174T>C (p.Tyr392His)	TXNRD2	Cardiovascular phenotype	GO-ESP:0.00037(G)	Uncertain significance(Last reviewed: May 27, 2013)	criteria provided, single submitter	22	19880630	GRCh38	263636	259121
NM_006440.4(TXNRD2):c.1150G>A (p.Gly384Ser)	TXNRD2	Cardiovascular phenotype	GMAF:0.00180(T), GO-ESP:0.00772(T)	Benign(Last reviewed: May 15, 2015)	criteria provided, single submitter	22	19880654	GRCh38	263784	259123
NM_006440.4(TXNRD2):c.1109T>C (p.Ile370Thr)	TXNRD2	Cardiovascular phenotype	GMAF:0.28180(A)	Benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	22	19880695	GRCh38	263369	259118
NM_006440.4(TXNRD2):c.1099C>T (p.Leu367=)	TXNRD2	Cardiovascular phenotype	GMAF:0.01700(A), GO-ESP:0.00709(A)	Benign(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	22	19880705	GRCh38	263358	259128
NM_006440.4(TXNRD2):c.957C>G (p.Val319=)	TXNRD2	Cardiovascular phenotype	GO-ESP:0.00014(C)	Likely benign(Last reviewed: Apr 17, 2013)	criteria provided, single submitter	22	19883454	GRCh38	263587	259122
NM_006440.4(TXNRD2):c.933C>T (p.Thr311=)	TXNRD2	Primary dilated cardiomyopathy|Cardiovascular phenotype	GMAF:0.00060(A), GO-ESP:0.00088(A)	Benign/Likely benign(Last reviewed: Dec 14, 2015)	criteria provided, multiple submitters, no conflicts	22	19895423	GRCh38	240658	243644
NM_006440.4(TXNRD2):c.917C>T (p.Thr306Met)	TXNRD2	Cardiovascular phenotype	GO-ESP:0.00005(A)	Uncertain significance(Last reviewed: Sep 11, 2015)	criteria provided, single submitter	22	19895439	GRCh38	264270	259124
NM_006440.4(TXNRD2):c.903C>T (p.Thr301=)	TXNRD2	Cardiovascular phenotype	GMAF:0.01240(T)	Benign(Last reviewed: May 20, 2013)	criteria provided, single submitter	22	19895453	GRCh38	263603	259127
NM_006440.4(TXNRD2):c.895A>C (p.Ser299Arg)	TXNRD2	Cardiovascular phenotype	GMAF:0.25120(G), GO-ESP:0.18788(G)	Benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	22	19895461	GRCh38	263411	259130
NM_006440.4(TXNRD2):c.763G>C (p.Gly255Arg)	TXNRD2	Cardiovascular phenotype	GMAF:0.00480(G), GO-ESP:0.00200(G)	Benign(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	22	19898050	GRCh38	264489	259125
NM_006440.4(TXNRD2):c.714C>T (p.Thr238=)	TXNRD2	Cardiovascular phenotype	GMAF:0.00020(A), GO-ESP:0.00018(A)	Likely benign(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	22	19898099	GRCh38	264405	259129
NM_006440.4(TXNRD2):c.529-5C>T	TXNRD2	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	22	19915281	GRCh38	264485	259139
NM_006440.4(TXNRD2):c.462C>T (p.Tyr154=)	TXNRD2	Cardiovascular phenotype	GMAF:0.00100(A), GO-ESP:0.00051(A)	Likely benign(Last reviewed: Jul 17, 2013)	criteria provided, single submitter	22	19915831	GRCh38	263667	259135
NM_006440.4(TXNRD2):c.431G>A (p.Arg144His)	TXNRD2	Cardiovascular phenotype	GO-ESP:0.00005(T)	Uncertain significance(Last reviewed: Feb 13, 2013)	criteria provided, single submitter	22	19918161	GRCh38	263503	259126
NM_006440.4(TXNRD2):c.303A>G (p.Ala101=)	TXNRD2	Cardiovascular phenotype	GMAF:0.00020(C), GO-ESP:0.00052(C)	Likely benign(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	22	19918931	GRCh38	264127	259131
NM_006440.4(TXNRD2):c.246C>T (p.Leu82=)	TXNRD2	Cardiovascular phenotype	GMAF:0.16810(A), GO-ESP:0.14628(A)	Benign(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	22	19918988	GRCh38	263409	259140
NM_006440.4(TXNRD2):c.196G>T (p.Ala66Ser)	TXNRD2	Cardiovascular phenotype	GMAF:0.48300(A), GO-ESP:0.44449(A)	Benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	22	19919576	GRCh38	263343	259137
NM_006440.4(TXNRD2):c.177C>T (p.Ala59=)	TXNRD2	Cardiovascular phenotype	GMAF:0.40320(G)	Benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	22	19919595	GRCh38	263370	259134
NM_006440.4(TXNRD2):c.174C>T (p.Ala58=)	TXNRD2	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00004(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jul 21, 2015)	criteria provided, conflicting interpretations	22	19919598	GRCh38	222881	224575
NM_006440.4(TXNRD2):c.110A>T (p.Gln37Leu)	TXNRD2	Primary dilated cardiomyopathy|Cardiovascular phenotype	GMAF:0.00120(A), GO-ESP:0.00316(A)	Benign/Likely benign(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	22	19931092	GRCh38	240653	243648
NM_006440.4(TXNRD2):c.46C>T (p.Arg16Trp)	COMT|TXNRD2	Cardiovascular phenotype	GO-ESP:0.00035(A)	Uncertain significance(Last reviewed: Jul 17, 2013)	criteria provided, single submitter	22	19941758	GRCh38	263690	259132
NM_000754.3(COMT):c.472G>A (p.Val158Met)	COMT	CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM|not specified|nicotine response - Efficacy	GO-ESP:0.45148(A), GMAF:0.36920(A), GO-ESP:0.47275(A)	drug response	reviewed by expert panel	22	19963748	GRCh38	17591	32630
NM_001283106.2(TANGO2):c.4delT (p.Cys2Alafs)	TANGO2	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration		Pathogenic(Last reviewed: Mar 24, 2016)	no assertion criteria provided	22	20036802	GRCh38	224773	226592
NM_152906.5(TANGO2):c.57-1743_*10769del	TANGO2	Cardiac arrhythmia|Intellectual functioning disability|Seizures|Episodic flaccid weakness|Acute rhabdomyolysis|Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration		Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	22	20041612 - 20075431	GRCh38	224770	226589
NM_001283106.2(TANGO2):c.418C>T (p.Arg140Ter)	TANGO2	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	GO-ESP:0.00001(T)	Pathogenic(Last reviewed: Mar 25, 2016)	no assertion criteria provided	22	20055980	GRCh38	224774	226593
NM_152906.6(TANGO2):c.460G>A (p.Gly154Arg)	TANGO2	Cardiac arrhythmia|Intellectual functioning disability|Seizures|Episodic flaccid weakness|Acute rhabdomyolysis|Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	GO-ESP:0.00023(A)	Pathogenic(Last reviewed: Mar 24, 2016)	criteria provided, single submitter	22	20061538	GRCh38	208823	205385
NM_152906.6(TANGO2):c.605+1G>A	TANGO2	Cardiac arrhythmia|Intellectual functioning disability|Seizures|Episodic flaccid weakness|Acute rhabdomyolysis|Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	GO-ESP:0.00032(A)	Pathogenic(Last reviewed: Mar 24, 2016)	criteria provided, single submitter	22	20061684	GRCh38	208824	205386
NM_032608.6(MYO18B):c.6496G>T (p.Glu2166Ter)	MYO18B	not provided		Uncertain significance(Last reviewed: Jun 1, 2015)	no assertion criteria provided	22	26026470	GRCh38	224413	226149
NM_000398.6(CYB5R3):c.218T>C (p.Leu73Pro)	CYB5R3	Methemoglobinemia, type I		Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	22	42631386	GRCh38	246	15285
NM_024105.3(ALG12):c.437G>A (p.Arg146Gln)	ALG12	Congenital disorder of glycosylation type 1G	GO-ESP:0.00015(T), GO-ESP:0.00015(T)	Pathogenic(Last reviewed: Jun 15, 2007)	no assertion criteria provided	22	49910466	GRCh38	3435	18474
NM_001169109.1(SCO2):c.107G>A (p.Trp36Ter)	SCO2|NCAPH2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency		Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	22	50524305	GRCh38	5685	20724
NC_000022.10:g.(?_21074920)_(21440514_?)del	CRKL|SERPIND1|PI4KA|SLC7A4|LZTR1|P2RX6|SNAP29|THAP7|AIFM3	See cases		Likely pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter			GRCh38	253361	247809
NM_152906.5(TANGO2):c.146-3605_451+2245del	TANGO2	Cardiac arrhythmia|Intellectual functioning disability|Seizures|Episodic flaccid weakness|Acute rhabdomyolysis|Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration		Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	22	20048857 - 20058261	GRCh38	224772	226591
NC_000022.10:g.(?_35680095)_(38098981_?)del	CSF2RB|HMOX1|IL2RB|LGALS1|LGALS2|MB|MCM5|MFNG|MPST|MYH9|NCF4|PVALB|RAC2|SSTR3|TST|APOL1|EIF3D|HMGXB4|TOM1|CACNG2|IFT27|TRIOBP|CDC42EP1|RBFOX2|RASD2|SH3BP1|APOL2|TXN2|GGA1|CYTH4|CARD10|PDXP|NOL12|KCTD17|FOXRED2|APOL6|APOL5|APOL4|APOL3|ELFN2|C1QTNF6|TMPRSS6|TEX33	See cases		Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter			GRCh38	221996	223684
GRCh38/hg38 22q11.21(chr22:18339130-20343532)x1	ARVCF|COMT|GP1BB|GSC2|SEPT5|PRODH|RANBP1|SLC25A1|TBX1|CLDN5|HIRA|UFD1L|DGCR6|DVL1P1|CLTCL1|DGCR14|CDC45|DGCR2|TXNRD2|TSSK2|DGCR11|DGCR9|DGCR10|TRMT2A|ZDHHC8|DGCR8|GNB1L|MRPL40|RTN4R|C22orf29|DGCR6L|RIMBP3|C22orf39|TANGO2|LINC00895|LINC00896|LOC284865|CCDC188|MIR185|LOC642643|FAM230A|GGTLC3|TMEM191B|LOC729461|MIR1286|MIR1306|MIR3618|SEPT5-GP1BB|MIR4761|LINC01311|LOC100996432|LOC101927859|MIR6816	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	18339130 - 20343532	GRCh38	161087	170931
GRCh38/hg38 22q11.21(chr22:18178957-21207225)x1	ARVCF|COMT|CRKL|GP1BB|GSC2|SERPIND1|PI4KA|SEPT5|PRODH|RANBP1|SLC7A4|SLC25A1|TBX1|CLDN5|HIRA|UFD1L|ZNF74|DGCR6|DVL1P1|LZTR1|CLTCL1|DGCR14|CDC45|P2RX6|SNAP29|DGCR2|TXNRD2|TSSK2|DGCR11|DGCR9|DGCR10|TRMT2A|ZDHHC8|MED15|DGCR8|GNB1L|MRPL40|RTN4R|C22orf29|THAP7|KLHL22|DGCR6L|RIMBP3|SCARF2|C22orf39|TANGO2|LINC00895|LINC00896|AIFM3|LOC284865|USP41|CCDC188|LRRC74B|BCRP2|MIR185|THAP7-AS1|FAM230B|LOC642643|FAM230A|MIR649|GGTLC3|TMEM191B|LOC729461|MIR1286|MIR1306|MIR3618|SEPT5-GP1BB|MIR4761|LINC01311|LOC100996415|LOC100996432|LOC101927859|LOC101928891|MIR6816	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	18178957 - 21207225	GRCh38	160956	170800
GRCh38/hg38 22q11.21(chr22:18339130-21151128)x1	ARVCF|COMT|CRKL|GP1BB|GSC2|SERPIND1|PI4KA|SEPT5|PRODH|RANBP1|SLC7A4|SLC25A1|TBX1|CLDN5|HIRA|UFD1L|ZNF74|DGCR6|DVL1P1|LZTR1|CLTCL1|DGCR14|CDC45|P2RX6|SNAP29|DGCR2|TXNRD2|TSSK2|DGCR11|DGCR9|DGCR10|TRMT2A|ZDHHC8|MED15|DGCR8|GNB1L|MRPL40|RTN4R|C22orf29|THAP7|KLHL22|DGCR6L|RIMBP3|SCARF2|C22orf39|TANGO2|LINC00895|LINC00896|AIFM3|LOC284865|USP41|CCDC188|LRRC74B|BCRP2|MIR185|THAP7-AS1|LOC642643|FAM230A|MIR649|GGTLC3|TMEM191B|LOC729461|MIR1286|MIR1306|MIR3618|SEPT5-GP1BB|MIR4761|LINC01311|LOC100996432|LOC101927859|LOC101928891|MIR6816	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, multiple submitters, no conflicts	22	18339130 - 21151128	GRCh38	160849	170693
GRCh38/hg38 22q13.32-13.33(chr22:48271979-49315577)x3	FAM19A5|LOC284933|LINC01310|MIR3201|MIR4535	See cases		Uncertain significance(Last reviewed: Dec 17, 2012)	no assertion criteria provided	22	48271979 - 49315577	GRCh38	155249	165003
GRCh38/hg38 22q11.21(chr22:18339130-21447315)x3	ARVCF|COMT|CRKL|GP1BB|GSC2|SERPIND1|PI4KA|SEPT5|PRODH|RANBP1|SLC7A4|SLC25A1|TBX1|CLDN5|HIRA|UFD1L|ZNF74|DGCR6|DVL1P1|LZTR1|CLTCL1|DGCR14|CDC45|P2RX6|SNAP29|DGCR2|TXNRD2|HIC2|TSSK2|DGCR11|DGCR9|DGCR10|TRMT2A|ZDHHC8|MED15|DGCR8|GNB1L|MRPL40|RTN4R|C22orf29|THAP7|KLHL22|DGCR6L|RIMBP3|SCARF2|C22orf39|TANGO2|LINC00895|LINC00896|AIFM3|LOC284865|USP41|CCDC188|LRRC74B|BCRP2|MIR185|THAP7-AS1|RIMBP3B|FAM230B|LOC642643|FAM230A|MIR649|GGTLC3|TMEM191B|GGT2|LOC729461|MIR1286|MIR1306|MIR3618|SEPT5-GP1BB|MIR4761|LINC01311|LOC100996335|LOC100996432|LOC101927859|LOC101928891|MIR6816	See cases		Pathogenic(Last reviewed: Feb 5, 2013)	no assertion criteria provided	22	18339130 - 21447315	GRCh38	154574	164328
GRCh38/hg38 22q13.32-13.33(chr22:48241375-50739836)x1	ACR|ARSA|CHKB|CPT1B|TYMP|MAPK11|MAPK12|SBF1|PPP6R2|ZBED4|SCO2|MLC1|MAPK8IP2|PLXNB2|BRD1|FAM19A5|NCAPH2|MOV10L1|MIOX|PANX2|ALG12|CRELD2|ADM2|TRABD|SELENOO|HDAC10|SHANK3|TUBGCP6|LOC90834|LMF2|KLHDC7B|TTLL8|LOC284933|C22orf34|CHKB-CPT1B|IL17REL|DENND6B|PIM3|ODF3B|SYCE3|LINC01310|CHKB-AS1|MIR3201|MIR3667|MIR4535|MIR6821|LOC105373100	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	22	48241375 - 50739836	GRCh38	154522	164276
GRCh38/hg38 22q11.1-11.21(chr22:16916608-18179006)x4	ATP6V1E1|BID|USP18|IL17RA|BCL2L13|CECR6|CECR5|CECR3|CECR2|TUBA8|CECR1|PEX26|MICAL3|SLC25A18|GAB4|LINC00528|MIR648|CECR7|CECR5-AS1|FLJ41941|MIR3198-1|LOC100996342|LOC100996415|LOC101929372	See cases		Pathogenic(Last reviewed: Jan 14, 2011)	no assertion criteria provided	22	16916608 - 18179006	GRCh38	154503	164257
GRCh38/hg38 22q11.21(chr22:18339130-21151128)x1	ARVCF|COMT|CRKL|GP1BB|GSC2|SERPIND1|PI4KA|SEPT5|PRODH|RANBP1|SLC7A4|SLC25A1|TBX1|CLDN5|HIRA|UFD1L|ZNF74|DGCR6|DVL1P1|LZTR1|CLTCL1|DGCR14|CDC45|P2RX6|SNAP29|DGCR2|TXNRD2|TSSK2|DGCR11|DGCR9|DGCR10|TRMT2A|ZDHHC8|MED15|DGCR8|GNB1L|MRPL40|RTN4R|C22orf29|THAP7|KLHL22|DGCR6L|RIMBP3|SCARF2|C22orf39|TANGO2|LINC00895|LINC00896|AIFM3|LOC284865|USP41|CCDC188|LRRC74B|BCRP2|MIR185|THAP7-AS1|LOC642643|FAM230A|MIR649|GGTLC3|TMEM191B|LOC729461|MIR1286|MIR1306|MIR3618|SEPT5-GP1BB|MIR4761|LINC01311|LOC100996432|LOC101927859|LOC101928891|MIR6816	See cases		Pathogenic(Last reviewed: Feb 4, 2013)	no assertion criteria provided	22	18339130 - 21151128	GRCh38	144408	154159
GRCh38/hg38 22q11.1-11.21(chr22:16916608-20354644)x1	ARVCF|ATP6V1E1|BID|COMT|GP1BB|GSC2|SEPT5|PRODH|RANBP1|SLC25A1|TBX1|CLDN5|HIRA|UFD1L|DGCR6|DVL1P1|CLTCL1|DGCR14|CDC45|DGCR2|TXNRD2|USP18|TSSK2|IL17RA|BCL2L13|DGCR11|DGCR9|DGCR10|TRMT2A|CECR6|CECR5|CECR3|CECR2|ZDHHC8|TUBA8|CECR1|DGCR8|GNB1L|PEX26|MICAL3|MRPL40|RTN4R|C22orf29|SLC25A18|DGCR6L|RIMBP3|GAB4|C22orf39|TANGO2|LINC00895|LINC00896|LINC00528|LOC284865|CCDC188|MIR185|LOC642643|FAM230A|MIR648|GGTLC3|TMEM191B|LOC729461|CECR7|CECR5-AS1|FLJ41941|MIR1286|MIR1306|MIR3198-1|MIR3618|SEPT5-GP1BB|MIR4761|LINC01311|LOC100996342|LOC100996415|LOC100996432|LOC101927859|LOC101929372|MIR6816	See cases		Pathogenic(Last reviewed: Feb 28, 2010)	no assertion criteria provided	22	16916608 - 20354644	GRCh38	144304	154055
GRCh38/hg38 22q11.23(chr22:23369950-24669609)x3	ADORA2A|DDT|GGT1|GGT5|GSTT2|IGLL1|MIF|MMP11|SMARCB1|SNRPD3|ZNF70|SPECC1L|CABIN1|VPREB3|DRICH1|UPB1|SUSD2|SLC2A11|GUCD1|DERL3|C22orf15|RGL4|MIF-AS1|LOC388882|LRRC75B|CHCHD10|BCRP3|ADORA2A-AS1|GSTT2B|DDTL|SPECC1L-ADORA2A|LOC101929374|PCAT14	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	23369950 - 24669609	GRCh38	59343	73938
GRCh38/hg38 22q11.22-11.23(chr22:22660238-23305976)x1	BCR|GNAZ|IGL|IGLC1|IGLC2|IGLC3|RAB36|RSPH14|IGLV4-3|IGLV3-27|IGLV3-25|IGLV3-22|IGLV3-21|IGLV3-19|IGLV3-16|IGLV3-12|IGLV3-10|IGLV3-9|IGLV3-1|IGLV2-23|IGLV2-18|IGLV2-14|IGLV2-11|IGLV2-8|IGLJ7|IGLJ6|IGLJ5|IGLJ4|IGLJ3|IGLJ2|IGLJ1|IGLC7|IGLVVI-22-1|MIR650|IGLL5|MIR5571	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	22660238 - 23305976	GRCh38	59285	73880
GRCh38/hg38 22q11.1-11.21(chr22:11121452-18167952)x3	ATP6V1E1|BID|USP18|IL17RA|POTEH|BCL2L13|CECR6|CECR5|CECR3|CECR2|TUBA8|CECR1|PEX26|MICAL3|OR11H1|SLC25A18|GAB4|CCT8L2|XKR3|LINC00528|MIR648|CECR7|CECR5-AS1|LINC01634|ZNF72P|MIR3198-1|POTEH-AS1|LINC01664|LINC01665|LOC101929372|LOC102723769|LINC01297	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	11121452 - 18167952	GRCh38	59275	73870
GRCh38/hg38 22q11.21-11.23(chr22:21457690-24220231)x1	BCR|BCRP4|DDT|GGT5|GNAZ|GSTT2|IGL|IGLC1|IGLC2|IGLC3|IGLL1|MIF|MMP11|MAPK1|SMARCB1|UBE2L3|VPREB1|ZNF70|TOP3B|RAB36|PPM1F|CABIN1|PRAME|SDF2L1|PPIL2|RSPH14|IGLV11-55|IGLV10-54|IGLV9-49|IGLV8-61|IGLV7-46|IGLV7-43|IGLV6-57|IGLV5-52|IGLV5-48|IGLV5-45|IGLV5-37|IGLV4-69|IGLV4-60|IGLV4-3|IGLV3-32|IGLV3-27|IGLV3-25|IGLV3-22|IGLV3-21|IGLV3-19|IGLV3-16|IGLV3-12|IGLV3-10|IGLV3-9|IGLV3-1|IGLV2-33|IGLV2-23|IGLV2-18|IGLV2-14|IGLV2-11|IGLV2-8|IGLV1-51|IGLV1-50|IGLV1-47|IGLV1-44|IGLV1-40|IGLV1-36|IGLJ7|IGLJ6|IGLJ5|IGLJ4|IGLJ3|IGLJ2|IGLJ1|IGLC7|YPEL1|VPREB3|DRICH1|SUSD2|SLC2A11|IGLVVI-22-1|GGTLC2|DERL3|ZNF280A|ZNF280B|RIMBP3C|YDJC|C22orf15|CCDC116|RGL4|MIF-AS1|LOC388882|CHCHD10|MIR130B|TMEM191C|LL22NC03-63E9.3|PRAMENP|GSTT2B|MIR650|DDTL|MIR301B|IGLL5|MIR5571|LOC101929374|PCAT14|LOC107985532	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	21457690 - 24220231	GRCh38	59264	73859
GRCh38/hg38 22q11.21-11.23(chr22:21454461-24247296)x1	BCR|BCRP4|DDT|GGT5|GNAZ|GSTT2|IGL|IGLC1|IGLC2|IGLC3|IGLL1|MIF|MMP11|MAPK1|SMARCB1|UBE2L3|VPREB1|ZNF70|TOP3B|RAB36|PPM1F|CABIN1|PRAME|SDF2L1|PPIL2|RSPH14|IGLV11-55|IGLV10-54|IGLV9-49|IGLV8-61|IGLV7-46|IGLV7-43|IGLV6-57|IGLV5-52|IGLV5-48|IGLV5-45|IGLV5-37|IGLV4-69|IGLV4-60|IGLV4-3|IGLV3-32|IGLV3-27|IGLV3-25|IGLV3-22|IGLV3-21|IGLV3-19|IGLV3-16|IGLV3-12|IGLV3-10|IGLV3-9|IGLV3-1|IGLV2-33|IGLV2-23|IGLV2-18|IGLV2-14|IGLV2-11|IGLV2-8|IGLV1-51|IGLV1-50|IGLV1-47|IGLV1-44|IGLV1-40|IGLV1-36|IGLJ7|IGLJ6|IGLJ5|IGLJ4|IGLJ3|IGLJ2|IGLJ1|IGLC7|YPEL1|VPREB3|DRICH1|SUSD2|SLC2A11|IGLVVI-22-1|GGTLC2|DERL3|ZNF280A|ZNF280B|RIMBP3C|YDJC|C22orf15|CCDC116|RGL4|MIF-AS1|LOC388882|CHCHD10|MIR130B|TMEM191C|LL22NC03-63E9.3|PRAMENP|GSTT2B|MIR650|DDTL|MIR301B|IGLL5|MIR5571|LOC101929374|PCAT14|LOC107985532	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	21454461 - 24247296	GRCh38	59255	73850
GRCh38/hg38 22q11.21(chr22:20379137-21151128)x1	CRKL|SERPIND1|PI4KA|SLC7A4|ZNF74|LZTR1|P2RX6|SNAP29|MED15|THAP7|KLHL22|SCARF2|AIFM3|USP41|LRRC74B|BCRP2|THAP7-AS1|MIR649|LINC01637	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	20379137 - 21151128	GRCh38	59234	73829
GRCh38/hg38 22q11.21(chr22:18339130-21101267)x1	ARVCF|COMT|CRKL|GP1BB|GSC2|SERPIND1|PI4KA|SEPT5|PRODH|RANBP1|SLC7A4|SLC25A1|TBX1|CLDN5|HIRA|UFD1L|ZNF74|DGCR6|DVL1P1|LZTR1|CLTCL1|DGCR14|CDC45|P2RX6|SNAP29|DGCR2|TXNRD2|TSSK2|DGCR11|DGCR9|DGCR10|TRMT2A|ZDHHC8|MED15|DGCR8|GNB1L|MRPL40|RTN4R|C22orf29|THAP7|KLHL22|DGCR6L|RIMBP3|SCARF2|C22orf39|TANGO2|LINC00895|LINC00896|AIFM3|LOC284865|USP41|CCDC188|LRRC74B|MIR185|THAP7-AS1|LOC642643|FAM230A|MIR649|GGTLC3|TMEM191B|LOC729461|MIR1286|MIR1306|MIR3618|SEPT5-GP1BB|MIR4761|LINC01311|LOC100996432|LOC101927859|LOC101928891|MIR6816	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	18339130 - 21101267	GRCh38	59207	73802
GRCh38/hg38 22q12.3-13.33(chr22:37061769-50738932)x3	ACR|ACO2|ADSL|ARSA|ATF4|BIK|TSPO|MPPED1|CHKB|CPT1B|CSNK1E|CYP2D6|CYB5R3|TYMP|EP300|FBLN1|XRCC6|MCHR1|H1F0|IL2RB|KCNJ4|LGALS1|LGALS2|MFNG|MGAT3|NAGA|NDUFA6|SNU13|PDGFB|PMM1|POLR2F|PPARA|MAPK11|RAC2|RANGAP1|RPL3|MAPK12|SBF1|SOX10|SREBF2|SSTR3|ST13|TCF20|TEF|TRU-TCA2-1|UPK3A|WNT7B|PLA2G6|GALR3|CACNA1I|SYNGR1|GRAP2|PICK1|GTPBP1|APOBEC3B|CELSR1|PPP6R2|ZBED4|JOSD1|RBX1|SCO2|DNAL4|PKDREJ|TAB1|SLC25A17|DDX17|NUP50|TOB2|KDELR3|TRIOBP|CDC42EP1|DMC1|PACSIN2|TNRC6B|GRAMD4|TTLL12|MLC1|ZC3H7B|KIAA0930|GCAT|CBX6|NPTXR|CBX7|SLC16A8|MAPK8IP2|SH3BP1|PLXNB2|MAFF|BRD1|ARHGAP8|TBC1D22A|CBY1|SUN2|TTLL1|SAMM50|ATXN10|FAM19A5|TMEM184B|SULT4A1|GGA1|RIBC2|ARFGAP3|SNORD43|SMC1B|CYTH4|CSDC2|RRP7A|MCAT|APOBEC3C|DESI1|SGSM3|CARD10|PARVB|NCAPH2|EIF3L|GTSE1|A4GALT|MOV10L1|MIEF1|FAM118A|TTC38|PRR34|MIOX|PRR5|TRMU|SEPT3|PANX2|TOMM22|PDXP|MKL1|APOBEC3G|XPNPEP3|PARVG|CERK|EFCAB6|CENPM|ALG12|NOL12|CRELD2|C22orf46|KCTD17|CCDC134|ADM2|BAIAP2L2|SCUBE1|TRABD|PNPLA3|SELENOO|L3MBTL2|HDAC10|LDOC1L|POLDIP3|C22orf23|PHF5A|KIAA1644|SHANK3|MICALL1|TUBGCP6|LOC90834|LMF2|RPS19BP1|SMDT1|SERHL|PHF21B|KLHDC7B|FAM83F|ELFN2|C1QTNF6|TNFRSF13C|SNORD139|SNORD83A|SNORD83B|ANKRD54|APOBEC3D|ENTHD1|DNAJB7|CHADL|MEI1|FAM109B|NFAM1|PNPLA5|PRR34-AS1|CDPF1|GTSE1-AS1|TMPRSS6|APOBEC3H|WBP2NL|TTLL8|POLR3H|APOBEC3A|APOBEC3F|SERHL2|RNU12|ATP5L2|LOC284930|LOC284933|LINC00634|C22orf34|CHKB-CPT1B|LINC00207|MIRLET7BHG|LINC00898|IL17REL|MIRLET7A3|MIRLET7B|MIR33A|LINC00229|DENND6B|PIM3|SHISA8|ODF3B|PRR5-ARHGAP8|TBC1D22A-AS1|SYCE3|FAM227A|MIR658|MIR659|LINC01310|LOC100130899|NDUFA6-AS1|CHKB-AS1|LINC00899|MIR1249|MIR1281|MIR3201|MIR3619|MIR3667|LOC100506271|LOC100506472|LOC100506679|NUP50-AS1|LINC01589|MIR4763|MIR4534|MIR4762|MIR378I|MIR4766|MIR4535|EFCAB6-AS1|APOBEC3B-AS1|LOC101927051|LOC101927257|EP300-AS1|LOC101927447|LOC101927526|LL22NC03-75H12.2|MIR6820|MIR6821|MIR6889|LINC01315|LOC400927-CSNK1E|MGAT3-AS1|LOC105373031|LOC105373044|LOC105373051|LOC105373100|SNORA92|SNORD140	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	37061769 - 50738932	GRCh38	57942	72537
GRCh38/hg38 22q13.2(chr22:40832364-41076954)x1	ST13|RBX1|XPNPEP3|DNAJB7|SNORD140	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	40832364 - 41076954	GRCh38	57634	72229
GRCh38/hg38 22q11.21(chr22:18177786-21101267)x1	ARVCF|COMT|CRKL|GP1BB|GSC2|SERPIND1|PI4KA|SEPT5|PRODH|RANBP1|SLC7A4|SLC25A1|TBX1|CLDN5|HIRA|UFD1L|ZNF74|DGCR6|DVL1P1|LZTR1|CLTCL1|DGCR14|CDC45|P2RX6|SNAP29|DGCR2|TXNRD2|TSSK2|DGCR11|DGCR9|DGCR10|TRMT2A|ZDHHC8|MED15|DGCR8|GNB1L|MRPL40|RTN4R|C22orf29|THAP7|KLHL22|DGCR6L|RIMBP3|SCARF2|C22orf39|TANGO2|LINC00895|LINC00896|AIFM3|LOC284865|USP41|CCDC188|LRRC74B|MIR185|THAP7-AS1|LOC642643|FAM230A|MIR649|GGTLC3|TMEM191B|LOC729461|MIR1286|MIR1306|MIR3618|SEPT5-GP1BB|MIR4761|LINC01311|LOC100996415|LOC100996432|LOC101927859|LOC101928891|MIR6816	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	18177786 - 21101267	GRCh38	57558	72153
GRCh38/hg38 22q11.21(chr22:18177786-21101267)x3	ARVCF|COMT|CRKL|GP1BB|GSC2|SERPIND1|PI4KA|SEPT5|PRODH|RANBP1|SLC7A4|SLC25A1|TBX1|CLDN5|HIRA|UFD1L|ZNF74|DGCR6|DVL1P1|LZTR1|CLTCL1|DGCR14|CDC45|P2RX6|SNAP29|DGCR2|TXNRD2|TSSK2|DGCR11|DGCR9|DGCR10|TRMT2A|ZDHHC8|MED15|DGCR8|GNB1L|MRPL40|RTN4R|C22orf29|THAP7|KLHL22|DGCR6L|RIMBP3|SCARF2|C22orf39|TANGO2|LINC00895|LINC00896|AIFM3|LOC284865|USP41|CCDC188|LRRC74B|MIR185|THAP7-AS1|LOC642643|FAM230A|MIR649|GGTLC3|TMEM191B|LOC729461|MIR1286|MIR1306|MIR3618|SEPT5-GP1BB|MIR4761|LINC01311|LOC100996415|LOC100996432|LOC101927859|LOC101928891|MIR6816	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	22	18177786 - 21101267	GRCh38	57557	72152
GRCh38/hg38 22q11.21(chr22:18339130-21151128)x1	ARVCF|COMT|CRKL|GP1BB|GSC2|SERPIND1|PI4KA|SEPT5|PRODH|RANBP1|SLC7A4|SLC25A1|TBX1|CLDN5|HIRA|UFD1L|ZNF74|DGCR6|DVL1P1|LZTR1|CLTCL1|DGCR14|CDC45|P2RX6|SNAP29|DGCR2|TXNRD2|TSSK2|DGCR11|DGCR9|DGCR10|TRMT2A|ZDHHC8|MED15|DGCR8|GNB1L|MRPL40|RTN4R|C22orf29|THAP7|KLHL22|DGCR6L|RIMBP3|SCARF2|C22orf39|TANGO2|LINC00895|LINC00896|AIFM3|LOC284865|USP41|CCDC188|LRRC74B|BCRP2|MIR185|THAP7-AS1|LOC642643|FAM230A|MIR649|GGTLC3|TMEM191B|LOC729461|MIR1286|MIR1306|MIR3618|SEPT5-GP1BB|MIR4761|LINC01311|LOC100996432|LOC101927859|LOC101928891|MIR6816	See cases		Pathogenic(Last reviewed: Sep 18, 2013)	no assertion criteria provided	22	18339130 - 21151128	GRCh38	32939	41604
NM_004016.2(DMD):c.1845_1857delTGATTTGGGCAGA (p.Asp615Glufs)	DMD	not specified|not provided	GO-ESP:0.00030(-)	Uncertain significance(Last reviewed: Jun 24, 2015)	criteria provided, multiple submitters, no conflicts	X	31121884 - 31121896	GRCh38	201754	198562
NM_004006.2(DMD):c.10940G>A (p.Ser3647Asn)	DMD	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	31134176	GRCh38	263511	259174
NM_004006.2(DMD):c.10789C>T (p.Leu3597=)	DMD	Duchenne muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.00502(A), GMAF:0.00190(A), GO-ESP:0.00472(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	X	31147283	GRCh38	94446	100346
NM_004006.2(DMD):c.9804A>G (p.Gln3268=)	DMD	not specified|Cardiovascular phenotype	GO-ESP:0.00019(C), GO-ESP:0.00040(C)	Benign/Likely benign(Last reviewed: Aug 14, 2015)	criteria provided, multiple submitters, no conflicts	X	31203964	GRCh38	94861	100761
NM_000109.3(DMD):c.9658T>C (p.Phe3220Leu)	DMD	Primary dilated cardiomyopathy|Becker muscular dystrophy|Duchenne muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.00180(G), GMAF:0.00270(G), GO-ESP:0.00071(G)	Likely benign(Last reviewed: Nov 3, 2015)	criteria provided, multiple submitters, no conflicts	X	31204086	GRCh38	94856	100756
NM_004006.2(DMD):c.9486G>A (p.Glu3162=)	DMD	Duchenne muscular dystrophy|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GMAF:0.00030(T), GO-ESP:0.00024(T)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	X	31209575	GRCh38	239614	243791
NM_004006.2(DMD):c.8762A>G (p.His2921Arg)	DMD	Becker muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.02055(C), GMAF:0.01480(C), GO-ESP:0.02629(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	X	31478281	GRCh38	11269	26308
NM_004006.2(DMD):c.8734A>G (p.Asn2912Asp)	DMD	Duchenne muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.03153(C), GMAF:0.03710(C), GO-ESP:0.02224(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	X	31478309	GRCh38	11268	26307
NM_004006.2(DMD):c.8729A>T (p.Glu2910Val)	DMD	Duchenne muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.03030(A), GMAF:0.03580(A), GO-ESP:0.02190(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	X	31478314	GRCh38	11267	26306
NM_004006.2(DMD):c.8226A>G (p.Gln2742=)	DMD	not specified|Cardiovascular phenotype	GO-ESP:0.00019(C)	Conflicting interpretations of pathogenicity(Last reviewed: May 8, 2015)	criteria provided, conflicting interpretations	X	31507445	GRCh38	197992	195153
NM_004006.2(DMD):c.8212T>C (p.Trp2738Arg)	DMD	Cardiovascular phenotype	GO-ESP:0.00005(G)	Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	X	31627678	GRCh38	264464	259175
NM_004006.2(DMD):c.7728T>C (p.Asn2576=)	DMD	not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.16788(G), GMAF:0.18120(G), GO-ESP:0.17125(G)	Benign/Likely benign(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	X	31679519	GRCh38	94776	100676
NM_004006.2(DMD):c.7712G>T (p.Arg2571Leu)	DMD	Cardiovascular phenotype	GO-ESP:0.00002(A)	Uncertain significance(Last reviewed: Jun 19, 2015)	criteria provided, single submitter	X	31679535	GRCh38	264181	259176
NM_000109.3(DMD):c.7547G>A (p.Arg2516His)	DMD	Muscular dystrophy|Cardiovascular phenotype	GMAF:0.00110(T), GO-ESP:0.00037(T)	Likely benign(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	X	31729720	GRCh38	161219	171246
NM_004006.2(DMD):c.7429C>T (p.Arg2477Trp)	DMD	Cardiovascular phenotype	GMAF:0.00030(A), GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	X	31774073	GRCh38	264219	259177
NM_004006.2(DMD):c.7281A>G (p.Leu2427=)	DMD	Cardiovascular phenotype		Likely benign(Last reviewed: Jun 12, 2013)	criteria provided, single submitter	X	31820003	GRCh38	263647	259178
NM_004006.2(DMD):c.7183G>A (p.Ala2395Thr)	DMD	not specified|Cardiovascular phenotype	GO-ESP:0.00142(T), GMAF:0.00030(T), GO-ESP:0.00074(T)	Benign/Likely benign(Last reviewed: Oct 30, 2015)	criteria provided, multiple submitters, no conflicts	X	31836735	GRCh38	94757	100657
NM_004006.2(DMD):c.6463C>T (p.Arg2155Trp)	DMD	Duchenne muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.02661(A), GMAF:0.01300(A), GO-ESP:0.02605(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	31968490	GRCh38	94741	100641
NM_004006.2(DMD):c.6322C>T (p.Arg2108Cys)	DMD	Duchenne muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.01184(A), GMAF:0.01330(A), GO-ESP:0.00374(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32217032	GRCh38	94703	100603
NM_004006.2(DMD):c.5485C>G (p.Gln1829Glu)	DMD	not specified|Cardiovascular phenotype	GMAF:0.00110(C), GO-ESP:0.00064(C)	Uncertain significance(Last reviewed: Feb 2, 2016)	criteria provided, multiple submitters, no conflicts	X	32346044	GRCh38	264026	259180
NM_004006.2(DMD):c.5390T>C (p.Leu1797Pro)	DMD	Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	X	32348464	GRCh38	264304	259179
NM_004006.2(DMD):c.5349G>A (p.Leu1783=)	DMD	Cardiovascular phenotype		Likely benign(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	X	32348505	GRCh38	264114	259181
NM_004006.2(DMD):c.5234G>A (p.Arg1745His)	DMD	not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.33311(T), GMAF:0.46520(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32362879	GRCh38	94657	100557
NM_004006.2(DMD):c.5216C>A (p.Ala1739Glu)	DMD	Cardiovascular phenotype	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: May 18, 2015)	criteria provided, single submitter	X	32362897	GRCh38	264005	259182
NM_004006.2(DMD):c.5048C>G (p.Thr1683Ser)	DMD	Cardiovascular phenotype	GO-ESP:0.00009(C)	Uncertain significance(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	X	32364688	GRCh38	264223	259183
NM_004006.2(DMD):c.5016T>A (p.Asn1672Lys)	DMD	not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.02490(T), GMAF:0.02310(T), GO-ESP:0.00755(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32365029	GRCh38	94648	100548
NM_004006.2(DMD):c.4878G>T (p.Val1626=)	DMD	not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.02481(A), GMAF:0.02280(A), GO-ESP:0.00757(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32365167	GRCh38	94642	100542
NM_004006.2(DMD):c.4684A>G (p.Arg1562Gly)	DMD	Cardiovascular phenotype	GO-ESP:0.00009(C)	Uncertain significance(Last reviewed: Feb 21, 2016)	criteria provided, single submitter	X	32380671	GRCh38	263352	259190
NM_004006.2(DMD):c.4233+2C>T	DMD	not specified|Cardiovascular phenotype	GO-ESP:0.00028(A), GMAF:0.00050(A), GO-ESP:0.00052(A)	Benign/Likely benign(Last reviewed: Sep 11, 2015)	criteria provided, multiple submitters, no conflicts	X	32411750	GRCh38	94616	100516
NM_004006.2(DMD):c.4162T>G (p.Phe1388Val)	DMD	not specified|Dilated cardiomyopathy 3B|not provided|Cardiovascular phenotype	GO-ESP:0.03305(C), GMAF:0.02810(C), GO-ESP:0.00978(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32411823	GRCh38	94615	100515
NM_004006.2(DMD):c.4125T>C (p.Thr1375=)	DMD	not specified|Cardiovascular phenotype	GO-ESP:0.00095(G), GMAF:0.00050(G), GO-ESP:0.00031(G)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2015)	criteria provided, conflicting interpretations	X	32411860	GRCh38	94613	100513
NM_004006.2(DMD):c.3970C>T (p.Arg1324Cys)	DMD	not specified|Cardiovascular phenotype	GO-ESP:0.00294(A), GMAF:0.00110(A), GO-ESP:0.00080(A)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2015)	criteria provided, conflicting interpretations	X	32438342	GRCh38	94608	100508
NM_004006.2(DMD):c.3734C>T (p.Thr1245Ile)	DMD	not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.00758(A), GMAF:0.00850(A), GO-ESP:0.01487(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32448508	GRCh38	94604	100504
NM_004006.2(DMD):c.3406A>T (p.Thr1136Ser)	DMD	not specified|Dilated cardiomyopathy 3B|Dilated cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00057(A), GMAF:0.01700(A), GO-ESP:0.01465(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32463465	GRCh38	94587	100487
NM_004006.2(DMD):c.3360G>A (p.Glu1120=)	DMD	Cardiovascular phenotype	GO-ESP:0.00020(T)	Likely benign(Last reviewed: Dec 10, 2012)	criteria provided, single submitter	X	32463511	GRCh38	263440	259185
NM_004006.2(DMD):c.3021G>A (p.Ser1007=)	DMD	Duchenne muscular dystrophy|not specified|Cardiovascular phenotype	GO-ESP:0.01203(T), GMAF:0.00870(T), GO-ESP:0.01273(T)	Benign(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	X	32468639	GRCh38	94548	100448
NM_004006.2(DMD):c.2884C>G (p.Leu962Val)	DMD	Cardiovascular phenotype	GO-ESP:0.00013(C)	Uncertain significance(Last reviewed: Aug 19, 2015)	criteria provided, single submitter	X	32472229	GRCh38	264229	259186
NM_004006.2(DMD):c.2575A>T (p.Thr859Ser)	DMD	not specified|Cardiovascular phenotype	GMAF:0.00030(A), GO-ESP:0.00010(A)	Uncertain significance(Last reviewed: Apr 21, 2015)	criteria provided, multiple submitters, no conflicts	X	32491324	GRCh38	195494	192655
NM_004006.2(DMD):c.2391T>G (p.Asn797Lys)	DMD	Duchenne muscular dystrophy|not specified|Dilated cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00597(C), GMAF:0.00290(C), GO-ESP:0.00767(C)	Benign(Last reviewed: Mar 8, 2016)	criteria provided, multiple submitters, no conflicts	X	32491508	GRCh38	94510	100410
NM_004006.2(DMD):c.2323A>G (p.Arg775Gly)	DMD	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32501812	GRCh38	263717	259184
NM_004006.2(DMD):c.2222T>C (p.Val741Ala)	DMD	Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	X	32518078	GRCh38	264364	259194
NM_004006.2(DMD):c.2143A>T (p.Thr715Ser)	DMD	Duchenne muscular dystrophy|not specified|Cardiovascular phenotype	GO-ESP:0.00549(A), GMAF:0.00740(A), GO-ESP:0.00208(A)	Benign(Last reviewed: Dec 19, 2015)	criteria provided, multiple submitters, no conflicts	X	32545184	GRCh38	94494	100394
NM_004006.2(DMD):c.2017C>T (p.Gln673Ter)	DMD	Duchenne muscular dystrophy		Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	X	32545310	GRCh38	11233	26272
NM_004006.2(DMD):c.1997C>T (p.Ser666Leu)	DMD	Duchenne muscular dystrophy|not specified|Cardiovascular phenotype	GO-ESP:0.00578(A), GMAF:0.00500(A), GO-ESP:0.00143(A)	Benign(Last reviewed: Feb 24, 2016)	criteria provided, multiple submitters, no conflicts	X	32545330	GRCh38	94487	100387
NM_004006.2(DMD):c.1888A>G (p.Thr630Ala)	DMD	not specified|Cardiovascular phenotype	GMAF:0.00050(C), GO-ESP:0.00155(C)	Benign/Likely benign(Last reviewed: Nov 21, 2015)	criteria provided, multiple submitters, no conflicts	X	32565806	GRCh38	201730	198591
NM_004006.2(DMD):c.1882_1884delCTT (p.Leu628del)	DMD	Cardiovascular phenotype	GO-ESP:0.00001(-)	Uncertain significance(Last reviewed: Sep 10, 2013)	criteria provided, single submitter	X	32565810 - 32565812	GRCh38	263735	259191
NM_004006.2(DMD):c.1869C>T (p.Leu623=)	DMD	not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.04005(A), GO-ESP:0.01141(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32565825	GRCh38	94482	100382
NM_004006.2(DMD):c.1718C>T (p.Ala573Val)	DMD	not specified|Cardiovascular phenotype	GMAF:0.00500(A), GO-ESP:0.00146(A)	Benign(Last reviewed: Jan 13, 2015)	criteria provided, multiple submitters, no conflicts	X	32573624	GRCh38	226566	231274
NM_004006.2(DMD):c.1704+3G>A	DMD	Cardiovascular phenotype	GO-ESP:0.00006(T)	Uncertain significance(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	X	32573742	GRCh38	263801	259188
NM_004006.2(DMD):c.1635A>G (p.Arg545=)	DMD	not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.13351(C), GMAF:0.11050(C), GO-ESP:0.11654(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32573814	GRCh38	94476	100376
NM_004006.2(DMD):c.1603-4C>G	DMD	Cardiovascular phenotype	GMAF:0.00030(T)	Uncertain significance(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	X	32573850	GRCh38	264085	259187
NM_004006.2(DMD):c.1554T>A (p.Asp518Glu)	DMD	Duchenne muscular dystrophy|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.01269(T), GMAF:0.01250(T), GO-ESP:0.00381(T)	Benign(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	X	32595805	GRCh38	94473	100373
NM_004006.2(DMD):c.1382A>G (p.Asn461Ser)	DMD	Cardiovascular phenotype	GO-ESP:0.00004(C)	Uncertain significance(Last reviewed: May 27, 2013)	criteria provided, single submitter	X	32614403	GRCh38	263605	259198
NM_004006.2(DMD):c.1337A>G (p.His446Arg)	DMD	Primary dilated cardiomyopathy|not provided|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00009(C), GO-ESP:0.00032(C)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2015)	criteria provided, conflicting interpretations	X	32614448	GRCh38	94461	100361
NM_004006.2(DMD):c.837G>A (p.Thr279=)	DMD	not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.17613(T), GMAF:0.15100(T), GO-ESP:0.08661(T)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32697993	GRCh38	94805	100705
NM_004006.2(DMD):c.835A>G (p.Thr279Ala)	DMD	Dilated cardiomyopathy 3B		Pathogenic(Last reviewed: May 20, 1997)	no assertion criteria provided	X	32697995	GRCh38	11279	26318
NM_004006.2(DMD):c.802T>C (p.Leu268=)	DMD	Duchenne muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype	GO-ESP:0.00009(G), GMAF:0.00950(G), GO-ESP:0.00658(G)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	32699141	GRCh38	94784	100684
NM_004006.2(DMD):c.694A>C (p.Ile232Leu)	DMD	Cardiovascular phenotype	GO-ESP:0.00001(G)	Uncertain significance(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	X	32699249	GRCh38	264201	259195
NM_004006.2(DMD):c.74T>C (p.Val25Ala)	DMD	not specified|Cardiovascular phenotype		Uncertain significance(Last reviewed: Sep 25, 2016)	criteria provided, multiple submitters, no conflicts	X	33020158	GRCh38	264149	259192
NM_017745.5(BCOR):c.254C>T (p.Pro85Leu)	BCOR	Oculofaciocardiodental syndrome		Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	X	40075092	GRCh38	10911	25950
NM_019056.6(NDUFB11):c.262C>T (p.Arg88Ter)	NDUFB11	Infantile histiocytoid cardiomyopathy|not provided|Linear skin defects with multiple congenital anomalies 3		Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	X	47142690	GRCh38	190302	188131
NM_005120.2(MED12):c.492T>C (p.Cys164=)	MED12	Cardiovascular phenotype		Likely benign(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	X	71120109	GRCh38	264453	259189
NM_005120.2(MED12):c.653C>T (p.Thr218Met)	MED12	not specified|Cardiovascular phenotype	GMAF:0.00050(T), GO-ESP:0.00015(T)	Uncertain significance(Last reviewed: Nov 13, 2015)	criteria provided, multiple submitters, no conflicts	X	71121070	GRCh38	197770	194931
NM_005120.2(MED12):c.934G>C (p.Val312Leu)	MED12	not specified|Cardiovascular phenotype	GO-ESP:0.00013(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2015)	criteria provided, conflicting interpretations	X	71121649	GRCh38	129589	135035
NM_005120.2(MED12):c.2259G>A (p.Arg753=)	MED12	not specified|Cardiovascular phenotype	GO-ESP:0.02145(A), GMAF:0.02280(A), GO-ESP:0.00624(A)	Benign(Last reviewed: Jul 20, 2015)	criteria provided, multiple submitters, no conflicts	X	71125383	GRCh38	129590	135036
NM_005120.2(MED12):c.2982C>T (p.Ser994=)	MED12	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	X	71127893	GRCh38	264382	259199
NM_005120.2(MED12):c.3204C>T (p.Pro1068=)	MED12	FG syndrome|not specified|Cardiovascular phenotype	GMAF:0.00030(T), GO-ESP:0.00158(T)	Benign/Likely benign(Last reviewed: Mar 8, 2016)	criteria provided, multiple submitters, no conflicts	X	71128115	GRCh38	167284	177831
NM_005120.2(MED12):c.4115A>G (p.Asn1372Ser)	MED12	not specified|Cardiovascular phenotype	GO-ESP:0.00009(G)	Uncertain significance(Last reviewed: Sep 4, 2015)	criteria provided, multiple submitters, no conflicts	X	71131617	GRCh38	213623	210566
NM_005120.2(MED12):c.4179A>C (p.Ser1393=)	MED12	not specified|Cardiovascular phenotype	GO-ESP:0.00005(C)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 25, 2015)	criteria provided, conflicting interpretations	X	71132132	GRCh38	211475	209160
NM_005120.2(MED12):c.4253+4G>A	MED12	Cardiovascular phenotype	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Dec 20, 2015)	criteria provided, single submitter	X	71132210	GRCh38	264566	259197
NM_005120.2(MED12):c.4650C>T (p.Ser1550=)	MED12	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 24, 2015)	criteria provided, single submitter	X	71134389	GRCh38	264188	259193
NM_005120.2(MED12):c.5535C>T (p.Asn1845=)	MED12	not specified|Cardiovascular phenotype	GO-ESP:0.00080(T), GMAF:0.02230(T)	Benign/Likely benign(Last reviewed: Nov 25, 2014)	criteria provided, multiple submitters, no conflicts	X	71137013	GRCh38	95254	101153
NM_005120.2(MED12):c.5650G>A (p.Gly1884Ser)	MED12	FG syndrome|not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00681(A), GMAF:0.00720(A), GO-ESP:0.00211(A)	Benign/Likely benign, not provided(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	X	71137285	GRCh38	129593	135039
NM_005120.2(MED12):c.5711C>T (p.Ala1904Val)	MED12	not specified|not provided|Cardiovascular phenotype	GO-ESP:0.00143(T), GMAF:0.00030(T), GO-ESP:0.00106(T)	Likely benign(Last reviewed: Jan 18, 2016)	criteria provided, multiple submitters, no conflicts	X	71137346	GRCh38	95255	101154
NM_005120.2(MED12):c.6168A>G (p.Gln2056=)	MED12	Cardiovascular phenotype		Likely benign(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	X	71140758	GRCh38	264561	259196
NM_005120.2(MED12):c.6201A>G (p.Gln2067=)	MED12	Cardiovascular phenotype	GO-ESP:0.00015(G)	Likely benign(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	X	71140791	GRCh38	263958	259200
NM_005120.2(MED12):c.6226_6228dupCAG (p.Gln2076_Tyr2077insGln)	MED12	not specified|Cardiovascular phenotype		Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2015)	criteria provided, conflicting interpretations	X	71140816 - 71140818	GRCh38	166875	177599
NM_005096.3(ZMYM3):c.1321C>T (p.Arg441Trp)	ZMYM3	not provided		Uncertain significance(Last reviewed: Apr 11, 2014)	no assertion criteria provided	X	71249610	GRCh38	127192	132676
NM_000169.2(GLA):c.982G>A (p.Gly328Arg)	GLA|RPL36A-HNRNPH2	Fabry disease		Pathogenic(Last reviewed: Apr 1, 1992)	no assertion criteria provided	X	101398387	GRCh38	10722	25761
NM_000169.2(GLA):c.937G>T (p.Asp313Tyr)	GLA|RPL36A-HNRNPH2	Fabry disease|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Sudden unexplained death	GO-ESP:0.00293(A), GMAF:0.00210(A), GO-ESP:0.00313(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2016)	criteria provided, conflicting interpretations	X	101398432	GRCh38	10738	25777
NM_000169.2(GLA):c.902G>A (p.Arg301Gln)	GLA|RPL36A-HNRNPH2	Fabry disease|Fabry disease, cardiac variant|Cardiovascular phenotype		Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, multiple submitters, no conflicts	X	101398467	GRCh38	10715	25754
NM_000169.2(GLA):c.888G>A (p.Met296Ile)	GLA|RPL36A-HNRNPH2	Fabry disease, cardiac variant		Pathogenic(Last reviewed: Aug 3, 1995)	no assertion criteria provided	X	101398481	GRCh38	10763	25802
NM_000169.2(GLA):c.886A>G (p.Met296Val)	GLA|RPL36A-HNRNPH2	Fabry disease|Fabry disease, cardiac variant		Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	X	101398483	GRCh38	10717	25756
NM_000169.2(GLA):c.835C>G (p.Gln279Glu)	GLA|RPL36A-HNRNPH2	Fabry disease, cardiac variant|not provided		Pathogenic(Last reviewed: Jul 10, 2014)	criteria provided, single submitter	X	101398534	GRCh38	10721	25760
NM_000169.2(GLA):c.815A>G (p.Asn272Ser)	GLA|RPL36A-HNRNPH2	Fabry disease		Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	X	101398554	GRCh38	10774	25813
NM_000169.2(GLA):c.639+919G>A	GLA|RPL36A-HNRNPH2	Fabry disease|Fabry disease, cardiac variant		Pathogenic(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	X	101399747	GRCh38	10768	25807
NM_000169.2(GLA):c.416A>G (p.Asn139Ser)	GLA|RPL36A-HNRNPH2	Cardiovascular phenotype	GO-ESP:0.00031(C)	Uncertain significance(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	X	101401763	GRCh38	222253	224055
NM_000169.2(GLA):c.295dupC (p.Gln99Profs)	GLA|RPL36A-HNRNPH2	Fabry disease|Cardiovascular phenotype		Pathogenic(Last reviewed: Feb 3, 2016)	criteria provided, multiple submitters, no conflicts	X	101403885	GRCh38	264377	259141
NM_000169.2(GLA):c.213G>A (p.Glu71=)	GLA|RPL36A-HNRNPH2	Cardiovascular phenotype		Likely benign(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	X	101403967	GRCh38	264386	259138
NM_000169.2(GLA):c.58G>C (p.Ala20Pro)	GLA|RPL36A-HNRNPH2	Fabry disease, cardiac variant		Pathogenic(Last reviewed: Aug 3, 1995)	no assertion criteria provided	X	101407846	GRCh38	10764	25803
NM_032946.2(NXF5):c.337C>T (p.Arg113Trp)	NXF5	Focal segmental glomerulosclerosis	GO-ESP:0.00019(A), GO-ESP:0.00044(A)	Uncertain significance(Last reviewed: Sep 15, 2013)	no assertion criteria provided	X	101841315	GRCh38	88735	94312
NM_018466.5(ALG13):c.421_422delACinsTT (p.Thr141Leu)	ALG13	Focal segmental glomerulosclerosis		Uncertain significance(Last reviewed: Sep 15, 2013)	no assertion criteria provided	X	111687924 - 111687925	GRCh38	88736	94313
NM_002294.2(LAMP2):c.1117_1119delGAC (p.Asp373del)	LAMP2	not specified	GO-ESP:0.00002(-)	Uncertain significance(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	X	120431437 - 120431439	GRCh38	180889	179883
NM_002294.2(LAMP2):c.1091C>T (p.Thr364Ile)	LAMP2	Cardiovascular phenotype	GMAF:0.00080(A), GO-ESP:0.00006(A)	Uncertain significance(Last reviewed: Oct 10, 2012)	criteria provided, single submitter	X	120441732	GRCh38	263405	259136
NM_002294.2(LAMP2):c.1069G>A (p.Val357Met)	LAMP2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Oct 28, 2013)	criteria provided, single submitter	X	120441754	GRCh38	263725	259133
NM_002294.2(LAMP2):c.927C>T (p.Ser309=)	LAMP2	Danon disease|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.02869(A), GMAF:0.01330(A), GO-ESP:0.02746(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	120442600	GRCh38	44445	53612
NM_002294.2(LAMP2):c.887T>G (p.Leu296Arg)	LAMP2	Cardiovascular phenotype		Uncertain significance(Last reviewed: Dec 10, 2012)	criteria provided, single submitter	X	120442640	GRCh38	263458	259142
NM_002294.2(LAMP2):c.755T>G (p.Ile252Ser)	LAMP2	not specified|Cardiovascular phenotype	GO-ESP:0.00170(C), GMAF:0.00050(C), GO-ESP:0.00104(C)	Benign/Likely benign(Last reviewed: Apr 14, 2015)	criteria provided, multiple submitters, no conflicts	X	120446414	GRCh38	44437	53604
NM_002294.2(LAMP2):c.586A>T (p.Thr196Ser)	LAMP2	not specified	GO-ESP:0.00047(A), GMAF:0.00030(A), GO-ESP:0.00024(A)	Conflicting interpretations of pathogenicity(Last reviewed: Aug 25, 2016)	criteria provided, conflicting interpretations	X	120447996	GRCh38	44432	53599
NM_001122606.1(LAMP2):c.520C>T (p.Gln174Ter)	LAMP2	Danon disease		Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	X	120449006	GRCh38	9981	25020
NM_002294.2(LAMP2):c.339C>T (p.Ser113=)	LAMP2	Danon disease|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00066(A), GO-ESP:0.00062(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	X	120455415	GRCh38	44426	53593
NM_002294.2(LAMP2):c.300G>C (p.Ala100=)	LAMP2	Cardiovascular phenotype	GMAF:0.00030(T)	Likely benign(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	X	120455454	GRCh38	264467	259144
NM_002294.2(LAMP2):c.183T>C (p.Tyr61=)	LAMP2	Cardiovascular phenotype	GO-ESP:0.00005(G)	Uncertain significance(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	X	120456651	GRCh38	264545	259143
NM_002294.2(LAMP2):c.156A>T (p.Val52=)	LAMP2	Danon disease|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.39856(A), GMAF:0.38090(A), GO-ESP:0.42800(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	120456678	GRCh38	44416	53583
NM_001008222.2(ZDHHC9):c.167+5G>C	ZDHHC9	Mental retardation, X-linked, syndromic, raymond type		Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	X	129841774	GRCh38	10710	25749
NM_001159702.2(FHL1):c.367C>T (p.His123Tyr)	FHL1	Myopathy, reducing body, X-linked, early-onset, severe		Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	X	136207827	GRCh38	11550	26589
NM_001159702.2(FHL1):c.369C>G (p.His123Gln)	FHL1	Myopathy, reducing body, X-linked, early-onset, severe		Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	X	136207829	GRCh38	11562	26601
NM_001159702.2(FHL1):c.625T>C (p.Cys209Arg)	FHL1	Emery-Dreifuss muscular dystrophy 6		Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	X	136208578	GRCh38	11557	26596
NM_001159702.2(FHL1):c.838G>A (p.Val280Met)	FHL1	Myopathy with postural muscle atrophy, X-linked		Pathogenic(Last reviewed: Aug 18, 2009)	no assertion criteria provided	X	136209392	GRCh38	11559	26598
NM_001449.4(FHL1):c.841T>G (p.Ter281Glu)	FHL1	Emery-Dreifuss muscular dystrophy 6		Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	X	136210023	GRCh38	11556	26595
NM_003413.3(ZIC3):c.763T>G (p.Trp255Gly)	ZIC3	Heterotaxy, visceral, X-linked		Pathogenic(Last reviewed: Nov 15, 2008)	no assertion criteria provided	X	137567454	GRCh38	11441	26480
NM_003413.3(ZIC3):c.1222A>T (p.Lys408Ter)	ZIC3	Congenital heart defects, multiple types, 1, X-linked		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	X	137569063	GRCh38	11435	26474
NM_001456.3(FLNA):c.7917_7918delCT (p.Ter2640Serfs)	FLNA	not provided		Pathogenic(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	X	154348851 - 154348852	GRCh38	213498	210455
NM_001110556.1(FLNA):c.7896G>A (p.Trp2632Ter)	FLNA	X-linked periventricular heterotopia		Pathogenic(Last reviewed: Jan 1, 2010)	criteria provided, single submitter	X	154348897	GRCh38	29928	38883
NM_001456.3(FLNA):c.7772C>A (p.Thr2591Asn)	FLNA	Cardiovascular phenotype	GO-ESP:0.00001(T)	Uncertain significance(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	X	154348997	GRCh38	264331	259146
NM_001456.3(FLNA):c.7662C>T (p.Ala2554=)	FLNA	not specified|Cardiovascular phenotype	GMAF:0.00240(A), GO-ESP:0.00086(A)	Benign(Last reviewed: Dec 2, 2015)	criteria provided, multiple submitters, no conflicts	X	154349432	GRCh38	197542	194703
NM_001456.3(FLNA):c.7584C>T (p.Asp2528=)	FLNA	Cardiovascular phenotype		Likely benign(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	X	154349510	GRCh38	264415	259145
NM_001456.3(FLNA):c.7580T>C (p.Val2527Ala)	FLNA	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	X	154349514	GRCh38	264256	259147
NM_001456.3(FLNA):c.7410G>A (p.Glu2470=)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.01350(T), GMAF:0.01110(T), GO-ESP:0.00429(T)	Benign(Last reviewed: Feb 3, 2015)	criteria provided, multiple submitters, no conflicts	X	154349767	GRCh38	129077	134523
NM_001456.3(FLNA):c.7377C>T (p.Asp2459=)	FLNA	Cardiovascular phenotype		Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	X	154349800	GRCh38	264226	259148
NM_001456.3(FLNA):c.7281C>T (p.Tyr2427=)	FLNA	Cardiovascular phenotype	GO-ESP:0.00004(A)	Likely benign(Last reviewed: Sep 6, 2015)	criteria provided, single submitter	X	154350059	GRCh38	264309	259155
NM_001456.3(FLNA):c.7200C>T (p.Gly2400=)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.02788(A), GMAF:0.02730(A), GO-ESP:0.00779(A)	Benign/Likely benign(Last reviewed: Dec 13, 2014)	criteria provided, multiple submitters, no conflicts	X	154350140	GRCh38	129076	134522
NM_001456.3(FLNA):c.7017C>G (p.Val2339=)	FLNA	Cardiovascular phenotype		Likely benign(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	X	154351024	GRCh38	264083	259149
NM_001456.3(FLNA):c.6912C>T (p.Asn2304=)	FLNA	Cardiovascular phenotype	GO-ESP:0.00005(A)	Likely benign(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	X	154351668	GRCh38	264582	259150
NM_001456.3(FLNA):c.6618G>C (p.Val2206=)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.06075(G), GMAF:0.05830(G), GO-ESP:0.01762(G)	Benign/Likely benign(Last reviewed: Apr 20, 2015)	criteria provided, multiple submitters, no conflicts	X	154352308	GRCh38	93770	99673
NM_001456.3(FLNA):c.6326A>G (p.Asn2109Ser)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.00015(C)	Uncertain significance(Last reviewed: Jan 28, 2016)	criteria provided, multiple submitters, no conflicts	X	154352801	GRCh38	213481	210471
NM_001456.3(FLNA):c.6300C>T (p.Pro2100=)	FLNA	Cardiovascular phenotype	GO-ESP:0.00004(A)	Likely benign(Last reviewed: May 20, 2015)	criteria provided, single submitter	X	154352827	GRCh38	264016	259151
NM_001456.3(FLNA):c.5948C>T (p.Ser1983Leu)	FLNA	X-linked periventricular heterotopia|Melnick-Needles syndrome|Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia|not specified|Cardiovascular phenotype	GO-ESP:0.00248(A), GMAF:0.00190(A), GO-ESP:0.00256(A)	Benign/Likely benign(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	X	154353346	GRCh38	93767	99670
NM_001456.3(FLNA):c.5883C>T (p.Ala1961=)	FLNA	Cardiovascular phenotype	GMAF:0.00030(A), GO-ESP:0.00025(A)	Likely benign(Last reviewed: Aug 30, 2015)	criteria provided, single submitter	X	154353411	GRCh38	264286	259156
NM_001456.3(FLNA):c.5635A>G (p.Thr1879Ala)	FLNA	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	X	154353942	GRCh38	264261	259152
NM_001456.3(FLNA):c.5565C>T (p.Val1855=)	FLNA	not provided|Cardiovascular phenotype	GMAF:0.00030(A), GO-ESP:0.00042(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 4, 2015)	criteria provided, conflicting interpretations	X	154354012	GRCh38	129063	134509
NM_001456.3(FLNA):c.5550C>T (p.Phe1850=)	FLNA	Cardiovascular phenotype		Likely benign(Last reviewed: Apr 25, 2015)	criteria provided, single submitter	X	154354027	GRCh38	263996	259153
NM_001110556.1(FLNA):c.5182G>T (p.Gly1728Cys)	FLNA	Otopalatodigital spectrum disorder		Pathogenic(Last reviewed: May 15, 2006)	no assertion criteria provided	X	154354860	GRCh38	11768	26807
NM_001456.3(FLNA):c.5116G>A (p.Ala1706Thr)	FLNA	Cardiovascular phenotype		Uncertain significance(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	X	154354902	GRCh38	264252	259160
NM_001110556.1(FLNA):c.4866C>T (p.Tyr1622=)	FLNA	not specified|Cardiovascular phenotype	GMAF:0.00050(A), GO-ESP:0.00079(A)	Benign/Likely benign(Last reviewed: Aug 3, 2015)	criteria provided, multiple submitters, no conflicts	X	154357513	GRCh38	190196	188021
NM_001456.3(FLNA):c.4726G>A (p.Gly1576Arg)	FLNA	Cardiac valvular dysplasia, X-linked		Likely pathogenic(Last reviewed: Oct 15, 2013)	criteria provided, single submitter	X	154358228	GRCh38	209154	205799
NM_001456.3(FLNA):c.4669A>G (p.Thr1557Ala)	FLNA	Cardiovascular phenotype	GO-ESP:0.00011(C)	Uncertain significance(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	X	154358285	GRCh38	263965	259157
NM_001456.3(FLNA):c.4533T>C (p.Tyr1511=)	FLNA	Cardiovascular phenotype	GMAF:0.00080(G), GO-ESP:0.00014(G)	Likely benign(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	X	154358510	GRCh38	264353	259154
NM_001456.3(FLNA):c.4233G>A (p.Ser1411=)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.00274(T), GMAF:0.00370(T), GO-ESP:0.00118(T)	Benign/Likely benign(Last reviewed: Dec 2, 2015)	criteria provided, multiple submitters, no conflicts	X	154359316	GRCh38	129073	134519
NM_001456.3(FLNA):c.4208T>G (p.Met1403Arg)	FLNA	Cardiovascular phenotype		Uncertain significance(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	X	154359341	GRCh38	264491	259162
NM_001456.3(FLNA):c.3995A>G (p.Asp1332Gly)	FLNA	Cardiovascular phenotype	GO-ESP:0.00015(C)	Uncertain significance(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	X	154359631	GRCh38	264534	259161
NM_001456.3(FLNA):c.3915G>A (p.Thr1305=)	FLNA	X-linked periventricular heterotopia|Melnick-Needles syndrome|Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia|not specified|Cardiovascular phenotype	GO-ESP:0.00036(T)	Benign/Likely benign(Last reviewed: Mar 27, 2016)	criteria provided, multiple submitters, no conflicts	X	154359796	GRCh38	137386	141089
NM_001456.3(FLNA):c.3756G>A (p.Ala1252=)	FLNA	Cardiovascular phenotype	GMAF:0.00080(T), GO-ESP:0.00019(T)	Likely benign(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	X	154360039	GRCh38	264213	259158
NM_001456.3(FLNA):c.3638G>A (p.Gly1213Asp)	FLNA	Cardiovascular phenotype		Uncertain significance(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	X	154360157	GRCh38	263979	259159
NM_001456.3(FLNA):c.3420C>T (p.Phe1140=)	FLNA	Cardiovascular phenotype	GO-ESP:0.00006(A)	Likely benign(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	X	154360375	GRCh38	263933	259163
NM_001456.3(FLNA):c.3270C>T (p.Ile1090=)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.01935(A), GMAF:0.02310(A), GO-ESP:0.00623(A)	Benign/Likely benign(Last reviewed: Mar 26, 2015)	criteria provided, multiple submitters, no conflicts	X	154360525	GRCh38	129071	134517
NG_011506.1:g.15883_17827del1945insTG	FLNA	Cardiac valvular dysplasia, X-linked		Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	X	154361812 - 154363756	GRCh38	11779	26818
NM_001456.3(FLNA):c.2778C>T (p.Ile926=)	FLNA	Cardiovascular phenotype	GO-ESP:0.00004(A)	Likely benign(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	X	154362027	GRCh38	264153	259164
NM_001456.3(FLNA):c.2433C>T (p.Ala811=)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.01594(A), GMAF:0.01170(A), GO-ESP:0.00393(A)	Benign/Likely benign(Last reviewed: Feb 27, 2015)	criteria provided, multiple submitters, no conflicts	X	154362550	GRCh38	129069	134515
NM_001456.3(FLNA):c.2379T>C (p.Thr793=)	FLNA	Cardiovascular phenotype	GO-ESP:0.00001(G)	Likely benign(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	X	154362686	GRCh38	264462	259165
NM_001110556.1(FLNA):c.2254_2268delGTCAGCATCCCCAACinsCACCCTGAAGGG (p.Val752_Asn756delinsHisProGluGly)	FLNA	not specified		Uncertain significance(Last reviewed: Jun 9, 2014)	criteria provided, single submitter	X	154364034 - 154364048	GRCh38	213493	210511
NM_001456.3(FLNA):c.2162C>T (p.Ala721Val)	FLNA	not specified	GO-ESP:0.00001(A)	Uncertain significance(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	X	154364140	GRCh38	213464	210514
NM_001110556.1(FLNA):c.2132T>A (p.Val711Asp)	FLNA	Cardiac valvular dysplasia, X-linked		Pathogenic(Last reviewed: Jan 2, 2007)	no assertion criteria provided	X	154364263	GRCh38	11778	26817
NM_001456.3(FLNA):c.2123G>A (p.Arg708Gln)	FLNA	not specified	GO-ESP:0.00002(T)	Uncertain significance(Last reviewed: May 9, 2015)	criteria provided, single submitter	X	154364272	GRCh38	213463	210515
NM_001456.3(FLNA):c.2001C>T (p.Pro667=)	FLNA	Cardiovascular phenotype	GMAF:0.00030(C)	Likely benign(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	X	154364547	GRCh38	264350	259166
NM_001456.3(FLNA):c.1968C>T (p.Leu656=)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.02419(A), GMAF:0.02570(A), GO-ESP:0.00700(A)	Benign/Likely benign(Last reviewed: Mar 26, 2015)	criteria provided, multiple submitters, no conflicts	X	154364580	GRCh38	129067	134513
NM_001110556.1(FLNA):c.1923C>T (p.Gly641=)	FLNA	Cardiac valvular dysplasia, X-linked|X-linked periventricular heterotopia		Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	X	154364625	GRCh38	11770	26809
NM_001110556.1(FLNA):c.1910C>A (p.Pro637Gln)	FLNA	Cardiac valvular dysplasia, X-linked		Pathogenic(Last reviewed: Jan 2, 2007)	no assertion criteria provided	X	154364638	GRCh38	11776	26815
NM_001456.3(FLNA):c.1812C>T (p.Asp604=)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.00009(A)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 22, 2015)	criteria provided, conflicting interpretations	X	154364837	GRCh38	194037	191200
NM_001456.3(FLNA):c.1686G>A (p.Gly562=)	FLNA	Cardiovascular phenotype	GO-ESP:0.00001(T)	Likely benign(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	X	154365141	GRCh38	264536	259167
NM_001456.3(FLNA):c.1439C>T (p.Pro480Leu)	FLNA	not provided|Cardiovascular phenotype	GO-ESP:0.00014(A)	Conflicting interpretations of pathogenicity(Last reviewed: Apr 18, 2016)	criteria provided, conflicting interpretations	X	154365477	GRCh38	235716	237396
NM_001456.3(FLNA):c.1326C>T (p.Tyr442=)	FLNA	Cardiovascular phenotype		Likely benign(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	X	154366127	GRCh38	264620	259168
NM_001110556.1(FLNA):c.1176G>A (p.Glu392=)	FLNA	X-linked periventricular heterotopia|Melnick-Needles syndrome|Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia|not specified|Cardiovascular phenotype	GO-ESP:0.00648(T), GMAF:0.00050(T), GO-ESP:0.00424(T)	Benign/Likely benign(Last reviewed: Mar 8, 2016)	criteria provided, multiple submitters, no conflicts	X	154366360	GRCh38	129065	134511
NM_001456.3(FLNA):c.1042C>G (p.Pro348Ala)	FLNA	Cardiovascular phenotype	GMAF:0.00030(C), GO-ESP:0.00006(C)	Uncertain significance(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	X	154366585	GRCh38	264416	259169
NM_001456.3(FLNA):c.1032C>A (p.Val344=)	FLNA	Cardiovascular phenotype		Likely benign(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	X	154366595	GRCh38	264168	259170
NM_001456.3(FLNA):c.1029C>T (p.Ser343=)	FLNA	X-linked periventricular heterotopia|Melnick-Needles syndrome|Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia|not specified|Cardiovascular phenotype	GMAF:0.00030(A), GO-ESP:0.00079(A)	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2015)	criteria provided, conflicting interpretations	X	154366598	GRCh38	198468	195629
NM_001456.3(FLNA):c.885_892delCAACATGG (p.Asn296Glufs)	FLNA	Cardiovascular phenotype		Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	X	154366827 - 154366834	GRCh38	263954	259171
NM_001456.3(FLNA):c.882A>G (p.Thr294=)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.00010(C), GMAF:0.00930(C), GO-ESP:0.00966(C)	Benign(Last reviewed: Mar 9, 2016)	criteria provided, multiple submitters, no conflicts	X	154366837	GRCh38	93777	99680
NM_001110556.1(FLNA):c.862G>A (p.Gly288Arg)	FLNA	Cardiac valvular dysplasia, X-linked		Pathogenic(Last reviewed: Jan 2, 2007)	no assertion criteria provided	X	154367403	GRCh38	11777	26816
NM_001456.3(FLNA):c.854G>A (p.Arg285His)	FLNA	not specified		Uncertain significance(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	X	154367411	GRCh38	213514	210534
NM_001110556.1(FLNA):c.663C>T (p.Pro221=)	FLNA	not specified|Cardiovascular phenotype	GO-ESP:0.00019(A), GMAF:0.01700(A), GO-ESP:0.01292(A)	Benign/Likely benign(Last reviewed: Feb 19, 2016)	criteria provided, multiple submitters, no conflicts	X	154367698	GRCh38	93771	99674
NM_001456.3(FLNA):c.234C>A (p.Ile78=)	FLNA	Cardiovascular phenotype	GO-ESP:0.00003(T)	Likely benign(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	X	154371012	GRCh38	264339	259172
NM_001456.3(FLNA):c.76G>C (p.Ala26Pro)	FLNA	Cardiovascular phenotype		Uncertain significance(Last reviewed: Jan 30, 2015)	criteria provided, single submitter	X	154371170	GRCh38	263897	259173
NM_000117.2(EMD):c.153dupC (p.Ser52Glnfs)	EMD	not provided|Cardiovascular phenotype		Pathogenic(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	X	154379760	GRCh38	234991	236822
NM_000117.2(EMD):c.187+1G>T	EMD	Cardiomyopathy		Pathogenic(Last reviewed: Aug 13, 2014)	criteria provided, single submitter	X	154379795	GRCh38	201772	198543
NM_000117.2(EMD):c.495G>A (p.Thr165=)	EMD	Emery-Dreifuss muscular dystrophy 1, X-linked|not specified|Cardiovascular phenotype	GO-ESP:0.00095(A), GMAF:0.00030(A), GO-ESP:0.00053(A)	Conflicting interpretations of pathogenicity(Last reviewed: Jun 6, 2016)	criteria provided, conflicting interpretations	X	154380927	GRCh38	42276	51446
NM_000117.2(EMD):c.545_547delATC (p.Tyr182_Pro183delinsSer)	EMD	not specified		Uncertain significance(Last reviewed: Apr 16, 2014)	criteria provided, single submitter	X	154380977 - 154380979	GRCh38	201781	198547
NM_000116.4(TAZ):c.280C>T (p.Arg94Cys)	TAZ	not provided		Pathogenic(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	X	154413248	GRCh38	202092	198554
NM_000116.4(TAZ):c.383T>C (p.Phe128Ser)	TAZ	3-Methylglutaconic aciduria type 2|Endocardial fibroelastosis|not specified|Dilated cardiomyopathy 3B|not provided|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.01913(C), GMAF:0.01640(C), GO-ESP:0.00660(C)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	154414113	GRCh38	42259	51429
NM_000116.4(TAZ):c.589G>A (p.Gly197Arg)	TAZ	3-Methylglutaconic aciduria type 2		Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	X	154420037	GRCh38	11105	26144
NM_000116.4(TAZ):c.718G>A (p.Gly240Arg)	TAZ	3-Methylglutaconic aciduria type 2|not provided		Pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, single submitter	X	154420676	GRCh38	35505	44181
NM_000116.4(TAZ):c.873G>A (p.Gly291=)	TAZ	3-Methylglutaconic aciduria type 2|Endocardial fibroelastosis|not specified|Dilated cardiomyopathy 3B|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype	GO-ESP:0.00464(A), GMAF:0.00160(A), GO-ESP:0.00408(A)	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	X	154420998	GRCh38	42270	51440
NM_001289.5(CLIC2):c.303C>G (p.His101Gln)	CLIC2	Mental retardation, X-linked, syndromic 32	GO-ESP:0.00004(C)	Pathogenic(Last reviewed: Oct 15, 2012)	no assertion criteria provided	X	155280059	GRCh38	39823	48422
NC_000023.10:g.(?_6134766)_(7023927_?)dup	PUDP|VCX3A|NLGN4X	See cases		Uncertain significance(Last reviewed: Jan 20, 2016)	criteria provided, single submitter			GRCh38	253995	248443
NC_000023.10:g.(154104116_154124111)_(154564398_154628663)dup	CLIC2|F8|MTCP1|VBP1|F8A1|FUNDC2|BRCC3|RAB39B|H2AFB2|H2AFB1|F8A2|CMC4	See cases		Pathogenic	no assertion criteria provided			GRCh38	189218	187098
GRCh38/hg38 Xp22.33-q28(chrX:251879-156004066)x1	ABCB7|AGTR2|NR0B1|ALAS2|ABCD1|AMELX|SLC25A5|SLC25A6|XIAP|SHROOM2|AR|ARAF|ARHGAP4|ARHGAP6|ARR3|STS|ARSD|ARSE|ARSF|ASMT|ATP2B3|ATP6AP1|ATP7A|ATRX|AVPR2|BGN|BMX|BRS3|BTK|CACNA1F|S100G|CAPN6|CD40LG|CDR1|CDX4|CETN2|CHM|CLCN4|CLCN5|CLIC2|CNGA2|COL4A5|COL4A6|COX7B|CSF2RA|CSTF2|CTAG1B|TEX28|CYBB|CYLC1|DCX|DDX3X|TIMM8A|DIAPH2|DKC1|DLG3|DMD|DNASE1L1|DRP2|TSC22D3|DUSP9|EDA|EFNB1|EIF1AX|EIF2S3|ELF4|ELK1|EMD|F8|F9|ACSL4|FANCB|GPC4|FGD1|FGF13|FHL1|FIGF|FLNA|FMR1|AFF2|CENPI|G6PD|GAGE1|GABRA3|GABRE|GAGE2C|GATA1|OPN1MW|GDI1|GJB1|GK|GLA|GPC3|GLRA2|GLUD2|GPM6B|CXCR3|LPAR4|GPR34|GRIA3|GRPR|GUCY2F|HSD17B10|HCCS|HCFC1|HMGB3|HNRNPH2|HPRT1|ERAS|HTR2C|IDH3G|IDS|IGBP1|IGSF1|IL2RG|IL3RA|IL9R|IL13RA1|IL13RA2|IRAK1|ANOS1|KCND1|L1CAM|LAMP2|PRICKLE3|SH2D1A|MAGEA1|MAGEA2|MAGEA3|MAGEA4|MAGEA5|MAGEA6|MAGEA8|MAGEA9|MAGEA10|MAGEA11|MAGEA12|MAGEB1|MAGEB2|MAGEB3|MAGEB4|MAOA|MAOB|MCF2|MECP2|CD99|MID1|FOXO4|MPP1|CITED1|MSN|MTCP1|MTM1|MYCLP1|NAP1L2|NAP1L3|NDP|NDUFA1|NHS|NONO|GPR143|TBC1D25|OCRL|OPHN1|OTC|P2RY4|PAK3|CDK16|PDHA1|PDK3|CFP|PFKFB1|PGK1|PHEX|PHKA1|PHKA2|PIGA|PIN4|PLP1|PLP2|PLS3|PLXNB3|POLA1|POU3F4|PPEF1|PRKX|PRPS1|PRPS2|PRRG1|PSMD10|RBBP7|RBM3|OPN1LW|RENBP|RP2|RPGR|RPL10|RPL39|RPL36A|RPS4X|RPS6KA3|RS1|SAT1|SCML1|TRAPPC2|SH3BGRL|SHOX|SLC6A8|SLC16A2|SMARCA1|SMS|SOX3|SSR4|SSX1|SSX2|SSX5|SSX4|CDKL5|SUV39H1|VAMP7|SYN1|SYP|TAF1|TAZ|SERPINA7|TBL1X|DYNLT3|TFE3|TIMP1|TSPAN7|TSPAN6|TMSB4X|TRO|TRPC5|UBA1|UBE2A|SLC35A2|KDM6A|VBP1|WAS|XG|XIST|XK|XPNPEP2|ZFX|ZIC3|ZNF711|ZNF182|ZNF41|ZNF75D|ZNF157|RNF113A|ZNF185|ZXDA|GTPBP6|PUDP|AKAP17A|PNPLA4|ZRSR2|USP11|USP9X|RBM10|KDM5C|SMC1A|NAA10|F8A1|UBL4A|TMEM187|LAGE3|SLC10A3|TKTL1|SRPX|UXT|CUL4B|IRS4|OGT|OFD1|IKBKG|PIR|INE2|INE1|CASK|ASMTL|PAGE1|MTMR1|FGF16|AKAP4|APLN|AP1S2|GYG2|FAM127A|SLC25A14|CLDN2|RGN|FAM50A|AIFM1|TMEM257|REPS2|ZBED1|ZMYM3|BMP15|GPR50|MED14|TCEAL1|RAB33A|RAB9A|TSIX|ITM2A|ARHGEF6|PCYT1B|MAGED1|XAGE2|PAGE4|MORF4L2|GPRASP1|STARD8|FRMPD4|JADE3|ARMCX2|HEPH|MAGEC1|AMMECR1|MED12|ZBTB33|HDAC6|MAMLD1|HUWE1|PQBP1|BCAP31|ADGRG2|ATP6AP2|TENM1|SSX3|TIMM17B|SPRY3|RRAGB|SCML2|SLC9A6|ENOX2|PRDX4|EBP|STAG2|RAI2|PLAC1|CYSLTR1|UTP14A|DIAPH2-AS1|ZNF275|PGRMC1|MAGED2|MSL3|TMSB15A|PIM2|MID2|IL1RAPL1|WDR45|TREX2|PRAF2|CA5B|SLC6A14|KLF8|VSIG4|CNKSR2|IQSEC2|PHF8|SEPT6|ARHGEF9|ATP1B4|ACOT9|KCNE5|LDOC1|SMPX|GSPT2|KIF4A|FTSJ1|HYPM|MXRA5|EGFL6|FAM127B|IL1RAPL2|ITGB1BP2|SRPK3|VCX|GAGE12I|GAGE2E|SNORA70|SNORA69|SNORD61|BEX3|NOX1|FAM155B|INGX|GPR82|GPKOW|SRPX2|APEX2|RBMX|PCDH11X|RPS6KA6|P2RY10|HTATSF1|PCSK1N|PPP2R3B|CCDC22|MCTS1|MAGEH1|FAM156A|C1GALT1C1|SNX12|RPA4|PNMA3|UBQLN2|SH3KBP1|SPANXA1|CTAG2|NSDHL|FOXP3|TBX22|ZDHHC9|RLIM|TCEAL9|RAB9B|LUZP4|PDZD11|PBDC1|TFDP3|TLR7|ARMCX1|TLR8|MBTPS2|MAGEC2|VGLL1|VCX2|VCX3A|ARMCX3|TAF9B|RBMX2|STK26|CPXCR1|CHIC1|FTHL17|GPR173|NLGN3|SASH3|TAF7L|SPIN2A|ARMCX6|WDR44|NDUFB11|GNL3L|ERCC6L|NUP62CL|GDPD2|BCOR|TBC1D8B|FAM120C|GEMIN8|CT55|TMEM255A|CXorf57|NUDT11|TMLHE|RBM41|PLCXD1|SAGE1|PLXNA3|HAUS7|OTUD5|ZNF280C|MTMR8|KRBOX4|TXLNG|MBNL3|WWC3|BEX1|HDAC8|GABRQ|ZC4H2|NXT2|NKRF|NXF5|NXF4|NXF3|NXF2|KLHL4|TEX13B|TEX13A|TEX11|MOSPD1|BEX4|CTPS2|CHST7|TCEAL7|GRIPAP1|THOC2|ZNF630|TMEM27|SHROOM4|KIAA1210|NLGN4X|PCDH19|RGAG1|PDZD4|LRCH2|MAGEE1|RAP2C|MID1IP1|ACE2|TMEM35A|FAM3A|EDA2R|NYX|BCORL1|DUSP21|CXorf56|DMRTC1|TSPYL2|TNMD|CRLF2|PJA1|SPANXD|SPANXC|WDR13|PORCN|ARMCX5|UPF3B|WNK3|FUNDC2|PRRG3|APOO|BRCC3|HMGN5|NKAP|RNF128|MAP7D3|MORC4|CXorf36|LONRF3|ALG13|MAGIX|TCEAL4|TRMT2B|POF1B|ASMTL-AS1|CXorf21|EFHC2|KLHL15|ESX1|BHLHB9|MAGED4B|LAS1L|GPR101|TMEM47|CD99L2|H2AFB3|USP26|MAGT1|TMEM164|PHF6|FRMPD3|ZMAT1|RHOXF2|TMEM185A|SLITRK2|GPR174|SLC9A7|BEX2|MIR503HG|SLC7A3|PNMA6A|TCEAL3|CCNB3|PPP1R3F|FATE1|CCDC120|TSR2|HS6ST2|FRMD7|KLHL13|TGIF2LX|FAM104B|PAGE5|TCEAL8|CHRDL1|CXorf40A|FAM58A|RIPPLY1|LINC01278|ATXN3L|SLC38A5|MMGT1|ACRC|SYAP1|SYTL4|SYTL5|PNMA5|GPRASP2|ATG4A|RAB39B|DACH2|SLITRK4|SPANXN3|MAGEC3|BEND2|PASD1|DCAF12L1|DGKK|PIH1D3|MUM1L1|FAM199X|AMER1|APOOL|HDX|FUNDC1|ADGRG4|PTCHD1|MAGEB10|DCAF8L1|OTUD6A|UPRT|MAGEE2|MAGEB16|FOXR2|XAGE-4|GAB3|PNCK|ZFP92|ACTRT1|GPR119|PAGE3|RBMXL3|DOCK11|SPIN4|ASB11|ASB9|TCEAL2|PABPC5|RAB40A|ASB12|AMOT|ZNF645|CSAG1|FMR1NB|USP27X-AS1|FAAH2|ZXDB|LINC00889|FAM47A|MOSPD2|ARHGAP36|RIBC1|AKAP14|RHOXF1|MAGEB6|CXorf65|AWAT1|AWAT2|ZDHHC15|USP51|TCEAL6|CH17-340M24.3|H2BFWT|CXorf38|FAM122B|FAM122C|DDX53|FAM46D|SPIN3|FAM47B|CXorf22|SUPT20HL2|TCEANC|ZCCHC12|ARX|XAGE3|XAGE5|NUDT10|FAM9A|FAM9B|FAM9C|CT83|LINC01560|SLC25A43|FAM226A|ZCCHC5|NRK|INTS6L|ZNF449|VMA21|TMEM31|PAGE2|DHRSX|CTAG1A|BRWD3|CXorf58|CT47A11|CXorf23|MAP7D2|KLHL34|TAB3|MAGEA2B|SSX6|SSX7|SSX8|SSX9|RAB40AL|LINC00685|ATP11C|LINC00632|NLRP2B|H2BFM|LOC286437|LINC01281|YIPF6|CFAP47|FIRRE|BRAFP1|FAM133A|MAGEB18|TMSB15B|P2RY8|FAM223B|RGAG4|NHSL2|PABPC1L2A|KIAA2022|BEX5|TCEAL5|MORF4L2-AS1|VSIG1|ZC3H12B|SATL1|DCAF12L2|LOC340581|ZCCHC16|LHFPL1|CXorf67|ZNF81|ITIH6|LANCL3|MPC1L|DCAF8L2|SOWAHD|OR13H1|CCDC160|CXorf66|DGAT2L6|RAB41|ARSH|MAGEB5|TLR8-AS1|MAP3K15|SPACA5|USP27X|PAGE2B|ZCCHC13|LOC389895|UBE2NL|CSAG3|GLOD5|FLJ44635|ARL13A|SMIM10L2A|LOC401585|ZNF674-AS1|SLC25A53|LINC00890|XKRX|YY2|MIRLET7F2|MIR105-1|MIR105-2|MIR106A|MIR188|MIR19B2|MIR221|MIR222|MIR223|MIR224|MIR92A2|MIR98|VCX3B|FTH1P18|LINC00891|GLRA4|FAM127C|CT45A3|CT45A5|SPANXN4|PGAM4|FAM47C|MIR325|MIR374A|SPIN2B|H2AFB2|H2AFB1|F8A2|F8A3|SPANXN1|SPANXN2|SPANXN5|MIR361|MIR384|MIR424|CT45A6|CT45A1|CXorf40B|SSX4B|LINC01420|JPX|MIR448|MIR450A1|MIR362|MIR363|MIR20B|MIR18B|MIR452|MIR500A|MIR501|MIR502|MIR450A2|MIR503|MIR504|MIR505|MIR513A1|MIR513A2|MIR506|MIR507|MIR508|MIR509-1|MIR510|MIR514A1|MIR514A2|MIR514A3|SPANXA2-OT1|ZNF674|DANT2|CT47B1|ZCCHC18|SMIM10|SMIM10L2B|SAGE2P|GAGE2B|GAGE13|GAGE12G|CXorf30|LOC645188|MAGEB17|PABPC1L2B|XAGE1E|XAGE1B|CT47A7|FAM226B|MIR545|MIR542|SCARNA23|SNORA11|SNORA35|SNORA36A|SNORA56|SNORD96B|MIR421|MIR532|MIR651|MIR652|MIR660|LINC01545|SSX2B|FAM156B|RHOXF2B|CT47A10|CT47A9|CT47A8|CT47A6|CT47A5|CT47A4|CT47A3|CT47A2|CT47A1|MAGED4|MAGEA9B|NXF2B|OPN1MW2|DMRTC1B|SPANXB1|SPANXA2|CT45A2|SPACA5B|GAGE12J|GAGE2D|GAGE12C|GAGE12B|GAGE12E|GAGE12H|GAGE2A|LOC729609|LINC00106|MIR767|MIR766|GAGE12F|GS1-600G8.3|GAGE8|SNORA11C|SNORA11D|FMR1-AS1|MIR509-2|MIR450B|MIR890|MIR891B|MIR888|MIR892B|MIR374B|MIR934|MIR509-3|MIR891A|MIR892A|LOC100126447|LINC00892|ARMCX3-AS1|GPR50-AS1|CXorf51A|LINC00684|LINC01546|LINC00633|TEX13C|FGF13-AS1|HSFX2|SUPT20HL1|CXorf49|PRR32|LINC00893|ARMCX4|PHKA2-AS1|LOC100132304|GAGE12D|LOC100132741|SMIM9|FAM223A|CXorf49B|CXorf51B|LINC01203|UXT-AS1|SCARNA9L|TRI-GAT1-2|TRI-GAT1-1|TRV-TAC1-2|TRI-GAT1-3|CMC4|LINC00894|LOC100287728|LINC00630|CLDN34|MIR1184-1|MIR513C|MIR1468|MIR1912|MIR1298|MIR320D2|MIR1321|MIR548I4|MIR1277|MIR1911|MIR548F5|MIR1264|FTX|SLC25A5-AS1|MIR548M|MIR718|MIR513B|MIR764|MIR2114|TRPC5OS|LINC00102|MIR514B|MIR3202-2|MIR500B|MIR4330|MIR4328|MIR1184-3|MIR1184-2|MIR3202-1|MIR4329|MTRNR2L10|MIR374C|MIR23C|MIR3937|MIR3672|MIR676|MIR3690|MIR3915|HSFX1|LINC00629|LOC100506790|CT47A12|TMLHE-AS1|LOC100509091|ARMCX5-GPRASP2|RPL36A-HNRNPH2|PIR-FIGF|MAGEA10-MAGEA5|MIR548AN|MIR4769|MIR4536-1|MIR4768|MIR1587|MIR548AJ2|MIR4770|MIR548AM|MIR4767|MIR3978|MIR4666B|MIR664B|MIR4536-2|MIR548AX|PTCHD1-AS|RNU6-30P|NHS-AS1|SYP-AS1|ZFX-AS1|DLG3-AS1|PHEX-AS1|PRKX-AS1|MED14OS|HCFC1-AS1|PPEF1-AS1|EIF1AX-AS1|PCYT1B-AS1|HS6ST2-AS1|INTS6L-AS1|ZNF630-AS1|FRMPD3-AS1|MID1IP1-AS1|ARHGEF9-IT1|LINC00269|LCA10|TCP11X2|LOC101059915|CT45A7|OPN1MW3|LINC00850|SNORA11E|MAGEA8-AS1|LINC01284|PLS3-AS1|LINC01282|LOC101927476|LOC101927501|LINC01204|LINC01186|LOC101927635|LOC101927685|LOC101927830|LOC101928128|LOC101928201|LOC101928259|LINC01285|LOC101928335|LOC101928336|PABPC1L2B-AS1|LOC101928358|LOC101928389|LOC101928402|LOC101928437|MIR325HG|LOC101928495|LOC101928564|RAP2C-AS1|LOC101928627|LOC101928917|RHOXF1P1|RHOXF1-AS1|MIR6087|MIR6089|MIR6134|MIR6857|MIR6858|MIR6895|MIR6086|MIR892C|MIR6894|MIR8088|LINC01496|KANTR|CSAG2|CT45A10|CT45A9|CT45A8|PABPC5-AS1|GAGE10|LINC01201|LINC01402|GS1-594A7.3|LINC01456|LOC105373156|LOC105373185|LOC105373300|LOC105373311|LOC105373338|LOC105373368|LOC105373378|LOC105373383|LOC105377213|XACT|SNORA109	See cases		Pathogenic	no assertion criteria provided	X	251879 - 156004066	GRCh38	155374	165128
GRCh38/hg38 Xp21.1(chrX:31518752-31636035)x3	DMD	See cases		Likely pathogenic(Last reviewed: May 14, 2013)	no assertion criteria provided	X	31518752 - 31636035	GRCh38	155368	165122
GRCh38/hg38 Xp22.33-q28(chrX:251879-156004066)x3	ABCB7|AGTR2|NR0B1|ALAS2|ABCD1|AMELX|SLC25A5|SLC25A6|XIAP|SHROOM2|AR|ARAF|ARHGAP4|ARHGAP6|ARR3|STS|ARSD|ARSE|ARSF|ASMT|ATP2B3|ATP6AP1|ATP7A|ATRX|AVPR2|BGN|BMX|BRS3|BTK|CACNA1F|S100G|CAPN6|CD40LG|CDR1|CDX4|CETN2|CHM|CLCN4|CLCN5|CLIC2|CNGA2|COL4A5|COL4A6|COX7B|CSF2RA|CSTF2|CTAG1B|TEX28|CYBB|CYLC1|DCX|DDX3X|TIMM8A|DIAPH2|DKC1|DLG3|DMD|DNASE1L1|DRP2|TSC22D3|DUSP9|EDA|EFNB1|EIF1AX|EIF2S3|ELF4|ELK1|EMD|F8|F9|ACSL4|FANCB|GPC4|FGD1|FGF13|FHL1|FIGF|FLNA|FMR1|AFF2|CENPI|G6PD|GAGE1|GABRA3|GABRE|GAGE2C|GATA1|OPN1MW|GDI1|GJB1|GK|GLA|GPC3|GLRA2|GLUD2|GPM6B|CXCR3|LPAR4|GPR34|GRIA3|GRPR|GUCY2F|HSD17B10|HCCS|HCFC1|HMGB3|HNRNPH2|HPRT1|ERAS|HTR2C|IDH3G|IDS|IGBP1|IGSF1|IL2RG|IL3RA|IL9R|IL13RA1|IL13RA2|IRAK1|ANOS1|KCND1|L1CAM|LAMP2|PRICKLE3|SH2D1A|MAGEA1|MAGEA2|MAGEA3|MAGEA4|MAGEA5|MAGEA6|MAGEA8|MAGEA9|MAGEA10|MAGEA11|MAGEA12|MAGEB1|MAGEB2|MAGEB3|MAGEB4|MAOA|MAOB|MCF2|MECP2|CD99|MID1|FOXO4|MPP1|CITED1|MSN|MTCP1|MTM1|MYCLP1|NAP1L2|NAP1L3|NDP|NDUFA1|NHS|NONO|GPR143|TBC1D25|OCRL|OPHN1|OTC|P2RY4|PAK3|CDK16|PDHA1|PDK3|CFP|PFKFB1|PGK1|PHEX|PHKA1|PHKA2|PIGA|PIN4|PLP1|PLP2|PLS3|PLXNB3|POLA1|POU3F4|PPEF1|PRKX|PRPS1|PRPS2|PRRG1|PSMD10|RBBP7|RBM3|OPN1LW|RENBP|RP2|RPGR|RPL10|RPL39|RPL36A|RPS4X|RPS6KA3|RS1|SAT1|SCML1|TRAPPC2|SH3BGRL|SHOX|SLC6A8|SLC16A2|SMARCA1|SMS|SOX3|SSR4|SSX1|SSX2|SSX5|SSX4|CDKL5|SUV39H1|VAMP7|SYN1|SYP|TAF1|TAZ|SERPINA7|TBL1X|DYNLT3|TFE3|TIMP1|TSPAN7|TSPAN6|TMSB4X|TRO|TRPC5|UBA1|UBE2A|SLC35A2|KDM6A|VBP1|WAS|XG|XIST|XK|XPNPEP2|ZFX|ZIC3|ZNF711|ZNF182|ZNF41|ZNF75D|ZNF157|RNF113A|ZNF185|ZXDA|GTPBP6|PUDP|AKAP17A|PNPLA4|ZRSR2|USP11|USP9X|RBM10|KDM5C|SMC1A|NAA10|F8A1|UBL4A|TMEM187|LAGE3|SLC10A3|TKTL1|SRPX|UXT|CUL4B|IRS4|OGT|OFD1|IKBKG|PIR|INE2|INE1|CASK|ASMTL|PAGE1|MTMR1|FGF16|AKAP4|APLN|AP1S2|GYG2|FAM127A|SLC25A14|CLDN2|RGN|FAM50A|AIFM1|TMEM257|REPS2|ZBED1|ZMYM3|BMP15|GPR50|MED14|TCEAL1|RAB33A|RAB9A|TSIX|ITM2A|ARHGEF6|PCYT1B|MAGED1|XAGE2|PAGE4|MORF4L2|GPRASP1|STARD8|FRMPD4|JADE3|ARMCX2|HEPH|MAGEC1|AMMECR1|MED12|ZBTB33|HDAC6|MAMLD1|HUWE1|PQBP1|BCAP31|ADGRG2|ATP6AP2|TENM1|SSX3|TIMM17B|SPRY3|RRAGB|SCML2|SLC9A6|ENOX2|PRDX4|EBP|STAG2|RAI2|PLAC1|CYSLTR1|UTP14A|DIAPH2-AS1|ZNF275|PGRMC1|MAGED2|MSL3|TMSB15A|PIM2|MID2|IL1RAPL1|WDR45|TREX2|PRAF2|CA5B|SLC6A14|KLF8|VSIG4|CNKSR2|IQSEC2|PHF8|SEPT6|ARHGEF9|ATP1B4|ACOT9|KCNE5|LDOC1|SMPX|GSPT2|KIF4A|FTSJ1|HYPM|MXRA5|EGFL6|FAM127B|IL1RAPL2|ITGB1BP2|SRPK3|VCX|GAGE12I|GAGE2E|SNORA70|SNORA69|SNORD61|BEX3|NOX1|FAM155B|INGX|GPR82|GPKOW|SRPX2|APEX2|RBMX|PCDH11X|RPS6KA6|P2RY10|HTATSF1|PCSK1N|PPP2R3B|CCDC22|MCTS1|MAGEH1|FAM156A|C1GALT1C1|SNX12|RPA4|PNMA3|UBQLN2|SH3KBP1|SPANXA1|CTAG2|NSDHL|FOXP3|TBX22|ZDHHC9|RLIM|TCEAL9|RAB9B|LUZP4|PDZD11|PBDC1|TFDP3|TLR7|ARMCX1|TLR8|MBTPS2|MAGEC2|VGLL1|VCX2|VCX3A|ARMCX3|TAF9B|RBMX2|STK26|CPXCR1|CHIC1|FTHL17|GPR173|NLGN3|SASH3|TAF7L|SPIN2A|ARMCX6|WDR44|NDUFB11|GNL3L|ERCC6L|NUP62CL|GDPD2|BCOR|TBC1D8B|FAM120C|GEMIN8|CT55|TMEM255A|CXorf57|NUDT11|TMLHE|RBM41|PLCXD1|SAGE1|PLXNA3|HAUS7|OTUD5|ZNF280C|MTMR8|KRBOX4|TXLNG|MBNL3|WWC3|BEX1|HDAC8|GABRQ|ZC4H2|NXT2|NKRF|NXF5|NXF4|NXF3|NXF2|KLHL4|TEX13B|TEX13A|TEX11|MOSPD1|BEX4|CTPS2|CHST7|TCEAL7|GRIPAP1|THOC2|ZNF630|TMEM27|SHROOM4|KIAA1210|NLGN4X|PCDH19|RGAG1|PDZD4|LRCH2|MAGEE1|RAP2C|MID1IP1|ACE2|TMEM35A|FAM3A|EDA2R|NYX|BCORL1|DUSP21|CXorf56|DMRTC1|TSPYL2|TNMD|CRLF2|PJA1|SPANXD|SPANXC|WDR13|PORCN|ARMCX5|UPF3B|WNK3|FUNDC2|PRRG3|APOO|BRCC3|HMGN5|NKAP|RNF128|MAP7D3|MORC4|CXorf36|LONRF3|ALG13|MAGIX|TCEAL4|TRMT2B|POF1B|ASMTL-AS1|CXorf21|EFHC2|KLHL15|ESX1|BHLHB9|MAGED4B|LAS1L|GPR101|TMEM47|CD99L2|H2AFB3|USP26|MAGT1|TMEM164|PHF6|FRMPD3|ZMAT1|RHOXF2|TMEM185A|SLITRK2|GPR174|SLC9A7|BEX2|MIR503HG|SLC7A3|PNMA6A|TCEAL3|CCNB3|PPP1R3F|FATE1|CCDC120|TSR2|HS6ST2|FRMD7|KLHL13|TGIF2LX|FAM104B|PAGE5|TCEAL8|CHRDL1|CXorf40A|FAM58A|RIPPLY1|LINC01278|ATXN3L|SLC38A5|MMGT1|ACRC|SYAP1|SYTL4|SYTL5|PNMA5|GPRASP2|ATG4A|RAB39B|DACH2|SLITRK4|SPANXN3|MAGEC3|BEND2|PASD1|DCAF12L1|DGKK|PIH1D3|MUM1L1|FAM199X|AMER1|APOOL|HDX|FUNDC1|ADGRG4|PTCHD1|MAGEB10|DCAF8L1|OTUD6A|UPRT|MAGEE2|MAGEB16|FOXR2|XAGE-4|GAB3|PNCK|ZFP92|ACTRT1|GPR119|PAGE3|RBMXL3|DOCK11|SPIN4|ASB11|ASB9|TCEAL2|PABPC5|RAB40A|ASB12|AMOT|ZNF645|CSAG1|FMR1NB|USP27X-AS1|FAAH2|ZXDB|LINC00889|FAM47A|MOSPD2|ARHGAP36|RIBC1|AKAP14|RHOXF1|MAGEB6|CXorf65|AWAT1|AWAT2|ZDHHC15|USP51|TCEAL6|CH17-340M24.3|H2BFWT|CXorf38|FAM122B|FAM122C|DDX53|FAM46D|SPIN3|FAM47B|CXorf22|SUPT20HL2|TCEANC|ZCCHC12|ARX|XAGE3|XAGE5|NUDT10|FAM9A|FAM9B|FAM9C|CT83|LINC01560|SLC25A43|FAM226A|ZCCHC5|NRK|INTS6L|ZNF449|VMA21|TMEM31|PAGE2|DHRSX|CTAG1A|BRWD3|CXorf58|CT47A11|CXorf23|MAP7D2|KLHL34|TAB3|MAGEA2B|SSX6|SSX7|SSX8|SSX9|RAB40AL|LINC00685|ATP11C|LINC00632|NLRP2B|H2BFM|LOC286437|LINC01281|YIPF6|CFAP47|FIRRE|BRAFP1|FAM133A|MAGEB18|TMSB15B|P2RY8|FAM223B|RGAG4|NHSL2|PABPC1L2A|KIAA2022|BEX5|TCEAL5|MORF4L2-AS1|VSIG1|ZC3H12B|SATL1|DCAF12L2|LOC340581|ZCCHC16|LHFPL1|CXorf67|ZNF81|ITIH6|LANCL3|MPC1L|DCAF8L2|SOWAHD|OR13H1|CCDC160|CXorf66|DGAT2L6|RAB41|ARSH|MAGEB5|TLR8-AS1|MAP3K15|SPACA5|USP27X|PAGE2B|ZCCHC13|LOC389895|UBE2NL|CSAG3|GLOD5|FLJ44635|ARL13A|SMIM10L2A|LOC401585|ZNF674-AS1|SLC25A53|LINC00890|XKRX|YY2|MIRLET7F2|MIR105-1|MIR105-2|MIR106A|MIR188|MIR19B2|MIR221|MIR222|MIR223|MIR224|MIR92A2|MIR98|VCX3B|FTH1P18|LINC00891|GLRA4|FAM127C|CT45A3|CT45A5|SPANXN4|PGAM4|FAM47C|MIR325|MIR374A|SPIN2B|H2AFB2|H2AFB1|F8A2|F8A3|SPANXN1|SPANXN2|SPANXN5|MIR361|MIR384|MIR424|CT45A6|CT45A1|CXorf40B|SSX4B|LINC01420|JPX|MIR448|MIR450A1|MIR362|MIR363|MIR20B|MIR18B|MIR452|MIR500A|MIR501|MIR502|MIR450A2|MIR503|MIR504|MIR505|MIR513A1|MIR513A2|MIR506|MIR507|MIR508|MIR509-1|MIR510|MIR514A1|MIR514A2|MIR514A3|SPANXA2-OT1|ZNF674|DANT2|CT47B1|ZCCHC18|SMIM10|SMIM10L2B|SAGE2P|GAGE2B|GAGE13|GAGE12G|CXorf30|LOC645188|MAGEB17|PABPC1L2B|XAGE1E|XAGE1B|CT47A7|FAM226B|MIR545|MIR542|SCARNA23|SNORA11|SNORA35|SNORA36A|SNORA56|SNORD96B|MIR421|MIR532|MIR651|MIR652|MIR660|LINC01545|SSX2B|FAM156B|RHOXF2B|CT47A10|CT47A9|CT47A8|CT47A6|CT47A5|CT47A4|CT47A3|CT47A2|CT47A1|MAGED4|MAGEA9B|NXF2B|OPN1MW2|DMRTC1B|SPANXB1|SPANXA2|CT45A2|SPACA5B|GAGE12J|GAGE2D|GAGE12C|GAGE12B|GAGE12E|GAGE12H|GAGE2A|LOC729609|LINC00106|MIR767|MIR766|GAGE12F|GS1-600G8.3|GAGE8|SNORA11C|SNORA11D|FMR1-AS1|MIR509-2|MIR450B|MIR890|MIR891B|MIR888|MIR892B|MIR374B|MIR934|MIR509-3|MIR891A|MIR892A|LOC100126447|LINC00892|ARMCX3-AS1|GPR50-AS1|CXorf51A|LINC00684|LINC01546|LINC00633|TEX13C|FGF13-AS1|HSFX2|SUPT20HL1|CXorf49|PRR32|LINC00893|ARMCX4|PHKA2-AS1|LOC100132304|GAGE12D|LOC100132741|SMIM9|FAM223A|CXorf49B|CXorf51B|LINC01203|UXT-AS1|SCARNA9L|TRI-GAT1-2|TRI-GAT1-1|TRV-TAC1-2|TRI-GAT1-3|CMC4|LINC00894|LOC100287728|LINC00630|CLDN34|MIR1184-1|MIR513C|MIR1468|MIR1912|MIR1298|MIR320D2|MIR1321|MIR548I4|MIR1277|MIR1911|MIR548F5|MIR1264|FTX|SLC25A5-AS1|MIR548M|MIR718|MIR513B|MIR764|MIR2114|TRPC5OS|LINC00102|MIR514B|MIR3202-2|MIR500B|MIR4330|MIR4328|MIR1184-3|MIR1184-2|MIR3202-1|MIR4329|MTRNR2L10|MIR374C|MIR23C|MIR3937|MIR3672|MIR676|MIR3690|MIR3915|HSFX1|LINC00629|LOC100506790|CT47A12|TMLHE-AS1|LOC100509091|ARMCX5-GPRASP2|RPL36A-HNRNPH2|PIR-FIGF|MAGEA10-MAGEA5|MIR548AN|MIR4769|MIR4536-1|MIR4768|MIR1587|MIR548AJ2|MIR4770|MIR548AM|MIR4767|MIR3978|MIR4666B|MIR664B|MIR4536-2|MIR548AX|PTCHD1-AS|RNU6-30P|NHS-AS1|SYP-AS1|ZFX-AS1|DLG3-AS1|PHEX-AS1|PRKX-AS1|MED14OS|HCFC1-AS1|PPEF1-AS1|EIF1AX-AS1|PCYT1B-AS1|HS6ST2-AS1|INTS6L-AS1|ZNF630-AS1|FRMPD3-AS1|MID1IP1-AS1|ARHGEF9-IT1|LINC00269|LCA10|TCP11X2|LOC101059915|CT45A7|OPN1MW3|LINC00850|SNORA11E|MAGEA8-AS1|LINC01284|PLS3-AS1|LINC01282|LOC101927476|LOC101927501|LINC01204|LINC01186|LOC101927635|LOC101927685|LOC101927830|LOC101928128|LOC101928201|LOC101928259|LINC01285|LOC101928335|LOC101928336|PABPC1L2B-AS1|LOC101928358|LOC101928389|LOC101928402|LOC101928437|MIR325HG|LOC101928495|LOC101928564|RAP2C-AS1|LOC101928627|LOC101928917|RHOXF1P1|RHOXF1-AS1|MIR6087|MIR6089|MIR6134|MIR6857|MIR6858|MIR6895|MIR6086|MIR892C|MIR6894|MIR8088|LINC01496|KANTR|CSAG2|CT45A10|CT45A9|CT45A8|PABPC5-AS1|GAGE10|LINC01201|LINC01402|GS1-594A7.3|LINC01456|LOC105373156|LOC105373185|LOC105373300|LOC105373311|LOC105373338|LOC105373368|LOC105373378|LOC105373383|LOC105377213|XACT|SNORA109	See cases		Pathogenic	no assertion criteria provided	X	251879 - 156004066	GRCh38	155366	165120
GRCh38/hg38 Xp11.4(chrX:41736613-41807412)x2	CASK	See cases		Likely pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	X	41736613 - 41807412	GRCh38	155082	164836
GRCh38/hg38 Xq27.2(chrX:141258990-141650260)x2	SPANXA1|SPANXA2-OT1|LOC645188|SPANXA2	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	X	141258990 - 141650260	GRCh38	154904	164658
GRCh38/hg38 Xq11.1(chrX:62779286-62913742)x2		See cases		Benign(Last reviewed: Oct 20, 2010)	no assertion criteria provided	X	62779286 - 62913742	GRCh38	154692	164446
GRCh38/hg38 Xp22.33-22.31(chrX:2790845-6495923)x0	ARSD|ARSE|ARSF|PRKX|XG|GYG2|MXRA5|NLGN4X|ARSH|LINC01546|TRI-GAT1-2|TRI-GAT1-1|TRI-GAT1-3|MIR4770|PRKX-AS1|LOC101928201|LOC105373156	See cases		Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	X	2790845 - 6495923	GRCh38	154679	164433
GRCh38/hg38 Xq13.3(chrX:75243922-75372926)x3	UPRT|ZDHHC15	See cases		Uncertain significance(Last reviewed: Dec 22, 2010)	no assertion criteria provided	X	75243922 - 75372926	GRCh38	154509	164263
GRCh38/hg38 Xp11.22(chrX:53375808-53387455)x3	SMC1A	See cases		Uncertain significance(Last reviewed: Jan 24, 2011)	no assertion criteria provided	X	53375808 - 53387455	GRCh38	154501	164255
GRCh38/hg38 Xq13.3-21.1(chrX:76344954-77070816)x3	MAGEE1|MIR325|MIR384|MIR325HG	See cases		Uncertain significance(Last reviewed: Dec 13, 2010)	no assertion criteria provided	X	76344954 - 77070816	GRCh38	154459	164213
GRCh38/hg38 Xq22.3(chrX:106986809-107315101)x0	MYCLP1|NUP62CL|RBM41|MORC4|PIH1D3	See cases		Uncertain significance(Last reviewed: Jan 14, 2013)	no assertion criteria provided	X	106986809 - 107315101	GRCh38	152744	162495
GRCh38/hg38 Xq26.2-26.3(chrX:133532321-137519462)x2	BRS3|CD40LG|FHL1|GPC3|HPRT1|ZNF75D|FAM127A|ARHGEF6|SLC9A6|PLAC1|FAM127B|SNORD61|RBMX|HTATSF1|VGLL1|CT55|SAGE1|MOSPD1|MAP7D3|GPR101|PHF6|MIR503HG|MMGT1|ADGRG4|FAM122B|FAM122C|INTS6L|ZNF449|LOC340581|CCDC160|SMIM10L2A|MIR106A|MIR19B2|MIR92A2|FAM127C|CT45A3|CT45A5|MIR424|CT45A6|CT45A1|MIR450A1|MIR363|MIR20B|MIR18B|MIR450A2|MIR503|SMIM10|SMIM10L2B|SAGE2P|MIR542|CT45A2|MIR450B|MIR934|LINC00892|LINC00633|LOC100287728|LINC00629|LOC100506790|INTS6L-AS1|CT45A7|CT45A10|CT45A9|CT45A8	See cases		Likely pathogenic(Last reviewed: Dec 17, 2012)	no assertion criteria provided	X	133532321 - 137519462	GRCh38	152215	161966
GRCh38/hg38 Xp11.23(chrX:48476537-48477781)x3	FTSJ1	See cases		Likely benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	X	48476537 - 48477781	GRCh38	150944	160695
GRCh38/hg38 Xq11.2(chrX:64145374-64905930)x3	MTMR8|AMER1|ASB12	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	X	64145374 - 64905930	GRCh38	60319	74914
GRCh38/hg38 Xp22.31(chrX:8672728-8961059)x2	ANOS1|FAM9A	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	X	8672728 - 8961059	GRCh38	60263	74858
GRCh38/hg38 Xq13.3(chrX:75243091-75431414)x3	UPRT|ZDHHC15	See cases		Benign(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	X	75243091 - 75431414	GRCh38	59830	74425
GRCh38/hg38 Xp22.31(chrX:6570680-8129470)x0	STS|PUDP|PNPLA4|VCX|MIR651|MIR4767	See cases		Pathogenic(Last reviewed: Jan 27, 2011)	no assertion criteria provided	X	6570680 - 8129470	GRCh38	59231	73826
GRCh38/hg38 Xp22.32-22.2(chrX:4557134-10838424)x1	SHROOM2|STS|CLCN4|ANOS1|MID1|GPR143|TBL1X|PUDP|PNPLA4|VCX|VCX2|VCX3A|WWC3|NLGN4X|FAM9A|FAM9B|VCX3B|MIR651|CLDN34|MIR4770|MIR4767|LOC101928201|LOC105373156	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	X	4557134 - 10838424	GRCh38	59212	73807
GRCh38/hg38 Xq13.3(chrX:75012979-75197052)x2	ABCB7	See cases		Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	X	75012979 - 75197052	GRCh38	58643	73238
GRCh38/hg38 Xp22.33(chrX:483809-884538)x3	SHOX	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	X	483809 - 884538	GRCh38	58503	73098
GRCh38/hg38 Xp22.12(chrX:19677033-19881974)x0	SH3KBP1	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	X	19677033 - 19881974	GRCh38	57650	72245
GRCh38/hg38 Xp22.33(chrX:2782275-2904175)x0	ARSD|XG|GYG2	See cases		Uncertain significance(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	X	2782275 - 2904175	GRCh38	57646	72241
GRCh37/hg19 Yp11.31-q12(chrY:2654852-59031480)x2	AMELY|DAZ1|PRKY|RBMY1A1|RPS4Y1|SRY|TSPY1|UTY|ZFY|KDM5D|USP9Y|DDX3Y|PRY|XKRY|BPY2|VCY|CDY1|EIF1AY|TMSB4Y|CDY2A|NLGN4Y|TTTY1|DAZ3|DAZ2|DAZ4|TTTY2|TSPY2|TTTY15|PCDH11Y|TTTY5|TTTY9A|TTTY11|TTTY12|TTTY13|TTTY14|GOLGA2P2Y|TTTY6|TTTY8|HSFY1|TGIF2LY|TBL1Y|CSPG4P1Y|TTTY3|TTTY4|RPS4Y2|HSFY2|RBMY1F|TTTY10|TTTY7|TXLNGY|TTTY16|TTTY17A|TTTY18|TTTY20|TTTY19|TTTY21|TTTY22|TTTY23|VCY1B|XKRY2|RBMY1B|RBMY1D|RBMY1E|RBMY1J|TTTY9B|TTTY6B|PRY2|BPY2B|BPY2C|TTTY3B|TTTY4B|TTTY4C|TTTY17B|TTTY17C|TSPY3|TSPY4|TSPY8|TTTY21B|TTTY1B|TTTY2B|TTTY8B|TTTY7B|TTTY23B|TTTY13B|TSPY10|PRORY	See cases		Pathogenic(Last reviewed: Jan 31, 2013)	criteria provided, single submitter			GRCh38	161065	170909
GRCh38/hg38 Yp11.2-q12(chrY:2133003-56884424)x0	AMELY|DAZ1|CD99|PRKY|RBMY1A1|RPS4Y1|SRY|TSPY1|UTY|ZFY|KDM5D|USP9Y|DDX3Y|PRY|XKRY|BPY2|VCY|CDY1|EIF1AY|TMSB4Y|ZBED1|CDY2A|NLGN4Y|TTTY1|DAZ3|DAZ2|DAZ4|TTTY2|TSPY2|TTTY15|PCDH11Y|TTTY5|TTTY9A|TTTY11|TTTY12|TTTY13|TTTY14|GOLGA2P2Y|TTTY6|TTTY8|HSFY1|TGIF2LY|TBL1Y|CSPG4P1Y|TTTY3|TTTY4|RPS4Y2|HSFY2|RBMY1F|CDY2B|DHRSX|TTTY10|TTTY7|TXLNGY|TTTY16|TTTY17A|TTTY18|TTTY20|TTTY19|TTTY21|TTTY22|TTTY23|CDY1B|FAM41AY1|VCY1B|XKRY2|RBMY1B|RBMY1D|RBMY1E|RBMY1J|FAM224B|FAM224A|TTTY9B|TTTY6B|PRY2|BPY2B|BPY2C|TTTY3B|TTTY4B|TTTY4C|TTTY17B|TTTY17C|TSPY3|TSPY4|TSPY8|TTTY21B|TTTY1B|TTTY2B|TTTY8B|TTTY7B|TTTY23B|TTTY13B|TSPY10|FAM197Y5P|FAM41AY2|LINC00102|PRORY|LINC00278|LINC00279|LINC00280|NLGN4Y-AS1|LOC101929148|MIR6089	See cases		Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	Y	2133003 - 56884424	GRCh38	150476	160227
m.1555A>G	MT-RNR1	Aminoglycoside-induced deafness|Deafness, nonsyndromic sensorineural, mitochondrial|Cardiomyopathy, restrictive|not provided|aminoglycoside antibacterials response - Toxicity/ADR		drug response	reviewed by expert panel	MT	1555	GRCh38	9628	24667
m.1624C>T	MT-TV	Leigh syndrome|Neonatal death		Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	MT	1624	GRCh38	9549	24588
m.3303C>T	MT-TL1	Cardiomyopathy with or without skeletal myopathy		Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	MT	3303	GRCh38	9592	24631
NC_012920.1:m.3548T>C	MT-ND1	not specified		Uncertain significance(Last reviewed: Mar 18, 2014)	no assertion criteria provided	MT	3548	GRCh38	235006	236826
m.4269A>G	MT-TI	Cardiomyopathy, fatal		Pathogenic(Last reviewed: Jul 15, 1992)	no assertion criteria provided	MT	4269	GRCh38	9602	24641
m.4295A>G	MT-TI	Deafness, nonsyndromic sensorineural, mitochondrial|Primary familial hypertrophic cardiomyopathy|not specified|not provided		Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2015)	criteria provided, conflicting interpretations	MT	4295	GRCh38	9603	24642
m.4300A>G	MT-TI	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: May 21, 2003)	no assertion criteria provided	MT	4300	GRCh38	9606	24645
m.5132_5133delAA	MT-ND2	Mitochondrial complex I deficiency		Pathogenic(Last reviewed: Aug 22, 2002)	no assertion criteria provided	MT	5132 - 5133	GRCh38	9719	24758
m.5703G>A	MT-TN	Ophthalmoplegia, isolated		Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	MT	5703	GRCh38	9620	24659
m.5814T>C	MT-TC	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke		Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	MT	5814	GRCh38	30001	38956
m.7587T>C	MT-CO2	Cytochrome-c oxidase deficiency		Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	MT	7587	GRCh38	9658	24697
m.8529G>A	MT-ATP6|MT-ATP8	Cardiomyopathy, apical hypertrophic, and neuropathy		Pathogenic(Last reviewed: Nov 2, 2016)	no assertion criteria provided	MT	8529	GRCh38	9639	24678
m.9997T>C	MT-TG	Primary familial hypertrophic cardiomyopathy		Pathogenic(Last reviewed: Sep 1, 1994)	no assertion criteria provided	MT	9997	GRCh38	9611	24650
m.12192G>A	MT-TH	Cardiomyopathy, idiopathic dilated, mitochondrial|Cardiomyopathy, hypertrophic, mitochondrial		Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	MT	12192	GRCh38	9608	24647
m.12297T>C	MT-TL2	Cardiomyopathy, mitochondrial		Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	MT	12297	GRCh38	9588	24627
m.13513G>A	MT-ND5	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome|Leigh syndrome due to mitochondrial complex I deficiency|not provided		Pathogenic(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	MT	13513	GRCh38	9702	24741
m.14674T>C	MT-TE	Mitochondrial myopathy, infantile, transient|not provided		Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	MT	14674	GRCh38	9618	24657
m.15498G>A	MT-CYB	Infantile histiocytoid cardiomyopathy		Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	MT	15498	GRCh38	9684	24723
